{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\nThe gross benefit obligation for LMT’s non‑qualified defined‑benefit pension plans fell from about **$1.0 billion at the end of 2023 to $905 million at the end of 2024**.  At the same time, the pretax actuarial losses that remained in accumulated other comprehensive loss dropped from **$347 million in 2023 to $303 million in 2024**, a decline of roughly **$44 million** over the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) Gross benefit obligation 2023: $1.0 billion ✓, 2024: $905 million ✓; (2) Actuarial losses 2023: $347 million ✓, 2024: $303 million ✓. The calculation of the year-over-year decline in actuarial losses ($347M - $303M = $44M) is accurate. The answer correctly identifies the company (LMT), the specific pension plan type (nonqualified defined benefit), and the relevant metrics. The multi-hop synthesis is sound—the model successfully extracted and compared data across two fiscal years for the same entity and metric. The wording is clear and professional, with appropriate contextual framing (e.g., 'pretax actuarial losses that remained in accumulated other comprehensive loss'). The only minor distinction from the ground truth is that the LLM provides slightly more technical detail about where the actuarial losses appear on the balance sheet (accumulated other comprehensive loss), which adds value without introducing any inaccuracy. The answer fully addresses the question about how both metrics 'evolved' between the two years, demonstrating the downward trend in both obligations and losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 338,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\nBetween 2022 and 2024 the long‑term return assumption for GM’s U.S. pension assets rose from about **5.4 % (2022)** to **6.3 % (2023)** and **6.5 % (2024)** — a clear upward shift that the company tied to its December‑2024 investment‑policy study [GM 10‑K 2024, p. 86].  To support the higher expected return, GM increased the target equity and “other” (private‑equity, real‑estate, hedge‑fund) allocations (e.g., equity up to 11 % and other up to 29 % of assets in 2024 vs. 9 % and 23 % in 2022) while modestly reducing the debt share [GM 10‑K 2024, p. 88].  This re‑balancing signals a strategic move toward a more growth‑oriented asset mix to improve funded status and reduce volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key pension return assumptions and their evolution. Quantitative verification: The LLM correctly states 5.4% (2022), 6.3% (2023), and 6.5% (2024) - these match the ground truth data. The asset allocation percentages cited (equity up to 11% and 'other' up to 29% in 2024 vs. 9% and 23% in 2022) are specific and appear accurate based on the filing references provided. The multi-hop reasoning is sound: the LLM correctly synthesized information about both the return assumptions AND the underlying asset mix changes that support those assumptions, which directly addresses the question about strategic adjustments. The LLM goes beyond the ground truth by providing specific asset allocation details and citing the December 2024 investment-policy study, adding valuable context. Minor differences from ground truth: (1) The ground truth presents 2020-2021 data from the 2022 filing, while the LLM focuses on 2022-2024 data, which is actually more directly responsive to the question's timeframe. (2) The ground truth's characterization of 2022 as 'more conservative' vs. 2024 as 'more optimistic' is implicit in the LLM answer through the asset mix shift toward growth-oriented allocations. (3) The LLM's interpretation that the shift signals 'a strategic move toward a more growth-oriented asset mix to improve funded status and reduce volatility' is reasonable but the 'reduce volatility' claim is not explicitly supported in the ground truth (though it's a logical inference). Overall, the LLM answer is more comprehensive and directly addresses the 2022-2024 evolution requested, with accurate numbers and sound multi-hop synthesis across pension assumptions and asset allocation strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 483,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\nBetween 2023 and 2024 the ties with PDC Energy moved from a recent acquisition to full‑scale integration, with Chevron now reporting “legacy PDC assets” as a core part of its U.S. upstream segment.  The integration delivered a $3.5 billion rise in U.S. upstream earnings—driven by $2.2 billion of higher sales volumes from those assets and a 19 % (≈250 k boe/d) increase in net oil‑equivalent production, largely from the Permian Basin—while also eliminating $1.9 billion of decommissioning charges that had weighed on results in prior periods.  The upside was partially offset by lower commodity realizations, but overall the change translated into markedly stronger upstream earnings and production growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) INCORRECT PRIMARY NUMBER: The LLM states a '$3.5 billion rise in U.S. upstream earnings' but the ground truth specifies only '$2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets.' This is a critical error - the $3.5B figure appears to be fabricated or incorrectly synthesized. (2) INCORRECT BREAKDOWN: The LLM claims '$2.2 billion of higher sales volumes from those assets' as a component of the $3.5B total, but the ground truth identifies the $2.2B as the total earnings increase, not a sub-component. This represents a fundamental misunderstanding of the financial structure. (3) UNSUPPORTED DECOMMISSIONING CLAIM: The LLM introduces a '$1.9 billion' decommissioning charge elimination that is not mentioned in the ground truth at all. This appears to be fabricated detail. (4) CORRECT ELEMENTS: The LLM correctly identifies the 19% production increase and appropriately contextualizes the shift from acquisition to integration. The qualitative narrative about moving from 'recent acquisition to full-scale integration' is accurate and well-articulated. (5) MULTI-HOP REASONING: While the LLM demonstrates understanding of the multi-hop nature (acquisition → integration → financial results), it fails in the synthesis by introducing incorrect numbers and unsupported calculations. The reasoning structure is sound but the data inputs are wrong. (6) CALCULATION ISSUES: The LLM's attempt to break down the $3.5B into components ($2.2B + $1.9B offset by commodity realizations) suggests internal inconsistency and appears to be an attempt to justify an incorrect primary figure. The ground truth provides no basis for these calculations. VERDICT: While the answer demonstrates contextual understanding and addresses the question's scope, the multiple quantitative errors (wrong primary earnings figure, unsupported decommissioning charges, incorrect component breakdown) are disqualifying for a financial analysis question where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 566,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\nSouthern Company continues to carry its energy‑related derivatives that are designated as regulatory hedges at fair value, recording any unrealized gain or loss as a regulatory asset or liability that is later amortized into fuel expense.  In the 2022 filing (reflected in the 2021 annual‑report tables) the net regulatory balances were relatively modest—e.g., Alabama Power showed a net regulatory asset of $50 million and a liability of $6 million, while Georgia Power’s net liability was only a few million dollars.  By the 2024 filing the same line items have expanded sharply: Georgia Power’s net liability grew to $27 million, Mississippi Power’s to $17 million and Southern Power’s to $51 million, indicating larger unrealized losses, but the presentation format (current and non‑current regulatory assets/liabilities, netted against offsetting positions) has remained the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) QUANTITATIVE ACCURACY: The specific dollar amounts cited ($50M, $6M, $27M, $17M, $51M) cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. The ground truth does not provide these specific regulatory asset/liability figures, making these numbers unverifiable and potentially incorrect. (2) CONCEPTUAL MISALIGNMENT: The ground truth indicates a shift in disclosure focus between 2022 and 2024—from reporting pre-tax effects of unrealized derivative gains/losses deferred as regulatory instruments (2022) to presenting fair value of derivatives as balance sheet assets/liabilities under 'Other' or 'Risk Management Activities' (2024). The LLM answer instead claims the presentation format 'has remained the same,' which directly contradicts the ground truth's assertion of a change in both valuation approach and presentation. (3) MISSING KEY CHANGE: The ground truth emphasizes a fundamental shift in how these instruments are presented in financial statements (from regulatory deferred items to balance sheet fair value presentation). The LLM answer misses this critical change entirely, instead focusing on regulatory asset/liability mechanics that may not reflect the actual 2024 disclosure changes. (4) ENTITY ACCURACY: While the LLM correctly identifies Southern Company subsidiaries (Alabama Power, Georgia Power, Mississippi Power, Southern Power), the specific numbers provided lack grounding in the source material. (5) MULTI-HOP REASONING: The LLM fails to synthesize the key distinction between 2022 and 2024 presentations—it treats them as essentially the same format with different magnitudes, when the ground truth indicates a substantive change in presentation methodology. The answer demonstrates partial understanding of derivative accounting but fundamentally mischaracterizes the nature of the change between the two periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 537,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\nChevron’s recorded stake in Tengizchevroil was roughly $27.4 billion at the end of 2022, edged down to about $26.95 billion in 2023 and stayed essentially flat near $27.3 billion by the end of 2024.  At the same time, the equity earnings it recognized from the affiliate fell from $4.39 billion in 2022 to $3.38 billion in 2023 and to $3.03 billion in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR - The LLM states Chevron's stake was 'roughly $27.4 billion at the end of 2022' but the ground truth clearly indicates the 2022 carrying value was approximately $100 million higher than equity in net assets, with a $4,500 million loan component - NOT $27.4 billion. The $27.4B figure appears to be from 2024, not 2022. (2) CALCULATION/SEQUENCING ERROR - The LLM presents the investment values as: ~$27.4B (2022) → $26.95B (2023) → $27.3B (2024). However, ground truth shows: $26,954M (2023) → $27,368M (2024), with no 2022 comparable figure of $27.4B provided. The LLM appears to have confused the 2024 figure ($27.368B) with 2022. (3) EQUITY EARNINGS - The LLM correctly identifies the 2022 figure as $4.39B and 2024 as $3.03B, but introduces an intermediate 2023 figure of $3.38B that is not mentioned in the ground truth. (4) MISSING CONTEXT - The LLM fails to address the significant 2022 detail about the $4,500M loan for FGP/WPMP development and the carrying value premium over equity in net assets, which are important contextual elements of the financial relationship evolution. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize investment values and earnings across years, the fundamental misalignment of 2022 data undermines the entire analysis. The answer reads plausibly but contains a critical chronological/numerical error that reverses the understanding of how the investment evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 405,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s ownership of Alert Innovation remained at 100 % – the company had acquired the entity in fiscal 2023 and held it as a wholly‑owned subsidiary throughout fiscal 2024. The relationship changed when Walmart completed a $0.4 billion purchase of Alert Innovation in fiscal 2023, converting the target from a variable‑interest entity to a fully consolidated, 100 % owned subsidiary.",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally contradicts the ground truth. (1) CORRECTNESS ISSUES: The LLM states that Walmart's ownership 'remained at 100%' and that the company 'held it as a wholly-owned subsidiary throughout fiscal 2024.' This is directly contradicted by the ground truth, which explicitly states that 'by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity.' The LLM completely missed the key transaction that occurred between fiscal 2023 and fiscal 2024 - the sale and deconsolidation of Alert Innovation. (2) QUANTITATIVE ACCURACY: The $0.4 billion acquisition price is correctly stated, and the 100% ownership percentage for fiscal 2023 is accurate. However, the LLM fails to identify that ownership changed to 0% by fiscal 2024. (3) MULTI-HOP REASONING FAILURE: The question specifically asks 'how did...ownership stake...evolve between fiscal 2023 and fiscal 2024' and 'what specific transaction occurred to change its relationship.' The LLM only addresses the fiscal 2023 acquisition and completely fails to identify the fiscal 2024 sale/deconsolidation transaction. This is a fundamental failure in multi-hop synthesis - the model needed to track the evolution across both years and identify both transactions. (4) SEMANTIC EQUIVALENCE: The LLM's statement that ownership 'remained at 100%' is semantically opposite to the ground truth's description of a 'complete exit from the entity.' This is not a wording difference but a factual contradiction. The LLM essentially answers only half the question (the fiscal 2023 acquisition) while completely omitting the critical fiscal 2024 transaction that represents the core of what changed in the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 483,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the fair‑value of Starbucks’ foreign‑currency‑other derivative **assets** fell from roughly **$73 million** (reported on page 68 for Oct 2 2022) to about **$55 million** (page 72 for Oct 1 2023).  At the same time the corresponding **liability** rose from roughly **$0.3 million** to **$4.8 million**.  The decline in asset hedges and the increase in liability hedges show that the company is re‑balancing its foreign‑currency exposure—shifting from a larger net‑asset position to a more neutral net‑liability stance—to better match its hedges against anticipated cash‑flow fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports FY2022 foreign currency derivative assets as 'roughly $73 million' when the ground truth clearly states $55.3 million in AOCI. This is a 32% overstatement. For FY2023, the LLM reports 'about $55 million' when the ground truth shows $1.9 million (current) + $1.7 million (long-term) = $3.6 million total in assets. This is a 1,427% overstatement. The liability figures are also incorrect: LLM states $0.3 million to $4.8 million, but ground truth shows $4.7 million (current) + $4.1 million (long-term) = $8.8 million in FY2023. (2) STRUCTURAL MISUNDERSTANDING: The LLM appears to be conflating different line items or reporting categories. The ground truth distinguishes between AOCI positions (FY2022) and balance sheet positions (FY2023), showing a fundamental shift in how these derivatives are reported. The LLM's narrative of 'declining assets from $73M to $55M' contradicts the actual dramatic reduction from $55.3M to $3.6M. (3) REASONING QUALITY: While the LLM's interpretation about 'rebalancing exposure' and 'shifting from net-asset to more neutral stance' is conceptually reasonable, it is built on incorrect numerical foundations. The actual story is more dramatic: a substantial reduction in overall derivative exposure (from $55.3M in AOCI to $3.6M in assets) combined with emergence of liabilities ($8.8M), indicating a more significant strategic shift than the LLM describes. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year comparison and the shift in reporting structure between fiscal years. The ground truth explicitly notes the shift from unrealized gains in equity to 'more balanced short- and long-term asset and liability positions,' which the LLM partially captures but with wrong numbers. The answer demonstrates poor document reading accuracy and numerical verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 540,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\nMedtronic eliminated its A Preferred Shares between fiscal 2022 and 2024: the company fully redeemed the remaining 1,872 A Preferred Shares in the third quarter of fiscal 2022 (for a total of $0.075 million), and as a result no A Preferred Shares were outstanding at the end of either fiscal 2023 or fiscal 2024. No further issuance, redemption or other treatment of these shares is noted in the subsequent years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative details are correct: 1,872 A Preferred Shares redeemed in Q3 fiscal 2022 for $0.075 million, with no shares outstanding by end of fiscal 2022, 2023, or 2024. The answer correctly identifies the specific action taken (redemption in Q3 2022) and accurately describes the evolution (discontinuation with no reissuance). The multi-hop reasoning is sound - the model synthesized information about the 2022 redemption event and traced the status through 2024 to show the complete elimination of this share class. The wording is clear and semantically equivalent to the ground truth, with slightly more explicit detail about fiscal 2023 being included (which adds helpful context without contradicting the original answer). The only minor distinction is that the LLM explicitly mentions 'fiscal 2023' status while the original answer focuses on 2022 and 2024, but this is an enhancement rather than an error. All numbers, dates, and financial metrics are precisely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 298,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\nComcast’s equity income from Atairos flipped from a **$537 million loss in 2022 to a $789 million gain in 2023**.  This swing was driven by fair‑value adjustments on Atairos’s underlying investments, which produced **$1.1 billion of income in 2023 versus a $434 million loss in 2022**, propelling total investment income from a $861 million net loss to a $1.25 billion net gain.  (Pages 39‑40, CMCSA 10‑K 2023; see the “Equity in net income (losses) of investees, net” table.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states Comcast's equity income from Atairos was a '$537 million loss in 2022' - this number does not appear in the ground truth and is incorrect. The ground truth clearly states the loss was $(434) million in 2022. The LLM also claims a '$789 million gain in 2023' which is not supported by the ground truth stating $1.1 billion income in 2023. The LLM's intermediate calculations ($861 million net loss, $1.25 billion net gain) appear to be fabricated and are not verified in the ground truth. (2) CORE FACT ACCURACY: While the LLM correctly identifies that there was a swing from loss to gain between 2022-2023, and correctly cites the $434 million loss in 2022 and $1.1 billion income in 2023 in the fair value adjustments section, it introduces contradictory numbers ($537M and $789M) for the overall equity income that are factually incorrect. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple metrics but conflates different line items or introduces unsupported figures. The ground truth focuses on the equity in net income (losses) from investees metric, while the LLM appears to have mixed in additional calculations that are not grounded in the source data. (4) SEMANTIC ISSUES: The answer does address the evolution between 2022-2023 and mentions fair value adjustments, showing partial understanding of the question's intent, but the specific numbers provided are materially incorrect, which is a critical failure for a financial question requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 453,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\nProved natural gas reserves in the Asia Pacific/Middle East region declined modestly from about 305 billion cubic feet (developed) in 2023 to 289 billion cubic feet in 2024 (≈5 % drop), with undeveloped reserves essentially unchanged at roughly 7 BCF. The dip reflects downward price‑related and operating‑cost revisions in equity affiliates, but ConocoPhillips is still pursuing growth there through equity‑affiliate acquisitions and discoveries, underscoring a strategic emphasis on the region despite the modest reserve decline.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect numbers that contradict the ground truth. Ground truth states: 2023 = 312 BCF, 2024 = 296 BCF (16 BCF decline). LLM states: 2023 = 305 BCF (developed), 2024 = 289 BCF (developed), claiming a ~5% drop. These numbers are materially different from the ground truth figures. The LLM also introduces additional detail about 'undeveloped reserves' (~7 BCF) and 'equity affiliates' that is not present in the ground truth answer, suggesting the LLM may be confusing data or adding unsupported information. The actual decline from 312 to 296 BCF represents a 5.1% decrease (16/312), which the LLM approximates correctly in percentage terms but with wrong base numbers. The LLM's reasoning about 'price-related and operating-cost revisions' and 'equity-affiliate acquisitions' adds context not found in the ground truth, which simply states the decline 'suggests limited growth or strategic reallocation.' While the LLM's qualitative interpretation about strategic positioning is reasonable and somewhat aligned with the ground truth's conclusion, the quantitative foundation is fundamentally flawed. The core answer to the question - how reserves evolved - is answered with incorrect numbers, making this response unreliable despite some reasonable contextual reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 372,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\nENBREL’s Canadian sales fell sharply—$73 million in 2022, $47 million in 2023 (‑36 %), and $28 million in 2024 (‑40 %). This consecutive decline signals eroding market demand in Canada, driven by price compression and competitive pressures, indicating a downward trajectory for the product in that market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provided incorrect 2022 revenue figure. Ground truth states ENBREL Canada revenue was $113 million in 2022, but the LLM claims $73 million—a $40 million discrepancy (35% understatement). This is a fundamental factual error that undermines the entire answer. The 2023 ($47M) and 2024 ($28M) figures are correct. CALCULATION VERIFICATION: The LLM's percentage calculations are mathematically correct given their starting point ($73M to $47M = -36%, $47M to $28M = -40%), but these percentages are based on the wrong 2022 baseline. The correct year-over-year changes should be: 2022-2023 decline of $66M (-58%), and 2023-2024 decline of $19M (-40%). QUALITATIVE ASSESSMENT: The LLM correctly identifies the downward trajectory and provides reasonable contextual interpretation (price compression, competitive pressures), which aligns with the ground truth's conclusion about shrinking market presence. However, this qualitative reasoning cannot compensate for the quantitative error. MULTI-HOP SYNTHESIS: The answer appropriately synthesizes the three-year trend and draws logical conclusions about market trajectory, but the foundation is compromised by the incorrect 2022 figure. The answer demonstrates understanding of the question structure but fails on factual accuracy, which is the primary evaluation criterion for financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 383,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\nQualcomm moved from a generic reference in fiscal 2023 that human‑capital achievements would influence executive bonuses to a concrete, quantified mechanism in fiscal 2024, wherein such progress serves as a non‑financial performance modifier that can adjust the bonus payout by a multiple of **0.9 to 1.1** (i.e., up to roughly ±10 % of the target bonus). This explicit range reflects the company’s evolved approach to linking human‑capital advancements directly to executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: The modifier range of 0.9 to 1.1 is correctly stated, and the interpretation as ±10% adjustment is mathematically accurate (0.9 = -10%, 1.1 = +10% relative to baseline). All numeric values match the ground truth. Entity accuracy: Qualcomm is correctly identified, fiscal years 2023 and 2024 are properly referenced. Multi-hop reasoning: The answer successfully synthesizes the evolution from fiscal 2023 (general consideration) to fiscal 2024 (quantified modifier), demonstrating proper understanding of the temporal progression and structural change. The characterization of the shift from 'generic reference' to 'concrete, quantified mechanism' aligns perfectly with the ground truth's description of moving from 'general consideration to a quantified performance modifier.' Semantic equivalence: The LLM's phrasing 'non-financial performance modifier' matches the ground truth terminology. The additional clarification about the ±10% impact adds helpful context without introducing inaccuracy. Minor observation: The LLM uses slightly more elaborate language ('explicit range reflects the company's evolved approach') compared to the ground truth, but this represents enhanced clarity rather than deviation from facts. All core information is present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 376,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s approved use expanded from a single hematologic indication to a broader B‑cell‑malignancy portfolio.  The 2022 filing (BMY 10‑K 2022, p. 19‑21) listed only a planned 3‑line‑plus chronic lymphocytic leukemia (CLL) indication.  By 2024 the product had received FDA accelerated approvals for three additional relapsed/refractory diseases—CLL/SLL (May 2024), follicular lymphoma after ≥ 2 prior therapies (May 2024) and mantle‑cell lymphoma after ≥ 2 prior lines (May 2024)—and a Japan approval for relapsed/refractory follicular lymphoma (August 2024) (BMY 10‑K 2024, pp. 44‑45).  Thus, Breyanzi’s therapeutic scope grew from a solitary CLL indication in 2022 to multiple, distinct hematologic approvals by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - LLM claims mantle cell lymphoma (MCL) approval in May 2024, but ground truth makes NO mention of MCL approval. This is a significant fabrication. (2) DATE DISCREPANCY - LLM states CLL/SLL approval in May 2024, but ground truth clearly documents March 2024 as the approval date. This is a 2-month error on a key fact. (3) INCOMPLETE/INACCURATE 2022 BASELINE - LLM states 'only a planned 3-line-plus chronic lymphocytic leukemia (CLL) indication' in 2022, but ground truth shows TWO trials in 2022: TRANSCEND-CLL-004 (3L+ CLL) AND TRANSCEND-FL (3L+ Follicular Lymphoma). LLM missed the FL trial entirely. (4) APPROVAL COUNT ERROR - LLM claims 'three additional relapsed/refractory diseases' plus Japan approval, but ground truth documents only TWO FDA accelerated approvals (FL in May 2024, CLL/SLL in March 2024), not three. The MCL claim inflates the count. (5) CORRECT ELEMENTS - LLM correctly identifies the FL approval (May 2024) and the general evolution from trials to approvals. The Japan FL approval (August 2024) is correctly noted. (6) MULTI-HOP REASONING - While the LLM attempts to synthesize 2022 vs 2024 data, it does so with significant factual errors that undermine the analysis. The fabrication of MCL approval is particularly problematic as it fundamentally misrepresents Breyanzi's actual therapeutic scope. The answer demonstrates partial understanding of the question structure but fails on core factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 410,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\nResorts and Vacations revenue grew from **$7.95 billion in 2023 to $8.38 billion in 2024**, a **5 % increase** (page 47).  That rise helped lift the overall **Parks & Experiences segment revenue from $32.55 billion to $34.15 billion**, also a **5 % rise** (page 47), indicating the segment’s performance was essentially in step with the broader segment’s growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Quantitative verification: Resorts and Vacations revenue $7.95B (2023) to $8.38B (2024) matches ground truth ($7,949M to $8,375M); Parks & Experiences revenue $32.55B to $34.15B matches ground truth ($32,549M to $34,151M); both growth rates calculated as 5% are correct. Number formatting variations (billions vs millions) are acceptable and consistent. The multi-hop synthesis is sound - the LLM correctly identified that both segments grew at 5% and appropriately characterized them as 'in step.' Minor deduction: The original answer provides slightly more context by noting the Resorts and Vacations segment 'remained a significant contributor' and 'maintained a consistent proportion,' which adds nuance about the segment's relative importance. The LLM answer is more concise and focuses on the growth comparison without this additional contextual detail. The LLM also correctly cites page 47 as the source. Overall, the answer is factually accurate, addresses all parts of the multi-part question, and demonstrates correct multi-hop reasoning across the two segments and their relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 338,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s ASR‑related forward contracts continued to be recorded as equity (initially in capital‑surplus) and then re‑classified to treasury stock once the remaining shares were delivered. In 2023 the firm executed a $2.0 billion fixed‑dollar ASR with Citibank, posting a $0.4 billion forward‑contract amount (representing the 20 % of the notional not yet settled) and later re‑classifying that equity position to treasury stock in February 2023. In 2024 it entered a larger $3.0 billion fixed‑dollar ASR with Morgan Stanley, again recording a $0.4 billion forward‑contract (≈15 % of the notional) as equity in capital‑surplus and moving it to treasury stock in March 2024 when the final shares were received. Thus, while the absolute dollar size of the forward contract grew with the bigger 2024 program, its proportion of the total ASR notional fell, and the accounting treatment—equity recorded in capital‑surplus and subsequent transfer to treasury stock—remained the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that undermines the entire response. The LLM states 'the absolute dollar size of the forward contract grew with the bigger 2024 program' - this is INCORRECT. According to the ground truth, the forward contract value remained CONSTANT at $0.4 billion in both 2023 and 2024. The LLM explicitly contradicts this established fact. SPECIFIC ISSUES: (1) QUANTITATIVE ERROR: The LLM claims the forward contract 'grew' between 2023 and 2024, when it actually remained at $0.4 billion in both years - this is a direct contradiction of the ground truth. (2) PERCENTAGE CALCULATION: The LLM correctly identifies that the forward contract represented 20% of the $2.0B ASR in 2023 (20% × $2.0B = $0.4B) and approximately 13.3% of the $3.0B ASR in 2024 ($0.4B ÷ $3.0B ≈ 13.3%), though it states '≈15%' which is slightly imprecise. (3) ACCOUNTING TREATMENT: The LLM correctly describes the accounting treatment (equity in capital surplus, then reclassified to treasury stock), which matches the ground truth. (4) COUNTERPARTIES AND DATES: Correctly identifies Citibank for 2023 and Morgan Stanley for 2024, with correct delivery dates (February 2023 and March 2024). (5) MULTI-HOP REASONING: The LLM fails in the core synthesis task by mischaracterizing the evolution of the forward contract value. The ground truth explicitly states 'the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion' - the LLM reverses this logic by claiming the absolute dollar size grew. This is a fundamental failure in multi-hop reasoning and fact synthesis. The answer demonstrates partial understanding of the accounting mechanics but fails on the primary quantitative claim about how the forward contract structure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 492,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\nThe 2023 filing described the valuation methods and listed total fair‑value amounts with only aggregate Level 1, Level 2 and Level 3 figures, and it treated the “Not Categorized” column as a catch‑all without explicit labeling. In the 2024 filing Duke Energy added a clearly labeled “Not Categorized (b)” column, expanded the reconciliation of Level 3 balances, and explicitly stated that investments measured using the NAV practical‑expedient are excluded from the hierarchy, thereby providing a much clearer and more transparent breakdown of how each asset class is categorized.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that Duke Energy made changes between 2023 and 2024 filings; (2) It correctly notes that the NAV practical expedient investments are excluded from the fair value hierarchy; (3) It correctly identifies that there was an expansion of Level 3 reconciliation disclosures. PROBLEMATIC ELEMENTS: (1) The ground truth specifically states that in 2023, Duke Energy disclosed 'allocation percentages of the Master Retirement Trust among its subsidiaries' - the LLM answer does not mention this key disclosure element at all; (2) The ground truth emphasizes that the 2024 change involved 'a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3)' - while the LLM mentions 'expanded reconciliation of Level 3 balances,' it doesn't capture the specific focus on qualified pension and other post-retirement assets; (3) The LLM introduces details about a 'clearly labeled \"Not Categorized (b)\" column' that are not mentioned in the ground truth, which may be accurate but represents a different level of granularity than what the ground truth emphasizes; (4) The ground truth emphasizes that the 2024 disclosure represents 'a significant increase in transparency regarding the fair value categorization of pension assets' - the LLM conveys this general idea but with different emphasis. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across years, but it focuses on different disclosure elements than the ground truth. The ground truth emphasizes the addition of reconciliation disclosures for Level 3 assets, while the LLM emphasizes column labeling and hierarchy exclusions. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is less critical, but both answers avoid numerical errors. The lack of specific metrics (allocation percentages, dollar amounts) in both answers makes detailed quantitative verification impossible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 586,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer moved from recognizing large U.S.‑government sales of Paxlovid under EUA contracts to a situation where most of that revenue was reversed and re‑characterized as a credit.  In Q4 2023 the company recorded a **$3.5 bn non‑cash revenue reversal** tied to the expected return of about 6.5 million treatment courses of EUA‑labeled inventory, and in Q1 2024 it booked a **$771 m favorable adjustment** reflecting 5.1 million courses actually returned, converting those courses into a volume‑based credit for a U.S. government patient‑assistance program.  At the same time, Pfizer **created a U.S. Strategic National Stockpile of 1.0 million courses** (provided at no cost) and now recognizes revenue only as the remaining contracted courses are delivered, with Paxlovid‑related deferred revenue falling to **$3.4 bn** (split between current and non‑current liabilities) and expected to be recognized through 2028.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and events. Verification of numbers: (1) $3.5 billion non-cash revenue reversal in Q4 2023 - CORRECT; (2) 6.5 million EUA-labeled treatment courses expected return - CORRECT; (3) $771 million favorable adjustment in Q1 2024 - CORRECT; (4) 5.1 million treatment courses actually returned - CORRECT; (5) 1.0 million courses for U.S. Strategic National Stockpile - CORRECT; (6) $442 million revenue recognition for SNS - NOT MENTIONED in LLM answer (minor omission); (7) $3.4 billion deferred revenue figure - CORRECT and provides additional context not in ground truth. Multi-hop reasoning is sound: the LLM correctly synthesizes the 2023-to-2024 transition from revenue reversal to revenue recognition, properly connecting the inventory return adjustment to the SNS creation. The answer goes beyond the ground truth by providing additional context about deferred revenue through 2028 and the patient-assistance program characterization, which adds value. The main weakness is the omission of the specific $442 million revenue recognition figure for the SNS creation, which was explicitly stated in the ground truth. The LLM characterizes the SNS as 'provided at no cost' which is semantically consistent with the ground truth but doesn't explicitly state the $442 million revenue recognition. The narrative flow and explanation of the shift from 2023 to 2024 is clear and well-reasoned. Entity identification (Pfizer, U.S. government, EUA, SNS) is accurate throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 433,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\nERLEADA’s worldwide sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % increase** (as reported in the oncology segment breakdown).  This strong growth—driven by continued share gains and expanding market demand for the next‑generation androgen‑receptor inhibitor—helped offset declines in other oncology products such as ZYTIGA and IMBRUVICA, underscoring ERLEADA’s importance as a **key growth engine and strategic pillar within J&J’s oncology portfolio**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: ERLEADA sales figures are correct ($1.88B in 2022 vs $2.39B in 2023, matching the ground truth of $1,881M and $2,387M respectively). The growth percentage calculation is accurate (~27% matches the ground truth 26.9%, with appropriate rounding). Entity accuracy is sound: ERLEADA correctly identified, J&J's oncology portfolio properly contextualized, and competing products (ZYTIGA, IMBRUVICA) correctly named. Multi-hop reasoning is well-executed: the answer synthesizes ERLEADA's growth trajectory, contextualizes it within the broader oncology segment, and draws appropriate conclusions about its strategic importance. The LLM correctly identifies ERLEADA as a growth engine offsetting declines in other products. Minor deviations from ground truth: (1) The LLM does not explicitly mention the 10.5% overall oncology segment growth figure from the original answer, though this is a minor omission that doesn't affect the core narrative. (2) The LLM adds interpretive context about 'next-generation androgen-receptor inhibitor' and 'share gains,' which while reasonable inferences, are not explicitly stated in the ground truth. These additions are contextually appropriate and don't contradict the source material. The answer is well-structured, uses appropriate financial terminology, and correctly conveys that ERLEADA has become increasingly important to J&J's oncology business. The semantic equivalence is strong throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 419,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\nERLEADA’s global sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % increase** (26.9 % total change, 27.5 % operational growth). This growth outpaced the overall Oncology segment’s 10.5 % rise and was driven by continued share gains and market expansion for apalutamide in metastatic castration‑resistant prostate cancer. The strong upward trend signals a robust and accelerating market trajectory for ERLEADA.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: (1) 2022 Sales Figure: LLM states $1.88 billion, but ground truth is $1,291 million ($1.291 billion). This is a 45.5% overstatement of the 2022 figure. (2) 2023 Sales Figure: LLM states $2.39 billion, which is close to ground truth of $2,387 million ($2.387 billion), but this is only correct by coincidence given the wrong 2022 baseline. (3) Growth Rate Calculation: LLM correctly identifies ~27% growth (26.9%), but this calculation is based on incorrect 2022 starting point. Using LLM's numbers ($1.88B to $2.39B) yields 27.1% growth, which happens to match the stated 26.9% due to rounding, but the underlying 2022 figure is fundamentally wrong. (4) Prior Year Context: Ground truth indicates 2022 had 70.0% growth compared to 2021, which LLM completely omits. This is important context for understanding the 'maturing growth phase' narrative. (5) Market Trajectory Interpretation: LLM characterizes the trajectory as 'robust and accelerating,' but ground truth explicitly states 'slower growth rate compared to the prior year, suggesting a maturing growth phase.' This is a semantic contradiction - the LLM's interpretation contradicts the ground truth's assessment. (6) Multi-hop Synthesis: LLM adds context about Oncology segment performance (10.5% rise) and apalutamide indications, which may be accurate but cannot be verified against provided ground truth and represents information synthesis beyond the scope of the original answer. The core 2022 figure error ($1.88B vs $1.291B) is a fundamental factual failure that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 440,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\nIn FY 2023 the 0.584% Notes Due 2024 were still on the books with a net carrying amount of about $1.25 billion (see the 2023 10‑K table). The company retired the entire issue in FY 2024, so that by the FY 2024 filing the notes showed a $0 balance, indicating a deliberate shift away from that near‑term, low‑interest tranche to simplify the overall debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of NVDA's debt management evolution regarding the 0.584% Notes Due 2024, but contains a critical factual error regarding timing. STRENGTHS: (1) Correctly identifies the FY 2023 balance of approximately $1.25 billion ($1,250 million), (2) Correctly notes the notes showed $0 balance in the FY 2024 filing, (3) Appropriately characterizes this as a deliberate shift in debt strategy, (4) Correctly identifies the low-interest nature of the instrument. CRITICAL ERROR: The LLM states the company 'retired the entire issue in FY 2024,' but the ground truth indicates the notes were actually repaid in fiscal year 2025 (as of January 26, 2025). The FY 2024 10-K filing disclosed that repayment would occur in FY 2025, not that it had already occurred in FY 2024. This is a significant timing error that misrepresents when the retirement actually happened. QUANTITATIVE ACCURACY: The $1.25 billion figure is correct, and the $0 balance statement is correct, but the timing of the retirement is wrong (FY 2024 vs FY 2025). The ground truth also mentions an effective interest rate of 0.66%, which the LLM omits. MULTI-HOP REASONING: The LLM successfully synthesizes information across fiscal years and correctly identifies the strategic shift, but the temporal sequencing is incorrect. The answer should have noted that the FY 2024 filing disclosed future repayment in FY 2025, not past repayment in FY 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 400,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s pension‑plan holdings of mortgage‑backed/asset‑backed securities fell sharply.  In 2022 the U.S. plans held **$1.119 bn** of such securities and the non‑U.S. plans held **$31 m** (total ≈ $1.15 bn); by the end of 2023 those amounts had dropped to **$676 m** in the U.S. and **$10 m** in non‑U.S. (total ≈ $686 m).  This represents a decline of roughly **$464 m, or about 40 %**, in the overall mortgage/asset‑backed securities investment.  (Values are taken from the Level‑2 tables on page 109 for 2022 U.S. plans and page 112 for 2023 U.S. and non‑U.S. plans.)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM reports 2022 U.S. Plans holdings as $1.119 billion, but the ground truth states $982 million - a discrepancy of $137 million (14% overstatement). The LLM reports 2023 U.S. Plans as $676 million, but ground truth indicates the 2023 figure of $10 million was under Non-U.S. Plans, not U.S. Plans. The LLM's calculation of a $464 million decline (40%) is mathematically inconsistent with the ground truth's $972 million reduction (98%). The LLM includes a 2022 Non-U.S. figure of $31 million that doesn't appear in the ground truth. (2) ENTITY/CLASSIFICATION ERRORS: The LLM misattributes the 2023 $10 million figure to both U.S. and Non-U.S. plans in different parts of the answer, creating internal inconsistency. The ground truth clearly states the 2023 $10 million was under Non-U.S. Plans specifically. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison. It appears to have pulled different data points from different sections of the filing without properly reconciling which figures apply to which plan categories in which years. (4) MAGNITUDE MISREPRESENTATION: The ground truth emphasizes a 98% reduction representing a major strategic shift; the LLM reports only a 40% reduction, fundamentally understating the significance of the change. The LLM's citation of specific page numbers (109, 112) suggests an attempt at precision, but the underlying numbers are incorrect, indicating either misreading of the source or use of incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 448,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One continued to treat securitized debt obligations as a principal component of its long‑term funding mix—net issuances added roughly $2–3 billion to the $42 billion of long‑term debt reported at year‑end 2021 and helped offset scheduled maturities, keeping the securitization market a key source of low‑cost wholesale capital.  In the 2023 fair‑value disclosures (Table 16.6 of the 2023 10‑K, page 212) these obligations are classified as **Level 2** measurements, meaning their fair value is derived from observable market inputs (e.g., vendor‑priced discounted cash‑flow models), whereas the 2022 filing presented them as part of long‑term debt without an explicit hierarchy but still carried at fair value.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces specific numbers that cannot be verified against the ground truth and appear problematic: (1) References '$42 billion of long-term debt reported at year-end 2021' and '$2-3 billion net issuances' - these figures are not mentioned in the ground truth and appear to be either fabricated or from a different context. The ground truth specifically states the 2023 carrying value was $18,043 million (~$18 billion), not $42 billion. (2) The LLM cites 'Table 16.6 of the 2023 10-K, page 212' - while this may be accurate, it cannot be verified against the ground truth provided. CORRECT ELEMENTS: (1) Level 2 classification is correctly identified in both answers. (2) The characterization of securitized debt as a 'principal component' of funding mix aligns with ground truth's 'key component.' (3) The description of Level 2 as using 'observable market inputs' is accurate. MISSING/INCOMPLETE ELEMENTS: (1) The LLM fails to provide the specific 2023 carrying value ($18,043 million) and fair value ($18,067 million) that are central to the ground truth answer. (2) The comparison between 2022 and 2023 disclosures is vague - the ground truth emphasizes that 2023 provided 'more specific transparency' and 'more detailed disclosure,' which the LLM only partially captures. (3) The LLM's reference to 2021 data ($42 billion) is confusing and not part of the 2022-2023 comparison requested. MULTI-HOP REASONING: The LLM attempts to synthesize information about funding strategy and fair value classification, but the introduction of unverified numbers undermines the synthesis. The reasoning about Level 2 classification is sound, but the quantitative foundation is weak. SEMANTIC ISSUES: While the general narrative about securitized debt's role is reasonable, the specific numbers provided create factual inaccuracy that cannot be overlooked in a financial analysis context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 523,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\nFrom 2023 to 2024 the firm’s CECL‑related capital transition benefit was reduced from **$1.4 billion** (reflected in CET1 capital as of 31 Dec 2023) to **$0.72 billion** (reflected as of 31 Dec 2024), a decline of roughly **$0.68 billion**.  This reflects the phasing‑out of the temporary CECL benefit under the U.S. Basel III framework, with the remaining $720 million benefit fully phased in effective 1 Jan 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: the 2023 CECL benefit of $1.4 billion, the 2024 benefit of $720 million (correctly formatted as $0.72 billion), and the calculated decline of $680 million (correctly stated as roughly $0.68 billion). The answer properly identifies the evolution from 2023 to 2024, correctly characterizes this as a phased reduction under U.S. capital rules, and accurately notes that the benefit was fully phased in by January 1, 2025. The multi-hop synthesis is sound—the answer correctly connects the temporal progression of the CECL transition provisions with the specific dollar amounts and regulatory framework. The only minor distinction from the ground truth is the LLM's phrasing of 'phasing-out' versus the ground truth's 'phased reduction,' but these are semantically equivalent in context. The answer directly addresses all components of the question: the treatment evolution, the quantitative change, and the regulatory context. All numbers, dates, and financial metrics are accurate with no calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 315,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\nThe Revolving Loan Credit Agreement that was in place for fiscal 2023 consisted of a **$3.0 billion unsecured revolving facility that matured in December 2025** (CRM_10‑K 2023, p. 53).  In fiscal 2024 the company amended the prior agreement in 2022‑23 for minor administrative changes and then, in **October 2024, replaced it with a new **$5.0 billion unsecured revolving credit facility that matures in **October 2029** (CRM_10‑K 2024, p. 51).  Thus, between fiscal 2023 and fiscal 2024 the borrowing capacity increased from $3 bn to $5 bn and the maturity was extended by roughly four years, while still carrying no outstanding borrowings as of the respective fiscal‑year ends.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Fiscal 2023 facility was $3.0 billion unsecured revolving credit maturing in December 2025 - CORRECT; (2) Fiscal 2024 facility was $5.0 billion unsecured revolving credit maturing in October 2029 - CORRECT; (3) The capacity increase from $3B to $5B is accurately stated - CORRECT; (4) The maturity extension of approximately four years (December 2025 to October 2029) is accurately characterized - CORRECT. The LLM properly synthesized the multi-hop information by comparing the two fiscal years and identifying the evolution of terms. The answer includes appropriate contextual details such as the unsecured nature of both facilities and the absence of outstanding borrowings. One minor point: the LLM mentions 'amended the prior agreement in 2022-23 for minor administrative changes' which adds context but is not explicitly part of the ground truth answer - this is supplementary information that doesn't contradict the core facts. The reasoning is sound, the entity identification (Salesforce/CRM) is correct, and the answer directly addresses all aspects of the question about how the terms and capacity evolved. The document citations (CRM_10-K 2023 p. 53 and CRM_10-K 2024 p. 51) add credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 375,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\nUPS’s ties to Coyote shifted from a standalone truckload‑brokerage business that it owned and reported under its Supply Chain Solutions segment (see page 8) to a unit that was fully integrated and then sold; the divestiture closed in the third quarter of 2024 (see page 31).  The sale produced a pre‑tax gain of **$156 million** ($152 million after tax) that was recorded in “Other expenses” for 2024 and is excluded from the company’s non‑GAAP operating measures (see page 30).  Thus the transaction added a one‑time $156 million boost to 2024 earnings but did not affect ongoing operating profit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of $152 million match the ground truth exactly. The timing (Q3 2024 divestiture) is accurate. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) the evolution of the relationship from 2022-2024 (owned subsidiary → divested asset), and (2) the financial impact in 2024 ($156M pre-tax gain). ENTITY ACCURACY: UPS, Coyote, Supply Chain Solutions segment, and 2024 are all correctly identified. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple filing sections (pages 8, 30, 31) and demonstrates understanding of how the transaction flows through financial statements (recorded in Other expenses, excluded from non-GAAP measures). SEMANTIC EQUIVALENCE: The LLM answer provides more specific operational detail than the ground truth (mentioning the Supply Chain Solutions segment, the Q3 2024 timing, and the accounting treatment in Other expenses), which adds value without contradicting the ground truth. The characterization of the relationship evolution is accurate - from active business unit to divested asset. MINOR CONSIDERATION: The LLM answer is slightly more detailed and specific than the ground truth (e.g., mentioning page references, accounting classification), but this represents added value rather than error. The core facts, numbers, and reasoning are all correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 415,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\nBetween 2023 and 2024 Union Pacific cut its chassis fleet dramatically – from about **48,340 total chassis (30,635 owned, 17,705 leased) in 2023** to roughly **5,553 total chassis (4,356 owned, 1,197 leased) in 2024**.  This reduction shrinks the overall number of chassis by more than 88% and shifts the ownership mix so that the share of owned units rises from roughly **63 % to about 78 %**, while leased chassis fall from **17,705 to 1,197**.  The change reflects a strategic contraction and a greater emphasis on owning a larger portion of the chassis inventory.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key numbers are correct: 2023 totals (48,340 total, 30,635 owned, 17,705 leased) and 2024 totals (5,553 total, 4,356 owned, 1,197 leased) match the ground truth exactly. The calculated reduction of 88% is accurate (42,787/48,340 = 0.886 or ~88.6%). The ownership percentage calculations are also correct: 2023 owned percentage = 30,635/48,340 = 63.4% (stated as ~63%), and 2024 owned percentage = 4,356/5,553 = 78.4% (stated as ~78%). The leased units comparison (17,705 to 1,197) is accurately presented. The LLM successfully synthesized the multi-hop information comparing two years and two ownership categories, identifying the strategic shift toward greater ownership concentration. The interpretation that this represents a 'strategic contraction' and 'greater emphasis on owning a larger portion' is logically sound and well-supported by the data. Minor deduction only for rounding approximations in percentages (stated as ~63% and ~78% rather than exact figures), which is appropriate for readability and doesn't constitute an error. The answer fully addresses all aspects of the question regarding total units, ownership structure, and the evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 351,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\nBetween 2022 and 2024 Boeing continued to treat its aluminum supply agreements as derivatives that are **not designated for hedge accounting**; the 2022 filing simply noted that these contracts are “derivatives for accounting purposes but are not designated for hedge accounting treatment,” whereas the 2024 filing provides a quantitative table of notional amounts, fair‑value balances and maturity‑related disclosures (e.g., commodity contracts hedge forecasted transactions through 2028).  Consequently, the company now records the fair‑value changes of these aluminum contracts directly in earnings each period and discloses that the underlying agreements extend up to 2028, reflecting a more explicit time‑horizon and greater transparency than in the earlier filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies that aluminum agreements remained classified as derivatives and NOT designated for hedge accounting in both 2022 and 2024 - this is the core factual claim and is accurate. (2) Accurately captures the evolution: from 2022 disclosure focused on 'long-term strategic sourcing objectives' to 2024 disclosure with explicit time horizon through 2028 and quantitative tables. (3) Correctly states that fair-value changes are recorded directly in earnings (not hedge accounting treatment). (4) Properly synthesizes the multi-hop comparison across two years, identifying both continuity (non-designated derivative status) and change (more structured hedging with defined time horizon). (5) All dates (2022, 2024, 2028) are correct. (6) The characterization of the shift from 'purely strategic sourcing to a more structured hedging strategy' is semantically equivalent to the ground truth's description. MINOR CONSIDERATIONS: (1) The LLM answer adds detail about 'quantitative table of notional amounts, fair-value balances and maturity-related disclosures' which, while not explicitly mentioned in the ground truth summary, is consistent with the evolution described and represents appropriate elaboration rather than error. (2) The phrasing 'greater transparency than in the earlier filing' is a reasonable inference from the evolution described. No factual errors detected. The answer successfully addresses all parts of the multi-part question regarding classification, hedge accounting treatment, and time horizon evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 451,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 P&G’s currency‑rate risk management was essentially unchanged – it continued to rely on short‑term forward contracts and currency swaps (generally with maturities under 18 months) as part of a diversified natural hedge.  The company reiterated that, at a 95 % confidence level based on historical rate movements, a near‑term change in exchange rates would not materially affect its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Verification of key elements: (1) QUANTITATIVE ACCURACY: The 95% confidence level is correctly stated and matches the ground truth. The maturity timeframe of 'less than 18 months' (LLM) vs 'less than 18 months' (ground truth) is identical. No numerical errors detected. (2) ENTITY ACCURACY: Procter & Gamble correctly identified, fiscal years 2023 and 2024 correctly referenced, hedging instruments (forward contracts and currency swaps) accurately named. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years, comparing the evolution (or lack thereof) of currency risk exposure and hedging strategies. The conclusion that exposure 'remained materially unchanged' is properly supported. (4) COMPLETENESS: The answer addresses all three components of the question: (a) how exposure evolved (remained unchanged), (b) hedging instruments used (forward contracts and currency swaps), and (c) confidence in mitigating near-term fluctuations (95% confidence level with no material impact). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially unchanged' is semantically equivalent to the ground truth's 'remained materially unchanged.' The mention of 'diversified natural hedge' in the LLM answer adds contextual detail not explicitly in the ground truth but is not contradictory and enhances understanding. Minor note: The LLM uses 'reiterated' which implies the company repeated the same assessment, which aligns with the 'remained materially unchanged' characterization. The answer demonstrates sound multi-hop synthesis across fiscal periods and accurate financial risk management terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 462,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe broadened Frame.io from a focused video‑review and collaboration tool into a full‑stack content‑production hub.  The 2022 filing described it as a cloud‑native platform that connects directly with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront for frame‑accurate commenting and Camera‑to‑Cloud uploads.  By the 2024 filing the scope had expanded: Frame.io is now marketed together with Adobe Express and Firefly Services in GenStudio, offering AI‑enhanced workflows, generative‑credit‑driven asset creation, and seamless integration across the entire Creative Cloud and Experience Cloud portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims that in 2022, Frame.io was 'described as a cloud-native platform that connects directly with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront for frame-accurate commenting and Camera-to-Cloud uploads.' However, the ground truth explicitly states that in 2022, Frame.io was ONLY 'listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with NO DETAILED DESCRIPTION of its functionality or integration.' This is a major contradiction. The LLM incorrectly backdated the detailed feature descriptions and integrations to 2022, when these were actually first documented in 2024. The LLM also introduces information about GenStudio, Adobe Express, Firefly Services, and AI-enhanced workflows that may or may not be accurate to the 2024 filing, but cannot be verified against the ground truth provided. The core narrative of evolution from 'trademarked asset' (2022) to 'core collaborative tool deeply embedded in Adobe's creative workflow' (2024) is inverted in the LLM response. While the LLM correctly identifies some 2024 features (frame-accurate commenting, Camera-to-Cloud, integrations with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront), it incorrectly assigns these to 2022. The multi-hop reasoning fails because it does not properly distinguish between what was known in 2022 versus 2024. The answer demonstrates poor synthesis of temporal information across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 436,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the equity stake the Company holds in the ATMP joint venture rose from roughly **$83 million to $99 million** (as disclosed on page 78 of the 2023 filing).  The investment is accounted for under the **equity‑method**, with no funding obligation, and the company reports related‑party balances (payables of $363 million in 2023 vs. $463 million in 2022 and receivables of $9 million vs. $2 million) and recognizes any share‑of‑gains in “Equity income in investee.”  Purchases from and resales to the JV are disclosed as part of the Company’s inventory‑management program and are presented separately from the consolidated statement of operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM claims the equity stake rose from $83 million to $99 million between 2022 and 2023. However, the ground truth explicitly states that in the 2022 filing, the carrying value was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. The LLM's figures of $83M and $99M do not match any values mentioned in the ground truth. (2) MISSING KEY INFORMATION: The ground truth emphasizes that the 2023 filing OMITS disclosure of carrying value and specific transaction figures, representing a reduction in financial disclosure. The LLM fails to capture this critical evolution - instead, it presents investment values as if they were disclosed in 2023, which contradicts the ground truth's core finding. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the equity-method accounting and mentions related-party balances and receivables, it misses the main point of the question: the CHANGE in disclosure practices between years. The ground truth shows 2022 had detailed figures (purchases of $1.1B in 2021, $831M in 2020) while 2023 omitted these. (4) RELATED-PARTY BALANCES: The LLM provides payables ($363M in 2023 vs $463M in 2022) and receivables ($9M vs $2M) figures that are not mentioned in the ground truth, suggesting these may be from a different source or misattributed. (5) MULTI-HOP REASONING FAILURE: The question asks about evolution in carrying value AND nature of disclosures. The LLM addresses only the former (incorrectly) and misses the latter entirely - the reduction in disclosure detail is the key finding. The answer demonstrates a fundamental misunderstanding of what changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 483,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\nHoneywell’s Commercial Aviation Original‑Equipment revenue slipped from **$2.397 billion in 2023 to $2.223 billion in 2024**, a decline of roughly **7 %** year‑over‑year.  The drop signals modest headwinds in the commercial aerospace market, but the segment remains a major contributor to Honeywell’s aerospace revenue, highlighting that the company still holds a strong, though slightly contracting, position among aerospace OEM suppliers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The revenue figures are correct ($2.397 billion in 2023 and $2.223 billion in 2024), matching the ground truth exactly (with proper format conversion from millions to billions). The calculated decline of approximately 7% is accurate: ($2.223B - $2.397B) / $2.397B = -7.26%, which rounds to ~7% as stated. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of revenue between 2023-2024 with specific numbers, and (2) what this indicates about Honeywell's position in the aerospace sector. ENTITY ACCURACY: All entities are correctly identified (Honeywell, Commercial Aviation Original Equipment segment, aerospace sector, fiscal years 2023-2024). REASONING QUALITY: The multi-hop synthesis is sound - the model correctly interprets the revenue decline as indicating 'modest headwinds' while acknowledging the segment remains significant. The reasoning aligns with the ground truth's assessment of 'contraction' and 'weakening in original equipment demand.' SEMANTIC EQUIVALENCE: The LLM's characterization of the decline as 'modest headwinds' and noting the company 'still holds a strong, though slightly contracting, position' conveys essentially the same meaning as the ground truth's assessment of 'potential weakening in original equipment demand or supply constraints.' Minor difference: The LLM adds slightly more nuanced interpretation ('modest headwinds' vs. the ground truth's more neutral 'contraction'), but this represents reasonable analytical judgment rather than factual error. The answer is comprehensive, accurate, and appropriately contextualizes the data within the broader aerospace market.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 475,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\nHeart Failure Devices revenue rose from **$1.16 billion in 2023 to $1.28 billion in 2024**, reflecting a **10.2 % increase** in the segment’s total revenue over that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metrics and percentage change for Heart Failure Devices revenue. Verification of numbers: 2023 revenue of $1.16 billion matches the ground truth $1,161 million (format variation acceptable), 2024 revenue of $1.28 billion matches $1,279 million (format variation acceptable), and the 10.2% increase is mathematically correct ($1,279M - $1,161M = $118M; $118M / $1,161M = 10.17% ≈ 10.2%). The LLM successfully synthesized the multi-hop comparison across two fiscal years and calculated the percentage change accurately. However, the answer is incomplete relative to the ground truth: it omits important contextual details about the growth being consistent across U.S. and international markets, and the minimal impact from exchange rate fluctuations, which were explicitly mentioned in the original answer as indicators of strong underlying demand and market expansion. The LLM answer addresses the core question (revenue evolution and percentage change) but lacks the fuller contextual analysis present in the ground truth. The quantitative accuracy is high with correct numbers and calculations, but qualitative accuracy is slightly lower due to missing contextual synthesis about market dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 351,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\nIn the 2022 filing the 0.300 % Notes due 2028 are only mentioned in the generic “Financing” discussion and are not listed as a separately registered security; by contrast, the 2023 Form 10‑K (page 1) explicitly registers the issue as “0.300 % Notes due 2028 – IBM 28B” in the table of securities registered under Section 12(b). This shows that IBM moved the notes from an unregistered, internally‑reported debt position in 2022 to a fully registered public debt instrument in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022 STATUS: The LLM claims the notes were 'only mentioned in generic Financing discussion' and 'not listed as a separately registered security' in 2022, but the ground truth indicates they were referenced as part of a list of debt instruments with rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. This is a material mischaracterization. (2) INCORRECT CLAIM ABOUT 2022 REGISTRATION STATUS: The LLM states the notes were 'unregistered' in 2022, which contradicts the ground truth that shows they were already referenced in SEC filings (Form 8-K). (3) INCORRECT CHARACTERIZATION OF 2023 CHANGE: The LLM claims IBM 'moved the notes from an unregistered...position in 2022 to a fully registered public debt instrument in 2023,' but the ground truth indicates the shift was from 'incorporation by reference' to 'explicit disclosure and formal registration' - a more nuanced distinction than the LLM presents. The notes were not unregistered in 2022; they were incorporated by reference. (4) MISSING KEY DETAIL: The LLM fails to mention the specific Form 8-K filing date (February 10, 2020) that was referenced in the 2022 filing, which is an important contextual detail. (5) CORRECT ELEMENTS: The LLM correctly identifies the trading symbol (IBM 28B) and correctly notes that 2023 shows explicit listing in a table of registered securities. The core insight about evolution from one disclosure method to another is directionally correct, but the characterization of the 2022 status as 'unregistered' is fundamentally wrong. The answer demonstrates partial understanding but makes critical errors in describing the actual nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 493,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\nFrom 2022 to 2023 the Rest of Asia Pacific segment saw a modest rise in net sales—up from about **$29.38 billion to $29.62 billion**—and a more noticeable increase in operating income, which grew from roughly **$11.57 billion to $12.07 billion**. This indicates that Apple’s profitability in that region improved slightly over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: Net sales figures are correctly stated as $29.38 billion (2022) and $29.62 billion (2023), which match the ground truth values of $29,375M and $29,615M respectively when converted to billions. Operating income figures are correctly stated as $11.57 billion (2022) and $12.07 billion (2023), matching ground truth values of $11,569M and $12,066M. The LLM appropriately used rounded billion figures rather than exact millions, which is a reasonable presentation choice and maintains semantic equivalence. The answer correctly identifies the year-over-year changes: net sales increase of approximately $240M (0.8%) and operating income increase of approximately $497M (4.3%), though the LLM did not explicitly state these percentage changes. The LLM's characterization of the growth as 'modest' for net sales and 'more noticeable' for operating income aligns well with the actual percentage changes (0.8% vs 4.3%). Multi-hop reasoning is sound: the answer correctly synthesizes data from the Rest of Asia Pacific segment across two fiscal years and properly compares the metrics. Entity identification is accurate (Apple, Rest of Asia Pacific segment, 2022-2023 period, net sales, operating income). The only minor omission is that the LLM did not explicitly calculate or state the percentage changes, though the qualitative characterization of the changes is appropriate. The answer directly addresses all parts of the question regarding how financial performance evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 430,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\nThe 2022 10‑K notes that “stock options granted **prior to 2022** under the 2007 Omnibus Incentive Plan generally vest pro‑rata over a **five‑year** period,” while the 2024 10‑K explains that “stock options granted **subsequent to December 31, 2021** under the amended and restated 2007 Omnibus Incentive Plan generally vest pro‑rata over a **four‑year** period.” Thus, the vesting schedule was shortened from a five‑year to a four‑year pro‑rata schedule for grants made after 2021 (with special cases for certain executives and outside directors).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong multi-hop synthesis across the 2022 and 2024 10-K filings. STRENGTHS: (1) All numeric values are accurate - correctly identifies the five-year vesting period for pre-2022 grants and four-year vesting period for post-December 31, 2021 grants. (2) Dates are precise - properly distinguishes between 'prior to 2022' and 'subsequent to December 31, 2021' as the cutoff points. (3) Multi-hop reasoning is sound - successfully synthesizes information from both the 2022 and 2024 filings to show the evolution and consistency of vesting terms. (4) Entity identification is correct - properly references the 2007 Omnibus Incentive Plan and its amended and restated version. (5) The answer correctly characterizes the change as a 'structural change' from five to four years. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'special cases for certain executives and outside directors' in parentheses, which adds nuance not explicitly stated in the ground truth answer. This is not incorrect but represents additional detail that goes slightly beyond the core ground truth statement. (2) The ground truth emphasizes 'consistent reduction' and 'showing a structural change,' while the LLM answer focuses more on the factual comparison. Both convey the same essential information. (3) The phrasing differs slightly (e.g., 'subsequent to' vs. 'after') but is semantically equivalent. The answer fully addresses all parts of the multi-part question regarding how vesting periods evolved between the two time periods and across both filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 438,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\nFrom 2022 through 2023 CVS continued to validate the fair‑value of its Level 2 debt securities by (1) obtaining observable market‑based quotes (e.g., matrix‑pricing models), (2) conducting a quarterly cross‑check of those prices against a secondary source and reviewing any variances that exceed a preset threshold, and (3) having its internal investment team compare the quoted prices to independent internal fair‑value estimates.  Importantly, the company reported that **no price adjustments were made to the Level 2 quotes in either 2023 or 2022**, indicating that the validation process remained unchanged and that the externally derived prices were considered reliable without modification.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The statement that no price adjustments were made in 2023 or 2022 is accurate and matches ground truth; (2) The description of quarterly cross-checks against secondary sources is correct; (3) The mention of internal investment team validation is accurate; (4) The overall characterization that the process remained unchanged is correct. PROBLEMATIC ELEMENTS: (1) The LLM introduces additional validation details (observable market-based quotes, matrix-pricing models, independent internal fair-value estimates) that are not mentioned in the ground truth answer, which raises questions about whether these details are from the actual filings or inferred; (2) The ground truth specifically mentions validation at December 31, 2021 and 2020 (no adjustments), but the LLM only references 2023 and 2022, missing the historical comparison context that was part of the original answer; (3) The ground truth emphasizes that the approach 'evolved' (or rather, remained stable) from 2022 to 2023, but the LLM's framing of 'continued to validate' doesn't clearly address the evolution aspect of the question - it reads more as a static description rather than a comparison of change over time; (4) The ground truth notes the emphasis on 'consistent internal validation by the investment team appears to have remained stable,' which is a subtle but important distinction about the stability of the approach, whereas the LLM focuses more on the mechanics of the process. MULTI-HOP REASONING: The LLM successfully synthesizes that the validation approach remained consistent across 2022-2023, but fails to fully address the temporal evolution aspect and the historical context (2021, 2020) that frames the stability claim. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, so this scores well on the factual statements made. The dates (2023, 2022) are correct, though incomplete relative to ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 538,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\nBetween 2022 and 2023 CVS kept all privately‑placed equity securities in **Level 3** of the fair‑value hierarchy, continuing to value them through an **internal analysis of each investment’s financial statements and cash‑flow projections** rather than using quoted market prices.  The key **unobservable inputs**—earnings and revenue multiples, discounts for lack of marketability and comparability adjustments—were unchanged, but the 2023 disclosures show a **larger Level 3 equity balance ($79 million vs. $60 million in 2022)** and a **$9 million net unrealized loss recorded in other‑comprehensive income**, reflecting updated internal assumptions and a greater volume of private‑equity holdings while the valuation methodology itself remained the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core classification and methodology aspects: (1) Level 3 classification maintained in both years - CORRECT, (2) internal analysis of financial statements and cash flow projections - CORRECT, (3) unobservable inputs (earnings/revenue multiples, discount for lack of marketability, comparability adjustments) - CORRECT, (4) emphasis on sensitivity analysis in 2023 - CORRECT. However, there are significant quantitative accuracy issues: The LLM introduces specific dollar amounts ($79 million vs. $60 million for Level 3 equity balance and $9 million net unrealized loss) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific figures, and introducing unverified numbers is a critical error in financial analysis. The LLM also adds detail about 'updated internal assumptions and a greater volume of private-equity holdings' which goes beyond what the ground truth states. The qualitative reasoning is sound - the LLM correctly synthesizes that methodology remained consistent while emphasizing increased scrutiny of inputs. The answer appropriately addresses the evolution question by noting what changed (balance amounts, emphasis on sensitivity) versus what remained constant (classification, methodology, input types). The main weakness is the introduction of specific financial figures without ground truth support, which violates the principle of strict accuracy on numbers. The answer would have been stronger by sticking to the documented evolution in disclosure emphasis rather than adding quantitative details not confirmed in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 449,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\nThe Alphagan/Combigan line saw its worldwide net revenue fall 8.8 % from $272 million in 2023 to $248 million in 2024.  At the same time, the international portion of the product grew modestly—up from about $151 million in 2023 to $153 million in 2024 (roughly a 1–2 % increase in actual dollars, or about a 7–8 % rise on a constant‑currency basis).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies all core financial figures and the main trend: total net revenue decline from $272M to $248M (8.8% decrease) and international revenue increase from $151M to $153M. The primary numbers are accurate and match the ground truth. However, there is a quantitative accuracy issue with the percentage calculation for international revenue growth. The LLM states '1–2% increase in actual dollars, or about a 7–8% rise on a constant-currency basis.' The ground truth specifies the international revenue growth as 1.5%, which falls within the stated 1-2% range, so this is acceptable. However, the introduction of constant-currency basis information (7-8% rise) is not mentioned in the ground truth answer and appears to be additional context that may or may not be accurate—this represents potential over-specification beyond what was asked. The LLM correctly synthesizes the multi-hop information (comparing 2023 vs 2024 for both total and international revenue) and properly identifies the contrasting trends (total declining while international growing). The wording is clear and semantically equivalent to the ground truth. The answer appropriately addresses both parts of the question regarding total revenue change and international revenue trend. The minor issue is the introduction of constant-currency basis information which, while potentially accurate, goes beyond the ground truth answer and could introduce unverified claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 405,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Chevron moved from completing the acquisition of PDC Energy to fully integrating its legacy upstream assets, so that PDC’s wells are now reported as part of Chevron’s own production portfolio.  This integration contributed the “full‑year of legacy PDC Energy production” that helped lift worldwide oil‑equivalent output about 7 % year‑over‑year, with Permian‑Basin net daily crude rising to 405 k bbl and NGLs to 251 k bbl in 2024.  (Pages 11 and 31 of the 2024 10‑K; see also the 2023 10‑K discussion of the acquisition.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Strengths: (1) Correctly identifies the evolution of Chevron's relationship with PDC Energy from 2023 acquisition to 2024 full integration; (2) Accurately cites the 7% increase in worldwide oil-equivalent production; (3) Provides specific operational metrics (Permian Basin crude at 405k bbl/day and NGLs at 251k bbl/day in 2024) that demonstrate concrete production impact; (4) Properly synthesizes multi-hop information showing how the acquisition transitioned from a recent event to an operational contributor; (5) Includes proper source citations (2024 10-K pages 11 and 31, plus 2023 10-K reference). Verification of numbers: The 7% production increase matches ground truth exactly. The specific production figures (405k bbl crude, 251k bbl NGLs) are additional details not contradicted by the ground truth and appear to be accurate supplementary information from the 10-K. Minor consideration: The LLM provides more granular operational details (specific Permian Basin production figures) than the ground truth, but these are accurate enhancements rather than errors. The answer fully addresses both parts of the question: (1) how the relationship evolved (acquisition to integration), and (2) the specific operational impact (7% production increase with full-year PDC contribution). The reasoning is sound and the multi-hop synthesis across 2023 and 2024 filings is correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 400,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\nFrom 2023 through 2024 UPS moved from building cold‑chain capacity with the 2023 acquisition of **MNX Global Logistics**—a global time‑critical and temperature‑sensitive logistics provider—and the earlier 2022 purchase of **Bomi Group**, which gave it a foothold in European and Latin‑American cold‑chain markets, to a dedicated 2024 investment in **Frigo‑Trans and Biotech & Pharma Logistics** (acquired for roughly $440 million) that is explicitly aimed at expanding its complex international cold‑chain capabilities. These acquisitions collectively deepened and broadened UPS’s cold‑chain logistics infrastructure across the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies all four key acquisitions: MNX Global Logistics (2023), Bomi Group (2023), Frigo-Trans (2024), and Biotech & Pharma Logistics (2024). (2) The $440 million figure for the 2024 German acquisitions is accurate. (3) The narrative correctly captures the evolution from general expansion to targeted international acquisitions. (4) The answer appropriately addresses the multi-hop question structure by synthesizing information across two years.\n\nWEAKNESSES: (1) CRITICAL DATING ERROR: The LLM states Bomi Group was acquired in 2022 ('the earlier 2022 purchase of Bomi Group'), but the ground truth clearly indicates it was acquired in 2023. This is a factual error that contradicts the original answer. (2) The ground truth explicitly lists Bomi Group as a 2023 acquisition alongside MNX Global Logistics, not as a 2022 acquisition. (3) While the LLM captures the strategic shift narrative, it introduces a timeline inconsistency that undermines the accuracy of the 2023-2024 comparison. (4) The answer doesn't clearly distinguish that both Bomi Group AND MNX Global Logistics were 2023 acquisitions, instead positioning Bomi as earlier.\n\nMULTI-HOP REASONING: The synthesis across years is generally sound—the LLM correctly identifies the progression from 2023 to 2024 and the shift toward higher-value international acquisitions. However, the dating error in the Bomi Group acquisition weakens the multi-hop analysis.\n\nNUMERIC VERIFICATION: The $440 million figure is correct and properly formatted. No calculation errors present.\n\nSCORE JUSTIFICATION: The answer is substantially correct in structure and most facts, but the Bomi Group dating error (2022 vs. 2023) is a significant factual mistake that affects the core comparison between 2023 and 2024 activities. This prevents a higher score despite otherwise solid reasoning and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 512,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\nBetween 2022 and 2024 Linde replaced the legacy 2009 non‑employee director RSU awards with a unified award under its 2021 Long‑Term Incentive Plan, standardising the grant as RSUs that vest over three years and tying a portion of the award to performance metrics such as Return on Capital and Total Shareholder Return.  Governance was tightened by adding a board‑approved deferral option and a claw‑back policy (effective Oct 2023) and, in the January 2024 amendment, requiring directors to retain their equity for at least three years—mechanisms designed to align director interests more closely with long‑term shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some accurate information but contains significant discrepancies with the ground truth and introduces unsupported claims:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2021 Long-Term Incentive Plan as the framework\n- Correctly mentions the deferral option as a governance enhancement\n- Correctly identifies the evolution toward stronger alignment mechanisms\n- Correctly notes the three-year vesting/retention period\n- Correctly identifies 2024 as a key year for program evolution\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. QUANTITATIVE ERRORS: The LLM claims a \"claw-back policy (effective Oct 2023)\" - this specific date and policy detail are not mentioned in the ground truth and cannot be verified\n2. The LLM references \"January 2024 amendment\" with specific retention requirements - while the ground truth mentions July 30, 2024 adoption of the deferral program, the January 2024 amendment is not corroborated\n3. The LLM mentions \"Return on Capital and Total Shareholder Return\" as performance metrics - these specific metrics are not mentioned in the ground truth\n4. The LLM claims replacement of \"legacy 2009 non-employee director RSU awards\" - the ground truth does not reference a 2009 program or its replacement\n\nMULTI-HOP REASONING:\nThe LLM attempts to synthesize evolution across 2022-2024 but introduces details not supported by the ground truth. The ground truth specifically mentions: (1) 2022 introduction under 2021 Plan, and (2) July 30, 2024 adoption of the deferral program. The LLM adds intermediate steps and specific policy details that cannot be verified.\n\nSEMANTIC ISSUES:\nWhile the LLM captures the general theme of governance enhancement and long-term alignment, it overstates specificity with unsupported claims about claw-back policies, performance metrics, and amendment dates. The ground truth is more conservative, focusing on the documented introduction and expansion of programs.\n\nThe answer demonstrates partial understanding but fails the strict accuracy requirement for financial/governance details by introducing unverified claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 567,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\nBetween 2022 and 2024 GM’s indemnification obligations stemming from its 2017 sale of Opel/Vauxhall to Stellantis remained in force, covering potential losses from breaches of representations and warranties, emissions‑related claims and certain recall liabilities (e.g., Takata inflators).  GM repeatedly noted that any further payments under these indemnities are “immaterial” or “remote” and that it was monitoring the related investigations by the European Commission and UK CMA as well as ongoing litigation, but it did not anticipate any material financial impact.  No material investment gains from Stellantis were recorded in the 2022‑2024 periods—the only prior gain was a $0.2 bn gain on Stellantis warrants recognized in 2021, and subsequent filings show only modest or non‑material financial effects.  (See GM 10‑K 2022 pp. 36‑37; GM 10‑K 2024 pp. 91‑94.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) Correctly identifies the $0.2 billion warrant gain, though dates it to 2021 rather than 2022 as stated in the original answer—this is a minor discrepancy but the LLM's dating appears more precise based on typical warrant recognition timing; (2) Accurately describes the indemnification obligations stemming from the 2017 Opel/Vauxhall sale, including coverage for emissions claims, product liabilities, and recalls; (3) Properly synthesizes the evolution from financial gains to contingent liabilities and legal risks; (4) Correctly notes GM's characterization of potential future payments as 'immaterial' or 'remote'; (5) Appropriately references ongoing investigations by European Commission and UK CMA; (6) Provides specific page citations (10-K 2022 pp. 36-37; 10-K 2024 pp. 91-94) that enhance credibility. MINOR ISSUES: (1) The original answer states the $0.2B gain was 'reported' in 2022, while the LLM clarifies it was recognized in 2021—this is actually a correction/refinement rather than an error, showing better precision; (2) The LLM provides slightly more nuanced detail about GM's risk assessment ('immaterial,' 'remote,' 'monitoring') compared to the original answer's more general statement about 'contingent liabilities and legal risks'; (3) The LLM explicitly notes 'no material investment gains' in 2022-2024 periods, which directly addresses the question's focus on how the relationship evolved. QUANTITATIVE VERIFICATION: The $0.2 billion figure is correctly stated and properly contextualized. No calculations are required or presented, so quantitative accuracy is high. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years (2017 sale, 2021 warrant gain, 2022-2024 indemnification obligations) and multiple document sources (10-K filings from different years), demonstrating sound multi-hop reasoning. The evolution narrative is clear and logically presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while providing additional specificity and nuance regarding GM's risk characterization and monitoring activities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 601,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\nBetween 2022 and 2024 Southern Company moved from a generic discussion of “regulatory, cash‑flow and non‑designated” hedges to a structured, three‑category framework that is disclosed with explicit balance‑sheet line‑items. The 2024 filing presents energy‑related derivatives in current vs. non‑current “Regulatory Hedge,” “Cash‑Flow Hedge” and “Not‑Designated” tables, shows gross amounts, offsetting balances and net values after intra‑contract netting, and clarifies that regulatory‑hedge gains/losses flow through fuel expense while cash‑flow hedge reclassifications are immaterial—providing a far more detailed and standardized financial presentation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the evolution of Southern Company's derivative disclosure from 2022 to 2024, but contains significant discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that there was a shift in how derivatives were presented between 2022 and 2024; (2) It correctly notes the move toward more structured and detailed financial presentation; (3) It appropriately mentions balance sheet categorization. INCORRECT/PROBLEMATIC ELEMENTS: (1) The ground truth specifically states the 2022 focus was on 'pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income' for prior years (2021, 2020, 2019), but the LLM answer discusses a 'generic discussion of regulatory, cash-flow and non-designated hedges' without clearly establishing this income statement focus; (2) The ground truth emphasizes a shift FROM income-focused reporting TO balance sheet-oriented transparency, but the LLM answer emphasizes the structural categorization framework (Regulatory Hedge, Cash-Flow Hedge, Not-Designated) without clearly articulating this fundamental shift in reporting orientation; (3) The LLM answer introduces specific details about 'gross amounts, offsetting balances and net values after intra-contract netting' and 'fuel expense' and 'cash-flow hedge reclassifications are immaterial' that are not mentioned in the ground truth, raising questions about whether these details are accurate or represent over-specification; (4) The LLM answer's characterization of the 2022 approach as 'generic' versus 2024 as 'structured' differs from the ground truth's characterization of the shift as income-statement-focused to balance-sheet-focused. MULTI-HOP REASONING: The answer attempts to synthesize the evolution across years but misses the core distinction highlighted in the ground truth—the shift from income statement presentation to balance sheet presentation. The answer focuses more on categorization structure than on the fundamental reporting location change. NO QUANTITATIVE ERRORS detected, but the qualitative framing diverges significantly from the ground truth's emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 581,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\nBetween 2023 and early 2024 Gilead expanded the Arcus collaboration by amending the agreement to add up to four new joint targets, paying a $35 million upfront fee and triggering a $100 million anniversary payment in 2024 while retaining options to license each program and to share development costs, milestone payments and U.S. profits.  At the same time Gilead’s equity stake in Arcus grew from roughly 20 % (≈14.8 million shares representing about 19.9 % of voting stock as of mid‑2023) to about 33 % after a $320 million equity investment in January 2024, and its board representation increased from two to three directors, giving it greater governance influence over Arcus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative facts are correct: (1) GILD's ownership increased from approximately 19.9% (described as 'roughly 20%' with specific detail of 14.8 million shares) to 33%, (2) the $320 million equity investment in January 2024 is accurate, (3) board representation expanded from two to three designees. The answer correctly synthesizes the multi-hop relationship evolution across 2023-2024. The LLM goes beyond the ground truth by providing additional context about the amended collaboration agreement (four new joint targets, $35 million upfront fee, $100 million anniversary payment), which is relevant and accurate supplementary information that enriches the answer without contradicting the core facts. The reasoning is sound: the answer clearly connects the financial investment to governance influence expansion. Minor note: the LLM uses 'roughly 20%' and 'about 33%' while ground truth uses 'approximately 19.9%' and 'increasing its ownership to 33%' - these are semantically equivalent and represent appropriate precision levels. The answer fully addresses both components of the question (equity ownership and governance influence) with correct multi-hop synthesis across the 2023-2024 period. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 370,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\nBetween the end of 2022 and the amendment dated June 29 2023, the 2021 Multicurrency Credit Facility kept its **$6 billion revolving commitment** (including the $3.5 billion multicurrency sub‑limit), but its **maturity was extended**—the facility, which was scheduled to mature on **June 30 2025**, was amended to a new maturity of **July 1 2026**. Thus, borrowing capacity stayed at $6 billion while the maturity date was pushed out by roughly one year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Borrowing capacity: $6.0 billion in both 2022 and 2023 - correctly stated; (2) Maturity dates: June 30, 2025 (2022) and July 1, 2026 (2023) - both dates are accurate; (3) Extension period: one year - correctly calculated and stated as 'roughly one year'; (4) Multi-hop synthesis: The answer properly synthesizes the evolution between the two years, comparing both the capacity (unchanged) and maturity date (extended). The LLM also provides additional context by mentioning the $3.5 billion multicurrency sub-limit and the specific amendment date (June 29, 2023), which adds helpful detail without contradicting the ground truth. The reasoning is sound - correctly identifying that this represents a strategic extension without capacity increase. Minor note: The LLM uses slightly different phrasing ('pushed out by roughly one year' vs. 'one-year extension') but this is semantically equivalent and actually more precise given the dates span from June 30 to July 1. All numbers, dates, and calculations are factually correct with no errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 323,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\nChevron’s share of imported crude in its U.S. refinery feedstocks stayed essentially constant—about 60 percent of the crude processed in both 2023 and 2024.  At the same time, overall refinery utilization slipped noticeably, with U.S. crude‑unit capacity running at **86.6 % in 2024 versus 90.8 % in 2023** (a drop of roughly 4 percentage points).  The stable imported‑crude proportion combined with lower capacity utilization reflects a pull‑back in refinery throughput rather than a shift in the source mix of crude.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: imported crude oil at ~60% in both 2023 and 2024, crude unit distillation capacity utilization at 90.8% in 2023 and 86.6% in 2024, with the calculated 4 percentage point decline accurately stated. The multi-hop synthesis is sound—the answer correctly connects the stable imported crude proportion with the declining refinery utilization to draw the logical conclusion that the pullback reflects reduced throughput rather than source mix changes. The wording differs slightly from the ground truth (e.g., 'slipped noticeably' vs 'declined slightly'), but this represents stylistic variation rather than factual error. The answer addresses all components of the multi-part question: (1) imported crude oil evolution (stable at 60%), (2) refinery capacity utilization changes (90.8% to 86.6%), and (3) the relationship between these trends. The reasoning is clear and well-integrated, explaining the implications of the data rather than merely stating facts. Minor deduction from perfect score only due to slight wording differences in characterizing the magnitude of change ('noticeably' vs 'slightly'), though both characterizations are defensible given a 4 percentage point decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 359,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\nUPS trimmed its British‑Pound‑sterling hedge coverage, with the notional amount of GBP‑denominated contracts falling from **$663 million at the end of 2023 to $536 million at the end of 2024** (see page 137 “Outstanding Positions”).  This reduction reflects a deliberate scaling‑back of cash‑flow hedge volume for GBP, indicating that the company is adjusting its currency‑risk program—likely because its expected GBP‑related cash flows have changed or it is relying more on natural hedges and a dynamic, exposure‑driven rebalancing of its overall foreign‑exchange risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - UNIT MISMATCH: The LLM answer states the GBP hedge position in DOLLAR AMOUNTS ($663 million to $536 million), but the ground truth specifies these are UNIT AMOUNTS (663 million units to 536 million units). This is a fundamental factual error. The ground truth explicitly states '663 million units' and '536 million units,' not dollar values. The LLM conflated the notional amount with the unit quantity, which are different metrics. CORRECT ELEMENTS: (1) The numeric values themselves are accurate (663 and 536), (2) The year-over-year comparison is correct (2023 to 2024), (3) The reduction of 127 units is mathematically correct (663-536=127), (4) The percentage reduction of ~19.15% is accurate, (5) The qualitative interpretation about strategic reduction and currency risk management is sound and well-reasoned, (6) The reference to page 137 'Outstanding Positions' adds credibility. ERRORS: (1) Critical unit error - should be 'million units' not 'million dollars' or '$663 million', (2) The LLM's interpretation about 'notional amount of GBP-denominated contracts' is imprecise - the ground truth treats these as hedge position units, not contract notional values, (3) The explanation about 'cash-flow hedge volume' and 'natural hedges' goes beyond what the ground truth states, though it's reasonable inference. The reasoning quality is good, but the fundamental unit/measurement error significantly undermines the answer's correctness. This is a 6/10 because while the narrative and reasoning are sound, the core factual representation of what is being measured is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 439,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\nThe fair‑value of Bank of America’s money‑market holdings rose from **about $868 million at the end of 2023** to **approximately $1.3 billion at the end of 2024** (an increase of roughly $430 million or 50 %).  This modest but noticeable uptick reflects a deliberate scaling‑up of the bank’s short‑term, low‑risk cash allocations—likely to capture the higher yields now available in the market and to reinforce its liquidity position amid the current interest‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG 2023 BASELINE: The LLM states the 2023 fair value was 'about $868 million,' but the ground truth clearly indicates it was $1.2 billion. This is a $332 million discrepancy (27.7% error). (2) INCORRECT CALCULATION: The LLM calculates the increase as 'roughly $430 million or 50%' based on its wrong baseline ($1.3B - $868M = $432M). The correct calculation should be $1.3B - $1.2B = $100 million increase, or approximately 8.3%. The LLM's 50% growth figure is completely inaccurate. (3) MISREPRESENTATION OF MAGNITUDE: By using the wrong 2023 figure, the LLM dramatically overstates the growth trajectory, characterizing it as a 'noticeable uptick' and 'scaling-up' when the ground truth describes it as 'modest growth.' (4) QUALITATIVE REASONING: While the LLM's interpretation about liquidity management and yield-seeking behavior is plausible and contextually relevant, it is built on false numerical premises. The reasoning quality is undermined by the factual errors. (5) ENTITY AND METRIC ACCURACY: The company (Bank of America) and metric (fair value of money market investments) are correctly identified, and the time periods (2023 and 2024 year-end) are correct. However, the core financial data is wrong. The LLM answer addresses the question structure appropriately but fails on the most critical dimension: accurate financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 413,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\nThe “sell‑back” ceiling fell sharply – from about **26 million mmBtu** in 2022 (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power) to **15 million mmBtu** in 2024 (4 mmBtu, 6 mmBtu, 2 mmBtu and 3 mmBtu respectively), a reduction of roughly **11 million mmBtu** across the subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: (1) 2022 total of 26 million mmBtu with subsidiary breakdown (6, 8, 4, 8 mmBtu respectively), (2) 2024 total of 15 million mmBtu with subsidiary breakdown (4, 6, 2, 3 mmBtu respectively), and (3) the calculated reduction of 11 million mmBtu. The multi-hop synthesis is sound, correctly identifying changes across all four subsidiaries (Alabama Power, Georgia Power, Mississippi Power, and Southern Power) between the two years. The answer demonstrates proper understanding of the metric (natural gas subject to physical supply contracts with sell-back options) and accurately characterizes the trend as a 'sharp' reduction with 'consistent reduction across all entities.' The only minor distinction from the ground truth is stylistic: the LLM uses 'sell-back ceiling' terminology and slightly different phrasing ('fell sharply' vs. 'decreased'), but these are semantically equivalent and enhance clarity. The calculation verification confirms: 26-15=11 million mmBtu reduction is correct. All entities are properly identified and the temporal comparison (2022 to 2024) is accurate. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 339,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Adobe moved the Firefly Vector Model from a single, experimental feature in Illustrator to a broadly embedded, enterprise‑ready capability across its Creative Cloud suite. In 2023 the model debuted in Illustrator (e.g., Generative Recolor) and was leveraged in Adobe Express for AI‑first content creation, while 2024 saw the vector‑generation engine natively integrated into Photoshop, Illustrator, Premiere Pro, After Effects, InDesign and Adobe Stock, offering fully editable vector graphics, AI‑driven tools such as Generative Fill/Expand, and expanded commercial‑safety guarantees through Firefly Services and Custom Models.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) ENTITY ACCURACY - The LLM claims the Firefly Vector Model 'debuted in Illustrator' in 2023, but the ground truth clearly states it was integrated into Adobe Express in 2023, not Illustrator. (2) TIMELINE REVERSAL - The LLM incorrectly positions Illustrator as the 2023 starting point, when the ground truth shows Express as the 2023 integration point and Illustrator as the 2024 expansion. (3) UNSUPPORTED CLAIMS - The LLM introduces multiple applications (Photoshop, Premiere Pro, After Effects, InDesign, Adobe Stock) and features (Generative Fill/Expand, Custom Models) that are not mentioned in the ground truth. These appear to be hallucinated details not supported by the source material. (4) SCOPE MISALIGNMENT - The ground truth specifically describes expansion from 'single-app integration' (Express) to 'multiple professional-grade applications' (Express + Illustrator), but the LLM dramatically expands this to six applications without evidence. (5) FEATURE MISCHARACTERIZATION - The ground truth mentions 'Generative Recolor' as the specific Illustrator feature, which the LLM does mention, but embeds it within a false narrative about Illustrator being the 2023 starting point. The LLM's answer fundamentally misrepresents the chronological evolution and scope of the Firefly Vector Model's integration, making it factually incorrect despite using some correct terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 410,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\nIn 2023 Biktarvy generated **$11.85 billion** of revenue—up from $10.39 billion in 2022 and accounting for roughly **44 % of GILD’s total sales**—making it the company’s flagship HIV product and the single largest contributor to its HIV franchise ($18.175 billion of HIV sales that year).  The 2024 filing, however, warns that **generic competition, pricing pressure from the Inflation‑Reduction Act’s Medicare‑negotiation provisions, and the risk of a shifting treatment paradigm** could erode Biktarvy’s growth trajectory, prompting GILD to **de‑emphasize reliance on Biktarvy and accelerate investment in next‑generation HIV regimens and broader portfolio diversification** to sustain its HIV business strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis across multiple data points. QUANTITATIVE VERIFICATION: All key numbers are correct—Biktarvy 2023 revenue of $11.85 billion (matches $11,850 million), 2022 revenue of $10.39 billion (matches $10,390 million), and the 44% calculation is accurate ($11.85B / ~$26.9B total GILD sales ≈ 44%). The HIV franchise total of $18.175 billion is correctly cited. QUALITATIVE ACCURACY: The answer successfully synthesizes multi-hop information: (1) identifies Biktarvy's historical significance in 2023, (2) recognizes its continued centrality in 2024, and (3) articulates the strategic implications (diversification pressure, generic competition, treatment paradigm shifts). The reasoning correctly connects financial dominance to strategic vulnerability. ENTITY ACCURACY: All entities correctly identified (GILD, Biktarvy, HIV portfolio, TAF-containing products). COMPLETENESS: The answer addresses both parts of the question—evolution from 2023 to 2024 AND strategic implications. The mention of specific 2024 risks (generic competition, IRA Medicare-negotiation provisions, treatment paradigm shifts) aligns with the ground truth's emphasis on 'mounting pressure to diversify or innovate.' MINOR CONSIDERATIONS: The LLM provides slightly more specific detail about regulatory/competitive pressures (IRA provisions) than the ground truth explicitly states, but this represents reasonable inference from 2024 filing context rather than factual error. The characterization of GILD's response as 'de-emphasizing reliance' and 'accelerating investment' is semantically equivalent to the ground truth's 'diversify or innovate within its HIV pipeline.' No calculation errors detected. Formatting variations are appropriate and consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 490,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Series 2018‑1A securities remained outstanding; their recorded principal rose only modestly, from roughly **$496.1 million to $496.8 million**, reflecting the accrual of interest and related adjustments.  The securities kept the same contractual **interest rate of 3.652 %** (fixed for the life of the tranche), and no scheduled principal repayments were required until the anticipated repayment date in March 2028 (or earlier only if a DSCR‑triggered amortization began).  Thus, the financial structure—interest‑rate level and the pass‑through nature of the tranche—did not change, only the outstanding balance showed a small net increase.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN PRINCIPAL AMOUNTS: The LLM answer contains a significant factual error regarding the 2022 principal amount. Ground truth states the 2022 principal was $500.0 million, but the LLM claims it was $496.1 million. This is a $3.9 million discrepancy (0.78% error) on a key metric. The 2023 figure of $496.8 million is correct. The LLM's characterization of the principal as 'rising' from $496.1M to $496.8M contradicts the ground truth showing a DECREASE from $500.0M to $496.8M (a $3.2M reduction). This is a fundamental misrepresentation of the financial evolution. CORRECT ELEMENTS: The interest rate of 3.652% is correctly identified for both years, and the statement that it remained unchanged is accurate. The additional context about the March 2028 repayment date and DSCR-triggered amortization, while not in the ground truth, appears reasonable and doesn't contradict it. MULTI-HOP REASONING: The answer attempts to synthesize information across years but fails on the core quantitative comparison. The reasoning about the fixed interest rate and pass-through nature is sound, but the principal amount error undermines the entire analysis. COMPLETENESS: The answer addresses both principal and interest rate evolution, but the principal analysis is factually incorrect, making the answer incomplete in its core requirement. The LLM appears to have confused or misread the 2022 baseline figure, which is a critical error for a financial question requiring precise numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 415,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved from testing and impairing Coyote’s goodwill and trade‑name (recording a $111 million impairment charge on the trade name and $56 million/$61 million of goodwill impairments in 2023) to completing a strategic divestiture of the business in September 2024. The sale generated a $156 million gain, eliminated the unit’s operating losses and cut Forwarding operating expenses by roughly $1 billion, allowing UPS to exit a low‑margin brokerage operation and re‑allocate capital toward higher‑growth areas such as its healthcare‑focused logistics and other Supply Chain Solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed narrative than the ground truth but introduces several unverified claims that create accuracy concerns. CORRECT ELEMENTS: (1) The $111 million impairment charge on Coyote trade name in 2023 is accurate. (2) The September 2024 divestiture is correctly identified. (3) The strategic evolution from impairment to divestiture is properly captured. (4) The characterization of Coyote as a low-margin operation is contextually appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces $56 million/$61 million goodwill impairment figures that are NOT mentioned in the ground truth, raising questions about their accuracy and source. (2) The $156 million gain on the sale is not mentioned in the ground truth and cannot be verified. (3) The claim about cutting Forwarding operating expenses by 'roughly $1 billion' is not in the ground truth and appears to be an unsupported extrapolation. (4) The specific reference to 'healthcare-focused logistics' as a reallocation target is not mentioned in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the 2023-to-2024 evolution and connects the impairment to the eventual divestiture. However, the addition of unverified financial metrics (goodwill impairments, sale gain, expense cuts) suggests the model may be hallucinating or drawing from unreliable sources. QUANTITATIVE ACCURACY ISSUE: While the $111 million figure is correct, the introduction of multiple unverified dollar amounts ($56M, $61M, $156M, $1B) significantly undermines confidence in the numerical accuracy. The ground truth is silent on these figures, making them impossible to validate as correct. The answer is more detailed but less reliable than the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 474,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\nThe 2022 10‑K shows that PSU grants initiated in 2019 were awarded under the 2021 Long‑Term Incentive Plan using either a Return‑on‑Capital performance metric or a Total‑Shareholder‑Return metric (Exhibits 10.03c‑d). The 2024 10‑K reveals that the First Amendment to the 2021 Plan (Exhibit 10.03e) revised the award structure—adding new performance criteria and refining the ROC/TSR targets—demonstrating how Linde’s PSU metric framework evolved between 2022 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) PLAN IDENTIFICATION ERROR: The LLM states PSU grants were under the '2021 Long-Term Incentive Plan' when the ground truth clearly identifies them as under the 'Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan.' This is a major entity misidentification. (2) EXHIBIT REFERENCE ERRORS: The LLM cites Exhibits 10.03c-d and 10.03e, but the ground truth references Exhibits 10.11k, 10.11l (2022) and 10.10l, 10.10m (2024). These are completely different exhibit numbers, suggesting the LLM fabricated or misidentified source documents. (3) STRUCTURAL EVOLUTION MISCHARACTERIZATION: The ground truth states the dual structure (ROC and TSR metrics) 'remained in place' without 'introducing new metrics or eliminating existing ones' - indicating NO significant structural change. The LLM claims the First Amendment 'revised the award structure—adding new performance criteria and refining the ROC/TSR targets,' which directly contradicts the ground truth's finding of continuity. (4) INCOMPLETE ANSWER: The LLM fails to properly address that the same two forms of PSU Awards (ROC and TSR) persisted from 2022 to 2024, instead suggesting material changes occurred. The multi-hop reasoning is fundamentally flawed because it misidentifies the underlying plan structure and mischaracterizes the evolution as involving changes when the ground truth indicates stability. The answer appears to confuse different plan structures or years entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 428,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\nBetween 2023 and 2024 Trodelvy shifted from its earlier accelerated approvals in metastatic triple‑negative breast cancer and second‑line urothelial cancer to gaining a **second FDA Breakthrough‑Therapy designation** for extensive‑stage small‑cell lung cancer (after progression on platinum chemotherapy) and an **EC approval for monotherapy in HR⁺/HER2‑ breast cancer**.  These actions show that the drug’s regulatory path is expanding into new tumor types and that the FDA is increasingly viewing it as a promising, expedited‑development candidate, indicating a trajectory toward broader oncology indications and further commercial growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) Trodelvy's 2023 indications for triple-negative breast cancer and urothelial cancer are accurately mentioned; (2) The 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy is correct; (3) The interpretation that this represents strategic expansion into new oncology indications is sound. PROBLEMATIC ELEMENTS: (1) The LLM claims a 'second FDA Breakthrough-Therapy designation' - the ground truth only mentions ONE Breakthrough Therapy designation granted in 2024 for small cell lung cancer. The phrasing 'second' is misleading and factually incorrect unless the LLM has evidence of a prior Breakthrough designation not mentioned in the ground truth; (2) The LLM introduces an 'EC approval for monotherapy in HR+/HER2- breast cancer' which is NOT mentioned in the ground truth. The ground truth only references the 2023 indication for HR+/HER2- breast cancer but does not mention any 2024 EC approval. This appears to be an unsupported addition; (3) The LLM states Trodelvy had 'accelerated approvals' in 2023, but the ground truth uses the term 'indicated for' without specifying the approval pathway as accelerated. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2023 to 2024 indications and draws a reasonable conclusion about development trajectory. However, the introduction of unverified regulatory actions (EC approval, 'second' designation) undermines the accuracy of the synthesis. The core insight about expansion into new oncology indications is valid, but the specific regulatory details contain errors that would mislead readers about Trodelvy's actual regulatory status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 477,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\nFrom 2023 to 2024 Vertex AI moved from a newly‑launched, unified hub for training, tuning and serving Gemini and other generative models into a mature, end‑to‑end platform that tightly integrates the newest Gemini 2.0 multimodal model and adds pre‑packaged AI agents (e.g., for code, security, search) and deeper connections to Imagen, Veo and other Google Cloud services. This evolution gives developers a complete pipeline—from model selection and grounding/distillation tools to production‑grade deployment and scaling—making Vertex AI the central engine for building and operating generative‑AI applications on Google Cloud.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) The ground truth makes no mention of 'Gemini 2.0' or 'Gemini 2.0 multimodal model' - the LLM introduces this unsupported detail. (2) The ground truth does not reference 'pre-packaged AI agents (e.g., for code, security, search)' - this is fabricated. (3) The ground truth does not mention 'Imagen' or 'Veo' integration - these are added without evidence. (4) The LLM's characterization of 2023 Vertex AI as 'newly-launched' contradicts the ground truth which describes it as an established platform. (5) The ground truth specifically mentions 'Enterprise Search and Conversations' as 2023 services, but the LLM omits these entirely. (6) The ground truth correctly identifies the evolution to include 'vector search, grounding, and distillation' - the LLM mentions grounding/distillation but misses vector search. (7) The LLM's claim about 'production-grade deployment and scaling' as a 2024 addition is not supported by the ground truth. The LLM appears to have hallucinated multiple specific product features and model names (Gemini 2.0, Imagen, Veo, AI agents) that are not present in the knowledge graph. While the general theme of platform evolution is correct, the specific capabilities and services mentioned are largely inaccurate or fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 385,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company continues to treat weather‑related derivatives as immaterial – both the 2022 MD&A (pages 122 & 124) and the 2024 combined notes (pages 283‑287) explicitly state that the premium and intrinsic value of weather derivatives are excluded from derivative fair‑value measurements and from the balance‑sheet and AOCI tables. Consequently, the amounts considered immaterial have not changed; they remain effectively zero and are consistently omitted from derivative valuations across the two reporting periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer has significant gaps and misses critical information from the ground truth. MAJOR ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth explicitly states that by 2024, SO disclosed cash collateral held in broker margin accounts of $17 million (2024) and $62 million (2023). The LLM answer completely omits these specific dollar amounts, which represent a material change in disclosure detail and are directly relevant to the question about how valuation treatment changed. (2) INCOMPLETE CHARACTERIZATION OF CHANGE: The LLM states 'the amounts considered immaterial have not changed; they remain effectively zero' - this is misleading. While weather derivatives themselves remained immaterial, the disclosure evolved to include specific collateral amounts ($17M and $62M), indicating a MORE DETAILED approach to derivative disclosures, not a static one. The ground truth explicitly notes this represents 'a more detailed and structured approach to derivative disclosures over time.' (3) MISSING TEMPORAL COMPARISON: The LLM fails to distinguish between 2022 (no specific amounts disclosed) and 2024 (specific collateral amounts disclosed), which is the core of the question about how treatment 'changed.' WHAT WAS CORRECT: The LLM correctly identifies that weather derivatives were treated as immaterial in both periods and excluded from fair-value measurements. The reference to pages and the general characterization of exclusion from balance sheet and AOCI tables appears accurate. REASONING QUALITY: The multi-hop synthesis is incomplete - the answer needed to connect the evolution from general immateriality statements (2022) to specific collateral disclosures (2024) to demonstrate the change in disclosure approach. The conclusion that 'amounts...remain effectively zero' oversimplifies the actual disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 501,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Gilead’s filings show that Biktarvy remained a cornerstone of its HIV portfolio, but its regulatory scope widened markedly in 2024.  The FDA granted an expanded indication allowing treatment of patients with suppressed viral loads who have M184V/I resistance—a common resistance mutation—and issued an updated label that includes new safety‑and‑efficacy data for use in pregnant women living with HIV‑1.  These approvals reinforce Biktarvy’s differentiated position as a high‑barrier, once‑daily regimen that can address treatment‑resistant and special‑population patients, while its U.S. patent protection (expiring 2033) secures its market exclusivity for the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of Biktarvy's regulatory evolution between 2023 and 2024. QUANTITATIVE ACCURACY: All numeric values are correct - the 2033 U.S. patent expiration date matches the ground truth exactly. No calculations are required for this question, and all dates/years are accurate. ENTITY ACCURACY: Correctly identifies Gilead (GILD), Biktarvy, FDA, and the specific resistance mutation (M184V/I). COMPLETENESS: The answer addresses all key elements from the ground truth: (1) 2023 patent protection status (2033 expiration), (2) 2024 expanded indication for M184V/I resistance in suppressed viral load patients, (3) 2024 updated label for pregnant people with HIV-1, and (4) the conceptual shift from patent protection to expanded therapeutic application. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and multiple regulatory developments, establishing the logical progression from patent-based exclusivity to expanded clinical utility. The characterization of Biktarvy as a 'high-barrier, once-daily regimen' adds appropriate context about its market positioning. SEMANTIC EQUIVALENCE: The LLM's phrasing 'pregnant women living with HIV-1' is semantically equivalent to 'pregnant people with HIV-1' in the ground truth. The description of the shift from 'primarily patent protection' to 'expanded therapeutic application' is accurately captured as moving from patent-based exclusivity to addressing 'treatment-resistant and special-population patients.' MINOR CONSIDERATIONS: The LLM adds interpretive language ('cornerstone of its HIV portfolio,' 'differentiated position,' 'near term') that enhances context without contradicting the ground truth. The answer is well-structured and clearly articulates the evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 501,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\nIn 2023 AMT borrowed roughly $3 billion under its 2021 Multicurrency Credit Facility and repaid about $6.1 billion, producing a net repayment of roughly $3 billion, and in June 2023 it amended the facility to extend the maturity to July 1 2026 and replace LIBOR with SOFR; by contrast, in 2022 the company’s draws on the facility were modest and the facility was not amended.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verification of key numbers: (1) 2023 borrowings of $3.0 billion - CORRECT; (2) 2023 repayments of $6.1 billion - CORRECT; (3) Net repayment calculation of ~$3.1 billion ($6.1B - $3.0B) - CORRECT (LLM states 'roughly $3 billion' which is semantically equivalent); (4) Maturity extension to July 1, 2026 - CORRECT; (5) LIBOR to SOFR replacement - CORRECT; (6) Facility commitment of $6.0 billion - NOT MENTIONED in LLM answer but present in ground truth. The LLM correctly identifies 2022 as having 'modest' draws (ground truth: $850.0 million net borrowings) and correctly notes no 2022 amendments. Multi-hop reasoning is sound: the answer synthesizes information about borrowing/repayment activity across two years and connects facility amendments to the 2023 period. Minor omissions: (1) The specific EUR repayment amount (842.6 million EUR / $919.1 million) is not mentioned, though this is a detail rather than a core fact; (2) The total facility commitment of $6.0 billion is not explicitly stated in the LLM answer. The characterization of 2022 activity as 'modest' is appropriate given the $850.0 million figure relative to 2023's $3.0 billion borrowing. The answer effectively captures the 'significant transformation' referenced in the ground truth through the contrast between years and the facility amendments. Overall, the answer demonstrates accurate synthesis of multi-hop information with only minor contextual details omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 418,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\nBetween 2023 and 2024 Alphabet moved from a simple “gross‑when‑principal” treatment of Google Ad Manager inventory to a more granular revenue‑recognition model.  In the 2024 filing the company explicitly notes that Ad Manager contracts can contain multiple performance obligations and that revenue is allocated to each obligation on the basis of relative standalone selling prices, while variable consideration (e.g., customer incentives and credits) is estimated and deducted from gross amounts.  This refinement integrates Ad Manager transactions more closely with Alphabet’s overall revenue‑reporting framework, expanding the scope of gross reporting and adding allocation and variable‑consideration adjustments that were not emphasized in the 2023 disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific technical details about 'multiple performance obligations,' 'relative standalone selling prices,' and 'variable consideration adjustments' that are NOT present in the ground truth answer. The ground truth focuses on a shift from transactional reporting to control-based evaluation, emphasizing Alphabet's assertion of principal status through inventory control, responsibility to customers, and pricing discretion. The LLM answer instead pivots to revenue allocation mechanics and variable consideration treatment, which represents a fundamentally different characterization of the evolution. WHAT WAS CORRECT: (1) The general timeframe (2023-2024) is correct; (2) The notion that there was an evolution in how Ad Manager is treated is correct; (3) The reference to gross reporting is appropriate. WHAT WAS INCORRECT: (1) The ground truth emphasizes a shift in JUSTIFICATION for gross revenue recognition (control-based vs. transactional), but the LLM answer claims the shift involves 'multiple performance obligations' and 'allocation...on the basis of relative standalone selling prices' - these specific mechanisms are not mentioned in the ground truth; (2) The ground truth does not discuss variable consideration, customer incentives, or credits in the context of this evolution; (3) The LLM answer mischaracterizes the nature of the change - it's not about 'expanding the scope of gross reporting' with new adjustments, but rather about how Alphabet justifies its principal role; (4) The phrase 'not emphasized in 2023 disclosures' is speculative and not supported by the ground truth. MULTI-HOP REASONING: The LLM failed to correctly synthesize the core evolution described in the ground truth. It appears to have generated plausible-sounding revenue recognition details rather than accurately capturing the shift from transactional to control-based justification. NO QUANTITATIVE ERRORS: There are no specific numbers, dates, or calculations to verify, so quantitative accuracy is relatively high for what is present, but the qualitative misdirection is severe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 569,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\nUPS recorded a $56 million goodwill impairment on Roadie in 2023, but no impairment charge was taken in 2024; nevertheless, Roadie remains one of three reporting units with only limited excess of fair value—accounting for roughly $1.1 billion of the company’s $4.3 billion goodwill balance—and is therefore flagged as a higher‑risk unit that is continuously monitored for potential future write‑downs.  Strategically, Roadie is housed within the Supply Chain Solutions segment, where UPS continues to pursue synergies and growth, but the thin fair‑value cushion means that any deterioration in performance or an increase in the cost of capital could trigger additional impairments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the $56 million goodwill impairment in 2023 and confirms no impairment in 2024, matching ground truth exactly. (2) Accurately adds specific quantitative details about Roadie's goodwill balance ($1.1 billion) and UPS's total goodwill ($4.3 billion), which are factually correct and enhance the answer. (3) Properly synthesizes the multi-hop information: 2023 impairment → 2024 monitoring status → ongoing risk assessment. (4) Correctly identifies Roadie as one of three reporting units with limited fair-value cushion, aligning with ground truth. (5) Appropriately contextualizes Roadie within Supply Chain Solutions segment and explains strategic positioning. (6) Accurately characterizes the evolution as a shift from active impairment to cautious monitoring. MINOR CONSIDERATIONS: (1) The LLM answer goes beyond the ground truth by providing additional context (goodwill amounts, segment placement, synergy discussion) that, while accurate and relevant, wasn't explicitly in the original answer. This represents enhancement rather than error. (2) The phrase 'one of three reporting units' is consistent with ground truth's 'among the reporting units.' (3) The explanation of sensitivity to cost of capital and performance forecasts aligns with ground truth's mention of 'sensitivity to cost of capital and performance forecasts.' QUANTITATIVE VERIFICATION: All numbers are accurate ($56M impairment, $1.1B Roadie goodwill, $4.3B total goodwill). No calculation errors detected. MULTI-HOP REASONING: Successfully synthesizes 2023-2024 comparison, connects impairment history to current risk status, and links financial metrics to strategic implications. The answer demonstrates sound understanding of the temporal evolution and causal relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 509,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium‑related business shifted from a modest growth contributor to a small drag on overall sales – in 2024 the “Other” segment (which includes global helium wholesale) posted a **$32 million (≈2 %) decline in sales** versus 2023, driven by lower helium volumes.  Despite that sales dip, operating profit in the same segment **rose $19 million (≈44 %)**, reflecting an insurance recovery that more than offset the higher helium‑related costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional shift in Linde's helium business from 2022-2024 and correctly identifies the 'Other' segment as the relevant reporting unit. However, there are significant quantitative accuracy issues: (1) The LLM provides specific dollar amounts ($32 million sales decline, $19 million operating profit increase, 44% operating profit growth) that are NOT present in the ground truth answer. The ground truth only states '2% underlying sales decrease' without specifying absolute dollar amounts. (2) The LLM's claim of a $19 million (44%) operating profit increase cannot be verified against the ground truth, which mentions 'increased costs related to helium, partially offset by an insurance recovery' but does not quantify the net operating profit impact as a positive $19 million increase. (3) The ground truth indicates operating profit faced 'increased costs' that were 'partially offset' by insurance recovery, which is ambiguous about net direction, whereas the LLM asserts a clear $19 million profit increase. Qualitatively, the LLM correctly identifies: the shift from neutral/positive to negative impact, the 2% sales decline in the 'Other' segment, the role of lower helium volumes, and the insurance recovery offsetting costs. The multi-hop reasoning is sound in connecting 2022-2024 evolution and synthesizing sales and profit impacts. However, the introduction of specific unverified dollar amounts ($32M, $19M, 44%) represents a critical factual error - the LLM appears to have fabricated precise numbers not supported by the ground truth. This is a major issue for financial analysis where precision matters.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 451,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\nThe amount of loans covered by the Corporation’s long‑term credit‑protection agreements with FNMA and FHLMC fell from **$8.7 billion at the end of 2023 to $8.0 billion at the end of 2024** (a decline of about $0.7 billion, or roughly 8 %).  \nBecause these guarantees provide full credit protection only on the covered residential‑mortgage loans, the reduction shows that a smaller share of the Corporation’s residential‑mortgage portfolio is now insulated from loss—i.e., the firm’s direct credit‑risk exposure on its remaining residential mortgages has increased.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the numerical values ($8.7 billion in 2023, $8.0 billion in 2024) and accurately calculates the decline ($0.7 billion or ~8%). The dates and entities (FNMA, FHLMC) are correct. The format and presentation are clear.\n\nCRITICAL WEAKNESS - INTERPRETATION ERROR: The LLM's interpretation of what the decline indicates is fundamentally incorrect and contradicts the ground truth. The LLM states: 'the reduction shows that a smaller share of the Corporation's residential-mortgage portfolio is now insulated from loss—i.e., the firm's direct credit-risk exposure on its remaining residential mortgages has increased.' This is backwards. The ground truth correctly explains that the decline 'suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio' and indicates 'a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent.' The LLM's conclusion that credit-risk exposure has INCREASED contradicts the logical implication that fewer loans need protection, suggesting lower risk exposure, not higher. This is a significant reasoning error that misrepresents the Corporation's credit risk profile.\n\nMULTI-HOP REASONING: While the LLM correctly synthesizes the numerical data across years, it fails in the critical second hop—interpreting what this change means for credit risk exposure. The ground truth provides the correct interpretation (decline in high-risk loans), while the LLM provides an inverted interpretation.\n\nCOMPLETENESS: The answer addresses both parts of the question (evolution of values and what it indicates about credit risk), but the second part is answered incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 475,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Adobe moved Firefly from a niche, standalone generative‑AI web app into a core, native capability woven throughout Photoshop, Illustrator, Adobe Express and the broader Experience Cloud, and it began marketing the service as “commercially safe” with multi‑language prompts, vector‑output models and enterprise‑level IP indemnification—key points of differentiation from other AI providers.  At the same time, the 2024 filing flags heightened regulatory risk, noting that emerging AI‑specific rules (e.g., the EU AI Act) and the need for extensive compliance, governance and indemnity frameworks could increase costs, expose Adobe to liability for AI‑generated content and constrain the rollout of new Firefly‑powered features.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of Adobe Firefly from 2023 to 2024, capturing both the competitive differentiation aspects (native integration, commercial safety positioning, multi-language support, vector outputs, IP indemnification) and the regulatory risk shift (EU AI Act, compliance costs, liability exposure). (2) No quantitative errors—no specific numbers, dates, or calculations are present in either answer, so quantitative accuracy is perfect by default. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information about product positioning changes across two fiscal years and connects them to regulatory developments. (4) Entity accuracy is correct: Adobe, Firefly, Photoshop, Illustrator, Adobe Express, Experience Cloud, and EU AI Act are all properly identified. (5) The semantic meaning matches the ground truth precisely—both answers convey that Firefly evolved from a competitive differentiator to a more risk-aware strategic positioning. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about specific product integrations (Photoshop, Illustrator, Adobe Express) and specific differentiators (multi-language prompts, vector-output models, enterprise-level IP indemnification) compared to the ground truth's more general framing. This additional specificity is not contradictory but rather enhances the answer without introducing errors. The LLM also explicitly mentions 'fiscal 2023 and 2024' which appropriately contextualizes the timeframe. The characterization of regulatory risks (compliance costs, liability exposure, feature rollout constraints) aligns perfectly with the ground truth's mention of 'compliance costs, delay development, or require changes to AI development practices.' Overall, this is a high-quality answer that accurately captures the strategic evolution and associated risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 532,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\nIn 2023 Trodelvy’s sales surged — up 56 % to $1.1 billion (page 41) — driven by strong demand in breast‑cancer and new markets, and the FDA approved it as a monotherapy for HR⁺/HER2‑ metastatic breast cancer while also granting a second Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer (pages 39, 7). Building on that momentum, in 2024 the company again received a Breakthrough‑Therapy designation for the SCLC indication (page 8), reinforcing an accelerating regulatory trajectory that expands Trodelvy’s approved uses and positions it for faster development and commercial growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 56% sales growth in 2023, the FDA Breakthrough Therapy designation for extensive-stage SCLC, and the HR+/HER2- metastatic breast cancer approval. The answer appropriately synthesizes financial and regulatory information across 2023-2024. The reasoning about regulatory trajectory and commercial positioning is sound and relevant.\n\nCRITICAL ERROR - QUANTITATIVE ACCURACY: The LLM states 2023 Trodelvy sales as '$1.1 billion' when the ground truth specifies '$1,063 million' ($1.063 billion). While $1.1B is a reasonable rounding, the ground truth provides a precise figure of $1,063M. This represents a ~$37M discrepancy (3.5% variance), which is material for financial reporting and violates the strict standard for numeric accuracy in SEC filings.\n\nMINOR ISSUE - REGULATORY TIMELINE: The LLM states 'in 2024 the company again received a Breakthrough-Therapy designation for the SCLC indication' which creates ambiguity. The ground truth indicates the second Breakthrough Therapy designation was granted in 2024 (not a repeat of 2023). The LLM's phrasing with 'again' could be misinterpreted as suggesting multiple 2024 designations, though the context suggests the LLM means this was the second designation overall.\n\nCOMPLETENESS: The answer addresses both financial performance (2023 sales growth) and regulatory trajectory (2024 Breakthrough designation), properly synthesizing multi-hop information. However, it adds contextual details about breast cancer markets and monotherapy approval that, while accurate, go beyond what the ground truth explicitly confirms.\n\nMULTI-HOP REASONING: The synthesis across 2023-2024 data and connection between financial growth and regulatory recognition is logically sound and demonstrates proper multi-document synthesis.\n\nJUSTIFICATION: The primary penalty is for the $1.1B vs $1.063M discrepancy. In financial analysis, precision matters significantly. The answer is otherwise well-reasoned and comprehensive, but the quantitative error prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 553,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\nChevron’s 36.4 % stake in Angola LNG Limited stayed unchanged, but the investment’s carrying value slipped from about **$1.76 bn (2023)** to **$1.66 bn (2024)** after having peaked at **$1.86 bn in 2022** (Notes 15 & 16, 2024 10‑K).  Correspondingly, equity‑method earnings fell sharply from **$1.86 bn in 2022** to **$0.51 bn in 2023** and remained modest in 2024, indicating a reduced financial contribution from the project.  The partnership continues to provide a strategic LNG outlet and generates tax cash‑flows (Chevron’s share of the 2024 affiliate tax expense was **$1.29 bn**), but the lower investment balance and earnings reflect a deliberate scaling back of Angola LNG’s role in Chevron’s overall cash‑flow strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Chevron's 36.4% ownership stake in Angola LNG Limited and appropriately addresses the evolution of financial involvement from 2022-2024. The qualitative reasoning about strategic positioning, LNG outlet value, and tax cash flows is sound and relevant. The answer demonstrates good multi-hop synthesis by connecting ownership percentages, carrying values, earnings trends, and tax implications.\n\nCRITICAL ISSUES WITH QUANTITATIVE ACCURACY: (1) The ground truth states that in 2022, Chevron reported 'income from equity affiliates' of $5,657 million (total across all affiliates, not Angola LNG-specific). The LLM claims equity-method earnings from Angola LNG were '$1.86 bn in 2022' - this specific number cannot be verified against the ground truth provided and appears to be unsupported. (2) The carrying values cited ($1.76bn 2023, $1.66bn 2024, $1.86bn 2022) are presented with high specificity but cannot be verified against the ground truth. (3) The 2023 earnings figure of $0.51bn and the 2024 tax expense of $1.29bn are specific numbers that lack verification in the provided ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions (ownership stake, carrying values, earnings trends, tax implications) and correctly identifies the evolution pattern. However, the specific financial figures used to support this narrative appear to be either fabricated or sourced from documents not provided in the ground truth.\n\nGROUND TRUTH ALIGNMENT: The original answer emphasizes (1) 2022 improved income from equity affiliates including Angola LNG contributing to $5,657M total, and (2) 2024 disclosure of 36.4% stake with strategic emphasis on LNG. The LLM answer provides much more granular detail but this detail is not substantiated by the ground truth provided.\n\nVERDICT: While the LLM demonstrates strong qualitative reasoning and correctly identifies key facts (36.4% stake, strategic LNG positioning), the quantitative claims lack verification and appear potentially inaccurate. The answer reads as plausible but the specific dollar amounts and year-over-year comparisons cannot be confirmed as correct based on the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 601,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\nBy year‑end 2024 Meta’s fixed‑rate senior unsecured notes had a face value of roughly **$29 billion**, compared with **$18.5 billion** at the end of 2023.  The jump reflects a **$10.5 billion issuance in August 2024** (on top of the $8.5 billion May 2023 tranche), expanding the total outstanding notes and driving interest expense up from $420 million in 2023 to $683 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Face values are correct - $29.0 billion (2024) vs $18.5 billion (2023), matching ground truth exactly; (2) August 2024 issuance of $10.5 billion is correct; (3) May 2023 issuance stated as '$8.5 billion' in LLM vs '$8.46 billion' in ground truth - this is a minor rounding difference ($8.46B rounded to $8.5B is reasonable and acceptable); (4) Interest expense figures ($420M in 2023, $683M in 2024) are additional context not in ground truth but appear reasonable and add value. Multi-hop synthesis is sound: the answer correctly traces the evolution from 2023 to 2024, identifies both issuance events, and explains the relationship between increased debt and higher interest expense. The answer directly addresses the question about how value and issuance activity evolved. The only minor discrepancy is the $8.46B vs $8.5B rounding, which is immaterial and represents standard financial reporting practice. The inclusion of interest expense data, while not in the ground truth, demonstrates deeper understanding and is contextually relevant to debt financing discussion. Overall, this is a comprehensive, accurate answer with sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 347,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\nIn the 2023 10‑K (page 62) helium was listed only as part of “Rawmaterials and supplies” with a $614 million balance and was treated simply as a routine supply, without any risk‑or‑dependency language. The 2024 filing (also page 62) shows the raw‑materials inventory falling to $529 million and the accompanying footnote now explicitly identifies helium as a “critical raw material” and notes heightened sourcing constraints and rising cost volatility, signalling that the company now views helium as a dependency rather than a mere supply.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The ground truth specifies helium costs as 4.2% of total raw material expenses in 2023 and 6.8% in 2024. The LLM answer provides no percentage data whatsoever, instead citing raw materials inventory figures ($614M in 2023, $529M in 2024) that are not mentioned in the ground truth and appear to be fabricated or misattributed. These inventory numbers are not the relevant metrics for answering the question about helium's financial exposure as a percentage of raw material costs. (2) MISSING KEY METRICS: The LLM completely omits the specific cost percentages (4.2% vs 6.8%) that are central to demonstrating how helium's financial exposure changed. This is a critical omission that undermines the entire answer. (3) REASONING FLAW: While the LLM correctly identifies the conceptual shift from 'supply' to 'dependency' and mentions sourcing constraints and cost volatility, it fails to quantify this shift with the actual financial data provided in the ground truth. The answer relies on qualitative language ('critical raw material,' 'heightened sourcing constraints') rather than the specific cost exposure percentages that demonstrate the magnitude of change. (4) PAGE REFERENCES: The LLM cites 'page 62' for both years, which cannot be verified against the ground truth and may be inaccurate. (5) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the relationship between the categorization change (supply→dependency) and the corresponding financial impact (4.2%→6.8% cost exposure). The ground truth explicitly connects these two elements; the LLM separates them. The answer demonstrates partial understanding of the conceptual shift but fails on the quantitative accuracy essential to this financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 506,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal’s management could designate for funding credit activities fell sharply—from **$3.8 billion approved in 2022 to $3.0 billion approved in 2023**.  This represents a **year‑over‑year decline of roughly 21 %** in the approved amount for such credit‑related uses.  (Source: PYPL_10k_2023.pdf p. 49; PYPL_10k_2022.pdf p. 75).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures ($3.8 billion in 2022 declining to $3.0 billion in 2023) and accurately calculates the percentage change at approximately 21% decline. The calculation is mathematically correct: ($3.8B - $3.0B) / $3.8B = $0.8B / $3.8B ≈ 21.05%. The answer properly addresses the main question about how the approved amount evolved between the two years and provides the percentage change requested. However, the answer is incomplete in one important respect: it fails to mention the percentage of European customer balances that these amounts represented (37% in 2022 and 39% in 2023), which was explicitly stated in the ground truth and provides important context about the utilization rate. The ground truth notes that while the absolute amount decreased, the percentage of available balances actually increased slightly, indicating a more conservative approach overall. The LLM answer characterizes this as a 'sharp' decline and 'more conservative approach' but doesn't fully explain the nuance that the percentage utilization rate increased despite the absolute amount decreasing. The multi-hop reasoning is sound in synthesizing the 2022 and 2023 data, and the source citations are appropriate. The answer is factually accurate on the numbers provided but incomplete in addressing all dimensions of the original question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 381,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\nBetween fiscal 2023 (Oct 1 2023) and fiscal 2024 (Sep 29 2024) the fair‑value of Starbucks’ “foreign‑currency – other” derivatives fell sharply on the asset side (from $32 million of derivative assets to $1.9 million) while the liability side grew (from $2.0 million accrued plus virtually no long‑term liability to $4.7 million accrued and $4.1 million long‑term).  As a result, the pre‑tax gain that remains in AOCI and is expected to be re‑classified to earnings over the next 12 months dropped from $28.2 million to $9.5 million, indicating that the anticipated earnings impact of these foreign‑currency hedges has been cut by roughly two‑thirds.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the question entirely. Critical issues: (1) NUMBERS ARE WRONG: The ground truth states fair value of $1,164M (2023) and $920M (2024), but the LLM discusses derivative assets of $32M and $1.9M - these are completely different metrics and magnitudes. The LLM appears to be discussing individual derivative asset/liability line items rather than the total fair value of foreign currency instruments. (2) AOCI GAINS MISREPORTED: Ground truth shows net gains in AOCI of $39.6M (2023) and $11.5M (2024), but LLM doesn't mention these figures at all. (3) RECLASSIFICATION AMOUNT ERROR: Ground truth shows $55.3M (2023) declining to $9.5M (2024). The LLM correctly identifies $9.5M for 2024 but states the 2023 figure as $28.2M - this is incorrect and represents only about half the actual amount. (4) FUNDAMENTAL MISUNDERSTANDING: The LLM appears to be analyzing derivative asset/liability positions rather than the comprehensive fair value exposure and AOCI impacts that the question asks about. The LLM's discussion of 'asset side' and 'liability side' derivatives in millions suggests it's looking at balance sheet line items rather than the consolidated fair value metrics. (5) INCOMPLETE ANSWER: The LLM fails to address the AOCI net gain component entirely, which is a key part of the original answer. The only correct number in the LLM response is the $9.5M reclassification amount for 2024. The calculation about 'two-thirds' reduction is based on incorrect 2023 baseline ($28.2M vs actual $55.3M), making even the analytical conclusion unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 443,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\nAlabama Power’s energy‑related derivative assets fell from about $55 million in 2022 to $15 million in 2023, while its liabilities rose from $11 million to $61 million; Georgia Power’s assets declined from roughly $75 million to $13 million and its liabilities increased from $8 million to $124 million. In each case the drop in derivative assets was matched by a rise in derivative liabilities, shifting both subsidiaries from a net derivative‑asset to a net derivative‑liability position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding Alabama Power's 2023 liability position. Ground truth states Alabama Power's liabilities increased to $110 million in 2023, but the LLM reports $61 million—a $49 million discrepancy. This is a material error that undermines the core factual accuracy of the response. CORRECT ELEMENTS: (1) Alabama Power assets: $55M (2022) → $15M (2023) ✓; (2) Georgia Power assets: $75M (2022) → $13M (2023) ✓; (3) Georgia Power liabilities: $8M (2022) → $124M (2023) ✓; (4) Alabama Power assets 2022: $11M → 2023 liabilities direction is correct (increase) but magnitude wrong. REASONING QUALITY: The LLM correctly identifies the directional shift from net asset to net liability positions for both entities and appropriately synthesizes the multi-hop comparison across two companies and two years. The logical framework is sound. COMPLETENESS: The answer addresses all parts of the question (both companies, both years, asset/liability positions, directional changes). However, the quantitative error in Alabama Power's 2023 liability figure ($61M vs. $110M ground truth) is a fundamental factual failure that significantly impacts the reliability of the response. The error represents a 45% understatement of the actual liability position, which is material for financial analysis. MULTI-HOP SYNTHESIS: The model successfully synthesizes information across two entities and two time periods, but the execution is compromised by the data accuracy issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 423,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\nThe U.S. Retiree Health Care Plan’s asset mix moved markedly toward fixed‑income securities between 2022 and 2023. In 2022 the plan held about $182 million of fixed‑income/cash equivalents (≈ 65 % of its $280 million total) and roughly $98 million of equity (≈ 35 %). By the end of 2023 the allocation had shifted to roughly $210 million of fixed‑income (≈ 80 % of its $264 million total) and only $54 million of equity (≈ 20 %). Thus, the strategy evolved from a roughly 65/35 split to an approximate 80/20 split in favor of fixed‑income securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All percentage allocations are correct - 65% fixed income/35% equity in 2022, shifting to 80% fixed income/20% equity in 2023, matching the ground truth exactly. (2) The dollar amounts provided ($182M, $98M, $210M, $54M) are internally consistent with the stated percentages and total asset values ($280M in 2022, $264M in 2023). Verification: 182/280 = 65%, 98/280 = 35%, 210/264 = 79.5% ≈ 80%, 54/264 = 20.5% ≈ 20%. (3) The multi-hop synthesis is sound - the answer correctly identifies the shift from 65/35 to 80/20 split and characterizes it as a move toward a more conservative strategy. (4) All entities are correctly identified (U.S. Retiree Health Care Plan, fixed income securities, equity securities, years 2022-2023). (5) The answer goes beyond the ground truth by providing specific dollar amounts and total asset values, which adds helpful context without contradicting the original answer. MINOR CONSIDERATIONS: The LLM provides additional quantitative detail (specific dollar amounts) not explicitly in the ground truth, but these are consistent with the percentages and enhance rather than detract from the answer. The characterization of the strategy shift as 'marked' and 'toward a more conservative investment strategy' aligns with the ground truth's description. No calculation errors detected. The answer fully addresses all aspects of the multi-part question regarding the evolution of asset allocation strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 414,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory standing moved from *accelerated‑approval only* for two prior indications—metastatic triple‑negative breast cancer and advanced urothelial cancer after platinum‑based chemotherapy plus a PD‑1/PD‑L1 inhibitor—to a **full FDA approval (with European Commission conditional authorization)** for a **new indication in 2023**: monotherapy treatment of adult patients with unresectable or metastatic HR‑positive/HER2‑negative breast cancer who have received endocrine therapy and at least two prior systemic therapies. The earlier accelerated approvals for TNBC and urothelial cancer remained in place, but the 2023 approval added the HR⁺/HER2⁻ breast‑cancer label.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2023 new indication for HR+/HER2- breast cancer is accurately described with correct patient population details (endocrine-based therapy and at least two additional systemic therapies). (2) The mention of EC approval alongside FDA approval for the 2023 indication is accurate. (3) The 2022 indications (TNBC and metastatic urothelial cancer) are correctly identified. (4) The overall narrative of expansion from 2022 to 2023 is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces the concept of 'accelerated-approval only' status in 2022 and claims the 2023 approval represented a shift to 'full FDA approval.' The ground truth does not specify the approval type (accelerated vs. full) for the 2022 indications, and the LLM appears to have added this detail without evidence from the source material. (2) The characterization that 'earlier accelerated approvals...remained in place' is speculative and not confirmed in the ground truth. (3) The phrasing 'European Commission conditional authorization' is technically accurate but the ground truth simply states 'EC approval' without specifying it as conditional. MULTI-HOP REASONING: The LLM correctly synthesized information about the evolution between 2022 and 2023, identifying the new indication and regulatory approvals. However, it added interpretive details about approval types that go beyond what the ground truth establishes. SEMANTIC EQUIVALENCE: The core factual content about the new HR+/HER2- indication and its approval status matches the ground truth, but the framing around approval type changes introduces uncertainty. The answer is substantially correct on the main question but contains unsupported characterizations about approval status transitions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 491,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\nIn the 2023 10‑K Meta warned that adverse media coverage, privacy‑related controversies and content‑moderation decisions (including those of the independent Oversight Board) could prompt marketers to cut ad spend and users to disengage, directly threatening revenue. By the 2024 filing the language was broadened: it flags heightened public scrutiny over data‑transfer rulings, the rollout of a paid‑ad‑free “subscription‑for‑no‑ads” option, and more general trust concerns, stressing that any erosion in user perception of the platform’s safety and integrity could materially reduce user growth, engagement and advertiser demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific, detailed examples from both 2023 and 2024 filings (adverse media coverage, privacy controversies, content moderation, data-transfer rulings, subscription-for-no-ads option, trust concerns), which demonstrates engagement with actual filing language. However, there is a significant discrepancy between the LLM answer and the ground truth regarding the overall evolution narrative. The ground truth emphasizes that user perception risks were REDUCED in 2024 with a strategic shift toward broader operational/financial risks (acquisitions, tax liabilities, investor sentiment). The LLM answer instead suggests the language was BROADENED and that user perception concerns were EXPANDED in 2024, presenting the opposite directional change. This is a fundamental mischaracterization of how Meta's risk disclosure evolved. The LLM correctly identifies specific risk factors mentioned in each year and accurately notes the shift in focus areas, but fails to capture the key insight that explicit user perception risks were 'notably reduced' in 2024 per the ground truth. The answer is well-detailed and contextually relevant but contains a critical error in interpreting the nature of the evolution (expansion vs. reduction of user perception emphasis). No quantitative errors are present, but the qualitative reasoning about the strategic shift is inverted from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 390,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\nThe notional amount of Lockheed Martin’s outstanding variable‑interest‑rate swaps rose from roughly **$0.5 billion in 2021** to **$1.3 billion by the end of 2023**, and remained at that $1.3 billion level through 2024. This expansion shows the company has deliberately increased its use of fair‑value hedges to convert fixed‑rate debt into variable‑rate exposure, a proactive move to manage interest‑rate risk in a period of rising rates and to stabilize earnings and cash‑flow volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The 2021 figure of $0.5 billion (correctly formatted as $500 million) matches ground truth exactly. The 2024 figure of $1.3 billion matches ground truth. However, the LLM states the amount 'remained at that $1.3 billion level through 2024' and specifies 'by the end of 2023,' which adds detail not explicitly in the ground truth but appears consistent with the data. The ground truth simply states 2024 reached $1.3 billion without specifying when during 2024 or whether it remained constant. QUALITATIVE ASSESSMENT: The LLM correctly identifies this as a significant increase (160% growth from $500M to $1.3B) and provides sound reasoning about interest rate risk management strategy. The explanation about converting fixed-rate debt to variable-rate exposure and managing earnings/cash-flow volatility is appropriate and demonstrates understanding of hedging mechanics. The reference to 'fair-value hedges' is a reasonable technical characterization. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the temporal evolution (2021→2024) and connects it to strategic implications, matching the ground truth's intent. MINOR ISSUES: The LLM provides slightly more specific temporal detail ('by the end of 2023') than the ground truth explicitly states, and mentions 'period of rising rates' which is contextually reasonable but not explicitly confirmed in the ground truth. These additions are reasonable inferences rather than errors. The core facts, numbers, and reasoning are sound and well-aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 446,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal’s Seller‑Protection reserve was trimmed only modestly – the allowance for transaction losses fell from **$66 million (as of 31 Dec 2022) to $64 million (as of 31 Dec 2023)** [page 113].  The company recorded a slightly higher provision expense in 2023 ($1.192 billion vs. $1.170 billion in 2022) but realized a larger reduction in actual losses ($1.313 billion of write‑offs versus $1.417 billion the prior year), resulting in a net decline in the reserve.  This reflects a more refined estimation of exposure—incorporating updated macro‑economic trends and loss experience—so that the financial provision for seller‑protection‑related transaction losses was modestly decreased while still being monitored closely.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and dates. Key quantitative elements verified: (1) Allowance for transaction losses correctly stated as $66 million (2022) and $64 million (2023) - matches ground truth exactly; (2) Provision expense figures of $1.192 billion (2023) vs $1.170 billion (2022) are presented with appropriate precision; (3) Write-off amounts of $1.313 billion (2023) vs $1.417 billion (2022) show proper year-over-year comparison. The LLM correctly identifies the modest decline in the reserve ($2 million decrease) and provides additional context about provision expenses and actual losses that enriches the answer beyond the ground truth baseline. Multi-hop reasoning is sound: the answer synthesizes the reserve change with provision and write-off data to explain the net decline. The LLM appropriately characterizes the evolution from 2022 to 2023 as moving toward 'more refined estimation' while acknowledging continued monitoring. Minor limitation: The ground truth mentions historical loss rates (0.09%-0.15% of TPV) and COVID-19 pandemic impacts from 2022 disclosures, which the LLM answer does not explicitly reference. However, the LLM does mention 'updated macro-economic trends' which captures the essence of this evolution. The answer is well-structured, provides specific page reference [page 113], and maintains semantic equivalence with the ground truth while adding substantive detail about provision and write-off dynamics. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 421,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\nFrom fiscal 2023 (balance as of Oct 1 2023) to fiscal 2024 (balance as of Sep 29 2024) the foreign‑currency‑other derivative **asset** fell from **$54.9 million** to **$3.6 million** – a **$51.3 million** decrease – while the foreign‑currency‑other derivative **liability** rose from **$2.0 million** to **$8.8 million** – an **$6.8 million** increase.  Consequently, the balance‑sheet shows a **$51.3 million reduction in derivative assets** and a **$6.8 million increase in derivative liabilities** for this category, producing a net swing of roughly **$44–$58 million** in the overall foreign‑currency‑other derivative position.  (Values are taken from the “Derivative Assets” and “Derivative Liabilities” rows for “Foreign currency – other” in the fair‑value tables on pages 72/73 of the 2023 and 2024 Form 10‑K filings.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key numerical values. Ground truth shows: (1) Derivative assets in 'Foreign currency - other' decreased from $1,164 million (FY2023) to $1.9 million (FY2024), a decrease of $1,162.1 million. The LLM reports $54.9M to $3.6M, a decrease of $51.3M - completely wrong numbers. (2) Derivative liabilities increased from $2.0 million (FY2023) to $4.7 million (FY2024), an increase of $2.7 million. The LLM reports $2.0M to $8.8M, an increase of $6.8M - also incorrect. The LLM's numbers are off by orders of magnitude on the asset side (reporting ~$55M instead of ~$1,164M) and significantly overstated on the liability side ($8.8M vs $4.7M). The LLM correctly identifies the direction of changes (assets down, liabilities up) and appropriately addresses the multi-part question structure, but the specific dollar amounts are dramatically inaccurate. The LLM also provides a citation to pages 72/73 of the 10-K, suggesting confidence in sourcing, but the numbers cited do not match the ground truth data. This is a critical failure on quantitative accuracy - the core requirement for financial analysis questions. The reasoning structure is sound, but it is built on incorrect foundational data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 348,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\nIn 2022 the energy‑related derivatives produced a $59 million net positive contribution to earnings from natural‑gas cost and revenue hedges, but by 2023 that contribution had reversed to a $76 million net loss. This swing reflects a shift in the revenue hedge from a $134 million gain (2021) to an $11 million loss (2023), while the cost‑hedge gain remained modest ($59 million in 2023), causing the overall hedging impact to move from a positive to a negative result.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all quantitative metrics and contains major factual errors. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims 2022 had a $59 million net positive contribution, but ground truth shows $117 million negative on revenues and $27 million negative on costs. The LLM claims 2023 had a $76 million net loss, but ground truth shows $59 million positive on costs and $0 on revenues. The LLM references a 2021 figure ($134 million gain) that is not part of the ground truth answer and appears to be fabricated or from a different context. (2) DIRECTIONAL ERRORS - The LLM incorrectly characterizes 2022 as positive when it was negative, and 2023 as negative when it was positive. This is a complete reversal of the actual trend. (3) INCOMPLETE SYNTHESIS - While the question asks about evolution from 2022 to 2023, the LLM introduces 2021 data that wasn't requested and doesn't properly synthesize the actual 2022-2023 comparison. (4) MISSING KEY FACTS - The ground truth clearly separates revenue hedging ($117M negative in 2022, $0 in 2023) from cost hedging ($27M negative in 2022, $59M positive in 2023). The LLM conflates these or presents different numbers entirely. (5) CALCULATION ISSUES - The LLM's net figures don't align with any reasonable combination of the ground truth numbers. The answer demonstrates a fundamental misunderstanding of the data and fails to accurately convey how the derivatives' impact evolved from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 412,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Deferred Compensation Matching Plan was only listed among the exhibit indexes and was not presented as a separately filed, restated agreement, so its effective date was not highlighted. The 2024 filing, however, includes the plan as Exhibit 10.1 and explicitly states that it was “amended and restated effective November 8, 2023,” formally documenting the update and providing a clear effective date. Thus, the treatment evolved from an informal, undated reference to a fully documented, restated plan with a specified November 8, 2023 effective date.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The quantitative accuracy is acceptable (the date November 8, 2023 is correct), but the core narrative is inverted. Ground truth states: (1) In 2023, the plan was 'newly introduced' with effective date November 8, 2023, and (2) In 2024, it was 'incorporated by reference' and no longer labeled as newly introduced. The LLM answer claims the opposite: that in 2023 the plan was 'only listed among exhibit indexes' without a highlighted effective date, and in 2024 it was 'explicitly stated' with the November 8, 2023 effective date. This is a critical reversal of the documented evolution. The LLM also mischaracterizes the 2023 treatment as 'informal, undated reference' when ground truth explicitly states it was introduced as 'amended and restated effective November 8, 2023.' The reasoning about the shift from informal to formal documentation is backwards—the ground truth indicates the plan became more integrated/referenced in 2024, not that it gained formal documentation then. While the date itself is correct, the entire narrative structure and the multi-hop synthesis across the two years is fundamentally incorrect, making this answer misleading despite containing one accurate date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 361,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\nBetween 2023 and 2024 the company continued to disclose LTIP Units as “potentially dilutive securities” in its earnings‑per‑share/unit tables, but in both years it concluded that they did **not** have a material dilutive effect and therefore made no adjustments to net income or to the weighted‑average share (or unit) counts.  The accrual policy for any distributions related to those units was unchanged – distributions are accrued only when they are declared.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies LTIP Units as 'potentially dilutive securities' in both years; (2) Accurately states no material dilutive effect was reported; (3) Correctly notes no adjustments were made to net income or weighted-average shares/units; (4) Accurately describes the accrual policy (distributions accrued when declared); (5) Properly synthesizes the multi-hop comparison showing stability between 2023 and 2024. The answer demonstrates sound multi-hop reasoning by comparing treatment across both years and identifying the consistency in policy. Minor observation: The LLM answer uses slightly more concise phrasing than the ground truth (e.g., 'unchanged' vs. 'remained consistent'), but this represents semantic equivalence rather than factual error. The answer directly addresses all components of the question: disclosure evolution, dilutive effect treatment, and accrual policy. No quantitative errors, dates are correct (2023, 2024, 2022, 2021 references), and entity identification is precise. The reasoning correctly synthesizes information across the two-year period to show continuity in treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 339,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\nBetween 2023 and 2024 Meta shifted from a defensive stance—appealing the Irish DPC’s €1.2 bn fine and corrective order that required it to suspend EU‑US transfers under the invalidated SCCs (with an interim stay in place)—to an active compliance posture built around the newly‑adopted EU‑U.S. Data Privacy Framework.  After the European Commission’s July 2023 adequacy decision, the company began revising its legal bases for processing in the EU (moving from “legitimate interests” to consent), introduced a “subscription‑for‑no‑ads” option, and invested in privacy‑by‑design controls and governance to meet the DPF’s safeguards.  It also engaged directly with EU regulators on DMA and DSA matters, reflecting a move from reactive appeals to proactive alignment with the DPF and related EU data‑protection requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- Correctly identifies the €1.2 billion fine from Irish DPC\n- Correctly mentions the EU-U.S. DPF adequacy decision (though dates it to July 2023, which is accurate)\n- Correctly identifies the 'subscription-for-no-ads' model as a compliance response\n- Correctly notes the shift from defensive to proactive compliance posture\n- Correctly identifies engagement with regulators on DMA and DSA matters\n\nSIGNIFICANT ERRORS AND OMISSIONS:\n1. TEMPORAL MISALIGNMENT: The LLM states the European Commission's adequacy decision was in July 2023, which is correct, but then frames this as the starting point for Meta's compliance shift. However, the ground truth indicates Meta was already implementing corrective orders in 2023 BEFORE the DPF was finalized, suggesting the timeline may be compressed or misrepresented.\n\n2. MISSING KEY 2024 DEVELOPMENT: The ground truth explicitly states that in 2024, the European Commission opened formal proceedings into the 'subscription for no ads' model's compliance with the DMA, issuing preliminary findings in July 2024 suggesting non-compliance. The LLM answer mentions DMA engagement but does NOT mention the July 2024 preliminary findings of non-compliance, which is a critical evolution point between 2023 and 2024.\n\n3. INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a shift from foundational compliance with EU-U.S. DPF to navigating complex regulatory scrutiny around specific business models. The LLM answer focuses heavily on the initial DPF implementation but underemphasizes the 2024 escalation regarding the subscription model's DMA compliance issues.\n\n4. MISSING CONTEXT: The ground truth mentions Meta was implementing compliance measures with corrective orders by 2024, which the LLM doesn't explicitly address.\n\nQUANTITATIVE ACCURACY: The €1.2 billion figure is correct. The date references (July 2023 for adequacy decision) are accurate. However, the critical omission of the July 2024 preliminary findings represents incomplete temporal coverage of the 2023-2024 evolution.\n\nQUALITATIVE ACCURACY: While the LLM correctly identifies the shift from defensive to proactive stance, it fails to capture the full complexity of the 2024 regulatory escalation. The answer reads as more of a 2023 compliance narrative than a true 2023-2024 evolution.\n\nCONTEXTUAL RELEVANCE: The answer is relevant to the question but incomplete in addressing the full scope of how Meta's approach evolved, particularly missing the critical 2024 DMA compliance challenge.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 702,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Linde moved from describing green hydrogen only as “hydrogen produced by electrolysis using renewable energy” — a side‑note among gray and blue pathways — to explicitly positioning renewable‑electrolysis hydrogen as a distinct, non‑fossil feedstock and a core element of its clean‑energy strategy.  The 2024 document emphasizes that this “renewable (green) hydrogen” is produced via electrolysis powered by renewable electricity and water, and it highlights Linde’s engineering, digital‑service and distribution capabilities as the platform for scaling those electrolytic projects, underscoring a stronger, dedicated focus on renewable‑energy‑driven production methods.  (Pages 5‑6 of the 2024 10‑K; comparable discussion appears on pages 4‑5 of the 2023 10‑K.)",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Linde's green hydrogen approach between 2023 and 2024, correctly identifying the shift toward emphasizing renewable electrolysis as a distinct, strategic offering. The answer accurately reflects the key differences: (1) 2023 positioning as one option among gray/blue pathways vs. 2024 positioning as a core element; (2) the emphasis on renewable electricity and water as feedstock; (3) the differentiation from low-carbon (blue) hydrogen. The page references (pages 5-6 of 2024 10-K and pages 4-5 of 2023 10-K) are appropriately cited. However, there are some notable omissions compared to the ground truth: (1) The LLM answer does not mention steam methane reforming of biomethane as an alternative green hydrogen production method described in 2023, which was explicitly noted in the original answer; (2) The LLM answer does not explicitly mention the increased emphasis on carbon intensity metrics as a differentiation tool in 2024, which the ground truth identifies as a key refinement in Linde's strategic framing. The LLM answer does add valuable context about Linde's engineering, digital-service, and distribution capabilities as scaling platforms, which provides useful supplementary information not in the ground truth but relevant to the evolution narrative. The multi-hop reasoning is sound—correctly synthesizing the comparison across two years and identifying the strategic shift. No quantitative errors are present (no specific numbers were required for this qualitative question). The semantic meaning largely aligns with the ground truth, though the answer is somewhat less comprehensive in capturing all dimensions of the evolution described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 471,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\nBetween 2022 and 2023 Southern Company completely exited its ownership of Sequent— the wholesale‑gas services business that had been reported as a distinct segment in 2021‑2022—by selling its controlling interest in July 2021 and then removing the segment from its 2022 and 2023 filings.  The 2021 transaction produced a $121 million pre‑tax gain (≈ $92 million after tax), but the subsequent re‑allocation of state‑apportionment rates created an additional $85 million tax expense, and after the sale Sequent no longer contributed any revenue or earnings, leaving the company without that source of income in the 2023 segment results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND FACTS: The LLM answer contains a fundamental factual error regarding the timing of the transaction. The LLM states the sale occurred in 'July 2021' and that Sequent was 'removed from its 2022 and 2023 filings,' but the ground truth clearly indicates the sale was completed in 2022 (not 2021), with full financial impact reflected in 2023. This is a major multi-hop reasoning failure. QUANTITATIVE ACCURACY ISSUES: (1) The $121 million pre-tax gain is correct. (2) The $85 million tax expense is correctly identified. (3) However, the LLM's calculation of the after-tax gain as '≈ $92 million' is problematic and unexplained—the ground truth does not provide this specific after-tax figure, and the LLM appears to have made an unsupported calculation. (4) The LLM fails to mention the $159 million sale price, which is a key financial metric in the ground truth. ENTITY AND TIMELINE ERRORS: The LLM incorrectly places the transaction in 2021 when it occurred in 2022, fundamentally misrepresenting the 2022-2023 evolution requested in the question. The ground truth explicitly states 'In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million.' COMPLETENESS: The LLM misses the buyer (Williams Field Services Group) and the sale price ($159 million), both important financial details. The LLM does correctly identify that the relationship evolved from ownership to divestiture and mentions the key financial impacts (gain and tax expense). REASONING QUALITY: The multi-hop synthesis is severely compromised by the timeline error. While the LLM correctly identifies that the relationship changed and mentions relevant financial metrics, the incorrect dating of the transaction undermines the entire answer's credibility and accuracy regarding the 2022-2023 evolution specifically requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 507,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart continued to list **Allswell** in the same “private‑brand” section of its 10‑K filings, but it no longer highlighted the brand with separate performance or growth language – the reference was identical in both years.  This consistency shows that Walmart is treating Allswell as a stable, value‑oriented home‑goods label that fits within its broader private‑brand portfolio, using it to reinforce the everyday‑low‑price proposition while expanding its home‑category offerings without creating a distinct strategic shift.  In short, the relationship has remained steady, indicating that Allswell is viewed as a core component of Walmart’s private‑brand strategy rather than a brand undergoing transformation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The LLM correctly identifies that Allswell was listed in both 2023 and 2024 10-K filings; (2) The fiscal year references (2023 and 2024) are accurate; (3) The characterization of Allswell as a 'stable, value-oriented home-goods label' aligns with the ground truth's conclusion that it became an 'established part' of the portfolio. PROBLEMATIC ASPECTS: (1) The LLM states the reference was 'identical in both years' with 'no separate performance or growth language,' but the ground truth indicates a meaningful evolution - Allswell was 'newly introduced' in 2023 and by 2024 was 'explicitly listed among other mature private brands' (bettergoods, Equate, Great Value). This represents a transition from new to established, not mere consistency; (2) The LLM's conclusion that 'the relationship has remained steady' contradicts the ground truth's narrative of evolution from introduction to maturation; (3) The LLM misses the key insight that Allswell's progression from new brand to being grouped with mature brands indicates 'likely gained traction.' MULTI-HOP REASONING: The LLM correctly synthesizes information across two fiscal years but arrives at a different interpretation - emphasizing stability rather than evolution. The ground truth emphasizes progression (new → established), while the LLM emphasizes consistency (same listing both years). SEMANTIC ISSUE: While both answers conclude Allswell is a 'core component,' they differ fundamentally on whether this represents strategic evolution or strategic consistency. The ground truth's framing of 'transition' and 'progression' is more aligned with the actual filing data showing movement from new to mature brand status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 480,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\nEmbedded Processing’s strategic weight grew noticeably from 2022 to 2023: its revenue rose 3 % year‑over‑year (to $3.37 bn) while Analog revenue fell 15 %, pushing Embedded Processing’s share of total sales upward and offsetting the decline in the Analog segment.  Management continues to allocate disproportionate resources—higher capital‑expenditure levels, expanded R&D and the CHIPS‑Act‑driven capacity build‑out—to Embedded Processing, even though its operating margin slipped (from 38.4 % to 29.9 %).  This reflects a clear shift toward positioning Embedded Processing as a longer‑term growth engine for cash‑flow generation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Major):\n   - Claims Embedded Processing revenue was $3.37 billion in 2023 - this specific figure is NOT provided in the ground truth\n   - States 3% YoY growth for Embedded Processing - no such figure appears in ground truth\n   - Claims Analog revenue fell 15% - not mentioned in ground truth\n   - States operating margins of 38.4% (2022) and 29.9% (2023) - these specific figures are NOT in the ground truth\n   - Ground truth explicitly states 'no specific revenue figures were disclosed' for 2022 Embedded Processing\n\n2. FACTUAL CONTRADICTIONS:\n   - Ground truth: 'no specific revenue figures were disclosed' for 2022\n   - LLM: Provides specific 2022 operating margin (38.4%) and implies specific revenue data\n   - This is a fundamental contradiction about data availability\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM synthesizes detailed financial metrics that the ground truth explicitly states were not disclosed\n   - The answer fabricates specific numbers rather than acknowledging the lack of disclosed figures\n   - The reasoning about 'disproportionate resource allocation' and 'CHIPS-Act-driven capacity build-out' goes beyond what the ground truth supports\n\n4. WHAT WAS CORRECT:\n   - General concept that Embedded Processing maintained strategic importance\n   - General concept that it offset Analog decline\n   - Total revenue figure of $17.52 billion for 2023 is consistent with ground truth\n   - Directional understanding that Embedded Processing's role became more pronounced\n\n5. CRITICAL ISSUE:\n   - The LLM appears to have hallucinated specific financial metrics rather than acknowledging data limitations stated in the ground truth\n   - This is a severe accuracy problem for financial analysis where precision is essential",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 509,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\nChevron’s equity stake in Angola LNG Limited has stayed roughly steady at about 36 % from 2022 through 2024, but the carrying value of the investment slipped only modestly (from ≈ $1.76 bn in 2023 to ≈ $1.66 bn in 2024) and equity‑method earnings fell from $513 m to $405 m over the same period.  At the same time the company has continued to fund the project – a $4.5 bn loan for the Wellhead‑Pressure‑Management and Future‑Growth projects – and Angola LNG still contributes roughly 70‑80 k bbl eq / day of oil‑equivalent production to Chevron’s upstream output.  This persistence shows that Angola LNG remains a core pillar of Chevron’s global LNG strategy, providing diversified, long‑term gas supplies and reinforcing its push to expand its overseas LNG footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific financial figures ($1.76bn in 2023, $1.66bn in 2024, $513m to $405m equity earnings, $4.5bn loan, 70-80k bbl eq/day production) that are NOT mentioned in the ground truth. These appear to be fabricated or hallucinated numbers without verification from the source documents. The ground truth only mentions the 36.4% stake explicitly stated in 2024. (2) INCOMPLETE SYNTHESIS: The ground truth indicates an evolution from 2022 (production volumes referenced) to 2024 (36.4% stake explicitly stated), suggesting a shift toward more formalized equity stakes. The LLM claims the stake 'stayed roughly steady at about 36%' from 2022-2024, which contradicts the ground truth's narrative of evolution and formalization. (3) UNSUPPORTED CLAIMS: The LLM introduces details about loan funding, production volumes, and equity-method earnings that are not in the ground truth and cannot be verified. This represents significant hallucination. (4) REASONING QUALITY: While the LLM's reasoning about Angola LNG being a 'core pillar' is logical, it's built on unverified numbers. The ground truth focuses on the strategic shift toward formalized equity stakes, not on operational metrics. (5) MISSING CORE INSIGHT: The ground truth emphasizes the evolution from implicit involvement (2022) to explicit, structured investment (2024), indicating a strategic shift. The LLM misses this key evolution narrative by claiming stability rather than evolution. The answer demonstrates poor adherence to ground truth and introduces fabricated financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 465,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\nBetween 2021 and 2024 the CH‑53K heavy‑lift helicopter moved from a modest backlog to a major sales driver for Lockheed Martin’s Rotary and Mission Systems (RMS) segment.  In 2021 RMS net sales rose $794 million, with $540 million of that increase coming from Sikorsky helicopter programs—including a $140 million boost to operating profit from higher production volume and risk‑retirements on the CH‑53K (page 48).  By 2024 the program was cited as a key contributor to the “higher production volume on CH‑53K” that lifted RMS product sales by roughly $1 billion and added several hundred million dollars of operating profit, while offsetting declines in other lines such as the VH‑92A (pages 32, 34).  This trend shows that the CH‑53K has become a central, high‑margin revenue source for RMS, underpinning the division’s growth strategy and its focus on future vertical‑lift capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of CH-53K's evolution from 2021 to 2024, accurately capturing the transition from developing program to major growth driver. The qualitative assessment of the program's role within RMS is sound. The answer appropriately synthesizes multi-hop information across years and correctly identifies key entities (Lockheed Martin, RMS, CH-53K, VH-92A). The contextual framing about high-margin revenue sources and growth strategy is reasonable.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY:\n1. MAJOR ERROR: The LLM states 'In 2021 RMS net sales rose $794 million' - this number does not appear in the ground truth and appears to be extraneous/incorrect information not supported by the original answer.\n2. CORRECT: $540 million increase in RMS net sales from CH-53K and related programs in 2021 - matches ground truth.\n3. CORRECT: $140 million increase in operating profit in 2021 - matches ground truth.\n4. APPROXIMATE: 2024 contribution described as 'roughly $1 billion' and 'several hundred million dollars of operating profit' - ground truth states '$1.1 billion to higher product sales' and does not specify operating profit amount. The LLM's characterization as 'several hundred million' is vague but not contradicted.\n5. UNSUPPORTED CLAIM: The reference to 'modest backlog' in opening sentence is not mentioned in ground truth.\n6. UNSUPPORTED DETAIL: The claim about 'high-margin' revenue is inference not explicitly stated in ground truth.\n\nMULTI-HOP REASONING: The synthesis across 2021 and 2024 data is logically sound and correctly identifies the progression. The connection between production volume increases and financial contribution is properly made. However, the introduction of the $794 million figure creates confusion about whether this is a separate fact or a misunderstanding.\n\nSEMANTIC EQUIVALENCE: The core message matches - CH-53K evolved from contributing program to key growth driver. The characterization of 'production ramp-up' phase is semantically equivalent to 'more mature, high-volume production phase.'\n\nJUSTIFICATION: The answer loses points primarily for the unexplained $794 million figure and vague characterization of 2024 operating profit impact. While the narrative arc is correct and most key numbers are accurate, the introduction of unsupported quantitative claims reduces confidence in the answer's reliability. The qualitative reasoning remains strong, preventing a lower score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 662,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal shifted from a short‑term, two‑year macro‑driven forecast for its revolving‑credit loss curves to a longer, more detailed horizon—approximately five years (with a 7‑month to 3.5‑year range for related segments)—and refreshed the loss models in the second quarter of 2023.  The updated models still rely on a single external macro scenario but now incorporate additional economic indicators such as household disposable‑income trends and retail‑e‑commerce sales alongside unemployment and charge‑off rates.  This evolution reflects a deeper integration of macroeconomic assumptions into the loss‑curve methodology, although the quantitative effect on the provision was immaterial.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) INCORRECT FORECAST HORIZON: The LLM claims PayPal shifted to a 'longer, more detailed horizon—approximately five years (with a 7-month to 3.5-year range)' but the ground truth makes no mention of forecast horizons or these specific timeframes. This appears to be fabricated detail. (2) TIMING ERROR: The LLM states the models were 'refreshed in the second quarter of 2023,' but the ground truth indicates the change occurred 'after the first quarter of 2023,' which is different and less precise. (3) INCOMPLETE MACROECONOMIC FACTORS: The ground truth clearly states that unemployment rates were REPLACED after Q1 2023, not retained alongside the new indicators. The LLM incorrectly suggests unemployment and charge-off rates were maintained ('alongside unemployment and charge-off rates'), which contradicts the ground truth's explicit statement about replacement. (4) CORRECT ELEMENTS: The LLM correctly identifies that household disposable income and retail e-commerce sales were added to the models, and correctly notes the use of a single external macro scenario. (5) UNSUPPORTED CLAIM: The statement about 'quantitative effect on the provision was immaterial' is not mentioned in the ground truth and appears to be added without basis. The answer demonstrates partial understanding of the core evolution but introduces multiple factual errors and unsupported details that significantly undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 424,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the foreign‑currency‑debt gains recorded in AOCI fell from **$140.2 million** to **$135.2 million** (a $5 million decline) – see the “Foreign currency debt” line under Net Investment Hedges in the table of “Net Gains/(Losses) Included in AOCI” on **page 70**.  This reduction shows that the company’s foreign‑currency hedging produced smaller net gains, indicating either less favorable currency movements or more effective hedging that limited its exposure to foreign‑currency fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the 2023 figure was $140.2 million, but the ground truth clearly indicates it was a LOSS of $6.3 million. The LLM also claims the 2024 figure was $135.2 million (which matches ground truth), but this creates an impossible comparison since 2023 was negative and 2024 was positive. The LLM's calculation of a '$5 million decline' is mathematically nonsensical when comparing a -$6.3M loss to a +$135.2M gain. (2) DIRECTIONAL ERROR - The ground truth explicitly states there was 'a significant shift from a loss to a substantial gain,' indicating a reversal in foreign currency exposure. The LLM incorrectly frames this as a decline in gains, missing the critical insight that 2023 was a loss position, not a gain position. (3) INTERPRETATION ERROR - The LLM's conclusion that 'smaller net gains' resulted from 'less favorable currency movements or more effective hedging' is logically flawed given the actual data shows a swing from loss to gain, which indicates MORE favorable currency movements or improved hedging effectiveness. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the year-over-year comparison, apparently confusing or misreading the 2023 data point entirely. The answer demonstrates a fundamental misunderstanding of the financial position change. The only correct element is the 2024 figure of $135.2 million and the page reference, but these cannot salvage an answer that gets the core comparison and interpretation completely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 447,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\nAlabama Power’s liability for energy‑related derivatives rose from roughly **$32 million in 2022 to $110 million in 2023**, and Georgia Power’s liability increased from about **$30 million to $124 million** over the same period.  Together, their combined derivative liabilities grew from approximately **$62 million to $234 million**, reflecting a clear upward trend.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all quantitative measures and reaches the opposite conclusion from the ground truth. CRITICAL ERRORS: (1) WRONG NUMBERS FOR 2022: LLM claims Alabama Power had ~$32M liability in 2022, but ground truth shows $144M net liability. Georgia Power's 2022 figure is not provided in ground truth but LLM's ~$30M is inconsistent with the stated combined $255M in 2022. (2) INCOMPLETE 2023 DATA: LLM only reports liabilities ($110M and $124M) but ignores the assets ($15M and $13M respectively) that are critical to calculating net positions. (3) WRONG COMBINED TOTALS: LLM calculates combined liabilities as $62M (2022) and $234M (2023), but ground truth shows net liabilities of $255M (2022) and $206M (2023). The LLM's $234M figure appears to be a simple sum of only the liability components ($110M + $124M), which is methodologically incorrect since it ignores offsetting assets. (4) OPPOSITE TREND CONCLUSION: LLM concludes an 'upward trend' with liabilities growing from $62M to $234M, but ground truth shows a DOWNWARD trend with net liabilities decreasing from $255M to $206M - a $49M reduction. This is a fundamental reversal of the correct answer. (5) INCOMPLETE ANALYSIS: LLM fails to account for the asset positions that are essential to understanding the net derivative exposure. The ground truth explicitly includes both assets and liabilities to calculate net positions, which the LLM completely omits. The LLM's methodology of only summing liabilities without considering offsetting assets is financially incorrect and leads to a materially misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 444,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\nIn fiscal 2023 Walmart spent roughly $0.4 billion to acquire the remaining non‑controlling interests and bring its stake in Alert Innovation to 100 % ownership (the same transaction that completed the buy‑out of Massmart’s minority shareholders). The company then held Alert Innovation as a consolidated subsidiary throughout fiscal 2024, but did not make any further acquisition or disposal moves; the eventual sale and de‑consolidation of Alert Innovation was executed in fiscal 2025, ending the relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The original answer clearly states that Walmart 'sold and deconsolidated the Alert Innovation entity' in fiscal 2024, representing a complete exit. However, the LLM answer claims the sale and de-consolidation occurred in fiscal 2025, not fiscal 2024. This is a major error that misrepresents the timeline of events and directly answers the question incorrectly. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount is correct, and the 100% ownership percentage is accurate. These numbers match the ground truth. QUALITATIVE ACCURACY: While the LLM correctly identifies the fiscal 2023 acquisition and the achievement of 100% ownership, it fundamentally mischaracterizes the fiscal 2024 activity. The ground truth explicitly states that fiscal 2024 involved 'sold and deconsolidated the Alert Innovation entity,' but the LLM claims Alert Innovation was 'held as a consolidated subsidiary throughout fiscal 2024' with no disposal moves until fiscal 2025. This represents a complete misunderstanding of the multi-hop synthesis required. The LLM also introduces an irrelevant comparison to Massmart's minority shareholders, which is not part of the ground truth answer. CONTEXTUAL RELEVANCE: The question specifically asks about the evolution 'between fiscal 2023 and fiscal 2024,' and the ground truth answer directly addresses this period showing acquisition-to-divestiture within one year. The LLM answer fails to properly address fiscal 2024 activities and instead pushes the key event (sale/de-consolidation) to fiscal 2025, making it contextually incorrect for the question asked. The core narrative of 'full evolution from acquisition to divestiture within a one-year span' is completely lost in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 497,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy moved from its earlier approvals (metastatic triple‑negative breast cancer and urothelial cancer) to new label expansions: the FDA and the European Commission granted approval for Trodelvy as a monotherapy for adult patients with unresectable or metastatic HR⁺/HER2‑ breast cancer who have already received endocrine therapy and at least two systemic treatments. This adds a high‑value solid‑tumor indication to its portfolio.  \n\nThe approvals illustrate Gilead’s oncology strategy of broadening the commercial reach of its antibody‑drug‑conjugate platform, diversifying into additional cancer types, and using Trodelvy to drive sustained growth across multiple oncology markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key 2023 regulatory approvals (FDA and EC) for Trodelvy in HR+/HER2- breast cancer with the correct patient population criteria (unresectable/metastatic, prior endocrine therapy, at least two systemic therapies). The strategic interpretation about broadening commercial reach and ADC platform expansion is reasonable and relevant. WEAKNESSES: (1) The LLM introduces information about 'earlier approvals' in triple-negative breast cancer and urothelial cancer that is NOT mentioned in the ground truth answer. While these approvals may be factually accurate from actual filings, they go beyond what the ground truth specifies and could represent hallucination or unsupported claims. (2) The ground truth explicitly states 'no specific regulatory updates were mentioned' for 2022, whereas the LLM characterizes 2022 as having 'earlier approvals' - this is a subtle but important distinction about what was documented in the filings. (3) The LLM's strategic analysis is more detailed and sophisticated than the ground truth, which is positive for interpretation but raises questions about whether this synthesis is supported by the actual filings or represents inference. (4) The phrase 'high-value solid-tumor indication' is interpretive language not present in ground truth. MULTI-HOP REASONING: The LLM does synthesize the regulatory evolution and strategic implications, but the introduction of unapproved claims about earlier indications undermines the reliability of the synthesis. The core 2023 approval information is correct, but the 2022 characterization diverges from ground truth. NUMERIC/DATE ACCURACY: Years (2022, 2023) are correct; patient population criteria are accurately stated; no calculations required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 480,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group systematically unwound its equity relationship with ABG.  In 2023 it sold portions of its stake, recognized a $157.1 million pretax gain and recorded non‑cash gains from dilution‑related disposals, and in early 2024 it sold the remaining ABG interest for $1.2 billion, generating a $414.8 million pretax gain that it used to pay down debt and reinvest in its core retail development pipeline.  This series of capital transactions reflects a strategic shift away from ABG toward its core property and development focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM claims a $157.1 million pretax gain in 2023, but the ground truth specifies $36.4 million in Q2 and $145.8 million in Q3 (totaling $182.2 million, not $157.1 million). More critically, the LLM introduces a $1.2 billion sale in early 2024 and a $414.8 million pretax gain that are NOT mentioned in the ground truth at all. These appear to be fabricated numbers. (2) FACTUAL INACCURACY - The ground truth explicitly states that 'In 2024, SPG no longer reported active capital transactions with ABG' and that 2024 filings 'only referenced historical transactions.' The LLM contradicts this by claiming SPG sold its remaining ABG interest for $1.2 billion in early 2024, which is not supported by the source material. (3) INCOMPLETE SYNTHESIS - The LLM fails to mention the strategic partnership context (Forever 21, Brooks Brothers, Eddie Bauer licensing ventures) that was central to the 2023 relationship. It also omits the 2021 and 2022 historical transactions that the ground truth emphasizes as important context for 2024. (4) REASONING FLAW - While the LLM correctly identifies a 'shift' in the relationship, it does so by inventing specific transactions rather than accurately characterizing the actual shift from active restructuring in 2023 to historical reference-only in 2024. The claim about using proceeds to 'pay down debt and reinvest in core retail development' is not mentioned in the ground truth. This answer demonstrates hallucination of specific financial figures and transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 453,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\nChevron’s equity investment in Chevron Phillips Chemical Company LLC rose from $7.765 billion (reported in the 2022 10‑K, page 33) to $8.571 billion at year‑end 2024 (2024 10‑K, page 84), and the equity‑method earnings from the venture increased from $608 million in 2023 to $867 million in 2024 (2024 10‑K, page 84). This growth is reflected in the downstream segment’s “Income from equity affiliates” and is underpinned by a $669 million loan to fund the Golden Triangle Polymers project disclosed in Note 15 of the 2024 filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant issues with quantitative accuracy and fails to address the core evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM cites a 2022 10-K value of $7.765 billion, but the ground truth indicates this was the 2023 value. The LLM appears to have confused the year - it should state the 2023 value was $7.765 billion, not 2022. (2) The LLM does not address the fundamental structural change that occurred: the shift from full consolidation (2022) to equity method investment (2024). This is the core evolution the question asks about, and the LLM completely omits this critical distinction. (3) The LLM introduces information about equity-method earnings ($608M in 2023, $867M in 2024) and the Golden Triangle Polymers loan ($669M) that, while potentially accurate, are not mentioned in the ground truth and represent a different analytical focus than what was asked. CORRECT ELEMENTS: (1) The investment values of $7.765 billion and $8.571 billion are correct. (2) The page references (84 for 2024 10-K) appear reasonable. (3) The equity method investment classification for 2024 is correct. MULTI-HOP REASONING: The LLM fails to synthesize the key multi-hop insight: that Chevron's relationship evolved from consolidated subsidiary status (2022) to equity method investee status (2024). Instead, it focuses on earnings and project financing details. The answer addresses financial reporting changes but misses the structural/ownership change that is central to understanding the relationship evolution. The LLM answer reads more like a financial performance analysis rather than an explanation of how the relationship itself changed between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 464,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\nBy the end of 2023 the 2022 facilities‑consolidation program was essentially finished—most lease‑exit and sub‑lease actions had been completed, the related accrual had been reduced to a modest balance, and the plan had generated about $2.255 billion of pre‑tax restructuring charges through 2023. In 2024 the company continued to advance the strategy, recording an additional $389 million of pre‑tax facilities‑consolidation charges (all tied to lease terminations and sub‑lease activities) and expecting roughly $721 million of deferred revenue to be recognized within the next year, showing that the consolidation effort had shifted from a multi‑year, large‑scale initiative to a smaller, ongoing set of lease‑exit costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported numerical claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($2.255 billion through 2023, $389 million in 2024, $721 million deferred revenue) that are NOT present in the ground truth answer. The ground truth explicitly states that a 'financial summary' was included in 2024 disclosures but does NOT provide these specific numbers, suggesting the LLM may have fabricated or misremembered these figures. (2) SEMANTIC MISALIGNMENT: The ground truth emphasizes the STATUS EVOLUTION from 'substantially completed' (2023) to 'completed' (2024), focusing on the completion milestone and the retrospective quantification disclosure. The LLM shifts focus to detailed financial metrics and characterizes the 2024 status as 'smaller, ongoing set of lease-exit costs,' which contradicts the ground truth's statement that the company 'completed' the initiatives by 2024. (3) MULTI-HOP REASONING: The ground truth correctly synthesizes that the key evolution was: (a) status change from ongoing to completed, and (b) disclosure of comprehensive financial summary in 2024. The LLM instead focuses on granular cost breakdowns and future revenue recognition, which are not mentioned in the ground truth. (4) FACTUAL CONTRADICTION: The LLM states the consolidation 'shifted from a multi-year, large-scale initiative to a smaller, ongoing set of lease-exit costs,' implying continuation. The ground truth states it was 'completed,' indicating finality. These are contradictory characterizations. (5) MISSING CORE INSIGHT: The LLM fails to capture the primary evolution identified in the ground truth—the transition from 'substantially completed' to 'completed' status and the disclosure of retrospective financial quantification. The answer addresses financial details not in the ground truth while missing the status completion milestone that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 539,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\nFrom 2022 to 2024 Lockheed Martin moved its hypersonics effort from a broad, early‑stage Advanced Development Program focus toward concrete, program‑level development and demonstration for the U.S. Army and Navy, emphasizing rapid‑prototype flight testing and a clear path to production.  The company also broadened the strategic emphasis, tying hypersonic strike weapons to multi‑domain “21st Century Security” initiatives (e.g., CJADC2, next‑gen air dominance) and integrating them across Aeronautics, Missiles & Fire Control and Space, positioning the capability as an imminent fielded system rather than a purely exploratory project.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces details not present in the ground truth and misses key aspects of the original answer. CORRECT ELEMENTS: (1) The answer correctly identifies the evolution from earlier-stage development to more concrete production-oriented programs between 2022-2024. (2) The mention of U.S. Army involvement is accurate. (3) The characterization of movement toward fielded systems is semantically aligned with the ground truth's shift from 'development phase' to 'active production program.' PROBLEMATIC ELEMENTS: (1) The LLM introduces specific details about 'Advanced Development Program focus,' 'rapid-prototype flight testing,' 'CJADC2,' 'next-gen air dominance,' and integration across 'Aeronautics, Missiles & Fire Control and Space' that are NOT present in the ground truth. While these may be factually accurate from the source documents, they represent additions beyond what the knowledge graph confirms. (2) The LLM mentions 'U.S. Navy' involvement, but the ground truth specifically states 'U.S. Air Force and Army' - this is a factual discrepancy. (3) The LLM's framing around '21st Century Security initiatives' and specific organizational integration details goes beyond the scope of what the ground truth establishes. MULTI-HOP REASONING: The LLM does synthesize information across the 2022-2024 timeframe and identifies the strategic shift, which is correct. However, the specific details about programs and initiatives appear to be inferred or from different source material rather than directly supported by the ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided by either answer, so this dimension is neutral (8/10 for not introducing false metrics). QUALITATIVE ACCURACY: The core narrative is partially correct but contaminated with unsupported details and contains at least one factual error (Navy vs. Air Force). The reasoning quality is good but the entity accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 537,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\nFrom 2022 to 2023 Southern Company kept its energy‑related contracts in the “regulatory‑hedging” category, but the size of the associated gains/losses changed dramatically.  In 2022 the regulatory‑hedge adjustment showed a modest $9 million gain that was recorded in OCI and the balance‑sheet, whereas by the end of 2023 the same adjustment had turned into a $257 million unrealized loss (Southern Company), reflecting larger foreign‑currency and commodity positions and a shift in the composition of the hedge program.  At the same time, derivatives that were no longer designated as hedges began to affect earnings directly—producing a $59 million gain in natural‑gas revenues and a $59 million increase in cost of natural gas in 2023—so the company’s hedge disclosures expanded both in scope and in financial impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces specific numbers that cannot be verified against the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($9 million gain in 2022, $257 million unrealized loss in 2023, $59 million gains/losses in 2023) that are not mentioned in the original answer and appear to be fabricated or incorrectly sourced. The ground truth does not provide these specific figures. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM claims the regulatory-hedge adjustment 'turned into a $257 million unrealized loss' suggesting a dramatic swing, but the ground truth indicates the evolution was about DISCLOSURE EXPANSION, not about specific gain/loss changes. The ground truth states the company 'expanded its disclosure to include' derivatives not designated as hedging instruments—this is about reporting scope, not about the magnitude of specific positions changing. (3) INCOMPLETE UNDERSTANDING OF CORE CHANGE: The ground truth emphasizes that the key evolution was from disclosing only regulatory hedging instruments to providing 'a broader view' including non-designated derivatives. The LLM focuses on magnitude changes rather than the disclosure scope expansion. (4) UNVERIFIABLE DETAILS: The specific claims about 'foreign-currency and commodity positions,' '$59 million gain in natural-gas revenues,' and '$59 million increase in cost of natural gas' are not supported by the ground truth and appear to be hallucinated. (5) PARTIAL CORRECTNESS: The LLM does correctly identify that the company moved from regulatory hedging focus to including non-designated derivatives affecting earnings, which aligns with the ground truth's core message about expanded disclosure. However, the fabricated numbers and misemphasis on magnitude changes rather than disclosure scope severely undermine the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 512,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\nBetween 2022 and 2023 Gilead’s 10‑K filings moved from describing Truvada’s core composition‑of‑matter patents as “expiring in the EU” with only pending U.S. manufacturing‑process applications (and noting the 2020 U.S. loss of exclusivity and generic‑competition settlements) to explicitly stating that those composition‑of‑matter patents are now fully expired in both the U.S. and EU, with no new patent claims covering Truvada itself—leaving only a few pending process‑patent applications and reliance on regulatory exclusivity (e.g., pediatric extensions) and trade‑secret know‑how for protection. This shift reflects a strategic pivot away from seeking new composition‑of‑matter exclusivity for Truvada and toward protecting future products through pending process patents and extensions rather than new Truvada‑specific patent filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that diverge substantially from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims that composition-of-matter patents for Truvada are 'now fully expired in both the U.S. and EU' in 2023, but the ground truth indicates Gilead was providing 'actual or estimated expiration dates' - suggesting future expirations, not already-expired patents. The LLM's assertion that patents are 'fully expired' contradicts the ground truth's framing of forward-looking disclosures. (2) MISCHARACTERIZATION OF STRATEGY SHIFT: The ground truth describes a shift from 'acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines' - a disclosure/transparency evolution. The LLM instead claims a 'strategic pivot away from seeking new composition-of-matter exclusivity' and toward 'process patents and extensions,' which is an unsupported interpretation not present in the ground truth. (3) OVERSPECIFICATION: The LLM provides highly specific details about 'pending manufacturing-process applications,' 'pediatric extensions,' and 'trade-secret know-how' that are not mentioned in the ground truth and appear to be fabricated or inferred without evidence. (4) MISSING CORE INSIGHT: The ground truth's key point - that 2023 filings introduced 'structured disclosures regarding patent expiration dates' - is largely absent from the LLM answer, which instead focuses on the status of patents themselves rather than the disclosure methodology change. (5) QUANTITATIVE ACCURACY: The LLM provides no specific dates or numbers, making verification difficult, but the claim about 'fully expired' patents in 2023 appears inconsistent with the ground truth's language about 'estimated expiration dates.' The answer demonstrates poor multi-hop synthesis and appears to conflate or invent details not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 522,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\nBetween 2022 and 2024 SPG’s use of the Supplemental Facility shifted from active borrowing to a planned wind‑down.  In the 2022 filing the company disclosed that, as of December 2021, it had drawn **$1.05 billion** under the Supplemental Facility (the balance was still reflected in 2022‑year‑end debt tables) and had used those funds to retire a group of mortgages and support other cash‑needs.  By late 2023 SPG tapped the public bond market, issuing **€750 million** of senior unsecured bonds and using the proceeds on **November 17, 2023** to **repay the entire €750 million outstanding under the Supplemental Facility**, effectively eliminating the balance.  Consequently, in the 2024 disclosures the Supplemental Facility carried **no outstanding borrowings**, with the company relying instead on its broader Credit Facility and commercial‑paper program for any remaining short‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its accuracy despite capturing the general narrative of SPG's Supplemental Facility evolution.\n\nCRITICAL ERRORS:\n1. TIMING DISCREPANCY: The LLM states the $1.05 billion was drawn \"as of December 2021\" and \"the balance was still reflected in 2022-year-end debt tables.\" However, the ground truth clearly states this was borrowed \"in January 2022\" and \"was repaid shortly after issuance.\" The LLM's characterization that the balance persisted through 2022 year-end contradicts the ground truth's statement of short-term repayment.\n\n2. CURRENCY CONVERSION ERROR: The LLM states SPG issued \"€750 million\" of senior unsecured bonds and used proceeds to repay \"the entire €750 million outstanding under the Supplemental Facility.\" The ground truth specifies the borrowing was \"€750.0 million ($815.4 million U.S. dollar equivalent)\" - indicating the facility was drawn in euros but the LLM fails to acknowledge this currency distinction or the USD equivalent amount.\n\n3. REPAYMENT DATE INCONSISTENCY: The LLM correctly identifies November 17, 2023 as the repayment date, but the ground truth indicates the borrowing occurred in \"November 2023\" with repayment on November 17, 2023 - suggesting an extremely short holding period (days, not months). The LLM's narrative of \"late 2023\" issuance followed by repayment on November 17 is vague about the actual timing.\n\n4. MISSING CONTEXT: The ground truth mentions the 2022 borrowing was used to \"fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion.\" The LLM vaguely references \"retire a group of mortgages\" without the specific details.\n\nPARTIALLY CORRECT ELEMENTS:\n- The $1.05 billion figure is correct\n- The €750 million figure is correct\n- November 17, 2023 repayment date is correct\n- The general narrative of shift from active borrowing to wind-down is reasonable\n- The conclusion about no outstanding borrowings in 2024 aligns with ground truth\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across years and documents, correctly identifying the evolution pattern. However, the temporal characterization of the 2022 borrowing (suggesting it persisted vs. being quickly repaid) represents a failure in multi-hop synthesis of the actual timeline.\n\nThe answer captures the directional narrative but contains material factual errors regarding timing and persistence of borrowings that would mislead readers about SPG's actual debt management practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 680,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\nFrom 2022 to 2024 MetLife moved from a general emphasis on statutory surplus and RBC compliance toward treating a sizeable cash buffer as a core element of its capital‑management framework.  The 2024 disclosures explicitly link the buffer to “cash‑buffer needs” that constrain dividend payments and share‑repurchase programs, forcing the company to prioritize liquidity preservation and conservative financing over more aggressive capital‑allocation moves.  Consequently, liquidity levels now directly shape capital‑allocation decisions, limiting payouts and guiding the firm’s risk‑adjusted investment and financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer provides NO specific numbers from either 2022 or 2024, while the ground truth explicitly cites $12.4 billion short-term liquidity and $223.0 billion total liquid assets for 2022. The LLM completely omits these critical quantitative benchmarks that are essential to answering 'how has the role...evolved.' (2) INCOMPLETE SYNTHESIS: The ground truth clearly documents the evolution from 2022 (emphasis on ample liquidity and strong buffer) to 2024 (cautious tone about cash buffers limiting capital for innovation, acquisitions, shareholder returns). The LLM answer mentions the constraint on dividends and share repurchases but fails to cite the specific 2022 baseline figures or the explicit 2024 concern about limiting innovation and acquisitions. (3) DIRECTIONAL ACCURACY: The LLM correctly identifies that cash buffers became more constraining over time and that liquidity now shapes capital allocation decisions, which aligns with the ground truth's narrative shift. However, this correct directional insight does not compensate for the absence of supporting quantitative evidence. (4) MISSING CONTEXT: The ground truth emphasizes MetLife's 'belief in having ample liquidity' in 2022 and 'active monitoring and adjustment' - nuances the LLM answer lacks. The ground truth also specifically mentions the impact on 'innovation, acquisitions, and shareholder returns' - the LLM only mentions dividends and share repurchases. (5) REASONING QUALITY: While the LLM's logic about cash buffers constraining capital allocation is sound, it reads more as a general statement about capital management rather than a documented evolution with specific evidence from 2022 to 2024. The multi-hop synthesis is incomplete because it doesn't bridge the two years with concrete data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 498,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\nIn the 2022 10‑K (page 68) the “foreign‑currency‑other” derivatives appeared as $39.9 million of derivative assets in prepaid expenses (current) and $33.5 million in other long‑term assets, with only $0.3 million of derivative liabilities recorded in accrued liabilities (current). By the 2023 10‑K (page 70) those assets had fallen to $32.0 million (current) and $22.9 million (long‑term), while derivative liabilities increased to $2.0 million in accrued liabilities (current). Thus the exposure moved from a large net‑asset position in 2022 to a smaller net‑asset position in 2023, with assets declining and liabilities modestly rising, though the classification between current and long‑term remained the same.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly all key metrics. Specific errors: (1) 2022 'Foreign currency - other' derivatives: LLM claims $39.9M current assets and $33.5M long-term assets, but ground truth shows $0 in assets and only $0.3M in liabilities. This is a massive discrepancy - the LLM appears to have cited wrong derivative categories or misread the filing. (2) 2023 'Foreign currency - other' derivatives: LLM claims $32.0M current assets and $22.9M long-term assets with $2.0M liabilities, but ground truth shows $1.9M in current assets and $4.7M in liabilities with no long-term assets mentioned. Again, significantly different numbers. (3) The LLM's characterization of the trend (large net-asset position declining to smaller net-asset position) is opposite to the ground truth narrative, which emphasizes a shift from liability-only exposure in 2022 to a more balanced asset-liability mix in 2023. (4) Multi-hop reasoning: The LLM failed to correctly synthesize the year-over-year comparison. The ground truth shows a qualitative shift in how these derivatives were classified (from pure liability to mixed asset-liability), which the LLM completely missed. (5) The LLM's specific page citations (page 68 for 2022, page 70 for 2023) cannot be verified but the numbers provided are demonstrably wrong compared to the ground truth. This appears to be a case of either hallucinated numbers or severe misreading of the source documents. The answer is not salvageable - it fails on quantitative accuracy, fails to capture the actual evolution described in the ground truth, and provides incorrect financial metrics across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 461,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\nFrom 2023 to 2024 the relationship moved beyond a standard bottler contract to a deeper strategic partnership: Coca‑Cola now holds a 28 % equity‑method investment in Coca‑Cola FEMSA (Note 6 of the 2024 10‑K, pages 85‑87), giving the Company a direct financial stake in FEMSA’s earnings, and FEMSA has been designated an “expanding participating bottler” with 10‑year renewable CBAs and exclusive territory rights (Bottler’s Agreements section, pages 5‑6). This increased equity ownership and the expanded long‑term bottler framework reflect a more aligned, collaborative strategy between the two companies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about the evolution of Coca-Cola's relationship with Coca-Cola FEMSA from 2023 to 2024. STRENGTHS: (1) The 28% equity ownership stake is correctly identified and matches the ground truth. (2) The characterization of the transition from bottler to equity method investee is accurate and semantically equivalent to the ground truth's description. (3) The answer correctly identifies the strategic deepening of the relationship with specific details about 10-year renewable CBAs and exclusive territory rights. (4) The multi-hop synthesis is sound—the answer connects the 2023 bottler status with the 2024 equity investment relationship. (5) Citation references to Note 6 and specific 10-K pages add credibility. MINOR WEAKNESSES: (1) The answer does not mention that in 2023, Coca-Cola FEMSA was one of the five largest independent bottling partners accounting for 42% of worldwide unit case volume—this contextual detail from the ground truth is omitted. (2) The answer does not explicitly state the geographic scope (Mexico, Brazil, Argentina) that was mentioned in the ground truth, though this is a minor omission. (3) The phrase 'expanding participating bottler' is introduced but not explicitly verified against the ground truth language. QUANTITATIVE VERIFICATION: The 28% ownership stake is correct and properly formatted. No calculations are required for this question, so quantitative accuracy is high. QUALITATIVE ASSESSMENT: The reasoning about the shift from traditional bottler-concentrate supplier model to equity method investee is sound and demonstrates understanding of the strategic evolution. The answer appropriately emphasizes the 'deeper financial commitment and alignment' concept from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 495,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\nBetween 2022 and 2024 Intel moved FPGAs out of a stand‑alone, legacy line‑card role and embedded them as a core element of its **adjacent‑product strategy**—positioning the devices alongside modems, Ethernet, silicon‑photonic and other non‑platform offerings in the CCG, DCG and IOTG segments to create “comprehensive platform solutions” for customers.  At the same time, the company refocused its **production footprint** on a Smart‑Capital model that relies on capacity investments, government incentives and external foundries, using that infrastructure to scale FPGA manufacturing while tying the technology to broader platform and services initiatives (e.g., AI, networking, edge computing).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual errors and unsupported claims not present in the ground truth. (1) INCORRECT CHARACTERIZATION: The ground truth states FPGAs moved FROM 'adjacent products' (2022) TO 'direct product definitions' (2024), representing a shift toward MORE central importance. The LLM answer reverses this logic, claiming FPGAs were 'embedded...as a core element of its adjacent-product strategy,' which contradicts the ground truth's core finding that FPGAs moved AWAY from the adjacent products category. (2) UNSUPPORTED CLAIMS: The LLM introduces entirely new information not in the ground truth: 'Smart-Capital model,' 'capacity investments,' 'government incentives,' 'external foundries,' 'AI, networking, edge computing' initiatives. While these may be factually true about Intel, they are NOT part of the ground truth answer about FPGA strategic positioning evolution. (3) MISSING KEY INFORMATION: The LLM fails to clearly state the fundamental shift from 'supporting role within comprehensive platform solutions' (2022) to 'core product offering' (2024). (4) ENTITY ACCURACY: Correctly identifies CCG, DCG, IOTG segments and years 2022-2024. (5) SEMANTIC EQUIVALENCE FAILURE: The answer's core narrative contradicts the ground truth's central thesis about the direction of strategic repositioning. The LLM appears to conflate 'adjacent products' as a permanent category rather than recognizing it as the 2022 positioning that changed by 2024. QUANTITATIVE ACCURACY is high (8/10) because no specific numbers are provided in either answer, so no calculation errors exist. QUALITATIVE ACCURACY is low (3/10) because the fundamental reasoning about the strategic shift is inverted or confused. CONTEXTUAL RELEVANCE is moderate (5/10) because while the answer discusses FPGAs and Intel's strategy, it misrepresents the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 517,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\nFrom 2022 to 2023 ConocoPhillips significantly expanded its Lower 48 position—capital spending rose to $6.5 billion (up from $5.6 billion in 2022) and purchases/extensions added several hundred MMBOE of reserves (notably the Concho acquisition and subsequent unconventional‑play development).  This larger, newly‑acquired asset base drove a jump in depreciation, depletion and amortization from $4.85 billion in 2022 to $5.73 billion in 2023, reflecting the higher DD&A expense associated with the expanded reserve base and the ongoing conversion of PUDs to developed status.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core financial metrics. The DD&A figures are correct: $4.85 billion (2022) and $5.73 billion (2023), matching the ground truth values of $4,854 million and $5,729 million respectively. The calculated increase of approximately $875 million is accurate. The LLM correctly identifies the Concho acquisition as a driver of Lower 48 expansion and appropriately contextualizes the DD&A increase as resulting from the larger asset base. The answer goes beyond the ground truth by providing additional context about capital spending ($6.5B vs $5.6B) and reserve additions, which adds valuable context though these specific figures were not in the original ground truth statement. The multi-hop reasoning is sound: the LLM correctly synthesizes that acquisitions led to asset base expansion, which in turn drove higher DD&A expenses. The explanation about PUD conversion to developed status is a reasonable inference about why DD&A increased. Minor strengths: the answer is well-structured and provides clear year-over-year comparison. Minor consideration: the additional capital spending figures, while contextually relevant, were not explicitly verified against the ground truth, though they appear reasonable and don't contradict the provided information. The answer fully addresses the question's focus on asset acquisition and DD&A evolution from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 392,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech moved from a **55 % equity position** (established after the May 2022 contribution of its software businesses and $6 bn cash, which gave Emerson a non‑controlling interest of $5.9 bn for the remaining 45 %) to a **planned full acquisition**—on Nov 5 2024 Emerson announced a cash offer to buy the ~45 % of AspenTech it did not already own, implying a $15 bn enterprise value.  This shift meant the relationship evolved from a minority, equity‑method investment to a near‑total ownership that would bring AspenTech fully under Emerson’s control.  \n\nFinancially, the deeper integration helped lift Emerson’s **consolidated gross margin** to **50.8 % in 2024**, an increase of 1.8 percentage points from 2023.  The improvement was driven by the Test & Measurement acquisition and higher pricing, but was partially offset by **$231 m of acquisition‑related inventory step‑up amortization**, which shaved roughly **1.3 pts** off the margin; the earlier Heritage AspenTech purchase had contributed a modest **~0.6‑pt** margin benefit.  (Pages 55‑59, 24‑28).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN OWNERSHIP STRUCTURE AND TIMELINE: The LLM answer fundamentally misrepresents the ownership evolution. Ground truth states Emerson owned 55% of AspenTech by 2024 (after the 2022 acquisition), but the LLM claims Emerson started with a 55% position and then announced a plan to acquire the remaining 45% in November 2024. This is backwards. The ground truth indicates the 2022 acquisition gave Emerson control, and by 2024 it owned 55% on a fully diluted basis—not that it was planning to acquire more. The LLM's characterization of the relationship as evolving 'from a minority, equity-method investment to a near-total ownership' contradicts the ground truth that Emerson completed the acquisition in 2022 and already owned 55% by 2024. CORRECT ELEMENTS: (1) $6.0 billion cash contribution is correct; (2) $231 million inventory step-up amortization is correct; (3) 1.3 percentage point margin reduction from amortization is correct; (4) 50.8% gross margin in 2024 is correct; (5) 1.8 percentage point increase is correct; (6) 0.6 percentage point benefit from Heritage AspenTech purchase is correct. MISSING/INCORRECT ELEMENTS: (1) The $87.69 per share price to Heritage stockholders is not mentioned; (2) The $168 million retained in AspenTech's balance sheet is not mentioned; (3) The characterization of the 2022 transaction as establishing a 'non-controlling interest' is misleading—the ground truth indicates Emerson acquired AspenTech and owned 55% by 2024; (4) The November 2024 announcement of a cash offer appears to be extraneous information not in the ground truth and suggests a future transaction rather than describing the 2022-2024 evolution. MULTI-HOP REASONING: The LLM failed to correctly synthesize the ownership structure evolution. It appears to have confused the 2022 acquisition with a partial stake, then added information about a 2024 announcement that doesn't align with the ground truth narrative of completed acquisition and existing 55% ownership. The financial impact numbers are largely correct, but the ownership narrative is fundamentally flawed, which is a core part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 573,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\nBetween 2022 and 2024 the 2015 Director Stock Plan saw a net **increase in recovered shares** (cumulative shares recovered rose from roughly 31.5 million at the end of 2021 to about 37.6 million by the end of 2024), but an even larger **increase in shares used for new awards and imputed dividend equivalents** (allocated shares grew from ~32.9 million through 2021 to ~42.3 million through 2024). Consequently, the **net pool of shares remaining available for future issuance fell** from about 34.1 million (reported for 2021) to roughly 30.7 million as of 31 December 2024. The mechanics involve re‑authorizing recovered shares (triggered by forfeiture, cash settlement, expiration, etc.) and then reducing that pool by the number of shares actually granted or credited as dividends on Deferred Shares, so recoveries are offset by subsequent award allocations and dividend imputations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the 2015 Director Stock Plan's evolution. STRENGTHS: (1) All key numeric values are correct: 37.6 million shares recovered (matches ground truth exactly), 42.3 million shares covered by new awards and reinvested dividends (matches ground truth), and 30.7 million shares available for future issuance (matches ground truth of 30,660,961). (2) The LLM correctly identifies the net reduction in available shares despite ongoing recovery, capturing the core dynamic. (3) The mechanics explanation is accurate and well-articulated: shares are recovered through forfeiture, cash settlement, and expiration, then re-authorized for issuance, with the pool reduced by actual grants and dividend credits. (4) Multi-hop synthesis is sound - the answer correctly traces the evolution from 2022 to 2024 by comparing cumulative figures across the period. (5) The contextual framing of 'net increase in recovered shares' offset by 'even larger increase in shares used' effectively conveys the balance shift. MINOR WEAKNESSES: (1) The LLM references 2021 baseline figures (~31.5M recovered, ~32.9M allocated, ~34.1M available) which are not explicitly stated in the ground truth, though these appear to be reasonable intermediate calculations. The ground truth focuses on 2022 and 2024 endpoints, while the LLM provides additional 2021 context that adds value but isn't directly verified. (2) The ground truth mentions the plan had '35,395,894 shares authorized for issuance as of January 1, 2015' - the LLM doesn't explicitly reference this baseline authorization figure, though it's not strictly necessary to answer the question about evolution between 2022-2024. (3) Minor semantic difference: ground truth says shares 'reduced the number of shares remaining for issuance by one' (2022 mechanics), while LLM describes the mechanics more generally without explicitly stating the 1:1 reduction ratio, though the overall mechanics description is accurate. CALCULATION VERIFICATION: All arithmetic checks out - the net change from ~34.1M to ~30.7M represents the expected reduction when recoveries (37.6M cumulative) are offset by allocations (42.3M cumulative). The answer correctly synthesizes multi-year data and explains the underlying mechanics clearly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 621,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\nFrom FY 2022 through FY 2023 the alliance moved from being a “revenue‑boost” that added roughly $250 million (≈ 16 %) to the Channel Development segment in 2022—driving segment growth but also pressuring operating margin as joint‑venture income slipped—to a more strategic, long‑term partnership that Starbucks continues to feature in its 2023 business overview as a key channel for Nestlé‑produced Starbucks‑branded products.  While the 2023 filing does not give a separate revenue figure, the partnership is now positioned as an integrated growth platform rather than a one‑off contributor, underscoring a shift in strategic emphasis toward sustained, expanded sales and royalty streams from the Global Coffee Alliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution narrative correctly—moving from a revenue-focused relationship to a more strategic, integrated partnership. However, there are significant issues with quantitative accuracy and unsupported claims:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM states the $250 million represented \"≈ 16%\" of Channel Development segment growth. This percentage calculation is not verified in the ground truth and appears to be an unsupported inference.\n- The LLM introduces a claim about \"joint-venture income slipped\" and \"pressuring operating margin\" which is NOT present in the ground truth answer. This is a factual addition not supported by the source material.\n- The ground truth explicitly states the $250 million was \"driven by product sales and royalty income from the alliance\" but does NOT mention margin pressure or income slippage.\n\n(2) COMPLETENESS:\n- The LLM answer addresses both FY2022 and FY2023 as required.\n- It correctly notes that FY2023 does not provide a separate revenue figure.\n- The shift from revenue driver to strategic enabler is captured.\n\n(3) ENTITY ACCURACY:\n- Correctly identifies Starbucks, Global Coffee Alliance, Nestlé, and Channel Development segment.\n- Correctly references FY2022 and FY2023.\n- Properly identifies the licensing relationship.\n\n(4) REASONING & SYNTHESIS:\n- The multi-hop reasoning is sound in connecting the evolution across years.\n- The characterization of the shift from \"revenue-boost\" to \"integrated growth platform\" aligns with ground truth's \"shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler.\"\n- However, the introduction of margin pressure claims represents unsupported inference beyond the ground truth.\n\n(5) SEMANTIC EQUIVALENCE:\n- The core message matches: evolution from revenue contribution focus to strategic partnership emphasis.\n- The $250 million figure is correctly cited.\n- The positioning as a key distribution channel is accurate.\n\nKEY PROBLEMS:\n- Unsupported claims about margin pressure and income slippage reduce credibility.\n- The 16% calculation lacks verification.\n- These additions, while plausible, go beyond what the ground truth supports and could be factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 608,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted from an equity‑method investment that was fully impaired in 2022 to a complete exit in 2023.  In 2022 the company recorded an impairment that wrote‑off its stake in the pipeline, and in 2023 it closed the sale of the related natural‑gas assets (including the MVP project), recognizing roughly $450 million of discontinued‑operations revenue and a $375 million gain on disposal.  This divestiture reflects NEE’s strategy of pruning lower‑margin pipeline assets and reallocating capital toward its core regulated utility and renewable‑energy growth initiatives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The ground truth clearly states NEE maintained equity method investments in the Mountain Valley Pipeline in both 2022 ($6,159M total) and 2023 ($6,156M total), with ownership interests ranging from 32%-55% in 2022 and 32.8%-52.6% in 2023. The LLM claims NEE completely exited the MVP in 2023 after a full impairment in 2022, which is directly contradicted by the knowledge graph showing MVP listed as a principal equity method investee in both years. (2) QUANTITATIVE INACCURACY: The LLM cites specific numbers ($450M discontinued-operations revenue, $375M gain on disposal) that do not appear in the ground truth and appear to be fabricated. The ground truth provides no evidence of a complete divestiture or sale of MVP assets. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the equity method investment data across 2022-2023. Instead of recognizing the continuity of MVP as an equity method investee with slight ownership adjustments (32%-55% to 32.8%-52.6%), the LLM invented a narrative of complete exit and asset sale. (4) STRATEGIC INTERPRETATION ERROR: The ground truth indicates a 'more refined or strategic investment posture' with narrower ownership ranges, while the LLM claims a strategic pivot away from pipeline assets entirely—a fundamentally different and incorrect interpretation. (5) MISSING CONTEXT: The ground truth notes MVP's inclusion in Nonrecurring Fair Value Measurements in 2023, suggesting revaluation rather than exit, which the LLM completely missed. The answer demonstrates hallucination of specific financial transactions and a complete misunderstanding of NEE's actual MVP involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 482,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic expanded the InterStim portfolio with newer platforms—including the InterStim X, InterStim II and the rechargeable InterStim Micro devices—and in April 2024 received FDA approval for the closed‑loop Inceptiv SCS. These devices now support a broader set of therapeutic indications, moving beyond the original chronic‑pain and diabetic peripheral neuropathy indications to include overactive bladder, urinary retention, bowel (fecal) incontinence and other pelvic‑health conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) INCORRECT PRODUCT FOCUS: The LLM conflates InterStim (a neuromodulation therapy for bladder/bowel conditions) with SCS (spinal cord stimulation for chronic pain). The mention of 'Inceptiv SCS' and 'chronic pain and diabetic peripheral neuropathy indications' is completely off-topic and not part of InterStim therapy evolution. (2) PRODUCT LINEUP ERRORS: The LLM mentions 'rechargeable InterStim Micro devices' but the ground truth indicates InterStim Micro was present in 2022 but NOT mentioned in 2024, and the 2024 devices are specifically labeled as 'recharge-free' (not rechargeable). This is a direct contradiction. (3) INCOMPLETE/INACCURATE THERAPEUTIC INDICATIONS: While the LLM mentions overactive bladder, urinary retention, and bowel incontinence, it incorrectly frames these as expansions from 'chronic pain' indications, which is not part of InterStim's history. The ground truth shows the evolution was from three indications (overactive bladder, urinary retention, bowel incontinence) in 2022 to the same three with 'chronic fecal incontinence' specifically called out in 2024. (4) MISSING KEY DETAIL: The ground truth emphasizes the shift to 'recharge-free' positioning in 2024, which is completely absent from the LLM answer. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the InterStim product evolution and instead mixed in unrelated SCS product information, suggesting a fundamental misunderstanding of the question scope. The answer addresses a different product line entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 446,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\nBetween 2022 and 2024 Simon steadily pared down its ownership in Authentic Brands Group, moving from roughly a 10‑12 % non‑controlling stake (after the 2021 licensing‑venture contributions) to essentially zero.  In 2022 it sold a portion of that interest to ABG, and a series of dilutive capital transactions in 2023 reduced the stake further—resulting in recognized gains of $157 million, $10 million, $12 million, $36 million and $146 million as the partnership’s share fell to about 9‑10 %.  In February 2024 Simon sold the remaining interest for $1.2 billion, generating a $415 million pretax gain and completing its exit from the strategic relationship with ABG.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every material fact. Key errors: (1) OWNERSHIP TRAJECTORY: Ground truth shows Simon held 1.37% in 2022 and increased to 50% stake in SPARC Group; LLM claims Simon went from 10-12% down to zero, which is completely wrong. (2) TRANSACTION DETAILS: Ground truth specifies Simon sold a portion of ABG stake for $18.8M gain in 2024 and acquired additional interests for $100M; LLM claims multiple sales generating $157M, $10M, $12M, $36M, $146M gains and a final $1.2B sale for $415M gain in February 2024 - none of these figures appear in ground truth. (3) STRATEGIC RELATIONSHIP: Ground truth indicates an evolving partnership with SPARC Group merger and continued investment; LLM describes a complete exit/divestment, which contradicts the ground truth narrative of dynamic evolution and additional acquisition. (4) FINAL POSITION: Ground truth shows Simon acquiring additional ABG interests for $100M (indicating continued stake); LLM claims complete exit with zero remaining interest, which is contradictory. (5) QUANTITATIVE VERIFICATION: The $1.2B sale price, $415M gain, and all intermediate gain figures cited by LLM cannot be verified against ground truth and appear to be fabricated. The LLM appears to have confused Simon's ABG relationship with a different transaction or entirely invented transaction details. The answer fails on factual accuracy, numerical precision, and multi-hop reasoning synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 413,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\nConocoPhillips has markedly expanded its Lower 48 investment between 2021 and 2023—capital spending in that region rose from $3.1 bn (2021) to $5.6 bn (2022) and $6.5 bn (2023) – and the resulting depreciation, depletion and amortization (DD&A) expense followed the same upward trend, climbing from $4.07 bn in 2021 to $4.85 bn in 2022 and $5.73 bn in 2023 (as shown in the segment DD&A tables for 2021‑2023).  This increase reflects the impact of major acquisitions (e.g., Concho and Shell Permian) and additional drilling/infrastructure, which added to the depletion base and drove higher DD&A charges each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) DD&A figures are correct - $4.07 billion (2021), $4.85 billion (2022), and $5.73 billion (2023) match the ground truth values of $4,067 million, and $5,729 million for 2023 (minor rounding differences acceptable). (2) Capital spending figures ($3.1bn, $5.6bn, $6.5bn) are provided but not in the ground truth, which only addresses DD&A - this is additional context that enhances rather than contradicts the answer. (3) The trend analysis is accurate: DD&A increased from 2021 to 2023, reflecting growing investment activity. Multi-hop reasoning: The answer correctly synthesizes capital investment data with DD&A expense trends, demonstrating understanding of how capital spending drives future depreciation charges. The answer goes beyond the ground truth by explaining the causal relationship (acquisitions like Concho and Shell Permian, plus drilling/infrastructure) that drove the DD&A increases. Entity accuracy: ConocoPhillips correctly identified, Lower 48 region correctly specified, DD&A metric properly defined, years 2021-2023 correctly referenced. Semantic equivalence: The answer conveys the same core message as the ground truth - significant increase in DD&A from 2021 to 2023 reflecting growing operational emphasis on Lower 48. The only minor consideration is that the LLM provides capital spending data not explicitly in the ground truth, but this adds valuable context without contradicting the core answer. The explanation of causation (acquisitions and infrastructure) is reasonable inference from the data pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 444,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\nVerizon continues to value its international bond holdings by matrix pricing using independent third‑party inputs and classifies them as Level 2 assets in both the 2023 and 2024 disclosures.  The only change is the size and composition of the holdings—international bonds dropped from $341 million (2023) to $113 million in the pension portfolio and from $12 million to $15 million in other post‑retirement assets—while the underlying valuation methodology remains the same.  (Pages 92‑95 2023 10‑K; pages 93‑94 2024 10‑K)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($341M in 2023 pension portfolio, $113M in 2024, $12M to $15M in other post-retirement assets) that are not mentioned in the ground truth. The ground truth specifically states international bonds had a total value of $12 million in 2024 (broken into $10M Level 1 and $2M Level 2), not the figures the LLM provides. These numbers appear to be fabricated or from incorrect sections of the filings. (2) VALUATION CLASSIFICATION ERROR: The LLM claims international bonds are classified as Level 2 assets in both years, but the ground truth explicitly states that in 2024, the $12M total was broken down as $10M Level 1 and $2M Level 2 - meaning the majority were Level 1, not Level 2. This is a fundamental mischaracterization of the valuation hierarchy. (3) METHODOLOGY CLAIM: While the LLM correctly identifies matrix pricing with third-party inputs as the valuation method, it incorrectly claims this remained unchanged. The ground truth indicates a shift from 'general description' in 2023 to 'specific itemization in a detailed table' in 2024 - a meaningful change in disclosure transparency and approach. (4) MULTI-HOP REASONING: The LLM failed to synthesize the key evolution described in the ground truth: the shift from general categorical treatment to specific itemized disclosure with clear Level 1/Level 2 breakdown. Instead, it focused on pension vs. post-retirement asset categories that aren't part of the ground truth answer. (5) PAGE CITATIONS: The LLM provides specific page numbers (92-95 for 2023, 93-94 for 2024) but these cannot be verified against the ground truth data provided, and the numbers cited don't match the ground truth figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 490,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Emerson’s ownership of AspenTech grew from roughly **55 % of the fully‑diluted share count** (after the Heritage AspenTech acquisition described on page 26) to about **57 %** (noted in the 2024 announcement on pages 24‑25), and in November 2024 Emerson unveiled a cash proposal to acquire the remaining shares, effectively taking AspenTech private.  The 2022 transaction also marked the start of operational integration—AspenTech’s businesses were run under Emerson’s structure and reported within Emerson’s segments—while the 2024 proposal signals a move toward full consolidation of the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of Emerson's relationship with AspenTech. Key issues: (1) OWNERSHIP PERCENTAGES INCORRECT: The LLM claims Emerson's ownership grew from ~55% to ~57% between 2022-2024, but the ground truth shows Emerson retained a 55% ownership stake in 'New AspenTech' formed in 2024 - not an increase to 57%. The LLM appears to have confused or fabricated the 57% figure. (2) MISSING CRITICAL FINANCIAL DATA: The ground truth explicitly states Emerson had an $8,326 million financial stake in AspenTech in 2022 and contributed $6.0 billion in cash in 2024. The LLM completely omits these crucial financial figures, which are central to understanding the financial evolution. (3) STRUCTURAL MISCHARACTERIZATION: The LLM describes a 'cash proposal to acquire remaining shares' and 'taking AspenTech private' in November 2024, but the ground truth indicates a strategic restructuring where Emerson contributed the AspenTech Industrial Software Business plus $6.0 billion to form 'New AspenTech' with 55% ownership - this is fundamentally different from a simple acquisition proposal. (4) INCOMPLETE SYNTHESIS: While the LLM mentions operational integration starting in 2022, it fails to capture the major 2024 restructuring event (formation of New AspenTech) as the primary evolution point. (5) TEMPORAL ACCURACY: The LLM references 'November 2024' but provides no context about the actual restructuring that occurred. The ground truth shows a clear transformation from a financial investment (2022: $8.3B stake) to a structured joint venture (2024: 55% ownership in New AspenTech with $6B cash contribution). The LLM's narrative of gradual ownership increase and eventual privatization attempt does not match the actual strategic restructuring described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 496,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the company’s interest‑rate swaps remained classified as **designated fair‑value hedging instruments** of its long‑term debt.  In 2022 a $34 million derivative liability for these swaps was recorded in **other long‑term liabilities**, and by the end of 2023 that liability had risen to **$41.4 million** (still in other long‑term liabilities), reflecting a larger notional position and higher fair‑value losses as market rates moved.  The liability is offset by the corresponding fair‑value adjustment on the hedged long‑term‑debt balance, which was $1.06 billion at the end of 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) MAJOR NUMBER ERROR: The LLM states the 2023 liability was $41.4 million in other long-term liabilities, but the ground truth shows $19.2 million in other long-term liabilities plus $0.4 million in current liabilities (accrued liabilities), totaling $19.6 million. This is a significant discrepancy of $21.8 million. (2) CLASSIFICATION ERROR: The LLM claims the entire liability remained in 'other long-term liabilities' in 2023, but the ground truth clearly shows a split classification with $0.4 million in current liabilities (accrued liabilities) and $19.2 million in long-term liabilities. The LLM completely missed this important shift in classification structure. (3) DIRECTIONAL ERROR: The LLM states the liability 'had risen' from $34M to $41.4M, implying an increase, but the ground truth shows a decrease from $34.0 million to $19.6 million. This is a fundamental misrepresentation of the trend. (4) PARTIAL CREDIT: The LLM correctly identified that these were designated fair-value hedging instruments and correctly noted the 2022 figure of $34 million. However, these correct elements are overshadowed by the major errors in the 2023 figures and classification changes. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the evolution between years, missing the key insight that the classification changed from purely long-term to split between current and long-term, and that the overall liability decreased rather than increased. The answer demonstrates a fundamental misunderstanding of the actual data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 447,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\nIn 2022 NextEra Energy Resources recorded a $0.8 bn impairment charge and fully wrote down its equity‑method stake in the Mountain Valley Pipeline, even recognizing a $0.2 bn liability for future ARO costs, effectively removing the investment from its balance sheet. By 2023 the company’s exposure had been reduced to a modest, planned equity contribution for 2024 under a 20‑year gas‑transport agreement, preserving only a 32.8 % equity interest and no further capital commitment beyond that contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $0.8 billion impairment charge in 2022 is accurate; (2) The 32.8% equity interest in 2023 is correct; (3) The 20-year natural gas transportation agreement is mentioned correctly; (4) The general narrative of write-down in 2022 followed by reduced exposure in 2023 is sound. PROBLEMATIC ELEMENTS: (1) The mention of a '$0.2 bn liability for future ARO costs' is not supported by the ground truth and appears to be an unsupported addition; (2) The characterization of 2023 exposure as 'a modest, planned equity contribution for 2024' is vague and potentially misleading - the ground truth specifies an 'annual obligation of approximately $70 million' under the transportation agreement, which the LLM fails to mention; (3) The phrase 'no further capital commitment beyond that contribution' is imprecise and contradicts the ground truth's statement of an ongoing annual obligation of ~$70 million; (4) The LLM states the investment was 'fully written off' and 'removing the investment from its balance sheet' but then says a 32.8% equity interest was maintained in 2023, which creates some logical tension. MULTI-HOP SYNTHESIS: The answer attempts to synthesize the 2022-to-2023 evolution but fails to clearly articulate the key commitment metric ($70 million annual obligation) that defines the 2023 involvement. The answer is somewhat vague about what the actual ongoing financial commitment entails. QUANTITATIVE ACCURACY: The $0.8 billion and 32.8% figures are correct, but the omission of the $70 million annual obligation is a significant gap in financial detail. The unsupported $0.2 billion ARO liability claim reduces confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 473,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\nThe captive insurance company that reinsures the group‑annuity policies holds a portfolio of marketable equity and debt securities that funds its solvency‑capital requirement.  At the end of 2023 the portfolio was valued at **$1.643 billion** in total equity and debt, and by the end of 2024 it had risen to **$1.883 billion**—an increase of roughly **$240 million (about 15 %)**.  This growth reflects a larger investment in both equity and debt securities to support the captive’s annuity‑reinsurance activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: (1) 2023 value of $1.643 billion matches ground truth ($1,643 million) - correct format conversion; (2) 2024 value of $1.883 billion matches ground truth ($1,883 million) - correct format conversion; (3) Calculated increase of $240 million is accurate ($1,883M - $1,643M = $240M); (4) Percentage increase of ~15% is accurate ($240M / $1,643M ≈ 14.6%, reasonably rounded to 15%). Multi-hop reasoning: The answer correctly synthesizes information across two fiscal years, identifies the captive insurance company's role in reinsuring group annuity contracts, and explains the purpose of the securities portfolio (solvency-capital requirement). Entity accuracy is perfect - correctly identifies The Coca-Cola Company's captive insurance company and the specific financial metrics. The answer goes slightly beyond the ground truth by providing additional context about the portfolio's purpose and calculating the percentage change, which adds value without introducing errors. Semantic equivalence is maintained throughout. Minor note: The LLM uses slightly more descriptive language ('marketable equity and debt securities,' 'solvency-capital requirement') compared to the ground truth, but this enhances clarity without compromising accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 370,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved the Intel 4 EUV node from early‑stage sampling to full‑scale production: the Core Ultra processor became the first high‑volume client chip on Intel 4 in 2023, and by 2024 the node had shifted to high‑volume manufacturing in the Ireland fab, with Intel 4 expected to represent an increasing share of the company’s processor output in 2025.  Strategically, Intel 4 anchors Intel’s AI‑PC and data‑center roadmap—supporting products such as the Xeon 6 Scalable family and serving as the foundation for future nodes (Intel 3 and the upcoming Intel 18A)—and it is a core element of the IDM 2.0 strategy that delivers both internal leadership products and external foundry opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Intel 4's evolution and strategic positioning, but contains a significant factual discrepancy regarding timing. CRITICAL ERROR: The LLM states 'Core Ultra processor became the first high-volume client chip on Intel 4 in 2023,' but the ground truth indicates this transition occurred by 2024, not 2023. This is a material factual error on a key date. CORRECT ELEMENTS: (1) The characterization of 2022 as early-stage/ramp-up period aligns with ground truth's mention of 'higher period charges' and 'early-stage production challenges'; (2) The 2024 transition to high-volume manufacturing in Ireland is accurate; (3) The mention of Core Ultra as the high-volume processor is correct; (4) The strategic positioning discussion (AI-PC, data-center, Xeon 6, IDM 2.0, foundry opportunities) adds relevant context not contradicted by ground truth. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across the 2022-2024 period and connects production status to strategic positioning. However, the temporal error undermines the accuracy of the progression narrative. COMPLETENESS: The LLM answer exceeds ground truth in strategic detail (IDM 2.0, foundry, Intel 3/18A roadmap) but this additional information, while contextually relevant, doesn't compensate for the date error. The core question about evolution from 2022-2024 is addressed but with a factual mistake in the 2023 claim. QUANTITATIVE ACCURACY: The only specific date mentioned (2023 for Core Ultra high-volume) is incorrect per ground truth (should be 2024). No other numeric values to verify.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 443,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s relationship with AspenTech shifted from a partial equity investment to full‑scale integration.  In 2022 Emerson acquired Heritage AspenTech and, after the transaction, owned roughly 55 % of AspenTech’s fully‑diluted shares, embedding the company’s asset‑optimization software into Emerson’s Automation Solutions segment and generating a 48 % jump in Software & Control sales.  By late 2024 Emerson announced a cash proposal to purchase the remaining ≈ 45 % of AspenTech shares (implying a $15.3 bn fully‑diluted market cap), which would give Emerson 100 % ownership and complete the financial and operational integration of AspenTech’s software portfolio into Emerson’s own earnings base.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM states 'In 2022 Emerson acquired Heritage AspenTech' and 'owned roughly 55% of AspenTech's fully-diluted shares,' but the ground truth explicitly states that in 2022 AspenTech was merely 'a strategic partner of Emerson, with no mention of ownership stakes.' The acquisition/merger occurred between 2022-2024, not in 2022. (2) INCORRECT CHARACTERIZATION - The LLM describes the 2022 situation as 'a partial equity investment' when the ground truth shows no ownership stake existed in 2022. (3) MISPLACED TIMELINE - The LLM's description of the 55% ownership and 'New AspenTech' formation appears to conflate the 2022-2024 evolution, placing the acquisition in 2022 rather than describing it as occurring during this period. (4) UNVERIFIED CLAIMS - The LLM mentions '48% jump in Software & Control sales' and '$15.3 bn fully-diluted market cap' which are not mentioned in the ground truth and cannot be verified. (5) PARTIAL ACCURACY - The LLM correctly identifies that by 2024 Emerson retained 55% ownership and announced plans to acquire remaining shares for 100% ownership, and correctly notes the integration of AspenTech's financials. However, the fundamental error about when the initial acquisition occurred (2022 vs. between 2022-2024) and the characterization of 2022 status severely undermines the answer's accuracy. The multi-hop reasoning fails because it misplaces the timeline of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 424,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved the Intel 4 node from early‑stage development to full‑scale production: the company began shipping its first high‑volume client product—Core Ultra—on Intel 4 in 2023 and, by 2024, shifted that node to high‑volume manufacturing in its Ireland fab, where it is now slated to become an increasingly dominant part of Intel’s processor output in 2025.  Intel 4 delivers roughly 20 % better performance‑per‑watt and markedly higher transistor density than the preceding Intel 7 node, and the company has continued to refine the process (e.g., adding EUV lithography, optimizing yield) to boost readiness and prepare it for broader adoption in upcoming client and data‑center products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Intel 4's evolution from 2022 to 2024. STRENGTHS: (1) All key numeric values are correct: 20% performance-per-watt improvement matches ground truth exactly; (2) Timeline is accurate: Intel 4 introduced in 2022, Core Ultra shipping in 2023, high-volume manufacturing in Ireland by 2024; (3) Multi-hop synthesis is sound: correctly connects the progression from conceptual roadmap item to full-scale production with quantified performance metrics; (4) Entity identification is correct: Intel, Intel 4, Intel 7, Core Ultra, Ireland fab all properly identified; (5) Manufacturing readiness evolution is well-captured: early-stage development → high-volume production → preparation for broader adoption. MINOR CONSIDERATIONS: (1) The LLM answer adds contextual detail about 'adding EUV lithography' and 'optimizing yield' as ongoing refinements, which is reasonable inference but not explicitly stated in the ground truth (though ground truth does mention Intel 4 as 'first EUV lithography node'); (2) The LLM mentions 'data-center products' as upcoming applications, which is reasonable but not explicitly confirmed in ground truth; (3) The phrase 'markedly higher transistor density' is added by LLM but not quantified in ground truth - this is a reasonable inference about process node improvements but represents slight elaboration beyond stated facts. QUANTITATIVE VERIFICATION: The 20% performance-per-watt figure is exact match; dates (2022, 2023, 2024) all correct; no calculation errors. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth while using slightly different phrasing and adding reasonable contextual details about ongoing process refinement. The core narrative of evolution from introduction to full-scale production with performance quantification is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 519,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\nBetween 2022 and 2024, InterStim Micro moved from being listed simply as one of several Pelvic‑Health neurostimulators (InterStim X, InterStim II, InterStim Micro) in Medtronic’s 2022 portfolio to being explicitly highlighted as the **rechargeable** option within the InterStim therapy suite.  The 2024 disclosures emphasize continued market acceptance and growth of “InterStim Micro rechargeable neurostimulator” for overactive bladder, non‑obstructive urinary retention and chronic fecal incontinence, underscoring its expanded positioning as a key, rechargeable solution that drives the overall Pelvic‑Health business forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of InterStim Micro's positioning from 2022 to 2024, correctly identifying it as moving from a generic listing among neurostimulators to an explicitly highlighted rechargeable option. The specific product names (InterStim X, InterStim II, InterStim Micro) and indications (overactive bladder, urinary retention, fecal incontinence) are all accurate. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. The years 2022 and 2024 are correctly referenced. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about product portfolio changes across the two-year period and identifies the key differentiator (rechargeable vs. recharge-free). The characterization of InterStim Micro as 'the rechargeable variant' and the emphasis on 'continued global growth and adoption' are both present and accurate. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about role and positioning evolution, providing appropriate context about MDT's Pelvic Health therapies. The LLM answer adds slightly more detail about 'market acceptance and growth' and explicitly notes it 'drives the overall Pelvic-Health business forward,' which enhances the answer without contradicting the ground truth. Minor difference: The LLM uses 'non-obstructive urinary retention' while ground truth uses 'urinary retention,' but this is a more precise clinical specification rather than an error. Overall, the answer demonstrates accurate multi-hop synthesis across the 2022-2024 timeframe with correct entity identification and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 505,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s footnote on diluted earnings per share/unit consistently identifies LTIP Units as potentially dilutive but explicitly states that, for each of those reporting periods, no security—including the LTIP Units—produced a material dilutive effect. Consequently, the filings do not adjust net income attributable to common stockholders (or unitholders) or the weighted‑average share (or unit) counts for any of the years 2022, 2023, or 2024. This language shows that the dilutive impact of LTIP Units has been considered immaterial across the three periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in capturing the evolution of disclosure from 2022 to 2024. CRITICAL ERRORS: (1) The LLM states that LTIP Units were 'potentially dilutive' across 2022-2024, but the ground truth indicates that by 2024, the disclosure no longer explicitly referenced the exchangeability of LTIP units into common stock - a key evolution the question asks about. (2) The LLM fails to capture the reduction in detail level that occurred between 2022 and 2024 disclosures. The ground truth explicitly notes this as 'a reduction in the level of detail provided about LTIP units' conversion features.' (3) The LLM conflates the 2022 disclosure (which covered 2021, 2020, 2019) with the 2024 disclosure (which covered 2024, 2023, 2022), missing the temporal evolution across reporting periods. PARTIAL CORRECTNESS: The LLM correctly identifies that no material dilutive effect was concluded in both periods and that no adjustments were made to earnings or share counts. However, this is only half the answer - the question specifically asks about HOW the disclosure EVOLVED, not just what the conclusion was. The LLM provides a static description rather than a comparative analysis of the evolution. MISSING ELEMENTS: The answer does not address the shift from explicitly discussing exchangeability features to omitting them, which is the core evolution the ground truth identifies. The answer treats 2022-2024 as a continuous period with consistent language, when the ground truth indicates meaningful changes in disclosure approach between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 432,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\nIn the 2022 filing MetLife disclosed a $3.0 billion common‑stock repurchase authorization with roughly $1.5 billion still available as of Dec 31 2021, and it warned that a larger cash‑buffer—needed to meet liquidity, claims‑paying and regulatory requirements—could curb further purchases. The 2024 filing keeps the same $3.0 billion ceiling but explicitly ties any increase in the required cash buffer to a reduced pool of capital for repurchases, indicating that the effective remaining authorization has become more constrained by liquidity and regulatory considerations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) All quantitative data is correct - the $3.0 billion authorization ceiling, $1.5 billion remaining as of Dec 31, 2021, and the date references are accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies the evolution from 2022 (more active repurchase posture with available capacity) to 2024 (more constrained by liquidity/regulatory considerations). (3) The answer properly captures the key insight that while the authorization amount remained the same, the effective capacity became more limited due to cash buffer requirements. (4) Entity identification is correct (MetLife, common stock repurchase authorization, liquidity buffers). MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly use the phrase 'shift from more active to more conservative' strategy, though this concept is clearly conveyed through the language about constraints becoming 'more constrained.' (2) The answer could have been slightly more explicit about the regulatory, market, and internal capital considerations mentioned in the ground truth, though it does reference 'liquidity and regulatory considerations.' (3) The phrasing 'effective remaining authorization has become more constrained' is a reasonable inference but represents a slight interpretive step beyond what's explicitly stated in the ground truth. Overall, the answer correctly addresses all parts of the multi-part question and accurately conveys the evolution of MetLife's approach to managing cash buffers in relation to stock repurchases.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 467,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the foreign‑currency‑other derivative asset fell from $73.4 million ( $39.9 million recorded in current “prepaid expenses and other current assets” and $33.5 million in long‑term “other assets”) to $54.9 million ( $32.0 million in current assets and $22.9 million in long‑term assets), showing a reduction in both classifications.  The related liability shifted from being recorded entirely in long‑term liabilities in FY 2022 to a split of $2.0 million in accrued liabilities (current) and $0.5 million in other long‑term liabilities in FY 2023, reflecting a partial reclassification of the liability to current‑liability accounts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth across nearly all key metrics. Specific issues: (1) ASSET POSITIONS - Ground truth reports FY2023 assets of $1.9M (current) + $1.7M (long-term) = $3.6M total, representing a significant reduction from FY2022's $103.9M. The LLM reports FY2023 assets of $54.9M ($32.0M current + $22.9M long-term), which is completely wrong and actually shows only a modest decline from the claimed FY2022 position of $73.4M. (2) LIABILITY POSITIONS - Ground truth reports FY2023 liabilities of $4.7M (current) + $4.1M (long-term) = $8.8M. The LLM reports $2.0M (current) + $0.5M (long-term) = $2.5M, which is significantly understated. (3) MAGNITUDE OF CHANGE - Ground truth shows a dramatic reduction in assets (from $103.9M to $3.6M, a 96.5% decrease). The LLM shows only a 25% decrease (from $73.4M to $54.9M), fundamentally mischaracterizing the scale of the change. (4) RECLASSIFICATION NARRATIVE - While the LLM correctly identifies that there was a shift in balance sheet classification, the specific numbers supporting this narrative are entirely incorrect. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the FY2022 and FY2023 balance sheet positions, providing numbers that don't match the ground truth for either year. The answer demonstrates a complete failure in quantitative accuracy with no correct financial figures provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 392,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 P&G’s cash‑management shifted from preserving liquidity and using modest $250‑$500 million of annual restructuring spend to recycling cash through working‑capital efficiencies, extended supplier payment terms and its $8 billion credit facilities in order to fund a much larger $659 million restructuring program (including about $216 million of non‑cash translation losses).  This enabled operating cash flow to rise to $19.8 billion and adjusted free cash flow to grow 21 % to $16.9 billion, but the higher restructuring outlays and a $1.4 billion impairment pushed corporate‑level earnings into a loss in 2024, even as credit ratings and overall cash positions remained strong.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key restructuring figures ($659 million in fiscal 2024, $216 million in non-cash translation losses, $1.4 billion Gillette impairment), accurately captures the shift from $250-$500 million historical range to higher restructuring spend, and properly synthesizes the multi-hop relationship between restructuring activities and corporate earnings decline. The answer appropriately addresses the evolution of cash management strategy and mentions relevant mechanisms (working capital efficiencies, supplier payment terms, credit facilities). The reasoning about pressure on earnings from restructuring and impairment is sound.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL FACTUAL ERROR: The LLM states 'corporate-level earnings into a loss in 2024' - the ground truth shows corporate net earnings decreased by $1.0 billion but does not indicate a loss position; this is an unsupported inference. (2) UNVERIFIED NUMBERS: The LLM introduces specific operating cash flow ($19.8 billion) and adjusted free cash flow ($16.9 billion) figures with a 21% growth rate that are not present in the ground truth. While these may be accurate from the filings, they cannot be verified against the provided ground truth and represent potential hallucination or unsourced data. (3) INCOMPLETE SYNTHESIS: The ground truth mentions specific accrual amounts ($147 million as of June 30, 2022) and corporate earnings improvement ($872 million to $485 million in fiscal 2022) that the LLM omits, reducing completeness of the fiscal 2022 comparison. (4) VAGUE REFERENCE: The mention of 'Enterprise Markets like Nigeria' in ground truth is not addressed, though this is a minor omission.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the relationship between restructuring activities, cash management strategy, and financial performance across the two-year period. However, the introduction of unverified cash flow metrics weakens the credibility of the synthesis.\n\nQUANTITATIVE VERIFICATION: Core numbers that can be verified are correct (restructuring amounts, impairment charge). However, the unverified cash flow figures and the unsupported claim about 'loss' position create quantitative accuracy concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 598,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA moved Omniverse from a primarily developer‑oriented, real‑time 3D collaboration tool to an enterprise‑grade simulation and digital‑twin platform, introducing a paid subscription model and tighter integration with its AI‑ and data‑center stack.  It is now used by industrial customers to create digital twins, real‑time product configurators and to test autonomous‑vehicle stacks through DRIVE Sim (built on Omniverse), while Omniverse Avatar and AI Enterprise extend the platform with generative‑AI services, positioning Omniverse as a core simulation engine within NVIDIA’s broader enterprise solution portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of NVIDIA Omniverse between 2022 and 2023 with generally accurate information. STRENGTHS: (1) Correctly identifies the shift from developer-oriented tool to enterprise-grade platform; (2) Accurately mentions DRIVE Sim integration for autonomous vehicle testing; (3) Correctly references digital twins and real-time product configurators as 2023 use cases; (4) Appropriately notes the introduction of paid subscription model; (5) Mentions Omniverse Avatar and AI Enterprise extensions, showing awareness of platform expansion. WEAKNESSES: (1) The LLM answer introduces 'paid subscription model' as a 2023 change, but the ground truth indicates Omniverse was already positioned as 'a software subscription for enterprise use' in 2022, suggesting this was not a new development in 2023 - this is a minor inaccuracy in characterizing what changed; (2) Missing some specific 2022 use cases mentioned in ground truth (virtual car showrooms, surgical training, architectural walkthroughs) - though these are illustrative examples rather than core positioning; (3) The ground truth emphasizes integration with 'accelerated computing infrastructure both on-premises and in the cloud' as a 2023 development, which the LLM answer only vaguely references as 'AI- and data-center stack'; (4) The ground truth's emphasis on Omniverse as an 'operating system for building virtual world simulation applications' in 2023 is not explicitly captured in the LLM answer. MULTI-HOP REASONING: The answer successfully synthesizes information about platform evolution, integration points, and enterprise positioning across the two-year period. No quantitative errors detected (no specific numbers provided in either answer). The semantic meaning largely aligns with ground truth despite some nuanced differences in emphasis and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 504,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 AMT trimmed its planned outlay on communications‑site development modestly but kept the focus on building new towers and data‑center assets: it spent about **$1.83 billion in 2023** (including the construction of roughly **3,200 sites** and **≈ $395 million for data‑center spend**) and, for 2024, projects **$1.55‑$1.66 billion** in total capital expenditures—​**$790‑$820 million on discretionary projects, $70‑$90 million on ground‑lease purchases, $165‑$175 million on improvements, $455‑$485 million on redevelopment and $65‑$85 million on start‑up capital**, still targeting **2,500‑3,500 new sites** and **≈ $450 million for data‑center expansion**.  \n\nAt the same time, the company’s future obligations have shifted toward larger debt‑service and lease commitments: **$3.7 billion of senior notes and term‑loan principal matures in 2025**, with **$986 million of operating‑lease payments due in 2025** and a cumulative **≈ $7.1 billion of lease obligations** over the long run, while covenant‑driven cash‑trap tests could restrict excess cash that might otherwise be used for these capital projects or distributions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) WRONG FOCUS: The LLM discusses actual 2023 capital expenditures ($1.83B) and 2024 projections, but the ground truth question asks about 'anticipated spending' and 'future obligations' - specifically the shift from $450M data center spending in 2023 to $4.5B in asset retirement obligations in 2024. (2) MISSING CRITICAL NUMBER: The ground truth's core finding is the $4.5 billion undiscounted future cash outlay for asset retirement obligations in 2024 - this is completely absent from the LLM answer. (3) WRONG METRIC: The LLM conflates actual capex spending with future obligations. The ground truth distinguishes between near-term capital allocation ($450M in 2023) and long-term retirement obligations ($4.5B in 2024). (4) INCORRECT SYNTHESIS: The LLM provides detailed breakdowns of 2024 capex projections ($790-820M discretionary, $455-485M redevelopment, etc.) which, while potentially accurate, are not responsive to the question about how financial commitments 'evolved' in terms of 'anticipated spending and future obligations.' (5) TANGENTIAL INFORMATION: The LLM discusses debt maturities ($3.7B senior notes), operating lease payments ($986M), and covenant restrictions - while these relate to financial obligations, they don't address the specific evolution of communications site commitments from 2023 to 2024. (6) SEMANTIC MISMATCH: The ground truth emphasizes a 'significant increase in long-term financial exposure' from $450M to $4.5B, representing a shift from near-term to mature obligation structures. The LLM's narrative of 'modest trimming' of planned outlays contradicts this fundamental finding. The answer demonstrates partial understanding of AMT's financial structure but fails to identify and synthesize the key multi-hop insight: the dramatic increase in disclosed future obligations related to communications sites.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 527,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\nIn the 2023 filing ExxonMobil described asset‑sale proceeds as the result of a “long‑standing and regular disciplined review process” that ensures assets align with strategic objectives, noting that such proceeds are useful for investors evaluating cash for investment and shareholder distributions (page 37). By the 2024 filing the language was reframed to present those proceeds as an explicit component of the company’s capital‑allocation strategy—emphasizing portfolio simplification and the redeployment of capital to higher‑return projects—thereby linking divestiture proceeds more directly to strategic objectives (page 39).",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about language evolution in asset divestiture characterization. STRENGTHS: (1) Correctly identifies 2023 and 2024 as the comparison years; (2) Acknowledges that language was reframed between the two periods; (3) References specific page numbers (37, 39) showing engagement with source material. CRITICAL WEAKNESSES: (1) The LLM answer does NOT accurately capture the specific language evolution described in the ground truth. The ground truth explicitly states 2023 used 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments' while 2024 used 'proceeds from asset sales and returns of investments'—the LLM answer fails to cite these actual phrases; (2) The LLM introduces concepts ('capital-allocation strategy,' 'portfolio simplification,' 'higher-return projects') that are not mentioned in the ground truth answer, suggesting either fabrication or misinterpretation of source material; (3) The ground truth emphasizes the CONSOLIDATION/STREAMLINING of language (removing specific mention of subsidiaries and equipment), but the LLM answer frames the evolution as adding strategic emphasis rather than simplifying terminology; (4) The LLM answer focuses on investor communication utility and capital allocation strategy framing, which diverges from the ground truth's focus on the actual linguistic/descriptive changes in how proceeds are categorized; (5) The ground truth's key insight—that 2024 language is 'more consolidated' and 'more generalized'—is not reflected in the LLM answer. QUANTITATIVE ACCURACY is rated 7 because page numbers are provided (though not verified against actual filings), but the specific language phrases that should be quoted are absent. QUALITATIVE ACCURACY is rated 3 because the reasoning about what changed is fundamentally misaligned with the ground truth—the LLM describes a shift toward MORE strategic emphasis when the ground truth describes a shift toward LESS specific categorization. The answer addresses the right question but with substantially incorrect characterization of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 575,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\nFrom 2022 to 2023 the amounts of Universal Beijing Resort that appear on Comcast’s consolidated balance sheet fell – assets dropped from roughly **$8.5 billion to $7.8 billion** and liabilities slipped from about **$7.9 billion to $7.2 billion**.  This decline in both the asset base and the debt level reduces Comcast’s maximum potential loss to its 30 % equity stake, meaning its financial exposure to the resort is lower in 2023 than it was in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the asset figures. Ground truth states 2022 assets were $9.7 billion, but LLM reports $8.5 billion - a $1.2 billion discrepancy (12% error). The 2023 asset figure of $7.8 billion is correct. For liabilities, the LLM reports 2022 at $7.9 billion when ground truth shows $8.1 billion - a $0.2 billion error. The 2023 liability figure of $7.2 billion is correct. REASONING QUALITY: The LLM's qualitative analysis is sound - it correctly identifies the downward trend in both assets and liabilities, and appropriately concludes this reduces financial exposure. The mention of the 30% equity stake adds relevant context. However, the reasoning is built on partially incorrect numbers, which undermines the analysis. COMPLETENESS: The answer addresses the core question about evolution from 2022 to 2023 and provides interpretation of what the changes mean. ENTITY ACCURACY: Correctly identifies Comcast and Universal Beijing Resort, correct years (2022-2023), correct metrics (assets and liabilities). The fundamental issue is that the 2022 asset figure is materially wrong, representing a major factual error that would mislead stakeholders about the actual magnitude of the change and Comcast's exposure level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 363,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Caterpillar’s description of customer‑demand volatility moved from a broad, cyclical macro‑economic risk—driven mainly by commodity‑price swings and pandemic‑related uncertainty—to a more acute, multi‑factor uncertainty amplified by inflation, higher interest rates, tighter credit conditions and persistent supply‑chain bottlenecks.  This heightened volatility now directly threatens revenue swings and forces tighter inventory and production scheduling, making demand instability a more immediate risk to both financial performance and the stability of Caterpillar’s supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL CONTRADICTION - The LLM answer claims the 2023 description was 'driven mainly by commodity-price swings and pandemic-related uncertainty,' but the ground truth explicitly states 2023 was 'primarily driven by economic uncertainties, including the lingering effects of a global pandemic' with NO mention of commodity-price swings as a primary 2023 driver. The ground truth indicates commodity prices became MORE prominent in 2024, not 2023. (2) MISSING KEY EVOLUTION - The LLM fails to capture the critical shift described in ground truth: from pandemic/economic uncertainty focus (2023) to broader commodity price changes and systemic supply-side challenges (2024). Instead, the LLM presents a narrative of 'heightened volatility' with interest rates and credit conditions that are NOT mentioned in the ground truth. (3) INTRODUCED UNSUPPORTED ELEMENTS - The LLM adds 'higher interest rates' and 'tighter credit conditions' which do not appear in the provided ground truth, suggesting either hallucination or synthesis from outside the specified knowledge graph. (4) PARTIAL ACCURACY - The LLM correctly identifies that supply chain challenges are part of the risk profile and that the risk evolved between years, but the specific characterization of what changed is fundamentally misaligned with ground truth. (5) REASONING QUALITY - While the LLM's logic about supply chain impacts on financial performance is sound, it's built on an incorrect factual foundation regarding what the actual evolution was. The multi-hop synthesis fails because it mischaracterizes the 2023 baseline. QUANTITATIVE: No numbers to verify, so scored on consistency with ground truth narrative (8/10 - mostly coherent but factually wrong). QUALITATIVE: 3/10 due to fundamental mischaracterization of the evolution and introduction of unsupported risk factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 505,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\nFrom the 2022 10‑K the net derivative position was only $5 million (largely Level 2, with a small Level 3 component), and it was measured using vendor‑based discounted‑cash‑flow models that rely on market‑observable inputs and credit‑risk adjustments. By year‑end 2023 the balance had jumped to $69 million, driven by a larger share of Level 3 derivatives (e.g., SOFR‑indexed swaps) and wider pricing variations among vendors, while the underlying valuation approach—discounted cash‑flow with observable inputs where available and internal pricing cross‑checks—remained the same. The 2024 roll‑forward shows the same $69 million balance, indicating stability in fair‑value magnitude but continued classification as Level 3 and the same methodology of applying credit‑risk adjustments and internal‑external pricing validation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth across multiple dimensions:\n\n(1) QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n- Ground truth: 2022 fair value was $19 million; LLM states $5 million (incorrect)\n- Ground truth: 2024 fair value was $58 million; LLM states $69 million (incorrect)\n- Ground truth: Changes driven by issuances ($68M), settlements (-$37M), transfers ($6M); LLM provides no such breakdown\n- The LLM's numbers ($5M → $69M → $69M) do not match the ground truth progression ($19M → $58M)\n\n(2) VALUATION METHODOLOGY - PARTIALLY INCORRECT:\n- Ground truth: Methodology shifted FROM realized/unrealized gains/losses in net income TO discounted cash flows with observable inputs (swap rates 3-5%, weighted average 4%)\n- LLM: Claims methodology was already discounted-cash-flow in 2022 and remained the same through 2024, missing the key methodological evolution\n- LLM mentions Level 2/Level 3 classifications and SOFR-indexed swaps, which are not mentioned in ground truth\n- LLM correctly identifies discounted cash flow approach but misses the shift in how it was applied\n\n(3) MULTI-HOP REASONING:\n- The question asks about evolution FROM 2022 TO 2024\n- Ground truth clearly shows: $19M (2022) → $58M (2024) with specific drivers and methodology shift\n- LLM shows: $5M (2022) → $69M (2023) → $69M (2024), which is a different trajectory entirely\n- LLM fails to correctly synthesize the multi-year progression\n\n(4) ENTITY/METRIC ACCURACY:\n- Ground truth references December 31, 2021 and December 31, 2023 dates\n- LLM references year-end 2023 and 2024 but with wrong values\n- Both discuss fair value and valuation methodology, but LLM's specific metrics (Level 2/3 classifications, SOFR swaps) appear to be from different disclosures or misidentified\n\n(5) SEMANTIC EQUIVALENCE:\n- While both answers discuss discounted cash flows and observable inputs, the LLM fundamentally misrepresents the evolution by claiming consistency when ground truth shows a methodological shift\n- The LLM's claim that methodology \"remained the same\" directly contradicts the ground truth's description of a shift from one approach to another\n\nThe LLM answer appears to reference different or incorrect source data, resulting in wrong dollar amounts, wrong year-over-year progression, and incorrect characterization of methodological changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 642,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA moved GeForce NOW from a stand‑alone cloud‑gaming service into a core part of its accelerated‑computing and AI cloud platform.  The 2023 disclosures highlight that the service now runs on the same RTX‑based data‑center GPUs that power AI workloads, leveraging AI‑enhanced features such as DLSS and ray‑tracing to deliver higher‑fidelity, lower‑latency streaming.  Consequently, GeForce NOW is positioned as a showcase and consumer‑facing extension of NVIDIA’s full‑stack GPU‑AI ecosystem, tying cloud gaming performance directly to the company’s broader GPU‑cloud and AI‑software strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2022 to 2023, capturing the shift from a stand-alone service to integration within NVIDIA's broader accelerated computing platform. The mention of RTX-based data center GPUs, DLSS, and ray-tracing features are appropriate technical details. The answer demonstrates understanding of the multi-hop synthesis required (comparing positioning across two years within the broader ecosystem context). WEAKNESSES: (1) The LLM introduces specific technical claims (RTX-based data center GPUs, DLSS, ray-tracing enhancements) that are not explicitly mentioned in the ground truth answer. While these may be factually accurate about GeForce NOW, they represent information not derived from the knowledge graph baseline. (2) The ground truth specifically mentions vGPU for enterprise use as a comparative platform in 2022, which the LLM omits. (3) The ground truth explicitly mentions NVIDIA DGX Cloud as a parallel AI training platform in 2023, which the LLM does not reference. (4) The LLM's phrasing about 'consumer-facing extension' and 'showcase' adds interpretive language not present in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension scores well (8/10) - the years 2022 and 2023 are correctly referenced. QUALITATIVE ACCURACY: The core narrative is correct (5/10 due to missing specific platform comparisons like vGPU and DGX Cloud that were in the ground truth). CONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and ecosystem positioning (7/10), though it adds technical details beyond the scope of the ground truth. The answer is directionally correct but incomplete in capturing all elements from the knowledge graph baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 492,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\nInlyta’s worldwide sales rose modestly from about **$1.00 billion in 2022 to $1.04 billion in 2023** (≈3‑4 % growth), with U.S. revenue up **4 %** (from $618 M to $642 M) and international sales up **3 %** (from $385 M to $394 M).  The increase was driven mainly by greater use of Inlyta in combination regimens for first‑line advanced renal‑cell carcinoma and continued expansion in emerging markets, although this was partially offset by lower volumes and price reductions in certain European markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: Global revenue figures are correct ($1.00B ≈ $1,003M in 2022; $1.04B ≈ $1,036M in 2023). The stated 3-4% growth range is accurate (actual: 3.3% = ($1,036-$1,003)/$1,003). U.S. segment breakdown is correct ($618M to $642M = 3.9% growth, reasonably rounded to 4%). International segment is correct ($385M to $394M = 2.3% growth, reasonably rounded to 3%). All calculations are mathematically sound. QUALITATIVE ASSESSMENT: The answer correctly identifies the primary growth drivers: (1) increased adoption of Inlyta in combination regimens for first-line advanced RCC treatment, and (2) expansion in emerging markets. The offsetting factors are also accurately captured: lower volumes and price reductions in certain European markets. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across geographic segments (U.S. vs. international) and therapeutic contexts (combination therapy adoption, market-specific dynamics). ENTITY ACCURACY: Inlyta is correctly identified, years 2022-2023 are correct, and the indication (advanced renal cell carcinoma/RCC) is properly referenced. MINOR OBSERVATIONS: The LLM uses approximate notation (≈) appropriately given the rounding from millions to billions. The answer provides more granular detail (segment breakdown) than the ground truth while maintaining consistency with it. No material factual errors detected. The semantic meaning and information content align perfectly with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 428,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\nFrom 2023 to 2024 the Company changed how it accounts for network‑location intangibles: the assets were previously amortized over the shorter of the underlying ground‑lease term (generally up to 20 years) and were tested for impairment on a tower‑by‑tower basis when cash‑flow indicators suggested a loss; beginning January 1 2024 the Company extended the estimated useful life of towers (and therefore of the related intangibles) to 30 years and began amortizing them over that period, which reduces annual amortization expense (the change was accounted for as a prospective ASC 250 accounting‑estimate adjustment and is expected to cut depreciation/amortization by about $730 million in 2024). The impairment review now uses the longer‑life cash‑flow model—projecting undiscounted future cash flows and comparing them to the revised carrying amount—to determine whether an impairment charge is required, but the underlying trigger criteria (e.g., loss of tenant leases or negative cash flows) remain the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) MAJOR DISCREPANCY ON USEFUL LIFE: The LLM claims the company extended useful life from 20 years to 30 years in 2024, but the ground truth states the weighted average amortization period was 15 years in 2023 with no mention of a change to 30 years. This is a fundamental factual error. (2) INCORRECT AMORTIZATION SAVINGS: The LLM cites a $730 million reduction in depreciation/amortization expense in 2024, but the ground truth mentions a $470 million increase in asset retirement obligation liability due to revised settlement dates - these are different metrics and the LLM's figure appears unsupported by the ground truth. (3) MISSING KEY DETAILS: The ground truth emphasizes the relationship between network location intangibles and tower assets in terms of revenue growth from leasing excess capacity, which the LLM completely omits. (4) IMPAIRMENT REVIEW PROCESS: While the LLM correctly identifies that impairment is assessed on a tower-by-tower basis with triggers like lack of tenant leases, it incorrectly characterizes the 2024 change as using a 'longer-life cash-flow model' when the ground truth simply states the company expanded its disclosures to include more detailed impairment review processes. (5) ASC 250 REFERENCE: The LLM's mention of ASC 250 accounting estimate adjustment is not mentioned in the ground truth and appears to be an unsupported addition. (6) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the connection between amortization assumptions and the asset retirement obligation impacts mentioned in the ground truth. The answer appears to describe a different company's accounting changes rather than accurately reflecting the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 491,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from the early‑stage development and name‑plate ramp‑up of three Stabroek Block FPSOs (Prosperity, Liza Destiny, Liza Unity) to a deliberate expansion strategy that treats Guyana as a core “advantaged” upstream asset.  The 2024 filing still lists Guyana alongside the Permian and LNG as a key growth pillar and targets six FPSOs on the block by 2027, including regulatory work on a sixth Whiptail project, underscoring a shift toward consolidating and scaling Guyana’s production capacity within the broader upstream growth portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of ExxonMobil's strategic evolution regarding Guyana between 2023 and 2024, with mostly accurate information but some notable differences from the ground truth:\n\nSTRENGTHS:\n1. Correctly identifies the shift from early-stage development to mature 'advantaged' asset status\n2. Accurately names the three FPSOs (Prosperity, Liza Destiny, Liza Unity)\n3. Correctly notes Guyana's positioning alongside Permian and LNG as core growth pillars in 2024\n4. Properly captures the strategic elevation and financial maturation theme\n5. Mentions the six FPSO target by 2027, showing forward-looking perspective\n6. Good multi-hop synthesis connecting 2023 and 2024 positioning\n\nWEAKNESSES/DISCREPANCIES:\n1. The ground truth specifically mentions \"nearly 440 kbd in the fourth quarter\" (2023) - the LLM answer omits this specific production capacity metric, which is a quantitative detail that should have been included\n2. The ground truth emphasizes \"four additional discoveries on the Stabroek Block\" in 2023 - the LLM answer doesn't mention the discovery aspect, focusing instead on FPSO ramp-up\n3. The LLM answer introduces the \"Whiptail project\" which is not mentioned in the ground truth, potentially adding information not verified in the source material\n4. The ground truth describes a transition from \"discovery and early production phase\" to \"mature, financially impactful asset\" - the LLM captures this but with slightly different framing\n\nQUANTITATIVE ACCURACY: The LLM correctly identifies the six FPSO target by 2027 and the three existing FPSOs, but misses the 440 kbd production figure from Q4 2023, which is a specific quantitative metric that should have been included.\n\nQUALITATIVE ACCURACY: The reasoning about strategic elevation and the shift from development to mature asset is sound and well-articulated. The multi-hop synthesis connecting 2023 and 2024 is logical and appropriate.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about strategic emphasis evolution and production capacity, though it could have been more specific about the 440 kbd baseline from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 581,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast moved the X1 platform from a separate Flex streaming dongle to a fully integrated X1 experience that natively aggregates third‑party DTC services (e.g., Disney+, Netflix, Peacock) and adds a new ad‑supported “NOW” streaming tier that can be accessed without a set‑top box; the platform also now earns commission revenue from DTC subscriptions.  This evolution reflects Comcast’s strategy of keeping broadband/video subscribers inside its own ecosystem—by embedding popular OTT services directly in X1 and offering premium, commission‑generating streaming options—thereby curbing cord‑cutting and driving higher average revenue per user.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT CLAIM ABOUT FLEX: The LLM states the X1 platform moved 'from a separate Flex streaming dongle to a fully integrated X1 experience' - this is not supported by the ground truth, which makes no mention of Flex or any such transition. This appears to be a fabrication or confusion with unrelated product information. (2) MISSING KEY SERVICES: The ground truth explicitly mentions Xumo Play, NBC, and Sky as part of NOW TV service integration in 2023, which the LLM completely omits. The LLM only mentions 'NOW' generically without identifying these specific services. (3) INACCURATE SERVICE CHARACTERIZATION: The LLM describes NOW as 'ad-supported' and 'accessible without a set-top box,' but the ground truth indicates NOW TV was 'specifically marketed to residential broadband customers' - a different positioning. The ground truth does not characterize it as ad-supported. (4) MISSING STRATEGIC CONTEXT: The ground truth emphasizes the strategic pivot toward 'enhancing the value of broadband subscriptions' and bundling to 'retain customers,' which the LLM mentions only vaguely. The ground truth's specific mention of broadband bundling strategy is not clearly captured. (5) COMMISSION REVENUE: While both mention commission revenue, the LLM's framing is less precise about the specific partnerships generating this revenue. WHAT WAS CORRECT: The LLM correctly identifies that the evolution involved integrating third-party services (Disney+, Netflix, Peacock), that commission revenue is earned, and that the strategy aims to reduce cord-cutting and increase ARPU. The overall strategic direction is directionally correct. MULTI-HOP REASONING: The LLM demonstrates understanding of the cause-effect relationship between platform integration and business outcomes, but the specific factual details supporting this reasoning are partially incorrect or fabricated. The synthesis is logically sound but built on incomplete/inaccurate premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 558,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar trimmed the FG Wilson distributor count from **110 to 108**, while expanding the geographic footprint from **109 to 158 countries** — a shift that tightens the partner base but broadens coverage of its electric‑power‑generation systems. This evolution is noted in the “Nature of operations” sections of the 2023 and 2024 10‑K filings (pages 65 and 66).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: distributor count decreased from 110 to 108 (verified), and geographic coverage expanded from 109 to 158 countries (verified). The multi-hop synthesis is sound—the answer correctly identifies the relationship between Caterpillar and FG Wilson, tracks the evolution across 2023-2024, and addresses both dimensions of the distribution network change (distributor count and country coverage). The semantic interpretation is accurate: the answer correctly characterizes this as a strategic optimization (fewer but more efficient distributors) with expanded geographic reach. The citation to specific 10-K filing pages (65 and 66) adds credibility, though these cannot be independently verified in this evaluation. The wording is clear and professional, using em-dashes and bold formatting effectively to highlight key metrics. Minor deduction from perfect score only because the answer could have slightly elaborated on the strategic implications (as the ground truth does with 'strategic shift toward optimizing distributor efficiency'), though the core insight is present. All entities are correctly identified (Caterpillar, FG Wilson, electric power generation systems), and the temporal comparison is properly structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 369,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\nBetween the 2022 filing (which reported consolidated VIE liabilities of about **$15.2 billion** — $13.0 billion for credit‑card securitizations plus $2.2 billion for auto securitizations) and the 2024 filing, the **carrying amount of Capital One’s securitized‑debt obligations fell to $14.3 billion** as of December 31 2024.  The **estimated fair value moved in step with the carrying amount**, declining from roughly **$15.3 billion** to **$14.3 billion** over the same period, reflecting a modest reduction in the company’s exposure to securitized debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2024 carrying value as $14.3 billion, but the ground truth clearly states it was $18,043 million ($18.043 billion). This is a $3.7 billion discrepancy - a 20% understatement. The LLM reports 2024 fair value as $14.3 billion, but ground truth shows $18,067 million ($18.067 billion) - another $3.7 billion error. The LLM's 2022 figures ($15.2 billion carrying value, $15.3 billion fair value) also appear inconsistent with the ground truth's description of 2022 data. (2) DIRECTIONAL ERROR: The LLM claims securitized debt obligations DECLINED from 2022 to 2024, but the ground truth indicates they INCREASED (from ~$15.2B to $18.043B carrying value). This is a fundamental misrepresentation of the trend. (3) MISSING KEY INFORMATION: The ground truth specifies that 2024 obligations were categorized under Level 2 of the fair value hierarchy - the LLM completely omits this important classification detail. (4) MULTI-HOP REASONING: While the LLM attempted to synthesize 2022 and 2024 data, it failed to correctly extract or report the actual figures from the filings. The comparison structure is sound, but the underlying numbers are wrong. (5) SEMANTIC ISSUES: The LLM's conclusion about 'modest reduction' is contradicted by the actual data showing an increase. The answer demonstrates a fundamental failure in data extraction and verification from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 426,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s replaced its prior $15 billion revolving‑credit facility (authorized in December 2022, with about $7.4 billion still unused at the end of 2023) with a new identical $15 billion facility that became effective on January 1 2025, while still maintaining a $4 billion committed line‑of‑credit availability. This restructuring preserves the same borrowing capacity and flexibility to meet short‑term funding needs—such as share‑repurchases, dividend payments and debt‑service obligations—without altering the company’s overall cash‑flow strategy, which continues to rely primarily on strong operating cash generation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses a different aspect of McDonald's line of credit agreements than what the ground truth covers, resulting in significant misalignment with the original question about evolution between 2023 and 2024. CRITICAL ISSUES: (1) The LLM focuses on the replacement of a $15 billion revolving credit facility effective January 1, 2025, which is outside the 2023-2024 timeframe specified in the question. (2) The LLM provides specific numbers ($15 billion facility, $7.4 billion unused at end of 2023, $4 billion committed line) that cannot be verified against the ground truth and appear to be structural/facility details rather than usage metrics. (3) The ground truth emphasizes CASH FLOW EVOLUTION: cash used for financing activities increased from $4.4B (2023) to $7.5B (2024), cash and equivalents dropped from $4.6B to $1.1B, and the company shifted from surplus liquidity to a more cash-constrained environment. The LLM completely omits these critical cash flow metrics. (4) The ground truth highlights increased reliance on credit facilities due to decreased bond issuances and timing of debt issuances, while the LLM states the restructuring 'without altering the company's overall cash-flow strategy.' (5) MULTI-HOP REASONING: The ground truth synthesizes financing activities, cash balances, and credit facility usage to show how McDonald's adapted its financing approach. The LLM provides facility restructuring details that don't address the actual evolution of how credit agreements were used in cash flow management. (6) The LLM's statement about 'strong operating cash generation' is not substantiated by the ground truth data provided. The answer appears to reference specific facility details from the 10-K but fails to address the core question about how LINE OF CREDIT USAGE evolved in relation to financing activities and cash flow management between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 513,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Company’s internal‑control disclosures shifted from a generic statement that the **Worldwide Business Conduct Manual “reinforces” a culture of integrity** to an explicit reference that the Manual underpins **specific control activities around complex financial estimates**—particularly the valuation and impairment of the Gillette indefinite‑lived intangible asset.  The 2024 report details testing of controls over forecasts, royalty rates and discount‑rate assumptions used in fair‑value measurements, showing that the Manual is now treated as an operational framework that drives documented, risk‑based procedures and independent validation of key judgments.  This evolution indicates that Procter & Gamble is embedding the Manual more tightly into its governance structure, using it to strengthen oversight, ensure consistent risk‑assessment practices, and demonstrate a proactive, transparent approach to financial reporting controls.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The LLM introduces specific claims about Gillette indefinite-lived intangible asset valuation, fair-value measurements, forecasts, royalty rates, and discount-rate assumptions that are NOT present in the original answer. The ground truth makes no mention of these financial estimation details. (2) MISALIGNMENT ON EVOLUTION: The ground truth describes the evolution as a shift from general integrity language to MORE SPECIFIC GOVERNANCE FRAMEWORKS (Global Leadership Council oversight, Disclosure Committee responsibilities). The LLM instead claims the shift is toward 'complex financial estimates' and 'fair-value measurements'—a completely different narrative that contradicts the ground truth. (3) MISSING KEY ELEMENTS: The LLM fails to mention the Global Leadership Council, the Disclosure Committee, or the shift toward structured governance mechanisms that are central to the ground truth answer. (4) FABRICATED DETAILS: The specific references to Gillette asset impairment testing, royalty rates, and discount-rate assumptions appear to be hallucinated details not supported by the ground truth. (5) SEMANTIC DIVERGENCE: While both answers discuss evolution of the Manual's role, they describe fundamentally different evolutions—one toward governance structures (ground truth) vs. one toward financial estimation controls (LLM). The LLM answer may be factually accurate about P&G's actual filings, but it does not match the ground truth answer provided, which is the evaluation standard. This represents a failure in multi-hop synthesis and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 468,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\nExxon’s Guyana exposure grew sharply in the 2023‑2024 reporting period – long‑lived assets in the country rose from roughly **$6.8 bn to $9.7 bn**, underscoring a larger capital commitment – and the company now classifies Guyana as an **“advantaged asset”** within its earnings‑driver framework (Advantaged Volume Growth), tying its future earnings to Guyana’s high‑value, lower‑emission oil production. This evolution reflects a strategic shift from early‑stage development to positioning Guyana as a core, high‑return growth pillar of Exxon’s upstream portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL QUANTITATIVE ERROR: The LLM states Guyana long-lived assets rose from '$6.8 bn to $9.7 bn' between 2023-2024. However, the ground truth indicates that in 2023, Exxon disclosed $9,689 million ($9.7 bn) in Guyana long-lived assets. The LLM's claim of a rise from $6.8 bn to $9.7 bn is factually incorrect - the 2023 figure was already $9.7 bn, not $6.8 bn. This represents a fundamental misstatement of the quantitative data. The LLM appears to have confused or misread the baseline figure. QUALITATIVE STRENGTHS: The LLM correctly identifies Guyana as part of 'Advantaged Assets' and the 'Advantaged Volume Growth' earnings driver framework in 2024, which matches the ground truth. The characterization of the strategic shift from early-stage development to a core growth pillar is semantically sound and aligns with the ground truth narrative. MULTI-HOP REASONING: The LLM successfully synthesizes information across the two years and connects asset disclosures to earnings driver definitions, demonstrating appropriate multi-hop reasoning. However, this strength is severely undermined by the incorrect baseline number. COMPLETENESS: The answer addresses both components of the question (asset disclosures and earnings driver definitions) but the quantitative foundation is flawed. The semantic framing about strategic positioning is appropriate but cannot overcome the factual error in the primary metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 393,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\nFrom the 2022 10‑K (pages 111‑115) Capital One was still building its securitization portfolio – it issued **$6.3 billion** of securitized‑debt obligations in 2021, which helped lift total long‑term debt to **$42.3 billion** (up $2.4 billion from the prior year).  \nIn contrast, the 2024 10‑K (pages 217‑221) shows the **carrying value of securitized‑debt obligations falling to $14.3 billion** (down from $18.0 billion in 2023) and no new issuance disclosed, indicating that the firm has markedly **reduced its reliance on securitized debt** over the 2022‑2024 period and is now funding growth primarily through senior/subordinated notes and deposit sources.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM cites $6.3 billion in 2021 securitized debt issuance and $42.3 billion total long-term debt for 2022, but the ground truth provides no such figures for 2022. More critically, the LLM states the 2024 carrying value is $14.3 billion (down from $18.0 billion in 2023), but the ground truth explicitly states the 2024 carrying value is $14,264 million ($14.264 billion), which matches the LLM's rounded figure. However, the ground truth makes NO mention of a 2023 figure of $18.0 billion - this appears to be fabricated or from an unreliable source. (2) INTERPRETATION ERROR: The LLM concludes Capital One has 'markedly reduced its reliance on securitized debt' based on the decline from $18.0B (2023) to $14.3B (2024). The ground truth, however, presents a different narrative: it emphasizes that 2022 had 'no specific dollar value disclosed' but the company 'emphasized strategic importance,' while 2024 shows 'increased transparency and continued use.' The ground truth does NOT characterize this as a reduction in reliance - rather, it highlights improved disclosure and continued strategic use. (3) MULTI-HOP REASONING FLAW: The LLM's synthesis incorrectly inverts the ground truth's conclusion. Ground truth shows evolution toward GREATER transparency and CONTINUED use; LLM shows evolution toward REDUCED reliance. (4) MISSING CONTEXT: The LLM fails to acknowledge that 2022 lacked specific dollar quantification, which is a key point in the ground truth's narrative about transparency evolution. (5) UNVERIFIED CLAIMS: The $18.0 billion 2023 figure and the claim about 'no new issuance disclosed' cannot be verified against the provided ground truth and appear to be unsupported assertions. The answer demonstrates poor multi-hop synthesis and contradicts the ground truth's core finding about continued strategic use and improved transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 535,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA reframed Omniverse from a real‑time 3D collaboration and simulation tool (offered as an enterprise subscription with a free individual tier) into a core “industrial‑metaverse” platform for building digital‑twin and AI‑driven virtual‑world applications.  This repositioning was accompanied by a sharp rise in enterprise adoption—industrial customers began deploying Omniverse at scale for factory digital twins, real‑time product configurators and autonomous‑vehicle simulation, and the platform was integrated with NVIDIA’s AI, cloud (vGPU/GeForce NOW) and DRIVE Sim services, driving a noticeable increase in enterprise‑level revenue and partner engagements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Omniverse from FY2022 to FY2023, capturing the shift toward enterprise adoption and digital twin applications. It accurately mentions key use cases (factory digital twins, real-time product configurators, autonomous vehicle simulation) that align with the ground truth. The subscription model for enterprises with free individual tier is correctly stated. The answer demonstrates understanding of the multi-hop synthesis required.\n\nWEAKNESSES: (1) The LLM introduces terminology not present in the ground truth ('industrial-metaverse' framing, 'AI-driven' emphasis, integration with vGPU/GeForce NOW/DRIVE Sim services). While these may be accurate from the filings, they represent additions beyond what the ground truth specifies, suggesting potential over-interpretation or hallucination. (2) The claim about 'sharp rise in enterprise adoption' and 'noticeable increase in enterprise-level revenue' lacks quantitative support - no specific numbers, percentages, or metrics are provided to substantiate these claims, which is problematic for a financial question context. (3) The answer conflates positioning evolution with revenue/engagement metrics without clear grounding in the source material as presented in the ground truth.\n\nMULTI-HOP REASONING: The answer attempts to synthesize positioning changes with adoption metrics and platform integrations, but the integration claims (vGPU, GeForce NOW, DRIVE Sim) go beyond what the ground truth explicitly states about Omniverse's evolution between these two fiscal years.\n\nQUANTITATIVE ISSUES: No specific financial metrics, adoption numbers, or revenue figures are provided despite the question's financial context. The ground truth also lacks these specifics, but the LLM's claims about 'sharp rise' and 'noticeable increase' require quantitative support that isn't provided.\n\nSEMANTIC ALIGNMENT: The core message about evolution from creative tool to enterprise simulation platform is correct, but the LLM adds interpretive layers (industrial-metaverse, AI-driven, specific service integrations) that may exceed the ground truth's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 581,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 Pfizer’s net payable to Viatris fell sharply — from **$94 million** (as reported on page 75 of the 2023 Form 10‑K) to **$33 million**, a reduction of about **$61 million** as the transitional MSAs, TSAs and other separation agreements were settled.  At the same time the receivable that Viatris owed Pfizer dropped from **$53 million** in 2021 to essentially zero by 2022, reflecting the collection or write‑off of the $401 million balance that had been recorded in 2020.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core financial relationship evolution between Pfizer and Viatris. CORRECT ELEMENTS: (1) The net payable amount decreased from $94 million (Dec 31, 2022) to $33 million (Dec 31, 2023) - both figures match ground truth exactly. (2) The calculation of the $61 million reduction is accurate ($94M - $33M = $61M). (3) The characterization of this as a 'sharp' reduction and reference to transitional agreements (MSAs, TSAs) aligns with the ground truth's description of 'winding down or stabilization.' (4) The answer appropriately addresses the multi-hop synthesis required by the question. ISSUES/CONCERNS: (1) The LLM introduces additional information about receivables from Viatris ($53 million in 2021 dropping to zero by 2022, and a $401 million balance from 2020) that is NOT present in the ground truth answer. While this information may be factually accurate from the 10-K filing, it goes beyond what was asked and what the ground truth covers. The question specifically asks about 'net amounts due under their various agreements' between 2022-2023, not about receivables or historical 2020-2021 data. (2) The citation to 'page 75 of the 2023 Form 10-K' is specific but cannot be verified against the ground truth provided. (3) The answer conflates 'net payable' with the broader concept of 'net amounts due' - while semantically similar, the ground truth uses the more neutral 'net amounts due' terminology. The core answer to the actual question asked is accurate and well-reasoned, but the inclusion of extraneous information about receivables and earlier years represents scope creep that, while potentially informative, dilutes focus from the specific 2022-2023 comparison requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 472,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\nExxonMobil’s focus on Guyana has shifted from early‑stage exploration toward treating the offshore discoveries as a core, high‑return growth pillar.  In the 2024 filing the company explicitly places Guyana within the “Advantaged Volume Growth” and “Advantaged Projects” earnings‑driver categories, and the 2024 disclosures show a larger share of development‑type wells (12.6 net development wells completed in 2023) being counted as development activity and earmarked for dedicated capital investment—highlighting the Payara, Yellowtail and Uaru projects as strategic, advantaged assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 12.6 net development wells completed in 2023 - this number matches the ground truth exactly. (2) Accurately names all three key projects: Payara, Yellowtail, and Uaru. (3) Correctly identifies the 2024 strategic reclassification into 'Advantaged Volume Growth' and 'Advantaged Projects' categories. (4) Properly synthesizes the multi-hop evolution from 2023 exploration/development phase to 2024 strategic prioritization. (5) Correctly characterizes the shift from operational reporting to strategic emphasis. MINOR ISSUES: (1) The LLM states '12.6 net development wells completed in 2023' but the ground truth specifies '12.6 net exploratory and development wells' - the LLM's phrasing is slightly narrower, though the number is correct. This is a minor semantic distinction that doesn't materially affect the answer's accuracy. (2) The LLM could have been slightly more explicit about the formal classification as 'Advantaged Assets' (the ground truth uses this specific term), though the answer conveys the same meaning through 'Advantaged Volume Growth' and 'Advantaged Projects.' QUANTITATIVE VERIFICATION: The 12.6 wells figure is accurate and properly contextualized. No calculations are required for this question, so quantitative accuracy is high. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly identifying the evolution in strategic emphasis and the specific projects involved. The reasoning connecting operational metrics to strategic classification is sound. OVERALL: The answer is substantially correct with only minor wording variations from the ground truth. The core factual content, numbers, and multi-hop synthesis are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 498,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\nThe weighted‑average interest rate on senior notes with maturities > 10 years was unchanged at **3.8 %** in both 2022 and 2023.  Their face‑value amount rose slightly, from **$52.8 billion** at the end of 2022 to **$53.4 billion** at the end of 2023.  (Pages 82 and 82 of the 2023 10‑K and the comparable 2022 table.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) INTEREST RATE ERROR: The LLM claims the rate was 3.8% in BOTH 2022 and 2023, but the ground truth shows it was 3.67% in 2022 and 3.8% in 2023. This is a critical error - the LLM failed to capture the actual change in the interest rate from 2022 to 2023. (2) FACE VALUE ERROR: The LLM states the face value was $52.8 billion in 2022, but the ground truth clearly shows $54.536 billion in 2022. This is a $1.736 billion discrepancy - a material error of approximately 3.2%. The 2023 figure of $53.4 billion is correct. (3) DIRECTIONAL ERROR: The LLM claims face value 'rose slightly' from $52.8B to $53.4B, but the ground truth shows it actually DECREASED from $54.536B to $53.4B (a decline of $1.136B). The LLM got the direction of change completely wrong. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identified the metrics and years involved, it failed to accurately synthesize the data across the two years. The answer should have shown: 2022 rate of 3.67% increasing to 3.8% in 2023, and face value decreasing from $54.536B to $53.4B. Instead, it presented incorrect baseline numbers and a false narrative of stability in rates and growth in face value. The contextual relevance is moderate because the answer addresses the right question structure, but the fundamental numerical errors make this response unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 405,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\nThe 2023 fair‑value tables show Alabama Power’s domestic equity split between $396 million classified as Level 2 and $169 million as Level 3, while Georgia Power’s domestic equity was $255 million Level 2 with only $1 million Level 3. In 2024 the private‑market equity in Alabama Power’s nuclear decommissioning trust increased to $190 million (up from $178 million) and is now valued via the NAV practical expedient, which the company classifies as a Level 2 input, so the holdings are reported primarily as Level 2 (with only minimal Level 1 components), whereas Georgia Power’s domestic equity remains classified as Level 2 with a stable allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that directly contradict the ground truth across all key metrics and classifications:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- Alabama Power 2023: LLM states '$396 million classified as Level 2 and $169 million as Level 3' but ground truth shows $396M Level 1 and $169M Level 2. The LLM has inverted the Level 1/Level 2 classification and incorrectly introduced Level 3.\n- Alabama Power 2024: LLM mentions '$190 million (up from $178 million)' for private-market equity with NAV practical expedient, but ground truth shows $443M Level 1 and $208M Level 2 (totaling $651M). These numbers are completely different and unrelated to the actual domestic equity allocations.\n- Georgia Power 2023: LLM states '$255 million Level 2 with only $1 million Level 3' but ground truth shows $255M Level 1 and $1M Level 2. Again, the LLM has misclassified the input levels and incorrectly introduced Level 3.\n- Georgia Power 2024: LLM provides no specific numbers, only vague statements about 'stable allocation' and 'Level 2 with minimal Level 1 components,' whereas ground truth shows $321M Level 1 and $1M Level 2.\n\n(2) CLASSIFICATION ERRORS:\nThe LLM systematically reverses Level 1 and Level 2 classifications for both companies in 2023, and then provides entirely different numbers for 2024 that don't match the ground truth at all. The introduction of Level 3 classifications is not supported by the ground truth data.\n\n(3) MULTI-HOP REASONING FAILURE:\nThe LLM fails to correctly synthesize the comparative analysis across both companies and both years. It does not identify the strategic shift toward higher Level 1 allocations (more actively traded instruments) that the ground truth clearly documents. Instead, it incorrectly characterizes the holdings as primarily Level 2.\n\n(4) MISSING KEY INSIGHTS:\nThe LLM completely misses the core finding: both companies increased their Level 1 domestic equity allocations from 2023 to 2024 (Alabama Power from $396M to $443M; Georgia Power from $255M to $321M), indicating a shift toward more liquid, transparently valued instruments. The LLM's narrative about NAV practical expedient and Level 2 classification contradicts this fundamental trend.\n\n(5) SEMANTIC MISALIGNMENT:\nThe LLM answer addresses a different topic (private-market equity valuations via NAV) rather than the actual domestic equity allocation shifts documented in the ground truth. This represents a fundamental misunderstanding of the question and the underlying data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 677,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA moved CUDA from a core accelerator inside its GPU‑centric platform to the central, unifying layer of a full‑stack computing architecture that now spans silicon (GPU, DPU and the 2024 Grace CPU), system software, enterprise AI suites (e.g., NVIDIA AI Enterprise), and cloud services such as DGX Cloud.  This evolution ties CUDA to a common programmable foundation that delivers end‑to‑end solutions across the data‑center, gaming, professional‑visualization and automotive end markets, leveraging a shared developer ecosystem and software stacks to integrate those markets around a single CUDA‑based platform.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. The LLM correctly identifies the evolution of CUDA from 2022 to 2023\n2. Correctly mentions the shift toward a full-stack computing architecture\n3. Accurately references end markets (data center, gaming, professional visualization, automotive)\n4. Correctly identifies CUDA as a unifying/foundational layer\n5. Appropriately mentions the developer ecosystem concept\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. FACTUAL ERROR - The LLM introduces 2024 Grace CPU and DPU references that are NOT part of the 2022-2023 evolution described in the ground truth. The ground truth specifically focuses on 2022 vs 2023 positioning, not forward-looking 2024 products.\n2. MISSING KEY INFORMATION - The LLM fails to mention the critical evolution regarding domain-specific software libraries, SDKs, and APIs that became explicitly emphasized in 2023 (healthcare, telecom, manufacturing, etc.). This is a major omission from the ground truth.\n3. INCOMPLETE VERTICAL INTEGRATION - The LLM mentions enterprise AI suites and DGX Cloud but doesn't capture the specific domain-specific vertical integration (healthcare, telecom, manufacturing) that was central to the 2023 positioning.\n4. SCOPE CREEP - By introducing 2024 products and broader system software components not explicitly mentioned in the ground truth, the LLM adds information that may not be directly supported by the 2022-2023 filing data.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of CUDA's role across markets but fails to properly synthesize the critical shift toward domain-specific software stacks that was emphasized in 2023.\n\nQUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this is not a differentiating factor. Both answers appropriately avoid unsupported quantitative claims.\n\nSEMANTIC EQUIVALENCE: While the LLM's description of CUDA as a unifying layer is semantically similar to the ground truth's 'foundational programming model,' the LLM's answer diverges significantly by introducing elements (2024 products, DPU, Grace CPU) not supported by the 2022-2023 comparison requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 598,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\nFrom 2022 to 2023 Pfizer’s post‑spin‑off transitional service and manufacturing agreements with Viatris were largely wound down.  Net amounts payable to Viatris under those agreements fell from **$94 million as of December 31 2022** to **$33 million as of December 31 2023**, reflecting the completion of the interim TSAs and supply arrangements by the end of 2023.  (See Notes to Consolidated Financial Statements on pages 72 and 74 of the 2023 Form 10‑K.)",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metrics and demonstrates sound multi-hop reasoning across the 2022-2023 period. STRENGTHS: (1) Both dollar amounts are accurate: $94 million (2022) and $33 million (2023) match the ground truth exactly. (2) Dates are correct (December 31, 2022 and December 31, 2023). (3) The core narrative about winding down TSAs and supply arrangements is accurate. (4) The answer correctly contextualizes this as post-spin-off activity related to the 2020 Viatris separation. (5) Citation to specific 10-K pages adds credibility. WEAKNESSES: (1) The LLM answer omits the explicit statement that TSA services were 'fully completed as of December 31, 2023' - it says they were 'completed by the end of 2023' which is semantically similar but less precise. (2) The ground truth notes that 2022 disclosures indicated TSA services were 'largely completed by the end of 2022,' but the LLM doesn't capture this intermediate status clearly. (3) The answer doesn't explicitly mention that amounts were 'not material to operations' in 2022, which provides important context about the significance of these obligations. (4) The LLM doesn't distinguish between TSAs and MSAs as clearly as the ground truth does. The answer is fundamentally correct on the quantitative evolution and main narrative, but lacks some of the nuanced contextual details present in the ground truth regarding the progression of completion status and materiality assessments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 408,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\nFrom 2022 to 2023 the filing shows that retail‑deregulation risk remained a “significant adverse impact” on earnings, but the discussion of environmental compliance costs grew more explicit about how those costs are tied to rate‑recovery mechanisms. In 2022 the 10‑K warned that deregulation could create stranded‑cost exposure while also noting that CCR‑related expenditures would be pursued for full recovery through regulated rates; by 2023 the company stresses that new EPA interpretations of the CCR rule and tighter state climate mandates are raising compliance outlays, and that any delay or denial of cost recovery—whether because of deregulation‑driven market changes or regulatory setbacks—could magnify the financial strain of those environmental obligations. Thus, the link between deregulation pressures and environmental‑regulation costs has tightened: the prospect of reduced rate‑recovery opportunities now directly amplifies the fiscal impact of Duke Energy’s environmental compliance spending.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between retail deregulation pressures and environmental compliance costs from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core evolution: deregulation risk remained significant while environmental compliance costs became more explicitly tied to rate-recovery mechanisms; (2) Accurately captures 2022 concerns about stranded costs and CCR-related expenditures; (3) Properly synthesizes 2023 developments including EPA interpretations and state climate mandates; (4) Correctly articulates the tightening link between deregulation pressures and environmental compliance spending; (5) Accurately conveys that reduced rate-recovery opportunities amplify fiscal impact. MINOR ISSUES: (1) The LLM answer uses slightly more technical/specific terminology (CCR rule, stranded-cost exposure) than the ground truth, though these are factually accurate references to Duke Energy's actual filings; (2) The ground truth mentions 'PURPA' and 'qualifying facilities' specifically, while the LLM answer generalizes to 'stranded-cost exposure'—both are correct characterizations but the LLM omits the specific mechanism; (3) The LLM answer emphasizes 'CCR-related expenditures' more prominently than the ground truth, which mentions 'cooling water intake structures' as one example among several EPA regulations. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is not directly testable. The temporal framing (2022 vs 2023) is correct in both. MULTI-HOP REASONING: The LLM successfully synthesizes information across two years and two domains (deregulation and environmental compliance), showing how they interact. The logic is sound: deregulation limits rate-recovery → environmental costs rise → inability to pass costs to customers creates financial strain. This matches the ground truth's reasoning. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly different emphasis and terminology but equivalent meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 563,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\nThe retail share of Skoal fell from **9.5 % in 2023 to 7.6 % in 2024** (a drop of roughly 1.9 percentage points). This decline happened even though Altria/USSTC raised Skoal’s list price several times during 2023—​including $0.09‑$0.10 per‑can increases in January, April, July and August — so the brand’s share eroded despite a higher pricing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states Skoal's retail share was 9.5% in 2023, but the ground truth clearly states 9.3% in 2023. This is a factual error of 0.2 percentage points. The 2024 figure of 7.6% is correct. The calculated decline of 1.9 percentage points is mathematically correct based on the LLM's incorrect 9.5% starting point, but should be 1.7 percentage points (9.3% - 7.6%). (2) PRICING STRATEGY DETAILS - The LLM provides different price increase amounts and timing than the ground truth. Ground truth specifies: $0.11 per can effective January 23, 2024 (announced in 2023), plus earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022. The LLM states '$0.09-$0.10 per-can increases in January, April, July and August' during 2023, which differs significantly from the ground truth's specific amounts and dates. The LLM appears to conflate 2022 and 2023 pricing actions. (3) MULTI-HOP REASONING - The LLM correctly synthesizes the contrast between declining market share and aggressive pricing strategy, which is the core of the question. The reasoning that higher prices may have contributed to share erosion is sound and matches the ground truth's implication. (4) COMPLETENESS - The answer addresses both parts of the question (share change and pricing strategy contrast), but with inaccurate details on the pricing specifics. The semantic understanding of the relationship between pricing and market share decline is correct, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 425,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\nBetween 2023 and 2024 the amortized cost of Amgen’s “Other short‑term interest‑bearing securities” slipped only slightly—from **$138 million** (2023) to **$135 million** (2024)—while the securities continued to be carried at essentially their fair value (no unrealized gains or losses).  The modest decline occurs even as the overall pool of available‑for‑sale investments grew, driven largely by higher money‑market fund holdings, indicating that Amgen is reallocating a small portion of its ultra‑short‑term cash from these securities into highly liquid money‑market funds.  This reflects the company’s stated investment objective of preserving principal and maintaining prudent liquidity, favoring the safest, most liquid instruments and keeping its short‑term portfolio modest and low‑risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2024 value was $135 million, but the ground truth clearly indicates it remained at $138 million in both 2023 and 2024. This is a $3 million discrepancy on a $138 million base—a material error of ~2.2%. The LLM incorrectly reports a 'modest decline' when the ground truth shows NO CHANGE. (2) CORE CLAIM CONTRADICTION: The ground truth explicitly states 'remained unchanged at $138 million in both 2023 and 2024,' while the LLM claims a decline from $138M to $135M. These are mutually exclusive statements. (3) REASONING BUILT ON FALSE PREMISE: The LLM's entire interpretation about 'reallocating a small portion of its ultra-short-term cash from these securities into highly liquid money-market funds' is based on the false premise of a decline. Since no decline occurred, this reasoning is unfounded speculation not supported by the data. (4) MULTI-HOP SYNTHESIS ISSUE: While the LLM attempts to synthesize information about investment strategy and liquidity management, it does so based on incorrect numerical data, making the synthesis fundamentally flawed. (5) WHAT WAS CORRECT: The LLM correctly identifies the 2023 figure ($138M), correctly names the company (Amgen), correctly identifies the metric ('Other short-term interest-bearing securities'), and appropriately discusses investment objectives around liquidity and principal preservation. However, these correct elements cannot overcome the critical numerical error in the 2024 figure. The answer demonstrates some understanding of investment strategy concepts but fails on the primary factual requirement of accurate financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 483,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\nFrom 2022 to 2024 the Abrams‑upgrade effort moved from a single $350 million Army contract that covered “engineering and logistics support services, and system and sustainment technical support” (GD 10‑K 2022, p. 44) to a broader, multi‑year package that now also funds the System‑Enhancement‑Package v3 (SEPv3) production for Romania and includes options that can lift the contract’s maximum potential value to roughly $1 billion (GD 10‑K 2024, p. 44).  Thus, while the base award amount stayed about $350 million, the scope expanded to include additional production and sustainment work and a larger potential value, reflecting a deeper, longer‑term involvement in the tank‑upgrade program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM answer states the 2022 contract was $350 million, but the ground truth clearly indicates it was $360 million. This is a $10 million factual error on a key data point. The LLM also omits the $285 million Romania SEPv3 production contract entirely, which is a significant omission representing a substantial portion of the contract portfolio evolution. The LLM mentions a potential $1 billion maximum value with options, which is not mentioned in the ground truth and appears to be unsupported information. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly identifies THREE distinct contracts (2022: $360M upgrade/support; 2024: $350M upgrades/support; 2024: $285M Romania production), showing a clear evolution in scope. The LLM only discusses two contracts and misses the Romania production contract entirely, failing to capture the full multi-hop synthesis required. (3) REASONING ISSUES: The LLM's conclusion that 'base award amount stayed about $350 million' is problematic because it conflates the 2022 $360M contract with the 2024 $350M contract without properly distinguishing them. The ground truth shows these are separate contracts with different values. The LLM's mention of options and $1 billion potential value lacks grounding in the provided ground truth. (4) CORRECT ELEMENTS: The LLM correctly identifies the shift from upgrade-focused to broader scope including production, and correctly notes the SEPv3 Romania production component. The general narrative about evolution is directionally correct. However, the specific numbers and contract details are materially inaccurate, which is critical for a financial question requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 470,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\nFrom 2023 through mid‑2024 AIG’s stake in Corebridge was steadily reduced until the June 9 2024 de‑consolidation, after which it held only about 22 % of Corebridge’s common stock and its borrowing link was limited to contingent guarantees and collateral obligations on Corebridge’s roughly $9.4 bn of debt.  Thereafter AIG accounts for the remaining interest as an equity‑method investment, so income from Corebridge is recognized only as dividends and fair‑value‑related gains (including the $282 m gain on the December 2024 share sale) in net investment income, rather than in consolidated segment earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct information with strong multi-hop synthesis. STRENGTHS: (1) Correctly identifies the June 9, 2024 de-consolidation date as the pivotal transition point; (2) Accurately states the ~22% ownership stake post-de-consolidation; (3) Correctly identifies the shift from consolidated accounting to equity method accounting; (4) Properly notes the $282M gain on December 2024 share sale; (5) Accurately describes the $9.4 billion debt figure; (6) Correctly explains that post-June 2024, income is recognized through dividends and fair-value gains rather than consolidated segment earnings. MINOR GAPS: (1) The original answer emphasizes the 2023 borrowing arrangement (ability to borrow through February 25, 2025) more explicitly, while the LLM answer mentions this only indirectly as 'contingent guarantees and collateral obligations'; (2) The LLM answer provides more granular detail about the accounting treatment and specific financial metrics than the original answer, which is actually more comprehensive but slightly beyond the scope of the original ground truth. QUANTITATIVE VERIFICATION: The 22% ownership stake, $9.4 billion debt figure, and $282 million gain are all stated correctly. The June 9, 2024 date is accurate. MULTI-HOP REASONING: The answer successfully synthesizes the evolution from 2023 (borrowing arrangement) through mid-2024 (stake reduction) to post-June 2024 (equity method accounting), demonstrating proper multi-hop synthesis across the time period. The logical flow from consolidated subsidiary to equity method investment is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental transformation as the original answer but with additional supporting details about accounting treatment and specific financial figures. The core message about the shift from borrowing-based to equity-based returns is clearly communicated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 516,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Solar Roof from a pilot‑scale, installation‑focused offering—sold directly and through channel partners and still being refined with real‑estate developers—to a core element of its vertically‑integrated energy strategy that now depends on large‑scale battery‑cell production and new factory capacity; by 2024 the company explicitly links Solar Roof volume to the development of its own lithium‑ion cells and to the reliable supply of raw materials such as lithium, nickel and cobalt, making the product’s rollout vulnerable to the same supply‑chain and raw‑material constraints that affect its vehicle and energy‑storage lines. This shift reflects a strategic dependency on in‑house cell manufacturing and global factory expansion, while production challenges have grown to include securing consistent component supplies and managing the complexities of ramping new manufacturing sites.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces claims about 'large-scale battery-cell production,' 'new factory capacity,' and explicit links to 'lithium-ion cells' and 'raw materials such as lithium, nickel and cobalt' that are NOT present in the ground truth. The ground truth makes no mention of these dependencies or cell manufacturing connections for Solar Roof. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from 'product development and sales emphasis' to 'production and dependency landscape,' but the LLM reframes this as a shift toward vertical integration and cell manufacturing—a narrative not supported by the provided ground truth. (3) MISSING CORE ELEMENTS: The LLM fails to accurately capture the ground truth's key points: (a) 2022 emphasis on 'collaboration with real estate developers and builders' and 'engineering efforts to combine aesthetics, durability, and power generation,' (b) 2024 focus on 'production ramp challenges, including bottlenecks, supplier risks, and cost control.' (4) SPECULATIVE ADDITIONS: The LLM adds details about 'channel partners,' 'global factory expansion,' and 'ramping new manufacturing sites' that go beyond what the ground truth establishes. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral, but the LLM's introduction of unverified technical dependencies (cell production, raw materials) represents a factual error in the absence of supporting evidence. The LLM answer appears to conflate Tesla's broader energy strategy with Solar Roof-specific dependencies, which is not supported by the ground truth. The core narrative of evolution from sales/development focus to production challenges is partially captured, but the specific mechanisms and dependencies described are largely fabricated or unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 539,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\nBetween 2023 and 2024 Skoal’s retail share fell from **9.3 % to 7.6 %** – a decline of roughly 1.7 percentage points (about an 18 % relative drop).  This loss of share, while the overall oral‑tobacco category grew, shows that Skoal is ceding ground to competitors such as Copenhagen and the on! nicotine‑pouch brand, indicating a weakening competitive position in the U.S. oral‑tobacco market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct market share figures for Skoal (9.3% in 2023 declining to 7.6% in 2024). The calculation of the decline is accurate: 9.3% - 7.6% = 1.7 percentage points, and the relative decline calculation of approximately 18% is mathematically correct (1.7/9.3 ≈ 0.183 or 18.3%). The answer correctly identifies the competitive positioning weakness and appropriately notes the contrast with competitor growth. However, there is one minor issue: the LLM mentions Copenhagen as a competitor gaining share, but the ground truth specifically mentions on! as the contrasting example (which increased from 6.8% to 8.3%). While Copenhagen may indeed be a competitor, the ground truth only explicitly provides comparative data for on!, so mentioning Copenhagen without supporting data from the filing represents a slight overreach beyond what can be verified from the provided ground truth. The answer correctly synthesizes the multi-hop information (comparing Skoal's performance across two years and relating it to competitive dynamics), and the semantic meaning aligns well with the ground truth. The reasoning about weakening competitive position is sound and well-supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 350,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\nThe 2024 filing sharpens the warning that premium‑tier device share is increasingly concentrated in a handful of OEMs—Apple, major Chinese manufacturers and a few other large customers—while also noting concrete developments that deepen the risk: Apple’s move to its own modem chips, the revocation of Huawei’s export licence in May 2024, and Chinese government‑driven “Made‑in‑China 2025” efforts that push OEMs to develop their own integrated circuits.  These trends give the few dominant customers greater purchasing power, forcing Qualcomm to face downward pricing pressure and making its revenue far more vulnerable to the purchase volumes and technology choices of those limited, high‑tier partners.  As a result, Qualcomm’s pricing power and revenue stability have weakened noticeably from 2023 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core risk evolution - that device share concentration among premium OEMs intensified from 2023 to 2024, with increased pricing pressure and revenue vulnerability. It accurately captures the shift in emphasis from 2023 (concentration leading to lower prices) to 2024 (broader implications including greater pricing pressure). The answer appropriately identifies specific concrete developments (Apple's modem chips, Huawei export license revocation, Made-in-China 2025) that deepen the risk. The multi-hop reasoning connecting customer concentration → purchasing power → pricing pressure → revenue instability is sound and matches the ground truth's core logic.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUES: The LLM introduces specific dates and events (Huawei export license revocation in May 2024, Made-in-China 2025 initiative) that are not mentioned in the ground truth answer. While these may be factually accurate external events, they represent information beyond what the ground truth knowledge graph contains, raising questions about whether these details actually appear in the 10-K filings being analyzed. (2) SPECIFICITY CONCERN: The ground truth emphasizes 'Chinese OEMs' as a key customer concentration point, while the LLM names specific companies (Apple, Huawei, major Chinese manufacturers) with more granularity than the ground truth provides. (3) TONE SHIFT: The LLM uses stronger language ('sharpens the warning,' 'weakened noticeably') that goes slightly beyond the ground truth's measured assessment that risk 'persisted but potentially intensified.' (4) MISSING NUANCE: The ground truth notes the risk relates to customers 'developing their own integrated circuits or using competitors,' which the LLM partially captures but doesn't fully articulate.\n\nMULTI-HOP REASONING: The answer successfully synthesizes the 2023-2024 comparison and connects customer concentration to pricing power and revenue stability, matching the ground truth's multi-hop structure. However, the introduction of specific external events not grounded in the provided knowledge graph creates uncertainty about factual accuracy.\n\nOVERALL ASSESSMENT: The answer captures the essential evolution of the risk and its implications correctly, but introduces specific details (dates, events) that cannot be verified against the ground truth, preventing a higher score. The core thesis is sound but the execution includes potentially unsourced specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 662,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\nAmgen’s short‑term liquidity was anchored in money‑market mutual funds that grew from **≈ $2.66 billion (amortized cost) in 2023** to **≈ $10.35 billion (amortized cost) in 2024**—a more than four‑fold increase that now makes up the bulk of its cash and cash‑equivalents. This shift reflects a deliberate move to hold a larger share of low‑risk, highly liquid assets to preserve liquidity while maintaining a conservative investment stance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual dimensions. (1) QUANTITATIVE ERRORS: The ground truth states money market mutual funds were $10,266 million in both 2023 and 2024 (unchanged). The LLM claims they grew from ~$2.66 billion in 2023 to ~$10.35 billion in 2024. These numbers are completely wrong - the 2023 figure is off by a factor of ~3.85x, and the 2024 figure is only marginally close but still incorrect ($10.35B vs $10.266B). More critically, the LLM claims growth when the ground truth explicitly states the allocation 'remained unchanged.' (2) CORE FINDING CONTRADICTION: The ground truth's central finding is that there was NO shift in money market mutual fund allocation between years. The LLM's entire narrative is built on the opposite premise - claiming a 'more than four-fold increase' and a 'deliberate move' to increase holdings. This is a direct contradiction of the ground truth. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the available-for-sale investment data across both years. It appears to have either misread the data or confused different investment categories. (4) SEMANTIC MEANING: The LLM's interpretation that this represents a strategic shift toward larger liquidity holdings is contradicted by the fact that the allocation remained static. The reasoning about 'deliberate move' and 'larger share' is unsupported by the actual data showing no change. The answer demonstrates a fundamental misunderstanding of Amgen's actual short-term liquidity management approach for these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 429,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\nGeneral Dynamics’ pledged U.S. government accounts receivable under the Capital Construction Fund rose from **$295 million at the end of 2022** to **$315 million in 2023** and further to **$333 million by the end of 2024**.  This reflects a modest but consistent increase of roughly $18‑$38 million over the two‑year period, underscoring growing participation in the program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN DATE ATTRIBUTION: The LLM states '$295 million at the end of 2022' but the ground truth clearly indicates this figure is 'as of December 31, 2021' (reported in the 2022 filing). This is a significant factual error in date attribution. The LLM correctly identifies the 2023 ($315M) and 2024 ($333M) figures. CALCULATION VERIFICATION: The LLM states increases of 'roughly $18-$38 million over the two-year period.' From $295M to $333M is a $38M increase total, or $20M average per year. The range stated ($18-$38M) is somewhat imprecise but not entirely wrong if interpreted as year-over-year variations ($295→$315 = $20M; $315→$333 = $18M). However, this calculation is presented ambiguously. COMPLETENESS: The answer addresses the core question about evolution of CCF participation and the amounts pledged. It captures the trend of steady increase. ENTITY ACCURACY: General Dynamics and Capital Construction Fund are correctly identified. The metric (U.S. government accounts receivable pledged) is correct. REASONING: The multi-hop synthesis is sound - the answer correctly identifies the progression across years and draws a reasonable conclusion about growing participation. SEMANTIC ISSUES: The phrase 'at the end of 2022' is misleading because the $295M figure is actually the December 31, 2021 balance (from the 2022 10-K). This conflates reporting year with balance sheet date. The core numbers are correct but the temporal framing is problematic. The answer would have been stronger with explicit date clarification (e.g., 'as of December 31, 2021, reported in the 2022 filing').",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 440,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s ownership of Corebridge fell from just over 80 % (post‑IPO) to 48.4 % on June 9 2024, triggering the de‑consolidation of Corebridge for U.S. federal tax purposes; thereafter AIG’s stake was further reduced to about 22.7 % by the end of 2024 after secondary sales.  The de‑consolidation moved Corebridge’s tax attributes—such as its net‑operating‑loss and credit‑carryforwards—into Corebridge’s own tax filing group, so AIG no longer includes those attributes in its consolidated tax return and must assess the realizability of any remaining deferred‑tax assets separately.  As a result, AIG’s financial income from Corebridge shifted from consolidated net‑investment income to equity‑method income (dividends plus changes in the market‑value‑based equity interest), and the 2024 de‑consolidation produced a $4.8 bn pre‑tax loss (primarily from an AOCI reclassification) that was recorded in discontinued operations, with an after‑tax loss of $4.754 bn after tax expense and the related tax adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially correct information about AIG's evolving relationship with Corebridge between 2023 and 2024, with strong multi-hop synthesis. STRENGTHS: (1) Correctly identifies the IPO date (September 19, 2022) and ownership threshold changes (80% to 48.4% to 22.7%), (2) Accurately describes tax deconsolidation mechanics and transfer of tax attributes (NOLs, credits) to Corebridge, (3) Correctly explains the shift from consolidated to equity method reporting, (4) Provides specific financial impact figures ($4.8bn pre-tax loss, $4.754bn after-tax loss in discontinued operations), (5) Demonstrates sound multi-hop reasoning connecting ownership changes to tax/financial reporting implications. WEAKNESSES/CONCERNS: (1) The ground truth answer references 'equity method income for the period from June 10, 2024, to December 31, 2024' with a placeholder '$X' amount, while the LLM provides specific loss figures ($4.8bn/$4.754bn) - these appear to be additional detail not contradicting the ground truth but going beyond it with specific numbers that cannot be verified against the provided ground truth, (2) The ground truth states ownership 'dropped below 80%' in 2023 (post-IPO September 2022), but the LLM specifies it fell to 48.4% on June 9, 2024 - this is more precise but the timing differs slightly from the ground truth's 2023 reference, (3) The ground truth mentions 'restrictions on future consolidated tax filings for five years' which the LLM does not explicitly address, though it does mention the broader tax attribute transfer. CALCULATION/NUMBER VERIFICATION: The specific ownership percentages (48.4%, 22.7%) and loss figures ($4.8bn, $4.754bn) cannot be directly verified against the ground truth but appear internally consistent and plausible. The after-tax calculation ($4.8bn to $4.754bn) represents approximately $46M in tax benefit, which is reasonable. MULTI-HOP REASONING: Excellent - correctly synthesizes ownership changes → tax deconsolidation → financial reporting method change → specific financial impacts. The answer demonstrates understanding of how these elements interconnect across the 2023-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 580,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\nFrom 2022 to 2024 Tesla shifted Solar Roof from a pilot‑scale, installation‑focused model—training new installers, partnering with developers to shorten install time and relying on external battery‑cell suppliers—to a more vertically integrated and supply‑chain‑resilient strategy.  It now stresses building its own cell production, diversifying and securing battery‑cell and raw‑material sources, expanding internal training and apprenticeship programs, and tightening inventory controls, while still contending with global component constraints, raw‑material price volatility and the risk of production delays.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims NOT supported by the ground truth, particularly regarding vertical integration and internal battery cell production. The ground truth explicitly states Tesla relied on 'external battery-cell suppliers' in 2022 and by 2024 focused on 'managing global component procurement' and 'supplier failures' - NOT building its own cell production. The LLM's claim about 'building its own cell production' and 'diversifying and securing battery-cell and raw-material sources' represents a fundamental mischaracterization of Tesla's actual strategy as documented in the knowledge graph. CORRECT ELEMENTS: (1) The 2022 focus on installer training and developer partnerships is accurately captured; (2) The 2024 shift to supply chain and production scalability concerns is correctly identified; (3) The mention of global component constraints and price volatility aligns with ground truth. INCORRECT/UNSUPPORTED ELEMENTS: (1) 'Vertically integrated' strategy - not mentioned in ground truth; (2) 'Building its own cell production' - contradicts ground truth which emphasizes external supplier reliance; (3) 'Expanding internal training and apprenticeship programs' - ground truth mentions hiring skilled electricians but not apprenticeship programs; (4) 'Tightening inventory controls' - not mentioned in ground truth. MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution from 2022 to 2024. While it captured the general shift from installation-focused to supply-chain-focused, it invented a vertical integration narrative that is not supported by the source material. The answer demonstrates partial understanding of the timeline but introduces fabricated strategic elements that significantly distort the actual evolution described in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 497,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\nDuke Energy’s cost estimate for permanently closing all of its North Carolina and South Carolina coal‑ash basins fell from **about $8 billion–$9 billion** in the 2022 filing (≈ $3.1 billion already spent through 2021) to **roughly $7 billion–$8 billion** in the 2023 filing, with **≈ $4 billion spent through 2023**【page_73】【page_68】.  The downward revision and the increase in expenditures indicate that the company is advancing its Coal Ash Act obligations—substantial excavation and closure work has been completed, and the remaining spend is now lower and spread over the next 10‑20 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - 2022 estimate of $8-9 billion, 2023 estimate of $7-8 billion, 2021 spending of $3.1 billion, and 2023 spending of $4 billion all match the ground truth exactly. The number format variations are appropriately handled. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) the 2022 cost estimate, (2) the 2023 cost estimate, (3) the evolution/change between years, (4) spending progression, and (5) what this indicates about Coal Ash Act progress. ENTITY ACCURACY: Duke Energy is correctly identified, both North Carolina and South Carolina are mentioned, the Coal Ash Act is properly referenced, and the time periods (2022, 2023, through 2021, through 2023) are all accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple filing years and documents, comparing estimates across time periods and connecting the downward cost revision with increased actual spending to demonstrate progress. The logical inference that 'downward revision + increased expenditures = measurable progress' is sound and well-supported. MINOR OBSERVATION: The LLM adds interpretive context about the remaining spend being 'spread over the next 10-20 years,' which is reasonable inference but not explicitly stated in the ground truth. This is a minor enhancement that doesn't contradict the original answer. The citation references (page_73, page_68) suggest proper source documentation. Overall, the answer is factually accurate, complete, well-reasoned, and appropriately contextual.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 453,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\nBetween 2023 and 2024 the retail share of **on!** grew from **6.8 % to 8.3 %** of the oral‑tobacco market – an increase of roughly 1.5 percentage points.  This rise occurred while the **overall oral‑tobacco segment’s share fell from 42.5 % to 37.5 %**, showing that on! is gaining ground in a contracting market and is becoming a more prominent growth driver within the segment, even though it still accounts for only a modest portion of total oral‑tobacco sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 'on!' retail share increased from 6.8% to 8.3% (1.5 percentage point increase correctly calculated), and the overall oral tobacco segment declined from 42.5% to 37.5% (5 percentage point decrease). The multi-hop synthesis is sound - the model correctly identified and compared the divergent trends between the specific product and the broader segment. The reasoning is logical: 'on!' is gaining market share while the overall segment contracts, indicating relative strengthening of 'on!' within the market. The answer appropriately characterizes 'on!' as a 'growth driver' and notes it 'still accounts for only a modest portion' - both accurate contextual observations. The only minor distinction from the ground truth is stylistic: the LLM uses slightly more interpretive language ('becoming a more prominent growth driver') versus the ground truth's more neutral 'strengthened its position,' but this represents semantic equivalence rather than factual error. All entities (on!, oral tobacco product segment, years 2023-2024) are correctly identified. The answer fully addresses both parts of the question: the evolution of retail share and what it indicates about market position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 360,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Qualcomm’s exposure to Chinese OEMs stayed high but grew more precarious: the 2024 filing stresses that a “significant portion” of its revenue still comes from a handful of Chinese device makers, and recent U.S. export‑license revocations (e.g., the $560 million of product sales to Huawei that ended in May 2024) together with China’s “Made‑in‑China 2025” push have already forced at least one major OEM to source its own chips or switch to competitors.  This heightened concentration—and the broader U.S./China trade and security tensions that can restrict sales or payments—means that any slowdown or displacement of these Chinese customers could sharply cut Qualcomm’s cash flow and jeopardize its growth outlook, undermining overall business stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core issue—Qualcomm's persistent reliance on Chinese OEMs from 2023 to 2024 and the associated business risks from U.S./China tensions. The answer appropriately synthesizes the multi-hop question by comparing the two years and drawing implications for business stability. The qualitative reasoning about concentration risk and potential customer displacement is sound and relevant.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites '$560 million of product sales to Huawei that ended in May 2024' as a specific factual claim. This number cannot be verified against the ground truth provided, and appears to be a fabricated or unsupported specific figure. The ground truth does not mention this specific dollar amount or date. This is a significant factual error that undermines credibility. (2) UNSUPPORTED CLAIMS - The LLM states that 'at least one major OEM' was forced to source chips elsewhere or switch competitors due to China's 'Made-in-China 2025' push. While this is plausible inference, it is not explicitly stated in the ground truth and represents speculation beyond what the filings confirm. (3) OVER-SPECIFICATION - The ground truth uses measured language ('significant portion,' 'persistent dependency') while the LLM adds specific details about export-license revocations and OEM switching that go beyond what can be confirmed from the provided ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings and draws logical implications about business stability. However, the introduction of unverified specific numbers and claims weakens the multi-hop synthesis quality.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth (persistent dependency, concentration risk, U.S./China tensions as ongoing threat), but the addition of specific unverified figures creates factual inaccuracy rather than mere wording variation.\n\nJUSTIFICATION: The answer demonstrates good understanding of the question and reasonable qualitative reasoning, but the introduction of specific dollar amounts and dates not found in the ground truth represents a critical factual error that cannot be overlooked in financial analysis. This drops the correctness score from 7-8 range to 5, as accuracy of numbers is paramount in financial contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 629,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\nBetween 2022 and 2023 Amgen shifted its available‑for‑sale portfolio away from Treasury‑bill holdings and toward cash‑equivalent money‑market funds.  In 2022 the AFS book was about $4.3 bn, comprised mainly of U.S. Treasury bills ($1.7 bn) and money‑market funds ($2.7 bn) with only a trivial amount of other short‑term securities.  By the end of 2023 Treasury holdings had fallen to near $0, money‑market funds rose sharply to roughly $10.3 bn, and a modest position in other short‑term interest‑bearing securities ($≈$0.1 bn) appeared, pushing total AFS investments up to about $10.4 bn.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally misrepresent Amgen's investment composition. MAJOR ERRORS: (1) 2022 composition is completely wrong - LLM states Treasury bills were $1.7bn and money-market funds were $2.7bn, but ground truth shows marketable securities were $1.676bn and cash/cash equivalents were $2.659bn. The LLM conflates these categories incorrectly. (2) The LLM incorrectly characterizes 2022 as having 'Treasury bills' as a primary component when the ground truth specifies 'marketable securities' - these are different categories. (3) Most critically, the LLM states that in 2023 'Treasury holdings had fallen to near $0' implying they existed in 2022, but ground truth explicitly states 'Amgen no longer held any marketable securities or U.S. Treasury bills' in 2023 - meaning they held ZERO in 2023, not 'near $0'. (4) The LLM's characterization of 2022 composition is inverted - it suggests money-market funds ($2.7bn) were a major component in 2022, but ground truth indicates the $2.659bn was 'cash and cash equivalents,' not money-market mutual funds. The 2023 composition is more accurate ($10.3bn in money-market funds, $0.1bn in other securities, totaling ~$10.4bn), but the 2022 baseline is fundamentally mischaracterized. The strategic narrative about 'shifting away from Treasury bills toward money-market funds' is partially correct directionally but built on incorrect 2022 baseline data. The answer demonstrates some understanding of the overall trend but fails on precise categorization and composition details that are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 439,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\nIn 2022 the only premium‑outlet listing for Shake Shack in the SPG filings appears at the Las Vegas Outlets (page 34 of the 2022 10‑K). By 2023 the brand is also listed as a tenant at Woodbury Common Premium Outlets (page 36 of the 2023 10‑K), indicating that SPG added Shake Shack to an additional premium‑outlet property, expanding its presence across the portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer states that in 2022, Shake Shack was at Woodbury Common Premium Outlets in New York, and by 2023 it expanded to Las Vegas Outlets North Premium in Nevada. The LLM answer reverses this sequence entirely: it claims Shake Shack was at Las Vegas Outlets in 2022 and then appeared at Woodbury Common in 2023. This is a fundamental inversion of the actual timeline and expansion pattern. The LLM correctly identifies both properties and the general concept of expansion across SPG's portfolio, and the page references provided appear plausible, but the core factual claim about which property had Shake Shack in which year is completely backwards. The reasoning structure is sound (comparing 2022 vs 2023 presence), and the contextual relevance to the question is appropriate, but the execution fails on the most critical element: the actual facts about when and where Shake Shack was present. This is a multi-hop synthesis error where the model appears to have confused or inverted the temporal sequence of events across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 326,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\nBetween 2022 and 2024 the retirement‑annuity contracts remained classified as **Level 3** in the fair‑value hierarchy—i.e., they continued to be valued with significant unobservable inputs (internal discount‑rate and actuarial assumptions) rather than quoted market prices.  The disclosed fair‑value declined from about **$38 million (2022)** to **$22 million (2024)**, but the hierarchy level did not change, indicating that GD’s valuation methodology for these assets stays rooted in proprietary, internally‑derived models rather than market‑observable pricing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that retirement annuity contracts remained classified as Level 3 in both 2022 and 2024, and accurately describes the valuation methodology using unobservable inputs (internal discount rates and actuarial assumptions). The reasoning about GD's proprietary valuation approach is sound and relevant to the question.\n\nHowever, there are significant issues with quantitative accuracy:\n\n1. CRITICAL ISSUE - Specific dollar amounts: The LLM provides specific figures ($38 million in 2022 and $22 million in 2024) that cannot be verified against the ground truth. The original answer does not provide these specific numbers, making it impossible to confirm their accuracy. This is a major concern for a financial question where precision is essential.\n\n2. MISSING KEY DISCLOSURE CHANGE: The LLM answer fails to address the most important evolution identified in the ground truth - that by 2024, investments valued using NAV as a practical expedient were now included in reconciliation tables, which was not explicitly stated in 2022. This represents a meaningful refinement in disclosure practices that the LLM completely omits.\n\n3. INCOMPLETE ANALYSIS: The ground truth emphasizes that the evolution represents \"a refinement in disclosure practices rather than a change in hierarchy classification.\" The LLM focuses only on the hierarchy classification remaining unchanged but misses the disclosure methodology evolution that is central to understanding how GD's reporting improved.\n\n4. REASONING GAP: While the LLM correctly notes the methodology remained complex, it doesn't synthesize the full multi-hop insight about improved transparency in reporting practices, which is a key part of what the question asks about (\"what does this indicate about GD's valuation methodology\").\n\nThe answer is partially correct on the hierarchy classification but incomplete on the disclosure evolution and potentially inaccurate on specific dollar amounts without verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 541,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s ownership in Corebridge fell dramatically—from roughly 52 % at the end of 2023 to about 22.7 % by the end of 2024—through a series of secondary offerings and sales (including the June 9 2024 de‑consolidation and the later $3.8 bn sale of 120 million shares to Nippon), which created potential equity dilution for AIG’s remaining stake.  As a result of the de‑consolidation AIG recorded a $4.8 bn loss (largely from re‑classifying accumulated other‑comprehensive loss) and then began accounting for its retained interest as an equity‑method investment, so that dividends received and the fair‑value changes of the Corebridge shares are now recognized in net investment income rather than consolidated earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about AIG's Corebridge relationship evolution but contains significant quantitative discrepancies and introduces information not present in the ground truth. STRENGTHS: (1) Correctly identifies the June 9, 2024 de-consolidation date; (2) Accurately describes the shift to equity method accounting post-de-consolidation; (3) Correctly notes that dividends and fair-value changes are now recognized in net investment income; (4) Appropriately addresses the transformation of AIG's relationship with Corebridge. CRITICAL ISSUES: (1) The ground truth makes no mention of ownership percentages (52% in 2023, 22.7% in 2024), secondary offerings, or the Nippon sale ($3.8bn for 120 million shares)—these appear to be introduced by the LLM without grounding in the provided knowledge graph; (2) The $4.8bn loss figure is not mentioned in the ground truth; (3) The ground truth emphasizes the 2022 IPO (September 19, 2022) terminating the Blackstone exchange right and the potential dilution of 24.1 million shares in 2022 and 4.4 million in 2023, which the LLM answer completely omits; (4) The ground truth's discussion of the pre-2024 equity dilution mechanism tied to Blackstone's exchange rights is entirely absent from the LLM response. REASONING ASSESSMENT: The LLM demonstrates sound understanding of equity method accounting and de-consolidation mechanics, but fails to synthesize the multi-hop information about the historical equity dilution scenario that was central to the ground truth answer. The answer addresses the 2024 portion of the evolution but misses the 2023 context about potential dilution mechanisms. QUANTITATIVE VERIFICATION: While the specific numbers provided (52%, 22.7%, $3.8bn, 120 million shares, $4.8bn loss) may be accurate to the actual filings, they are not validated by the ground truth knowledge graph provided, creating uncertainty about their correctness in this evaluation context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 528,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\nFrom the 2022 10‑K (page 71) Comcast reported roughly **$3.6 billion** of debt at Universal Beijing Resort, and by the 2024 filing (page 86) that figure had fallen to **about $3.4 billion**, reflecting modest repayments on the resort’s term‑loan.  The resort is treated as a variable‑interest entity that Comcast consolidates, so the debt now appears on Comcast’s balance sheet, but the exposure is non‑recourse—Comcast’s maximum loss is limited to its 30 % equity stake and a remaining unfunded capital commitment of roughly **$1.4 billion**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the debt trajectory ($3.6B in 2022 to $3.4B in 2024), accurately notes the VIE consolidation treatment, and appropriately characterizes the debt as non-recourse. The page references and general narrative structure are sound. The mention of a 30% equity stake and unfunded capital commitment adds relevant context about Comcast's actual exposure.\n\nWEAKNESSES: (1) MISSING KEY DATA: The LLM omits the 2023 debt figure ($3.5B) that appears in the ground truth, which is important for showing the debt trajectory evolution across the full 2022-2024 period. (2) INCOMPLETE BALANCE SHEET CONSOLIDATION: The ground truth specifies that as of 2024, Universal Beijing Resort has $7.3B in consolidated assets and $7.0B in consolidated liabilities on Comcast's balance sheet. The LLM completely omits these consolidated balance sheet figures, which are critical to understanding Comcast's full financial exposure. (3) MISSING HISTORICAL CONTEXT: The ground truth includes 2020-2021 debt figures ($2.5B and $3.6B respectively), providing important context for the debt evolution narrative. The LLM only addresses 2022-2024. (4) UNFUNDED COMMITMENT FIGURE: The $1.4B unfunded capital commitment mentioned by the LLM is not verified in the ground truth, which doesn't reference this specific figure.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting debt disclosures to consolidation treatment and then to exposure limitations. However, it fails to fully synthesize the complete financial picture by omitting the consolidated balance sheet amounts.\n\nNUMERIC VERIFICATION: The $3.6B (2022) and $3.4B (2024) figures are correct. The 30% equity stake reference appears reasonable but isn't explicitly confirmed in the ground truth. The $1.4B unfunded commitment cannot be verified against the provided ground truth.\n\nOVERALL: The answer captures the core debt evolution and consolidation treatment correctly but significantly underdelivers on completeness by omitting the 2023 debt figure and the consolidated balance sheet amounts ($7.3B assets, $7.0B liabilities), which are essential to fully answering the question about financial exposure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 593,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\nThe trade‑in rights that accompany new‑aircraft orders continue to be offered only to a limited set of Gulfstream customers who have options in their purchase contracts; they can be structured either as an option to sell the aircraft at its then‑fair‑market value (determined within roughly 45 days of delivery and requiring the customer to exercise or let it expire) or as a guarantee of a pre‑established trade‑in price.  In the 2023 filing the company notes that the estimated deviation of the guaranteed price from fair market value was immaterial, indicating that the exposure to adverse market movements has been characterized as negligible, whereas earlier disclosures did not highlight such a quantitative assessment.  Consequently, customer eligibility has not changed materially, but the perceived risk associated with the guaranteed‑price commitments is now described as immaterial.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) CUSTOMER ELIGIBILITY CLAIM: The LLM states 'customer eligibility has not changed materially,' directly contradicting the ground truth which explicitly documents a narrowing from 'some customers' in 2022 to 'some Gulfstream customers' in 2023. This is a fundamental factual error on a core aspect of the question. (2) STRUCTURAL CHANGES: The ground truth clearly identifies a structural change in customer eligibility scope, but the LLM dismisses this as immaterial, which misrepresents the filing disclosures. (3) RISK EXPOSURE FRAMING: While the LLM correctly notes that 2023 characterized the deviation as 'immaterial,' it incorrectly claims 'earlier disclosures did not highlight such a quantitative assessment.' The ground truth states both years reported the change as 'not material,' indicating consistency rather than a new 2023 development. (4) STRATEGIC FOCUS: The ground truth identifies that the narrowing to Gulfstream customers 'may indicate a strategic focus or increased risk concentration,' but the LLM presents this as unchanged eligibility. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the year-over-year comparison that is central to the question. The answer conflates current-state description with historical comparison. (6) COMPLETENESS: The LLM provides operational details about how trade-in rights work (45-day window, option vs. guarantee structures) that, while potentially accurate, are not responsive to the specific question about how the structure CHANGED between 2022 and 2023. The answer reads more like a general description of the 2023 program rather than a comparative analysis. The LLM answer demonstrates a fundamental misunderstanding of the question's comparative nature and makes a direct factual error regarding whether customer eligibility changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 522,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Semi from a announced commercial‑vehicle concept to a modest pilot‑production effort that remains confined to its Nevada factory; the 2024 filing shows the Semi still listed under “Pilot production” alongside the still‑in‑development Cybercab and Roadster, with no indication of volume‑scale manufacturing.  Strategically, the Semi is now positioned as one of several next‑generation commercial‑vehicle offerings (alongside Cybertruck and future models on the next‑generation platform) that support Tesla’s broader goal of expanding into fleet and commercial markets while the company continues to prioritize profitable growth, cost‑reduction, and the rollout of full‑self‑driving and battery‑cell technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Tesla's Semi evolution. STRENGTHS: (1) Correctly identifies the progression from 'announced' in 2022 to 'pilot production' in 2024, matching the ground truth timeline and status descriptions. (2) Accurately specifies Nevada facility as the location for pilot production. (3) No quantitative errors - all dates (2022, 2024) and status descriptions are factually correct. (4) Multi-hop reasoning is sound: synthesizes information about the Semi's development stage, its positioning relative to other vehicles (Cybercab, Roadster, Cybertruck), and Tesla's broader strategic objectives. (5) Provides additional valuable context about strategic positioning within commercial vehicle markets and Tesla's priorities (profitable growth, cost-reduction, FSD, battery technology) that enriches the answer without contradicting ground truth. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and contextual than the ground truth, adding information about strategic positioning alongside other next-generation vehicles and commercial market expansion goals. This is not an error but rather an expansion that demonstrates deeper synthesis. (2) The phrase 'modest pilot-production effort' adds interpretive language not explicitly in ground truth, but this characterization is reasonable given the pilot production status. (3) The answer correctly notes the Semi remains 'confined to its Nevada factory' which aligns with the ground truth's reference to 'Nevada facility.' The LLM answer successfully captures the core evolution (announced → pilot production) while providing sophisticated strategic context that demonstrates multi-hop reasoning across Tesla's product portfolio and business objectives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 483,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\nThe valuation allowance tied to Altria’s Cronos investment rose from about **$379 million at the end of 2022 to $397 million in 2023 and to roughly $402 million by the end of 2024**. This modest increase shows that Altria continues to view the deferred tax assets associated with its Cronos stake as uncertain of realization and therefore maintains a full valuation allowance against them.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: The numbers provided are correct - $379 million (2022), $397 million (2023), and $402 million (2024). These match the ground truth values. The LLM provides additional detail by including the 2023 intermediate value ($397 million), which the original answer did not explicitly state but is factually accurate and enhances the response. Multi-hop reasoning: The answer correctly synthesizes information about Altria's Cronos investment and the associated valuation allowance across three fiscal years, demonstrating proper understanding of the temporal evolution. Entity accuracy: All entities are correctly identified (Altria, Cronos, deferred tax assets, valuation allowance). Semantic equivalence: The LLM's interpretation that the allowance indicates 'uncertainty regarding the realizability of deferred tax assets' and that Altria 'maintains a full valuation allowance against them' aligns perfectly with the ground truth's statement about 'significant uncertainty regarding the realizability' and the company's expectation that 'the temporary difference' would not reverse. The characterization of the increase as 'modest' is reasonable given the $23 million increase over two years. The only minor distinction is that the original answer emphasizes this as a 'cautious stance,' while the LLM frames it as 'uncertainty of realization' - both convey the same meaning. The LLM answer is slightly more comprehensive by including the 2023 data point, making it marginally superior to the ground truth in terms of completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 443,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\nBetween 2023 and 2024 Amgen’s accounting for its BeiGene stake shifted from the equity‑method to fair‑value measurement, so that changes in the investment’s fair value moved from “Other income (expense), net” into earnings. In 2023 the fair‑value adjustment generated recognized gains that boosted other‑income and overall profit, while in 2024 the same fair‑value approach produced net unrealized losses on the BeiGene (and other strategic equity) holdings, turning that line item negative and reducing net income; the shift also altered the composition of earnings that drove the lower effective tax rate reported for 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but contains significant issues with accuracy and clarity. CORRECT ELEMENTS: (1) The accounting method change from equity method to fair value in 2023 is accurate; (2) The shift from gains in 2023 to losses in 2024 is correct; (3) The placement in 'Other income (expense), net' is accurate; (4) The overall narrative of reversal from gains to losses is sound. PROBLEMATIC ELEMENTS: (1) The statement that fair-value changes moved 'from Other income (expense), net into earnings' is confusing and potentially inaccurate - the ground truth indicates the investment remained in Other income (expense), net in both years, not that it moved into earnings; (2) The claim about 'altered composition of earnings that drove the lower effective tax rate reported for 2024' introduces information not present in the ground truth and appears to be speculative or incorrect - the ground truth makes no mention of tax rate impacts; (3) The phrasing 'so that changes in the investment's fair value moved from Other income (expense), net into earnings' is misleading - it suggests a change in line item placement that the ground truth does not support. MULTI-HOP REASONING: The answer attempts to synthesize the 2023-2024 comparison but introduces extraneous claims about tax rates that are not supported by the ground truth. The core comparison (gains to losses) is correct, but the mechanism and implications are overstated or inaccurate. QUANTITATIVE ACCURACY: No specific dollar amounts are provided in either answer, so this dimension is neutral. The temporal accuracy (2023 vs 2024) is correct. SEMANTIC EQUIVALENCE: While the general narrative of reversal is preserved, the specific claims about earnings composition and tax rates diverge significantly from the ground truth, reducing semantic equivalence on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 504,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney+ Hotstar moved from being promoted as a distinct, India‑only DTC brand to being folded into a more unified Disney+ platform.  The 2023 filing describes Hotstar as a separate service that offers general‑entertainment, family and sports content in India, while the 2024 filing notes that the company merged its Latin‑American “Star+”/“Combo+” bundles into a single Disney+ product and now treats Hotstar as the local brand of that global service rather than a stand‑alone offering.  This reflects a strategic shift toward a consolidated Disney+ brand and multi‑product subscription structure, with Hotstar retained only where a separate regional brand is needed.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the strategic shift but contains a significant factual error and mischaracterization that reduces accuracy. CORRECT ELEMENTS: (1) The answer correctly identifies that Disney+ Hotstar was positioned as a distinct regional brand in 2023; (2) It correctly notes the merger of Star+ and Disney+ services in Latin America by end of June 2024; (3) It accurately describes the shift toward consolidating under the Disney+ brand umbrella; (4) The characterization of Hotstar being retained as a local brand where needed is reasonable. CRITICAL ERROR: The LLM states that Hotstar moved from being 'India-only' to being 'folded into a more unified Disney+ platform' and 'now treats Hotstar as the local brand of that global service rather than a stand-alone offering.' This is INCORRECT. The ground truth explicitly states that in 2024, Disney+ Hotstar remained 'branded as Disney+ Hotstar in India and Southeast Asia' - it was NOT folded into a unified global Disney+ platform. The regional consolidation occurred in LATIN AMERICA (Star+/Combo+ merged into Disney+), NOT with Hotstar. The LLM conflates the Latin American consolidation with Hotstar's positioning, suggesting Hotstar itself was merged into a global Disney+ service, which contradicts the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize that there were TWO different regional strategies: (1) Hotstar remained distinct in India/Southeast Asia, and (2) Latin American services were consolidated. Instead, it presents a single unified strategy. QUANTITATIVE ACCURACY: No specific numbers or dates were required, but the timeline reference (fiscal 2023 to 2024, end of June 2024) is correct. The answer demonstrates partial understanding of the strategic evolution but makes a fundamental error in characterizing Hotstar's actual positioning in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 507,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal’s protection‑program disclosures stayed anchored on the same premise—recording estimated fraud‑ and dispute‑related losses as transaction and credit‑loss provisions and attempting to recover those losses from merchants—but the 2024 filing sharpened the focus on heightened risk exposure.  It warned that increasingly sophisticated fraud, potential regulatory changes to charge‑back and error‑resolution rules, and the possibility of excessive loss rates could erode the company’s ability to accept payment cards, making loss‑recovery “uncertain” and “potentially insufficient.”  Consequently, while the core recovery approach was unchanged, the 2024 narrative underscores a more cautious view of how much of those losses can realistically be recouped.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively captures the evolution of PayPal's protection program disclosures between 2023 and 2024. STRENGTHS: (1) Correctly identifies that both years recorded losses in 'transaction and credit losses' - maintaining consistency with ground truth; (2) Accurately characterizes the shift toward more explicit risk acknowledgment and cautious outlook; (3) Properly synthesizes multiple risk factors mentioned in 2024 filings (fraud sophistication, regulatory changes, chargeback requirements, merchant insolvency challenges); (4) Correctly emphasizes the uncertainty around loss recovery and the 'potentially insufficient' recovery mechanisms; (5) No quantitative errors or incorrect dates/numbers. MINOR GAPS: (1) The LLM answer is somewhat more focused on the 2024 risk narrative than on explicitly contrasting the 2023 baseline - it states the core approach was 'unchanged' but could have been slightly more explicit about what 2023 disclosed (that it 'did not provide a separate service'); (2) The phrase 'loss-recovery uncertain and potentially insufficient' captures the essence but the ground truth emphasizes 'challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency' - the LLM touches on this but with less specificity about merchant-related barriers. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple risk dimensions (fraud, regulatory, recovery mechanisms), demonstrating sound multi-hop reasoning. The comparison between years is logical and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental insight as the ground truth - a shift from basic loss recording to more detailed risk disclosure and acknowledgment of recovery challenges. The wording differs but the meaning aligns well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 507,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\nFrom 2022 through 2024 NextEra moved away from direct ownership of solar projects and began selling controlling stakes in many of them—often 50 % to a NEP subsidiary and the other 50 % to third‑party investors—while retaining a controlling interest and consolidating the entities as variable‑interest‑entity (VIE) holdings.  This restructuring left the company with sizable contingent liabilities: it may have to repurchase the sold assets for up to $668 million, honor guarantees of roughly $1.3 billion, and settle contract‑liability balances that are tied to the receipt of a solar production‑tax credit and to construction‑completion milestones.  As a result, although NextEra’s direct equity in solar assets has shrunk, its financial exposure to those assets has grown through these VIE‑related repurchase, guarantee and revenue‑recognition obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic shift from direct ownership to VIE structures with contingent liabilities, which aligns with the ground truth's core narrative. However, there are significant quantitative discrepancies and some conceptual issues:\n\nSTRENGTHS:\n1. Correctly identifies the shift from direct ownership to VIE structures (2022-2024)\n2. Accurately describes the 50/50 partnership model with NEP subsidiaries and third-party investors\n3. Correctly identifies contingent liabilities including repurchase obligations, guarantees, and contract-liability balances\n4. Properly synthesizes the paradox: reduced direct equity but increased financial exposure\n5. Appropriately references tax credits and construction milestones as drivers of contingent liabilities\n\nWEAKNESSES:\n1. QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($668M repurchase, $1.3B guarantees) that are NOT mentioned in the ground truth. These numbers cannot be verified against the original answer and may be fabricated or from different contexts.\n2. MISSING KEY METRICS: The ground truth specifically mentions \"approximately 765 MW of capacity\" for consolidated VIEs and \"100 MW solar facility in Arizona\" and \"90% ownership interest in a portfolio of four solar facilities\" from 2022 divestiture. The LLM answer omits these specific capacity and ownership percentages.\n3. INCOMPLETE 2022 CONTEXT: The ground truth emphasizes 2022 divestiture activities (100% sale of 100 MW facility, 90% sale of four-facility portfolio). The LLM answer doesn't clearly distinguish the 2022 divestiture phase from the later VIE consolidation strategy.\n4. CONTROLLING INTEREST CLAIM: The LLM states NextEra retains \"controlling interest\" in the VIEs, but the ground truth indicates a 10% direct ownership interest in some facilities, which may not constitute controlling interest depending on VIE consolidation rules.\n5. VAGUE FINANCIAL EXPOSURE: While the LLM mentions specific dollar amounts for contingent liabilities, these cannot be verified against the ground truth, raising accuracy concerns.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the evolution across the 2022-2024 period and connects ownership structure changes to financial exposure changes. However, the reasoning is somewhat incomplete in distinguishing between the divestiture phase (2022) and the VIE consolidation phase (2024).\n\nCONCEPTUAL ACCURACY: The understanding of VIE mechanics and contingent liabilities is sound, but the specific numbers provided lack grounding in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 685,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\nACN’s Mutual Fund Debt Securities held in its defined‑benefit plans grew in fair‑value (the $379.9 million Level 2 balance reported as of August 31 2022 was higher in the 2023 disclosure), and the securities continued to be classified as Level 2 in the 2023 fair‑value hierarchy, meaning the same observable‑market‑price methodology was retained with no shift in hierarchy level.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth: (1) CRITICAL NUMBER ERROR: The LLM states the 2022 balance of $379.9 million was 'higher in the 2023 disclosure,' but the ground truth clearly shows the value DECREASED from $379,989 (thousands, or ~$380M) in 2022 to $253,025 (thousands, or ~$253M) in 2023. This is a directional error - the LLM claims growth when there was actually a decline. (2) INCOMPLETE SYNTHESIS: The LLM correctly identifies that both years used Level 2 valuation methodology and that observable market data was used, which is accurate. However, this correct element does not offset the major quantitative error. (3) MISSING KEY INFORMATION: The LLM fails to clearly state the actual dollar decrease ($379,989 to $253,025 thousand, or approximately $127M reduction), which is the core finding of the question. (4) MISLEADING FRAMING: The phrase 'grew in fair-value' and 'was higher in the 2023 disclosure' directly misrepresents the data trend. The answer appears to confuse or invert the year-over-year comparison. (5) METHODOLOGY CONSISTENCY: While the LLM correctly notes that Level 2 classification remained consistent (which is accurate), this cannot compensate for the fundamental error in describing the investment value evolution. The question specifically asks 'how did...evolve' - and the answer provides the wrong direction of evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 393,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\nChevron’s 50 % equity interest in Tengizchevroil was unchanged, but the investment’s carrying amount grew modestly—from about **$26.5 billion at the end of 2022 to $26.9 billion at the end of 2023**.  Consequently, Chevron’s share of the affiliate’s earnings rose sharply, from roughly **$2.8 billion in 2022 to $4.4 billion in 2023**, and the $4.5 billion loan it has to TCO remained fully reported on its books.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM states carrying values of $26.5B (2022) and $26.9B (2023), but the ground truth clearly states $23,727 million ($23.7B) for 2022. This is a $2.8B discrepancy. The LLM also claims equity in earnings of $2.8B (2022) and $4.4B (2023), but ground truth shows $1,238 million ($1.2B) for 2022 - a massive $1.6B error. These are not minor rounding differences but substantial misstatements. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes a key evolution: the 2023 disclosure of carrying value being $80M higher than underlying equity in net assets, indicating a more complex valuation approach. The LLM completely misses this important qualitative shift in how Chevron valued the investment. (3) LOAN INFORMATION: While the LLM correctly mentions the $4.5B loan, it doesn't contextualize this as a new development in 2023 showing deepened involvement, which is central to answering how the relationship 'evolved.' (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year comparison. The ground truth shows a strategic deepening with new loan provision and changed valuation methodology. The LLM presents only a modest carrying amount increase without capturing the substantive changes in financial involvement. (5) ENTITY ACCURACY: While Chevron and Tengizchevroil are correctly identified, the financial metrics are fundamentally wrong. The 50% equity interest detail is correct but doesn't compensate for the massive numerical errors. The answer reads plausibly but is factually incorrect on the core numbers that define the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 464,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\nBetween 2023 and 2024 Disney kept ABC as the broadcast home for ESPN’s sports programming, using the “ESPN on ABC” arrangement to generate affiliate fees and advertising revenue that flow to the Sports segment and bolster the Entertainment segment’s linear‑network business.  At the same time, Disney announced a joint‑venture sports‑DTC platform (Venu Sports) with Fox and Warner Bros. Discovery—later blocked by a court injunction—signaling a strategic shift that may eventually change how ABC‑distributed sports content is delivered, but for now ABC remains a key conduit for ESPN’s linear and streaming offerings within Disney’s broader entertainment ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core question about ABC Network's evolution. CRITICAL ERRORS: (1) The answer focuses heavily on ESPN sports programming and 'ESPN on ABC' rather than ABC Network itself as a broadcast network. While ESPN on ABC is related, the ground truth specifically discusses ABC Network's positioning within the Linear Networks segment and its eight owned television stations. (2) The answer introduces Venu Sports (a joint venture sports platform) which is not mentioned in the ground truth and appears to be a tangential topic that distracts from the actual evolution of ABC Network. (3) MISSING KEY INFORMATION: The LLM completely fails to mention the critical strategic shift from linear distribution to digital integration - specifically that ABC content became available on Hulu one day after linear airing in 2024. This is the core evolution described in the ground truth. (4) The answer does not address the shift from affiliate fees as a primary revenue source to streaming service contributions. (5) The answer does not mention the eight owned ABC television stations or ABC's role in content distribution within the Linear Networks segment. WHAT WAS CORRECT: The answer does acknowledge ABC's continued role in Disney's entertainment ecosystem and mentions affiliate fees, which aligns with 2023 positioning. However, this is insufficient given the major omissions. The answer reads more like a response about ESPN's distribution strategy rather than ABC Network's strategic evolution. The multi-hop reasoning required synthesizing ABC's 2023 vs 2024 positioning, but the LLM instead pivoted to sports content and a failed joint venture, missing the primary narrative of digital integration and streaming platform prioritization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 487,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\nBetween 2022 and 2023 General Dynamics elevated the ASCOD from one of several European‑market tracked vehicles to a core, growth‑focused platform—highlighting it in the Land Systems portfolio, expanding its production backlog and tying it to OTS’s ammunition‑capacity investments (e.g., 155 mm LAP capacity to 50 K rounds/month by 2025).  The segment’s revenue share rose from 18 % to 20 % of consolidated sales and military‑vehicle sales jumped from $4.58 bn to $5.04 bn, indicating that the company is shifting production emphasis and capital toward tracked combat vehicles and their associated munitions rather than spreading investment across the broader land‑systems lineup.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to and factually incorrect relative to the ground truth. Ground truth states that ASCOD positioning DECLINED from 2022 to 2023 (from 'producing and upgrading' to merely 'offering'), suggesting a shift AWAY from ASCOD investment. The LLM answer claims the opposite—that ASCOD was 'elevated' to a 'core, growth-focused platform' with 'expanded production backlog,' which directly contradicts the ground truth's core finding. Regarding quantitative claims: (1) The LLM cites revenue share rising from 18% to 20% and military-vehicle sales jumping from $4.58bn to $5.04bn, but provides no source verification and these figures cannot be confirmed against the ground truth provided. (2) The LLM references '155 mm LAP capacity to 50 K rounds/month by 2025' and ties this to ASCOD, but the ground truth makes no such connection and does not mention these specific ammunition metrics. (3) The LLM's claim about 'OTS's ammunition-capacity investments' is not mentioned in the ground truth at all. The multi-hop reasoning is inverted: rather than synthesizing information showing ASCOD de-emphasis, the LLM synthesizes a narrative of ASCOD elevation. The answer misidentifies the direction of strategic shift entirely. The ground truth explicitly indicates resource reallocation AWAY from ASCOD toward Piranha 5 and AJAX; the LLM suggests the opposite allocation. This represents a fundamental failure to correctly interpret the 2022-2023 positioning shift and its implications for investment allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 424,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the amount of European customer balances that PayPal has designated to fund its credit activities fell sharply—from roughly **$3 billion (about 39 % of eligible European balances) in 2023 to about $2 billion (≈ 26 % of those balances) by the end of 2024**.  This pull‑back shows that PayPal is deliberately reducing its reliance on internal customer deposits as a source of credit‑funding and is instead turning to external sources—such as debt issuances, the sale of loan portfolios and partnership financing—to meet the liquidity needs of its credit products.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: $3.0 billion (39%) in 2023 declining to $2.0 billion (26%) in 2024. The percentages and dollar amounts match the ground truth precisely. The answer correctly identifies the strategic shift toward reducing reliance on customer balances for credit funding and mentions external financing sources. However, there is a notable omission: the ground truth specifically cites the multi-year agreement to sell consumer installment receivables with concrete evidence ($20.8 billion in loans sold in 2024 vs. $5.5 billion in 2023), which substantiates the shift to external financing. The LLM answer mentions 'sale of loan portfolios' generically but does not provide these specific quantitative details that would strengthen the evidence for the strategic shift. The reasoning is sound and the semantic meaning aligns well with the ground truth, but the lack of specific supporting metrics (the receivables sale figures) represents an incomplete synthesis of the multi-hop information available. The answer correctly synthesizes the relationship between the decline in customer balance utilization and the pivot to external sources, but could have been more comprehensive by including the specific receivables sale data as concrete evidence of this strategic transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 376,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\nBetween 2022 and 2024 the equity portion of NEE’s Special Use Funds moved from a portfolio that was mostly Level 1 (quoted market prices) – about $2.3 bn of Level 1 equity in 2022 versus $2.7 bn of Level 2 and only a few $ million of Level 3 – to a composition dominated by Level 2 valuations.  In the 2024 filing the Level 1 equity fell to roughly $2.6 bn while Level 2 equity grew to about $3.3 bn (and Level 3 stayed under $0.3 bn), indicating that the fund’s holdings increasingly rely on observable inputs for similar securities (e.g., commingled funds) rather than direct market quotes.  This shift reflects a deliberate move toward less‑liquid, pooled investments that require more judgment and valuation techniques, suggesting reduced transparency and a more complex investment mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims 2022 had '$2.3 bn of Level 1 equity' and '$2.7 bn of Level 2', but the ground truth explicitly states that in 2022, NEE reported $906 million total equity securities WITHOUT detailed categorization by valuation levels (Level 1, 2, 3 breakdown). The LLM's 2022 numbers ($2.3B Level 1 + $2.7B Level 2 = $5B+) are completely fabricated and inconsistent with the $906M total reported. For 2024, the LLM claims Level 1 fell to '$2.6 bn' while the ground truth states NEE held $2,614 million (which equals $2.614B, not $2.6B - minor rounding) in Level 1, but the LLM's Level 2 figure of '$3.3 bn' is not supported by the ground truth. (2) DIRECTIONAL ANALYSIS ERROR - The LLM claims a shift FROM Level 1 dominance TO Level 2 dominance, but the ground truth indicates the opposite: in 2024, the detailed breakdown shows Level 1 securities were the primary category disclosed ($2,614M for NEE alone), with the ground truth emphasizing 'more granular disclosures that included Level 2 and Level 3 valuations' without suggesting Level 2 became dominant. (3) TRANSPARENCY CONCLUSION REVERSED - The LLM concludes the shift 'suggests reduced transparency and a more complex investment mix,' but the ground truth explicitly states this indicates 'a shift toward more transparent and detailed reporting of asset valuation methodologies.' This is a direct contradiction of the key insight. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the 2022 vs 2024 comparison. The ground truth shows: 2022 had no Level breakdown (less transparent), 2024 had detailed Level 1/2/3 breakdown (more transparent). The LLM inverted this narrative. (5) MISSING FPL DATA - The ground truth includes FPL figures ($672M in 2022, $1,028M Level 1 in 2024), which the LLM completely omitted. The answer demonstrates fundamental misunderstanding of the source data and reaches conclusions opposite to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 548,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\nAccenture expanded the scope of its share‑repurchase framework between fiscal 2022 and 2023, raising the open‑market authorization from $3.1 bn to $6.1 bn and continuing to use the public program as the dominant channel. In fiscal 2022, roughly 1.96 million shares (≈95 % of the quarter’s total) were acquired under the public program, while only about 97 k shares (≈5 %) came from employee‑related payroll‑tax withholding; the same pattern held in fiscal 2023, with the public program absorbing the bulk of purchases and employee‑related transactions remaining a small, non‑authorised fraction.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth:\n\n1. MAJOR FACTUAL ERROR - Fiscal 2023 Activity: The LLM claims \"the same pattern held in fiscal 2023, with the public program absorbing the bulk of purchases.\" This directly contradicts the ground truth which explicitly states \"In fiscal 2023, there is no mention of shares purchased under the public program.\" This is a fundamental misrepresentation of the key evolution being asked about.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM correctly identifies 1.96 million shares and 97k shares for fiscal 2022, matching ground truth (1,964,612 and 97,251 shares)\n   - However, the LLM provides NO fiscal 2023 share purchase numbers, yet claims the \"same pattern held in fiscal 2023\" - this is internally inconsistent and factually wrong\n   - The percentages cited (95% public vs 5% employee-related) appear reasonable for fiscal 2022 but are presented as applying to fiscal 2023 when no public program activity occurred\n\n3. AUTHORIZATION AMOUNTS: The LLM mentions raising authorization from $3.1bn to $6.1bn, which is not mentioned in the ground truth and cannot be verified. The ground truth only mentions the $576 million aggregate price for fiscal 2022 public purchases.\n\n4. CORE NARRATIVE FAILURE: The question specifically asks about the \"evolution\" from fiscal 2022 to 2023. The ground truth clearly shows a SHIFT: public program activity ceased while employee-related transactions continued. The LLM incorrectly claims continuity of the public program as \"the dominant channel\" in both years, missing the critical evolution that defines the answer.\n\n5. TERMINOLOGY ERROR: The LLM describes employee-related shares as \"non-authorised fraction\" when the ground truth states these \"do not affect the aggregate available authorization\" - different concepts that suggest misunderstanding.\n\nThe LLM answer fundamentally mischaracterizes the evolution of Accenture's share purchase program by claiming continued public program dominance in fiscal 2023 when the ground truth indicates no public program activity that year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 574,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\nChevron does not consolidate Chevron Phillips Chemical Company LLC in either the 2022 or 2023 Form 10‑K – it continues to account for its 50 % stake as an unconsolidated equity‑method investment.  The 2023 filing simply provides updated, more detailed summarized financial data for the joint venture, but the consolidation status and the equity‑method accounting approach remain the same as in 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. Key issues: (1) CORE FACTUAL ERROR: The LLM claims Chevron Phillips Chemical was NOT consolidated in either 2022 or 2023 and was always accounted for using equity method. The ground truth explicitly states that in 2022, it WAS consolidated (evidenced by 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among consolidated subsidiaries), but in 2023 it transitioned to equity method accounting and was no longer consolidated. This is a critical reversal of the actual evolution. (2) QUANTITATIVE ACCURACY: The LLM mentions a '50% stake' which may be accurate, but this detail doesn't address the core question about the CHANGE in consolidation status between years. The ground truth emphasizes the transition FROM consolidation TO equity method, which the LLM completely misses. (3) MULTI-HOP REASONING FAILURE: The question specifically asks about how the relationship 'evolved between 2022 and 2023' - requiring comparison across two years. The LLM fails to identify any evolution, claiming the status 'remain[s] the same as in 2022.' This is the opposite of what occurred. (4) ENTITY/STRUCTURAL ACCURACY: The LLM correctly identifies Chevron Phillips Chemical Company LLC and Chevron, but mischaracterizes the consolidation status in both years. The ground truth indicates a structural change; the LLM denies any change occurred. (5) SEMANTIC EQUIVALENCE: There is no semantic equivalence here - the answers make opposite claims about whether consolidation status changed. The LLM's assertion that 'the consolidation status...remain[s] the same' directly contradicts the ground truth's statement of 'a significant structural change.' This is a fundamental factual error, not a wording difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 491,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\nFrom 2022 into 2023 the Hydra‑70 rocket shifted from a modest, occasional contract line‑item—evidenced by the $175 million 2021 award for production listed in the Combat Systems backlog (page 42)—to a strategic, high‑volume growth driver.  In 2023 OTS received awards to expand its metal‑parts capacity from 18,000 to 86,000 rounds per month by 2025 and to increase propellant output, underscoring a major production‑capacity expansion and deeper contract involvement for the rocket within the Combat Systems segment (page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key evolution of Hydra-70 rockets in General Dynamics' Combat Systems segment, accurately citing the $175 million contract value, the 18,000 to 86,000 rounds per month capacity expansion by 2025, and OTS's market-leading position. The multi-hop synthesis across 2022-2023 is sound, and the answer appropriately characterizes the shift from a contract line-item to a strategic growth driver. The contextual framing is relevant and well-structured.\n\nWEAKNESSES: (1) CRITICAL DATE ERROR: The LLM states the $175 million award was from 2021 (\"2021 award for production listed in the Combat Systems backlog\"), but the ground truth specifies this was a 2022 contract. This is a significant factual error in dating the contract. (2) INCOMPLETE INFORMATION: The LLM mentions \"increase propellant output\" but the ground truth does not explicitly reference propellant expansion—this appears to be an inference or addition not supported by the provided ground truth. (3) TEMPORAL CLARITY: While the LLM discusses the evolution from 2022 to 2023, the phrasing \"2021 award\" creates confusion about the actual timeline being evaluated.\n\nQUANTITATIVE ACCURACY: The numbers cited ($175M, 18,000 to 86,000 rounds/month, 2025 deadline) are all correct in value, but the year attribution for the $175M contract is wrong (2021 vs. 2022). This is a material error for a financial question.\n\nQUALITATIVE ACCURACY: The reasoning about market position, strategic importance, and capacity expansion is sound and well-synthesized. The identification of OTS as the relevant entity is correct. However, the date error undermines the multi-hop reasoning about the 2022-2023 evolution.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about contract involvement and production capacity expansion, with appropriate detail and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 509,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\nIn the 2023 filing the “Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement” appears only as part of Exhibit 10.07+ under the 2015 Equity Incentive Award Plan, disclosed merely by reference to the plan and without a separate, stand‑alone agreement. By the 2024 filing the same notice is still listed as Exhibit 10.07+, but a new “Global Performance‑Based Restricted Stock Unit Award Grant Notice and Performance‑Based RSU Award Agreement” (Exhibit 10.08+) is added and the accompanying compensation policy is now filed as a distinct exhibit, showing that PayPal has moved to a more granular, separately documented set of RSU award agreements for 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PayPal's RSU documentation between 2023 and 2024 filings with substantial accuracy. STRENGTHS: (1) Correctly identifies that Exhibit 10.07+ (Global RSU Award Grant Notice) remained unchanged between 2023 and 2024, both referencing the 2015 Equity Incentive Award Plan; (2) Accurately notes the introduction of Exhibit 10.08+ (Global Performance-Based RSU Award Grant Notice) in 2024; (3) Correctly characterizes the shift toward more granular, separately documented RSU agreements; (4) Properly identifies the 2015 plan as the underlying framework. WEAKNESSES: (1) The LLM answer lacks specific reference to the May 14, 2015 incorporation date mentioned in the ground truth, which is a factual detail that should have been included; (2) The ground truth specifies that the 2024 performance-based variant was 'linked to a more recent 10-Q filing on April 30, 2024,' but the LLM answer does not mention this specific date or the 10-Q reference, representing a minor omission of supporting documentation details; (3) The characterization of 2023 documentation as 'disclosed merely by reference to the plan and without a separate, stand-alone agreement' is somewhat imprecise—the ground truth indicates it was 'incorporated by reference' which is a specific legal term that the LLM captures but could have been more precise about; (4) The LLM answer mentions 'accompanying compensation policy is now filed as a distinct exhibit' which is not explicitly confirmed in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the differential treatment of base RSU notices versus performance-based variants. The logic connecting the unchanged base notice to the updated performance-based variant is sound. NUMERIC/DATE ACCURACY: The answer correctly references 2023 and 2024 filings and exhibit numbers (10.07+, 10.08+) but omits the specific May 14, 2015 date and April 30, 2024 date that appear in the ground truth. Overall, the answer demonstrates solid understanding of the evolution but misses some specific documentary references that would strengthen the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 586,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\nFrom 2020‑2021 Opdivo’s sales rose from **$6.99 billion to $7.52 billion**, cementing its position as one of BMS’s top‑line growth engines, and the upward trend continued into 2024 as the product’s label expanded dramatically.  In 2024 the company secured a series of new regulatory milestones—including Japan’s approval for unresectable urothelial carcinoma, the EC’s first‑line Opdivo + Yervoy regimen for colorectal cancer, and the launch of the subcutaneous formulation **Opdivo Qvantig**—which broadened its therapeutic reach and deepened its contribution to total revenues.  Consequently, Opdivo’s role evolved from a strong oncology pillar in 2022 to a more diversified, globally‑approved flagship immunotherapy that now drives a larger share of BMS’s sales and underpins several near‑term growth initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states Opdivo sales rose from $6.99 billion to $7.52 billion in 2020-2021, but the ground truth specifies 2022 revenue was $7,523 million ($7.523 billion). The LLM conflates different time periods and provides data from 2020-2021 when the question specifically asks about 2022-2024 evolution. The $6.99B figure is not verified in the ground truth. (2) REGULATORY APPROVALS - The ground truth explicitly mentions only ONE FDA approval in March 2024 for urothelial carcinoma (first-line combination with cisplatin and gemcitabine). The LLM introduces multiple unverified approvals: Japan's approval for urothelial carcinoma, EC approval for colorectal cancer with Opdivo + Yervoy, and Opdivo Qvantig (subcutaneous formulation). None of these are mentioned in the ground truth, representing significant factual additions without source verification. (3) REVENUE CLAIMS - The LLM claims Opdivo 'drives a larger share of BMS's sales' and shows 'upward trend continued into 2024,' but the ground truth explicitly states 'despite not showing a significant revenue increase from earlier years,' directly contradicting the LLM's assertion. (4) MULTI-HOP REASONING - The LLM failed to properly synthesize the 2022-2024 evolution. It should have focused on the 2022 baseline ($7.523B) and the March 2024 FDA approval for urothelial carcinoma, then noted the lack of significant revenue growth despite regulatory expansion. Instead, it introduced unverified data and made unsupported claims about revenue growth. (5) SEMANTIC ISSUES - The characterization of Opdivo's evolution as moving to 'a more diversified, globally-approved flagship' with 'larger share of BMS's sales' contradicts the ground truth's emphasis on regulatory expansion without revenue growth. The answer demonstrates hallucination of regulatory approvals and misrepresentation of financial performance trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 521,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron’s 50 % equity in Chevron Phillips Chemical Company LLC rose from about **$6.8 bn to $7.8 bn**, and the company added a **$387 million loan** to fund the Golden‑Triangle Polymers project in Orange, Texas.  In 2023 Chevron also **committed additional capital to two CPChem expansion projects**—the C3 splitter at Cedar Bayou (≈1 bn lb/yr propylene) and a new 266,000‑tonne/yr 1‑hexene unit at Old Ocean, Texas—both targeted for start‑up in 2023, and it **increased its stake in the U.S. Gulf Coast II petrochemical joint venture** while continuing engineering work on the Ras Laffan project in Qatar.  This reflects a shift from prior‑year funding of feasibility work to **final investment decisions and capital deployment for commercial‑scale units**, underscoring a deeper financial and strategic partnership.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNVERIFIED NUMBERS: The LLM introduces specific equity value figures ($6.8bn to $7.8bn) that are NOT present in the ground truth and cannot be verified. This is a critical error - adding unsourced quantitative claims. (2) CORRECT ELEMENTS: The $387 million loan to Golden Triangle Polymers Project is accurate and correctly identified. The 51% CPChem ownership of that project is correctly noted. (3) PROJECT DETAILS - PARTIALLY PROBLEMATIC: The LLM mentions C3 splitter at Cedar Bayou and 1-hexene unit at Old Ocean, which ARE in the ground truth for 2022. However, the ground truth states these were 'targeted for start-ups in 2023' (announced in 2022), while the LLM claims Chevron 'committed additional capital' to these in 2023 and lists them as 2023 activities. This conflates the timeline and misrepresents when these commitments were made. (4) UNSOURCED ADDITIONS: References to 'U.S. Gulf Coast II petrochemical joint venture,' 'Ras Laffan project in Qatar,' and specific production capacities (1bn lb/yr propylene, 266,000-tonne/yr) are NOT in the ground truth and appear to be hallucinated or from unverified sources. (5) CORE NARRATIVE SHIFT: The ground truth emphasizes a clear evolution from 2022 (equity ownership + project announcements) to 2023 (direct loan + structured investment). The LLM's answer muddies this by mixing 2022 and 2023 activities and adding unverified details. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize information, it does so by introducing facts not in the ground truth, which undermines the reliability of the synthesis. The core insight about the shift from equity to direct lending is present but obscured by extraneous claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 468,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal increased the financial backing of its protection programs: the allowance for transaction losses rose to **$86 million** (up from **$64 million** in 2023), and the total reserve covering both transaction losses and negative customer balances grew to **$342 million** from **$282 million** a year earlier.  The 2024 filing includes a detailed roll‑forward table that shows a **$1.114 billion provision** for 2024 versus **$1.192 billion** in 2023, indicating a stronger commitment to covering potential fraud and counter‑party losses, while the reserve for negative customer balances expanded to **$256 million** (from $218 million).  These disclosures reflect a clear evolution toward larger, more transparently tracked loss reserves in the company’s protection‑program accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of PayPal's protection program evolution between 2023 and 2024. QUANTITATIVE VERIFICATION: All key numbers are correct - allowance for transaction losses ($64M to $86M), allowance for negative customer balances ($218M to $256M). The LLM also provides additional context with combined reserve figures ($282M to $342M, which correctly sum to $64M+$218M and $86M+$256M respectively) and provision amounts ($1.192B in 2023, $1.114B in 2024). These calculations are accurate. COMPLETENESS: The answer addresses all core elements of the question: (1) financial commitments evolution, (2) transaction loss reserves, (3) year-over-year comparison, and (4) disclosure improvements. ENTITY ACCURACY: PayPal correctly identified, years 2023-2024 properly specified, all financial metrics correctly labeled. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple reserve categories and time periods, correctly identifying the pattern of increased financial commitments and enhanced disclosure transparency. MINOR CONSIDERATIONS: The LLM provides additional detail beyond the ground truth (provision amounts, combined totals) which adds value without contradicting the original answer. The characterization of 'stronger commitment' and 'more transparently tracked' aligns with the ground truth's assessment of 'significant increase' and 'more detailed disclosures.' The semantic meaning is fully preserved and enhanced with supporting detail. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 428,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted the narrative around its franchise relationship from a model that emphasized **company‑owned real estate combined with franchisee co‑investment to boost performance** to one that presents **franchising itself as the core strategic growth engine**.  The 2024 filing explicitly frames co‑investment as a **collaborative partnership that accelerates restaurant modernization, technology adoption and brand‑value creation**, underscoring a more strategic, long‑term view of the franchisee relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the shift in McDonald's framing but introduces interpretations not clearly supported by the ground truth. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe; (2) Accurately notes the shift from descriptive to more strategic framing; (3) Correctly emphasizes franchising as core to the business model in 2024; (4) No quantitative errors or incorrect numbers. WEAKNESSES: (1) The LLM characterizes the 2022 position as 'company-owned real estate combined with franchisee co-investment' - the ground truth describes 2022 as using 'neutral, structural terms' emphasizing 'division of responsibilities' without this specific characterization of the 2022 model; (2) The LLM's description of 2024 framing as 'collaborative partnership that accelerates restaurant modernization, technology adoption and brand-value creation' goes beyond what the ground truth states - the ground truth simply notes that 2024 emphasizes franchisee co-investment 'enables McDonald's to achieve high restaurant performance' without these specific operational details; (3) The LLM introduces the concept of 'company-owned real estate' which is not mentioned in the ground truth's characterization of either year; (4) The ground truth emphasizes the shift from 'neutral, structural terms' to 'strategic and value-laden framing' - the LLM captures this but adds interpretive details about specific operational benefits not explicitly stated in the ground truth. The answer demonstrates reasonable understanding of the directional shift but overstates or adds details beyond what the ground truth supports, particularly regarding the specific mechanisms and 2022 baseline characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 467,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\nBetween 2022 and 2023 the FDA moved from the 2020‑2021 authorizations of the IQOS system and, in March 2022, the three tobacco‑flavored Marlboro HeatStick varieties under the PMTA pathway, to taking no new marketing‑order actions for HeatSticks; the agency instead focused on broader product‑standard rulemaking and the ITC import ban that had been imposed in 2021 remained in effect. This shows that Altria has secured initial FDA clearance for HeatSticks but has not yet obtained further authorizations or a stable market entry, indicating that its regulatory progress with heated‑tobacco products remains dependent on future FDA decisions and ongoing legal challenges.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DATE ERROR - The LLM claims authorizations occurred in 'March 2022' while the ground truth explicitly states they occurred in 'January 2023', a critical 10-month discrepancy. (2) CONTRADICTORY NARRATIVE - The LLM states the FDA took 'no new marketing-order actions for HeatSticks' between 2022-2023, directly contradicting the ground truth which indicates the FDA authorized PMTAs for three new tobacco-flavored varieties in January 2023. (3) MISCHARACTERIZATION OF PROGRESS - The LLM concludes Altria 'has not yet obtained further authorizations' when the ground truth explicitly identifies January 2023 authorizations as 'a significant regulatory milestone.' (4) INCORRECT TIMELINE FRAMING - The LLM incorrectly references 2020-2021 IQOS authorizations as the baseline for 2022-2023 comparison, when the question specifically asks about evolution between 2022 and 2023. (5) MISSING KEY FACT - The LLM fails to identify the January 2023 PMTA authorizations for three tobacco-flavored varieties, which is the central regulatory development between these two years. The LLM's conclusion about 'dependent on future FDA decisions' is contradicted by the actual January 2023 authorizations that already occurred. The answer demonstrates a fundamental misunderstanding of the regulatory timeline and progress made.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 391,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\nThe fair‑value of the mutual‑fund equity securities held in ACN’s defined‑benefit pension portfolio was $239.3 million as of August 31 2022 (comprised $4.9 million Level 1 and $234.3 million Level 2).  In the 2023 target‑allocation tables the company plans essentially zero equity exposure in its U.S. plans and only 27 % of assets in equity for the non‑U.S. plans, reflecting a deliberate reduction in equity weighting.  This shift shows that ACN is moving its investment positioning away from mutual‑fund equity toward a more stable, debt‑ and cash‑heavy allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental numerical error that undermines the entire response. The ground truth states mutual fund equity securities were $239,293 million in 2022 and $196,226 million in 2023 (a decline of $43,067 million). The LLM reports $239.3 million in 2022, which is off by a factor of 1,000 - this appears to be a unit conversion error (millions vs. thousands or a decimal misplacement). The 2023 figure is completely missing from the LLM answer, making it impossible to assess the year-over-year comparison that is central to the question. PARTIAL CREDIT: The LLM correctly identifies ACN as the company and references the defined-benefit pension portfolio context. It also provides reasonable qualitative interpretation about the strategic shift toward debt and cash-heavy allocations and mentions target allocation percentages (27% equity for non-U.S. plans, essentially zero for U.S. plans). However, this qualitative analysis cannot compensate for the missing 2023 data and the incorrect 2022 figure. MULTI-HOP SYNTHESIS: The question requires comparing two years of data and drawing conclusions about investment positioning. The LLM only provides one year's data (2022) with incorrect magnitude, failing to complete the essential multi-hop comparison. The answer addresses investment positioning strategy but lacks the quantitative foundation needed to support conclusions about 'evolution' between the two years. COMPLETENESS: The answer is incomplete - it does not provide the 2023 valuation figure or calculate the year-over-year change ($43,067 million decline), both of which are explicitly requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 455,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\nChevron retained its 36.4 % equity stake in Angola LNG Limited through 2022‑2023, but the character of its involvement shifted.  The 2022 report highlighted active development work—such as the Sanha Lean Gas Connection and offshore non‑associated‑gas projects—to secure feedstock for the plant—whereas the 2023 filing lists the investment under equity‑method assets with only a modest change in carrying value, indicating a move from new development spending to a focus on maintaining and financing the existing LNG operation.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Chevron's 36.4% equity stake in Angola LNG Limited and accurately notes it remained constant from 2022-2023. (2) Numeric accuracy is strong - the percentage is correct and properly formatted. (3) The LLM appropriately recognizes a shift in disclosure/reporting emphasis between the two years. WEAKNESSES: (1) The LLM introduces specific operational details (Sanha Lean Gas Connection, offshore non-associated-gas projects) that are NOT present in the ground truth answer. These appear to be fabricated or inferred details not supported by the knowledge graph. (2) The ground truth emphasizes a shift from 'operational development' to 'financial stake and integration within Chevron's global portfolio,' highlighting how Angola LNG was listed alongside other major investments. The LLM instead frames this as a shift from 'new development spending to maintaining and financing the existing LNG operation' - a different characterization that lacks the portfolio integration context. (3) The LLM mentions 'modest change in carrying value' which is not addressed in the ground truth and appears to be an unsupported inference. (4) The ground truth explicitly notes Angola LNG being listed 'alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC' - this portfolio context is completely absent from the LLM answer. MULTI-HOP REASONING: The LLM attempts to synthesize 2022 vs 2023 information but does so incompletely and with some inaccurate characterizations. The core insight about disclosure shift is present but underdeveloped and partially misdirected. The introduction of specific project names without ground truth support is a significant concern for factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 477,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\nFrom 2022 to 2023 the amount recorded for **Certificates of Deposit/Time Deposits** in 3M’s marketable‑securities portfolio rose from **$21 million** (2022) to **$49 million** (2023).  This represents an **increase of $28 million**, or roughly a **133 % growth** in the investment over the one‑year period.  (Source: Note 12 “Marketable Securities” in the 2023 10‑K, page 64, which lists $49 million for 2023 versus $21 million for 2022.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers. Ground truth shows: 2022 = $14 million, 2023 = $49 million, change = $35 million (250% increase). LLM answer states: 2022 = $21 million, 2023 = $49 million, change = $28 million (133% increase). The 2022 figure is incorrect ($21M vs $14M - off by $7M or 50%). The calculated change is therefore wrong ($28M vs $35M). The percentage calculation is also incorrect (133% vs 250%). While the 2023 figure of $49 million is correct, the 2022 baseline is fundamentally wrong, which cascades into incorrect calculations. The LLM correctly identified the company (MMM/3M), the metric (Certificates of Deposit/Time Deposits), the years (2022-2023), and the source document (Note 12, 2023 10-K). The answer structure and reasoning approach are sound - the model correctly understood the multi-hop requirement to compare two years and calculate the magnitude of change. However, the factual accuracy is severely compromised by the incorrect 2022 starting value. This is a case where the model appears to have cited a source correctly but pulled the wrong data point from that source, or confused data from different sections of the filing. The semantic understanding of the question is appropriate, but the execution fails on the most critical element: accurate financial data retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 385,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\nBetween 2021 and 2024 the share of McDonald’s restaurants operated by franchisees rose modestly—from about 93 % of the system at the end of 2021 to roughly 95 % of the 43,477 restaurants reported at the end of 2024. This reflects the company’s continued emphasis on expanding its heavily franchised model, maintaining a high proportion of franchised locations while still growing the overall store count.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative facts are correct: 93% franchised in 2021, approximately 95% in 2024, and the total restaurant count of 43,477 at end of 2024. The percentages match the ground truth exactly, and the modest increase (2 percentage points) is accurately characterized. The answer successfully synthesizes multi-hop information by comparing franchising percentages across the 2021-2024 period and contextualizing this within McDonald's overall business strategy. The reasoning is sound—the LLM correctly identifies this as a deliberate strategic shift toward franchising while acknowledging overall store growth. The only minor distinction from the ground truth is that the LLM provides additional context (the specific 2024 restaurant count of 43,477) which adds value without contradicting the original answer. The semantic meaning is fully preserved: both answers convey that McDonald's increased its reliance on franchisees from 93% to ~95% as part of a strategic business model emphasis. The wording differs slightly but conveys identical information. No calculation errors are present, and all entities (McDonald's, franchisees, years, percentages) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 354,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\nBetween 2022 and 2023 the 2015 Stock Compensation Plan for Non‑Employee Directors was restated — the amendment became effective on **October 26, 2022** (disclosed in the 2023 Form 10‑K, Item 10.22) and replaced the prior restatement that had been effective March 31, 2021.  The restated plan retained its original structure of granting restricted‑stock units, performance‑stock units and deferred fees to directors, but it updated the share‑reserve numbers (e.g., reducing the remaining available shares from ≈ 24 million in 2021 to ≈ 21 million in 2023) and incorporated the latest equity‑award provisions.  No fundamental change in the plan’s purpose or award types occurred; the evolution was limited to an amendment and restatement to reflect updated share‑reserve figures and revised procedural language.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution: the plan was amended and restated with an effective date of October 26, 2022 (disclosed in 2023 10-K), replacing the prior March 31, 2021 restatement. The multi-hop synthesis is sound and the qualitative description of the plan's structure (RSUs, PSUs, deferred fees) and the nature of updates (share reserves, procedural language) is reasonable and relevant.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. SHARE RESERVE NUMBERS: The LLM claims share reserves were reduced from \"≈ 24 million in 2021 to ≈ 21 million in 2023.\" These specific figures are not provided in the ground truth and appear to be unsupported claims. The ground truth makes no mention of these share reserve quantities, so the LLM has introduced unverified numerical data.\n\n2. CITATION ISSUE: The LLM cites \"Item 10.22\" as the disclosure location. This is problematic because Item 10 in SEC filings typically covers executive compensation and related matters, but Item 10.22 is not a standard SEC form item designation. This suggests either a misremembering of the actual disclosure location or an invented citation.\n\n3. MISSING GROUND TRUTH DETAILS: The ground truth emphasizes that the plan \"underwent at least one additional amendment during the 2022–2023 period,\" which the LLM captures, but the LLM adds unsupported quantitative details about share reserves that go beyond what can be verified.\n\nThe core factual answer about the effective dates (March 31, 2021 → October 26, 2022) and the nature of the restatement is correct. The reasoning about why the plan was updated (procedural/structural updates) is sound. But the introduction of unverified share reserve figures and the questionable citation significantly undermine the quantitative reliability of the response.\n\nScore justification: The answer gets the main facts right (7-8 range) but loses points for introducing unsupported numerical claims and a potentially incorrect citation, dropping it to a 6 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 548,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture’s equity investment in Duck Creek Technologies moved from a modest carrying amount of **$138.9 million** (with an estimated fair value of **$223 million** as of 31 Aug 2022) to a **$253 million pre‑tax gain** that was recognized in earnings during 2023.  The gain—highlighted in the 2023 results as a key driver of the increase in adjusted earnings‑per‑share and operating margin—reflects a substantial appreciation of the stake (still roughly a 16 % ownership) and shows how the investment’s fair‑value increase translated into a material financial impact on Accenture’s reported profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Accenture's Duck Creek Technologies investment evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - carrying amount of $138.9 million (matches $138,902 in thousands), fair value of $223 million (matches $223,166 in thousands), 16% ownership stake, and $253 million pre-tax gain. Number formatting variations are appropriately handled. COMPLETENESS: The answer addresses both fiscal years (2022 and 2023) and covers the three main dimensions requested: investment valuation, ownership percentage, and reported financial impact. ENTITY ACCURACY: Correct identification of Accenture, Duck Creek Technologies, and proper fiscal year references. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - connecting the carrying amount and fair value from 2022, the gain realization in 2023, and the impact on adjusted EPS and operating margin. The logical flow from equity stake to gain realization is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'modest carrying amount' to 'substantial appreciation' and 'material financial impact' accurately conveys the ground truth's description of movement from 'long-term equity stake to more active financial realization event.' Minor note: The LLM uses 'pre-tax gain' which is semantically equivalent to the ground truth's description of the gain impact. The answer is well-structured, factually accurate, and provides appropriate context about the investment's significance to Accenture's 2023 financial results.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 442,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s therapeutic scope widened well beyond its original 2021 launch, which was limited to relapsed or refractory large‑B‑cell lymphoma after ≥ two prior systemic therapies.  In 2024 the FDA granted accelerated approvals for three additional B‑cell malignancies—relapsed/refractory follicular lymphoma (May 2024), chronic lymphocytic leukemia/small‑lymphocytic lymphoma (March 2024) and mantle‑cell lymphoma (May 2024)—and Japan’s MHLW approved Breyanzi in August 2024 for relapsed/refractory follicular lymphoma after a single prior line (including high‑risk disease).  These new indications expand the eligible patient population and markedly increase Breyanzi’s commercial market potential.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims three new indications were approved in 2024, including mantle cell lymphoma in May 2024. However, the ground truth specifies only TWO new approvals in 2024: CLL/SLL (March 2024) and follicular lymphoma (May 2024). The mantle cell lymphoma approval is NOT mentioned in the ground truth and appears to be fabricated. (2) GEOGRAPHIC SCOPE ADDITION - The LLM introduces Japan's MHLW approval in August 2024 for follicular lymphoma, which is not mentioned in the ground truth. While this may be factually accurate from other sources, it goes beyond the scope of the ground truth answer and introduces unverified information. (3) DOSING/PRIOR THERAPY DETAILS - The LLM specifies Japan's approval was 'after a single prior line' while the US approvals required 'at least two prior lines.' The ground truth does not provide this level of detail for the Japanese approval, suggesting the LLM may be adding unsourced specificity. (4) CORRECT ELEMENTS - The LLM correctly identifies the 2022 baseline indication (relapsed/refractory large B-cell lymphoma after ≥2 prior therapies), correctly dates the March 2024 CLL/SLL approval and May 2024 follicular lymphoma approval, and correctly notes the expansion of eligible patient populations. (5) MULTI-HOP REASONING - The LLM demonstrates sound reasoning about market expansion, but this is undermined by the factual errors regarding the number and scope of approvals. The synthesis of information is logical but built on partially incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 428,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\n3M continued to apply ASC 450 (and ASC 610‑30) to accrue probable, reasonably‑estimable losses from respirator‑asbestos litigation and to record insurance recoveries only when recovery was probable, using a consistent analysis of policy terms, case law and historical experience.  In 2023 the company increased its accrual for these matters by $57 million to $574 million (excluding the Aearo trust) and noted an immaterial insurance‑receivable balance, whereas in 2022 the accrual was lower and the related insurance receivable was also described as immaterial—indicating a more quantified estimate of both the liability and its offsetting insurance recovery.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that 3M applied ASC 450 and ASC 610-30 for insurance receivables, mentions the consistent methodology across years, and notes that insurance receivables were immaterial in both years. The answer appropriately addresses the evolution question by noting a more quantified approach. CRITICAL WEAKNESSES: (1) MISSING KEY EVOLUTION DETAIL: The ground truth explicitly states that in 2022, 3M 'did not specifically mention the methodology for estimating insurance receivables' but in 2023 'explicitly described applying the loss recovery and/or gain contingency models.' The LLM answer suggests the methodology was consistent across both years ('continued to apply'), which contradicts the ground truth's core finding about the evolution. (2) MISSING CLAIMANT DATA: The ground truth provides specific claimant numbers (4,028 in 2022 vs 4,042 in 2023) as evidence of growing exposure influencing the more detailed 2023 approach. The LLM answer completely omits this quantitative evidence. (3) QUANTITATIVE ISSUES: The LLM provides specific accrual figures ($57 million increase to $574 million) that are not mentioned in the ground truth, raising questions about whether these numbers are accurate or introduced without verification. The ground truth does not reference these specific dollar amounts. (4) INCOMPLETE SYNTHESIS: The question asks specifically about evolution 'between 2022 and 2023' - the ground truth clearly delineates what changed (explicit methodology description, more detailed analysis), but the LLM presents it as continuity rather than evolution. The answer reads more like a general description of 3M's consistent approach rather than highlighting the specific methodological evolution that occurred. CALCULATION/VERIFICATION: Cannot independently verify the $57M increase and $574M total accrual figures against ground truth, as these are not provided in the original answer. This represents either additional information not in the knowledge graph or potential inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 548,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo moved from full ownership of the Naked brand to selling it – along with Tropicana and other select juice brands – to PAI Partners while retaining a 39 % non‑controlling interest in the newly formed joint‑venture that now owns those brands.  Operationally, PepsiCo was appointed the exclusive distributor in the United States for the JV’s portfolio, handling chilled direct‑store‑delivery (DSD) for small‑format and food‑service customers, thereby turning its involvement from production to distribution and marketing rather than direct ownership.  Financially, PepsiCo’s stake remains a minority, non‑consolidated 39 % interest, so it no longer records the brand’s sales or earnings but earns distributor fees and continues to support the brand through its DSD network.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 39% noncontrolling interest retained by PepsiCo. (2) Accurately names PAI Partners as the acquirer. (3) Correctly identifies the brands sold (Tropicana, Naked, and other select juice brands). (4) Properly describes the shift from ownership to a financial stake. (5) Correctly identifies the exclusive distributor role for small-format and foodservice customers via chilled DSD. (6) Numeric values (39%, 2022-2023 timeframe) are accurate.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to address the key evolution between 2022 and 2023. The ground truth explicitly states that \"By 2023, PepsiCo no longer directly distributed Naked products\" - this represents a significant operational change. The LLM describes the 2022 distribution arrangement but does not clearly articulate that this operational involvement ended by 2023. (2) The LLM states PepsiCo was appointed \"exclusive distributor in the United States\" but the ground truth specifies the distribution was for \"small-format and foodservice customers via chilled direct-store-delivery\" - the LLM mentions this but doesn't emphasize the limited scope. (3) The LLM mentions \"distributor fees\" which is not explicitly stated in the ground truth and may be inferential. (4) The LLM does not clearly establish the temporal evolution - it conflates 2022 and 2023 activities rather than showing how the relationship changed between these years.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the sale transaction, the retained stake, and the distributor role. However, it fails to complete the full multi-hop reasoning by not addressing the 2023 change where PepsiCo exited the distribution role entirely. This is a significant gap in answering the question about how the relationship \"evolved between 2022 and 2023.\"\n\nSEMANTIC ACCURACY: The LLM's description of the 2022 arrangement is semantically accurate, but the answer is incomplete regarding the 2023 evolution. The question specifically asks about evolution/change between the two years, and the LLM does not adequately address the discontinuation of the distribution role by 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 587,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s disclosure of the ExtraBucks Rewards program kept the same core accounting model but added clearer language about the performance‑obligation timing and the contract‑liability measurement.  In both years the Company treats the reward as a separate performance obligation that is allocated to the initial transaction on a relative‑stand‑alone‑selling‑price basis and recognizes revenue **only when the ExtraBucks are actually redeemed**; unredeemed rewards remain in contract liability.  The 2024 filing refines the presentation by explicitly quantating the change in the contract‑liability balance (including the impact of recent acquisitions) and emphasizing that breakage estimates are based on historical redemption patterns, but the timing of revenue recognition—recognition upon redemption rather than at the point of issuance—has not changed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the core accounting treatment and evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies that the ExtraBucks Rewards program creates a separate performance obligation in both years; (2) Accurately states revenue recognition occurs upon redemption, not issuance; (3) Correctly notes unredeemed rewards are reflected as contract liabilities; (4) Properly identifies that allocation is based on relative standalone selling prices; (5) Accurately captures that 2024 language became more refined and explicit; (6) Correctly notes historical redemption patterns inform the accounting; (7) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer mentions '2024 filing refines the presentation by explicitly quantating the change in the contract-liability balance (including the impact of recent acquisitions)' - while this is a reasonable inference about more detailed disclosure, the original answer does not explicitly mention quantification of contract liability changes or acquisition impacts, so this represents a slight addition beyond the ground truth rather than a direct match; (2) The phrase 'breakage estimates are based on historical redemption patterns' is accurate but the original answer uses 'historical redemption patterns' in the context of relative standalone selling prices rather than explicitly as 'breakage estimates,' though these concepts are related; (3) The LLM answer could have been slightly more explicit about the 'more mature and formalized approach' language from the original answer. MULTI-HOP REASONING: The answer correctly synthesizes the comparison across two years and identifies both continuities (core model unchanged) and evolutions (refined language, more structured approach). The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 554,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix’s cost of revenues rose from **$19.7 bn (58 % of revenue)** to **$21.0 bn (54 % of revenue)**.  The filing attributes the entire dollar increase to higher content‑amortization, noting that payment‑processing fees paid to integrated payment partners are part of “other operating costs” but were not a driver of the growth.  Consequently, the share of those payment‑partner fees within total cost of revenues fell, indicating that Netflix’s reliance on integrated payment partners stayed flat or modestly decreased in 2024 relative to overall cost structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues that prevent it from being considered substantially correct: (1) QUANTITATIVE PROBLEMS: The LLM provides specific dollar amounts ($19.7bn in 2023, $21.0bn in 2024) and percentages (58% and 54%) without verification against the actual 10-K filings. These numbers cannot be confirmed as accurate from the ground truth provided, and the LLM appears to have fabricated specific figures. The ground truth does not provide these exact numbers. (2) MISALIGNMENT WITH GROUND TRUTH: The original answer emphasizes a SHIFT IN DISCLOSURE STRATEGY - that Netflix removed granular details about payment processing fees between 2023 and 2024, indicating less explicit disclosure rather than a change in actual reliance. The LLM answer instead focuses on cost structure changes and claims reliance 'stayed flat or modestly decreased,' which is a different interpretation not supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth specifically states that in 2024 'the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees.' The LLM does not address this key disclosure change - it instead analyzes cost composition and percentage changes. (4) LOGICAL INFERENCE ERROR: The LLM concludes that because payment partner fees represent a smaller share of total cost of revenues, reliance decreased. However, the ground truth indicates the relationship 'persisted' and the change reflects disclosure strategy, not necessarily actual business reliance. The LLM conflates disclosure changes with business changes. (5) MISSING KEY INSIGHT: The ground truth's core finding - that this represents 'a shift in disclosure strategy rather than a substantive discontinuation' - is entirely absent from the LLM answer. The LLM provides financial analysis instead of addressing the actual question about how disclosure and relationship details evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 526,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\nFrom 2022 to 2023, 3M shifted from simply carrying out the remedial actions required by the 2007 Settlement Agreement and Consent Order to actively confronting tighter state health‑based standards—most notably the January 2024 Minnesota Department of Health updates to the HBV values for PFOA and PFOS that were being evaluated throughout 2023.  At the same time the company faced new regulatory moves such as the March 2023 MPCA Notice of Violation for PFAS‑contaminated storm‑water discharges and the December 2023 draft Clean Water Act permit for the Cottage Grove facility, which imposes significantly lower PFAS limits.  In response, 3M expanded its monitoring and treatment programs, developed storm‑water control plans, and entered into ongoing negotiations with MPCA and EPA to align its PFAS management with the newer, more stringent health‑based criteria.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant date errors that undermine its factual accuracy. CRITICAL ERRORS: (1) The LLM states 'December 2023 draft Clean Water Act permit' when the ground truth clearly indicates this was 'January 2024' - this is a one-month error on a key regulatory milestone. (2) The LLM references 'March 2023 MPCA Notice of Violation' which is correct per ground truth, but then contradicts itself by stating 'December 2023 draft Clean Water Act permit' when ground truth shows 'December 2022' MPCA order for Cottage Grove stormwater and 'January 2024' for the proposed new permit. This represents confusion about the timeline. (3) The LLM correctly identifies the January 2024 Minnesota Department of Health HBV updates but places them in the future tense ('being evaluated throughout 2023') which is awkward phrasing. CORRECT ELEMENTS: The LLM accurately captures that 3M faced tightening regulatory standards, the shift from maintenance activities to confronting stricter standards, the involvement of MPCA and EPA, and the general evolution toward more stringent PFAS management. The qualitative characterization of the regulatory environment tightening is sound. MISSING/INCOMPLETE: The LLM does not mention the Decatur, Alabama facility and its 2020 interim Consent Order with ADEM, which represents a significant omission of relevant PFAS management context. The LLM also doesn't specifically mention the Hutchinson facility Notice of Violation details. The answer provides reasonable inference about 3M's response (monitoring, treatment programs, negotiations) but these are not explicitly stated in the ground truth as confirmed actions. MULTI-HOP REASONING: The synthesis across regulatory changes and health standards is generally sound, but the date errors create confusion about the actual timeline of events from 2022-2023 and into 2024. The core narrative of evolution is correct but execution is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 524,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the notional amount of PepsiCo’s foreign‑currency derivatives grew from about **$3.0 billion to $3.8 billion** (an increase of roughly 27 %).  The company continues to manage exposure with short‑term forward contracts and net‑investment hedges that offset unhedged currency movements, so the larger derivative book reflects a deliberate scaling‑up of its hedging program to blunt earnings volatility from foreign‑exchange fluctuations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metrics. Quantitative verification: (1) 2022 notional value of $3.0 billion - CORRECT, (2) 2023 notional value of $3.8 billion - CORRECT, (3) percentage increase calculation: ($3.8B - $3.0B) / $3.0B = $0.8B / $3.0B = 26.67%, rounded to 27% - CORRECT. The LLM successfully synthesized the multi-hop information by comparing values across two fiscal years and calculating the percentage change. Entity accuracy is sound: PepsiCo correctly identified, years 2022-2023 correctly specified, foreign currency derivatives correctly identified as the metric. The reasoning about strategic expansion and hedging program scaling is logically sound and aligns with the ground truth interpretation. Minor omission: The LLM answer does not explicitly mention that the company achieved 'no material net impact on earnings in 2023' as stated in the ground truth, which was a specific detail about the effectiveness of the hedging strategy. However, the LLM's statement about 'offset unhedged currency movements' and 'blunt earnings volatility' conveys similar conceptual meaning. The answer appropriately addresses both parts of the question: (1) how the derivatives evolved (quantitative change), and (2) what this indicates about risk management strategy (qualitative interpretation). The wording differs from ground truth but maintains semantic equivalence regarding the strategic intent and program expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 413,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil moved from a primarily North‑American expansion to a dual‑track strategy that couples continued U.S. capacity growth with a major new investment in China.  In 2023 the company brought online a 400 k‑ton‑per‑year performance‑polymer line at Baytown, Texas, while also reaching final investment on a $‑billion petrochemical complex in the Dayawan Petrochemical Industrial Park (Huizhou, Guangdong) – the first 100 % foreign‑owned plant in China and slated to deliver >2.5 million t/yr of high‑performance polyethylene and polypropylene to meet China’s rising domestic demand.  This geographic shift reflects a deliberate pivot to capture the faster‑growing chemical markets driven by improving living standards in Asia, while still leveraging its North‑American feed and integration advantages.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall strategic evolution and geographic shift correctly, but contains a significant quantitative error and some omissions. CORRECT ELEMENTS: (1) The shift from North American focus to dual-track strategy with China investment is accurate; (2) Baytown, Texas expansion is correctly identified; (3) Dayawan/Huizhou, China complex details are correct (100% foreign-owned, >2.5 million t/yr capacity); (4) The strategic rationale about improving living standards in Asia is sound; (5) The characterization of the shift from domestic to foreign investment is accurate. ERRORS AND ISSUES: (1) QUANTITATIVE ERROR - The LLM states '400 k-ton-per-year performance-polymer line' but the ground truth does not specify this exact capacity figure for 2023. The ground truth mentions 'expanding performance polymers and linear alpha olefins capacity' but does not provide a 400 k-ton figure; (2) OMISSION - The LLM fails to mention the 2022 completion of the ethane cracker near Corpus Christi, Texas, which is a key 2022 milestone; (3) OMISSION - The LLM does not mention the planned 500,000 metric tons annually of advanced recycling capacity in Baytown by 2026, which was a significant 2022 initiative; (4) INCOMPLETE SYNTHESIS - The answer doesn't fully capture the evolution from 'advanced recycling and integrated U.S. projects' to 'high-performance product expansions,' missing the advanced recycling component entirely. The LLM provides good strategic context and reasoning about the geographic pivot and market drivers, but the quantitative inaccuracy (the 400 k-ton figure appears unsupported) and significant omissions of 2022 initiatives weaken the multi-hop synthesis required to properly answer the 2022-2023 evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 478,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\nFrom 2022 to 2023 3M’s holdings of certificates of deposit/time deposits rose sharply—from **$21 million** (2022) to **$49 million** (2023) 【MMM_10k_2023 p. 64】—essentially doubling the prior‑year balance. This increase signals that 3M is allocating a larger share of its short‑term cash to higher‑yielding, low‑risk time‑deposit instruments, reflecting a more defensive cash‑management stance likely driven by rising interest rates and a desire to preserve liquidity while earning modest returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: Both key figures are correct—$21 million (2022) and $49 million (2023). The characterization of this as 'doubling' or 'more than doubling' is accurate (49/21 = 2.33x, or 133% increase). ENTITY ACCURACY: Company (3M/MMM), metric (Certificates of Deposit/Time Deposits), and years (2022-2023) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the numerical data with strategic interpretation, addressing both the 'how' (the numbers) and 'what does this indicate' (the strategic implications) components of the question. QUALITATIVE ANALYSIS: The LLM provides enhanced context beyond the ground truth by explaining the likely drivers (rising interest rates, defensive cash management) and the strategic rationale (higher-yielding, low-risk instruments). This additional reasoning is logical and appropriate, though not explicitly stated in the ground truth. The ground truth answer is more concise, while the LLM answer is more detailed and explanatory. SEMANTIC EQUIVALENCE: The LLM's interpretation that this reflects 'a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments' aligns well with the ground truth's characterization. The citation reference (MMM_10k_2023 p. 64) adds credibility. MINOR CONSIDERATIONS: The LLM's additional interpretive layer about 'defensive cash-management stance' and 'rising interest rates' goes slightly beyond the ground truth but represents reasonable financial analysis rather than factual error. All core facts are accurate and the answer fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 466,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\nMastercard’s 2023 filing explicitly frames its “proprietary insights” as coming from a “principled and responsible use of secure consumer and merchant data,” a phrasing that was only implicit in the 2022 discussion. By coupling the insights language with a clear emphasis on data‑responsibility and trust‑building—highlighting value‑added, cyber‑ and intelligence‑focused services—the company signals a more deliberate, stewardship‑oriented approach to leveraging data in 2023 than in the prior year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Mastercard's language around proprietary insights from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key shift from '2022 discussion' (implicit) to '2023 filing' (explicit) regarding data responsibility; (2) Accurately captures the specific phrase evolution: from 'principled use' to 'principled and responsible use of secure consumer and merchant data'; (3) Properly synthesizes the multi-hop reasoning that this linguistic shift reflects a deliberate stewardship-oriented approach; (4) No quantitative errors or date inaccuracies; (5) Correctly identifies the trust-building and cybersecurity emphasis as central to the evolution. MINOR WEAKNESSES: (1) The LLM answer characterizes 2022 language as 'only implicit' rather than explicitly stating what the 2022 phrasing was ('principled use of consumer and merchant data'), which slightly reduces clarity of the direct comparison; (2) The phrase 'value-added, cyber- and intelligence-focused services' appears to be an inference or elaboration not explicitly confirmed in the ground truth, though it aligns with the narrative; (3) The ground truth provides the exact 2022 phrasing while the LLM answer references it more obliquely. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two years and identifies the semantic shift in corporate messaging. The reasoning that this reflects 'stewardship-oriented approach' is sound and supported by the language evolution. Overall, this is a high-quality answer with accurate core facts and appropriate contextual understanding, with only minor presentation differences from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 461,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\nIn 2022 the company recorded a **$0.3 bn (pre‑tax) pension‑and‑retiree‑medical charge**—the only line‑item impact of those plans in the ROIC reconciliation (page 57, 2022 column).  By 2023 that same line shows “‑” (no impact) (page 57, 2023 column), indicating that after re‑evaluating the assumptions—discount rates, health‑care cost inflation, mortality and related macro‑economic factors—the company determined no material adjustment was required.  This shift reflects a **changing external environment**: the heightened inflation and interest‑rate pressures that drove the 2022 charge have eased, so the estimates for pension and retiree medical liabilities are now considered stable enough to require no additional charge.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides incorrect information. CRITICAL ISSUES: (1) The question asks about factors influencing accounting estimates (qualitative drivers like COVID-19, geopolitical risks, interest rates, inflation), not about specific charge amounts or ROIC reconciliation line items. The LLM conflates two different concepts: the magnitude of charges ($0.3bn in 2022 vs. no charge in 2023) with the underlying factors influencing estimates. (2) The LLM's core claim is factually incorrect: it states that 'heightened inflation and interest-rate pressures that drove the 2022 charge have eased,' which contradicts the ground truth that 2023 was characterized by 'high interest rate and inflationary cost environment.' The LLM incorrectly suggests conditions improved when they actually persisted or worsened. (3) The LLM completely misses the key evolution identified in the ground truth: the shift from COVID-19 pandemic impacts (2022) to geopolitical conflicts (Ukraine, Middle East) and macroeconomic uncertainty (2023). (4) The LLM's reasoning about why no charge was recorded in 2023 ('estimates are now considered stable enough') is speculative and unsupported by the ground truth, which indicates the external environment actually became MORE uncertain with geopolitical and economic challenges. (5) While the LLM correctly identifies that assumptions like discount rates, healthcare cost inflation, and mortality were re-evaluated, it draws the wrong conclusion about what this indicates about the external environment. The answer demonstrates a fundamental misunderstanding of the question's intent and provides contradictory information about the economic environment between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 475,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil’s undeveloped acreage in the Other Americas region slipped modestly—from about 25.1 million gross and 12.0 million net acres (thousands) in 2022 to roughly 24.2 million gross and 11.5 million net acres in 2023, a decline of roughly 3–4 % in both gross and net terms. This slight contraction reflects a deliberate scaling back of new lease acquisitions, with the company focusing instead on developing existing undeveloped holdings and securing lease extensions, while still preserving a sizable acreage base that underscores ongoing exploration upside in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The numbers are correct - 2022 figures of 25,096 gross and 11,977 net thousands of acres are accurately represented as 'about 25.1 million gross and 12.0 million net acres (thousands)' (minor rounding acceptable). The 2023 figures of 24,221 gross and 11,548 net thousands of acres are correctly stated as 'roughly 24.2 million gross and 11.5 million net acres.' The percentage decline calculation is accurate: (25,096-24,221)/25,096 = 3.5% for gross acres and (11,977-11,548)/11,977 = 3.6% for net acres, matching the stated '3-4% decline.' ENTITY ACCURACY: All entities correctly identified - ExxonMobil, Other Americas region, 2022-2023 timeframe, gross and net acreage metrics. MULTI-HOP REASONING: The answer successfully synthesizes the acreage data and provides sound interpretation about what the decline indicates (relinquishment/transition to developed status, focus on higher-potential properties). The LLM adds reasonable contextual interpretation about 'deliberate scaling back of new lease acquisitions' and 'developing existing undeveloped holdings,' which aligns with the ground truth's indication of strategic focus. COMPLETENESS: Addresses both parts of the question - the evolution of acreage position and what it indicates about exploration potential. The answer is slightly more detailed than the ground truth in explaining the strategic implications, which adds value without contradicting the original answer. Minor note: The parenthetical '(thousands)' placement in the LLM answer is slightly awkward but does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 449,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\nFrom 2022 to 2023 3M kept using foreign‑currency forwards and options that are **not designated as hedging instruments** to offset the impact of non‑functional‑currency balances, but the program was markedly reduced – the gross notional fell from roughly $2.8 billion in 2022 to about $1.0 billion in 2023, and the fair‑value adjustment recorded in earnings moved from a $76 million pre‑tax loss in 2022 to a $9 million pre‑tax loss in 2023 (an improvement of roughly $67 million).  As a result, the year‑on‑year foreign‑currency transaction effect shifted from adding about $127 million of pre‑tax income in 2022 to decreasing pre‑tax loss by roughly $40 million in 2023, indicating a substantially smaller adverse financial impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) GROSS NOTIONAL AMOUNT DISCREPANCY: The LLM states the gross notional fell from $2.8 billion in 2022 to $1.0 billion in 2023, but the ground truth explicitly states the 2022 gross notional amount was $3.7 billion. This is a major quantitative error ($900 million discrepancy). (2) DIRECTIONAL MISINTERPRETATION: The ground truth indicates the company 'continued to use such contracts' with a shift in strategy from designated to non-designated hedging instruments, suggesting continuity with strategic evolution. The LLM characterizes this as a 'markedly reduced program,' which misrepresents the nature of the change. (3) FINANCIAL IMPACT NUMBERS: The LLM provides specific figures for fair value adjustments ($76M loss in 2022 to $9M loss in 2023) and transaction effects ($127M income in 2022 to $40M loss decrease in 2023) that are NOT present in the ground truth. These appear to be fabricated or sourced from incorrect data. (4) MISSING KEY CONTEXT: The ground truth emphasizes the strategic shift from 'primarily designated hedging strategies to a more direct financial exposure management approach,' which the LLM fails to adequately capture. The LLM focuses on quantitative reduction rather than the qualitative strategic shift. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize year-over-year changes, it does so with incorrect baseline numbers, undermining the entire analytical framework. The ground truth's emphasis on the shift in hedging designation strategy is more nuanced than the LLM's reduction narrative. The answer demonstrates poor factual accuracy on the primary quantitative metric (gross notional amount) and introduces unverified financial figures not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 499,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved Cyber and Intelligence Solutions from a peripheral “other‑revenue” line item to a central pillar of its value‑added portfolio.  In the 2022 filing the solutions were noted simply as fraud‑prevention and security offerings, but the 2023 MD&A frames them as strategic, proprietary insights that enable secure, seamless transactions across the company’s expanding network of payments, open‑banking and digital‑identity capabilities.  This shift reflects a broader emphasis on high‑margin, data‑driven services that reinforce Mastercard’s overall growth and differentiate its ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Cyber and Intelligence Solutions from 2022 to 2023, correctly identifying the shift from a peripheral/supporting role to a more central, strategic position. The answer accurately conveys the semantic meaning of the ground truth: that these solutions moved from being listed alongside other services to being positioned as a core component of Mastercard's value proposition. The LLM adds helpful context about the shift from 'fraud-prevention and security offerings' to 'strategic, proprietary insights' and mentions the connection to high-margin, data-driven services and ecosystem differentiation, which aligns with the ground truth's emphasis on strategic elevation. However, there are some minor issues: (1) The LLM characterizes the 2022 positioning as 'peripheral' and an 'other-revenue line item,' which goes slightly beyond what the ground truth states (the ground truth says they were 'part of a broader list' and had a 'supporting role,' not necessarily that they were in an 'other-revenue' category). (2) The LLM adds specific details about 'open-banking and digital-identity capabilities' that are not explicitly mentioned in the ground truth, though these may be accurate from the actual filings. (3) The phrasing about 'high-margin, data-driven services' is an inference not directly stated in the ground truth. No quantitative errors are present (no specific numbers, dates, or calculations to verify). The multi-hop reasoning is sound—the answer correctly synthesizes the evolution across the two years. The answer is well-structured and contextually relevant to the question about how the role and emphasis evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 458,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\nThe 2022 Form 10‑K presented “Income Tax Expense and Accruals” as a stand‑alone critical‑accounting‑policy section (page 61) that explained the annual tax‑rate determination, the judgment required, and the establishment of reserves that are adjusted when tax positions are challenged. In the 2023 filing the same topic remains a critical policy, but its discussion has been moved to the “Income Tax Expense and Accruals” subsection (now on page 35) and includes expanded language on transfer‑pricing, pandemic‑related tax risks and the ongoing reassessment of reserves, while preserving the core emphasis on judgment and reserve adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable qualitative description of the evolution of Income Tax Expense and Accruals disclosure between 2022 and 2023, correctly identifying that the topic remained a critical accounting policy but was reorganized/moved to a subsection with expanded discussion. However, there are significant issues with quantitative accuracy: (1) The page numbers cited (page 61 for 2022, page 35 for 2023) cannot be verified against the ground truth and appear potentially incorrect - the ground truth does not provide specific page references, making these claims unverifiable and potentially inaccurate. (2) The LLM introduces specific details about 'transfer-pricing, pandemic-related tax risks' that are not mentioned in the ground truth, which may be fabricated or from a different source. (3) The ground truth emphasizes a 'shift toward more detailed and organized reporting' and mentions 'Note 5 - Income Taxes' specifically, but the LLM answer does not reference this note structure. The qualitative reasoning about the evolution (from stand-alone to subsection with expanded language) aligns with the ground truth's core message about reorganization and deeper transparency. The answer is contextually relevant to the question about evolution of treatment/disclosure between 2022 and 2023. The main weakness is the introduction of unverified page numbers and specific details not in the ground truth, combined with omission of the Note 5 reference that the ground truth explicitly mentions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 417,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\nIn 2023 Intel first demonstrated the Universal Chiplet Interconnect Express (UCIe) in silicon, positioning it as the key interconnect standard for its emerging “systems‑of‑chips” approach. By 2024 the company had folded UCIe into the broader Open System Foundry and IFS Accelerator ecosystem—leveraging its ARM and Synopsys partnerships, reference designs, and design‑win momentum—to make UCIe the default chiplet‑communication standard that underpins Intel’s systems‑level strategy for AI‑centric, chiplet‑based products.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023 demonstration phase and 2024 progression of UCIe. (2) Accurately captures the core evolution from demonstration to active production/integration. (3) Correctly names the standard (Universal Chiplet Interconnect Express/UCIe) and its role in systems-of-chips strategy. (4) Dates (2023, 2024) are accurate. WEAKNESSES: (1) The LLM introduces significant new claims not present in the ground truth: mentions of 'Open System Foundry and IFS Accelerator ecosystem,' 'ARM and Synopsys partnerships,' 'reference designs,' and 'design-win momentum.' While these may be factually true from Intel's 2024 filings, they represent substantial additions beyond what the ground truth specifies. (2) The ground truth emphasizes 'advanced semiconductor assembly and test offerings' as the integration mechanism, but the LLM shifts focus to ecosystem partnerships and design frameworks. (3) The characterization of UCIe as 'default chiplet-communication standard' and emphasis on 'AI-centric, chiplet-based products' goes beyond the ground truth's more measured description of 'core component' and 'system-level standards.' (4) MULTI-HOP REASONING: The LLM attempts to synthesize additional ecosystem context, but this synthesis appears to introduce information not validated by the ground truth knowledge graph. The core evolution (2023 demo → 2024 production) is correct, but the supporting details diverge. CALCULATION/NUMERIC CHECK: No calculations required; dates and timeline are accurate. SEMANTIC EQUIVALENCE: The fundamental narrative (evolution from demonstration to integration) matches, but the LLM significantly expands the scope with partnership and ecosystem details that may be accurate but aren't grounded in the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 485,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\nThe 2023 10‑K describes the $2.0 bn ASR with Citibank that was entered into on January 4 2023, settled in February 2023, and was accounted for by recording the initial 80 % of shares as treasury stock while the remaining forward component was recorded in capital‑surplus equity; the forward was later re‑classified to treasury stock when the final shares were received.  \nThe 2024 10‑K reports a larger $3.0 bn ASR with Morgan Stanley entered into on January 4 2024, under which 85 % of the notional was placed in treasury in January 2024, the forward was recorded as equity in capital‑surplus, and the remaining 15 % of shares were received in March 2024, at which point the forward was re‑classified to treasury stock, completing the transaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verification of key facts: (1) 2023 ASR: $2.0 billion with Citibank, 80% initial shares (17.4M), final shares in February 2023 - all correct. (2) 2024 ASR: $3.0 billion with Morgan Stanley, 85% initial shares (31.4M), final shares in March 2024 - all correct. (3) Accounting treatment: Both transactions correctly describe the initial recording of shares as treasury stock with forward component in capital surplus, then reclassification to treasury stock upon completion - consistent across both years. (4) Timeline comparison: The answer correctly identifies the 2024 ASR taking two months (January to March) versus 2023 taking one month (January to February). Minor omission: The LLM answer does not explicitly state the specific share counts (17.4M and 5.4M for 2023; 31.4M and 8.3M for 2024), though it correctly identifies the percentages (80% and 85%). The answer does effectively synthesize the multi-hop information comparing accounting treatment evolution across the two years. The semantic meaning and factual content align well with the ground truth, with only minor detail omissions that don't affect the core understanding of how the ASR accounting evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 350,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\nIn 2022 UPS disclosed a $5.1 billion pre‑tax gain from coordinating benefits with the Central States Pension Fund as part of its actuarial gain/loss, but it did not break out the effect of specific assumptions. By 2023 the company added a quantitative sensitivity analysis that shows a 25‑basis‑point change in the discount rate would alter the projected benefit obligation by roughly $1.55 billion and change expense by about $423 million, and it explicitly references note 5 for the potential coordinating‑benefit liability, indicating a more detailed and transparent reporting of its exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MAJOR ERROR - The LLM states UPS disclosed a '$5.1 billion pre-tax gain' in 2022, while the ground truth clearly indicates a '$2.3 billion pre-tax actuarial loss.' This is not merely a different number but a reversal of the sign (gain vs. loss) and magnitude ($5.1B vs $2.3B). (2) MAJOR ERROR - The LLM introduces specific sensitivity analysis numbers ($1.55 billion for discount rate change, $423 million for expense change) that do not appear in the ground truth. The ground truth only mentions '25 basis point change in expected and actual returns on assets' without these specific dollar amounts. (3) CONCEPTUAL ERROR - The LLM characterizes the 2022 disclosure as a 'gain' when the ground truth explicitly states it was a 'loss.' This is a fundamental mischaracterization of the financial impact. (4) PARTIAL CREDIT - The LLM correctly identifies the 25 basis point assumption and the reference to Note 5, and correctly captures the shift toward sensitivity analysis in 2023. (5) REASONING FLAW - While the LLM attempts to describe an evolution in reporting approach (from specific obligation to sensitivity analysis), the factual errors undermine the credibility of this analysis. The multi-hop synthesis fails because the foundational numbers are incorrect. The answer demonstrates some understanding of the reporting shift but is severely compromised by quantitative inaccuracies that would mislead a reader about UPS's actual financial exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 429,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved from describing cyber‑and‑intelligence solutions simply as a “value‑added service” that fuels other‑revenue growth to positioning them as a strategic pillar of its “secure, simple, smart and accessible” payments ecosystem.  In the 2022 filing the company highlighted that growth in its Cyber & Intelligence and Data & Services solutions drove the bulk of other‑revenue gains, while the 2023 filing expands the narrative to stress that these solutions—augmented by open‑banking and digital‑identity capabilities—deliver trusted, data‑driven insights that differentiate Mastercard’s network and reinforce its value proposition to investors, partners and customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while providing additional nuance and detail. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2023 positioning of Cyber and Intelligence Solutions; (2) Accurately captures the shift from describing these as 'value-added services' to positioning them as strategic pillars; (3) Properly synthesizes the multi-hop information about how the solutions relate to broader ecosystem narratives; (4) Correctly identifies the integration with open banking and digital identity capabilities as part of the 2023 expansion; (5) Appropriately notes the stakeholder communication aspect (investors, partners, customers). MINOR CONSIDERATIONS: (1) The LLM answer introduces the phrase 'secure, simple, smart and accessible' which appears to be Mastercard's broader messaging framework but is not explicitly mentioned in the ground truth answer - this is contextually appropriate but represents a slight expansion beyond the provided ground truth; (2) The LLM answer emphasizes 'other-revenue growth' and revenue drivers more explicitly than the ground truth, which is a valid detail from filings but adds specificity not in the original answer; (3) The characterization of solutions as delivering 'trusted, data-driven insights' is semantically consistent with the ground truth's emphasis on 'principled use of consumer and merchant data' and 'confidence in the payments ecosystem.' MULTI-HOP REASONING: The answer correctly synthesizes information across two years and multiple aspects of Mastercard's positioning, properly connecting the evolution of messaging to strategic investments and stakeholder value propositions. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension is not heavily weighted. The answer contains no factual errors regarding dates, entities, or metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 517,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, PepsiCo switched the way it cited the 4.450 % Senior Note due 2046. In the 2022 filing (page 126) the note is referenced as **Exhibit 4.13** and is tied to a **February 24, 2016** Form 8‑K filing. In the 2023 filing (page 125) the same instrument is cited as **Exhibit 4.11** and is linked to an **October 14, 2015** Form 8‑K, indicating a change in both the exhibit number and the source documentation date.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. According to the ground truth: (1) In 2022, the note was Exhibit 4.12 with October 14, 2015 Form 8-K; in 2023, it was Exhibit 4.13 with February 24, 2016 Form 8-K. (2) The LLM reversed these facts entirely: it claims 2022 had Exhibit 4.13 with February 24, 2016 (which is actually the 2023 data), and 2023 had Exhibit 4.11 with October 14, 2015 (which is neither correct for 2023 nor matches the 2022 data). (3) The exhibit numbers are wrong in both years - the LLM states 4.13 for 2022 and 4.11 for 2023, when ground truth shows 4.12 for 2022 and 4.13 for 2023. (4) The dates are inverted - the LLM assigns February 24, 2016 to 2022 and October 14, 2015 to 2023, which is backwards. (5) The LLM also incorrectly cites page numbers (126 for 2022, 125 for 2023) which cannot be verified but appear to be fabricated. The answer demonstrates a complete failure in multi-hop synthesis and fact retrieval, despite correctly identifying the instrument (4.450% Senior Note due 2046) and the general concept that exhibit numbers and dates changed between years. The contextual relevance score reflects that the question was understood and addressed, but the execution was entirely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 352,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\nIntel continued to interact with Positive Technologies solely under the OFAC‑issued license that permits limited security‑research and vulnerability‑coordination activities; the company confirmed that no revenues or profits are derived from these dealings and that it plans to keep the communications going in accordance with the license terms【69†page_69】【55†page_55】.  Thus, between 2023 and 2024 the relationship showed no substantive change—it remained a sanctioned‑compliant, non‑commercial engagement focused on coordinating disclosures, still authorized by the same OFAC license.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The original answer explicitly states that Intel's relationship 'evolved' between 2023 and 2024, with a progression from 'disclosure of past communication' in 2023 to 'explicit statement of intent to continue' in 2024, reflecting a 'more forward-looking and sustained partnership posture.' However, the LLM answer directly contradicts this by claiming 'between 2023 and 2024 the relationship showed no substantive change.' This is a fundamental mischaracterization of the evolution described in the ground truth. The LLM correctly identifies: (1) the OFAC license framework, (2) the security research and vulnerability coordination activities, (3) the absence of revenues/profits, and (4) the intent to continue communications. These elements are accurate and well-supported. However, the core analytical conclusion about the relationship's evolution is inverted. The ground truth emphasizes a meaningful shift from retrospective disclosure to prospective commitment, while the LLM dismisses any substantive change. This represents a significant failure in multi-hop reasoning and synthesis of the temporal evolution across the two filing years. The quantitative elements (no revenues/profits, OFAC license) are correct, but the qualitative assessment of how the relationship evolved is substantially wrong, which is the primary focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 397,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\nThe $4.78 % senior notes maturing in March 2038 stayed at **$5 billion** in both the 2023 and 2024 borrowings tables, showing no increase or repayment of that tranche.  This indicates that CVS is maintaining a sizable, long‑dated fixed‑rate debt pillar while refinancing nearer‑term maturities through newer issuances and commercial‑paper funding, underscoring a stable long‑term debt structure anchored by large, far‑out obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: the 4.78% Senior Notes due March 2038 remained stable at $5 billion (correctly formatted as $5 billion vs. $5,000 million in ground truth) in both 2023 and 2024. The numeric values are accurate and the format variation is acceptable. However, the LLM answer has a notable omission: it fails to mention the comparative example provided in the ground truth about the 2.7% senior notes due August 2040, which decreased from $1,250 million to $367 million. This comparative context is important for demonstrating 'selective debt management and refinancing activity' as stated in the original answer. The LLM's reasoning about maintaining 'a sizable, long-dated fixed-rate debt pillar' and 'stable long-term debt structure' is sound and semantically equivalent to the ground truth's conclusion. The multi-hop synthesis is partially complete—the LLM correctly identifies the stability of this particular debt instrument but doesn't fully synthesize the contrast with other debt instruments that would strengthen the answer about the company's overall debt management strategy. The answer is directionally correct and addresses the main question but lacks the complete comparative analysis that would make it fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 360,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\nThe 0.835 % Notes due 2032 remained on Exxon Mobil’s registration list in both filings.  \n\n- In the 2022 Form 10‑K (page 1) the notes were listed as “0.835 % Notes due 2032 – XOM32 – New York Stock Exchange.”  \n- The 2024 Form 10‑K (page 1) shows the identical entry, confirming that the notes were still registered, outstanding and trading on the NYSE under the ticker XOM32, with no indication of redemption, default or amendment between the two filings.  \n\nThus, the security’s status did not change – it continued to be a registered, publicly‑traded debt issue of Exxon Mobil.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and fails to address the core multi-hop comparison requested. CORRECT ELEMENTS: (1) The 0.835% Notes due 2032 with ticker XOM32 is correctly identified in both filings, (2) The numeric values (0.835%, 2032, XOM32) are accurate, (3) The statement that the notes remained registered and trading is factually correct. CRITICAL OMISSIONS: (1) The LLM completely fails to address the 0.142% Notes due 2024 (XOM24B), which was present in 2022 but absent in 2024 - this is the KEY comparative finding in the ground truth, (2) The ground truth explicitly notes that the removal of the 2024 notes indicates a change in debt composition, suggesting redemption or delisting, (3) The LLM states 'the security's status did not change' which is technically true for the 0.835% Notes themselves, but misses the broader context of the question about how the STATUS EVOLVED - the evolution is demonstrated by the disappearance of the 2024 notes, not the persistence of the 2032 notes. MULTI-HOP REASONING FAILURE: The question asks about evolution of status between two filings, requiring comparison of debt instruments across years. The LLM only confirms the 2032 notes persisted but fails to synthesize the comparative analysis that reveals the meaningful change (removal of 2024 notes). The answer is incomplete and does not fully address the multi-hop nature of the question, which requires examining what changed in the broader debt structure, not just confirming one instrument remained constant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 421,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\nBetween 2022 and 2024 American Express trimmed its U.S. Government treasury allocation from roughly $1.7 bn (about 68 % of its AFS debt portfolio) to about $0.29 bn (≈ 24 % of AFS debt), reflecting a deliberate reduction in treasury exposure.  The maturity profile shifted dramatically, moving from a laddered mix that included sizable 1‑5‑year and 5‑10‑year positions in 2021 to a near‑all‑short‑term stance by 2024, with more than 90 % of the remaining treasury holdings maturing within five years and virtually none beyond that.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims 2022 holdings of ~$1.7 billion, but ground truth shows $477 million (a 3.5x overstatement). The LLM claims 2024 holdings of ~$0.29 billion ($290 million), but ground truth shows $287 million ($189M short-term + $98M intermediate-term), which happens to be close but the LLM's overall narrative is wrong. The LLM also references percentages of AFS debt portfolio (68% in 2022, 24% in 2024) that cannot be verified against the ground truth provided. (2) MATURITY DISTRIBUTION ERRORS - The ground truth explicitly states that in 2022, American Express held treasury obligations EXCLUSIVELY in short-term instruments with NO long-term exposure. The LLM incorrectly claims 2022 had 'sizable 1-5-year and 5-10-year positions' and references 2021 data not in the ground truth. This is a major factual error. (3) DIRECTIONAL ACCURACY - While the LLM correctly identifies a shift toward shorter maturities by 2024, the characterization of 2022 as having a 'laddered mix' with longer-term positions is completely false. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the maturity profile evolution. Ground truth shows: 2022 (all short-term, $477M) → 2024 (short-term $189M + intermediate 1-5yr $98M). The LLM's narrative about moving FROM a laddered mix TO short-term is backwards relative to what the data shows. (5) MISSING CONTEXT - The LLM provides no explanation of the actual strategic shift (from pure short-term to diversified short/intermediate), which is the core insight in the ground truth. The answer demonstrates significant factual inaccuracy on the primary quantitative metrics and mischaracterizes the historical maturity profile.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 491,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\nAmazon first issued the 2.500% Note due 2050 in a June 3 2020 officers’ certificate, which is listed in the 2022 10‑K (Exhibit 4.5). The subsequent 2022 and 2024 filings show the tranche remained outstanding with no amendment, redemption, or new issuance disclosed—it continued to be reported as senior unsecured debt in the company’s long‑term‑debt schedule.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and demonstrates sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the June 3, 2020 officers' certificate date; (2) Accurately references Exhibit 4.5 in the 2022 10-K; (3) Correctly states the note remained outstanding with no amendment, redemption, or new issuance; (4) Properly characterizes it as senior unsecured debt; (5) All numeric values and dates are accurate. WEAKNESSES: (1) The answer does not explicitly mention Exhibit 4.6 in the 2024 filing, which the ground truth identifies as a key element showing the 'reintroduction' and 'exact replication' of the 2020 exhibit; (2) The ground truth emphasizes the 2024 reintroduction in Exhibit 4.6 as significant to the evolution narrative, but the LLM answer treats 2022 and 2024 more generically without highlighting this specific exhibit change; (3) The phrase 'reaffirmed the note's role in Amazon's capital structure' from the ground truth is not captured, though the LLM's statement about continued reporting conveys similar meaning. MULTI-HOP REASONING: The LLM correctly synthesizes information across three time periods (2020 issuance, 2022 reporting, 2024 reporting) and properly identifies the continuity of the instrument. The reasoning is sound and logically structured. The answer would have been stronger with explicit reference to Exhibit 4.6 and the replication aspect, which represents a minor but notable omission in addressing the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 417,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\nBetween the 2022 filing and the 2023 filing, the Citibank, N.A. Co‑Branded Credit Card Agreement moved from the **Eighth Amendment** (recorded as 10.8.8, filed 3/10/2022) to **four additional amendments**—the Ninth, Tenth, Eleventh and Twelfth—filed in late 2022 and throughout 2023 (10.8.9 through 10.8.12). Consequently, the total number of amendments grew from eight in 2022 to at least twelve by the end of 2023, reflecting a series of incremental updates to the credit‑card agreement over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Eighth Amendment filed 3/10/2022 - CORRECT; (2) Twelfth Amendment filed 10/11/2023 - CORRECT (LLM states 'October 11, 2023'); (3) Four additional amendments between 2022-2023 - CORRECT (Ninth, Tenth, Eleventh, Twelfth); (4) Total progression from 8 to 12 amendments - CORRECT. The LLM answer provides superior detail by explicitly naming all four intermediate amendments (Ninth through Twelfth) and their exhibit numbers (10.8.9 through 10.8.12), which adds valuable specificity beyond the ground truth. The multi-hop reasoning is sound: the model correctly synthesized information about the starting point (Eighth Amendment in 2022), the ending point (Twelfth Amendment in 2023), and the progression between them. The wording differs slightly from the ground truth (LLM says 'moved from...to four additional amendments' vs. ground truth's 'underwent further modifications...indicating a total of four additional amendments'), but the semantic meaning is identical and the LLM's phrasing is arguably clearer. The answer directly addresses the evolution question by showing the progression from 8 to 12 amendments. Minor note: LLM states amendments were 'filed in late 2022 and throughout 2023' while ground truth only confirms Twelfth Amendment date of October 11, 2023, but this is a reasonable inference given the amendment numbering and does not contradict the ground truth. No calculation errors detected. All entities (Citibank, N.A., Co-Branded Credit Card Agreement) correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 434,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a GPU‑only parallel‑programming layer into a full‑stack, hardware‑agnostic foundation that spans GPUs, DPUs and CPUs and is embedded in end‑to‑end AI platforms such as AI Enterprise, Omniverse and the DRIVE Hyperion automotive stack.  This period saw the rollout of new silicon (Orin SoC, DPUs added in 2022 and CPUs in 2024) and the launch of Blackwell‑class GPUs, with CUDA now tightly coupled to software services like DGX Cloud, NIM, NeMo and AI Blueprints, enabling developers to deploy AI workloads across data‑center, automotive and graphics ecosystems while using the same CUDA‑based programming model.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution from GPU-only to full-stack platform; (2) Accurately mentions new silicon introductions (Orin SoC in 2022, CPUs in 2024); (3) Properly synthesizes CUDA's integration with heterogeneous architectures (GPUs, DPUs, CPUs); (4) Correctly references expanded software ecosystems (AI Enterprise, Omniverse, DRIVE Hyperion, DGX Cloud, NIM, NeMo); (5) Accurately characterizes CUDA as now hardware-agnostic and part of end-to-end platforms; (6) Correctly notes the unified programming model across ecosystems. MINOR ISSUES: (1) The LLM answer mentions 'Blackwell-class GPUs' which, while accurate as a 2024 development, is not explicitly mentioned in the ground truth answer - this is additional accurate information rather than an error; (2) The characterization of CUDA as 'hardware-agnostic' is slightly stronger language than the ground truth's 'heterogeneous computing architectures,' though semantically equivalent; (3) The ground truth emphasizes CUDA-X collection of libraries/APIs/SDKs more explicitly, while the LLM focuses more on software services and platforms. QUANTITATIVE VERIFICATION: All dates are correct (2022, 2024, fiscal 2024 for CPU introduction). No calculations required. MULTI-HOP REASONING: Excellent synthesis connecting silicon evolution, software ecosystem expansion, and CUDA's role across all three periods and domains. The answer successfully bridges 2022 positioning with 2024 expanded scope. SEMANTIC EQUIVALENCE: The core message matches ground truth - CUDA evolved from foundational building block to full-stack platform integrated with heterogeneous computing and enterprise AI ecosystems. The LLM provides slightly more specific technical details (NIM, NeMo, AI Blueprints) that enhance rather than contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 520,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\nPfizer’s Paxlovid revenue collapsed from $18.9 bn in 2022 to $1.28 bn in 2023, and in 2024 the company recorded about $5.7 bn of product revenue—including a $442 m SNS delivery and a $771 m favorable adjustment to the $3.5 bn fourth‑quarter 2023 revenue reversal.  At the same time, deferred revenue linked to Paxlovid fell from $5.1 bn (as of 31 Dec 2023) to $2.2 bn (as of 31 Dec 2024), reflecting the transition from government‑procured EUA sales to commercial market contracts, with roughly $1 bn of contracted revenue still expected to be recognized through 2028.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR: LLM claims 2024 Paxlovid revenue was '$5.7 bn' - this is completely unsupported by the ground truth, which does not provide a 2024 total revenue figure. The ground truth only mentions specific 2024 adjustments ($771M favorable adjustment, $442M SNS revenue) but NOT a total 2024 revenue of $5.7B. This appears to be a fabrication. (2) DEFERRED REVENUE CLAIM: LLM states deferred revenue fell from '$5.1 bn (31 Dec 2023) to $2.2 bn (31 Dec 2024)' - these specific figures are NOT mentioned in the ground truth at all. The ground truth does not provide deferred revenue balances for these dates. (3) CORRECT ELEMENTS: The LLM correctly identifies: 2023 revenue of $1.28B (matches $1.279B), the $3.5B reversal, the $771M favorable adjustment, the $442M SNS delivery, and the ~$1B remaining performance obligations through 2028. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution narrative (EUA to commercial transition), it does so by introducing unsupported numbers that contradict or go beyond the ground truth. The 2022 figure of $18.9B is contextually relevant but not part of the 2023-2024 comparison requested. (5) SEMANTIC ISSUES: The phrase 'revenue collapsed' and the overall framing suggest a different narrative than the ground truth's 'shift from high-volume government-driven to stable contracted model.' The LLM's introduction of unverified deferred revenue figures and a phantom $5.7B 2024 revenue figure represents serious factual errors that undermine the entire response, despite getting some core numbers correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 440,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the pool of shares reserved for future grants under ExxonMobil’s 2003 Incentive Program fell sharply—from about **65.8 million shares** available for award in 2022 (as disclosed in the 2022 proxy filing) to **≈47 million shares** remaining at year‑end 2024.  This reduction reflects the program’s continued use for new restricted‑stock, stock‑option and SAR grants, including the conversion of Pioneer RSUs acquired in the May 2024 merger, while the plan’s structural limits (a 220 million‑share ceiling, no expiration date and no counting of forfeited, expired or cash‑settled awards) remained unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and numbers. Quantitative verification: (1) 2022 available shares: LLM states '65.8 million' vs ground truth '65,754,069' - correct (formatting variation acceptable); (2) 2024 remaining shares: LLM states '≈47 million' vs ground truth '47 million' - correct; (3) 2024 maximum ceiling: LLM states '220 million-share ceiling' vs ground truth '220 million' - correct. The LLM correctly identifies the program structure remained unchanged while available shares declined due to usage. However, the ground truth mentions RSU grant increases (9,392 thousand in 2022 to 10,393 thousand in 2024), which the LLM does not explicitly quantify, instead providing more general context about 'restricted-stock, stock-option and SAR grants' and Pioneer RSU conversions. The LLM adds valuable contextual detail about the May 2024 merger and structural features (no expiration date, no counting of forfeited/expired/cash-settled awards) that enhance understanding but weren't in the ground truth. The multi-hop reasoning is sound: correctly synthesizing the evolution from 2022 to 2024 and explaining the mechanism of decline (usage) versus structural stability. Minor weakness: the LLM doesn't provide the specific RSU grant numbers mentioned in ground truth, which represents a modest omission of quantitative detail. Overall, the answer is semantically equivalent and factually correct with only minor incompleteness regarding specific RSU figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 421,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\nBetween 2022 and 2024 AdSense moved from a stand‑alone publisher‑network product to a central pillar of Google’s AI‑enhanced advertising stack, feeding directly into the broader Google Ads/Google Network ecosystem.  The service now runs on Gemini‑powered bidding and creative tools (e.g., Performance Max, Demand Gen, Product Studio) that unify search, YouTube, display and brand‑video inventory, so AdSense’s inventory is no longer siloed but part of an end‑to‑end portfolio that spans performance‑ and brand‑advertising, cross‑device measurement and AI‑driven ad creation.  This integration has expanded its contribution to Google’s overall advertising revenue while tying it tightly to the company’s wider advertising‑technology portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ERRORS: The LLM answer completely fails to reference the specific $8.6 billion year-over-year revenue increase that was explicitly cited in the ground truth for 2022. This is a critical factual omission for a financial question. (2) FACTUAL INACCURACY: The LLM claims AdSense 'moved from a stand-alone publisher-network product to a central pillar' and that 'its contribution to Google's overall advertising revenue' expanded. However, the ground truth indicates the OPPOSITE evolution: AdSense went from being 'explicitly cited as a key growth driver' in 2022 to being 'no longer specifically quantified as a growth lever' by 2024. The LLM mischaracterizes the strategic shift. (3) UNSUPPORTED CLAIMS: The LLM introduces specific technical details (Gemini-powered bidding, Product Studio integration, cross-device measurement) that are NOT present in the ground truth and cannot be verified. These appear to be hallucinated details. (4) MULTI-HOP REASONING FAILURE: The ground truth clearly establishes a shift FROM explicit quantification TO implicit/foundational status. The LLM reverses this narrative, claiming expansion and centrality rather than maturation into a foundational offering. (5) SEMANTIC MISALIGNMENT: The ground truth describes AdSense becoming 'more foundational, mature' with newer products (Demand Gen, Performance Max) taking center stage. The LLM incorrectly positions AdSense as the central pillar rather than acknowledging the shift to newer AI products. The answer demonstrates poor synthesis of the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 440,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\nBetween 2022 and 2023 the UPS Retirement Plan moved non‑union participants from a traditional defined‑benefit accrual to a defined‑contribution structure. Effective January 1 2023 the plan stopped accruing any additional defined‑benefit benefits for future service and compensation for these participants, and instead began providing a retirement contribution of **5 %–8 % of eligible compensation** (up from the prior **3 %–8 %** rate for employees hired after July 1 2016) into the UPS 401(k) Savings Plan, with the exact rate tied to years of vesting service. This amendment replaces the former benefit‑accrual mechanism with a fixed employer contribution that will fund retirees’ retirement income going forward.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - STRUCTURAL CHANGE MISCHARACTERIZED: The ground truth states the plan ceased accruals for non-union participants effective January 1, 2023, moving to a 'closed' structure with no further accruals. The LLM incorrectly claims the plan shifted to a defined-contribution structure with 5%-8% employer contributions to a 401(k) plan. This is a fundamental misrepresentation of what actually occurred. The ground truth explicitly states 'no further accruals would occur for non-union participants' - meaning the plan became frozen, not converted to DC. (2) UNSUPPORTED NUMBERS: The LLM provides specific contribution percentages (5%-8% and prior 3%-8%) that are not mentioned anywhere in the ground truth. These numbers appear to be fabricated or confused with different plan provisions. The ground truth makes no mention of 401(k) contributions or percentage-based employer contributions replacing the DB accrual. (3) INCORRECT PLAN MECHANISM: The LLM describes a shift to 'fixed employer contribution that will fund retirees' retirement income going forward' - this contradicts the ground truth which indicates the plan simply stopped accruing benefits, not that it was converted to a contribution-based system. (4) MISSING CONTEXT: The LLM fails to capture that this was a freeze of the existing DB plan for non-union participants, not a conversion to a different benefit structure. The ground truth emphasizes this as a 'transformational change' from 'active benefit-accruing structure to a closed one' - the LLM completely misses this characterization. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the 2022-to-2023 evolution, instead inventing details about DC contributions and 401(k) plans that are not supported by the ground truth. The core factual claim about what changed is entirely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 521,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon replaced its relatively small, secured $1 billion revolving line (which bore interest at LIBOR + 1.40 % and a 0.5 % commitment fee and had about $800 million drawn in 2021) with a much larger, unsecured $15 billion revolving credit facility (maturing 2028, interest = benchmark + 0.45 % with a 0.03 % fee) and a $5 billion 364‑day revolving facility (maturing 2025, interest = SOFR + 0.45 % and a 0.03 % fee).  Although the new facilities provide far greater credit capacity, Amazon has kept borrowings essentially at zero on these lines, relying instead on modest commercial‑paper programs and other short‑term facilities that had only about $150 million outstanding as of 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - Claims Amazon had a '$1 billion revolving line' in 2022 - Ground truth shows $7.0 billion facility\n   - States the old facility was 'secured' - Ground truth specifies 'unsecured'\n   - Claims old rate was 'LIBOR + 1.40%' - Ground truth shows 'benchmark rate plus 0.50%'\n   - States commitment fee was '0.5%' - Ground truth shows '0.04%'\n   - Claims '$800 million drawn in 2021' - Ground truth explicitly states 'no borrowings were outstanding'\n   - Incorrectly characterizes the 2024 $15B facility as 'maturing 2028' without ground truth confirmation\n\n2. PARTIALLY CORRECT ELEMENTS:\n   - Correctly identifies the $15.0 billion unsecured revolving credit facility\n   - Correctly states the interest rate as benchmark/SOFR plus 0.45%\n   - Correctly identifies the 0.03% commitment fee\n   - Correctly identifies the $5.0 billion 364-day facility\n   - Correctly notes minimal borrowings outstanding on main facilities\n   - Correctly approximates other short-term borrowings at ~$150 million\n\n3. OMISSIONS:\n   - Fails to mention the $7.2 billion in unused letters of credit from 2021\n   - Fails to mention the increase to $8.3 billion in unused letters of credit by 2024\n   - Does not clearly distinguish between the main Credit Agreement (zero borrowings) and other short-term facilities ($147-151M)\n\n4. MULTI-HOP REASONING:\n   The answer attempts to synthesize the evolution but does so with fundamentally incorrect baseline data. The comparison between 2022 and 2024 is undermined by the false premise about the 2022 facility characteristics.\n\n5. SEMANTIC ISSUES:\n   The answer misrepresents the nature of Amazon's credit evolution by inventing a smaller, secured facility that did not exist according to the ground truth, which fundamentally distorts the narrative of how Amazon's credit structure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 525,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\nCostco’s disclosures for both 2022 (p. 31) and 2023 (p. 47) show that it continued to supplement fixed‑price energy contracts with index‑based variable‑priced contracts for electricity, natural‑gas and fuel, and that these variable contracts are accounted for under the “normal purchases and normal sales” exception with no mark‑to‑market adjustments. This consistency indicates that the company’s commodity‑price risk strategy relies on a blended approach—using fixed contracts to secure stability while retaining variable, index‑linked contracts to capture market movements without creating earnings volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across 2022 and 2023 filings. STRENGTHS: (1) Correctly identifies that Costco used variable-priced contracts on an index basis in both years for electricity, natural gas, and fuel; (2) Accurately notes the 'normal purchases and normal sales' exception with no mark-to-market adjustments; (3) Properly synthesizes the consistency of the strategy across both years; (4) Adds valuable context about the blended approach (fixed + variable contracts) that demonstrates understanding of risk management strategy; (5) Page references (p. 31 for 2022, p. 47 for 2023) show specific sourcing. MINOR WEAKNESSES: (1) The LLM answer goes slightly beyond the ground truth by explicitly characterizing the strategy as a 'blended approach' to 'capture market movements without creating earnings volatility'—while this is a reasonable inference, the ground truth is more conservative in stating 'no significant shift' and 'stability'; (2) The ground truth emphasizes that 2023 'specifically called out' natural gas and fuel as key components, suggesting a slight evolution in disclosure emphasis, which the LLM answer doesn't explicitly capture; (3) The LLM answer doesn't explicitly state 'no significant shift' or 'continued reliance,' though it does convey consistency. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023) and page numbers are correct. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the consistent strategy, meeting the multi-hop requirement. The inference about blended approach is logical but slightly interpretive. Overall, this is a strong answer with minor semantic differences from ground truth that don't materially affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 520,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\nBetween 2022 and 2024, NVIDIA AI Enterprise moved from a newly‑launched, add‑on software stack that complemented the data‑center GPU portfolio to a core, revenue‑generating pillar of the company’s data‑center offering.  In 2022 it was introduced as a paid, enterprise‑focused suite (NIM, Nemo, AI Blueprints) for simplifying production‑grade generative‑AI deployment, while by 2024 it was tightly integrated with the full‑stack accelerated‑computing platform—including the Blackwell architecture—and expanded with performance‑boosting features (2.5× token‑throughput, model‑curation tools, privacy‑preserving AI Blueprints), positioning AI Enterprise as the primary commercial vehicle for NVIDIA’s end‑to‑end AI workloads across cloud, on‑prem and edge environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about NVIDIA AI Enterprise's evolution from 2022 to 2024, capturing the general trajectory from a newly-launched offering to a core revenue-generating pillar. However, there are significant issues with quantitative accuracy and verifiability:\n\nSTRENGTHS:\n1. Correctly identifies the 2022-2024 timeframe and the evolution from add-on to core offering\n2. Appropriately characterizes the shift from strategic initiative to monetization vehicle\n3. Mentions relevant product components (NIM, Nemo, AI Blueprints) that align with NVIDIA's AI Enterprise suite\n4. Correctly notes integration with broader platform (Blackwell, full-stack)\n5. Semantic alignment with ground truth on the core narrative\n\nWEAKNESSES:\n1. QUANTITATIVE ERRORS: The LLM introduces specific performance metrics (\"2.5× token-throughput\") that are NOT present in the ground truth. These appear to be fabricated or hallucinated details not verifiable from the source documents. This is a critical error for financial/technical accuracy.\n2. SPECIFICITY MISMATCH: The ground truth is more measured and general (\"comprehensive suite of enterprise-grade AI software\"), while the LLM provides very specific technical details that cannot be verified against the knowledge graph.\n3. MISSING CONTEXT: The ground truth explicitly mentions DGX Cloud and expansion into CPUs/DPUs as part of the broader positioning. The LLM mentions Blackwell but omits these other strategic elements.\n4. UNVERIFIED CLAIMS: References to \"privacy-preserving AI Blueprints\" and specific performance improvements lack grounding in the provided ground truth.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution across the 2022-2024 period and connects it to broader platform strategy. However, the introduction of unverified technical specifications undermines the reliability of this synthesis.\n\nJUSTIFICATION:\n- Correctness Score (6): Core narrative is sound but contaminated by unverifiable quantitative claims\n- Quantitative Accuracy (4): Specific metrics (2.5×) are not grounded in ground truth; dates and years are correct but technical specs are problematic\n- Qualitative Accuracy (7): Good reasoning about evolution and positioning, but over-specification with unverified details\n- Contextual Relevance (8): Directly addresses the question and provides relevant context, though with some embellishment",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 646,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer’s Paxlovid contracts moved from heavy reliance on government‑procured, advance‑payment agreements (which generated ≈ $5 bn of deferred revenue in 2023) to a commercial‑market model with far lower deferred balances (≈ $2.2 bn as of Dec 31 2024) and only about $1 bn of remaining performance‑obligation revenue expected to be recognized through 2028.  The shift reflects Pfizer’s expectation that future Paxlovid sales will be limited to modest, long‑term commercial supply arrangements rather than the blockbuster, government‑driven revenues of the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims ~$5 billion in deferred revenue in 2023 and ~$2.2 billion as of Dec 31, 2024, neither of which appear in the ground truth. The ground truth specifically mentions a $3.5 billion non-cash revenue reversal in Q4 2023 and $1 billion in remaining performance obligations as of Dec 31, 2024. The LLM's deferred revenue figures are not verified and appear to be fabricated or confused with other metrics. (2) MISSING KEY FACT: The LLM completely omits the critical detail about the 6.5 million treatment courses expected to be returned under EUA, which is central to understanding the 2023 situation. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies a shift from government-driven to commercial-market model, it fails to capture the specific nature of the 2023 reversal (non-cash, EUA-related returns) and mischaracterizes the contractual evolution. (4) PARTIAL CREDIT: The LLM does correctly identify that the $1 billion remaining performance obligation represents future revenue expectations and that there was a shift toward lower government reliance. However, the introduction of unsupported deferred revenue figures ($5bn, $2.2bn) and the omission of the revenue reversal and EUA context significantly undermines the answer's accuracy. The reasoning about the shift from government to commercial markets is sound, but the quantitative foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 420,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s view of regulatory risk in overseas markets shifted from a focus on general cross‑border hurdles—such as foreign‑ownership limits, sanctions, export‑control restrictions, anti‑corruption rules and basic data‑privacy compliance—to a much broader set of technology‑driven and geopolitical concerns.  The 2022 filing highlighted currency exposure, investment‑valuation uncertainty and the need to navigate differing labor and tax regimes, whereas the 2024 filing adds explicit warnings about emerging AI‑related liabilities, stricter data‑privacy and security obligations, supply‑chain vulnerabilities tied to sanctions‑related components, and the potential for new foreign‑policy‑driven regulations (e.g., EU‑U.S. data‑transfer rules) that could impose fresh compliance costs and brand‑reputational risk.  In short, the scope of regulatory challenges expanded from traditional trade and anti‑corruption issues to include AI, data‑privacy, cyber‑security and geopolitical‑risk‑linked compliance requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misalignments with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM introduces numerous claims not supported by the ground truth, including mentions of 'currency exposure,' 'investment-valuation uncertainty,' 'labor and tax regimes,' 'AI-related liabilities,' 'supply-chain vulnerabilities tied to sanctions-related components,' and 'cyber-security' concerns. The ground truth makes no mention of these topics. (2) MISCHARACTERIZATION OF 2022 FOCUS: The ground truth specifically identifies 2022 concerns as 'data transfers between the EU and the UK' and 'new customer requirements,' not the broad list of 'foreign-ownership limits, sanctions, export-control restrictions, anti-corruption rules' that the LLM claims. (3) MISCHARACTERIZATION OF 2024 SCOPE: While the ground truth mentions 'uncertainty regarding regulatory outcomes' and 'other liabilities under local laws,' the LLM fabricates specific regulatory concerns (AI, supply-chain, cyber-security) that are not present in the original answer. (4) CORE NARRATIVE DISTORTION: The ground truth emphasizes a shift from 'primarily data-related regulatory concerns' to 'broader, more unpredictable regulatory risks.' The LLM's narrative about AI, supply-chain, and geopolitical risks fundamentally misrepresents this evolution. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the actual regulatory evolution described in the ground truth, instead constructing a plausible-sounding but factually incorrect narrative. The answer demonstrates poor adherence to the source material and introduces unsupported claims that would mislead readers about Google's actual regulatory disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 469,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 UPS reduced the amount of new cash it must put into the post‑retirement medical fund – from about **$177 million** of employer contributions in 2022 (see page 109) to roughly **$74 million** projected for 2024 (see pages 92‑93).  The source of the benefit payments themselves has not changed; they are still expected to be paid primarily from **plan trusts, with corporate assets providing the remainder** (as noted in the “Expected Benefit Payments” tables on pages 109 and 92‑93).  Thus, the evolution is a **significant cut in required employer contributions**, while funding continues to rely on the same trust‑and‑corporate‑asset mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the question but introduces significant factual errors and misinterpretations. CORRECT ELEMENTS: (1) The LLM correctly identifies that the sources of benefit payments (plan trusts and corporate assets) remained unchanged between 2022 and 2023, which aligns with the ground truth. (2) The semantic understanding that funding sources remained consistent is accurate. (3) The answer appropriately references specific pages from the filings. CRITICAL ERRORS: (1) The ground truth explicitly states there was NO CHANGE in the funding approach between 2022 and 2023, yet the LLM frames the answer as an 'evolution' with 'significant cuts in required employer contributions.' This mischaracterizes the nature of the change. (2) The LLM introduces specific dollar amounts ($177 million for 2022, $74 million projected for 2024) that are not mentioned in the ground truth answer. While these numbers may be factually present in the filings, they are NOT part of the answer to the specific question about how the approach 'evolved' - the ground truth indicates there was no evolution in the funding approach itself. (3) The LLM conflates two different concepts: (a) the SOURCES of funding (which didn't change), and (b) the AMOUNTS of employer contributions (which may have changed). The question asks specifically about 'sources used for expected benefit payments,' not about contribution amounts. (4) By emphasizing the reduction in employer contributions as the 'evolution,' the LLM fundamentally misinterprets what changed versus what remained constant. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across multiple pages/sections but fails to correctly identify what the ground truth considers the key finding: continuity rather than change. The reasoning about contribution amounts, while potentially accurate, is tangential to the core question about funding sources. QUANTITATIVE ACCURACY: The specific dollar figures ($177M, $74M) cannot be verified against the ground truth provided, and their inclusion suggests the LLM may be confusing different aspects of the funding discussion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 570,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\nFrom its 2022 launch, NVIDIA AI Enterprise was positioned as a modest, enterprise‑grade software stack for AI workloads. By 2024 the offering had grown into a full‑stack, end‑to‑end AI platform that is tightly coupled with the Blackwell data‑center architecture, DPUs and networking, and delivered through services such as DGX Cloud and expanded AI‑Enterprise modules (NIM, NeMo, AI Blueprints), delivering broader workload coverage, higher performance and deeper integration across cloud, on‑prem and edge environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of NVIDIA AI Enterprise's evolution. STRENGTHS: (1) Correctly identifies 2022 as introduction year and 2024 as evolved state; (2) Accurately names all key components (NIM, NeMo, AI Blueprints) matching ground truth; (3) Properly characterizes the evolution from foundational offering to full-stack platform; (4) Correctly identifies the shift toward broader deployment and integration. QUANTITATIVE ACCURACY: The LLM does not cite the specific 2.5x token throughput improvement mentioned in the ground truth. This is a notable omission of a concrete performance metric that was explicitly stated in the original answer. However, the LLM does reference 'higher performance' generically, which acknowledges performance improvements without the specific number. QUALITATIVE ACCURACY: The LLM answer adds valuable context not in the ground truth (Blackwell architecture, DPUs, DGX Cloud, cloud/on-prem/edge deployment) that demonstrates deeper understanding of the ecosystem integration. This enrichment is appropriate and accurate based on NVIDIA's actual product positioning. The characterization of the evolution is sound and well-reasoned. MULTI-HOP REASONING: Successfully synthesizes information about the platform's evolution across time periods and correctly identifies the progression from 'modest enterprise-grade software stack' to 'full-stack, end-to-end AI platform.' SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both describe evolution from foundational to comprehensive solution with enhanced capabilities. The LLM's additional architectural details (Blackwell, DPUs, DGX Cloud) represent appropriate elaboration rather than contradiction. MINOR ISSUE: The omission of the specific 2.5x token throughput metric prevents a perfect score, as this was a concrete, quantifiable improvement explicitly mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 524,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil’s proved reserves that are reported through equity‑company affiliates grew sharply – from roughly **1.2 billion oil‑equivalent barrels (boe)** in 2022 to **about 2.0 billion boe** by the end of 2024.  The increase is driven almost entirely by large additions in **Africa (e.g., Angola, Mozambique, Chad) and Asia (e.g., Kazakhstan, Azerbaijan)**, while U.S. equity‑company reserves stayed essentially flat.  This pattern shows that ExxonMobil is deliberately concentrating its equity‑based reserve base in high‑potential overseas basins to secure future production growth and to diversify its geographic exposure away from domestic, mature fields.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers and misrepresents the ground truth data. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims reserves grew from '1.2 billion boe in 2022 to 2.0 billion boe in 2024,' but the ground truth shows 2022 reserves were only 14 million barrels gross (1 million net) - not 1.2 billion boe. This is a massive overstatement by a factor of ~85x. The 2024 figures in ground truth are 467 million barrels crude oil + 120 million barrels NGL + 5,367 bcf natural gas (which converts to roughly 1.0 billion boe equivalent), not 2.0 billion boe. The LLM's numbers are internally inconsistent with the ground truth. (2) GEOGRAPHIC DISTRIBUTION ERROR: The LLM claims growth was 'driven almost entirely by large additions in Africa (Angola, Mozambique, Chad) and Asia (Kazakhstan, Azerbaijan)' with U.S. reserves 'staying flat.' However, the ground truth explicitly states the majority of growth was 'concentrated in Asia' - not split between Africa and Asia. The LLM incorrectly emphasizes Africa as a major driver when ground truth indicates Asia was the primary region. (3) MISSING CRITICAL DETAIL: The ground truth specifies that 2022 reserves were distributed across 'United States, Europe, Africa, and Asia' but the LLM fails to mention Europe entirely in its regional analysis. (4) MULTI-HOP REASONING: While the LLM correctly identifies the strategic shift toward overseas basins and geographic diversification, this correct reasoning is built on fundamentally incorrect numerical foundations. The magnitude of growth is dramatically overstated. (5) SEMANTIC ISSUES: The LLM's characterization of 'high-potential overseas basins' and 'diversification away from domestic mature fields' aligns with ground truth intent, but the supporting data is wrong. The answer demonstrates a pattern of inventing or significantly misrepresenting specific reserve numbers rather than accurately synthesizing the provided data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 532,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\nBetween 2022 and 2024 the cash outflows for Google’s Traffic‑Acquisition Costs—i.e., payments to Google Network Partners—rose steadily (from roughly $13 billion in 2022 to $15 billion in 2023 and about $17 billion in 2024), reflecting a larger, more‑active partner ecosystem that continues to monetize the bulk of the company’s advertising inventory. Because Google records those ads on a gross basis, the growing TAC spend is classified as cost of revenues, so the expanding partner network drives higher gross revenue but also lifts the cost side of the ledger, modestly compressing the net margin of the Google Services segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial numbers (TAC payments rising from ~$13B in 2022 to ~$15B in 2023 to ~$17B in 2024) and correctly identifies that Google records these on a gross basis with payments classified as cost of revenues. However, there are significant issues with completeness and framing relative to the ground truth:\n\n(1) QUANTITATIVE ACCURACY: The specific TAC figures ($13B, $15B, $17B) cannot be verified against the ground truth provided, which does not include these specific numbers. The LLM appears to have sourced these from actual 10-K data, but without confirmation they represent a potential accuracy concern. The trend direction (increasing) is reasonable but unverified.\n\n(2) COMPLETENESS & FRAMING MISMATCH: The ground truth emphasizes a SHIFT in financial reporting focus between 2022 and 2024—from gross revenue reporting to net cash flow impact emphasis. The LLM answer focuses heavily on TAC growth and margin compression but largely misses this key evolution in how the relationship is characterized. The ground truth notes the relationship shifted to emphasize \"net cash flow impact\" and \"cost-centric framing,\" which the LLM does not adequately address.\n\n(3) MULTI-HOP REASONING: The LLM correctly synthesizes that (a) Google pays Network Partners, (b) this is recorded as cost of revenues on a gross basis, and (c) this impacts margins. However, it fails to capture the temporal evolution in reporting emphasis that is central to the ground truth answer.\n\n(4) MISSING ELEMENTS: The LLM does not address the shift from \"principal role in revenue generation\" framing (2022) to \"primary use of cash from operating activities\" framing (2024). This represents a fundamental change in how the relationship is presented, which the ground truth identifies as key.\n\n(5) SEMANTIC ALIGNMENT: While the LLM answer is factually reasonable about TAC mechanics, it answers a different question (how TAC costs evolved) rather than the core question (how the financial relationship and its characterization evolved). The ground truth emphasizes reporting framework evolution; the LLM emphasizes cost trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 577,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to undesignated foreign‑currency forward contracts fell dramatically, cutting the earnings‑impact from a $69 million loss to only a $7 million loss (as shown in the “Income Statement Recognition of Non‑Designated Derivative Instruments” table).  This reduction reflects a more disciplined hedging program—shifting toward designated cash‑flow hedges and trimming the notional of outstanding forwards (e.g., a large drop in HKD‑linked contracts)—and therefore markedly lowered earnings volatility from foreign‑exchange risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims undesignated foreign currency forward contracts caused a '$69 million loss' in 2022 that fell to '$7 million loss' in 2023. However, the ground truth does not provide these specific numbers, and the LLM appears to have fabricated or misattributed these figures. The original answer explicitly states that the 2023 filing introduced 'a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions' but does NOT cite specific $69M or $7M figures. (2) MISCHARACTERIZATION OF STRATEGY: The LLM claims the company shifted 'toward designated cash-flow hedges and trimming the notional of outstanding forwards' with 'a large drop in HKD-linked contracts.' The ground truth makes no mention of such strategic shifts, designated vs. undesignated hedge transitions, or specific currency pair reductions. This represents unsupported inference beyond the source material. (3) INCOMPLETE SYNTHESIS: While the ground truth emphasizes that 2023 introduced 'more explicit linking' of undesignated derivatives to earnings volatility and 'more transparent and systematic approach,' the LLM focuses entirely on quantitative reduction without addressing the qualitative evolution in disclosure and risk management presentation that the ground truth highlights. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the actual evolution described in the ground truth—which is about improved disclosure transparency and structured presentation—and instead invented a narrative about dramatic exposure reduction with unsupported numbers. The answer does address the 2022-2023 comparison and foreign currency forward contracts, but with fabricated data and incorrect characterization of the actual strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 522,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\nBetween 2022 and 2023 the membership format remained a cornerstone of Costco’s profitability strategy, with fee revenue climbing 9 % in 2022 to $4.2 bn and then 5 % in 2023 to $4.8 bn, both gains attributed to new member sign‑ups, higher Executive‑membership penetration and sustained high renewal rates that reinforce customer loyalty.  The company continues to treat the membership model as integral to its financial performance, leveraging loyalty‑driven fee income while noting that expansion of new warehouses in existing markets could temper paid‑membership growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and fails to address key aspects of the ground truth. QUANTITATIVE ISSUES: (1) The LLM provides specific fee revenue figures ($4.2bn in 2022, $4.8bn in 2023) with growth percentages (9% and 5%) that cannot be verified against the ground truth, which does not provide these specific numbers. These appear to be fabricated or incorrectly sourced. (2) The calculation implied (9% growth to $4.2bn, then 5% growth to $4.8bn) is mathematically inconsistent - if 2022 was $4.2bn with 9% growth, the prior year would be ~$3.85bn, but the 5% growth from $4.2bn to $4.8bn represents a 14.3% increase, not 5%. This is a calculation error. QUALITATIVE ISSUES: (1) The LLM answer completely misses the key evolution described in the ground truth - the shift in language from 'has a significant effect' (2022) to 'is integral' (2023), indicating a more consolidated role. (2) The LLM fails to address the critical new concern introduced in 2023 about lower renewal rates in newer markets and their potential adverse impact on worldwide renewal rates - this is explicitly mentioned in the ground truth as a key difference between years. (3) The LLM mentions 'expansion of new warehouses in existing markets could temper paid-membership growth' which is not mentioned in the ground truth and appears to be an unsupported claim. COMPLETENESS: The answer addresses member loyalty and fee revenue but misses the core evolution of the membership format's role and the emerging challenges around renewal rates in newer markets. The ground truth emphasizes emerging challenges; the LLM answer presents an overly optimistic view without acknowledging these concerns. MULTI-HOP REASONING: The LLM fails to synthesize the year-over-year evolution properly, instead providing disconnected financial metrics without establishing the conceptual shift in how Costco framed the membership model's importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 522,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a GPU‑only programming model into the core of a full‑stack data‑center platform, pairing its GPUs with new CPUs (Grace), DPUs (Mellanox), and high‑speed networking and wrapping them in the AI‑Enterprise software suite (NIM, NeMo, AI Blueprints) and the managed DGX Cloud service. This tighter integration has expanded the CUDA ecosystem—now used by >5 million developers—and binds CUDA to NVIDIA’s broader software stack, including Omniverse, DRIVE, and enterprise AI workloads across data‑center, automotive and professional‑visualization markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM states '>5 million developers' use CUDA by 2024, but the ground truth indicates 'nearly 3 million developers' in 2022. The LLM provides no specific 2024 developer count from the ground truth and appears to have inflated this number without source justification. This is a critical factual error on a specific quantitative claim. PARTIAL CORRECTNESS ON QUALITATIVE EVOLUTION: The LLM correctly identifies the shift from GPU-only to full-stack platform integration and mentions the broader ecosystem (CPUs/Grace, DPUs/Mellanox, networking). However, the ground truth specifically emphasizes CUDA-X (collection of acceleration libraries, APIs, SDKs, domain-specific frameworks) as the key 2024 positioning, which the LLM does not mention. ADDITIONAL CONCERNS: The LLM introduces entities (NIM, NeMo, AI Blueprints, DGX Cloud, Omniverse, DRIVE) that are not present in the ground truth answer. While these may be accurate NVIDIA products, they represent information synthesis beyond what the knowledge graph provided and cannot be verified against the ground truth. The ground truth specifically mentions 'Deep Learning Institute and Inception program' for 2022, which the LLM omits. STRENGTHS: The LLM correctly captures the strategic shift from developer-focused tool to enterprise infrastructure layer, and accurately identifies the integration of GPUs, CPUs, and DPUs. The semantic understanding of the evolution is generally sound. MULTI-HOP REASONING: The LLM attempts to synthesize across years and product categories, but the quantitative error (developer count) and introduction of unverified entities undermines the reliability of the synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 464,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\nFrom 2023 to 2024 Pfizer shifted Paxlovid from a largely government‑procured, high‑volume revenue source to a commercial market, causing total Paxlovid revenue to climb to **$5.7 billion in 2024** (up from **$1.28 billion in 2023**) while deferred revenue fell sharply from **$5.1 billion** to **$2.2 billion**.  The company now expects to recognize roughly **$1 billion of remaining contracted Paxlovid revenue over the next four years (2025‑2028)**, with product deliveries scheduled to continue through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The ground truth makes no mention of Paxlovid revenue figures of $5.7 billion in 2024 or $1.28 billion in 2023 - these numbers are not verified and appear to be fabricated or from unreliable sources. (2) The ground truth does not reference deferred revenue figures of $5.1 billion or $2.2 billion for Paxlovid - these are completely absent from the original answer. (3) The LLM correctly identifies the ~$1 billion remaining performance obligations and 2025-2028 delivery timeline, which matches the ground truth. (4) The LLM correctly notes the shift in market dynamics and product delivery expectations. WHAT WAS CORRECT: The $1 billion remaining contracted revenue figure and the 2025-2028 delivery timeline are accurate. The conceptual shift from government procurement to commercial market is reasonable contextually. WHAT WAS INCORRECT: The specific revenue numbers ($5.7B, $1.28B) and deferred revenue figures ($5.1B, $2.2B) are not mentioned in the ground truth and cannot be verified. The ground truth specifically highlights the $3.5 billion non-cash revenue reversal in Q4 2023 related to 6.5 million treatment course returns, which the LLM completely omits. This is a critical detail showing the evolution of Pfizer's financial commitment. The LLM's answer introduces unverified quantitative claims while missing the key 2023 reversal event that is central to understanding the evolution. The multi-hop reasoning is partially sound (connecting 2023 to 2024 changes) but is built on unverified numbers rather than ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 458,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil moved Guyana from a newly‑discovered frontier with ≈1.3 billion oil‑equivalent barrels of proved undeveloped reserves — and a $8 bn upstream investment to advance its development — to a core “advantaged asset” that is now explicitly cited in the company’s earnings‑driver framework as a source of advantaged volume growth.  This shift reflects a strategic emphasis on accelerating Guyana’s production and treating it as a high‑return, near‑term contributor to earnings, rather than a long‑lead‑time undeveloped reserve.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 1.3 billion oil-equivalent barrels figure for proved undeveloped reserves in 2022, matching the ground truth exactly. (2) Accurately captures the strategic evolution from reserves growth region to 'advantaged asset' designation by 2024. (3) Properly synthesizes the multi-hop information showing the transition in ExxonMobil's strategic emphasis. (4) Uses semantically equivalent language ('earnings-driver framework' vs 'earnings drivers') that conveys the same meaning. (5) Adds contextual depth by characterizing Guyana as 'high-return, near-term contributor' and contrasting it with 'long-lead-time undeveloped reserve,' which enriches understanding without contradicting ground truth. MINOR CONSIDERATIONS: (1) The LLM introduces an $8 billion upstream investment figure that is not present in the ground truth answer. While this may be factually accurate from the filings, it represents information beyond what was explicitly confirmed in the ground truth, creating a slight expansion of scope. This is not necessarily incorrect but adds a detail not verified against the original answer. (2) The phrasing 'newly-discovered frontier' is slightly more interpretive than the ground truth's more neutral 'key contributor to extensions and discoveries,' though semantically similar. MULTI-HOP REASONING: The answer correctly synthesizes information across the 2022-2024 period, comparing reserve classifications and strategic positioning. The logical flow from 'frontier with undeveloped reserves' to 'core advantaged asset' is sound and well-articulated. QUANTITATIVE ACCURACY: The 1.3 billion barrel figure is correct; the $8 billion investment figure cannot be verified against the provided ground truth but appears reasonable for a major development project. Overall, this is a high-quality answer with strong factual grounding and only minor additions beyond the confirmed ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 545,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\nFrom 2022 to 2024 the schedule for the ATR 72‑600F shifted from 11 aircraft slated for delivery in 2023, 6 in 2024 and 6 in 2025 (total 24) to a more modest pipeline of 7 aircraft arriving in 2025 and 3 in 2026 (total 10) as shown in the 2024 commitment tables.  This reduction reflects FedEx’s decision to use the ATR 72‑600F as a niche, fuel‑efficient regional freighter that supplements its larger jet fleet on high‑density, short‑ to medium‑range routes, underscoring its role in the company’s broader fleet‑modernization strategy to improve operating economics and support growth in regional and international package traffic.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) NUMBERS INCORRECT: The LLM states the 2022 projection showed '11 aircraft slated for delivery in 2023, 6 in 2024 and 6 in 2025 (total 24)' but the ground truth indicates 11 in 2023 declining to 1 by 2026 - not 6 in 2024 and 6 in 2025. The LLM fabricated intermediate year numbers not supported by the ground truth. (2) 2024 PROJECTION ACCURACY: The LLM correctly identifies 7 for 2025 and 3 for 2026, which matches the ground truth. (3) CALCULATION ERROR: The LLM calculates the 2022 projection total as 24 units, but if the actual numbers were 11, then declining to 1 by 2026, the total would be different. The LLM appears to have invented the 6+6 breakdown. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution and provide strategic context about the aircraft's role as a 'niche, fuel-efficient regional freighter,' this contextual analysis goes beyond what the ground truth provides and may be speculative. The ground truth focuses on the quantitative shift in projections, not strategic rationale. (5) SEMANTIC ISSUE: The ground truth emphasizes that the aircraft 'continued to play a more sustained, albeit reduced, role' - indicating stabilization rather than the dramatic reduction the LLM implies. The LLM's framing of 'more modest pipeline' and reduction from 24 to 10 is based on incorrect 2022 baseline numbers. The answer demonstrates poor quantitative accuracy with fabricated numbers and fails to correctly represent the ground truth comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 440,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA shifted Omniverse from a pure 3‑D collaboration and simulation tool to a central hub of its AI‑driven simulation stack.  The platform now embeds directly with AI Enterprise software (e.g., NIM, NeMo, AI Blueprints) and Blackwell GPUs to generate synthetic data, power digital‑twin and autonomous‑vehicle testing, and support AI‑enhanced avatars and generative‑AI workflows, while still being offered as an enterprise subscription and a free individual tier.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key evolution points but introduces unverified claims and misses important ground truth details. CORRECT ELEMENTS: (1) The shift from general 3D collaboration to more specialized enterprise use is accurately conveyed; (2) The mention of enterprise subscription and free individual tier matches ground truth; (3) The focus on digital twins and autonomous vehicle testing aligns with the original answer. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific product names (NIM, NeMo, AI Blueprints, Blackwell GPUs) that are NOT mentioned in the ground truth answer. While these may be accurate NVIDIA products, they represent information synthesis beyond what the knowledge graph provided, creating potential factual risk; (2) The characterization of Omniverse as a 'central hub of its AI-driven simulation stack' is more interpretive than the ground truth's description of it as 'a more comprehensive development platform and operating system'; (3) The mention of 'synthetic data generation' and 'AI-enhanced avatars and generative-AI workflows' are not explicitly stated in the ground truth, though they may be reasonable inferences; (4) The ground truth specifically mentions VR/AR enterprise applications (virtual car showrooms, surgical training) in 2022, which the LLM completely omits. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but does so by introducing external product references rather than strictly synthesizing from the provided knowledge graph. The core narrative of evolution from collaboration tool to enterprise digital twin platform is present but less clearly articulated than the ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores well by default. The years (2022, 2024) are correctly referenced. OVERALL ASSESSMENT: The answer demonstrates understanding of the general direction of Omniverse's evolution but introduces unverified product-specific details and omits concrete examples from the ground truth, reducing confidence in factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 565,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the share of Google Play in Alphabet’s non‑advertising revenue grew noticeably.  The 2023 filing notes that “non‑advertising revenues—including sales of apps and in‑app purchases from Google Play—are increasing and now represent a larger portion of total revenue,” helping drive the overall rise in Google Services revenue (which grew $19 billion, or 8 %).  Thus, Google Play’s contribution to the company’s non‑advertising earnings expanded materially over that period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Google Play's evolution (growing importance in non-advertising revenue) and correctly identifies that Google Play revenues come from app sales and in-app purchases. However, there are significant issues with quantitative accuracy and factual grounding:\n\n(1) QUANTITATIVE ACCURACY PROBLEMS:\n- The LLM cites a $19 billion growth in Google Services revenue with an 8% growth rate, but this specific figure is not verified against the ground truth and appears to be an unsupported claim\n- The answer states Google Play's share \"grew noticeably\" but provides no actual metrics, percentages, or comparative data to substantiate this claim\n- No specific revenue figures for Google Play in 2022 vs 2023 are provided\n\n(2) FACTUAL ACCURACY ISSUES:\n- The ground truth indicates Google Play was \"introduced\" in 2022 as part of a broader strategy, but the LLM doesn't clearly establish this baseline\n- The ground truth emphasizes a shift in categorization (from diversification component to defined 'platforms' revenue stream), which the LLM doesn't explicitly address\n- The LLM's claim about \"larger portion of total revenue\" is vague and unsupported by specific data\n\n(3) MULTI-HOP REASONING:\n- The LLM attempts to synthesize information about Google Play's role and its contribution to Google Services revenue growth\n- However, the reasoning relies on a quoted statement that isn't verified against the ground truth\n- The connection between Google Play growth and the $19B Google Services growth is asserted but not clearly established\n\n(4) SEMANTIC ALIGNMENT:\n- The LLM answer does convey that Google Play became more important in non-advertising revenue between 2022-2023, which aligns with the ground truth\n- However, it misses the key insight about the strategic shift in how Google Play was categorized/structured\n- The answer is more about quantitative growth than the qualitative evolution described in the ground truth\n\nThe answer is directionally correct but lacks the specificity, verification, and nuanced understanding of the strategic categorization shift that characterizes the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 582,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept the same basic rule‑of‑thumb but refined its application: for guaranteed‑cost workers‑comp business it still assigns significant weight to expected‑loss‑ratio estimates only in the most recent accident year, whereas for excess‑of‑deductible business it now extends that weighting to the five most recent accident years to accommodate slower claim emergence and the growing share of large‑deductible policies. The 2023 disclosures note that the expected‑loss‑ratio inputs are adjusted for inflation, rate changes and market conditions and that the portfolio is segmented by deductible size, state and third‑party administrator to capture the evolving development patterns.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains a mix of correct and problematic elements. CORRECT ELEMENTS: (1) The core distinction between guaranteed cost (most recent accident year) and excess of deductible (five most recent accident years) is accurately stated and matches the ground truth. (2) The identification of large deductible business slowing claim reporting patterns is correct. (3) The general characterization of methodology consistency between 2022 and 2023 is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific details about 'inflation, rate changes and market conditions' adjustments and 'segmentation by deductible size, state and third-party administrator' that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated details not supported by the source material. (2) The LLM fails to mention the important 2023 reporting refinement noted in the ground truth: that incurred and paid losses were presented 'net of reinsurance and undiscounted,' which the ground truth identifies as potentially reflecting 'a refinement in reporting transparency.' (3) The LLM does not mention the 2022 observation about changes in claims strategy and loss mitigation efforts accelerating settlements and increasing paid losses along latest diagonals. MULTI-HOP REASONING: The LLM correctly synthesizes the comparison between 2022 and 2023 methodologies for the two business types, but introduces unsupported details that suggest either hallucination or confusion with other sources. The failure to include the net-of-reinsurance reporting change is a notable omission of a key 2023 evolution. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is less critical, but the LLM's introduction of unverified details reduces confidence in accuracy. OVERALL: The answer gets the main structural comparison correct but undermines credibility by adding details not in the ground truth and omitting a significant reporting methodology change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 545,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco reshaped how it groups its products: in FY22 it reported six distinct categories (Secure & Agile Networks, Internet for the Future, **Collaboration**, End‑to‑End Security, Optimized Application Experiences, Other), but by FY24 the taxonomy was consolidated to four broader groups—Networking, Security, **Collaboration**, and Observability—with the former six‑category structure folded into these four.  During that span the **Collaboration** segment moved from a 5 % revenue decline in FY22 to a deeper 9 % drop in FY23, then rebounded with a modest 2 % increase in FY24, reflecting both the category‑re‑organization and a turnaround in its sales trend.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the structural evolution of Cisco's product categories from six categories in FY22 to four in FY24, and accurately names the categories involved (Collaboration, Networking, Security, Observability). The qualitative description of the consolidation and introduction of Observability is sound and matches the ground truth. However, the answer introduces specific revenue performance metrics (5% decline in FY22, 9% decline in FY23, 2% increase in FY24 for Collaboration) that are NOT present in the original ground truth answer. These numbers cannot be verified against the provided ground truth, which makes no mention of specific percentage changes in Collaboration revenue across these fiscal years. This is a critical issue because the evaluation instructions emphasize strict accuracy on numbers and metrics. While the structural/categorical information is correct, the addition of unverified quantitative claims significantly undermines the answer's reliability. The LLM appears to have synthesized information beyond what was confirmed in the ground truth, which violates the principle of sticking to verifiable facts. The core structural answer (6 categories to 4 categories, with specific names) is accurate and well-reasoned, but the revenue performance claims are problematic and unsupported by the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 380,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\nFrom the 2022 filing (10‑K pages 128‑132) the $1 billion 3.125% 2025 Notes were disclosed as having a notional amount of $1 bn and, because of interest‑rate swaps, an effective floating rate of **LIBOR + 1.8 %** (the swap conversion was shown in the “Effective interest rates on notes” table for 2021/2020).  \n\nIn the 2023 filing (10‑K pages 142‑146) the same $1 bn of 3.125% 2025 Notes appears in the “Effective interest rates on notes” table with an updated effective spread of **SOFR + 2.1 %**, reflecting the market transition from LIBOR to SOFR and a modest increase in the swap‑derived margin. The 2023 disclosure also explicitly notes that the swaps are designated cash‑flow hedges and places the notes alongside other SOFR‑linked swaps in the aggregate presentation.  \n\nThus, the financial presentation of the 3.125% 2025 Notes remained the same $1 bn notional, but the underlying interest‑rate framework shifted from a LIBOR‑plus‑1.8 % swap structure in 2022 to a SOFR‑plus‑2.1 % structure in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the 2022 disclosure showed 'LIBOR + 1.8%' as the effective rate, but the ground truth explicitly states 'no specific interest rate framework was disclosed' in 2022. The LLM also introduces a 2021/2020 reference that is not part of the ground truth answer. The LLM's claim of 'LIBOR + 1.8%' in 2022 is factually incorrect according to the knowledge graph. (2) FRAMEWORK MISCHARACTERIZATION: The ground truth indicates the 2022 disclosure was purely quantitative (carrying value of $1,000 million) with NO interest rate framework disclosed. The LLM incorrectly asserts a LIBOR-based framework existed in 2022. (3) CORRECT ELEMENTS: The LLM correctly identifies the 2023 framework as SOFR + 2.1% and correctly notes the $1 billion notional amount. The LLM also correctly identifies the transition from LIBOR to SOFR between years. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so based on incorrect 2022 data. The comparison structure is sound, but the underlying facts are wrong. (5) PRESENTATION EVOLUTION: The ground truth emphasizes a shift from 'purely quantitative disclosure' to 'detailed qualitative and quantitative presentation,' but the LLM frames this as a swap structure change rather than a disclosure methodology change. The LLM's interpretation of what changed (the swap mechanics) differs from the ground truth's focus (the disclosure approach and framework transparency). The answer demonstrates partial understanding but contains fundamental factual errors that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 470,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia Pacific/Middle East fell from **≈ 326 billion cubic feet (BCF) at the end of 2022** to **≈ 312 BCF in 2023** and **≈ 296 BCF by the end of 2024** – a net decline of roughly **30 BCF (about 9 %)** over the two‑year span.  The decrease reflects normal production and price‑related revisions, but the company continues to invest in the region through equity‑affiliate participation, targeted acquisitions and development projects, underscoring a deliberate strategic focus on maintaining a presence in Asia Pacific/Middle East despite modest reserve growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct key numbers: 326 BCF (2022), 296 BCF (2024), and the net decline of 30 BCF over two years. The percentage calculation of ~9% decline is accurate (30/326 ≈ 9.2%). The intermediate 2023 figure of 312 BCF is provided, which adds useful detail not in the ground truth but appears reasonable as a progression. The LLM correctly identifies the core finding: a decline in reserves in the Asia Pacific/Middle East region. However, the LLM goes beyond the ground truth by providing additional strategic context about 'equity-affiliate participation, targeted acquisitions and development projects' and characterizing the decline as reflecting 'normal production and price-related revisions.' While this interpretation is reasonable and adds valuable context, it introduces information not explicitly confirmed in the ground truth, which simply states the decline 'suggests a potential strategic shift or divestment.' The LLM's more nuanced interpretation (maintaining strategic presence despite modest reserve decline) is plausible but represents inference beyond what the ground truth explicitly states. The answer is well-structured, addresses all parts of the question (evolution of reserves and strategic positioning), and the multi-hop reasoning is sound. Minor deduction for adding interpretive elements not grounded in the provided knowledge graph, though these additions are contextually reasonable and don't contradict the core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 413,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 Alphabet repurchased **450 million Class C shares for $52.9 billion in 2023**, versus **469 million shares for $52.6 billion in 2022** – a small drop in the number of shares bought back but a modest rise in total dollars spent.  The company therefore kept its shareholder‑return program active, yet executed it more selectively (maintaining a $36 billion remaining repurchase authorization), reflecting a capital‑allocation strategy that prioritizes returning excess cash to investors while balancing other investments and market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Key issues: (1) MAJOR NUMBER ERRORS: The ground truth states Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023 (Class A and C combined). The LLM claims $52.6 billion in 2022 and $52.9 billion in 2023 - both figures are substantially lower and incorrect. The LLM's numbers are off by approximately $6.7 billion in 2022 and $9.3 billion in 2023. (2) INCOMPLETE INFORMATION: The LLM provides share count data (450M and 469M shares) that is not in the ground truth and appears to be fabricated or from a different source. More critically, the LLM completely omits the April 2023 Board authorization of $70.0 billion in additional repurchase authority, which is a key element of the original answer and demonstrates the company's expanded capital allocation strategy. (3) MISSING CONTEXT: The ground truth emphasizes the year-over-year increase from $59.3B to $62.2B (a 4.9% increase), indicating 'continued and expanding emphasis.' The LLM incorrectly characterizes the activity as 'a small drop in the number of shares' and 'modest rise in total dollars,' which misrepresents the trend. (4) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the complete picture of Alphabet's capital allocation strategy, missing the significant $70.0 billion authorization and the $36.3 billion remaining authorization as of year-end 2023. (5) REASONING QUALITY: While the LLM's general conclusion about shareholder returns and capital allocation is directionally reasonable, it is built on incorrect financial data, making the analysis unreliable. The characterization of the strategy as 'more selective' contradicts the ground truth's emphasis on 'continued and expanding' buybacks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 483,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\nBetween 2022 and 2023 AIG continued to rely on frequency‑severity techniques for its short‑tail property and program‑business lines (U.S. Property, program property and, where appropriate, liability classes), while deliberately **not** using them for high‑severity, long‑tail classes such as aviation.  In 2023 the company expanded the same approach to U.S. Workers’ Compensation and to excess‑casualty business, but it emphasized that the growing proportion of large‑deductible and high‑attachment policies—producing slower, more variable claim‑reporting patterns—required additional segmentation and a more cautious, blended use of frequency‑severity methods together with expected‑loss‑ratio and Bornhuetter‑Ferguson approaches.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Accurately identifies that in 2022, AIG used frequency/severity methods for short-tail classes like U.S. Property; (2) Correctly notes that aviation was explicitly avoided due to high severity; (3) Correctly identifies the 2023 expansion to U.S. Workers' Compensation; (4) Accurately describes the shift toward blended approaches combining frequency/severity with expected loss ratio and Bornhuetter-Ferguson methods; (5) Properly contextualizes the reasoning around large deductible business and risk-sharing features. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'excess-casualty business' as a 2023 expansion, which is NOT mentioned in the ground truth answer. This appears to be an addition not supported by the source material; (2) The ground truth specifically characterizes U.S. Workers' Compensation as a 'long-tail line of business' to emphasize the strategic shift, while the LLM mentions it but doesn't emphasize this important distinction as clearly; (3) The LLM's mention of 'Bornhuetter-Ferguson approaches' is more specific than the ground truth, which only mentions 'loss development and expected loss ratio methods' - while not necessarily wrong, this adds detail not in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across 2022-2023 and identifies the strategic shift from short-tail to long-tail applications. However, the introduction of excess-casualty business without ground truth support represents a factual error in the synthesis. The reasoning about why the methods evolved (large deductible business, variable claim patterns) is sound and well-articulated. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension focuses on factual precision of categorical claims, which is mostly accurate except for the excess-casualty addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 518,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen’s net cost recoveries from BeiGene fell sharply—from **$199 million** in 2022 to **$109 million** in 2023—while product sales to BeiGene rose from **$64 million** to **$125 million**.  Accordingly, profit‑and‑loss sharing expenses dropped from **$53 million** to **$40 million**, and the receivable for cost‑recovery and P&L payments declined from **$99 million** to **$61 million**, reflecting a shift toward higher sales and lower shared‑cost reimbursements in the later year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all core financial figures correctly stated: cost recovery ($199M to $109M), product sales ($64M to $125M), and P&L sharing expenses ($53M to $40M). The multi-hop synthesis across 2022-2023 is sound, correctly identifying the shift from R&D cost sharing to product sales dominance. The answer includes additional detail about receivables ($99M to $61M) that was not in the ground truth but appears factually accurate and adds relevant context. The reasoning is logical and well-articulated, explaining the maturation of the collaboration. Minor deduction: the ground truth explicitly states the shift 'suggests a maturation of the collaboration,' while the LLM uses 'reflecting a shift toward higher sales and lower shared-cost reimbursements'—semantically equivalent but slightly less explicit about the maturation narrative. The LLM's inclusion of receivable information, while not in the original answer, demonstrates deeper filing analysis and is contextually appropriate. All numbers are formatted correctly and calculations are accurate (differences: $199-$109=$90M decrease, $125-$64=$61M increase, $53-$40=$13M decrease). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 342,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024, natural‑gas reserves in the Asia‑Pacific/Middle‑East region fell from 326 bcf to 240 bcf in 2023 before edging up to 279 bcf by the end of 2024. The 2023 decline reflected a modest upward revision of 6 bcf that was far outweighed by 25 bcf of production and zero purchases, while the 2024 rebound came from a slightly larger upward revision of 9 bcf, still no purchases, and continued production of 25 bcf, yielding a net gain of 39 bcf.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. Key issues: (1) WRONG 2024 FIGURE: LLM states 279 bcf for end of 2024, but ground truth clearly states 296 bcf - a 17 bcf discrepancy. (2) WRONG 2023 FIGURE: LLM states 240 bcf for 2023, but ground truth does not provide a 2023 year-end figure, only mentioning 2022 (326 bcf) and 2024 (296 bcf). (3) WRONG REVISION NUMBERS: LLM claims 6 bcf revision in 2023 and 9 bcf in 2024, but ground truth states 9 bcf revision in 2023 with no separate 2024 revision mentioned. (4) CALCULATION ERRORS: LLM's math is internally inconsistent - claiming a 'net gain of 39 bcf' from 9 bcf revision minus 25 bcf production doesn't yield 39 bcf. (5) PRODUCTION TIMING: LLM incorrectly attributes 25 bcf production to both 2023 and 2024, while ground truth specifies 25 bcf production in 2024 only. (6) PURCHASES: LLM correctly identifies zero purchases, matching ground truth. The LLM appears to have fabricated intermediate year data (2023 figures) and misallocated revisions and production across years. The core narrative about reserve decline is partially correct directionally, but the specific numbers, timing, and calculations are substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 348,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\nFrom the 2022 filing FedEx had pledged to purchase **14 B767F aircraft in 2024 and a further 10 in 2025** (total 38 B767Fs over 2023‑2025). By the 2024 filing the commitment had been reshaped to **11 deliveries in 2025 and 3 in 2026**, reducing the near‑term cadence and spreading the intake over later years. This evolution shows that FedEx is now staggering the B767F rollout—using the type to modernize its cargo fleet while preserving cash flow and aligning the aircraft’s fuel‑efficient capacity with longer‑term strategic capacity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misrepresents the ground truth data. (1) QUANTITATIVE ERRORS: The LLM states '14 B767F aircraft in 2024 and a further 10 in 2025' but the ground truth shows 2022 projections were for 14 aircraft in BOTH 2023 AND 2024, with reduction to 10 by 2025. The LLM incorrectly assigns 14 to 2024 and 10 to 2025, reversing the timeline. The LLM also claims 'total 38 B767Fs over 2023-2025' which cannot be verified from the ground truth and appears to be a fabrication. (2) MISCHARACTERIZATION OF CHANGE: The ground truth indicates the 2022 projection was 14→14→10 (2023-2024-2025), while 2024 projection was 11→3 (2025-2026). The LLM incorrectly frames this as '14 in 2024 and 10 in 2025' changing to '11 in 2025 and 3 in 2026,' which misrepresents the baseline comparison. (3) INTERPRETATION ERROR: The LLM interprets the change as 'staggering the rollout' and 'spreading intake over later years,' but the ground truth indicates an ACCELERATED REDUCTION—the aircraft are being phased out faster, not spread out. The 2024 projection shows only 3 aircraft by 2026 versus the 2022 plan of 10 by 2025, indicating faster phase-out, not delayed intake. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison from the two filings. The core insight about strategic shift toward accelerated reduction is inverted in the LLM's narrative about 'staggering' and 'spreading.' This is a fundamental misunderstanding of the strategic implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 418,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG expanded the expected‑loss‑ratio (ELR) approach from a narrow set of specialty lines (mainly aviation and program‑business, used only for the most recent accident year) to a broader portfolio that now includes long‑tail classes such as U.S. Workers’ Compensation and Excess Casualty.  The 2023 disclosures explain that ELRs are applied when loss‑development patterns are inconsistent, emergence is slow, or historical data are thin, and the ratios are derived from premiums and adjusted for rate changes, inflation and current market conditions, with particular weight given to the latest five accident years.  This evolution reflects a shift toward using premium‑based ELR estimates as a more reliable reserve driver for lines where traditional development methods are less effective.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The general evolution from narrow to broader application of ELR methods is accurate; (2) The identification of U.S. Workers' Compensation as a long-tail line where ELR was applied in 2023 is correct; (3) The reasoning about why ELR methods are used (inconsistent loss-development patterns, slow emergence, thin historical data) aligns with the ground truth context. PROBLEMATIC ELEMENTS: (1) The LLM claims ELR was applied to 'Excess Casualty' in 2023, but the ground truth only mentions U.S. Workers' Compensation as the specific example of expanded application - this is an unsupported addition; (2) The LLM states ELR was used 'only for the most recent accident year' in 2022, but the ground truth says 'primarily for the latest accident year' - the word 'only' is too absolute and potentially inaccurate; (3) The LLM introduces specific methodological details about 'latest five accident years' and adjustment factors (rate changes, inflation, market conditions) that are not present in the ground truth - these may be accurate but cannot be verified against the provided ground truth and represent potential over-specification; (4) The LLM characterizes 2022 focus as 'short-term forecasting in high-severity contexts' which is somewhat different from the ground truth's emphasis on 'latest accident year' and 'aviation exposures'; (5) The LLM mentions 'program-business' as a 2022 specialty line, which is not mentioned in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the shift from specialty/high-severity lines to long-tail lines. However, the addition of unsupported details and the claim about Excess Casualty weaken the multi-hop synthesis. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is less critical, but the LLM's reference to 'latest five accident years' is unverified. The answer demonstrates reasonable understanding of the evolution but introduces claims not supported by the ground truth, which reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 586,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Cisco shifted from merely describing the enterprise‑data‑center “convergence of computing, networking, storage and software” to actively building an ecosystem of strategic alliances—e.g., with Equinix, Microsoft, Amazon Web Services, Google and Apple—to co‑develop, finance and market end‑to‑end data‑center solutions.  At the same time, the competitive set widened: traditional networking rivals (Arista, Juniper, HPE) and hyperscale cloud providers are expanding their own data‑center offerings, and some alliance partners can also become competitors, intensifying price‑focused and technology‑driven competition in this space.  Consequently, Cisco’s positioning now hinges on leveraging these partnerships and outcome‑based services to differentiate itself amid a more crowded and collaborative landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from 2022 to 2024 regarding Cisco's positioning on enterprise data center transformation. (2) The answer accurately captures the shift from describing convergence to actively building strategic alliances. (3) The mention of competitive landscape expansion is correct. (4) The timeframe (fiscal 2022 to 2024) is accurate. (5) The semantic understanding of the strategic shift is sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The ground truth explicitly mentions Nvidia Corporation as a new entrant in the competitive landscape by 2024, but the LLM answer does not mention Nvidia at all. This is a significant factual gap given that Nvidia's emergence in data center competition is a major market dynamic shift. (2) ALLIANCE SPECIFICITY: While the LLM lists specific alliance partners (Equinix, Microsoft, AWS, Google, Apple), the ground truth does not specify these particular companies. The ground truth uses more general language about 'strategic alliance partners' and 'industry advancement.' The LLM's specific company names may be accurate from the filings but represent added detail not in the ground truth. (3) COMPETITIVE LANDSCAPE DETAIL: The LLM mentions traditional rivals (Arista, Juniper, HPE) and hyperscale cloud providers, which is reasonable inference but not explicitly stated in the ground truth. The ground truth focuses on Nvidia as the key new entrant. (4) TONE DIFFERENCE: The ground truth notes that 'alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco' - a more cautionary tone about alliance risks. The LLM's framing is more positive about leveraging partnerships.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by connecting 2022 positioning to 2024 evolution and relating this to both alliance strategy and competitive dynamics. However, the failure to identify Nvidia specifically weakens the multi-hop accuracy.\n\nNUMERIC/QUANTITATIVE: No specific numbers, dates, or calculations are present in either answer, so quantitative accuracy is not directly testable. Both answers use appropriate temporal references (2022, 2024, fiscal years).\n\nJUSTIFICATION: The answer is partially correct on the main thesis but has a critical omission (Nvidia) that represents a material gap in competitive landscape analysis. The additional specific alliance names, while potentially accurate, diverge from the ground truth's more general framing. The overall reasoning quality is good but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 676,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\nBetween 2022 and 2023 the 3.125% 2025 Notes kept the same notional exposure of **$1 billion**, and the effective interest rate tied to the swap remained **SOFR + 2.1%** in both years—i.e., it did not change materially.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical points: (1) NOTIONAL AMOUNT ERROR: The LLM claims the notional amount was $1 billion in both 2022 and 2023 with no change. However, the ground truth clearly states that in 2022, the notional amount was $5.2 billion, and it decreased to $1.0 billion by 2023. This is a major factual error - the LLM missed the significant $4.2 billion reduction in hedged notional exposure between the two years. (2) EFFECTIVE INTEREST RATE: The LLM correctly identifies SOFR + 2.1% for 2023, but fails to address what the effective interest rate was in 2022. The ground truth indicates there was a 'shift in the interest rate environment' and mentions 'new interest rate swaps were entered into after termination of previous swaps,' suggesting the 2022 rate may have been different. The LLM's claim that the rate 'did not change materially' is unsupported and potentially incorrect. (3) MISSING CONTEXT: The LLM completely omits the important hedging strategy context - that new swaps were entered into in 2022 due to low interest rates, and that there was a reduction in hedged exposure by 2023. This represents a failure to synthesize the multi-hop information about how the hedging strategy evolved. (4) SEMANTIC MISREPRESENTATION: The LLM's statement that exposure 'kept the same notional exposure' directly contradicts the ground truth's statement about 'reduction in the hedged notional exposure.' The answer fundamentally mischaracterizes the evolution of these notes between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 433,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Cisco folded AppDynamics into its broader **Observability** offering rather than keeping it as a stand‑alone APM product.  In the 2022 filing the company highlighted AppDynamics as part of a “full‑stack observability” push that spanned application performance monitoring to infrastructure visibility.  By fiscal 2024 the Observability category is presented as a distinct revenue line that includes network‑assurance tools (ThousandEyes), the Splunk‑based observability suite, and the AppDynamics technology, with growth driven primarily by ThousandEyes and Splunk.  Thus, AppDynamics has evolved from a discrete application‑performance solution into one component of an end‑to‑end observability platform that Cisco promotes as a strategic pillar for hybrid‑work, multicloud and security‑focused customer outcomes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's strategic evolution of AppDynamics from 2022 to 2024, correctly identifying the key shift from a discrete APM product to a component within a broader Observability category. STRENGTHS: (1) Accurately captures the 2022 positioning of AppDynamics as part of full-stack observability strategy; (2) Correctly identifies the 2024 restructuring that created Observability as a distinct revenue line; (3) Properly names related offerings (ThousandEyes, Splunk-based tools, Intersight implied); (4) Sound multi-hop reasoning synthesizing information across 2022 and 2024 filings; (5) Appropriate contextual framing around hybrid-work, multicloud, and security outcomes. MINOR ISSUES: (1) The LLM introduces 'Splunk-based observability suite' which, while potentially accurate, goes slightly beyond what the ground truth explicitly states - the ground truth mentions AppDynamics, Intersight, and ThousandEyes specifically, without detailed mention of Splunk integration in the provided context; (2) The statement about growth being 'driven primarily by ThousandEyes and Splunk' adds specificity not present in the ground truth, which could be accurate but represents inference beyond the provided knowledge graph; (3) Minor semantic difference: ground truth emphasizes 'formalized and integrated strategic emphasis' while LLM uses 'folded into' which is slightly less formal in tone but semantically equivalent. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were provided in either answer, so this dimension is not directly testable. The temporal references (2022, 2024, fiscal 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and multiple product offerings, correctly identifying the evolution and structural change. The logic connecting the 2022 positioning to the 2024 restructuring is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 529,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\nThe 4.663% 2051 Notes kept the same outstanding notional amount of **$1.5 billion** from the end of 2022 through the end of 2023, and their **effective interest rate remained indexed to SOFR + 4.3%** (i.e., the spread did not change between the two years).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT: The notional amount of $1.5 billion for 2023 is accurate, and the effective interest rate of SOFR + 4.3% for 2023 is correct. INCORRECT/INCOMPLETE: The LLM claims the notional amount remained at $1.5 billion 'from the end of 2022 through the end of 2023,' but the ground truth indicates that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes (not specifically $1.5 billion for just these notes in 2022). The LLM fails to capture the evolution/change from 2022 to 2023 - it presents the 2023 figures as if they were static across both years. The ground truth explicitly states 'This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure' - suggesting there was a change or refinement in how the notes were disclosed/hedged between years. The LLM's statement that 'the spread did not change between the two years' is unsupported by the ground truth, which doesn't explicitly compare the 2022 rate to the 2023 rate. The answer misses the key narrative of evolution - the ground truth mentions swaps were 'terminated and replaced at then-current interest rates,' indicating a material change in the hedging strategy. The LLM provides accurate 2023 figures but fails to properly characterize the year-over-year evolution that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 395,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG broadened and refined its use of expected‑loss‑ratio techniques. In 2022 the method was applied chiefly to long‑tail, claims‑made lines—particularly U.S. Excess Casualty, U.S. Financial Lines (D&O) and U.S. Workers’ Compensation—with segmentation by “guaranteed‑cost” versus “excess‑of‑deductible” and by state/industry subsets. By 2023 the Company extended the approach to additional run‑off and short‑tail lines, used the expected‑loss‑ratio assumption across more recent accident years, and applied a finer segmentation (e.g., deductible size, third‑party administrator handling, and risk‑sharing features) when selecting loss‑cost trends and development factors for reserve estimates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that in 2022, AIG applied expected loss ratio methods to U.S. Excess Casualty, U.S. Financial Lines (D&O), and U.S. Workers' Compensation with specific segmentation criteria. However, the ground truth explicitly states that in 2022, AIG only referenced these methods 'in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business.' The LLM has fabricated specific lines of business and segmentation details for 2022 that do not exist in the ground truth. (2) The ground truth indicates that the detailed application to U.S. Workers' Compensation with granular segmentation (risk-sharing features, state and industry subsets, deductible size, claim handling entities) was introduced in 2023, not that it existed in 2022. (3) The LLM's claim about 'guaranteed-cost' versus 'excess-of-deductible' segmentation in 2022 is not supported by the ground truth. (4) The LLM's description of extending to 'additional run-off and short-tail lines' in 2023 is not mentioned in the ground truth, which focuses on U.S. Workers' Compensation as a long-tail line. The core narrative of evolution from general/unspecified use in 2022 to structured/detailed application in 2023 is inverted in the LLM answer. The LLM appears to have confused the 2023 detailed application with 2022, creating a false historical progression. While the answer is contextually relevant to the question asked, it fundamentally misrepresents the factual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 453,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\nPepsiCo first issued the 2.850% Senior Notes due 2026 in February 2023 (8‑K filing). In 2024 the Board re‑authorized that tranche and, as part of a wider multi‑year debt program, added a suite of new senior and floating‑rate notes—including 4.650% 2027, 4.550% 2029 and 4.700% 2034 issues through its Singapore financing vehicle—showing a strategic shift toward diversifying funding sources and extending the maturity profile of its debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM cites specific interest rates (4.650% 2027, 4.550% 2029, 4.700% 2034) that do NOT match the ground truth, which explicitly mentions 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 as the new instruments introduced in 2024. (2) The LLM introduces a 'Singapore financing vehicle' detail that is not mentioned in the ground truth and appears to be fabricated. (3) The LLM references an 8-K filing for February 2023 issuance, which is not corroborated by the ground truth. PARTIAL CREDIT: The LLM correctly identifies that (a) the 2.850% Senior Notes due 2026 were maintained, (b) new senior notes were added in 2024, and (c) the strategy involved diversification and extending maturity profiles. However, the specific interest rates and maturity dates of the new instruments are fundamentally wrong. The multi-hop reasoning structure is sound (comparing 2023 vs 2024 debt strategy), but the factual content is severely compromised by incorrect numerical data. The answer demonstrates understanding of the conceptual evolution but fails on quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 345,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\nCisco’s channel‑partner financing guarantee exposure was about $1.4 billion in outstanding guarantees and roughly $188 million in maximum potential future payments at the close of fiscal 2022; by fiscal 2024 the underlying financing receivables slipped to $6.7 billion and the guarantee levels remained essentially unchanged. This stability shows that Cisco manages the risk by keeping off‑balance‑sheet commitments modest, closely monitoring credit exposure, and preserving liquidity to absorb any potential guarantor obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM claims $1.4 billion in outstanding guarantees for FY2022 (correct per ground truth), but then introduces unsupported figures of $188 million in 'maximum potential future payments' and $6.7 billion in 'underlying financing receivables' for FY2024 - none of these specific numbers appear in the ground truth. The ground truth explicitly states that by FY2024, 'the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures.' The LLM fabricates precise numbers ($6.7B, $188M) that contradict this key finding. (2) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesizes a narrative of 'stability' and 'guarantee levels remained essentially unchanged,' when the ground truth indicates the opposite - that disclosure transparency decreased and specific figures were no longer provided. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes Cisco 'manages the risk by keeping off-balance-sheet commitments modest,' but the ground truth suggests the opposite interpretation - that the reduction in transparency may reflect 'a potential strategic move toward reducing transparency around these financial commitments.' (4) MISSING KEY INSIGHT: The LLM completely misses the ground truth's central finding that the absence of updated FY2024 figures 'prevents definitive conclusions about the actual change in exposure,' instead confidently asserting specific numbers that don't exist in the source material. The answer demonstrates hallucination of financial data rather than accurate synthesis of available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 474,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\nThe $1 billion 2.45% 2030 Notes remained outstanding through 2022‑2023 and continued to be hedged by the same interest‑rate swap that converts the fixed 2.45% coupon into a floating SOFR + 1.3% rate; the swap’s notional amount and spread were unchanged during that period. Consequently, their effective interest‑rate structure and hedge designation were unchanged from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth clearly states that in 2022, the interest rate swap converted the fixed-rate to LIBOR-based coupon, and by 2023, it had transitioned to SOFR + 1.3%. However, the LLM answer claims the swap was 'unchanged' and that the SOFR + 1.3% rate existed in both 2022 and 2023. This is incorrect. The LLM states 'their effective interest-rate structure and hedge designation were unchanged from 2022 to 2023,' which directly contradicts the ground truth's explicit statement that there was a transition from LIBOR to SOFR between these years. The quantitative elements (notional amount of $1 billion, the 2.45% coupon, SOFR + 1.3% rate) are individually correct, but the LLM fundamentally mischaracterizes the evolution of the interest rate structure. The question specifically asks 'how has the status and interest rate structure evolved,' implying change, and the ground truth documents a clear evolution (LIBOR to SOFR transition). The LLM's assertion of 'unchanged' status represents a failure in multi-hop reasoning and synthesis of the temporal evolution across 2022-2023. This is a significant error in addressing the core question about how the structure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 354,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the $970 million of FedEx Express Series 2020‑1AA pass‑through certificates continued to be “fully and unconditionally guaranteed by FedEx” – the guarantee itself did not change. The only evolution was a modest update to the collateral valuation (the pledged aircraft’s net book value fell from about $1.8 billion in 2022 to $1.7 billion in 2023) and corresponding wording adjustments; the financial guarantee and payment obligations remained the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core issue. The ground truth clearly states that there was a significant shift in FedEx's relationship with Pass-Through Certificates between 2022 and 2023: in 2022, FedEx Express had issued $970 million of certificates that were 'fully and unconditionally guaranteed by FedEx,' but in 2023, FedEx clarified that pass-through certificates were NOT direct obligations of, nor guaranteed by, FedEx or FedEx Express. This represents a material change in financial guarantees and obligations. The LLM answer incorrectly claims the guarantee 'did not change' and remained the same, which is the opposite of what the ground truth indicates. While the LLM correctly identifies the $970 million amount and the Series 2020-1AA designation, and notes a collateral valuation change (though with a slightly different figure: $1.7B vs $1.8B), it completely misses the fundamental evolution of the relationship - the elimination of FedEx's direct guarantee. The LLM's assertion that 'the financial guarantee and payment obligations remained the same' directly contradicts the ground truth's statement that there was a shift from direct guarantees in 2022 to no direct financial obligation in 2023. This is a critical factual error that undermines the entire answer. The LLM failed to synthesize the multi-hop information showing how FedEx's position changed materially between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 403,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard’s gross settlement exposure edged up from **$75.0 bn to $78.4 bn**, while the amount of risk‑mitigation arrangements applied grew from **$12.2 bn to $13.5 bn**.  Consequently, net settlement exposure rose only modestly, from **$62.9 bn to $64.9 bn**.  This pattern shows that the company is scaling its collateral‑ and credit‑enhancement framework in step with higher transaction volumes, continuously revising its risk‑management methodology to keep potential losses low and to preserve financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Mastercard's risk mitigation evolution. Quantitative verification: (1) Gross settlement exposure 2023: $75.0bn matches $75,023 million (acceptable format variation); (2) Gross settlement exposure 2024: $78.4bn matches $78,385 million (acceptable format variation); (3) Risk mitigation arrangements 2023: $12.2bn matches $12,167 million (acceptable format variation); (4) Risk mitigation arrangements 2024: $13.5bn matches $13,466 million (acceptable format variation). The LLM additionally calculated net settlement exposure ($62.9bn and $64.9bn), which while not explicitly stated in the ground truth, appears mathematically sound ($75,023M - $12,167M = $62,856M ≈ $62.9bn; $78,385M - $13,466M = $64,919M ≈ $64.9bn). This demonstrates sophisticated multi-hop reasoning by synthesizing the provided data to derive additional insights. The qualitative analysis correctly identifies the strategic implication: Mastercard is scaling its risk mitigation framework proportionally with exposure growth, indicating a more robust risk management strategy. The answer addresses all components of the question (evolution from 2023-2024, specific amounts, and strategic implications). Minor note: The LLM provides additional context about 'collateral and credit-enhancement framework' and 'transaction volumes' which, while reasonable inferences, are not explicitly stated in the ground truth but represent reasonable interpretations of the data pattern. Overall, the answer is factually accurate, well-reasoned, and appropriately contextual.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 441,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\nThe liability recorded for foreign‑exchange forwards and options that are designated as hedging instruments was roughly $48 million at the end of fiscal 2022 and stayed at about the same level at the end of fiscal 2024 (after having dropped sharply from $426 million in 2023).  This flat, low‑level liability indicates that Nike’s formal derivative hedge book is now minimal – the company has largely unwound or let mature its foreign‑currency hedges and is managing most currency risk through natural/operational offsets rather than through new hedge positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the liability 'stayed at about the same level' between 2022 and 2024 at ~$48 million, but the ground truth shows it INCREASED from $48 million (2022) to $115 million (2024) - a 139% increase. This is a fundamental factual error. The LLM also introduces a 2023 figure of $426 million that is not mentioned in the ground truth and appears to be unsupported. (2) INCOMPLETE SYNTHESIS - The LLM fails to break down the 2024 liability composition ($110M in accrued liabilities + $5M in deferred taxes = $115M total), missing the important detail that the accrued liability component nearly tripled while the deferred tax component decreased. (3) CONTRADICTORY INTERPRETATION - The LLM concludes Nike has 'largely unwound' hedges based on a claimed flat liability level, but the actual data shows a significant INCREASE in total hedging liabilities, which contradicts this interpretation. The correct interpretation should indicate increased hedging activity or exposure, not decreased. (4) UNSUPPORTED CLAIMS - The reference to a $426 million figure in 2023 and the assertion about 'natural/operational offsets' are not supported by the ground truth data provided. (5) DIRECTIONAL ERROR - The LLM's conclusion about minimal hedge positions is directly opposite to what the data suggests - the increase from $48M to $115M indicates expanded hedging activity, not unwinding. The answer demonstrates poor multi-hop reasoning and arrives at conclusions that contradict the actual financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 427,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\nIn the 2022 filing (page 19) Bounty was explicitly highlighted— the narrative singled out “Bounty paper‑towel” and noted that it captured “over 40 % market share” in North America, underscoring its importance within the Baby, Feminine & Family Care segment. By contrast, the 2023 filing (page 20) merely lists Bounty among the segment’s major brands without any share‑related commentary or emphasis. This shift indicates that P&G is giving Bounty markedly less explicit focus, suggesting a decline in its brand visibility and strategic prominence.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) QUANTITATIVE ERROR: The LLM claims Bounty had 'over 40% market share' in the 2022 filing, but the ground truth explicitly states 'the filings do not provide specific market share or sales figures.' This is a fabricated statistic with no basis in the evidence. (2) DIRECTIONAL ERROR: The LLM concludes that Bounty's visibility DECLINED from 2022 to 2023 (stating it went from 'explicitly highlighted' to 'merely lists'), which is the opposite of the ground truth. The ground truth clearly indicates Bounty was NOT explicitly listed in 2022 but WAS explicitly included in 2023, suggesting an INCREASE in visibility. (3) ENTITY/CONTEXT ERROR: The LLM mischaracterizes the 2022 representation, claiming Bounty was 'explicitly highlighted' when the ground truth states it was 'not explicitly listed among the key brands.' (4) REASONING FAILURE: The LLM's conclusion about declining brand visibility is logically inverted from what the evidence supports. The ground truth indicates a strategic move to highlight Bounty more prominently in 2023. (5) PAGE REFERENCES: The LLM provides specific page numbers (19 and 20) that cannot be verified against the ground truth and appear to be fabricated details. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required, inventing data points and reaching the opposite conclusion from the actual evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 407,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\nOracle still records hardware product sales—including its Engineered Systems—at the point in time when the hardware and its bundled software are delivered, and it recognizes hardware‑support fees ratably over the contract term; this accounting treatment is unchanged in the FY 2022 and FY 2023 filings (see 2022 Notes 104‑107 and 2023 page 44).  However, the strategic focus on the hardware segment has shifted: both years report that hardware represents only about 6 % of total revenue, operates at lower margins than the cloud‑and‑license business, and is described as a “difficult‑to‑predict” line that receives only modest R&D investment, indicating that Oracle is scaling back the priority of Engineered Systems in favor of its higher‑growth cloud and license offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON STRATEGIC EMPHASIS: The ground truth states Oracle shifted toward 'more strategic focus on innovation and integration of hardware and software components' with 'ongoing R&D investments to improve and develop new hardware products and services' in 2023. The LLM answer claims the opposite—that hardware receives 'only modest R&D investment' and Oracle is 'scaling back the priority of Engineered Systems.' This is a fundamental mischaracterization of Oracle's strategic direction. (2) UNVERIFIED CLAIMS: The LLM cites specific note references ('Notes 104-107' and 'page 44') that cannot be verified and appear to be fabricated citations. The ground truth does not reference these specific notes. (3) INCOMPLETE REVENUE RECOGNITION ANALYSIS: While the LLM correctly identifies that revenue is recognized at point of delivery for hardware and ratably for support fees, it fails to capture the key evolution mentioned in the ground truth—the shift from describing 'contractual activities' in 2022 to explicitly describing 'hardware and related software as a combined performance obligation' in 2023. This is a material difference in how Oracle presents its accounting treatment. (4) MISSING STRATEGIC CONTEXT: The ground truth emphasizes the evolution toward 'more detailed explanation' and 'strategic focus on innovation,' which the LLM completely inverts. The claim about 'difficult-to-predict' and 'scaling back' contradicts the ground truth's emphasis on increased R&D investment and strategic integration. (5) QUANTITATIVE CLAIMS: The statement that hardware represents '6% of total revenue' is presented without source verification and may be inaccurate relative to the actual filings. The ground truth does not provide this specific percentage. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual evolution of Oracle's strategic messaging between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 553,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\nERLEADA’s sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % year‑over‑year increase** (operations‑adjusted growth of ~27.5 %). This strong upside—driven by continued share gains and expanding use in metastatic castration‑resistant prostate cancer—signals a **robust and upward market trajectory**, indicating that the product is gaining traction and is on a positive growth path.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: (1) 2022 sales of $1.88 billion matches ground truth $1,881 million (format variation acceptable); (2) 2023 sales of $2.39 billion matches ground truth $2,387 million (format variation acceptable); (3) Growth calculation: ($2,387M - $1,881M) / $1,881M = $506M / $1,881M = 26.9%, which the LLM rounds to ~27%, a reasonable approximation (ground truth states 26.9%, LLM states ~27%—minor rounding difference acceptable); (4) The mention of 'operations-adjusted growth of ~27.5%' adds context not in ground truth but doesn't contradict it. Multi-hop reasoning: The answer correctly synthesizes the two-year comparison and draws appropriate conclusions about market trajectory. Entity accuracy: ERLEADA correctly identified, years 2022-2023 correct, financial metrics properly stated. The LLM provides additional context about the product's indication (metastatic castration-resistant prostate cancer) and drivers (share gains, expanding use) that enhance understanding without contradicting the ground truth. The conclusion about 'robust and upward market trajectory' and 'gaining traction' aligns perfectly with the ground truth assessment. Minor deduction (1 point) only for the slight rounding of 26.9% to ~27%, though this is a negligible difference and standard practice in financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 385,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\nFrom 2023 to 2024 the affiliate model that once gave CMCSA a relatively predictable pipeline of linear‑television carriage has become far more contested and costly.  The 2023 filing describes the need to secure “must‑carry” or retransmission‑consent agreements with independent local stations to reach a nationwide audience, while the 2024 filing stresses that these stations are increasingly demanding higher fees and more favorable terms as they vie for compensation amid audience fragmentation and the rise of OTT competitors.  Consequently, CMCSA’s competitive positioning now hinges not only on delivering popular network programming but also on navigating a landscape where local broadcast stations are both a critical distribution channel and a growing source of financial and carriage risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific claims NOT present in the ground truth, including references to 'must-carry' agreements, 'increasingly demanding higher fees,' 'audience fragmentation,' and 'OTT competitors' - these details are fabricated and not supported by the original answer. (2) The LLM fundamentally mischaracterizes the evolution: it describes a shift from 'predictable pipeline' to 'contested and costly,' whereas the ground truth describes a shift from COMPETITION to DEPENDENCY/INTERDEPENDENCE. These are different narratives. (3) The ground truth explicitly states the relationship shifted to one where CMCSA became 'reliant on local broadcast television stations for retransmission consent,' which is about dependency, not about rising costs or contested carriage. (4) The LLM adds interpretive layers about 'financial and carriage risk' that go beyond what the ground truth establishes. (5) No quantitative data is provided in either answer, so quantitative accuracy cannot be verified, but the LLM's qualitative framing diverges significantly from the ground truth's core message. WHAT WAS CORRECT: The LLM does correctly identify that the relationship involves retransmission consent and local broadcast stations, and it acknowledges a shift in the relationship between 2023-2024. However, the characterization of that shift and the specific mechanisms driving it are materially different from the ground truth. The answer reads as plausible but appears to be constructed from general industry knowledge rather than the specific filing information that generated the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 443,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\nThe Company’s held‑to‑maturity portfolio fell dramatically — from **$306 million at the end of 2023 to just $38 million at the end of 2024** (a decline of roughly 87 %).  This sharp reduction signals that Mastercard is moving away from low‑yield, short‑term time‑deposit holdings and reallocating capital toward more flexible, higher‑return assets such as marketable equity securities and strategic investments (e.g., the growth of non‑marketable equity investments and the Recorded Future acquisition).  The shift reflects a strategic emphasis on liquidity and higher‑yield investments rather than maintaining a large portfolio of securities held to maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and calculations. Quantitative verification: 2023 HTM securities of $306 million and 2024 amount of $38 million are both correct. The calculated decline of approximately 87% is accurate ($306M - $38M = $268M decline; $268M/$306M = 87.6%, rounds to ~87%). The company identification (Mastercard/MA) is correct, and the fiscal years (2023 and 2024) are properly identified. The multi-hop synthesis is sound—the answer correctly connects the numerical shift to strategic implications. However, there are minor issues: (1) The LLM introduces specific strategic details (Recorded Future acquisition, non-marketable equity investments) that go beyond what the ground truth explicitly states. While these may be accurate contextual details from the filings, they represent inference beyond the core answer provided. (2) The characterization of HTM securities as 'low-yield, short-term time-deposit holdings' is more specific than the ground truth's general statement about 'long-term held securities,' though this interpretation is reasonable. (3) The ground truth uses the phrase 'long-term held securities' while the LLM uses 'securities held to maturity'—these are semantically equivalent and both correct. The core answer structure matches well: both identify the dramatic decline and interpret it as a strategic shift toward more liquid/flexible positions. The LLM provides more detailed strategic context, which adds value but introduces minor speculative elements not in the ground truth. Overall, the answer is substantially correct with strong quantitative accuracy and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 455,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\nBetween 2022 and 2023 the Always brand remained classified under the **Feminine Care (Adult Incontinence & Menstrual Care)** sub‑category of the Baby, Feminine & Family Care segment.  In the 2022 10‑K (page 17) it was listed among several major brands, but the 2023 filing (page 16) singled out **Always** (and Always Discreet) as a primary major brand, highlighting a more focused, higher‑margin positioning within the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims Always remained classified under 'Feminine Care (Adult Incontinence & Menstrual Care)' in both years, but the ground truth explicitly states that in 2022 it was under 'Feminine Care' with sub-categories including Adult Incontinence and Feminine Care, while in 2023 it was 'more specifically aligned with Menstrual Care' - indicating a CHANGE in positioning, not consistency. (2) The LLM's characterization of the evolution is fundamentally wrong - it emphasizes increased prominence/higher-margin positioning rather than the actual strategic shift toward more targeted 'Menstrual Care' categorization. (3) The LLM references specific page numbers (page 17 for 2022, page 16 for 2023) without verification and makes claims about 'Always Discreet' being singled out that are not supported by the ground truth. (4) The LLM misses the core insight that the positioning EVOLVED from a broader Feminine Care category to a more specific Menstrual Care focus. WHAT WAS CORRECT: The LLM correctly identifies Always as part of the Baby, Feminine & Family Care segment and mentions both 2022 and 2023 filings. However, the interpretation of how the positioning evolved is inverted - the ground truth indicates a narrowing/refinement of focus (toward Menstrual Care specifically), while the LLM suggests increased prominence. The multi-hop reasoning failed to correctly synthesize the year-over-year changes in categorization structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 425,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\nOracle continues to recognize Engineered‑Systems revenue on a point‑in‑time basis when the hardware (and its tightly coupled software) is delivered and control transfers to the customer, a policy that has not changed between 2022 and 2023.  Although Engineered Systems still accounted for roughly 6 % of total revenue in both fiscal years, the company’s strategic focus shifted markedly toward cloud and license services—highlighting that hardware now carries lower margins, volatile quarterly volumes and is positioned mainly as a complementary offering rather than a growth driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that revenue recognition for Engineered Systems occurs on a point-in-time basis when hardware and software are delivered, and accurately notes this policy remained unchanged between 2022-2023. (2) The 6% revenue figure for both fiscal years is accurate and matches the ground truth. (3) Numeric accuracy is strong with correct percentages and time periods. WEAKNESSES: (1) The LLM introduces unsupported claims about 'lower margins, volatile quarterly volumes' and positioning as 'complementary offering rather than growth driver' that are NOT present in the ground truth. These appear to be inferences or assumptions rather than facts from the filings. (2) The LLM fails to address a key evolution mentioned in the ground truth: the shift from 2022 (no specific percentage disclosed) to 2023 (explicit 6% disclosure). The ground truth emphasizes this represents 'clearer and more consistent measurement' - a significant strategic evolution that the LLM misses. (3) The LLM omits the ground truth's mention of Oracle's 2023 emphasis on R&D investments to improve hardware offerings and introduction of detailed factors affecting hardware revenue predictability (manufacturing partner performance, competitive positioning against cloud infrastructure). (4) The LLM's characterization of strategic shift toward 'cloud and license services' is partially supported but oversimplifies the nuanced evolution described in the ground truth. MULTI-HOP REASONING: The LLM partially synthesizes information but introduces unsupported interpretations and misses the key evolution in disclosure and strategic emphasis between the two years. The answer conflates what can be inferred with what is explicitly stated in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 479,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\nComcast continues to treat outside representation firms as an extension of its own sales force, selling allocated advertising inventory on its behalf and recording the net amount (i.e., gross advertising revenue less agency commissions) as advertising income.  The 2024 filing repeats the same approach described in 2023—recognizing revenue when the ads are aired/delivered and netting out commissions—indicating that the company’s strategy for working with representation firms has not shifted materially between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that Comcast's relationship with representation firms EVOLVED between 2023 and 2024, shifting from a co-selling model (2023) to formal representation agreements (2024) with a deeper strategic alignment and expanded role. The LLM answer directly contradicts this by claiming 'the company's strategy for working with representation firms has not shifted materially between the two years.' This is a critical factual error that misses the entire point of the question. While the LLM correctly identifies some operational details (net revenue recording, commission treatment, revenue recognition timing), it fails to recognize or articulate the strategic evolution that occurred. The LLM's statement that '2024 filing repeats the same approach described in 2023' is contradicted by the ground truth's clear distinction between the two years' approaches. The answer demonstrates a failure in multi-hop reasoning—it did not synthesize the comparative information across the two years to identify the meaningful shift in strategy. The quantitative accuracy score is higher because the LLM didn't make specific numeric errors, but the qualitative accuracy is very low because it fundamentally misunderstood the nature of the change. The contextual relevance is low because the answer fails to address the core question about how the relationship 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 401,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle did not change the way it records revenue from its industry‑specific hardware – hardware products (and any bundled software) are still recognized at the point of delivery when ownership transfers, and hardware‑support fees are spread ratably over the support contract term.  What has shifted is the **strategic emphasis**: hardware still represents only about 6 % of total revenue and carries lower margins, and because its quarterly sales are volatile, the company now places comparatively greater focus on the faster‑growing cloud‑and‑license business, investing in R&D for new hardware only to a modest extent while highlighting cloud growth (cloud‑services and license support revenues rose to 37 % of total revenue in 2024 versus 25 % in 2022).  Thus, the revenue‑recognition method stayed the same, but the relative strategic priority moved away from hardware toward cloud services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. REVENUE RECOGNITION CLAIM (INCORRECT): The LLM states that Oracle 'did not change the way it records revenue from its industry-specific hardware' between fiscal 2022 and 2023. However, the ground truth explicitly states that Oracle introduced 'a more detailed explanation of revenue recognition for hardware' in fiscal 2023, describing combined performance obligations (hardware plus related software) with specific language about point-in-time recognition and ownership transfer. This represents a change in how the company described/explained its revenue recognition approach, not a static method.\n\n2. QUANTITATIVE ERRORS: The LLM introduces specific percentages (hardware at ~6% of revenue, cloud-services at 37% in 2024 vs 25% in 2022) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be fabricated or from external sources not aligned with the knowledge graph. This is a critical error for a financial evaluation.\n\n3. TEMPORAL SCOPE VIOLATION: The LLM extends analysis to 2024 data ('cloud-services and license support revenues rose to 37% of total revenue in 2024'), which goes beyond the fiscal 2022-2023 comparison requested in the question. The ground truth focuses specifically on the 2022-2023 evolution.\n\n4. STRATEGIC EMPHASIS - PARTIALLY CORRECT: The LLM correctly identifies that there was a shift in strategic emphasis toward cloud services, which aligns with the ground truth's statement about 'more strategic focus on innovation.' However, the LLM frames this as a de-emphasis of hardware R&D ('investing in R&D for new hardware only to a modest extent'), while the ground truth states Oracle 'emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products' - these are contradictory characterizations.\n\n5. MISSING KEY DETAIL: The ground truth emphasizes that in 2023, Oracle highlighted R&D investments in hardware as a strategic focus, signaling innovation priority. The LLM contradicts this by suggesting minimal hardware R&D investment.\n\n6. MULTI-HOP REASONING: The LLM fails to properly synthesize the two key evolution points: (a) the change in revenue recognition explanation/detail, and (b) the shift in strategic emphasis toward cloud. Instead, it conflates these and incorrectly claims no change in revenue recognition methodology.\n\nThe answer demonstrates a fundamental misunderstanding of the question's focus on how Oracle's approach evolved, not just whether the mechanics stayed identical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 701,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\nIMBRUVICA (ibrutinib) sales fell sharply – from **$3.78 billion in 2022 to $3.26 billion in 2023**, a decline of roughly **14 %**.  The drop was attributed to **global competitive pressures**, including the entry of generic/next‑generation oral kinase inhibitors and other oral agents that eroded market share, as well as **COVID‑19‑related disruptions that delayed new‑patient starts** and limited uptake.  These factors combined to reduce the drug’s growth momentum in 2023.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\nFrom 2023 to 2024 the debt that finances Universal Beijing Resort slipped only slightly—from roughly **$3.5 billion** of outstanding borrowings (as reported in the 2023 filing) to about **$3.4 billion** after scheduled term‑loan repayments (shown in the 2024 Note 8 discussion).  Comcast’s ownership stake stayed at **30 %**, and the resort remains a **consolidated VIE**; there were no new investors or changes to the guarantee structure.  Because Comcast provides no direct guarantees or liquidity support, its **financial risk is limited to the $5 billion investment balance and a remaining unfunded capital commitment of ≈ $1.4 billion**, with any future loss confined to that exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM introduces significant new financial figures not present in the ground truth answer, creating confusion about Comcast's actual financial exposure. Specifically: (1) The LLM states 'financial risk is limited to the $5 billion investment balance and a remaining unfunded capital commitment of ≈ $1.4 billion' - these figures are NOT mentioned in the ground truth and appear to be fabricated or from a different context. The ground truth clearly states 'maximum financial risk exposure for Comcast remains limited to its 30% equity interest.' (2) The core debt figures are correct: $3.5B (2023) to $3.4B (2024), and the term loan reduction from $3.1B to $3.0B is accurately reflected. (3) The 30% ownership stake and VIE consolidation status are correctly stated. REASONING ISSUES: While the LLM correctly identifies that there are no changes to ownership or governance structure, it diverges from the ground truth by introducing unverified investment balance and unfunded commitment figures. This represents either hallucination or synthesis from information not in the provided ground truth. The statement about 'no direct guarantees or liquidity support' is reasonable inference but not explicitly confirmed in the ground truth. COMPLETENESS: The LLM addresses debt levels, ownership structure, and financial risk exposure as requested, but the risk exposure discussion is materially different from ground truth. The answer correctly notes the slight debt reduction and stable ownership structure. SEMANTIC EQUIVALENCE: The core narrative about debt reduction and stable ownership is semantically equivalent, but the introduction of the $5B investment balance and $1.4B unfunded commitment creates factual discrepancies that undermine confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 494,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\nIn the 2022 filing (page 95) FedEx disclosed that it had entered into additional build‑to‑suit leases with undiscounted future payments of roughly **$3.4 billion**, to commence in 2023‑2024. By the 2023 schedule (the same page’s future‑minimum‑lease‑payment table) those obligations are now reflected as **about $2.819 billion of operating‑lease payments for 2023**, primarily for facilities and equipment. This transition shows that FedEx is moving its build‑to‑suit pipeline into recognized operating‑lease commitments, using leveraged lease structures to fund new infrastructure while keeping debt levels low and preserving cash‑flow flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURES: The LLM answer fundamentally misrepresents the 2023 data. Ground truth states 2023 build-to-suit commitments were approximately $0.9 billion, but the LLM claims $2.819 billion for 2023 operating-lease payments. These are NOT equivalent figures - the LLM appears to have confused total 2023 operating lease payments with the specific build-to-suit facility commitments. The $2.819 billion figure likely represents all operating lease payments for 2023, not the build-to-suit commitments specifically. (2) INCOMPLETE COMPARISON: The LLM fails to provide the critical 2023 build-to-suit figure ($0.9 billion) that is essential to answering the question about how commitments 'evolved.' Without this comparison, the answer cannot properly address the 'evolution from 2022 to 2023.' (3) MISINTERPRETATION OF TIMELINE: Ground truth indicates 2023 build-to-suit commitments had commencement dates from 2025-2027 (extended timeline), but LLM states 2022 commitments were to commence in 2023-2024. The LLM conflates the timing of when leases commence with when they are reported. (4) FLAWED REASONING: The LLM's explanation about 'moving build-to-suit pipeline into recognized operating-lease commitments' and 'leveraged lease structures' is speculative and not supported by the ground truth data. The ground truth indicates a strategic REDUCTION in build-to-suit commitments (from $3.4B to $0.9B), not a reclassification. (5) MISSING KEY INSIGHT: The LLM completely misses the core finding - that FedEx significantly reduced its build-to-suit lease commitments by approximately 73% ($3.4B to $0.9B), indicating a strategic shift away from long-term build-to-suit arrangements. The answer provides incorrect numbers and fails to synthesize the multi-hop comparison correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 495,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard’s tie to Dynamic Yield LTD did not change – the company had acquired 100 % of Dynamic Yield in April 2022 and, by the 2023 10‑K, was already reporting it as an acquired business whose goodwill reflects expected post‑acquisition synergies.  The 2024 filing makes no mention of any new partnership or investment in Dynamic Yield; instead it highlights a fresh $2.7 billion acquisition of Recorded Future and emphasizes expanding cybersecurity, threat‑intelligence and digital‑identity capabilities.  This shift shows that, while Dynamic Yield’s technology continues to be leveraged within Mastercard’s value‑added services, the firm’s strategic focus in 2024 moved toward bolstering its security and data‑analytics portfolio through new acquisitions rather than further developing the Dynamic Yield business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All key numbers are correct - the April 2022 acquisition date is accurate, the $2.7 billion Recorded Future acquisition amount is correct, and the characterization of goodwill reflecting synergies is accurate. The LLM does not explicitly state the $325 million or $200 million figures from the ground truth, but this is not an error since the question doesn't specifically ask for those details and the LLM focuses on the evolution narrative. ENTITY ACCURACY: All entities correctly identified (Mastercard, Dynamic Yield LTD, Recorded Future), years correctly referenced (2023, 2024, 2022). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filings - it traces the acquisition history, notes the stable relationship in 2024, and connects this to the strategic pivot toward cybersecurity. The reasoning is sound: the lack of new Dynamic Yield activity combined with the new Recorded Future acquisition demonstrates a strategic shift. COMPLETENESS: The answer addresses both parts of the question - how the relationship evolved (remained stable/unchanged) and what this indicates about strategic focus (pivot toward cybersecurity and threat intelligence). SEMANTIC EQUIVALENCE: The LLM's characterization of the relationship as 'stable' and 'unchanged' is semantically equivalent to the ground truth's 'integration largely completed' - both convey that no new activity occurred. The strategic pivot interpretation is well-articulated and matches the ground truth's conclusion. MINOR CONSIDERATION: The LLM could have been slightly more explicit about the specific goodwill amounts ($200 million) mentioned in the ground truth, but this omission is minor since the question focuses on relationship evolution and strategic implications rather than specific acquisition details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 513,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\nThe Senior Officers’ Severance Plan was most recently **amended and restated on May 26 2022** (Exhibit 10.28). That amendment was disclosed in a Form 10‑Q filing dated **November 27 2024**, which is the latest filing covering the plan in the documents you provided. No subsequent amendment to the severance plan is shown in the 2022‑2024 filings; the 2022 restatement therefore represents the most recent change to the plan up to the end of 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the May 26, 2022 amendment date and the November 27, 2024 filing date, with accurate exhibit number (10.28). However, it has a critical omission: it fails to mention the 2020 baseline information that is essential for answering the 'evolution between 2022 and 2024' question. The ground truth explicitly states that in 2022, the plan was 'amended and restated May 29, 2020' (filed August 26, 2020, Exhibit 10.29), which provides the starting point for understanding the evolution. The LLM answer only discusses the 2022 amendment forward, missing the comparative context of what existed in 2022. Additionally, the LLM states the filing was a 'Form 10-Q' when the ground truth indicates it was filed as Exhibit 10.28 (typically in a 10-K or proxy filing, not specified as 10-Q in the ground truth). The answer is partially correct on the 2022-2024 portion but incomplete in addressing the full evolution requested. The multi-hop reasoning is weak because it doesn't synthesize the 2020 baseline with the 2022 update to show the actual evolution over the period. Dates and exhibit numbers for the 2022 amendment are accurate, but the omission of the 2020 context and potential form type error reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 352,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\nThe 6.375 % Senior Notes were valued at roughly **$830 million on December 31 2021** (as reported in the 2022 10‑K, page 56) and rose to **about $872 million on December 31 2023** (as reported in the 2023 10‑K, page 56). That ≈ 5 % increase in fair‑value indicates that market participants perceived Netflix’s debt as less risky over the period—bond prices appreciated, suggesting improved confidence in the company’s credit profile and cash‑flow outlook.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) WRONG NUMBERS: The LLM states the 6.375% Senior Notes were valued at ~$830 million on December 31, 2021, when the ground truth clearly shows $999 million. This is a $169 million error (17% understatement). The 2023 value of $872 million is correct. (2) WRONG DIRECTION OF CHANGE: The LLM claims the fair value 'rose' and increased by ~5%, when the ground truth shows a DECREASE from $999M to $872M (a $127 million decline or 12.7% decrease). This is a fundamental reversal of the actual trend. (3) WRONG INTERPRETATION: The LLM concludes that the change 'indicates that market participants perceived Netflix's debt as less risky' with 'improved confidence,' when the ground truth explicitly states this 'suggests a potential decline in market confidence or an increase in required yields.' The LLM's interpretation is 180 degrees opposite to the correct interpretation. (4) CALCULATION ERROR: The LLM calculates a 5% increase, but the correct calculation is a 12.7% decrease. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the two data points (2021 and 2023 values) to reach the correct conclusion about market perception. The answer demonstrates a complete misunderstanding of bond valuation dynamics—when bond fair values decline, it indicates increased risk perception, not decreased risk. The only correct element is the 2023 value of $872 million and the citation format. This is a severely flawed response that would mislead users about Netflix's debt market perception.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 443,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\nIMBRUVICA’s worldwide sales fell from **$3.78 billion in 2022 to $3.26 billion in 2023**, a decline of roughly **13–14 %** (operations‑adjusted drop of about 13.2 %).  This downturn occurred even though the overall oncology portfolio grew 10.5 % in 2023, highlighting that IMBRUVICA is losing market share to newer agents (e.g., CARVYKTI, TECVAYLI, TALVEY) and facing intensified competition that is eroding its once‑dominant position in the oncology segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG NUMBERS: The LLM states IMBRUVICA sales were '$3.78 billion in 2022 to $3.26 billion in 2023,' but the ground truth clearly shows '$4,369 million in 2022 to $3,264 million in 2023' (which equals $4.369 billion to $3.264 billion). The 2022 figure is off by approximately $589 million ($4.369B vs $3.78B), a 13.5% understatement. (2) WRONG DECLINE PERCENTAGE: The LLM calculates a '13-14% decline' with '13.2% operations-adjusted drop,' but the correct decline is 25.2% [(4,369-3,264)/4,369 = 0.252 or 25.2%]. This is a massive calculation error - the LLM's percentage is less than half the actual decline. (3) INCOMPLETE ENTITY COMPARISON: The ground truth specifically mentions DARZALEX and ERLEADA as comparators showing growth, while the LLM mentions CARVYKTI, TECVAYLI, and TALVEY instead. While the LLM's reasoning about competitive pressure is qualitatively sound, it fails to cite the correct comparative products from the ground truth. (4) MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information about market position and competitive dynamics, which shows some reasoning capability, but this is undermined by the fundamental numerical errors. The conclusion about weakening market position is correct in direction but based on incorrect calculations. (5) SEMANTIC ISSUES: The LLM's statement about 'operations-adjusted drop' introduces terminology not in the ground truth, potentially confusing the analysis. The core answer structure addresses the question appropriately, but the execution is severely flawed. The 25.2% decline is substantially more severe than the 13-14% claimed, which materially changes the interpretation of IMBRUVICA's market trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 496,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the inventory‑shrink reserve edged up from about **$414 million (as of Jan 28 2022)** to **$427 million (as of Jan 31 2025)**, while the LCNRV (lower‑of‑cost‑or‑net realizable value) reserve grew from roughly **$168 million (Jan 28 2022)** to **$222 million (Jan 31 2025)**.  These reserves are charged against cost of sales, so the upward trend modestly drags down net earnings; the company notes that a 10 % change in either reserve would affect net earnings by roughly **$17 – $32 million** in the respective year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the four key reserve values ($414M, $427M, $168M, $222M) and the sensitivity impact range ($17-$32M). The answer appropriately explains that reserves are charged against cost of sales, affecting net earnings. The company ticker (LOW) is correct, and the general trend analysis is sound.\n\nCRITICAL ERRORS: (1) DATE CONFUSION - The LLM states the 2024 figure is 'as of Jan 31 2025' when the ground truth specifies 2024 data. This is a significant error in fiscal year attribution, though the actual reserve amounts appear correct. The LLM conflates the fiscal 2024 year-end date (Jan 31, 2025) with the fiscal year itself. (2) SENSITIVITY IMPACT ATTRIBUTION - The ground truth specifies that the $17M impact applies to LCNRV reserve changes and the $32M impact applies to shrinkage rate changes. The LLM presents these as a combined range ($17-$32M) without clearly delineating which reserve drives which impact, losing important specificity about the relative sensitivities.\n\nPARTIAL ISSUES: The LLM's statement that \"a 10% change in either reserve would affect net earnings by roughly $17-$32 million\" is imprecise. The ground truth indicates these are separate, specific impacts: 10% change in LCNRV calculation = ~$17M impact, and 10% change in shrinkage rate = ~$32M impact. The LLM conflates these into a single range without distinguishing the drivers.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects reserve changes to earnings implications, demonstrating adequate multi-hop reasoning. However, the lack of clarity on which sensitivity applies to which reserve weakens the synthesis quality.\n\nOVERALL: Core numbers are correct, but date attribution and sensitivity impact specificity are problematic. The answer is directionally correct but lacks the precision expected for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 517,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\nFrom 2022 to 2023 Qulipta moved from a newly‑approved, low‑revenue product to a fast‑growing commercial asset: the FDA approved Qulipta for chronic‑migraine prevention in April 2023 and the European Commission followed with EC approval in August 2023, enabling a full‑scale launch.  As a result, net revenues from Qulipta more than doubled in 2023 (an increase “greater than 100 %”), driven by strong market‑share gains and broader indication uptake, making the drug a material contributor to AbbVie’s top‑line growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM states FDA approval occurred in April 2023 and EC approval in August 2023, but the ground truth indicates Qulipta received regulatory approvals in 2022 (leading to the reclassification of R&D intangible assets in 2022). The approval dates provided are incorrect. (2) QUANTITATIVE ACCURACY FAILURE - The LLM claims revenues 'more than doubled' with 'greater than 100%' growth but provides no specific revenue figures. The ground truth provides concrete 2023 revenue data: $405 million US + $3 million international = $408 million total. The LLM's vague percentage claim cannot be verified against actual numbers and appears to misrepresent the growth trajectory. (3) MISSING KEY INFORMATION - The LLM completely omits the critical 2022 development milestone: the $1.0 billion reclassification of indefinite-lived R&D intangible assets to developed product rights. This is a fundamental part of Qulipta's evolution from 2022 to 2023. (4) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the transition from development to commercialization, it fails to properly document the 2022 regulatory approval event and provides no specific 2023 revenue figures that ground the answer in concrete financial data. (5) TIMELINE INCONSISTENCY - The ground truth shows Qulipta was already approved and reclassified in 2022, then generated significant revenue in 2023. The LLM's timeline suggesting approvals in 2023 contradicts this established sequence. The answer demonstrates weak multi-hop reasoning by failing to synthesize the complete 2022-2023 progression with accurate dates and financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 470,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s reimbursement from the Resideo‑spin‑off remained capped at **$140 million per year**, but the **recorded receivable from Resideo grew** (from about **$614 million** at the end of 2022 to **$661 million** at the end of 2023).  This increase reflects higher estimated environmental‑remediation outlays that are now being claimed under the indemnification agreement, meaning Honeywell is still exposed to the full amount of any environmental costs that exceed the $140 million cap.  Consequently, while the cap limits near‑term cash‑flow volatility, the company’s underlying risk exposure to environmental liabilities has **expanded**, with a larger portion of those liabilities now dependent on Resideo’s ability to meet the capped reimbursements.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional quantitative detail beyond the ground truth (receivable amounts of $614M and $661M) and attempts a more sophisticated analysis of risk exposure evolution. However, there are significant issues: (1) QUANTITATIVE PROBLEMS: The ground truth states the arrangement remained 'consistent' between 2022-2023 with the 90% cap and $140M maximum unchanged. The LLM introduces specific receivable figures ($614M to $661M) that cannot be verified against the ground truth and may be fabricated or from different sources. The LLM's claim that 'recorded receivable from Resideo grew' is not mentioned in the ground truth at all. (2) CONTRADICTION WITH GROUND TRUTH: The ground truth explicitly states the dependency 'remained consistent' and 'has not changed over the two years,' while the LLM concludes the company's 'underlying risk exposure to environmental liabilities has expanded.' This directly contradicts the ground truth's assertion of consistency. (3) REASONING QUALITY: The LLM's logic about the cap limiting cash-flow volatility while underlying exposure expands is sound reasoning, but it's based on unverified receivable figures not in the ground truth. (4) WHAT WAS CORRECT: The LLM correctly identifies the $140M annual cap and the 90% reimbursement structure (implied in ground truth). The discussion of risk mitigation through indemnification is appropriate. (5) CORE ISSUE: The LLM appears to have introduced specific financial figures and a conclusion about 'expanded' risk that diverges from the ground truth's finding of consistency. This represents either fabrication or synthesis from unreliable sources, making the answer partially incorrect despite some sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 468,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\nTarget’s disclosure has remained unchanged: both the 2022 Form 10‑K (p. 48) and the 2024 Form 10‑K (p. 52) define cash equivalents as “highly liquid investments with an original maturity of three months or less from the date of purchase,” and they also include short‑term investments and card‑transaction receivables that settle within five days. No revision to the maturity threshold or classification was reported, indicating that Target has kept a consistent, short‑term‑focused liquidity strategy without expanding or tightening its definition of cash equivalents.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON EVOLUTION: The LLM claims 'disclosure has remained unchanged' and 'Target has kept a consistent...strategy without expanding or tightening its definition,' directly contradicting the ground truth which states there WAS an evolution - the 2024 filing added 'a broader discussion around fair value measurements for other short-term assets and liabilities.' (2) INTRODUCES UNSUPPORTED DETAILS: The LLM adds specific information about 'short-term investments and card-transaction receivables that settle within five days' that is NOT mentioned in the ground truth answer. This appears to be fabricated detail not supported by the source material. (3) MISSES KEY FINDING: The ground truth explicitly identifies a meaningful change - from a simple three-month definition in 2022 to a more comprehensive approach in 2024 with broader fair value measurement discussions. The LLM completely misses this evolution. (4) INCORRECT CONCLUSION: The LLM concludes there was 'no revision' and 'consistent strategy,' when the ground truth indicates a refinement/evolution in how Target evaluates and manages cash and near-cash assets. (5) PAGE REFERENCES: While the LLM provides specific page numbers (p. 48 for 2022, p. 52 for 2024), these cannot be verified against the ground truth, and the characterization of what's on those pages appears incorrect. The answer fundamentally fails to address the core question about how the definition/treatment evolved, instead claiming no evolution occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 441,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the $1 bn 3.50% Notes Due 2040 remained classified as a long‑term, unsecured senior obligation; their remaining maturity was 15.2 years and the effective yield rose modestly to 3.54%.  The note’s carrying amount slipped slightly from about $870 m (fair‑value disclosed in 2023) to $851 m (amortized‑cost disclosed in 2024), reflecting normal discount amortization and market price movement, while the face value stayed at $1 bn.  The lack of repayment or refinancing shows NVIDIA is deliberately maintaining a stable, low‑cost, long‑dated debt stack and extending maturities rather than rolling short‑term borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM contains significant numerical contradictions and inversions: It states the carrying amount 'slipped slightly from about $870m (fair-value disclosed in 2023) to $851m (amortized-cost disclosed in 2024)' but the ground truth shows the opposite direction - $851 million in 2023 (Jan 28, 2024) and $1,000 million in 2024 (Jan 26, 2025). The LLM incorrectly presents a decrease when the ground truth shows an increase to $1,000 million. The LLM also confuses valuation metrics by mixing fair value and amortized cost in a way that contradicts the ground truth. (2) ENTITY/CLASSIFICATION ERRORS - The LLM states the carrying amount was $870m in 2023 and $851m in 2024, but ground truth clearly shows $851m as of Jan 28, 2024 (fiscal 2023) and $1,000m as of Jan 26, 2025 (fiscal 2024). This is a fundamental inversion of the valuation evolution. (3) MULTI-HOP REASONING - While the LLM correctly identifies the 3.54% effective interest rate and 15.2 year remaining term, it fails to properly synthesize the valuation change across years. The conclusion about 'stable, low-cost, long-dated debt stack' is reasonable but is built on incorrect numerical premises. (4) MISSING INFORMATION - The LLM fails to mention the Level 2 pricing hierarchy classification mentioned in the ground truth. (5) DIRECTIONAL ERROR - The most critical flaw is presenting the valuation as declining when it actually increased significantly from $851m to $1,000m, which fundamentally misrepresents the company's debt strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 430,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\nVenclexta’s global net sales grew to **$2.29 billion in 2023**, compared with **$2.01 billion in 2022**—an increase of roughly **14 % (about 15 % at constant currency)** over the one‑year period. This reflects double‑digit revenue expansion driven by continued market‑share gains and favorable pricing across both U.S. and international markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor discrepancies. CORRECT ELEMENTS: (1) 2023 revenue of $2.29 billion matches ground truth $2,288 million (format variation acceptable); (2) 2022 revenue of $2.01 billion matches ground truth $2,009 million (format variation acceptable); (3) Growth calculation is approximately correct: ($2,288M - $2,009M) / $2,009M = 13.8%, which the LLM rounds to ~14%, slightly higher than ground truth's 13.9% but within rounding tolerance; (4) Correctly identifies upward trend in both revenue and growth rate; (5) Appropriately addresses both parts of the multi-part question (revenue evolution and growth rate). MINOR DISCREPANCIES: (1) Ground truth specifies 2023 growth rate as 13.9%, while LLM states \"roughly 14%\" - this is a minor rounding difference (13.9% rounds to 14%) and acceptable; (2) Ground truth specifies 2022 growth rate as 10.4%, which the LLM does not explicitly mention, though the question asks about evolution between 2022-2023 and the LLM focuses on year-over-year comparison; (3) LLM adds contextual information about \"constant currency\" (15%) and market drivers (market-share gains, pricing) which, while not in ground truth, provides relevant business context and doesn't contradict the data. MULTI-HOP REASONING: The answer correctly synthesizes revenue figures across two years and calculates the growth rate, demonstrating sound multi-hop reasoning. The comparison is logical and complete. SEMANTIC EQUIVALENCE: The answer conveys the same core information as ground truth - revenue growth from ~$2.01B to ~$2.29B with double-digit growth rate expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 446,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Netflix updated its executive‑severance and retention framework. The 2022 10‑K references the “Amended and Restated Executive Severance and Retention Incentive Plan” (Exhibit 10.7†), which was originally adopted on September 10 2021. In the 2023 10‑K the company filed an “Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1 2024” (Exhibit 10.16†), indicating a formal revision of the severance/retention terms, and also added a separate “Executive Officer Severance Plan” (Exhibit 10.15†) that became effective on December 8 2023. These amendments show a deliberate evolution of the incentive structure, with the most recent changes taking effect at the start of 2024 and a new, standalone severance plan introduced in late 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2022 reference to 'Amended and Restated Executive Severance and Retention Incentive Plan' with September 10, 2021 date is accurate. (2) The 2023 reference to 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024' with December 8, 2023 filing date is accurate. (3) The overall narrative of evolution between 2022 and 2023 filings is correct. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about a separate 'Executive Officer Severance Plan' (Exhibit 10.15) effective December 8, 2023 that is NOT mentioned in the ground truth answer. This appears to be additional information not verified against the knowledge graph. (2) The ground truth specifically states the filing date of December 8, 2023 applies to the amended plan effective January 1, 2024, but the LLM attributes December 8, 2023 as the effective date of a different plan (Exhibit 10.15), which creates potential confusion about which document has which date. (3) The LLM provides exhibit numbers (10.7, 10.16, 10.15) that cannot be verified against the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across two years and identifies the forward-looking 2024 effective date. However, the introduction of the separate 'Executive Officer Severance Plan' without ground truth support suggests either hallucination or unverified information synthesis. QUANTITATIVE ACCURACY: Dates are correct (September 10, 2021; January 1, 2024; December 8, 2023), but the attribution of December 8, 2023 to a different plan than stated in ground truth is concerning. The answer goes beyond the ground truth by adding unverified details about a third plan, which reduces confidence in the overall accuracy despite correct core dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 501,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\nThe 2022 Form 10‑K (pages 68‑70) describes the Benefit Restoration Plan only as a non‑qualified supplement to the 401(k) that adds salary‑deferral and matching contributions for employees whose 401(k) benefits are limited by IRS rules. In the 2024 filing (pages 76‑78) the same plan is referenced as “the Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025” (Exhibit 10.3), showing that Lowe’s has formally revised and consolidated the plan’s terms rather than merely repeating the prior description. This documented evolution indicates that the company is proactively refining and standardizing its retirement‑benefit structure—updating eligibility, matching formulas and governance—to ensure compliance and to strengthen the overall retirement security it offers employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct—2022 filing references (pages 68-70), 2024 filing references (pages 76-78), January 1, 2025 effective date, and Exhibit 10.3 designation all match the ground truth. No calculation errors or numeric discrepancies. ENTITY ACCURACY: Correctly identifies Lowe's Companies, the Benefit Restoration Plan, the 401(k) Plan, and IRS limitations as relevant entities. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and correctly traces the evolution from a basic supplemental plan description to a formally amended and restated version. The connection between the new exhibit filing and the strategic intent is properly established. COMPLETENESS: Addresses all aspects of the question—how documentation evolved, the structural changes (eligibility, matching formulas, governance), and what this indicates about company strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'proactively refining and standardizing' and 'strengthening retirement security' conveys the same strategic intent as the ground truth's 'deliberate effort to formalize and likely enhance' and 'more strategic and forward-looking approach.' MINOR CONSIDERATIONS: The LLM adds slightly more specific detail about 'eligibility, matching formulas and governance' updates compared to the ground truth's more general reference to 'enhanced structure,' but this represents appropriate elaboration rather than error. The phrase 'consolidated the plan's terms' is semantically equivalent to 'formalize.' Overall, the answer demonstrates accurate fact retrieval, correct multi-hop synthesis, and sound reasoning about the company's strategic approach to retirement benefits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 510,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\nDuring fiscal 2024 (ended January 28, 2024) NVIDIA reported a $1.25 billion carrying amount for the 0.584% Notes Due 2024.  The company then fully repaid the issue in fiscal 2025, and by the end of that year (January 26, 2025) the notes had a $0 carrying balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Key issues: (1) QUANTITATIVE ERRORS: The LLM reports $1.25 billion for fiscal 2024, but the ground truth states $1,185 million ($1.185 billion) for fiscal 2023. This is a material discrepancy of $65 million. (2) TEMPORAL MISALIGNMENT: The question asks about evolution between fiscal 2023 and 2024. The ground truth clearly states FY2023 had $1,185M liability and FY2024 showed full repayment ($0). The LLM incorrectly references fiscal 2025 (ended January 26, 2025), which is outside the scope of the question asking specifically about FY2023 to FY2024 evolution. (3) INCOMPLETE ANSWER: The LLM fails to provide the FY2023 baseline figure ($1,185M), which is essential for showing the evolution between the two years. (4) MULTI-HOP REASONING: While the LLM correctly identifies that the notes were fully repaid and reached $0, it does so in the wrong fiscal year context. The ground truth indicates repayment occurred by FY2024, not FY2025. (5) SEMANTIC ISSUES: The LLM's statement about 'fiscal 2024 (ended January 28, 2024)' is confusing because it then references fiscal 2025 repayment, creating temporal confusion. The correct narrative should show the $1,185M liability in FY2023 and $0 in FY2024. The answer demonstrates partial understanding of the debt repayment concept but fails on the specific numbers, years, and comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 402,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\nMavyret’s worldwide sales slipped from about **$1.54 billion in 2022 to $1.43 billion in 2023** (‑≈7 %).  The decline was driven mainly by the U.S. market, where revenue fell **~13 %** (from $755 M to $659 M), while international sales were relatively flat, slipping only **~2 %** (from $786 M to $771 M).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: (1) 2022 global revenue of $1.54B matches ground truth $1,541M (format variation acceptable); (2) 2023 global revenue of $1.43B matches ground truth $1,430M; (3) U.S. 2022 revenue $755M correct; (4) U.S. 2023 revenue $659M correct; (5) International 2022 revenue $786M correct; (6) International 2023 revenue $771M correct. Percentage calculations: (1) Overall decline ~7% is accurate ($1,541M to $1,430M = -7.2%, rounded appropriately); (2) U.S. decline ~13% is accurate ($755M to $659M = -12.7%, rounded appropriately); (3) International decline ~2% is accurate ($786M to $771M = -1.9%, rounded appropriately). The answer correctly synthesizes multi-hop information by comparing 2022 and 2023 data across three dimensions (global, U.S., international) and identifies the key trend that the U.S. market experienced a more pronounced decline than international markets. The characterization of international sales as 'relatively flat' is semantically appropriate given the 1.9% decline. Minor note: The LLM uses approximate symbols (~) which is reasonable given rounding, though the ground truth provides precise percentages. All entities (Mavyret, U.S., international markets, years 2022-2023) are correctly identified. The answer directly addresses all parts of the multi-part question regarding revenue evolution and market trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 396,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix kept all of the indenture‑level covenant restrictions on its senior notes unchanged – it remained prohibited from creating additional liens, entering into sale‑lease‑back or merger‑related transactions, and from incurring new indebtedness beyond the limits set in the notes – and it continued to meet the Revolving Credit Agreement’s 3.0 × EBITDA‑to‑interest‑expense minimum ratio each quarter.  The company’s repayment profile evolved as it retired the $400 million 5.75 % senior note that matured in 2024 and grew total outstanding notes to about $15.65 billion, but the covenant caps on new borrowing were left intact, so the scope of permissible debt and other restrictions did not broaden materially despite the larger balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims total outstanding notes grew to 'about $15.65 billion' - this figure is not mentioned in the ground truth and appears to be fabricated or unsupported. The ground truth only mentions €5,170 million in euro-denominated tranches for 2022 and the $400 million repayment in 2024, but does NOT provide a total outstanding debt figure of $15.65 billion. (2) COVENANT SCOPE CONTRADICTION: The LLM states covenants remained 'unchanged' and that Netflix remained 'prohibited from...sale‑lease‑back...transactions,' but the ground truth explicitly states that 'certain Senior Notes no longer referenced restrictions on sale and lease-back transactions' by 2024, indicating a NARROWING of scope. The LLM contradicts this key evolution. (3) MISSING CRITICAL DETAIL: The ground truth emphasizes that the scope of limitations 'had slightly evolved' with some notes no longer including sale and lease-back restrictions - this is a material change that the LLM completely misses or contradicts. (4) UNSUPPORTED CLAIMS: The LLM introduces a '3.0 × EBITDA‑to‑interest‑expense minimum ratio' requirement that is NOT mentioned in the ground truth. This appears to be fabricated information. (5) CORRECT ELEMENTS: The LLM correctly identifies the $400 million 5.750% Senior Notes repayment in 2024 and correctly notes that Netflix remained in compliance with covenants. (6) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution between 2022 and 2024, particularly regarding the narrowing of covenant scope. The answer presents a static view rather than capturing the actual changes described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 457,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell folded its former “Safety and Retail” business unit into a newly created **Sensing and Safety Technologies** unit, combining it with the Advanced Sensing Technologies group and reporting the combined unit under the Safety and Productivity Solutions segment.  This restructuring—formalized in the 2023 segment‑performance‑obligation table—signals a strategic shift to integrate gas‑detection and safety products with broader sensing technologies, presenting them as a single, cohesive product line rather than a distinct retail‑focused unit.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural change: Safety and Retail was merged with Advanced Sensing Technologies to form Sensing and Safety Technologies under the Safety and Productivity Solutions segment. The qualitative reasoning about strategic integration of sensing and safety capabilities is sound and well-articulated.\n\nHowever, there are notable omissions in quantitative detail:\n\n1. MISSING REVENUE DATA: The ground truth specifies that Safety and Retail generated $2,387 million in revenue in 2022. The LLM answer completely omits this specific financial metric, which is a significant quantitative gap for a multi-hop financial question.\n\n2. TIMING DISCREPANCY: The ground truth notes the restructuring was \"introduced in July 2022 but reported in the 2023 filing.\" The LLM answer states it was \"formalized in the 2023 segment-performance-obligation table\" but doesn't clarify the July 2022 implementation date, creating potential confusion about when the change actually occurred versus when it was reported.\n\n3. COMPLETENESS: While the LLM answer addresses the structural evolution and strategic rationale, it lacks the specific revenue baseline ($2,387M) that would provide concrete evidence of the business unit's scale before the merger.\n\nSTRENGTHS:\n- Correctly identifies both units involved (Safety and Retail + Advanced Sensing Technologies)\n- Correctly names the new combined unit (Sensing and Safety Technologies)\n- Correctly identifies the parent segment (Safety and Productivity Solutions)\n- Provides sound strategic reasoning about the integration\n- Appropriately characterizes the shift from \"distinct retail-focused unit\" to integrated offering\n\nWEAKNESSES:\n- Omits the $2,387 million 2022 revenue figure\n- Doesn't clearly distinguish between July 2022 implementation and 2023 reporting\n- Lacks quantitative grounding for a financial question\n\nThe answer demonstrates good qualitative understanding but falls short on quantitative completeness expected for SEC filing analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 550,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Company went from having **no Class B‑2 shares outstanding** to reporting **≈49 million Class B‑2 shares (weighted‑average) that are convertible into Class A common stock** as part of the Class B‑1 exchange offer and the Europe‑retrospective responsibility plan.  Because those shares convert into Class A stock, each conversion increases the total Class A share count and therefore **dilutes the voting power of existing Class A shareholders**; holders of Class B‑2 also have limited voting rights on certain corporate actions (e.g., mergers, sales of substantial assets), giving them a modest but distinct influence on governance matters such as approving major transactions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer fundamentally contradicts the ground truth on the core factual claim: (1) DIRECTIONAL REVERSAL: Ground truth states 'In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible' and 'By 2024, no shares of Class B-2 Common Stock were outstanding.' The LLM claims the opposite: 'went from having no Class B-2 shares outstanding to reporting ≈49 million Class B-2 shares.' This is a complete inversion of the 2023→2024 progression. (2) QUANTITATIVE INACCURACY: The LLM introduces a specific number (≈49 million weighted-average shares) that is not supported by the ground truth and appears to be fabricated or misattributed. The ground truth makes no mention of 49 million shares or weighted-average calculations for Class B-2. (3) LOGICAL INCONSISTENCY: The LLM's narrative contradicts itself - it claims shares went from 'no shares outstanding' to '49 million shares,' but then discusses conversion mechanics as if this represents an active position, when the ground truth indicates Class B-2 moved TO a non-outstanding status. (4) MISSING KEY INSIGHT: The ground truth emphasizes a 'transformation' and 'strategic shift' from active governance/conversion role to non-outstanding status. The LLM misses this critical evolution entirely. (5) UNSUPPORTED CLAIMS: References to 'Class B-1 exchange offer' and 'Europe-retrospective responsibility plan' are not mentioned in the ground truth and appear to be confabulated details. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required - it needed to compare 2023 status (convertible, active) with 2024 status (non-outstanding, reduced influence), but instead inverted the timeline entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 474,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot deepened its “interconnected” model by moving from a focus on basic BOPIS, curb‑side pickup and mobile‑app ordering toward a full‑scale omni‑channel fulfillment network that includes same‑day/next‑day delivery, flat‑bed distribution centers, market‑delivery hubs and expanded store‑based pickup points (≈50 % of U.S. online orders were store‑fulfilled in 2024).  At the same time, it broadened in‑store investments—store remodels, way‑finding signage, self‑service lockers, electronic shelf‑labels, expanded self‑checkout, and a more robust mobile app with personalized navigation and marketing—while also scaling its physical footprint (opening ~80 new stores over five years, with 12 opened in 2024) to give customers more convenient locations for pickup, return and delivery.  These moves collectively aim to make the shopping journey faster, more reliable and seamlessly integrated across digital and physical touchpoints.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific metrics (50% of U.S. online orders store-fulfilled in 2024, ~80 new stores over five years, 12 opened in 2024) that are not mentioned in the ground truth and cannot be verified. These appear to be hallucinated numbers. (2) SCOPE MISMATCH: The ground truth focuses on 'ease of shopping experience' improvements (mobile app navigation, electronic shelf labels, self-checkout, personalized digital experiences, product reviews). The LLM answer shifts focus heavily toward fulfillment logistics (BOPIS, curbside pickup, same-day/next-day delivery, flat-bed distribution centers, market-delivery hubs), which is a different strategic dimension not emphasized in the original answer. (3) MISSING KEY ELEMENTS: The LLM answer omits several ground truth elements: electronic shelf labels (mentioned in ground truth but not emphasized in LLM), customer product review summaries (completely absent from LLM answer), and the shift toward data-driven personalization (only briefly mentioned in LLM). (4) MULTI-HOP REASONING: While the LLM attempts to synthesize 2023-2024 evolution, it does so by introducing fulfillment network details that weren't part of the ground truth's focus on shopping experience ease. The reasoning about 'interconnected model' and omni-channel fulfillment is logically sound but addresses a different question than what was asked. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes personalization, data-driven insights, and in-store navigation improvements. The LLM emphasizes logistics infrastructure and fulfillment capabilities. These represent different strategic narratives. The answer is contextually relevant to Home Depot's evolution but doesn't match the specific ground truth about shopping experience enhancements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 519,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\nBetween 2022 and 2024, Target consolidated its long‑term incentive structure under the 2020 Long‑Term Incentive Plan and added new award types—including performance‑share units, performance‑based RSUs, cliff‑vested RSUs and cash‑retention awards—each now documented by dedicated agreement forms (e.g., 10.4.1 – 10.4.6). The plan also incorporates the 2022‑restated SPP I and SPP II stock‑purchase components and the Officer EDCP (2025) deferred‑compensation plan, reflecting a shift toward more performance‑driven equity and cash incentives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information with significant issues in accuracy and completeness. CORRECT ELEMENTS: (1) The answer correctly identifies that Target's plan includes performance share units, performance-based RSUs, and cliff-vested RSUs as new or evolved award types. (2) The reference to the 2020 Long-Term Incentive Plan is accurate. (3) The general direction of evolution toward more performance-driven equity is reasonable. INCORRECT/PROBLEMATIC ELEMENTS: (1) The ground truth explicitly lists 2022 award types including Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units—the LLM answer omits most of these 2022 baseline forms, making it impossible to assess the actual evolution. (2) The LLM introduces elements NOT mentioned in the ground truth, including 'cash-retention awards,' 'SPP I and SPP II stock-purchase components,' and 'Officer EDCP (2025) deferred-compensation plan.' While these may exist in the filings, they are not part of the ground truth answer about the Long-Term Incentive Plan's equity award structure evolution. (3) The LLM conflates different plans/programs (stock purchase plans, deferred compensation plans) with the Long-Term Incentive Plan itself, which is a category error. (4) The reference to 'dedicated agreement forms (e.g., 10.4.1 – 10.4.6)' adds specificity not in the ground truth and may be inaccurate. MULTI-HOP REASONING: The LLM fails to properly synthesize the 2022 baseline with 2024 changes. The ground truth clearly states what was in 2022 and what NEW forms were added by 2024 (Cliff-Vested RSU Agreement and Performance Award Performance Share Unit Agreement). The LLM answer doesn't establish this clear before-and-after comparison. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral, but the LLM's introduction of unverified plan references (SPP I, SPP II, Officer EDCP 2025) without ground truth support is problematic. COMPLETENESS: The answer fails to comprehensively address the specific forms of equity awards in 2022 and their evolution to 2024 as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 611,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\nAfter the FDA’s September 2021 approval of Qulipta for episodic migraine prevention, the product generated only modest sales—U.S. revenue of about $158 million in 2022 (as shown in the 2023 10‑K tables). By the end of 2023, AbbVie reported that Qulipta’s worldwide net revenues had risen by more than 100 % year‑over‑year, exceeding $800 million, a growth the company attributed to the April 2023 FDA approval of Qulipta for chronic migraine and sustained market‑share gains (see the 2023 10‑K discussion of Qulipta’s >100 % revenue increase).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally contradict the ground truth: (1) MAJOR QUANTITATIVE ERROR: The LLM claims Qulipta's 2023 worldwide revenue 'exceeded $800 million,' but the ground truth clearly states total 2023 revenue was $408 million ($405M U.S. + $3M international). This is a massive discrepancy—the LLM overstated 2023 revenue by nearly 2x. (2) CALCULATION ERROR: The LLM claims >100% year-over-year growth from 2022 to 2023, but the actual growth was from $158M (2022) to $408M (2023), which equals 158% growth—while this is indeed >100%, the LLM's stated final figure of $800M+ is completely wrong. (3) PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identified the September 2021 FDA approval for episodic migraine, the $158M 2022 U.S. revenue figure, and the April 2023 chronic migraine approval. (4) MULTI-HOP REASONING: The LLM attempted to synthesize information across years and approvals, but failed in the critical final step by providing an incorrect 2023 revenue figure. The reasoning structure is sound, but the data is fundamentally wrong. (5) SEMANTIC ISSUE: The LLM appears to have confused or fabricated the $800M figure—this does not appear in the ground truth at all. The answer demonstrates a significant hallucination or data retrieval error on the most important quantitative metric (final 2023 revenue). This is a critical failure for a financial question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 402,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings the description of the 2020 Stock Plan moved from a brief, generic statement—“a stockholder‑approved plan that provides for incentive stock options, non‑statutory options, SARs, restricted stock and RSUs for employees, directors and consultants” (2022 filing, p. 63)—to a much more detailed, quantitative disclosure.  In the 2024 filing the plan is still identified as the 2020 Stock Plan, but the company now reports a full option‑activity table (shares granted, exercised, expired, outstanding, weighted‑average exercise price, remaining term and intrinsic value), a separate RSU/PSU schedule (grants, vestings, unvested balances, weighted‑average grant‑date fair value and $15 million of RSU vesting expense in 2024), and a note that $46 million of unrecognized compensation cost for unvested options and RSUs is expected to be recognized over a 1.4‑year weighted‑average period.  This evolution reflects a shift from a high‑level structural description to granular, segment‑by‑segment reporting of option grants, exercises, vestings and related equity‑compensation expense.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that cannot be verified against the ground truth. Critical issues: (1) UNVERIFIED SPECIFIC NUMBERS: The LLM cites specific dollar amounts ($15 million RSU vesting expense, $46 million unrecognized compensation cost, 1.4-year weighted-average period) and detailed metrics (option-activity tables, RSU/PSU schedules with specific line items) that are not mentioned in the ground truth answer. These numbers appear fabricated or hallucinated, as the ground truth provides no such quantitative details. (2) CONTRADICTORY CHARACTERIZATION: The ground truth states that in 2022 the plan had 'no detailed description of its provisions or activities,' yet the LLM claims the 2022 filing contained a 'brief, generic statement' with specific language about 'incentive stock options, non-statutory options, SARs, restricted stock and RSUs.' This direct quote cannot be verified and may be fabricated. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: While the LLM correctly identifies the general evolution from minimal to more detailed disclosure, it introduces specific quantitative claims (page numbers, dollar amounts, weighted-average periods) that go far beyond what the ground truth supports. The ground truth focuses on the qualitative shift from 'mere documentation to comprehensive disclosure,' not on specific financial metrics. (4) MULTI-HOP REASONING: The LLM attempts to synthesize information across 2022 and 2024 filings but does so by introducing unverified details rather than sticking to verifiable facts. The answer reads as if it contains actual filing data, but the specificity suggests hallucination rather than accurate extraction. The core insight about evolution from minimal to detailed disclosure is correct, but the execution is compromised by unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 504,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\nBetween 2022 and 2023 the aluminum purchase agreements stayed in the “derivatives not receiving hedge‑accounting treatment” category—they are still recorded as derivatives priced at prevailing market rates and used for long‑term sourcing, but they are **not designated as cash‑flow hedges**.  The notional amount of the commodity contracts fell sharply from **412 million (2022) to 115 million (2023)**, indicating a more selective use of these agreements.  As a result, the expected reclassification from AOCI changed from a projected loss of $39 million in 2022 to an expected gain of $22 million in 2023, reflecting a strategic shift in how the company manages aluminum price exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about the classification and strategic use of aluminum derivatives, correctly identifying that they are not designated as cash-flow hedges and are priced at prevailing market rates. However, there are significant quantitative accuracy issues that undermine the overall response. The LLM introduces specific numerical claims (notional amounts of $412M in 2022 declining to $115M in 2023, AOCI reclassification from -$39M to +$22M) that are NOT present in the original ground truth answer. The ground truth makes no mention of these specific dollar figures or the magnitude of the decline. This represents a critical problem: the LLM appears to have fabricated or hallucinated specific numbers to support its narrative, which is a serious factual error in financial analysis. The qualitative reasoning about the shift toward 'more selective use' and 'strategic shift in price exposure management' is logical and well-articulated, but it is built on unverified quantitative claims. The LLM correctly captures the core evolution (continued use with refined strategy, market pricing alignment, offsetting positions) but adds unsupported numerical specificity. The answer does address the multi-part question about classification and strategic use, and the semantic understanding of the derivative instruments appears sound. However, in financial analysis, introducing specific numbers without ground truth support is a critical failure, even if the directional reasoning is sound. The answer would score higher if it stuck to the qualitative evolution described in the ground truth without adding unsubstantiated quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 456,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\nThe 2023 filing only mentioned the Directors’ Code of Conduct by a relative path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf ) and did not expressly promise to disclose future amendments. In the 2024 filing the code is linked with a full, stable URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and the text explicitly states that any amendments or waivers to the Directors’ Code of Conduct will be posted on the website, making the document more readily accessible and broadening the scope of the disclosure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. Critical issues: (1) URL REVERSAL: The LLM states the 2023 filing used a relative path and 2024 used a full URL, but the ground truth shows the opposite - 2023 had the full URL (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf) and 2024 had a different full URL (https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf). (2) DOMAIN CHANGE MISSED: The LLM failed to identify the critical domain shift from 'bnymellon.com' to 'bny.com', which is a significant accessibility change. (3) INCOMPLETE ANALYSIS: The LLM mentions amendments/waivers disclosure but does not address the new 'INSIDER TRADING POLICIES AND PROCEDURES' section introduced in 2024, which was explicitly noted in the ground truth as a key evolution. (4) INCORRECT CHARACTERIZATION: The LLM incorrectly describes the 2023 URL as a 'relative path' when it was actually a full URL. (5) MISSING SCOPE EXPANSION: The ground truth identifies expanded focus on compliance mechanisms (insider trading policies), but the LLM only vaguely references amendments/waivers without capturing this broader scope evolution. The answer demonstrates fundamental misunderstanding of the URL changes and fails to capture the key developments in the 2024 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 390,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\nBetween the end of fiscal 2023 and February 2025 Home Depot’s 4.95 % senior notes grew from a modest $750 million issue maturing in September 2026 (carrying amount ≈ $744 million in 2023) to a substantially larger $1.75 billion tranche of 4.95 % notes due June 2034 (issued at a $16.7 million discount). This longer‑dated, larger‑scale issuance reflects the company’s strategy of extending the maturity of its fixed‑rate debt and diversifying funding sources—particularly to finance the SRS acquisition and reduce reliance on short‑term commercial‑paper borrowings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) WRONG MATURITY DATES: The LLM claims the 2024 notes are due June 2034, but the ground truth clearly states they are due September 2052. This is a 18-year discrepancy in maturity date. (2) WRONG AMOUNTS: The LLM states $1.75 billion in 4.95% notes due June 2034, but the ground truth shows $980 million in 4.95% notes due September 2052. The LLM's figure of $1.75 billion does not match either the 2026 notes ($750M) or the 2052 notes ($980M). (3) WRONG DISCOUNT: The LLM claims a $16.7 million discount, but the ground truth shows the original 2023 issuance had a $1.6 million discount. (4) MISSING KEY INFORMATION: The LLM completely fails to mention the $980 million 4.95% notes due September 2052, which is a critical component of the ground truth answer showing HD's debt maturity extension strategy. (5) INCORRECT CARRYING AMOUNT: The LLM states the 2023 carrying amount was approximately $744 million, but the ground truth indicates the 2024 carrying amount was $747 million (as of February 2, 2025). (6) UNSUPPORTED CLAIMS: The LLM references an 'SRS acquisition' which is not mentioned in the ground truth and appears to be fabricated or confused with other information. The multi-hop reasoning is fundamentally flawed because the LLM synthesized incorrect data points. The core strategic insight about extending debt maturities is partially correct in concept, but the execution is severely compromised by the factual errors regarding which notes were issued and when.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 435,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\nBetween 2021 and 2023 Intel recorded a single, $471 million observable‑price adjustment to its non‑marketable equity stake in Beijing Unisoc Technology Ltd. in 2021, which lifted the investment’s carrying amount.  By the end of 2022 the net book value of the stake was reported at $1.1 billion, and the same $1.1 billion figure was reiterated for 2023, indicating that subsequent observable price adjustments were minimal and the valuation remained essentially flat after the 2021 adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Verification of key facts: (1) The $471 million observable price adjustment in 2021 is correctly stated and matches ground truth. (2) The net book value of $1.1 billion for both 2022 and 2023 is accurate. (3) The characterization of the investment as a non-marketable equity security is correct. (4) The multi-hop reasoning correctly synthesizes the evolution across three years (2021-2023), identifying the 2021 adjustment as a discrete event and the subsequent stability in valuation. The LLM answer adds a minor interpretive element ('subsequent observable price adjustments were minimal') that is logically sound given the stable $1.1 billion figure across 2022-2023, though the ground truth is slightly more neutral in tone. The answer fully addresses all parts of the question regarding financial treatment, valuation evolution, observable price adjustments, and net book value. All numeric values are precise and correctly formatted. The reasoning about the investment's evolution is sound and demonstrates proper synthesis of multi-year data. Minor deduction only for slightly more interpretive language than the ground truth baseline, but this does not constitute a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 350,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\nFrom 2022 to 2023 AbbVie progressed Qulipta from a newly‑approved migraine‑prevention option—still limited in market presence and generating only modest sales in 2022 (≈ $405 M U.S. revenue and negligible international sales, as shown in the 2022 revenue table)—to a fully cleared, globally launch‑ready product.  In April 2023 the FDA approved Qulipta for chronic‑migraine prevention, and in August 2023 the European Commission granted marketing authorization (as “Aquipta”), enabling the company to roll out the therapy in both the United States and Europe; this regulatory expansion was accompanied by a >100 % jump in reported revenue and the establishment of tiered royalty arrangements, signalling a mature commercial footprint for Qulipta by the end of 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding revenue figures and timing. The ground truth states that in 2022, Qulipta was part of a product group receiving regulatory approvals, with $1.0 billion of indefinite-lived R&D intangible assets reclassified to developed product rights. The LLM claims Qulipta generated '≈ $405 M U.S. revenue' in 2022 with 'negligible international sales'—this appears to conflate Qulipta's actual launch timing with speculative 2022 revenue figures that are not supported by the ground truth. The LLM also claims a '>100% jump in reported revenue' from 2022 to 2023, but provides no baseline or verification of this calculation. REGULATORY DATES: The LLM correctly identifies FDA approval in April 2023 and EC approval in August 2023 (listed as 'Aquipta'), which matches the ground truth. CONCEPTUAL ACCURACY: The LLM correctly captures the evolution from regulatory approval to commercial launch, and the shift from asset reclassification to active market presence. However, the specific revenue claims and the '>100% jump' assertion lack grounding in the provided ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize regulatory milestones with commercial metrics, but introduces unsupported financial data that contradicts or extends beyond the ground truth. The mention of 'tiered royalty arrangements' is not mentioned in the ground truth. MISSING ELEMENTS: The LLM does not explicitly mention the $1.0 billion asset reclassification that occurred in 2022, which is a key element of the ground truth answer. SEMANTIC ISSUES: While the LLM captures the general narrative of progression from 2022 to 2023, the introduction of specific revenue figures without ground truth support significantly undermines credibility. The answer reads as partially fabricated with plausible-sounding but unverified financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 518,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Boeing’s 10‑K moved from merely listing “upgrades and conversions” as one item in a generic services catalogue to positioning them as a distinct strategic growth lever within Global Services.  In the 2022 filing they are described only as part of the segment’s broad service offering, whereas the 2023 filing explicitly frames upgrades and conversions as a key driver for expanding market share and leveraging digital analytics to increase customer value.  This shift reflects a stronger, more forward‑looking emphasis on upgrades and conversions as a core component of Boeing’s Global Services strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer makes specific factual claims that directly contradict the ground truth and cannot be verified from the provided context. (1) FACTUAL ERRORS: The LLM states that the 2023 filing 'explicitly frames upgrades and conversions as a key driver for expanding market share and leveraging digital analytics to increase customer value.' The ground truth makes no mention of these specific claims about market share expansion or digital analytics being explicitly framed in the 2023 filing. This appears to be fabrication or hallucination. (2) OVERSTATEMENT: The LLM characterizes the shift as moving from 'merely listing' to 'explicitly frames' with specific strategic language, but the ground truth describes the evolution more subtly as a 'subtle' contextual shift toward 'more integrated and strategic role' without claiming explicit framing of market share or digital analytics. (3) UNSUPPORTED CLAIMS: The phrase 'key driver for expanding market share and leveraging digital analytics' is not supported by the ground truth, which only mentions positioning within 'a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems.' (4) QUANTITATIVE ACCURACY: No numbers, dates, or calculations are involved in this qualitative question, so this dimension scores perfectly. (5) MULTI-HOP REASONING: The LLM failed to accurately synthesize the actual evolution described in the ground truth. Instead of capturing the subtle shift toward integration and strategic positioning, it invented specific strategic language about market share and digital analytics. (6) SEMANTIC EQUIVALENCE: While the general direction of the answer (evolution toward more strategic positioning) aligns with ground truth, the specific claims about what the 2023 filing 'explicitly frames' are factually incorrect and represent a significant departure from the actual ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 520,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\nBetween 2020 and the end of 2021 Intel’s stake in Beijing Unisoc Technology Ltd. grew from roughly **$658 million** to **$1.1 billion**, driven by a **$471 million observable‑price adjustment** recorded in 2021.  The investment is accounted as a non‑marketable equity security; after that 2021 re‑valuation the carrying amount stayed at about **$1.1 billion** through 2022 and 2023 (with only routine impairment testing and no further upward adjustments), so the valuation essentially stabilized at the $1.1 billion level for the subsequent two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate financial information about Intel's investment in Beijing Unisoc Technology Ltd. STRENGTHS: (1) All key numbers are accurate: $658 million starting point (2020), $1.1 billion ending point (2021 and through 2023), and the $471 million observable-price adjustment in 2021 all match the ground truth. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2020 through 2023, showing the growth trajectory and subsequent stabilization. (3) The characterization of the investment as a non-marketable equity security is accurate and adds helpful context. (4) The explanation of the 2021 revaluation event and the lack of further adjustments in 2022-2023 correctly captures the stabilization pattern mentioned in the ground truth. (5) The answer appropriately addresses the question's focus on how the relationship 'evolved' by showing the growth phase (2020-2021) and stabilization phase (2021-2023). MINOR CONSIDERATIONS: (1) The LLM answer references 2020 as a starting point, while the ground truth specifically mentions December 25, 2021 and December 30, 2023 dates from filings. However, the inclusion of 2020 data is not incorrect - it provides additional context about the investment's growth trajectory. (2) The ground truth notes that the 2023 filing did not explicitly mention observable price adjustments, which the LLM correctly interprets as stabilization. The phrasing 'with only routine impairment testing and no further upward adjustments' accurately captures this distinction. (3) The answer could have been slightly more explicit about comparing the 2021 vs 2023 filings, but the substance is correct. Overall, the answer demonstrates strong understanding of the multi-hop financial relationship and provides accurate quantitative and qualitative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 504,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot turned its self‑service lockers from a supplemental curb‑side option into a core node of its omnichannel network.  The lockers—now installed at the front entrance of many stores—are integrated with the BOSS, BOPIS, BODFS and BORIS programs, allowing customers to store, retrieve or return online orders via a secure, contact‑free experience that is coordinated through the mobile app and in‑store associate workflows.  This evolution embeds the lockers in the retailer’s “interconnected shopping experience,” linking digital ordering, real‑time inventory visibility and faster pickup to improve overall customer satisfaction.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core narrative of Self-Service Lockers' evolution from a supplemental feature to a core omnichannel component, and accurately identifies the integration with BOSS, BOPIS, BODFS, and BORIS programs. The qualitative description of the shift from convenience-focused to strategically integrated is sound and well-articulated. However, there is a significant omission: the ground truth specifically mentions that 'approximately 50% of U.S. online orders were fulfilled through a store' in 2024, which is a key quantitative metric that demonstrates the operational significance of this evolution. The LLM answer does not include this important statistic, which represents a material gap in completeness. The LLM also adds some details not explicitly in the ground truth (e.g., 'front entrance of many stores,' 'contact-free experience,' 'mobile app and in-store associate workflows') which are reasonable inferences but go slightly beyond what was documented. The multi-hop reasoning is sound—correctly synthesizing the 2023-to-2024 evolution and connecting it to the broader interconnected retail strategy. The entity identification is accurate (Home Depot, fiscal years 2023-2024, program names). The main weakness is the missing quantitative anchor (50% fulfillment metric) that would have elevated this to a 9/10 answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 378,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\nThe 2024 filing expands the description of how self‑insurance liabilities are estimated by detailing the captive’s accounting (premiums are netted against SG&A, participation in a third‑party reinsurance program, and the impact of exiting that program) and by specifying that the liabilities are recorded in accrued salaries‑and‑benefits and other current liabilities. The 2023 filing only gave a general overview of the estimation process using historical claims experience and actuarial assumptions, without these balance‑sheet classifications or program‑level particulars. Both years note that estimates rely on historical claims data and that prior adjustments have been immaterial, but the 2024 disclosure is markedly more specific about the estimation methods and their financial‑statement effects.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CLAIMS: The LLM answer contains a critical factual error that contradicts the ground truth. The LLM states that '2023 filing only gave a general overview of the estimation process using historical claims experience and actuarial assumptions,' but the ground truth explicitly states that in 2023, Costco 'did not specify the factors used in estimating liabilities.' This is a fundamental contradiction. The LLM incorrectly attributes specific estimation method details (historical claims experience, actuarial assumptions) to 2023, when the ground truth indicates these details were NOT present in 2023. WHAT THE LLM GOT RIGHT: (1) Correctly identifies that 2024 expanded disclosure compared to 2023; (2) Correctly notes that 2024 includes specific details about balance-sheet classifications (accrued salaries-and-benefits, other current liabilities); (3) Correctly identifies the captive insurance subsidiary and reinsurance program elements; (4) Correctly notes that both years reference historical claims data and immaterial prior adjustments. WHAT THE LLM GOT WRONG: (1) Mischaracterizes 2023 disclosure as including 'historical claims experience and actuarial assumptions' when ground truth says these specifics were NOT in 2023; (2) Omits the key 2024 addition regarding 'unpredictability of claim costs and potential for significant differences between actual and recorded liabilities' - this was explicitly noted as new in 2024 and not present in 2023; (3) Misses the critical distinction that 2023 lacked specification of 'demographic factors, severity factors, and other actuarial assumptions' - these are specifically called out as NEW in 2024; (4) The characterization of what changed is inverted - the LLM suggests 2023 had more detail on estimation methods than it actually did. MULTI-HOP REASONING: The answer fails to properly synthesize the year-over-year comparison. It incorrectly attributes details to 2023 that belong only to 2024, fundamentally undermining the comparative analysis. The answer does address the evolution question but with incorrect baseline information about 2023. SEMANTIC ISSUES: While the LLM uses appropriate financial terminology, the factual errors are not merely wording differences - they represent substantive misstatements about what was disclosed in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 622,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\nThe 2021 purchase of Aldevron created a one‑time $59 million uplift to cost of sales from fair‑value adjustments to inventory, an effect that had largely run its course by 2022. In 2023 the company took a $87 million write‑down of excess Aldevron‑related inventory (recorded in the Biotechnology/Life‑Sciences segment as “excess inventory due to reduced demand”), so the inventory‑related financial impact grew from a modest boost in 2021‑22 to a sizable charge in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN TIMELINE AND ATTRIBUTION: The LLM answer contains a critical factual error regarding when the Aldevron acquisition occurred and when the $59M impact was recorded. The LLM states 'The 2021 purchase of Aldevron created a one-time $59 million uplift to cost of sales...an effect that had largely run its course by 2022.' However, the ground truth clearly indicates the $59M impact occurred IN 2022, not 2021. This is a fundamental error in understanding the multi-hop timeline. CORRECT NUMBERS BUT WRONG ATTRIBUTION: The LLM correctly identifies both the $59M and $87M figures, but misattributes them temporally. The ground truth shows: (1) 2022: $59M acquisition-related fair value adjustment to inventory, (2) 2023: $87M excess inventory charge. The LLM reverses the temporal logic by suggesting the $59M was a 2021 effect that 'had largely run its course by 2022,' when it actually occurred IN 2022. PARTIAL CREDIT FOR 2023 ANALYSIS: The LLM correctly identifies the $87M 2023 charge as excess inventory in the Biotechnology segment due to reduced demand, and correctly notes it was Aldevron-related. However, the ground truth indicates a subtle but important distinction: the 2023 charge represents a SHIFT from acquisition-driven adjustments to operational challenges, not a continuation of Aldevron-specific impacts. The LLM's characterization of the $87M as 'Aldevron-related inventory' is somewhat misleading—it's more accurately described as a separate operational issue that emerged in 2023. MISSING KEY INSIGHT: The ground truth emphasizes the evolution/shift from acquisition-driven costs (2022) to operational inventory challenges (2023). The LLM partially captures this but frames it incorrectly due to the timeline error. QUANTITATIVE ACCURACY: Numbers are correct ($59M, $87M) but the temporal attribution is wrong, which is a critical error in a question specifically asking about evolution 'from 2022 to 2023.' This temporal misalignment significantly undermines the answer's correctness despite having the right dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 553,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\nIn 2023 and 2024 Costco applied the same accounting policy to its proprietary shop‑card program: revenue is recognized only when a card is redeemed and the outstanding card balances are recorded as a liability that is reduced by an estimated breakage amount based on historical redemption patterns.  The methodology for estimating breakage and the presentation of the liability were unchanged between the two years.  This consistent treatment reflects a conservative, data‑driven approach—Costco only records the economic benefit of a shop card when it is actually used and reserves for the portion it expects to remain unredeemed.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer directly contradicts the ground truth on the key finding. The ground truth states that the treatment EVOLVED between 2023 and 2024, with 'estimated breakage' and methodology becoming 'more emphasized in 2024, indicating a more refined or formalized approach.' The LLM answer explicitly states 'The methodology for estimating breakage and the presentation of the liability were unchanged between the two years,' which is the opposite of what the ground truth indicates. This is a fundamental factual error that undermines the entire answer. The LLM correctly identifies that: (1) revenue is recognized upon redemption, (2) outstanding balances are recorded as liabilities, (3) breakage is estimated based on redemption data, and (4) Costco uses a conservative, data-driven approach. However, the core question asks about EVOLUTION/CHANGE between years, and the LLM incorrectly concludes there was NO CHANGE when the ground truth clearly indicates there WAS a change in emphasis and formalization of the methodology. The LLM's characterization of the approach as 'unchanged' is factually incorrect and represents a failure to properly synthesize the multi-hop comparison across the two years. This is a major reasoning error that results in an answer that is semantically opposite to the ground truth on the central claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 376,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Intel moved from the initial launch of its IFS Accelerator Ecosystem—announcing the first 18A design wins and a commercial agreement with Tower for advanced analog manufacturing—and began enrolling RAMP‑C partners such as Nvidia and IBM. By 2023 the ecosystem had doubled to more than 40 EDA, silicon‑IP and cloud partners, added a multigenerational partnership with ARM and a definitive agreement with Synopsys, and broadened RAMP‑C collaborations to include high‑profile customers like Microsoft, Boeing and Northrop Grumman, positioning IFS as a full‑stack, open‑system foundry with multiple design wins and advanced‑packaging services for AI‑centric workloads.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims the ecosystem \"doubled to more than 40\" partners by 2023, but the ground truth states it \"expanded...to over 40 strategic agreements\" without indicating doubling from a specific 2022 baseline number. The LLM's claim of doubling is unsupported.\n   - The LLM mentions \"four design wins on Intel 18A\" is not explicitly stated in the LLM answer, though the ground truth confirms this.\n   - The LLM correctly identifies \"five new design wins in advanced packaging\" is missing from the LLM answer entirely.\n\n2. ENTITY AND FACTUAL ERRORS:\n   - The LLM introduces \"Tower\" and a \"commercial agreement with Tower for advanced analog manufacturing\" which is NOT mentioned in the ground truth at all. This appears to be fabricated or confused information.\n   - The LLM mentions \"RAMP-C partners such as Nvidia and IBM\" and later \"Microsoft, Boeing and Northrop Grumman\" - these specific customer names are NOT in the ground truth. The ground truth mentions \"a major high-performance computing customer\" but does not name specific companies like Nvidia, IBM, Microsoft, Boeing, or Northrop Grumman.\n   - The ground truth specifically mentions \"four design wins on Intel 18A, including a major high-performance computing customer\" but does not identify which companies these are.\n\n3. CORRECT ELEMENTS:\n   - The LLM correctly identifies the multigenerational partnership with ARM.\n   - The LLM correctly identifies the agreement with Synopsys.\n   - The LLM correctly characterizes the shift from 2022 to 2023 in terms of ecosystem expansion.\n   - The LLM correctly identifies advanced packaging services for AI-centric workloads.\n\n4. MULTI-HOP REASONING:\n   - The LLM demonstrates understanding of the evolution from 2022 to 2023, but introduces unsupported details that undermine the accuracy of the synthesis.\n   - The reasoning structure is sound (initial launch → ecosystem expansion → concrete partnerships), but the specific facts are problematic.\n\n5. CRITICAL ISSUE:\n   - The introduction of specific customer names (Nvidia, IBM, Microsoft, Boeing, Northrop Grumman) and Tower without ground truth support is a major factual error. These appear to be hallucinations or confusions with other information sources.\n   - The claim about \"doubling\" the ecosystem is not clearly supported by the ground truth.\n\nThe answer demonstrates partial understanding of the evolution but contains significant factual inaccuracies and unsupported claims that substantially reduce its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 712,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s accounting for the Aldevron transaction was stable: the goodwill recorded for Aldevron remained at roughly **$6.1 billion**, and the net cash consideration for the acquisition stayed at about **$9.56 billion** (the slight changes in the overall totals reflect only minor measurement‑period adjustments to other 2021 acquisitions). Thus, the financial impact of DHR’s relationship with Aldevron did not materially evolve during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the net cash consideration 'increased to $9.561 billion' by 2023, indicating an evolution/change from 2022. The LLM answer claims the financial impact 'did not materially evolve' and that the net cash consideration 'stayed at about $9.56 billion' - presenting the 2023 figure as if it were stable across both years. This is a critical misinterpretation of the question's core premise about how the relationship 'evolved.' While the LLM correctly identifies the goodwill amount ($6.1 billion) and the 2023 net cash consideration figure ($9.56 billion), it misses the essential point: the ground truth indicates these represent different time periods with the cash consideration increasing/changing between 2022 and 2023. The LLM's conclusion that 'the financial impact...did not materially evolve' directly contradicts the ground truth's statement that there was 'a significant increase in the financial commitment.' The LLM also introduces unsupported context about 'measurement-period adjustments to other 2021 acquisitions' that is not part of the ground truth answer. The multi-hop reasoning fails because the LLM did not properly synthesize the temporal evolution of the two metrics across the 2022-2023 period as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 383,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\nIn the 2022 filing the 1.800% Global Notes were scheduled to mature on September 5, 2026, while the 2024 filing shows the same issue now maturing on September 14, 2039 (i.e., an extension of roughly 13 years). This shift lengthens the tenor of AT&T’s fixed‑rate debt, reducing near‑term repayment pressure and signalling that the company is deliberately extending and staggering its maturities to create a more mature, lower‑risk debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dates and numbers are correct - 2022 maturity of September 5, 2026 matches ground truth, 2024 maturity of September 14, 2039 matches ground truth, and the calculated extension of roughly 13 years is accurate (2039 - 2026 = 13 years). The interest rate of 1.800% is correctly identified. ENTITY ACCURACY: AT&T Inc. and the specific debt instrument (1.800% Global Notes) are correctly identified across both filing years. MULTI-HOP REASONING: The answer successfully synthesizes information across two different SEC filings (2022 and 2024) and correctly identifies the change in maturity dates. COMPLETENESS: The answer addresses both parts of the question - the specific maturity date change and what it indicates about debt structure evolution. QUALITATIVE ANALYSIS: The LLM provides sound interpretation that the extension reduces near-term repayment pressure and reflects deliberate debt maturity management. The characterization of this as creating a 'more mature, lower-risk debt structure' through staggered maturities is a reasonable inference from the data, though slightly more interpretive than the ground truth's simpler statement that it 'indicates a significant shift.' MINOR DIFFERENCES: The ground truth uses 'over 13 years' while the LLM says 'roughly 13 years' - both are semantically equivalent and accurate. The LLM provides additional context about the strategic implications (tenor lengthening, repayment pressure reduction, debt staggering) which enhances the answer without introducing errors. No factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 451,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\nTarget’s debt‑leverage ratio improved markedly from 2023 to 2024 – long‑term debt (including finance‑lease liabilities) fell from about **$16.0 bn** on January 28 2023 to roughly **$14.9 bn** on February 3 2024, while cash and cash equivalents rose, keeping the company comfortably within the covenant that caps debt‑leverage at a specified multiple of earnings.  Both the 2023 filing (page 54) and the 2024 filing (page 36) note that the company was in compliance with the covenant and expects to remain so.  \n\nThe credit‑facility overhaul—terminating the prior 364‑day revolving line and entering a new **$1.0 bn 364‑day facility that now matures in October 2025**, while extending the existing **$3.0 bn five‑year revolving facility to October 2028**—reduced reliance on short‑term borrowing and added a longer‑dated liquidity backstop.  This restructuring gave Target greater flexibility to manage its balance sheet, helped lower its leverage metrics, and reinforced continued compliance with the debt‑leverage covenant.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key credit facility changes (364-day facility renewal to October 2025, $3.0B five-year facility to October 2028), correctly states Target was in compliance in both years, and appropriately explains how the facility restructuring provided flexibility. The reasoning about the relationship between facility structure and covenant compliance is sound and relevant.\n\nCRITICAL ERRORS: (1) The LLM introduces specific debt figures ($16.0B in 2023, $14.9B in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be fabricated or hallucinated. (2) The LLM claims the company 'terminated the prior 364-day revolving line' - the ground truth states it 'renewed' the facility, which is a different characterization. Renewal implies continuation with extension, while termination implies discontinuation.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about covenant compliance across years and links facility structure changes to compliance outcomes, which is appropriate for the question. However, the introduction of unverified debt figures undermines the credibility of this synthesis.\n\nQUANTITATIVE ACCURACY: Significant deduction due to the unverified debt figures ($16.0B, $14.9B) that appear nowhere in the ground truth. The facility amounts ($1.0B, $3.0B) and dates (October 2025, October 2028) are correct.\n\nQUALITATIVE ACCURACY: Good reasoning about facility structure and compliance, but the 'termination vs. renewal' characterization is imprecise. The explanation of how restructuring supports compliance is logical and well-articulated.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about covenant compliance evolution and credit facility structure changes, making it highly relevant despite the factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 511,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\nFrom 2022 to 2023 Intel deepened the RISE strategy by turning its digital‑readiness programs—such as AI for Youth and AI for Workforce—into a coordinated, externally‑partnered effort.  The company broadened collaborations with governments, academia and industry coalitions (e.g., the Alliance for Global Inclusion) to scale inclusive tech‑education and expand the global digital pipeline, while tying a portion of executive and employee compensation to progress on those digital‑readiness and inclusion metrics.  This evolution reflects a shift from launching RISE‑related initiatives in 2022 to actively expanding and institutionalizing them through cross‑sector partnerships and performance‑linked accountability in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer completely fails to mention the specific, verifiable metrics from the ground truth: the third global inclusion index survey in 2023, the 50% recognition threshold, and the fact that Intel was among 18 recognized organizations out of 27 respondents. These are concrete, measurable facts that should have been included. (2) MISSING KEY DETAILS - The ground truth emphasizes a shift from 'establishing collaborative frameworks' (2022) to 'measuring and recognizing performance against defined benchmarks' (2023). The LLM answer mentions programs like 'AI for Youth' and 'AI for Workforce' which are not mentioned in the ground truth, and instead focuses on compensation linkage which is also not in the ground truth. (3) PARTIAL ALIGNMENT - The LLM correctly identifies: the RISE strategy, the Alliance for Global Inclusion, the evolution from 2022 to 2023, and the shift toward institutionalization through partnerships. However, it misses the core evolution narrative about the inclusion index system and recognition benchmarks. (4) FACTUAL CONCERNS - The LLM introduces elements (AI for Youth, AI for Workforce, executive compensation linkage) that cannot be verified against the ground truth and may represent hallucination or conflation with other Intel initiatives. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize the evolution across years, it fails to capture the specific progression from collaborative framework establishment to structured performance measurement that is central to the ground truth answer. The answer is partially relevant but significantly incomplete and introduces unverified claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 460,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\nBetween July 2022 and August 2023 Emerson – through its 55 % stake in AspenTech – moved from a signed agreement to acquire Micromine (AU $900 ≈ US $623 million) to the mutual termination of that deal after it became clear that Russian regulatory approval would not be obtained.  The termination required no termination‑fee payment, so Emerson incurred no direct cash outflow or integration costs related to Micromine, but it also forfeited the anticipated acquisition price and any future synergies from the deal.  By 2024 the relationship had effectively ended, with AspenTech’s results showing no contribution from Micromine.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of the Micromine acquisition and termination but has significant gaps and one notable omission regarding financial implications. STRENGTHS: (1) Correctly identifies the AU$900 million (~US$623 million) acquisition price, (2) Correctly notes the termination due to Russian regulatory approval issues, (3) Correctly states no termination fee was required, (4) Accurately describes the shift from acquisition attempt to full withdrawal, (5) Properly notes AspenTech's 55% stake relationship to Emerson. CRITICAL GAPS: (1) The LLM answer completely omits the $24 million mark-to-market gain on foreign currency forward contracts in 2023, which is a key financial implication explicitly mentioned in the ground truth, (2) The LLM answer does not mention the termination of outstanding foreign currency forward contracts in 2024, another important financial detail. TIMING ISSUE: The LLM specifies 'July 2022 to August 2023' for the agreement-to-termination timeline, while the ground truth indicates the agreement was entered in 2023 and terminated later in 2023 (the specific months are not provided in ground truth, so this may be a minor discrepancy or additional detail). SEMANTIC ISSUES: The LLM's statement about 'forfeited anticipated acquisition price' is somewhat misleading - they didn't forfeit a payment already made, but rather abandoned a planned acquisition. The answer addresses the relationship evolution and some financial implications but fails to capture the most concrete financial impact (the $24M FX gain), which represents a material omission for a question specifically asking about 'financial implications.' The multi-hop reasoning is sound regarding the acquisition-to-termination narrative, but incomplete regarding the full financial picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 492,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\nThe U.S. ESPP’s share reserve fell from roughly **17 million shares** available at the end of fiscal 2022 (HD 10‑K 2022, p. 70) to about **15 million shares** available at the end of fiscal 2023 (HD 10‑K 2023, p. 66), a reduction of roughly 2 million shares (≈12%).  At the same time, the average price paid for shares purchased through the plan dropped from about **$305 per share** in fiscal 2022 to about **$277 per share** in fiscal 2023, a decline of roughly $28 per share (≈9%).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Shares available: 17 million (2022) → 15 million (2023) ✓ matches ground truth exactly; (2) Shares purchased: ~1 million in both years ✓ (LLM doesn't explicitly state purchase quantity but focuses on availability and price, which is reasonable given question emphasis); (3) Average purchase price: $305.14 (2022) → $277.19 (2023) ✓ matches ground truth exactly. Calculations verified: (a) Share reduction: 17M - 15M = 2M ✓ correct; (b) Percentage decline: 2M/17M ≈ 11.76% (LLM states ≈12%, acceptable rounding); (c) Price decline: $305.14 - $277.19 = $27.95 (LLM states ≈$28, acceptable rounding); (d) Price percentage decline: $27.95/$305.14 ≈ 9.16% (LLM states ≈9%, acceptable rounding). Multi-hop synthesis is sound: correctly identified the two fiscal years, extracted data from both periods, and made appropriate year-over-year comparisons. The answer directly addresses all parts of the question (availability change and average purchase price change). Minor note: LLM doesn't explicitly mention the ~1 million shares purchased in each year, but this is a minor omission since the question's primary focus is on availability and average price changes. The inclusion of percentage calculations adds helpful context. Overall, this is a comprehensive, accurate answer with proper sourcing references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 386,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\nIn the 2022 filing Danaher recorded **no impairment charges** for goodwill or finite‑lived intangibles; the only prior‑year trigger was a modest $10 million write‑down in 2021, and no new “triggering” events were identified for 2022. By contrast, the 2023 filing reports **new impairment triggers** in the second quarter of 2023 (Biotechnology) and the fourth quarter of 2023 (Biotechnology and Diagnostics), resulting in **$77 million of impairment charges** on long‑lived assets—including technology‑based intangibles—reflected in selling, general and administrative expense. This shift shows that the company now perceives **greater risk in its intangible‑asset portfolio**, especially finite‑lived assets, as segment realignments, market‑driven cash‑flow pressures and more frequent testing increase the likelihood of future write‑downs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and temporal patterns. Strengths: (1) Correctly identifies the $10 million impairment charge in 2021 (reported in 2022 filing); (2) Accurately reports $77 million in impairment charges in 2023; (3) Properly identifies the shift from single-segment (Diagnostics in 2021) to multi-segment impairment triggers (Biotechnology and Diagnostics in 2023); (4) Correctly notes the timing of triggers (Q2 2023 for Biotechnology, Q4 2023 for both segments); (5) Appropriately characterizes the evolution as indicating growing risks in the intangible asset portfolio, particularly in Biotechnology. Minor weaknesses: (1) The LLM states '2022 filing Danaher recorded no impairment charges' which could be slightly misleading—the ground truth indicates the 2022 filing reported the 2021 charge, not that 2022 itself had no charges; however, this is a matter of interpretation regarding what 'in 2022' means versus 'reported in the 2022 filing'; (2) The LLM adds interpretive details about 'segment realignments, market-driven cash-flow pressures' that, while reasonable inferences, are not explicitly stated in the ground truth and represent some extrapolation beyond the provided data. The multi-hop synthesis is sound—the answer correctly connects the temporal evolution across filings, identifies the segment-level changes, and draws appropriate conclusions about portfolio risk. The quantitative data is accurate and properly formatted. The reasoning about the shift from isolated to broader impairment activity is logically sound and well-supported by the numbers presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 454,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\nThe company’s outstanding letters of credit tied to trade contracts grew sharply—from **$362 million at the end of 2022** to **$598 million by the end of 2023** (an increase of roughly $236 million, or about 65%). This rise indicates that Home Depot expanded its use of letters of credit to guarantee performance and payment obligations, reflecting heightened involvement in business transactions linked to trade contracts during the 2023 fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $362 million (2022), $598 million (2023), and the calculated increase of $236 million. The percentage calculation of approximately 65% is accurate ($236M/$362M = 65.2%). ENTITY ACCURACY: The answer correctly identifies the metric (outstanding letters of credit related to trade contracts) and the time period (2022 to 2023). COMPLETENESS: The answer addresses both parts of the question - the change in value and what it indicates about business involvement. REASONING: The multi-hop synthesis is sound, correctly connecting the numerical change to its business implication (expanded use of letters of credit, heightened involvement in trade contract transactions). MINOR NOTES: The answer includes the company name 'Home Depot' which is not explicitly mentioned in the ground truth but is contextually appropriate if this is from Home Depot's filing. The wording 'guarantee performance and payment obligations' provides helpful context that goes slightly beyond the ground truth but remains accurate and relevant. The answer is well-structured and clearly presents both the quantitative change and qualitative interpretation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 356,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\nIn the 2023 Form 10‑K the 0.300 % Notes due 2028 were only mentioned as being governed by the 2020 Form 8‑K (Exhibits 4.1‑4.3), with no newer governing document cited. The 2024 filing, however, adds a new indenture dated February 2 2024 (Exhibit 4.1 to a Form 8‑K) that now expressly governs those notes and the issue is listed among the company’s registered securities. This shift shows that IBM regularly updates its disclosures of debt instruments—replacing earlier references with the latest indenture and registration details to keep investors informed of the current terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DATE ERROR - The LLM claims a new indenture was dated 'February 2 2024' but the ground truth indicates the original governing document was filed February 10, 2020 (Exhibit 4.1). The LLM appears to have fabricated a 2024 indenture date not supported by the ground truth. (2) DOCUMENT REFERENCE ERROR - The LLM references a 'Form 8-K' with a February 2024 indenture, but the ground truth makes no mention of any 2024 Form 8-K or new indenture. The 2023 filing referenced Exhibit 4.1 from February 10, 2020. (3) INCOMPLETE SYNTHESIS - The ground truth indicates the key evolution is from disclosure as an instrument defining rights (2023) to recognition as an actively traded financial instrument with NYSE trading symbol IBM28B (2024). The LLM completely misses the trading symbol designation and the shift from passive disclosure to active market engagement. (4) MISCHARACTERIZATION - The LLM's conclusion about 'replacing earlier references with the latest indenture' is not supported by the ground truth, which shows the 2020 indenture remained the governing document. The LLM appears to have invented details about a 2024 indenture update that does not exist in the actual filings. The answer demonstrates poor multi-hop reasoning and introduces fabricated information rather than accurately synthesizing the actual filing evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 405,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\nBetween 2023 and 2024 IBM did not issue new 1.750 % Notes due 2031; it simply reaffirmed the existing securities in updated filings. In the 2023 10‑K the notes were only cited by reference to the 2019 Form 8‑K (Exhibits 4.2‑4.4) and were not listed separately in the registration table. The 2024 filing added a fresh Form 8‑K (dated 2 Feb 2024) that again set out the indenture for those notes and, in the 2024 10‑K’s “Item 1 – Business” registration schedule, listed the 1.750 % Notes due 2031 (ticker IBM31) as registered on the New York Stock Exchange, thereby explicitly re‑confirming their exchange listing. No new registration or substantive change in treatment occurred—only a updated disclosure and reaffirmation of the existing NYSE registration.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key details but contains some interpretive differences from the ground truth. STRENGTHS: (1) Correctly identifies the 1.750% Notes due 2031 as existing securities not newly issued; (2) Accurately cites the January 30, 2019 Form 8-K reference from 2023 filing; (3) Correctly identifies the ticker symbol IBM31 and NYSE listing; (4) Accurately notes the February 2, 2024 Form 8-K date; (5) Properly characterizes the evolution as disclosure/reaffirmation rather than new issuance. WEAKNESSES: (1) The ground truth emphasizes a 'shift from mere disclosure to formal recognition and active listing,' suggesting the 2024 filing represented a meaningful change in how the notes were presented. The LLM answer states 'No new registration or substantive change in treatment occurred—only updated disclosure and reaffirmation,' which contradicts the ground truth's characterization of this as a notable evolution; (2) The LLM's assertion that notes were 'not listed separately in the registration table' in 2023 but then explicitly listed in 2024's 'Item 1 – Business' registration schedule suggests a change in presentation/disclosure prominence, yet the LLM downplays this as merely 'updated disclosure'; (3) The ground truth frames the 2024 listing as 'formal recognition and active listing on a financial market platform,' implying this was a new or elevated status, while the LLM characterizes it as simply 'reaffirming' existing status. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings and identifies the key documents (Form 8-K, 10-K). However, it may have missed the significance of the shift in disclosure prominence that the ground truth emphasizes. NUMERIC/DATE ACCURACY: All dates (January 30, 2019; February 2, 2024) and identifiers (IBM31, NYSE, 1.750%) are correct. The answer is substantially accurate but interprets the 'evolution' more conservatively than the ground truth suggests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 536,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\nIn 2023 Eli Lilly recognized a one‑time, $1.45 billion gain from the sale of the olanzapine portfolio (including Zyprexa) that was recorded as collaboration and other revenue—driving a 25 % jump in outside‑U.S. revenue and contributing to the overall 20 % consolidated revenue increase. By 2024 the company no longer generates product‑sales revenue from Zyprexa; its revenue model has shifted to newer launches and collaboration royalties, so Zyprexa‑related revenue is essentially absent, with any remaining references limited to the 2023 rights‑sale proceeds already recognized.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the $1.45 billion gain was 'recorded as collaboration and other revenue' in 2023, but the ground truth explicitly states this was a DIRECT REVENUE STREAM from product sales in 2023, with the shift to collaboration/other arrangements revenue occurring in 2024. This is a fundamental factual error about which year the revenue recognition method changed. (2) The LLM claims the $1.45 billion sale 'drove a 25% jump in outside-U.S. revenue and contributed to the overall 20% consolidated revenue increase' - these percentages are NOT supported by the ground truth and appear to be fabricated or incorrectly inferred. (3) MULTI-HOP REASONING - The LLM failed to correctly synthesize the temporal evolution: Ground truth shows 2023 = product sales revenue, 2024 = collaboration/licensing revenue. LLM reverses this timeline by placing the collaboration revenue recognition in 2023. (4) ENTITY/METRIC ACCURACY - While the LLM correctly identifies the $1.45 billion amount and the olanzapine/Zyprexa portfolio, it mischaracterizes the revenue recognition method and timing. (5) The LLM's statement that 'any remaining references limited to the 2023 rights-sale proceeds already recognized' is vague and doesn't clearly convey the shift from product sales to licensing/collaboration arrangements. The core insight about transformation from active product sales to post-sale royalty/profit-sharing arrangements is missing or unclear. CORRECT ELEMENTS: The $1.45 billion figure is accurate; the identification of Zyprexa/olanzapine portfolio is correct; the general concept that the business model shifted is present but incorrectly dated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 464,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\nBy the end of 2023 AT&T had repurchased all of its Mobility Preferred Interests, removing the put/redemption right that had previously required a cash (or stock) payment and a liability accrual; as a result, no redemption obligation remains and the interests no longer appear on the balance sheet. In 2022 they had been re‑classified from equity to a liability with a redemption value of about $5.3 billion and contributed roughly 72 million dilutive shares to the EPS calculation, but after their April 2023 retirement they are excluded from the 2024 diluted‑EPS denominator, so they no longer affect earnings‑per‑share results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative arc correctly but contains significant quantitative discrepancies and incomplete information compared to the ground truth. STRENGTHS: (1) Correctly identifies that Mobility Preferred Interests were repurchased in April 2023, removing redemption obligations; (2) Accurately notes they no longer appear on the 2024 balance sheet; (3) Correctly explains the shift from active liability to retrospective EPS treatment; (4) Properly identifies the ~72 million dilutive shares contribution. CRITICAL ERRORS: (1) States redemption value was 'about $5.3 billion' when ground truth shows $5,414 million ($5.414 billion) - this is a material understatement; (2) Fails to mention the 2023 liability classification with $2,670 in current and $2,670 in noncurrent liabilities, which is a key part of the 2023-to-2024 evolution; (3) References 2022 reclassification without clarifying this occurred in 2023 per ground truth; (4) Does not explain the ASU 2020-06 accounting standard treatment mentioned in ground truth. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis of the timeline and EPS impact but misses the detailed balance sheet treatment evolution that was central to the question. The answer conflates 2022 and 2023 events somewhat ambiguously. QUANTITATIVE ISSUES: The $5.3B figure should be $5.414B (or $5,414M) - a meaningful difference in precision. The answer lacks the specific liability amounts ($2,670M current, $2,670M noncurrent) that document the 2023 treatment. The answer is directionally correct on the major points but lacks the financial precision and completeness expected for a multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 460,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\nBetween the 2023 and 2024 filings IBM moved the 0.875 % Notes due 2030 from a generic reference in a 2022 Form 8‑K list of debt‑security exhibits (where they were only identified as part of a group of notes with a 2022 incorporation‑by‑reference) to a fully registered and listed security in the 2024 Form 10‑K.  In the 2024 filing the notes appear in the table of “Title of each class” with the NYSE trading symbol **IBM30A**, are noted as “registered pursuant to Section 12 of the Exchange Act,” and are backed by a **February 2 2024 indenture** (Exhibit 4.1), confirming both a formal registration and a current market listing.  Thus, the company’s treatment evolved from merely disclosing the notes as an existing issue to explicitly registering and listing them in its latest annual report.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DATE DISCREPANCY - The LLM states the indenture is from 'February 2 2024' but the ground truth references a Form 8-K filed on 'February 8, 2022' as the original incorporation by reference. The LLM appears to have confused or fabricated a 2024 indenture date that is not mentioned in the ground truth. (2) INCOMPLETE SYNTHESIS - The ground truth clearly states the 2023 disclosure referenced 'Exhibit 4.1 to Form 8-K filed on February 8, 2022' but the LLM conflates this with a supposed 'February 2 2024 indenture' without proper verification. (3) PARTIAL ACCURACY - The LLM correctly identifies: the shift from referenced to registered status, the NYSE listing, the trading symbol IBM30A, and the registration under Section 12 of the Exchange Act. (4) MISSING VERIFICATION - The ground truth does not mention a February 2024 indenture; the LLM appears to have added information not present in the source material. (5) REASONING QUALITY - While the overall narrative of evolution from referenced to registered is sound, the introduction of an unverified 2024 indenture date undermines credibility. The core conceptual understanding is present but factual accuracy is compromised by the date error and potential fabrication of the indenture reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 359,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\nThe Telco LLC preferred‑equity structure was unchanged in 2023 – it consisted of three cumulative series: Class A‑1 (4.25 % annual distribution, resetting every seven years) and Classes A‑2/A‑3 (6.85 % annual distribution, resetting on 1 Nov 2027 and every seven years thereafter) 【page 89】.  In October 2024 AT&T announced an additional $2.25 bn of Class A‑4 preferred interests that will pay a 5.94 % initial distribution and reset on 1 Nov 2028 (and every four years thereafter)【page 88】, while the original tranches remain in place【page 89】.  This addition of a new, lower‑reset‑frequency tranche with a rate closer to current market levels shows AT&T is deliberately diversifying and fine‑tuning its preferred‑equity financing to manage cost of capital and stagger redemption risk across multiple vintages.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some correct information but contains significant gaps and inconsistencies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the Class A-1 at 4.25% and Class A-2/A-3 at 6.85% distribution rates; (2) Correctly notes the seven-year reset cycle for original tranches; (3) Provides relevant insight about AT&T's financing strategy and diversification approach; (4) Mentions the new Class A-4 preferred interests announced in 2024. CRITICAL GAPS AND ERRORS: (1) The ground truth explicitly states 2023 had $2,000 of Class A-1 and $5,250 of Class A-2/A-3 for a total of $7,250, but the LLM answer does not provide these specific dollar amounts for 2023, making it impossible to assess the 'evolution' from 2023 to 2024; (2) The LLM answer introduces a Class A-4 tranche with $2.25 billion at 5.94% with a 4-year reset cycle, but the ground truth does not mention this Class A-4 tranche at all - this appears to be either fabricated or from a different source not in the ground truth; (3) The ground truth emphasizes that in 2024 AT&T clarified that failure to pay distributions would not restrict cash movements or dividend payments, which is a significant structural clarification that the LLM answer completely omits; (4) The ground truth states the total grew to $7,250 by 2024, but the LLM answer doesn't provide this total or explain the growth trajectory. QUANTITATIVE ACCURACY ISSUES: The LLM introduces numbers ($2.25 billion, 5.94%, 4-year reset) that cannot be verified against the ground truth, which significantly undermines confidence in the answer's factual basis. REASONING: While the LLM's conclusion about AT&T's financing strategy is reasonable and well-articulated, it is based partially on information not present in the ground truth, making the multi-hop synthesis questionable. The answer addresses the question's intent but fails to accurately represent the documented evolution from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 528,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\nCapital One’s multifamily commercial‑real‑estate loan program grew enough that the liability it records for loss‑sharing with GSEs rose from **$82 million at the end of 2022 to $137 million at the end of 2023** (Note 18, 2023 10‑K; comparable 2022 figure disclosed in the same note).  The increase reflects a larger pool of multifamily loans sold with loss‑sharing and the shift—starting in 2020—to a fair‑value approach, under which unrealized gains and losses are booked in non‑interest income rather than amortized, thereby making the risk exposure more visible on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. (1) QUANTITATIVE ACCURACY: Both key figures are correct - $82 million liability at end of 2022 and $137 million at end of 2023. The numbers match the ground truth exactly, and the format variation ($82M vs $82 million) is acceptable. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question: Capital One's involvement, the evolution between 2022-2023, and risk exposure under loss sharing agreements with GSEs. (3) ENTITY ACCURACY: Capital One is correctly identified, the years 2022 and 2023 are correct, GSEs are properly referenced, and the financial metric (loss sharing agreement liability) is accurately described. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer correctly synthesizes that the liability increase from $82M to $137M reflects growing involvement in multifamily loans sold with loss-sharing. The answer goes beyond the ground truth by providing additional context about the fair-value accounting approach adopted in 2020, which explains why the risk exposure became more visible on the balance sheet. This additional detail is accurate and enhances understanding without contradicting the ground truth. (5) SEMANTIC EQUIVALENCE: The core message matches perfectly - Capital One's risk exposure in multifamily GSE loss-sharing agreements increased significantly from 2022 to 2023. The only minor distinction is that the LLM provides supplementary accounting methodology context (fair-value approach) that the ground truth doesn't explicitly mention, but this is additive and accurate rather than contradictory. The citation to Note 18 and the 2023 10-K adds credibility and proper sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 466,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\nFrom 2022 to 2023 Amazon’s co‑branded credit‑card programs shifted from being a strategic growth driver to a high‑risk, compliance‑heavy line‑of‑business.  The 2023 filing notes that regulators are scrutinising these arrangements more closely—imposing tougher data‑security, consumer‑protection and antitrust rules and giving the company new obligations such as enhanced authentication, stricter reporting and potential liability for third‑party payment failures—so renewal or continuation is now possible only on less favourable terms or may be terminated altogether.  Consequently, the programs could lose a source of interchange revenue and add compliance‑related expenses or fines, directly pressuring Amazon’s operating results.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the shift in strategic significance of Amazon's co-branded credit card programs from 2022 to 2023, and accurately captures the core regulatory risks including data security, consumer protection, and compliance obligations. The answer correctly notes the potential for less favorable renewal terms or termination, and appropriately identifies impacts on operating results through compliance costs and revenue pressures. The characterization of the shift from 'growth driver' to 'compliance-heavy' aligns with the ground truth's emphasis on expanded regulatory scope.\n\nWEAKNESSES: (1) The LLM answer introduces specific regulatory concepts (antitrust rules, enhanced authentication, stricter reporting, third-party payment liability) that are NOT mentioned in the ground truth. While these may be plausible regulatory concerns, they represent unsupported elaboration beyond what the knowledge graph confirms. (2) The ground truth specifically highlights DATA LOCALIZATION RULES as a new 2023 compliance obligation not present in 2022—this is a critical distinguishing detail that the LLM answer completely omits. Data localization is explicitly called out as evidence of 'broader set of regulatory risks, particularly in international jurisdictions.' (3) The LLM answer mentions 'interchange revenue' loss, which is a reasonable inference but not explicitly stated in the ground truth. (4) The answer lacks the specific emphasis on international/cross-border data transfer risks that the ground truth emphasizes as a key 2023 development.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting regulatory changes to operational impacts (compliance costs, renewal risks, operating results pressure). However, it fails to properly synthesize the specific data localization evolution that distinguishes 2022 from 2023.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided by either answer, so quantitative accuracy is based on the absence of errors. The LLM introduces no false numbers but also provides no specific metrics to verify.\n\nSEMANTIC ISSUES: The LLM's framing of 'antitrust rules' and 'third-party payment failures' as new obligations appears to be extrapolation rather than synthesis from the ground truth, which focuses on data security, certification, and data localization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 639,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\nBetween 2022 and 2024 RBH remained **de‑consolidated** from PMI’s consolidated statements; the company held only an equity‑method investment that was carried at cost (or “without readily determinable fair value”) and was not reflected in the consolidated balance sheet aside from a line‑item in other assets.  In 2024, after RBH’s objection to the CCAA plan of arrangement and a reassessment of the settlement‑allocation and tax‑deductibility assumptions, PMI performed a fair‑value test and concluded that the investment’s recoverable amount was about **$714 million**, prompting a **$2.3 billion non‑cash impairment charge**—the first material valuation adjustment since the 2019 de‑consolidation.  Consequently, while the consolidation status did not change, the financial relationship shifted from a passive, cost‑basis holding to a recognized impairment reflecting a substantial decline in the expected recoverable value of RBH.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about RBH's de-consolidation status and the shift from a passive holding to an impairment-adjusted investment. However, there are significant quantitative discrepancies that undermine the answer's reliability. CRITICAL ISSUES: (1) The LLM introduces specific numbers ($714 million recoverable amount, $2.3 billion impairment charge) that are NOT present in the ground truth answer. The ground truth mentions a CAD 3.1 billion allocation of compensatory damages against RBH but does NOT cite a $714M or $2.3B figure. These appear to be fabricated or sourced from outside the provided ground truth. (2) The LLM states the impairment was 'the first material valuation adjustment since the 2019 de-consolidation,' but the ground truth does not explicitly confirm this is the first adjustment. (3) The LLM references 'RBH's objection to the CCAA plan of arrangement' as a 2024 event, which is not mentioned in the ground truth. STRENGTHS: (1) Correctly identifies that RBH remained de-consolidated between 2022-2024. (2) Accurately captures the shift from passive cost-basis holding to impairment-adjusted valuation. (3) Properly synthesizes the multi-hop concept of evolving financial relationship. (4) Correctly notes the emphasis on fair value estimation and judgment in audit processes. (5) Appropriately identifies key assumptions (discount rates, sales volumes, operating margins, tax treatment). WEAKNESSES: (1) Introduces unverified specific dollar amounts that contradict the instruction to match ground truth. (2) Adds details about CCAA objections not in ground truth. (3) The quantitative specificity creates false precision where the ground truth is more general. The answer demonstrates good qualitative understanding of the relationship evolution but fails on quantitative accuracy by introducing numbers not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 515,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\nIn 2023 Baqsimi generated $677.6 million of net product revenue (U.S. $645.7 M, ex‑U.S. $31.9 M), up from $139.3 M in 2022, with the increase driven in part by a $579 million upfront payment from the sale of its rights (see LLY 10‑K 2023 pp. 46‑47). By 2024 the product no longer appears as a separate line in the net‑product‑revenue table (LLY 10‑K 2024 p. 65) and its commercial sales are effectively discontinued, so any remaining economic benefit is captured only through collaboration milestones and royalties—making Baqsimi a marginal contributor to LLY’s portfolio compared with higher‑growth assets such as Mounjaro, Jardiance and Verzenio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023 Baqsimi revenue figures ($677.6M total, $645.7M U.S., $31.9M ex-U.S.) and accurately captures the strategic shift from direct product revenue in 2023 to divestment/collaboration arrangements in 2024. The reasoning about the transition from internally commercialized product to divested asset is sound and well-articulated. The comparison to other portfolio products (Mounjaro, Jardiance, Verzenio) adds relevant context.\n\nCRITICAL ERRORS: (1) The LLM introduces a $579 million upfront payment figure and attributes it to a 'sale of its rights' in 2023, claiming this drove the revenue increase from 2022 to 2023. This is problematic because: the ground truth explicitly states that in 2024 Baqsimi was disclosed as part of 'the 2023 sale of rights,' indicating the divestment occurred in 2023, not that revenue in 2023 included proceeds from a sale. The LLM conflates product revenue with transaction proceeds. (2) The $139.3M 2022 figure is introduced without ground truth verification and appears to be unsupported by the provided knowledge graph. (3) The statement that the $579M upfront payment 'drove in part' the 2023 revenue increase is misleading—upfront payments from asset sales are typically not included in product revenue; this suggests confusion about revenue classification.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the 2023-2024 comparison and identifies the strategic transition, but the introduction of unverified financial figures and mischaracterization of the sale mechanics weakens the analysis. The reasoning about collaboration milestones and royalties replacing direct revenue is sound and aligns with the ground truth.\n\nQUANTITATIVE ISSUES: While the 2023 revenue numbers are correct, the 2022 comparison figure ($139.3M) and the $579M upfront payment attribution lack verification against the ground truth. The calculation logic (increase from 2022 to 2023) is presented but the underlying data integrity is questionable.\n\nSEMANTIC ALIGNMENT: The core message—Baqsimi transitioned from direct product revenue to collaboration/royalty arrangements—is correct. However, the financial narrative around the sale proceeds introduces inaccuracy that undermines confidence in the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 608,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\nFrom 2022 to 2024 the share of owned equipment rose sharply and the leased share fell for both containers and chassis.  \n- **Containers:** owned ≈ 96 % (48,962) → owned ≈ 99 % (46,375) and leased dropped from about 4 % (1,856) to under 1 % (288).  \n- **Chassis:** owned ≈ 68 % (29,875) → owned ≈ 78 % (4,356) and leased fell from roughly 32 % (14,148) to about 21 % (1,197).  \n\nThus, Union Pacific moved from a more balanced owned‑versus‑leased mix in 2022 to a much higher‑ownership profile by 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains multiple significant factual errors that contradict the ground truth:\n\n1. OWNED CHASSIS NUMBERS - MAJOR ERROR: The LLM states owned chassis went from 29,875 to 4,356, then calculates this as 68% → 78% ownership. This is mathematically and logically impossible. If owned chassis decreased from 29,875 to 4,356 (an 85% reduction), the ownership percentage should DECREASE, not increase from 68% to 78%. The ground truth confirms owned chassis dropped to 4,356, but the percentage interpretation is backwards.\n\n2. LEASED CHASSIS NUMBERS - MAJOR ERROR: The LLM claims leased chassis fell from 32% (14,148) to 21% (1,197). However, the ground truth states leased units fell to 1,485 total, not 1,197. More critically, if total leased equipment dropped from 16,004 to 1,485, the leased chassis figure of 1,197 appears inconsistent with the stated total.\n\n3. OWNED CONTAINERS - INCORRECT: The LLM states owned containers were 48,962 in 2022 and 46,375 in 2024. The ground truth indicates owned units totaled 78,837 in 2022 and 50,731 in 2024. The container-specific breakdown provided by the LLM doesn't align with these totals.\n\n4. PERCENTAGE CALCULATIONS - FUNDAMENTALLY FLAWED: The claim that ownership increased from 68% to 78% for chassis while the absolute number dropped from 29,875 to 4,356 demonstrates a logical contradiction. The LLM appears to have calculated percentages incorrectly or used wrong denominators.\n\n5. DIRECTIONAL ACCURACY: While the LLM correctly identifies that the company moved toward higher ownership ratios for containers (96% → 99%), the chassis analysis is inverted and mathematically inconsistent.\n\n6. MISSING CONTEXT: The LLM fails to adequately convey the dramatic overall reduction in equipment (78,837 + 16,004 = 94,841 total in 2022 vs. 50,731 + 1,485 = 52,216 in 2024), which is a 45% reduction in total assets - a critical strategic insight.\n\nThe answer demonstrates partial understanding of the trend but contains fundamental calculation errors and contradictory statements that make it unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 569,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s securitized‑debt balance grew from about **$16.97 billion to $18.04 billion**—an increase of roughly **$1.1 billion (≈6 %)**, driven by net issuances in its securitization programs.  This modest rise kept securitized obligations at **around 4 % of total funding**, underscoring their role as a supplemental, low‑cost source of liquidity that helps finance the loan portfolio while deposits remain the dominant funding source.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific dollar amounts ($16.97B to $18.04B) and calculates the growth correctly (~$1.1B or ~6%), which aligns with the ground truth's mention of $18.043 billion in 2023. However, there are significant issues with completeness and reasoning: (1) The LLM introduces quantitative claims not present in the ground truth (4% of total funding, specific growth percentages) without verification against the source documents. (2) The ground truth emphasizes a qualitative shift in how securitized debt was categorized (Level 2 fair value hierarchy) and describes a move toward 'more standardized valuation methods' and 'more structured and possibly less volatile role'—critical contextual information the LLM completely omits. (3) The LLM's characterization of securitized debt as 'supplemental, low-cost source of liquidity' is reasonable but not explicitly supported by the ground truth provided. (4) The LLM fails to address the key evolution highlighted in the ground truth: the shift from being 'explicitly described as one of the company's key funding sources' in 2022 to being categorized under Level 2 in the fair value hierarchy in 2023. (5) The multi-hop reasoning is incomplete—the answer focuses narrowly on balance sheet growth while missing the structural/methodological evolution that was the core of the original answer. The numeric accuracy is acceptable, but the answer misses the substantive point about how the role and treatment of securitized debt evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 418,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\nIn 2023 the revenue that LLY reported from Zyprexa came from a one‑time sale of the olanzapine portfolio rights, which was recorded in **collaboration and other revenue** and recognized when the performance obligation was satisfied (i.e., when the buyer obtained the licensed rights)【page_66】. By 2024 there was no comparable rights‑sale; Zyprexa revenue is now reported only as **net product revenue**, recognized at the point the customer obtains control of the drug (shipping) and net of estimated rebates, discounts and returns【page_64】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that in 2023, Zyprexa revenue came from the sale of rights and was categorized as collaboration revenue, while in 2024 it was recognized as part of collaboration arrangements (still collaboration revenue, not product revenue). The LLM answer incorrectly claims the opposite: it states that in 2023 the revenue was from a one-time rights sale in collaboration revenue, but then claims that by 2024 'Zyprexa revenue is now reported only as net product revenue.' This is a critical reversal of the actual evolution described in the ground truth. The ground truth explicitly states the 2024 revenue was 'included in collaboration revenue rather than product sales,' not the other way around. The LLM appears to have inverted the 2023 vs 2024 categorization. Additionally, the LLM introduces details about 'shipping' and 'rebates, discounts and returns' that are not mentioned in the ground truth and appear to be fabricated or misapplied. The multi-hop reasoning is fundamentally flawed because it synthesizes the information in reverse order from what actually occurred. While the LLM correctly identifies that there was a shift in revenue recognition between the two years, it gets the direction and nature of that shift completely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 378,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\nThe pension plan has consistently valued Federal Government Securities using a bid‑evaluation process with independent pricing sources, and they have always been placed in the Level 2 category of the fair‑value hierarchy. What has changed between the 2022 and 2024 filings is the presentation and scale of the disclosure—​the 2022 filing listed the securities as “Federal government securities – Level 2 – $742 million” (2021), while the 2024 filing expands the same Level 2 classification to a much larger balance (≈ $1.5 billion in 2023) and spells out the methodology in a dedicated “Fair Value Measurements” table, but the underlying valuation approach and Level 2 classification remain unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims the 2024 filing shows 'approximately $1.5 billion in 2023' for Federal Government Securities. The ground truth states the 2022 value was $742 million with no mention of a $1.5 billion figure in 2024. This is a significant factual error - the LLM appears to have introduced an unsupported number. (2) METHODOLOGY CLAIM - The LLM asserts that Federal Government Securities 'have always been placed in the Level 2 category' and 'have consistently valued...using a bid-evaluation process.' However, the ground truth indicates that in 2022, the classification was 'Significant Other Observable Inputs (Level 2)' and the methodology explanation was added/clarified by 2024, not that it was always present. The LLM overstates the consistency of disclosure. (3) MULTI-HOP REASONING - The LLM correctly identifies that the classification remained Level 2 from 2022 to 2024, which is accurate. However, it mischaracterizes the evolution as merely 'presentation and scale' when the ground truth emphasizes that the methodology explanation itself evolved/was clarified. (4) MISSING NUANCE - The ground truth specifically notes the 2024 filing 'clarified' and 'adds specificity in methodology explanation,' suggesting these details were not as explicit in 2022. The LLM's claim that the methodology was always spelled out is contradicted by the ground truth's emphasis on clarification and added specificity. (5) CORRECT ELEMENTS - The LLM correctly identifies: Level 2 classification in both years, bid evaluation process with independent pricing sources, and that classification remained consistent. The $742 million 2022 figure is correct. OVERALL: The answer contains a major unsupported numerical claim ($1.5 billion), overstates the consistency of methodology disclosure, and misses the key point about evolution/clarification of the methodology explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 519,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\nFrom 2022 to 2023 the only measurable change in Capital One’s credit‑score data was a modest rise in the share of domestic credit‑card balances with FICO scores ≤ 660—from 31 % to 32 %—while the proportion of scores > 660 slipped from 69 % to 68 %.  The auto‑loan score distribution remained essentially unchanged (≈ 53 % > 660, 27 % ≤ 620 in both years).  This slight shift toward a higher‑risk segment indicates that the bank is increasingly leveraging credit‑score information to fine‑tune product segmentation—targeting more sub‑prime borrowers with tailored offers—reflecting a more granular, risk‑based approach to pricing and product placement in its credit‑risk model.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific credit score percentages and comparisons (31% to 32% for FICO ≤660, 69% to 68% for >660, auto-loan data at ~53% and 27%) but these numbers are NOT verified in the ground truth. The ground truth explicitly states that Capital One updated from using 2020-2021 credit score distributions in 2022 to using 2022-2023 distributions in 2023, referencing Table 21. The LLM answer does not mention this critical methodological shift or Table 21 at all. Instead, it provides granular percentage data that may or may not be accurate but cannot be verified against the provided ground truth. The LLM's interpretation about 'increasingly leveraging credit-score information to fine-tune product segmentation' and 'targeting more sub-prime borrowers' represents speculation beyond what the ground truth establishes. The ground truth's key insight—that the evolution reflects a shift to more current data sources (2022-2023 vs 2020-2021) indicating a 'more current and dynamic credit risk modeling strategy'—is completely absent from the LLM answer. The LLM focuses on year-over-year changes in credit score distributions rather than the methodological evolution in data sourcing that the ground truth emphasizes. While the LLM does address the general topic of credit risk modeling strategy, it misses the fundamental point about how Capital One updated its data recency and sourcing approach, which is the core of what the evolution indicates about their strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 410,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\nFrom 2022 to 2023 Amazon moved AWS from an internal “technology‑and‑content” investment that supported its retail operations to a distinct, stand‑alone business segment.  In the 2022 filing AWS was highlighted only as a major area of capital spending within the company’s broader infrastructure budget, whereas the 2023 filing explicitly lists AWS as one of three segments and emphasizes expanding its compute, storage, database, analytics and machine‑learning services—allocating an ever‑larger share of technology‑infrastructure capex to scale AWS globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the core evolution of AWS's strategic positioning from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key transformation from AWS being positioned within 'technology-and-content' investment spending in 2022 to becoming one of three distinct business segments in 2023; (2) Accurately lists the specific service categories (compute, storage, database, analytics, machine learning) that AWS offers; (3) Properly synthesizes the multi-hop information showing AWS's elevated strategic importance; (4) Correctly characterizes the shift from internal infrastructure support to standalone business segment. MINOR WEAKNESSES: (1) The phrase 'allocating an ever-larger share of technology-infrastructure capex to scale AWS globally' is somewhat speculative and not explicitly stated in the ground truth—while the ground truth mentions investment emphasis, the LLM adds interpretive language about 'ever-larger share' that goes slightly beyond what the original answer documents; (2) The ground truth emphasizes AWS's role in 'supporting geographic expansion, new product categories, and internal operational efficiencies' in 2022, which the LLM simplifies to just 'supporting its retail operations'—this is a minor semantic compression but loses some nuance. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022 vs 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the structural change in how AWS is presented in the company's business model. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—AWS evolved from a strategic investment area to a core business segment with expanded service offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 519,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\nBetween 2022 and 2024 the nature of PMI’s exposure to Rothmans, Benson & Hedges Inc. shifted dramatically.  In 2022 RBH was already fully de‑consolidated from PMI’s consolidated statements (its results have been excluded since the March 2019 CCAA filing – see PM 10‑K 2022 p. 113), and the company’s only remaining link was disclosure of the pending Canadian tobacco litigation and related contingencies – PM 10‑K 2022 p. 115.  By the end of 2024 PMI recorded a $2.3 bn non‑cash impairment of its equity investment in RBH, driven by uncertainty over the proposed CAD 32.5 bn settlement allocation and the potential liability from the stayed Canadian tobacco cases – PM 10‑K 2024 p. 32, Note 6 and p. 115.  Consequently, the relationship moved from a de‑consolidated subsidiary with only disclosed contingencies to a material equity holding that now carries a sizable, uncertain financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of PMI's evolving relationship with RBH. STRENGTHS: (1) All key financial figures are correct: $2.3 billion impairment charge (matches ground truth $2,316 million with acceptable rounding), CAD 32.5 billion settlement amount, and the 2024 timing. (2) Dates and timeline are accurate: March 2019 CCAA filing, March 31, 2022 stay of litigation, and 2024 impairment recording. (3) Multi-hop synthesis is sound: correctly traces the evolution from deconsolidation (2022) to equity investment with impairment (2024), and properly connects the proposed settlement to the impairment trigger. (4) Accounting treatment is correctly characterized: deconsolidation in 2022 with contingency disclosure, then equity investment model with impairment in 2024. (5) The answer appropriately cites specific 10-K pages and note references, demonstrating document-level accuracy. (6) Semantic equivalence is maintained throughout - 'non-cash impairment charge' and 'non-cash impairment' are equivalent. MINOR CONSIDERATIONS: The LLM rounds $2,316 million to $2.3 billion, which is an acceptable format variation and actually more readable. The answer provides slightly more granular detail about the CCAA filing date (March 2019) and litigation stay date (March 31, 2022) than the ground truth, which adds value without introducing errors. The characterization of the relationship shift from 'deconsolidated subsidiary with only disclosed contingencies' to 'material equity holding with uncertain financial exposure' accurately captures the essence of the evolution described in the ground truth. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 471,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy continued to generate roughly $8–9 billion of annual product sales—still one of Gilead’s largest single‑product revenue streams—but its share of total company sales slipped slightly as other franchises (e.g., Veklury, cell‑therapy) grew faster.  At the same time, the product’s commercial outlook has become more vulnerable: generic competition, the pricing‑curbs introduced by the Inflation‑Reduction Act and other Medicare‑Part D rebate reforms, and intensified market‑share pressure in the HIV space have increased the risk of revenue erosion compared with earlier years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Biktarvy as a major revenue driver for GILD and accurately captures the evolution of commercial risks from 2022 to 2024, including generic competition, IRA pricing reforms, and competitive pressures in HIV treatment. The qualitative assessment of heightened vulnerability aligns well with the ground truth. The answer appropriately addresses both revenue contribution and product risks as requested.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUE - The LLM states Biktarvy generated 'roughly $8–9 billion of annual product sales' between 2022-2024, but the ground truth only provides a specific 2022 figure of $8,624 million ($8.624 billion). The LLM extrapolates this to 2024 without acknowledging that specific 2024 revenue figures are not provided in the ground truth. This is a significant overreach. (2) The ground truth explicitly states 'By 2024, while specific revenue figures are not provided,' but the LLM presents a range ($8-9B) as if it has confirmed data for the 2022-2024 period. (3) The LLM introduces specific risk factors (IRA, Medicare Part D rebates, generic competition) that are reasonable inferences but are not explicitly mentioned in the provided ground truth excerpt, which only references 'heightened risks related to the HIV product class' and 'reliance on TAF-based therapies.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the dual aspects of the question (revenue contribution + product risks) and correctly identifies the temporal evolution. However, it overstates the certainty of 2024 revenue data.\n\nSEMANTIC EQUIVALENCE: The core message about Biktarvy's continued importance but increased vulnerability is semantically equivalent to the ground truth. The mention of other franchises growing faster is a reasonable inference about relative market share changes.\n\nJUSTIFICATION: The answer loses points primarily for quantitative overreach (presenting estimated ranges as if confirmed for 2024) and for introducing specific regulatory details not in the ground truth. The qualitative assessment is sound, but the quantitative claims exceed what the ground truth supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 578,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\nFrom 2022 through 2024 Union Pacific’s equity stake in TTX expanded, with the carrying value of its investment climbing from about **$1.8 billion at the end of 2023 to $1.9 billion at the end of 2024** (up from roughly $1.5 billion in 2020), underscoring the continued 37 % ownership.  At the same time, car‑hire expenses paid to TTX—shown in “equipment and other rents”—rose from **$402 million in 2022 to $399 million in 2023 and then to $432 million in 2024**, reflecting higher utilization or rates even though overall operating‑lease cost fell slightly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the investment value at end of 2024 ($1.9 billion) and the car hire expense for 2024 ($432 million), matching ground truth. The answer appropriately addresses the multi-hop question about both investment value and car hire expenses across the 2022-2024 period. The reasoning about growing financial involvement is sound, and the 37% ownership detail adds relevant context.\n\nWEAKNESSES: (1) CRITICAL NUMBER ERROR - The LLM states the investment was '$1.8 billion at the end of 2023' but provides no ground truth verification for this intermediate year value. More importantly, the LLM cites '$1.5 billion in 2020' as a reference point, but the ground truth baseline is $1.6 billion in 2021 (from the 2022 filing), not 2020. This represents a factual discrepancy in the historical comparison. (2) CAR HIRE EXPENSE DISCREPANCY - The LLM reports $402 million in 2022 and $399 million in 2023, but the ground truth shows $375 million in 2021 rising to $432 million in 2024. The LLM's 2022-2023 figures cannot be verified against the provided ground truth, which only specifies 2021 and 2024 values. The LLM appears to have sourced different years than what the ground truth references. (3) INCOMPLETE BASELINE - The ground truth explicitly references the 2021 investment value ($1.6 billion) as stated in the 2022 filing, establishing the proper temporal baseline. The LLM's use of 2020 data ($1.5 billion) and 2023 data ($1.8 billion) creates a different narrative arc than the ground truth's 2021-2024 progression.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two metrics (investment value and car hire expenses) and multiple years, demonstrating sound multi-hop reasoning. However, the specific years chosen for comparison differ from the ground truth's intended comparison period.\n\nCALCULATION VERIFICATION: The increase from $1.8B to $1.9B (2023-2024) is correctly stated as an increase. The car hire expense progression ($402M → $399M → $432M) shows correct arithmetic, though the baseline years differ from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 563,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\nIn 2022 Tesla outlined a hands‑on scaling plan for Solar Roof that relied on on‑boarding and training new installers, collaborating with real‑estate developers to shorten installation time, and securing battery‑cell supply while hiring additional skilled electricians. By 2023 the company framed installer training as part of a broader, risk‑aware expansion—emphasizing that supply‑chain constraints and the need to staff and operate new production equipment make the recruitment and retention of qualified personnel a critical lever for sustaining Solar Roof growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of Tesla's Solar Roof scaling approach but has significant issues with completeness and accuracy of the strategic shift described. STRENGTHS: (1) Correctly identifies 2022 focus on installer training, onboarding, and collaboration with real estate developers; (2) Correctly notes hiring of skilled electricians in 2022; (3) Accurately reflects 2023 shift toward supply chain risk management and supplier reliability concerns; (4) No quantitative errors (no specific numbers were provided to verify). WEAKNESSES: (1) The LLM answer introduces 'battery-cell supply' as a 2022 concern, which is not mentioned in the ground truth and appears to conflate Solar Roof with battery/energy storage initiatives—this is a factual error; (2) The 2023 characterization is incomplete and somewhat misleading—the ground truth emphasizes a shift FROM installer-focused growth TO supply chain resilience, but the LLM frames it as installer training becoming 'part of a broader, risk-aware expansion,' which softens the strategic pivot and suggests continuity rather than the clear shift described in ground truth; (3) Missing the key insight that 2023 language indicated 'delays in production ramps could harm the business,' signaling a more risk-averse posture; (4) The LLM's framing of 'recruitment and retention of qualified personnel as a critical lever' in 2023 somewhat contradicts the ground truth's emphasis on supply chain resilience over installer-focused strategies. MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2023 changes but fails to fully capture the directional shift from installer-centric to supply-chain-centric strategy. The introduction of battery-cell supply suggests incomplete or inaccurate source material synthesis. SEMANTIC EQUIVALENCE: While the general themes are present, the specific strategic pivot is not accurately conveyed—the answer suggests evolution rather than the more significant shift described in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 538,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s core arrangement with U.S. fountain retailers did not change: under the bottler agreements (2022 KO 10‑K p. 9; 2023 KO 10‑K p. 38) bottlers are still prohibited from manufacturing fountain syrups, so the Company continues to produce the syrups and sell them to authorized fountain wholesalers and, directly or via those wholesalers, to fountain retailers (2022 KO 10‑K p. 7; 2023 KO 10‑K p. 37).  \n\nThe evolution lies in the pricing and contractual framework – the 2023 Comprehensive Beverage Agreements introduced a more formal incidence‑based pricing model and mandatory pricing provisions that give the Company tighter control over syrup prices and performance expectations while still using the same wholesaler‑to‑retailer distribution chain.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The core factual claim that bottlers are prohibited from manufacturing fountain syrups in both 2022 and 2023 is accurate and well-supported with proper 10-K citations. (2) The identification that the Company manufactures and sells fountain syrups directly to authorized fountain wholesalers and fountain retailers is correct. (3) The page citations (2022 10-K p. 9, p. 7; 2023 10-K p. 38, p. 37) appear appropriately referenced. (4) The statement that the core arrangement did not fundamentally change between 2022 and 2023 is reasonable. PROBLEMATIC ASPECTS: (1) The LLM introduces information about '2023 Comprehensive Beverage Agreements' with 'incidence-based pricing model' and 'mandatory pricing provisions' that is NOT present in the ground truth answer. This represents an unsupported addition beyond what the knowledge graph confirms. (2) The ground truth specifically highlights an EVOLUTION in how the Company describes its distribution model - moving from stating it sells 'directly to authorized fountain wholesalers (including some bottlers)' in 2022 to explicitly acknowledging 'bottling partners who then distribute them to fountain retailers' in 2023. The LLM characterizes this as merely 'pricing and contractual framework' changes rather than acknowledging the explicit clarification of the tiered distribution model involving bottling partners. (3) The LLM's framing that 'the core arrangement...did not change' somewhat contradicts the ground truth's emphasis on evolution and clarification of roles. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2023 filings but introduces unsupported details about pricing models that go beyond the ground truth. The answer demonstrates good document navigation but fails to accurately capture the specific evolution highlighted in the ground truth regarding explicit acknowledgment of bottling partners' distribution role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 538,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\nIn the 2022 filing the 0.950% Notes due 2025 were only mentioned in the “Reference Number per Item 601” exhibit list and were not set out as a separate line in the “Securities Registered Pursuant to Section 12(b)” table. By the 2024 Form 10‑K the notes appear explicitly in that table as “0.950% Notes due 2025 (IBM25B)”, identified as registered debt securities under the 1933 Act with a specific NYSE ticker, thereby providing clearer classification and registration details.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a partially correct response with some accurate elements but notable discrepancies from the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies the 0.950% Notes due 2025 as the instrument in question, (2) The ticker symbol 'IBM25B' is correctly cited, (3) The general evolution from less formal disclosure to more explicit registration is conceptually aligned with the ground truth, (4) The mention of Form 10-K and Securities Registered table is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM states the notes were 'only mentioned in the Reference Number per Item 601 exhibit list' in 2022 and 'not set out as a separate line' in the registration table - this is more specific than the ground truth which references Form 8-K filings and Exhibit 4.1 from May 22, 2017, suggesting the LLM may be conflating or misremembering the specific filing types and exhibit references, (2) The ground truth emphasizes a shift from 'merely disclosing' (via Form 8-K exhibits) to 'formally registering and listing it for trading' - the LLM's framing focuses on Form 10-K table presentation rather than the Form 8-K to active trading evolution described in ground truth, (3) The LLM mentions '1933 Act' registration which is not explicitly stated in the ground truth, (4) The specific filing date of May 22, 2017 from the ground truth is absent from the LLM answer. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the evolution concept but appears to have accessed different or incomplete source information, resulting in a different narrative arc than the ground truth. The answer is logically coherent but factually divergent in key details about which filings and exhibits are relevant to the 2022-2024 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 478,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has pushed Biktarvy from a niche, late‑line integrase‑inhibitor into the center of its HIV franchise—expanding its label (e.g., earlier‑line and potential pediatric use) and relying on it for a growing share of product revenue.  This concentration heightens the company’s financial risk because any margin squeeze from the Inflation‑Reduction Act’s Medicare price‑negotiation rules, generic‑entry pressure, or rebate‑driven payer negotiations would directly impact the flagship drug’s profitability.  Consequently, Biktarvy’s competitive edge now rests less on pure efficacy/safety and more on Gilead’s ability to protect pricing through payer‑engagement programs, real‑world outcome data, and formulation advantages while fending off rival integrase‑inhibitor pipelines and generic competition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT CHARACTERIZATION OF BIKTARVY'S POSITIONING: The LLM claims Gilead 'pushed Biktarvy from a niche, late-line integrase-inhibitor into the center of its HIV franchise' with 'expanding label' and 'earlier-line' use. However, the ground truth states Biktarvy was ALREADY 'listed among GILD's key marketed products' in 2022, indicating it was already central to the portfolio. The LLM's narrative of expansion from niche to center is not supported by the ground truth. (2) MISCHARACTERIZATION OF RISK DRIVERS: The LLM emphasizes 'Inflation-Reduction Act's Medicare price-negotiation rules' and 'payer-engagement programs' as primary competitive concerns. The ground truth specifically identifies the risk as stemming from 'potential shift in HIV treatment paradigms away from TAF-based regimens' and 'rising generic competition and changing therapeutic preferences.' The LLM focuses on pricing/payer dynamics rather than the fundamental therapeutic paradigm shift that is central to the ground truth. (3) INCORRECT THERAPY CLASSIFICATION: The LLM refers to Biktarvy as an 'integrase-inhibitor' when the ground truth explicitly identifies it as a 'nucleoside-based therapy' with TAF (tenofovir alafenamide) as a key component. This is a material factual error in drug classification. (4) MISSING KEY INSIGHT: The ground truth emphasizes concern about 'long-term competitive differentiation and its ability to sustain revenue' due to paradigm shifts away from TAF-based regimens. The LLM completely misses this critical insight about therapeutic paradigm evolution. (5) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize financial risk and competitive positioning, it does so based on incorrect premises about what changed from 2022 to 2024. The evolution described in the ground truth is about growing recognition of structural risks (paradigm shift, generics), not about Gilead's strategic expansion of the drug's label. The LLM answer demonstrates a fundamental misunderstanding of the actual strategic evolution and risk profile documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 591,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin accelerated the wind‑down of its defined‑benefit obligations—first by purchasing group annuity contracts that transferred $4.3 billion of DB liabilities in Q2 2022 (resulting in a $1.5 billion non‑cash settlement charge) and then, in Q4 2023, by offering a voluntary lump‑sum settlement that moved roughly $414 million of DB obligations out of the pension trust, lowering the liability and the related accumulated‑other‑comprehensive‑loss balance.  At the same time, the company’s defined‑contribution retirement savings plan was unchanged; employees hired after 2005 continued to be eligible only for the DC plan, and the 2020 freezing of the qualified DB plans had already cemented the shift toward DC participation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Lockheed Martin's pension strategy evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - $4.3 billion pension obligation transfer in 2022, $1.5 billion noncash settlement charge, $414 million settlement payments in 2023, and approximately 6,500 former employees. Dates are accurate (Q2 2022 for annuity purchase, Q4 2023 for lump-sum settlement). COMPLETENESS: The answer addresses the core question about the evolution from 2022 to 2023, capturing the strategic shift from group annuity contracts to direct lump-sum settlements. It also appropriately contextualizes the defined contribution plan aspects (employees hired after 2005, 2020 DB plan freeze). MULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and connects the pension obligation transfers to their financial impacts (settlement charges, AOCL balance changes). The logical flow from 2022 annuity purchase to 2023 direct settlements is clearly articulated. MINOR CONSIDERATIONS: The LLM answer adds contextual detail about the DC plan eligibility and DB plan freeze that, while accurate and relevant, goes slightly beyond the specific ground truth statement. However, this additional context is appropriate and enhances understanding rather than detracting from accuracy. The characterization of the shift as an 'acceleration' of wind-down is a reasonable interpretation of the strategic evolution. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth - the transition from transferring large blocks of obligations to insurers to settling smaller portions directly with participants. The terminology used (group annuity contracts, voluntary lump-sum settlement, AOCL) is precise and appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 495,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s 2025‑maturity profile remained anchored by the 2.875 % Notes due 2025 (identified as IBM 25A). In the 2022 filing the 2025 cohort consisted of three note series – 2.875 %, 0.950 % and 0.875 % – plus a 7.00 % debenture – all of which continued to appear in the 2024 table, with the 2.875 % series still listed as IBM 25A. Consequently, the 2.875 % Notes due 2025 have stayed in IBM’s debt‑maturity mix, showing no retirement or new issuance; the overall composition of 2025‑maturing instruments has simply evolved by retaining the same series while other tranches may have shifted in relative size.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error that directly contradicts the ground truth. The ground truth explicitly states that by 2024, the 0.875% Notes due 2025 (IBM 25C) 'were no longer listed,' indicating a shift in debt composition. However, the LLM answer claims 'all of which continued to appear in the 2024 table,' asserting that all three note series from 2022 (2.875%, 0.950%, and 0.875%) plus the 7.00% debenture 'continued to appear in the 2024 table.' This is factually incorrect. The LLM also introduces a 7.00% debenture that is not mentioned in the ground truth at all, suggesting either fabrication or confusion with other debt instruments. The ground truth's key finding—that the 0.875% Notes due 2025 were retired or removed between 2022 and 2024—is completely missed or contradicted by the LLM. The LLM does correctly identify the 2.875% Notes due 2025 (IBM 25A) as remaining in both years, and correctly notes the 0.950% Notes due 2025 (IBM 25B), but the assertion that composition 'simply evolved by retaining the same series' is incorrect given the removal of the 0.875% Notes. The reasoning about 'no retirement or new issuance' for the 2.875% series is accurate, but this is only a partial answer to the question about how composition evolved. The multi-hop synthesis fails because the LLM did not properly identify the key compositional change (removal of 0.875% Notes) that distinguishes 2022 from 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 404,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Biktarvy evolved from a “recovery” product that was filling the gap left by the loss of exclusivity of Truvada/Atripla into the core profit‑driver of Gilead’s HIV franchise, delivering year‑over‑year sales growth as the company expects the legacy‑product impact to be largely behind it.  Its strategic importance is underscored by label expansions (e.g., the 2021 FDA approval of a low‑dose pediatric tablet) and continued investment in next‑generation HIV candidates such as long‑acting capsid inhibitors, positioning Biktarvy as the anchor of Gilead’s antiviral portfolio.  At the same time, its risk profile has broadened: it now faces intensified competition from generic and emerging novel HIV regimens, aggressive payer‑driven pricing pressures (including the IRA’s Medicare price‑negotiation and rebate reforms), and uncertainty about the treatment paradigm’s shift toward dual‑ or long‑acting therapies that could erode its market share.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) MAJOR ERROR - The LLM characterizes Biktarvy as evolving INTO 'the core profit-driver' and 'anchor' of Gilead's HIV franchise by 2024, while the ground truth explicitly states that by 2024 'the strategic importance of Biktarvy appears more precarious' and increasingly vulnerable. This is a fundamental mischaracterization of the trajectory. (2) QUANTITATIVE ISSUES - The LLM cites a '2021 FDA approval of a low-dose pediatric tablet' but provides no verification this is accurate or relevant to the 2022-2024 evolution being asked about. The ground truth mentions '11% revenue increase' attributed to Biktarvy in 2022, which the LLM does not reference. (3) DIRECTIONAL ERROR - The ground truth emphasizes a SHIFT in risk profile from growth asset (2022) to vulnerable asset (2024) due to paradigm shifts toward non-TAF therapies. The LLM instead emphasizes continued strategic importance with broadened risks, missing the core insight that strategic positioning DECLINED. (4) MISSING KEY INSIGHT - The ground truth specifically highlights the TAF vulnerability risk ('many of our HIV products contain TAF' and 'any shift away from nucleoside-based therapies could materially impact sales'). The LLM mentions 'shift toward dual- or long-acting therapies' but doesn't capture the specific TAF-based vulnerability that the 2024 10-K emphasizes. (5) SEMANTIC CONTRADICTION - The LLM describes Biktarvy as 'recovery' product filling gaps, then as 'core profit-driver,' suggesting improvement. The ground truth shows deterioration in strategic positioning from 2022 to 2024. (6) INCOMPLETE SYNTHESIS - The LLM fails to synthesize the multi-hop comparison between 2022 positioning (growth driver) and 2024 positioning (increasingly vulnerable to paradigm shifts). The answer reads as a general description of Biktarvy's market position rather than a specific evolution analysis showing the change in strategic importance and risk profile.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 547,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\nThe U.S. litigation‑escrow balance rose from **$1.449 billion at the end of fiscal 2022** to **$1.764 billion at the end of fiscal 2023**.  The change was driven by a **$1.0 billion deposit** into the escrow account during fiscal 2023 (with a net $0.685 billion of payments to opt‑out merchants), producing a net increase of roughly **$0.315 billion** over the year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. Specific issues: (1) ENDING BALANCE FY2023: LLM states $1.764 billion, but ground truth is $3.089 billion - this is a massive discrepancy of $1.325 billion or 43% understatement. (2) ENDING BALANCE FY2022: LLM correctly states $1.449 billion, matching ground truth. (3) DEPOSIT CONTRIBUTIONS: LLM mentions a $1.0 billion deposit in FY2023, but ground truth specifies $1.500 million in FY2023 (and $1.000 million in FY2022). The LLM appears to have confused or misreported the deposit amounts. (4) NET CHANGE CALCULATION: LLM calculates a $0.315 billion increase, but the correct increase from $1.449B to $3.089B is $1.640 billion. The LLM's calculation is internally inconsistent with its own stated beginning and ending balances. (5) ADDITIONAL INFORMATION: The LLM introduces information about 'opt-out merchant payments' ($0.685 billion) that, while potentially relevant context, does not appear in the ground truth answer and suggests the LLM may be conflating different accounts or time periods. The answer fails to correctly address the core question about how the balance evolved and what the specific deposit contributions were during each period. The multi-hop synthesis is fundamentally broken due to incorrect data retrieval or calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 372,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s manufacturing of fountain syrups remained anchored in the United States, where it continues to produce the syrups and sell them directly to fountain retailers (and, through authorized wholesalers or bottling partners, to other fountain accounts) – a responsibility that is counted within the North America operating segment 【page 37】.  What shifted is the relative importance of those syrup sales: concentrate operations, which include fountain‑syrup revenue, rose from 56 % of net operating revenue in 2022 to 58 % in 2023, while finished‑product operations fell from 44 % to 42 % 【page 38】.  Thus, the manufacturing role stayed the same but its contribution to overall revenue grew, reflecting a modest evolution toward a larger share of syrup‑based sales in North America.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues that prevent it from being considered substantially correct: (1) QUANTITATIVE ERRORS: The LLM provides specific percentages (concentrate operations rising from 56% to 58%, finished-product operations falling from 44% to 42%) without verification against the ground truth. These numbers are presented as factual but cannot be confirmed from the provided context and appear to be fabricated or misattributed. The ground truth makes no mention of these specific revenue percentages. (2) INCOMPLETE ADDRESSING OF QUESTION: The original question asks about the EVOLUTION of fountain syrups' role between 2022 and 2023, particularly regarding manufacturing and distribution responsibilities. The ground truth indicates a nuanced shift: in 2022, Coca-Cola manufactured fountain syrups in the U.S. and sold directly; by 2023, the description shifted to indicate bottling partners were authorized to manufacture fountain syrups using company concentrates (particularly outside the U.S.). The LLM answer states 'the manufacturing role stayed the same' and focuses instead on revenue contribution percentages, which misses the key evolution described in the ground truth about the shift toward a more decentralized, authorization-based manufacturing model. (3) MISSING KEY INSIGHT: The ground truth emphasizes that the evolution involves a shift toward emphasizing a 'decentralized, authorization-based model, particularly outside the U.S.' The LLM answer does not capture this important distinction about the changing authorization structure for bottling partners. (4) CITATION ISSUES: The LLM provides page references (page 37, page 38) but these cannot be verified and the specific percentages cited do not appear in the ground truth. (5) PARTIAL CORRECTNESS: The LLM correctly identifies that manufacturing remained anchored in the United States and that fountain syrups are sold through various channels (direct to retailers, through wholesalers/bottling partners), which aligns with the 2022 description in the ground truth. However, this represents only a partial understanding of the evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 574,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the 0.950 % Notes due 2025 (series IBM 25B) on its balance‑sheet, but the share of the 2025‑maturity cohort represented by that ultra‑low‑coupon tranche fell.  The 2025 maturities now consist of the 2.875 % Notes (IBM 25A), the 0.950 % Notes (IBM 25B) and the 7 % Debentures (IBM 25), with the 2.875 % and 7 % issues making up a larger portion of the total 2025 debt than the 0.950 % series.  Consequently, while the 0.950 % Notes remain outstanding, their relative composition within IBM’s 2025 debt has decreased from 2022 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces a '7% Debentures (IBM 25)' that does not appear in the ground truth. The ground truth explicitly states that by 2024, IBM had only TWO debt instruments maturing in 2025: (1) 2.875% Notes due 2025 (IBM 25A) and (2) 0.950% Notes due 2025 (IBM 25B). The 0.875% Notes due 2025 (IBM 25C) were removed between 2022 and 2024. The LLM's claim about a '7% Debentures' instrument is factually incorrect and represents a significant error in entity identification. CORRECT ELEMENTS: The LLM correctly identifies that the 0.950% Notes (IBM 25B) remained outstanding and that the 2.875% Notes (IBM 25A) continued to exist. The general concept that the relative composition of the 0.950% Notes decreased is directionally correct. CRITICAL ISSUES: (1) Introduces non-existent debt instrument (7% Debentures), (2) Fails to identify the removal of the 0.875% Notes due 2025, (3) Provides incomplete and inaccurate composition of 2025 maturities, (4) The multi-hop synthesis is fundamentally flawed due to the fabricated instrument. The answer demonstrates poor accuracy in identifying which specific debt instruments existed in each year, which is the core requirement of this multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 345,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 Disney’s cruise‑ship strategy shifted from simply announcing a new shore‑based port—Lighthouse Point on Eleuthera, slated to open as a Disney Cruise Line destination in 2024 (2022 10‑K)—to explicitly framing that project as a core, capital‑intensive growth initiative and integrating it into the company’s broader Experiences segment (2024 10‑K).  The 2024 filing underscores ongoing investment and risk disclosures around the development, indicating that expanding the cruise‑line fleet and its private‑destination assets has become a sustained strategic priority rather than a one‑off announcement.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's cruise ship strategy evolution between 2022 and 2024, with generally accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the shift from announcement to strategic investment focus; (2) Accurately references Lighthouse Point on Eleuthera as a specific 2024 opening destination mentioned in 2022 10-K; (3) Properly synthesizes the integration into the Experiences segment; (4) Correctly characterizes the evolution as moving from one-off announcement to sustained strategic priority; (5) Appropriately notes capital-intensive nature and risk disclosures. WEAKNESSES: (1) The LLM answer is more specific and narrowly focused on Lighthouse Point as the primary example of evolution, whereas the ground truth takes a broader approach discussing general mentions of cruise ships in 2022 versus explicit expansion plans in 2024; (2) The ground truth emphasizes a shift from 'general dependence on consumer demand' to 'active investment and growth strategy,' which is a more conceptual framing than the LLM's focus on a specific project; (3) The LLM answer doesn't explicitly mention the broader fleet expansion language from 2024 as prominently as the ground truth does; (4) Minor: The LLM could have been clearer about whether Lighthouse Point was mentioned in 2022 as a future project versus being a 2024 opening. QUANTITATIVE ACCURACY: The dates (2022, 2024) and project name (Lighthouse Point, Eleuthera) are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and connects specific project details to broader strategic positioning. SEMANTIC EQUIVALENCE: While the LLM uses different framing (specific project focus vs. broader strategic shift), the core message about evolution from announcement to strategic investment is conveyed accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 518,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\nLockheed Martin’s 2022 filing disclosed that the August 2021 purchase of $4.9 billion of group‑annuity contracts— which produced a $1.7 billion non‑cash pension‑settlement charge—was only the first of a series of pension‑risk‑transfer actions the company intends to pursue. The 2023 filing reiterates that strategy, stating the goal is to reduce the volatility of its defined‑benefit obligations and improve cash flow, while acknowledging that future transfers may generate additional non‑cash settlement charges that could affect reported earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key quantitative facts: the August 2021 transaction involving $4.9 billion in group annuity contracts and the $1.7 billion noncash pension settlement charge. The dates and dollar amounts are accurate. However, the answer has significant gaps in completeness and contextual depth compared to the ground truth. MISSING ELEMENTS: (1) The cumulative $11.6 billion in pension obligations transferred since December 2018 is not mentioned, which is important context for understanding the scale of the program. (2) The 95,000 retirees affected is omitted. (3) Most critically, the answer fails to capture the key evolution from 2022 to 2023: the shift from emphasizing past accomplishments to acknowledging residual liability exposure and insurer default risk. The ground truth explicitly notes that 2023 introduced 'a nuanced risk' regarding potential insurer defaults that 'reflects a more cautious framing' not emphasized in 2022. The LLM answer mentions 'future transfers may generate additional non-cash settlement charges' but misses the important risk acknowledgment about GAC liability exposure. QUANTITATIVE ACCURACY: Strong (8/10) - all numbers cited are correct. QUALITATIVE ACCURACY: Weaker (5/10) - the answer captures the basic strategic intent but fails to synthesize the important evolution in risk framing and disclosure emphasis between years. CONTEXTUAL RELEVANCE: Moderate (6/10) - addresses the question but incompletely, missing the nuanced shift in how the company framed pension risk transfer strategy. The answer reads more like a summary of 2022-2023 consistency rather than capturing the meaningful evolution in approach and risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 463,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\nBetween 2022 and 2023 Tesla shifted from a largely outsourced financing structure—where it recorded receivables from third‑party leasing and credit partners and relied on allowances for doubtful accounts—to a model in which it directly funds and manages operating leases and customer financing, heightening its exposure to residual‑value and credit‑risk.  The 2022 filing noted only periodic fluctuations in accounts‑receivable balances caused by payment‑cycle timing, whereas the 2023 filing explicitly warns that inaccurate residual‑value forecasts, price changes, or customer defaults could materially impair the leasing program and force the company to seek additional financing or face funding constraints.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims Tesla shifted from outsourced financing to directly funding and managing operating leases in 2023. The ground truth indicates the opposite direction of concern—from operational cash flow timing focus in 2022 to broader risk management in 2023, with no evidence of Tesla taking on direct lease funding. This is a fundamental mischaracterization. (2) QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates, or metrics from the filings. The ground truth mentions 'approximately two weeks' for accounts receivable settlement in 2022, which the LLM completely omits. (3) MISREPRESENTATION OF 2022 DISCLOSURE: The LLM states 2022 noted 'only periodic fluctuations in accounts-receivable balances caused by payment-cycle timing,' which aligns with ground truth's mention of two-week settlement cycles. However, the LLM then incorrectly frames this as evidence of an outsourced model that Tesla abandoned. (4) INCORRECT CHARACTERIZATION OF 2023: The LLM claims 2023 shows Tesla 'directly funds and manages operating leases,' but the ground truth states Tesla's leasing business 'depends on securing adequate financing or partners'—indicating continued reliance on external partners, not direct funding. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution described in ground truth: from short-term liquidity concerns (2022) to scaled program risks (2023), while maintaining partnership reliance. Instead, it invented a narrative about Tesla internalizing financing operations. (6) MISSING KEY DETAILS: The LLM omits the specific risk categories mentioned in ground truth: residual value risks, credit risks, and compliance risks that emerged in 2023. While the LLM mentions residual value, it does so in the context of an incorrect business model shift. The answer demonstrates poor document synthesis and introduces false information not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 555,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola refined its fountain‑syrup distribution by moving more of the syrup sales directly to authorized fountain‑wholesalers and by extending incidence‑based pricing to selected bottlers—especially the “expanding participating bottlers”—that now purchase (and, in some markets, manufacture) syrup under new contractual terms.  As a result, bottlers evolved from being merely distributors of finished drinks to active purchasers and, where permitted, co‑producers of fountain syrup, while fountain‑wholesalers assumed a larger logistics and retail‑delivery role, handling the bulk distribution of syrup to restaurants and other end‑users.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM claims Coca-Cola moved 'more of the syrup sales directly to authorized fountain-wholesalers,' but the ground truth indicates the opposite—the strategy evolved toward bottlers becoming MORE active in manufacturing and selling fountain syrups, not less. (2) MISSING CRITICAL GEOGRAPHIC DISTINCTION: The ground truth explicitly states that in 2022, U.S. bottlers were 'generally not authorized to manufacture fountain syrups,' but by 2023, 'outside the United States, bottlers were typically authorized to manufacture fountain syrups.' The LLM answer mentions 'selected bottlers' and 'some markets' but fails to clearly articulate this crucial geographic shift and the U.S. vs. international distinction. (3) INVENTED CONCEPTS: The LLM introduces 'incidence-based pricing' and 'expanding participating bottlers' which do not appear in the ground truth and appear to be fabricated details. (4) INCOMPLETE CHARACTERIZATION: While the LLM correctly notes bottlers evolved from 'merely distributors' to 'active purchasers and co-producers,' it misses the key point that this was primarily an international phenomenon, not a universal change. (5) FOUNTAIN WHOLESALER ROLE: The LLM's description of fountain wholesalers assuming 'a larger logistics and retail-delivery role' contradicts the ground truth, which shows they maintained their role as intermediaries but with bottlers now competing in this space internationally. The answer demonstrates partial understanding of the evolution but fundamentally misrepresents the direction and scope of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 466,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s receivables from the ATMP joint venture rose modestly—from about $9 million to roughly $12 million—while the amount it owes the JV grew from roughly $363 million to about $476 million.  In addition, AMD made new financial commitments to the JV: it contributed an extra $17 million of equity in August 2024 (raising its equity‑method investment to ≈ $149 million) and, on October 9 2024, extended a $100 million term loan to the JV (secured by the receivable balance) that bears interest at SOFR + 50 bps and can be extended for up to another year.  These actions reflect a deepening of AMD’s financial involvement with the ATMP JV beyond simple purchase‑resale transactions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial additional information beyond the ground truth but contains significant discrepancies in key metrics. CORRECT ELEMENTS: (1) Receivables increase from $9M to $12M is accurate; (2) $100M term loan on October 9, 2024 is correct; (3) SOFR + 50 bps interest rate detail is accurate; (4) General characterization of deepening financial involvement is appropriate; (5) Multi-hop synthesis across receivables, payables, equity investment, and loan activities is well-structured. PROBLEMATIC ELEMENTS: (1) The ground truth makes NO mention of AMD owing the JV $363M in 2023 or $476M in 2024—the LLM introduces payables/liabilities that are not in the original answer; (2) The $17M equity contribution in August 2024 is not mentioned in ground truth; (3) The claim that equity-method investment rose to approximately $149M is not in the original answer; (4) The detail about the loan being 'secured by the receivable balance' is not in ground truth. ASSESSMENT: The LLM appears to have synthesized information from actual 10-K filings that goes beyond what was provided in the ground truth answer. While the core receivables ($9M→$12M) and loan ($100M) facts are correct, the introduction of substantial payables figures and equity contribution details that contradict or extend the ground truth creates factual inconsistencies. The ground truth explicitly states 'there was no mention of any direct investment or loan made by AMD to the JV' in 2023, yet the LLM's discussion of payables and equity contributions suggests a more complex financial relationship. This represents either: (a) additional accurate information from filings not captured in the ground truth, or (b) hallucinated/incorrect details. Given the evaluation framework prioritizes ground truth accuracy, the introduction of unverified figures (payables, equity contribution) that aren't in the original answer constitutes a significant error, even though the core loan and receivables facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 538,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin moved from a broad, market‑based strategy—purchasing group annuity contracts that transferred $4.3 bn of defined‑benefit obligations in 2022 (and $4.9 bn in 2021) and generating a $1.5 bn non‑cash settlement charge in the second quarter of 2022—to a much more targeted approach in 2023, offering a voluntary lump‑sum settlement of $414 million to roughly 6,500 former employees, which reduced the pension liability by that amount and eliminated the need for a large settlement charge.  The financial impact was a smaller, one‑time reduction in accumulated other‑comprehensive‑loss and a modest adjustment to net pension expense, reflecting the shift from large‑scale annuity buy‑outs to smaller, voluntary settlements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Lockheed Martin's pension strategy from 2022 to 2023, with accurate characterization of the shift from large-scale annuity purchases to targeted voluntary settlements. However, there are significant quantitative accuracy issues: (1) The LLM introduces a $4.9 billion figure for 2021 that is not mentioned in the ground truth and appears to be extraneous information not directly relevant to the 2022-2023 comparison requested. (2) All core numbers for the 2022-2023 period are correct: $4.3 billion in 2022 obligations transferred, $1.5 billion settlement charge in 2022, $414 million voluntary settlement in 2023, and approximately 6,500 former employees. (3) The qualitative reasoning is sound - the LLM correctly synthesizes the strategic shift and explains the financial impacts (smaller one-time reduction in AOCI, modest adjustment to net pension expense). (4) The multi-hop synthesis is appropriate, connecting the 2022 and 2023 transactions to show evolution. However, the inclusion of the 2021 figure ($4.9 billion) without ground truth support and the statement that the 2023 settlement 'eliminated the need for a large settlement charge' is slightly imprecise - the ground truth indicates the 2023 approach simply didn't generate a large charge rather than eliminating a need for one. The answer demonstrates good understanding of the strategic evolution but contains an unsupported data point and minor semantic imprecision that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 419,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s stake in the ATMP joint venture expanded both in size and financial activity.  The carrying value of its equity‑method investment rose from roughly **$83 million (as of Dec 30 2023)** to **about $149 million (as of Dec 28 2024)**, helped by a **$17 million additional equity contribution in August 2024**, while equity‑method income jumped from **$16 million in 2023 to $33 million in 2024**.  At the same time, AMD’s transactions with the JV grew: payables to the JV increased from **$363 million to $476 million**, receivables from the JV rose from **$9 million to $12 million**, and AMD even extended a **$100 million, SOFR‑plus‑50 bps term loan** to the JV in October 2024, underscoring a deeper financial relationship beyond the earlier purchase‑and‑resale arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY ON CARRYING VALUE: The LLM states the carrying value was 'roughly $83 million (as of Dec 30 2023)' but the ground truth clearly states it was $99 million at the end of 2023. This is a significant factual error ($16 million difference, ~16% variance). The LLM correctly identifies the 2024 carrying value of $149 million, the $17 million contribution in August 2024, and both equity income figures ($16M in 2023, $33M in 2024). STRENGTHS: (1) Correctly synthesizes the multi-hop relationship evolution across 2023-2024; (2) Accurately captures the $17 million contribution and its timing; (3) Correctly reports equity income figures for both years; (4) Goes beyond the ground truth to provide additional context about payables ($363M to $476M), receivables ($9M to $12M), and the $100M term loan, which adds valuable detail; (5) Proper semantic understanding of the relationship deepening. WEAKNESSES: (1) The $83M vs $99M discrepancy on 2023 carrying value is a material error that undermines the core comparison; (2) This error affects the calculation of the total increase (should be $50M increase from $99M to $149M, not $66M from $83M to $149M). MULTI-HOP REASONING: The model successfully synthesizes information across multiple financial metrics and time periods, correctly linking contributions to carrying value changes and equity income evolution. However, the foundational number error weakens the overall analysis. The additional details about payables, receivables, and the term loan demonstrate good contextual understanding but weren't part of the ground truth answer, suggesting the LLM may be drawing from different or supplementary sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 458,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Johnson & Johnson’s stake in Kenvue was gradually unwound.  After the May 2023 IPO the company held about 89.6 % of Kenvue and, following the August 2023 exchange offer, retained roughly 9.5 % of the shares (recorded at fair value of $4.3 bn, later $3.9 bn), which generated a one‑time, tax‑free gain of about $2.8 bn on the retained equity and a total $21 bn gain on the transaction.  In the second quarter of 2024 J&J completed a debt‑for‑equity swap of the remaining 182 million Kenvue shares for commercial paper, eliminating its equity interest and recording an approximate $0.4 bn loss, so that by the end of 2024 the company owned **no** shares of Kenvue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 ownership stake of 9.5% - CORRECT; (2) Fair value of $4.3 billion - CORRECT; (3) $2.8 billion gain on retained shares - CORRECT; (4) Total $21.0 billion gain on transaction - CORRECT; (5) 2024 debt-for-equity exchange of 182 million shares (182,329,550 in ground truth) - CORRECT with minor rounding; (6) Approximately $0.4 billion loss - CORRECT; (7) Complete elimination of ownership by end of 2024 - CORRECT. The answer provides additional helpful context (89.6% stake post-IPO, fair value later adjusted to $3.9 billion, Q2 2024 timing, exchange for commercial paper) that enhances understanding without contradicting the ground truth. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from 89.6% → 9.5% → 0% ownership across 2023-2024, properly connecting the financial gains/losses to each transaction phase. The only minor deviation is the rounding of 182,329,550 shares to '182 million' which is acceptable formatting variation. The answer directly addresses all aspects of the question regarding retained equity, ownership relationship evolution, and associated gains/losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 339,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T did not add or remove any guarantee of Southwestern Bell Telephone Co.’s obligations – the same “Guaranty of certain obligations of Southwestern Bell Telephone Co.” that was first filed in 2011 continued to be referenced in both years. The 2022 filing simply carried forward the existing guarantee, and the 2023 filing reaffirmed it (see Exhibit 4‑b in the 2023 Form 10‑K), so the guarantee relationship remained unchanged, merely re‑stated in the later filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AT&T's guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023. However, there is a critical discrepancy regarding the exhibit location. The ground truth states the guarantee was listed in 'Exhibit 4-c' in both years, while the LLM answer references 'Exhibit 4-b in the 2023 Form 10-K.' This is a factual error in entity identification that undermines the answer's accuracy. Additionally, the LLM introduces information about the guarantee being 'first filed in 2011,' which is not mentioned in the ground truth and represents unsupported additional detail. The LLM correctly captures the semantic meaning that the guarantee relationship remained consistent and was not modified between the two years, and appropriately notes that it was 'carried forward' and 'reaffirmed.' The reasoning is sound in concluding no change occurred. However, the exhibit reference error is significant because exhibit citations are precise factual elements in SEC filings. The answer would have been stronger if it had maintained consistency with the ground truth's specific reference to Exhibit 4-c for both years. The answer demonstrates partial understanding of the multi-hop synthesis required (comparing 2022 vs 2023 guarantee status) but fails on precise entity/document identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 383,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Lockheed Martin broadened its hypersonics effort—adding U.S. Navy‑focused strike‑weapon programs while continuing its Air Force and Army collaborations—and shifted the work from primarily development toward early‑production phases, with multiple hypersonics programs expected to enter production through 2026. This reflects a strategic positioning of hypersonics as a core growth pillar and an expanded, end‑to‑end responsibility for designing, testing and moving the programs into production.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT present in the ground truth: 'adding U.S. Navy-focused strike-weapon programs,' 'shifted from development toward early-production phases,' and 'multiple hypersonics programs expected to enter production through 2026.' These details are fabricated and not supported by the original answer. (2) QUANTITATIVE ACCURACY PROBLEMS - The LLM provides a specific timeline ('through 2026') that is not mentioned in the ground truth, representing an unsupported factual claim. (3) PARTIAL ALIGNMENT - The LLM correctly identifies: (a) the evolution from 2022 to 2023, (b) the shift in strategic positioning, (c) the involvement of multiple military branches (Army, Navy, Air Force), and (d) the characterization as a 'core growth pillar.' However, these correct elements are mixed with fabricated details. (4) MULTI-HOP REASONING - While the LLM demonstrates understanding of the general trajectory (growth area → active program), it invents intermediate steps (production phases, 2026 timeline) not present in the knowledge graph. (5) SEMANTIC ISSUES - The ground truth emphasizes a shift from 'potential growth area' to 'clearly defined and active program portfolio,' while the LLM adds unsubstantiated production-phase details that overstate the level of detail available in the source material. The answer reads plausibly but contains material fabrications that would mislead readers about Lockheed Martin's actual program status as documented in SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 425,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\nThe U.S. litigation escrow account balance grew from **$1.44 billion at the end of fiscal 2022** to **$1.76 billion at the end of fiscal 2023**.  Deposits into the account were **$0.85 billion during fiscal 2022** and **$1.00 billion during fiscal 2023**, the latter raising the balance to $1.76 billion after net payments of $175 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors in the primary financial figures. Ground truth shows the U.S. litigation escrow account balance was $1.4 billion (Sept 30, 2022) and $3.089 billion (Sept 30, 2023), but the LLM states $1.44 billion and $1.76 billion respectively. This represents a major discrepancy - the actual balance increase was $1.689 billion, not $0.32 billion as implied by the LLM figures. The deposit amounts are partially correct: the LLM correctly identifies $0.85 billion for FY2022 and $1.00 billion for FY2023, matching the ground truth. However, the LLM's calculation of the ending balance is mathematically inconsistent with its own stated deposits and the ground truth. The LLM attempts to explain the discrepancy by mentioning '$175 million in net payments,' but this doesn't reconcile the figures ($1.44B + $0.85B + $1.00B - $0.175B = $3.115B, not $1.76B). The core issue is that the LLM provides incorrect ending balances for both fiscal years, which are the primary metrics requested in the question. While the deposit amounts are correct, they represent only a portion of the multi-part question, and the balance evolution figures are fundamentally wrong. The reasoning about net payments shows an attempt at multi-hop synthesis but fails to produce accurate results.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 365,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\nOutdoor Garden has stayed within the **Hardlines** merchandising group throughout the 2022‑2024 periods, but its relative weight in the company’s sales mix has slipped slightly—from about **6.8 % of total net sales in fiscal 2021‑22 to roughly 6.5 % in fiscal 2024**—reflecting a modest shift in emphasis toward other Hardlines categories.  Nonetheless, Home Depot continues to treat Outdoor Garden as a strategic growth pillar within Hardlines, maintaining its focus on garden‑related products while adjusting its internal merchandising structure to align with evolving category priorities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Outdoor Garden 'stayed within the Hardlines merchandising group throughout the 2022-2024 periods,' but the ground truth explicitly states that in 2022, Outdoor Garden was 'disclosed as a distinct product line' and only 'by 2024' was it 'grouped under the broader Hardlines merchandising department.' This is a critical mischaracterization of the evolution being asked about. (2) QUANTITATIVE ERRORS - The LLM provides a percentage decline from 6.8% to 6.5%, but the ground truth only mentions 6.8% for 2022 and does not provide a 2024 percentage figure. The LLM appears to have fabricated the 6.5% figure. (3) MISSING KEY INFORMATION - The ground truth emphasizes the strategic shift from 'a separate focus area to a component of a consolidated category,' which represents a significant repositioning. The LLM completely misses this core evolution by incorrectly stating Outdoor Garden remained in Hardlines throughout. (4) REASONING FAILURE - The multi-hop synthesis required understanding that Outdoor Garden's classification changed from standalone (2022) to integrated within Hardlines (2024). The LLM failed this synthesis entirely. (5) The LLM's claim about 'strategic growth pillar' and 'adjusting internal merchandising structure' appears speculative and unsupported by the ground truth. The answer fundamentally misrepresents the nature of the change from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 418,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\nAMD has kept its “engaging and open” culture as headcount rose from roughly 26 K (2023) to 28 K (2024) by institutionalising regular employee‑voice tools—confidential annual surveys reviewed by the Board, open town‑halls, executive roundtables, and an enterprise‑wide mentoring program—while expanding inclusive benefits, flexible‑work options, and robust DEI initiatives such as employee resource groups (over 85 % of new hires join an ERG) and the “Advancing Women in Technology” program.  This focus on continuous cultural measurement, transparent communication, and career‑development investments signals a talent‑retention strategy that leverages an inclusive, growth‑oriented environment to attract and keep top engineers and leaders in a fiercely competitive semiconductor market.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ACCURACY - The LLM answer introduces extensive details NOT present in the ground truth or original question, including: confidential annual surveys reviewed by Board, open town-halls, executive roundtables, enterprise-wide mentoring programs, flexible-work options, 85% of new hires joining ERGs, and 'Advancing Women in Technology' program. These specific programs and statistics are NOT mentioned in the ground truth and appear to be fabricated or hallucinated. (2) QUANTITATIVE ACCURACY - The workforce numbers (26K in 2023, 28K in 2024) are correct, matching ground truth exactly. The 7.7% growth calculation is accurate. However, the 85% ERG participation statistic is NOT in the ground truth and cannot be verified. (3) CORE ANSWER DIVERGENCE - The ground truth emphasizes that AMD maintained IDENTICAL messaging about culture ('engaging and open environment') across both years despite workforce growth, suggesting intentional cultural preservation. The LLM answer instead focuses on specific HR programs and mechanisms that are not mentioned in the source material. (4) MULTI-HOP REASONING - The LLM failed to synthesize the key insight from the ground truth: that AMD's repetition of the same cultural language across years (despite 7.7% growth) is the strategic signal about talent retention. Instead, it invented a narrative about specific programs. (5) SEMANTIC EQUIVALENCE - While both answers discuss talent retention strategy in semiconductors, they address fundamentally different evidence. The ground truth uses messaging consistency as evidence; the LLM uses invented program details. This is NOT semantically equivalent. (6) HALLUCINATION RISK - The specific percentages, program names, and HR mechanisms appear to be plausible-sounding fabrications rather than facts from the filings. This is a serious accuracy failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 506,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T did not negotiate any new guarantee arrangements with The Ohio Bell Telephone Company; the company simply continued to reference the same legacy guarantee that had been disclosed in earlier filings. Both the 2022 Form 10‑K (pages 133‑137) and the 2023 Form 10‑K (page 103) list the 2011‑dated “Guaranty of certain obligations of … The Ohio Bell Telephone Company” as an existing commitment, and no material change or additional guarantee was reported in either year. Thus, the guarantee obligations toward Ohio Bell remained unchanged during that period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Strengths: (1) Correctly identifies that AT&T maintained a guarantee obligation for The Ohio Bell Telephone Company across both 2022 and 2023; (2) Accurately references the 2011 origin date of the guarantee; (3) Properly notes that no new guarantee arrangements were negotiated; (4) Correctly states the guarantee remained unchanged between the two years; (5) Appropriately cites specific Form 10-K page references (pages 133-137 for 2022, page 103 for 2023), demonstrating document-level accuracy. The answer effectively synthesizes the multi-hop requirement by comparing the relationship across two fiscal years and confirming continuity. Minor considerations: (1) The LLM answer is slightly more specific about page references than the ground truth, which is appropriate and adds credibility; (2) The ground truth mentions 'Exhibit 4-c' and 'documentation practices' while the LLM focuses on the guarantee itself - both perspectives are valid and complementary; (3) The LLM's statement about 'no material change' aligns with the ground truth's 'continuation of the guarantee without any explicit discontinuation or expansion.' The semantic meaning is equivalent - both convey stability in the relationship. No quantitative errors detected. The reasoning correctly synthesizes information across two fiscal years to establish continuity. The answer directly addresses all aspects of the question regarding how the relationship evolved (answer: it remained stable/unchanged).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 423,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\nIn 2023 GE recorded about **$5.78 billion** of gains on retained and sold ownership interests, a substantial portion of which came from its investment in **AerCap** (see page 14). By 2024 those gains had fallen by roughly **$5.2 billion**, leaving only a modest net gain of roughly **$0.6 billion** (page 13), so the financial upside from the AerCap relationship dropped sharply between the two years.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the key financial evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 gains figure (~$5.7-5.78 billion), with minor rounding variation acceptable; (2) Accurately captures the $5.2 billion decrease from 2023 to 2024; (3) Properly synthesizes that AerCap was a primary driver of these gains; (4) Correctly notes the sharp decline in financial upside year-over-year; (5) Appropriately references specific page numbers; (6) Semantic meaning aligns well with ground truth. MINOR ISSUES: (1) The LLM calculates a residual of ~$0.6 billion ($5.78B - $5.2B = $0.58B), which is mathematically correct but the ground truth doesn't explicitly state this residual figure - this is an inference rather than stated fact, though logically sound; (2) The ground truth mentions both AerCap AND GE HealthCare as drivers, but the LLM focuses primarily on AerCap without explicitly mentioning GE HealthCare's contribution to the gains, which is a minor omission of context; (3) The phrasing 'leaving only a modest net gain' could be slightly misleading as it suggests this is the total 2024 gain, when it's actually the year-over-year change. CALCULATION VERIFICATION: $5.78B - $5.2B = $0.58B ≈ $0.6B (correct). The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings and properly identifies the relationship evolution. Overall, the answer is substantially correct with minor contextual gaps regarding GE HealthCare's role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 429,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Home Depot shifted from merely owning HD Supply to actively weaving its MRO catalog and distribution network into a dedicated professional ecosystem—expanding a specialized sales force, credit and loyalty programs (e.g., Pro X Tra) and using HD Supply’s distribution channels to serve pros and specialty trades. The company deepened its focus on professional customers by integrating HD Supply’s MRO products into its interconnected retail strategy and by acquiring SRS to broaden that offering, while investing in supply‑chain and technology upgrades to deliver faster, low‑cost delivery and tailored assortments for pros.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces unsupported claims and misses key ground truth details. CORRECT ELEMENTS: (1) The answer correctly identifies the shift from post-acquisition integration concerns to a more strategic role for HD Supply between 2022-2024; (2) Correctly identifies MRO services and professional customer focus as central to HD Supply's role; (3) Correctly mentions Pro X Tra loyalty program and supply chain investments; (4) Correctly identifies the SRS acquisition as part of broadening professional offerings. PROBLEMATIC ELEMENTS: (1) The LLM introduces the SRS acquisition without verification in the ground truth—this is a factual claim not supported by the original answer and potentially inaccurate; (2) The answer goes beyond the ground truth by adding specific details about 'specialized sales force,' 'credit programs,' and 'tailored assortments' that, while plausible, are not explicitly confirmed in the provided ground truth; (3) The phrase 'interconnected retail strategy' is vague and not directly supported. MISSING ELEMENTS: (1) The ground truth explicitly mentions the 2020 acquisition date and 2022 integration risks/challenges—the LLM answer doesn't reference these specific temporal markers or the integration uncertainty that characterized 2022; (2) The ground truth specifically names the customer segments served (multifamily, hospitality, healthcare, government housing)—the LLM answer uses generic 'pros and specialty trades' language instead. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution narrative across the 2022-2024 period, but the introduction of unsupported claims (SRS acquisition) and lack of specific customer segment details weakens the synthesis quality. The answer demonstrates understanding of the strategic shift but adds information not grounded in the provided knowledge graph, which is a significant concern for factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 523,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\nBetween the 2023 and 2024 filings AMD’s patent portfolio showed only modest change – it still held roughly 7,500 U.S. patents and about 18.5 k–18.8 k worldwide patent matters (≈12.8 k–13.2 k issued, with pending applications falling slightly from ~2 k to ~1.9 k).  Both the 2023 and 2024 disclosures stress that AMD maintains “numerous cross‑licensing and technology‑exchange agreements” with other companies, indicating that it continues to rely on these arrangements to share and acquire semiconductor‑related IP.  The slight increase in issued patents (12.8 k → 13.2 k) and the steady presence of cross‑licensing agreements suggest that AMD’s dependence on such agreements has not shifted dramatically; it remains a stable mechanism for technology exchange while the company’s patent assets experience only incremental growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative errors. CORRECT ELEMENTS: (1) The overall worldwide patent matters range (18.5k-18.8k) is accurate; (2) The issued patents progression (12.8k→13.2k) is correct; (3) The pending applications figure (~5.6k) is correctly identified in ground truth but the LLM incorrectly states they fell from ~2k to ~1.9k, which contradicts the ground truth showing 5,600 pending in both years; (4) The qualitative assessment about cross-licensing agreements remaining stable and important is sound; (5) The synthesis of patent growth implications for leverage in licensing is reasonable. CRITICAL ERRORS: (1) The LLM introduces a U.S. patent figure of 'roughly 7,500' which is not mentioned in the ground truth and appears to be fabricated or confused data; (2) The pending applications numbers are significantly understated and incorrectly characterized as declining from ~2k to ~1.9k when ground truth shows 5,600 in both years - this is a major quantitative error; (3) The LLM's statement about pending applications 'falling slightly' directly contradicts the ground truth which shows them remaining constant at 5,600. MULTI-HOP REASONING: The answer correctly synthesizes information about patent portfolio evolution and cross-licensing importance, but the quantitative foundation is compromised by the pending applications error. The conclusion that reliance 'has not shifted dramatically' is reasonable but based partly on incorrect numbers. The answer appropriately addresses both the patent portfolio size and cross-licensing implications aspects of the question, though with flawed supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 456,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\nFrom the 2023 separation through the end of 2024, Johnson & Johnson’s stake in Kenvue fell dramatically: after the IPO it owned roughly 89.6 % of Kenvue, and by the August 2023 exchange it retained only about 9.5 % of the shares (recorded as a $4.3 billion fair‑value investment). In May 2024 the company completed a debt‑for‑equity exchange that swapped the remaining ~182 million Kenvue shares for commercial paper, eliminating its equity position entirely and generating a ≈ $0.4 billion loss recorded in other income/expense. Thus, J&J moved from a substantial ownership and ongoing strategic partnership to a full disposal of its Kenvue shares within the 2023‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of J&J's evolving relationship with Kenvue from 2023-2024. STRENGTHS: (1) All key numbers are correct: 9.5% stake in 2023, $4.3 billion valuation, 182,329,550 shares (approximated as ~182 million), $3.6 billion debt-for-equity exchange, and $0.4 billion loss. (2) Dates are accurate: August 2023 exchange offer and May 2024 debt-for-equity transaction. (3) The multi-hop synthesis is sound, correctly tracing the evolution from post-IPO ownership (~89.6%) through the August 2023 exchange to complete exit in May 2024. (4) The answer properly identifies the strategic shift from substantial ownership to complete disposal. (5) Financial recording details are correct (fair-value investment in other assets, loss in other income/expense). (6) The answer addresses all aspects of the question: retention of stake in 2023, subsequent disposal in 2024, and the strategic relationship evolution. MINOR CONSIDERATIONS: (1) The LLM uses approximations (≈ $0.4 billion, ~182 million shares) which are appropriate given the context and match ground truth values. (2) The answer includes additional context about the 89.6% post-IPO ownership, which while not explicitly in the ground truth, provides helpful framing and is factually accurate. (3) The semantic equivalence is excellent - 'debt-for-equity exchange' and 'using shares to satisfy commercial paper' convey the same transaction. The answer fully captures the financial stake evolution and strategic relationship changes requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 431,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T stopped singling out Indiana Bell Telephone Co. Inc. in its guarantee disclosures. In the 2022 filing the company’s “Guaranty of certain obligations of Indiana Bell” appeared in the exhibit list (and was referenced in the earlier portions of the 10‑K), but the 2023 10‑K (pages 101‑105) contains no separate mention of that guaranty—only a generic reference to historic exhibits—showing that the Indiana Bell guarantee is no longer a distinct disclosure item. This reflects a de‑emphasis of the relationship in AT&T’s formal guarantee reporting.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth clearly states that Indiana Bell Telephone Co. Inc. was listed in guarantee disclosures in both 2022 and 2023, with the guarantee remaining in place without modification or removal. The LLM answer claims the opposite: that AT&T 'stopped singling out' Indiana Bell in its guarantee disclosures between 2022 and 2023, and that the 2023 10-K contains 'no separate mention' of the guarantee. This is a critical factual error. The LLM mischaracterizes the relationship as a 'de-emphasis' when the ground truth indicates continuity and consistency. The LLM appears to have fabricated specific page references (pages 101-105) and made unsupported claims about the content of the 2023 filing. The core finding—that there was NO CHANGE in the guarantee relationship—is completely inverted in the LLM response. This represents a fundamental failure in multi-hop reasoning and factual accuracy regarding the disclosure status across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 297,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\nIn 2023 GE still owned an equity interest in AerCap, which it completely divested in the fourth quarter of 2023; the sale generated a sizable gain that helped drive the $5.7 billion increase in “gains on retained and sold ownership interests,” and GE also paid a net $203 million of cash to AerCap for transition‑service arrangements. By 2024 the equity stake was gone, leaving only a senior note receivable (valued at $944 million) and ongoing service fees, so there were no further material investment gains and cash involvement was reduced to routine note repayments and service‑fee collections rather than the large equity sale and cash outflow of 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains a critical contradiction with the ground truth regarding the timing and nature of GE's AerCap divestment. (1) QUANTITATIVE ERRORS: The LLM states GE 'completely divested in the fourth quarter of 2023' and generated a '$5.7 billion increase in gains on retained and sold ownership interests.' However, the ground truth indicates the $5.2 billion DECREASE in gains on retained and sold ownership interests occurred in 2024 (not a 2023 increase of $5.7B). The LLM's $5.7B figure contradicts the ground truth's $5.2B decrease. The $203 million cash payment is correctly cited. The $944 million senior note receivable is mentioned but not verified against ground truth. (2) ENTITY/TIMING ERRORS: The LLM fundamentally mischaracterizes the evolution - it claims GE divested completely in Q4 2023, but the ground truth indicates GE held an investment stake in AerCap in 2024 (not divested). This is a core factual error about the relationship's evolution. (3) REASONING FLAWS: The LLM's narrative suggests the large gain occurred in 2023 from equity sale, but ground truth shows a DECREASE in gains in 2024 attributed to AerCap and GE HealthCare investments, suggesting a different transaction or valuation event. The LLM misinterprets whether gains increased or decreased and in which year. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'strategic transition from operational collaboration to investment-based returns,' but the LLM describes a complete exit, which contradicts the ground truth's statement that GE 'held an investment stake in AerCap' in 2024. The LLM correctly identifies the $203M cash payment and the shift from operational to investment focus, but fundamentally errs on the divestment timing and the direction/magnitude of gains changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 490,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\nFrom 2022 to 2024 Home Depot moved beyond modest store‑refreshes to a systematic overhaul that couples physical‑appearance upgrades (new signage, store‑refresh packages, self‑service lockers, electronic shelf‑labeling and expanded curb‑side pickup) with deeper digital integration (mobile‑app navigation, AI‑driven inventory tools, computer‑vision shelf visibility and personalized marketing).  These investments are tied to a broader supply‑chain and fulfillment expansion that delivers faster same‑day/next‑day delivery and uses stores as omnichannel fulfillment hubs, making store appearance a core competitive differentiator that directly enhances the customer experience for both DIY and professional shoppers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. MAJOR ISSUES: (1) UNSUPPORTED SPECIFICS: The LLM provides highly specific operational details (self-service lockers, electronic shelf-labeling, computer-vision shelf visibility, AI-driven inventory tools, personalized marketing) that are NOT mentioned in the ground truth. These appear to be fabricated or hallucinated details not sourced from actual 10-K filings. (2) MISSING CORE FRAMEWORK: The ground truth emphasizes a strategic evolution from 'store appearance as a competitive factor' (2022) to 'interconnected shopping experience' linking physical stores, digital platforms, and on-site services (2024). The LLM fails to capture this key conceptual framework and instead focuses on operational tactics. (3) DIGITAL INTEGRATION FRAMING: While both answers mention digital integration, the ground truth specifically highlights 'investments in digital platforms to enhance presentation and ease of navigation,' whereas the LLM invents specific technologies (AI-driven tools, computer-vision) without evidence. (4) SUPPLY CHAIN CLAIMS: The LLM introduces supply-chain and fulfillment expansion concepts not present in the ground truth, suggesting synthesis from external knowledge rather than the actual filings. (5) OMNICHANNEL FRAMING: While 'omnichannel' is a reasonable inference, the specific claim about 'stores as fulfillment hubs' is not substantiated in the provided ground truth. The LLM answer reads as plausible but appears to be constructed from general retail industry knowledge rather than actual 10-K filing content. The ground truth's more measured, document-grounded approach (emphasizing 'interconnected shopping experience' and digital platform investments) is fundamentally different from the LLM's operational detail-heavy narrative. This represents a failure in multi-hop reasoning grounded in actual source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 532,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s commercial interaction with the ATMP joint venture expanded markedly: purchases stayed roughly $1.7 billion, but resales to the JV surged from only $14 million in 2023 to $121 million in 2024, while payables to the JV grew from $363 million to $476 million and receivables rose from $9 million to $12 million.  In addition, AMD added a new $100 million one‑year term loan (SOFR + 50 bps) to the JV in October 2024 and contributed $17 million of extra equity in August 2024, which helped lift equity‑method income from $16 million in 2023 to $33 million in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and comprehensive. Verification of key numbers: (1) Resales figures are accurate - $14M in 2023 and $121M in 2024 match ground truth exactly. (2) The $100M one-year term loan in October 2024 is correctly stated. (3) Additional details provided by LLM (payables $363M to $476M, receivables $9M to $12M, equity contribution of $17M in August 2024, equity-method income $16M to $33M, and loan terms SOFR + 50 bps) are factually accurate and enhance the answer beyond the ground truth baseline. (4) Multi-hop reasoning is sound - the answer correctly synthesizes the evolution of the relationship across multiple dimensions (resales, payables, receivables, loans, equity contributions, and income). The answer demonstrates deeper knowledge of the financial relationship than the ground truth summary. Minor consideration: The ground truth focuses specifically on resales and loan arrangements as the primary indicators of relationship evolution, while the LLM answer expands to include additional balance sheet and income statement metrics. This expansion is factually correct and contextually relevant, providing a more complete picture of the financial relationship. The answer directly addresses the question about how the relationship evolved between 2023 and 2024, with clear before-and-after comparisons and identification of new arrangements. All numbers are accurate, calculations are correct, and the synthesis across multiple financial dimensions is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 417,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\nBetween 2023 and 2024 J&J strengthened its privacy‑compliance framework in direct response to emerging global privacy statutes.  The 2024 filing notes that the company has expanded mandatory data‑privacy training, formalized third‑party risk assessments and integrated privacy controls into its AI‑ and cybersecurity‑investment programs, all to meet new data‑localisation requirements and tighter cross‑border‑data‑flow rules that regulators are imposing worldwide.  This evolution reflects a more proactive, governance‑driven approach to satisfy heightened enforcement and to mitigate the legal and reputational risks associated with the evolving privacy‑law landscape.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims when compared to the ground truth. CRITICAL ERRORS: (1) The LLM claims J&J 'expanded mandatory data-privacy training' - this specific detail is NOT mentioned in either the 2023 or 2024 ground truth disclosures. (2) The LLM states the company 'formalized third-party risk assessments' - while the ground truth mentions 'multiple vendors and third parties' in 2024, it does not specifically claim formalized risk assessments were newly implemented. (3) The LLM claims privacy controls were 'integrated into AI and cybersecurity-investment programs' - this is NOT supported by the ground truth, which mentions 'evolving technology and data-driven initiatives' but does not specifically reference AI or cybersecurity investment integration. (4) The LLM introduces specific regulatory mechanisms ('data-localisation requirements and tighter cross-border-data-flow rules') that go beyond what the ground truth states. WHAT WAS CORRECT: The LLM correctly identifies the evolution from 2023 to 2024, the shift from 'other territories' to 'globally' in scope, and the general theme of increased regulatory focus on data flows. However, the LLM fabricates specific compliance mechanisms and initiatives not present in the source material. MULTI-HOP REASONING: The LLM failed to accurately synthesize the actual evolution described in the ground truth - which is about broadening scope and anticipatory posture, not about specific new programs like mandatory training or AI integration. The answer reads as plausible but is largely speculative rather than grounded in the actual filing disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 455,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s estimate of borrower‑litigation losses for Bank BPH fell from **$2.67 billion to $2.46 billion**.  Accordingly, the valuation allowance recorded against the bank’s financing receivables – of which about **$1.71 billion was tied to the litigation in 2023 and $1.52 billion in 2024** – was reduced from roughly **$1.96 billion to $1.59 billion**.  Because of this decline, GE did not need any additional capital contributions in 2024 (unlike the $1.8 billion non‑cash loan‑forgiveness it provided in mid‑2023).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CORRECT ELEMENTS: (1) Total estimated losses correctly stated as $2.67 billion (2023) and $2.46 billion (2024); (2) Valuation allowance components correctly identified as $1.71 billion (2023) and $1.52 billion (2024); (3) General direction of decline is correct; (4) Mentions the settlement program context appropriately. CRITICAL ERRORS: (1) The LLM states total valuation allowance was 'roughly $1.96 billion to $1.59 billion' - this is INCORRECT. The ground truth shows $1.712 billion (2023) and $1.517 billion (2024) in valuation allowances against financing receivables held for sale, plus $957 million and $944 million in other liabilities respectively. The LLM's figures don't match either component or any logical sum; (2) The LLM introduces information about '$1.8 billion non-cash loan-forgiveness' in mid-2023 that is NOT in the ground truth answer and cannot be verified; (3) The LLM states 'GE did not need any additional capital contributions in 2024' - this conclusion is not supported by the ground truth and represents unsupported inference. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution of exposure but makes calculation errors and introduces unverified claims. The answer conflates or miscalculates the valuation allowance figures, which is a fundamental error in a financial analysis question. The ground truth clearly breaks down the $2.461 billion total into $1.517 billion (valuation allowances) and $944 million (other liabilities), totaling $2.461 billion. The LLM's stated range of '$1.96 billion to $1.59 billion' doesn't align with any component. MISSING ELEMENTS: The LLM fails to mention the 'other liabilities' component ($957M and $944M) which is explicitly part of the ground truth answer and important for understanding the full exposure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 511,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\nIn 2022 the Indoor Garden line was grouped only under the **Hardlines** merchandising department (it generated about $10.1 billion of Hardlines sales). By fiscal 2024 the company still reports Indoor Garden within Hardlines but now lists it as a **stand‑alone merchandising department**, giving it its own net‑sales line and emphasizing its growth; Indoor Garden sales rose modestly to **$10.5 billion in 2024**, indicating that HD is positioning the category as a distinct, higher‑visibility driver within its Primary segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM states Indoor Garden generated '$10.1 billion' in 2022 and '$10.5 billion' in 2024, but the ground truth clearly states $15,546 million ($15.546 billion) in 2022 net sales. This is a massive discrepancy of approximately $5.4 billion in 2022 alone. The 2024 figure of $10.5 billion is also incorrect and represents a decline from 2022, not growth as the LLM claims. (2) DIRECTIONAL REVERSAL - The LLM completely reverses the evolution described in the ground truth. Ground truth states: Indoor Garden was a STANDALONE category in 2022 (10.3% of total revenue), then was GROUPED under Hardlines in 2024. The LLM states the opposite: that it was grouped under Hardlines in 2022 and became a 'stand-alone merchandising department' in 2024. This is a 180-degree inversion of the actual strategic shift. (3) MISCHARACTERIZATION OF STRATEGY - The LLM interprets the 2024 reclassification as 'higher-visibility' and 'distinct' positioning, when the ground truth indicates it was actually integrated/grouped with related product lines (a consolidation, not elevation). (4) CALCULATION/REASONING FAILURE - The LLM's claim of 'modest' growth from $10.1B to $10.5B contradicts both its own numbers and the ground truth. The multi-hop reasoning required to synthesize 2022 financial performance with 2024 categorization was fundamentally misexecuted. The answer demonstrates a complete failure to accurately extract and synthesize the key facts from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 442,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\nFrom 2022 to 2024 the company moved beyond simple cost‑containment and productivity programs to a more layered sourcing approach that now couples those initiatives with selective commodity‑hedging (notably in Hill’s Pet Nutrition) and explicit price‑adjustment actions, while still relying on productivity and sustainability‑focused sourcing to blunt raw‑material price swings. The 2024 disclosures also emphasize managing heightened climate‑related supply‑chain risks through a broader set of sourcing tactics, ongoing efficiency programs and limited hedging, indicating an evolution toward a more diversified risk‑management toolkit for commodity‑price volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM answer correctly identifies the evolution from 2022 to 2024 in Colgate-Palmolive's sourcing strategies. (2) It accurately captures the shift toward more comprehensive risk management approaches, including hedging, productivity initiatives, and cost containment. (3) The mention of Hill's Pet Nutrition and specific commodities (resins, essential oils, soybeans) aligns with ground truth. (4) The recognition of climate-related and geopolitical supply-chain risks in 2024 is accurate. (5) No quantitative errors detected (no specific numbers were provided in either answer to verify). WEAKNESSES: (1) The LLM answer introduces 'selective commodity-hedging (notably in Hill's Pet Nutrition)' which is not explicitly mentioned in the ground truth. While Hill's Pet Nutrition is a Colgate subsidiary, the ground truth does not specifically attribute hedging practices to this division. This represents a potential over-specification or inference not supported by the source material. (2) The characterization of 2022 strategies as 'simple cost-containment' is somewhat reductive compared to the ground truth's more nuanced description of 'derivative instruments and local currency borrowings' as part of a broader risk management framework. (3) The phrase 'moved beyond simple cost-containment' implies 2022 was less sophisticated, but the ground truth suggests continuity with evolution rather than abandonment of earlier approaches. (4) The LLM answer uses 'limited hedging' which could be interpreted as contradicting the earlier mention of 'selective commodity-hedging,' creating slight internal inconsistency. MULTI-HOP REASONING: The answer demonstrates sound synthesis across the 2022-2024 timeframe and correctly identifies the progression in strategy sophistication. However, the specific attribution to Hill's Pet Nutrition lacks clear grounding in the provided ground truth. SEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding evolution toward more diversified and defensive sourcing tactics, but the specific details about Hill's Pet Nutrition hedging represent an unsupported inference that reduces confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 586,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\nTREMFYA’s worldwide sales rose sharply from **$3.15 billion in 2023 to $3.67 billion in 2024** – an increase of roughly **16–17 %**.  This growth was attributed to **continued market expansion in psoriasis and psoriatic arthritis, stronger physician and patient adoption, favorable patient‑mix, and share‑gain momentum** (the company specifically cites “market growth and share gains” as the drivers of TREMFYA’s performance).  Additional contributions came from the rollout of new indications (e.g., ulcerative colitis, Crohn’s disease) and the subcutaneous formulation, which helped sustain its upward trajectory despite modest declines in other immunology products.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial figures ($3.15B in 2023, $3.67B in 2024) and accurately calculated the growth rate (16-17%, matching the ground truth's 16.6%). The answer appropriately addresses the multi-part question about sales evolution and contributing factors. WEAKNESSES: (1) The LLM introduced information about 'new indications (ulcerative colitis, Crohn's disease)' and 'subcutaneous formulation' that are NOT mentioned in the ground truth answer. While these may be factually accurate from the filing, they represent unsourced additions beyond what the knowledge graph provided. (2) The LLM failed to include the specific operational breakdown provided in the ground truth: the 18.1% change from operations and the -1.5% currency impact. These quantitative details are important for understanding the drivers of growth and represent a gap in synthesis. (3) The phrasing 'market growth and share gains' is paraphrased from the ground truth but lacks the precision of the original's specific metrics (18.1% operations, -1.5% FX). QUANTITATIVE ACCURACY: The core numbers are correct ($3.15B, $3.67B, 16-17% growth), but the answer omits the operational and currency impact percentages that were explicitly stated in the ground truth. QUALITATIVE ACCURACY: The answer captures the general drivers (market expansion, patient adoption, favorable mix) but introduces unverified details and misses the specific operational/FX breakdown. CONTEXTUAL RELEVANCE: The answer appropriately addresses both parts of the question (sales evolution and contributing factors) but with incomplete attribution of causes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 447,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\nThe 2023 filing re‑classified A+E’s audience metrics from the main “Linear Networks” subscriber tables into a separate “Equity Investments” table and began citing the figures from internal management reports rather than Nielsen estimates.  Disney’s ownership stake in A+E stayed at 50 % (jointly held with Hearst), but the way the partnership is now presented means the subscriber numbers are disclosed only as part of the equity‑method investment disclosures and the financial return is shown solely as “Equity in the income (loss) of investees.”",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the structural change from partnership to equity investment and accurately describes the 50% ownership stake jointly held with Hearst. It also correctly notes the shift in reporting methodology (from Linear Networks tables to Equity Investments disclosures) and the use of 'Equity in the income of investees' for financial reporting. However, there are significant quantitative omissions: (1) The LLM fails to provide the specific subscriber numbers that are central to the question - the ground truth shows 69 million domestic subscribers in 2022 and 58 million in 2023, which are critical data points for understanding how the structural change affected subscriber reporting. (2) The LLM mentions the shift to internal management reports vs. Nielsen estimates but doesn't quantify or explain the impact of this methodological change. (3) The answer lacks the comparative analysis between 2022 and 2023 subscriber counts (69M vs 58M), which directly demonstrates how the relationship change affected reporting. The reasoning about the equity-method investment classification is sound and the multi-hop synthesis is logically coherent, but the answer is incomplete without the specific subscriber numbers that form the core of the question. The LLM demonstrates good understanding of the structural and reporting changes but fails to provide the quantitative evidence that would fully answer how the change 'affected its reporting of subscriber numbers.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 411,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\nBetween 2022 and 2023 the AerCap investment moved from an **$865 million unrealized loss** (reported in 2022 under “Investment in and note with AerCap realized and unrealized gain (loss)”) to a **$129 million realized gain** in 2023, reflecting the partial sale of the equity stake and the write‑up of the remaining position. By the end of 2023 GE had sold all of its AerCap common shares, leaving only a senior note; therefore in 2024 there were **no further realized or unrealized gains or losses from AerCap**—the note is carried at cost (with any changes shown only as interest income), so the company’s financial impact from AerCap essentially ceased after 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that fundamentally contradict the ground truth. Key issues: (1) WRONG TIME PERIOD: The LLM discusses 2022-2023 evolution, but the question explicitly asks about 2023-2024 evolution. The ground truth clearly states the comparison is between 2023 and 2024. (2) INCORRECT NUMBERS: The LLM claims a $129 million 'realized gain' in 2023, but the ground truth specifies this was an 'unrealized gain' of $129 million - a critical distinction in financial reporting. (3) MISSING 2024 DATA: The LLM claims 'no further realized or unrealized gains or losses from AerCap' in 2024, but the ground truth explicitly states that in 2024, GE recognized 'a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline.' This is a major omission of the core answer to the question. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop comparison between 2023 and 2024 as requested. Instead, it provides information about 2022-2023 and then claims 2024 had no impact, which contradicts the ground truth's statement about a $5.2 billion decline in gains. (5) LOGICAL INCONSISTENCY: The claim that GE sold all AerCap shares and retained only a note (which would explain no 2024 gains/losses) contradicts the ground truth's indication that AerCap was a 'primary contributor' to the $5.2 billion decline in 2024. The answer demonstrates a fundamental misunderstanding of the question's temporal scope and the actual financial impact reported in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 449,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard refined its multi‑layered security model by adding explicit, proactive monitoring and performance‑standard requirements that target risks arising from third‑party service providers, and by embedding those controls into new ecosystem platforms such as VCN, Mastercard Send and Track BPS that are delivered through partnerships with fintechs, central banks and other external partners.  This evolution shows that the company is moving from a generic cyber‑risk posture to a strategic, ecosystem‑wide approach that treats third‑party integration as a core security concern, demonstrating a pre‑emptive response to emerging cyber threats.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific product names (VCN, Mastercard Send, Track BPS) and claims about 'new ecosystem platforms' that are NOT mentioned in the ground truth knowledge graph. This represents factual fabrication rather than synthesis from actual filing data. (2) The ground truth explicitly states there was 'no explicit mention of addressing risks related to third-party service providers' in 2022, but the LLM answer implies a more continuous evolution without clearly establishing this baseline difference. (3) The LLM answer claims Mastercard added 'explicit, proactive monitoring and performance-standard requirements' but the ground truth only mentions 'explicitly integrated third-party provider risk management' - the specific performance standards claim is not supported. WHAT WAS CORRECT: (1) The core insight about evolution from 2022 to 2024 is directionally correct. (2) The characterization of the shift toward 'ecosystem-wide approach' aligns with ground truth. (3) The identification of third-party provider risk as a key evolution is accurate. (4) The framing of this as a 'strategic shift' and 'pre-emptive response' is semantically aligned with ground truth's 'strategic shift toward strengthening ecosystem-wide resilience.' QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages were required or provided, so this scores well (8/10) - the years 2022 and 2024 are correctly referenced. QUALITATIVE ACCURACY: Significantly compromised (3/10) due to the introduction of unsupported specific product names and platform details that appear to be hallucinated rather than derived from the knowledge graph. The reasoning structure is sound but built on partially fabricated details. CONTEXTUAL RELEVANCE: Moderate (5/10) - while the answer addresses the question's core themes, the inclusion of unverified product-specific claims reduces relevance to the actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 521,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\nTarget has continued to meet its debt‑leverage covenant in both years.  In 2022 it swapped its $2.5 bn revolving line that was set to expire in 2023 for a new $3 bn five‑year unsecured facility (now maturing in 2028) and added a $1 bn 364‑day facility, and the company repeatedly states it is “in compliance with these covenants” and expects to remain so.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. QUANTITATIVE ERRORS: (1) The LLM states Target 'swapped its $2.5 bn revolving line' but the ground truth indicates the original facility was $3.0 billion, not $2.5 billion. This is a material misstatement of the baseline facility size. (2) The LLM correctly identifies the new $3.0 billion five-year facility maturing in 2028 and the $1.0 billion 364-day facility, but the context of how these relate to the original facility is confused. (3) The LLM implies the swap occurred in 2022 ('In 2022 it swapped...'), but the ground truth indicates the $3.0 billion facility was already in place in 2022 and was extended in 2023. The timeline and sequencing of events is muddled. COMPLETENESS ISSUES: The LLM answer does address covenant compliance in both years and mentions the credit facility changes, but it fails to clearly distinguish between 2022 and 2023 activities. The ground truth explicitly states the $3.0 billion facility was 'set to expire in October 2026' in 2022 and was 'extended...to October 2028' in 2023 - a key distinction the LLM misses. REASONING QUALITY: While the LLM correctly concludes that Target remained in compliance with debt leverage covenants across both years, the explanation of how the credit facilities evolved is inaccurate and confusing. The multi-hop synthesis fails because the LLM incorrectly characterizes the 2022 baseline facility size and conflates the timing of facility changes. POSITIVE ASPECTS: The LLM correctly identifies that Target asserted compliance with covenants in both years and correctly identifies the $1.0 billion 364-day facility and the $3.0 billion five-year facility maturing in 2028. The overall conclusion about continued compliance is correct, but the supporting details contain material errors that would mislead a reader about the actual evolution of Target's credit facilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 521,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\nThe 2023 filing warned only of generic “social and ethical” concerns that AI could damage the brand, whereas the 2024 filing spells out concrete, regulator‑driven risks: emerging AI‑specific rules (e.g., the EU AI Act, DSA), heightened liability for inaccurate, biased or copyrighted generative‑AI outputs, and the need for extensive testing, governance and compliance investments to mitigate those technical and legal exposures. In short, the risk has shifted from a broad reputational warning to a detailed, compliance‑heavy exposure tied to accuracy, bias, toxicity, privacy and copyright of generative‑AI products such as Agentforce.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Salesforce's AI risk profile from 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift from generic 'social and ethical' concerns in 2023 to specific, regulation-driven risks in 2024; (2) Accurately names concrete regulatory frameworks (EU AI Act, DSA) that emerged as concerns; (3) Properly synthesizes the multi-hop comparison across years, identifying new risk categories: accuracy, bias, copyright infringement, toxicity, and privacy; (4) Correctly notes the expansion to include governance, compliance, and testing costs; (5) Appropriately highlights Agentforce as the specific generative AI product driving these concerns; (6) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM characterizes 2023 risks as 'generic social and ethical concerns' while the ground truth specifies 'third-party integrations and applications' with warranty-related liabilities as the primary 2023 focus - this is a slight mischaracterization of what the 2023 baseline was, though the characterization of 2024 risks is accurate; (2) The answer doesn't explicitly mention that third-party integration risks were the 2023 baseline before AI risks expanded, which is a minor omission in the comparative framing. The answer effectively captures the essence of the evolution and the specific nature of new risks in 2024, with accurate synthesis of multi-hop information across years. The semantic meaning aligns well with the ground truth despite the slight reframing of 2023 baseline risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 431,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Lowe’s moved beyond the baseline two‑day delivery that was already in place for most parcel‑eligible items.  The company expanded its gig‑partner network to offer same‑day delivery on select products and, for the first time, can deliver major appliances next‑day to almost every U.S. ZIP code.  In addition, it finalized a market‑based delivery model that adds extra distribution capacity for big‑and‑bulky items, giving customers faster, broader‑coverage shipping options.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. CRITICAL ERRORS: (1) The LLM claims Lowe's expanded to offer 'same-day delivery on select products' - this is NOT mentioned in the ground truth and appears to be fabricated information. (2) The LLM references a 'market-based delivery model' and 'big-and-bulky items' distribution capacity - these details are not present in the ground truth and represent unsupported claims. CORRECT ELEMENTS: (1) The LLM correctly identifies the two-business-day delivery baseline for parcel-eligible items in FY2023. (2) The LLM correctly identifies next-day delivery for major appliances to nearly every U.S. ZIP code as a FY2024 improvement. (3) The fiscal year comparison (2023 vs 2024) is correctly framed. MISSING/INCOMPLETE: The ground truth states delivery capability was refined to 'within two business days or less' in 2024, but the LLM doesn't clearly articulate this refinement - instead it focuses on same-day and next-day options that aren't supported by the source material. The LLM appears to have hallucinated details about gig-partner networks and market-based delivery models that contradict or go beyond what the ground truth establishes. The answer demonstrates partial understanding of the core improvements (next-day appliance delivery) but introduces false information that significantly undermines accuracy. This is a case where the model added plausible-sounding but unsupported details, which is particularly problematic for financial/factual questions requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 433,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\nThe February 2021 sale of Dermstore produced a one‑time $335 million pretax gain that lifted 2021 operating income, but Dermstore represented less than 1 % of Target’s consolidated revenue, so its contribution to total sales was essentially negligible and did not recur. Consequently, in 2022—when operating income was $3.85 billion (without any Dermstore gain)—and again in 2023—when operating income rose to $5.71 billion—Target’s revenue and operating performance reflect the post‑sale period, with the sale’s financial impact now confined to that single, non‑recurring gain.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct but has some issues with focus and completeness relative to the ground truth. STRENGTHS: (1) Correctly identifies the $335 million pretax gain from the February 2021 sale; (2) Accurately states Dermstore represented less than 1% of consolidated revenues; (3) Correctly notes the gain was non-recurring and one-time; (4) Provides accurate operating income figures for 2022 ($3.85 billion) and 2023 ($5.71 billion); (5) Properly synthesizes that the sale's impact was confined to 2021. WEAKNESSES: (1) The question specifically asks about the financial impact evolution FROM 2022 TO 2023, but the LLM answer spends significant effort discussing the 2021 gain and its impact on 2021 operating income, which is outside the requested timeframe; (2) The ground truth explicitly states 'no significant post-sale financial contribution or change was observed in either year' (2022-2023), emphasizing the consistency/stability of minimal impact across both years; (3) The LLM answer doesn't directly address whether the impact evolved or remained consistent between 2022 and 2023—it implies consistency but doesn't explicitly state it as the ground truth does; (4) The LLM answer could be clearer that Dermstore had essentially zero impact on both 2022 and 2023 revenues and operating income (post-sale period). QUANTITATIVE VERIFICATION: All numbers are accurate ($335M gain, <1% of revenues, $3.85B and $5.71B operating income figures). MULTI-HOP REASONING: The answer correctly synthesizes information about the sale date, the gain amount, and post-sale performance, though it doesn't fully address the 2022-to-2023 comparison as directly as the ground truth. The answer is factually sound but somewhat misaligned with the specific focus of the question on the 2022-2023 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 492,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Salesforce shifted Data Cloud from a supplemental data‑integration layer to the central “hyperscale, trusted data engine” that powers the entire Customer 360 platform and fuels AI‑driven outcomes across Sales, Service, Marketing and Commerce. The 2024 filing positions Data Cloud as the foundation for Agentforce and industry‑specific clouds, using it to differentiate Salesforce in a crowded cloud‑AI market while also exposing the company to new competitive pressures around pricing, data‑privacy and AI‑model governance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key positioning elements from both years - the 2023 description of Data Cloud as a 'hyperscale, trusted data engine' is accurate and matches the ground truth. The answer appropriately notes the shift toward acknowledging competitive risks and challenges in 2024. The mention of Agentforce and industry-specific clouds as part of the 2024 positioning is relevant context. WEAKNESSES: (1) The LLM introduces claims not explicitly supported by the ground truth, particularly the assertion that Data Cloud shifted from 'supplemental data-integration layer' to 'central' engine - the ground truth describes it as already being a 'hyperscale, trusted data engine' in 2023, not a supplemental layer. This represents a factual mischaracterization of the 2023 baseline. (2) The LLM mentions 'pricing, data-privacy and AI-model governance' as competitive pressures, but the ground truth specifically emphasizes 'limited experience in pricing consumption-based models' and 'increasing competition as AI and data platforms evolve' - the LLM adds 'data-privacy' and 'AI-model governance' which are not explicitly mentioned in the ground truth as key 2024 positioning shifts. (3) The ground truth emphasizes the shift from 'product-centric messaging to one that includes strategic risk and monetization challenges,' but the LLM frames this more as competitive differentiation rather than acknowledging the monetization uncertainty. (4) The LLM's claim about 'fuels AI-driven outcomes across Sales, Service, Marketing and Commerce' goes beyond what the ground truth states about integration across Marketing and Analytics. MULTI-HOP REASONING: The answer does synthesize 2023 vs 2024 positioning, but introduces unsupported claims that weaken the accuracy. The core insight about shifting from product benefits to risk acknowledgment is present but underemphasized. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics). OVERALL: The answer captures directional accuracy but introduces factual claims not supported by the ground truth and omits the specific emphasis on monetization/pricing model uncertainty that is central to the ground truth's characterization of the 2024 shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 617,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Lowe’s moved from **designating forward interest‑rate swaps as cash‑flow hedges**—a $1.3 bn notional that was settled when the 2023 Notes were issued and produced a $247 m cash receipt (with the effective portion recorded in OCI and later re‑classified to earnings as the hedged interest expense accrued)—to **using the same type of swaps as fair‑value hedges** of its existing fixed‑rate debt.  In 2024 the Company held $850 m of fixed‑to‑floating swaps and elected the shortcut method, which assumes perfect effectiveness; consequently the fair‑value changes of those swaps offset the carrying amount of the hedged debt and **have no net impact on earnings**.  Thus, the hedge designation shifted from cash‑flow (where gains/losses flow through OCI and eventually earnings) to fair‑value (where the offset eliminates earnings volatility), and the financial impact changed from a recognized $247 m gain (and related OCI reclassifications) in 2023 to essentially zero earnings effect from the remaining fair‑value swaps in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall evolution in hedge accounting treatment but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) Correctly identifies the shift from cash flow hedges (2023) to fair value hedges (2024); (2) Correctly states the $247 million cash receipt in 2023; (3) Correctly explains the shortcut method and perfect effectiveness assumption in 2024; (4) Correctly describes the accounting impact difference (OCI/earnings flow vs. no net earnings impact); (5) Good semantic explanation of how fair value hedges offset carrying amounts. CRITICAL ERROR: The LLM states the 2023 forward interest rate swap contracts had a notional amount of $1.3 billion, but the ground truth clearly states $2.0 billion. This is a material discrepancy (35% understatement). ADDITIONAL ISSUES: (1) The LLM introduces a $850 million notional for 2024 fair-value swaps, which is not mentioned in the ground truth answer, creating potential confusion about whether this is additional information or an error; (2) The ground truth specifies these were 'forward interest rate swap contracts related to its March 2023 Notes,' which the LLM doesn't explicitly connect. MULTI-HOP REASONING: The LLM successfully synthesizes the multi-year comparison and explains the accounting treatment differences appropriately. The logic connecting hedge designation to financial statement impact is sound. SEMANTIC EQUIVALENCE: The explanation of how cash flow hedges flow through OCI and eventually earnings, versus fair value hedges offsetting debt carrying amounts, is semantically equivalent to the ground truth. The description of 'no net impact on earnings' matches the ground truth's statement about 'no net impact on the consolidated statements of earnings.' The quantitative error on the notional amount is the primary factor preventing a higher score, as financial precision is critical in SEC filing analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 529,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\nBetween 2022 and 2023 Target shifted from merely showcasing a broad list of owned‑brand names (which represented about one‑third of sales) to treating the owned‑brand portfolio as a strategic growth engine.  The 2023 strategy explicitly calls for **strengthening and curating** that portfolio—adding exclusive, higher‑margin brands and deepening signature partnerships—to differentiate Target’s assortment, boost traffic and market‑share gains, and support its broader objectives of relevance, sustainability and technology‑enabled shopping.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - QUANTITATIVE DISCREPANCY: The LLM states owned brands represented 'about one-third of sales' in 2022, but the ground truth explicitly states 'over 40 such brands' with no mention of one-third sales figure. This is a significant factual error that contradicts the original answer. The LLM appears to have introduced an unsupported quantitative claim. QUALITATIVE ASSESSMENT: The LLM correctly captures the core strategic evolution - from showcasing brands to leveraging them as a strategic differentiator. The language about 'strengthening and curating,' 'exclusive higher-margin brands,' and 'deepening signature partnerships' aligns well with the ground truth's emphasis on 'actively leveraging them as a strategic differentiator.' The connection to traffic, sales, and market share growth is accurate. MULTI-HOP REASONING: The LLM successfully synthesizes the 2022-to-2023 comparison and identifies the shift in strategic positioning. However, the introduction of the 'one-third of sales' metric without ground truth support is problematic. MISSING ELEMENTS: The LLM adds details about 'sustainability and technology-enabled shopping' that are not mentioned in the ground truth, which could be accurate but cannot be verified against the provided original answer. The ground truth mentions 'delight with newness, style, and value' as the broader strategic framework, which the LLM does not explicitly reference. OVERALL: While the qualitative understanding of the strategic shift is sound, the quantitative error regarding sales representation is a material factual mistake that significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 451,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\nFrom 2022 to 2023 GM moved beyond isolated software‑enabled services such as OnStar and Super Cruise to roll out a full‑stack, over‑the‑air software platform that will be standard on most of its vehicles.  The 2023 filing notes that this platform will deliver new subscription‑based features—security, climate and comfort controls, personal themes, and an EV‑ownership experience—while integrating with the company’s expanding EV‑charging ecosystem and supporting future services like GM Defense.  This evolution signals a strategic, heavy investment in scalable digital solutions that can generate recurring revenue and underpin GM’s EV and autonomous‑vehicle growth agenda.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2022 to 2023, mentions specific features (Super Cruise, security, climate/comfort controls, EV ownership experience), and accurately characterizes the shift toward a scalable platform with OTA capabilities. The mention of subscription-based revenue models and integration with EV charging is relevant and supported. The answer appropriately addresses the investment in scalable digital solutions.\n\nWEAKNESSES: (1) The LLM introduces specific feature details (personal themes, GM Defense, EV-charging ecosystem integration) that are not explicitly mentioned in the ground truth answer, raising questions about whether these are accurate to the actual filings or represent hallucination. (2) The LLM characterizes the 2023 platform as 'standard on most of its vehicles' and 'will deliver' future features, but the ground truth specifies that select 2024 models (Cadillac LYRIQ, Chevrolet Silverado EV) were 'already using' the platform - this is a subtle but important distinction about deployment status. (3) The LLM mentions 'OnStar' as an example of 2022 isolated services, which is not mentioned in the ground truth and may not be accurate to the actual filing context. (4) The answer lacks the specific vehicle examples (Cadillac LYRIQ, Chevrolet Silverado EV) that the ground truth identifies as concrete evidence of platform deployment.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the evolution across years and connects platform deployment to business strategy (recurring revenue, EV/AV growth). However, the reasoning about specific features and ecosystem integrations goes beyond what the ground truth explicitly states, suggesting either additional research or potential inaccuracy.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or percentages are provided in either answer, so quantitative accuracy cannot be directly verified. The qualitative claims about feature sets and deployment status show partial alignment but with concerning additions not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 557,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Optimized Application Experiences/Observability category’s revenue rose 14%—from $581 million to $661 million, an $80 million increase—with ThousandEyes cited as a key driver of that growth. This reflects a noticeable uptick in ThousandEyes’ contribution to the segment’s total sales over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and potential inaccuracies. CORRECT ELEMENTS: (1) The 14% growth rate for FY2023 matches the ground truth, (2) The $80 million increase for FY2023 is correct, (3) ThousandEyes is correctly identified as a key driver, (4) The overall narrative of upward trend is accurate. PROBLEMATIC ELEMENTS: (1) The LLM provides specific revenue figures ($581M to $661M) that are NOT mentioned in the ground truth answer, making it impossible to verify their accuracy from the provided context. These numbers may be correct from the actual filing, but they cannot be confirmed against the ground truth provided. (2) The LLM completely omits the FY2022 data ($75 million growth at 11%), which is a significant omission given the question explicitly asks about evolution 'between fiscal years 2022 and 2023.' The ground truth emphasizes both years' performance to show the evolution. (3) The LLM does not explicitly compare the two years' growth rates (11% vs 14%) or absolute growth amounts ($75M vs $80M), which would better demonstrate the 'evolution' requested. MULTI-HOP REASONING: The LLM correctly synthesizes that ThousandEyes drove growth in both years, but fails to fully synthesize the comparative analysis across both fiscal years. The answer focuses primarily on FY2023 without adequately addressing the FY2022 baseline. CALCULATION VERIFICATION: The $80M increase and 14% growth for FY2023 are mathematically consistent with the stated revenue change ($661M - $581M = $80M), but the FY2022 figures cannot be verified. The omission of FY2022 analysis is a material gap in answering a question specifically about evolution between two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 466,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\nIn the 2023 Form 10‑K, Amendment No. 4 to the Executive Severance Plan is listed as a distinct exhibit (Exhibit 10.34), but the 2024 filing no longer presents it as a separate exhibit—it is only referenced within the general description of the restated plan. This shift shows Lockheed Martin is consolidating older amendments into the core plan document and de‑emphasizing them as stand‑alone exhibits, indicating a more streamlined disclosure strategy that focuses on the most recent, restated version rather than individual prior amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and mischaracterizations. CORRECT ELEMENTS: (1) The identification that Amendment No. 4 was listed as Exhibit 10.34 in 2023, (2) The recognition that treatment changed between 2023 and 2024, (3) The general concept that the amendment was de-emphasized. CRITICAL ERRORS AND OMISSIONS: (1) The LLM states Amendment No. 4 'is only referenced within the general description of the restated plan' in 2024, but the ground truth indicates it actually appears as part of a sequence including Amendments 2, 3, 4, and 5 - this is a material mischaracterization of how it was presented, (2) The LLM claims it's 'no longer presented as a separate exhibit' but doesn't accurately describe that it was incorporated from the September 2022 10-Q in both years, (3) The LLM's interpretation that this represents 'consolidating older amendments into the core plan document' is speculative and not supported by the ground truth, which indicates a more integrated sequence approach rather than consolidation into a single document, (4) The LLM misses the key detail that Amendment No. 4 was incorporated from the same September 2022 10-Q in both filings, suggesting continuity rather than a fundamental strategic shift. REASONING ASSESSMENT: The LLM's multi-hop synthesis is incomplete. While it correctly identifies a shift in treatment, it oversimplifies the nature of that shift and provides an interpretation ('streamlined disclosure strategy focusing on the most recent, restated version') that goes beyond what the ground truth supports. The ground truth's characterization of a 'more consolidated and retrospective approach' is more nuanced than the LLM's 'de-emphasizing' narrative. QUANTITATIVE ACCURACY: The exhibit number (10.34) and years (2023, 2024) are correct, but the description of how the amendment appears in 2024 is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 516,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\nFrom 2023 to 2024 JPMorgan’s Standardized CET1 capital ratio edged up from roughly **15.0 % to 15.7 %**, driven by higher CET1 capital and only modest growth in risk‑weighted assets.  Its Tier 1 leverage ratio remained essentially unchanged at **about 7.2 %** (well above the 4 % minimum), and the supplementary leverage ratio stayed at **6.1 %**, comfortably exceeding the 5 % regulatory floor.  Thus, the firm strengthened its CET1 position while maintaining ample leverage buffers throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies JPMorgan as the subject, addresses both Tier 1 leverage ratio (7.2%) and CET1 capital ratio metrics, and provides accurate 2024 Tier 1 leverage ratio of 7.2% matching ground truth. The answer correctly notes regulatory minimums (4.0% for leverage ratio) and demonstrates sound reasoning about capital strength and compliance. The supplementary leverage ratio (6.1%) and its 5% floor are appropriately contextualized.\n\nCRITICAL ERRORS: (1) The LLM claims Standardized CET1 ratio increased from 15.0% in 2023 to 15.7% in 2024, but the ground truth only provides 2023 data (15.0%) with no 2024 CET1 figure mentioned. The LLM appears to have fabricated the 15.7% 2024 figure. (2) The ground truth specifies the 2023 CET1 requirement was 11.4%, but the LLM does not mention this comparison for 2023. (3) The LLM introduces supplementary leverage ratio (6.1%) which is not mentioned in the ground truth answer, suggesting potential hallucination or information from different sources not validated against ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize year-over-year evolution but fails because it provides unverified 2024 CET1 data. The reasoning about capital strength is sound, but it's built on potentially incorrect premises.\n\nQUANTITATIVE ISSUES: While the 7.2% Tier 1 leverage ratio for 2024 is correct, the 15.7% CET1 for 2024 cannot be verified and appears to be an error. The 15.0% 2023 CET1 is correct. The regulatory minimums cited (4.0%, 5.0%) are accurate.\n\nCOMPLETENESS: The answer addresses both metrics requested but introduces unverified data for 2024 CET1, making the year-over-year comparison unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 462,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\nBetween 2022 and 2023 GM Financial moved from being a largely “behind‑the‑scenes” financing unit to a clearly‑identified, stand‑alone reportable segment in the consolidated statements.  In the 2023 filing (Note 23 Segment Reporting, page 98) the segment shows $13.4 bn of revenue and $5.0 bn of EBT‑adjusted earnings, and its interest income ($146 m), interest expense ($‑950 m), allowance for loan losses and related financing‑activity cash flows are disclosed separately in the consolidated income‑statement and cash‑flow statement (pages 61‑65).  Compared with the 2022 presentation, the segment’s share of total assets, cash‑flow from financing activities and earnings before income taxes has grown, and its results are now presented net of eliminations within consolidated net income and EBT, reflecting a tighter integration of GM Financial’s operations into GM’s overall financial reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) FUNDAMENTAL MISCHARACTERIZATION: The LLM claims GM Financial moved from 'behind-the-scenes' to a 'clearly-identified, stand-alone reportable segment' between 2022-2023, but the ground truth indicates GM Financial WAS ALREADY a segment in both years - the evolution was about MORE DETAILED DESCRIPTION of its tax integration, not a change in segment status. (2) QUANTITATIVE ERRORS: The LLM provides specific numbers ($13.4bn revenue, $5.0bn EBT-adjusted earnings, $146m interest income, $950m interest expense) that are NOT verified in the ground truth and appear to be fabricated or misattributed. These numbers are presented with false confidence and specific page citations (Note 23, page 98, pages 61-65) that cannot be verified against the provided ground truth. (3) INCORRECT CHARACTERIZATION OF EVOLUTION: The ground truth describes an evolution in DESCRIPTION DETAIL and emphasis on tax integration/consolidation adjustments, NOT a change from non-segment to segment status. The LLM fundamentally misunderstands what changed. (4) UNSUPPORTED CLAIMS: Statements about 'tighter integration,' 'results presented net of eliminations,' and comparative growth metrics lack support in the ground truth. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the actual evolution described in the filings - which was about more explicit disclosure of consolidation tax impacts, not a change in segment classification. The answer reads as plausible but is factually incorrect on the core claim about how GM Financial's role evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 457,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\nCostco continues to account for step‑rent and other periodic rent increases that are tied to price indices or sales volume as **variable lease payments**—they are recognized only when the underlying event occurs and are not included in the lease‑asset/liability measurement. Both the 2022 and 2024 filings disclose that such escalations are allocated on a **straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised)**, with no material change in policy; the 2024 disclosure merely refines the wording and adds a note about the absence of residual‑value guarantees, but the recognition and measurement treatment remains the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental evolution of accounting treatment. Ground truth states: (1) 2022: step-rent increases were accounted for on a straight-line basis, (2) 2024: these are NOW recognized as variable lease payments (shift in treatment). LLM answer claims: (1) Both 2022 and 2024 treat them as variable lease payments, (2) Both years allocate on straight-line basis, (3) 'no material change in policy.' This is factually incorrect and represents a complete misunderstanding of the multi-hop comparison required. The LLM explicitly states 'no material change in policy' when the ground truth indicates a clear evolution/shift from straight-line treatment to variable lease payment recognition. The LLM also contradicts itself by saying they are 'variable lease payments' but then 'allocated on a straight-line basis'—these are mutually exclusive treatments. The quantitative accuracy score is higher only because there are no specific numbers to verify; the dates (2022, 2024) are correct. However, the qualitative accuracy is severely compromised because the core reasoning about the evolution of treatment is inverted from the ground truth. The answer fails the primary multi-hop synthesis requirement: comparing how treatment evolved between two years. Instead, it claims no evolution occurred, which is the opposite of what the ground truth establishes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 398,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\nThe company’s disclosures show a modest reduction in the expected cash outflows.  In the 2023 outlook the qualified pension plan’s 2025 payment was projected at **$1.86 billion**, but the 2024 outlook lowers that to **$1.80 billion**.  Likewise, the long‑term aggregate of **$10.0 billion** projected for the 2029‑2033 period in 2023 is revised to about **$9.99 billion** for the 2030‑2034 window in the 2024 filing, indicating a slight decline in the overall future funding obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies in the primary quantitative data. (1) 2023 2025 Payment: Ground truth states $1,860 million ($1.86 billion), but LLM claims it was 'lowered' to $1.80 billion in 2024. This is INCORRECT - the ground truth explicitly states the 2025 payment remained at $1,860 million in both years, not a decrease to $1.80 billion. (2) Long-term period comparison: Ground truth specifies 2023 projection was for 2029-2033 period ($10,020 million), while 2024 projection was for 2030-2034 period ($9,990 million). The LLM correctly identifies the periods and approximate amounts ($10.0B and $9.99B), but the characterization of the 2023 figure as '$10.0 billion' is slightly imprecise (should be $10.02 billion). (3) Multi-hop reasoning: The LLM failed to correctly synthesize the year-over-year comparison. The ground truth shows the 2025 payment was STABLE at $1,860M, not reduced to $1.80B. This is a fundamental error in the core comparison being asked. (4) The LLM's conclusion about 'modest reduction' and 'lowers that to $1.80 billion' directly contradicts the ground truth data. The only actual reduction is in the long-term period (from $10,020M to $9,990M, a $30M decrease), not in the 2025 payment. The answer demonstrates partial understanding of the long-term trend but makes a critical error on the 2025 payment projection, which is a key part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 399,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\nIn the 2023 filing JPMorgan merely flagged that “funding costs could be negatively affected by actions taken to satisfy liquidity‑coverage and net‑stable‑funding‑ratio requirements and to address obligations under its resolution plan,” linking those obligations to the need to pre‑position liquidity in its non‑U.S. subsidiaries. By the 2024 filing the language was expanded: the bank now explicitly ties any credit‑rating downgrade or stress‑buffer increase to higher funding spreads, stresses the importance of maintaining additional liquidity buffers in its subsidiaries to meet resolution‑plan requirements, and notes that upcoming regulatory changes (e.g., Basel III revisions and the GSIB surcharge) could further raise the cost of complying with those resolution‑plan‑related liquidity standards.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key concepts and evolution between 2023 and 2024 filings. STRENGTHS: (1) Correctly identifies the 2023 focus on liquidity coverage ratio, net stable funding ratio requirements, and pre-positioning obligations in non-U.S. subsidiaries; (2) Accurately captures the 2024 expansion to include credit-rating downgrades, stress-buffer increases, and regulatory changes (Basel III, GSIB surcharge); (3) Properly synthesizes the multi-hop comparison showing evolution from basic funding cost concerns to more sophisticated regulatory interaction framework; (4) No quantitative errors or incorrect dates/entities. WEAKNESSES: (1) The LLM answer is more specific and granular than the ground truth in some areas (e.g., explicitly mentioning credit-rating downgrades, Basel III, GSIB surcharge) which, while accurate, goes slightly beyond what the ground truth emphasizes; (2) The ground truth emphasizes the broader shift toward 'dynamic regulatory expectations and systemic events' and 'macroeconomic uncertainty,' while the LLM focuses more on specific regulatory mechanisms; (3) The LLM's framing of 'upcoming regulatory changes' is somewhat forward-looking, whereas the ground truth frames 2024 as already incorporating this broader context; (4) Minor semantic difference: ground truth emphasizes 'systemic events' as a key contextual addition in 2024, while LLM focuses more on specific regulatory mechanisms. The answer correctly addresses the core question about evolution between years and captures the essential shift in disclosure approach, though with slightly different emphasis and granularity than the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 466,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\nBetween 2022 and 2023 Optum Rx’s accounts‑receivable rose from **$7.1 bn to $8.6 bn**, signalling larger amounts due from its pharmacy‑network payers, and the company recorded **no material bad‑debt expense**. Revenue is still recognized on a **gross basis when prescriptions are dispensed**, but the business now carries a **$11.8 bn backlog of future performance‑obligation revenue**—about half of which is expected to be recognized in the next three years—reflecting a shift toward longer‑term contracts and more revenue to be earned over time. (Pages 46 & 47)",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the accounts receivable increase from $7.1 billion to $8.6 billion (2022-2023), matching the ground truth exactly. The statement about gross revenue recognition at point of prescription dispensing is accurate. The mention of no material bad-debt expense is a reasonable addition that doesn't contradict the ground truth.\n\nWEAKNESSES: (1) The introduction of the $11.8 billion performance obligation backlog and the claim about 'half expected in next three years' is NOT mentioned in the ground truth answer. While this may be factually accurate from the filing, it represents a significant expansion beyond what the original answer covers and shifts the focus away from the core question about evolution of financial structure between 2022-2023. (2) The phrase 'larger amounts due from its pharmacy-network payers' is somewhat imprecise—accounts receivable typically represents amounts due FROM customers/payers TO the company, but the phrasing could be clearer. (3) The claim about 'shift toward longer-term contracts' is an interpretation not explicitly stated in the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across multiple dimensions (revenue recognition, accounts receivable, performance obligations), but the ground truth focuses specifically on the evolution between 2022-2023 in terms of revenue recognition model and accounts receivable changes. The LLM introduces new information (performance obligations) that, while potentially relevant to financial structure, wasn't part of the original answer's scope.\n\nQUANTITATIVE VERIFICATION: Both key numbers ($7.1bn and $8.6bn) are correct. The $11.8bn figure cannot be verified against the ground truth provided.\n\nCORE ISSUE: The LLM answer is partially correct on the core metrics but introduces substantial additional information not in the ground truth, which may indicate either over-elaboration or potential hallucination of details not verifiable from the provided context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 544,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\nUPS’s quantitative exposure to interest‑rate risk through floating‑to‑fixed swaps remained modest, with a $4 million cumulative fair‑value hedge adjustment on long‑term debt and a $5 million reclassification of AOCI gains to interest expense in 2024 (down from $10 million in 2023). At the same time, the company’s strategy evolved to rely more on cash‑flow swaps and forward‑starting interest‑rate agreements to lock in fixed rates on future debt issuances, reflecting a more targeted approach to managing rising borrowing costs while keeping the overall hedge footprint limited.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. CRITICAL ISSUES: (1) WRONG NUMBERS: The ground truth states UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps in 2022, which is the key quantitative metric requested. The LLM answer provides completely different numbers ($4 million fair-value hedge adjustment, $5 million AOCI reclassification) that are not comparable to the ground truth metric and appear to be from different accounting categories. (2) MISSING KEY DATA: The LLM answer fails to mention the $28 million notional amount from 2022 or provide any comparable 2024 notional amount for Floating to Fixed swaps, which is essential to answering the question about how exposure 'evolved between 2022 and 2024.' (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about the evolution of 'quantitative exposure' and 'strategic approach' between two specific years. The ground truth shows a clear progression: 2022 had limited use ($28M notional) vs. 2024 had broader strategic intent. The LLM answer discusses different metrics (fair-value adjustments, AOCI reclassifications) and introduces new instruments (cash-flow swaps, forward-starting agreements) not mentioned in the ground truth, suggesting either different source data or misunderstanding of the question. (4) STRATEGIC APPROACH: While the LLM does attempt to address strategy evolution (mentioning 'more targeted approach'), it contradicts the ground truth's characterization by stating the 'hedge footprint' remained 'limited' rather than showing the evolution to 'more comprehensive' management described in the ground truth. (5) YEAR-OVER-YEAR COMPARISON: The LLM provides 2023-2024 comparison ($10M to $5M) rather than the requested 2022-2024 comparison. The answer appears to reference different financial metrics entirely rather than the notional amounts of Floating to Fixed Interest Rate Swaps that form the basis of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 539,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\nBetween 2022 and 2023 GM deepened its partnership with LG Energy Solution by expanding the equally‑owned Ultium Cells LLC battery‑cell joint venture—adding production sites in Ohio, Tennessee and Michigan to feed its growing EV lineup.  At the same time the Chevrolet Bolt battery recall was broadened to cover additional model years, and GM recorded a $2.6 billion accrual for recall costs, of which $1.6 billion was reimbursed by LG and a $0.6 billion balance remained on the books as of 31 Dec 2023, showing both the growth of the JV and the shifting financial exposure tied to the LG‑related recall.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about GM's evolving relationship with LG Energy Solution. STRENGTHS: (1) All key financial figures are correct: $2.6 billion accrual, $1.6 billion reimbursed by LG, and the $0.6 billion remaining balance ($2.6B - $1.6B = $1.0B, though the answer states $0.6B which appears to be additional detail about remaining exposure). (2) The temporal evolution is properly captured: 2022 focus on Ultium Cells LLC joint venture expansion, 2023 shift toward financial liabilities and recall costs. (3) Multi-hop synthesis is sound: correctly connects the strategic JV activities with the financial/liability dimension, showing the transition from collaboration to cost-driven dynamics. (4) Entity identification is accurate: GM, LG Energy Solution, Ultium Cells LLC, Chevrolet Bolt EV all correctly named. (5) The answer appropriately addresses both components of the question: joint venture activities AND recall-related costs. MINOR CONSIDERATIONS: The answer includes additional detail about the $0.6 billion balance remaining as of Dec 31, 2023, which represents a more granular breakdown than the ground truth explicitly states, but this is consistent with the $2.6B accrual and $1.6B reimbursement figures and adds helpful context. The mention of specific production sites (Ohio, Tennessee, Michigan) adds relevant detail about the JV expansion. The characterization of the relationship shift from 'strategic collaboration to transactional and cost-driven dynamic' is well-captured through the narrative structure. All calculations are mathematically sound and the reasoning properly synthesizes information across the 2022-2023 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 471,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\nThousandEyes revenue grew and was a key driver of the 14 % rise in the Observability product category, adding roughly $80 million in fiscal 2023 versus fiscal 2022. This increase reflects a higher contribution from ThousandEyes within the broader Observability suite.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete information. QUANTITATIVE ERRORS: (1) The LLM states ThousandEyes added 'roughly $80 million in fiscal 2023 versus fiscal 2022' - this is incorrect. The ground truth shows $80 million was the increase in fiscal 2022, while fiscal 2023 saw a $176 million increase in the Observability category. (2) The LLM cites a '14% rise' in Observability, but ground truth shows 27% revenue increase in fiscal 2023. The 14% figure is not mentioned in the ground truth. (3) The LLM fails to distinguish between fiscal 2022 and fiscal 2023 growth rates and magnitudes. COMPLETENESS ISSUES: (1) The answer does not address the evolution from fiscal 2022 to fiscal 2023 - it conflates the two years. (2) Missing critical information about the 27% growth in fiscal 2023 and the $176 million increase. (3) No mention of the Splunk/Observability Suite acquisition impact in fiscal 2023. (4) Missing the 15% organic growth metric excluding Splunk. REASONING ISSUES: The multi-hop synthesis is incomplete - the question asks for evolution across two fiscal years, but the LLM provides only a single data point ($80M) and misattributes it to fiscal 2023 when it actually represents fiscal 2022 growth. The answer lacks the comparative analysis needed to show how the contribution evolved between the two years. CORRECT ELEMENTS: ThousandEyes is correctly identified as a key driver of Observability growth, and the general direction of growth is correct, but the specific metrics and year-to-year comparison are fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 433,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 UPS left the $276 million 7.620% debentures unchanged: they remain callable at any time with a redemption price equal to the greater of principal plus accrued interest or the present‑value of the remaining scheduled payments discounted at the Treasury rate plus 5 bps, and interest continues to be paid semi‑annually at the fixed 7.620% rate (April and October). No sinking‑fund requirement or interest‑rate adjustment has been introduced, and the debentures are still carried at roughly $280 million on the balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental misinterpretation of the question and the ground truth. The question asks how the relationship 'evolved' between 2022 and 2024, implying a change or development over time. The ground truth explicitly states there was an 'evolution' - a shift from 'a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.' The LLM answer incorrectly claims the debentures were 'left unchanged' and that they 'remain callable,' which contradicts the ground truth's core finding. While the LLM correctly identifies the specific redemption terms (greater of principal plus accrued interest or present value calculation with Treasury rate plus 5 bps) and the semi-annual payment schedule (April and October), it misses the critical narrative: in 2022, these details were NOT specified - they were only clarified/detailed in 2024. The LLM also correctly states the principal amount ($276 million), maturity date (April 1, 2030), and carrying value (~$280 million). However, the semantic meaning is fundamentally wrong - the answer describes a static situation rather than an evolution. The LLM's statement that 'no sinking-fund requirement or interest-rate adjustment has been introduced' is accurate but irrelevant to the actual evolution described in the ground truth. The multi-hop reasoning fails because the LLM did not synthesize the temporal comparison between 2022 and 2024 disclosures correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 417,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Fixed‑Maturity‑Securities‑AFS portfolio that backs MetLife’s pension and post‑retirement plans slipped modestly in total size—from roughly **$6.80 bn to $6.71 bn**.  The shift in composition was slight but notable: **U.S. government‑bond holdings rose from about $1.51 bn to $1.58 bn** (an increase of roughly 4–5 %), while **corporate‑security holdings edged up from about $3.00 bn to $3.08 bn** (a rise of roughly 2–3 %).  Consequently, the share of the portfolio devoted to both U.S. Treasuries and corporate bonds grew modestly, even as the overall fair‑value of the AFS holdings declined a little.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) YEAR MISMATCH: The LLM discusses 2022-to-2023 evolution, but the ground truth explicitly states the 2022 figure is from December 31, 2021 ($2,164 million), and the 2023 figure is $6,714 million. The LLM's claim of $6.80 bn in 2022 is incorrect—the actual 2022 carrying amount was $2,164 million ($2.164 bn), not $6.80 bn. (2) DIRECTIONAL ERROR: The LLM claims the portfolio 'slipped modestly' from $6.80 bn to $6.71 bn (a decline), but the ground truth shows a MASSIVE INCREASE from $2,164 million (2022) to $6,714 million (2023)—a tripling of the portfolio size. This is a fundamental mischaracterization of the trend. (3) COMPONENT VALUES: While the LLM's 2023 figures for U.S. government bonds ($1.58 bn vs. ground truth $1.575 bn) and corporate securities ($3.08 bn vs. ground truth $3.083 bn) are approximately correct, they are based on an entirely wrong baseline year comparison. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison, confusing the 2023 total with a 2022 baseline that doesn't match the ground truth. (5) SEMANTIC INVERSION: The LLM's narrative of modest decline contradicts the ground truth's narrative of 'substantial transformation' and significant increase. The answer demonstrates a fundamental misunderstanding of the data and provides misleading conclusions about portfolio evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 410,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\nFrom 2022 through 2023 GM’s cash commitment to the Ultium Cells LLC joint venture grew materially – the 2022 10‑K shows a $0.5 billion outflow in 2021 and the 2023 MD&A references additional capital infusions (including the $0.5 billion “Investment in Ultium Cells LLC” line and the broader $5.2 billion credit facility that GM extended to support Cruise, which underpins Ultium’s expansion).  At the same time, the partnership faced heightened regulatory scrutiny: in February 2023 GM self‑disclosed potential TSCA violations tied to imports into Ultium, and in November 2023 the EPA settled the matter with a consent agreement that imposes roughly $5.1 million in civil penalties that are jointly borne by GM and Ultium Cells LLC.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a significant factual error regarding the timing and nature of the $0.5 billion investment. The ground truth states GM reported a $0.5 billion investment in 2022 (as part of 2022 investing activities). However, the LLM answer confusingly states 'the 2022 10-K shows a $0.5 billion outflow in 2021' - this is incorrect and contradicts the ground truth which places the investment in 2022. The LLM then compounds this by suggesting 'additional capital infusions' and references a '$5.2 billion credit facility' related to Cruise, which is NOT mentioned in the ground truth and appears to conflate separate financial arrangements. This is a critical error that misrepresents GM's financial commitment timeline and magnitude. CORRECT ELEMENTS: The LLM correctly identifies (1) the February 2023 TSCA violation self-disclosure, (2) the November 2023 EPA settlement, (3) the approximately $5.1 million in joint civil penalties, and (4) the shift from investment-based to operationally integrated partnership. REASONING ISSUES: While the LLM correctly synthesizes the regulatory evolution, the quantitative foundation is flawed. The introduction of the $5.2 billion Cruise credit facility is extraneous and misleading - it's not part of the Ultium Cells LLC relationship evolution described in the ground truth. MULTI-HOP SYNTHESIS: The answer attempts to connect financial involvement with regulatory implications, which is appropriate, but the financial involvement portion contains material inaccuracies that undermine the overall credibility. The regulatory portion is well-synthesized and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 454,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\nBetween 2022 and 2024 the company continued to purchase natural‑gas and fuel under variable‑price, index‑linked contracts, but it consistently applied the “normal purchases and normal sales” exception, meaning these contracts are not marked‑to‑market and are accounted for at cost. No material shift in the nature or volume of such variable‑priced contracts is disclosed; the practice remains the same across the three fiscal years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM claims 'no material shift' and that 'the practice remains the same across the three fiscal years,' which directly contradicts the ground truth's core finding that there WAS an evolution from 2022 to 2024. (2) The ground truth explicitly states that by 2024, the company 'explicitly noted that these contracts met the characteristics of derivative instruments' - this is a KEY development showing formalization/strategic shift. The LLM completely misses this evolution. (3) The ground truth indicates that in 2022, specific volumes/values were 'not disclosed,' whereas by 2024 there was more explicit accounting framework alignment - this represents a meaningful change in how contracts are managed/accounted for. The LLM's assertion of consistency contradicts this. WHAT WAS CORRECT: The LLM correctly identifies that variable-priced, index-linked contracts were used in both periods and that the 'normal purchases and normal sales' exception applies, preventing mark-to-market accounting. The accounting treatment description is accurate. MULTI-HOP REASONING FAILURE: The question asks about EVOLUTION between 2022 and 2024. The LLM failed to synthesize the key difference: the shift from undisclosed/informal use (2022) to formalized derivative accounting framework alignment (2024). This is a significant analytical failure on a multi-hop temporal comparison question. The answer reads as if comparing two identical states rather than identifying the progression described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 446,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Cisco kept the same set of expenses excluded from its segment‑performance metrics for the APJC region.  The company continues to omit research‑and‑development, sales‑and‑marketing, general‑and‑administrative costs, amortization and impairment of acquisition‑related intangible assets, share‑based compensation, significant litigation settlements and other contingencies, restructuring and asset‑impairment charges, and certain other items from gross‑margin calculations when evaluating the APJC segment.  No new expense categories were introduced or removed; the exclusion policy remained unchanged across the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about Cisco's APJC segment financial reporting evolution between fiscal 2022 and fiscal 2023. STRENGTHS: (1) Correctly identifies that no change occurred in the exclusion policy between the two years; (2) Accurately lists all excluded expense categories mentioned in the ground truth: R&D, sales and marketing, general and administrative, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, and restructuring/asset impairment charges; (3) Properly synthesizes the multi-hop information by comparing the two fiscal years and drawing the correct conclusion that the approach remained consistent; (4) Uses appropriate financial terminology and maintains semantic equivalence with the ground truth. MINOR CONSIDERATIONS: The LLM answer includes a reference to 'certain other items' which is a reasonable generalization but not explicitly detailed in the ground truth statement. However, this is a minor addition that doesn't contradict the ground truth and may reflect additional context from the actual filings. The answer is well-structured, clear, and directly answers the core question about consistency in exclusion policies. No numerical errors, calculation errors, or factual inaccuracies are present. The reasoning correctly identifies that the consistency itself is the key finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 398,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 UnitedHealth moved from a largely underwriting‑and‑contract‑focused cost‑containment model to a more data‑driven, senior‑specific strategy that directly targets the rise in outpatient procedures.  The 2023 disclosures note that “increased care patterns, primarily related to outpatient procedures for seniors” are driving higher medical costs, and the company says it is “mitigating those increases by engaging physicians and consumers with information and helping them make clinically‑sound choices” — a clear shift toward proactive care‑management and value‑based payment designs that adjust pricing and benefit structures to curb senior outpatient spending. (See UNH 2022 p. 17; 2023 p. 27‑28; 2023 p. 26 on Medicare‑Advantage rate pressure.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of UNH's evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from general cost-containment concerns in 2022 to targeted senior outpatient procedure strategies in 2023; (2) Accurately captures the specific problem: rising outpatient procedure costs for seniors; (3) Properly synthesizes the company's response strategy: engaging physicians and consumers with data-driven insights to guide clinical decisions; (4) Correctly attributes the shift as moving from underwriting/contract-focused to data-driven, proactive care management; (5) Appropriately cites specific page references (2022 p. 17; 2023 p. 27-28; 2023 p. 26) showing multi-hop synthesis across documents. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'value-based payment designs' and 'pricing and benefit structures' that, while logically consistent with the strategy described, goes slightly beyond what the ground truth explicitly states about the company's approach; (2) The phrase 'underwriting-and-contract-focused cost-containment model' characterizes 2022 strategy in a way that is reasonable but not explicitly stated in the ground truth, which focuses more on 'concern over increased medical care costs' and 'accurate cost prediction'; (3) The answer could have more explicitly mentioned the pandemic-related deferred care context from 2022. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, correctly identifying the evolution of strategy and the specific problem domain (senior outpatient procedures). The reasoning chain is sound and logically presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth despite different wording - both identify a shift toward more targeted, data-driven strategies focused on senior outpatient procedures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 575,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UPS expanded the scope of its time‑definite services—adding same‑day, next‑day, two‑day and three‑day air options and growing its day‑definite ground offering to move more than 17 million U.S. packages daily—while tightening network integration through RFID‑enabled “Smart Package” facilities, a single global air‑and‑ground network, and the insourcing of SurePost final‑mile delivery (effective Jan 2025) to gain greater control over last‑mile service.  At the same time the company reshaped its network (Fit‑to‑Serve, Efficiency Reimagined) to focus on higher‑yielding volumes and to better leverage its 188,000 entry points and 52,000 global Access Point locations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of UPS's time-definite delivery services between 2022 and 2024, but contains several issues: (1) CORRECT ELEMENTS: The answer correctly identifies the insourcing of SurePost final-mile delivery, the emphasis on integrated global air-and-ground network, and the expansion of service scope. The mention of same-day pickup and expanded returns services aligns with the ground truth. (2) QUANTITATIVE ACCURACY ISSUES: The LLM introduces specific numbers (17 million U.S. packages daily, 188,000 entry points, 52,000 global Access Point locations) that are NOT mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent additional detail beyond what the ground truth synthesized. More critically, the LLM states SurePost insourcing is 'effective Jan 2025' which is FUTURE-DATED from the 2024 perspective and creates temporal confusion about what actually occurred by 2024 versus what was planned. (3) MISSING ELEMENTS: The ground truth emphasizes that in 2022 UPS highlighted its integrated network as foundational, and by 2024 expanded returns services across approximately 150 countries. The LLM mentions returns services expansion but doesn't specify the geographic scope (150 countries). The LLM also introduces 'RFID-enabled Smart Package facilities' and 'Fit-to-Serve, Efficiency Reimagined' initiatives that aren't in the ground truth, suggesting potential over-specification or hallucination. (4) MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across years and connect service scope with network integration, which is appropriate for the question. However, the temporal framing of SurePost (Jan 2025) undermines the 2022-2024 comparison framework. (5) SEMANTIC ISSUES: The answer conflates planned changes (Jan 2025 implementation) with actual 2024 developments, which is a significant accuracy problem for a question asking about evolution 'between 2022 and 2024.' The ground truth clearly states the insourcing gave UPS 'greater control' while the LLM frames it as gaining control, which is semantically similar but the timing issue is problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 580,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.50 % Notes maturing in April 2026 were explicitly listed as part of the Thirteenth Supplemental Indenture (Exhibit 4.14) dated April 20 2016, confirming that the series remained outstanding. By the 2023 filing the same indenture is still referenced, but the latest supplemental indentures (the 20th Supplemental Indenture of March 2022 and the 22nd Supplemental Indenture of March 2023) no longer mention the 2.50 % notes, showing that the company now treats the issue as a legacy tranche and does not include it in any newer debt‑package amendments.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the evolution of the notes' treatment. CRITICAL ISSUES: (1) The LLM claims the 2022 filing 'explicitly listed' the 2.50% Notes as part of the Thirteenth Supplemental Indenture, but the ground truth states they were 'referenced...in the context of historical documentation' - a fundamentally different characterization. (2) The LLM introduces information about the 20th and 22nd Supplemental Indentures (dated March 2022 and March 2023) that is NOT mentioned in the ground truth answer. This appears to be fabricated detail not supported by the source material. (3) The LLM's interpretation that the notes became a 'legacy tranche' not included in newer amendments contradicts the ground truth's statement that by 2023 the notes were 'explicitly recognized as issued instruments' - these are opposite conclusions. (4) The ground truth describes a shift FROM historical documentation TO active recognition, while the LLM describes a shift FROM explicit listing TO legacy/excluded status. NUMERIC ACCURACY: The dates (April 2026, April 20 2016, March 2022, March 2023) and percentage (2.50%) are correct, but the indenture numbering (20th, 22nd) appears to be unsupported invention. REASONING FAILURE: The multi-hop synthesis is fundamentally flawed - the LLM mischaracterizes the 2022 treatment and invents a narrative about newer supplemental indentures that doesn't align with the ground truth's description of the evolution. The answer demonstrates poor understanding of the actual disclosure transition described in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 440,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\nFrom 2022 to 2024 the way sovereign‑debt concerns affect Costco’s supply chain has become more pronounced and direct. In 2022 the filings noted that macro‑economic stresses—including sovereign‑debt crises, tariffs and commodity‑price volatility—could raise merchandise costs and force pricing adjustments, but the impact was largely indirect. By 2024 the same disclosures show that expanding international operations (now generating roughly one‑third of sales abroad) and heightened exposure to foreign‑currency swings mean that sovereign‑debt‑related financing pressures and trade restrictions now have a clearer effect on sourcing costs, prompting Costco to tighten supplier contracts and pass on—or absorb—higher inventory expenses to protect margins.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a specific claim that international operations generate 'roughly one-third of sales abroad' by 2024. This metric is NOT present in the ground truth answer and cannot be verified against the original filing data. This is a significant factual insertion that may be inaccurate. (2) MISSING KEY GROUND TRUTH ELEMENTS - The LLM fails to capture the explicit 2024 language that sovereign debt crises 'negatively impact' Costco's business, financial condition, and results of operations. The ground truth emphasizes this shift from indirect/potential impact (2022) to explicit negative impact (2024). (3) INCOMPLETE SYNTHESIS - The ground truth specifically mentions the 2022 framing included 'potential for higher tariffs' and 'change in product mix' considerations. The LLM conflates tariffs with sovereign debt but doesn't clearly distinguish the evolution in how sovereign debt specifically was characterized. (4) REASONING QUALITY - While the LLM attempts to show evolution from 'indirect' to 'direct' impact, it does so by introducing unsourced claims about supplier contracts and margin protection rather than grounding the answer in the actual filing language about 'negatively impact' and 'cascading effects.' (5) WHAT WAS CORRECT - The LLM correctly identifies that there was an evolution from 2022 to 2024 in how these risks were characterized, and correctly notes the connection to supply chain and sourcing costs. However, the specific mechanisms and language used to describe this evolution are either missing or inaccurate. The answer reads more like inference than extraction from actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 459,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\nBetween the end of 2021 and the end of 2023 the shares reserved for future grants under the 2020 Stock Incentive Plan fell from **≈ 64 million** to **≈ 53 million** (a reduction of about 11 million shares).  This decline shows that UnitedHealth has already used a sizable portion of its authorized equity pool for prior awards, but it still retains a meaningful—though diminished—reserve of roughly 53 million shares that can be tapped for new share‑based compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: The numbers are correct - 64 million shares in 2021, 53 million shares in 2023, with a calculated reduction of 11 million shares. All numeric values match the ground truth exactly. The use of '≈' (approximately) is appropriate given typical rounding in financial reporting. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in available shares between 2021-2023, and (2) what this indicates about UnitedHealth's capacity for issuing new awards. ENTITY ACCURACY: Company name (UnitedHealth Group), plan name (2020 Stock Incentive Plan), years (2021, 2023), and metric (shares available for future grants) are all correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified the trend (decline from 64M to 53M), calculated the difference (11M), and provided appropriate interpretation about capacity constraints. The additional context about the company having 'already used a sizable portion' and 'still retains a meaningful reserve' adds valuable insight beyond the ground truth while remaining factually consistent. SEMANTIC EQUIVALENCE: The LLM's phrasing 'shares reserved for future grants' is semantically equivalent to 'shares available for future grants.' The interpretation that this 'indicates a reduction in the company's available capacity' is conveyed through the LLM's statement about 'diminished reserve.' Minor note: The LLM uses slightly more elaborate language and provides additional context about the implications, which enhances rather than detracts from the answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 455,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\nBetween 2022 and 2024 the collective‑bargaining agreement for the IAM National Pension Fund / National Pension Plan was extended—its expiration moved from 31 July 2024 (2022 filing) to 31 July 2029 (2024 filing).  UPS’s annual contributions remained material, hovering around $50 million per year (≈ $48‑$53 million in 2022‑2024) and consistently exceeding 5 % of the plan’s total contributions.  In 2024 the company also formalized a withdrawal from the related District 9 IAM pension trust, recording a $19 million liability, which shows the relationship is still strategically important even as its terms evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the core evolution of the relationship: (1) expiration date moved from July 31, 2024 to July 31, 2029 - this is accurate; (2) UPS contributions exceeded 5% of total plan contributions - this is correct; (3) the multi-hop synthesis across 2022 and 2024 filings is sound; (4) the contextual framing about extension and sustained significance is appropriate. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduced specific dollar amounts ($48-$53 million annually) that are NOT present in the ground truth answer. The ground truth only states contributions were 'more than 5%' without specifying absolute dollar amounts. This is a significant addition of unverified numbers that could be incorrect. (2) ADDITIONAL INFORMATION NOT IN GROUND TRUTH - The LLM mentions a $19 million liability related to withdrawal from District 9 IAM pension trust in 2024. While this may be factually accurate from the filing, it was not included in the ground truth answer and represents information beyond what was asked or confirmed. (3) The ground truth specifies contribution percentages for specific year ranges (2019-2021 in 2022 filing; 2022-2024 in 2024 filing), which the LLM does not explicitly mention, though it does note the >5% threshold was maintained. MULTI-HOP REASONING: The LLM correctly synthesized information across two filing years and identified the evolution of terms. However, the introduction of unverified quantitative details (specific dollar amounts and District 9 withdrawal) suggests the model may have hallucinated or added information not in the source documents. The core answer structure is sound but the additional specificity is problematic without verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 469,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Company’s 2020 revolving credit facility was amended and restated as the 2023 Credit Agreement, extending its maturity from **March 2025 to September 2028** while keeping the borrowing capacity at **$2 billion**; the related third‑amended and restated agreement (entered in December 2021) was also extended to **September 2028**, leaving the **combined $4 billion of available credit** essentially unchanged.  (Pages 60 – 2022 filing show the $2 billion, March 2025 maturity; pages 59 – 2023 filing show the amendment extending the term to September 2028 and confirming the $4 billion total availability.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) The 2020 Credit Agreement maturity date correctly evolved from March 2025 (FY2022) to September 2028 (FY2023); (2) The borrowing capacity remained at $2 billion throughout; (3) The combined availability across both credit agreements remained at $4 billion; (4) The amendment and restatement into the 2023 Credit Agreement in September 2023 is correctly identified; (5) The Third Amended and Restated Credit Agreement is appropriately mentioned as also being extended to September 2028. The multi-hop synthesis is sound - the answer correctly traces the evolution of terms across two fiscal years and identifies the relationship between the 2020 Credit Agreement becoming the 2023 Credit Agreement while maintaining the overall credit facility structure. The answer includes helpful citations to specific pages in the filings (pages 60 for 2022, pages 59 for 2023), demonstrating source verification. The only minor observation is that the ground truth explicitly mentions the Third Amended and Restated Credit Agreement was 'entered in December 2021,' which the LLM answer doesn't include, but this is a very minor detail that doesn't affect the core answer to the question about evolution between 2022 and 2023. All quantitative data (dates, dollar amounts) are precisely correct with no calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 387,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\nMDLZ’s net‑investment‑hedge derivative program expanded materially: the notional amount of the contracts was about **$6.9 billion at the end of 2022**, rose to **$7.5 billion at year‑end 2023**, and reached **$8.6 billion as of 31 December 2024** (see MDLZ_10k_2022.pdf p. 111; MDLZ_10k_2024.pdf p. 96). This roughly 25 % increase over the two‑year span reflects a deliberate scaling‑up of cross‑currency swaps and forwards to hedge a larger share of the company’s non‑U.S. investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "ANALYSIS: The LLM answer provides a reasonable narrative about MDLZ's net investment hedge derivative program evolution, but contains significant quantitative discrepancies with the ground truth.\n\nQUANTITATIVE ACCURACY ISSUES:\n1. 2022 figure: LLM states ~$6.9 billion at end of 2022, but ground truth indicates $3,915 million (2021) and $4,551 million (2020) in the 2022 filing. The LLM appears to have conflated or misread the 2022 year-end figure. The actual 2022 year-end figure should be verified, but the LLM's $6.9B seems inconsistent with the progression shown in ground truth.\n2. 2023 figure: LLM states $7.5 billion, which matches ground truth ($7,456 million) - CORRECT\n3. 2024 figure: LLM states $8.6 billion, which matches ground truth ($8,647 million) - CORRECT\n4. Percentage calculation: LLM claims \"roughly 25% increase over the two-year span.\" If using $6.9B (2022) to $8.6B (2024): ($8.6-$6.9)/$6.9 = 24.6%, which is approximately correct. However, if the actual 2022 figure differs significantly from $6.9B, this calculation would be wrong.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesized information across multiple years (2022-2024) and identified the trend of increasing notional amounts. The reasoning about \"deliberate scaling-up of cross-currency swaps and forwards\" is logical and contextually appropriate, though not explicitly verified against the ground truth.\n\nCOMPLETENESS:\nThe LLM focused on the 2022-2024 period as requested, but the ground truth also mentions 2020-2021 data from the 2022 filing. The LLM's answer is appropriately focused on the requested timeframe.\n\nKEY CONCERN:\nThe 2022 figure of $6.9 billion appears problematic. The ground truth shows $3,915M (2021) and $4,551M (2020) in the 2022 filing context, suggesting the 2022 year-end figure should be somewhere in that range or higher, but $6.9B seems like a potential misreading or conflation with a different metric. This is the primary source of the score reduction.\n\nSTRENGTHS:\n- Correct 2023 and 2024 figures\n- Appropriate narrative framing\n- Reasonable percentage calculation (if 2022 figure were correct)\n- Good contextual explanation of hedging strategy",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 585,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft 365 shifted from a broad AI‑platform foundation (Azure AI and the early Copilot stack) to a tightly integrated generative‑AI layer that can understand and act on business data across Outlook, Teams, Word, Excel and other apps.  In 2024 the company added role‑specific Copilot assistants (Copilot for Sales, Service and Finance), the Copilot Studio customization environment, a consumer‑focused Copilot Pro subscription, and expanded ambient‑intelligence capabilities from Nuance—all of which embed AI‑driven automation, insights and security (e.g., Copilot for Security) directly into productivity and collaboration workflows.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and provides accurate information about Microsoft 365's AI evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from broad AI-platform foundation to generative-AI integration; (2) Accurately names all role-specific Copilot assistants (Sales, Service, Finance) mentioned in ground truth; (3) Properly dates the 2024 enhancements; (4) Correctly identifies key 2024 additions including Copilot Studio and Copilot Pro; (5) Accurately references Microsoft Graph and business data integration; (6) No quantitative errors or incorrect dates. WEAKNESSES: (1) The LLM answer introduces additional details not in the ground truth (Nuance ambient-intelligence capabilities, Copilot for Security, Copilot Pro subscription) which, while potentially accurate from SEC filings, go beyond the specific ground truth provided and could represent synthesis from different sources; (2) The ground truth emphasizes the 2022 baseline of 'Office 365, Windows, and Enterprise Mobility + Security' integration, which the LLM answer doesn't explicitly reference, instead using more general language about 'Azure AI and early Copilot stack'; (3) The ground truth's specific framing of 2024 as an 'AI first platform' is not explicitly stated in the LLM answer, though the concept is conveyed; (4) The LLM answer's mention of 'consumer-focused Copilot Pro subscription' and 'Copilot for Security' may be accurate but aren't in the ground truth baseline. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across the 2022-2024 timeframe and connects specific capabilities to their business purpose. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns well - Microsoft 365 evolved from AI-integrated platform to AI-first platform with role-specific extensions. The LLM provides more granular detail but maintains factual accuracy on all verifiable claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 534,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\nBetween 2022 and 2024 3M moved from an ad‑hoc, self‑reported acknowledgement that its NPDES permit for the Decatur, AL plant omitted several PFAS compounds—prompting temporary process idling and the start of treatment‑control upgrades—to a formal, regulator‑approved interim Consent Order (July 2020, still the governing framework in 2024) that obligates the company to continuously characterize PFAS discharges, conduct periodic analytical studies and reporting, and implement capital‑improvement and remediation actions as part of a defined, ongoing compliance program. In other words, the approach evolved from a one‑time disclosure and pause in operations to a binding, multi‑year regulatory agreement that mandates sustained PFAS discharge monitoring, characterization and corrective measures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL DATE ERROR: The LLM references a 'July 2020' Consent Order as the governing framework in 2024, but the ground truth makes no mention of any 2020 Consent Order. The question specifically asks about evolution between 2022 and 2024 disclosures. (2) INCORRECT CHARACTERIZATION: The ground truth states that in 2022, 3M 'had not fully characterized' PFAS discharge and 'submitted an application to ADEM to add additional PFAS to the permit.' The LLM claims the permit 'omitted several PFAS compounds' and references 'temporary process idling'—neither of which appears in the ground truth. (3) MISSING CORE FACTS: The ground truth explicitly states that by 2024, 3M 'had installed and was upgrading wastewater treatment controls' and 'controls were being optimized, though ADEM had not yet acted on the permit modification request.' The LLM does not mention the installation and upgrading of treatment controls or the status of ADEM's response. (4) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'formal, regulator-approved interim Consent Order,' 'continuous characterization,' 'periodic analytical studies,' and 'capital-improvement and remediation actions' that are not present in the ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize an evolution narrative, it does so by introducing information not supported by the source material, rather than accurately synthesizing the 2022-to-2024 progression described in the ground truth. The core evolution (from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval) is not captured. The answer appears to conflate or confuse different regulatory frameworks and timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 499,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s did not issue any new 4.550 % notes; the only reference to that coupon appears in the **Fifteenth Supplemental Indenture of April 5, 2019**, which created the 4.550 % Notes due April 5, 2049.  The **Twentieth Supplemental Indenture (March 24, 2022)** and the **Twenty‑Second Supplemental Indenture (March 30, 2023)** added other tranches—e.g., 4.450 % notes in 2022 and 4.800 %, 5.150 %, 5.750 % and 5.850 % notes in 2023—but they did not reference or expand the 4.550 % series.  Thus, the 4.550 % notes remained part of the indenture from 2019 and were not altered or supplemented in the 2022‑2023 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides more comprehensive detail than the ground truth. Verification of key facts: (1) Fifteenth Supplemental Indenture dated April 5, 2019 - CORRECT; (2) 4.550% Notes due April 5, 2049 - CORRECT; (3) No new issuance of 4.550% Notes between 2022-2023 - CORRECT; (4) Twentieth Supplemental Indenture (March 24, 2022) with 4.450% notes - CORRECT and adds valuable context; (5) Twenty-Second Supplemental Indenture (March 30, 2023) with 4.800%, 5.150%, 5.750%, 5.850% notes - CORRECT and adds valuable context. All dates are accurate. The LLM answer goes beyond the ground truth by providing additional context about other supplemental indentures and note issuances in 2022 and 2023, which helps clarify that the 4.550% Notes specifically were not modified or reissued. The core conclusion matches the ground truth: the 4.550% Notes remained unchanged from their 2019 issuance through 2023. The multi-hop reasoning is sound - the answer correctly synthesizes information about the original issuance, the lack of changes to that specific instrument, and the context of other debt issuances. The only minor point is that the LLM provides more detail than strictly necessary to answer the question, but this additional context is accurate and enhances understanding rather than detracting from it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 372,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MDLZ’s stake in Keurig Dr Pepper fell from roughly 13 % to below the 5 % threshold that triggers significant influence, forcing a move from equity‑method accounting to fair‑value measurement of marketable securities.  In 2022 the company sold 6.8 million KDP shares for $185 million and recorded a $71 million pre‑tax gain, and in 2023 the re‑classification to marketable securities allowed it to recognize a $593 million pre‑tax gain on the remaining shares (including the $493 million gain from prior equity‑method transactions).  By the end of 2024 MDLZ had fully exited its KDP investment, concluding the relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite some correct elements. CORRECT ELEMENTS: (1) The general narrative about MDLZ's stake falling below 5% threshold and the shift from equity-method to fair-value accounting is conceptually sound; (2) The 2022 pre-tax gain of $71 million is correct; (3) The mention of a 2023 reclassification event is directionally correct. CRITICAL ERRORS: (1) The LLM states a '$593 million pre-tax gain on the remaining shares (including the $493 million gain from prior equity-method transactions)' in 2023, but the ground truth indicates the $493 million gain occurred in 2024, not 2023. This is a major temporal error; (2) The LLM claims the $593 million includes the $493 million, which is mathematically inconsistent with the ground truth showing $493 million as the 2024 figure; (3) The claim about 'fully exited its KDP investment' by end of 2024 is not supported by the ground truth, which only discusses the 2024 gain without confirming complete exit; (4) The $185 million sale price for 6.8 million shares is not mentioned in the ground truth and cannot be verified. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but makes a critical error in attributing the $493 million gain to 2023 instead of 2024. The ground truth explicitly states the $493 million gain was recorded in 2024 due to a change in accounting for the investment. The LLM's statement that this $493 million was 'from prior equity-method transactions' is confusing and potentially incorrect. QUANTITATIVE ISSUES: The year assignment for the $493 million gain is fundamentally wrong (2023 vs 2024), which is a critical factual error in a financial question. The relationship between the $593 million and $493 million figures is unclear and appears to contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 504,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the Xbox Game Pass library expanded dramatically—from a curated catalog of roughly 100 first‑ and third‑party titles in 2022 to “over 400 first‑ and third‑party console and PC titles” by 2024.  Microsoft has repositioned the service as the central pillar of its gaming strategy, emphasizing subscription growth, cloud‑gaming accessibility across consoles, PC and mobile, and deeper integration with advertising and first‑party content to broaden the user base and increase engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: Both key numbers are correct—100 titles in 2022 and over 400 titles in 2024 match the ground truth exactly. The fiscal year references (2022 and 2024) are accurate. QUALITATIVE ASSESSMENT: The answer correctly identifies the multi-hop synthesis required: (1) scale evolution (100→400 titles), (2) strategic repositioning (from 'key part' to 'cornerstone'), and (3) emphasis shift (content/community/cloud to subscriptions/community/advertising). STRENGTHS: The LLM answer adds valuable context beyond the ground truth by specifying 'console and PC titles' and mentioning cloud-gaming accessibility, advertising integration, and mobile expansion—all legitimate strategic details that enhance understanding without contradicting the source material. The characterization of Game Pass as the 'central pillar' is semantically equivalent to 'cornerstone.' MINOR CONSIDERATIONS: The ground truth mentions 'cloud services' as part of 2022 positioning, while the LLM emphasizes 'cloud-gaming accessibility' in 2024—this is a reasonable interpretation of strategic evolution rather than an error. The LLM's mention of advertising integration and mobile expansion represents reasonable elaboration on the strategic emphasis shift. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 timeframe and correctly identifies both the quantitative expansion and qualitative strategic shift. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 421,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, 3M continued to incorporate the identical “Formof Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to non‑employee directors under the 2016 Long‑Term Incentive Plan” by reference to the 2018 filing. No new or amended DSU agreement, exhibit, or revised disclosure was introduced in either the 2022 or 2024 filings, so the structure and wording of the award have remained unchanged from 2022 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT REFERENCE SOURCE: The LLM states the agreement is 'incorporated by reference to the 2018 filing,' but the ground truth indicates it references grants 'on or after January 1, 2019' with no mention of a 2018 incorporation. This is a material factual error about the source document. (2) MISSING KEY EVOLUTION: The ground truth explicitly states that 'by 2024, the disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.' The LLM completely omits this important evolution and the May 8, 2023 amendment date, which is a critical detail about how the disclosure changed. (3) INCOMPLETE ANALYSIS: The LLM claims 'no new or amended DSU agreement...was introduced' and that structure 'remained unchanged,' but the ground truth indicates there WAS an update in how the 2024 disclosure incorporated the 2023 10-K reference, representing a change in the disclosure structure even if the underlying agreement remained substantively the same. (4) DATES: The LLM correctly identifies January 1, 2019 as the grant date threshold, which matches the ground truth. (5) ENTITY ACCURACY: Correctly identifies 3M Company, the 2016 Long-Term Incentive Plan, and non-employee directors. The core issue is that the LLM provides an oversimplified conclusion ('unchanged from 2022 through 2024') when the ground truth shows there was a meaningful evolution in how the disclosure was maintained and updated through the 2023 amendments. The answer fails to capture the nuanced distinction between the agreement structure remaining the same while the disclosure methodology evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 481,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the First‑Mortgage book grew from about $26.1 bn to $27.3 bn (≈ 4‑5 % increase) while HELOCs slipped from $0.473 bn to $0.421 bn (≈ 11 % decline).  Origination‑cost exposure rose from $100 million to $112 million, and the share of the combined First‑Mortgage + HELOC portfolio concentrated in California fell only modestly from roughly 43 % to 42 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. CORRECT ELEMENTS: (1) Origination costs increased from $100M to $112M - matches ground truth exactly; (2) California concentration decreased from 43% to 42% - matches ground truth exactly; (3) The characterization of the change as 'modest' is appropriate and semantically equivalent to ground truth's 'slightly decreased'; (4) Multi-hop synthesis is sound - correctly combined information about portfolio composition changes, origination costs, and geographic concentration. ADDITIONAL VALUE: The LLM answer provides supplementary context about First Mortgages and HELOCs portfolio sizes ($26.1bn to $27.3bn and $0.473bn to $0.421bn respectively) with calculated growth/decline percentages. While this information was not explicitly in the ground truth answer, it is relevant to understanding portfolio composition evolution and does not contradict the ground truth. MINOR CONSIDERATIONS: The ground truth focused specifically on 'origination costs' while the LLM characterized this as 'origination-cost exposure,' which is semantically equivalent. The LLM's inclusion of separate portfolio size metrics for First Mortgages and HELOCs goes beyond the ground truth but enhances understanding of the portfolio composition question. All core metrics match exactly: $100M→$112M and 43%→42%. The reasoning correctly synthesizes multi-hop information across portfolio components and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 402,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\nIn fiscal 2023 Nike’s research‑and‑development text highlighted Dri‑FIT as a flagship performance fabric, underscoring its importance for moisture‑wicking apparel and product differentiation. By fiscal 2024 the same paragraph merely lists Dri‑FIT among a broader set of Nike technologies (Air, Zoom, Flyknit, etc.), reflecting a shift from a singular Dri‑FIT emphasis to a more integrated, portfolio‑wide innovation focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth explicitly states that Nike's strategic emphasis on Dri-FIT technology 'remained stable between fiscal 2023 and fiscal 2024' with 'the exact same language used in both the 2023 and 2024 10-K filings, showing no change.' The LLM answer claims the opposite - that there was a 'shift from a singular Dri-FIT emphasis to a more integrated, portfolio-wide innovation focus,' describing Dri-FIT as a 'flagship performance fabric' in 2023 that was then 'merely listed' among other technologies in 2024. This is a direct factual error. The LLM fabricated a narrative of change where none existed according to the actual SEC filings. The answer demonstrates a failure in multi-hop reasoning by not accurately synthesizing the comparative language analysis across both fiscal years. While the answer is well-written and addresses the question's structure, it provides completely incorrect information about the actual evolution (or lack thereof) of Nike's Dri-FIT emphasis. No numeric values were involved in this question, so quantitative accuracy is not applicable, but the core factual claim is entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 338,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\nFrom 2022 through 2024 Mondelez has treated backup and disaster‑recovery as a core pillar of its cyber‑risk program, repeatedly noting that it “continues to invest and augment” those capabilities.  In the 2022 filing (page 45) the company said it was dedicating focused resources to network security, backup and disaster‑recovery, and workforce training, and the 2024 filing (page 21) reiterates that it is “enhancing the monitoring and detection of threats… and adjusting information‑security controls” while still emphasizing continued investment in backup and disaster‑recovery to guard against the growing frequency and sophistication of ransomware and state‑sponsored cyber attacks.  Thus, the company’s backup‑and‑recovery investment has evolved from a baseline, reactive measure in 2022 to a more robust, continuously‑upgraded component of a broader, proactive cybersecurity strategy by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the evolution of Mondelez's backup and disaster recovery investment from 2022 to 2024; (2) Accurately captures the company's language about 'continues to invest and augment' capabilities; (3) Properly synthesizes multi-hop information across two filing years; (4) Correctly identifies key threat categories (ransomware, state-sponsored attacks) mentioned in the ground truth; (5) Appropriately characterizes the shift from reactive to proactive measures; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer includes specific page references (page 45 for 2022, page 21 for 2024) that cannot be verified against the ground truth provided, though this addition doesn't contradict the ground truth; (2) The characterization of 2022 measures as 'baseline, reactive' is the LLM's interpretation rather than explicitly stated in the ground truth, though it's a reasonable inference; (3) The ground truth mentions 'emerging technologies like artificial intelligence' as a threat consideration, which the LLM answer does not explicitly include, though it does mention 'increasingly sophisticated threats.' The answer successfully addresses all parts of the question (evolution from 2022-2024, response to cybersecurity threats, investment trajectory) and demonstrates sound multi-hop reasoning by connecting information across the two filing periods. No numerical errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 440,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\nBetween fiscal years 2022 and 2024 Microsoft shifted from merely working toward a $500 million target for spending with Black‑ and African‑American‑owned suppliers—reaching roughly 90 % of that goal in FY 2022—and by FY 2024 it had fully met the commitment, actually spending the full $500 million while doubling the number of Black‑owned suppliers in its pipeline.  In addition, the company announced a new $150 million investment in minority depository institutions to further increase capital available to Black‑owned small businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative facts are correct: (1) FY 2022 reached ~90% of $500M goal with doubled supplier numbers, (2) FY 2024 achieved the full $500M spending commitment, (3) $150M allocated to Minority Depository Institutions and Black-owned small businesses. The multi-hop synthesis is sound, correctly tracing the evolution from 2022 to 2024 across both the primary spending goal and the expanded commitment. The answer captures the strategic progression and deepening engagement. Minor observation: The LLM uses 'Black‑owned' (with special hyphen character) while ground truth uses 'Black and African American-owned,' but this is a stylistic variation that doesn't affect factual accuracy. The LLM's phrasing 'shifted from merely working toward' and 'fully met the commitment' effectively conveys the progression. The answer is well-structured, addresses all components of the question, and maintains semantic equivalence with the ground truth while using slightly different wording. No calculation errors, no missing key facts, and proper entity identification throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 322,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\nFrom the 2022 filing Abbott reported ≈ 10.6 million common shares reserved for future issuance under the Non‑U.S. Employee Stock Purchase Plan, while the 2023 filing shows that number had fallen to ≈ 8.6 million shares (as of Dec 31 2023).  The decline indicates that Abbott is exhausting the ESPP reserve and is therefore deploying a larger share of its authorized capital toward employee‑stock purchases—signaling a more aggressive use of equity‑based incentives to motivate global staff.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identifies the approximate share counts (10.6M and 8.6M) which match the ground truth values of 10,638,639 and 8,565,087 shares respectively. The use of approximations (≈) is reasonable for large numbers. The dates are correctly referenced (Dec 31, 2023). However, there is a subtle but important dating error: the ground truth states the 2022 figure is 'as of December 31, 2021' while the LLM implies it's from the 2022 filing without clarifying the as-of date. This is a minor but notable discrepancy in precision.\n\nCOMPLETENESS: The LLM addresses both the quantitative evolution (10.6M to 8.6M decline) and attempts to interpret what this indicates about Abbott's strategy. However, the interpretation diverges significantly from the ground truth.\n\nENTITY ACCURACY: The LLM correctly identifies Abbott Laboratories, the Employee Stock Purchase Plan for Non-U.S. Employees, and the relevant years/dates. All entities are properly named.\n\nREASONING & INTERPRETATION ISSUE: This is where the critical problem lies. The ground truth interpretation states the reduction 'suggests a potential tightening or adjustment in Abbott's stock-based incentive strategy.' The LLM interprets the same data as indicating 'Abbott is exhausting the ESPP reserve and is therefore deploying a larger share of its authorized capital toward employee-stock purchases—signaling a more aggressive use of equity-based incentives.' These are fundamentally opposite interpretations. A decline in available shares could indicate either: (1) tightening/adjustment (ground truth view) or (2) aggressive deployment/exhaustion (LLM view). The LLM's interpretation is logically defensible but contradicts the ground truth's more conservative interpretation. The LLM adds unsupported inference about 'more aggressive use' when the data only shows shares were consumed.\n\nSEMANTIC EQUIVALENCE: The factual data points match, but the strategic interpretation is materially different and not equivalent to the ground truth.\n\nKEY ISSUES: (1) The interpretation of what the decline means differs substantially from ground truth; (2) The LLM makes an affirmative claim about 'more aggressive' incentives that isn't supported by the ground truth's more cautious 'potential tightening or adjustment' language; (3) Minor dating precision issue regarding the 2022 figure's as-of date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 636,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\nNike moved from simply listing Air cushioning as one of many innovative technologies in 2023 to establishing a dedicated Air Manufacturing Innovation subsidiary in 2024 that directly supplies Air‑Sole and related components from its own facilities in Oregon, Vietnam and Missouri. This vertical‑integration reflects a strategic shift toward centralising Air‑technology development, expanding the Air platform across multiple product lines (e.g., Air Max, ZoomX, React) and tying its evolution to performance and sustainability goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and introduces information not supported by the ground truth. Critical issues: (1) FACTUAL ERRORS: The LLM claims Nike established a 'dedicated Air Manufacturing Innovation subsidiary in 2024' with facilities in Oregon, Vietnam, and Missouri. This specific claim about a subsidiary and these manufacturing locations is not mentioned in the ground truth and appears to be fabricated. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth describes a strategic shift from Nike Air being presented as an 'emerging innovation' (FY2023) to being treated as a 'standard component' and 'foundational offering' (FY2024) alongside mature technologies like Zoom, Free, and React. The LLM instead describes vertical integration and subsidiary creation, which is a completely different narrative. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the actual evolution described in the filings - the shift from positioning Air as a distinct growth driver to embedding it as part of a mature technology platform. Instead, it invented a corporate restructuring narrative. (4) ENTITY ACCURACY: While Nike is correctly identified, the specific claims about subsidiary creation, facility locations, and manufacturing operations are not grounded in the provided ground truth. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes strategic positioning and market messaging evolution; the LLM discusses operational/manufacturing changes that are not supported. The answer demonstrates hallucination of specific corporate actions rather than accurate synthesis of the actual strategic evolution described in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 451,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott kept Osmolite® as a core offering within its Nutritional Products enteral‑feeding portfolio—listing it alongside Jevity®, Glucerna®, Oxepa®, Freego™ and other disease‑specific formulas in both years’ disclosures.  The 2023 filing emphasizes ingredient innovation and a broader product‑line strategy, positioning Osmolite as a flagship, nutritionally complete solution for adult enteral nutrition while maintaining its place among Abbott’s other enteral brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Osmolite remained in Abbott's enteral feeding portfolio in both 2022 and 2023, accurately lists companion products (Jevity®, Glucerna®, Oxepa®, Freego™), and correctly characterizes the positioning as stable across both years. The product names and years are accurate. WEAKNESSES: (1) The LLM introduces unsupported claims not present in the ground truth, specifically stating that '2023 filing emphasizes ingredient innovation' and positioning Osmolite as a 'flagship, nutritionally complete solution'—these characterizations are not substantiated by the original answer and represent interpretive overreach. (2) The LLM omits specific products mentioned in the ground truth (Nepro®, Vital®, and the specific Glucerna® variants: 1.2 Cal and 1.5 Cal), reducing completeness of the product portfolio description. (3) The phrase 'broader product-line strategy' is vague and not explicitly supported by the ground truth, which states the portfolio 'remained largely consistent.' (4) The LLM's characterization of Osmolite as 'flagship' goes beyond what the ground truth supports—the ground truth indicates stable positioning, not elevated status. MULTI-HOP REASONING: The LLM correctly synthesizes the 2022-2023 comparison and identifies the stable positioning across years, which is sound. However, it adds interpretive layers (ingredient innovation emphasis, flagship status) that constitute factual overreach rather than synthesis of provided information. SEMANTIC EQUIVALENCE: While the core message of stability is preserved, the LLM's additions create a different narrative than the ground truth's emphasis on consistency without significant repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 465,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\nBetween 2022 and 2024, 3M’s PFAS remediation in Minnesota and Alabama shifted from relying on the long‑standing 2007 Minnesota Settlement Agreement and 2009 Alabama TSCA consent order to facing newer, state‑driven enforcement actions—including MPCA violation notices, updated health‑based water limits, a draft NPDES permit with stricter PFAS limits, and a series of EPA information requests and a July 2024 RCRA consent order for the Decatur site.  At the same time the company increased its PFAS‑related accrual by $0.7 billion and paid $3.1 billion in 2024, reflecting a move from prior planning to active, closely supervised cleanup and compliance oversight.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - References a \"July 2024 RCRA consent order for the Decatur site\" - the ground truth specifies a \"July 2020 Interim Consent Order with ADEM\" (wrong year and type of order)\n   - Mentions \"$0.7 billion\" accrual increase and \"$3.1 billion\" paid in 2024 - these specific financial figures are NOT present in the ground truth and cannot be verified\n   - These dollar amounts appear to be fabricated or from external sources not in the knowledge graph\n\n2. ENTITY/FACTUAL ERRORS:\n   - References \"2009 Alabama TSCA consent order\" - ground truth states \"July 2020 Interim Consent Order with ADEM\" (wrong year and characterization)\n   - Mentions \"MPCA violation notices\" - not explicitly stated in ground truth\n   - References \"EPA information requests\" - not mentioned in ground truth\n   - The characterization of the Alabama agreement as a \"TSCA consent order\" is incorrect; it's an ADEM Interim Consent Order\n\n3. INCOMPLETE/MISSING INFORMATION:\n   - Fails to mention the Cottage Grove facility specifically and its remediation status\n   - Omits the multilayer cap installation at Decatur facility\n   - Doesn't address the December 2024 revised draft permit from MPCA\n   - Missing reference to updated HBVs from MDH (January 2024) and proposed HRLs (October 2024)\n   - Doesn't mention the August 2024 public comments submission\n\n4. MULTI-HOP REASONING:\n   - The answer attempts to synthesize evolution over time but does so with incorrect foundational facts\n   - The connection between regulatory changes and financial impacts is asserted but not properly grounded in the source material\n   - The financial figures ($0.7B, $3.1B) represent a major factual claim that cannot be verified against the ground truth\n\n5. SEMANTIC ISSUES:\n   - While the general theme of \"intensifying regulatory scrutiny\" is correct, the specific details are largely inaccurate\n   - The answer conflates different regulatory instruments and timelines\n\nThe answer demonstrates an attempt to address the multi-hop question but fails on factual accuracy, introduces unverified financial data, and contains multiple date/entity errors that significantly undermine its credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 625,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola HBC AG remained classified as an equity‑method investment for The Coca‑Cola Company, with the ownership stake essentially unchanged at roughly 19 % (approximately 19 % as of Dec 31 2022 and 19 % as of Dec 31 2024). No reclassification or material shift in the nature of the relationship occurred, indicating a stable financial tie over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the ownership percentage. The ground truth clearly states that Coca-Cola HBC AG had a 22% ownership stake as of December 31, 2024, but the LLM claims it was approximately 19% in both 2022 and 2024. This is a significant quantitative error (22% vs 19% = 3 percentage point discrepancy). Additionally, the LLM states the ownership was 'essentially unchanged' and 'roughly 19%' for both years, which contradicts the ground truth's narrative of 'formalization and quantification' where the 2022 percentage was not disclosed but 2024 explicitly stated 22%. The LLM's conclusion that there was 'no material shift' and a 'stable financial tie' misses the key point that the relationship evolved from undisclosed to explicitly quantified at 22%. The investment classification as equity method investee is correctly identified in both answers, but the core numerical finding is wrong. The LLM failed to synthesize the multi-hop information correctly: it should have noted that while the classification remained consistent (equity method), the disclosure evolved from non-specific to explicit 22% ownership. The reasoning about stability is undermined by the incorrect percentage figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 353,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Oracle has shifted hybrid deployment from a peripheral option to a core growth pillar, investing ≈ $7 billion + each year in R&D to build hybrid‑ready capabilities such as Oracle Cloud@Customer, OCI and SaaS extensions that let customers run workloads across on‑premise, cloud and hybrid environments.  This spending underpins the rising share of cloud‑services and license‑support revenue—up to 71 % of total sales in FY 2022 and expected to keep climbing—and reflects a tight integration of cloud, license, hardware and services in Oracle’s product roadmap.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Oracle's hybrid deployment emphasis and correctly identifies key products (Oracle Cloud@Customer, OCI) and the shift toward hybrid as a core offering. However, there are significant quantitative accuracy issues: (1) The LLM states R&D spending of '≈ $7 billion + each year' but the ground truth specifies $7.2 billion for fiscal 2022 only, not a consistent annual figure across the period. The LLM's phrasing suggests this was maintained annually, which is not supported by the ground truth. (2) The LLM introduces a specific metric ('71% of total sales in FY 2022') that is not present in the ground truth answer, and this appears to be an unsupported claim that may be inaccurate or from a different source. (3) The ground truth emphasizes the evolution from 'development-focused approach to a more mature, integrated deployment model' as the key strategic shift, while the LLM frames it as 'peripheral option to core growth pillar' - similar but not identical characterization. The LLM does correctly address the multi-hop synthesis by connecting R&D investment to product development (Cloud@Customer, OCI) and deployment model integration. The reasoning about interoperability and customer choice is sound. The answer is contextually relevant and addresses the question's core components about evolution between fiscal 2022 and 2024, but the introduction of unsupported percentages and the ambiguous R&D spending claim reduce confidence in the quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 421,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Mandatory Clawback Policy was presented as a newly filed exhibit (Exhibit 97 – “Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023”) that was “Filed herewith.” In the 2024 Form 10‑K the same policy is no longer filed as a separate exhibit; it is merely “Incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023.” Thus, the policy moved from a fresh filing in 2023 to an incorporated reference in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about the evolution of the Mandatory Clawback Policy filing status between 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company. STRENGTHS: (1) Correctly identifies the 2023 status as a newly filed exhibit (Exhibit 97) with specific effective date (October 2, 2023) and 'Filed herewith' designation; (2) Accurately describes the 2024 status as incorporated by reference to the prior year's Exhibit 97; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Correctly identifies this as a procedural change rather than substantive policy change; (5) All dates and exhibit references are accurate; (6) The specific language quoted ('Filed herewith' and 'Incorporated by reference') demonstrates precise knowledge of SEC filing conventions. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes the effective date of October 2, 2023, and more precise language about the filing status), but this additional detail is accurate and enhances rather than detracts from the answer. The semantic meaning is fully aligned with the ground truth - both convey that the policy moved from direct filing in 2023 to incorporation by reference in 2024. No factual errors, calculation errors, or entity misidentifications detected. The answer demonstrates sound multi-hop reasoning by correctly comparing the filing methodologies across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 411,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\nThermo Fisher acquired CorEvitas, LLC in August 2023 for roughly $0.9 billion of cash, adding real‑world‑evidence capabilities to its Laboratory Products and Biopharma Services segment; the purchase contributed about $486 million of additional segment income (raising that segment’s income from $2.87 B in 2022 to $3.36 B in 2023) and introduced definite‑lived intangibles that are being amortized over 13‑18‑year lives, generating $2.34 billion of amortization expense that is added back in the company’s adjusted operating income. By 2024 the integrated business was fully reflected in the segment’s revenue and income results, influencing adjusted operating income, the adjusted tax rate and the outlook for free‑cash‑flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about the CorEvitas acquisition and its integration, but contains several significant quantitative discrepancies that reduce overall accuracy:\n\nCORRECT ELEMENTS:\n- Acquisition timing (August 2023) and approximate amount (~$0.9 billion) match ground truth\n- Correct identification of CorEvitas as a real-world evidence provider\n- Correct segment placement (Laboratory Products and Biopharma Services)\n- Correct general concept that the relationship evolved from investment to full integration\n- Appropriate mention of amortization of intangible assets\n- Correct identification of 2024 as the year of full integration\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. AMORTIZATION PERIOD: LLM states \"13-18-year lives\" while ground truth specifies \"weighted average period of 18 years.\" The range is imprecise and doesn't match the ground truth's specific weighted average figure.\n\n2. AMORTIZATION EXPENSE: LLM claims \"$2.34 billion of amortization expense\" - this specific number is not mentioned in the ground truth and appears to be unsupported. This is a significant quantitative error.\n\n3. SEGMENT INCOME FIGURES: LLM provides specific numbers ($486 million contribution, $2.87B in 2022, $3.36B in 2023) that are not present in the ground truth. While these may be accurate from the actual filings, they cannot be verified against the provided ground truth and represent additional claims not substantiated.\n\n4. FINANCING DETAILS: Ground truth mentions $5.94 billion in senior notes issued and $3.00 billion in stock repurchases as part of the broader strategy, but LLM omits these important financial implications entirely.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the evolution of the relationship across 2023-2024 and identifies the integration into segment results. However, the inclusion of unverified specific numbers (particularly the $2.34B amortization figure) suggests either hallucination or reliance on information not in the ground truth.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the acquisition's strategic importance and integration timeline, but the quantitative inaccuracies (especially the amortization expense figure and incomplete financing details) and imprecise amortization period prevent a higher score. The answer would benefit from sticking to verifiable figures from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 641,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\nUnder the 2012 IAE acquisition agreement RTX must make payments to Rolls‑Royce that are tied to the flight‑hours flown by V2500‑powered aircraft through June 2027.  Both the 2022 and 2023 filings state that these payments are recorded as collaboration‑intangible assets when they are paid, and the 2023 disclosure simply refines the expected payment schedule (showing amounts through 2028) without changing the timing or capitalization treatment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about RTX's flight hour payment obligations to Rolls-Royce under the 2012 IAE acquisition agreement. Key strengths: (1) Correctly states the contingent payment structure tied to V2500-powered aircraft flight hours through June 2027; (2) Accurately identifies that payments are capitalized as collaboration intangible assets; (3) Correctly notes that there was no change in timing or capitalization treatment between 2022 and 2023; (4) Properly synthesizes the multi-hop information across two years of filings. Minor issues: (1) The LLM mentions '2023 disclosure simply refines the expected payment schedule (showing amounts through 2028)' - the ground truth specifies the obligation extends through June 2027, not 2028. This appears to be an error or confusion about the disclosure refinement; (2) The answer could have been more explicit about the 'Other commercial aerospace commitments' classification mentioned in the ground truth, though this is a minor omission; (3) The phrase 'IAE acquisition' is correct but could have been more clearly contextualized. The answer demonstrates solid multi-hop reasoning by comparing 2022 and 2023 disclosures and identifying the stability of the commitment structure. The quantitative accuracy is strong (dates, payment structure) with one potential date discrepancy (2028 vs 2027). Overall, the answer captures the essential information and correctly addresses the question's focus on evolution (or lack thereof) between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 421,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the Company’s contingent obligation to fairlife has moved from a quarterly‑remeasured liability to an actual cash payment and a remaining performance‑based payment.  The 2020 acquisition created a contingent‑consideration liability that is re‑measured each quarter; a $275 million milestone payment was made in 2023 (KO_10k_2022.pdf p. 56), and the 2024 filing notes that the **remaining milestone payment—up to an uncapped amount tied to fairlife’s 2024 financial results and payable in 2025—continues to be carried at fair value, with any fair‑value changes recorded in income** (KO_10k_2024.pdf pp. 112‑111).  Thus, the relationship has evolved from an accrued, unpaid contingent liability to a partially settled, still‑contingent payment that is now expected to be settled in 2025 contingent on achieving the agreed‑upon performance targets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct information with strong multi-hop synthesis across 2022-2024 filings. STRENGTHS: (1) Correctly identifies the 2020 acquisition as the foundation; (2) Accurately references the $275 million milestone payment made in 2023; (3) Properly characterizes the evolution from accrued liability to partially settled contingent obligation; (4) Correctly notes that remaining payment is tied to 2024 financial targets with 2025 settlement; (5) Accurately describes fair-value remeasurement treatment and income statement impact; (6) Provides specific document citations (KO_10k_2022.pdf p. 56, KO_10k_2024.pdf pp. 112-111). MINOR ISSUES: (1) The LLM states the remaining payment is 'uncapped' - the ground truth does not explicitly confirm this characterization, though it's plausible given typical earnout structures; (2) Page citation for 2024 filing appears to reference pp. 112-111 (reversed order) which is unusual formatting, though this may reflect actual document structure; (3) The LLM provides more granular detail about quarterly remeasurement and fair-value accounting than the ground truth, which is additional context rather than contradictory. MULTI-HOP REASONING: Excellent synthesis across three fiscal years showing progression from 2020 acquisition → 2022 status → 2023 payment → 2024 remaining obligation. The answer correctly traces the evolution of the financial relationship and explains the accounting treatment changes. QUANTITATIVE VERIFICATION: The $275 million payment in 2023 is correctly cited; 2024 and 2025 dates are accurate; no calculation errors detected. The answer goes beyond the ground truth by providing more specific accounting details while remaining consistent with the core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 478,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle shifted its Cloud Services narrative from a collection of discrete SaaS and infrastructure products to an integrated, end‑to‑end business‑innovation platform.  The company now positions Oracle Fusion Cloud ERP, HCM, SCM and other SaaS modules as tightly coupled services that run on Oracle Cloud Infrastructure (OCI) with a common data model, enabling seamless front‑ and back‑office connectivity and smoother migration of on‑premise workloads.  This integration is underscored by the growing share of cloud services and license‑support revenue—about 71 % of total revenue—reflecting a strategic emphasis on choice, flexibility, and a unified cloud‑based ecosystem for enterprise applications and infrastructure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Oracle's cloud strategy from discrete products to an integrated platform, which aligns with the ground truth's core narrative. However, there are significant issues with quantitative accuracy and some conceptual gaps.\n\nSTRENGTHS:\n1. Correctly identifies the shift from discrete offerings to integrated platform positioning\n2. Accurately names specific SaaS modules (Fusion Cloud ERP, HCM, SCM)\n3. Properly emphasizes integration with OCI and common data model\n4. Captures the customer-centric 'choice and flexibility' messaging\n5. Contextually relevant to the question about strategic evolution\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR: States cloud services revenue is \"about 71% of total revenue\" - this specific percentage is not mentioned in the ground truth and cannot be verified. The ground truth does not provide this metric, making this an unsupported claim.\n2. MISSING KEY DETAIL: Fails to mention Oracle Autonomous Database, which the ground truth explicitly identifies as a key 2022 offering that utilized machine learning for automation and leaner processes.\n3. INCOMPLETE SYNTHESIS: The ground truth emphasizes the 2022 focus on \"flexibility, interoperability, and customer choice across deployment models (cloud-based, hybrid, on-premise)\" - the LLM answer mentions choice and flexibility but doesn't adequately capture the hybrid/on-premise deployment model emphasis from 2022.\n4. LACKS TEMPORAL SPECIFICITY: Doesn't clearly delineate what was emphasized in 2022 vs. 2024 as distinctly as the ground truth does.\n5. OVER-SPECIFICATION: Introduces specific product coupling details (\"front- and back-office connectivity\") that aren't in the ground truth, which could be accurate but represents information not grounded in the provided knowledge graph.\n\nMULTI-HOP REASONING: The answer demonstrates reasonable synthesis of cloud strategy evolution but misses the specific technological innovations (Autonomous Database) that were central to 2022 positioning. The connection between revenue growth and strategic positioning is mentioned but not substantiated with verified data.\n\nVERIFICATION ISSUES: The 71% revenue figure is a critical quantitative claim that cannot be verified against the ground truth and appears to be either fabricated or from an unverified source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 626,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\nIn both the 2023 Form 10‑K (see page 18) and the 2024 Form 10‑K (see page 20), the Key/Specified Employee Policy is no longer reproduced in the filing’s main text; it is simply incorporated by reference as Exhibit 10(r) – originally listed as Exhibit 10(v) in the 2018 filing. The 2024 filing retains the identical exhibit reference and does not add a new version or additional documentation, so the policy’s treatment and documentation have remained unchanged between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the policy is 'incorporated by reference as Exhibit 10(r) – originally listed as Exhibit 10(v) in the 2018 filing.' This is contradictory and factually incorrect. The ground truth clearly states it was incorporated by reference to Exhibit 10(v) from the 2018 filing in BOTH 2023 and 2024 filings. The LLM introduces 'Exhibit 10(r)' with no basis in the ground truth, creating confusion about which exhibit number is correct. (2) INCOMPLETE SYNTHESIS: The ground truth distinguishes between 2023 (policy 'introduced') and 2024 (policy 'announced as continuing'), suggesting a subtle shift in how the policy was presented. The LLM fails to capture this distinction, instead claiming the treatment 'remained unchanged between the two years.' (3) PAGE REFERENCES: The LLM cites specific page numbers (page 18 for 2023, page 20 for 2024) that cannot be verified against the ground truth and may be inaccurate. (4) CORE ACCURACY: The LLM correctly identifies that the policy was not newly reproduced and relied on the same exhibit reference, but the exhibit number error and failure to distinguish between 'introduced' vs. 'continuing' status significantly undermines the answer's reliability. The answer partially addresses the question but contains a fundamental factual error regarding the exhibit designation that would mislead readers about the actual documentation structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 401,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\nThe 6.700 % notes maturing in 2028 ended 2022 with a principal balance of **$285 million** and, according to the 2023 long‑term‑debt tables (pages 96 and 84), that balance remained **$285 million** at the end of 2023 – unchanged from the prior year (after having been reduced from $400 million in 2020 following the 2021 tender‑offer repayment).  \n\nThis flat‑line indicates that RTX is not using this tranche to raise or retire debt aggressively; instead, it is maintaining a stable, lower‑cost funding pillar while focusing its debt‑management strategy on refinancing higher‑coupon maturities and issuing new lower‑rate instruments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth states the 2022 balance was $115 million and increased to $285 million in 2023. The LLM claims the 2022 balance was $285 million and remained flat at $285 million in 2023. This is a complete reversal of the actual evolution. The LLM incorrectly states the balance was unchanged year-over-year, when the ground truth shows a $170 million increase ($115M to $285M). (2) MULTI-HOP REASONING FAILURE: The LLM's interpretation of RTX's debt management strategy is based on the false premise that the balance remained flat. The ground truth indicates a significant increase in this debt tranche, suggesting RTX strategically retained or expanded exposure to this fixed-rate instrument. The LLM's conclusion about 'maintaining a stable, lower-cost funding pillar' is contradicted by the actual $170 million increase. (3) ENTITY AND METRIC ACCURACY: While the LLM correctly identifies the 6.700% notes due 2028 and RTX, it misidentifies the principal balances for both years. (4) SEMANTIC EQUIVALENCE: The LLM's narrative about debt management strategy is fundamentally incompatible with the actual data showing significant growth in this debt instrument. The reference to a prior $400 million balance in 2020 is contextually interesting but does not excuse the incorrect 2022-2023 comparison. This is a case where the LLM appears to have confused or inverted the year-over-year progression, leading to an entirely incorrect assessment of RTX's debt management decisions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 446,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\nThe 1.95 % 12‑Year Senior Notes carried a book value of $773 million at the end of 2023, which fell to $725 million by the end of 2024.  During that period the effective interest rate on the notes slipped slightly, from 2.08 % to 2.07 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. Quantitative verification: (1) 2023 carrying value of $773 million - CORRECT, (2) 2024 carrying value of $725 million - CORRECT, (3) 2023 effective interest rate of 2.08% - CORRECT, (4) 2024 effective interest rate of 2.07% - CORRECT. All four critical data points match the ground truth exactly. The answer correctly identifies the evolution: carrying value decreased by $48 million (from $773M to $725M) and effective interest rate decreased by 0.01 percentage points (from 2.08% to 2.07%). The LLM uses 'book value' as a synonym for 'carrying value,' which is semantically equivalent and appropriate. The phrase 'slipped slightly' accurately characterizes the marginal 0.01% decline in the effective interest rate. The answer successfully synthesizes multi-hop information across two fiscal years (2023 and 2024) for the same financial instrument (TMO's 1.95% 12-Year Senior Notes). The only minor difference from the ground truth is that the LLM answer omits the interpretive statement about 'reduction in the financial liability' and 'marginal improvement in the effective borrowing cost,' but this is a minor contextual addition rather than a factual requirement. The core factual content is complete and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 364,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\nThe 2022 filing merely disclosed that the Directors’ Code of Conduct was posted on BNY Mellon’s website (page 9), whereas the 2024 filing explicitly lists the Code of Conduct among the corporate‑governance documents incorporated by reference and pledges to disclose any amendments or waivers on the website (page 3). This change makes the code a formally incorporated, readily accessible governance material and signals a stronger, more transparent disclosure commitment to investors.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) DIRECTIONAL ERROR: The LLM claims the 2024 filing shows a STRONGER, MORE TRANSPARENT approach with explicit incorporation by reference and amendment disclosure pledges. The ground truth states the opposite—that 2024 shows a LESS VISIBLE approach with the Code listed among other materials WITHOUT a direct link or specific mention of updates. This is a critical reversal of the actual governance implication. (2) QUANTITATIVE ISSUES: The LLM cites specific page numbers (page 9 for 2022, page 3 for 2024) without verification against actual filings. These page references cannot be confirmed and may be inaccurate. (3) CHARACTERIZATION ERROR: The LLM describes 2024 as showing 'stronger, more transparent disclosure commitment' when the ground truth indicates a 'more streamlined or consolidated approach' that 'potentially reducing the visibility' of the Code. These are opposite characterizations. (4) MISSING KEY INSIGHT: The ground truth emphasizes that while the Code remains accessible, the change could 'affect transparency and stakeholder engagement' and 'influence perceptions of governance accountability.' The LLM misses this nuance entirely, instead claiming enhanced transparency. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative analysis between 2022 and 2024 presentations. The core finding—that visibility and prominence decreased—is inverted in the LLM response. This represents a fundamental failure in understanding the governance implications of the presentation change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 443,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\nAmazon replaced its $5 billion 364‑day revolving credit facility in October 2024 with a new $5 billion 364‑day facility that matures in **October 2025** (instead of the prior October 2024 maturity) and can be extended for an additional 364‑day period subject to lender approval. The new Short‑Term Credit Agreement superseded the facility originally entered into in **November 2023**, and as of December 31 2023 and 2024 there were no borrowings outstanding under either agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $5 billion facility size for both 2023 and 2024, correctly states the October 2025 maturity date for the 2024 agreement, and accurately notes that no borrowings were outstanding. The 364-day revolving credit facility structure is correctly described. CRITICAL ERRORS: (1) The LLM states the 2024 facility 'superseded the facility originally entered into in November 2023' - this is INCORRECT. According to ground truth, the 2023 facility was entered into in November 2023 (not the 2024 facility superseding a November 2023 facility). The 2024 facility replaced the 2023 facility. (2) The LLM fails to mention the November 2022 agreement that was replaced by the 2023 agreement, missing important historical context about the evolution pattern. (3) The LLM does not clearly establish the 2023 agreement's maturity date (October 2024), which is essential for showing the evolution between years. INCOMPLETE SYNTHESIS: The answer addresses the 2024 facility details but inadequately covers the 2023-to-2024 evolution. The ground truth emphasizes a pattern of annual renewal with consistent $5.0 billion size but shifting establishment dates (November 2022→November 2023→October 2024) and maturity dates advancing by one year each cycle. The LLM captures only the 2024 renewal details without properly synthesizing the multi-year evolution. The mention of the extension option for an additional 364-day period is additional detail not in ground truth but not contradictory. QUANTITATIVE: Numbers are correct ($5B, 364-day, October 2025), but the dating/sequencing of which agreement replaced which is confused. QUALITATIVE: The reasoning about the evolution is incomplete and somewhat muddled regarding which facility superseded which.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 482,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its APU roadmap from a graphics‑centric, cost‑effective integration of CPU + GPU for mainstream consumer notebooks toward a heterogeneous, AI‑ready platform that adds a dedicated neural‑processing unit and expanded AI software support.  The 2024 “Ryzen AI 300” series, billed as the first x86 CPU with an on‑chip NPU, is explicitly targeted at the emerging AI‑PC market and is backed by AMD’s broader AI‑hardware and ROCm‑software strategy.  This tighter integration expands the addressable market and raises ASP, giving AMD a sizable revenue upside in AI‑PCs—provided it can capture sufficient share of the new AI‑centric workload ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the strategic shift from 2022 to 2024, moving from external GPU-based solutions to integrated APUs with NPU cores; (2) Accurately names the Ryzen AI 300 series as the first x86 CPU with on-chip NPU; (3) Properly identifies the target market as AI PCs and emerging AI-centric workloads; (4) Correctly synthesizes the multi-hop reasoning: 2022 strategy → 2024 strategy → revenue implications; (5) Appropriately emphasizes the differentiation through dedicated NPU integration and the revenue upside potential through ASP expansion and market capture. MINOR GAPS: (1) The LLM answer mentions 'Ryzen AI 300' series specifically but doesn't reference the original answer's mention of Instinct MI200 series and Radeon PRO V620 GPUs as the 2022 baseline—though this is a minor omission since the focus is on the evolution rather than exhaustive 2022 details; (2) The phrase 'provided it can capture sufficient share' introduces a conditional caveat not explicitly in the ground truth, though this is reasonable forward-looking analysis rather than factual error. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022, 2024) are correct. QUALITATIVE ACCURACY: The reasoning about heterogeneous platforms, on-device AI processing, and market differentiation is sound and matches the ground truth's logic. The mention of ROCm software strategy adds relevant context. SEMANTIC EQUIVALENCE: The LLM's description of 'graphics-centric, cost-effective integration' for 2022 vs. 'heterogeneous, AI-ready platform' for 2024 effectively conveys the same strategic pivot as the ground truth's 'external GPU-based solutions' to 'integrated APUs with NPU cores.' The revenue implications discussion (ASP expansion, market capture, addressable market growth) aligns well with the ground truth's assessment of 'enhanced revenue potential' and 'differentiated player positioning.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 566,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\nThe 2024 filing repeats the same 25 % Irish dividend‑withholding tax that applied in 2023, but it adds a clear statement that the tax withheld “discharges any Irish income‑tax liability” for a U.S. shareholder who satisfies one of the exemption conditions (a U.S. address in the DTC records or a valid Form 6166/Irish V2 certification). In other words, the substantive treatment has not changed – U.S. shareholders remain subject to the 25 % withholding unless they qualify for an exemption, and when the withholding is applied it now explicitly serves as the final discharge of any Irish tax obligation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the key facts and numbers. Strengths: (1) Correctly identifies the 25% Irish dividend withholding tax rate in both years; (2) Accurately notes the exemption conditions (U.S. address in DTC records, Form 6166, Irish V2 certification); (3) Correctly states that withholding discharges Irish income tax liability; (4) Properly concludes there was no change between 2023 and 2024. Quantitative accuracy is high - the 25% rate is correct and consistently applied. Weaknesses: (1) The LLM states the exemption is based on 'a U.S. address in the DTC records' but the ground truth specifies 'residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2' - the DTC records reference is not explicitly mentioned in the ground truth as the primary basis; (2) The phrasing 'it now explicitly serves as the final discharge' suggests a change in how the discharge is stated/emphasized, but the ground truth indicates the substantive treatment was stable with no change in conditions - this could be interpreted as the LLM implying a change in disclosure/emphasis rather than substance, which is a subtle but important distinction; (3) Missing the explicit statement that 'a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability' - the Irish branch caveat is omitted. The multi-hop reasoning is sound in comparing 2023 and 2024 treatment, but the characterization of what changed (disclosure vs. substance) could be clearer. Overall, the answer captures the essential facts correctly but has minor gaps in completeness and precision regarding exemption documentation requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 475,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings the company’s risk‑factor language remained largely the same—both years note that “new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks, and the failure to implement these initiatives could affect our results of operations” — but the 2024 filing makes the reference more explicit.  In the 2024 document the risk discussion highlights the ongoing transition to a **platforms operating model** as a distinct strategic initiative, emphasizing that any shortfall in delivering the expected efficiencies or capabilities could materially impact the business, whereas the 2022 filing only mentioned the risk in a more general sense.  Consequently, the evolution shows a clearer, more detailed articulation of the platforms‑operating‑model risk within the broader new‑product/services risk category.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies BNY Mellon as the company and accurately references both 2022 and 2024 Form 10-K filings; (2) Accurately captures the evolution of risk disclosure language, noting that both years contain similar foundational language about 'new lines of business, new products and services or transformational or strategic project initiatives'; (3) Correctly identifies the key evolution: the 2024 filing explicitly highlights 'platforms operating model' as a distinct strategic initiative with specific implementation risks; (4) Properly synthesizes the multi-hop comparison showing progression from general strategic risk language to more concrete platform-specific risks; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing than the ground truth when describing the 2024 risk ('shortfall in delivering expected efficiencies or capabilities' vs. the ground truth's 'may not realize some or all of the expected benefits'), though both convey the same semantic meaning; (2) The LLM answer could have been more explicit in quoting the exact 2024 language about 'may not realize some or all of the expected benefits,' though the paraphrasing is accurate; (3) The characterization of the 2022 filing mentioning the risk 'only in a more general sense' is reasonable but the ground truth more clearly states it was not explicitly mentioned in 2022. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and correctly identifies the evolution pattern. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The answer conveys the essential information that risk disclosure evolved from general strategic language to specific platform model implementation risks, which matches the ground truth's core message.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 520,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Amazon’s disclosure of the 3.600 % senior unsecured note due 2032 is unchanged – the note is still referenced through the April 13 2022 Supplemental Indenture (Exhibit 4.2) and listed in the long‑term‑debt footnote tables of both years.  The only evolution is that the 2024 filing adds newer debt exhibits (e.g., a 4.700 % note due 2032) but does not modify or retire the 3.600 % note, which remains outstanding with the same terms and maturity in 2032.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the disclosure is 'unchanged' between 2023 and 2024, but the ground truth explicitly states there WAS an evolution - specifically a formal transition in trustee structure from Wells Fargo Bank, National Association (as prior trustee) to Computershare Trust Company, National Association (as successor trustee). The 2024 filing only references Computershare, not Wells Fargo. (2) The LLM fails to identify and explain this key trustee relationship shift, which is the core of the question about how the relationship 'evolved.' (3) The LLM's statement that 'the only evolution is that the 2024 filing adds newer debt exhibits' misses the actual evolution entirely - the trustee transition is the substantive change, not the addition of other debt instruments. CORRECT ELEMENTS: (1) The note percentage (3.600%) is correct. (2) The maturity year (2032) is correct. (3) The Supplemental Indenture date (April 13, 2022) is correct. (4) The note remaining outstanding with same terms is correct. MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the trustee information across the two years' filings. The question specifically asks about evolution in 'debt instrument disclosures,' and the trustee transition represents a material procedural evolution that should have been identified. The LLM's answer suggests no meaningful change occurred, which directly contradicts the ground truth's clear documentation of the trustee relationship shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 430,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\nIn 2023 MDLZ carried its net‑investment‑hedge derivatives as a $219 million liability (shown in “Other current liabilities”) and recorded a $185 million after‑tax loss in accumulated other‑comprehensive income, of which $148 million was later re‑classified to earnings through interest‑and‑other expense. By 2024 the same hedges were re‑classified as a $255 million asset (recorded in “Other current assets”), reflecting a swing in fair‑value driven by foreign‑exchange movements and the addition of more non‑U.S.‑dollar debt designated as hedging instruments; the 2024 footnote discloses the fair‑value hierarchy (Level 2), the notional amounts by currency, and an expectation of transferring modest gains to earnings over the next 12 months.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to describe a different financial scenario than the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM cites specific numbers ($219 million liability, $185 million loss, $148 million reclassification, $255 million asset) that do not appear in the ground truth. The ground truth provides different figures: $1,347 million and $377 million in other current assets for 2023, and $250 million and $413 million in other assets for 2022. The LLM's numbers are entirely inconsistent with these disclosed amounts. (2) STRUCTURAL MISALIGNMENT - The ground truth describes derivative assets/liabilities in 'other current assets' and 'other assets' categories, while the LLM describes them in 'other current liabilities' and 'other current assets,' suggesting confusion about the balance sheet presentation. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes a shift from balance sheet focus (2023) to income statement impact (2024), highlighting 'Other income, net' and hedge effectiveness exclusions. The LLM discusses fair value hierarchy (Level 2) and notional amounts by currency, which are not mentioned in the ground truth and appear to be fabricated details. (4) MISSING KEY INFORMATION - The LLM fails to capture the core evolution described in the ground truth: the transition from disclosing fair values of derivative positions to emphasizing income statement volatility effects. (5) CALCULATION/LOGIC ISSUES - The LLM's narrative about 'swings in fair value' and 'addition of more non-U.S.-dollar debt' lacks support in the ground truth and appears speculative. The answer demonstrates poor multi-hop synthesis and introduces numbers that cannot be verified against the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 479,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\nFrom 2023 to 2024 the Abrams modernization moved from incremental SEPv3 upgrades and continued foreign‑partner upgrades toward a more fundamental redesign – the Army’s new **M1E3** variant that adopts a next‑generation systems‑architecture standard, delivers greater lethality, fuel‑efficiency and mobility while cutting sustainment footprint.  At the same time, demand from NATO and other allies for new builds and upgrades has remained strong, with a growing installed base of Abrams tanks across Europe, the Middle East, North Africa and the Indo‑Pacific.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of Abrams modernization strategy from 2023 to 2024. STRENGTHS: (1) Correctly identifies SEPv3 as the 2023 focus and M1E3 as the forward-looking initiative; (2) Accurately characterizes M1E3 as a more fundamental redesign with next-generation systems architecture; (3) Properly identifies the key technical improvements (lethality, fuel-efficiency, mobility, reduced sustainment footprint); (4) Correctly notes the geographic expansion of international demand (Europe, Middle East, North Africa, Indo-Pacific); (5) Appropriately synthesizes the shift from technical roadmap focus (2023) to global strategic relevance (2024). MINOR GAPS: (1) The LLM answer omits specific mention of General Dynamics as the company responsible, though this is implied context; (2) Does not explicitly mention communications, power generation, and optics upgrades that were part of SEPv3 in the ground truth; (3) Uses 'Army's new M1E3' which could be slightly misleading as M1E3 is a General Dynamics development, not strictly an Army designation at that point. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not directly testable. The temporal framing (2023 vs 2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information about technological development (SEPv3→M1E3 progression) and international demand (growing installed base across multiple regions), correctly linking these as parallel evolution tracks. The semantic equivalence is strong - the LLM captures the core narrative of evolution from incremental to more fundamental modernization while demand grows globally.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 471,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s APU strategy shifted from a primarily client‑focused, value‑segment product for mainstream desktop and notebook PCs (with a secondary presence in embedded and semi‑custom consoles, as noted on 2022 page 9) to a cross‑segment cornerstone that now underpins its Data‑Center, Embedded, Gaming and Client businesses.  In the 2024 filing (page 69) APUs are explicitly listed as a reportable‑segment offering for data‑center AI/ML workloads, while still powering commercial client platforms and custom SoCs for game consoles and handheld devices (e.g., PlayStation 5, Xbox Series X/S, Steam Deck), reflecting a strategic emphasis on high‑performance, AI‑centric and heterogeneous computing across all markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. The answer correctly identifies that APUs evolved from a narrower focus to broader market segmentation between 2022 and 2024\n2. The answer correctly notes that by 2024, APUs were positioned in data center and client segments\n3. The reference to page 69 in the 2024 filing appears reasonable for segment information\n4. The mention of APUs in gaming/console contexts (PlayStation 5, Xbox Series X/S, Steam Deck) is contextually appropriate\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: The LLM claims APUs are in \"four reportable segments\" including \"Embedded\" and \"Gaming\" as separate segments. The ground truth explicitly states APUs were in \"two of AMD's four reportable segments: the Data Center segment and the Client segment.\" The LLM incorrectly expands this to four segments and misidentifies which segments contain APUs.\n2. The ground truth does NOT mention APUs being explicitly positioned in an \"Embedded\" or \"Gaming\" reportable segment in 2024. The ground truth only mentions Data Center and Client segments.\n3. The LLM's characterization of 2022 positioning as \"primarily client-focused, value-segment product\" is not directly supported by the ground truth, which states APUs were discussed \"in general terms without specific market segmentation or strategic emphasis.\"\n4. The LLM adds specific product examples (PlayStation 5, Xbox Series X/S, Steam Deck) that, while contextually reasonable, are not mentioned in the ground truth and may represent inference beyond what the filings explicitly state.\n5. The phrase \"cross-segment cornerstone\" overstates the positioning compared to the ground truth's more measured description of \"structured and strategic integration.\"\n\nMULTI-HOP REASONING:\nThe LLM attempts to synthesize information across years but makes a critical error in identifying which segments contain APUs in 2024. The ground truth clearly states TWO segments (Data Center and Client), but the LLM implies or states FOUR segments, which is a fundamental factual error in the multi-hop synthesis.\n\nQUANTITATIVE ACCURACY:\nNo specific numbers or calculations are present in either answer, so this is primarily about segment count accuracy. The LLM's claim about segment distribution is factually incorrect.\n\nSEMANTIC EQUIVALENCE:\nWhile the general narrative of evolution is similar, the specific factual claims diverge significantly, particularly regarding which segments contain APUs in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 686,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\nIn the 2023 filing Medtronic explained that Ireland’s Financial Transfers Act 1992 lets the Irish Minister for Finance restrict capital movements between Ireland and certain third‑country jurisdictions, that the list of restricted countries is limited and can change, and that transfers involving UN‑ or EU‑sanctioned parties may be blocked. The 2024 filing repeats this analysis but re‑states it more explicitly—emphasising that the Minister’s power to restrict such transfers remains, that the “restricted‑country” list is subject to ongoing change, and that any transaction tied to a sanctioned government or entity may be subject to those restrictions—while also adding clearer detail on the documentation required for U.S. shareholders to qualify for the Irish dividend‑withholding‑tax exemption.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CLAIM: The LLM answer directly contradicts the ground truth on the key evolution between 2023 and 2024. Ground truth states that by 2024, Medtronic 'no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization.' However, the LLM answer claims the 2024 filing 're-states it more explicitly—emphasising...that the \"restricted-country\" list is subject to ongoing change.' This is the opposite of what the ground truth indicates. The LLM has fundamentally mischaracterized the evolution of the disclosure. CORRECT ELEMENTS: The LLM accurately identifies the Financial Transfers Act 1992, the Irish Minister for Finance's role, the concept of restricted countries, and mentions of UN/EU-sanctioned parties. The dates (2023 and 2024) are correct. INCORRECT ELEMENTS: The core analytical finding about how the disclosure evolved is backwards. The LLM suggests increased emphasis on the dynamic nature of the list in 2024, when the ground truth indicates decreased emphasis. The LLM also introduces information about 'documentation required for U.S. shareholders to qualify for the Irish dividend-withholding-tax exemption' which is not mentioned in the ground truth answer and appears to be extraneous detail that may not be relevant to the specific question about the Financial Transfers Act disclosure evolution. MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative analysis between 2023 and 2024 filings. The question specifically asks about evolution/change, and the LLM provided an answer that contradicts the documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 451,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\nIn the 2023 filing GD said the ultra‑large‑cabin G700 was on track for FAA certification “in early 2024” and would join the Gulfstream lineup, but it had not yet entered service. The 2024 filing reports that the G700 “began deliveries in the second quarter of 2024,” noting that the ramp‑up of its production drove the increase in inventories and customer deposits—signaling that the aircraft has now moved from a pending certification milestone to active production and early‑stage deliveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative accuracy is perfect: all dates are correct (early 2024 for FAA certification in 2023 filing, Q2 2024 for deliveries in 2024 filing), and the timeline progression is accurately captured. The multi-hop reasoning is sound—the answer correctly synthesizes information from two different filing years (2023 and 2024) to show the evolution of the G700 from a pre-certification product to an actively delivered aircraft. Entity identification is correct (G700, Gulfstream, GD, FAA). The answer captures all key elements: (1) 2023 status as pending certification with early 2024 expected entry into service, (2) 2024 status showing actual Q2 deliveries, and (3) the business impact (inventory and customer deposit increases). The semantic meaning matches the ground truth perfectly—both answers convey the same progression from future product to realized deliveries. The LLM answer adds slightly more context by mentioning the impact on inventories and customer deposits, which enriches the response without introducing any inaccuracies. Minor: The LLM uses 'ultra-large-cabin' descriptor which adds helpful detail. No calculation errors, no date errors, no entity confusion. The answer directly addresses the evolution question with clear before/after comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 370,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\nFrom 2023 to 2024 the PMI‑KT&G tie‑up shifted from the 2020‑era exclusive global commercialization of KT&G’s smoke‑free products (outside South Korea) to a 15‑year renewal that adds performance‑based volume milestones, three‑year review cycles and continued worldwide exclusivity for all of KT&G’s heated‑tobacco and oral‑product pipelines.  The extension deepens PMI’s strategic dependency on KT&G for its next‑generation smoke‑free portfolio and expands commercialization into new markets and product launches, making KT&G a core pillar of PMI’s smoke‑free growth strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) INCORRECT TIMELINE: The LLM claims the agreement shifted 'from the 2020-era exclusive global commercialization' to a '15-year renewal,' but the ground truth clearly states the 2023 announcement was the initial long-term collaboration with a 15-year agreement through January 29, 2038. There is no evidence of a 2020-era agreement being renewed. (2) INCORRECT AGREEMENT TERMS: The LLM introduces 'performance-based volume milestones' and 'three-year review cycles' that are NOT mentioned in the ground truth. These appear to be fabricated details. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM describes the evolution as adding new terms and expanding scope, but the ground truth describes it as a shift from 'exclusive distribution' to 'inclusion within PMI's broader smoke-free product strategy' - a qualitative change in how the products are positioned, not a renewal with new performance metrics. (4) PRODUCT SCOPE CONFUSION: The LLM mentions 'heated-tobacco and oral-product pipelines' while the ground truth specifically references 'heat-not-burn products' and 'smoke-free devices and consumables.' (5) MISSING KEY DETAIL: The LLM fails to mention the specific geographic scope (worldwide excluding South Korea) and the specific end date (January 29, 2038). The core insight about evolution from exclusive distribution to integrated portfolio inclusion is present but overshadowed by incorrect framing about agreement renewal and fabricated performance metrics. The answer demonstrates partial understanding of strategic dependency but fundamentally misrepresents the nature and timing of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 472,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\nIn 2022 AMD’s semi‑custom SoCs were chiefly a gaming‑console/handheld revenue stream, driven by occasional design wins, engineering fees and a heavy reliance on third‑party IP and supply‑chain stability. By 2024 the company had repositioned those SoCs as a cross‑segment core that ties together its gaming, AI‑PC and data‑center portfolios, securing longer‑term wafer and ATMP capacity and co‑engineering with customers to embed the chips in a broader ecosystem of products.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AMD's evolution but contains significant semantic and strategic inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the shift in positioning; (2) Accurately notes the move from gaming-console/handheld focus to broader ecosystem integration; (3) Correctly mentions AI-PC and data-center integration; (4) Appropriately references supply chain/capacity planning evolution. WEAKNESSES: (1) The 2022 characterization is incomplete and somewhat misleading - the LLM emphasizes 'gaming-console/handheld revenue stream' and 'occasional design wins' but the ground truth emphasizes the broader risk profile around third-party dependency, lack of control over marketing, and revenue uncertainty. The LLM's framing is narrower and misses the strategic risk context; (2) The LLM introduces specific details ('longer-term wafer and ATMP capacity,' 'co-engineering with customers') that are not explicitly mentioned in the ground truth, which could be accurate but represents extrapolation beyond what was verified; (3) The LLM's 2024 characterization mentions 'gaming, AI-PC and data-center portfolios' but the ground truth specifically highlights NPU integration on x86 CPUs for AI PCs, gaming, cloud services, and embedded systems - the LLM omits the NPU detail and cloud services specificity; (4) The ground truth emphasizes a shift from 'dependency model to proactive, integrated product leadership strategy' - a more nuanced strategic positioning that the LLM's answer doesn't fully capture. The LLM focuses more on operational/supply chain aspects than strategic positioning. MULTI-HOP REASONING: The answer does synthesize information across 2022 and 2024 periods, but the synthesis is incomplete - it misses the strategic risk/dependency narrative that is central to the ground truth's explanation of the evolution. SEMANTIC EQUIVALENCE: While the LLM conveys general directional accuracy (evolution from narrow to broad), it misses critical nuances about strategic positioning and the nature of the transformation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 567,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\nThe 2023 filing states that Irish dividend withholding tax of 25 % applies to Medtronic dividends, but U.S. residents are exempt when they hold the shares through DTC with a U.S. address (or furnish a valid U.S. certification of residence/Form 6166), and the withholding payment then satisfies any Irish income‑tax liability. The 2024 filing does not introduce any new exemption criteria or change the 25 % rate, so the treatment of Irish income tax on dividends paid to U.S. residents remains the same—still subject to the 25 % withholding unless one of the stated exemptions is met.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH CORE ANSWER: The LLM answer fundamentally misrepresents the evolution between 2023 and 2024. The ground truth explicitly states there WAS an evolution/change in treatment, with 2024 providing 'more structured conditions for exemption and clarified post-withholding tax procedures.' The LLM incorrectly claims 'the treatment...remains the same' and 'does not introduce any new exemption criteria,' which directly contradicts the ground truth. QUANTITATIVE ACCURACY: The 25% withholding tax rate is correctly stated in both answers (7/10 - correct number but incomplete context). QUALITATIVE ACCURACY: Critical failures include: (1) The LLM states exemptions are based on 'DTC with U.S. address' and 'Form 6166' - these specific mechanisms are not mentioned in the ground truth, which instead references 'withholding tax exemption' and 'not holding shares through an Irish branch' as conditions; (2) The LLM misses the key 2024 clarification about 'furnishing a statement to Irish Revenue' to discharge liability; (3) The LLM fails to capture the distinction between 2023's general statement ('generally would not be subject') versus 2024's more specific conditions ('qualify for exemption and do not hold shares through Irish branch'); (4) The LLM incorrectly concludes no evolution occurred when the ground truth explicitly describes structural changes in how exemptions and post-withholding procedures are defined. MULTI-HOP REASONING: The answer fails to properly synthesize the year-over-year comparison that is central to the question. The question specifically asks 'how has...evolved' and the LLM's answer that nothing evolved is factually incorrect per the ground truth. CONTEXTUAL RELEVANCE: While the answer addresses Irish dividend withholding, it fundamentally misses the evolution aspect that is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 501,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\nIn 2023 General Dynamics’ Marine Systems segment grew revenue ≈ 13 % to $12.5 B, led by higher volume on the Columbia‑class submarine program, but operating margin slipped to 7.0 % as supply‑chain cost pressures slowed the Virginia‑class submarine schedule and added cost growth to the DDG‑51 destroyer (Arleigh Burke) program.  For 2024 the company projects Marine Systems revenue of about $12.8‑12.9 B with an operating margin of roughly 7.6 %, indicating continued revenue expansion from the Columbia‑class effort while cost pressures on the Virginia‑class and DDG‑51 remain but are expected to be partially offset by the stronger program mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key financial metrics and strategic trends. STRENGTHS: (1) All major numbers are accurate: 2023 Marine Systems revenue of $12.5B, 2024 projected revenue of $12.8-12.9B, 2024 operating margin of ~7.6% all match ground truth. (2) Correctly identifies the three main programs: Virginia-class, DDG-51, and Columbia-class. (3) Accurately captures the 2023 margin pressure narrative (supply chain disruptions, cost overruns) and 2024 improvement outlook. (4) Properly synthesizes multi-hop information across years and programs. (5) Contextually relevant to all aspects of the question. MINOR ISSUES: (1) The LLM states 2023 operating margin as 7.0%, while ground truth indicates a 110 basis point decline from prior year but doesn't explicitly state the 2023 margin was 7.0%. The ground truth says margin declined 110 bps but doesn't provide the absolute 2023 figure, making this a reasonable inference but not explicitly confirmed. (2) The LLM adds detail about '13% revenue growth' which is not mentioned in the ground truth, though this appears to be a reasonable calculation (from ~$11.1B implied prior year to $12.5B). This addition is not contradicted by ground truth but goes slightly beyond what was provided. (3) The phrase 'cost pressures...remain but are expected to be partially offset' is a reasonable interpretation of the shift from 2023 to 2024 but adds interpretive language not explicitly in ground truth. CALCULATION VERIFICATION: The 2024 margin improvement from 7.0% to 7.6% (60 basis points) is correctly identified as improvement. The revenue growth from $12.5B to $12.8-12.9B is correctly characterized as continued expansion. Overall, the answer demonstrates solid multi-hop reasoning across years and programs with accurate core facts, though with minor interpretive additions beyond the explicit ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 517,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\nBased on the filings, roughly 89 % of Booking Holdings’ total revenue in 2022 (page 5 of BKNG_10k_2022.pdf) and again about 89 % in 2023 (page 85 of BKNG_10k_2023.pdf) came from online accommodation‑reservation services— the segment dominated by Booking.com.  Consequently, the company’s financial dependency on Booking.com remained essentially unchanged, holding steady at roughly 89 % of revenue across the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: All factual information matches the ground truth. The LLM correctly identifies that Booking.com's accommodation reservations contributed 89% of BKNG's total revenues in both 2022 and 2023, with no change between the years. The conclusion that dependency 'remained essentially unchanged' is accurate and semantically equivalent to the ground truth statement. (2) QUANTITATIVE ACCURACY: The 89% figure is cited correctly for both years with proper sourcing (page references to the 10-K filings). The comparison showing no change (89% in both years) is mathematically accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM correctly synthesized information across two different 10-K filings (2022 and 2023) to compare the revenue dependency metrics. The identification of 'online accommodation-reservation services' as the segment dominated by Booking.com is accurate and contextually appropriate. The conclusion about 'sustained and concentrated dependency' is logically derived from the data. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about how financial dependency evolved between 2022 and 2023, properly framing the finding that there was no evolution (remained steady). The wording 'remained essentially unchanged' and 'holding steady' effectively conveys the ground truth's meaning. Minor note: The LLM uses slightly different phrasing ('remained essentially unchanged' vs. ground truth's 'remained unchanged') but this is a negligible semantic variation that actually adds nuance. The answer is complete, accurate, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 454,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the company’s Swiss‑franc‑denominated note fell from a $299 million balance (1.625 % interest, maturing in 2024) to $0 — the line is blank in the 2024 foreign‑currency‑obligations table.  This shows that the firm has fully retired that CHF note, eliminating a specific foreign‑currency liability and signaling a deliberate reduction of its foreign‑currency debt exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: The $299 million 2023 balance and $0 2024 balance are correct and match the ground truth exactly. The additional detail about the 1.625% interest rate and 2024 maturity date is accurate and adds valuable context. The answer correctly identifies the complete elimination of the Swiss Franc obligation. Multi-hop reasoning: The LLM successfully synthesized information across two fiscal years (2023 and 2024) and correctly identified the evolution of the foreign currency obligation. The reasoning that the company 'fully retired' the CHF note is sound and supported by the data. Entity accuracy: All entities are correct - the Swiss Franc note, the specific dollar amounts, and the time period are all properly identified. Semantic equivalence: The LLM answer conveys the same core information as the ground truth ('completely removed' = 'fell from $299 million to $0' = 'fully retired'). The LLM's interpretation that this represents a 'deliberate reduction of foreign-currency debt exposure' is a logical inference that aligns with the ground truth's characterization of a 'strategic shift in managing its Swiss Franc exposure.' Minor note: The LLM provides slightly more specific detail (interest rate, maturity date) than the ground truth, which enhances rather than detracts from the answer. The only minor consideration is that the LLM uses 'CHF note' terminology which is appropriate but not explicitly in the ground truth, though this is a standard abbreviation for Swiss Franc and adds clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 435,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\nIn the 2023 Form 10‑K Goldman Sachs listed only two director‑RSU templates – a standard “Non‑Employee Director RSU Award Agreement” and a cash‑settled variant (items 10.31‑10.32). The 2024 filing keeps those legacy forms but expands the disclosure by adding several new, more granular agreements (e.g., a fully‑vested one‑time/year‑end RSU award, a base / non‑fully‑vested “One‑Time/Year‑End RSU Award Agreement,” and a short‑term RSU agreement) while still referencing the pre‑2015 versions by incorporation, showing a refinement and broadening of the director RSU framework rather than a wholesale change.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT EXHIBIT NUMBERS: The LLM references items 10.31-10.32 for 2023 director RSU agreements, but the ground truth specifically identifies Exhibit 10.8 as the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' in 2023. The LLM provides no evidence these exhibit numbers are correct. (2) MISSING KEY INFORMATION: The LLM fails to mention Exhibit 10.18 'Amendments to Certain Non-Employee Director Equity Award Agreements' which was introduced in 2024 - this is the central new disclosure highlighted in the ground truth. (3) SPECULATIVE DETAILS: The LLM invents specific agreement types ('fully-vested one-time/year-end RSU award,' 'short-term RSU agreement') that are not mentioned in the ground truth and appear to be fabricated. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that 2024 expanded disclosures compared to 2023, it fails to accurately capture what was actually added (the amendments exhibit) and instead provides unverified claims about new agreement types. (5) STRUCTURAL MISALIGNMENT: The ground truth clearly states the evolution was: 2023 had pre-2015 RSU agreement → 2024 retained that AND added amendments exhibit. The LLM's narrative about 'legacy forms' and 'granular agreements' doesn't match this documented evolution. The answer demonstrates a fundamental failure to accurately synthesize the multi-hop information about what changed between filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 420,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\nBetween 2023 and 2024 the financial link to Swedish Match AB shifted from rapid debt‑financed growth to a deliberate deleveraging.  PMI’s 2022 acquisition was funded with a €5.5 bn senior unsecured term‑loan (a €3 bn 3‑year tranche and a €2.5 bn 5‑year tranche); by the end of 2023 the 3‑year tranche still had €2.5 bn outstanding, and in November 2024 PMI repaid essentially the whole €3 bn of that tranche using bond proceeds, leaving only the €2.5 bn 5‑year tranche (≈$2.6 bn) on the books.  At the same time, the goodwill recorded for Swedish Match fell from $10.877 bn (Dec 31 2023) to reflect a $2.57 bn measurement‑period adjustment and a $665 m impairment, underscoring that the acquisition’s value had been reassessed while the associated debt was being trimmed.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PM's financial relationship with Swedish Match AB and the deleveraging process between 2023 and 2024. STRENGTHS: (1) The core narrative is correct - debt obligations decreased significantly from 2023 to 2024, with the LLM providing more granular detail about the specific tranches (€3bn 3-year and €2.5bn 5-year). (2) The key numbers align with ground truth: the LLM states €2.5bn ≈ $2.6bn remaining, which matches the ground truth's 2024 figure of $2,610 million. (3) The LLM correctly identifies the November 2024 repayment of the €3bn tranche using bond proceeds, explaining the mechanism of deleveraging. (4) Additional context about goodwill adjustments ($10.877bn in Dec 2023, $2.57bn measurement-period adjustment, $665m impairment) is relevant and adds depth. (5) Multi-hop reasoning is sound - connecting debt reduction to acquisition financing to goodwill reassessment. MINOR ISSUES: (1) The ground truth states 2023 long-term debt was $6,121 million, but the LLM's breakdown (€2.5bn outstanding from €3bn tranche plus €2.5bn 5-year tranche) doesn't explicitly reconcile to this figure. The €5bn total (€2.5bn + €2.5bn) converts to approximately $5.4-5.5bn, which is less than $6,121 million, suggesting either other debt components existed or currency conversion timing differences. (2) The LLM doesn't explicitly state the 2023 figure of $6,121 million for comparison, though it implies the reduction through the narrative. (3) The answer provides more detail than the ground truth but doesn't directly cite the $6,121 million → $2,610 million comparison. VERIFICATION: The €2.5bn ≈ $2.6bn conversion is accurate (approximately 1.04 EUR/USD ratio). The narrative of debt reduction from 2023 to 2024 is correct. The answer successfully synthesizes information about acquisition financing, debt repayment, and goodwill adjustments across multiple time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 519,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\nFrom 2023 to early 2024 BMS moved from a largely exploratory KRAS‑inhibition program to a market‑ready, acquisition‑driven strategy.  The January 2024 purchase of Mirati (for $4.8 bn) gave BMS an FDA‑approved KRAS‑G12C inhibitor—Krazati—plus a pipeline of next‑generation KRAS‑targeting assets (e.g., the PRMT5 inhibitor MRTX1719) and the ability to test Krazati in combination with PD‑1 blockade for first‑line NSCLC.  Consequently, BMS’s KRAS‑inhibition effort shifted from early‑stage discovery to a fully integrated, clinically advanced portfolio that now includes a marketed second‑line NSCLC therapy and multiple late‑stage combination trials aimed at expanding KRAS‑targeted treatment across solid tumours.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) Acquisition amount ($4.8 billion) is correct and properly formatted; (2) Timing (January 2024) is accurate; (3) Krazati's FDA approval for second-line NSCLC is correctly stated; (4) First-line NSCLC combination development with PD-1 inhibitor is accurately mentioned. The answer effectively synthesizes the multi-hop information showing BMY's evolution from 2023 (pre-acquisition) to 2024 (post-acquisition). However, there is one notable omission: the LLM answer does not mention Krazati's FDA approval for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, which was explicitly stated in the ground truth as occurring in 2024 and representing an important expansion of the therapeutic footprint. The LLM does mention 'expanding KRAS-targeted treatment across solid tumours' in general terms, but lacks the specific colorectal cancer indication. The answer includes additional context about MRTX1719 (PRMT5 inhibitor) and the broader pipeline, which adds value but goes slightly beyond the ground truth scope. The reasoning is sound and the narrative effectively captures the strategic shift from exploratory to market-ready positioning. The omission of the colorectal cancer indication prevents a perfect score, as this was a material development in 2024 that directly answers the question about Krazati's development trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 401,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\nBetween 2023 and 2024 the disclosure shifted from a simple historical footnote to the Restricted Partner Compensation Plan (first referenced as an exhibit from 2006) to a explicit linkage with the firm’s newer governance regime.  The 2024 filing incorporates the **Amended and Restated Clawback Policy (effective Dec 1 2023)** and places the restricted‑partner plan within the updated 2021 Stock‑Incentive/Permitted Compensation framework, signaling that the plan is now presented as part of a broader, risk‑aware compensation governance structure that includes the newer clawback and performance‑based rules.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The identification of the Clawback Policy as a new 2024 disclosure is accurate and matches the ground truth. (2) The general concept that the plan's positioning shifted to emphasize governance and risk mitigation is directionally correct. (3) The mention of the Amended and Restated Clawback Policy with effective date Dec 1, 2023 appears factually sound. SIGNIFICANT ERRORS: (1) The LLM states the Restricted Partner Compensation Plan was 'first referenced as an exhibit from 2006' - this historical claim is not verified in the ground truth and appears to be an unsupported assertion. (2) The LLM claims the plan is 'placed within the updated 2021 Stock-Incentive/Permitted Compensation framework' - the ground truth makes no mention of a 2021 framework or this specific linkage. This appears to be fabricated detail. (3) The LLM's description of the shift is less precise than ground truth: it mentions 'simple historical footnote' which contradicts the ground truth's statement that the plan was 'listed as Exhibit 10.3' and 'appeared early in the exhibit list' in 2023 - these are formal exhibit placements, not footnotes. (4) The ground truth specifically notes the exhibit number changed from 10.3 (2023) to 10.4 (2024), but the LLM does not capture this specific detail. MULTI-HOP REASONING: The LLM attempts to synthesize the relationship between the Clawback Policy and the Restricted Partner Compensation Plan, which is appropriate for the question. However, the synthesis includes unsupported claims about a 2021 framework that cannot be verified. The core insight about repositioning for governance is present but undermined by inaccurate supporting details. QUANTITATIVE ACCURACY: The date 'Dec 1 2023' for the Clawback Policy effective date is specific but unverified against ground truth. The exhibit numbers (10.3 vs 10.4) are not mentioned by the LLM, which is an omission. The reference to 2006 is unsubstantiated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 543,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\nFrom 2022 to 2023 PMI re‑classified heat‑not‑burn from a broad “reduced‑risk product” into its own sub‑segment of **smoke‑free products**, reporting it separately in the product‑category financial tables (see 2023 pages 39‑40).  The 2023 disclosures also added licensed KT&G heated‑tobacco units to the portfolio and incorporated HTU shipment volumes into regional segment results, showing a tighter integration of heat‑not‑burn into the company’s go‑to‑market and reporting structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of PMI's heat-not-burn product categorization from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key reclassification from 'Reduced-Risk Products' (RRPs) to 'smoke-free products' as a distinct sub-segment; (2) Accurately notes the addition of licensed KT&G heat-not-burn products to the portfolio in 2023; (3) Properly synthesizes the multi-hop information showing both product categorization changes and business integration improvements (reporting structure, regional segment results, go-to-market integration); (4) Appropriately references specific document pages (2023 pages 39-40) showing attention to source documentation; (5) Correctly identifies specific product examples (HTUs, IQOS Platform 1 implied through context). MINOR WEAKNESSES: (1) The answer does not explicitly mention IQOS Platform 1 device or specific product names like HEETS and Marlboro HeatSticks that were highlighted in the ground truth as part of the 2022 positioning; (2) Does not explicitly state that RRPs were the 2022 categorization framework (though this is implied through the reclassification statement); (3) Slightly less comprehensive in describing the 2022 baseline positioning (smoke-free future strategy, long-term replacement of traditional cigarettes). QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is not directly testable. The page references (2023 pages 39-40) appear reasonable for financial reporting sections. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: product categorization changes, portfolio expansion (KT&G licensing), and business integration (reporting structure, regional segments). The logical flow from reclassification to integration is sound. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - PMI evolved its heat-not-burn categorization and expanded the product line with licensed offerings while improving business integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 554,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\nBetween 2023 and 2024 BMS moved the business‑risk and disclosure group from a newly created remedial measure under the 2004 SEC Consent Order to a fully institutionalized governance function.  The 2024 filing notes that the group now operates as part of a formal review‑and‑certification process for all SEC reports, continuously monitors the company‑wide policy that limits sales to direct customers (including inventory‑based compliance checks), and escalates any compliance questions to senior management and the board—evolving the group from an ad‑hoc oversight unit into a standing, integrated component of BMS’s risk‑management and disclosure framework.  (Pages 61, 63‑64, 2023 10‑K; 63‑64, 2024 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of the business risk and disclosure group from a remedial measure (2023) to an institutionalized governance function (2024); (2) Accurately captures the key components: formal review-and-certification process, policy monitoring (sales to direct customers with inventory-based compliance checks), and escalation to senior management and board; (3) Properly synthesizes multi-hop information showing the progression and integration of the group into BMS's risk management framework; (4) Correctly cites the 2004 SEC Consent Order context; (5) Provides specific page references (61, 63-64 for 2023 10-K; 63-64 for 2024 10-K) that support the claims; (6) Uses appropriate terminology ('remedial measure,' 'institutionalized,' 'standing, integrated component'). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (e.g., mentioning 'inventory-based compliance checks' and the specific policy limiting sales to direct customers), but these details appear to be accurate elaborations rather than errors. The ground truth states 'no indication of modifications or reductions in scope,' while the LLM characterizes this as an evolution from 'ad-hoc oversight unit' to 'standing, integrated component'—this is a reasonable interpretation of the same underlying fact pattern. No quantitative errors detected. The answer fully addresses the question's focus on how the approach evolved between 2023 and 2024 regarding SEC Consent Order compliance and the role of the business risk and disclosure group.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 458,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\nBetween 2023 and 2024 UNP’s pension plan completed its de‑risking shift, moving from a higher‑equity mix to a target of roughly 25 % equity and 75 % debt (the “20‑30 % equity / 70‑80 % debt” ranges remain the same in 2024). The plan now ties its long‑term expected return of 5.25 % to this more debt‑heavy allocation, maintaining the same target ranges while signaling that the expected‑return assumption is anchored to the stabilized asset‑allocation mix achieved by the end of 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and addresses a different aspect of UNP's pension plan than what the question asks. CRITICAL ISSUES: (1) The question asks about the TREATMENT/EXPLANATION of the relationship between expected return and asset allocation - specifically how the disclosure language evolved. The LLM instead focuses on the actual de-risking shift and asset allocation percentages (25% equity/75% debt), which is not what was asked. (2) The LLM introduces specific numbers (5.25% expected return, 20-30% equity/70-80% debt ranges) that are not mentioned in the ground truth answer and cannot be verified against it. (3) The ground truth clearly states the key evolution: 2023 had explicit mention of historical returns and market conditions PLUS a 6% actual return disclosure, while 2024 shifted to only mentioning asset allocation mix with NO mention of historical returns, market conditions, or actual return. The LLM completely misses this linguistic/disclosure shift. (4) The LLM's claim about 'de-risking shift' and 'stabilized asset-allocation mix achieved by end of 2023' is not addressed in the ground truth answer at all. (5) The LLM does not address the key finding that 2024 had 'no disclosure of the actual return for 2024' - a critical difference from 2023. The answer demonstrates a fundamental misunderstanding of what the question is asking (disclosure treatment evolution vs. actual asset allocation changes) and fails to capture the core insight about the narrowing of explanatory factors in the pension plan disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 427,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon shifted the way it presents its Directors’ Code of Conduct from a stand‑alone ethics paragraph that merely linked to a PDF (Item 10 of the 2022 filing) to a clearly integrated governance element. In the 2023 Form 10‑K the Code is listed alongside the Corporate Governance Guidelines, By‑laws and committee charters under “Available Information,” and the filing explicitly notes that any amendments or waivers will be posted on the company’s website. This change makes the Directors’ Code more readily accessible and embeds it within the corporate‑governance disclosure rather than treating it as an ancillary ethics statement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in BNY Mellon's disclosure approach between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from a stand-alone reference to integrated governance disclosure; (2) Accurately notes the 2023 placement alongside Corporate Governance Guidelines, By-laws, and committee charters under 'Available Information'; (3) Properly captures the enhanced accessibility and structural integration; (4) Correctly identifies the addition of language about amendments/waivers being posted on the website; (5) Uses appropriate terminology ('ancillary ethics statement' vs. integrated governance element). MINOR WEAKNESSES: (1) The LLM specifies 'Item 10 of the 2022 filing' which is a specific structural detail not explicitly confirmed in the ground truth, though this is a reasonable inference about where such disclosures typically appear; (2) The ground truth emphasizes the Code being 'specifically listed among governance materials' while the LLM says it's listed 'alongside' these materials - semantically equivalent but slightly different framing; (3) The ground truth mentions 'Board Meetings and Committee Information' context in 2022, which the LLM doesn't reference, though this is a minor contextual detail. MULTI-HOP REASONING: The answer successfully synthesizes the comparison across two years and correctly identifies the evolution in presentation and integration. The logic connecting accessibility improvements to structural placement is sound. QUANTITATIVE ACCURACY: No specific numbers or dates are disputed; years (2022, 2023) are correct. Overall, this is a well-reasoned answer that captures the essential evolution with only minor omissions of contextual details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 481,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Oracle broadened the deployment flexibility of Oracle Database — it is now offered as the self‑driving Autonomous Database on OCI with consumption‑based pricing and can be run on‑premise or in a hybrid mode through new options such as Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud, and the partner‑focused Alloy and Roving Edge services — while deepening its integration with engineered systems like the Exadata Database Machine, which is available across all three deployment models.  This evolution shows that Oracle is positioning the database as a portable, automated engine that can be moved gradually into the Oracle Cloud without forcing a full lift‑and‑shift, underscoring a hybrid‑and‑multi‑cloud strategy that preserves existing on‑prem investments while accelerating cloud migration.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key strategic elements and deployment options. STRENGTHS: (1) Correctly identifies the evolution from flexible deployment models (2023) to deeper integration with engineered systems (2024); (2) Accurately names specific offerings: Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud, Alloy, Roving Edge Infrastructure, and Exadata Database Machine; (3) Properly synthesizes the multi-hop concept that Oracle shifted from standalone database flexibility to integrated engineered systems; (4) Correctly interprets the strategic implication regarding hybrid/multi-cloud positioning and gradual cloud migration without forced lift-and-shift; (5) Accurately characterizes the Autonomous Database with consumption-based pricing and self-driving capabilities. MINOR WEAKNESSES: (1) The LLM answer introduces 'OCI Dedicated Region' and 'Sovereign Cloud' as 2024 additions, which are mentioned but the ground truth doesn't explicitly frame these as new 2024 offerings in the same way; (2) The answer emphasizes 'self-driving Autonomous Database' more prominently than the ground truth, which focuses more on the engineered systems integration; (3) The ground truth emphasizes the 'holistic, performance-optimized solutions' and 'comprehensive, high-performance infrastructure packages' aspect more explicitly, while the LLM focuses on portability and gradual migration. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension is not directly testable. The temporal framing (2023 vs 2024) is correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across the strategic evolution, deployment models, and business implications. The reasoning about gradual cloud migration and hybrid preservation is sound and well-articulated. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - Oracle evolved from flexible deployment options to integrated engineered systems as part of a mature cloud migration strategy. The LLM's characterization of 'portable, automated engine' and 'hybrid-and-multi-cloud strategy' captures the essence of the ground truth's 'holistic, performance-optimized solutions' concept.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 609,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\nThe formal review and certification of BMY’s annual and quarterly SEC reports, mandated by the 2004 Consent, was deepened between 2023 and 2024.  In 2023 the company had a company‑wide sales‑policy and a governance process for escalating compliance questions, but by 2024 it added a dedicated business‑risk and disclosure group, retained an outside consultant to continuously re‑engineer its reporting controls, and required more rigorous documentation of budgeting and sales‑incentive disclosures—thereby strengthening monitoring and oversight of the certification process.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) ENTITY MISMATCH - The LLM answer references 'BMY' (Bristol Myers Squibb) and a '2004 Consent,' but the ground truth does not specify which company or consent agreement is being discussed. The LLM has introduced a specific company identifier and date that cannot be verified against the ground truth. (2) FACTUAL DISCREPANCIES - The ground truth states the formal process was 'established' in 2023 as part of 'the Consent agreement' (unspecified year), while the LLM claims it was 'mandated by the 2004 Consent.' This is a significant factual error regarding the timeline and origin of the requirement. (3) UNSUPPORTED DETAILS - The LLM answer introduces specific claims not present in the ground truth: 'dedicated business-risk and disclosure group,' 'retained an outside consultant to continuously re-engineer its reporting controls,' and 'more rigorous documentation of budgeting and sales-incentive disclosures.' These details cannot be verified against the provided ground truth and may represent hallucination or information from a different source. (4) PARTIAL ALIGNMENT - The LLM correctly identifies that there was evolution from 2023 to 2024, and mentions governance processes and compliance monitoring, which aligns with the ground truth's core themes. However, the specific mechanisms described differ significantly. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the information as presented in the ground truth, instead introducing external details that contradict or extend beyond the source material. The ground truth emphasizes integration into 'company-wide sales policies' and 'inventory and sales limitations,' while the LLM focuses on different control mechanisms. CONCLUSION: While the LLM captures the general evolution theme, it introduces factual errors (wrong company/consent date), unsupported details, and fails to accurately reflect the specific governance procedures and compliance monitoring mechanisms described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 541,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\nFrom 2022 to 2023 Philip Morris International treated heat‑not‑burn (HNB) as a mature, revenue‑generating pillar of its reduced‑risk portfolio rather than an experimental side‑project.  The company reported a 14.7 % increase in heated‑tobacco‑unit shipments and $3.5 bn of HNB revenue in 2023, and it now groups HNB under the “smoke‑free products excluding Wellness and Healthcare” line (alongside licensed KT&G brands), positioning it as a distinct growth segment within its broader smoke‑free offering.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that cannot be verified against the ground truth and introduces specific quantitative claims not present in the original answer. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims '14.7% increase in heated-tobacco-unit shipments' and '$3.5 bn of HNB revenue in 2023' - these specific numbers are not mentioned in the ground truth and cannot be verified. The ground truth does not provide these revenue figures or growth percentages. (2) CATEGORIZATION DISCREPANCY: The LLM states HNB is grouped under 'smoke-free products excluding Wellness and Healthcare' - the ground truth simply states it was 'explicitly included heat-not-burn products within the smoke-free product segment' without this specific exclusionary language. (3) PARTIAL ACCURACY: The LLM correctly identifies that PMI included licensed KT&G heat-not-burn products, which matches the ground truth. (4) MISSING CONTEXT: The LLM fails to address the evolution from 'Reduced-Risk Products (RRPs)' framing in 2022 to the 2023 categorization, which is central to the ground truth's narrative about strategic positioning shift. (5) TONE MISALIGNMENT: The LLM characterizes HNB as 'mature, revenue-generating' in 2022, while the ground truth indicates products were 'in various stages of development, scientific assessment, and commercialization' - a significant semantic difference. The answer provides specific financial metrics that appear fabricated or sourced from outside the provided ground truth, which is a critical failure in multi-hop reasoning evaluation. The core evolution narrative is partially captured but undermined by unverifiable quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 459,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle broadened the ways customers can run its flagship database, making Oracle Database available not only as a perpetual on‑premise license but also as a native service on Oracle Cloud Infrastructure (OCI) and through hybrid‑cloud options such as Exadata Cloud@Customer and OCI Dedicated Region.  The company further reinforced this flexibility with the launch of **Oracle Autonomous Database**, which automates provisioning, scaling, patching and security and is tightly integrated with other Oracle Cloud services—including Java Cloud, Oracle APEX, MySQL HeatWave and the broader Oracle Middleware stack—so that databases can be deployed, managed and scaled as part of a unified, cloud‑first architecture.  This evolution reflects Oracle’s strategy of delivering the database with far greater deployment choice and deeper, end‑to‑end integration across its cloud, engineered‑system and middleware offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate information about Oracle Database deployment flexibility and integration, but introduces content not present in the ground truth while omitting key elements. STRENGTHS: (1) Correctly identifies deployment flexibility across on-premise, OCI, and hybrid cloud options (Exadata Cloud@Customer, OCI Dedicated Region) - this aligns with ground truth emphasis on deployment choice; (2) Accurately describes Oracle Autonomous Database features (provisioning, scaling, patching, security automation); (3) Correctly identifies integration with other Oracle technologies (Java Cloud, Oracle APEX, MySQL HeatWave, middleware stack); (4) Properly characterizes the evolution toward cloud-first architecture and unified integration. WEAKNESSES: (1) The ground truth specifically emphasizes Oracle Exadata Database Machine as the key engineered system integration point, highlighting integration with storage, operating system software, and hardware components. The LLM mentions Exadata Cloud@Customer but doesn't emphasize the on-premise Exadata Database Machine as the primary engineered systems integration story; (2) The LLM introduces Oracle Autonomous Database as a major strategic evolution point, but the ground truth doesn't mention Autonomous Database specifically - it focuses on Exadata as the engineered systems integration vehicle; (3) The ground truth emphasizes the perpetual licensing model in 2023 as a key strategic element, which the LLM mentions but doesn't emphasize equally; (4) The ground truth's core insight about the shift from standalone product to 'core element of Oracle Engineered Systems' is partially captured but not as clearly articulated. MULTI-HOP REASONING: The LLM correctly synthesizes information about deployment flexibility and integration across multiple Oracle technologies, but the synthesis emphasizes different products (Autonomous Database) than the ground truth (Exadata Database Machine). Both answers address the 2023-2024 evolution, but with different focal points. The LLM's answer is not factually wrong but represents a different interpretation of Oracle's strategic positioning emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 579,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\nBetween 2023 and 2024 BMS moved Krazati from a partner‑licensed asset (held by Mirati) to a fully owned product after acquiring Mirati in January 2024, thereby gaining worldwide commercial rights and a related oncology pipeline. The deal required a $4.1 bn net cash outlay, created a $1 bn contingent value right contingent on FDA acceptance of the PRMT5‑inhibitor NDA, and resulted in the capitalization of $640 m of definite‑lived product‑rights and $3.5 bn of indefinite‑lived IPRD—financial commitments that reflect the deepening strategic integration of Krazati into BMS’s portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides a $4.1 billion net cash outlay figure, but the ground truth clearly states the acquisition price was $4.8 billion. This is a significant discrepancy ($700 million difference) that cannot be attributed to formatting variations. The LLM also introduces specific balance sheet items ($640M definite-lived product rights and $3.5B indefinite-lived IPRD) that are not mentioned in the ground truth, making it impossible to verify their accuracy against the source material. CORRECT ELEMENTS: The LLM correctly identifies (1) the January 2024 acquisition of Mirati, (2) the $1.0 billion contingent value right tied to PRMT5 Inhibitor development, (3) the transition from partner-licensed to fully owned asset, and (4) the regulatory approvals for second-line NSCLC. MULTI-HOP REASONING: The answer demonstrates sound reasoning about the evolution from 2023 to 2024, correctly synthesizing the relationship change and financial commitments. However, the fundamental acquisition price error undermines the credibility of the financial analysis. COMPLETENESS: The answer addresses both parts of the question (evolution and financial commitments) but introduces unverified accounting details that go beyond the ground truth. The core narrative about strategic integration is appropriate but marred by the quantitative inaccuracy on the primary deal value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 389,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV appear in the same “Securities Registered Pursuant to Section 12(b)” table, are still listed under the ticker BK/P, and continue to be “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation.” No redemption, conversion, amendment or other change in their terms is disclosed in the comparative excerpts, indicating that their legal status and outstanding nature remained unchanged from 2022 through 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about the evolution of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities between 2022 and 2023. STRENGTHS: (1) All key facts are correct - the securities are accurately identified with the exact percentage rate (6.244%), the correct issuer (Mellon Capital IV), the correct ticker symbol (BK/P), the correct exchange (NYSE), and the correct guarantee structure (fully and unconditionally guaranteed by The Bank of New York Mellon Corporation). (2) The registration status under Section 12(b) is correctly stated for both years. (3) The core conclusion that there was no change in treatment or status between 2022 and 2023 is accurate and properly supported. (4) The multi-hop synthesis is sound - the answer correctly compares the securities' status across two different fiscal years and identifies the consistency. (5) The reasoning is logical and well-structured, noting the absence of any disclosed changes in terms, redemption, conversion, or amendments. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'appear in the same table' vs. 'were introduced/remained registered') but this represents semantic equivalence rather than factual error. The LLM's approach of explicitly noting the absence of disclosed changes is actually a more thorough analytical approach. No quantitative errors, calculation errors, or entity misidentifications are present. The answer fully addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 429,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\nBetween 2022 and 2023 the total short‑term credit capacity that PMI has available grew from roughly **$1.9 billion to about $2.7 billion**, while the amount actually borrowed under those facilities slipped only slightly from **$295 million to $283 million**.  The combination of a larger credit line and a modest decline in borrowings signals that PMI’s near‑term liquidity position is stronger and that it is relying less on short‑term financing to meet working‑capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: capacity increased from $1.9 billion to $2.7 billion (exact match), utilization decreased from $295 million to $283 million (exact match). The number formatting variations are acceptable and consistent with standard financial reporting conventions. The multi-hop reasoning is sound - the model correctly synthesized the two separate data points (capacity and utilization) and drew the appropriate logical conclusion about PMI's improved liquidity posture. The interpretation that 'PMI has expanded its available liquidity buffer without increasing its drawdown' and that this 'signals a stronger near-term liquidity position' and 'relying less on short-term financing' is semantically equivalent to the ground truth and demonstrates proper understanding of what these metrics indicate. The answer addresses all components of the question: (1) capacity change, (2) utilization change, and (3) what this shift suggests about liquidity posture. The only minor distinction is that the LLM uses slightly different phrasing ('stronger and relying less' vs. 'more conservative approach') but both convey the same fundamental insight. The answer is well-structured, clear, and appropriately emphasizes the key metrics with bold formatting for clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 377,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle has moved the Autonomous Database from a stand‑alone, self‑driving database to a core engine of its next‑generation cloud platform.  The 2024 filing stresses that the database is now tightly integrated with a broader set of OCI services—including Java Cloud, Oracle APEX low‑code, Analytics Cloud, MySQL HeatWave and AI/ML offerings—via open interfaces that let developers build cloud‑native applications, while its automation has been expanded to cover automatic scaling, patching, security‑threat detection and remediation, and consumption‑based pricing.  This evolution positions the Autonomous Database as an end‑to‑end, fully automated database service that spans OCI compute, storage, networking and emerging AI capabilities, and can be deployed flexibly across shared OCI, dedicated regions, Exadata Cloud@Customer and sovereign‑cloud environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent alignment to the ground truth on key positioning evolution points. STRENGTHS: (1) Correctly identifies the shift from 2023 to 2024 positioning; (2) Accurately lists integrated services (Java Cloud, Oracle APEX, Analytics Cloud, MySQL HeatWave, AI/ML) - all mentioned in ground truth; (3) Properly emphasizes open interfaces and machine learning automation; (4) Correctly identifies expanded automation capabilities (scaling, patching, security-threat detection); (5) Adds valuable context about deployment flexibility (shared OCI, dedicated regions, Exadata Cloud@Customer, sovereign-cloud) that aligns with 2024 positioning; (6) No quantitative errors or incorrect numbers/dates. MINOR GAPS: (1) The ground truth specifically mentions 'diagnostics' and 'fault prediction' as ML-powered automation capabilities, while LLM answer focuses more on operational automation (scaling, patching, threat detection) without explicitly calling out diagnostics/fault prediction; (2) Ground truth emphasizes 'data lake houses and real-time analysis of transactional data' as part of 2024 positioning, which the LLM answer doesn't explicitly mention (though Analytics Cloud reference partially covers this); (3) The characterization of 2023 positioning as 'stand-alone, self-driving database' is slightly more interpretive than the ground truth's description, though not inaccurate. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two fiscal years and correctly identifies the integration points and capability expansions. The logical flow from 2023 to 2024 is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential information about positioning evolution with appropriate emphasis on integration and automation, matching the ground truth's core message despite some wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 508,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 GM trimmed its direct financial stake in Ultium Cells Holdings LLC: the committed capital contribution that had been $1.4 billion in 2022 fell to $0.8 billion by Dec 31 2023, and in 2024 the company recorded only about $0.5 billion of new equity investment (a $0.7 billion cash outflow in the cash‑flow schedule), whereas it had invested $0.8 billion in 2022.  This reduction lowered GM’s maximum loss exposure tied to the joint venture and signaled a strategic pull‑back, positioning Ultium Cells as a more passive partnership rather than a core capital‑intensive investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of GM's financial relationship with Ultium Cells Holdings LLC. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a $1.4 billion committed contribution in 2022 and $0.8 billion by Dec 31 2023, but the ground truth states the committed contribution was $0.8 billion in 2023. The LLM then claims $0.5 billion of new equity investment in 2024 with a $0.7 billion cash outflow, but the ground truth indicates a $0.7 billion direct investment in 2024. The numbers are inconsistent with the ground truth and appear to conflate different metrics. (2) DIRECTIONAL ERROR: The ground truth describes an EVOLUTION from contingent capital commitments ($0.8B committed in 2023) to a realized direct investment ($0.7B in 2024), representing a shift toward more concrete involvement. The LLM incorrectly characterizes this as a 'pull-back' and 'reduction,' suggesting GM was decreasing its stake when the ground truth indicates a transition from contingent to realized investment. (3) CLASSIFICATION ERROR: The ground truth emphasizes GM's classification of Ultium Cells as a VIE where GM lacked voting control in 2023, and the 2024 shift suggests potential for greater influence. The LLM misses this critical VIE classification and voting control dimension entirely. (4) SEMANTIC MISALIGNMENT: The ground truth describes a 'strategic realignment' providing 'potentially greater influence,' while the LLM describes a 'strategic pull-back' and 'more passive partnership.' These are opposite interpretations. (5) INCOMPLETE SYNTHESIS: The LLM fails to address the multi-hop reasoning required: the relationship between contingent commitments, VIE status, voting control, and how these evolved between 2023-2024. The answer demonstrates fundamental misunderstanding of the nature of the financial relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 508,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\nBetween the sixth‑anniversary release on June 21 2022 and the eighth‑anniversary release on June 21 2024, the Litigation Management Deed’s “anniversary releases” saw the as‑converted value released decline from **$3.5 billion** to **$2.7 billion**, and the number of series A preferred shares issued fell from **176,655** to **99,264** (with cash payments of $3 million and $5 million, respectively, to cover fractional shares). This reduction reflects a smaller release of protection under the Europe retrospective responsibility plan in the later year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $3.5 billion (2022) vs $2.7 billion (2024) for as-converted value released, and 176,655 vs 99,264 shares issued. The dates (June 21, 2022 for sixth anniversary and June 21, 2024 for eighth anniversary) are accurate. The additional detail about cash payments ($3 million and $5 million for fractional shares) is correct and adds useful context not explicitly in the ground truth but consistent with typical SEC filing disclosures. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two different anniversary release events (2022 and 2024), properly identifying the progression and calculating the decline in both metrics. ENTITY ACCURACY: Correctly identifies Visa, the Litigation Management Deed, series A preferred stock, and the VE territory context. REASONING QUALITY: The conclusion that this reflects 'a smaller release of protection under the Europe retrospective responsibility plan' is a reasonable interpretation, though the ground truth uses slightly different phrasing ('reduction in the financial burden associated with the VE territory covered litigation'). Both convey the same essential meaning. MINOR DIFFERENCES: The LLM provides slightly more specific context about the cash payments for fractional shares, which is an enhancement rather than an error. The phrasing 'Europe retrospective responsibility plan' is a reasonable characterization of the underlying mechanism, though the ground truth doesn't explicitly use this term. Overall, the answer is factually accurate, complete, and demonstrates sound multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 461,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the Aearo entities moved from a voluntary Chapter 11 restructuring (July 2022–June 2023) to full re‑consolidation after the bankruptcy dismissal in June 2023, while 3M executed the $6 bn CAE Settlement (initial $10 m administrative payment, $147 m for bellwether releases, $250 m in Dec 2023 and $253 m in Jan 2024). The settlement triggered a $4.2 bn pre‑tax charge in 2023 that was recorded as a corporate special item and reduced the Safety & Industrial segment’s operating income; by 2024 the charge is largely settled, the special‑item cost has fallen, and the Aearo businesses are now reported as part of the re‑combined Safety & Industrial results, with segment margins adjusted for the residual PFAS‑exit costs and the Solventum spin‑off.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$6 bn CAE Settlement' with specific payment breakdowns ($10m administrative, $147m bellwether, $250m Dec 2023, $253m Jan 2024) and a '$4.2 bn pre-tax charge in 2023' - none of these specific numbers appear in the ground truth, which only mentions 'CAE Settlement' without quantifying the total amount or payment schedule. These appear to be fabricated or incorrectly sourced numbers. (2) SEGMENT ATTRIBUTION ERROR: The LLM states the charge 'reduced the Safety & Industrial segment's operating income' and that 'Aearo businesses are now reported as part of the re-combined Safety & Industrial results' - the ground truth explicitly states the charge was 'recorded as a corporate special item' and references the 'Transportation and Electronics segment,' not Safety & Industrial. This is a fundamental entity/segment misidentification. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: While the LLM correctly identifies the June 2023 reconsolidation and CAE Settlement, it adds unverified financial details and misattributes segment impacts. (4) MULTI-HOP REASONING: The LLM attempts to synthesize the evolution from 2023 to 2024 but does so with incorrect segment assignments and unsupported numbers. (5) CORRECT ELEMENTS: The LLM does correctly identify the bankruptcy dismissal timing (June 2023), the reconsolidation event, and the general shift from litigation to financial treatment. However, the specific financial figures and segment attributions are materially incorrect, making this answer unreliable for decision-making purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 464,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the **Class C common stock kept its limited‑voting profile** (no voting rights except for a few defined matters) and remained convertible only through the indirect mechanisms that affect the broader capital structure (e.g., conversion‑rate adjustments tied to litigation releases and the exchange of Class B‑1 shares for Class C).  However, the **earnings‑per‑share performance of Class C improved markedly**, rising from **$28.00 (basic) / $28.00 (diluted) in 2022** to **$33.13 / $33.17 in 2023** and then to **$38.92 / $38.97 in 2024**, outpacing the growth of Class A’s EPS over the same periods.  This EPS acceleration reflects the allocation of a growing share of net income to Class C in the company’s as‑converted earnings‑per‑share calculations, while the total as‑converted share count remained relatively stable due to modest conversion‑rate adjustments and share‑repurchase activity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamentally incorrect EPS figures that directly contradict the ground truth. Ground truth states Class C had $33.17 basic EPS and $33.13 diluted EPS in 2024, but the LLM claims $38.92 basic and $38.97 diluted in 2024—a discrepancy of approximately $5.75-$5.80 per share (17% overstatement). The LLM also invents 2023 figures ($33.13/$33.17) that are not mentioned in the ground truth and appear to be confused with the actual 2024 figures. For Class A, the ground truth specifies $8.29 basic and $8.28 diluted EPS in 2024, but the LLM does not provide Class A 2024 figures for comparison, making it impossible to verify the claimed 'outpacing' assertion. The LLM's claim of 2022 Class C EPS at $28.00 cannot be verified against the ground truth, which does not provide 2022 EPS data. The qualitative discussion of governance (limited voting rights, convertibility mechanisms) adds detail not in the ground truth but does not contradict it. However, the core quantitative claims—which are the most verifiable and important aspects of the answer—are materially incorrect. The multi-hop reasoning about the relationship between stock classes and EPS performance is undermined by these numerical errors. The answer demonstrates some understanding of the structural elements but fails on the primary metric of factual accuracy for the specific financial figures that form the crux of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 400,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved ADAS/AD from an internal R&D focus to a commercialized revenue stream within its automotive segment—its financial tables now list a dedicated “Automotive (2)” line that explicitly includes ADAS/AD and show that automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024.  The company also began reporting ADAS/AD‑related sales‑based royalties and included ADAS/AD in its performance‑obligation disclosures, signaling that development and commercialization activities have shifted to market‑driven licensing and product sales.  This evolution reflects Qualcomm’s expanded R&D investment and strategic positioning of ADAS/AD as a distinct growth driver alongside handsets and IoT.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from development/investment phase in fiscal 2022 to commercialization by fiscal 2024, matching the ground truth narrative. The answer appropriately mentions the shift from R&D focus to revenue-generating product line, QSI/Qualcomm Ventures involvement, and the inclusion of ADAS/AD in automotive revenue categorization. The reasoning about sales-based royalties and performance-obligation disclosures demonstrates sound multi-hop synthesis. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($1.5B in 2022 to $2.9B in 2024) that cannot be verified against the ground truth provided. The ground truth does not include these specific numbers, and the LLM appears to have fabricated or hallucinated these figures. This is a serious factual error. (2) UNVERIFIED CLAIMS - The reference to 'Automotive (2)' line item and specific sales-based royalties disclosures are not confirmed in the ground truth. While plausible, these details go beyond what can be verified. (3) INCOMPLETE GROUNDING - The answer adds specificity that may be accurate but cannot be validated against the provided ground truth, creating uncertainty about factual accuracy. The ground truth focuses on the transition from investment to commercialization and revenue categorization changes, which the LLM captures well qualitatively, but the quantitative additions undermine confidence in the overall response. The semantic understanding of the evolution is sound, but the introduction of unverified numbers significantly reduces the reliability of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 446,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa has tightened the mechanics of its U.S. Retrospective Responsibility Plan by (1) significantly expanding the U.S. litigation escrow account (deposits rose to $1.5 billion in 2024 and the balance reached $3.1 billion) and by amending the loss‑sharing and omnibus agreements to expressly include post‑2015 opt‑out MDL‑1720 cases, thereby allocating any settlement or judgment on a ≈ 66.7 % Visa / 33.3 % Mastercard split; and (2) reinforcing the conversion‑feature of its class B‑stock and the makewhole reimbursement obligations, which dilute the B‑stock conversion rate whenever escrow funds are added, shifting any shortfall onto participating members.  This evolution shows Visa is moving from a primarily internal reserve‑based approach to a contractual, member‑shared liability model that externalizes litigation risk and makes the company’s exposure contingent on the financial strength of its network participants.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific dollar amounts ($1.5 billion in deposits, $3.1 billion balance) and a precise liability split (66.7% Visa / 33.3% Mastercard) that are NOT present in the ground truth. These appear to be fabricated numbers not supported by the original answer. The ground truth makes no mention of specific dollar amounts or percentage splits. (2) ENTITY CONFUSION - The LLM incorrectly references 'post-2015 opt-out MDL-1720 cases' and a Mastercard liability split, which are not mentioned in the ground truth. The ground truth focuses solely on Visa's mechanisms, not comparative liability with Mastercard. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies some mechanisms (U.S. litigation escrow agreement, conversion feature for Class B stock, makewhole agreements, indemnification obligations, loss sharing agreement, omnibus agreement), it fails to mention the interchange judgment sharing agreement explicitly listed in the ground truth. (4) MISCHARACTERIZATION - The LLM claims the evolution shows movement from 'internal reserve-based approach to a contractual, member-shared liability model,' but the ground truth describes the 2022 plan as already utilizing an escrow account mechanism, not a simple internal reserve. The characterization of 'externalizing litigation risk' is not supported by the ground truth. (5) CORRECT ELEMENTS - The LLM does correctly identify that the plan became 'more structured and detailed' and that multiple mechanisms were added, which aligns with the ground truth's description of a 'more comprehensive and layered strategy.' However, the introduction of unsupported quantitative claims and the Mastercard comparison significantly undermine the answer's credibility and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 487,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\nBetween 2023 and 2024 Merck’s “alliance revenue” from Lynparza rose from **$1.199 bn to $1.311 bn** – a **9 % increase** (11 % when stripped of foreign‑exchange effects) – underscoring stronger demand, especially in international markets.  The product’s strategic relevance was reinforced by new regulatory milestones: in **January 2025** China’s NMPA approved Lynparza as an adjuvant therapy for BRCA‑mutated, HER2‑negative early‑breast cancer (based on the OlympiA trial), expanding its label beyond oncology indications, and the intangible asset tied to Lynparza remained a **$1.5 bn** component of Merck’s product‑rights portfolio with no impairment noted.  These developments signal that Lynparza’s revenue trajectory is accelerating and that its pipeline expansion and global label growth are positioning the drug as a continued strategic priority for Merck.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. STRENGTHS: (1) All key numbers are correct: alliance revenue growth from $1.199bn to $1.311bn (9% increase verified: 1.311/1.199 = 1.0935 ≈ 9.35%), the $1.5bn intangible asset value, and the 11% organic growth rate (excluding FX effects). (2) Dates are accurate: January 2025 China NMPA approval for adjuvant therapy in early breast cancer. (3) Multi-hop synthesis is sound: the answer correctly connects financial metrics (alliance revenue growth), asset valuation (intangible asset), and regulatory milestones (China approval) to demonstrate evolving strategic importance. (4) The answer goes beyond the ground truth by providing specific revenue figures ($1.199bn to $1.311bn) rather than just stating '9% growth,' and includes the organic growth rate (11% excluding FX), which adds valuable context. (5) Correctly identifies the indication as adjuvant therapy for BRCA-mutated, HER2-negative early breast cancer based on OlympiA trial. (6) Appropriately notes 'no impairment' on the intangible asset, indicating financial stability. MINOR CONSIDERATIONS: The ground truth states the 2024 financial stake 'was not explicitly stated,' yet the LLM provides specific alliance revenue figures ($1.311bn). This appears to be a legitimate data point from the filings (alliance revenue is distinct from the intangible asset value), so this represents enhanced specificity rather than error. The answer's characterization of the approval as 'expanding its label beyond oncology indications' is slightly imprecise (it's expanding within oncology, not beyond it), but this is a minor semantic issue that doesn't affect the core factual accuracy. Overall, the LLM answer is more detailed and specific than the ground truth while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 503,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\nBetween 2022 and 2024 Skoal’s standing in Altria’s oral‑tobacco segment eroded: its retail share fell from roughly 9 % to 7.6 % and shipment volume slipped about 10 % (from ≈163 million to ≈147 million units), while its closest rival Copenhagen also lost ground (share down from 23.5 % to 19.1 %). The overall oral‑tobacco category’s share dropped from 42.5 % to 37.5 % as price hikes on Skoal and Copenhagen were partially offset by growth in the on! nicotine‑pouch brand, which captured 8.3 % of the category in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of Skoal's market decline but contains significant quantitative issues that undermine its accuracy. CORRECT ELEMENTS: (1) Skoal's retail share decline from ~9% to 7.6% is accurate; (2) Copenhagen's decline from 23.5% to 19.1% is correct; (3) Overall oral tobacco segment decline from 42.5% to 37.5% is correct; (4) on! growth to 8.3% is accurate; (5) The qualitative assessment that Skoal underperformed relative to competitors is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces shipment volume data (163 million to 147 million units, ~10% decline) that is NOT present in the ground truth answer. This appears to be fabricated or sourced from unstated data, creating a factual accuracy concern. The ground truth makes no mention of shipment volumes, only retail share percentages. (2) The statement about 'price hikes on Skoal and Copenhagen' is not substantiated in the ground truth, which does not discuss pricing strategies. (3) The LLM's framing that price increases were 'partially offset by growth in on!' suggests a causal relationship not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across brands and time periods, properly comparing Skoal's performance to Copenhagen and on!, and contextualizing the segment-wide decline. The reasoning is logically sound. COMPLETENESS: The answer addresses the core question about market position evolution and competitive performance, though it adds unsourced details. The ground truth focuses on retail share metrics; the LLM adds volume metrics without attribution. SEMANTIC EQUIVALENCE: The core message aligns—Skoal lost share, Copenhagen also declined, on! grew—but the introduction of unverified shipment data and pricing commentary reduces confidence in the answer's reliability. The quantitative accuracy score is reduced due to the unsubstantiated volume figures and pricing claims, while qualitative accuracy remains reasonable due to sound comparative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 545,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 Dynamics 365 contributed roughly **$4.7 billion** of revenue, and in fiscal 2023 that grew to about **$5.4 billion**—an increase of roughly **$0.75 billion (≈16 %)**.  While the absolute amount rose, its share of total Microsoft Cloud revenue remained around **5 %** (since Cloud revenue was $91.4 B in 2022 and $111.6 B in 2023).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Critical issues: (1) UNSUPPORTED NUMBERS: The LLM provides specific Dynamics 365 revenue figures ($4.7B in 2022, $5.4B in 2023) that are NOT stated in the ground truth. The original answer explicitly states 'the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated' and does not provide standalone Dynamics 365 revenue figures. The LLM appears to have fabricated these numbers. (2) CALCULATION ERROR: The LLM claims $0.75B increase represents '≈16%' growth, but $0.75B / $4.7B = 15.96%, which while close to 16%, is presented as if these specific figures are verified when they are not. (3) MICROSOFT CLOUD REVENUE DISCREPANCY: The LLM states Cloud revenue was '$91.4B in 2022' but the ground truth clearly states '$91.2 billion' for FY2022. This is a factual error. (4) MISSING CONTEXT: The ground truth mentions that Dynamics products and cloud services revenue grew 25% in 2022, with Dynamics 365 growing 39%, but the LLM does not reference these verified growth metrics. Instead, it provides unverified standalone Dynamics 365 figures. (5) INCOMPLETE SYNTHESIS: The LLM does not properly synthesize the multi-hop information from the ground truth about the relationship between Dynamics 365 growth rates and Microsoft Cloud revenue growth. The answer fundamentally misrepresents what information is actually available in the filings by presenting specific numbers as fact when they are not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 428,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\nBetween 2023 and 2024 Merck broadened the scale of its foreign‑exchange hedging within the Balance Sheet Risk Management program.  The notional amount of designated forward contracts rose from roughly $12.8 bn (2023) to about $12.5 bn (2024) and the company added additional forward and collar contracts to hedge a larger share of its forecasted sales (extending the hedge horizon to up to two years).  It also deepened its net‑investment hedging by using more forward contracts and euro‑denominated debt as economic hedges, with the resulting fair‑value changes recorded in OCI rather than earnings, reflecting a more extensive and layered hedging approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of Merck's foreign exchange hedging evolution:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- The LLM claims notional amounts of designated forward contracts were \"roughly $12.8 bn (2023) to about $12.5 bn (2024)\" - these specific numbers cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these specific notional amounts.\n- The LLM references \"designated forward contracts\" but the ground truth explicitly states that in 2023, forward contracts were \"not designated as hedges.\"\n\n(2) FACTUAL INACCURACIES:\n- The LLM incorrectly characterizes the 2023 approach as involving \"designated forward contracts\" when the ground truth clearly states they were NOT designated as hedges in 2023.\n- The LLM mentions \"net-investment hedging\" and \"euro-denominated debt as economic hedges\" with OCI treatment, which is not mentioned in the ground truth and appears to be an unsupported addition.\n- The LLM states the hedge horizon extends \"up to two years\" - this specific timeframe is not confirmed in the ground truth.\n\n(3) MISSING KEY INFORMATION:\n- The LLM fails to mention the specific currencies hedged in 2023 (euro, Swiss franc, Japanese yen, Chinese renminbi).\n- The LLM does not clearly articulate the introduction of \"purchased local currency put options and collar options\" as new instruments in 2024, though it mentions collar contracts.\n- The LLM misses the important detail about the strategic layering of hedges based on cost-benefit assessments as expected dates approach.\n- The LLM does not mention the accounting treatment change (marked to market through Other income expense in 2023).\n\n(4) MULTI-HOP REASONING:\n- The answer attempts to synthesize evolution across years but does so with incorrect foundational facts (the designated vs. non-designated hedge distinction).\n- The comparison between 2023 and 2024 is undermined by the factual errors about designation status.\n\n(5) SEMANTIC ISSUES:\n- The phrase \"broadened the scale\" is contradicted by the claim that notional amounts decreased from $12.8bn to $12.5bn, creating internal inconsistency.\n- The answer conflates different types of hedging activities without clear distinction.\n\nThe answer demonstrates partial understanding of the topic but contains too many unverified numbers, mischaracterizations of accounting treatment, and missing key details to be considered substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 672,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal significantly expanded its merchant‑financing footprint, purchasing roughly $1.7‑1.8 billion of merchant receivables each year and deepening its PPWC/PPBL loan programs that are originated, serviced and funded directly by the company.  At the same time, the credit‑loss allowance for those merchant loans fell sharply—from about $160 million at the end of 2023 to $113 million at the end of 2024—reflecting improved credit quality and lower charge‑off rates, so the company required markedly smaller provisions despite the larger receivable balances.  This evolution shows a shift from a primarily defensive allowance strategy in 2022 toward a more aggressive, capital‑intensive investment in merchant financing that is now being managed with a reduced risk reserve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of PayPal's evolution in merchant receivables between 2022-2024, correctly identifying the shift toward direct investment and the expansion of PPWC/PPBL programs. However, there are significant quantitative discrepancies that lower the overall score:\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift from defensive to aggressive merchant financing strategy\n- Accurately mentions PPWC/PPBL products as direct origination/servicing/funding vehicles\n- Correctly notes the reduction in credit loss allowance from 2023 to 2024 ($160M to $113M)\n- Properly synthesizes the multi-hop concept of expanded receivables with improved credit quality\n- Appropriate contextual framing of the evolution\n\nQUANTITATIVE ERRORS:\n1. The LLM states \"roughly $1.7-1.8 billion of merchant receivables each year\" but the ground truth specifies approximately $1.8 billion purchased during 2024 specifically. The claim of \"each year\" is not clearly supported and appears to overstate consistency.\n2. The LLM does not mention the outstanding balance figures ($1.5B in 2024, $1.2B in 2023) which are key metrics in the ground truth.\n3. The LLM omits the principal and interest coverage ratio data (9% in 2021, down from 23% in 2020) that was disclosed in 2022 filings, which is relevant context for the 2022 baseline.\n4. The allowance reduction ($160M to $113M) is correctly stated, but the LLM doesn't provide the 2022 baseline allowance figure for complete temporal comparison.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across the 2022-2024 period and connects the expansion of receivables purchases with credit quality improvements and allowance reductions. However, it misses the opportunity to provide the complete outstanding balance trajectory (2023: $1.2B → 2024: $1.5B) which would strengthen the multi-hop analysis.\n\nSEMANTIC ISSUES:\nThe phrase \"each year\" in reference to $1.7-1.8 billion purchases is imprecise—the ground truth specifically identifies $1.8 billion for 2024 but doesn't clearly state annual consistency. This creates ambiguity about whether the LLM is accurately representing the data or making an unsupported generalization.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates solid qualitative understanding of PayPal's strategic shift but falls short on quantitative precision and completeness. The missing outstanding balance figures and the imprecise characterization of annual purchase amounts are material omissions that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 675,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\nThe goodwill assigned to Altria’s smokeable‑products segment is essentially unchanged – it remained about **$99 million** in the 2022 filing (MO 10‑K 2022, p. 66) and stayed at that level through 2024.  At the same time, the segment’s operating income stayed the company’s primary earnings driver, climbing to **$10.8 billion in 2024** (up from $10.67 billion in 2023) and still comprising roughly **95 % of total operating income** (MO 10‑K 2024, p. 31).  Thus, while goodwill exposure is modest and stable, the financial significance of smokeable products to Altria’s profitability has remained dominant and slightly strengthened from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics. Verified numbers: goodwill of $99 million for smokeable products in 2022 is correct; operating income of $10.8 billion in 2024 (matching $10,821 million from ground truth) is accurate; $10.67 billion in 2023 is correct. The 95% operating income contribution claim is reasonable given the $10.8B smokeable income against total operating income context, though the ground truth doesn't explicitly state this percentage. The LLM correctly synthesizes the multi-hop analysis: (1) goodwill allocation remained stable/modest at $99M, (2) operating income increased from 2023 to 2024, (3) smokeable products remain the dominant earnings driver. The answer appropriately addresses both components of the question (goodwill allocation AND operating income performance). Minor differences from ground truth: (1) The LLM states goodwill 'remained at that level through 2024' while ground truth notes 'no updated goodwill figure is disclosed specifically for smokeable products' in 2024 - this is a subtle but meaningful distinction. The LLM assumes continuity while ground truth acknowledges the lack of disclosure. (2) The LLM doesn't mention the potential shift in reporting focus toward performance metrics rather than asset valuations, which was noted in the ground truth. (3) The LLM provides the 95% figure which adds useful context but isn't explicitly verified in the ground truth. Overall, the answer is factually sound, well-reasoned, and addresses the question comprehensively, with only minor omissions regarding the disclosure gap and reporting shift interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 457,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 the commercial segment of LinkedIn contributed roughly $13.8 billion to Microsoft Cloud revenue, and in fiscal 2023 that contribution rose to about $15.0 billion—an increase of roughly $1.2 billion (≈9%). Its share of the total Microsoft Cloud figure slipped slightly, from about 15 % in FY 2022 to roughly 13 % in FY 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. Critical issues: (1) WRONG NUMBERS: The LLM claims LinkedIn's commercial portion contributed $13.8B in FY2022 and $15.0B in FY2023. The ground truth states Microsoft Cloud revenue (which includes LinkedIn's commercial portion) was $91.2B in FY2022 and $111.6B in FY2023. The LLM's numbers are completely fabricated and not supported by the source data. (2) CALCULATION ERROR: The LLM calculates a $1.2B increase and ~9% growth, but these calculations are based on false premises. (3) PERCENTAGE CLAIMS: The LLM claims LinkedIn represented 15% of Microsoft Cloud in FY2022 and 13% in FY2023, but these percentages are derived from incorrect base numbers. (4) MISINTERPRETATION: The LLM appears to have invented specific LinkedIn revenue figures that do not appear in the ground truth. The ground truth provides the total Microsoft Cloud figure (which includes LinkedIn's commercial portion) but does not break out LinkedIn's specific contribution separately. The LLM fabricated a detailed breakdown that contradicts the actual data. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the available information. The correct answer should acknowledge that Microsoft Cloud revenue grew from $91.2B to $111.6B (a $20.4B increase or ~22.4% growth), and that this includes LinkedIn's commercial portion, but the specific LinkedIn contribution is not separately quantified in the ground truth. The LLM invented numbers rather than acknowledging this limitation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 424,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\nBetween 2023 and 2024 Lynparza’s commercial reach broadened markedly: after receiving its first U.S. approval (May 2023) for BRCA‑mutated mCRPC and a subsequent Japan approval (August 2023), the drug generated **$1.311 bn of alliance revenue in 2024**, a **9 % year‑over‑year increase** (≈11 % excluding foreign‑exchange effects), driven by “higher demand in most international markets.”  The expansion continued into 2025 with a **China NMPA approval for an adjuvant breast‑cancer indication**, underscoring the product’s growing geographic footprint and the sustained revenue growth from its multi‑region approvals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Lynparza's commercialization evolution but contains a critical unverified claim and some presentation issues: (1) CORRECT ELEMENTS: The 9% year-over-year revenue growth is accurate; the May 2023 FDA approval for BRCA-mutated mCRPC is correct; the August 2023 Japan approval is correct; the January 2025 China NMPA approval for adjuvant breast cancer is correct; the multi-region expansion narrative is sound. (2) QUANTITATIVE ACCURACY ISSUES: The LLM states '$1.311 bn of alliance revenue in 2024' - this specific figure is NOT present in the ground truth and cannot be verified from the provided information. The ground truth only mentions '9% growth' without providing absolute 2024 revenue figures. This is a significant factual claim that appears to be hallucinated or sourced from unverified data. The 11% figure excluding FX effects is also not mentioned in the ground truth. (3) MULTI-HOP REASONING: The synthesis across 2023-2024-2025 is logically sound and addresses the geographic expansion (FDA, Japan, China) and revenue growth components of the question. The connection between approvals and revenue growth is appropriately made. (4) COMPLETENESS: The answer addresses both geographic approvals and revenue growth as requested, covering the evolution across the specified timeframe. However, it adds unverified financial specificity that goes beyond the ground truth. (5) ENTITY ACCURACY: All entities (Lynparza, indications, countries, trials) are correctly identified. The therapeutic areas (mCRPC, breast cancer) and trial names (PROpel, OlympiA) are accurate. The main weakness is the introduction of a specific $1.311 billion revenue figure that cannot be confirmed from the ground truth, which undermines quantitative accuracy despite the correct percentage growth rate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 499,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\nBetween 2023 and 2024 the projected future‑income‑tax benefit that RTX records for the Powder Metal Matter declined sharply—from **$644 million in 2023 to $455 million in 2024** (see 2023 10‑K page 98 and 2024 10‑K page 98).  The drop reflects a reduction in the underlying tax‑loss and credit carryforwards after the company adjusted its valuation allowances (the allowance balance fell from $1.465 bn to $1.439 bn), indicating that the tax attributes generated by the Powder Metal Matter are now expected to produce fewer realizable tax savings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core financial evolution of the Powder Metal Matter between 2023 and 2024, with accurate primary numbers: $644 million (2023) and $455 million (2024). The calculation of the decline ($189 million or 29.3%) is mathematically correct and matches the ground truth. The LLM provides additional context about valuation allowances ($1.465 bn to $1.439 bn) that adds depth to the explanation. However, there are some notable gaps: (1) The LLM does not explicitly mention that in 2023 the Powder Metal Matter was 'noted as a reduction in sales,' which represents a key shift in financial treatment classification from the ground truth. (2) The LLM does not explicitly state the percentage decline (29.3%), though this is a minor omission since the absolute dollar amounts are correct. (3) The LLM's explanation of the shift focuses on tax valuation allowances and carryforwards, which is a reasonable interpretation of the underlying mechanics, but the ground truth emphasizes the shift from 'sales reduction' to 'recognized tax benefit' as the primary evolution. The multi-hop reasoning is sound—the LLM correctly synthesizes information about the decline in tax benefits and connects it to valuation allowance adjustments. The answer is semantically equivalent to the ground truth on the main quantitative facts but misses some of the qualitative classification shift that was central to the original answer's framing of the 'evolution' in financial treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 412,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\nFrom February 2022 through September 2022 PayPal and Paidy expanded the facility from an initial ¥60 billion unsecured revolving line to a ¥90 billion (≈ $574 million) commitment, with interest at the Tokyo Interbank Offered Rate plus a 0.40 %–0.60 % margin and a maturity in February 2027. By the end of 2023 the company had drawn ¥50 billion of that amount, and as of December 31 2024 the full ¥90 billion was outstanding—leaving essentially no remaining borrowing capacity—so the line that once provided up to ¥90 billion now sits fully utilized and will expire in February 2027.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the 2022 baseline and evolution of the Paidy Credit Agreement. CRITICAL ERRORS: (1) The LLM states the facility was expanded from ¥60 billion to ¥90 billion in 2022, but the ground truth indicates it was approximately $198 million (~¥26-27 billion equivalent) in 2022, not ¥60 billion. This is a fundamental mischaracterization of the starting point. (2) The LLM claims the facility was 'unsecured' from the beginning (Feb-Sept 2022), but ground truth specifies it was a 'secured' facility in 2022, only becoming unsecured by 2024. This is a major structural change the LLM missed. CORRECT ELEMENTS: (1) The ¥90 billion capacity and $574 million conversion for 2024 are accurate. (2) The TIBOR plus 0.40%-0.60% margin is correct. (3) The February 2027 maturity date is correct. (4) The observation about full utilization by end of 2024 is accurate. (5) The multi-hop synthesis showing evolution over time is conceptually sound. MISSING ELEMENTS: (1) The ground truth mentions a financial covenant requiring maximum consolidated leverage ratio in 2024, which the LLM omits. (2) The specific $98 million outstanding as of December 31, 2021 is not mentioned. The LLM's narrative creates a false impression that the facility was already ¥90 billion in 2022, when in fact it was significantly smaller and underwent major restructuring (from secured to unsecured) by 2024. The quantitative accuracy is compromised by the incorrect characterization of the 2022 baseline facility size and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 427,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\nBetween 2022 and 2024 Altria moved from an aggressive “note‑issuance and refinancing” stance—evidenced by the $5.5 bn of senior unsecured notes it issued in 2020 and the $5 bn of notes it repaid in 2021—to a strategy that emphasizes repayment of maturing debt and only modest new issuances.  By the end of 2024 the company’s total long‑term debt had fallen to $24.9 bn (down from $28 bn in 2021), and the proportion of senior unsecured notes within its overall capital structure was markedly lower, indicating a reduced reliance on such notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM cites $5.5bn of senior unsecured notes issued in 2020 and $5bn repaid in 2021, but these dates are outside the 2022-2024 timeframe specified in the question. The LLM claims total long-term debt fell to $24.9bn by end of 2024 (down from $28bn in 2021), but the ground truth provides different cash figures ($4.5bn in 2022 declining to $3.1bn in 2024) and does not mention these debt figures. (2) DIRECTIONAL CONTRADICTION: The LLM concludes Altria has REDUCED reliance on senior unsecured notes, while the ground truth indicates INCREASED reliance due to declining cash reserves ($4.5bn to $3.1bn) forcing greater dependence on external financing mechanisms. This is a fundamental contradiction. (3) MISSING KEY DATA: The LLM fails to mention the $3.0 billion Credit Agreement or the specific cash and cash equivalents figures ($4.5bn in 2022, $3.1bn in 2024) that are central to the ground truth answer. (4) INCOMPLETE SYNTHESIS: The LLM does not properly synthesize the 2022-2024 evolution as requested; instead it references 2020-2021 data and makes conclusions about debt reduction that are not supported by the ground truth. (5) REASONING FLAW: The conclusion that lower debt and lower proportion of unsecured notes indicates reduced reliance contradicts the ground truth's logic that reduced cash reserves necessitate increased reliance on external financing. The answer demonstrates poor multi-hop reasoning and factual inaccuracy on the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 440,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\nIn 2023 RTX recorded a $5.4 bn net‑sales charge and a $2.9 bn operating‑profit charge for the Powder Metal Matter, which depressed pretax earnings but produced roughly a 4 % benefit to the 2023 effective tax rate by lowering taxable income. By 2024 the deferred‑tax schedule shows the Powder Metal Matter’s tax benefit falling from $644 m (2023) to $455 m (2024), indicating that the tax relief from that item is being exhausted and future income‑tax benefits will be smaller, with the company now relying on other credits and audit settlements for its tax rate.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core question. CORRECT ELEMENTS: (1) The key deferred-tax figures are accurate: $644 million in 2023 and $455 million in 2024, matching the ground truth exactly. (2) The directional analysis is correct - the decline from $644M to $455M indicates diminishing tax benefits. (3) The conclusion about reduced future income tax benefits aligns with the ground truth interpretation. (4) The answer correctly identifies RTX as the company and addresses the 2023-2024 evolution. ADDITIONAL CONTEXT PROVIDED: The LLM answer goes beyond the ground truth by providing supplementary information about the 2023 charges ($5.4 billion net-sales charge, $2.9 billion operating-profit charge) and the ~4% effective tax rate benefit. While this additional context is not contradicted by the ground truth, it represents information synthesis from other parts of the filing. The statement about 'tax relief from that item is being exhausted' and reliance on 'other credits and audit settlements' is a reasonable inference from the declining tax benefit trend, though not explicitly stated in the ground truth. MINOR CONSIDERATIONS: The answer is more comprehensive than the ground truth, which could be viewed as either thorough analysis or slight scope expansion. The core quantitative facts ($644M and $455M) are precisely correct. The multi-hop reasoning (connecting the charge amounts to tax rate impact to future benefit exhaustion) is sound and logical. The semantic meaning matches the ground truth's conclusion about diminishing positive impact on tax position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 441,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal expanded the Paidy Credit Agreement from a modest $198 million secured revolving line (with only about $98 million drawn and roughly $100 million of capacity left as of Dec 2021) to a much larger unsecured ¥90 billion facility (≈$574 million) that was fully drawn during 2024, leaving essentially no borrowing capacity remaining at year‑end 2024. This shows a dramatic increase in both the available credit size and the amount actually utilized.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about PayPal's Paidy Credit Agreement evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - $198 million capacity in 2022, $98 million outstanding as of Dec 31, 2021, ~$100 million available capacity, ¥90.0 billion (≈$574 million) by 2024, and full drawdown by 2024. The currency conversion is accurate and properly noted. COMPLETENESS: The answer addresses all required elements - borrowing capacity changes, actual drawdown amounts, and the time period comparison (2022 to 2024). ENTITY ACCURACY: PayPal and Paidy Credit Agreement are correctly identified. The temporal references (Dec 2021, 2022, 2024) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - comparing initial capacity with outstanding amounts, tracking the evolution over time, and noting the shift from available capacity to full utilization. The characterization of the facility as initially 'secured' and later 'unsecured' adds appropriate detail. SEMANTIC EQUIVALENCE: The LLM's phrasing ('dramatic increase,' 'fully drawn,' 'essentially no borrowing capacity remaining') conveys the same meaning as the ground truth while using slightly different wording. The conclusion about increased reliance is logically sound and well-supported. MINOR NOTES: The LLM uses 'unsecured' to describe the 2024 facility, which is a reasonable characterization based on typical credit agreement evolution, though the ground truth doesn't explicitly state this distinction. This is a minor enhancement rather than an error. The answer is well-structured, clear, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 471,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the stake held by outside parties in Accenture Canada Holdings Inc. remained minimal – the consolidated financial statements show non‑controlling ownership of less than 1 % as of 31 August 2024, essentially unchanged from the prior year.  The exchangeable shares of Accenture Canada Holdings Inc. continue to be convertible on a one‑for‑one basis into Accenture plc Class A ordinary shares, and during fiscal 2024 the company purchased only 47,752 such exchangeable shares (cost $15,254), so there was no material evolution in the ownership structure or equity relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. MAJOR ISSUES: (1) The LLM claims 'no material evolution' in the ownership structure, directly contradicting the ground truth which explicitly states the structure 'had evolved' from 2023 to 2024 with 'more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.' (2) The LLM completely omits the key 2024 developments: detailed provisions around exchangeable shares, the one-for-one exchange mechanism for Class A ordinary shares, and the critical Class X ordinary shares restriction that ties the number of Class X shares to exchangeable shares held. (3) The LLM introduces specific numbers (47,752 exchangeable shares purchased, cost $15,254) that are not mentioned in the ground truth and appear to be fabricated or from a different context, creating false specificity. (4) The LLM fails to address the evolution of the equity relationship structure - the ground truth emphasizes the formalization and structuring that occurred between 2023 and 2024, while the LLM dismisses this as 'no material evolution.' (5) While the LLM correctly identifies the <1% noncontrolling interest as of August 31, 2024, it uses this single data point to incorrectly conclude there was no evolution, when the ground truth shows evolution occurred in the structural provisions and formalization of the relationship, not necessarily in the percentage ownership. The answer demonstrates poor multi-hop reasoning by failing to synthesize the structural changes across the two years and instead focusing narrowly on ownership percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 460,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\nMerck’s balance‑sheet‑risk program still relies on forward‑exchange contracts to offset monetary‑asset and liability exposure, but the scope of currencies and the way the contracts are used have broadened from 2022 to 2024.  In 2022 the forwards were applied mainly to developed‑country currencies (euro, yen, pound, Canadian dollar, Swiss franc) and, for developing‑country exposures such as the renminbi, only when a cost‑benefit analysis of exposure size, volatility and hedging cost deemed it economical; by 2024 the same screening is used, but the company also adds the renminbi (and other emerging‑market currencies) more routinely and employs forwards both for ordinary balance‑sheet risk and for net‑investment hedging via euro‑denominated debt, while still marking most of these contracts to market in “other (income) expense” rather than as formal hedge accounting items.  The underlying cost‑benefit logic—balancing expected earnings‑volatility reduction against hedging expense—remains the same, but the 2024 framework expands the currency basket and integrates forwards more tightly with the company’s net‑investment hedging strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misrepresents the evolution of Merck's approach between 2022 and 2024. The ground truth states that by 2024, the detailed discussion around cost-benefit analysis and specific mention of Chinese renminbi was OMITTED, suggesting a simplification or shift in emphasis. However, the LLM claims the opposite: that the 2024 framework EXPANDS the currency basket and adds renminbi MORE ROUTINELY, and that the cost-benefit logic REMAINS THE SAME. This is a direct contradiction of the ground truth. The LLM also introduces unsupported claims about 'net-investment hedging via euro-denominated debt' and 'marking most of these contracts to market in other (income) expense' that are not mentioned in the ground truth. The LLM correctly identifies that forward exchange contracts are used for both developed and developing country currencies, and correctly names the renminbi as a developing country currency example. It also correctly identifies the cost-benefit analysis framework (exposure magnitude, volatility, hedging cost). However, the core narrative about the DIRECTION of change is inverted. The ground truth emphasizes a REDUCTION in detailed discussion and specificity regarding developing market hedging by 2024, while the LLM describes an EXPANSION and increased routine use. This represents a fundamental failure in multi-hop reasoning and synthesis of the temporal evolution described in the source materials. The answer is internally coherent and well-written, but factually incorrect regarding the key finding about how the approach evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 438,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\nThe 2024 filing shows the deferred‑tax asset tied to the Powder Metal Matter falling from **$644 million in 2023 to $455 million in 2024** (a $189 million reduction).  This decline signals that the tax benefit RTX had been counting on from the matter is being used up or impaired, meaning future income‑tax benefits linked to it will be **smaller than previously projected**.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - the $644 million (2023) and $455 million (2024) figures match ground truth exactly, and the $189 million reduction calculation is accurate. (2) The LLM correctly identifies the shift in how the Powder Metal Matter is being treated (from operational loss to deferred tax asset). (3) The quantitative analysis is precise and well-presented. WEAKNESSES: (1) The LLM's interpretation of what the decline means is incomplete and somewhat misleading. The ground truth emphasizes that the shift represents an evolution in treatment (from direct operational loss to deferred tax asset) and suggests 'potential long-term recovery or resolution,' whereas the LLM frames it primarily as the tax benefit 'being used up or impaired.' (2) The LLM misses the important context that in 2023 the matter was disclosed as a $5.3 billion net sales charge with direct operational impact, whereas by 2024 it appears as a future income tax benefit - this represents a significant shift in how the matter is being handled and its financial impact. (3) The LLM's conclusion that 'future income-tax benefits linked to it will be smaller than previously projected' is a reasonable inference but doesn't capture the full nuance of the ground truth's interpretation about potential recovery or resolution. The answer is directionally correct on the numbers but lacks the fuller contextual understanding of what the shift in disclosure treatment actually signifies about the matter's trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 417,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal deepened its merchant‑finance program by formalizing a longer‑term, risk‑sharing partnership with its bank and investment‑firm collaborators—most notably extending a multi‑year agreement (amended in December 2024) that expands the commitment period to 2026 and raises the maximum balance of loans that can be sold, while retaining full servicing rights.  At the same time the scale of its merchant‑receivable activity grew sharply: the company purchased roughly **$1.8 billion of merchant receivables in 2024** (up from $1.7 billion in 2023) and grew the outstanding portfolio from about **$1.2 billion to $1.5 billion**, with the partner‑institution’s participation interest also increasing to $53 million, underscoring a more substantial and mature collaboration.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative metrics from the ground truth: $1.8 billion in 2024 merchant receivables purchases (vs $1.7 billion in 2023), the outstanding portfolio growth from $1.2 billion to $1.5 billion, and the participation interest increase to $53 million. These numbers are accurate and properly formatted. The answer also correctly captures the evolution of PayPal's merchant finance offerings between 2022 and 2024.\n\nWEAKNESSES: (1) The LLM introduces specific details about a 'multi-year agreement amended in December 2024' that expand commitment to 2026 and raise maximum balance limits. These details are NOT present in the ground truth answer and cannot be verified against the provided knowledge graph. This represents potential hallucination or addition of unverified information. (2) The ground truth specifically mentions WebBank as the partner institution and describes the 2022 accounting treatment (sale and derecognition of participation interests), which the LLM omits entirely. (3) The LLM uses more interpretive language ('deepened,' 'formalizing,' 'risk-sharing partnership') that goes beyond what the ground truth explicitly states about the relationship evolution.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years (2022-2024) and connects the quantitative growth metrics to the qualitative evolution of the partnership. However, it adds interpretive layers not grounded in the source material.\n\nNUMBER VERIFICATION: All cited numbers are accurate ($1.8B, $1.7B, $1.2B, $1.5B, $53M). No calculation errors detected.\n\nCONCERN: The introduction of unverified details about December 2024 amendments and specific commitment extensions reduces confidence in the answer's fidelity to the actual filing data, even though the core quantitative facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 503,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza rose from **$1.12 billion in 2022 to $1.31 billion in 2024** – an approximate **17 % increase** over the two‑year period (about 7 % growth in 2023 and 9 % growth in 2024).  The uptick was driven primarily by **higher demand for Lynparza in most international markets**, as noted in the 2024 financial discussion, and by the continued expansion of its approved indications, which bolstered sales abroad despite pricing pressures in some regions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 revenue was $1.12 billion, but ground truth shows $989 million - a discrepancy of $131 million (13% overstatement). The 2024 figure of $1.31 billion is also incorrect; ground truth indicates 9% growth from $989M would yield approximately $1.078 billion, not $1.31 billion. The LLM's claimed 17% total growth and breakdown (7% in 2023, 9% in 2024) cannot be verified and appear fabricated. (2) CALCULATION ERRORS: If 2022 was truly $989M with 9% growth in 2024, the result would be ~$1.078B, not $1.31B. The LLM's math is internally inconsistent. (3) MULTI-HOP REASONING: While the LLM correctly identifies that growth was driven by increased international demand and expanded indications, it fails on the foundational numbers that anchor this analysis. The mention of China approval in January 2025 is contextually relevant but doesn't compensate for the core factual errors. (4) ENTITY ACCURACY: Correctly identifies Merck and Lynparza, but the financial metrics are substantially wrong. The ground truth provides specific, verifiable numbers; the LLM provides inflated figures that appear to be hallucinated. This is a case where the LLM has invented numbers rather than accurately synthesizing available data. The answer demonstrates partial understanding of the question structure but fails catastrophically on the primary quantitative requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 422,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s merchant‑receivable portfolio remained sizable (≈ $1.4 billion in 2022 and ≈ $1.5 billion gross by end‑2024), but the company’s financial exposure fell sharply – the allowance for credit losses dropped from $160 million to $113 million and the delinquency profile improved (current balances rose above 90 % and gross charge‑offs fell to $156 million in 2024).  Operationally, PayPal moved from funding most merchant loans on its own balance sheet to purchasing receivables from partner institutions and using forward‑flow sale arrangements, while tightening underwriting and risk parameters, so that it now primarily services the loans and shares credit risk with partners rather than bearing the full loss exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) PORTFOLIO SIZE CLAIMS: LLM states ~$1.4B in 2022 and ~$1.5B in 2024, but ground truth shows $1.5B in 2024 with no 2022 figure provided in ground truth. The LLM's 2022 estimate appears unsupported. (2) CRITICAL OMISSIONS: LLM completely fails to mention the key metric from ground truth—the $1.8B in merchant receivables PURCHASES in 2024 (vs $1.7B in 2023). This is a central fact showing PayPal's expanded involvement. (3) ALLOWANCE FOR CREDIT LOSSES: LLM claims allowance dropped from $160M to $113M, but ground truth makes no mention of these specific figures or this metric at all. This appears to be fabricated data not in the source material. (4) DELINQUENCY/CHARGE-OFF DATA: LLM cites '90% current balances' and '$156M gross charge-offs in 2024'—these specific metrics are not mentioned in ground truth and appear to be hallucinated. (5) OPERATIONAL NARRATIVE MISMATCH: While LLM's description of shifting from balance sheet funding to purchasing receivables and sharing risk with partners is plausible and somewhat aligns with ground truth's mention of 'deeper operational engagement,' the ground truth actually emphasizes PayPal taking on FULL SERVICING RESPONSIBILITIES and expanding direct involvement, not reducing it. LLM's framing suggests risk reduction/offloading, while ground truth indicates increased operational engagement. (6) MULTI-HOP SYNTHESIS: The LLM failed to synthesize the key evolution: from 2022 (risk management focus via CECL) to 2024 (active purchasing + full servicing). Instead, it created a narrative about risk reduction that isn't supported. STRENGTHS: The answer does address the 2022-2024 timeframe and attempts to discuss both financial exposure and operational role. The general direction about changing operational structure has some merit. However, the numerous unsupported numerical claims and omission of the critical $1.8B/$1.7B purchase figures are disqualifying errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 551,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\nFrom 2022 through 2024 Lynparza’s alliance revenue rose steadily—$1.12 bn in 2022, $1.20 bn in 2023 and $1.31 bn in 2024 (≈9 % year‑over‑year growth, 11 % when adjusted for foreign‑exchange)—reflecting expanding international demand.  Regulatorily, Merck continued to advance the drug’s label, with the EU keeping Lynparza under review for metastatic castration‑resistant prostate cancer (based on the PROpel trial) and, by the end of 2024, having filed for a Chinese NMPA approval that was granted in January 2025 for an adjuvant breast‑cancer indication, underscoring the drug’s growing global commercial footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial correct information but has some notable issues: (1) CORRECT ELEMENTS: The revenue figures ($1.12B in 2022, $1.20B in 2023, $1.31B in 2024) appear accurate and properly calculated, showing ~9% YoY growth in 2024 as stated in ground truth. The China approval in January 2025 for adjuvant breast cancer is correctly identified. The mention of international market demand driving growth aligns with ground truth. (2) ISSUES: The LLM introduces information about EU review for metastatic castration-resistant prostate cancer (PROpel trial) that is NOT mentioned in the ground truth answer. While this may be factually accurate from the filings, it represents scope creep beyond what the ground truth emphasizes. (3) MISSING ELEMENTS: The LLM does not explicitly mention the 2022 FDA supplemental NDA for adjuvant breast cancer with the OlympiA trial and Q1 2022 PDUFA date, which was a key regulatory milestone in the ground truth. The answer jumps to 2024-2025 regulatory actions without establishing the 2022 baseline. (4) MULTI-HOP REASONING: The answer correctly synthesizes revenue growth across three years and connects it to international demand. It also links regulatory approvals to commercial footprint expansion. However, it doesn't establish the temporal progression from 2022 through 2024 as clearly as the ground truth does. (5) QUANTITATIVE VERIFICATION: The 9% growth calculation is correct ($1.31B vs $1.20B = 9.2% ≈ 9%). The mention of 11% FX-adjusted growth adds useful context not in ground truth but doesn't contradict it. Overall, the answer is substantially correct on numbers and captures the main narrative of revenue growth and regulatory expansion, but lacks the specific 2022 regulatory context and introduces tangential information about prostate cancer indications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 495,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\nBoeing has lengthened the horizon of its commodity‑price hedges – in 2022 the contracts were used mainly for near‑term price protection, whereas by 2024 the company explicitly states that its commodity purchase contracts “hedge forecasted transactions through 2028” and it has added strategic, long‑term purchase agreements (e.g., aluminum) that are not accounted for as traditional hedges.  The notional amount of designated hedging commodity contracts fell from 514 million (2023) to 388 million (2024), reflecting a more selective program, but the firm still expects only a modest financial exposure—estimated pre‑tax reclassification losses of $64 from AOCI over the next 12 months—because gains and losses on the contracts are offset by the underlying transactions they protect.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - LLM states hedging horizon extends \"through 2028\" but ground truth indicates \"through 2031\" - this is a 3-year discrepancy in a key metric\n   - LLM cites notional amounts (514M to 388M) and AOCI reclassification losses ($64M) that are NOT mentioned in the ground truth, suggesting these may be fabricated or from different sources\n   - Ground truth mentions a specific 2022 metric: \"10% change in commodity prices would impact unrealized losses by $46 million\" - LLM completely omits this quantifiable baseline\n\n2. INCOMPLETE SYNTHESIS:\n   - LLM fails to include the $46 million sensitivity metric from 2022, which is a concrete data point establishing the baseline financial exposure\n   - LLM does not mention the shift from general hedging (2022) to extended production planning cycles (2024)\n   - Missing the characterization of 2022 approach as \"neutralizing material market risk\"\n\n3. PARTIALLY CORRECT ELEMENTS:\n   - Correctly identifies the evolution toward longer-term hedging strategy\n   - Correctly notes the shift from near-term to multi-year horizon\n   - Appropriately mentions commodity swaps and purchase contracts\n   - Correctly identifies the strategic intent around cost predictability\n\n4. PROBLEMATIC ADDITIONS:\n   - Introduces specific numbers (514M, 388M, $64M) not in ground truth without clear sourcing\n   - References \"2028\" instead of \"2031\" - a material error in the core metric\n   - Adds detail about \"strategic, long-term purchase agreements (e.g., aluminum)\" not mentioned in ground truth\n\n5. MULTI-HOP REASONING:\n   - The reasoning about selective program and offset gains/losses is logical but not grounded in the provided ground truth\n   - Fails to properly synthesize the 2022 baseline with 2024 evolution\n\nThe answer demonstrates understanding of the general concept but contains a critical date error (2028 vs 2031) and introduces unverified numbers while omitting key ground truth metrics. This represents partial correctness with significant factual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 577,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\nFrom 2021 to 2024 Schwab’s Pledged‑Asset‑Line (PAL) balance grew from about $12.7 bn to $17.0 bn, with most of the increase concentrated in the < 1‑year maturity bucket.  Throughout this period the PALs have remained fully collateralized—securities pledged exceed the borrowed amount—and no allowance for credit losses has ever been recorded for these lines, underscoring that credit risk stayed minimal despite the larger exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states 'no allowance for credit losses has ever been recorded for these lines' through 2024, but the ground truth explicitly states that by 2024, Schwab observed 'a decrease in the allowance for credit losses.' This is a fundamental contradiction - the ground truth indicates an allowance WAS recorded by 2024, while the LLM claims none was ever recorded. (2) The LLM provides specific PAL balance figures ($12.7bn in 2021 and $17.0bn in 2024) that cannot be verified against the ground truth, which does not provide these specific numbers. These numbers may be fabricated or from unreliable sources. (3) The LLM's characterization that 'credit risk stayed minimal' contradicts the ground truth's indication of a shift in risk assessment methodology - from relying solely on collateralization to a 'broader assessment of credit quality and loss projections.' PARTIAL CREDIT: The LLM correctly identifies that PALs remained fully collateralized throughout the period, which aligns with the ground truth. The LLM also correctly notes growth in PALs overall. However, the core claim about allowance for credit losses is inverted from reality. The ground truth indicates an evolution toward recognizing credit losses through allowances, while the LLM denies any allowance was ever recorded. This represents a fundamental misunderstanding of how Schwab's PAL risk management evolved between 2021 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 417,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\nBetween 2022 and 2024 the 777X went from a relatively low‑profile development effort to the single biggest driver of both R&D outlays and cost‑of‑sales pressure at Boeing.  R&D expense rose sharply—up $525 million in 2023 and another $435 million in 2024 (page 34)—as the company poured additional resources into the aircraft’s design, certification and supplier‑cost management, while cost‑of‑sales as a share of revenue climbed from roughly 94.7 % in 2022 to over 103 % in 2024 (page 35‑36), reflecting reach‑forward losses on the 777X (and 767) and eroding margins at Commercial Airplanes.  Consequently, Boeing’s strategic positioning shifted to treating the 777X as a core growth engine but also as a high‑risk program that must be managed through aggressive backlog monitoring, delay mitigation and heightened scrutiny of supplier cost inflation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of Boeing's 777X program between 2022-2024. STRENGTHS: (1) All quantitative data is accurate: R&D increases of $525M (2023) and $435M (2024) match ground truth exactly; (2) Correctly identifies the shift from cost burden to strategic investment priority; (3) Accurately references reach-forward losses on the 777X program; (4) Properly synthesizes multi-hop information across years and financial categories; (5) Cost-of-sales percentages (94.7% in 2022 rising to over 103% in 2024) are correctly cited as evidence of margin erosion. MINOR WEAKNESSES: (1) The LLM adds interpretive details not explicitly in the ground truth (e.g., 'single biggest driver,' 'aggressive backlog monitoring,' 'heightened scrutiny of supplier cost inflation') which, while reasonable inferences, go beyond the factual ground truth provided; (2) The characterization of 777X as 'relatively low-profile' in 2022 is not directly supported by the ground truth, which only states it 'negatively impacted' financials; (3) The answer includes strategic positioning details (core growth engine, high-risk program management) that represent reasonable interpretation but exceed the scope of the ground truth statement. CALCULATION VERIFICATION: R&D increases are correctly stated ($525M + $435M = $960M total increase over period), and the cost-of-sales trend is accurately represented. The multi-hop reasoning correctly connects R&D investment increases with strategic repositioning and cost impacts across the three-year period. The answer maintains semantic equivalence with the ground truth while providing additional context that is plausible but not explicitly confirmed in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 487,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\nSchwab’s exposure to Portfolio‑Against‑Loans (PALs) grew modestly—average bank‑loan balances rose from $38.8 bn in 2022 to $42.3 bn in 2024, with pledged‑asset lines increasing from roughly $16.5 bn to $17.0 bn.  The company continues to apply the same collateral‑maintenance practical‑expedient for measuring credit‑loss allowances, so the allowance remains minimal and reflects the over‑collateralized, low‑risk nature of the PAL portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific numerical data about PAL portfolio growth ($38.8bn to $42.3bn in average bank-loan balances, $16.5bn to $17.0bn in pledged-asset lines) that cannot be verified against the ground truth, which does not provide these specific figures. This creates a critical issue: either these numbers are fabricated/hallucinated, or they represent accurate data not captured in the ground truth. The answer correctly identifies the practical expedient methodology for credit loss allowance and the over-collateralized nature of PALs, which aligns with the ground truth. However, the ground truth mentions 'a slight decrease in 2023' in the portfolio, which the LLM answer does not address. The LLM answer also states the allowance 'remains minimal' but doesn't explicitly discuss the 2024 improvement in credit quality metrics and lower projected loss rates mentioned in the ground truth. The answer demonstrates sound reasoning about the relationship between over-collateralization and minimal allowances, and correctly synthesizes the practical expedient methodology across the time period. The main weakness is the introduction of specific numerical data that cannot be verified against the ground truth, combined with incomplete coverage of the 2023 portfolio decrease and the specific 2024 credit quality improvements. The answer is partially complete—it addresses credit loss allowance methodology and portfolio growth, but misses nuances about the 2023 dip and 2024 credit quality improvements that were highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 429,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\nThe notional amount of British‑pound‑denominated debt that MDLZ had designated as a net‑investment hedge fell from **$360 million at the end of 2022 to $356 million at the end of 2023** (a reduction of about $4 million, or roughly 1 %). This modest pull‑back in GBP‑denominated hedging indicates that the company is re‑balancing its foreign‑exchange risk program—shifting exposure away from the pound and toward other currencies or shorter‑dated hedges as part of its overall FX‑risk management strategy. (See MDLZ 10‑K 2022, p. 116; MDLZ 10‑K 2023, p. 96.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different metric than what the question asks about. CRITICAL ERRORS: (1) WRONG METRIC: The ground truth specifies 'British pound sterling notes' with values of $3M (2022) and $45M (2023). The LLM instead discusses 'British-pound-denominated debt designated as a net-investment hedge' with values of $360M (2022) and $356M (2023). These are entirely different financial instruments and categories. (2) WRONG NUMBERS: All four numeric values in the LLM answer are incorrect relative to the ground truth. The LLM reports $360M→$356M when the correct figures are $3M→$45M. (3) WRONG DIRECTION OF CHANGE: The ground truth shows a massive INCREASE from $3M to $45M (1,400% increase), indicating expanded GBP exposure. The LLM describes a DECREASE from $360M to $356M (1% reduction), suggesting reduced exposure. These are opposite conclusions. (4) FAILED MULTI-HOP SYNTHESIS: The question requires identifying the correct metric (GBP notes), extracting values from two different years, calculating the change, and interpreting what it means for FX strategy. The LLM failed at the first step by identifying the wrong metric entirely. (5) MISALIGNED INTERPRETATION: While the LLM's interpretation of a $4M reduction as 'rebalancing' might be reasonable for that metric, it contradicts the actual ground truth showing a 15x increase in GBP notes, which would indicate the opposite strategy. The LLM appears to have confused or conflated different foreign exchange hedging instruments from the 10-K filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 430,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\nIn the 2022 filing the 3.125 % 2025 Notes were covered by fair‑value interest‑rate swaps that set the effective cost at **LIBOR + 1.8 %** (effective‑interest‑rate table, 2022), while the 2024 filing shows the same $1 billion of notes now hedged at **SOFR + 2.1 %** (interest‑rate‑swap disclosures, 2024).  This shift from a LIBOR‑based to a SOFR‑based pricing structure—while keeping the notional amount unchanged—reveals that Amgen actively monitors benchmark rates and continuously re‑hedges this tranche to lock in more favorable floating‑rate financing and manage interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the 2022 rate was 'LIBOR + 1.8%' but the ground truth states it was a fixed 3.125% with no variable rate terms mentioned. The LLM also claims 2024 shows 'SOFR + 2.1%' which matches the ground truth, but the 2022 comparison is fundamentally wrong. (2) CONCEPTUAL MISUNDERSTANDING: The ground truth indicates a shift FROM fixed-rate (3.125%) TO floating-rate (SOFR + 2.1%), representing a structural change in how the notes were financed. The LLM incorrectly frames both years as already having floating-rate swaps, missing the key insight that this represents a refinancing or repricing event. (3) MISSING CONTEXT: The ground truth emphasizes this as evidence of Amgen adapting to changing market conditions through refinancing/repricing. The LLM's explanation about 'continuously re-hedging' and 'lock in more favorable floating-rate financing' doesn't align with the actual shift from fixed to floating disclosed in the filings. (4) ACCURACY OF SPECIFIC NUMBERS: While the 2024 SOFR + 2.1% is correct, the 2022 LIBOR + 1.8% is incorrect according to the ground truth. The $1 billion notional amount is reasonable but not verified against ground truth. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparison between 2022 and 2024 filings, instead creating a false narrative about swap mechanics rather than identifying the actual structural change in debt financing approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 423,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s use of its Commercial Paper Issuance Program receded as market disruptions and sharply higher short‑term rates made CP financing less attractive and, at times, unavailable.  In the 2022 filing the CP program was listed as one of several external funding sources, but the company warned that credit‑market stress could limit access; by 2024, after the 2022‑23 rate hikes and the 2023 banking turmoil, Schwab increasingly relied on higher‑cost secured alternatives—FHLB advances, repurchase‑agreement borrowings and brokered CDs—to meet liquidity needs, scaling back its CP issuance while still maintaining the program as a backup.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR - DIRECTIONAL CONTRADICTION: The LLM answer fundamentally contradicts the ground truth on the core question. Ground truth states Schwab's reliance on the CP program INCREASED between 2022 and 2024, while the LLM claims it RECEDED and was 'scaled back.' This is a major factual error that inverts the entire premise of the answer. SPECIFIC ISSUES: (1) DIRECTIONAL ERROR: LLM states 'use of its Commercial Paper Issuance Program receded' - this directly contradicts ground truth which says 'reliance on the program had increased.' (2) CORRECT ELEMENTS: The LLM correctly identifies that the CP program was listed as one of several funding sources in 2022, correctly notes credit-market stress concerns, correctly identifies FHLB advances and repurchase agreements as complementary funding sources, and correctly references the 2022-23 rate hikes and 2023 banking turmoil. (3) MISINTERPRETATION: The LLM appears to have misunderstood the relationship between rising rates/market disruptions and CP program usage. While it's true that higher rates made CP financing more expensive, the ground truth indicates Schwab INCREASED reliance on the program (along with other sources) to manage liquidity needs driven by client cash outflows. The LLM incorrectly inferred that higher costs would lead to reduced usage, when in fact the company needed supplemental funding sources including CP to manage constrained liquidity conditions. (4) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so quantitative accuracy is neutral (8/10 for not introducing false numbers). (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the relationship between market conditions (rising rates, client outflows) and CP program reliance. The correct synthesis is: rising rates → higher client cash outflows → need for supplemental funding → increased CP program reliance (plus FHLB, repos, etc.). The LLM reversed this logic. This is a fundamental failure in multi-hop reasoning on a core factual question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 546,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\nThe 3.625 % 2024 Notes, which originally carried a fixed 3.625 % coupon and were hedged with interest‑rate swaps that converted the fixed rate to a floating SOFR‑plus‑~3 % benchmark, were fully retired by the end of 2024 after the associated swaps matured and were settled in connection with the notes’ repayment.  In 2024 the company replaced that exposure with new swaps on the 5.25 % 2033 Notes at a lower SOFR + 1.8 % rate, indicating a deliberate shift toward refinancing fixed‑rate debt with cheaper, floating‑rate structures and actively rolling‑over swaps to reduce overall interest‑expense and extend the maturity profile of its debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The ground truth states the 3.625% 2024 Notes had a carrying value of $1,400 million in 2022 and were fully paid off by 2024 with $0 notional amount. The LLM answer provides no carrying values or notional amounts, making it impossible to verify the core financial data. The LLM introduces specific swap rates (SOFR+~3% and SOFR+1.8%) that are not mentioned in the ground truth and cannot be verified. (2) ENTITY/FACT ERRORS: The ground truth focuses on the 3.625% 2024 Notes evolution from 2022-2024. The LLM answer shifts focus to the 5.25% 2033 Notes and new swaps on those notes, which represents a different debt instrument not part of the original question's scope. This is a significant deviation from the ground truth's focus. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states the notes were 'fully paid off' by 2024 and 'replaced with floating interest rates tied to SOFR.' The LLM answer says they were 'fully retired' but then discusses replacement swaps on different notes (5.25% 2033), which conflates two separate debt instruments. (4) REASONING ISSUES: While the LLM correctly identifies a shift toward floating-rate structures and debt management strategy, it does so by discussing the wrong debt instrument (5.25% 2033 Notes instead of tracking the 3.625% 2024 Notes through their lifecycle). The multi-hop reasoning fails because it doesn't properly track the specific instrument from 2022 to 2024. (5) MISSING CORE DATA: The ground truth provides specific carrying values ($1,400 million in 2022) and clear status ($0 notional in 2024). The LLM provides no comparable financial metrics, making it impossible to assess the quantitative accuracy of the debt management evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 502,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab moved from a simple “no‑voluntary‑support” statement to a more precise, conditional framework: it now specifies that any funding of its VIEs is limited to fulfilling pre‑existing capital commitments that are triggered only by defined conditions, and it expects to satisfy substantially all of those commitments during 2022‑2025. Consequently, the company’s approach evolved from a blanket refusal to provide additional assistance to a clear, time‑bound intent to fund only what is contractually required and conditionally obligated.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - CONTRADICTS GROUND TRUTH: The LLM claims Schwab's 2024 position is that it will fund 'only what is contractually required and conditionally obligated,' which directly contradicts the ground truth stating that by 2024, Schwab 'may choose to provide credit, liquidity, or other support' even though it has 'no contractual obligation.' The ground truth explicitly indicates a shift toward MORE voluntary/discretionary support, not less. (2) QUANTITATIVE ACCURACY: The LLM introduces a specific time-bound commitment period ('2022-2025') that does not appear in the ground truth and cannot be verified. This appears to be fabricated detail. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM describes the evolution as moving from 'blanket refusal' to 'clear, time-bound intent to fund only what is contractually required,' but the ground truth shows the opposite evolution - from 'did not intend to provide' support to 'may choose to provide' support under certain conditions. (4) MISSING KEY INSIGHT: The LLM completely misses the critical distinction in the ground truth that the 2024 position acknowledges discretionary support for 'significant declines in valuation or redemption activity' - this is a proactive, market-responsive stance, not a contractually-bound one. (5) SEMANTIC INVERSION: The LLM's characterization of the 2024 position as more restrictive ('limited to fulfilling pre-existing capital commitments') is the opposite of what the ground truth indicates - the 2024 position is actually more permissive and discretionary. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required and provides information that directly contradicts the established ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 490,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\nBetween 2022 and 2023 MDLZ kept its equity‑method investment in JDE Peet’s and the €300 million zero‑interest exchangeable notes tied to that stake remained outstanding, giving the company the option to settle the obligation in cash or JDE Peet’s shares.  The 2023 Liquidity and Capital Resources discussion (page 55) notes that this investment “provides us additional flexibility,” and the financing‑costs note (page 45) describes the exchangeable notes as a low‑cost source of funding that does not increase leverage.  Consequently, while the stake itself does not materially change MDLZ’s capital structure, it cushions cash outflows and, together with the $3.5 bn reduction in total debt (2022 $22.9 bn → 2023 $19.4 bn), helps improve the company’s liquidity and debt‑to‑capitalization ratio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific financial details (€300 million exchangeable notes, $3.5 billion debt reduction, debt figures of $22.9 billion in 2022 and $19.4 billion in 2023) that appear factually grounded and demonstrate concrete knowledge of MDLZ's filings. The quantitative data appears accurate based on typical 10-K disclosures. However, there is a significant disconnect between the LLM answer and the ground truth regarding the core evolution being described. The ground truth emphasizes a RECLASSIFICATION of the relationship from 'Has_Stake_In' (2022) to 'Invests_In' (2023), which is a categorical shift in how the investment is characterized. The LLM answer does not address this relationship reclassification at all, instead focusing on the mechanics of the equity-method investment and exchangeable notes structure. While the LLM correctly identifies that the investment 'provides additional flexibility' (matching ground truth language), it misses the fundamental point about the relationship evolution and reclassification. The LLM answer is more detailed about specific financial instruments and their impact on liquidity/capital structure, but it fails to capture the key insight about the changing nature of the relationship itself. The multi-hop reasoning is partially sound (connecting investment to liquidity to debt reduction), but it doesn't synthesize the relationship classification change that appears central to the ground truth answer. The answer is contextually relevant to liquidity and capital structure impacts but incomplete in addressing the full scope of how the 'financial relationship evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 447,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\nThe 3.125 % 2025 Notes were originally hedged with fair‑value interest‑rate swaps that converted the fixed 3.125 % coupon to a floating rate of **LIBOR + 1.8 %** (see the 2021‑2022 debt tables on pages 130‑132).  When the Company updated its hedging documentation for the 2023‑2024 reporting periods, the same $1 billion notional swap was re‑designated to a **SOFR + 2.1 %** floating rate (page 149), reflecting the post‑LIBOR transition and keeping the notional amount unchanged.  Thus, between 2022 and 2024 the hedging strategy shifted from a LIBOR‑based swap at roughly 1.8 % over the reference rate to a SOFR‑based swap at about 2.1 % over the reference rate, while the notional exposure remained at $1 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces information that contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 rate was 'LIBOR + 1.8%', but the ground truth explicitly states 'the exact rate for the 3.125% 2025 Notes was not disclosed' in 2022. This is a fundamental factual error - the LLM fabricated a specific rate that was not in the source documents. (2) The 2024 rate of SOFR+2.1% is CORRECT and matches ground truth. (3) The notional amount of $1,000 million ($1 billion) is CORRECT for both years. (4) MULTI-HOP REASONING ISSUE: While the LLM correctly identifies the transition from LIBOR to SOFR and the change in spread (1.8% to 2.1%), it does so by inventing the 2022 LIBOR rate rather than acknowledging the rate was not disclosed. (5) The LLM provides page references (130-132, 149) which cannot be verified against the ground truth but appear to be fabricated details to add false credibility. (6) SEMANTIC ISSUE: The ground truth indicates the company 'reentered into new swap agreements at then-current interest rates' in 2022 without specifying the exact rate, but the LLM presents a definitive LIBOR+1.8% figure. This is a material misrepresentation of what was actually disclosed. The answer demonstrates good structural understanding of the hedging evolution and correctly identifies the 2024 SOFR+2.1% rate, but the fabrication of the 2022 rate is a critical failure that undermines the entire response's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 411,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\nThe fair‑value of Walmart’s equity investments that are measured using Level 2 inputs fell from **$5,819 million** at the end of fiscal 2022 to **$5,570 million** at the end of fiscal 2023, a decline of **$249 million** (about a 4 % reduction).  \n\n*Source: Level 2 equity‑investment fair‑value figures from WMT 10‑K 2022 (page 72) and WMT 10‑K 2023 (page 71).*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: FY2022 value of $5,819 million, FY2023 value of $5,570 million, and the calculated decline of $249 million are all correct. The percentage calculation (4% reduction) is also accurate: $249M / $5,819M = 4.28%, which rounds to approximately 4%. The answer correctly identifies the metric (fair value of equity investments measured using Level 2 inputs), the company (Walmart), and the fiscal years (2022 to 2023). The multi-hop reasoning is sound - the model synthesized the comparison across two fiscal years and calculated the magnitude of change. The answer addresses all parts of the question: how the value evolved (decreased), the specific values for each year, and the magnitude of change ($249 million). The inclusion of source citations (WMT 10-K pages) adds credibility. The wording is clear and professional, conveying the same information as the ground truth while adding the percentage context, which enhances understanding without introducing any inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 311,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\nIn the 2023 filing Apple only listed “marketing and distribution capability” as one of several competitive factors (page 6), whereas the 2024 filing elevates it to a principal competitive factor and explicitly ties marketing‑driven product introductions and consumer anticipation to swings in net‑sales volume (page 6). This shift shows Apple now places a far greater emphasis on its marketing abilities as a driver of demand and revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION: The LLM claims the 2023 filing only listed 'marketing and distribution capability' as 'one of several competitive factors,' but the ground truth shows Apple explicitly stated it 'relies primarily' on three factors including marketing abilities. The LLM misrepresents the 2023 baseline. (2) MISSING CORE LANGUAGE SHIFT: The ground truth identifies the critical evolution from 'relies primarily' (2023) to 'depends heavily' (2024)—this specific and important linguistic shift is completely absent from the LLM answer. This is the central point of the question. (3) INCOMPLETE SYNTHESIS: The LLM mentions 'marketing-driven product introductions and consumer anticipation' affecting sales volume, but this appears to be an inference not explicitly stated in the ground truth, and it doesn't capture the actual language evolution that occurred. (4) PAGE REFERENCES: The LLM cites 'page 6' for both filings, but provides no verification these are accurate or relevant citations. (5) MISSING CONTEXT: The ground truth notes the shift reflects 'stronger emphasis on strategic importance' in context of 'increasing pressure from rivals imitating features and offering lower-priced alternatives'—important context the LLM omits. (6) DIRECTIONAL ACCURACY: While the LLM correctly identifies that Apple's emphasis on marketing increased between 2023-2024, it fundamentally mischaracterizes what the 2023 filing said and misses the specific language evolution that defines the answer. The answer demonstrates partial understanding of the trend but fails on factual accuracy regarding the baseline and the specific linguistic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 480,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the 3.625 % 2024 Notes still had a $1.4 billion notional amount, but the way the interest‑rate exposure was hedged changed.  In 2022 the swaps that hedged the notes converted the fixed 3.625 % coupon into a floating rate of **LIBOR + 3.2 %**, whereas by 2024 the outstanding swaps had been terminated and replaced with new agreements that now reference **SOFR + 3.4 %** (the swap maturing in connection with the 2024 note redemption).  This shift—from a LIBOR‑based hedge to a SOFR‑based hedge and the modest increase in the spread—shows that Amgen is actively rolling its hedges to align with the new benchmark and maintain a comparable floating‑rate protection strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) NOTIONAL AMOUNT ERROR: The LLM states the notional amount was $1.4 billion 'between 2022 and the end of 2024,' but the ground truth clearly indicates it dropped to $0 by December 31, 2024 (from $1.4 billion in December 2023). The LLM fails to capture this critical change and the full unwinding of the hedging position. (2) INTEREST RATE STRUCTURE ERRORS: The LLM claims the 2022 swaps converted the coupon to 'LIBOR + 3.2%' but provides no ground truth verification for this specific rate. More critically, the LLM mischaracterizes the 2024 situation by stating swaps 'had been terminated and replaced with new agreements' referencing SOFR+3.4%, when the ground truth indicates the hedging position was fully unwound (notional = $0), meaning there were no active swaps by end of 2024. (3) HEDGING STRATEGY INTERPRETATION: The LLM's conclusion that Amgen is 'actively rolling its hedges to align with the new benchmark' is fundamentally incorrect. The ground truth indicates Amgen 'fully unwound its hedging position' by end of 2024, which is the opposite of active rolling. The LLM misinterprets the strategic intent. (4) MISSING KEY CONTEXT: The LLM fails to mention the 2022 termination of $5.2 billion in swaps and re-entry at then-current rates, which is important context for understanding the hedging strategy evolution. (5) TEMPORAL ACCURACY: The LLM conflates the 2023 state (SOFR+3.4%) with the 2024 state without clearly distinguishing that by end of 2024, the position was fully unwound. The answer demonstrates partial understanding of hedging mechanics but fails on the most critical factual elements: the notional amount reduction to zero and the complete unwinding of the hedge.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 484,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\nFrom 2022 to 2023 Schwab progressed from simply **retaining** TD Ameritrade Institutional’s iRebal rebalancing tool for independent advisors to **fully integrating** it into its own platform and promoting it as part of the unified offering for RIAs—tying the solution to the new “Schwab Trading Powered by Ameritrade” experience. This deeper integration demonstrates Schwab’s strategy of differentiating its advisor services with a best‑in‑class, customizable rebalancing capability, reinforcing its competitive positioning as a comprehensive, technology‑rich platform for RIAs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of iRebal from 2022 to 2023 (retention to fuller integration) and accurately captures the strategic intent regarding competitive positioning in the RIA market. The characterization of the progression from 'retaining' to 'fully integrating' aligns with the ground truth. However, there are significant issues: (1) The LLM introduces a specific claim about 'Schwab Trading Powered by Ameritrade' experience that is not present in the ground truth and cannot be verified from the provided context. This is a potential hallucination or unsupported detail. (2) The LLM omits important quantitative context from the ground truth—specifically the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to Schwab by 2023. These numbers are material to understanding the scale and significance of the integration effort. (3) The LLM does not mention Schwab's competitive advantage strategy of 'introducing new products credibly through its strong brand and corporate reputation,' which is explicitly stated in the ground truth as relevant context. (4) The semantic meaning is largely preserved regarding the strategic positioning argument, but the answer is less comprehensive and includes an unverified claim. The quantitative accuracy score reflects the omission of key financial metrics rather than calculation errors. The qualitative accuracy is lower due to the introduction of unsupported details and incomplete synthesis of the ground truth information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 429,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\nApple’s iMac remained a focal point of its desktop strategy, with a refreshed iMac model highlighted in the **first‑quarter 2024 product announcements** (10‑K 2024, p. 24).  The company tied the new iMac to its broader silicon roadmap—leveraging the latest M‑series chip and Apple Intelligence features—to sustain growth in the Mac segment, which posted a **2 % year‑over‑year sales increase in fiscal 2024** driven largely by higher laptop and desktop sales (10‑K 2024, p. 25).  Thus, between 2023 and 2024 Apple shifted from simply maintaining the iMac line to actively refreshing it with newer hardware, integrated services and AI capabilities to keep the desktop offering competitive.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Apple's iMac strategy between 2023 and 2024, correctly identifying that the product received a refresh with new M-series chips and AI capabilities. The qualitative reasoning about the shift from maintenance to active innovation is sound and aligns with the ground truth's assertion that iMac gained strategic importance. However, there are significant quantitative accuracy issues: (1) The LLM cites 'first-quarter 2024 product announcements' and references page 24 of the 2024 10-K, but the ground truth indicates the iMac was elevated in the MD&A section of the 2024 10-K filing itself, not necessarily tied to Q1 2024 announcements specifically. (2) The LLM states 'Mac segment...posted a 2% year-over-year sales increase in fiscal 2024' - this specific percentage cannot be verified against the ground truth provided, which does not include this metric. (3) The LLM attributes growth to 'higher laptop and desktop sales' but the ground truth does not provide this breakdown. These unverified numerical claims reduce quantitative accuracy significantly. The answer does address the core question about evolution between 2023 and 2024, correctly noting the shift from standard offering to highlighted product with new features. The multi-hop reasoning connecting product refresh to strategic importance is sound. However, the introduction of specific metrics and page references that cannot be confirmed against the ground truth, combined with the lack of explicit mention of the MD&A elevation noted in the original answer, prevents a higher score. The answer is directionally correct but contains potentially inaccurate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 462,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the 2.820 % Notes due 2051 remained on RTX’s balance sheet at roughly $1 billion (the 2022 10‑K shows $1 bn as of Dec 31 2021, and the 2024 10‑K still lists $1 bn as of Dec 31 2024).  The company had partially retired the issue in late 2021 through a cash‑tender offer, but it did not retire the entire series; instead it kept the remaining $1 bn tranche while continuing to pay down higher‑coupon, near‑term debt.  This demonstrates RTX’s long‑term debt strategy of preserving a low‑cost, far‑out maturity bucket to balance its overall maturity profile and fund future obligations without relying on short‑term borrowing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The principal balance of $1 billion for the 2.820% Notes Due 2051 is accurate for both 2022 and 2024, matching the ground truth. (2) The semantic interpretation that the notes remained unchanged during the period is correct. (3) The strategic reasoning about preserving low-cost, far-out maturity debt is reasonable and contextually relevant. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about a 'partial retirement in late 2021 through a cash-tender offer' that is NOT mentioned in the ground truth answer. This appears to be either fabricated or from external knowledge not verified against the filing data. The ground truth makes no mention of any retirement or tender offer. (2) The LLM states the 2022 10-K shows '$1 bn as of Dec 31 2021' - this is confusing and potentially inaccurate. The ground truth indicates the notes were 'introduced' in 2022 with $1,000 million principal, not that they existed in 2021. (3) The LLM fails to address the broader long-term debt structure expansion mentioned in the ground truth (from $40,078M to $41,146M), which is a key part of answering what the evolution 'indicates about the company's long-term debt structure.' (4) The LLM's claim about 'paying down higher-coupon, near-term debt' is not substantiated by the ground truth. MULTI-HOP REASONING: The LLM partially addresses the multi-hop aspect by connecting the specific notes to broader debt strategy, but misses the quantitative synthesis of total debt growth that the ground truth emphasizes. The answer is contextually relevant but introduces unverified claims and omits key quantitative comparisons that demonstrate RTX's overall debt expansion strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 478,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab’s IDA agreement was revised to lower the service‑fee it pays on client‑cash deposits at the TD depository institutions from **25 basis points to 15 basis points** (the amendment is noted in the 2023 pro‑forma footnote [page 85] and referenced in the 2023 MD&A [page 54]).  At the same time, Schwab completed the **LIBOR transition**, moving its IDA and related inter‑company lending agreements off the LIBOR benchmark and onto alternative reference rates, and incorporated updated deposit‑beta assumptions into its 2023 net‑interest‑revenue modeling (see the 2023 MD&A discussion of deposit‑beta updates [page 52] and the LIBOR‑phase‑out note [page 86]).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numeric values are correct - the service fee reduction from 25 basis points to 15 basis points is accurately stated and matches the ground truth. The dates (2022 and 2023) are correct. COMPLETENESS: The answer addresses both key aspects of the question: (1) service fee evolution and (2) reference rate adjustments. It successfully synthesizes information across multiple filing sections (pro-forma footnote, MD&A discussions, LIBOR phase-out note). ENTITY ACCURACY: Schwab, TD Depository Institutions, LIBOR, and alternative reference rates are all correctly identified. The fiscal years 2022 and 2023 are properly contextualized. REASONING: The multi-hop synthesis is sound - the answer correctly connects the fee reduction (disclosed in 2022) with the LIBOR transition (completed by 2023), showing the evolution from fee structure adjustments to reference rate modifications. The inclusion of deposit-beta assumptions adds relevant context about how these changes affected financial modeling. SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, using slightly more specific language (e.g., 'completed the LIBOR transition' vs. 'transitioned reference rates'). The addition of specific page references and filing sections enhances credibility without contradicting the ground truth. Minor note: The LLM provides more granular detail about the timing and implementation (e.g., incorporation into 2023 net-interest-revenue modeling) which goes slightly beyond the ground truth but remains factually consistent and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 449,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\nThe 2024 filing no longer presents Filorga as a stand‑alone reporting unit with $221 million of goodwill; instead it is grouped with other trademarks in broader segments, indicating that the company now treats its value as part of an aggregate brand portfolio rather than as a distinct business. This shift reflects a more consolidated valuation approach—using overall trademark fair‑value (which the company notes approximates carrying value) and qualitative assessments—suggesting that Filorga’s strategic importance is being evaluated collectively and that any future goodwill or impairment testing will be applied at the segment‑wide or portfolio level rather than to Filorga in isolation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key shift in Filorga's financial treatment from 2023 to 2024. Quantitative accuracy is excellent: the $221 million goodwill figure is correctly cited, and the transition from standalone reporting unit to grouped trademark status is accurately described. The multi-hop reasoning is sound—the model successfully synthesizes the change across years and explains its implications for valuation methodology. The answer correctly identifies that Filorga moved from discrete impairment testing to segment-level or portfolio-level assessment. However, the LLM answer is somewhat narrower in scope compared to the ground truth. The original answer explicitly mentions potential strategic implications such as 'divestiture, investment, or brand prioritization' and frames the change as potentially signaling 'a shift in strategic focus or a consolidation of brand management.' The LLM answer focuses more narrowly on the mechanical/technical aspects of the valuation approach change (moving from standalone to aggregate fair-value assessment) without fully exploring the broader strategic implications this change might suggest about the company's view of Filorga's importance. The LLM does mention 'consolidated valuation approach' and 'collective' evaluation, which touches on this, but doesn't fully develop the strategic significance angle. The answer is accurate and relevant but slightly incomplete in addressing the full scope of what the change 'suggests about its strategic importance'—it emphasizes the valuation methodology shift more than the strategic positioning implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 454,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\nThe 2024 10‑K now lists the iPhone 16 Pro (along with the 16, 16 Plus and 16 Pro Max) in the “Product, Service and Software Announcements” section (page 24), whereas the 2023 filing only referenced earlier‑generation iPhone models and did not single out a forthcoming “Pro” variant.  In the 2024 report Apple also isolates iPhone net‑sales performance in the segment operating‑performance table (page 25‑26), noting that iPhone revenue was essentially flat in 2024 and linking the result to macro‑economic pressures and the introduction of the new Pro line.  This shift—from a generic forward‑looking statement to a concrete product‑launch disclosure paired with detailed sales metrics—shows Apple’s evolution toward more proactive, data‑driven reporting that ties its product‑development pipeline directly to financial outcomes for investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR FACTUAL ERROR: The LLM claims the 2024 10-K lists iPhone 16 Pro in a 'Product, Service and Software Announcements' section on page 24, and that the 2023 filing 'only referenced earlier-generation iPhone models and did not single out a forthcoming Pro variant.' This directly contradicts the ground truth, which states the 2023 10-K announced the iPhone 16 Pro as part of the Fourth Quarter 2024 product lineup. The LLM has reversed the temporal relationship. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific page numbers (24, 25-26) without verification against actual filings. The claim about 'iPhone revenue was essentially flat in 2024' is presented as fact but cannot be verified against the ground truth provided. (3) MULTI-HOP REASONING FAILURE: The LLM's core argument about the evolution from 'generic forward-looking statement to concrete product-launch disclosure' is logically inverted. According to ground truth, 2023 had the forward-looking announcement, and 2024 had the retrospective inclusion—the opposite of what the LLM describes. (4) SEMANTIC MISALIGNMENT: While the LLM attempts to address the question about evolution in reporting strategy, it fundamentally mischaracterizes the timeline and nature of the disclosures. The ground truth emphasizes a shift from planning/launch phase (2023) to established product (2024), but the LLM suggests the opposite progression. (5) UNVERIFIABLE CLAIMS: The LLM adds details about 'macro-economic pressures' and specific segment operating performance tables that are not mentioned in the ground truth and cannot be verified. The answer demonstrates poor multi-hop synthesis and contains core factual inversions that make it substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 492,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab refined its EVE methodology by updating the assumptions that drive deposit‑beta and non‑maturity cash‑allocation behavior—specifically adding rate‑floor scenarios, more detailed prepayment expectations, and a revised view of client cash reallocation in a declining‑rate environment.  At the same time the company changed its balance‑sheet assumptions, noting a shorter liability duration (now below asset duration) and higher allocations to margin‑loan and cash balances funded partly by FHLB and other short‑term borrowings.  These modeling updates altered the magnitude and direction of EVE sensitivity to interest‑rate shifts compared with the prior year.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant issues with factual accuracy and entity identification. MAJOR PROBLEMS: (1) ENTITY ERROR - The answer attributes the analysis to 'Schwab' when the ground truth does not specify the company name. This is a critical error as the evaluator cannot verify if this is the correct company from the filing. (2) MISSING KEY INFORMATION - The ground truth explicitly states that in 2023, the company 'expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach.' The LLM answer mentions 'revised view of client cash reallocation' but frames it differently and doesn't clearly convey that this was a NEW addition to the modeling approach in 2023. (3) INCOMPLETE 2022 BASELINE - The ground truth specifies 2022 assumptions including 'non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior.' The LLM answer does not establish what the 2022 baseline was, making the comparison less clear. (4) UNSUPPORTED DETAILS - The LLM answer introduces specific details not in the ground truth: 'rate-floor scenarios,' 'shorter liability duration (now below asset duration),' 'higher allocations to margin-loan and cash balances funded partly by FHLB and other short-term borrowings,' and 'altered the magnitude and direction of EVE sensitivity.' While these may be accurate details from the filing, they cannot be verified against the ground truth provided and represent potential hallucination or over-specification. (5) PARTIAL CREDIT - The answer does correctly identify that deposit-beta assumptions were updated and that there was a shift in modeling approach between years, which aligns with the ground truth. The mention of 'declining-rate environment' also matches the ground truth's reference to 'declining interest rate environment.' REASONING QUALITY: The multi-hop synthesis is partially sound but incomplete - the answer attempts to connect modeling assumptions to balance sheet dynamics, but doesn't clearly establish the 2022 baseline before describing 2023 changes, which weakens the comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 593,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\nThe 2023 move let Qualcomm turn its long‑standing “enabler” role for Wi‑Fi/access‑point standards into a direct hardware business, launching its own AP‑grade chipsets and reference designs rather than only licensing the IP.  By doing so it broadened the QCT portfolio from modems and SoCs for handsets into complete networking ASICs and modules, giving the company a stronger, end‑to‑end competitive position against traditional networking vendors in the enterprise and carrier markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's strategic shift from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core strategic transition from 'enabler' role to direct hardware production; (2) Accurately captures the shift from licensing IP to producing AP-grade chipsets and reference designs; (3) Properly identifies the portfolio expansion from modems/SoCs to networking ASICs and modules; (4) Correctly names competitive positioning against traditional vendors like Broadcom and Intel; (5) Appropriately emphasizes the move toward full-system/end-to-end solutions. MINOR GAPS: (1) The LLM answer doesn't explicitly mention Wi-Fi 6 adoption or 5G-driven edge networking growth that provided context for this shift in the original answer; (2) Doesn't specifically reference the broader networking product suite components (Wi-Fi chips, routers, network processors) mentioned in ground truth; (3) Doesn't explicitly mention enterprise and carrier markets as clearly as the original (though it does reference 'enterprise and carrier markets'). QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations in either answer, so this dimension is not heavily tested. The years (2022 vs 2023) are correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes the strategic shift and its implications for competitive positioning, demonstrating sound multi-hop reasoning. The connection between portfolio expansion and competitive advantage is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and organization. The core facts align well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 458,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\nFrom 2022 to 2023 the share of Schwab’s adjustable‑rate mortgages that have interest‑only payment terms slipped slightly—from about 28 % of the portfolio to roughly 27 %—and the portion of those interest‑only balances that are not scheduled to reset for three or more years fell from roughly 89 % to about 86 %.  In other words, both the proportion of interest‑only loans and the length of their reset protection declined modestly over the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative metrics are correct: (1) 2022 interest-only percentage: 28% ✓, (2) 2023 interest-only percentage: 27% ✓, (3) 2022 non-reset-for-3+ years: 89% ✓, (4) 2023 non-reset-for-3+ years: 86% ✓. The multi-hop synthesis is sound—the answer correctly identifies and compares both metrics across both years, establishing the trend of decline in both measures. The reasoning is logical and well-articulated: the LLM correctly interprets that both metrics declined modestly, characterizing this as a 'tightening' of the interest-only structure. The wording is slightly different from the ground truth (e.g., 'slipped slightly' vs. 'shifted slightly,' 'fell from' vs. 'with') but semantically equivalent and arguably more precise. The answer appropriately addresses all components of the multi-part question regarding the evolution of Schwab's HELOC product structure. Minor deduction (1 point) only for very minor stylistic variations that don't affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 298,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Qualcomm kept XR in the IoT/consumer category of its QCT revenue—page 12 of the 2022 filing lists “XR” among the consumer applications tracked under IoT, and page 71 of the 2023 filing shows IoT revenue (which includes XR) falling from $7.35 billion in 2022 to $5.94 billion in 2023.  At the same time, the company’s strategic‑investment arm (Qualcomm Ventures) continued to target early‑stage XR startups, as noted on page 71 of the 2023 filing where “XR” is listed alongside 5G, AI, automotive and other focus areas for Qualcomm Ventures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that diverge substantially from the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF XR EVOLUTION: The LLM claims XR remained in the IoT/consumer category in both 2022 and 2023, contradicting the ground truth which states XR evolved from strategic investments in 2022 to explicit product revenue disclosure in 2023. The ground truth indicates a shift from investment-focused to commercialization-focused, not a static categorization. (2) QUESTIONABLE REVENUE FIGURES: The LLM cites specific IoT revenue numbers ($7.35B in 2022 declining to $5.94B in 2023) with page references, but these cannot be verified against the ground truth provided. More critically, the ground truth does not mention these specific revenue figures or attribute XR revenue to the IoT category. The LLM appears to be conflating XR's categorization with broader IoT revenue trends. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Qualcomm Ventures continued targeting XR startups in 2023, it fails to capture the core evolution described in the ground truth—the transition from purely strategic investment to direct revenue generation from XR products. The answer presents parallel activities (IoT categorization + Ventures investment) rather than the evolution narrative. (4) MISSING KEY INSIGHT: The ground truth emphasizes a qualitative shift in business model engagement (investment → commercialization), which the LLM answer does not address. The LLM focuses on revenue categorization and amounts rather than the strategic evolution. (5) SEMANTIC MISMATCH: The ground truth's claim that XR was 'explicitly listed among industries and applications for which Qualcomm sold products' in 2023 is not the same as saying XR remained in the IoT category throughout both years. The LLM's interpretation suggests continuity where the ground truth indicates change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 523,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.030 % Notes Due 2052 were issued in November 2021 with an aggregate principal of **$1.1 billion**.  Neither the 2022 nor the 2023‑2024 filings record any repayment or additional issuance of that series, and the long‑term‑debt tables for 2022‑2024 still list **$1.1 billion** outstanding.  This flat‑line trajectory shows that RTX is keeping a sizable, long‑dated fixed‑rate tranche on its balance sheet as a stable component of its overall debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: The principal balance of $1.1 billion (equivalent to $1,100 million) is correctly stated for both 2022 and 2024, matching the ground truth exactly. The issuance date of November 2021 is accurate and provides helpful context. The answer correctly identifies that no repayments or additional issuances occurred during the 2022-2024 period. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the aggregate principal balance (showing it remained stable at $1.1 billion), and (2) what this indicates about RTX's long-term debt structure (strategic consistency, stable fixed-rate component). MULTI-HOP REASONING: The synthesis is sound - the model correctly connected information across multiple years' filings to demonstrate the stability of this debt instrument and drew appropriate conclusions about RTX's capital structure strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of the debt as a 'sizable, long-dated fixed-rate tranche' and 'stable component' is semantically equivalent to the ground truth's description of 'strategic consistency in managing this portion of its capital structure.' The phrase 'flat-line trajectory' effectively conveys the unchanged nature of the balance. MINOR CONSIDERATIONS: The LLM provides slightly more context (issuance date, reference to 2023 filings) than the ground truth, which adds value without introducing errors. The answer uses '$1.1 billion' format while ground truth uses '$1,100 million' - both are correct and acceptable variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 442,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\nBetween 2023 and 2024 AXP shifted from a broad “commercial‑payments” emphasis to a concrete evolution of its corporate‑card portfolio—explicitly “evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions, and designing innovative financing, banking and payment products for business customers.”  This focus shows that AXP is treating corporate‑card and commercial‑payment offerings as a distinct growth pillar, leveraging its high‑spending member base and partner ecosystem to deepen relationships with enterprises and expand revenue from business‑to‑business spending.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AXP's strategic evolution between 2023 and 2024, with accurate capture of the key shift from broad commercial payments emphasis to a more integrated, solution-oriented approach. STRENGTHS: (1) Correctly identifies the core evolution - from differentiating corporate card/accounts payable solutions (2023) to designing innovative financing, banking and payment products (2024); (2) Accurately quotes or paraphrases the strategic language from both years; (3) No quantitative errors or incorrect dates; (4) Properly synthesizes the multi-hop information showing progression of strategy; (5) Contextually relevant interpretation that AXP is embedding corporate card into wider business financial services. WEAKNESSES: (1) The LLM answer adds interpretive elements ('treating corporate-card and commercial-payment offerings as a distinct growth pillar,' 'leveraging its high-spending member base and partner ecosystem') that, while reasonable inferences, go beyond what the ground truth explicitly states; (2) The ground truth emphasizes the shift toward 'holistic commercial needs' and 'integrated and solution-oriented approach,' which the LLM captures but frames slightly differently through the lens of 'growth pillar' and 'deepen relationships with enterprises'; (3) Minor semantic difference: ground truth frames this as 'expanding beyond just product differentiation' while LLM frames it as 'distinct growth pillar' - slightly different emphasis. MULTI-HOP REASONING: Sound - correctly synthesizes 2023 and 2024 positioning and draws appropriate conclusion about broader strategy. ENTITY ACCURACY: Correct (AXP, years 2023-2024, corporate card, commercial payments). The answer is substantively correct with minor interpretive additions that don't contradict the ground truth but add analytical layers not explicitly stated in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 514,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\nPCA SKIN remains positioned as a skin‑health brand inside Colgate‑Palmolive’s Oral, Personal and Home Care segment, and its products continue to be sold through the same multi‑channel network used for other personal‑care offerings—namely traditional retailers, wholesalers, distributors and, especially, skin‑health professionals (with growing direct‑to‑consumer sales). The 2024 filing shows no structural shift in these distribution channels; PCA SKIN still leverages professional‑grade outlets and e‑commerce to reach consumers.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a significant factual error that contradicts the ground truth. The original answer explicitly states that in 2023, PCA SKIN was sold 'primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists' with NO mention of 'skin health professionals' in that year. The ground truth indicates that the 2024 filing EXPANDED distribution channels to 'include sales to skin health professionals in some geographies' - this is a KEY EVOLUTION between 2023 and 2024. The LLM answer incorrectly suggests that skin health professionals were already part of the distribution network in both years ('especially, skin-health professionals'), thereby obscuring the actual strategic evolution that occurred. The LLM also introduces 'growing direct-to-consumer sales' which is not mentioned in the ground truth and appears to be an unsupported inference. CORRECT ELEMENTS: The LLM correctly identifies PCA SKIN as a principal trademark within the Oral, Personal and Home Care segment, correctly notes the presence of traditional retailers, wholesalers, distributors, and eCommerce channels, and correctly states there was no structural shift in production or brand status. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal comparison between 2023 and 2024, which was the core requirement of the question. The answer should have clearly articulated that skin health professionals were a NEW addition to the distribution channels in 2024, not an existing channel. This represents a fundamental failure in the comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 444,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\nBetween 2022 and 2023 the Opdivo strategy moved from a broad IO‑expansion focus to a more‑targeted push into earlier disease settings and new tumor types, underscored by FDA/EU approvals of Opdivo for adjuvant melanoma (both monotherapy and in combination) and for neoadjuvant NSCLC chemotherapy (EU and Japan), plus continued development of subcutaneous formulations and new IO combos such as Opdualag.  These added indications and combination regimens are positioned to offset the company‑wide revenue dip by sustaining Opdivo sales growth—particularly in high‑value earlier‑line markets—while the broader portfolio faces pricing pressure and generic erosion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the strategic evolution from 2022 to 2023 toward earlier disease settings and new tumor types; (2) Accurately mentions adjuvant melanoma approvals and neoadjuvant NSCLC development; (3) Correctly references subcutaneous formulation development; (4) Appropriately contextualizes the strategic rationale (offsetting revenue pressures, sustaining growth); (5) Mentions Opdualag as a combination therapy. WEAKNESSES: (1) MAJOR OMISSION: The ground truth explicitly lists 2022 approvals across 10+ specific indications (bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach cancers) - the LLM answer provides no baseline 2022 indication portfolio, making the 'evolution' comparison incomplete; (2) INCOMPLETE COMBINATION THERAPY COVERAGE: Ground truth emphasizes Opdivo + Yervoy combinations across NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers in 2022 - the LLM answer mentions Yervoy only implicitly and focuses heavily on Opdualag without comprehensive coverage of the Yervoy combination portfolio; (3) MISSING REVENUE CONTEXT: Ground truth explicitly states 2022 U.S. revenue growth was driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers - the LLM answer references 'high-value earlier-line markets' but lacks this specific revenue driver detail; (4) VAGUE CHARACTERIZATION: The LLM describes the shift as 'broad IO-expansion focus to more-targeted push' which is somewhat contradictory to the ground truth's emphasis on 'broadening its use' - this represents a subtle but meaningful semantic divergence; (5) SPECULATIVE ELEMENTS: The LLM introduces 'company-wide revenue dip' and 'pricing pressure and generic erosion' which, while contextually reasonable, are not explicitly stated in the ground truth and represent inference beyond the provided data. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2023 timeframes and connects strategic approvals to revenue implications, but fails to comprehensively map the full indication portfolio evolution. QUANTITATIVE ACCURACY: No specific numbers are provided by either answer, so this is not a differentiator, but the LLM's lack of specific indication counts (10+ in 2022 vs. new additions in 2023) represents incomplete quantitative grounding. OVERALL ASSESSMENT: The answer captures the directional strategy shift and key new approvals but significantly underspecifies the 2022 baseline portfolio and combination therapy landscape, making the comparative analysis incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 701,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\nAmerican Express’s holdings of foreign government bonds and obligations showed virtually no change in fair‑value between the two years – the cost basis fell slightly from $770 million in 2023 to $765 million in 2024, and the reported fair value moved in the same direction (≈$770 million to $765 million).  The maturity profile remained heavily front‑loaded: as of 2024, about $764 million (nearly 100 %) of these securities were due within one year, with only $1 million maturing between one and five years and none beyond five years, underscoring a continued emphasis on short‑term exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally contradict the ground truth. (1) MAJOR ERROR - Fair Value Change: The LLM claims fair value 'showed virtually no change' and remained '≈$770 million to $765 million' in both years. The ground truth clearly states fair value was $549 million in 2023 and increased to $765 million in 2024 - a significant $216 million increase (39% growth). The LLM's claim of ~$770 million in 2023 is incorrect. (2) MAJOR ERROR - Cost Basis Misrepresentation: The LLM states cost basis fell from $770 million in 2023 to $765 million in 2024, but the ground truth does not provide cost basis figures for 2023 - only fair value ($549M) and unrealized loss ($1M). The LLM appears to have confused or fabricated the 2023 cost basis figure. (3) CORRECT - Maturity Distribution 2024: The LLM correctly identifies that in 2024, $764 million matures within one year and $1 million between one and five years. (4) CORRECT - Maturity Profile Description: The characterization of the maturity profile as 'heavily front-loaded' and 'short-term exposure' is accurate. (5) INCOMPLETE - Missing 2023 Maturity Data: The LLM fails to mention that in 2023, all $549 million matured in 12 months or more (i.e., no short-term exposure in 2023), which is a critical part of the evolution story. This represents a major shift from long-term to short-term maturity that the LLM completely missed. (6) MISSING CONTEXT: The LLM omits the unrealized loss information ($1 million in 2023), which provides important context about the investment quality. The core narrative is inverted - the ground truth shows substantial growth and a dramatic shift toward short-term maturities, while the LLM claims stagnation and continuity. This is a fundamental mischaracterization of the investment evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 493,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the pool of cash that cannot be moved freely to the United States shrank – from roughly **$4.3 billion** of restricted cash as of January 31 2022 to about **$3.3 billion** of restricted cash as of January 31 2025.  The remaining restricted cash can only be repatriated through dividends or intercompany financing that must be **approved by the non‑controlling interest shareholders (e.g., Flipkart’s minority owners) and is subject to local legal or regulatory limitations**.  Consequently, while the absolute amount of non‑freely‑transferable cash has declined, the conditions governing any transfer have remained tied to shareholder approval and local restrictions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core numbers and evolution of Walmart's restricted cash. Key strengths: (1) Correctly identifies the $4.3 billion figure for 2022 and $3.3 billion for 2024, showing proper multi-hop synthesis across years; (2) Accurately captures the decline in restricted cash amounts; (3) Correctly identifies that transfers require approval from noncontrolling interest shareholders and are subject to local restrictions. However, there are some issues: (1) The LLM references 'January 31 2025' as the 2024 date, which appears to be a minor dating inconsistency (the ground truth references 2024 without specifying the exact date, but Walmart's fiscal year would end January 31, 2025 for fiscal 2024, so this is technically correct but potentially confusing); (2) The LLM answer mentions 'e.g., Flipkart's minority owners' in parentheses, which adds helpful context but slightly shifts the framing from the ground truth's observation that the language moved from 'specifically tied to Flipkart' to 'generally subject to approval from noncontrolling interest shareholders.' The ground truth emphasizes this as a shift in framing/structure, while the LLM treats it more as a consistent condition with Flipkart as an example. (3) The LLM adds the phrase 'through dividends or intercompany financing' which provides useful operational detail but goes slightly beyond what the ground truth explicitly states about the evolution. Overall, the answer correctly synthesizes the multi-hop information (comparing 2022 to 2024 amounts and conditions) and maintains semantic equivalence with the ground truth, though with minor framing differences regarding the significance of the shift in how conditions are described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 477,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\nBased on the disclosed weighted‑average asset allocations, the U.S. Retiree Health Care Plan held roughly 80 % of its assets in fixed‑income securities and cash equivalents and about 20 % in equity securities in both the 2023 and 2024 filings. The plan’s target ranges (75‑85 % fixed income, 15‑25 % equity) were unchanged, and the actual 2023 (80 % / 20 %) and 2024 (80 % / 20 %) percentages show essentially no evolution in the composition between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key finding that asset allocation remained essentially unchanged between 2023 and 2024, with approximately 80% fixed income and 20% equity in both years. The percentages stated (80%/20%) are semantically equivalent to the ground truth's more precise figures (79.5%/20.5%), representing acceptable rounding. The LLM also appropriately mentions target ranges (75-85% fixed income, 15-25% equity) which adds relevant context.\n\nHowever, there is a significant omission: the LLM answer fails to provide the actual dollar amounts ($210 million in fixed income securities and cash equivalents, and $54 million in equity securities, totaling $264 million) that are explicitly stated in the ground truth. These specific dollar figures are important quantitative details that directly address the question about how the composition 'evolved' (or in this case, remained static). The ground truth emphasizes these exact figures as evidence of the unchanged allocation.\n\nThe reasoning is sound - the LLM correctly synthesizes that there was no evolution in the asset allocation strategy and that the percentages remained constant. The multi-hop synthesis across the two filing years is accurate. The mention of target ranges, while not in the ground truth answer, is contextually relevant and doesn't contradict the core findings.\n\nThe main weakness is the incomplete quantitative disclosure - providing percentages without the supporting dollar amounts represents a material omission for a financial question that specifically asks about asset composition evolution. A complete answer would have included both the percentages AND the dollar amounts to fully demonstrate the unchanged nature of the plan assets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 475,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell has moved its non‑employee director compensation onto the 2016 Stock Plan for Non‑Employee Directors (the successor to the 2006 plan) and has updated the governing award documents twice since 2021.  The 2023 amendment (Exhibit 10.54* to the 2024 10‑K) revises the “Form of Stock‑Option Agreement” (Exhibit 10.52*) and the “Form of Restricted‑Stock‑Unit Agreement” (Exhibit 10.53*), adding performance‑based vesting triggers, cash‑settlement alternatives and revised change‑in‑control provisions.  This evolution shows a deliberate shift toward more performance‑linked, flexible director pay that can be adjusted without launching a new plan, reflecting a broader move to align non‑employee director compensation with long‑term shareholder interests.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) MAJOR ERROR - Plan Identification: The ground truth explicitly states the question concerns Honeywell's '2006 Stock Plan for Non-Employee Directors,' but the LLM answer claims the company 'moved its non-employee director compensation onto the 2016 Stock Plan for Non-Employee Directors (the successor to the 2006 plan).' This is a critical misidentification of which plan is being discussed. (2) MAJOR ERROR - Exhibit Numbers: The ground truth specifies that in 2022, the exhibits were 'Form of Option Agreement (Exhibit 10.30)' and 'Form of Restricted Unit Agreement (Exhibit 10.32),' and in 2024 the Option Agreement was 'Exhibit 10.29.' The LLM provides completely different exhibit numbers (10.52, 10.53, 10.54) that do not match the ground truth. (3) MAJOR ERROR - Award Forms: The ground truth indicates the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned by 2024, suggesting a shift away from restricted units. The LLM claims both 'Form of Stock-Option Agreement' and 'Form of Restricted-Stock-Unit Agreement' were updated in 2023, which contradicts the ground truth's finding that restricted units were dropped from the exhibit list. (4) UNSUPPORTED CLAIMS: The LLM introduces claims about 'performance-based vesting triggers, cash-settlement alternatives and revised change-in-control provisions' that are not mentioned in the ground truth and cannot be verified. (5) REASONING FAILURE: While the LLM's conclusion about alignment with shareholder interests is reasonable, it is based on incorrect factual premises. The multi-hop synthesis failed because the LLM did not correctly identify which plan documents were being compared or accurately track the evolution of exhibit forms between 2022 and 2024. The answer demonstrates a fundamental misunderstanding of the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 517,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Walmart’s ownership in Flipkart was cut from roughly 83 % to about 75 % after the subsidiary’s $3.2 billion equity raise in FY 2022, generating a cash inflow that reduced the carrying value of the investment and diluted Walmart’s voting control.  At the same time, Flipkart is under intensified Indian regulatory scrutiny—including a Competition Commission of India antitrust investigation that could bring monetary penalties or conduct remedies, and a foreign‑direct‑investment show‑cause notice that may lead to further fines or restrictions on its ownership structure—creating material uncertainty about the long‑term financial return and legal exposure of Walmart’s stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core quantitative facts: (1) ownership stake reduction from 83% to 75%, (2) $3.2 billion equity funding in FY 2022, (3) cash inflow and dilution of voting control. The timeframe (2022-2024) is appropriately addressed. The answer correctly notes regulatory scrutiny and its potential financial implications.\n\nWEAKNESSES: (1) The LLM introduces a 'Competition Commission of India antitrust investigation' that is NOT mentioned in the ground truth. The ground truth specifically references a 'show cause notice issued in July 2021' and 'information requests related to alleged violations of India's Foreign Direct Investment rules during 2009-2015.' The LLM conflates or adds regulatory details not supported by the source material. (2) The LLM fails to mention the critical detail that the regulatory issues relate to Flipkart's PRE-ACQUISITION history (2009-2015, before Walmart's 2018 acquisition), which is a key contextual element explaining why Walmart faces legacy risks despite reduced ownership. (3) The LLM mentions 'share ownership restrictions' generically but doesn't capture the ground truth's specific point about Walmart's 'inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders.' (4) The characterization of the evolution as 'managing legacy risks' is implicit in the LLM answer but not explicitly articulated.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between the ownership reduction (financial participation) and regulatory exposure (legacy risks), showing understanding that these are related but distinct aspects of Walmart's strategic position. However, the introduction of unsubstantiated regulatory details (CCI antitrust investigation) suggests either hallucination or conflation of information.\n\nNUMERIC VERIFICATION: All numbers are correct (83%, 75%, $3.2 billion, FY 2022). No calculation errors detected.\n\nCRITICAL ERROR: The mention of 'Competition Commission of India antitrust investigation' is a factual inaccuracy not present in the ground truth and potentially misleading about the nature of regulatory risks Walmart faces.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 584,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\nBetween the end of 2022 (cash ≈ $9.6 bn) and the end of 2024 (cash ≈ $10.6 bn), Honeywell’s total cash rose after a dip in 2023, with the net increase driven by $10.4 bn of long‑term debt issuance and $2.3 bn of commercial‑paper proceeds used to fund acquisitions and shareholder returns.  The company continued to keep a large share of its liquidity abroad—about $8 bn of cash, cash equivalents and short‑term investments were held in non‑U.S. subsidiaries as of 31 Dec 2024—while U.S.‑based cash grew to roughly $3 bn, reflecting a strategic emphasis on deploying domestic cash for dividend increases, share‑repurchase programs and U.S.‑based M&A while still maintaining ample offshore cash for global investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states 2022 cash was ~$9.6bn and 2024 was ~$10.6bn, but the ground truth clearly indicates 2021 year-end cash was $11.5bn (reported in 2022 filing) and 2024 year-end cash was $11.0bn. The LLM's figures are substantially lower and incorrect. (2) GEOGRAPHIC DISTRIBUTION - The LLM correctly identifies $8.0bn held in non-U.S. subsidiaries as of Dec 31, 2024, which matches the ground truth. However, the LLM's claim that U.S.-based cash was 'roughly $3bn' is problematic: if total cash is $11.0bn and $8.0bn is non-U.S., then U.S. cash would be approximately $3.0bn, which is mathematically consistent with the LLM's statement but inconsistent with the LLM's stated total of $10.6bn. (3) EXTRANEOUS INFORMATION - The LLM introduces details about debt issuance ($10.4bn), commercial paper ($2.3bn), acquisitions, and shareholder returns that are not part of the ground truth answer and appear to be unsupported synthesis. While these may be factually accurate from the filings, they are not relevant to answering the specific question about composition and geographic distribution evolution. (4) MISSING CONTEXT - The LLM fails to mention the 2021 baseline ($11.5bn) and the strategic emphasis on 'safety of principal and diversification among counterparties' that the ground truth emphasizes. (5) MULTI-HOP REASONING - The LLM attempts to synthesize information across years but does so with incorrect baseline numbers, undermining the validity of the comparison. The core issue is that the LLM's 2022 and 2024 cash figures are materially wrong, making the entire analysis unreliable despite some correct elements (non-U.S. cash amount, general strategic direction).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 492,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\nFrom 2023 to 2024 the Company expanded the Membership Rewards liability model to include explicit sensitivity metrics—projecting that a 25‑basis‑point increase in the ultimate redemption rate would add roughly $197 million to the liability and a 1‑basis‑point rise in the weighted‑average cost‑per‑point would add about $220 million—while emphasizing that the estimate now relies on statistical‑actuarial inputs and periodic reassessment of partner contracts and redemption‑pattern shifts.  At the same time, the accounting for deferred fees was refined, with a more granular breakdown of deferred Membership Rewards fees, direct acquisition‑cost offsets and cancellation reserves, yielding a clearer presentation of the related liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness. QUANTITATIVE VERIFICATION: All numeric values are correct—the 25 basis point URR increase adding $197 million and the 1 basis point WAC increase adding $220 million match the ground truth exactly. Number formats are consistent and accurate. COMPLETENESS: The answer addresses all key aspects of the question: (1) evolution from 2023 to 2024, (2) deferred fees treatment, (3) liability estimation methodology, and (4) modeling assumptions. The multi-hop synthesis correctly connects the shift from simple deferred fee recognition to a comprehensive model-driven approach. ENTITY ACCURACY: All metrics are correctly identified (URR, WAC, deferred fees, liability) and the temporal comparison (2023 to 2024) is properly framed. REASONING QUALITY: The answer effectively synthesizes the evolution narrative, explaining both the quantitative sensitivity metrics and the qualitative shift toward statistical-actuarial inputs. The mention of 'periodic reassessment of partner contracts and redemption-pattern shifts' adds appropriate context about the methodology refinement. SEMANTIC EQUIVALENCE: The LLM's phrasing ('expanded the Membership Rewards liability model,' 'refined accounting for deferred fees,' 'granular breakdown') conveys the same substantive meaning as the ground truth's description of the shift from 'simpler mention' to 'comprehensive, model-driven approach.' MINOR CONSIDERATIONS: The LLM answer includes slightly more operational detail (partner contracts, cancellation reserves) than the ground truth, but this represents appropriate elaboration rather than error. The answer maintains factual accuracy while providing additional context that enhances understanding of the methodology evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 484,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Adobe has moved Frame.io from a newly‑acquired, stand‑alone video‑collaboration tool into the core of its Creative Cloud and Digital Experience stacks.  The platform is now tightly integrated with Creative Cloud apps (e.g., Premiere Pro, Photoshop, Express), the Adobe Experience Platform, and AI‑driven services such as Firefly, positioning Frame.io as the collaboration hub that links video workflows, document‑cloud services and generative‑AI capabilities across Adobe’s end‑to‑end creative ecosystem while contributing to the growth of Digital‑Media ARR.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Frame.io's strategic evolution at Adobe between 2022 and 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the transition from newly-acquired standalone tool to core ecosystem component; (2) Accurately names key integrated applications (Premiere Pro, Photoshop, After Effects implied through Creative Cloud reference); (3) Correctly identifies strategic alignment with Adobe's broader ecosystem including AI capabilities; (4) Appropriately references Digital Media ARR growth contribution; (5) Captures the essence of the evolution from initial integration to full ecosystem incorporation. MINOR ISSUES: (1) The LLM mentions 'Express' as an integrated app, which is not mentioned in the ground truth's specific list of Premiere Pro, After Effects, Photoshop, and Workfront - this is a minor addition not contradicted by ground truth but not explicitly confirmed; (2) The LLM references 'Adobe Experience Platform' and 'Firefly' which represent broader ecosystem positioning but are not explicitly mentioned in the ground truth answer, though they align with the spirit of deeper strategic alignment; (3) The original $1.18 billion acquisition price is not mentioned in the LLM answer, though the question doesn't specifically ask for this detail. QUANTITATIVE ACCURACY: The LLM does not provide specific numbers or dates that could be verified as incorrect - it uses appropriate temporal markers (fiscal 2022 vs 2024) and avoids false specificity. MULTI-HOP REASONING: The answer successfully synthesizes information about Frame.io's positioning across multiple product lines and strategic initiatives, demonstrating proper understanding of how the acquisition evolved within Adobe's broader strategy. The reasoning connecting collaboration, creative workflows, and AI capabilities is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 519,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\nBetween the 2022 and 2023 reporting periods the fair‑value amount attributed to “equity‑like” private‑alternative funds that is measured using significant unobservable inputs (Level 3) grew sharply—from $5.5 million in 2022 to $25.1 million in 2023, an increase of roughly $19.6 million (about a 350 % rise). This shows that a much larger share of the equity‑like fund holdings was valued through Level 3 inputs in 2023, indicating greater reliance on internal, unobservable valuation techniques over the two‑year span.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about the evolution of equity-like funds' Level 3 fair value measurements between 2022 and 2023, with generally sound reasoning and appropriate contextual framing. However, there is a critical quantitative discrepancy that significantly impacts accuracy. The ground truth states the 2023 value was $25.4 million, but the LLM answer reports $25.1 million—a $0.3 million difference. While this may seem minor in absolute terms, it represents a factual error in a financial context where precision is essential. Additionally, the LLM's calculated percentage increase of 'roughly 350%' is mathematically inconsistent with the numbers provided. Using the LLM's own figures ($5.5M to $25.1M), the increase would be approximately 356%, which rounds to 356%, not 350%. Using the correct ground truth figures ($5.5M to $25.4M), the increase would be approximately 362%, which the ground truth correctly characterizes as a 'fivefold increase' (which equals 400% growth from the base). The LLM's percentage calculation appears to be an approximation that doesn't align precisely with either set of numbers. The qualitative analysis is sound—the LLM correctly identifies the shift toward Level 3 inputs and appropriately characterizes this as indicating greater reliance on unobservable valuation techniques. The multi-hop reasoning is adequate, synthesizing the year-over-year comparison and drawing logical conclusions about valuation methodology shifts. The answer is contextually relevant and addresses all parts of the question, but the numerical inaccuracy in the 2023 figure and the imprecise percentage calculation prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 458,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Frame.io from a freshly‑acquired video‑collaboration tool into a core, AI‑enhanced hub that is tightly woven into the Creative Cloud suite and the broader Digital Media portfolio.  The 2022 filings note its integration into Digital Media and its connection to Premiere Pro, Photoshop and other Creative Cloud apps, while the 2024 disclosures emphasize expanded integrations—such as Camera‑to‑Cloud, Firefly‑powered generative features, and availability in Adobe GenStudio—positioning Frame.io as the primary collaborative layer that accelerates end‑to‑end content creation and drives subscription growth within Adobe’s Digital Media business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Frame.io's evolution within Adobe's portfolio between 2022 and 2024. STRENGTHS: (1) Correctly identifies the acquisition timing (October 2021) and 2022 baseline state; (2) Accurately lists specific integrations mentioned in ground truth (Premiere Pro, Photoshop, After Effects, Lightroom, Workfront, GenStudio); (3) Properly characterizes the strategic evolution from initial integration to deeper ecosystem embedding; (4) Adds relevant context about AI-enhancement and Camera-to-Cloud features that align with 2024 positioning; (5) Correctly synthesizes multi-hop information across years and product lines. MINOR CONSIDERATIONS: (1) The LLM answer introduces 'Camera-to-Cloud' and 'Firefly-powered generative features' which are not explicitly mentioned in the ground truth, though these appear to be reasonable inferences about 2024 positioning that don't contradict the ground truth; (2) The phrase 'primary collaborative layer' is the LLM's characterization rather than direct ground truth language, but semantically aligns with the 'core part' description; (3) The emphasis on 'subscription growth' is contextually appropriate but not explicitly stated in ground truth. QUANTITATIVE ACCURACY: All dates and entity names are correct (Adobe, Frame.io, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio). No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information about Frame.io's role across 2022 and 2024, properly identifying the progression from standalone tool to integrated ecosystem component. The answer demonstrates sound understanding of Adobe's strategic positioning. CONTEXTUAL RELEVANCE: Directly addresses the evolution question with appropriate temporal framing and product ecosystem context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 503,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\nBetween 2022 and 2024 CVS shifted from a set of discrete medication‑management programs (e.g., Pharmacy Advisor, disease‑management and weight‑management services, and basic digital adherence tools) to a unified, AI‑driven clinical platform—its proprietary **Canopy** system—that weaves pharmacy, claims and clinical data together.  The newer platform adds predictive‑analytics and machine‑learning‑based rules engines, real‑time adherence alerts, and integrated scheduling/virtual‑care tools (e.g., MinuteClinic appointment engines, SMS reminders, and digital results portals) that let clinicians intervene earlier, personalize therapy and drive lower‑cost drug choices.  This evolution also expands value‑based contracts (Oak Street Health, Signify Health, Cordavis biosimilars) that tie reimbursement to adherence and cost‑efficiency outcomes, making medication‑management a core component of CVS’s broader cost‑containment and quality‑improvement strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) FABRICATED INFORMATION: The 'Canopy' system is not mentioned in the ground truth at all. This appears to be a hallucinated proprietary platform. (2) MISSING KEY FACTS: The LLM completely omits several concrete initiatives mentioned in ground truth: National Pharmacy and Therapeutics Committee, formulary management, generic drug promotion, real-time benefit information, mail order/specialty pharmacies, the seven-day opioid supply limit (an industry-leading clinical program), and the NovoLogix preauthorization platform. (3) INCOMPLETE ENTITY COVERAGE: While the LLM mentions Oak Street Health and value-based contracts, it adds Signify Health and Cordavis biosimilars without ground truth support. The CVS Weight Management program with GLP-1 medication optimization is mentioned in ground truth but not in LLM answer. (4) QUANTITATIVE ERRORS: The ground truth specifies Oak Street Health operates 239 primary care centers across 27 states—the LLM provides no such specificity. (5) SEMANTIC MISALIGNMENT: The ground truth describes an evolution from 'cost-containment strategies to integrated, digitally enabled, and clinically proactive model.' The LLM's framing around 'Canopy' and AI-driven platforms is speculative and not grounded in the actual filing data. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022-2024 evolution, it does so by inventing details rather than synthesizing actual documented changes. The answer reads as plausible but is fundamentally unreliable due to hallucination of the central 'Canopy' platform claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 461,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Adobe moved Frame.io from a newly‑acquired platform that was first integrated only into Premiere Pro and After Effects for native review and approval (page 7) to a broadly‑embedded collaboration layer across the Creative Cloud suite. By 2024 the company had added real‑time upload, frame‑accurate commenting, Camera‑to‑Cloud ingest and tight integration with Adobe Express, Firefly Services and GenStudio, making Frame.io’s workflows a native collaborative layer for video, design and document projects (pages 6, 12).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Frame.io's evolution within Adobe's ecosystem from 2022-2024 and correctly identifies the key trajectory from video-specific to broader creative collaboration platform. Strengths: (1) Correctly identifies the 2022 acquisition and initial integration into Premiere Pro and After Effects; (2) Accurately describes the 2024 expansion to include real-time upload, frame-accurate commenting, and Camera-to-Cloud functionality; (3) Properly synthesizes the multi-hop information showing progression across the time period; (4) Correctly identifies expanded integrations with Adobe Express, Firefly Services, and GenStudio. Minor weaknesses: (1) The LLM answer mentions 'frame-accurate commenting' which is not explicitly mentioned in the ground truth (though this is a reasonable detail that doesn't contradict it); (2) The answer omits specific mentions of integration with Photoshop, Lightroom, and Workfront that were highlighted in the ground truth as part of the 2024 evolution; (3) The answer doesn't explicitly mention still images, design files, and PDFs as expanded content types, though it does reference 'design and document projects' which partially captures this; (4) The reference to 'pages 6, 7, 12' suggests this is from a specific filing, but these page citations cannot be verified against the ground truth. The core narrative of evolution from video-specific to broader creative asset platform is accurately conveyed. The answer successfully addresses the multi-part question about both integration evolution and specific enhancements, though with some omissions of specific product integrations mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 461,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\nIn 2024 the Firm shifted a larger share of its loan‑valuation work from Level 3 (unobservable) inputs to Level 2 by treating recently executed transaction prices, market price quotations and CDS‑spread adjustments as the primary observable inputs (see Notes 2‑3 in the 2023 10‑K and the “Loans and Lending Commitments” discussion on pages 99‑100).  This refinement reduced the reliance on proprietary discounted‑cash‑flow models and made the fair‑value estimate more directly anchored to observable market trades, which is reflected in the narrower gap between contractual principal and reported fair value (‑$11.1 bn in 2023 versus ‑$10.2 bn in 2024).  Consequently, recently executed transactions now play a more central and transparent role in the Firm’s fair‑value determination for loans and other assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific quantitative details (fair value gaps of -$11.1bn in 2023 vs -$10.2bn in 2024, references to Notes 2-3 and pages 99-100) that appear factually grounded and add concrete evidence. However, there are significant issues with alignment to the ground truth:\n\n1. SCOPE MISMATCH: The ground truth discusses evolution across both 2023 and 2024 with emphasis on how recently executed transactions were used in BOTH years - as a key input in 2023 and with more targeted application in 2024 (particularly for held-for-sale loans and other investments). The LLM answer focuses heavily on a 2024 SHIFT from Level 3 to Level 2 inputs, which is a different analytical framework than what the ground truth emphasizes.\n\n2. MISSING KEY ELEMENTS: The ground truth specifically mentions that by 2024, recently executed transactions extended to \"other investments\" and were used with \"discounted cash flow models and comparable company multiples.\" The LLM answer mentions discounted cash flow models but frames them as being REDUCED in reliance, not as complementary tools used alongside transaction data.\n\n3. FRAMING DIFFERENCE: The ground truth describes a \"more targeted application\" of transaction data, while the LLM describes a \"shift\" and \"refinement\" that reduces reliance on proprietary models. These are subtly different narratives - one emphasizes refinement of application scope, the other emphasizes a methodological shift in input hierarchy.\n\n4. QUANTITATIVE VERIFICATION: The specific dollar amounts (-$11.1bn vs -$10.2bn) and reference citations appear plausible but cannot be verified against the ground truth, which does not provide these specific numbers. This is additional detail not contradicted but also not confirmed.\n\n5. MULTI-HOP REASONING: The LLM successfully synthesizes information about fair value determination methodology and provides a logical explanation of how observable inputs replaced unobservable ones. However, it doesn't fully capture the evolution described in the ground truth regarding the EXTENSION of transaction use to other asset categories.\n\nThe answer is partially correct with good quantitative specificity but misses the nuanced evolution described in the ground truth regarding scope expansion and complementary use of valuation methods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 620,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Substance 3D Stager from a stand‑alone, separately‑priced app in the Substance 3D suite to a core, tightly‑integrated hub of the **Adobe Substance 3D ecosystem**.  In the 2022 filing the company noted that Substance 3D apps were sold apart from Creative Cloud, but by the 2024 filing it describes Stager together with Painter, Sampler, Designer and Modeler as part of a unified desktop‑and‑VR workflow that “builds and assembles 3D scenes,” links to other Substance 3D tools, and is positioned alongside Firefly‑powered generative services for a seamless, end‑to‑end 3D content‑creation pipeline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. MAJOR ERRORS: (1) The LLM claims Substance 3D Stager moved from 'stand-alone, separately-priced app' to 'core, tightly-integrated hub' - the ground truth makes no such claim about pricing changes or hub status. This appears to be fabricated detail not supported by the knowledge graph. (2) The LLM states 'In the 2022 filing the company noted that Substance 3D apps were sold apart from Creative Cloud' - the ground truth only mentions Stager was 'listed among Adobe's trademarks' in 2022 with 'no detailed information about its functionality or strategic positioning.' The claim about separate pricing is unsupported. (3) The LLM introduces 'Firefly-powered generative services' as part of the 2024 positioning - the ground truth makes no mention of Firefly integration. CORRECT ELEMENTS: The LLM correctly identifies the 2022-2024 timeframe, correctly names the companion products (Painter, Sampler, Designer, Modeler), and correctly describes Stager's 2024 role as 'builds and assembles 3D scenes.' The core concept of evolution from standalone to ecosystem integration is directionally correct. However, the LLM has added substantial details (separate pricing model, hub status, Firefly integration) that are not in the ground truth and appear to be hallucinations. The answer demonstrates partial understanding but introduces false specificity that undermines credibility. The multi-hop reasoning is partially sound but contaminated by unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 426,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\nFrom 2022 to 2023 GE moved from a peripheral, “may‑be‑important” reference to grid‑scale batteries in its decarbonisation narrative to a more central, explicitly‑strategic role for the technology within its new energy platform (GE Vernova). In the 2022 filing the company noted that deep‑decarbonisation would “likely depend … on technologies that are not yet deployed … (such as grid‑scale batteries or other storage solutions),” treating storage as an uncertain future opportunity. By the 2023 filing—after the separation of the power and renewable‑energy businesses—GE repeatedly cites grid‑scale batteries (alongside hydrogen, CCS, SMRs, etc.) as a key enabler of its long‑term growth and decarbonisation goals, signalling a higher level of strategic reliance, though still contingent on policy incentives, cost reductions and technology maturation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and provides a nuanced understanding of GE's evolving strategic positioning on grid-scale batteries from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core shift from peripheral/speculative treatment in 2022 to more central strategic role in 2023; (2) Accurately captures the language evolution ('may become more important' to explicit strategic dependency); (3) Properly contextualizes the separation of power and renewable-energy businesses as a catalyst for this shift; (4) Correctly identifies grid-scale batteries as part of a broader portfolio of enabling technologies (hydrogen, CCS, SMRs); (5) Appropriately notes contingencies (policy incentives, cost reductions, technology maturation); (6) Mentions GE Vernova as the new platform, adding relevant context. MINOR ISSUES: (1) The LLM answer includes slightly more specific language from the 2022 filing ('likely depend...on technologies that are not yet deployed') compared to the ground truth's paraphrase, but this is actually more precise and accurate to the source material; (2) The ground truth uses 'depend in part' while LLM uses 'likely depend...on' - these are semantically equivalent but the LLM's phrasing appears more directly sourced; (3) The LLM adds contextual details about contingencies that, while accurate and relevant, go slightly beyond what the ground truth explicitly states, though this represents enhancement rather than error. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, correctly identifying the temporal evolution and the structural change (business separation) that influenced strategic positioning. The reasoning is sound and logically presented. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less applicable, but the temporal references (2022 vs 2023) and entity references (GE, GE Vernova) are all correct. The answer maintains semantic equivalence with the ground truth while providing slightly more granular detail and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 564,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\nBetween 2022 and 2024 CVS continued to report that it holds **no broker‑quoted debt securities** for the periods it evaluates—​the 2022 filing notes the company had none for the years ended 2022 and 2021 (the language was carried forward into the 2024 filing, which explicitly states there were “no broker‑quoted debt securities for the years ended December 31, 2024 and 2023”). Consequently, broker‑quoted inputs no longer appear in its fair‑value hierarchy disclosures, and the absence of such securities means they have **no direct effect on the company’s fair‑value measurements, earnings, or other‑comprehensive‑income balances** in either year. The company now relies solely on observable market‑based Level 2 inputs and internally derived Level 3 pricing for private‑placement securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that CVS had no broker-quoted debt securities in both 2022 and 2024, which aligns with the ground truth. However, there are several significant issues: (1) QUANTITATIVE ERROR: The LLM states '2022 filing notes the company had none for the years ended 2022 and 2021' but the ground truth specifies the 2022 filing covered 'years ended December 31, 2021, and 2020' - this is a factual error in the years cited. (2) INCOMPLETE SYNTHESIS: The LLM adds information about 'Level 2 inputs and internally derived Level 3 pricing' that is not present in the ground truth answer, which could be accurate but represents unsupported elaboration beyond what was verified. (3) MISSING KEY EVOLUTION: The ground truth emphasizes that the 2024 disclosure 'no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance' - this important evolution in disclosure emphasis is completely absent from the LLM answer. The LLM focuses on the static fact (no securities) rather than the dynamic evolution of disclosure approach. (4) SEMANTIC ISSUE: The LLM's statement about 'no direct effect on the company's fair-value measurements, earnings, or other-comprehensive-income balances' is a logical inference but not explicitly stated in the ground truth. The answer is partially correct on the main point but fails to capture the nuanced evolution in disclosure emphasis that was central to the original question about how disclosure 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 428,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\nBetween 2023 and 2024 the “Equity securities / mutual funds” line in BlackRock’s Equity Securities at FVTNI grew from **$1,585 million to $1,950 million** – an increase of about **$365 million (≈23 %)**.  The broader equity‑method investment balance rose only modestly, from **$2,756 million to $2,783 million** (+$27 million), but its composition shifted: private‑equity holdings fell from **$1,264 million to $1,060 million**, while real‑asset and multi‑asset mutual‑fund holdings increased (from $417 million to $520 million) and the deferred‑cash‑compensation component declined (from $241 million to $173 million).  In short, mutual‑fund exposure expanded substantially, private‑equity exposure contracted, and the overall equity‑method portfolio was essentially flat with a different mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) EQUITY SECURITIES/MUTUAL FUNDS: Ground truth states 2023 value was $1,211 million, but LLM claims $1,585 million - a $374 million discrepancy (31% error). The 2024 value of $1,950 million is correct. (2) EQUITY METHOD INVESTMENTS: Ground truth states 2023 value was $1,895 million, but LLM claims $2,756 million - a $861 million discrepancy (45% error). The 2024 value of $2,783 million is correct. (3) The LLM introduces detailed breakdowns of private-equity holdings ($1,264M to $1,060M), real-asset holdings ($417M to $520M), and deferred-cash-compensation ($241M to $173M) that are NOT mentioned in the ground truth and cannot be verified. These appear to be fabricated or sourced from incorrect data. (4) CALCULATION VERIFICATION: The LLM's calculation of $365M increase for equity securities/mutual funds is based on the incorrect 2023 baseline ($1,585M vs correct $1,211M). The correct increase should be $739M ($1,950M - $1,211M), not $365M. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize composition changes across categories, it does so using fundamentally incorrect baseline numbers, making all downstream analysis unreliable. (6) The answer demonstrates a pattern of providing confident but incorrect financial data, which is particularly problematic in financial analysis contexts where accuracy is paramount. The only correct values in the LLM response are the 2024 figures ($1,950M for equity securities/mutual funds and $2,783M for equity method investments).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 442,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\nBoth the 2022 10‑K (pages 55‑59) and the 2024 10‑K (pages 47‑51) describe the same impairment process: the Company tests each available‑for‑sale debt security for credit‑related impairment by comparing its fair value to amortized cost and evaluating cash‑flow expectations and issuer credit ratings. It concludes that the unrealized losses observed through 2024 are driven by interest‑rate movements rather than borrower credit deterioration, so no material allowance for credit losses has been recorded in either year.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant omissions and misses the core evolution described in the ground truth. Specific issues: (1) MISSING KEY EVOLUTION: The ground truth explicitly states that by 2024, the allowance for credit losses is 'now explicitly described as being recorded as a separate component through an allowance account' - a material shift from 2022. The LLM answer incorrectly claims 'no material allowance for credit losses has been recorded in either year,' which contradicts the ground truth's description of the 2024 evolution. (2) INCOMPLETE CHARACTERIZATION: The ground truth describes a shift 'from a qualitative, low-risk assessment to a more formalized impairment accounting framework' - this evolution is entirely absent from the LLM answer. (3) ACCOUNTING TREATMENT CHANGE: The ground truth notes that credit-related impairments now impact 'investment and other income,' indicating a change in how these are recognized. The LLM answer does not capture this distinction. (4) METHODOLOGY CONSISTENCY: While the LLM correctly notes that evaluation methodology remained consistent (assessing present value, issuer credit condition, fair value vs. amortized cost), it fails to highlight that the ACCOUNTING RECOGNITION changed - the allowance moved from 'not material' to being 'explicitly described as being recorded as a separate component.' (5) TEMPORAL ACCURACY: The LLM correctly identifies 2022 and 2024 periods and correctly notes that unrealized losses were driven by interest rates rather than credit deterioration in both years. However, this correct observation masks the failure to identify the structural accounting change. The answer reads as if nothing materially changed between 2022 and 2024, when the ground truth clearly indicates a formalization of the impairment accounting framework. The LLM answer is partially correct on the surface-level assessment but fundamentally misses the evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 530,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 AMD’s equity interest in the ATMP joint venture rose from roughly **$83 million to $99 million** (page 79), and the equity‑method income it records—recorded as “Equity income in investee”—increased from **$14 million in 2022 to $16 million in 2023** (also page 79).  This growth reflects a larger investment balance and higher gains from the JV’s operations, indicating that AMD’s financial relationship with the ATMP JV deepened over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Carrying value of ATMP JV investment: $83 million in 2022 → $99 million in 2023 ✓; (2) Equity income: $14 million in 2022 → $16 million in 2023 ✓. The multi-hop synthesis is sound—the answer correctly identifies and compares the two key financial metrics across both years, demonstrating proper synthesis of investment value and equity income data. The LLM appropriately identifies the source (page 79) and correctly labels the equity income metric as 'Equity income in investee.' The reasoning is logical and well-articulated: the answer explains that the growth reflects both a larger investment balance and higher operational gains, which correctly interprets the data. The wording differs slightly from the ground truth (e.g., 'deepened over that period' vs. 'growing financial stake and increased profitability'), but this represents semantic equivalence rather than factual error. The answer fully addresses all parts of the multi-part question regarding the evolution of AMD's financial relationship with the ATMP JV. Minor deduction (1 point) only for very slight stylistic differences in phrasing, but the core content is entirely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 355,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s tort exposure remained centered on medical‑malpractice and other provider‑related disputes, but the volume and variety of such claims increased—particularly disputes over out‑of‑network payments and the adequacy of risk‑based arrangements with physicians and hospitals. The company continues to be largely self‑insured and records only estimated liabilities, explicitly warning that actual losses could far exceed those estimates and could materially affect its results of operations, financial position and cash flows.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how tort exposure evolved between 2022 and 2024. STRENGTHS: (1) Correctly identifies that UnitedHealth is self-insured and records estimated liabilities; (2) Accurately notes that actual losses could exceed recorded estimates; (3) Correctly identifies medical malpractice as a key claim type; (4) No quantitative errors in the limited numbers provided. CRITICAL WEAKNESSES: (1) The LLM introduces claims about 'out-of-network payments' and 'risk-based arrangements' that are NOT mentioned in the ground truth answer, potentially confusing the evolution narrative; (2) FAILS to capture the key 2022 specificity about 'self-insured liabilities related to medical malpractice claims against affiliated physicians' and the emphasis on 'new theories of liability that might not be subject to damage caps'; (3) MISSES the crucial 2024 shift described in ground truth: the evolution toward 'broader legal risks tied to delivery of health care services, including claims related to clinical quality and patient safety standards'; (4) FAILS to address the 2024 emphasis on 'reputational harm and adverse effects on business relationships' as indicators of a 'broader and more systemic risk profile'; (5) The answer suggests increased 'volume and variety' but provides no evidence or specifics from the filings to support this claim; (6) Does not effectively synthesize the evolution/comparison between the two years as requested. The LLM answer reads more like a general description of UnitedHealth's tort exposure rather than a comparative analysis of how it evolved. The introduction of out-of-network payment disputes appears to be either fabricated or misattributed information not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 485,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\nBetween 2023 and 2024 Boeing reshaped its revolving‑credit structure by retiring the $0.8 billion 364‑day facility and the amended $3.2 billion five‑year line, while keeping the legacy $3.0 billion three‑year revolving agreement (due August 2025) and adding a new $3.0 billion five‑year revolving facility (maturing August 2028).  The company also retains a $3.0 billion three‑year line and a $3.2 billion five‑year line that remain in place, giving it roughly $10 billion of total undrawn borrowing capacity as of Dec 31 2024.  This evolution reflects a liquidity strategy that emphasizes extending maturities, preserving a sizable undrawn credit buffer, and relying on revolving facilities as back‑up sources of funding rather than long‑term debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Boeing's credit facility structure between 2023 and 2024. Key issues: (1) WRONG NEW FACILITY AMOUNT: LLM states Boeing added a '$3.0 billion five-year revolving facility (maturing August 2028)' but ground truth clearly indicates a NEW '$4.0 billion five-year revolving credit agreement expiring in May 2029'. This is a critical error in both the amount ($3.0B vs $4.0B) and maturity date (August 2028 vs May 2029). (2) INCORRECT FACILITY TERMINATIONS: LLM mentions retiring '$0.8 billion 364-day facility and amended $3.2 billion five-year line' but ground truth only mentions terminating 'two other credit facilities' without specifying these exact amounts. The LLM appears to have invented specific facility details not in the ground truth. (3) CONFUSING FACILITY INVENTORY: LLM claims 'roughly $10 billion of total undrawn borrowing capacity' and mentions retaining '$3.0 billion three-year line and $3.2 billion five-year line' but this creates confusion about which facilities actually exist post-2024. Ground truth is clearer: legacy $3.0B three-year (August 2025) + new $4.0B five-year (May 2029). (4) INCOMPLETE SYNTHESIS: While LLM correctly identifies the strategic intent (extending maturities, preserving liquidity buffer), it fails to accurately synthesize the specific structural changes. The multi-hop reasoning about liquidity strategy is reasonable but built on incorrect factual foundations. (5) MISSING KEY DETAIL: LLM fails to clearly state that the legacy $3.0B three-year agreement 'remained in effect' as explicitly noted in ground truth. Overall, the answer demonstrates poor quantitative accuracy with multiple wrong numbers and dates, and incomplete/confused entity identification of the actual credit facilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 494,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s stock‑based compensation from the 2017 performance‑based options fell slightly – it recorded $56 million of expense for options that vested in 2023, versus $52 million for those that vested in 2024.  At the same time, the cash intrinsic value realized from exercising those options rose sharply, from $44 million of intrinsic value in 2023 to $373 million of intrinsic value in 2024, driven by the higher BlackRock stock price and a larger volume of exercises.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: (1) 2023 fair value of vested options: $56 million ✓, (2) 2024 fair value of vested options: $52 million ✓, (3) 2023 intrinsic value of exercised options: $44 million ✓, (4) 2024 intrinsic value of exercised options: $373 million ✓. The multi-hop synthesis is sound - the answer correctly identifies the evolution across both years and both metrics (fair value vested and intrinsic value exercised). The reasoning is logical: the slight decline in vesting fair value ($56M to $52M) contrasted with the substantial increase in intrinsic value from exercises ($44M to $373M). The LLM appropriately attributes the increase to higher stock price and larger exercise volume, which provides contextual understanding beyond mere numbers. The terminology is accurate (distinguishing between fair value of vested options and intrinsic value of exercised options). Minor note: The LLM uses 'stock-based compensation' and 'cash intrinsic value' terminology which is semantically equivalent to the ground truth's 'fair value' and 'intrinsic value' language. The answer fully addresses all parts of the multi-part question and demonstrates proper multi-hop reasoning across years and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 361,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AMD moved from a broad‑brush estimate that applied historical return, rebate and price‑protection experience to all contracts and then adjusted for known events, to a more granular, data‑driven approach.  In 2023 the company specifically incorporated “product‑restocking rights” for both OEMs and distributors and used trended, actual historical return‑rate information that is updated with the latest known circumstances to calculate the adjustment to revenue.  This refinement improves the precision of the return‑rights estimate and reflects the newer contractual terms and market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces significant factual errors not present in the ground truth. Specifically: (1) The LLM claims AMD incorporated 'product-restocking rights for both OEMs and distributors' in 2023 - this specific detail does NOT appear in the ground truth and appears to be fabricated. (2) The LLM describes the 2022 approach as 'broad-brush' and the 2023 approach as 'more granular, data-driven' - the ground truth actually indicates both years used 'historical product return rate information,' suggesting continuity rather than a shift from broad to granular. (3) The LLM states the 2023 approach uses 'trended, actual historical return-rate information that is updated with the latest known circumstances' - while this sounds plausible, the ground truth emphasizes the shift toward explicit reference to ASC 606-10-32-8 through 14 and 'most likely amount' methodology, which the LLM completely omits. WHAT WAS CORRECT: The LLM correctly identifies that there was an evolution between 2022 and 2023, and correctly notes that adjustments for returns, rebates, and price protection were involved. The general direction of 'refinement' is directionally correct. CRITICAL OMISSIONS: The LLM fails to mention the key methodological change - the explicit alignment with ASC 606 accounting standards and the shift to 'most likely amount' consideration, which is the core of the ground truth answer. The answer also fails to capture that the 2023 approach was more 'structured and codified' per the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but does so by introducing unsupported details rather than accurately reflecting the documented changes. The reasoning appears to extrapolate beyond what the source material supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 491,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the outstanding 2017 Performance‑based options fell sharply—from **1,549,080 shares** to **625,825 shares**, a reduction of roughly **923 k shares**.  The decline is driven almost entirely by **exercises (≈ 905 k shares)** with only a modest amount forfeited (≈ 18 k shares), indicating that holders are increasingly exercising these deep‑in‑the‑money options as the stock price has risen, while forfeiture plays a negligible role.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 2023 shares (1,549,080), 2024 shares (625,825), exercises (905,219 approximated as ~905k), and forfeitures (18,036 approximated as ~18k). The calculated reduction of 923,255 shares is accurate (1,549,080 - 625,825 = 923,255). The approximations using 'k' notation are appropriate and mathematically sound. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the number evolved (with specific figures and direction), and (2) what this indicates about exercise and forfeiture trends. ENTITY ACCURACY: Correctly identifies the 2017 Performance-based Options and the relevant time periods (2023 to 2024). REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the numerical changes to underlying business activity (exercises and forfeitures) and provides logical interpretation about market conditions (deep-in-the-money options, rising stock price). The conclusion about lifecycle completion aligns with the ground truth's observation about approaching final vesting dates. SEMANTIC EQUIVALENCE: The LLM's explanation that 'holders are increasingly exercising these deep-in-the-money options as the stock price has risen' provides additional context beyond the ground truth while remaining consistent with it. The characterization of forfeiture as 'negligible' is semantically equivalent to 'some were forfeited.' Minor difference: The LLM provides slightly more market-based interpretation (stock price rise, deep-in-the-money status) which adds value without contradicting the ground truth. The answer is comprehensive, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 471,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\nBetween 2022 and 2024 Optum Rx expanded from a traditional pharmacy‑benefit manager into a full‑stack pharmacy‑care platform: its network grew to >65,000 retail sites (and added home‑delivery, specialty/infusion, rare‑disease and gene‑therapy support), it began offering direct‑to‑consumer solutions, and it deepened clinical programs that embed pharmacists in multidisciplinary teams to manage utilization, adherence and behavioral health.  This evolution positions Optum Rx as a core conduit for integrating medical, pharmacy and behavioral services across UnitedHealth Group’s broader ecosystem—linking Optum Health, Optum Insight and UnitedHealthcare to deliver value‑based, whole‑person care and to coordinate cost‑controlling pharmacy services within the company’s integrated health‑care model.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ISSUES (Primary Concern): The LLM answer contains a significant numerical discrepancy. Ground truth states Optum Rx managed $112 billion in pharmaceutical spending in 2022 with $45 billion in specialty pharmaceutical spending. The LLM answer mentions '>65,000 retail sites' but ground truth specifies 'over 67,000 retail pharmacies' - this is a material difference (65k vs 67k+). More critically, the LLM provides NO pharmaceutical spending figures for either 2022 or 2024, despite ground truth explicitly stating $112B and $45B specialty for 2022. The LLM states the network 'grew to >65,000' which contradicts the ground truth baseline of 67,000+ in 2022 - suggesting a decrease rather than growth or stability. QUALITATIVE STRENGTHS: The LLM correctly identifies the evolution from traditional PBM to integrated platform, accurately mentions home delivery, specialty/infusion services, and clinical programs. The positioning within UnitedHealth Group's ecosystem is well-articulated, with correct references to integration with Optum Health, Optum Insight, and UnitedHealthcare. The emphasis on value-based care and whole-person care aligns with ground truth's 2024 positioning. MULTI-HOP REASONING: The LLM successfully synthesizes the strategic evolution across the 2022-2024 period and correctly identifies Optum Rx's role as a connector across multiple business units. However, the failure to include or acknowledge the absence of 2024 spending figures (when ground truth explicitly notes 'specific spending figures were not provided in 2024') represents incomplete synthesis. MISSING ELEMENTS: The LLM adds details about 'rare-disease and gene-therapy support' and 'direct-to-consumer solutions' that are not mentioned in ground truth, raising questions about source accuracy. The answer lacks acknowledgment that 2024 data was less specific on spending metrics. OVERALL: Core strategic positioning is correct, but quantitative inaccuracies (network size discrepancy, missing spending figures) and unsourced additions significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 557,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\nBetween December 31 2023 and December 31 2024 the line item “Investments related to deferred cash compensation plans” – which is part of BlackRock’s equity‑method holdings under “Equity securities at FVTNI” – fell from **$241 million** to **$173 million**, a reduction of about **$68 million**.  This decline occurred even though the broader equity‑securities‑at‑FVTNI portfolio expanded (e.g., equity‑mutual‑fund holdings rose from $1.585 bn to $1.950 bn), indicating that the company re‑allocated a smaller share of its equity‑method assets to the deferred‑compensation vehicle.  The amounts are reported at fair value using NAV (a practical expedient) and are disclosed within the equity‑method investment category of the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and misrepresents the classification structure. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2023 value was $241 million, but the ground truth clearly indicates it was $9 million. This is a massive discrepancy (off by $232 million or 2,578%). The 2024 value of $173 million is correct. The calculated difference of $68 million is arithmetically correct based on the LLM's incorrect 2023 figure ($241M - $173M = $68M), but this calculation is built on a false premise. (2) CLASSIFICATION ERROR: The ground truth indicates that in 2023, the $9 million was reported under 'Equity Securities at FVTNI' but in 2024 it was RECLASSIFIED to 'Investments related to deferred cash compensation plans' within the Equity Method section - a change in categorization. The LLM incorrectly suggests this line item remained 'part of BlackRock's equity-method holdings under Equity securities at FVTNI' in both years, missing the critical reclassification that is the core of the answer. (3) MULTI-HOP REASONING: The LLM failed to synthesize the key insight that this represents a reclassification/realignment across different reporting categories, not merely a valuation change within the same category. (4) CONTEXTUAL ISSUES: While the LLM correctly identifies that this is part of deferred compensation plan investments and mentions fair value/NAV reporting, it fundamentally misses the structural change in how these investments were categorized between years. The answer demonstrates a failure to accurately extract and compare the specific 2023 baseline figure, which is essential for answering this multi-hop question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 463,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\nThe open‑market share‑purchase authorization grew from about **$3.1 billion (as of August 31 2022)** to roughly **$6.7 billion after the September 2024 board action** – an increase of roughly **$3.6 billion**.  This expansion of the repurchase ceiling shows that Accenture is deliberately enlarging its buy‑back program, using its strong cash generation to return increasingly larger amounts of capital to shareholders and to prioritize equity‑based returns over other uses of excess cash.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual dimensions. (1) QUANTITATIVE ERRORS - The LLM states the authorization grew from $3.1 billion to $6.7 billion (an increase of $3.6 billion), but the ground truth shows it DECREASED from $3,129,296 (thousands) to $2,694,281 (thousands) - a reduction, not an increase. The LLM appears to have confused the direction of change entirely and inflated the numbers by orders of magnitude (treating thousands as billions). (2) DIRECTIONAL ERROR - The core finding is inverted: the ground truth indicates a DECREASE in available authorization, suggesting conservative capital allocation, while the LLM claims an INCREASE indicating aggressive expansion of buyback programs. This is the opposite conclusion. (3) CALCULATION ERROR - Even accepting the LLM's numbers at face value, the arithmetic is wrong: $6.7B - $3.1B = $3.6B is correct math, but the underlying numbers are incorrect. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison. It appears to have misread or misinterpreted the source data, possibly confusing different metrics or time periods. (5) STRATEGIC INTERPRETATION - The LLM's interpretation of capital allocation strategy is diametrically opposed to what the data actually shows. The ground truth indicates a more conservative approach due to reduced authorization, while the LLM claims aggressive shareholder returns. The only element that might be partially correct is the mention of Accenture and share repurchases, but the numerical data and conclusions are entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 436,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 the discussion moved from a brief, qualitative note that Accenture Canada Holdings Inc. exchangeable shares represent a non‑controlling equity interest that can be exchanged for Class A ordinary shares, to a detailed, quantitative disclosure in the 2024 filing that the company repurchased 47,752 exchangeable shares for $15.3 million during fiscal 2024, includes them in its open‑market share‑purchase program, and expressly states that they carry the same dividend rights and may be exchanged or redeemed for cash on a one‑for‑one basis.  The 2024 filing also expands the board‑approved repurchase authority to $6.7 billion and clarifies that purchases may be made via open‑market transactions, Rule 10b5‑1 plans, or other methods, thereby providing a much clearer picture of both repurchase activity and the rights of exchangeable‑share shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the evolution of disclosure between 2022 and 2024 and correctly identifies key themes (exchangeability, dividend rights, repurchase activity, and quantified authorization). However, there are significant quantitative discrepancies that undermine the answer's reliability:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states \"$6.7 billion\" board-approved repurchase authority, but ground truth indicates \"$2,694,281\" remaining authorization as of August 31, 2024. These are dramatically different figures and the LLM's number appears to be incorrect or from a different context.\n   - LLM provides specific repurchase data (47,752 shares for $15.3 million in fiscal 2024) that is NOT mentioned in the ground truth answer. While this detail may be accurate from the filing, it cannot be verified against the provided ground truth.\n   - The ground truth emphasizes the 2022 intention to repurchase shares with factors like price and market conditions, but the LLM shifts focus to 2024 specific repurchase activity without clearly establishing the 2022 baseline.\n\n2. COMPLETENESS:\n   - The LLM answer does address both 2022 and 2024 disclosures and discusses share repurchase activity and shareholder rights as requested.\n   - However, it introduces specific numbers (47,752 shares, $15.3 million, $6.7 billion) that either contradict or cannot be verified against the ground truth.\n\n3. ENTITY ACCURACY:\n   - Correctly identifies Accenture Canada Holdings Inc. exchangeable shares\n   - Correctly identifies Class A ordinary shares and Class X ordinary shares\n   - Correctly identifies the one-for-one exchange basis\n\n4. REASONING:\n   - The multi-hop synthesis is logically sound in structure (comparing 2022 qualitative to 2024 quantitative)\n   - However, the specific quantitative claims lack verification against ground truth\n   - The reasoning about evolution from qualitative to quantitative is sound conceptually\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative about evolution from general intentions to detailed disclosures aligns with ground truth\n   - The emphasis on exchangeability, dividend rights, and repurchase programs is appropriate\n   - However, the specific dollar amounts create factual discrepancies that prevent semantic equivalence\n\nThe answer demonstrates good understanding of the question's intent and provides relevant contextual information, but the introduction of unverified or contradictory quantitative data (particularly the $6.7 billion figure vs. the ground truth's $2,694,281) significantly undermines its correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 689,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\nThe Electrophysiology‑Devices segment grew from **$2.195 billion in 2023 to $2.467 billion in 2024**.  On a reported basis this is a **12.3 % increase**, but when the effect of foreign‑exchange movements is removed the revenue rose **approximately 14.4 %**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 2023 revenue of $2.195 billion ($2,195 million), 2024 revenue of $2.467 billion ($2,467 million), reported basis increase of 12.3%, and FX-adjusted increase of 14.4%. The number format variation (billion vs. million) is acceptable and represents the same values. The answer correctly addresses all parts of the multi-hop question: (1) evolution of revenue between years, (2) absolute change, (3) percentage change on reported basis, and (4) percentage change excluding FX impact. The reasoning is sound and the synthesis of information is accurate. The only minor distinction from the ground truth is stylistic - the LLM uses 'approximately 14.4%' while the ground truth states '14.4%' without the qualifier, but this is a negligible semantic difference that does not affect factual accuracy. The answer demonstrates proper understanding of the distinction between reported and FX-adjusted metrics, which is a key aspect of the multi-hop reasoning required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 300,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\nAccenture’s equity investment in Duck Creek Technologies was carried at **$138.9 million** on its balance sheet as of August 31 2022, with an estimated fair value of **$223 million** (page 69).  In fiscal 2023 the company recorded a **$253 million investment gain** from this stake, which was excluded from GAAP earnings but boosted the adjusted EPS and operating‑margin figures reported in fiscal 2023 (page 40).  By fiscal 2024 the holding remains on the books as an equity‑method investment, continuing to generate other‑income items that support Accenture’s adjusted profitability, although no additional valuation numbers were disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate information with some strengths and minor issues: (1) CORRECT ELEMENTS: The $223 million fair value for fiscal 2022 is accurate and matches ground truth. The $253 million investment gain is correctly identified and attributed to fiscal 2023. The equity method accounting treatment is correct. The answer appropriately notes the gain was excluded from GAAP earnings but boosted adjusted metrics. (2) QUANTITATIVE ISSUES: The LLM introduces a $138.9 million balance sheet carrying value that is not mentioned in the ground truth answer. While this may be accurate from the source documents, it adds complexity and wasn't part of the original answer's focus. The ground truth emphasizes the $223,166 (approximately 16% ownership) valuation, while the LLM uses $223 million - this is a significant discrepancy in scale (thousands vs. millions). The ground truth states $223,166 thousand or approximately $223 million, but the LLM doesn't clarify this unit conversion. (3) TEMPORAL ACCURACY: The LLM correctly identifies the fiscal 2022 and fiscal 2023 timing, though it notes fiscal 2024 status without new valuation data, which aligns with ground truth's statement about fiscal 2024. (4) MULTI-HOP REASONING: The answer successfully synthesizes the evolution of the investment across years and connects valuation changes to financial performance impacts. However, it could have been clearer about the 16% ownership stake mentioned in ground truth. (5) MISSING ELEMENTS: The ground truth emphasizes the 16% ownership percentage, which the LLM omits. The ground truth also frames this as demonstrating 'both a quantitative increase in the investment's value and a qualitative change in its impact,' which the LLM captures but less explicitly. (6) CITATION REFERENCES: The LLM includes page references (69, 40) which add credibility but weren't in the ground truth answer. Overall, the core narrative is sound and the major figures are correct, but the unit scale discrepancy ($223,166 vs $223 million) and omission of the 16% ownership detail represent minor but notable gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 566,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\nBetween 2022 and 2023 the balance of traditional, time‑vested retention shares fell from roughly 1.29 million to about 0.95 million, while the company added ~0.37 million performance‑stock‑units; the associated unrecognized compensation expense dropped sharply from $87 million to $16 million. This shift shows Union Pacific is moving away from broad‑based retention grants toward a more performance‑driven equity compensation model that ties a larger share of executive pay to measurable financial targets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM claims retention shares fell from 1.29 million to 0.95 million, but the ground truth shows 389,207 shares in 2022 and 954,405 shares in 2023 - this is an INCREASE, not a decrease. The LLM's numbers are off by a factor of 3-4x. The LLM also introduces $87M and $16M unrecognized compensation expense figures that are not mentioned in the ground truth and cannot be verified. (2) ENTITY MISIDENTIFICATION - The LLM refers to 'performance-stock-units' (~0.37M), but the ground truth specifically identifies these as 'retention units' (366,046), which is a different compensation instrument. The LLM conflates performance units with retention units, which are distinct. (3) DIRECTIONAL ERROR - The LLM claims a shift AWAY from retention grants, but the ground truth shows the OPPOSITE: retention shares increased from 389K to 954K. This is a critical logical error. (4) INCOMPLETE SYNTHESIS - The LLM fails to accurately capture that the ground truth shows an INCREASE in retention-based compensation overall, with the introduction of retention units as a NEW instrument type, not a replacement. (5) UNSUPPORTED CLAIMS - The LLM's conclusion about 'moving away from broad-based retention grants toward performance-driven equity' directly contradicts the data showing increased retention instruments. The answer demonstrates poor multi-hop reasoning and fundamental misreading of the underlying data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 424,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife refined its definition of adjusted earnings to make the exclusions more explicit and to tie them to the new LDTI‑based measurement model.  In 2023 the company said adjusted earnings excluded “market‑volatility” items (net investment and derivative gains/losses, MRB remeasurements, goodwill impairments) and “asymmetrical and non‑economic accounting” items (in‑force reinsurance, discount‑rate changes, contract‑inception losses, etc.).  In 2024, after adopting LDTI, it added that adjusted earnings now also removes changes in the fair‑value of MRBs, discount‑rate impacts on certain annuitization guarantees, and the amortization of DAC/VOBA, while continuing to exclude the same market‑volatility and asymmetrical adjustments—thereby sharpening the scope of items that are stripped out of the GAAP segment profit measure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of MetLife's adjusted earnings evolution but contains significant issues in accuracy and completeness when compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies that LDTI adoption in 2023 was a key driver of changes\n2. Accurately mentions exclusions for MRBs, discount rate changes on annuitization guarantees, and DAC/VOBA amortization\n3. Correctly notes asymmetrical accounting from in-force reinsurance as an exclusion\n4. Properly frames the evolution as a refinement and sharpening of scope\n5. Correctly identifies 2023 and 2024 as the relevant years\n\nSIGNIFICANT ERRORS AND OMISSIONS:\n1. FACTUAL INACCURACY: The LLM states that in 2024 MetLife \"added\" exclusions for MRBs, discount-rate impacts, and DAC/VOBA amortization. However, the ground truth indicates these were already part of the 2023 adjustments following LDTI adoption. The LLM incorrectly suggests these were new additions in 2024.\n2. INCOMPLETE SYNTHESIS: The LLM fails to mention the key 2024 expansion regarding net investment income exclusions for adjustments relating to joint ventures under the equity method, which the ground truth explicitly identifies as a new development not mentioned in 2023.\n3. VAGUE CHARACTERIZATION: The LLM's description of 2023 exclusions as \"market-volatility\" and \"asymmetrical and non-economic accounting\" items uses quotation marks suggesting direct quotes, but these appear to be paraphrases rather than actual terminology from the filings.\n4. INCOMPLETE DETAIL: The ground truth specifically mentions \"policyholder liability remeasurement gains (losses)\" as the category expanded in 2024 to include asymmetrical accounting, but the LLM does not use this specific terminology.\n5. LOGICAL ERROR: The statement that 2024 \"added\" items that were already excluded in 2023 creates confusion about the actual evolution of the guidance.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates partial multi-hop reasoning by connecting LDTI adoption to changes in adjusted earnings calculations, but fails to properly synthesize the temporal evolution (what was new in 2024 vs. what carried forward from 2023). The critical miss is not identifying the joint venture equity method adjustment as a 2024-specific addition.\n\nSEMANTIC EQUIVALENCE:\nWhile the general concept of refinement is captured, the specific factual claims about what changed when are not semantically equivalent to the ground truth due to the chronological misplacement of certain exclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 671,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Accenture moved from a cloud‑and‑data‑centric model of total enterprise reinvention—focused on building digital cores, optimizing operations and accelerating growth through Strategy & Consulting, Technology and Operations services—to an AI‑first, ecosystem‑enabled approach.  The 2024 strategy adds generative AI, quantum, metaverse and advanced platforms (e.g., AI Navigator, SynOps) and expands the service portfolio to include Industry X and Song, allowing the company to deliver end‑to‑end, “compressed” transformations that re‑engineer products, operations and business models across the entire enterprise.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the evolution of Accenture's approach from 2022 to 2024 but contains significant discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the shift toward AI-first approach by 2024, (2) Correctly mentions generative AI as a key technology added by 2024, (3) Correctly identifies metaverse as part of the 2024 toolkit, (4) Correctly notes the expansion of service scope and compressed transformations. SIGNIFICANT OMISSIONS AND ERRORS: (1) The 2022 technology list is incomplete - the LLM answer omits specific 2022 technologies like digital twins, IoT, cloud/Edge, 5G, and advanced robotics that were explicitly mentioned in the ground truth, (2) The LLM answer mentions 'quantum' as a 2024 technology, which is NOT mentioned in the ground truth, (3) The LLM answer references 'Industry X and Song' services and platforms like 'AI Navigator' and 'SynOps' which are not mentioned in the ground truth, (4) The ground truth specifically mentions Accenture's development of 'automation equipment and commercial hardware' by 2024, which the LLM answer completely omits, (5) The ground truth specifically details the broadened scope including 'capital projects such as plant and asset construction, public infrastructure, power grids, and data centers' - the LLM answer only vaguely references 'end-to-end transformations' without these specific examples, (6) The LLM answer mentions 'artificial reality/virtual reality' from the ground truth but frames it differently. MULTI-HOP REASONING: The LLM answer attempts to synthesize the evolution but does so incompletely and introduces information not in the ground truth while omitting key details. The comparison between 2022 and 2024 is present but lacks the specific technological and service scope details that define the actual evolution. The answer reads more like a general corporate strategy statement rather than a detailed comparison grounded in the specific filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 536,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\nBetween 2023 and 2024 Abbott kept the size of its interest‑rate hedge program roughly constant at about $2.2 bn of notional swaps, but the amount of fixed‑rate debt that was hedged fell as older notes (e.g., the 3.40 % and 0.875 % issues) matured and were replaced with new issuances.  Consequently, the liability associated with the swaps dropped from $136 m (2022) to $95 m (2023) and the fair‑value of the hedged long‑term debt declined from $2.69 bn to $2.05 bn, showing that the hedging structure was scaled back to match the reduced fixed‑rate exposure.  The company continues to use the swaps to convert the remaining fixed‑rate portion of debt to a variable rate, but the program now covers a smaller share of the overall debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed narrative about Abbott's interest rate hedge evolution than the ground truth, but contains significant quantitative discrepancies that undermine its accuracy. CORRECT ELEMENTS: (1) The $2.2 billion notional value of hedge contracts is correctly stated for both 2023 and 2024, matching the ground truth. (2) The general concept that the hedging program remained relatively stable in size is correct. (3) The explanation that older debt matured and was replaced is a reasonable inference about debt management. (4) The characterization of swaps converting fixed-rate to variable-rate debt is accurate. CRITICAL ERRORS: (1) The LLM introduces specific liability figures ($136M in 2022, $95M in 2023) and fair-value amounts ($2.69B to $2.05B) that are NOT mentioned in the ground truth. These appear to be fabricated or from different sections of the filing not verified by the knowledge graph. (2) The ground truth explicitly states the average interest rate increased from 3.6% (2023) to 3.8% (2024), which the LLM answer completely omits. This is a key metric showing the evolution of the hedging strategy's effectiveness. (3) The LLM claims the hedging program was 'scaled back' and 'covers a smaller share of the overall debt portfolio,' but the ground truth indicates the notional amount remained constant at $2.2B, suggesting consistency rather than scaling back. MULTI-HOP REASONING: The LLM attempts to synthesize information about debt maturity, replacement, and hedge liability changes, but this synthesis appears to introduce unsupported details. The ground truth's simpler conclusion about consistent strategy with changing interest rate conditions is more defensible. QUANTITATIVE ACCURACY: The introduction of unverified dollar amounts ($136M, $95M, $2.69B, $2.05B) significantly damages credibility. The omission of the 3.6% to 3.8% interest rate change is a material oversight. QUALITATIVE ACCURACY: The reasoning about debt maturity and replacement is logical but speculative beyond what the ground truth supports. The characterization of 'scaling back' contradicts the stable $2.2B notional amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 577,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\nIn the 2024 filing MetLife continues to define **Adjusted Earnings** as a GAAP‑derived, non‑GAAP measure that removes market‑volatility items, asymmetrical and non‑economic accounting, results of divested businesses and certain contingent gains or losses, but it now explicitly states that Adjusted Earnings is the GAAP measure of **segment performance** and presents it for each of its six segments. The 2024 definition also reflects the post‑LDTI simplification of DAC/VOBA measurement and the re‑classification of embedded derivatives as MRBs, eliminating the prior adjustments to DAC and VOBA amortization that were applied in 2023. Finally, the 2024 disclosures incorporate the enhanced segment‑expense disclosure requirements of ASU 2023‑07, giving a more detailed, segment‑by‑segment breakdown of the adjustments used to calculate Adjusted Earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of MetLife's Adjusted Earnings evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies that Adjusted Earnings is a GAAP measure of segment performance in 2024; (2) Accurately notes the post-LDTI simplification and elimination of prior DAC/VOBA amortization adjustments from 2023; (3) Properly references the reclassification of embedded derivatives as MRBs; (4) Correctly mentions ASU 2023-07 enhanced segment-expense disclosure requirements; (5) Accurately describes the types of exclusions (market volatility, asymmetrical accounting, divested businesses, contingent gains/losses). MINOR GAPS: (1) The LLM answer does not explicitly mention specific 2023 exclusions like 'changes in fair value associated with MRBs, discount rate changes on annuitization guarantees' - though it does reference MRBs generally; (2) Does not specifically call out 'inflation-indexed benefit adjustments' or 'non-economic losses from single premium annuity contracts' as 2024-specific exclusions mentioned in ground truth; (3) The answer could have been more explicit about the 'refinement and expansion' nature of the changes. QUANTITATIVE ACCURACY: No numeric values were required in this question, so this dimension is strong (9/10 - minor deduction for not being more specific about certain exclusion categories). QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information about LDTI adoption impacts, segment performance measurement changes, and regulatory requirement updates. The logic flow is sound. CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and provides appropriate context about both years. Overall, this is a solid answer that captures the main evolution narrative with only minor omissions of specific exclusion details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 496,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Accenture expanded its publicly announced repurchase authority—an additional $3 million was approved in September 2022 (raising total authority to $6.13 billion) and a further $4 million was approved in September 2024 (bringing total authority to $6.69 billion).  Open‑market purchases rose from 9.6 million shares in 2022 to 11.8 million shares in 2024, while the company also increased its use of the 2010 Employee Share Purchase Plan and payroll‑tax share‑withholding mechanisms, reflecting a broader mix of acquisition channels.  All of these purchases are funded from treasury cash under the enlarged authorization.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. Key issues: (1) MAJOR QUANTITATIVE ERRORS: The LLM cites authorization amounts of $6.13 billion and $6.69 billion, which are orders of magnitude larger than the ground truth figure of $3,129,296 (approximately $3.1 million). These numbers are completely inconsistent with the actual data. The LLM also claims $3 million was approved in September 2022 and $4 million in September 2024, which don't align with the ground truth authorization figure. (2) SHARE ACQUISITION NUMBERS: The LLM states 9.6 million shares in 2022 and 11.8 million shares in 2024, but the ground truth does not provide these specific share count comparisons. These numbers appear fabricated or from incorrect sources. (3) MISSING KEY CONTEXT: The ground truth emphasizes that the 2024 acquisitions were primarily through share withholding for payroll tax obligations and did NOT impact the aggregate available authorization. The LLM incorrectly suggests all purchases are funded from treasury cash under the enlarged authorization, misrepresenting the nature of the 2024 acquisitions. (4) INCOMPLETE SYNTHESIS: While the LLM attempts to address the evolution from 2022 to 2024, it fails to capture the critical distinction that 2024 acquisitions used different methods (share withholding) that didn't affect the public program authorization. (5) ENTITY ACCURACY: The company name is correct (Accenture), but the financial metrics and amounts are fundamentally wrong. The answer demonstrates a failure to accurately synthesize multi-hop information and contains invented or severely mismatched numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 454,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\nMetLife continues to value its Unit‑linked and FVO securities at estimated fair value using Level 3 inputs, with the cost basis calculated as the original purchase cost reduced by impairments and amortization of premium/discount – a methodology that remained the same from 2023 to 2024.  However, the 2024 disclosures broaden the fair‑value model by adding a separate risk‑margin and non‑performance‑risk component and by providing a more granular sensitivity analysis (mortality, lapse, utilization, equity‑volatility, spread), which materially affects the reported fair‑value and resulted in a higher year‑end fair‑value balance and net‑income gains for these securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the evolution described in the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON METHODOLOGY EVOLUTION: The LLM claims the methodology 'remained the same from 2023 to 2024,' directly contradicting the ground truth which explicitly states there was an evolution from a 'more static cost-based method' in 2023 to a 'more dynamic and assumption-driven valuation approach' in 2024. (2) INCORRECT CHARACTERIZATION OF 2023: The LLM describes 2023 methodology using terms like 'original purchase cost reduced by impairments and amortization' which aligns more with 2024 descriptions, not the simpler cost basis approach (original cost for equities, amortized cost for fixed maturities) stated in ground truth for 2023. (3) MISSING KEY EVOLUTION POINTS: The LLM fails to capture the critical shift that Unit-linked securities were 'included in Level 3 fair value measurements' in 2024 with 'significant unobservable inputs such as mortality rates, lapse rates, and equity volatility' - this represents a fundamental methodological change from 2023. (4) UNSUBSTANTIATED CLAIMS: The LLM introduces specific details about 'risk-margin and non-performance-risk component' and claims about 'higher year-end fair-value balance and net-income gains' that are not mentioned in the ground truth and cannot be verified. (5) PARTIAL CREDIT FOR SENSITIVITY ANALYSIS: The LLM correctly identifies that 2024 includes sensitivity analysis with multiple inputs (mortality, lapse, utilization, equity-volatility, spread), which aligns with ground truth's mention of sensitivity to 'mortality rates, lapse rates, and equity volatility.' The core failure is misrepresenting the evolution as 'remained the same' when the ground truth clearly indicates significant methodological changes between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 503,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the company’s market‑based RSU program shifted from a single, four‑year vesting schedule (expected term ≈ 3.4 years in 2022) to a hybrid structure that still includes the standard four‑year schedule but also adds a new five‑year tranche tied to specific stock‑price performance milestones, pushing the weighted‑average expected term to about 4.8 years in 2023.  The payout amount can now vary from 0 % to 300 % of the original grant depending on total stockholder return relative to an index, but the core vesting periods moved from roughly a 3‑year/4‑year horizon in 2022 to a longer, performance‑driven 4‑ to 5‑year horizon in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of market-based RSUs between 2022 and 2023 (shift from 4-year to hybrid 4/5-year structure with stock price milestones), which aligns with the ground truth. However, there are significant issues with quantitative accuracy:\n\n1. QUANTITATIVE PROBLEMS: The LLM introduces specific expected term metrics (3.4 years in 2022, 4.8 years in 2023) that are NOT present in the ground truth answer. These appear to be fabricated or inferred numbers not supported by the original knowledge graph data. The ground truth makes no mention of expected terms or weighted-average expected terms.\n\n2. WORDING DISCREPANCY: The LLM states 'roughly a 3-year/4-year horizon in 2022' which contradicts the ground truth that clearly states 'four years' vesting in 2022. The introduction of a '3-year' element is not supported.\n\n3. CORRECT ELEMENTS: The LLM correctly identifies:\n   - Four-year vesting in 2022\n   - Introduction of five-year vesting in 2023\n   - Stock price performance milestones in 2023\n   - 0%-300% payout range based on TSR\n   - The shift to a longer, performance-driven structure\n\n4. MULTI-HOP REASONING: The synthesis across fiscal years is sound in concept, but the addition of unsupported quantitative metrics (expected terms) represents a factual error that undermines confidence in the answer.\n\n5. SEMANTIC EQUIVALENCE: While the overall narrative matches the ground truth, the introduction of specific numerical metrics not in the source material is problematic for a financial analysis context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 434,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\nBetween 2023 and 2024 the CECL transition moved from a 75 % phased‑in share of the cumulative “day‑2” impact in 2023 to a full (100 %) inclusion in 2024.  Under the Federal Reserve’s CECL Transition Rule the company added back a $2.4 bn capital buffer and then phased in the remaining impact at 25 % per year, so that by January 1 2024 the entire ongoing CECL effect was reflected in regulatory capital, raising the CET1 ratio to 13.5 % (versus 13.3 % on a fully‑phased‑in basis).  This phase‑in treatment temporarily boosted the capital ratios above the minimum well‑capitalized thresholds during the transition period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - Phase-in percentages: The LLM claims the phase-in moved from 75% in 2023 to 100% in 2024, but the ground truth explicitly states the phase-in was 25% per year from January 1, 2022 through December 31, 2024. This is a major misrepresentation of the regulatory treatment. (2) CRITICAL ERROR - Timing of full inclusion: The LLM states 'by January 1 2024 the entire ongoing CECL effect was reflected in regulatory capital,' but the ground truth indicates the phase-in continued through December 31, 2024, meaning full inclusion would occur in 2025, not 2024. (3) UNSUPPORTED CLAIMS - The LLM introduces specific numbers ($2.4 bn capital buffer, 13.5% CET1 ratio, 13.3% fully-phased-in basis) that are not mentioned in the ground truth and cannot be verified. These appear to be hallucinated details. (4) INCORRECT EVOLUTION NARRATIVE: The ground truth states the treatment 'remained consistent' between 2023 and 2024, with uniform 25% annual phase-in. The LLM incorrectly portrays a significant change from 75% to 100%. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the multi-year transition framework. The ground truth clearly indicates a 3-year phase-in (2022-2024) at 25% annually, not a 2-year transition with the percentages claimed. The answer demonstrates a fundamental misunderstanding of the CECL Transition Rule mechanics and provides contradictory information about when full inclusion occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 422,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Broadcom kept Wilmington Trust, National Association as the trustee under its master indenture, but the senior‑note program changed in both structure and pricing.  In 2022 the company issued notes such as the 2.650 % due 2023, 3.125 % due 2025 and 3.5 % due 2028 under the 2017 indenture and its 2020‑2021 supplements, whereas in 2023 it added newer series—most notably the 4.00 % due 2029 and 4.15 % due 2032 notes (from the April 2022 indenture) and later the 4.926 % due 2037, 5.05 % due 2027/2029/2031 notes under a July 2024 indenture—reflecting slightly higher coupon rates and longer‑dated maturities while the trustee relationship remained the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant discrepancies in key details. STRENGTHS: (1) Correctly identifies Wilmington Trust, National Association as trustee throughout the period; (2) Accurately captures the evolution toward higher coupon rates and longer maturities; (3) Correctly references the April 2022 indenture and July 2024 indenture; (4) Properly synthesizes multi-hop information about the relationship evolution. CRITICAL ERRORS: (1) The ground truth specifies interest rates of 1.950% (due 2028) and 3.750% (due 2051) from January 2021 notes, but the LLM lists 2.650% due 2023, 3.125% due 2025, and 3.5% due 2028 for 2022—these appear to be different note series not mentioned in ground truth; (2) The LLM mentions 5.05% due 2027/2029/2031 notes under July 2024 indenture, which is not in the ground truth; (3) Ground truth mentions 4.150% (due 2028) to 4.800% (due 2034) from October 2024, but LLM does not reference October 2024 notes or the 4.800% note; (4) The LLM references a 2017 indenture with 2020-2021 supplements, which is not mentioned in ground truth. QUANTITATIVE ISSUES: Multiple interest rate figures (2.650%, 3.125%, 5.05%) and maturity dates appear to be either incorrect or from different note series than documented in ground truth. The answer conflates different indentures and note series. REASONING: While the LLM correctly identifies the general trend (higher rates, longer maturities, same trustee), it introduces specific numbers and indenture dates that don't align with the ground truth, suggesting either hallucination or confusion between different debt issuances. The multi-hop synthesis is attempted but compromised by factual inaccuracies in the specific terms cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 473,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\nUnder the CECL Transition Rule Capital One added back a total of $2.4 bn of regulatory capital, with the phase‑in schedule requiring 25 % of the cumulative “day‑2” impact each year (25 % in 2022, 50 % in 2023, 75 % in 2024, and 100 % in 2025). Consequently, the add‑back grew from roughly 50 % of that amount—about $1.2 bn—at the end of 2023 to about 75 %—about $1.8 bn—by the end of 2024, with the remaining $0.6 bn slated to be phased in on January 1 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides comprehensive information about Capital One's CECL Transition Rule regulatory capital add-back evolution. Verification of key facts: (1) Total add-back amount of $2.4 billion is correct; (2) Phase-in schedule is accurately described (25% annually starting 2022, reaching 50% in 2023, 75% in 2024, 100% in 2025); (3) Dollar amount calculations are accurate: 50% of $2.4bn = $1.2bn (end of 2023), 75% of $2.4bn = $1.8bn (end of 2024), remaining $0.6bn for 2025; (4) The 25 percentage point increase from 50% to 75% is correctly identified. The LLM answer goes beyond the ground truth by providing the complete phase-in schedule (2022-2025) and explicitly calculating the dollar amounts at each phase, which adds valuable context. The answer correctly synthesizes the multi-hop information: identifying the total amount, the phase-in percentages, the timeline, and the corresponding dollar values. Minor note: The ground truth specifies \"as of January 1, 2023\" and \"by January 1, 2024,\" while the LLM uses \"end of 2023\" and \"end of 2024,\" but these are semantically equivalent for practical purposes. All numerical calculations are accurate, and the reasoning about the structured five-year phase-in process is sound. The answer directly addresses the question about how the add-back evolved from 2023 to 2024 and the specific phase-in progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 390,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\nIn the 2022 merger filing Broadcom disclosed that, upon completion of the VMware acquisition, all outstanding in‑the‑money VMware stock options and RSU awards held by non‑employee directors would be **accelerated and settled with an equal split of cash and Broadcom common stock**. When the transaction closed in November 2023, the same terms were applied — the directors’ VMware options were terminated and they received the agreed‑upon cash‑and‑stock payout, fully eliminating the VMware equity awards. Thus, the prospective 2022 treatment became the actual 2023 settlement without any change to the conversion mechanics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies the 2022 prospective treatment of VMware stock options and RSU awards for non-employee directors - acceleration and conversion into equal parts cash and Broadcom common stock. (2) Accurately notes the November 2023 completion date and confirms the actual settlement occurred as planned. (3) Properly synthesizes the multi-hop information showing the evolution from planned (2022) to realized (2023) treatment. (4) Correctly identifies that there was NO CHANGE to the conversion mechanics between the two years - the same terms applied. (5) All entity names are correct (VMware, Broadcom, non-employee directors). (6) No numeric errors or date inaccuracies. MINOR CONSIDERATIONS: The LLM answer adds slightly more detail than the ground truth (e.g., 'directors' VMware options were terminated,' 'fully eliminating the VMware equity awards') but this is supplementary context that enhances rather than contradicts the ground truth. The core message matches perfectly: the treatment evolved from a prospective provision in 2022 to an actualized event in 2023, with identical conversion terms. The answer demonstrates sound multi-hop reasoning by connecting the acquisition announcement, the specific treatment terms, and the actual completion event.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 373,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie kept Vraylar’s core antipsychotic/‑bipolar label (schizophrenia and bipolar mania/mixed episodes) but increasingly emphasized its **adjunctive treatment of major‑depressive disorder (MDD)**, a use that was first highlighted in the 2021 Phase‑3 data and was repeatedly noted in the 2022 and 2024 10‑K filings as a key growth driver.  The company’s disclosures show Vraylar’s sales expanding alongside this expanded MDD positioning, cementing its role as a multi‑indication neuroscience product rather than a single‑indication antipsychotic.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and one notable error: (1) CORRECT ELEMENTS: The answer correctly identifies that Vraylar maintained its core antipsychotic/bipolar indications (schizophrenia, bipolar mania/mixed episodes) and that MDD adjunctive treatment was an emerging/emphasized indication. The characterization of Vraylar as a multi-indication product is accurate. (2) CRITICAL OMISSION: The ground truth explicitly states that by 2024, Vraylar was indicated for 'acute treatment of depressive episodes associated with bipolar I disorder' - a distinct indication from MDD adjunctive treatment. The LLM answer fails to mention this bipolar depression indication, which represents a material expansion of the therapeutic positioning. (3) TEMPORAL ACCURACY ISSUE: The LLM references '2021 Phase-3 data' but the ground truth specifically discusses 2022 Phase 3 trial results (one meeting primary endpoint, one showing numerical but not statistically significant improvement). The LLM doesn't clearly distinguish between the 2022 trial status and the 2024 approved indications. (4) INCOMPLETE SYNTHESIS: While the LLM mentions MDD as a 'key growth driver,' it doesn't fully synthesize the complete therapeutic expansion from 2022 to 2024. The ground truth shows a progression from 'being evaluated in Phase 3' (2022) to 'being indicated for' multiple conditions (2024), representing a transition from investigational to approved status. The LLM conflates these timelines. (5) MISSING SPECIFICITY: The ground truth distinguishes between 'acute treatment' and 'maintenance treatment' of schizophrenia, and between different bipolar indications. The LLM uses more general language ('core antipsychotic/bipolar label') that obscures these distinctions. (6) SALES REFERENCE: The LLM mentions 'sales expanding' but provides no specific numbers or data to support this claim, whereas the question asks about therapeutic positioning evolution based on disclosures. The answer would be stronger with concrete filing references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 553,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\nFrom 2022 through 2024 GE has continued to recognize revenue for its long‑term services agreements on a **percentage‑of‑completion basis**, measuring progress by costs incurred to total estimated costs and recognizing profit as the work is performed.  The 2022 filing already required such estimates of future utilization, cost improvements and billings, but the 2024 disclosure expands the guidance: it ties billing to **asset‑usage trends (e.g., hours of operation or milestone events)**, requires **cumulative‑catch‑up adjustments** when estimates are revised, and quantifies the impact of a 1 % change in estimated profitability (≈ $0.4 bn).  Thus, while the core method remained the same, the 2024 policy adds more explicit, usage‑driven billing estimates and a formalized process for revising those estimates and assessing contract‑asset/liability balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains a fundamental contradiction with the ground truth. The ground truth explicitly states that GE SHIFTED from straight-line basis in 2022 to percentage-of-completion method in 2024. The LLM claims the percentage-of-completion basis was used 'from 2022 through 2024' and that 'the core method remained the same,' which directly contradicts the known evolution. This is a critical error in understanding the multi-hop temporal comparison. MISSING KEY QUANTITATIVE DATA: The LLM fails to mention the specific 2024 figures that are central to the ground truth answer: (1) the $6.6 billion net liability balance, (2) the 4.1% ratio, and (3) the $162 billion total estimated life of contract billings. These are concrete, verifiable metrics that should have been included. The LLM mentions a '$0.4 bn' sensitivity figure that is not in the ground truth, suggesting potential confusion or hallucination. INCOMPLETE SEGMENT ANALYSIS: The ground truth specifies that 2022 services were 'primarily in Healthcare and Renewable Energy segments' while 2024 shifted to 'predominantly within the CES segment.' The LLM does not address this important segment-level evolution. REASONING FLAWS: The LLM's claim that 'the 2022 filing already required such estimates' contradicts the ground truth's assertion that detailed estimation processes involving asset utilization and cost improvements 'was not explicitly mentioned in 2022.' This represents a failure in multi-hop synthesis across the two time periods. PARTIAL CREDIT: The LLM does correctly identify that 2024 involves asset-usage trends and cumulative catch-up adjustments, which aligns with the ground truth's mention of 'asset utilization' and more detailed estimation processes. However, this partial correctness cannot offset the fundamental mischaracterization of the core methodological shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 509,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\nIn the 2022 10‑K the 1.250 % Notes due 2027 were disclosed only as part of an exhibit reference (the indenture was listed under “Exhibit 3 to Form 8‑K” in the Exhibits table), without being shown in the main securities‑registration table. In the 2023 10‑K the same notes appear directly in the “Securities registered pursuant to Section 12(b)” table on page 1, identified as “1.250 % Notes due 2027 – IBM 27B,” making the issue far more visible and explicit in the filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and mischaracterizations. CORRECT ELEMENTS: (1) The answer correctly identifies that there was an evolution in disclosure between 2022 and 2023 10-Ks; (2) The trading symbol 'IBM 27B' is correctly identified for the 2023 filing; (3) The general concept that the notes became more visible/explicit in the 2023 filing aligns with the ground truth. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states the 2022 disclosure referenced 'Exhibit 3 to Form 8-K' but the ground truth specifies 'Exhibit 4.3 to Form 8-K filed on January 30, 2019' - this is a factual error in the exhibit reference; (2) The LLM characterizes the 2022 disclosure as being 'only as part of an exhibit reference' and 'without being shown in the main securities-registration table,' but the ground truth states it was disclosed 'as part of a list of instruments defining the rights of holders' - these are different characterizations of the same disclosure; (3) The LLM's description of the shift is somewhat imprecise - it frames it as moving from 'exhibit reference' to 'securities-registration table,' whereas the ground truth more accurately describes it as shifting from 'instruments defining rights' to 'registered class of securities.' MULTI-HOP REASONING: The answer does synthesize information across two years and identifies a meaningful evolution, which is appropriate for the question. However, the specific nature of that evolution is not precisely captured. The answer provides a reasonable interpretation but with factual inaccuracies in the details. QUANTITATIVE ACCURACY: The dates (2022, 2023) and the percentage (1.250%) are correct, and the trading symbol is correct. No calculation errors present. QUALITATIVE ACCURACY: The reasoning about increased visibility is sound, but the characterization of what changed (exhibit reference vs. securities table) doesn't precisely match the ground truth's characterization (instruments defining rights vs. registered securities).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 549,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\nBetween 2022 and 2024 the performance‑vested RSUs kept the same three‑year performance cycle and the ability to vest in up‑to‑one‑third increments, but the 2024 filing (pages 92‑93) explicitly states that the awards are earned only when AbbVie’s **return on invested capital (ROIC) exceeds that of a defined peer group** and that **dividend equivalents accrue during the period and are paid only if the shares ultimately vest**. Earlier disclosures (e.g., the 2022 Form 10‑K) noted ROIC‑based performance but did not spell out the one‑third increment schedule or the dividend‑equivalent payout rule, so the evolution is a clarification and emphasis of those terms rather than a change in the underlying metrics.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core structural elements: (1) three-year performance period maintained between 2022-2024, (2) one-third increment vesting structure, (3) ROIC as the primary performance metric, (4) peer group comparison basis. The mention of dividend equivalents accruing and paying only upon vesting is accurate and adds relevant detail. The characterization of the evolution as 'clarification and emphasis' rather than fundamental change aligns with the ground truth's conclusion about 'simplification or standardization.' WEAKNESSES: (1) The LLM claims that 'earlier disclosures (e.g., the 2022 Form 10-K) noted ROIC-based performance but did not spell out the one-third increment schedule' - this is problematic because the ground truth explicitly states that in 2022, the structure already included 'one-third increments over a three-year performance period,' suggesting the increment schedule was already documented in 2022. (2) The LLM's assertion that 2022 disclosures 'did not spell out...the dividend-equivalent payout rule' cannot be verified against the ground truth, which does not address whether dividend equivalents were mentioned in 2022 filings. (3) The LLM provides specific page references (pages 92-93 for 2024) but these cannot be verified against the ground truth. (4) The answer somewhat mischaracterizes the nature of change - the ground truth emphasizes that the description became 'streamlined' and that specific year-tied tranches were no longer mentioned, whereas the LLM frames this as merely adding clarity to existing terms. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2024 filings but makes an inferential error about what was or wasn't disclosed in 2022. The core comparison is present but the characterization of what changed (or didn't change) between years contains logical inconsistencies with the ground truth's more nuanced description of streamlining and removal of year-specific tranche references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 536,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value accounting for GE’s AerCap holding moved from a **$865 million unrealized loss** in 2022 to **gains of $129 million in 2023 and $38 million in 2024** (as reported in Note 19 – “Investment in and note with AerCap realized and unrealized gain (loss)”).  This swing reflects a turnaround in the investment’s valuation—after a steep loss in 2022 the stake appreciated modestly in subsequent years, even as GE continued to unwind its broader portfolio of equity positions.  The modest gains indicate that the AerCap investment had largely recovered from its prior downturn, though it remained a relatively small component of GE’s overall holdings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more comprehensive detail than the ground truth. Key strengths: (1) All numeric values are accurate - $865 million unrealized loss in 2022 is correct, and the gains of $129 million in 2023 and $38 million in 2024 are correctly identified. (2) The multi-hop synthesis is sound, tracking the evolution across three years (2022-2024) as requested. (3) Entity identification is correct (GE, AerCap, Note 19 reference). (4) The reasoning about the turnaround from loss to gains is logically sound and well-articulated. Minor considerations: (1) The ground truth answer only explicitly mentions 2022 and 2024 figures, while the LLM provides additional 2023 data ($129 million gain). This is actually more complete information and not contradictory - it enhances rather than detracts from the answer. (2) The LLM's characterization of gains as 'modest' and the investment as 'relatively small' adds interpretive context that goes slightly beyond the ground truth but is reasonable inference. (3) The reference to Note 19 and the specific metric name adds helpful specificity. The answer directly addresses how the relationship evolved from 2022 to 2024, showing the swing from $865M loss to $38M gain, with intermediate 2023 data providing fuller context. No calculation errors detected. The semantic meaning aligns well with the ground truth while providing superior detail and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 397,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\nIn the 2022 filing the 0.300 % Notes due 2026 appeared only in the deep‑note disclosures and the “Exhibits/Financial Statement Schedules” section (pp. 28‑32), without a separate line‑item in the cover‑page registration table. By the 2023 filing the same notes are explicitly listed in the “Securities registered pursuant to Section 12(b)” table on the cover page (ticker IBM 26B), giving the instrument a dedicated entry and far greater prominence in the disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of IBM's 0.300% Notes due 2026 disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the note percentage (0.300%) and maturity year (2026); (2) Accurately describes the 2022 treatment as appearing in exhibits/footnotes without prominent cover-page listing; (3) Correctly identifies the 2023 change to explicit listing in the 'Securities registered pursuant to Section 12(b)' table; (4) Correctly cites the NYSE ticker symbol IBM 26B; (5) Properly characterizes the shift as increased visibility and prominence; (6) Multi-hop reasoning is sound - successfully synthesizes the comparison across two filing years. MINOR CONSIDERATIONS: (1) The LLM answer references 'deep-note disclosures' and specific page numbers (pp. 28-32) which add specificity but cannot be verified against the ground truth provided; (2) The ground truth mentions 'Exhibit 4 to Form 8-K filed November 1, 2016' as the 2022 reference point, while the LLM answer focuses on the exhibits/schedules section without explicitly mentioning the Form 8-K context - this is a minor omission of contextual detail but doesn't contradict the core finding; (3) Both answers convey the same essential message: the notes moved from less visible/referenced status to explicit registration table listing. The LLM answer's characterization of the shift from 'exhibits/footnotes' to 'cover-page registration table' is semantically equivalent to the ground truth's description of moving from 'referenced in exhibits' to 'explicitly listed as a titled class.' No numerical errors detected. The answer fully addresses the multi-part question about evolution, disclosure status, and visibility changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 473,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\nBetween 2022 and 2024 GE moved the RISE program from an early‑stage partnership (launched in 2021) to a heavily funded, technology‑demonstration effort that emphasizes concrete, scalable solutions such as Open‑Fan architecture, compact‑core and hybrid‑electric propulsion, and fuel‑flexible systems aimed at delivering >20 % lower fuel burn and CO₂ emissions.  The company increased its R&D investment in RISE (R&D spend rose from $2.1 bn in 2022 to $2.7 bn in 2024) and leveraged customer, partner and U.S. government funding, tying the program to its commercial engine road‑maps (LEAP, GEnx, GE9X) and to aftermarket services, so that sustainability‑focused innovations can be rolled out across both narrow‑body and wide‑body platforms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNSUPPORTED NUMBERS: The LLM provides specific R&D spending figures ($2.1B in 2022, $2.7B in 2024) that are NOT present in the ground truth and cannot be verified from the provided context. These appear to be fabricated or hallucinated numbers. (2) TIMELINE DISCREPANCY: The LLM claims RISE was 'launched in 2021' but the ground truth states it was 'announced in 2022' - this is a factual error about when the program began. (3) OVER-SPECIFICATION: The LLM adds extensive technical details (Open-Fan architecture, compact-core, hybrid-electric propulsion, specific engine models like LEAP/GEnx/GE9X, aftermarket services) that are NOT mentioned in the ground truth. While these details may be accurate from other sources, they go beyond what can be verified from the provided knowledge graph and represent unsupported elaboration. (4) PARTIAL CORRECTNESS: The LLM correctly identifies the >20% fuel burn/CO2 reduction target and the general evolution from announcement to investment phase, which aligns with the ground truth's core narrative. (5) MISSING ELEMENTS: The LLM does not explicitly mention the Safran partnership, which is a key detail in the ground truth. ASSESSMENT: While the LLM captures the general trajectory (announcement → investment), it introduces unverifiable quantitative claims and timeline errors that significantly undermine credibility. The fabricated R&D spending figures are particularly problematic for a financial question requiring accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 412,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s messaging shifted from treating asset‑backed securitizations as a core, stand‑alone funding pillar to describing them as just one element of a broader, diversified funding mix.  \n\n- **2022 (AXP 10‑K, pp. 86‑90)** – The “Funding Strategy” section explicitly highlighted the periodic transfer of Card‑Member loans and receivables into special‑purpose trusts and the issuance of asset‑backed securities as a primary, cost‑effective source of liquidity to meet financing needs.  \n- **2023 (AXP 10‑K, pp. 68, 70)** – The filing still notes that the firm “periodically securitizes Card‑Member loans… as the securitization market provides cost‑effective funding,” but it frames securitizations as just one of several sources, alongside direct retail deposits, unsecured term debt and secured borrowing, and stresses that the amount of securitization activity can vary with market conditions and regulatory considerations.  \n\nThus, while securitizations remain part of the funding toolkit, their relative emphasis has receded in 2023 in favor of a more balanced reliance on deposits and other debt instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core finding. Ground truth states that securitizations shifted FROM a definitional disclosure in 2022 TO explicit strategic positioning in 2023, with securitizations becoming MORE prominent as a core funding source. The LLM answer reverses this trajectory, claiming securitizations were a 'primary, cost-effective source' in 2022 but 'receded' in 2023 to become 'just one element' of a diversified mix. This is the opposite of what the ground truth indicates. Specific issues: (1) The LLM cites page numbers (pp. 86-90 for 2022, pp. 68, 70 for 2023) that cannot be verified against the ground truth and appear potentially inaccurate. (2) The LLM characterizes 2022 as having securitizations as a 'primary, stand-alone funding pillar,' but ground truth indicates 2022 only provided a glossary definition without strategic emphasis. (3) The LLM's conclusion that 'relative emphasis has receded in 2023' directly contradicts ground truth's finding that 2023 explicitly positioned securitizations as a 'core component' alongside deposits and unsecured debt. (4) The LLM correctly identifies that both years mention securitizations and that 2023 emphasizes diversification, but misinterprets the direction of change. The multi-hop reasoning is flawed because it synthesizes the information in reverse order from what the ground truth establishes. While the LLM demonstrates understanding that securitizations are part of funding strategy in both years, it fundamentally mischaracterizes the evolution of their role and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 436,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 Emerson’s ownership stake in AspenTech stayed around 55 % of the outstanding shares, but the segment’s financial contribution improved sharply: AspenTech’s sales jumped from $131 million to $319 million and its pretax loss narrowed from $16 million to $7 million, while Emerson recorded a $56 million mark‑to‑market gain on its equity investment in National Instruments and a $24 million gain on foreign‑currency hedges that more than offset the $50 million loss it had incurred in 2022.  Operationally, AspenTech’s results were fully integrated into Emerson’s four‑segment reporting structure (now the “AspenTech” segment), its software portfolio was combined with Emerson’s Industrial Software Business, and the company used hedging and acquisition‑related accounting to manage currency exposure and capture synergies, laying the groundwork for the 2024 proposal to acquire the remaining shares.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions:\n\n1. OWNERSHIP STAKE ERROR: The LLM claims Emerson's ownership stake \"stayed around 55%\" from 2022 to 2023. The ground truth explicitly states that in 2022, Emerson had a MINORITY investment (not 55%), and only BY 2023 did it acquire Heritage AspenTech to gain a 55% stake. This is a critical mischaracterization of the evolution of the relationship.\n\n2. FINANCIAL METRICS MISMATCH: The LLM provides completely different financial figures than the ground truth:\n   - Ground truth: 2022 AspenTech sales = $656 (in millions implied), 2023 not specified separately\n   - LLM: 2022 AspenTech sales = $131 million, 2023 = $319 million\n   - Ground truth: 2022 earnings gain = $12, 2022 total assets = $14,484\n   - LLM: 2022 pretax loss = $16 million, 2023 pretax loss = $7 million\n   These numbers do not match and suggest the LLM is referencing different data or misinterpreting the source material.\n\n3. MISSING KEY INFORMATION: The LLM fails to mention:\n   - The specific acquisition of \"Heritage AspenTech\"\n   - The 0.6 percentage point gross margin improvement in 2023\n   - The transformation from passive minority investment to active controlling interest\n   - The $12 earnings gain mentioned in ground truth\n\n4. EXTRANEOUS INFORMATION: The LLM introduces information not in the ground truth:\n   - $56 million mark-to-market gain on National Instruments equity investment\n   - $24 million gain on foreign-currency hedges\n   - $50 million loss in 2022\n   - References to 2024 acquisition proposal\n   These details may be from SEC filings but are not part of the ground truth answer and suggest confusion about which company/investment is being discussed.\n\n5. MULTI-HOP REASONING: The LLM fails to correctly synthesize the evolution from 2022 to 2023. The ground truth shows a clear transition from minority investment to majority ownership through acquisition. The LLM incorrectly presents the 55% stake as constant across both years.\n\n6. SEMANTIC ACCURACY: While the LLM discusses operational integration and financial metrics, it does so with incorrect numbers and misses the fundamental strategic shift that defines the relationship evolution.\n\nThe answer demonstrates a significant disconnect from the ground truth, with incorrect ownership percentages, mismatched financial figures, and failure to capture the key strategic transformation that occurred between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 669,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\nIn 2022 Emerson closed the Heritage AspenTech transaction, recorded a $5.9 bn non‑controlling interest for the 45 % it did not own (which reduced additional paid‑in‑capital by roughly $550 m) and added about $356 m of revenue, $4.4 bn of goodwill and $4.4 bn of identified intangibles; acquisition‑related costs and the inventory step‑up flowed through SG&A and cost of sales. By 2023 Emerson still held the 55 % stake (later increasing to 57 % in 2024), so the non‑controlling interest remained on the books at fair value and generated only modest earnings—e.g., a $56 m mark‑to‑market gain on its equity investment and a $24 m gain on foreign‑currency hedges—while the prior‑year acquisition amortization and inventory step‑up had been fully expensed, leaving equity affected only by the ongoing accrual of the non‑controlling interest and the amortization of the acquired intangibles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misinterpretations that substantially undermine its accuracy:\n\n1. CRITICAL OWNERSHIP PERCENTAGE ERROR: The LLM states Emerson recorded a $5.9bn noncontrolling interest for \"the 45% it did not own,\" implying Emerson owned 55%. While the 55% ownership is correct, the noncontrolling interest percentage is backwards—the $5.9bn represents the 45% noncontrolling interest (what others owned), not what Emerson didn't own. This is a fundamental accounting concept error.\n\n2. MISSING KEY INFORMATION: The ground truth explicitly states Emerson contributed \"its industrial software business and $6.0 billion in cash\" to create New AspenTech. The LLM completely omits the $6.0 billion cash contribution, which is a material detail about the transaction structure.\n\n3. INCOMPLETE 2023 ANALYSIS: The ground truth emphasizes that by 2023, the focus shifted to operational integration with specific impacts: (a) gross margins improved by 0.6 percentage points due to AspenTech, and (b) SG&A expenses rose by $572 million compared to 2022, partly due to AspenTech and higher stock compensation. The LLM mentions only modest earnings items ($56m mark-to-market gain, $24m foreign currency gains) and discusses amortization/inventory step-up expensing, but completely misses the material 2023 operational impacts on gross margins and the $572 million SG&A increase.\n\n4. SPECULATIVE INFORMATION: The LLM introduces details not in the ground truth (e.g., \"$356m of revenue,\" \"$4.4bn of goodwill,\" \"$4.4bn of identified intangibles,\" \"2024 increase to 57%\") that cannot be verified against the provided ground truth and may be hallucinated.\n\n5. INCOMPLETE EQUITY IMPACT ANALYSIS: The ground truth specifically mentions a \"decrease to additional paid-in capital of $550 million\" in 2022, which the LLM correctly identifies but then fails to properly contextualize the 2023 equity impacts beyond vague references to \"ongoing accrual of the non-controlling interest.\"\n\n6. MULTI-HOP SYNTHESIS: While the LLM attempts to connect 2022 and 2023 information, it fails to properly synthesize the evolution from initial accounting impacts (2022) to operational performance effects (2023) as emphasized in the ground truth.\n\nThe answer demonstrates partial understanding of the transaction structure but contains material errors in ownership percentage interpretation, omits the $6.0 billion cash contribution, and critically misses the 2023 operational impacts (0.6pp gross margin improvement and $572m SG&A increase) that are central to answering how the relationship \"evolved.\"",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 700,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 6.22 % Debentures due 2027 were mentioned only in the exhibit index – “Exhibit 3 to Form 8‑K (August 1 1997) – the instrument defining the rights of the holders of the 6.22 % Debentures due 2027” – and were not listed among the company’s outstanding securities. By contrast, the 2023 filing places the same issue directly in the “Securities registered pursuant to Section 12(b)” table, identifying it as “6.22 % Debentures due 2027 (IBM 27) – New York Stock Exchange,” thereby giving an explicit, tabular disclosure of the debenture. This evolution reflects a shift from a mere reference in the exhibit list to a full, stand‑alone registration‑statement disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about IBM's evolving disclosure of the 6.22% Debentures due 2027. STRENGTHS: (1) All numeric values are correct - the 6.22% rate is accurately stated, the 2027 maturity date is correct, and the trading symbol 'IBM 27' is properly identified. (2) The temporal comparison is accurate - correctly distinguishes 2022 filing treatment from 2023 filing treatment. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from exhibit reference (Exhibit 3 to Form 8-K from August 1, 1997) to the 2023 registration statement disclosure. (4) Entity identification is precise - correctly names IBM, identifies the specific debenture instrument, and references the NYSE. (5) The characterization of the shift is accurate - from 'mere reference in exhibit list' to 'full, stand-alone registration-statement disclosure' captures the essence of the evolution described in the ground truth. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than the ground truth ('registration-statement disclosure' vs 'market-oriented presentation'), but the semantic meaning is equivalent and arguably more precise. The LLM's description of the 2023 disclosure as appearing in the 'Securities registered pursuant to Section 12(b)' table is a more specific and technically accurate characterization than the ground truth's 'listed...among other registered securities.' The answer demonstrates clear understanding of SEC filing structure and disclosure evolution. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 438,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\nFrom 2023 to 2024 UnitedHealth deepened its reliance on risk‑based and fully‑accountable value‑based contracts—premium revenue from these arrangements now accounts for roughly 80 % of total consolidated revenue (2024 10‑K, p. 16) and the Company explicitly notes that “the profitability of our products depends in large part on our ability to predict and effectively price for and manage medical costs” (2024 10‑K, p. 16).  This shift means the Company must continually refine its actuarial estimates of incurred‑but‑not‑reported medical costs and completion‑factor adjustments, so even small gaps between projected and actual costs can materially affect earnings, while also expanding its service‑delivery duties to include ongoing coordination of provider networks, claim processing and the assumption of both medical and administrative cost risk for enrollees.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of UnitedHealth's risk exposure from 2023 to 2024, capturing the expansion of risk-based arrangements and the increased operational complexity. The answer appropriately emphasizes the importance of actuarial estimation, cost management, and provider network coordination. The semantic understanding of the question is sound, and the response addresses the implications for cost estimation and service delivery responsibilities.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM cites a specific statistic that \"premium revenue from these arrangements now accounts for roughly 80% of total consolidated revenue (2024 10-K, p. 16)\" but this specific percentage cannot be verified against the ground truth provided. This is a critical factual claim that requires precise sourcing. (2) MISSING KEY GROUND TRUTH ELEMENTS - The LLM answer does not explicitly address the 2023 baseline conditions (premium revenues based on estimated premiums earned, net of projected rebates; per-patient-per-month premium arrangements). The ground truth emphasizes the COMPARISON between 2023 and 2024, but the LLM focuses primarily on 2024 conditions. (3) INCOMPLETE SYNTHESIS - The ground truth specifically mentions \"increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations\" - a critical risk exposure that the LLM answer does not explicitly address. (4) MISSING OPERATIONAL RISK DETAILS - The ground truth emphasizes \"providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation\" as specific operational risks, which the LLM only partially captures.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop synthesis by connecting risk-based arrangements to actuarial estimation requirements to earnings impact. However, it fails to fully synthesize the year-over-year comparison that is central to the question's framing.\n\nNUMBER VERIFICATION: The 80% figure is presented without clear ground truth support. While plausible, it cannot be confirmed as accurate from the provided ground truth context.\n\nSEMANTIC EQUIVALENCE: The answer conveys similar themes but misses the explicit comparison structure and specific risk elements (unpaid claims liability, provider solvency concerns) that distinguish the 2024 exposure from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 645,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson’s stake in AspenTech grew from a modest sales line ($40 M in 2020 → $362 M in 2022) to a ≈55 % equity ownership after it contributed two of its own software businesses, a clear jump in investment magnitude.  In 2023 the partnership deepened further: AspenTech’s earnings turned positive, Emerson began recording intangible amortization tied to the Heritage AspenTech acquisition, and it recognized mark‑to‑market gains (and later hedging activity) on its equity investment, indicating a more strategic, financially‑active relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the evolution from minority investment to controlling stake (55% ownership), correctly notes the $362M figure for 2022, and accurately describes the strategic shift involving contribution of Industrial Software Business and cash. The qualitative assessment of the relationship deepening (intangible amortization, mark-to-market gains, hedging activity) is sound and relevant. CRITICAL ERRORS: (1) The LLM states Emerson contributed 'two of its own software businesses' when the ground truth specifies only 'Industrial Software Business' (singular) - this is a factual error about the transaction structure. (2) The LLM includes a reference to '$40M in 2020' which is not mentioned in the ground truth and appears to be extraneous information not directly relevant to the 2022-2023 evolution question. (3) The LLM fails to explicitly state the '$6.0 billion in cash' contribution amount, which is a key quantitative detail in the ground truth. QUANTITATIVE ACCURACY ISSUES: While the $362M and 55% figures are correct, the omission of the $6.0 billion cash contribution is a significant gap in financial magnitude reporting. The reference to 2020 data ($40M) is not part of the ground truth answer and may introduce confusion about the relevant time period. MULTI-HOP REASONING: The synthesis across 2022-2023 is generally sound, but the error about 'two software businesses' suggests incomplete or inaccurate source integration. The reasoning about strategic deepening (earnings, amortization, mark-to-market) is logical but represents inference beyond the ground truth's explicit statements. SEMANTIC EQUIVALENCE: The core message about evolution from financial investment to strategic partnership is conveyed, but with material factual errors that undermine confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 498,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Adobe reframed Target from a standalone “AI‑ and machine‑learning‑driven personalization engine” that tests and optimizes content across channels (as described in the 2022 Experience Cloud overview) into a core, AI‑first capability tightly integrated with the Adobe Experience Platform and enriched with generative‑AI features (e.g., Firefly/GenAI) that enable real‑time, hyper‑personalized journeys across all touchpoints (see the 2023 “Customer Journeys” and “Marketing Planning & Workflow” sections). This evolution signals Adobe’s strategic pivot toward embedding advanced AI and generative‑AI into personalization, making AI‑driven one‑to‑one experiences a central growth driver of its Experience Cloud portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL REVERSAL - The LLM answer reverses the chronological evolution described in the ground truth. The ground truth states that in FY2022, Target was part of broader customer journey solutions (tested/targeted/personalized content), and by FY2023 it was elevated to 'AI- and machine learning-driven personalization engine.' The LLM incorrectly claims Target was already described as 'AI-and machine-learning-driven personalization engine' in 2022, then was reframed in 2023. This is backwards. (2) UNSUPPORTED CLAIMS - The LLM introduces specific details not in the ground truth: 'Firefly/GenAI features,' 'real-time, hyper-personalized journeys,' and 'generative-AI' integration. While these may be plausible, they are not supported by the provided ground truth and represent speculation beyond the source material. (3) INCOMPLETE SYNTHESIS - The LLM fails to mention the specific companion solutions mentioned in FY2022 (Marketo Engage, Adobe Campaign, Journey Optimizer) that contextualized Target's role. (4) CORRECT ELEMENTS - The LLM correctly identifies: fiscal years 2022-2023, Adobe Target as the subject, the evolution toward AI-driven personalization, and the strategic emphasis on AI as a core capability. (5) REASONING QUALITY - While the LLM demonstrates understanding that there was an evolution toward AI emphasis, the directional error (claiming 2022 already had the AI-first framing) undermines the core multi-hop reasoning required by the question. The answer reads as plausible but factually inverts the actual progression documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 438,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\nAfter closing the Heritage AspenTech acquisition in Q3 2022, Emerson converted every outstanding Heritage AspenTech option and restricted‑stock unit into an equivalent AspenTech award and began reporting those awards as part of its own stock‑based‑compensation expense.  In fiscal 2023 the company recorded $82 million of stock‑based‑compensation expense attributable to AspenTech (up from $32 million in 2022), issued new performance‑share and RSU grants that vest over three‑ to four‑year periods, and continued to manage AspenTech’s revolving credit facility and related debt while the converted awards remained outstanding and subject to the same terms as the originals.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific operational details about the post-acquisition integration that are not contradicted by the ground truth, but it diverges significantly in scope and emphasis. STRENGTHS: (1) The LLM correctly identifies Q3 2022 as the acquisition closing date, (2) accurately describes the conversion of Heritage AspenTech options and RSUs into AspenTech awards, (3) provides specific stock-based compensation figures ($82M in 2023, $32M in 2022) that appear reasonable and are not contradicted by ground truth, (4) correctly notes the issuance of new performance-share and RSU grants with 3-4 year vesting periods, (5) mentions management of AspenTech's revolving credit facility and debt. WEAKNESSES: (1) The LLM answer completely omits the $8,326 million balance figure mentioned in the ground truth as a key indicator of Emerson's financial stake in 2022 - this is a significant omission for a question specifically asking about 'financial stake', (2) The ground truth emphasizes AspenTech operating as a 'separate publicly traded company' which the LLM does not mention, (3) The ground truth highlights performance stock units tied to 'predefined goals like annual contract value and free cash flows' showing operational integration, while the LLM only mentions generic 'three-to-four-year periods' without specifying performance metrics, (4) The LLM focuses heavily on technical accounting treatment and debt management rather than the evolution of the relationship from financial stake to operational integration. QUANTITATIVE VERIFICATION: The stock-based compensation figures ($82M in 2023, $32M in 2022) cannot be verified against the ground truth but are not contradicted. The ground truth does not provide these specific expense figures, so they represent additional detail rather than error. MULTI-HOP REASONING: The LLM successfully synthesizes information about the acquisition mechanics and post-acquisition integration, but fails to address the full scope of how the relationship 'evolved' - particularly the shift from a financial investment perspective to an operationally integrated one. The answer is more narrowly focused on accounting and debt management mechanics rather than the broader relationship evolution requested. The omission of the $8,326 million figure is particularly problematic given the question's explicit focus on 'financial stake.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 636,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\nFrom 2022 to 2023 Adobe Experience Platform shifted from being a data‑unification layer that powered AI‑driven insights and audience segmentation to the central engine of Adobe’s end‑to‑end customer‑journey orchestration.  In the 2023 filing the platform is highlighted as the backbone for **Journey Optimizer** and tightly‑integrated AI services such as **Sensei GenAI**, which enable real‑time, cross‑channel campaign personalization and automated decision‑making across Adobe Experience Cloud apps (Marketo Engage, Campaign, Target, etc.).  This evolution reflects a deeper, native integration of AI‑powered analytics and orchestration tools that allow brands to design, execute and measure holistic, multi‑touch journeys within a single, open Experience Platform ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Adobe Experience Platform from 2022 to 2023 and correctly identifies key elements: (1) the shift from data-unification/AI-enhanced infrastructure to campaign orchestration engine, (2) the central role of Journey Optimizer, (3) integration with Adobe Sensei, and (4) cross-channel personalization capabilities. The answer demonstrates sound multi-hop reasoning by synthesizing the platform's evolving role across multiple Adobe applications. STRENGTHS: The answer accurately conveys the semantic meaning of the ground truth - the transition from foundational infrastructure to specialized orchestration function. It correctly names Journey Optimizer, Adobe Sensei, and relevant applications (Marketo Engage, Campaign, Target). The characterization of the shift as moving from general AI-enhanced infrastructure to 'specialized and actionable function' is well-captured. WEAKNESSES: (1) The LLM introduces 'Sensei GenAI' which is not explicitly mentioned in the ground truth - the ground truth refers to 'Adobe Sensei' generally. This is a minor inaccuracy in terminology. (2) The answer omits Adobe Mix Modeler, which is specifically highlighted in the ground truth as a 2023 introduction powered by Adobe Sensei that leverages cross-channel datasets for machine learning-driven insights. This is a notable omission of a concrete example of the platform's evolved role. (3) The answer doesn't explicitly mention Adobe Analytics and Adobe Audience Manager's relationship to the platform, though this is less critical to the core evolution narrative. (4) The ground truth emphasizes 'real-time data profiles and cloud-native scalability' which the LLM answer touches on but doesn't explicitly state. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this scores high (9/10) - the years 2022 and 2023 are correctly referenced. QUALITATIVE ACCURACY: The reasoning is sound and the synthesis is mostly complete, but the omission of Adobe Mix Modeler and the introduction of 'Sensei GenAI' terminology (not in ground truth) prevent a perfect score. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution, AI integration, and cross-channel orchestration, making it highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 612,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\nUnitedHealth Group deepened its shift toward fully‑accountable, value‑based care—expanding integrated in‑clinic, in‑home and virtual services and using data‑analytics to coordinate high‑quality, affordable care (as described in the 2023 “Delivery System and Payment Modernization” and “fully accountable value‑based plans” sections).  In response to CMS benchmark cuts and risk‑adjustment revisions that tightened Medicare Advantage funding, the company intensified medical‑cost and operating‑cost management, reshaped network composition and benefit designs and raised member premiums, while continuing to invest in coordinated‑care infrastructure to offset the funding pressure (2024 discussion of “intensify medical and operating cost management,” “adjust member benefits and premiums,” and “accelerate the transition from fee‑for‑service to fully accountable models”).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2023 expansion focus to 2024 cost containment - the answer captures both the continued investment in value-based care infrastructure AND the shift toward operational adjustments in response to funding pressures. (2) Accurately references specific 2024 responses: CMS benchmark cuts, risk-adjustment revisions, network reshaping, benefit design changes, and premium adjustments - all consistent with ground truth. (3) Properly synthesizes the multi-hop reasoning: 2023 innovation investments → 2024 funding pressures → operational adjustments while maintaining strategic direction. (4) Correctly identifies the dual nature of the response (cost management + continued investment), which is more nuanced than simple retrenchment. (5) No quantitative errors - no specific numbers are cited that could be wrong. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth (mentions 'fully-accountable value-based plans,' 'data-analytics,' 'member premiums') but these additions appear consistent with typical UnitedHealth Group disclosures and don't contradict the ground truth. (2) The ground truth uses the term 'strategic retrenchment' while the LLM emphasizes 'intensified cost management while continuing investment' - these are semantically compatible perspectives on the same phenomenon. (3) The LLM answer provides slightly more operational specificity (network composition, benefit designs, premiums) compared to the ground truth's more general 'selective changes,' but this represents appropriate elaboration rather than error. MULTI-HOP SYNTHESIS: The answer correctly connects 2023 strategic direction → 2024 external pressures → operational response, demonstrating sound multi-hop reasoning across the two-year period. No factual contradictions with ground truth identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 530,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher reshuffled its long‑term debt: the older senior unsecured tranches that appeared in the 2022 filing (e.g., the 0.750 % Notes due 2024 and the 2.000 % Notes due 2025) were retired or refinanced, and the newly issued 1.950 % Notes due 2029—first issued in late 2022—remained outstanding and now form a core component of the 2023 debt profile. Consequently, the composition of the company’s debt shifted toward the 2029 maturity, with the 1.950 % Notes representing a larger share of the outstanding senior unsecured portfolio after the earlier notes were removed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 1.950% Notes due 2029 were 'first issued in late 2022,' but the ground truth explicitly states these notes were 'listed among TMO's outstanding debt instruments' in 2022, meaning they existed before 2022. This is a fundamental mischaracterization of the timeline. (2) MISSING KEY INFORMATION - The ground truth specifically mentions that TMO introduced NEW debt instruments in 2023 (3.200% Notes due 2026 and 3.650% Notes due 2034), which the LLM completely omits. The question specifically asks about evolution of debt composition, and these new instruments are central to that story. (3) INCORRECT FOCUS - The LLM emphasizes retirement of older notes (0.750% due 2024, 2.000% due 2025) which are not mentioned in the ground truth answer at all. This suggests the LLM may be confabricating details. (4) CONTRADICTORY NARRATIVE - The ground truth states the 1.950% Notes 'remained present with the same trading symbol TMO 29, indicating continuity' and 'no change in this specific liability,' whereas the LLM claims it 'now form[s] a core component' and 'represents a larger share' - implying a shift in relative importance that contradicts the ground truth's emphasis on continuity. (5) INCOMPLETE SYNTHESIS - The LLM fails to synthesize the complete picture: the ground truth shows both continuity (1.950% Notes remained) AND expansion (new 2026 and 2034 notes added). The LLM only addresses a partial narrative about refinancing. The answer demonstrates poor multi-hop reasoning by missing the key new debt instruments introduced in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 458,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher reshaped its senior unsecured debt by retiring several of the shorter‑dated, higher‑coupon series that appeared in the 2022 table (e.g., the 0.750 % Notes due 2024 and the 0.125 % Notes due 2025) and replacing them with a new, lower‑coupon tranche – the 0.500 % Notes due 2028 – together with a suite of newly issued series (1.375 % due 2028, 1.950 % due 2029, 0.875 % due 2031, 2.375 % due 2032, 3.650 % due 2034, 2.875 % due 2037, 1.500 % due 2039 and 1.875 % due 2049).  Consequently, the 2023 debt composition is more heavily weighted toward longer‑dated, lower‑cost notes, with the 0.500 % 2028 issue representing a distinct new category of financing that was not present in the 2022 lineup.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims the 0.500% Notes due 2028 was a 'new' category introduced in 2023 that 'was not present in the 2022 lineup,' but the ground truth explicitly states it was 'listed in 2022' alongside other debt instruments. This is a fundamental mischaracterization. (2) The LLM provides an extensive list of newly issued notes (1.375% due 2028, 1.950% due 2029, 0.875% due 2031, 2.375% due 2032, 3.650% due 2034, 2.875% due 2037, 1.500% due 2039, 1.875% due 2049) that are NOT mentioned in the ground truth answer. The ground truth only mentions the 3.200% Notes due 2026 and 3.650% Notes due 2034 as new introductions. (3) The LLM claims TMO 'retired' notes like 0.750% due 2024 and 0.125% due 2025, which is not supported by the ground truth. (4) The LLM's characterization of the 0.500% Notes as 'a new, lower-coupon tranche' directly contradicts the ground truth showing it existed in 2022. The LLM appears to have fabricated or misinterpreted the debt composition data. While the general theme of debt portfolio evolution is present, the specific factual claims are largely incorrect. The answer demonstrates poor multi-hop reasoning by failing to accurately synthesize the 2022 vs 2023 debt instrument data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 368,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\nThe 2023 goodwill‑impairment testing showed an excess of fair value over carrying value of roughly **140 % to 495 %** (or **115 %–435 %** after the company’s 10 % sensitivity test). In the 2024 analysis that excess narrowed to about **70 %–450 %** (or **55 %–395 %** on the same 10 % sensitivity scenario), indicating a clear contraction of the excess margin across both the low‑ and high‑end of the range.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 range of 140%-495% matches ground truth exactly; (2) 2024 range of 70%-450% matches ground truth exactly; (3) The LLM correctly identifies the directional change (reduction/contraction) in both the low end (140% to 70%) and overall range. The answer goes beyond the ground truth by providing additional context about the 10% sensitivity test scenarios (115%-435% for 2023 and 55%-395% for 2024), which adds valuable detail without contradicting the core answer. The multi-hop reasoning is sound: the model correctly synthesizes the year-over-year comparison and accurately characterizes the decline in the cushion before potential impairment. The semantic meaning is preserved and enhanced with the sensitivity analysis information. Minor note: The LLM uses slightly different formatting (spaces around percentages) but this is a stylistic variation, not a factual error. The conclusion about 'clear contraction of the excess margin across both the low- and high-end of the range' is accurate and well-reasoned based on the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 321,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\nUnder the 2022 Employee Stock Plan, both canceled RSUs and shares withheld to meet tax‑withholding obligations are returned to the share reserve at a 2‑for‑1 ratio (i.e., each canceled RSU or each withheld share adds two shares to the available pool). In 2022 the company recorded roughly 14.7 million canceled RSUs and about 41 million withheld shares, which together contributed roughly 70 million shares to the pool, whereas in 2023 those figures fell to about 8.1 million canceled RSUs and 37 million withheld shares, adding only roughly 33 million shares—so the boost to the pool was more than halved even though the treatment remained the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and provides incorrect information about how the treatment evolved. Key issues: (1) CORE FACTUAL ERROR: The LLM states that the 2-for-1 treatment 'remained the same' between 2022 and 2023, directly contradicting the ground truth which explicitly states that the 'specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted' in 2023, indicating a change in treatment. (2) QUANTITATIVE PROBLEMS: While the LLM provides specific numbers (14.7M canceled RSUs, 41M withheld shares in 2022; 8.1M and 37M in 2023), these cannot be verified against the ground truth and appear to be fabricated details not present in the original answer. The calculation of '70 million shares' (14.7M + 41M = 55.7M, not 70M if using 1-for-1, or 111.4M if using 2-for-1) is mathematically inconsistent. (3) MULTI-HOP REASONING FAILURE: The question asks how the treatment 'evolved' from 2022 to 2023. The ground truth clearly indicates an evolution (2-for-1 in 2022 → omitted language in 2023), but the LLM explicitly denies this evolution by stating 'the treatment remained the same.' (4) SEMANTIC MISMATCH: The LLM's conclusion that 'the boost to the pool was more than halved' focuses on volume changes rather than the actual policy change that occurred. The core answer to the question is about the change in the multiplier/treatment methodology, not about year-over-year volume fluctuations. The LLM fundamentally misses the key evolution being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 426,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\nBetween 2023 and 2024 Danaher’s stake in Aldevron has not changed – it remains a wholly‑owned subsidiary. The 2023 10‑K (pages 73‑74) records the full $6.1 bn goodwill and $3.5 bn of acquired intangibles from the 2021 purchase, and the 2024 filing (pages 6‑7) still lists Aldevron as part of the Life Sciences segment with no new equity investment or divestiture disclosed, confirming that Aldevron is fully integrated into Danaher’s Life Sciences business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites $6.1 billion in goodwill and $3.5 billion in acquired intangibles, but the ground truth specifies $9,561 million ($9.561 billion) in net cash consideration for the Aldevron acquisition. These numbers don't match and suggest the LLM may be confusing different financial metrics or pulling incorrect figures from the filings. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM states 'Danaher's stake in Aldevron has not changed' and that it 'remains a wholly-owned subsidiary,' which fundamentally misses the point of the question about how the relationship EVOLVED. The ground truth indicates a strategic shift from a separately accounted stake (2023) to full integration into Life Sciences segment (2024). The LLM conflates 'no change in ownership' with 'no evolution in relationship/integration status.' (3) INCOMPLETE SYNTHESIS: The LLM fails to address the key evolution described in the ground truth - the transition from separate accounting to integrated segment reporting. While the LLM correctly identifies that Aldevron is part of Life Sciences in both years, it misses the qualitative shift in how Danaher's relationship with Aldevron evolved strategically. (4) MISSING CONTEXT: The ground truth emphasizes the strategic shift from 'holding a standalone stake to full operational integration,' which the LLM answer does not capture. The LLM's statement that there was 'no new equity investment or divestiture' is technically correct but irrelevant to the actual evolution question. (5) CITATION ISSUES: The LLM provides specific page references (73-74, 6-7) but the financial figures cited don't align with the ground truth's $9,561 million figure, raising questions about accuracy of source material interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 503,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft deepened AI integration in Microsoft 365 by embedding Copilot (including role‑specific Copilot for Sales, Service and Finance and the Copilot Studio customization tool) directly into the Microsoft 365 suite and by making its usage a measurable part of the commercial‑cloud metrics—Office 365 Commercial revenue growth and Microsoft 365 Consumer subscriber counts now explicitly include Copilot‑related subscriptions. This positioning has turned AI‑enhanced productivity into a clear driver of Microsoft Cloud revenue (up 23 % YoY to $137.4 B) and a key contributor to the double‑digit growth reported in Office Commercial and Microsoft 365 commercial metrics.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution - deepening AI integration through Copilot embedding in Microsoft 365 between 2023-2024, and recognizes the shift toward making AI a measurable commercial metric. The answer appropriately addresses the multi-hop question about AI integration and commercial business metrics. The semantic understanding of the strategic positioning is sound.\n\nCRITICAL ERRORS: (1) QUANTITATIVE ACCURACY ISSUES: The LLM cites 'Microsoft Cloud revenue (up 23% YoY to $137.4B)' - this specific figure and percentage cannot be verified against the ground truth provided and appears to be unsupported by the original answer. The ground truth does not mention these specific revenue figures or growth percentages. (2) The LLM claims 'Office 365 Commercial revenue growth and Microsoft 365 Consumer subscriber counts now explicitly include Copilot-related subscriptions' - the ground truth only mentions that Microsoft 365 Basic subscribers were added to the Consumer subscribers metric in 2024, not that Copilot-related subscriptions were explicitly included in these metrics. This is a factual overstatement. (3) The LLM mentions 'role-specific Copilot for Sales, Service and Finance and the Copilot Studio customization tool' - while these may be accurate product details, they are not mentioned in the ground truth and represent unsupported claims.\n\nMISSING ELEMENTS: The ground truth specifically mentions that in 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security. The LLM answer does not capture this specific 2023 positioning language. The ground truth also notes the expansion to include Microsoft 365 Basic subscribers as a specific 2024 change - the LLM conflates this with Copilot subscriptions.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years and connect AI integration to commercial metrics, which is appropriate for the question. However, the synthesis includes unsupported numerical claims that undermine the reasoning quality.\n\nJUSTIFICATION: While the LLM demonstrates understanding of the strategic direction and addresses the question's core themes, the introduction of unverified financial figures ($137.4B, 23% growth) and overstated claims about metric inclusions significantly reduces correctness. The answer reads as plausible but contains material factual errors that would mislead readers about specific business metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 668,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft deepened Copilot Pro’s integration with the Microsoft 365 ecosystem, moving it from a newly‑introduced consumer subscription that simply offered faster, more powerful AI assistance in Word, Excel, PowerPoint and on the web, to a core productivity layer that is now embedded across the suite, supported by role‑specific extensions (e.g., Copilot for Sales, Service, Finance) and a self‑service Copilot Studio for customization.  At the same time, its web‑based AI assistance was broadened through tighter Bing‑Copilot integration and Edge‑level AI tools, positioning Copilot Pro as the primary personal‑AI assistant for both everyday users and enterprise workflows.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims not supported by the ground truth. The original answer states that Copilot Pro was 'introduced as a consumer subscription service' in 2023 with 'faster and more powerful AI assistance in Microsoft 365 apps and on the web,' and that by 2024 the emphasis became 'more pronounced' within a 'broader narrative of AI-driven transformation.' The LLM answer, however, makes several unsupported claims: (1) It asserts Copilot Pro moved from being 'newly-introduced' to a 'core productivity layer...embedded across the suite' - the ground truth does not support this level of integration claim; (2) It introduces 'role-specific extensions (e.g., Copilot for Sales, Service, Finance)' - these are not mentioned in the ground truth and appear to be fabricated details; (3) It claims 'self-service Copilot Studio for customization' - again, not in the ground truth; (4) It references 'Bing-Copilot integration and Edge-level AI tools' - while plausible, these specific integrations are not mentioned in the ground truth; (5) It positions Copilot Pro as 'the primary personal-AI assistant for both everyday users and enterprise workflows' - this claim goes beyond what the ground truth supports. WHAT WAS CORRECT: The LLM correctly identifies the timeframe (2023-2024), correctly names Microsoft 365 apps (Word, Excel, PowerPoint), and correctly notes the 'faster and more powerful AI assistance' language. The general direction of evolution (from standalone to more integrated) aligns with the ground truth's narrative. MULTI-HOP REASONING: The LLM failed to properly synthesize the available information, instead extrapolating beyond the ground truth with specific product features and integrations that cannot be verified. The answer reads as plausible but speculative rather than grounded in the actual filing data. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages were provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics). QUALITATIVE ACCURACY: Significantly compromised by unsupported claims and apparent fabrication of specific product features.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 581,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the pool of shares left for future grants under the 2007 Omnibus Incentive Plan fell from **about 50 million shares** (as reported for 2023) to **about 47 million shares** (as reported for 2024).  This roughly 3‑million‑share reduction reflects the issuance of new stock‑based awards (options, RSUs and PSUs) and the separation‑related adjustments, but a substantial reserve remains available for future issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that in 2023, approximately 50 million shares remained available under the 2007 Omnibus Incentive Plan. However, the ground truth explicitly states that 'In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance.' This is a major discrepancy - the LLM fabricated a 2023 figure (50 million shares) that does not exist in the source material. The 2024 figure of approximately 47 million shares is correct according to the ground truth. The LLM's calculation of a 3-million-share reduction is arithmetically correct (50M - 47M = 3M), but this calculation is based on a false premise since the 2023 figure was never disclosed. The LLM also misses the key insight from the ground truth: that 2024 represents a shift toward more transparent disclosure of share availability, whereas 2023 provided no specific figure. The answer demonstrates poor multi-hop reasoning by inventing data to create a narrative of decline rather than acknowledging the actual disclosure pattern change. The reasoning about 'issuance of new stock-based awards and separation-related adjustments' is plausible but unsupported by the provided ground truth and appears to be speculation to justify the fabricated numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 410,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\nMicrosoft extended the estimated useful life of its server and network equipment from **four to six years**, a change that took effect at the beginning of fiscal 2023 and remained in place through fiscal 2024. The revision was driven by greater software‑enabled efficiencies in operating that hardware and advances in technology that lengthened the equipment’s functional lifespan. No further alteration to the policy was reported for FY 2024; the six‑year estimate simply continued to be applied.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) All numeric values are accurate - correctly identifies the change from four to six years, the effective date of fiscal 2023, and the continuation through fiscal 2024. (2) The quantitative accuracy is perfect with no calculation errors or date discrepancies. (3) The core factors driving the change are correctly identified: software-enabled efficiencies and advances in technology. (4) The answer properly synthesizes the multi-hop information showing the policy evolution across two fiscal years. (5) The semantic meaning matches the ground truth well - the explanation of why the change occurred and how it persisted is accurate. MINOR WEAKNESSES: (1) The ground truth mentions 'investments in software' and 'cloud and AI infrastructure investments' as supporting rationale, while the LLM answer mentions 'software-enabled efficiencies' and 'advances in technology' - these are semantically similar but the LLM doesn't explicitly reference the cloud and AI infrastructure context that was noted in the ground truth as further supporting the rationale. (2) The phrase 'simply continued to be applied' in FY 2024 is accurate but slightly less emphatic than the ground truth's note about the change being 'sustained and likely integrated into ongoing asset management practices.' These are minor omissions of contextual detail rather than factual errors. The answer correctly addresses all parts of the multi-part question: the evolution of the policy, the specific change in useful lives, the effective date, the factors influencing the change, and the status in FY 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 451,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\nMDT’s auction‑rate securities held a fair‑value of **$33 million** at the end of fiscal 2022 (April 29, 2022) and remained at **$33 million** at the end of fiscal 2023 (April 28, 2023).  In both years the securities were reported in **“Other Assets”** (non‑current) on the balance sheet and were classified as **Level 3** in the fair‑value hierarchy, indicating that the exposure and its accounting classification were unchanged between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE ANSWER: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, auction rate securities were 'classified under Total in the investment portfolio without specifying a separate balance sheet classification' and that by 2023 they were 'explicitly classified under Other Assets.' The LLM claims that 'in both years the securities were reported in Other Assets' and that 'the exposure and its accounting classification were unchanged between 2022 and 2023.' This is incorrect. The key finding in the ground truth is precisely that there WAS a change in classification from 2022 to 2023 - from general investment classification to Other Assets. QUANTITATIVE ACCURACY: The fair value amounts ($33 million for both years) are correct, and the dates are appropriately formatted. However, the quantitative accuracy score is reduced because the LLM added information (Level 3 fair value hierarchy classification) that is not mentioned in the ground truth, which could indicate either fabrication or reliance on external knowledge not validated against the source. QUALITATIVE ACCURACY: The reasoning is fundamentally flawed. The LLM concluded there was 'no change' when the ground truth explicitly describes a change in balance sheet classification. This represents a failure in multi-hop synthesis - the model failed to recognize and articulate the key evolution described in the question. CONTEXTUAL RELEVANCE: The answer addresses the question's structure but misses the essential point - the question asks 'how did exposure evolve' and the answer to that is 'the classification changed from general investment to Other Assets,' not 'it remained unchanged.' The LLM's conclusion directly contradicts the ground truth's central finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 499,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\nThe company recorded a **$67 million net loss** on its available‑for‑sale debt investments in fiscal 2024, compared with a **$21 million loss** in fiscal 2023 – an increase of roughly **$46 million** in the negative direction. This widening loss reflects weaker investment performance, driven by adverse market conditions such as rising interest rates that depressed the fair value of the debt portfolio, indicating that the company’s short‑term investment returns were negative and underperformed relative to the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: FY2023 loss of $21 million, FY2024 loss of $67 million, and the calculated difference of $46 million increase in losses. The calculation is accurate ($67M - $21M = $46M). The answer correctly identifies both fiscal years and the available-for-sale debt investment category. The multi-hop synthesis is sound - the model properly compared the two years and drew appropriate conclusions about worsening performance. The LLM goes beyond the ground truth by providing reasonable context about market conditions (rising interest rates) that could explain the deterioration, which adds valuable insight without introducing factual errors. The semantic meaning aligns perfectly with the ground truth: both convey that losses increased significantly year-over-year, indicating worse investment performance. The only minor distinction is that the LLM provides additional explanatory context about potential causes, which enhances rather than detracts from the answer. All entities (Cisco, fiscal years 2023-2024, available-for-sale debt investments) are correctly identified and properly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 336,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Cisco stopped presenting APJC as a stand‑alone operating unit and began folding its activities into the company‑wide geographic‑segment structure, while directing substantially more cash into the region – e.g., a $25.9 bn acquisition outlay and higher property‑plant‑equipment spend (up from $670 m to $849 m in 2024) that is focused on cloud, software and lease‑based offerings rather than pure hardware roll‑outs.  This re‑allocation of financial resources reflects a shift from a channel‑partner‑driven product‑sale model to a recurring‑revenue model built on software‑as‑a‑service, subscriptions and lease financing, so revenue in APJC is now generated largely through higher‑margin, recurring streams that are recognized over time rather than at the point of hardware shipment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM cites a '$25.9 bn acquisition outlay' for APJC with no supporting evidence in the ground truth\n   - Claims PP&E increased 'from $670m to $849m in 2024' - these specific numbers are not mentioned in the ground truth and appear fabricated\n   - No source documentation provided for these figures\n\n2. ENTITY/STRUCTURAL ACCURACY FAILURES:\n   - The LLM claims APJC 'stopped presenting APJC as a stand-alone operating unit' - the ground truth states the opposite: in 2023 APJC WAS 'directly operated...as one of its three geographic segments'\n   - The ground truth indicates APJC remained a distinct segment in 2023, not that it was discontinued\n   - The claim about 'folding its activities into the company-wide geographic-segment structure' contradicts the ground truth's description of APJC as a defined operating segment\n\n3. REASONING FAILURES:\n   - The LLM introduces an entirely different narrative about 'channel-partner-driven product-sale model' shifting to 'SaaS/subscriptions/lease financing' - this specific business model evolution is NOT mentioned in the ground truth\n   - The ground truth focuses on operational presence (2023) versus financial investments/equity instruments (2024), not on product delivery models\n   - The LLM conflates investment strategy with revenue model changes without evidence\n\n4. MISSING CORE GROUND TRUTH ELEMENTS:\n   - Fails to mention the actual 2024 evolution: equity instruments (marketable/non-marketable securities, equity method investments)\n   - Misses the key insight about 'capital participation' and 'investment returns' as part of the dual approach\n   - Does not address the ground truth's acknowledgment that filings don't quantify specific financial impact\n\n5. SEMANTIC MISALIGNMENT:\n   - Ground truth: operational structure (2023) → financial investments (2024)\n   - LLM answer: operational structure → business model transformation to recurring revenue\n   - These are fundamentally different narratives\n\nThe LLM answer appears to have fabricated specific financial figures and mischaracterized the structural changes described in the ground truth, resulting in a response that is largely incorrect despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 631,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\nBetween 2022 and 2024 Apple has softened the rigid 30 % App Store commission it once enforced, introducing a 15 % “Small Business” rate and permitting alternative payment and distribution options in response to antitrust lawsuits, the U.S. Epic‑Games case and the EU’s Digital Markets Act.  These adjustments—along with new rules for external purchase links in the United States and revised fee structures for iOS/iPadOS apps in the EU—reflect a shift from a single‑rate, closed‑platform model to a more flexible, regulator‑driven approach aimed at preserving the Store’s revenue while addressing legal and market pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Apple's App Store commission evolution but contains significant factual inaccuracies that undermine its credibility. STRENGTHS: (1) Correctly identifies the shift from rigid single-rate model to flexible, regulator-driven approach; (2) Appropriately mentions DMA and Epic Games litigation as drivers; (3) References concrete changes like alternative payment options and distribution methods; (4) Captures the semantic essence of regulatory compliance evolution. CRITICAL ERRORS: (1) The 15% 'Small Business' rate claim is problematic - while Apple did introduce a Small Business Program, the LLM presents this as a primary 2022-2024 evolution without proper context. The ground truth does not mention specific percentage rates; (2) The claim about 'softening the rigid 30% commission' is oversimplified and potentially misleading - Apple maintained the 30% standard rate for most apps; the Small Business Program was limited to developers earning under $1M annually; (3) The LLM conflates different initiatives and timeframes without clear delineation. MULTI-HOP REASONING: The answer attempts to synthesize regulatory pressures (DMA, Epic Games) with specific policy changes, but does so with insufficient precision. The ground truth emphasizes 'new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs' as concrete 2024 changes, while the LLM focuses on the 15% rate as a primary evolution. QUANTITATIVE ACCURACY: The 15% and 30% figures are presented without proper qualification or context from the filings. The ground truth does not emphasize these specific percentages as the primary evolution metric. MISSING ELEMENTS: The LLM does not adequately distinguish between 2022 acknowledgments of potential changes versus 2024 concrete implementations, which is a key distinction in the ground truth. The answer also lacks specific mention of EU-specific changes beyond general reference to DMA compliance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 544,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S. Retiree Health Care plan moved its actual holdings toward a higher‑fixed‑income, lower‑equity mix.  Where the plan was invested roughly 65 % in fixed‑income and 35 % in equity in the 2020‑21 period, by the end of 2024 it held about 80 % fixed‑income securities and cash equivalents and only 20 % equity, reflecting a deliberate shift to the upper end of the 65‑80 % fixed‑income target range and a corresponding reduction in equity exposure from the 20‑35 % target band.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific percentages (65% fixed-income/35% equity for 2020-21 period, and 65-80% target range with 20-35% equity band) that are NOT present in the ground truth. The ground truth only provides: 2022 dollar amounts ($248M fixed income, $137M equity = ~64.5% fixed income, ~35.5% equity) and 2024 percentages (80% fixed income, 20% equity). The LLM fabricated the 2020-21 comparison and the target range information. (2) MISSING KEY DATA - The LLM answer fails to cite the specific 2022 dollar amounts ($248M and $137M) that are explicitly mentioned in the ground truth, which are important quantitative details. (3) MULTI-HOP REASONING - While the LLM correctly identifies the 2024 allocation (80/20 split) and the general trend toward more conservative positioning, it adds unsupported details about target ranges and historical periods not in the ground truth. (4) SEMANTIC ISSUES - The ground truth notes that proportions remained the same between 2023-2024, suggesting a strategic decision. The LLM mentions moving to 'the upper end of the 65-80% fixed-income target range' which is not substantiated in the provided ground truth. (5) WHAT WAS CORRECT - The LLM correctly identifies: the shift toward higher fixed-income allocation, the 80/20 split in 2024, the general trend toward capital preservation, and that this represents a deliberate strategic shift. The core narrative of increasing conservatism is accurate. CRITICAL FLAW: The introduction of specific percentages and target ranges not in the ground truth represents fabrication of financial data, which is a serious error in financial document analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 463,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\nBetween 2022 and 2024 the Embedded Processing segment’s revenue slipped from $3.26 bn to $2.53 bn and its operating profit fell from $1.25 bn to $0.35 bn, reflecting a strategic pull‑back from aggressive growth toward a more mature, cash‑generating role.  Nevertheless, Embedded Processing remains a distinct reportable segment that underpins TI’s four‑point competitive advantage—providing a broad, diversified portfolio that reinforces supply‑chain control, product breadth and market reach—though its share of total revenue and profit has declined, signalling a reduced strategic emphasis relative to the Analog business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally misrepresent the ground truth. (1) MAJOR FACTUAL ERROR - SEGMENT REPORTING: The ground truth explicitly states that in 2022, Embedded Processing was NOT a reportable segment, and only by 2024 was it elevated to a reportable segment. The LLM answer incorrectly claims Embedded Processing 'remains a distinct reportable segment' in both periods, missing the key strategic shift that is central to the question. This is a fundamental misunderstanding of the core finding. (2) QUANTITATIVE ERRORS - UNVERIFIABLE NUMBERS: The LLM provides specific revenue figures ($3.26bn in 2022, $2.53bn in 2024) and operating profit figures ($1.25bn to $0.35bn) that cannot be verified against the ground truth and appear to be fabricated. The ground truth does not provide these specific numbers, and the LLM's inclusion of precise figures without source verification is problematic. (3) MISALIGNED INTERPRETATION: The LLM characterizes the evolution as a 'strategic pull-back' and 'reduced strategic emphasis,' which directly contradicts the ground truth's characterization of elevation to a reportable segment as indicating that 'Embedded Processing has become more central to TI's competitive positioning.' The LLM's narrative of decline conflicts with the ground truth's narrative of increased strategic importance. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution in strategic emphasis AND contribution to competitive advantages AND segment reporting structure. The LLM addresses segment reporting but mischaracterizes it, and fails to properly synthesize how the elevation to reportable segment status reflects increased strategic importance and competitive positioning. (5) REASONING FLAW: The LLM's logic that declining revenue/profit indicates 'reduced strategic emphasis' contradicts the ground truth's finding that elevation to reportable segment status indicates increased strategic importance. These are not necessarily correlated—a segment can be strategically important for reasons beyond revenue growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 561,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\nThermo Fisher issued a €‑denominated 2.00% 10‑Year Senior Note in 2022 (effective interest rate ≈ 2.07%).  The note’s carrying value slipped from $706 million at Dec 31 2023 to $663 million at Dec 31 2024, as the discount was amortized and the security approached its 2025 maturity, while the effective rate stayed close to the 2.00% coupon.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG INSTRUMENT: The ground truth specifies USD-denominated 2.00% 10-Year Senior Notes due October 15, 2031, but the LLM describes a €-denominated note with 2025 maturity - these are completely different debt instruments. (2) WRONG NUMBERS: Ground truth shows $1,200 million principal in both 2022 and 2024 with 2.23% effective rate. LLM provides $706M and $663M carrying values with ~2.07% effective rate - none of these match. (3) WRONG TIMEFRAME: Ground truth addresses 2022-2024 evolution; LLM discusses 2023-2024 carrying value changes and a 2025 maturity date. (4) WRONG ANALYSIS: Ground truth correctly identifies no change in the debt position over the period; LLM incorrectly describes amortization and maturity approach for a different instrument entirely. (5) FAILED MULTI-HOP SYNTHESIS: The LLM appears to have confused or conflated different debt instruments from TMO's capital structure, failing to correctly identify and track the specific 2.00% 10-Year Senior Notes referenced in the question. The answer demonstrates fundamental misidentification of the financial instrument being analyzed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 335,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\nREMICADE’s sales have continued to slide – falling 12.8 % from $1.839 bn in 2023 to $1.605 bn in 2024 (the decline began in 2022 as biosimilars entered the market) – and its share of the Immunology portfolio dropped from roughly 9.7 % of total revenue in 2021 to a smaller portion in 2024.  This erosion of market share signals that REMICADE is no longer a primary growth driver for Johnson & Johnson’s Pharmaceutical segment, prompting the company to rely more on newer biologics such as TREMFYA and SIMPONI to sustain immunology‑related earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Verified numbers: $1.839 billion (2023) and $1.605 billion (2024) are correct, and the 12.8% decline calculation is accurate. The answer correctly identifies REMICADE's role in the Immunology segment and provides sound reasoning about market dynamics (biosimilar competition, market saturation). The LLM goes beyond the ground truth by adding contextual details about the 2021 market share (9.7%) and mentioning specific competitor products (TREMFYA, SIMPONI), which enriches the analysis. The multi-hop synthesis is sound - connecting sales decline to market share erosion to strategic implications for J&J's portfolio. Minor deduction: The ground truth mentions the decline 'potentially due to market saturation, increased competition, or emergence of newer biologics,' while the LLM more definitively attributes it to biosimilars entering the market in 2022 and newer biologics. This is a reasonable inference but slightly more assertive than the ground truth's cautious language. The answer fully addresses the question's two-part structure (financial evolution 2022-2024 and role in Pharmaceutical segment) with appropriate synthesis across multiple data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 356,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\nREMICADE’s revenue has continued to slide – it fell from about **$3.19 billion in 2021** (the last full‑year figure shown in the 2022 10‑K) to **$1.61 billion in 2024**, a **12.8 % drop from 2023** and roughly a **50 % reduction over the three‑year span**.  The decline is attributed to ongoing biosimilar competition (e.g., European biosimilars and U.S. filings) and share loss, especially in Europe, as noted on pages 31‑32 of the 2024 10‑K.  Consequently, REMICADE now represents only a small, shrinking slice of J&J’s Immunology portfolio, which is increasingly driven by newer assets such as STELARA and TREMFYA.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2024 sales figure of $1.61 billion and the 12.8% decline from 2023. (2) The qualitative analysis is sound - correctly attributes decline to biosimilar competition and notes REMICADE's diminished role in the Immunology portfolio. (3) Appropriately contextualizes the decline within JNJ's broader portfolio strategy. (4) Provides relevant supporting details about competitive pressures.\n\nCRITICAL ERRORS: (1) MAJOR QUANTITATIVE ERROR: The LLM states 2021 sales as '$3.19 billion' but the ground truth specifies 2022 sales were $3,190 million ($3.19 billion). The LLM incorrectly labels this as '2021' when it should be '2022'. This is a significant dating error. (2) The LLM claims a '50% reduction over the three-year span' from 2021 to 2024, but the ground truth shows 2022 to 2024 data. The calculation itself ($3.19B to $1.61B = ~49.5% decline) is mathematically correct, but it's based on the wrong year comparison. (3) Missing the 2022-to-2023 comparison data that would show the 12.8% decline context more clearly.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about REMICADE's market position decline and connects it to competitive factors and portfolio implications. However, the year mislabeling undermines the temporal accuracy of the multi-hop analysis.\n\nNUMBER VERIFICATION: Ground truth shows $3,190M (2022) → $1,605M (2024). LLM shows $3.19B (labeled as 2021) → $1.61B (2024). The dollar amounts are correct (format variation acceptable), but the year attribution is wrong, which is a factual error in entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 442,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\nBetween 2021 and 2024 REMICADE’s sales fell sharply—from roughly **$3.2 billion in 2021** to **$1.6 billion in 2024**, a decline of about **50 %**.  The drop is attributed mainly to **biosimilar competition** (infliximab biosimilars launched in the United States and Europe, with additional entrants expected in 2025), **loss of market exclusivity** and related patent expirations, and the resulting **share erosion**, especially in European markets, all of which have continued to pressure demand for the drug.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2021 baseline. The ground truth states REMICADE sales were $16.8 billion in 2021, but the LLM claims $3.2 billion in 2021. This is a massive discrepancy (off by a factor of ~5.25x). The 2024 figure of $1.6 billion ($1,605 million) is approximately correct. However, the calculated decline of 50% is mathematically incorrect given the wrong 2021 baseline. The ground truth shows a decline from $16.8B to $1.6B, which represents approximately a 90.5% decline overall, not 50%. Additionally, the ground truth specifies a 12.8% decline from 2023 to 2024 alone, which the LLM does not mention. QUALITATIVE ASSESSMENT: The LLM correctly identifies biosimilar competition as a primary driver, which aligns with the ground truth. However, the LLM introduces additional factors (loss of market exclusivity, patent expirations, European market share erosion) that, while plausible and potentially accurate, are not explicitly mentioned in the ground truth answer. The LLM also mentions future biosimilar entrants in 2025, which adds forward-looking context not in the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize information about sales trends and causal factors, but the foundational data error undermines the entire analysis. The reasoning structure is sound, but it's built on incorrect numbers. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about sales evolution and contributing factors, but the severe quantitative inaccuracy makes it fundamentally unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 441,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\nBetween 2022 and 2024, STELARA (ustekinumab) continued to be a major driver of J&J’s immunology franchise, with U.S. sales rising to roughly **$6.7 billion in fiscal 2024** (up from about **$5.9 billion in 2021**). However, the product’s growth slowed and turned negative in 2024 (‑4.6 % YoY) as the **U.S. patent expired in September 2023** and **biosimilar competition intensified**, prompting the company to expect biosimilar launches in 2025 that will further erode sales. In Europe, share loss to biosimilars already contributed to a **1.2 % decline in total immunology sales** and a **4.6 % drop in STELARA sales** versus the prior year. Thus, while STELARA remained a top‑selling immunology drug with about **$10.4 billion in global sales in 2024**, its commercial momentum plateaued and began to decline as exclusivity wanes and biosimilars enter the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial correct information but contains some discrepancies with the ground truth. CORRECT ELEMENTS: (1) The 4.6% YoY decline in 2024 is accurate and matches ground truth; (2) The ~$10.4 billion global sales figure for 2024 is essentially correct (ground truth: $10,361 million = $10.361 billion, LLM states $10.4 billion - acceptable rounding); (3) The 2023 sales comparison is accurate (ground truth: $10,858 million); (4) The patent expiration in September 2023 and biosimilar competition context is relevant and accurate; (5) The reasoning about market saturation and competitive pressure is sound and aligns with ground truth interpretation. DISCREPANCIES: (1) The LLM provides U.S.-specific sales figures ($6.7 billion in 2024, $5.9 billion in 2021) that are not mentioned in the ground truth, which focuses on global sales; (2) The ground truth explicitly mentions 2022 regulatory filing status for pediatric psoriatic arthritis approval, which the LLM answer completely omits - this is a significant gap as it was a key part of the original answer's narrative about STELARA's evolution from regulatory development to commercial maturity; (3) The LLM references 'fiscal 2024' and '2021' comparisons, but the ground truth specifically addresses 2022-2024 evolution; (4) The LLM mentions European share loss and 1.2% decline in immunology sales, which adds context not in ground truth but doesn't contradict it. MULTI-HOP REASONING: The LLM successfully synthesizes information about patent expiration, biosimilar competition, and sales decline, showing good multi-hop reasoning. However, it fails to address the 2022 regulatory/filing status transition that was central to the ground truth answer's narrative arc. QUANTITATIVE VERIFICATION: All numeric values provided are either accurate or acceptable rounding variations. The 4.6% decline is correctly stated. The $10.4B figure matches the $10,361M ground truth within acceptable rounding. MAIN WEAKNESS: The answer omits the critical 2022 regulatory status information and doesn't fully capture the 'evolution' aspect of the question by showing the transition from filing/regulatory stage to commercial maturity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 588,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\nRestasis U.S. net revenue fell from **$382 million in 2023 to $172 million in 2024**, a decline of about **$210 million or roughly 55 %**. The prior year it had already dropped **38.5 %**, falling from **$621 million in 2022 to $382 million in 2023**. (Values are taken from the net‑revenue tables on page 44 of the 2024 Form 10‑K.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $382 million (2023), $172 million (2024), and $621 million (2022). The calculations are accurate: the 2023-to-2024 decline of $210 million represents a 55.2% decrease (correctly rounded to ~55%), and the 2022-to-2023 decline represents a 38.5% decrease. The LLM successfully synthesized multi-hop information by comparing three consecutive years and calculating year-over-year percentage changes. The answer directly addresses both parts of the question: (1) the change between 2023 and 2024 ($382M to $172M), and (2) the percentage decreases in each year (38.5% in 2023, 55.2% in 2024). The LLM even provided additional context by citing the source (page 44 of the 2024 Form 10-K), which adds credibility. The only minor consideration is that the LLM rounded 55.2% to 'roughly 55%' which is acceptable for practical purposes and doesn't constitute an error. The semantic meaning and factual content perfectly match the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 297,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\nBetween 2022 and 2023 the Master Lease Agreements moved from being chiefly a tool for securing steady, long‑term revenue and limiting churn in the U.S. portfolio to a strategic pillar of AMT’s international growth plan.  The 2023 disclosures highlight that these MLAs now underpin the company’s diversification into emerging markets, accelerate colocation cycles, and deepen partnerships with large multinational carriers—enabling incremental site‑leasing revenue and reducing non‑contractual churn abroad.  Consequently, MLAs have become essential for sustaining organic revenue growth and strengthening tenant relationships across AMT’s global footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific portfolio size metrics that are central to the ground truth. Ground truth explicitly states ~177,000 communications sites in 2022 and ~182,000 in 2023—these are key quantitative facts demonstrating international growth. The LLM provides no numbers whatsoever. (2) FACTUAL INACCURACY: The LLM claims MLAs moved from 'chiefly a tool for securing steady, long-term revenue...in the U.S. portfolio' to international focus. This is INCORRECT. The ground truth shows MLAs were already instrumental in the international portfolio in 2022 (~177,000 sites), not primarily U.S.-focused. The evolution was NOT from U.S. to international, but rather a continued emphasis on international growth with an expanded portfolio. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies some elements (colocation cycle times, tenant retention, churn reduction, multinational carriers), it mischaracterizes the baseline position in 2022. The ground truth shows international focus was already present in 2022, not a 2023 shift. (4) MISSING KEY DETAILS: The LLM fails to mention the specific portfolio expansion (177K to 182K sites), the emphasis on risk mitigation (customer consolidation, regulatory changes), and the 'comprehensive in nature' characterization from 2022. (5) REASONING FLAW: The multi-hop synthesis incorrectly frames the evolution as a directional shift from U.S. to international, when the ground truth indicates continuous international strategic importance with portfolio expansion. The LLM's narrative of transformation is not supported by the actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 458,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Google Marketing Platform moved from being a peripheral buying option to a core channel for advertisers purchasing inventory on Google Network properties, and the company’s accounting treatment stayed the same—advertising revenues are recorded on a **gross basis** (the full amount billed to the customer is recognized as revenue and the portion paid to network partners is recorded as cost of revenues), with performance‑ad revenue recognized on user engagement and brand‑ad revenue recognized on impression.  Consequently, the platform’s share of gross advertising revenue grew, but the **recognition and management methodology across the Google Network did not change**.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution between 2023 and 2024. Ground truth states that 2024 introduced 'a more nuanced evaluation of its principal versus agent status' and 'a more detailed explanation of the platform's role,' indicating the accounting treatment and recognition methodology DID evolve. The LLM explicitly claims 'the recognition and management methodology across the Google Network did not change,' which directly contradicts the ground truth's assertion of evolution in how the platform's role is evaluated and explained. CORRECT ELEMENTS: (1) The LLM correctly identifies that revenues are recorded on a gross basis in both years; (2) Correctly notes that the full amount billed to customers is recognized as revenue; (3) Correctly identifies that amounts paid to network partners are recorded as cost of revenues; (4) Correctly distinguishes between performance-ad and brand-ad revenue recognition methods. INCORRECT/MISSING ELEMENTS: (1) The LLM's characterization of GMP moving from 'peripheral' to 'core channel' is not supported by the ground truth and appears to be an inference not grounded in the filing data; (2) The claim that 'recognition and management methodology...did not change' is factually wrong—the ground truth explicitly states the methodology evolved to include 'more nuanced evaluation' and 'more detailed explanation'; (3) The LLM fails to capture the key evolution: the shift from direct involvement in revenue recognition to a more sophisticated principal/agent status evaluation; (4) Missing the important detail about the platform's control over advertising inventory before transfer to customers. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal comparison (2023 vs 2024) and instead made an unsupported claim about market positioning. The answer demonstrates partial understanding of the accounting mechanics but fundamentally misses the evolution in how the platform's role is evaluated and explained in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 553,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\nBetween 2023 and 2024 the liability for Federal Funds Purchased & Securities Loaned rose from roughly **$436 billion to $570 billion** (≈ 31 % growth), and the fair‑value measurement of that liability increased from about **$133 billion to $193 billion** (≈ 45 % growth) (see the “Federal fundspurchasedandsecuritiesloaned or sold under agreements to repurchase” line in the Level 2 fair‑value tables on pages 154‑155).  \n\nThis expansion indicates that Bank of America deliberately increased its short‑term wholesale funding, using market‑based borrowing to supplement its deposit base as interest rates rose and to support continued asset‑side growth. The higher reliance on Federal‑funds and securities‑loaned funding reflects a strategic shift toward short‑term market financing to meet liquidity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer provides substantially different numbers than the ground truth, raising serious accuracy concerns. (1) QUANTITATIVE ERRORS: The LLM claims the liability rose from ~$436B to ~$570B (31% growth) and fair value from ~$133B to ~$193B (45% growth). However, the ground truth states: (a) 2023 net change was $16,466 million ($16.5B), not the implied starting point; (b) 2024 fair value was $192,859 million (~$193B), which the LLM does cite correctly for 2024, but the 2023 fair value comparison of ~$133B cannot be verified against ground truth which only provides the 2024 fair value figure of $192,859M. The LLM's claim of a 45% increase from $133B to $193B cannot be validated. (2) MISSING GROUND TRUTH DATA: The ground truth specifically mentions a 2023 net change of $16,466 million but does NOT provide absolute volume figures for 2023 or 2024 that would support the LLM's $436B-to-$570B claim. The LLM appears to have sourced different data (possibly from pages 154-155 referenced) that diverges from the knowledge graph ground truth. (3) PARTIAL CORRECTNESS: The LLM correctly identifies the 2024 fair value as approximately $193 billion (~$192,859M), which matches ground truth. The qualitative interpretation about BAC expanding short-term secured funding and strategic shift toward market financing is reasonable and aligns with the ground truth's conclusion about expanded reliance on short-term funding mechanisms. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the concept that increased Federal Funds Purchased & Securities Loaned indicates strategic funding decisions, which is sound reasoning. However, the factual foundation (the specific dollar amounts and year-over-year changes) appears to be incorrect or sourced from different data than the ground truth. The core insight about liquidity management and wholesale funding is valid, but built on potentially incorrect numerical premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 529,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s wording about the pension and retiree‑medical plan’s exposure to market fluctuations remained the same – it still points to the “Critical Accounting Policies and Estimates” section for a discussion of that exposure – but the level of detail evolved. In the 2022 filing the company gave only a generic statement that the plan’s assets and liabilities are subject to market‑related risks, whereas the 2024 filing adds a concrete quantitative illustration, noting that other pension and retiree‑medical benefits expense rose $272 million in 2024 due to higher settlement charges and a group‑annuity purchase, thereby showing how market‑driven events directly affect the plan’s financial results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF EVOLUTION: The ground truth states that by 2024, PepsiCo expanded disclosure to explicitly link sensitivity to 'inflationary, deflationary, and recessionary conditions' in addition to market fluctuations. The LLM answer completely misses this critical expansion and instead focuses on a $272 million expense figure related to settlement charges and group-annuity purchases, which is not mentioned in the ground truth and appears to be a different disclosure point entirely. (2) QUANTITATIVE ACCURACY PROBLEM: The LLM introduces a specific dollar amount ($272 million) that is not present in the ground truth answer. While this number may exist in the actual filing, it is not the relevant metric for answering the question about how disclosure regarding sensitivity to market fluctuations evolved. The ground truth focuses on the TYPE of risks disclosed (market vs. inflationary/deflationary/recessionary), not expense amounts. (3) MISSED CORE FINDING: The ground truth's key insight is that PepsiCo moved from discussing only 'market fluctuations' to a broader discussion of 'inflationary, deflationary, and recessionary conditions.' The LLM answer does not identify this expansion at all. (4) REASONING FLAW: The LLM conflates disclosure evolution with quantitative illustration of financial impact. The question asks about how disclosure regarding SENSITIVITY evolved, not about how expense amounts changed. The $272 million figure, even if accurate, does not address the evolution of sensitivity disclosure. (5) PARTIAL CREDIT: The LLM correctly identifies that both years reference 'Critical Accounting Policies and Estimates' section, which aligns with the ground truth's statement about 2022 disclosure location.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 508,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe reframed Adobe Scan from a stand‑alone, free mobile scanner into a core, AI‑enhanced component of the Adobe Document Cloud suite.  The 2024 disclosures stress that Scan now works natively alongside Acrobat, Acrobat Sign and the new Acrobat AI Assistant, is offered within subscription plans for individuals, teams and enterprises, and is marketed as part of an end‑to‑end document‑management ecosystem that combines scanning, OCR, e‑signatures and cloud‑based collaboration.  This evolution positions Scan not just as a pocket‑sized scanner but as a integrated step in Adobe’s broader document‑workflow platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some key evolution points but introduces claims not supported by the ground truth and makes unsupported assertions about 2024 positioning.\n\nCORRECT ELEMENTS:\n- Correctly identifies Adobe Scan as part of Adobe Document Cloud in both years\n- Accurately notes the shift toward integration with other Adobe products (Acrobat, Acrobat Sign)\n- Correctly identifies AI-driven features as part of the 2024 evolution\n- Properly characterizes the broader ecosystem emphasis on document workflows\n- Correctly identifies the shift from standalone to integrated positioning\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIMS: The LLM states Adobe Scan is \"offered within subscription plans for individuals, teams and enterprises\" in 2024. The ground truth describes it as a \"free mobile scanning tool\" in 2023 and does not indicate it transitioned to paid subscription-only offerings in 2024. This is a significant factual claim not supported by the knowledge graph.\n\n2. OVER-SPECIFICATION: The LLM mentions \"Acrobat AI Assistant\" as a 2024 integration point. While the ground truth mentions \"Firefly-powered generative AI workflows,\" the specific naming of \"Acrobat AI Assistant\" is not explicitly confirmed in the ground truth.\n\n3. INCOMPLETE SYNTHESIS: The ground truth specifically mentions \"Content Credentials\" as a key 2024 feature emphasizing \"digital trust mechanisms.\" The LLM answer omits this important element entirely.\n\n4. TONE MISMATCH: The LLM characterizes the shift more dramatically (\"reframed from stand-alone, free mobile scanner\") than the ground truth supports. The ground truth indicates it \"remained part of Adobe Document Cloud\" with emphasis shifts, not a fundamental repositioning away from free access.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension scores well (8/10) - the years 2023 and 2024 are correctly referenced.\n\nQUALITATIVE ACCURACY: The reasoning about integration and ecosystem positioning is sound, but the introduction of unsupported claims about subscription models and incomplete coverage of Content Credentials/digital trust mechanisms reduces this score (5/10).\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution and positioning within the broader ecosystem (7/10), though it adds details not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 644,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\nSince its debut in December 2023, Gemini was embedded as a multimodal foundation across Google’s core services—powering AI‑enhanced Search results, ads tools (Performance Max, Product Studio), Android experiences such as Circle‑to‑Search, Chrome, YouTube, and Google Cloud’s Vertex AI platform. In 2024 Gemini 2.0 was released, offering a larger, more capable model that can simultaneously understand and generate text, code, audio, images and video, supports longer context and faster latency through TPU‑optimized inference, and drives new experimental assistants like Project Astra and Project Mariner, turning Gemini from a single model into a pervasive AI layer that underpins virtually every Google product.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Gemini's evolution and correctly identifies key developments. STRENGTHS: (1) Accurately captures the December 2023 launch timing and multimodal capabilities (text, code, audio, images, video); (2) Correctly identifies Gemini 2.0 as the 2024 advancement with improved capabilities; (3) Properly mentions experimental projects (Project Astra, Project Mariner); (4) Accurately describes integration across multiple Google products and services; (5) Correctly notes improvements like longer context and faster latency through TPU optimization. WEAKNESSES: (1) The ground truth specifies integration into 'all seven of Google's two billion-user products' (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube), but the LLM answer mentions some of these plus additional services (ads tools, Vertex AI) without explicitly stating the 'seven products' framework or the 'two billion-user' metric that appears in the original answer; (2) Missing explicit mention of Gmail and Maps from the core product list; (3) The LLM answer adds details about 'ads tools' and 'Vertex AI' that, while potentially accurate, are not mentioned in the ground truth and may represent additional context not directly from the source documents. MULTI-HOP REASONING: The answer successfully synthesizes information about Gemini's evolution across time periods (2023 vs 2024) and correctly identifies the progression from initial launch to broader integration and more advanced capabilities. The reasoning connecting product integration to experimental prototypes is sound. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer that require verification, though both reference the same timeline and product count concepts. The answer avoids numerical errors. SEMANTIC EQUIVALENCE: The core message matches the ground truth—Gemini evolved from initial launch to broader integration with enhanced capabilities—though the specific framing differs slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 541,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s helium business—grouped in the “Other” category—has seen a modest sales contraction.  In 2024 vs. 2023, sales in this line fell about 2 % (≈ $32 million) as lower volumes dragged down revenue, a trend that continued from the prior year [page 28].  However, operating profit in “Other” rose sharply—up $19 million or 44 % in 2024 vs. 2023—because insurance recoveries and cost‑control measures more than offset the higher helium‑related expenses, turning a volume‑driven decline into a profit‑improvement story [page 28].  Thus, while helium’s contribution to top‑line sales has been pressured, its impact on earnings has improved, reflecting a shift from volume reliance to margin‑focused performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of Linde's helium business evolution but contains significant quantitative discrepancies and incomplete alignment with the ground truth. STRENGTHS: (1) Correctly identifies the 2% sales decline in the 'Other' segment for 2024; (2) Accurately notes the 44% operating profit increase; (3) Properly contextualizes helium as part of the 'Other' segment; (4) Recognizes the shift from volume pressure to margin improvement; (5) Mentions insurance recoveries and cost-control measures. CRITICAL ISSUES: (1) The LLM states sales fell 'about 2% (≈ $32 million)' but this specific dollar amount cannot be verified against the ground truth, which only mentions the 2% decrease without providing the exact dollar figure. This is a potential calculation error or unsupported quantification. (2) The LLM claims operating profit rose '$19 million or 44%' - while the 44% figure is correct, the $19 million figure is not verified in the ground truth and appears to be an unsupported calculation. (3) The ground truth emphasizes that helium 'negatively impact[ed]' the company by 2024, whereas the LLM frames this more positively as 'profit-improvement story,' which somewhat misrepresents the nature of the negative impact. (4) The ground truth specifically mentions that 'higher costs due to helium partially offset an insurance recovery for LAMT,' but the LLM reverses this causality, suggesting insurance recoveries 'offset' helium costs rather than helium costs offsetting the recovery. (5) Missing the explicit 2022 baseline comparison mentioned in the ground truth ('In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship'). MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 and connects sales volume declines to operating profit dynamics, but the specific dollar amounts introduced without source verification weaken the analysis. The reasoning about margin-focused performance is sound but slightly overstates the positive framing compared to the ground truth's emphasis on negative impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 564,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\nThe net carrying amount of acquired franchise rights fell from $626 million at the end of 2023 to $598 million at the end of 2024, a decline of $28 million (about 4.5%).  Over the longer 2022‑to‑2024 horizon the net value dropped by roughly $30 million, indicating a modest downward trend.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its correctness. (1) CRITICAL ERRORS: The LLM states the 2023 value was $626 million, but the ground truth only provides 2022 ($789M) and 2024 ($598M) data. The LLM appears to have fabricated or misidentified the 2023 figure. More importantly, the LLM claims the 2022-to-2024 change was 'roughly $30 million' when the ground truth clearly shows it was $191 million ($789M - $598M = $191M), a decline of approximately 24%, not the modest downward trend suggested. (2) QUANTITATIVE ACCURACY FAILURES: The LLM's calculation of the 2022-to-2024 change is off by $161 million ($191M actual vs ~$30M stated). The percentage decline is also drastically understated (24% actual vs implied ~5%). The 2023 figure of $626M cannot be verified against the provided ground truth. (3) MULTI-HOP REASONING: The question asks about evolution from 2022 to 2024. The LLM correctly identified this as a multi-year comparison but failed to properly synthesize the correct values. The LLM appears to have focused on 2023-2024 data (which may be from a different source) while missing or mishandling the critical 2022 baseline. (4) COMPLETENESS: The answer addresses the question's structure but with fundamentally wrong numbers, making it misleading rather than helpful. The characterization of the change as 'modest' is contradicted by the actual 24% decline. The LLM answer demonstrates poor data synthesis and significant calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 414,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\nChevron’s net natural‑gas output from the Tengizchevroil field (reported as part of its Kazakhstan affiliate) fell slightly from about **114 MMcf/d in 2023 to roughly 113 MMcf/d in 2024** – a modest 1 % decline.  No new, field‑specific delivery commitments were disclosed for 2024; the existing gas‑sale contracts that include Tengizchevroil remain embedded in the company’s broader natural‑gas delivery framework (the U.S. 2024‑2026 obligations and the non‑U.S. 2025‑2027 3.2 trillion‑cubic‑foot schedule for Australia and Israel) and are expected to be satisfied using existing proved reserves and third‑party purchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM reports Tengizchevroil-specific volumes of 114 MMcf/d (2023) and 113 MMcf/d (2024), which are NOT supported by the ground truth. The ground truth provides total company-wide natural gas figures: 596 MMcf/d consumed and 7,148 MMcf/d sold in 2023; 609 MMcf/d consumed and 7,569 MMcf/d sold in 2024. The LLM appears to have fabricated field-specific numbers that don't appear in the source data. (2) DIRECTIONAL ERROR: The LLM claims a 'modest 1% decline' from 2023 to 2024, while the ground truth shows INCREASES across all metrics (consumed: 596→609 MMcf/d; sold: 7,148→7,569 MMcf/d). This is a fundamental misrepresentation of the trend. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states that both consumed and sold volumes increased, reflecting growth in Chevron's involvement with Tengizchevroil. The LLM instead focuses on a purported decline and discusses delivery commitments (U.S. 2024-2026, Australia/Israel 2025-2027) that are not mentioned in the ground truth answer. (4) ENTITY/METRIC CONFUSION: The LLM conflates field-specific production with company-wide natural gas volumes, creating a category error. The ground truth addresses Chevron's total natural gas volumes including its Tengizchevroil share, not isolated field production. (5) MISSING KEY DATA: The LLM fails to report the actual 2023-2024 figures (596→609 consumed; 7,148→7,569 sold) that directly answer the question. The answer demonstrates poor multi-hop reasoning by introducing unsupported numbers and missing the clear growth trend documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 462,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 the filing moved from simply noting “amounts paid to Google Network partners primarily for ads displayed on their properties” as part of cost‑of‑revenues to explicitly framing those payments as a distinct cost‑of‑revenues item that is evaluated under a “principal vs. agent” test.  In the 2024 Form 10‑K Google says it may recognize advertising revenue **net of the share paid to network partners** when it acts as an agent, whereas in 2023 the payments were described only as a cost‑of‑revenues expense without that net‑revenue distinction.  This change shows that the role of Network partners has evolved from a behind‑the‑scenes cost to a consciously accounted‑for revenue‑sharing component of Google’s advertising model.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of Google Network partners' role between 2023 and 2024, but with significant differences from the ground truth in how it characterizes the change. CORRECT ELEMENTS: (1) The answer correctly identifies that there was a shift in how payments to Google Network partners were described between 2023 and 2024; (2) It correctly notes that the 2024 filing introduced a 'principal vs. agent' accounting framework; (3) It accurately captures that the 2024 description involves net revenue recognition when Google acts as an agent; (4) The years (2023 and 2024) are correct. INCORRECT/PROBLEMATIC ELEMENTS: (1) The ground truth states the shift was from 'payments as a standard operating expense' to 'Traffic Acquisition Costs (TAC)' - the LLM answer does not mention TAC at all, instead focusing on principal vs. agent accounting; (2) The ground truth emphasizes the categorization under 'TAC' and 'performance-based dependency,' while the LLM answer emphasizes the principal vs. agent test and net revenue recognition - these are different characterizations of the evolution; (3) The LLM's framing of 'behind-the-scenes cost to revenue-sharing component' is somewhat accurate but misses the specific TAC categorization that was the key evolution according to the ground truth. MULTI-HOP REASONING: The LLM successfully synthesized information about how the accounting treatment changed, but it appears to have focused on a different aspect of the evolution (principal vs. agent accounting) rather than the primary shift (to TAC classification) that the ground truth identifies. The reasoning is sound but addresses a different dimension of the change. SEMANTIC EQUIVALENCE: While both answers discuss an evolution in how Network partner payments are treated, they emphasize different aspects - the ground truth emphasizes TAC categorization and performance-based dependency, while the LLM emphasizes principal vs. agent accounting and net revenue recognition. These are not fully equivalent characterizations of the same evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 554,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\nBetween 2023 and 2024 the firm moved from a general reference to “increasing global regulatory focus” on climate change to a concrete warning that state, federal and non‑U.S. jurisdictions are adopting new or heightened climate‑related rules, creating jurisdictional divergence that will amplify legal, compliance and disclosure costs. This fragmentation makes it harder to meet the company’s GHG‑emissions targets and raises the risk that overlapping or conflicting policy requirements will generate additional compliance uncertainty.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2023 to 2024, capturing the shift from anticipatory language ('expected to increase') to tangible impacts ('actively impacting'). It accurately references jurisdictional divergence as a key challenge and correctly identifies the three jurisdictional levels (state, federal, non-U.S.). The answer properly synthesizes the multi-hop information about regulatory evolution. WEAKNESSES: (1) The LLM introduces an unsupported claim about 'GHG-emissions targets' - the ground truth makes no mention of this connection, representing a factual addition not present in the original answer. This is a significant error as it adds information not verified in the source material. (2) The phrase 'overlapping or conflicting policy requirements' is a reasonable inference but goes beyond what the ground truth explicitly states - the ground truth mentions 'jurisdictional divergence' but doesn't specifically characterize it as 'overlapping or conflicting.' (3) The answer lacks the explicit temporal framing present in the ground truth: the shift from 'expected to increase' (2023) to 'actively impacting' (2024) is implied but not as clearly articulated. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension scores well (8/10) - the years 2023 and 2024 are correctly referenced. QUALITATIVE ACCURACY: The reasoning is partially sound but compromised by the unsupported GHG-emissions claim, reducing this score to 5/10. CONTEXTUAL RELEVANCE: The answer addresses the question's core elements but the introduction of unverified information about emissions targets reduces relevance to 6/10. The answer would have scored 8-9 without the GHG-emissions addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 483,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\nFrom 2022 through 2024 GM has kept full‑size pickups at the core of its North‑American strategy, but by 2024 the emphasis has deepened: the company is selling more of these trucks, capturing higher prices and higher‑margin variable profit, and rolling out EV versions (e.g., Silverado EV) to sustain growth.  In 2024 wholesale unit volume for GM North America’s full‑size pickups rose 10.1 % (≈317 k units), driving an 11.4 % jump in GMNA net sales to $157.5 bn and an 18.1 % increase in EBIT‑adjusted to $14.5 bn, with the EBIT‑adjusted margin expanding to 9.2 % from 8.7 %—clear quantitative evidence of a stronger performance and market position for the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: The LLM answer contains numerous unverified and likely incorrect quantitative claims that cannot be reconciled with the ground truth. SPECIFIC PROBLEMS: (1) UNVERIFIED NUMBERS: The LLM provides very specific figures (317k units, 10.1% volume increase, 11.4% sales jump to $157.5bn, 18.1% EBIT increase to $14.5bn, margin expansion from 8.7% to 9.2%) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated data points. (2) MISSING KEY GROUND TRUTH DATA: The ground truth specifically mentions 'variable profit of approximately 160% for trucks on a weighted-average basis' - a critical quantitative indicator that the LLM completely omits. This is a major factual gap. (3) CALCULATION CONCERNS: The LLM's specific percentages and dollar amounts lack supporting evidence in the provided ground truth, raising serious questions about their accuracy. (4) PARTIAL ALIGNMENT: The LLM correctly identifies the evolution from 2022 (risk factor) to 2024 (strength), mentions higher sales volumes, improved profitability, and EV rollout (Silverado EV), which aligns with the ground truth narrative. However, the specific quantitative support is problematic. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information about strategic evolution and performance indicators, the unverified numbers undermine the credibility of the entire response. The ground truth provides clear but limited quantitative data (160% variable profit), while the LLM invents additional metrics. VERDICT: The answer demonstrates understanding of the qualitative evolution but fails on quantitative accuracy by introducing unverified figures and omitting the key 160% variable profit metric from the ground truth. This is a significant failure for a financial analysis question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 502,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\nThe exposure to U.S. Treasury and government‑agency securities in the nuclear decommissioning trusts dropped from roughly $284 million in 2022 to about $190 million in 2024—a decline of roughly one‑third. This pull‑back from low‑yielding government bonds signals a strategic shift toward higher‑return private‑equity and credit assets, indicating a more aggressive investment strategy for the trusts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. (1) QUANTITATIVE ERRORS: The LLM claims the allocation dropped from $284 million in 2022 to $190 million in 2024. However, the ground truth shows: 2022 total was $21M (Alabama Power) + $293M (Georgia Power) = $314M, and 2024 total was $20M (Alabama Power) + $349M (Georgia Power) = $369M. The LLM's numbers are completely wrong—it understated 2022 by $30M and drastically understated 2024 by $179M. The direction of change is also inverted: the LLM claims a decline when the actual trend shows an increase from $314M to $369M. (2) ENTITY IDENTIFICATION: The LLM failed to identify and distinguish between the two separate entities (Alabama Power and Georgia Power) that comprise the nuclear decommissioning trusts. The ground truth explicitly breaks down allocations by company, showing divergent trends (Alabama Power flat, Georgia Power increasing). The LLM collapsed these into a single aggregate figure and missed the important subsidiary-level analysis. (3) MULTI-HOP REASONING: The LLM failed to synthesize information across the two companies correctly. It should have recognized that while Alabama Power's allocation remained stable, Georgia Power's increased significantly, indicating a shift in focus toward Georgia Power's portfolio. Instead, the LLM invented a narrative about a strategic shift toward higher-return assets that contradicts the actual data. (4) STRATEGIC INTERPRETATION: The LLM's conclusion about 'aggressive investment strategy' and 'pull-back from low-yielding government bonds' is unsupported by the actual data, which shows an increase in these safer assets. The ground truth interpretation about reallocation toward Georgia Power is more nuanced and data-driven. The answer demonstrates a fundamental misunderstanding of the underlying data and failed to properly synthesize multi-hop information across the two subsidiaries.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 524,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\nFrom 2022 through 2024 PepsiCo moved from a broad‑based, discretionary bottler‑funding program to a more formal, performance‑linked system in which annual incentives are tied to volume, advertising, new‑product support and vending/cooler‑equipment placement.  At the same time the company expanded exclusive territorial rights and concentrated its distribution through a smaller group of independent bottlers that serve key retail accounts (e.g., Walmart), making those bottlers increasingly critical to PepsiCo’s revenue and strategic growth.  Consequently, financial incentives have become tighter‑coupled to bottler performance while the firm’s strategic dependency on those partners has deepened.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from discretionary to performance-linked incentive systems and accurately captures the shift toward greater strategic dependency on bottlers. The qualitative characterization of the relationship evolution is sound and semantically aligned with the ground truth. The mention of specific programs (advertising, new product launches, vending/cooler equipment) matches the original answer. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM answer completely omits the specific, verifiable metric from the ground truth: Walmart's ~14% of consolidated net revenue. This is a concrete, measurable fact that directly supports the claim about strategic dependency and should have been included. (2) MISSING SPECIFICITY - The ground truth explicitly states that bottler funding is 'negotiated annually' and mentions 'trade and consumer programs' with specific allocations. While the LLM captures the general concept, it lacks the precision about annual negotiation cycles. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes that 'sales through independent bottlers contributed to a significant portion of revenue' with the Walmart example as evidence. The LLM discusses dependency conceptually but fails to ground it in the actual revenue contribution data. REASONING ASSESSMENT: The multi-hop reasoning is sound in structure (comparing 2022 vs 2024, identifying evolution, linking to strategic dependency), but incomplete in execution because it doesn't synthesize the quantitative evidence that proves the dependency claim. The answer would be stronger with the 14% Walmart figure and explicit mention of revenue contribution percentages. The claim about 'exclusive territorial rights' and 'smaller group of bottlers' appears to be inference not directly supported by the provided ground truth text.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 504,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\nIn the 2023 10‑K, Adobe Firefly is mentioned only as a newly introduced generative‑AI product in the risk‑factor discussion and appears in the trademark list as a nascent brand. By the 2024 10‑K, Firefly is highlighted both in the trademark filings and in the AI‑related risk disclosures, showing that Adobe has promoted it from an experimental offering to a central, strategically protected component of its product‑innovation roadmap and is now integrating it across its portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual inversion that contradicts the ground truth. The ground truth states that in 2023, Adobe Firefly was listed among trademarks (established brand), and by 2024 it was highlighted in risk factors as a newly released product. However, the LLM answer reverses this timeline, claiming that in 2023 Firefly appeared in risk-factor discussion as 'newly introduced' and only by 2024 was it promoted to a 'central, strategically protected component.' This is a direct contradiction of the documented evolution. The LLM also introduces unsupported claims about 'experimental offering' and 'integrating it across its portfolio' that are not present in the ground truth. The multi-hop reasoning is fundamentally flawed because it misrepresents the chronological progression of Firefly's positioning. While the LLM correctly identifies the two key sources (trademark listings and risk disclosures) and the general concept of evolution, the actual directional change is inverted. The answer demonstrates poor synthesis of multi-hop information across the 2023 and 2024 filings, as it fails to accurately track how Firefly's role changed from one year to the next. The semantic meaning is substantially different from ground truth, not merely a wording variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 369,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\nBetween 2022 and 2023 the importance of contractual rent escalations as a driver of tenant‑billing growth increased.  Churn rose slightly to roughly 3 % in 2023—primarily from T‑Mobile lease cancellations in the U.S. & Canada—yet the company still treats annual escalations (≈3 % in the United States and inflation‑linked abroad) as a core, net‑of‑churn growth engine.  As a result, revenue growth now relies more on the steady escalation of existing lease rents than on the modest churn that was historically present.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth:\n\n1. DIRECTIONAL ERROR - CRITICAL: The LLM states 'the importance of contractual rent escalations as a driver of tenant-billing growth increased' between 2022 and 2023. The ground truth indicates the opposite: while escalations remained a stated driver, the context shifted negatively due to elevated churn, creating a 'countervailing force' against growth. The LLM's claim that 'revenue growth now relies more on the steady escalation of existing lease rents than on the modest churn that was historically present' contradicts the ground truth's characterization of a 'more challenging environment.'\n\n2. QUANTITATIVE ACCURACY: The 3% churn figure is correct, as is the identification of T-Mobile lease cancellations in U.S. & Canada. The mention of ~3% escalations in the United States is reasonable but not explicitly verified in the ground truth provided.\n\n3. MISSING KEY CONTEXT: The LLM fails to adequately capture the critical point that churn was 'expected to remain elevated through 2025,' which is a significant forward-looking concern mentioned in the ground truth.\n\n4. SEMANTIC MISALIGNMENT: The ground truth emphasizes that escalations faced a 'countervailing force' and created a 'more challenging environment,' suggesting escalations became LESS effective as a growth driver. The LLM frames escalations as MORE important and treats them as a 'core, net-of-churn growth engine,' which inverts the intended meaning.\n\n5. INCOMPLETE SYNTHESIS: The LLM does not adequately synthesize the tension between escalations and churn as a net negative for organic growth, instead presenting escalations as increasingly relied upon despite headwinds.\n\nThe answer gets some facts right (churn rate, T-Mobile, segment) but fundamentally misinterprets the directional change and fails to convey the challenging context that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 530,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\nChevron kept the Tengizchevroil joint‑venture in its capital‑allocation plan throughout the transition from 2023 to 2024 – the 2023 Form 10‑K shows that the company spent about $3.5 billion on affiliate‑level projects, with roughly ½ of that amount earmarked for Tengizchevroil’s FGP/WPMP development in Kazakhstan, and the 2024 filing projects a similar $3 billion affiliate‑capex budget in which “nearly half” again goes to that same Kazakh project.  Production data in the 2024 filing list Kazakhstan’s net oil‑equivalent output at about 45 kb/d (essentially unchanged from 2023), confirming that the JV continues to contribute a measurable slice of Chevron’s worldwide production.  Consequently, the partnership’s financial commitment and production involvement have remained steady, with no major shift in either capital spending or output volume between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a critical factual error regarding 2023 affiliate capex. The LLM states '2023 Form 10-K shows that the company spent about $3.5 billion on affiliate-level projects' but the ground truth indicates the 2024 expected affiliate capex was $3 billion, with nearly half going to Tengizchevroil. The LLM conflates 2023 actual spending ($3.5B) with 2024 projected spending ($3B), creating confusion about which year's figures are being discussed. CORRECT ELEMENTS: (1) The LLM correctly identifies that nearly half of affiliate capex goes to Tengizchevroil's FGP/WPMP project in Kazakhstan; (2) Correctly notes the $3 billion affiliate capex budget for 2024; (3) Correctly identifies the shift from capital commitment focus to production contribution. INCORRECT/PROBLEMATIC ELEMENTS: (1) The $3.5 billion figure for 2023 is introduced without clear sourcing and appears to conflate actual vs. projected spending; (2) The claim about 'essentially unchanged' production at 45 kb/d cannot be verified against the ground truth, which does not provide specific production volume numbers; (3) The conclusion that there was 'no major shift' contradicts the ground truth's explicit statement that 2024 'emphasized ongoing production contributions' representing 'a shift from investment to operational phase.' MULTI-HOP REASONING: The LLM attempts to synthesize information across years but mischaracterizes the nature of the evolution. The ground truth clearly indicates a SHIFT from investment phase (2023) to operational phase (2024), while the LLM concludes the relationship 'remained steady' with 'no major shift.' This is a fundamental misinterpretation of the multi-hop synthesis required. The answer provides production data (45 kb/d) that cannot be verified against the provided ground truth, suggesting potential hallucination or unsourced information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 516,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\nBetween 2023 and 2024 UPS shifted from a generic statement that it “uses a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments” to a concrete, quantitative methodology that ties the discount rate to a yield‑curve built from long‑term, high‑quality fixed‑income securities and reports the resulting rate (5.88 % for 2024 versus 5.42 % in 2023). The 2024 note also supplies the sensitivity of the projected benefit obligation to each basis‑point change in the discount rate, showing a far more detailed and specific application of the bond‑matching process for both U.S. pension and post‑retirement medical plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - QUANTITATIVE: The LLM claims specific discount rates of 5.88% for 2024 and 5.42% for 2023, but provides no evidence these numbers appear in UPS filings. The ground truth makes no mention of these specific percentages. Without verification from actual SEC filings, these numbers appear to be fabricated or incorrectly sourced. (2) MAJOR ERROR - CHARACTERIZATION OF EVOLUTION: The ground truth states the evolution was subtle and involved framing language ('guides' vs. 'uses'), with no material change in mechanics. The LLM characterizes this as a shift from 'generic statement' to 'concrete, quantitative methodology,' which misrepresents the nature of the change. The ground truth explicitly states 'the underlying practice remained consistent.' (3) UNSUBSTANTIATED CLAIMS: The LLM mentions 'sensitivity of the projected benefit obligation to each basis-point change in the discount rate' as a 2024 addition, but the ground truth provides no evidence this level of detail was added. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the actual evolution described in the ground truth - which is about subtle shifts in disclosure language and framing emphasis, not about introducing quantitative methodologies or specific discount rate percentages. (5) SEMANTIC MISMATCH: The ground truth emphasizes consistency in underlying practice with evolved framing language; the LLM emphasizes a shift to more concrete quantitative methodology, which is fundamentally different and appears incorrect. The answer demonstrates poor fidelity to the source material and introduces specific numbers without proper justification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 471,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium business moved from a growth contributor to a constrained, volume‑declining operation – the “Other” segment (which includes global helium wholesale) saw sales fall $32 million, or about 2 %, in 2024 as helium volumes dropped, while operating profit in that same segment rose $19 million, or 44 %, because lower helium‑related costs and an insurance recovery for LAMT more than offset the revenue dip.  Consequently, the modest sales contraction from helium weighed on overall sales, but the segment’s profit improvement helped lift consolidated operating profit despite the revenue decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims operating profit in the Other segment rose $19 million or 44% in 2024. The ground truth makes NO mention of operating profit increasing; it only states that helium-related costs contributed to DOWNWARD PRESSURE on operating profit, partially offset by insurance recovery. The LLM has fabricated a $19M profit increase figure that contradicts the ground truth's statement about downward pressure. (2) DIRECTIONAL ERROR - Ground truth indicates helium had a NEGATIVE IMPACT on operations by 2024, with downward pressure on operating profit. The LLM frames this as a profit improvement scenario where 'the segment's profit improvement helped lift consolidated operating profit,' which is fundamentally contradictory to the ground truth's characterization. (3) PARTIAL ACCURACY - The LLM correctly identifies: the $32 million/2% sales decrease in the Other segment, the lower helium volumes, and the insurance recovery for LAMT. However, these correct elements are embedded within an overall narrative that misrepresents the financial impact. (4) MULTI-HOP REASONING FAILURE - The question asks about financial impact on sales AND operating profit. While the LLM addresses both, it inverts the operating profit impact, claiming improvement when the ground truth indicates pressure/decline. This is a fundamental synthesis error. (5) MISSING CONTEXT - The ground truth emphasizes a SHIFT from neutral/positive to operational challenges. The LLM's framing of profit improvement contradicts this characterization of deterioration. The fabricated $19M operating profit increase and 44% improvement are not supported by any ground truth data and represent a major factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 474,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\nBank of America’s unfunded capital commitments for renewable‑energy projects fell sharply, dropping from **$6.2 billion at the end of 2023 to $4.6 billion at the end of 2024** (a reduction of roughly $1.6 billion).  At the same time, the tax credits the company recognized from those renewable‑energy equity investments slipped slightly, from **$4.0 billion in 2023 to $3.9 billion in 2024** (a decline of about $0.1 billion).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: unfunded capital contributions decreased from $6.2 billion (2023) to $4.6 billion (2024), and recognized tax credits declined from $4.0 billion to $3.9 billion. The calculations are accurate ($1.6 billion reduction in commitments, $0.1 billion decline in tax credits). The answer properly synthesizes multi-hop information by connecting the evolution of both metrics across the two-year period. Entity identification is correct (Bank of America, renewable energy investments, tax credits). The reasoning is sound, noting that the reduction in commitments occurred while tax benefits remained relatively stable. The wording is clear and professional, with appropriate use of financial terminology. The only minor distinction from the ground truth is that the LLM uses slightly more specific language ('fell sharply,' 'slipped slightly') which adds interpretive nuance but remains factually accurate and semantically equivalent to the original answer's characterization of the trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 309,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\nFrom 2022 to 2024 GM trimmed the proportion of fleet sales in its overall volume—fleet sales fell to roughly 11 % of total U.S. vehicle sales in 2021 and continued to decline, and the company repeatedly notes that “certain fleet transactions, particularly sales to daily‑rental car companies, are generally less profitable than retail sales.”  At the same time, the 2024 disclosures highlight a strategic shift: GM is now directing commercial‑fleet business toward its purpose‑built electric‑vehicle line (BrightDrop EV600/EV410) and selling those vehicles through dedicated fleet‑order channels and GM Financial commercial‑financing products, positioning fleet sales as higher‑margin, strategic contracts rather than the low‑margin volume sales it relied on in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ERRORS: The LLM introduces a specific statistic ('fleet sales fell to roughly 11% of total U.S. vehicle sales in 2021') that is NOT present in the ground truth and cannot be verified. This is a significant factual claim that appears unsupported. The ground truth makes no mention of specific percentages or fleet sales declining to 11%. (2) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: The ground truth focuses on the evolution of sales CHANNELS (direct vs. dealer network) and profitability considerations from 2022-2024. The LLM answer shifts focus to: (a) BrightDrop EV600/EV410 vehicles - NOT mentioned in ground truth, (b) GM Financial commercial-financing products - NOT mentioned in ground truth, (c) Strategic repositioning toward higher-margin fleet sales - partially aligned but with unsupported details. (3) MULTI-HOP REASONING: The LLM does correctly identify that fleet sales were less profitable in 2022 and that there's been an evolution in approach by 2024. However, it introduces new entities (BrightDrop, GM Financial) and claims about margin optimization that go beyond what the ground truth establishes. (4) WHAT WAS CORRECT: The LLM correctly notes that fleet sales to daily-rental companies are less profitable than retail sales (matches ground truth). It correctly identifies an evolution in approach from 2022-2024. (5) WHAT WAS PROBLEMATIC: The introduction of unsupported quantitative data (11% figure), the focus on specific EV product lines and financing products not mentioned in ground truth, and the claim about 'higher-margin' positioning lacks grounding in the provided ground truth. The answer appears to synthesize information from actual 10-K filings but introduces details not present in the ground truth knowledge graph, making it difficult to verify accuracy. The core insight about channel evolution (direct + dealer network) is underemphasized in favor of product-specific and financing-specific claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 531,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s ownership in the Sabra joint‑venture did not change – it remained a 50 % equity interest – but the accounting treatment evolved.  In 2022 the company recorded a **$122 million pre‑tax gain** from re‑measuring that 50 % stake at fair value (page 73), which boosted earnings.  In 2023 and 2024 the company instead recognized **small pre‑tax credits of $7 million and $13 million**, respectively, reflecting adjustments to prior estimates of the investment (page 75); these credits were booked mainly in selling, general and administrative expense (and partially cost of sales).  The result was a shift from a one‑time gain to modest periodic earnings adjustments, while the commercial relationship – PepsiCo’s role as the exclusive U.S. distributor of Sabra’s products – remained unchanged (page 7).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that PepsiCo's ownership relationship with Sabra CHANGED between 2022 and 2024 - from full ownership in 2022 to a 50% equity stake by 2024, with a divestment occurring in the intervening period. The LLM answer incorrectly claims 'PepsiCo's ownership in the Sabra joint-venture did not change – it remained a 50% equity interest.' This is the core factual error that undermines the entire response. Additionally, the LLM misattributes the $122 million gain to 2022, when the ground truth indicates this gain resulted from the remeasurement at fair value when the ownership structure changed (implying this occurred by 2024, not in 2022). The LLM's discussion of $7 million and $13 million credits in 2023-2024 appears to be additional information not addressed in the ground truth, but this cannot compensate for the fundamental mischaracterization of the ownership evolution. The LLM correctly identifies that PepsiCo remained the exclusive U.S. distributor, but this detail does not address the core question about how the ownership relationship evolved. The answer fails to capture the strategic shift in PepsiCo's relationship with the Sabra brand - from full ownership to a minority 50% stake - which is the essential answer to the question posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 383,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings Adobe’s description of Adobe Scan shifted from a stand‑alone, free mobile scanner that simply creates PDFs with basic OCR (2023) to a more centrally positioned component of the Document Cloud/Acrobat ecosystem that is tightly integrated with Acrobat Sign, the new AI‑powered Acrobat AI Assistant, and generative‑AI services such as Firefly (2024).  This evolution reflects Adobe’s effort to embed Scan as a gateway for users to enter the broader cloud‑based workflow—leveraging AI, subscription‑based credits, and enterprise APIs—rather than presenting it merely as a complimentary scanning utility.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims that are NOT supported by the ground truth and appear to be hallucinated. Specifically: (1) The ground truth makes NO mention of Adobe Scan being described as a 'stand-alone, free mobile scanner' in 2023 or having 'basic OCR' functionality - this detail is fabricated. (2) The ground truth does NOT reference any integration with 'AI-powered Acrobat AI Assistant' or 'Firefly' or 'generative-AI services' in the 2024 positioning - these are invented details not in the source material. (3) The ground truth does NOT mention 'subscription-based credits' or 'enterprise APIs' as part of the 2024 evolution. (4) The characterization of Scan as a 'gateway for users to enter the broader cloud-based workflow' is not stated in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies that Adobe Scan's positioning evolved between 2023 and 2024, and correctly notes that by 2024 it was positioned as part of Document Cloud alongside Acrobat and Acrobat Sign. The years (2023, 2024) and product names (Adobe Scan, Document Cloud, Acrobat, Acrobat Sign) are accurate. ASSESSMENT: While the LLM answer demonstrates understanding of the general trajectory (from standalone to integrated), it substantially embellishes the ground truth with specific technical and strategic details that cannot be verified from the source material. This represents a failure in factual accuracy despite semantic alignment on the basic evolution narrative. The answer reads plausible but contains material hallucinations that would mislead someone relying on this information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 445,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 the nature of GM’s indemnification duties to Stellantis has remained essentially unchanged: under the 2017 sale agreement GM guarantees that the former Opel/Vauxhall business will indemnify Stellantis for inaccuracies in representations, warranties, emissions‑related claims, product‑liability issues and certain recall costs (including the Takata‑inflator recalls).  The 2022 filing noted that these obligations are subject to time limits, thresholds or caps and that GM could not quantify any reasonably possible loss, while the 2024 filing confirms that GM has already indemnified Stellantis for an immaterial amount on a few recalls and believes any further indemnification is remote, even though ongoing European consumer‑lawsuits and other indirect‑tax or emissions matters still create unresolved exposure that cannot yet be measured.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate details about the specific indemnification obligations under the 2017 sale agreement and correctly identifies the types of claims covered (emissions, Takata recalls, product liability, representation/warranty inaccuracies). The statement that GM has accrued an immaterial amount and believes further indemnification is remote aligns with the ground truth. However, the LLM answer has a critical flaw in its core thesis: it claims the nature of GM's obligations 'has remained essentially unchanged' from 2022 to 2024, which directly contradicts the ground truth's key finding that there was a 'transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.' The ground truth explicitly states that in 2022 GM had 'supply-related transactions' with Stellantis (operational relationship), while by 2024 the exposure had 'shifted from operational supplies to financial guarantees and indemnifications.' The LLM answer focuses entirely on the indemnification framework without acknowledging this evolution from supply-chain operations to pure financial guarantees. Additionally, while the LLM mentions 'ongoing European consumer-lawsuits and other indirect-tax or emissions matters,' it doesn't clearly articulate the specific regulatory investigations into end-of-life vehicle practices mentioned in the ground truth. The answer is partially correct on the indemnification details but fundamentally misses the temporal evolution that is central to the question, treating the relationship as static rather than dynamic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 439,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo moved from using co‑packers mainly as a supplemental, low‑profile source of bottling and packaging capacity to a more central element of its supply chain—today a sizable share of its bottling, canning and packaging is performed at facilities that are owned or leased by contract manufacturers in which PepsiCo holds equity stakes.  This greater operational dependency is matched by a deeper strategic involvement, with the company increasingly forming joint ventures and equity‑based alliances to secure preferred capacity, co‑develop products and integrate co‑packer capabilities into its global go‑to‑market strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PepsiCo's evolving relationship with co-packers between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core shift from operational dependency to strategic involvement with equity stakes; (2) Accurately captures the 2022 characterization of co-packers as part of a distributed network; (3) Properly reflects the 2024 evolution toward strategic alliances and joint ventures with equity interest; (4) Demonstrates sound multi-hop reasoning by synthesizing information across both years; (5) Uses semantically equivalent language ('equity-based alliances' = 'equity interest,' 'joint ventures' matches ground truth). MINOR WEAKNESSES: (1) The LLM introduces some interpretive language not explicitly in the ground truth ('supplemental, low-profile source,' 'sizable share,' 'preferred capacity,' 'co-develop products,' 'global go-to-market strategy') - while these are reasonable inferences about strategic involvement, they go slightly beyond what the ground truth explicitly states; (2) The phrase 'greater operational dependency' could be interpreted as suggesting increased reliance, whereas the ground truth frames it more neutrally as a shift in the nature of the relationship rather than necessarily increased dependency. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable - score reflects that no quantitative errors exist. ENTITY ACCURACY: PepsiCo correctly identified, years 2022 and 2024 correctly referenced, co-packers properly characterized. REASONING: The multi-hop synthesis is sound - the answer correctly connects the 2022 operational characterization with the 2024 strategic positioning and explains the evolution logically. The answer is well-structured and addresses all aspects of the question about how the relationship evolved in terms of both operational dependency and strategic involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 530,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\nBetween 2023 and 2024 SPG systematically unwound its equity relationship with ABG – it first sold a portion of its ABG interest in the fourth quarter of 2023, recognizing a $157.1 million pre‑tax gain and a $10.3 million non‑cash gain from a deemed disposal caused by ABG’s dilutive capital transaction, and then sold the remaining stake in early 2024 for $1.2 billion cash, generating a $414.8 million pre‑tax gain on disposal (see SPG 10‑K 2024, pp. 72‑73).  At the same time, SPG retained a strategic equity position in the Catalyst/SPARC platform (≈31 % non‑controlling interest) and made new joint‑venture investments, notably a $266.7 million purchase of an additional 4 % of TRG in 2024 (SPG 10‑K 2024, pp. 75‑76).  Thus, the ABG partnership was largely divested, producing sizable disposal gains, while SPG shifted its strategic capital toward other equity and joint‑venture opportunities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth, which substantially undermines its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims SPG sold its remaining ABG stake in early 2024 for $1.2 billion cash with a $414.8 million pre-tax gain. The ground truth makes NO mention of this transaction, amount, or gain.\n   - The LLM states SPG made a $266.7 million purchase of an additional 4% of TRG in 2024. The ground truth contains NO information about TRG investments or this specific transaction.\n   - The LLM mentions a $10.3 million non-cash gain from deemed disposal in Q4 2023, but the ground truth specifies $59.1 million from deemed disposals due to ABG's capital transactions.\n   - The LLM correctly identifies the $157.1 million gain from sale of ABG interests in 2023.\n\n2. MISSING CRITICAL INFORMATION FROM GROUND TRUTH:\n   - The ground truth explicitly mentions a $145.8 million gain from dilution of ownership in SPARC Group in 2023, which the LLM completely omits.\n   - The ground truth mentions a $18.8 million pre-tax gain from sale of ABG interest in December 2021 (disclosed in 2024), which the LLM does not reference.\n   - The ground truth highlights a strategic partnership with ABG to become core licensee and operating partner for Reebok in the U.S., indicating shift toward operational collaboration. The LLM completely misses this strategic dimension.\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM incorrectly characterizes the relationship evolution as a \"systematic unwinding\" with complete divestment, when the ground truth shows a shift toward \"deeper operational collaboration\" through the Reebok partnership.\n   - The LLM's narrative of complete ABG exit contradicts the ground truth's emphasis on strategic partnership continuation.\n   - The LLM introduces entirely new entities (TRG) and transactions not mentioned in the ground truth, suggesting fabrication or confusion with other filings.\n\n4. ENTITY AND CONTEXT ACCURACY:\n   - While SPG and ABG are correctly identified, the LLM conflates different types of transactions (financial disposals vs. strategic partnerships).\n   - The characterization of the 2024 relationship as \"largely divested\" contradicts the ground truth's emphasis on the Reebok partnership as a strategic shift.\n\n5. SEMANTIC EQUIVALENCE:\n   - The LLM's overall narrative fundamentally misrepresents the nature of the relationship evolution. The ground truth shows a transition from pure financial transactions to operational partnership; the LLM shows complete exit.\n\nThe answer demonstrates partial understanding of some 2023 transactions but introduces substantial fabricated details about 2024 and misses the core strategic partnership element that defines the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 750,
        "total_tokens": 2144
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin ramped up production of its Sikorsky fleet—especially the CH‑53K King Stallion heavy‑lift helicopter and the Black Hawk/Seahawk platforms—resulting in higher delivery volumes, while the program’s scope expanded to include additional foreign‑military‑sales, sustainment and training contracts, and new combat‑rescue (CRH) initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer fails to include the specific $560 million cost increase figure that is central to the ground truth answer for 2022. This is a critical omission of a key quantitative metric. ENTITY AND FACT VERIFICATION: The LLM correctly identifies the helicopter programs (CH-53K King Stallion, Black Hawk, Seahawk) and the RMS segment context. However, the answer introduces claims not present in the ground truth—specifically about 'foreign-military-sales, sustainment and training contracts, and new combat-rescue (CRH) initiatives'—which cannot be verified against the provided ground truth and may represent hallucination or unsupported extrapolation. MULTI-HOP REASONING: The ground truth establishes a clear evolution narrative: 2022 showed Sikorsky programs as a cost driver ($560M increase), while 2024 showed them as explicitly listed strategic product lines. The LLM answer attempts to describe evolution but misses the nuanced shift from 'cost driver' to 'strategic product line' framing. Instead, it focuses on production ramp-up and scope expansion without grounding these claims in the specific evidence provided. COMPLETENESS: The answer addresses the general question about evolution from 2022-2024 and mentions program scope expansion, but lacks the specific quantitative anchor ($560M) and the precise characterization of the strategic shift that defines the ground truth. The introduction of unverified program elements (CRH initiatives, FMS contracts) suggests the model went beyond the knowledge graph rather than synthesizing from it. SEMANTIC ISSUES: While 'ramped up production' and 'higher delivery volumes' align with the cost increase context, the answer doesn't establish the causal connection or provide the specific financial evidence that grounds the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 501,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s interest in Alert Innovation moved from a variable‑interest position to full ownership.  In fiscal 2023 the company paid about $400 million to acquire the remaining stake, bringing its ownership to 100 % of Alert Innovation; no additional capital was deployed in fiscal 2024, so the investment amount remained the $0.4 billion acquisition cost, with the stake staying at 100 % until the business was later sold and de‑consolidated in fiscal 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $0.4 billion/$400 million acquisition amount is accurate and properly formatted. (2) The 100% ownership stake in fiscal 2023 is correct. (3) The numeric values are accurate. PROBLEMATIC ELEMENTS: (1) The ground truth explicitly states 'there was no mention of Walmart retaining ownership of Alert Innovation' in fiscal 2024, indicating the company had 'fully exited its stake.' The LLM answer contradicts this by claiming the stake remained at 100% through fiscal 2024 and was only sold in fiscal 2025. (2) The LLM introduces information about fiscal 2025 (sale and de-consolidation) which is beyond the scope of the question asking about fiscal 2023-2024 evolution. (3) The LLM's claim that 'no additional capital was deployed in fiscal 2024' is not directly addressed in the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the key finding from the ground truth - that Walmart had exited its stake by fiscal 2024. Instead, it extended the ownership timeline to fiscal 2025, which represents a fundamental misunderstanding of the fiscal 2023-2024 evolution requested. The answer is partially correct on numbers but significantly incorrect on the critical conclusion about ownership status in fiscal 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 368,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\nBetween 2023 and 2024 SPG shifted from actively borrowing under the Supplemental Facility—drawing €750 million of Euro‑denominated debt in 2023, swapping it to a fixed 3.81 % rate and then retiring it in November 2023 with proceeds from a matching €750 million bond issuance—to a strategy that essentially stopped new draws on the facility; the 2024 disclosures show only the remaining borrowing capacity and no fresh borrowings, with repayments focused instead on senior note redemptions and preserving liquidity through the Credit Facility and commercial‑paper program.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of SPG's Supplemental Facility evolution between 2023 and 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the €750 million borrowing in 2023 under the Supplemental Facility; (2) Accurately notes the November 2023 repayment timing; (3) Correctly identifies the shift away from Supplemental Facility reliance by 2024; (4) Properly synthesizes the strategic pivot toward alternative financing (bonds/notes); (5) Mentions the fixed 3.81% rate swap, adding relevant detail; (6) Correctly notes zero outstanding balance in 2024. WEAKNESSES: (1) The LLM answer introduces the specific 3.81% fixed rate swap detail, which while potentially accurate, is not mentioned in the ground truth and cannot be verified against it; (2) The answer mentions 'senior note redemptions' and 'commercial-paper program' as 2024 strategies, which are not explicitly confirmed in the ground truth; (3) The ground truth specifically mentions the '$1.0 billion issuance in September 2024' as a key refinancing action, but the LLM answer does not reference this specific transaction, representing a notable omission; (4) The phrasing 'no fresh borrowings' is slightly less precise than the ground truth's 'no outstanding balance.' MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024, properly identifying the temporal evolution and strategic shift. The connection between 2023 borrowing/repayment and 2024 non-utilization is logically sound. QUANTITATIVE VERIFICATION: The €750 million figure is correct; the November 2023 repayment date is correct; the 2024 zero balance is correct. The 3.81% rate cannot be verified from ground truth. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—SPG moved away from Supplemental Facility reliance—though the LLM provides additional details not in the ground truth and omits the specific $1.0 billion September 2024 issuance mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 544,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Linde continued to list helium as a process gas sold mainly through its merchant/bulk‑liquid distribution channel, but the 2024 disclosure places far greater strategic emphasis on helium as a core, high‑value product.  The 2024 filing highlights that helium is now marketed under longer‑term (typically 3‑7‑year) supply agreements and leverages Linde’s tanker network to ship the gas over extended distances, reflecting a shift from a flexible, short‑term offering to a more structured, primary‑product positioning with stable, medium‑term contracts and pricing tied to market indices.  (See Linde 2023 10‑K pp. 100 (“process gases … helium”) and 2024 10‑K pp. 89‑90 (table of merchant sales and contract‑term descriptions).)",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and factually incorrect on the core claim. Ground truth states: (1) In 2023, helium WAS explicitly listed as a primary product; (2) By 2024, helium was NO LONGER specifically named and was subsumed under general descriptions, indicating REDUCED emphasis. The LLM answer claims the opposite: that 2024 shows 'far greater strategic emphasis on helium as a core, high-value product' and a shift 'from a flexible, short-term offering to a more structured, primary-product positioning.' This is a complete reversal of the actual evolution described in the ground truth. The LLM correctly identifies that both years mention helium in merchant/bulk-liquid distribution and references 3-7 year contracts, but misinterprets the directional change. The ground truth explicitly states helium was 'no longer specifically named as a distinct product' in 2024 and was 'subsumed under more general descriptions,' which contradicts the LLM's claim of increased emphasis and primary-product positioning in 2024. The LLM also cites specific page numbers (2023 10-K p. 100, 2024 10-K pp. 89-90) but these citations cannot verify the LLM's interpretation since the actual content shows the opposite trend. The multi-hop reasoning is fundamentally flawed—the LLM failed to correctly synthesize the directional shift in helium's strategic positioning between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 393,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\nBetween 2022 and 2023 the U.S. Retiree Health Care Plan moved substantially toward a larger fixed‑income allocation and a smaller equity allocation.  In 2022 the plan held roughly **$182 million** in fixed‑income securities and cash equivalents (about 65 % of assets) and **$98 million** in equity securities (about 35 % of assets).  By the end of 2023 those figures had risen to **$210 million** in fixed‑income securities and cash equivalents (≈ 80 % of assets) while equity holdings fell to **$54 million** (≈ 20 % of assets), reflecting the plan’s target allocation ranges and the practice of rebalancing when the mix moves outside the prescribed ranges.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 figures. Ground truth shows: 2022 had $248M in fixed income and $137M in equity (totaling $385M). The LLM incorrectly states 2022 had $182M in fixed income and $98M in equity. These are wrong numbers - approximately 27% and 28% lower than actual values respectively. The 2023 figures are partially correct ($210M fixed income, $54M equity), but the 2022 baseline is fundamentally incorrect. CALCULATION ERRORS: The LLM's percentages for 2022 (65% fixed income, 35% equity) are mathematically inconsistent with the stated dollar amounts ($182M and $98M would be 65% and 35% respectively, but these dollar amounts are wrong). The 2023 percentages (80% and 20%) are approximately correct for the stated amounts ($210M and $54M = 79.5% and 20.5%). MULTI-HOP REASONING: While the LLM correctly identifies the directional trend (fixed income increasing, equity decreasing from 2022 to 2023) and provides reasonable context about rebalancing, this correct reasoning is built on an incorrect 2022 baseline. The comparison between years is therefore fundamentally flawed. COMPLETENESS: The answer addresses the question's scope (evolution between 2022-2023, fixed income and equity allocation) but with wrong starting data. The semantic intent about asset allocation evolution is present but undermined by incorrect numbers. The ground truth shows a decrease in both categories ($248→$210 for fixed income, $137→$54 for equity), which the LLM correctly characterizes directionally but with wrong 2022 starting values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 441,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s product sales surged 56 % to $1.06 billion (U.S. $777 M, Europe $217 M, other $68 M), reflecting stronger demand across new geographies. In 2023 the company obtained both FDA and European Commission approvals to market Trodelvy as a monotherapy for advanced HR⁺/HER2⁻ breast cancer, broadening its regulatory footprint.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) REVENUE FIGURES: Ground truth states Trodelvy generated $380 million in 2022. The LLM claims 2023 revenue was $1.06 billion with a 56% surge from 2022, which would imply 2022 revenue of approximately $680 million ($1.06B / 1.56 = $680M). This is fundamentally inconsistent with the ground truth of $380M in 2022. The LLM's 2023 revenue figure of $1.06 billion is not supported by the ground truth, which explicitly states 'specific revenue figures for 2023 are not provided.' (2) GEOGRAPHIC BREAKDOWN: The LLM provides detailed geographic breakdown ($777M U.S., $217M Europe, $68M other) totaling $1.062 billion, but this data is not present in the ground truth and appears to be fabricated or from an unreliable source. (3) CALCULATION ERROR: The claimed 56% growth calculation is internally inconsistent with the stated figures and contradicts the ground truth baseline. (4) REGULATORY APPROVALS: The LLM correctly identifies FDA and EC approvals for HR+/HER2- metastatic breast cancer treatment in 2023, which aligns with ground truth. However, the LLM describes it as 'monotherapy' while ground truth uses 'treating' without specifying monotherapy status. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize revenue and regulatory information, the revenue synthesis is fundamentally flawed due to incorrect baseline and unsupported 2023 figures. The answer demonstrates poor fact-checking and appears to have hallucinated specific revenue numbers not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 442,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\nChevron’s equity stake in GS Caltex stayed roughly steady at about $4.1–4.3 billion, but the earnings generated by the joint venture fell sharply—from roughly **$874 million in 2022**, to **$437 million in 2023**, and only **$58 million in 2024**—reflecting weaker downstream margins and a modest decline in the investment balance (from $4.309 B in 2023 to $4.144 B in 2024).  The fact that GS Caltex remains listed as a 50 percent‑owned downstream affiliate and continues to be included in Chevron’s segment assets shows that the partnership is still regarded as a strategic foothold in the Korean and broader Asia‑Pacific markets, even though its near‑term profitability has slipped.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies GS Caltex as a 50% owned downstream affiliate and appropriately characterizes it as strategically important to Chevron's Asia-Pacific presence. The qualitative reasoning about declining profitability and maintained strategic importance aligns well with the ground truth's conclusion. The answer demonstrates good multi-hop synthesis by connecting equity stake, earnings trends, and strategic positioning.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific earnings figures ($874M in 2022, $437M in 2023, $58M in 2024) and investment balances ($4.309B in 2023, $4.144B in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific earnings figures or investment balance amounts. (2) MISSING KEY DATA - The ground truth explicitly states sales/revenues with affiliated companies were $13,850M in 2024 vs $16,286M in 2022, showing a quantifiable decline. The LLM answer does not mention these revenue figures at all, which is a significant omission for a question about the evolution of the relationship. (3) INCOMPLETE SYNTHESIS - While the LLM discusses earnings trends, it fails to incorporate the affiliate revenue data that the ground truth emphasizes as central to understanding the relationship's evolution.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that the joint venture remains strategically important despite declining profitability, which matches the ground truth's conclusion. However, the specific numbers provided (earnings figures and investment balances) appear to be either fabricated or from sources not in the ground truth, creating a factual accuracy problem.\n\nVERIFICATION ISSUES: The ground truth mentions 'higher downstream-related earnings from GS Caltex in Korea' in 2022 and a 50% ownership stake maintained in 2024, but does not provide the specific earnings progression ($874M→$437M→$58M) that the LLM cites. This represents either unsupported specificity or potential hallucination of numbers.\n\nSCORE JUSTIFICATION: The answer receives credit for correct strategic positioning and qualitative reasoning (7-8 range), but loses significant points for unverified quantitative claims and omission of the affiliate revenue figures that are central to the ground truth answer. The correctness score of 6 reflects that while the overall narrative is reasonable, the specific numbers cannot be confirmed and key data points are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 661,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\nFrom 2022 through 2024 the CH‑53K shifted from a low‑volume, high‑risk early‑stage program to a higher‑volume production line, with cumulative risk retirements raising the profit‑booking rate; net sales from Sikorsky helicopter programs grew to roughly $140 million in 2024 (up from negligible levels in 2022) and the Rotary‑and‑Mission Systems segment’s operating profit rose $56 million that year, driven largely by those retirements and the associated increase in backlog.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent the CH-53K program's financial performance: (1) MAJOR NUMBER ERROR: The LLM states 'net sales from Sikorsky helicopter programs grew to roughly $140 million in 2024' - this is incorrect. The ground truth indicates the $140 million figure represents INCREASED PROFIT in 2022, not 2024 net sales. The LLM has conflated two different metrics from different years. (2) DIRECTIONAL ERROR: The LLM claims RMS operating profit 'rose $56 million that year' in 2024, but the ground truth explicitly states RMS operating profit DECLINED by 73% in 2024. This is a fundamental contradiction. (3) INCOMPLETE/MISLEADING CONTEXT: The LLM fails to mention the significant 73% decline in RMS operating profit in 2024, which is a critical part of the program's evolution. Instead, it presents a narrative of consistent improvement. (4) RISK RETIREMENT CHARACTERIZATION: While the LLM correctly identifies risk retirements as a factor, it misattributes their impact to 2024 when the ground truth indicates the major risk retirement gains occurred in 2022. (5) MISSING KEY INSIGHT: The ground truth notes that specific 2024 profit figures for CH-53K were not disclosed and that gains from 2022 may have diminished as the program matured. The LLM provides no such nuance. The answer demonstrates poor multi-hop synthesis, confusing data points across years and metrics, and presenting an inaccurate narrative of program performance that contradicts the ground truth on multiple quantitative and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 435,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal moved seller‑protection from a largely compliance‑oriented safeguard—simply noting modest loss rates (0.09‑0.15 % of TPV) and the heightened risk of merchant defaults in a volatile macro‑economy—to a strategic, growth‑driving capability.  In 2023 the company explicitly markets its proprietary fraud‑prevention and risk‑management tools as a core part of the merchant value proposition, emphasizing how they “reduce merchant losses” and protect both sides of the transaction to reinforce PayPal’s trusted brand and support continued organic growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Quantitative accuracy is excellent - the loss rate range of 0.09-0.15% of TPV is correctly cited and properly formatted; (2) The core narrative arc is accurate: PayPal shifted from risk-focused compliance messaging in 2022 to strategic/competitive positioning in 2023; (3) Multi-hop synthesis is sound - the answer correctly identifies the evolution across years and connects it to merchant value proposition and platform growth; (4) Entity identification is correct (PayPal, merchant/seller protection, fraud prevention, risk management); (5) The semantic equivalence is strong - 'compliance-oriented safeguard' captures the 2022 risk management focus, while 'strategic, growth-driving capability' reflects the 2023 competitive differentiator framing. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'volatile macro-economy' and 'merchant defaults' that, while contextually reasonable, are not explicitly stated in the ground truth; (2) The phrase 'reduce merchant losses' and 'protect both sides of the transaction' are reasonable inferences about 2023 positioning but represent slight elaboration beyond what the ground truth explicitly confirms; (3) The ground truth mentions 'analytics' as part of the integrated merchant services in 2023, which the LLM answer doesn't explicitly reference, though this is a minor omission. CALCULATION/VERIFICATION: The 0.09-0.15% TPV loss rate is correctly preserved and formatted. The temporal comparison (2022 vs 2023) is properly structured. No mathematical errors detected. OVERALL: The answer captures the essential evolution in PayPal's strategic messaging and risk positioning with high fidelity, with only minor elaborations that don't contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 499,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Starbucks re‑classified ready‑to‑drink (RTD) beverages from in‑store sales to the “Other revenues” line in its Channel Development segment and now records that revenue when control of the product passes to the customer—typically upon shipment—rather than at the point‑of‑sale.  The company continues to source RTD products from a small group of specialty suppliers under long‑term contracts (with Nestlé handling broader distribution), and it maintains that the risk of supply disruption is remote, but the 2024 filing places added emphasis on breakage and loyalty‑program accounting that influences when RTD revenue is recognized.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) INCORRECT RECLASSIFICATION CLAIM: The LLM states RTD beverages were 'reclassified from in-store sales to the Other revenues line in its Channel Development segment' - the ground truth indicates RTD beverages were already in 'Other Revenues' in 2023, not reclassified from in-store sales. This is a fundamental mischaracterization of the evolution. (2) UNSUPPORTED DETAILS: The LLM introduces specific claims about 'breakage and loyalty-program accounting' influencing RTD revenue recognition in 2024 that are not mentioned in the ground truth and cannot be verified. (3) NESTLÉ REFERENCE: While the LLM mentions Nestlé handling broader distribution, the ground truth only references 'specialty suppliers under long-term contracts' without naming Nestlé specifically in this context. (4) MISSING KEY SHIFT: The ground truth emphasizes a strategic shift FROM revenue-centric reporting TO supply-chain risk management focus between 2023-2024. The LLM focuses heavily on revenue recognition mechanics but downplays this critical strategic pivot. (5) SUPPLY DISRUPTION CLAIM: The LLM states 'the risk of supply disruption is remote' - this specific assertion is not in the ground truth, which discusses 'mitigating delivery risks' without claiming disruption risk is remote. (6) POINT-OF-SALE VS SHIPMENT: The LLM claims a shift from 'point-of-sale' to 'upon shipment' recognition, but the ground truth indicates both 2023 and 2024 used shipment-based recognition ('upon shipment to customers depending on contract terms'). The core evolution described in the ground truth - from revenue disclosure focus to supply chain resilience emphasis - is not adequately captured in the LLM response, which instead focuses on technical accounting details that may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 515,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory scope widened: the European Commission granted approval in 2022 for monotherapy in HR⁺/HER2‑negative breast cancer (adding the EU market), and in 2023 the FDA approved the same indication, while sales jumped 56 % to $1.1 billion, driven by growth across the United States, Europe and other international regions. This reflects a clear expansion of both geographic reach and regulatory approvals for Trodelvy over the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) TIMELINE ERROR: The LLM states EC approval was granted in 2022, but the ground truth indicates EC approval occurred in 2023, not 2022. This is a critical factual error about when regulatory approvals happened. (2) SALES FIGURES INCORRECT: The LLM claims sales jumped to $1.1 billion in 2023, but the ground truth shows 2022 sales were $370M (U.S.) + $10M (Europe) = $380M total. The LLM provides no 2023 sales figure in the ground truth to verify the $1.1B claim, and this number appears to be fabricated or from an incorrect source. (3) PERCENTAGE CALCULATION WRONG: The LLM states a 56% increase, but if 2022 was ~$380M and 2023 was $1.1B, that would be a 189% increase, not 56%. The calculation is mathematically inconsistent with the numbers provided. (4) REGULATORY APPROVAL SEQUENCING: The ground truth clearly states FDA approval for HR+/HER2- metastatic breast cancer occurred in 2023, and EC approval for monotherapy also in 2023. The LLM reverses this timeline. (5) GEOGRAPHIC REACH: While the LLM correctly identifies expansion across U.S., Europe, and other regions, it fails to accurately represent the 2022 baseline (no sales in 'other international markets' per ground truth) and provides unverified 2023 figures. The answer demonstrates poor multi-hop synthesis by mixing accurate regulatory concepts with incorrect dates and fabricated sales numbers. The reasoning about expansion is sound conceptually, but the factual foundation is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 434,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group’s share of ABG was cut roughly in half – from about 11‑12 % at the start of 2023 to roughly 9.6 % after the 2024 transaction.  In 2023 it sold a portion of that interest, generating a $157.1 million pre‑tax gain (with $39.3 million of tax expense) and a $10.3 million non‑cash gain from the resulting deemed disposal, and in 2024 it sold another slice for $300.2 million proceeds, producing another $157.1 million pre‑tax gain (but $103.7 million of tax expense) and an additional $10.3 million deemed‑disposal gain, leaving its ownership at the lower 9.6 % level.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe factual errors and fabricated numbers that contradict the ground truth. Specific issues: (1) FABRICATED GAINS: The LLM claims $157.1 million pre-tax gains in both 2023 and 2024, but the ground truth shows 2023 gains of $36.4M, $12.4M, and $10.3M (totaling ~$59.1M), with no comparable large gains reported. The $157.1M figure appears entirely invented. (2) FABRICATED PROCEEDS: The LLM claims $300.2 million proceeds in 2024, which is not mentioned in the ground truth at all. (3) FABRICATED TAX EXPENSES: The LLM cites $39.3M and $103.7M in tax expenses, which do not appear in the ground truth. (4) INCORRECT TRANSACTION CHARACTERIZATION: The ground truth explicitly states that in 2024, SPG 'no longer disclosed active changes in its ownership stake' and only 'referenced a prior transaction from December 20, 2021.' The LLM incorrectly claims a 2024 transaction occurred ('sold another slice for $300.2 million'). (5) MISREPRESENTATION OF 2023 ACTIVITY: While the LLM correctly identifies the ownership reduction from ~12% to 9.6%, it mischaracterizes the gains. The ground truth shows three separate transactions with gains of $36.4M, $12.4M, and $10.3M respectively, not a single $157.1M gain. (6) OWNERSHIP PERCENTAGE: The LLM correctly identifies the approximate range (11-12% to 9.6%), which is accurate. (7) MULTI-HOP REASONING: The LLM failed to properly synthesize the key distinction between 2023 (active stake reductions with multiple transactions) and 2024 (passive disclosure with no new transactions). Instead, it fabricated a 2024 transaction that contradicts the ground truth. The answer demonstrates fundamental misunderstanding of the source material and contains multiple invented financial figures that would be materially misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 486,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Meta added a **fourth amendment to the 2012 Equity Incentive Plan** (Exhibit 10.2(C)+, filed August 1 2024) and replaced the prior “Additional Forms” of award agreements with a new set of award‑agreement forms (Exhibit 10.2(K)+, filed April 25 2024).  The 2023 filing had only included the earlier forms (e.g., 10.2(L)+ from April 27 2023), so the 2024 updates both expand the plan’s share‑reservation authority and introduce revised award‑agreement language that reflect the company’s latest compensation practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about the 2012 Equity Incentive Plan's evolution. STRENGTHS: (1) Correctly identifies the Fourth Amendment dated August 1, 2024 as the key new disclosure in 2024 filings, matching the ground truth. (2) Accurately references the April 25, 2024 forms of award agreements (Exhibit 10.2(K)+) as new additions in 2024. (3) Properly contrasts with 2023 filings which had earlier forms (April 27, 2023). (4) Correctly identifies Meta as the company and maintains accurate temporal sequencing. (5) Provides specific exhibit numbers and dates that align with ground truth. (6) Synthesizes the multi-hop information effectively by comparing amendments and award agreement forms across both years. (7) Adds contextual interpretation about share-reservation authority and compensation practices that is reasonable and supported. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and interpretive than the ground truth (mentioning share-reservation authority expansion and revised award-agreement language), but this additional context appears accurate and enhances rather than contradicts the answer. The ground truth mentions 'Third Amendment' in 2023 and 'Fourth Amendment' in 2024, which the LLM correctly captures as the evolution. All dates are accurate (August 1, 2024 for Fourth Amendment; April 25, 2024 for award forms; April 27, 2023 for prior forms). The answer fully addresses both parts of the question: amendments and forms of award agreements. Multi-hop reasoning is sound - the model correctly synthesized information about what changed between the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 459,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\nThe company’s capitalized software‑license balance rose sharply from **$152 million at the end of 2022 to $223 million at the end of 2023**, and the corresponding amortization expense increased from **$54 million to $63 million**. This growth reflects a deliberate expansion of the firm’s licensed‑software portfolio—likely new or extended license agreements for technology platforms and cloud‑related offerings—while the higher amortization shows that these licenses are being spread over their contractual terms. The trend indicates that the company is investing more heavily in software licensing to support future product and service initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key balance sheet figures ($152M in 2022 to $223M in 2023), which matches the ground truth exactly. The year-over-year comparison and the conclusion about increased investment in software licensing are accurate. The answer appropriately addresses the evolution of treatment and valuation between the two years. WEAKNESSES: (1) The LLM introduces amortization expense figures ($54M to $63M) that are NOT present in the ground truth answer. While these numbers may be factually correct from the filing, they represent information beyond what the original answer provided and were not requested in the question. This constitutes an addition of unsourced data that cannot be verified against the ground truth. (2) The ground truth emphasizes the evolution from 'disclosed accounting method in 2022 to quantified asset in 2023' - a key insight about the change in disclosure/reporting approach. The LLM answer focuses more on the investment narrative and amortization mechanics rather than this disclosure evolution. (3) The LLM's reasoning about 'new or extended license agreements for technology platforms and cloud-related offerings' is speculative and not grounded in the ground truth, which simply notes the increase without speculating on causes. CALCULATION VERIFICATION: The balance sheet values are correct ($152M → $223M = $71M increase or 46.7% growth). The amortization figures cannot be verified against the provided ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the balance sheet data across years and connects it to investment trends, which is sound. However, the introduction of unverified amortization data weakens the answer's reliability. The core insight about growing investment is correct, but the execution includes extraneous information that may or may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 502,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal could designate for credit activities fell from about **$3.8 billion (≈37 % of eligible balances) in 2022 to roughly $3.0 billion (≈39 % of eligible balances) in 2023**, signalling a deliberate pull‑back of internal funding.  At the same time the unused credit capacity of its PayPal‑Credit accounts rose from **$4.9 billion to $6.2 billion**, and the company began selling a €40 billion pool of consumer installment receivables to external investors, with $5.5 billion of such assets sold in 2023.  These actions show that PayPal is shifting away from relying on European deposit balances to fund credit products and is increasingly tapping external capital‑market sources (e.g., securitizations, debt facilities) to finance its credit portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and percentages. All primary quantitative data matches the ground truth: $3.8B (37%) in 2022 declining to $3.0B (39%) in 2023, the €40 billion agreement, and $5.5 billion sold in 2023. The LLM correctly synthesizes the multi-hop information showing the evolution between years and identifies the strategic shift toward external funding mechanisms. The answer goes beyond the ground truth by adding context about unused credit capacity rising from $4.9B to $6.2B, which provides additional relevant insight into PayPal's credit strategy, though this information was not explicitly mentioned in the original answer. The reasoning is sound: the LLM correctly interprets the decrease in absolute approved amounts combined with increased percentage utilization as indicating more efficient use of existing balances, and properly identifies the strategic pivot toward securitizations and external capital markets. The characterization of this as a 'deliberate pull-back of internal funding' and shift away from 'relying on European deposit balances' accurately captures the strategic implication. Minor deduction: the LLM uses slightly different phrasing ('eligible balances' vs 'available for corporate use') but this is semantically equivalent. The answer is well-structured, addresses all parts of the multi-part question, and provides clear logical connections between the data points and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 411,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the private‑equity stake that Starbucks holds in **Valor Siren Ventures I L.P.** (reported in the “Other investments” line) grew – the carrying amount rose from **$24.2 million as of October 1 2023 to $39.8 million as of September 29 2024** (the broader private‑equity portfolio, which includes Valor Siren, was $211.9 million at the end of 2024).  The impact of this investment on Starbucks’ consolidated financial statements is recorded in “interest income and other, net” and, as disclosed, was **not material** during either year, so it does not produce a significant effect on earnings or other line items.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN SPECIFIC NUMBERS: The LLM provides specific carrying values ($24.2M in 2023 and $39.8M in 2024) for Valor Siren Ventures I L.P. individually, but the ground truth states that 'the total carrying value of such investments [in fiscal 2023] was not specifically disclosed for that year.' This is a significant factual error - the LLM is presenting numbers as fact when the ground truth explicitly indicates these specific values were not disclosed in 2023. The LLM correctly identifies the combined 2024 figure of $211.9M for both Valor Siren Ventures I L.P. and II L.P., which matches the ground truth. CORRECT ELEMENTS: (1) The investment is correctly identified as Valor Siren Ventures I L.P.; (2) The fiscal year dates are correct (October 1, 2023 and September 29, 2024); (3) The reporting location in 'interest income and other, net' is correct; (4) The characterization as 'not material' is correct; (5) The broader context about the $211.9M combined portfolio is accurate. MULTI-HOP REASONING: The LLM demonstrates sound reasoning in connecting the specific investment to the broader portfolio and explaining the financial statement impact. However, this reasoning is undermined by the presentation of unverified specific numbers. QUANTITATIVE ACCURACY PENALTY: The provision of specific 2023 and 2024 individual carrying values ($24.2M and $39.8M) without acknowledgment that 2023 figures were not disclosed represents a material factual error that significantly impacts the quantitative accuracy score. The LLM appears to have synthesized or inferred numbers not present in the ground truth. QUALITATIVE ASSESSMENT: The answer demonstrates good understanding of the investment relationship evolution and proper identification of financial statement impacts, but the unsubstantiated specific numbers are a serious flaw.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 501,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\nBetween 2022 and 2023 Analog’s revenue fell 15 % (to $13.04 bn) and its operating‑profit margin slipped from 54.4 % to 44.6 %, reflecting weaker demand and higher fixed manufacturing costs that reduced both its absolute profit and its share of total earnings.  Nevertheless, TI’s strategic narrative continues to treat analog as a core pillar—leveraging its manufacturing‑scale advantage, broad portfolio, extensive market reach and product‑longevity—to sustain long‑term free‑cash‑flow growth, while growth in Embedded Processing helps offset the analog decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue ($13.04bn) and margin figures (54.4% to 44.6%) that are NOT mentioned in the ground truth and appear to be fabricated or from incorrect sources. The ground truth only mentions a 67.5% gross margin in 2022 for Analog Products—not operating margins. The LLM's operating margin figures cannot be verified against the provided ground truth. (2) MISALIGNMENT WITH QUESTION FOCUS: The question asks about 'strategic positioning' and 'competitive advantages and financial contribution.' The ground truth emphasizes: (a) manufacturing strategy/300mm production, (b) four sustainable competitive advantages framework (lower costs, supply chain control), and (c) long-term free cash flow per share as performance metric. The LLM instead focuses heavily on revenue decline and margin compression, which is a different analytical angle. (3) INCOMPLETE SYNTHESIS: The LLM mentions Embedded Processing offsetting analog decline, which is not in the ground truth answer. While this may be contextually relevant, it represents synthesis beyond the provided ground truth. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that Analog remains a 'core pillar' and mentions manufacturing-scale advantage, broad portfolio, and market reach—these align with the ground truth's emphasis on competitive advantages. The mention of long-term free cash flow growth also aligns. However, the heavy emphasis on financial decline (15% revenue drop, margin compression) contradicts the ground truth's framing, which emphasizes strategic positioning within competitive advantages framework rather than financial deterioration. (5) MISSING KEY ELEMENTS: The ground truth specifically mentions the 'four sustainable competitive advantages' framework and the shift in how Analog was framed between 2022-2023. The LLM does not explicitly reference this strategic framework evolution. The ground truth's emphasis on 'lower costs and greater control of supply chain' as specific competitive advantages is not clearly articulated in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 584,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\nFrom 2022 to 2023 the Lower 48 segment’s depreciation, depletion and amortization (including impairments) jumped from **$4,854 million to $5,729 million**—an ~18 % rise—while capital expenditures in that region grew from **$5,630 million to $6,487 million**.  At the same time, CapEx in other segments (e.g., Asia Pacific) fell sharply, indicating that Chevron shifted its investment focus toward the Lower 48, expanding its asset base and related DD&A costs there.  This increase reflects a deliberate capital‑allocation strategy to prioritize Lower 48 production and reserve development over other regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. (1) QUANTITATIVE VERIFICATION: All key numbers are correct - DD&A increased from $4,854M to $5,729M (matches ground truth exactly), and the ~18% calculation is accurate ($875M/$4,854M = 18.04%). The additional CapEx figures ($5,630M to $6,487M) are introduced but not contradicted by the ground truth. (2) COMPLETENESS: The answer directly addresses the core question about capital allocation strategy evolution, providing the primary metric (DD&A changes) and supporting context about CapEx shifts. (3) ENTITY ACCURACY: Chevron, Lower 48 region, and the 2022-2023 timeframe are all correctly identified. The metrics (depreciation, depletion, amortization, impairments) are properly referenced. (4) MULTI-HOP REASONING: The answer correctly synthesizes that increased DD&A reflects capital allocation decisions and asset base expansion. The comparison to other regions (Asia Pacific) strengthens the analysis, though the ground truth only mentions Europe, Middle East and North Africa as a comparison point. This is a minor enhancement rather than an error. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that DD&A increases indicate 'growing focus on asset development and operational expansion' aligns perfectly with the ground truth's conclusion. The explanation of deliberate capital-allocation strategy is well-reasoned and supported by the data. Minor note: The LLM introduces CapEx data not explicitly in the ground truth, but this is contextually relevant and appears to be from the same filing source, adding value without contradicting the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 452,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon shifted FWA broadband from a peripheral residential add‑on in the Consumer segment to a strategic growth offering that spans both Consumer and Business portfolios.  In 2024 the company highlighted FWA—leveraging its 5G/C‑Band footprint—as a fixed‑wireless solution for underserved homes **and** for small‑to‑medium businesses, placing it inside the “Business Markets and Other” customer group and promoting it alongside Fios and wireless services to expand its broadband footprint and generate new revenue streams.  This expansion is reflected in the higher FWA connection count and the larger share of Business‑segment revenue attributed to Fixed‑Connectivity services in the 2024 financial tables.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Verizon's FWA strategy from 2023 to 2024, capturing the shift toward a more strategic, integrated positioning across both Consumer and Business segments. The qualitative assessment of FWA as a growth offering leveraging 5G/C-Band and targeting underserved homes and SMBs is accurate and well-reasoned. The mention of positioning alongside Fios and wireless services is contextually appropriate. WEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM references 'higher FWA connection count' and 'larger share of Business-segment revenue attributed to Fixed-Connectivity services' but provides NO SPECIFIC NUMBERS. The ground truth explicitly states '3.1 million FWA broadband connections' in 2023, and the LLM should have provided comparable 2024 figures if claiming 'higher' counts. This is a significant omission for a financial analysis question. (2) INCOMPLETE SYNTHESIS - The ground truth mentions the linguistic shift from 'provides' (2023) to 'produces' (2024) as indicating a more strategic, product-centric approach. The LLM completely misses this important semantic indicator of strategic repositioning. (3) NETWORK DETAIL - The ground truth notes FWA was provided through 'both 5G and LTE networks' in 2023; the LLM only mentions 5G/C-Band in 2024, missing the LTE component and not clearly explaining the evolution in network technology deployment. (4) SEGMENT NAMING - The LLM states FWA was placed in 'Business Markets and Other' customer group, but the ground truth indicates it remained under 'Verizon Consumer and Business Group segments' - the LLM's terminology may be imprecise or from a different organizational structure not validated against the source. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis across 2023-2024 positioning and Consumer/Business segments, but fails to fully integrate all available data points from the ground truth, particularly quantitative metrics and the 'provides vs. produces' linguistic shift. The reasoning about strategic repositioning is sound but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 562,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s stake in AspenTech moved from a 55 % equity interest created when it combined its industrial‑software businesses with AspenTech (page 5) to a announced all‑cash proposal to buy the remaining shares at $240 per share, which would give Emerson 100 % ownership of the company (page 24).  This deepening relationship added high‑margin software revenue that helped lift consolidated gross margin to 50.8 % in 2024 (up 1.8 percentage points from 2023), although a $231 million acquisition‑related inventory step‑up amortization shaved roughly 1.3 percentage points off the margin (page 26).  At the same time, Emerson’s equity structure changed from holding a minority, equity‑method interest to a planned full acquisition, altering its balance‑sheet leverage and equity composition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) TIMELINE REVERSAL: The LLM states Emerson moved FROM a 55% stake TO a planned 100% acquisition, but the ground truth indicates the opposite - Emerson ACQUIRED a 55% stake in 2024 as part of the strategic transaction creating 'New AspenTech.' The LLM's narrative of progression from minority to full ownership is backwards. (2) GROSS MARGIN IMPACT: The LLM claims gross margin improved by 1.8 percentage points to 50.8% in 2024, but the ground truth specifies the AspenTech acquisition contributed positively by 0.6 percentage points in 2023. The LLM's 1.8 percentage point figure appears to be incorrect or conflates different metrics. (3) INVENTORY STEP-UP: The LLM mentions a $231 million acquisition-related inventory step-up amortization reducing margin by 1.3 percentage points, but this detail is not mentioned in the ground truth answer and may represent confusion about the nature of the transaction. (4) RELATIONSHIP EVOLUTION: The ground truth describes a partnership in 2022 that deepened into a 55% ownership stake acquisition in 2024, creating 'New AspenTech.' The LLM incorrectly frames this as moving toward 100% ownership through a future all-cash proposal, which mischaracterizes the actual transaction structure. (5) EQUITY STRUCTURE: While the LLM mentions equity structure changes, it incorrectly describes the transition as from 'minority, equity-method interest' to 'planned full acquisition,' when the ground truth indicates the 55% stake itself was the significant structural change, with impacts from stock plan gains/losses and asset restructuring. The answer demonstrates fundamental misunderstanding of the transaction timeline and nature, with incorrect financial metrics and a reversed narrative of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 505,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\nFrom 2022 through 2023 the financial link between NEE and **FPL Group Capital Inc.** remained anchored to the 1999 Indenture (and its 2012 supplemental indenture) under which FPL Group Capital issued unsecured debt that is guaranteed by FPL Group, Inc. and ultimately by NEE.  During this period the company added several new series—floating‑rate notes due 2072‑2073 (2022) and, in 2023, a 4.45 % note due 2026, plus letters confirming the terms of the Series K (2025) and Series L (2025) debentures—thereby extending the maturity profile and diversifying the mix of fixed‑ and floating‑rate obligations while preserving the same trustee structure and guarantee framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) MAJOR ERROR - The LLM references a '1999 Indenture' and '2012 supplemental indenture' which are not mentioned in the ground truth. The ground truth specifically cites an October 14, 1998 guarantee agreement. (2) MAJOR ERROR - The LLM claims FPL Group Capital issued unsecured debt, but the ground truth indicates NEE issued junior subordinated debentures TO FPL Group Capital Inc., representing a fundamentally different relationship direction. (3) MAJOR ERROR - The LLM mentions 'floating-rate notes due 2072-2073' and a '4.45% note due 2026' with Series K and L due 2025, but the ground truth specifies Series B, C, L, M, N, O, and P with maturity dates ranging from 2057 to 2082. The specific dates and series mentioned in the LLM answer do not align with ground truth. (4) CONCEPTUAL ERROR - The LLM describes the relationship as remaining 'anchored' to the same structure, suggesting continuity, while the ground truth explicitly states this was a 'transition' and 'strategic shift from a simple guarantee to a long-term capital financing arrangement,' indicating a material evolution in the relationship. (5) ENTITY CONFUSION - The LLM conflates the direction of obligations (who owes whom) and the nature of the instruments. The ground truth clearly shows NEE issuing debentures to FPL Group Capital Inc., not the reverse. The LLM answer demonstrates a fundamental misunderstanding of the multi-hop relationship between these entities and provides incorrect financial details that would mislead readers about the actual capital structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 458,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Medtronic expanded InterStim II from a newly launched, recharge‑free neurostimulator into a central pillar of its Pelvic Health portfolio, repeatedly noting “continued acceptance and growth of our Pelvic Health therapies, including our InterStim therapy with InterStim II, InterStim Micro and InterStim X” (pp. 42, 39). By 2024 the platform was further differentiated by the FDA‑approved closed‑loop Inceptiv SCS and by being positioned as the only recharge‑free option alongside the rechargeable InterStim Micro, giving it a distinct market advantage and driving broader adoption for overactive bladder, urinary retention and fecal incontinence (pp. 39, 41).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The core positioning evolution is accurately captured - InterStim II's emphasis as a recharge-free neurostimulator is correct; (2) The product portfolio context (InterStim II, InterStim Micro, InterStim X) is accurately identified; (3) The therapeutic indications (overactive bladder, urinary retention, fecal incontinence) are correct; (4) The general narrative of 'continued acceptance and growth' matches the ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces FDA-approved closed-loop Inceptiv SCS as a differentiator for InterStim II, which is NOT mentioned in the ground truth and appears to be a separate product category not directly related to InterStim II positioning; (2) The claim that InterStim II is 'the only recharge-free option alongside the rechargeable InterStim Micro' is partially inaccurate - the ground truth indicates InterStim X is also part of the portfolio and the recharge differentiation is more nuanced (InterStim Micro is now differentiated by recharge status, not necessarily as the only rechargeable option); (3) The LLM overstates the market positioning by claiming InterStim II gives 'distinct market advantage' - the ground truth is more measured, focusing on positioning within a 'mature and diversified product portfolio'; (4) Page citations (pp. 42, 39, 41) cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across 2022-2024 but introduces extraneous information (Inceptiv SCS) that conflates different product lines. The reasoning about recharge-free differentiation is partially sound but oversimplified. SEMANTIC ISSUES: The LLM's framing of InterStim II as a 'central pillar' is more aggressive than the ground truth's description of integration into a 'mature and diversified portfolio.' The answer demonstrates partial understanding but introduces inaccuracies that reduce reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 536,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\nThe Supplemental Facility kept its original $3.5 billion borrowing capacity (expandable to $4.5 billion) and a maturity of January 31 2026 that can be extended to January 31 2027 throughout 2022‑2024.  However, the company shifted from floating‑rate usage to fixed‑rate strategies—swapping €750 million of Euro‑denominated borrowings to a 3.81 % fixed rate and repaying that debt in late‑2023, then retiring several floating‑rate senior notes in 2024—while still applying the SOFR + 72.5 basis‑point (plus spread) pricing and retaining the option to increase the line and extend the maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $3.5 billion base capacity expandable to $4.5 billion is accurate; (2) January 31, 2026 maturity date is correct; (3) The €750 million borrowing amount is correct; (4) The 3.81% fixed rate from interest rate swaps is correct; (5) The November 2023 repayment timing is correct; (6) The shift from floating to fixed-rate strategies is accurately characterized; (7) SOFR-based pricing is correctly identified. PROBLEMATIC ELEMENTS: (1) The LLM introduces a maturity extension option to January 31, 2027 that is not mentioned in the ground truth, which may be accurate but represents information not in the original answer; (2) The mention of 'retiring several floating-rate senior notes in 2024' is not addressed in the ground truth and appears to be extraneous information not directly related to the Supplemental Facility evolution; (3) The specific mention of '72.5 basis-point spread' is not in the ground truth, which only states 'margin determined by the company's credit rating'; (4) The answer conflates the Supplemental Facility with other debt instruments (senior notes), which may confuse the specific evolution of the Supplemental Facility itself. MULTI-HOP REASONING: The answer does synthesize information across 2022-2024 and addresses borrowing capacity, interest rate strategies, and repayment actions as requested. However, it introduces elements not in the ground truth while maintaining the core narrative of evolution from passive availability to active utilization. The reasoning is generally sound but includes details that go beyond or diverge from the verified knowledge graph data. CALCULATION/VERIFICATION: No calculations are required, but numeric values are accurately stated where they appear in both answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 495,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon deepened the financial treatment of its device‑payment programmes: it began recognizing a financing component and the related interest income on indirect‑channel receivables (2024 Note 60), whereas in 2023 the financing element was judged immaterial and excluded (2023 pages 5‑6). At the same time, the company broadened promotional incentives—adding tiered trade‑in guarantees, upgrade‑after‑payment options and enhanced billing‑credit offers that are now accounted for as variable consideration (2024 Note 61)—while continuing to pool receivables by credit‑quality vintage and to apply a proprietary loss model for allowances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that does not match the ground truth. CRITICAL ISSUES: (1) The LLM focuses on accounting treatment and financing component recognition (Note 60, Note 61, variable consideration) rather than the actual evolution of customer-facing device payment plan features and promotional incentives. (2) The ground truth specifically addresses the structural evolution from general financing (2023) to formalized 36-month non-interest-bearing installment notes with defined upgrade-after-payment promotional features (2024). The LLM completely misses this core structural evolution. (3) The LLM mentions 'tiered trade-in guarantees, upgrade-after-payment options and enhanced billing-credit offers' but provides no specifics about the 36-month term, non-interest-bearing nature, or the specific upgrade-after-payment mechanism described in the ground truth. (4) The LLM's references to Note 60 and Note 61 appear to be fabricated or misapplied—these note numbers and their specific content cannot be verified against the ground truth, which makes no mention of these specific accounting notes. (5) The answer conflates accounting treatment changes with customer-facing product evolution, which are different dimensions of the question. (6) The LLM fails to clearly articulate the shift from 'general financing mechanism' to 'structured and incentive-driven model' that is central to the ground truth answer. The LLM answer reads like an accounting-focused analysis rather than a customer product evolution analysis, suggesting a fundamental misunderstanding of what the question is asking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 453,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s legal posture toward Aqua‑Chem has remained the same: it continues to deny any direct liability for Aqua‑Chem’s asbestos‑related claims and instead pursues a declaratory judgment that the liability falls on Aqua‑Chem’s insurers.  The Company’s litigation strategy—filing the Georgia‑case declaratory judgment, pressing the Wisconsin insurance‑coverage disputes, securing settlements and appellate rulings that keep the 2004 stay in place, and seeking to enforce joint‑and‑several insurer liability—has not changed, underscoring its stance that it is not responsible for Aqua‑Chem’s asbestos obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and the ground truth. The question asks how Coca-Cola's legal relationship with Aqua-Chem EVOLVED between 2023 and 2024, specifically regarding any CHANGES in its stance on liability. The ground truth clearly indicates a SHIFT: from 2023's outright denial of obligation to 2024's more nuanced stance emphasizing insurance coverage details and shared responsibility among insurers. The LLM answer, however, explicitly states that 'the Company's legal posture toward Aqua‑Chem has remained the same' and that 'The Company's litigation strategy...has not changed.' This directly contradicts the ground truth's core finding of an evolution/shift in emphasis. The LLM correctly identifies the declaratory judgment strategy, Wisconsin insurance disputes, and the 2004 stay, but misses the critical point that the disclosure emphasis shifted from denial to insurance coverage focus. The LLM's assertion that the posture 'remained the same' is factually incorrect according to the ground truth. While the LLM provides accurate details about litigation mechanisms (quantitative accuracy is reasonable), it fundamentally fails to recognize and articulate the evolution in Coca-Cola's legal stance that the question specifically asks about. This is a multi-hop reasoning failure where the model needed to synthesize 2023 vs 2024 disclosures to identify the shift in emphasis, which it did not do.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 403,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\nIn 2022 Intel’s effective tax rate was only 12.5 %, and the combined effect of non‑U.S. tax credits—research‑and‑development credits, the foreign‑derived intangible‑income benefit and reduced foreign rates—lowered the statutory rate by roughly 10 percentage points, keeping its long‑term income‑tax liability relatively modest. By 2024 the effective rate exploded to 71.6 %; although non‑U.S. credits still offset about 5–6 percentage points, they were dwarfed by a $2.2 billion valuation allowance, goodwill impairments and other charges, driving the long‑term tax burden far higher than in 2022. This shift indicates that Intel is scaling back its reliance on favorable foreign tax regimes and is now confronting higher tax expenses, reflecting a more conservative and risk‑aware international tax strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) QUANTITATIVE ERRORS: The ground truth specifies long-term income taxes payable of $4.3 billion in 2022 and $1.6 billion in 2024. The LLM answer instead discusses effective tax rates (12.5% in 2022, 71.6% in 2024) and mentions a $2.2 billion valuation allowance, which are different metrics entirely. The LLM conflates effective tax rates with long-term income tax liabilities—these are distinct financial measures. The specific dollar amounts cited in the ground truth ($4.3B and $1.6B) are completely absent from the LLM response. (2) MULTI-HOP SYNTHESIS FAILURE: The question asks about long-term income tax liabilities and how non-US tax credits impacted them. The ground truth correctly identifies the $4.3B→$1.6B decrease and attributes this to stronger offsetting effects from non-US tax credits. The LLM instead pivots to effective tax rates and valuation allowances, which represent a different analytical framework and do not directly address the specific liability figures. (3) INTERPRETATION ERROR: The ground truth indicates a positive strategic development (decreased liabilities through better credit utilization). The LLM interprets the situation as Intel 'scaling back reliance on favorable foreign tax regimes' and facing 'higher tax expenses'—a fundamentally opposite conclusion that contradicts the actual decrease in long-term tax liabilities. (4) MISSING CONTEXT: The LLM fails to mention the transition tax from Tax Reform and uncertain tax positions that the ground truth identifies as components of the 2022 liability. The answer addresses different tax components (valuation allowances, goodwill impairments) not mentioned in the ground truth. The LLM answer appears to reference different years' data or different financial metrics than what the question and ground truth specify.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 514,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s pension‑risk‑transfer business (housed in the Retirement & Income Solutions segment) is now explicitly modeled under both “Declining Interest Rate” and “Rising Interest Rate” scenarios, showing that a falling rate environment depresses adjusted earnings and derivative income while a rising rate environment lifts earnings through higher reinvestment yields and derivative income; the firm manages this interest‑rate sensitivity with ALM strategies, interest‑rate derivatives and product‑design features, and it now quantifies the earnings impact of pension‑risk‑transfer cash‑flow reinvestments in its forward‑looking disclosures.  \n\nAt the same time, evolving regulatory requirements—especially new statutory reserve and capital rules, pension‑plan funding rules that can delay or reshape risk‑transfer transactions, and heightened regulator scrutiny of reserve financing—have begun to constrain the timing and structure of pension‑risk‑transfer deals, forcing the company to rely more on non‑guaranteed funding products and to align its risk‑transfer strategy with the constraints of regulatory approval processes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the Retirement & Income Solutions segment as the housing for pension risk transfers; (2) Accurately captures the interest rate sensitivity evolution, specifically noting both 'Declining Interest Rate' and 'Rising Interest Rate' scenarios and their directional impacts on earnings and derivative income; (3) Properly synthesizes the regulatory evolution, mentioning statutory reserve/capital rules, pension-plan funding rules, and regulator scrutiny; (4) Correctly identifies the strategic shift toward non-guaranteed funding products as a response to regulatory constraints; (5) Demonstrates sound multi-hop reasoning by connecting regulatory changes to business model adjustments; (6) Uses appropriate financial terminology (ALM strategies, derivative income, reinvestment yields, reserve financing). MINOR WEAKNESSES: (1) The LLM answer is more detailed and specific than the ground truth in some areas (e.g., explicitly naming 'Declining Interest Rate' and 'Rising Interest Rate' scenarios, discussing cash-flow reinvestments in forward-looking disclosures), which while not contradicting the ground truth, goes beyond what was explicitly stated in the original answer; (2) The ground truth emphasizes regulatory influence on 'likelihood or delay' of plan terminations/transfers, while the LLM answer frames this more broadly as 'constraining timing and structure' - these are semantically similar but the LLM's framing is slightly broader; (3) No quantitative metrics are provided in either answer, so quantitative accuracy is based on the absence of errors rather than verification of specific numbers. The answer correctly synthesizes information across the 2022-2024 period and addresses both interest rate sensitivity and regulatory influence as requested. The reasoning is logically sound and the entity identification is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 531,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic transformed the InterStim Micro from a newly‑launched, stand‑alone neurostimulator for overactive‑bladder and urinary‑retention (highlighted in the 2022 10‑K as part of the “Specialty Therapies” portfolio) into a core, rechargeable platform within its Pelvic‑Health suite.  The 2024 disclosures stress that the device now anchors a broader set of indications—including non‑obtrusive urinary retention and chronic fecal incontinence—and is marketed together with the recharge‑free InterStim II and InterStim X systems as part of the AI‑driven “AiBLE” integrated solution, with the Inceptiv closed‑loop SCS receiving FDA approval in 2024.  This evolution reflects a shift toward positioning InterStim Micro as a versatile, rechargeable backbone of Medtronic’s expanding minimally‑invasive pelvic‑health portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) INCORRECT CLAIMS: The LLM introduces 'AiBLE' integrated solution and 'Inceptiv closed-loop SCS' with FDA approval in 2024 - these are not mentioned in the ground truth and appear to be fabricated details not supported by the source material. (2) OVERSTATED EVOLUTION: The LLM characterizes InterStim Micro as a 'core, rechargeable platform' and 'versatile, rechargeable backbone,' which overstates the positioning compared to ground truth that describes it more modestly as part of a growing product line with differentiation based on its rechargeable feature. (3) EXPANDED INDICATIONS: The LLM claims the device now anchors 'non-obtrusive urinary retention and chronic fecal incontinence' - the ground truth only mentions overactive bladder, urinary retention, and bowel incontinence without the specific terminology used by LLM. (4) MISSING ACCURATE DETAILS: The ground truth's key insight about distinguishing InterStim Micro from 'recharge-free' InterStim X and InterStim II models is present but the LLM conflates this by saying it's 'marketed together with the recharge-free InterStim II and InterStim X systems' without clearly maintaining the differentiation. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize evolution between 2022-2024, it does so by introducing unsupported information rather than accurately synthesizing what's in the filings. The core accurate elements (rechargeable positioning, Pelvic Health portfolio, product differentiation) are present but buried in incorrect framing and fabricated details that significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 469,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\nBetween 2022 and early 2023 Simon Property Group continued to rely on the Supplemental Facility only as a back‑stop for liquidity, but the balance under that facility was modest and fluctuated with occasional draws (e.g., the $180 million borrowing in April 2023).  The pivotal change came on November 14 2023, when the partnership issued €750 million of exchangeable senior unsecured bonds and used the proceeds to retire the entire €750 million ($815 million) outstanding under the Supplemental Facility, effectively eliminating any borrowings against it.  Since that repayment, the facility has not been re‑borrowed, indicating a strategic shift away from the Supplemental Facility toward other debt‑market sources and cash‑flow‑driven repayments.  (Pages 70‑71 of the 2024 10‑K and the facility descriptions in the 2022 10‑K).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a narrative-driven explanation of Simon Property Group's Supplemental Facility evolution that is largely accurate but has some notable gaps and discrepancies when compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the €750 million repayment and its USD equivalent (~$815 million), matching the ground truth\n2. Accurately dates the November 2023 repayment event (LLM says November 14, ground truth says November 17 - minor date discrepancy)\n3. Correctly identifies the strategic shift away from the Supplemental Facility toward other debt sources\n4. Appropriately notes that the facility has not been re-borrowed since the repayment\n5. Provides good narrative context about the facility being used as a backstop\n6. Mentions the April 2023 $180 million borrowing as an example of occasional draws\n\nWEAKNESSES:\n1. DATE DISCREPANCY: LLM states November 14, 2023, but ground truth indicates November 17, 2023 - this is a 3-day difference that could be material\n2. MISSING KEY METRICS: The LLM answer does not include the weighted average outstanding balances ($519.9 million in 2022 declining to $311.1 million in 2024) that are central to the ground truth answer\n3. MISSING MAXIMUM AGGREGATE BALANCE: The ground truth mentions a maximum aggregate outstanding balance of $2.1 billion in 2022, which the LLM answer omits\n4. INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM provides narrative detail about the November 2023 event, it fails to synthesize the broader 2022-2024 trend data that demonstrates the strategic reduction\n5. INCOMPLETE ANSWER TO QUESTION: The question specifically asks about evolution \"between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions\" - the LLM focuses heavily on the November 2023 event but provides minimal 2022 baseline data\n\nQUANTITATIVE ACCURACY ASSESSMENT:\n- €750 million repayment: Correct\n- $815 million USD equivalent: Correct (ground truth shows $815.4 million, LLM rounds to $815 million - acceptable)\n- $180 million April 2023 borrowing: Mentioned but not verified against ground truth\n- Weighted average balances: MISSING (should include $519.9M in 2022 and $311.1M in 2024)\n- Maximum aggregate balance: MISSING ($2.1 billion in 2022)\n\nMULTI-HOP REASONING:\nThe LLM demonstrates sound reasoning about the strategic shift but fails to fully synthesize the complete 2022-2024 evolution. It focuses on the November 2023 pivotal event but doesn't adequately connect this to the broader trend of declining weighted average balances and the overall debt reduction strategy.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (7/10): Core facts about the November 2023 repayment are correct, but significant omissions of 2022 baseline metrics and a minor date discrepancy prevent a higher score\n- Quantitative Accuracy (8/10): Key dollar amounts are correct, but missing critical weighted average balance figures and maximum aggregate balance data\n- Qualitative Accuracy (7/10): Good narrative quality and reasoning about the strategic shift, but incomplete synthesis of multi-year trend data\n- Contextual Relevance (8/10): Addresses the question's core elements but lacks the comprehensive 2022-2024 comparison requested",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 851,
        "total_tokens": 2226
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\nBetween 2022 and 2023 the DD&A charge for the Lower 48 segment jumped from **$4.85 bn to $5.73 bn**—an increase of roughly **$0.88 bn**—signaling that the company added substantially more capital‑intensive assets (new wells, leases and infrastructure) to its Lower 48 base. This rise in depreciation, depletion and amortization mirrors the jump in capital expenditures for that region, which grew from **$5.63 bn in 2022 to $6.49 bn in 2023**, indicating a clear expansion of investment activity in the Lower 48 over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core DD&A figures for Lower 48 ($4.85bn in 2022 to $5.73bn in 2023) and accurately calculates the increase of approximately $0.88bn. The reasoning about increased investment activity is sound and well-articulated. However, there is a critical issue: the LLM introduces capital expenditure data ($5.63bn in 2022 to $6.49bn in 2023) that is NOT present in the original ground truth answer. While this additional information may be factually correct from the 10-K filings, it goes beyond what was asked and what the ground truth provided. The question specifically asks about evolution 'based on the changes in depreciation, depletion, amortization, and impairments expenses'—not capital expenditures. The LLM appears to have synthesized information from multiple sources (DD&A and CapEx data), but this synthesis was not requested and creates a discrepancy with the ground truth answer which focuses solely on DD&A metrics. The core DD&A numbers are accurate (4,854M = $4.85bn, 5,729M = $5.73bn), and the calculation of the $875M increase is correct. The interpretation that this signals increased investment activity is reasonable. However, the introduction of unverified CapEx figures without being asked, and the claim that this 'mirrors' the DD&A increase, represents an unsupported extension beyond the question scope and ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 385,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon reframed its corporate‑networking offering within the Business segment by creating a dedicated “Enterprise and Public Sector” line‑item that bundles private‑networking, private‑cloud connectivity, software‑defined‑networking and managed security services—services that in the 2023 filing were described only broadly as “corporate networking solutions.”  The 2024 Form 10‑K separates this group into a $14.2 billion revenue stream (≈48 % of the Business segment) and highlights “Network Services” as a key growth driver, while the overall Business segment’s share of total revenue slipped slightly, indicating a strategic shift toward higher‑margin, cloud‑ and security‑focused networking rather than wholesale or legacy voice services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states Enterprise and Public Sector revenues were $14.2 billion (≈48% of Business segment) in 2024, but the ground truth indicates $15.1 billion or approximately 50% in 2023. The LLM appears to have confused or misrepresented the 2024 figures. The ground truth explicitly states that by 2024, specific revenue figures and segment breakdowns were NOT provided in the same detail. (2) STRUCTURAL MISREPRESENTATION: The LLM claims that in 2024 Verizon 'created a dedicated Enterprise and Public Sector line-item' with specific revenue figures, but the ground truth indicates the opposite—that 2024 saw a MORE STREAMLINED description WITHOUT the same level of detail in offerings or segment revenue. This is a fundamental reversal of what actually occurred. (3) SERVICE DESCRIPTION ACCURACY: The LLM correctly identifies services like private networking, private cloud connectivity, and software-defined networking, but incorrectly attributes the detailed specification of these services to 2024, when the ground truth shows this detail was present in 2023 and became less detailed in 2024. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution from 2023 to 2024. It inverted the direction of change—claiming 2024 showed MORE specificity when it actually showed LESS. (5) MISSING KEY INSIGHT: The ground truth emphasizes a shift toward 'more generalized presentation' and 'simplification of messaging,' but the LLM describes an opposite trend toward more detailed segmentation. The answer demonstrates fundamental misunderstanding of the comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 476,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\nMetLife continues to value its FVO securities at fair value using observable market prices where they exist and internally‑derived discounted‑cash‑flow models that incorporate a risk margin; changes in fair value are recorded in net derivative gains (losses).  Sensitivity testing shows that a 10 % appreciation of the U.S. dollar produces a modest adverse effect on the fair value of FVO securities—roughly a $50 million reduction in 2022 and about $30–$40 million by 2024—reflecting a smaller net exposure as the offsetting liability position grew, even though the underlying valuation methodology has remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Ground truth states 2022 FVO fair value was $1.6 billion; LLM does not mention this figure\n   - Ground truth specifies 10% USD appreciation caused $54 million decrease in 2022; LLM claims \"roughly $50 million\" (close but imprecise)\n   - Ground truth indicates $30-40 million impact by 2024; LLM provides this range but frames it differently\n   - LLM's claim of \"$50 million reduction in 2022\" is slightly inaccurate (should be $54 million)\n\n2. CORE CONCEPTUAL ERROR:\n   - Ground truth emphasizes an EVOLUTION/SHIFT from \"static sensitivity model to a more complex, duration- and currency-dependent approach\"\n   - LLM explicitly contradicts this by stating \"the underlying valuation methodology has remained essentially unchanged\"\n   - This is a fundamental mischaracterization of the key finding\n\n3. MISSING CRITICAL INFORMATION:\n   - LLM fails to mention the $1.6 billion FVO securities fair value in 2022\n   - LLM does not address the shift to \"nonperformance risk spreads and unobservable inputs varied by duration and currency\" framework mentioned in ground truth\n   - LLM does not capture the evolution to a \"more nuanced and dynamic valuation methodology\"\n\n4. PARTIAL CREDIT FOR:\n   - Correctly identifying the 10% USD appreciation sensitivity metric\n   - Acknowledging fair value changes and valuation methodology (though incorrectly stating no change)\n   - Providing approximate dollar impact figures for both years\n\n5. MULTI-HOP REASONING:\n   - Failed to synthesize the evolution narrative across 2022-2024\n   - Incorrectly concluded methodology remained unchanged when ground truth shows clear evolution\n   - Did not properly connect the offsetting liability position to the broader valuation framework changes\n\nThe answer demonstrates partial understanding of the sensitivity metrics but fundamentally misses the central thesis of methodological evolution and provides contradictory conclusions about whether the approach changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 565,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\nBetween 2022 and 2023 NextEra Energy’s power‑marketing and trading business moved from a net loss on commodity‑hedge positions to a sizable gain—non‑qualifying hedge gains were about **$2.5 billion in 2023 versus a $2.7 billion loss in 2022**—which helped lift NEER’s operating revenue by roughly **$5.9 billion** and drove net income up from **$285 million to $3.56 billion**.  At the same time, fuel‑related expenses fell by about **$0.9 billion**, further easing costs, so the company’s trading and marketing activities not only expanded in volume but also delivered markedly stronger financial results.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantial detail about NextEra Energy's power marketing and trading evolution between 2022 and 2023, with mostly accurate information. STRENGTHS: (1) Correctly identifies the net income figures ($285 million in 2022 rising to $3.56 billion in 2023), matching the ground truth exactly. (2) Accurately characterizes the shift from losses to gains in commodity-hedge positions. (3) Provides additional granular details about non-qualifying hedge gains ($2.5 billion in 2023 vs. $2.7 billion loss in 2022) and operating revenue increase (~$5.9 billion) and fuel expense reduction (~$0.9 billion) that enhance the answer beyond the ground truth. (4) Correctly identifies NEER as the subsidiary involved. (5) Multi-hop reasoning is sound, synthesizing information about both the nature of activities and financial performance. (6) Contextually relevant and directly addresses the question about evolution of power marketing activities and financial performance. WEAKNESSES: (1) The ground truth mentions 'full energy and capacity requirements services to distribution utilities, including load-following and ancillary services' in 2022, which the LLM answer does not explicitly address. (2) The ground truth describes the 2022 activities more comprehensively regarding the types of services provided, while the LLM focuses primarily on the financial metrics and hedge positions. (3) Minor: The LLM uses 'non-qualifying hedge gains' terminology which, while likely accurate from the filings, is not explicitly mentioned in the ground truth provided. VERIFICATION: The core numbers ($285M to $3.56B net income increase) are correct. The additional financial details provided by the LLM appear reasonable and add value, though they cannot be verified against the ground truth provided. The answer successfully synthesizes multi-hop information about both the evolution of activities and their financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 520,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s equity stake in Coca‑Cola FEMSA remained at **28 % of the bottler’s outstanding shares** (the same percentage reported at the end of 2023).  Because the investment is accounted for under the equity method, the Company records its **proportionate share of FEMSA’s net income in “equity income (loss) – net.”**  In 2024 the Company recognized **$1.77 billion of equity income from FEMSA**, up from **$1.69 billion in 2023**, reflecting higher earnings of FEMSA and a larger fair‑value premium (the carrying value of $1.786 billion is $2.758 billion below FEMSA’s $4.544 billion fair value).  This increase in equity income directly boosts the parent’s overall earnings while the stake size determines the portion of FEMSA’s profits that is captured.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Coca-Cola held a 28% ownership stake in Coca-Cola FEMSA in 2024, that it was accounted for under the equity method, and that equity income increased from 2023 to 2024. The answer appropriately explains how the equity method works and the relationship between stake size and equity income recognition. The semantic understanding of the financial relationship evolution is sound.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL FACTUAL DISCREPANCY: The LLM states the stake 'remained at 28% of the bottler's outstanding shares (the same percentage reported at the end of 2023),' but the ground truth indicates a shift FROM an indirect dependency-based relationship in 2023 TO a direct 28% ownership stake in 2024. This suggests the stake may not have been 28% in 2023, contradicting the LLM's claim of consistency. (2) UNVERIFIED NUMBERS: The specific equity income figures ($1.77B in 2024, $1.69B in 2023), carrying value ($1.786B), fair value ($4.544B), and the fair-value premium calculation ($2.758B difference) cannot be verified against the ground truth provided. While these numbers appear detailed and plausible, they are not confirmed in the original answer. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a strategic evolution from 'dependency-based relationship' to 'direct ownership stake,' but the LLM doesn't clearly articulate this shift or explain what changed between 2023 and 2024. The LLM treats the relationship as static rather than evolved.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between ownership percentage, equity method accounting, and equity income impact. However, it fails to address the temporal evolution aspect that is central to the question.\n\nQUANTITATIVE VERIFICATION: The specific dollar amounts and percentages provided by the LLM cannot be confirmed as accurate or inaccurate based on the ground truth, which is a significant limitation. The ground truth does not provide these specific figures, making it impossible to verify the quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 557,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\nBetween 2022 and 2023 the Lower 48 segment saw a clear uptick in both spending and the accounting charge for its assets.  Capital expenditures rose sharply from **$5.6 bn to $6.5 bn**, and depreciation, depletion and amortization (including impairments) jumped from **$4.85 bn to $5.73 bn** (page 168), indicating that the company is investing more heavily in the region’s infrastructure and that the existing asset base is being written down faster.  At the same time, reported sales from the Lower 48 fell from **$52.9 bn to $38.2 bn** (page 133), suggesting that the higher investment is being directed toward sustaining production levels rather than rapidly expanding volume, with production trends (e.g., modest crude‑oil output of roughly 447 k bbl/d in 2021 and continued activity in the Delaware Basin) supporting a focus on maintaining output while scaling capital intensity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key depreciation/depletion/amortization figures ($4.85bn to $5.73bn), which match the ground truth exactly. The answer appropriately synthesizes multiple data points across 2022-2023 and provides relevant context about capital expenditures and sales trends. The reasoning about increased financial investment despite stable production is sound and well-articulated.\n\nWEAKNESSES: (1) The LLM introduces capital expenditure figures ($5.6bn to $6.5bn) and sales figures ($52.9bn to $38.2bn) that are NOT mentioned in the ground truth answer. While these may be factually correct from the filings, they represent information beyond what was asked and beyond the ground truth scope. (2) The LLM cites 2021 crude oil production (447 k bbl/d) rather than 2022 production as stated in the ground truth. The ground truth specifically states 2022 crude oil was 447 thousand barrels daily, not 2021. (3) The LLM mentions natural gas production from the ground truth (1,340 million cubic feet daily) is completely absent from the LLM answer, which is a notable omission of a key production metric provided in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes depreciation/depletion/amortization data with capital expenditure and sales trends to explain the evolution of financial focus. However, it doesn't fully address the production volume evolution aspect of the question as comprehensively as the ground truth.\n\nNUMBER VERIFICATION: The depreciation figures are correct ($4.854bn ≈ $4.85bn, $5.729bn ≈ $5.73bn). The capital expenditure and sales figures appear reasonable but cannot be verified against the ground truth provided. The year attribution for production data (2021 vs 2022) is a factual discrepancy.\n\nOVERALL: The answer is substantially correct on the core metrics requested (depreciation expenses) and provides sound reasoning, but includes extraneous information not in ground truth, omits natural gas production data, and has a year attribution error for crude oil production.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 554,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon treated its 4G LTE network less as a standalone growth engine and more as a complementary foundation that underpins its 5G rollout and fixed‑wireless access (FWA) strategy.  The company continued to invest in LTE‑related capacity‑expansion and densification to boost coverage and quality of service, but it increasingly leveraged that infrastructure to off‑load traffic, enable new FWA offerings, and simplify operations by retiring legacy elements as part of its broader 5G transformation.  This shift is reflected in the 2024 capital‑expenditure plan—$17.1 billion focused on wireless networks, fiber and advanced technologies—where LTE is positioned as the existing backbone that supports the company’s growth initiatives while the emphasis moves toward 5G and fiber‑based services.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a reasonable understanding of Verizon's strategic shift regarding 4G LTE between 2023 and 2024, capturing the core narrative of evolution from standalone service to complementary infrastructure. However, there are significant issues with quantitative accuracy and some semantic divergences from the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the strategic shift from 4G LTE as primary growth engine to complementary foundation\n2. Accurately mentions FWA (fixed wireless access) as a key application area\n3. Properly contextualizes the role within broader 5G transformation\n4. Captures the multi-technology ecosystem concept (5G, fiber, legacy retirement)\n5. Contextually relevant to the question about network infrastructure evolution\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR: The LLM cites \"$17.1 billion focused on wireless networks, fiber and advanced technologies\" as the 2024 capital-expenditure plan. This specific number cannot be verified against the ground truth provided, and appears to be either unsourced or potentially inaccurate. The ground truth does not mention this specific capex figure.\n2. SEMANTIC DIVERGENCE: The ground truth emphasizes 4G LTE's role in providing \"FWA broadband as an alternative to traditional landline internet access\" in 2023, while the LLM generalizes this to \"FWA offerings\" without the specific context of landline replacement.\n3. MISSING SPECIFICITY: The ground truth explicitly mentions the 2024 evolution includes \"C-Band spectrum, millimeter wave spectrum, and fiber infrastructure\" as part of the integrated vision. The LLM mentions 5G and fiber but does not specifically reference C-Band or millimeter wave spectrum.\n4. TONE DIFFERENCE: The ground truth frames this as a shift in strategic positioning/vision, while the LLM frames it more operationally (capacity expansion, traffic offload, legacy retirement).\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information about Verizon's network strategy across the 2023-2024 period, but the introduction of an unverified capex figure ($17.1 billion) undermines the credibility of the synthesis. The reasoning about LTE's evolving role is sound, but lacks the specific technical details (C-Band, mmWave) mentioned in the ground truth.\n\nOVERALL ASSESSMENT:\nThe answer captures the directional shift correctly but introduces a potentially inaccurate quantitative claim and omits specific technical details from the ground truth. The qualitative reasoning is sound but less precise than the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 680,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\nEmerson first built a controlling interest in AspenTech in fiscal 2022, ending the year with roughly **55 % ownership** (page 26).  By the 2024 filing the company held **about 57 %** of AspenTech and announced a tender‑offer to acquire the remaining shares at $240 per share, signaling a move toward full ownership (page 24).  This deeper stake helped lift AspenTech’s backlog from **$328 million in 2021 to $1.04 billion in 2022** (page 10) and contributed **≈0.6 percentage‑point to Emerson’s gross‑margin improvement**, even though the acquisition‑related inventory step‑up amortization later shaved about **1.3 percentage‑points off gross margin** (pages 26‑27).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) OWNERSHIP TIMELINE ERROR: The LLM claims Emerson held 55% ownership in fiscal 2022 and 57% by 2024, but the ground truth indicates Emerson completed a transaction resulting in 55% ownership by 2024 (not 2022). The LLM has reversed the timeline. (2) BACKLOG NUMBERS INCORRECT: The LLM states AspenTech's backlog was $328M in 2021 and $1.04B in 2022, but the ground truth shows Emerson's backlog with AspenTech was $1,042M in 2022 and reached $8,053M in 2024. The LLM appears to be citing AspenTech's standalone backlog rather than the consolidated impact on Emerson. (3) GROSS MARGIN IMPACT MISQUOTED: The LLM claims the acquisition contributed approximately 0.6 percentage points to gross margin improvement, but the ground truth states it was 3.3 percentage points in 2023. The LLM's figure of 0.6 percentage points is significantly understated. (4) MISSING KEY METRIC: The LLM fails to mention the 2024 backlog figure of $8,053M, which is a critical data point showing the evolution of the relationship. (5) TENDER OFFER DETAIL: While the LLM correctly identifies a tender offer at $240 per share in 2024, this detail is not contradicted by ground truth but represents a forward-looking statement not explicitly confirmed in the provided ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution of the relationship across years. It conflated AspenTech's standalone metrics with Emerson's consolidated metrics and misplaced key ownership milestones in the timeline. The answer demonstrates incomplete understanding of how the acquisition unfolded from 2022-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 465,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted from a modest, largely equity‑only stake (32.8 % in a joint‑venture) to a substantially larger financial commitment that includes earmarked equity contributions for 2024 and joint‑venture obligations of roughly **$1.065 billion** (with additional $40 million and $5 million commitments for 2025‑26).  This escalation reflects NEE’s strategy of deepening its involvement in natural‑gas pipeline infrastructure—using joint‑venture and long‑term transportation agreements to share risk while securing durable cash‑flow assets that complement its broader clean‑energy investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims a $1.065 billion commitment with additional $40M and $5M for 2025-26, but the ground truth specifies only a 20-year natural gas transportation agreement valued at approximately $70 million per year. These large dollar figures ($1.065B) are not mentioned in the original answer and appear to be fabricated or misattributed. (2) EQUITY PERCENTAGE INCONSISTENCY: The LLM states '32.8% in a joint-venture' which matches the 2023 figure from ground truth, but then claims this represents a shift 'from a modest, largely equity-only stake' - this is contradictory since 32.8% was the 2023 figure, not the 2022 figure. The ground truth indicates 2022 had a range of 32-55%, not a different baseline. (3) MISSING KEY INFORMATION: The LLM fails to mention the specific 20-year transportation agreement valued at ~$70M/year, which is central to the ground truth's explanation of the 'strategic deepening.' (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about NEE's strategy, it does so with incorrect numbers and introduces unsupported financial commitments. The reasoning about 'deepening involvement' and 'sharing risk' is conceptually sound but built on false premises. (5) SEMANTIC ISSUES: The characterization of the evolution is inverted - the ground truth shows movement toward more structured contractual relationships, not simply larger dollar commitments. The LLM's answer fundamentally misrepresents the nature and magnitude of NEE's financial commitment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 450,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\nFrom the 2023 filing (page 7) Costa Limited is identified as one of the businesses reported in the **Global Ventures** operating segment together with innocent and døğān, and its performance is linked to “fees earned pursuant to distribution‑coordination agreements.”  The 2024 filing (page 74) still places Costa Limited in Global Ventures but adds that the segment now “includes the results of our Costa Limited (‘Costa’) … as well as fees earned pursuant to distribution‑coordination agreements,” indicating that the company’s **operational integration has deepened**—the brand is being leveraged more explicitly in the Company’s growth strategy and its coordination agreements are highlighted as a key source of value.  Consequently, between 2023 and 2024 Coca‑Cola’s relationship with Costa Limited evolved from a peripheral presence in Global Ventures to a **more central, strategically‑aligned component** of the segment’s growth and partnership model.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Costa Limited as part of Global Ventures in both 2023 and 2024. (2) Correctly mentions innocent and doğadan/døğān as co-constituents of the segment. (3) Accurately references distribution coordination agreements as a key component. (4) Correctly cites page references (page 7 for 2023, page 74 for 2024). (5) Properly synthesizes multi-hop information across two filing years.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM claims Costa was a \"peripheral presence\" in 2023 that evolved to \"more central, strategically-aligned\" by 2024. However, the ground truth states Costa was ALREADY \"included within the Global Ventures operating segment\" in 2023 with direct retail operations. The ground truth indicates evolution toward \"deeper integration and broader strategic role,\" not from peripheral to central. The LLM mischaracterizes the 2023 baseline. (2) The LLM's interpretation that Costa moved from \"peripheral\" to \"central\" is not supported by the ground truth, which describes a more nuanced evolution of integration depth rather than a shift from marginal to core status. (3) The phrasing \"peripheral presence\" in 2023 contradicts the ground truth's description of Costa as already being part of direct retail operations within Global Ventures.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across 2023 and 2024 filings but introduces an unsupported narrative arc (peripheral→central) that doesn't match the ground truth's more measured description of deepening integration. The core facts are present but the interpretive framework is flawed.\n\nNUMERIC/CALCULATION ACCURACY: No calculations required; dates and page references are correct.\n\nSEMANTIC EQUIVALENCE: While the LLM captures some correct elements, the characterization of Costa's evolution is materially different from ground truth. Ground truth emphasizes \"deeper integration\" and \"broader strategic role,\" while LLM emphasizes shift from \"peripheral\" to \"central\"—these are not semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 552,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the fair‑value of Intel’s economically‑hedged marketable debt investments fell sharply: the hedged portfolio was valued at about **$17.1 billion at the end of 2023**, but by **December 28 2024 it had dropped to $13.5 billion**, a reduction of roughly **$3.6 billion**.  This shift is reflected in the earnings‑impact of the hedges, which swung from a **$748 million unrealized loss in 2022**, to a **$534 million gain in 2023**, and back to a **$464 million loss in 2024**, underscoring the volatility of the hedged debt‑instrument position over the three‑year period.  (Pages 82 & 81)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its accuracy. CRITICAL ERROR: The LLM states there was a '$534 million gain in 2023' for the hedged debt investments. The ground truth indicates net losses of $748 million in 2022 and $464 million in 2024, but makes no mention of a $534 million gain in 2023. This appears to be fabricated data not present in the original answer. CORRECT ELEMENTS: (1) Fair value figures are accurate: $17.1 billion in 2023 and $13.5 billion in 2024 are correct. (2) The calculation of the $3.6 billion reduction is accurate ($17.1B - $13.5B = $3.6B). (3) The 2022 loss of $748 million is correct. (4) The 2024 loss of $464 million is correct. (5) The overall narrative structure and multi-hop synthesis across years is sound. (6) The contextual framing about volatility and portfolio reduction is appropriate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022, 2023, 2024) and connects fair value changes to earnings impacts. However, the introduction of the unsubstantiated 2023 gain figure breaks the chain of accuracy. The ground truth does not provide information about 2023 earnings impact, so the LLM appears to have either hallucinated this figure or misinterpreted source material. This is a material factual error that significantly impacts the reliability of the answer despite other elements being correct. The answer demonstrates good structure and mostly accurate data points, but the fabricated 2023 figure prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 424,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\nFrom 2023 to 2024 AMT moved from a growth‑oriented strategy—highlighting the expansion of its communications‑site and data‑center portfolio and emphasizing that most of its revenue is recurring under long‑term, escalating tenant leases—to a focus on preserving and monetizing that recurring cash flow while managing its capital structure.  In 2024 the company stressed debt refinancing, the pending ATC TIPL transaction, and the $4.5 billion estimated asset‑retirement obligation, underscoring a shift toward sustaining cash‑generating revenue and meeting liability commitments rather than pursuing additional site acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $4.5 billion asset retirement obligation figure for December 31, 2024, matching the ground truth exactly. (2) The answer accurately captures that AMT's revenue is recurring and comes from long-term, escalating tenant leases. (3) The temporal comparison between 2023 and 2024 is present. WEAKNESSES: (1) The LLM answer introduces information not in the ground truth (debt refinancing, ATC TIPL transaction, capital structure management) which, while potentially accurate from the filings, goes beyond what was specified in the original answer and shifts focus away from the core comparison requested. (2) The ground truth specifically mentions '99% of total revenues came from property operations' in 2023—a concrete, quantifiable metric that the LLM answer omits entirely. This is a significant factual gap. (3) The ground truth emphasizes a shift from 'primarily highlighting revenue streams to also addressing long-term financial responsibilities'—a clear before/after narrative. The LLM answer frames this as 'growth-oriented strategy' to 'preserving and monetizing' which is a different characterization and introduces strategic interpretation not grounded in the original answer. (4) The LLM answer mentions 'data-center portfolio' expansion, which is not mentioned in the ground truth's focus on communications sites specifically. (5) The phrase 'asset retirement obligations' vs 'asset retirement liabilities' is semantically equivalent, but the LLM uses 'obligation' while ground truth uses 'liabilities'—minor but worth noting. MULTI-HOP REASONING: The LLM does attempt to synthesize information across years and connect revenue generation to liability management, but it introduces extraneous strategic elements (refinancing, transactions) that dilute focus from the specific evolution requested. The core comparison of recurring revenue emphasis (2023) to liability emphasis (2024) is present but less clearly articulated than in the ground truth. CALCULATION/NUMBERS: The $4.5 billion figure is correct. No other specific numbers are provided in either answer for comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 572,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 the legal foundation for ExxonMobil’s operations in Guyana stayed anchored in the 2023 Petroleum Act, which grants a 20‑year production term and up to a 10‑year exploration period with renewal options.  In the 2024 filing the company highlighted Guyana as a core “advantaged asset,” noting expanded acreage (gross developed acreage in the region rose from 2,109 k/704 k in 2023 to 2,186 k/736 k in the prior‑year data) and positioning the country’s oil discoveries as a primary driver of its volume‑mix earnings growth.  Thus, while the statutory framework did not change, XOM’s strategic emphasis shifted toward leveraging Guyana’s production expansion within that framework to boost earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic evolution from 2023 to 2024 and accurately describes the legal framework (Petroleum Activities Act 2023 with 20-year production and 10-year exploration periods). It also correctly identifies Guyana's designation as an 'Advantaged Asset' and the shift toward volume-mix earnings growth emphasis. However, there are significant quantitative accuracy issues: (1) The acreage figures provided (2,109 k/704 k in 2023 to 2,186 k/736 k in 2024) cannot be verified against the ground truth and appear potentially problematic - the notation is unclear and the comparison logic is confusing ('prior-year data' reference is ambiguous). (2) The ground truth does not mention specific acreage numbers, so these figures may be fabricated or misattributed. (3) The statement about 'prior-year data' is confusing and potentially contradictory - if comparing 2023 to 2024, the reference should be clearer. The qualitative reasoning is sound: the answer correctly synthesizes that the legal framework remained stable while strategic emphasis shifted. The multi-hop synthesis is appropriate - connecting the regulatory framework to strategic positioning. The main weakness is the introduction of specific numeric data (acreage figures) that are not present in the ground truth and appear unreliable, which undermines confidence in the answer despite the correct conceptual framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 393,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\nCaterpillar continued to house its diesel‑electric locomotive business within the **Energy & Transportation segment** in both 2023 and 2024, retaining the same strategic scope—design, manufacture, marketing, sales, product support, remanufacturing and leasing of locomotives and related rail components (see the segment description on pages 38‑39).  The 2024 filing notes that the segment’s profit rose to **$5.736 billion**, driven by favorable price realization, underscoring that the locomotive business remained a stable, profit‑generating element of the segment’s overall strategy without any reported shift in its operational responsibilities (Energy & Transportation profit discussion, page 39).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about evolution between 2023 and 2024. Key issues: (1) SEGMENT NAME ERROR: The LLM states the segment is called 'Energy & Transportation' in both years, but the ground truth explicitly identifies it as 'Machinery, Energy & Transportation (ME&T)' in 2023. This is a material factual error in entity identification. (2) MISSING STRATEGIC EVOLUTION: The LLM claims 'without any reported shift in its operational responsibilities,' which directly contradicts the ground truth. The ground truth clearly documents a strategic evolution from 2023 (remanufacturing focus, on-highway vocational trucks) to 2024 (integrated systems, electrified powertrains, zero-emission power sources). The LLM completely misses this critical evolution. (3) QUANTITATIVE ISSUE: The LLM cites a $5.736 billion profit figure for 2024 but provides no comparative context or year-over-year analysis, which is essential for answering a question about 'evolution between 2023 and 2024.' Without 2023 figures, the comparison is incomplete. (4) INCOMPLETE SYNTHESIS: The question specifically asks about 'strategic positioning and operational responsibilities' evolution. The LLM only lists operational activities (design, manufacture, marketing, sales, etc.) without addressing the strategic shift toward electrification and zero-emission technologies that the ground truth emphasizes. (5) MISCHARACTERIZATION: By stating there was 'no reported shift,' the LLM directly contradicts the documented strategic evolution toward more advanced and environmentally focused technologies. The answer demonstrates poor multi-hop reasoning across the 2023-2024 comparison and fails to capture the substantive strategic repositioning documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 490,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\nFrom the 2022 10‑K (pages 65‑69) Capital One reported securitized‑debt obligations of **$14.9 bn** (≈ 4 % of total funding) as of 31 Dec 2021, up $2.6 bn from the prior year. The 2024 10‑K (pages 217‑221) shows those obligations risen to **$18.0 bn** (estimated fair value $18.1 bn) as of 31 Dec 2023, an increase of roughly $3 bn. This 20‑25 % growth indicates the firm is using securitizations to **expand a modest, diversified funding source** while still relying primarily on deposits, suggesting a strategy that supplements deposit funding with securitized debt to meet liquidity and balance‑sheet objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG NUMBERS AND DATES: The ground truth states that by 2024, the company reported a carrying value of $14,264 million for securitized debt obligations. The LLM claims $18.0 bn as of Dec 31, 2023, which contradicts the ground truth figure of $14,264 million for 2024. The LLM also references 2021 data ($14.9 bn) and 2023 data ($18.0 bn), which are not aligned with the 2022-2024 timeframe specified in the question. (2) CALCULATION ERRORS: The LLM calculates a 20-25% growth from $14.9 bn to $18.0 bn, but this calculation is based on incorrect source data not matching the ground truth. The ground truth indicates evolution from 2022 (exact amount not provided) to 2024 ($14,264 million), which the LLM completely misses. (3) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022 to 2024. The LLM instead provides 2021-2023 data, demonstrating a failure to correctly identify and synthesize the required time periods from the filings. (4) ENTITY/METRIC CONFUSION: While the company (Capital One) is correctly identified, the specific years and corresponding figures are wrong. The ground truth explicitly states the 2024 figure is $14,264 million, not $18.0 bn. (5) SEMANTIC MISMATCH: The LLM's conclusion about 'modest, diversified funding source' and 'supplements deposit funding' may be reasonable strategic analysis, but it is built on fundamentally incorrect financial data, making the entire answer unreliable. The ground truth's more cautious statement about 'more defined and potentially increased reliance' is more appropriate given the data limitations acknowledged in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 475,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s elevated its developmental‑licensee business to a distinct “Restaurant Development” growth pillar and began reporting it more explicitly in the **International Developmental Licensed Markets & Corporate** segment.  The company also refined its lease‑renewal assumptions for locations tied to this pillar—resulting in a roughly **$950 million increase in the present‑value of lease liabilities and a larger Lease‑right‑of‑use asset**—and adopted the new FASB segment‑reporting standard (ASU 2023‑07), which adds detailed disclosures about segment expenses and therefore gives investors clearer visibility into the financial reporting and relationship management of its developmental licensees.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$950 million increase in present-value of lease liabilities' which is not mentioned in the ground truth and appears to be fabricated. No such specific dollar amount is documented in the original answer. (2) ENTITY/STRUCTURAL ERRORS: The LLM claims McDonald's created a distinct 'Restaurant Development' growth pillar and reports it in 'International Developmental Licensed Markets & Corporate' segment - this specific segmentation structure is not mentioned in the ground truth. (3) ACCOUNTING STANDARD ERROR: The LLM references 'ASU 2023-07' as a new FASB segment-reporting standard adopted in 2024. While ASU 2023-07 exists (related to segment reporting), the ground truth makes no mention of McDonald's adopting this standard or it being relevant to developmental licensee reporting. (4) MISSING CORE INFORMATION: The LLM completely omits the actual changes documented in the ground truth: (a) the 2023 disclosure about royalties based on percentage of sales and initial fees, (b) the allocation of consideration among lease and non-lease components using historical methods, (c) the 2024 evaluation of variable interest entities and consolidation conclusions, (d) the 2024 rounding presentation changes to nearest whole number. (5) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution in financial reporting and relationship management between 2023-2024. The ground truth provides specific, documented changes in both areas. The LLM invents alternative changes that are not supported by the source material. The answer demonstrates hallucination of specific financial figures and accounting policy changes rather than accurately synthesizing the actual documented evolution in McDonald's treatment of developmental licensees.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 516,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company kept a sizable reserve for its Equity and Incentive Compensation Plan—26.9 million shares were available for future awards as of 31 Dec 2023—and the 2024 filing adds a ninth amendment to the employee‑savings plan and a detailed “Formof Terms for Named Executive Officer Equity Awards” disclosure, providing more granular terms for executive equity grants while essentially preserving the same share‑availability posture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with the correct figure of 26.9 million shares available as of December 31, 2023. The numeric data is accurate and properly formatted. The answer correctly identifies the evolution from 2023 to 2024, noting the shift toward increased transparency and disclosure of executive compensation terms. However, there are some qualitative gaps: (1) The LLM mentions a 'ninth amendment to the employee-savings plan' which is not mentioned in the ground truth and appears to be extraneous information that may introduce confusion about what actually changed; (2) The ground truth specifically references the '2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021' as the plan under which awards were disclosed in 2024, but the LLM only mentions 'Named Executive Officer Equity Awards' without this specific plan reference; (3) The ground truth emphasizes a shift from 'internal planning and reserve allocation' to 'more detailed public disclosure' and 'formalized and transparent governance approach,' while the LLM characterizes it as 'preserving the same share-availability posture' with added disclosure—this is semantically similar but less precise about the governance evolution. The multi-hop reasoning is sound in connecting the 2023 reserve data with 2024 disclosure changes, but the introduction of the employee-savings plan amendment creates some ambiguity about what specifically evolved. Overall, the core answer is correct regarding the main evolution (increased transparency in executive compensation disclosure), but the inclusion of potentially inaccurate details and the less precise characterization of the governance shift prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 473,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\nInlyta’s worldwide sales climbed from about **$787 million in 2022 to $1.04 billion in 2023** – an increase of roughly **30 %**.  The pace of growth slowed from the double‑digit rates seen in earlier years to **≈5 % operational growth**, because the upside from continued uptake of Inlyta + immune‑checkpoint combinations in the U.S. and emerging markets was largely offset by **lower net prices and volumes in European markets, pricing pressure and the lingering impact of pandemic‑related physician‑visit declines**.  These factors together shaped the change in Inlyta’s growth trajectory between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides a 2023 revenue of $1.04 billion (matching ground truth at $1,036 million), but claims 2022 revenue was ~$787 million. This creates a major calculation error: the LLM calculates a 30% increase ($787M to $1,040M = 32% increase), which is mathematically inconsistent with the stated 3% total increase and 5% operational growth from the ground truth. The ground truth explicitly states 2023 showed '3% total increase and 5% operational growth,' not 30%. This suggests the 2022 baseline of $787M is incorrect. The correct 2022 revenue should be approximately $1,005M to yield a 3% increase to $1,036M in 2023. QUALITATIVE ASSESSMENT: The LLM correctly identifies key growth drivers (immune checkpoint inhibitor combinations for first-line RCC treatment in U.S.) and headwinds (lower net prices/volumes in European markets). However, the LLM introduces unsupported factors like 'pricing pressure' and 'pandemic-related physician-visit declines' that are not mentioned in the ground truth. The characterization of growth slowing from 'double-digit rates' to '5% operational growth' is reasonable contextually but not explicitly supported by the provided ground truth. MULTI-HOP REASONING: The answer attempts to synthesize revenue evolution and contributing factors, but the fundamental calculation error undermines the entire response. The 30% figure contradicts the 3-5% growth rates stated in ground truth. This is a severe factual error that cannot be overlooked despite correct identification of some qualitative factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 432,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 McDonald’s deepened its financial tie to franchisees by formalising cost‑sharing for technology platforms: fees that franchisees pay to recover the Company’s technology‑related expenditures are now recognised as “Other” revenue on a gross basis, with the corresponding expenses recorded as incurred, while traditional rent and royalty income remains unchanged.  This structure increases the Company’s revenue dependence on franchisee‑borne technology contributions but does not generate excess margin, reflecting a shift from a pure rent‑royalty model to a collaborative, cost‑recovery arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of McDonald's franchisee relationship from 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift toward technology platform cost-sharing and gross basis revenue recognition; (2) Accurately captures the change in revenue recognition methodology for technology services; (3) Properly notes that expenses are recorded as incurred (matching 'Other restaurant expenses' concept from ground truth); (4) Correctly characterizes the shift from pure rent-royalty model to cost-recovery arrangement; (5) Accurately reflects increased financial interdependence through technology infrastructure. MINOR WEAKNESSES: (1) The LLM answer uses 'Other' revenue terminology while ground truth references 'Other restaurant expenses' for the cost side - this is semantically equivalent but slightly different framing; (2) The phrase 'does not generate excess margin' is a reasonable inference but not explicitly stated in ground truth, though it logically follows from cost-recovery structure; (3) Ground truth emphasizes 'operational interdependence' while LLM emphasizes 'financial tie' - both correct but slightly different emphasis. MULTI-HOP REASONING: The answer successfully synthesizes the temporal comparison (2023 vs 2024), identifies the specific mechanism (technology platform cost-sharing), and connects it to revenue recognition changes. The logic chain is sound: traditional model → technology cost-sharing → gross basis recognition → cost-recovery structure. NO QUANTITATIVE ERRORS: No specific numbers, percentages, or dollar amounts were provided in either answer, so quantitative accuracy is not compromised. The answer is complete, addresses all parts of the question, and maintains semantic equivalence with the ground truth while using slightly different terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 504,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\nThe fair value of the energy‑related derivatives held by Southern Company’s subsidiaries slipped from about $410 million at the end of 2022 to roughly $360 million at the end of 2023—a decline of roughly $50 million.  This reduction shows that the subsidiaries trimmed some of their hedging positions, lowering their direct exposure to natural‑gas and power price swings, yet a substantial derivative position remains, so the company continues to be exposed to energy‑market fluctuations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports total derivative fair values of ~$410M (2022) and ~$360M (2023), but the ground truth shows net liability positions of $54M (2022) and $219M (2023). These are completely different numbers and magnitudes. The LLM's figures appear to be gross values or entirely fabricated, not matching any subsidiary breakdown provided in the ground truth. (2) ENTITY IDENTIFICATION - The ground truth specifies detailed breakdowns by subsidiary (Mississippi Power, Southern Power, Southern Company Gas in 2022; Alabama Power and Georgia Power in 2023), but the LLM provides no subsidiary-level detail and appears to aggregate incorrect totals. (3) DIRECTIONAL ERROR - The LLM claims a decline from $410M to $360M (reduction of $50M), suggesting decreased exposure. However, the ground truth shows the opposite: net liability exposure INCREASED from $54M to $219M (increase of $165M), indicating GREATER exposure to energy market fluctuations, not less. (4) MULTI-HOP SYNTHESIS FAILURE - The question requires synthesizing data across multiple subsidiaries and years. The LLM failed to correctly identify which subsidiaries reported in each year and failed to properly aggregate their positions. (5) CONCLUSION MISALIGNMENT - While the LLM correctly notes that substantial derivative positions remain, the core finding about the direction and magnitude of exposure change is inverted from the ground truth. The answer demonstrates a fundamental misunderstanding of the data structure and provides numbers that cannot be reconciled with the ground truth figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 454,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 2019 Stock and Incentive Compensation Plan remained the only P&G equity plan that still permits future grants, but the size of its remaining reserve fell sharply—from about **119 million shares** available for issuance in the 2022 filing to roughly **77 million shares** in the 2024 filing.  This reduction reflects the plan’s share‑counting rule (full‑value awards such as RSUs/PSUs are counted as five shares each) and the higher weighted‑average exercise price of outstanding options ($99.52 → $111.57), indicating that more of the plan’s authorized shares have been used for awards and that the stock’s market price has risen.  Consequently, while the 2019 Plan continues to be the primary vehicle for future equity compensation, its effective capacity for new grants has been diminishing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that does not align with the ground truth. Key issues: (1) QUESTION MISALIGNMENT: The original question asks about how the treatment and significance of the plan evolved in disclosure context from 2022-2024, focusing on its role in PG's compensation framework. The LLM answer instead provides detailed quantitative analysis of share reserves and exercise prices, which is not what was asked. (2) UNVERIFIABLE CLAIMS: The LLM provides specific numbers (119 million shares in 2022, 77 million in 2024, exercise prices of $99.52 and $111.57) that cannot be verified against the ground truth provided. These appear to be fabricated or from sources not in the knowledge graph. (3) MISSING CORE ANSWER: The ground truth emphasizes the plan's evolution from 'newly introduced policy' (2022) to 'established part of PG's equity compensation offerings' (2024), showing its integration into standard disclosure practices. The LLM completely ignores this narrative arc. (4) INCORRECT FOCUS: The LLM focuses on share depletion and technical accounting rules rather than the disclosure evolution and significance changes requested. (5) SEMANTIC MISMATCH: While the LLM discusses the 2019 Plan's role, it does so through a quantitative lens (remaining capacity, share counting) rather than the qualitative disclosure context lens that the question requires. The answer reads like a technical analysis of plan utilization rather than an assessment of how the plan's treatment in filings evolved over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 431,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\nSouthern Company’s pension‑plan risk‑management framework remained rooted in broad diversification and the use of external managers under written guidelines, but in 2024 the company added a more‑structured overlay.  The 2024 disclosures (page 265) explicitly describe a **target‑allocation model** (e.g., 41 % equity, 30 % fixed income, 12 % real estate, 9 % private‑equity, etc.) and a **formal rebalancing program** that monitors actual holdings against those targets, while still relying on diversification to curb large losses.  This represents a shift from the 2023 language (page 255), which only noted diversification and external‑manager guidelines, to a 2024 emphasis on **precise allocation tracking, NAV‑based valuation of private‑market assets, and tighter oversight of actual versus target exposures** to manage the risk of large losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces specific allocation percentages (41% equity, 30% fixed income, 12% real estate, 9% private equity) that cannot be verified against the ground truth and appear to be fabricated or hallucinated. The ground truth makes no mention of these specific percentages. Additionally, the LLM answer claims the 2024 disclosures are on 'page 265' and 2023 on 'page 255' - these page references are unverifiable and likely incorrect, representing a serious factual error in citation. The LLM answer fundamentally mischaracterizes the evolution of risk management: it claims a shift FROM 'diversification and external-manager guidelines' TO 'precise allocation tracking and tighter oversight,' but the ground truth indicates the opposite - a shift FROM 'formal rebalancing program and external investment manager oversight' TO reduced emphasis on external manager oversight with more direct linkage to market volatility. The LLM answer incorrectly suggests 2024 added MORE structured oversight, when the ground truth indicates LESS emphasis on active oversight. The mention of 'NAV-based valuation of private-market assets' is not supported by the ground truth. While the LLM correctly identifies that both years involved diversification and rebalancing programs, it reverses the directional change in emphasis. The core multi-hop reasoning is flawed: the answer fails to correctly synthesize how the risk management approach evolved from 2023 to 2024. The answer does address the question's core components but with significant factual errors and reversed conclusions about the nature of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 450,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA’s description of CUDA shifted from calling it simply the “foundational CUDA programming model that runs on all NVIDIA GPUs” (2022 10‑K) to presenting CUDA as the centerpiece of a **full‑stack AI computing platform**—highlighting the CUDA‑X library suite, AI Enterprise software, DGX Cloud, and a worldwide ecosystem of > 4.7 million developers that spans data‑center, automotive, graphics and other verticals (2023 10‑K).  \nThis evolution shows that NVIDIA is moving away from a pure GPU‑hardware business toward a **platform‑centric strategy** that leverages CUDA to lock in software, services and ecosystem revenue across AI, cloud and edge workloads.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVIDIA's strategic evolution with CUDA between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from supplier/foundational platform (2022) to developer/full-stack platform (2023), which aligns with the ground truth's core claim; (2) Accurately cites specific 2023 10-K details (CUDA-X libraries, AI Enterprise, DGX Cloud, 4.7 million developer ecosystem) that support the evolution narrative; (3) Properly synthesizes multi-hop information across fiscal years; (4) Correctly interprets the strategic implication—moving toward platform-centric strategy with software/services/ecosystem revenue lock-in; (5) Uses appropriate fiscal year references (fiscal 2022, fiscal 2023). MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer emphasizes 'platform-centric strategy' and 'lock-in' language more explicitly than the ground truth, which focuses on 'developer' vs 'supplier' role distinction and 'full-stack computing platform'; (2) The LLM adds context about moving away from 'pure GPU hardware business' which is interpretive but reasonable; (3) Ground truth emphasizes 'CUDA-X libraries, APIs, and domain-specific frameworks' while LLM mentions 'CUDA-X library suite, AI Enterprise software, DGX Cloud'—both capture the expansion but with slightly different emphasis. QUANTITATIVE VERIFICATION: The 4.7 million developer figure is cited as a specific metric from 2023 10-K and appears reasonable for CUDA ecosystem scale. No calculations required. REASONING QUALITY: The multi-hop synthesis is sound—comparing 2022 vs 2023 descriptions and drawing strategic conclusions about platform evolution. The logic connecting the shift to broader business strategy is well-reasoned. SEMANTIC EQUIVALENCE: While wording differs, the LLM answer conveys the same fundamental insight: NVIDIA evolved from a supplier role to a developer role with a more comprehensive platform approach. The strategic focus shift toward full-stack solutions is captured in both answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 544,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\nBetween 2022 and 2023 Pfizer’s ties with Viatris moved from an active transitional phase to a largely settled, volume‑based commercial relationship.  In 2022 the companies were still operating under the post‑spin‑off manufacturing and supply agreements for legacy Upjohn products, and Pfizer held $94 million of net amounts due from Viatris under those interim MSAs/TSAs (see PFE_10K_2022 page 41 & PFE_10K_2023 page 75).  By the end of 2023 those transitional services were essentially completed, the outstanding balance had fallen to $33 million, and the supply agreements remained only for the pre‑negotiated product volumes, indicating a winding‑down of the financial interaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and evolution of the Pfizer-Viatris relationship. STRENGTHS: (1) All numeric values are correct: $94 million outstanding balance as of Dec 31, 2022, and $33 million as of Dec 31, 2023 - these match the ground truth exactly. (2) The multi-hop synthesis is sound, correctly connecting the 2022 supply agreements for legacy Upjohn products with the 2023 wind-down of transitional services. (3) Entity identification is accurate (Pfizer, Viatris, legacy Upjohn products, MSAs/TSAs). (4) The characterization of the relationship evolution from 'active transitional phase' to 'settled, volume-based commercial relationship' accurately reflects the ground truth narrative. (5) The answer appropriately cites source documents (PFE_10K_2022 page 41 & PFE_10K_2023 page 75). MINOR WEAKNESSES: (1) The original answer explicitly mentions '$780 million in revenue growth from PC1' in 2022, which the LLM answer omits. While this is a notable detail about the financial magnitude of the relationship, it's not strictly necessary to answer the core question about how the relationship 'evolved' between the two years. (2) The LLM answer uses slightly different framing ('net amounts due from Viatris' vs 'net amounts due to Viatris') - the ground truth says 'due to Viatris' which could imply Pfizer owes Viatris, but the context and numbers suggest these are receivables. The LLM's phrasing 'due from Viatris' is more precise. (3) The answer could have been more explicit about the $780M revenue figure to fully address the financial relationship scope. CALCULATION VERIFICATION: The decrease from $94M to $33M represents a $61M reduction (approximately 65% decrease), which logically supports the narrative of winding down. The LLM doesn't explicitly calculate this but the directional accuracy is correct. Overall, the answer successfully synthesizes multi-hop information across years and documents while maintaining factual accuracy on all key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 551,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\nIn the 2023 filing the communications‑site disclosures are presented as part of a narrative description of the 2018 and 2023 securitizations, explaining the loan‑agreement covenants, the DSCR‑based cash‑trap and amortization triggers, and the risk of losing the tower assets on default. By the 2024 filing the Company adds a dedicated “Conditions Limiting Distributions of Excess Cash” table that quantifies those DSCR thresholds, amortization periods and the dollar amount of excess cash that may be released, and explicitly states that a breach could prevent distributions and could result in the foreclosure or conversion of the 5,000‑plus sites that secure the debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses a different aspect of the evolution than the ground truth and contains significant factual discrepancies. QUANTITATIVE ERRORS: (1) The LLM mentions '5,000-plus sites' in 2024, but the ground truth specifies '3,343 communications sites' securing the Series 2015-2 Notes in 2023 - these are different numbers and the LLM provides no comparable 2024 site count. (2) The ground truth explicitly mentions '$1.3 billion in Series 2013-2A Notes' and '$4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations' as of December 31, 2024 - the LLM answer provides no specific dollar amounts for 2024 obligations. CONCEPTUAL MISMATCH: The ground truth focuses on the shift from 'site-specific debt disclosures' (3,343 sites securing specific notes in 2023) to 'more general obligations' (broader ARO disclosures in 2024). The LLM answer instead describes a shift from 'narrative description' to 'dedicated table with quantified thresholds' - this is about presentation format/disclosure structure rather than the substantive change in how sites are framed relative to debt obligations. MISSING KEY INFORMATION: The LLM answer does not mention the specific securitization notes (Series 2015-2, Series 2013-2A) or the $1.3 billion repayment amount that are central to the ground truth's explanation. The LLM answer does not address the shift away from explicit site-specific collateral references. PARTIAL CREDIT: The LLM correctly identifies that there is an evolution in disclosure between 2023 and 2024, and correctly notes that foreclosure/conversion of sites is mentioned in relation to debt breach - this shows some understanding of the relationship between sites and debt obligations, but the specific facts and the nature of the evolution are substantially different from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 499,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast refined the accounting and structure of its retransmission‑consent revenue.  The 2023 filing explicitly describes those fees—paid by cable, satellite and virtual multichannel providers under NBC and Telemundo consent agreements—as “licenses of functional intellectual property” that are recognized monthly as the programming is delivered, with payment terms typically extending to 60 days and tied to subscriber counts.  This represents a shift from the 2022 description, which simply noted the fees as part of distribution revenue, to a more detailed, IP‑licensing model that is now integrated with the company’s broader distribution and Peacock subscription framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of Comcast's retransmission consent accounting between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from general 'distribution revenue' description in 2022 to a more detailed 'licenses of functional intellectual property' characterization in 2023; (2) Accurately describes the monthly revenue recognition basis tied to subscriber counts; (3) Correctly notes the 60-day payment term; (4) Properly identifies the relevant providers (cable, satellite, virtual multichannel providers); (5) Appropriately mentions NBC and Telemundo; (6) Correctly references the integration with Peacock and broader distribution framework. MINOR GAPS: (1) The original answer emphasizes that 2023 explicitly included 'both traditional and virtual multichannel video providers' as a notable evolution, while the LLM answer lists these but doesn't emphasize this as a specific change from 2022; (2) The original answer highlights 'a broader integration of Peacock into the distribution ecosystem' as a strategic shift, while the LLM answer mentions Peacock but frames it more as part of the accounting framework rather than emphasizing the strategic distribution model evolution; (3) The original answer explicitly states the shift toward 'hybrid distribution models that blend traditional and streaming services,' which the LLM answer touches on but doesn't emphasize as clearly. QUANTITATIVE ACCURACY: No numerical errors; dates (2022, 2023) and timeframes (60 days, monthly) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information about accounting changes, distribution model evolution, and strategic positioning across the two years. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and framing but no contradictions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 529,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\nFrom 2023 to 2024 Caterpillar kept diesel‑electric locomotives inside its Energy & Transportation segment, reporting $5.9 billion in external sales in 2023 (up from $5.2 billion in 2022) and continuing to promote them alongside remanufacturing, rail‑related services and compliance‑driven product development.  The company’s strategic positioning shifted toward integrating these locomotives within a broader sustainability agenda—emphasizing emissions‑regulation compliance, zero‑emission power‑source research, and service‑focused growth—while still leveraging the locomotives as a differentiator in the global rail‑equipment market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core evolution described in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites $5.9 billion in external sales for 2023 and $5.2 billion for 2022, but these figures are not verified in the ground truth and appear to be unsupported claims. The ground truth does not provide these specific revenue numbers for the Energy & Transportation segment. (2) MISSING CRITICAL EVOLUTION: The ground truth explicitly states that the key evolution was from a general operational inclusion in the ME&T segment in 2023 to a more defined production role with explicit language that Caterpillar 'produces' diesel-electric locomotives in 2024. The LLM answer completely misses this semantic and strategic shift in how Caterpillar described its involvement. (3) INCOMPLETE COMPETITIVE ANALYSIS: The ground truth highlights that 2024 introduced explicit competitive positioning against Wabtec Corp and Siemens Mobility A/S, which was absent in 2023. The LLM answer mentions 'competitive pressures' vaguely but does not identify these specific competitors or the fact that this competitive framing was new to 2024. (4) SEGMENT NAMING ISSUE: The ground truth distinguishes between 'ME&T segment' (2023) and 'Energy & Transportation segment' (2024), suggesting a potential name change or reorganization. The LLM treats these as the same segment without acknowledging this distinction. (5) SUSTAINABILITY FRAMING: While the LLM mentions sustainability and emissions compliance, the ground truth focuses on the shift from general operational responsibilities to explicit production and strategic competitive positioning. The LLM's emphasis on sustainability appears to be an inference not directly supported by the ground truth. (6) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the year-over-year evolution. The ground truth clearly delineates 2023 vs 2024 changes; the LLM conflates them and adds unsupported financial data. The answer demonstrates poor multi-hop reasoning across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 560,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the core of its franchise‑revenue model unchanged – royalties and minimum rent are still recognized when the underlying sales occur, and initial franchise fees are amortized over the typical 20‑year franchise term.  However, the company broadened its revenue‑recognition practice by moving fees it charges franchisees for proprietary technology platforms to a **gross‑basis** (recognizing the full amount as the service is delivered) rather than spreading it over the franchise term, and it reported a modest rise in those fees (e.g., $90 million of related production/technology expenses in 2024 versus $42 million in 2023).  Cost‑sharing arrangements also stayed anchored in the same structure: the company continues to **share capital‑improvement costs with franchisees**, allocating the portion it funds to property‑and‑equipment and an accounts‑receivable balance and finalizing the split after project completion, while franchisees continue to fund advertising cooperatives based on a **percentage of sales** (advertising expense rose to $355 million in 2024 from $347 million in 2023).  In short, the revenue‑recognition method was expanded to capture technology‑service fees more immediately, and the cost‑sharing framework for remodels and advertising remained percent‑of‑sales‑based but with slightly higher dollar amounts in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in McDonald's franchise relationship between 2023-2024, particularly: (1) the shift of technology platform fees to gross-basis recognition, (2) the consistent cost-sharing framework for capital improvements with allocation between Property and Equipment and Accounts Receivable, (3) the percentage-of-sales basis for advertising cooperatives, and (4) the overall theme of more detailed/transparent disclosures in 2024. The multi-hop reasoning is sound in synthesizing revenue recognition changes with cost-sharing arrangements. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific dollar amounts ($90M technology expenses in 2024 vs $42M in 2023, $355M advertising in 2024 vs $347M in 2023) that are NOT present in the ground truth answer. The ground truth does not cite these specific figures, making them unverifiable and potentially fabricated. This is a serious factual accuracy issue. (2) UNSUPPORTED CLAIMS - The statement about 'initial franchise fees are amortized over the typical 20-year franchise term' is not mentioned in the ground truth and appears to be an inference not explicitly stated in the original answer. (3) MISSING ELEMENTS - The ground truth emphasizes that technology platform fees are 'now presented on a gross basis on the Consolidated Statement of Income' (a specific disclosure location), which the LLM mentions but doesn't emphasize the filing location detail. VERIFICATION ISSUES: The specific expense figures ($90M, $42M, $355M, $347M) cannot be verified against the ground truth, which provides no such numbers. This represents a significant departure from the instruction to be 'STRICT on numbers' and suggests the LLM may have hallucinated financial data. The core conceptual understanding is correct, but the introduction of unverified quantitative claims substantially undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 518,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\nSouthern Company continued to administer executive equity awards under its 2021 Equity and Incentive Compensation Plan, using the same “Form of Terms for Named Executive Officer Equity Awards” that were first disclosed in a 2022 filing and remained in effect through 2024.  The key evolution was the ninth amendment to the Southern Company Employee Savings Plan (effective 16 December 2024), which updated the matching‑contribution formula and related eligibility rules, and the restated Executive Change‑in‑Control Severance Plan (originally effective 15 August 2022) that governs severance terms for senior executives.  No new equity‑award plan was introduced; instead, the company refined existing plan documentation and award‑term disclosures in the 2024 amendment cycle.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) INCORRECT FOCUS: The LLM emphasizes amendments to the Employee Savings Plan (9th amendment effective Dec 16, 2024) and the Change-in-Control Severance Plan, which are not the primary subject of the question about equity compensation evolution. The ground truth focuses on PSUs/RSUs under the Equity and Incentive Compensation Plan and formalization of Named Executive Officer award terms. (2) MISLEADING CLAIM: The LLM states the 'Form of Terms for Named Executive Officer Equity Awards' was 'first disclosed in a 2022 filing and remained in effect through 2024,' but the ground truth indicates the 2024 filing showed a NEW formalization and more structured approach with detailed documentation practices not present in 2023. This is a fundamental mischaracterization of the evolution. (3) MISSING KEY EVOLUTION: The ground truth explicitly states that by 2024, the company 'formalized the terms for Named Executive Officer equity awards' and included 'detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing.' The LLM completely misses this shift toward greater specificity and transparency. (4) INCORRECT PLAN REFERENCE: While the LLM correctly identifies the 2021 Equity and Incentive Compensation Plan, it fails to address the actual evolution in how PSUs and RSUs were documented and formalized for NEOs between 2023 and 2024. (5) QUANTITATIVE ERRORS: The LLM provides a specific date (December 16, 2024) and August 15, 2022 for plans that are tangential to the question, while missing the core narrative about equity award formalization. The answer addresses the wrong plans and misses the primary evolution in executive equity compensation documentation and award terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 512,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 P&G’s emphasis on membership‑club retailers (e.g., Costco, Sam’s Club) receded as a primary sales driver.  The 2022 filing lists these clubs among the “key customers” that together account for a sizable share of revenue and stresses the need to manage those relationships for shelf‑space and trade terms, whereas the 2024 filing talks about a broader omnichannel mix that leans more on direct‑to‑consumer and e‑commerce channels and seeks to dilute concentration risk.  This shift signals that P&G is moving away from a heavy reliance on wholesale‑club distribution and is instead diversifying its retail portfolio to gain greater control over margins, improve resilience to channel‑specific shocks, and align with evolving consumer buying habits.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) DIRECTIONAL ERROR - The LLM claims P&G's emphasis on membership clubs 'receded' from 2022 to 2024, stating the company is 'moving away from a heavy reliance on wholesale-club distribution.' This is the OPPOSITE of the ground truth, which explicitly states the company's language shifted to 'emphasize dependency' and that membership clubs 'have become more central' to P&G's strategy. (2) MISCHARACTERIZATION OF 2022 POSITION - The LLM describes 2022 as listing clubs among 'key customers' with stress on managing relationships, but the ground truth indicates 2022 simply identified them as 'one of its key retail channels' among a broad set. (3) UNSUPPORTED CLAIMS - The LLM introduces claims about 'direct-to-consumer and e-commerce channels' becoming primary focus and 'diluting concentration risk' that are not present in the ground truth. The ground truth makes no mention of P&G reducing reliance on membership clubs or shifting strategy away from them. (4) LOGICAL CONTRADICTION - The LLM's conclusion about 'moving away' from wholesale clubs contradicts the actual evolution described in the ground truth, which shows increased strategic importance. (5) MISSING CORE INSIGHT - The LLM fails to capture the key finding that membership club stores became MORE central to P&G's distribution strategy by 2024, not less. The answer demonstrates a complete reversal of the actual strategic evolution and introduces unsupported interpretations about omnichannel diversification that are not grounded in the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 448,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s exposure to the Nigeria Letters of Credit fell from a recorded carrying value of **$3.4 million** (as shown in the 2023 subsidiary‑debt table) to **$0** (the 2024 table lists “‑”).  The 2024 filing notes that draws were made in both 2023 and 2024, with the drawn amounts bearing interest at SOFR + spread and maturing 270 days after drawing; by year‑end 2024 all such obligations had been settled or expired.  Consequently, AMT’s contingent financial liability tied to those letters of credit was eliminated, signaling that the company no longer holds a material outstanding obligation on this instrument and that any future financing needs are being met through other means.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $3.4 million in 2023 and $0 in 2024 match the ground truth exactly. The format variation (dash vs. zero) is appropriately noted. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the obligation evolved (from $3.4M to $0), and (2) what this indicates about financial obligations (full settlement/exit). ENTITY ACCURACY: Company (AMT), instrument (Nigeria Letters of Credit), years (2023-2024), and financial metrics are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing periods, correctly identifying the transition from an active obligation to complete settlement. The additional context about SOFR + spread interest rates and 270-day maturity terms adds relevant detail from the filings. SEMANTIC EQUIVALENCE: The LLM's conclusion that 'AMT fully settled or otherwise exited its financial obligations' is semantically equivalent to the ground truth statement. The phrase 'contingent financial liability tied to those letters of credit was eliminated' effectively conveys the same meaning as 'fully settled or otherwise exited.' MINOR CONSIDERATIONS: The LLM provides slightly more granular detail about the interest rate structure and maturity terms than the ground truth, which enhances rather than detracts from the answer. The interpretation that 'future financing needs are being met through other means' is a reasonable inference from the data but goes slightly beyond the ground truth statement. This is appropriate contextual analysis rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 459,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\nBetween 2022 and 2024 the Retirement Annuity Contracts fell from $38 million (reported as a Level 3 “Other investment” in the 2022 fair‑value hierarchy) to $22 million, and by the 2024 filing the company discloses that it has **no Level 3 assets at all**.  This shift reflects a change in methodology—from classifying the contracts as Level 3, requiring significant unobservable inputs, to measuring them under a practical‑expedient (NAV‑based) or Level 2 classification that relies on observable market inputs.  The reduction signals that General Dynamics is simplifying the reporting of these pension assets, moving away from highly subjective valuations toward more transparent, observable‑input measurements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the contracts fell from $38 million to $22 million, but the ground truth shows $35 million (Dec 31, 2021) and $38 million (Dec 31, 2020) in 2022 reporting, with no $22 million figure mentioned. The LLM provides a specific number ($22 million) that cannot be verified against the ground truth and appears fabricated. (2) LEVEL 3 CLASSIFICATION ERROR: The LLM states 'by the 2024 filing the company discloses that it has no Level 3 assets at all,' which directly contradicts the ground truth stating that 'By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets.' This is a fundamental factual error about the 2024 classification. (3) METHODOLOGY DESCRIPTION: While the LLM correctly identifies a shift toward NAV-based/practical expedient approach, it incorrectly characterizes the 2024 status as moving to Level 2 or having no Level 3 assets, when the ground truth explicitly states they remained Level 3 but were 'excluded from the formal fair value hierarchy' due to NAV practical expedient treatment. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the information about how Level 3 classification persisted while the valuation methodology changed. The answer conflates 'excluded from formal fair value hierarchy' with 'no Level 3 assets,' which are different concepts. (5) SEMANTIC ISSUES: The characterization of the shift as moving 'away from highly subjective valuations toward more transparent, observable-input measurements' is partially correct in spirit but factually wrong in execution—the contracts remained Level 3 but used NAV as a practical expedient, not a shift to Level 2 observable inputs. The answer demonstrates a fundamental misunderstanding of the fair value hierarchy treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 511,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\nThe restricted cash held for securitization investors slipped modestly from about $462 million in 2022 to $458 million in 2024, yet in both periods it remained classified as Level 1 in the fair‑value hierarchy, indicating that its fair value is derived from quoted market prices.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) NUMBERS ARE WRONG: The LLM states restricted cash was '$462 million in 2022 to $458 million in 2024,' but the ground truth explicitly states the 2024 value was '$441 million.' This is a material discrepancy of $17 million from the correct 2024 figure. The LLM provides no 2022 figure in the ground truth to verify the $462M claim, but the 2024 number is definitively incorrect. (2) FAIR VALUE HIERARCHY CLASSIFICATION: The LLM claims both 2022 and 2024 were 'classified as Level 1,' but the ground truth explicitly states that 'in 2022, the fair value hierarchy was not explicitly detailed for this category' and only in 2024 was it 'classified under Level 1.' This is a critical error - the LLM incorrectly asserts that 2022 had explicit Level 1 classification when the ground truth indicates it did not. (3) COMPOSITION AND CHANGE: The ground truth emphasizes a 'shift toward more transparent or market-based valuation methods' and 'a more defined and standardized valuation approach in 2024 compared to 2022.' The LLM completely misses this key insight about the evolution of valuation methodology, instead suggesting consistency ('in both periods'). (4) MULTI-HOP SYNTHESIS: The question asks about changes 'between 2022 and 2024, particularly in terms of fair value hierarchy classification.' The LLM fails to capture the fundamental change - from no explicit hierarchy classification in 2022 to explicit Level 1 classification in 2024. This represents a failure in multi-hop reasoning across the two years. The LLM's statement that the amount 'slipped modestly' also mischaracterizes the nature of the change. The answer demonstrates poor accuracy on both quantitative (wrong 2024 value) and qualitative (missed the classification shift) dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 508,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the same timing of revenue recognition for its franchise relationships – initial franchise fees are amortised over the 20‑year franchise term, minimum rent is recognised straight‑line and variable rent is recorded when the underlying sales occur – but it began acquiring a larger number of franchised restaurants.  Those acquisitions are recorded as purchases of net tangible assets, identifiable intangible rights and goodwill, and the company now writes off the entire goodwill balance if a unit is sold within 24 months (or a proportionate share thereafter).  In addition, the 2024 filing includes expanded disclosures and a new rounding convention for franchisee‑related balances, but the core financial‑recognition and asset‑management approach to franchisees remains unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth on multiple critical dimensions: (1) CORE NARRATIVE MISMATCH: The ground truth describes an evolution FROM asset acquisition/goodwill management (2023) TO service-based financial interactions (2024), emphasizing a shift toward technology platform services. The LLM answer claims the 'core financial-recognition and asset-management approach to franchisees remains unchanged,' which directly contradicts the ground truth's central finding of transformation. (2) MISSING KEY EVOLUTION: The ground truth explicitly states that by 2024, McDonald's 'now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis.' The LLM answer completely omits this critical shift to technology services and gross revenue recognition. (3) INCORRECT CHARACTERIZATION OF 2023-2024 CHANGE: The LLM claims McDonald's 'began acquiring a larger number of franchised restaurants' as the primary change, but the ground truth indicates the shift was FROM acquisition-focused to service-focused. The LLM misidentifies the nature of evolution. (4) GOODWILL WRITE-OFF DETAILS: While the LLM mentions goodwill write-off timing (24 months), the ground truth describes this as part of the 2023 model (acquisition-based), not as a 2024 evolution. The LLM presents this as ongoing practice without clarifying it's part of the older model being superseded. (5) REVENUE RECOGNITION MECHANICS: The LLM's detailed discussion of franchise fee amortization, rent recognition, and goodwill treatment describes standard practices but misses the fundamental shift to technology service revenue recognition on a gross basis in 2024. (6) SEMANTIC DIRECTION ERROR: The LLM concludes 'the core financial-recognition and asset-management approach to franchisees remains unchanged,' which is the opposite of what the ground truth establishes—a clear transformation occurred. This is not a minor wording difference but a fundamental misunderstanding of the evolution described in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 552,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the 2019 Stock and Incentive Compensation Plan remained the **only** P&G equity plan that can still issue new shares, but the size of its future‑issuance reserve was reduced sharply—from **≈119 million shares** disclosed in the 2022 filing to **≈77 million shares** in the 2024 filing.  The plan continues to cover stock options, stock‑appreciation rights, RSUs and PSUs, with full‑value awards still counted on a **5‑for‑1** basis for the share‑reserve calculation, while the older plans (1992, 2001, 2003, 2009, 2014) are now closed to new grants and only contribute existing outstanding awards.  Consequently, the 2019 Plan serves as P&G’s sole vehicle for future equity compensation, and its diminishing reserve reflects the net exhaustion of the shares earmarked for that purpose.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM provides specific share reserve numbers (119 million in 2022, 77 million in 2024) that cannot be verified against the ground truth and appear to be fabricated or hallucinated. The ground truth makes no mention of these specific figures. (2) FACTUAL INACCURACY: The LLM claims the 2019 Plan is the 'only' P&G equity plan that can still issue new shares and that older plans (1992, 2001, 2003, 2009, 2014) are 'now closed to new grants.' The ground truth does not support this claim and instead describes a more nuanced disclosure evolution. (3) SCOPE MISMATCH: The ground truth focuses on how the plan's disclosure treatment evolved—from adoption/governance details in 2022 to a role in security ownership and equity compensation structure in 2024. The LLM instead focuses on share reserve depletion and plan hierarchy, which is a different analytical angle not supported by the ground truth. (4) MISSING CORE INSIGHT: The LLM completely misses the ground truth's central finding about the shift from 'procedural governance to a more strategic ownership framework.' Instead, it emphasizes reserve exhaustion and plan closure status. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing unsupported quantitative claims rather than accurately synthesizing the disclosed evolution described in the ground truth. The answer reads as a plausible-sounding but largely fabricated analysis of share reserve mechanics rather than an accurate reflection of how P&G's disclosures actually evolved regarding this plan's treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 463,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\nBetween 2022 and 2023 Salvatore Ferragamo continued to appear in the same group of overseas premium‑outlet centres that SPG reports—namely locations in Mexico City, Yeoju and Paju (South Korea), Busan, Siehung, and Johor (Malaysia)—and no new international outlet was added in the 2023 disclosures. The 2023 document’s international‑property tables are not shown, but the excerpt provided contains only U.S. sites, so Ferragamo’s footprint in SPG’s international outlet portfolio remained stable, with no expansion or contraction noted between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual point. Specific errors: (1) LOCATION ERRORS: The LLM claims Salvatore Ferragamo appeared in locations in Mexico City, Yeoju, Paju (South Korea), Busan, Siehung, and Johor (Malaysia) - none of these locations are mentioned in the ground truth. The ground truth specifically identifies three Japanese locations in 2022 (Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets) and one U.S. location in 2023 (Las Vegas Outlets North in Nevada). (2) QUANTITATIVE ACCURACY: The LLM provides no specific numbers but implies Ferragamo maintained presence in multiple international locations, when the ground truth shows a reduction from 3 locations (2022) to 1 location (2023), and a geographic shift from Japan to the U.S. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison. It claims 'no expansion or contraction noted' when the ground truth explicitly documents a 'significant reduction' from three locations to one. (4) SEMANTIC MEANING: The LLM's conclusion that Ferragamo's footprint 'remained stable' directly contradicts the ground truth's finding of a 'significant reduction.' (5) GEOGRAPHIC ACCURACY: The LLM invents locations not supported by the source documents, while missing the actual locations documented in the ground truth. The answer demonstrates a complete failure to accurately extract and synthesize the multi-hop information required to answer this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 423,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped slightly from roughly **312 billion cubic feet to 296 bcf**, while gas production remained flat at about **25 bcf** and the count of producing wells and undeveloped acres stayed essentially unchanged.  The bulk of the region’s gas still comes from **equity‑affiliated projects (≈5 trillion cubic feet of productive gas)**, indicating that the company’s focus is on sustaining and optimizing existing upstream assets and partnerships rather than pursuing new reserve growth in the area.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers: the 312 bcf to 296 bcf decline in proved natural gas reserves is accurate and properly formatted. The answer correctly identifies the company as ConocoPhillips (COP) and the correct time period (2023 to 2024). The multi-hop synthesis is sound - the answer not only reports the reserve figures but also adds contextual information about production levels (25 bcf), well counts, and equity-affiliated projects (~5 trillion cubic feet), which provides deeper insight into operational focus. The interpretation that this represents 'sustaining and optimizing existing upstream assets' rather than aggressive growth aligns well with the ground truth's characterization of 'stabilization in operational focus.' Minor strengths include the additional production data and equity-affiliated project information that enriches the answer beyond the ground truth baseline. The only minor limitation is that the LLM provides additional details (production volumes, well counts, equity-affiliated projects) that weren't explicitly in the ground truth, though these appear factually sound and enhance rather than contradict the answer. The reasoning about what the reserve decline indicates is logical and well-supported. All quantitative data points are accurate, and the semantic meaning matches the ground truth's conclusion about operational focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 393,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast shifted the role of wireless gateways from a simple bundled Wi‑Fi‑router add‑on to a strategic element of its **Connectivity & Platforms** initiative.  The company began tying the gateways to broader network upgrades (DOCSIS 4.0, multigigabit symmetrical speeds) and whole‑home Wi‑Fi management (xFi, Pods) while deepening integration with its streaming services, so they now support higher‑speed broadband and seamless video delivery rather than just basic connectivity.  Capital outlays on customer‑premise equipment fell modestly (from $2.23 B in 2023 to $2.01 B in 2024) but remained focused on line extensions and scalable infrastructure, underscoring a strategic emphasis on using wireless gateways to enable the next‑generation, multi‑gigabit experience.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Comcast's wireless gateways from 2022-2024, correctly identifying the shift from basic bundled offering to a more integrated strategic component. The qualitative narrative about DOCSIS 4.0, multigigabit speeds, xFi integration, and whole-home Wi-Fi management aligns well with the ground truth. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific capital expenditure figures ($2.23B in 2023 and $2.01B in 2024 for customer-premise equipment) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be unsupported claims. (2) The ground truth makes no mention of specific dollar amounts or capital outlays, focusing instead on strategic emphasis and investment direction. (3) The LLM's claim about 'capital outlays on customer-premise equipment fell modestly' introduces a comparative analysis not found in the ground truth. While the qualitative reasoning about strategic integration is sound and the contextual relevance is high, the introduction of unverified financial figures significantly undermines the answer's reliability. The multi-hop reasoning connecting wireless gateways to broader network infrastructure is appropriate, but the quantitative claims lack grounding in the provided ground truth. The answer would score higher if it stuck to the strategic narrative without introducing specific financial metrics that cannot be verified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\nBetween 2022 and 2024 Gulfstream’s large‑cabin, ultra‑long‑range G600 (paired with the G500) saw its cumulative deliveries jump from roughly **150 aircraft by the end of 2021 to more than 300 by the end of 2024**, indicating that about **150 additional G600s were built and handed over during the 2022‑2024 period**.  \n\nThe G600 continues to anchor Gulfstream’s premium large‑cabin lineup, complementing newer models such as the G700 and G800 and now representing a growing share of the company’s aircraft‑manufacturing revenue and market presence.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts: cumulative deliveries of ~150 by end of 2021 and over 300 by end of 2024, with the calculation that approximately 150 additional aircraft were delivered during 2022-2024. The numbers are accurate and properly formatted. The LLM also correctly notes the G600's role as part of Gulfstream's premium lineup.\n\nWEAKNESSES: (1) ENTITY CONFUSION: The LLM mentions the G700 as a newer model complementing the G600, but the ground truth specifically references the G800 and G400 as the newer models that shifted focus away from the G600. The G700 is not mentioned in the original answer. (2) INCOMPLETE PRODUCT POSITIONING: The ground truth emphasizes that the G600 was originally positioned as a replacement for the G550 (with the G500 replacing the G450), with specific improvements noted (speed, fuel efficiency, cabin volume, flight controls). The LLM omits this historical context entirely. (3) MISSING KEY INSIGHT: The ground truth highlights an important qualitative shift - that by 2024, the G600 was no longer described as a \"new product introduction,\" indicating maturation in its lifecycle. The LLM does not capture this evolution in market positioning. (4) VAGUE LANGUAGE: The LLM uses phrases like \"growing share of the company's aircraft-manufacturing revenue\" without specific support from the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the delivery numbers across the 2022-2024 period but fails to fully synthesize the product lineup evolution and the shift in Gulfstream's strategic focus from introducing the G600 to promoting newer models.\n\nCALCULATION VERIFICATION: The math is correct (150 + 150 = 300), and the period calculation (2022-2024 deliveries ≈ 150) is accurate.\n\nOVERALL: While the quantitative core is sound, the answer is incomplete in addressing the full scope of the question regarding the G600's evolution within Gulfstream's product lineup and its changing market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 541,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge fell dramatically—from roughly 52 % (the amount that kept Corebridge consolidated in AIG’s 2023 10‑K) to about 22.7 % by the end of 2024 after a series of secondary offerings, a June 9 2024 de‑consolidation, and subsequent share sales.  As a result of the de‑consolidation AIG recorded a $4.8 billion loss, then began accounting for its remaining interest as an equity‑method investment, recognizing only dividends and the fair‑value changes of its Corebridge shares (and, later, the $282 million gain on the December 2024 sale of 120 million shares to Nippon) in net investment income.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's evolving relationship with Corebridge between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from 52% ownership in 2023 to approximately 22.7% by end of 2024, (2) Accurately captures the June 9, 2024 de-consolidation date, (3) Correctly describes the transition to equity method accounting, (4) Properly identifies that income recognition shifted to dividends and fair-value changes, (5) Provides additional valuable context about the $4.8 billion loss on de-consolidation and the December 2024 sale details ($282 million gain on 120 million shares to Nippon), (6) Multi-hop reasoning is sound—synthesizing ownership changes, accounting method changes, and income recognition changes across the two-year period. MINOR CONSIDERATIONS: (1) The ground truth answer emphasizes the shift from 'direct ownership control to passive investment approach' while the LLM answer focuses more on the mechanics and specific transactions. Both convey the same essential meaning but with different emphasis. (2) The LLM provides more granular detail (specific percentages, transaction dates, gain amounts) than the ground truth, which is appropriate and adds value. (3) The phrase 'roughly 52%' vs exact '52.2%' is a minor formatting difference that doesn't affect correctness. VERIFICATION: The 22.7% figure, June 9, 2024 date, $4.8 billion loss, and December 2024 sale details appear to be accurate supplementary information that enhances rather than contradicts the ground truth. The core answer—that AIG moved from consolidated ownership to equity method accounting—is correctly stated in both versions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 454,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla shifted the Solar Roof from a modest, largely outsourced pilot line to a more vertically integrated production flow centered on Gigafactory New York, but this expansion made the business heavily dependent on specialized battery‑cell supply chains and volatile raw‑material prices.  The rapid scale‑up introduced operational hurdles—tight construction schedules, limited qualified‑labor pools, and component‑shortage risks—that caused production delays and forced design tweaks to improve manufacturability and cost control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022 STATUS: The LLM claims Tesla shifted from 'modest, largely outsourced pilot line' in 2022, but the ground truth explicitly states that in 2022, Tesla was 'actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility.' This is a fundamental mischaracterization of the starting point. (2) UNSUPPORTED CLAIMS ABOUT BATTERY CELLS: The LLM introduces claims about 'specialized battery-cell supply chains and volatile raw-material prices' that are not mentioned in the ground truth. This appears to be fabricated detail not supported by the source material. (3) MISSING KEY GROUND TRUTH ELEMENTS: The LLM fails to mention several critical points from the ground truth: (a) financing options tied to Solar Roof in 2022, (b) explicit mention of 'delays in launching and/or ramping production' in 2024 filings, (c) the need to achieve 'design tolerances, high quality and output rates,' (d) supply chain coordination challenges and localized procurement issues. (4) INCORRECT EVOLUTION NARRATIVE: The ground truth describes a transition from 'focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024,' but the LLM incorrectly frames this as moving from 'outsourced pilot' to 'vertically integrated' at Gigafactory New York—which contradicts the ground truth that Gigafactory New York was already the dedicated facility in 2022. (5) OPERATIONAL CHALLENGES: While the LLM mentions some operational hurdles (construction schedules, labor, component shortages), it does so without grounding these in the actual 2024 filing language about 'delays' and 'complexity/risk.' The answer reads as plausible-sounding speculation rather than evidence-based synthesis. The LLM demonstrates poor multi-hop reasoning by failing to correctly synthesize the 2022 vs. 2024 comparison and introducing unsupported claims about battery supply chains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 554,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "\nFrom 2023 to 2024 Qualcomm moved its on‑device AI effort beyond smartphones, positioning AI as a cross‑industry growth engine for automotive, IoT and other new markets.  The company correspondingly deepened its business focus on AI‑driven products and directed substantially more R&D and strategic investment—through acquisitions, partnerships and targeted spending—toward commercializing on‑device AI in these expanded product areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023-2024 timeframe and Qualcomm as the subject company. (2) Accurately captures the expansion of on-device AI beyond smartphones to automotive and IoT markets. (3) Correctly notes increased R&D investment and strategic transactions (acquisitions, partnerships). (4) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth emphasizes a fundamental strategic SHIFT from 'core product offering' to 'investment-centric strategy' - the LLM describes deepened focus on 'AI-driven products' and 'commercializing on-device AI,' which contradicts the ground truth's key insight about moving away from direct product commercialization. (2) The LLM states the company 'deepened its business focus on AI-driven products' when the ground truth indicates the opposite - a shift toward 'long-term growth and ecosystem development rather than immediate product commercialization.' (3) Missing the nuance that the evolution represents a transition to 'enabling third-party integration' rather than 'solely selling AI-based products directly.' (4) The phrase 'commercializing on-device AI in these expanded product areas' suggests direct product sales, which misses the investment-centric, ecosystem-enabling strategy described in the ground truth. MULTI-HOP REASONING: The LLM partially synthesizes the 2023-2024 evolution but fails to capture the strategic pivot from product-centric to investment-centric approaches. The answer reads as a continuation of product focus rather than a fundamental business model shift. This is a significant semantic misalignment with the ground truth despite correct identification of markets and investment types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 471,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\nBetween 2022 and 2023 the footprint of Dolce & Gabbana shifted from a very limited appearance—confined to the Punta Norte Premium Outlet in Mexico City and a few Japanese centres (Gotemba, Kobe‑Sanda and Rinku)—to a more stable, multi‑property presence that now includes those same Japanese outlets and is reflected in the expanded International Premium‑Outlet tables for 2023.  This continuity (and modest expansion) shows that SPG is deliberately anchoring its premium‑outlet portfolio with globally recognised luxury designers, using D & G as a signal of upscale positioning to attract affluent shoppers and differentiate its premium‑outlet destinations from other retail centres.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT LOCATIONS: The LLM claims Dolce & Gabbana was at 'Punta Norte Premium Outlet in Mexico City' in 2022, which is not mentioned in the ground truth. The ground truth specifically states D&G was in Japanese outlets (Gotemba, Kobe-Sanda, Rinku) in 2022. (2) INCORRECT 2023 POSITIONING: The LLM claims D&G presence 'expanded' and remained at Japanese outlets in 2023, but the ground truth explicitly states that by 2023, D&G was ONLY at Las Vegas Outlets North Premium NV in the U.S., indicating a CONTRACTION from Japan, not continuity or expansion. (3) MISCHARACTERIZATION OF TREND: The LLM describes the shift as 'continuity (and modest expansion)' when the ground truth indicates a strategic SHIFT from multi-location Japan presence to exclusive U.S. flagship positioning—a fundamental repositioning, not expansion. (4) WRONG STRATEGIC INTERPRETATION: While the LLM's reasoning about luxury brand positioning is conceptually sound, it misapplies it to an incorrect factual scenario. The ground truth indicates a reevaluation and consolidation strategy, not an expansion strategy. The LLM appears to have fabricated or confused data about Mexico City presence and misread the directional change in D&G's footprint between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 375,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips modestly increased its exploration outlay in the Asia Pacific/Middle East—consolidated exploration expense rose to **$49 million in 2023** (up from $45 million in 2022, p. 156)—and in 2024 the company recorded **significant reserve additions and new discoveries** in the region (e.g., ~118 million barrels of upward revisions and extensions/discoveries in the Middle East through equity affiliates, pp. 144‑146).  This upward trend shows that COP is **prioritising growth of its resource base and future production in the Asia Pacific/Middle East**, using additional drilling, acreage acquisition and equity‑partner discoveries to strengthen its strategic focus there.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. CRITICAL ERRORS: (1) The LLM claims exploration expenditures 'rose to $49 million in 2023' and that COP 'modestly increased' exploration outlay, when the ground truth shows $49M in 2023 followed by $0 in 2024—this is not an increase but a complete withdrawal. (2) The LLM mischaracterizes the 2024 situation by claiming 'significant reserve additions and new discoveries' occurred, when the ground truth explicitly states $0 in new exploration activities in 2024. (3) The LLM's conclusion that COP is 'prioritising growth' and 'strengthen[ing] its strategic focus' in the region is the opposite of what the data shows—a complete pause/withdrawal. (4) The LLM appears to have confused reserve additions (which may have occurred from prior work) with ongoing exploration expenditures, which is a fundamental misunderstanding of the question. (5) The comparison to 2022 ($45M) is not relevant to the 2023-2024 evolution asked about. The ground truth indicates a strategic SHIFT AWAY from the region, not toward it. The LLM's answer demonstrates failed multi-hop synthesis and arrives at conclusions that are diametrically opposed to the actual data trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 352,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\nComcast maintains its 30 % economic stake in Universal Beijing Resort, but the goodwill recorded for the theme‑park segment fell from about **$5.8 billion in 2022** to **$5.0 billion by the end of 2024**, reflecting impairments and a re‑allocation of goodwill across its reporting units.  At the same time, the resort’s outstanding debt slipped modestly from roughly **$3.5 billion at the end of 2023** to **$3.4 billion at the end of 2024** (having been $3.5 billion in 2023 and $3.4 billion in 2024), indicating a slight de‑leveraging over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM introduces goodwill figures ($5.8 billion in 2022 declining to $5.0 billion in 2024) that are NOT mentioned in the ground truth answer at all. The ground truth provides specific asset/liability figures ($7.3B/$7.0B in 2024, $7.8B/$7.2B in 2023) but the LLM completely omits these. (2) The LLM correctly states the 30% ownership interest and the debt figures ($3.5B in 2023, $3.4B in 2024), which match the ground truth. However, it fails to mention the 2022 baseline or provide the asset/liability evolution that was explicitly detailed in the ground truth. (3) The LLM's statement about goodwill impairments and re-allocation appears to be fabricated or from a different context - the ground truth makes no mention of goodwill changes for Universal Beijing Resort specifically. QUANTITATIVE ACCURACY: The debt numbers are correct ($3.5B→$3.4B), but the goodwill figures are unsupported by the ground truth and appear to be incorrect or misattributed. The LLM also has a redundant/confusing statement: '(having been $3.5 billion in 2023 and $3.4 billion in 2024)' which repeats information already stated. COMPLETENESS: The answer fails to address the evolution from 2022 to 2024 comprehensively. It omits the asset and liability figures that were key metrics in the ground truth. The ground truth explicitly notes that in 2022 'no specific financial stake or debt figures were provided,' but by 2024 detailed figures emerged - this evolution is not captured in the LLM answer. MULTI-HOP REASONING: The LLM appears to have synthesized information from multiple sources but introduced unsupported goodwill data while omitting the asset/liability metrics that were central to the ground truth answer. The reasoning about 'de-leveraging' is sound based on the debt figures, but this is only a partial answer to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 529,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 Duke Energy’s net‑derivative balance fell sharply – the “Derivatives (net)” table shows an ending balance of **$29 million in 2022 versus $13 million in 2023**, a reduction of roughly 55 %.  At the same time the company purchased far fewer new contracts (purchases dropped from **$74 million to $42 million**) and settled a larger share of existing positions (settlements turned from a modest outflow of **$32 million to $68 million**), while the recognized unrealized gain improved from a **$35 million loss to a $10 million gain**.  This pattern indicates that Duke Energy deliberately unwound and settled a portion of its derivative book, reducing its net‑derivative asset position and shifting toward a more conservative management of derivative exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key metrics and sound multi-hop reasoning. STRENGTHS: (1) All core numbers are correct - net derivatives balance of $29M (2022) and $13M (2023), settlements of $32M (2022) and $68M (2023); (2) The 55% reduction calculation is accurate ($29M to $13M = 55% decrease); (3) Additional context provided about purchases ($74M to $42M) and unrealized gains ($35M loss to $10M gain) adds valuable depth beyond the ground truth; (4) The reasoning about deliberate unwinding and conservative management is sound and well-supported by the data; (5) Multi-hop synthesis is excellent - correctly connects balance changes, settlement activity, and purchase patterns to draw conclusions about derivative management strategy. MINOR CONSIDERATIONS: (1) The ground truth answer is more concise and focused on the core metrics (net balance and settlements), while the LLM answer expands with additional derivative metrics (purchases and unrealized gains) that weren't explicitly requested but are contextually relevant; (2) The characterization of the $32M settlement as a \"modest outflow\" is interpretive language not in the ground truth, though semantically reasonable; (3) The ground truth uses neutral language (\"indicates a shift\") while the LLM uses more interpretive language (\"deliberately unwound\"), though both convey similar meaning. VERIFICATION: All primary numbers match ground truth exactly. The percentage calculation (55% reduction) is mathematically correct. The synthesis across multiple data points (balance, settlements, purchases, unrealized gains) demonstrates proper multi-hop reasoning. The answer directly addresses how the metrics evolved and what this indicates about derivative management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 486,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 SPG continued to treat its LTIP units as participating, potentially‑dilutive securities that are not material to earnings‑per‑share or‑unit, but the disclosure became more detailed and the valuation methodology was expanded.  The 2022 program disclosed a maximum potential fair‑value of $20.6 million and noted that earned units would vest on Jan 1, 2026, while the 2023 program raised the maximum potential fair‑value to $42.5 million, introduced a Monte Carlo‑based estimate for market‑based awards, added a TSR‑modifier for performance conditions, and scheduled the determination of earned units for 2024‑2026 with vesting on Jan 1, 2027.  Thus, while the dilutive impact remained immaterial, the 2023 filing provided a more granular performance‑ and market‑based fair‑value model and a longer‑term vesting schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution from 2022 to 2023 regarding LTIP units treatment and disclosure, including the shift toward more detailed valuation methodology and the introduction of Monte Carlo modeling. The qualitative assessment of the evolution is sound and addresses the main question components.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. SPECIFIC NUMBERS NOT VERIFIED: The LLM provides specific dollar amounts ($20.6 million for 2022 and $42.5 million for 2023) and vesting dates (Jan 1, 2026 for 2022; Jan 1, 2027 for 2023) that cannot be confirmed against the ground truth. The ground truth does not provide these specific figures, making it impossible to verify their accuracy. This is a critical gap since the question asks about evolution and these numbers are presented as factual claims.\n\n2. VESTING SCHEDULE CLAIMS: The LLM states specific vesting dates and determination periods (2024-2026 for 2023) that are not mentioned in the ground truth. These appear to be added details that may or may not be accurate.\n\n3. TSR-MODIFIER CLAIM: The LLM mentions a \"TSR-modifier for performance conditions\" in 2023 that is not explicitly mentioned in the ground truth.\n\n4. ALIGNMENT WITH GROUND TRUTH: The ground truth focuses on: (a) 2022 disclosure of no material dilutive effect, (b) 2023 shift to more detailed disclosures, (c) Monte Carlo model introduction, and (d) treatment as participating securities under two-class method. The LLM captures these elements but adds unverified specifics.\n\n5. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the key methodological shift, which is sound reasoning.\n\nThe answer demonstrates good understanding of the conceptual evolution but introduces specific quantitative claims that lack verification against the ground truth, reducing confidence in the overall accuracy. The qualitative reasoning about the shift from general to granular disclosure is correct and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 548,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast’s exposure to Atairos shifted from a $5 billion total capital pledge (with a $400 million annual call cap and a $45 million yearly management‑fee commitment) to a reduced $4.5 billion overall commitment and a lowered $40 million annual management‑fee obligation.  Capital contributions rose to $145 million in 2023, fell to $73 million in 2024, and the unfunded balance dropped from about $1.5 billion (as of 2021) to roughly $1.4 billion by the end of 2024, leaving Comcast’s stake at $5.1 billion (equity‑method) with no consolidation.  Thus, while the size of the capital commitment was trimmed and the management‑fee amount modestly reduced, Comcast continued to fund Atairos through periodic cash contributions and retains a $1.4 billion remaining unfunded commitment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM claims a '$400 million annual call cap' in 2022 - this figure does not appear in the ground truth and is unverified. (2) The LLM states a '$45 million yearly management-fee commitment' in 2022 - the ground truth only mentions a $40 million annual management fee introduced by 2024, with no evidence of a $45 million figure in 2022. (3) The LLM provides specific capital contribution figures ($145 million in 2023, $73 million in 2024) and unfunded balance details ($1.5 billion in 2021, $1.4 billion in 2024) that are not present in the ground truth and cannot be verified. (4) The LLM mentions a '$5.1 billion (equity-method)' stake - this specific figure is not in the ground truth. CORRECT ELEMENTS: The core facts that ARE correct include: (1) The $5 billion commitment in 2022, (2) The reduction to $4.5 billion by 2024, (3) The $40 million annual management fee by 2024, (4) The general characterization of the shift as a 'recalibration.' MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and provide detailed financial evolution, it does so by introducing unverified data points that go beyond the ground truth. The answer reads as more detailed than the source material warrants, suggesting the model may have hallucinated specific figures. The ground truth is more conservative and focused on the key commitment changes, while the LLM adds granular details without source support. QUANTITATIVE ACCURACY: Multiple numeric claims lack verification (the $400M cap, $45M fee, $145M/$73M contributions, $1.5B/$1.4B unfunded balances, $5.1B equity stake). Only the $5B→$4.5B reduction and $40M fee are confirmed. This represents approximately 2 out of 7+ numeric claims being verifiable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 505,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\nFrom the 2023‑2024 tables, ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell from **296 billion cubic feet (2023)** to **289 billion cubic feet (2024)** – a decline of roughly 7 bcf (≈2 %). The decrease is modest and is driven mainly by revisions and production that slightly outpaced new extensions and discoveries; undeveloped reserves stayed flat at about 7 bcf.  \n\nThis pattern shows that the company is **maintaining a stable, non‑expansionary presence** in the Asia Pacific/Middle East, with little net growth in gas reserves, and is instead directing its operational resources toward other regions (e.g., the Lower 48 and Canada) where it is pursuing more aggressive development and acquisition activity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2023 = 312 bcf, 2024 = 296 bcf (a decrease of 16 bcf). The LLM claims: 2023 = 296 bcf, 2024 = 289 bcf (a decrease of 7 bcf). The LLM has reversed or misread the data entirely - it appears to have used 2024's correct figure (296 bcf) as the 2023 baseline, then provided an incorrect 2024 figure (289 bcf). This is a major factual error that undermines the entire answer. The percentage calculation (≈2%) is mathematically consistent with the LLM's incorrect numbers (7/296 ≈ 2.4%), but this does not validate the answer since the underlying data is wrong. The qualitative reasoning about 'maintaining a stable, non-expansionary presence' and 'directing resources toward other regions' may be reasonable interpretations, but they are built on incorrect numerical foundations. The answer does address the multi-part question structure (evolution + operational focus implications), but the factual inaccuracy is disqualifying. The LLM appears to have confused or inverted the year-over-year data, which is a critical failure in a financial analysis context where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 341,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\nIn 2022 Comcast’s wireless‑gateway strategy was to procure a standardized set of customer‑premise equipment from a limited group of suppliers and make the devices available to broadband subscribers either as a direct purchase or through interest‑free 24‑month financing, bundling them with its internet service. By contrast, the 2024 plan shifts the investment focus to the underlying network, with capital spending directed toward scalable infrastructure, line‑extensions and DOCSIS 4.0 upgrades that will deliver multigigabit symmetrical speeds rather than expanding gateway procurement. (2022 10‑K pp. 6‑7; 2024 10‑K p. 51)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop comparison question. STRENGTHS: (1) Correctly identifies the 2022 strategy as procurement-focused with customer premise equipment from limited suppliers, matching the ground truth. (2) Accurately captures the financing mechanism (interest-free 24-month financing) and bundling approach, adding specific operational details. (3) Properly synthesizes the 2024 shift toward infrastructure investment rather than gateway procurement expansion. (4) Correctly identifies DOCSIS 4.0 upgrades and multigigabit symmetrical speeds as the 2024 focus, aligning with ground truth. (5) Provides proper source citations (2022 10-K pp. 6-7; 2024 10-K p. 51) demonstrating document-specific evidence. (6) The comparison logic is sound: 2022 = passive procurement/distribution vs. 2024 = active infrastructure investment. MINOR CONSIDERATIONS: The LLM answer emphasizes 'line-extensions' and 'scalable infrastructure' as capital spending priorities, which represents a slightly more granular breakdown than the ground truth's broader statement about 'network upgrades' and 'infrastructure strategy.' However, this is not contradictory—it's a more detailed specification of the same strategic shift. The ground truth emphasizes the 'move from passive procurement to active integration,' while the LLM answer frames it as a shift from 'gateway procurement' to 'underlying network' investment—semantically equivalent and both accurate. No numerical errors detected. Multi-hop reasoning is sound: correctly synthesizes information across two different fiscal years and two different strategic focuses. The answer fully addresses both parts of the comparison question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 471,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla’s treatment of the Solar Roof shifted from a growth‑focused initiative to a more restrained, engineering‑driven priority.  In the 2022 filing the roof was highlighted as a revenue driver for the Energy segment—deployments were rising and the company was working to lower unit costs—but it still suffered from under‑utilized factories and modest gross margins.  By the 2024 filing the product is no longer presented as a central growth pillar; instead Tesla emphasizes broader energy‑storage and battery‑cell programs, and the disclosed challenges center on limited supplies of specialized glass and solar‑cell materials and the complexity of scaling a new, highly engineered manufacturing process.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but introduces details not supported by the ground truth and misses the core framing shift. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024, (2) Accurately notes the transition from growth-focused to more cautious positioning, (3) Appropriately mentions manufacturing/scaling challenges in 2024. WEAKNESSES: (1) The ground truth emphasizes a shift from 'emphasizing deployment success' to 'cautioning about operational and manufacturing risks,' but the LLM introduces specific unsupported details like 'limited supplies of specialized glass and solar-cell materials' and 'under-utilized factories' in 2022 that are not mentioned in the ground truth. (2) The LLM states Solar Roof 'is no longer presented as a central growth pillar' and that Tesla 'emphasizes broader energy-storage and battery-cell programs' - while this may be true, the ground truth specifically frames the shift as positioning Solar Roof as 'facing potential production ramp delays similar to past vehicle and energy storage product launches,' which is a more specific and important distinction. (3) The LLM's characterization of 'modest gross margins' in 2022 is not explicitly stated in the ground truth. (4) The phrase 'engineering-driven priority' in the opening is vague and doesn't precisely capture the ground truth's emphasis on manufacturing risks and scaling challenges. MULTI-HOP REASONING: The answer does synthesize information across the two years, but it adds interpretive details that go beyond what the ground truth supports. The core insight about the shift from deployment success to production risk warnings is present but somewhat obscured by the additional details. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiating factor. SEMANTIC EQUIVALENCE: While the general direction is correct, the specific framing differs meaningfully - the ground truth emphasizes 'potential production ramp delays' as the key 2024 concern, whereas the LLM emphasizes material supply constraints and manufacturing complexity, which are related but distinct concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 583,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\nFrom 2022 to 2023 the “Net pending transactions and other investments” line in the Duke Energy Master Retirement Trust rose from **$14 million (2022)** to **$54 million (2023)** – an increase of roughly **$40 million (≈ 285 %)**. This jump shows that Duke Energy has markedly expanded its short‑term, highly liquid holdings, likely to fund upcoming capital projects, manage cash‑flow timing and support strategic initiatives such as regulatory‑driven investments or growth opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual dimensions. (1) QUANTITATIVE ERRORS - The numbers are completely reversed: Ground truth shows $53M (2022) → $14M (2023), but LLM states $14M (2022) → $54M (2023). This is a directional reversal of the trend. The LLM also calculates a $40M increase and 285% growth, which would be correct IF the numbers were accurate, but they are not. The actual change is a $39M DECREASE (not increase), representing approximately a 74% reduction. (2) ENTITY/CONTEXT CONFUSION - The LLM references 'Duke Energy Master Retirement Trust' which appears to be a specific trust entity, whereas the ground truth refers to Duke Energy's general investment category. This suggests the LLM may have pulled data from a different source or misidentified the relevant financial statement line item. (3) DIRECTIONAL ANALYSIS FAILURE - The LLM's interpretation that this represents an 'expansion' of holdings is the opposite of what the ground truth indicates (a 'significant reduction'). The strategic implications drawn (funding capital projects, managing cash flow) are contradicted by the actual decrease in investments. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison, which is the core requirement of this question. The answer demonstrates a fundamental misreading of the financial data rather than a minor calculation error or wording difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 398,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\nThe company kept the same liability‑driven investment targets – ≈20 % equity/80 % fixed‑income for its pension assets and 55 % equity/45 % for post‑retirement assets – but the actual portfolio was tweaked between 2023 and 2024: equity rose modestly (pension equity ↑ from 18 % to 21 %; post‑retirement equity ↑ from 53 % to 57 %) while the Treasury‑related fixed‑income share fell (pension ↓ from 25 % to 16 %; post‑retirement ↓ from 16 % to 13 %).  At the same time, defined‑contribution plan expense increased to **$112 million in 2024** (up from $109 million in 2023), and the 2024 filing added a more detailed fair‑value hierarchy disclosure of plan assets (Level 1/2/NAV breakdowns and a note that Level 3 holdings are immaterial), providing a clearer view of the asset composition than the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific asset allocation percentages (pension equity 18%→21%, post-retirement equity 53%→57%, Treasury fixed-income 25%→16% and 16%→13%) that are NOT present in the ground truth. The ground truth only mentions a 20%/80% equity/fixed income target allocation for pension assets and does NOT mention post-retirement asset allocations at all. These specific percentage changes appear to be fabricated or from a different source. (2) ENTITY ACCURACY - The ground truth makes no mention of post-retirement assets or their allocation targets (55% equity/45%), yet the LLM prominently features this. This is a significant factual error. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) defined contribution plan expenses of $109M in 2023 and $112M in 2024, (b) the 20%/80% equity/fixed income target allocation for pension assets, (c) enhanced disclosure in 2024 regarding plan asset composition. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize information about asset allocation changes and disclosure improvements, it does so by introducing data points not supported by the ground truth. The reasoning structure is sound, but the underlying facts are problematic. (5) DISCLOSURE ENHANCEMENT - The LLM correctly identifies that 2024 added more detailed fair-value hierarchy disclosure (Level 1/2/NAV breakdowns), which aligns with the ground truth's mention of 'more detailed transparency in reporting.' However, the ground truth is more general ('actual composition of plan assets at year-end would be characterized') while the LLM provides specific technical details about fair-value hierarchy that may or may not be accurate. The core answer is partially correct on the defined contribution expenses and target allocation, but the introduction of unsupported post-retirement asset data and specific percentage changes significantly undermines the response's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 531,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\nBetween FY 2023 and FY 2024 Qualcomm moved from a broad‑based AI research agenda to a concrete, revenue‑driving on‑device AI strategy.  The 2024 10‑K explicitly calls out “on‑device artificial intelligence (AI)” as a core growth pillar and notes that the company will continue to invest heavily in AI‑centric silicon, AI‑software ecosystems and related R&D—particularly for automotive and IoT applications—while also expanding patents and strategic investments in AI‑related technologies.  In short, the company deepened its focus on commercializing on‑device AI, tying future growth to AI‑enabled products in new markets beyond mobile handsets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Qualcomm's On-Device AI strategy between FY2023 and FY2024, correctly identifying the shift from strategic vision to active investment. The answer accurately reflects that the company moved toward commercializing on-device AI with focus on automotive and IoT applications beyond mobile handsets. However, there are some notable differences from the ground truth: (1) The LLM answer introduces language about 'broad-based AI research agenda' transitioning to 'concrete, revenue-driving' strategy, which is not explicitly stated in the ground truth and represents some interpretive framing. (2) The LLM mentions 'AI-centric silicon, AI-software ecosystems and related R&D' and 'expanding patents and strategic investments' - these are reasonable inferences but not explicitly confirmed in the ground truth provided. (3) The ground truth emphasizes the shift from positioning as a leader in 5G/integrated circuits to 'investment-driven strategy' with 'acquisitions or strategic transactions,' while the LLM focuses more on R&D and product development without explicitly mentioning acquisitions/strategic transactions. (4) The LLM's characterization of the evolution is slightly different - ground truth emphasizes 'vision to active investment and expansion' while LLM emphasizes 'research to revenue-driving commercialization.' The answer is factually sound on the key points (On-Device AI focus, automotive/IoT expansion, investment in new areas) but lacks some of the specific strategic elements mentioned in the ground truth regarding acquisitions and the explicit investment-driven approach. No quantitative errors detected. The multi-hop reasoning is sound in connecting FY2023 positioning to FY2024 strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 480,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\nThe Voting Trust Agreement continues to be filed as **Exhibit 9.1** (and 9.2) in both the 2022 and 2023 Form 10‑K filings, with the identical caption “**Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated March 1 2004**” between Melvin Simon & Associates and the Simon family members. No re‑classification, amendment, or relocation of the exhibit appears in the 2023 filing, signalling that the underlying governance structure remains unchanged and stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the 2022 10-K filing describes the agreement as 'Second Amended and Restated' while the 2023 10-K filing refers to it WITHOUT this modifier, representing an evolution in presentation. However, the LLM answer claims the identical caption 'Second Amended and Restated Voting Trust Agreement' appears in BOTH filings with no change. This is the opposite of what the ground truth indicates. The LLM correctly identifies the exhibit numbers (9.1 and 9.2), the date (March 1, 2004), and the parties involved (Melvin Simon & Associates and Simon family members). The LLM also correctly concludes that the governance structure remains stable. However, the core claim about the evolution of classification and presentation is entirely incorrect. The ground truth's key insight—that the removal of 'Second Amended and Restated' from the 2023 filing indicates no further amendments were made—is completely missed. The LLM's assertion that 'No re-classification, amendment, or relocation of the exhibit appears in the 2023 filing' contradicts the ground truth's explicit statement that the presentation DID change between years. This is a critical multi-hop reasoning failure where the model failed to accurately synthesize the differences between the two filings' presentations of the same agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 395,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia Pacific/Middle East fell from about **312 billion cubic feet (BCF) at the end of 2023 to roughly 296 BCF at the end of 2024** – a decline of roughly 5 %.  The drop is driven by **downward price‑related revisions in the region’s equity‑affiliate holdings (≈ 81 BCF of lower‑price revisions, partially offset by ~ 55 BCF of technical gains)** and only modest reserve additions from extensions and discoveries (mainly in the Middle East and Australia).  \n\nBecause the region’s reserve base is now a **small, slightly shrinking share of COP’s total global gas portfolio**, the trend signals that COP is **de‑emphasising the Asia Pacific/Middle East** as a strategic growth area and is instead focusing reserve development on North‑American unconventional plays and other regions with more robust reserve growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Core numbers are correct: 312 BCF (2023) and 296 BCF (2024) match ground truth exactly. (2) Percentage decline calculation is accurate (~5% matches the ground truth's 5.1%). (3) The LLM correctly identifies the region as a 'small, slightly shrinking share' of global portfolio. (4) Multi-hop reasoning is sound - the answer synthesizes reserve changes with strategic implications. (5) Contextual relevance is strong - addresses both the evolution question and strategic importance question. WEAKNESSES: (1) The LLM introduces specific details about 'downward price-related revisions (~81 BCF)' and 'technical gains (~55 BCF)' that are NOT present in the ground truth. While these details may be factually accurate from the source filings, they go beyond what the ground truth confirms and represent information not validated in this evaluation. (2) The ground truth mentions equity affiliates held 5,870 BCF in 2024, which the LLM does not explicitly reference (though it does mention 'equity-affiliate holdings'). (3) The LLM's statement about 'North-American unconventional plays' as the focus area is a reasonable inference but not explicitly confirmed in the ground truth. CALCULATION VERIFICATION: 312 - 296 = 16 BCF decline; 16/312 = 5.13% ≈ 5% (both answers correct). MULTI-HOP SYNTHESIS: The LLM successfully connects reserve decline data to strategic implications, though it adds interpretive details beyond the ground truth. The core answer structure and conclusions align with ground truth, but the additional specificity about price revisions and technical gains introduces unverified information that, while potentially accurate, cannot be confirmed against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 467,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\nBetween 2023 and early 2024 AIG moved from fully consolidating Corebridge—so that Corebridge’s debt and earnings were reflected in AIG’s balance sheet and results—to de‑consolidating the insurer after it fell below the 50 % ownership threshold and lost board control on June 9 2024.  Following the de‑consolidation AIG retained a 22.7 % equity stake and began accounting for the investment under the equity method, recognizing income from dividends and changes in Corebridge’s stock price (e.g., a $601 million equity‑method gain in 2024) and later realized gains on share sales; Corebridge’s own debt (≈ $9.4 bn of senior notes, DDTL facility, etc.) remained on Corebridge’s books and was no longer consolidated into AIG’s debt, leaving AIG’s own debt structure essentially unchanged aside from the $261 million equity‑increase recorded from the secondary offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's relationship evolution with Corebridge between 2023-2024. STRENGTHS: (1) Correctly identifies the key transition from consolidation to equity method accounting on June 9, 2024; (2) Accurately states the 22.7% equity stake retained by AIG; (3) Correctly notes the $601 million equity-method gain in 2024; (4) Properly explains the mechanics of de-consolidation and its impact on debt reporting; (5) Accurately describes the equity method income components (dividends and stock price changes); (6) Correctly identifies the $261 million equity increase from secondary offering. MINOR ISSUES: (1) The LLM provides approximate debt figures ('≈ $9.4 bn') rather than the specific $9,368 million cited in ground truth for 2023, though this is a reasonable approximation and the LLM correctly notes the debt remained on Corebridge's books rather than AIG's; (2) The LLM answer is more detailed and contextual than the ground truth (mentioning realized gains on share sales, DDTL facility, secondary offering impact), which adds value but goes slightly beyond what was explicitly in the original answer. MULTI-HOP REASONING: Excellent synthesis across multiple concepts - correctly connects the ownership threshold change, board control loss, de-consolidation trigger, equity method accounting, and specific financial metrics. The answer properly explains the causal chain and financial statement impacts. QUANTITATIVE VERIFICATION: The 22.7% stake, $601M gain, and $261M equity increase are all accurate. The debt figures are reasonably approximated. DATE ACCURACY: June 9, 2024 de-consolidation date is correct. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental transformation described in the ground truth while providing additional helpful context about the mechanics and specific financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 505,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s Special‑Use funds moved from a largely short‑term, high‑quality fixed‑income tilt—reflecting the need for highly liquid assets to cover storm‑damage reserves and short‑duration nuclear‑decommissioning cash‑flows (see 2022 10‑K pages 56‑57)—to a more balanced portfolio that now carries a noticeably larger equity component (equity holdings of roughly $2.6 bn for NEE and $1.0 bn for FPL at 31 Dec 2024, versus a smaller equity share in 2022).  This modest increase in equity exposure indicates a slight expansion of risk appetite, while the continued heavy weighting in short‑duration debt and regulatory‑linked assets shows the company is still prioritising liquidity to meet its storm‑damage and decommissioning obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) EQUITY HOLDINGS DISCREPANCY: The LLM states equity holdings of 'roughly $2.6 bn for NEE and $1.0 bn for FPL at 31 Dec 2024,' but the ground truth clearly states NEE's Special Use Funds included $6,164 million ($6.164 billion) in equity securities by 2024—more than double the LLM's figure. The LLM appears to have conflated or underestimated the equity component. (2) MISSING DETAILED BREAKDOWN: The ground truth provides a complete 2024 allocation: $6,164M equity, $722M U.S. Government/municipal bonds, $685M corporate debt, $873M asset-backed securities (total ~$8.4B). The LLM provides no such detailed breakdown and only vague references to 'roughly $2.6 bn' equity. (3) 2022 BASELINE ERROR: The ground truth explicitly states 2022 Special Use Funds were 'entirely composed of fixed income securities, with a carrying amount of $2,505 million.' The LLM's characterization of 2022 as 'largely short-term, high-quality fixed-income' is directionally correct but lacks the precise $2,505M figure and doesn't clearly establish the 100% fixed-income baseline. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the shift from fixed-income to equity-heavy allocation and mentions increased risk appetite, it fails to quantify this transformation accurately. The shift from $2,505M (all fixed income) to $6,164M equity alone represents a dramatic strategic change that the LLM understates. (5) CONTEXTUAL REASONING: The LLM's discussion of storm-damage reserves and nuclear decommissioning is contextually relevant but doesn't directly address the specific investment allocation evolution asked in the question. The reasoning about liquidity priorities is sound but secondary to the core quantitative question. (6) ENTITY ACCURACY: The LLM mentions both NEE and FPL, which adds complexity not present in the ground truth answer (which focuses on NEE). This introduces potential confusion about whether the question concerns consolidated or subsidiary-level data. VERDICT: The answer demonstrates understanding of the strategic shift but fails on the primary metric—accurate quantification of the portfolio evolution. The $6.164B equity figure is fundamentally misrepresented as $2.6B, representing a 58% understatement of the actual equity allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 634,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\nBetween 2022 and 2024 the risk that site‑infrastructure sharing would curb new lease activity grew from a general caution to a concrete, 5G‑driven threat.  In both years the filings warned that “extensive sharing of site infrastructure, roaming or resale arrangements … including due to increases in advanced network technology such as 5G, as an alternative to leasing our communications sites, without compensation to us, may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment, or may result in the decommissioning of equipment on certain existing sites.”  However, the 2024 discussion tightens this language to “RAN sharing, roaming or resale arrangements … due to increases in advanced network technology such as 5G,” explicitly linking the rise of 5G‑based sharing models to a higher likelihood of reduced lease renewals, lower lease rates and greater churn, thereby amplifying the magnitude of the risk for American Tower.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of the risk from 2022 to 2024, capturing the shift from general caution to concrete, 5G-driven threat; (2) Accurately references the specific language from both years' filings, including the quoted text about 'site infrastructure sharing, roaming or resale arrangements' and the 2024 tightening to 'RAN sharing'; (3) Properly synthesizes the multi-hop information showing how 5G technology adoption drove the evolution of this risk; (4) Correctly identifies American Tower (AMT) as the company in question; (5) Accurately conveys the financial impact dimension - that carriers' use of shared infrastructure without compensation to AMT represents the core threat; (6) Properly characterizes the magnitude evolution, noting increased specificity and perceived threat level in 2024. MINOR CONSIDERATIONS: The LLM answer adds slightly more interpretive language ('tightens this language,' 'amplifying the magnitude') compared to the ground truth's more straightforward description, but this represents enhanced clarity rather than factual error. The answer correctly captures that the 2024 filing shows a 'stronger emphasis on the financial impact' through its more specific focus on RAN sharing and explicit linkage to reduced lease renewals, lower rates, and greater churn. No quantitative errors detected. The multi-hop reasoning correctly synthesizes information about how 5G adoption influenced carrier behavior and how this behavior evolved the nature of the risk AMT faces. All entities, dates, and concepts are accurately identified and properly contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 465,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\nChevron’s equity investment in Angola LNG Limited slipped from **$1.96 billion at the end of 2022 to $1.76 billion at the end of 2023**, a decline of about $200 million.  The stake is still accounted for under the **equity‑method** – Chevron records its share of Angola LNG’s earnings (reported as $513 million for 2023) and adjusts the carrying amount of the investment accordingly, while retaining its **36.4 percent ownership** and the same accounting treatment used in prior years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses a different dimension of the question than the ground truth, resulting in significant misalignment. CRITICAL ISSUES: (1) The ground truth focuses on the relationship classification evolution ('Depends_On' to 'Invests_In') and strategic posture changes, while the LLM answer provides investment valuation data ($1.96B to $1.76B) and equity method accounting details that are not mentioned in the ground truth. (2) The LLM introduces specific dollar amounts ($1.96B, $1.76B, $513M earnings) that cannot be verified against the provided ground truth and may be fabricated or from different sources. (3) The LLM correctly identifies the 36.4% ownership percentage and equity method accounting, which aligns with ground truth, but this represents only partial correctness. (4) The LLM fails to address the core evolution described in ground truth: the shift from 'Depends_On' relationship classification to 'Invests_In' classification, which is the primary indicator of how the relationship evolved. (5) The LLM's focus on financial valuation changes and earnings reporting, while potentially accurate information about Angola LNG investments, does not directly answer the question about the evolution of the relationship structure and accounting classification. The answer demonstrates knowledge of equity method accounting but misses the fundamental relationship reclassification that defines the evolution between 2022-2023. The 36.4% ownership consistency is correctly noted but insufficient to address the full scope of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 428,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\nFrom 2022 to 2023 the G600 stayed a core element of Gulfstream’s large‑cabin fleet, with cumulative deliveries climbing from almost 150 aircraft (as of year‑end 2021) to more than 250 by the end of 2023—demonstrating uninterrupted production and rising market demand. Its performance specifications—top‑tier cruise speeds (≈Mach 0.90), an ≈8,000‑nautical‑mile range, enhanced fuel efficiency and a larger cabin, plus more than 90 city‑pair speed records—remain unchanged, keeping the G600 at the benchmark level of Gulfstream’s product line while newer models such as the G700 and G800 are positioned to extend range and capability further.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the evolution of the G600 from 2022 to 2023 and correctly identifies key performance metrics and production status. However, there are significant quantitative accuracy issues that lower the overall score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the G600 as a core element of Gulfstream's large-cabin fleet\n- Accurately states cumulative deliveries exceeded 250 by end of 2023\n- Correctly mentions performance specs (Mach 0.90 cruise speed, ~8,000 nautical mile range)\n- Appropriately notes the G700 and G800 as newer models extending range/capability\n- Correctly identifies the shift in positioning (though less explicitly than ground truth)\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERROR: The LLM states deliveries climbed \"from almost 150 aircraft (as of year-end 2021) to more than 250 by the end of 2023.\" The ground truth does not provide a 2021 baseline of 150 deliveries. This appears to be an unsupported interpolation or inference not present in the source material.\n2. MISSING KEY INSIGHT: The ground truth emphasizes the shift from 'new' product (2022) to 'mature' product (2023), which the LLM answer does not explicitly capture. The LLM says it \"stayed a core element\" but doesn't convey the maturation narrative.\n3. MISSING CRITICAL DETAIL: The ground truth specifically mentions the Symmetry Flight Deck as an advanced technology being extended to newer models (G700, G800, G400). The LLM answer omits this technological integration detail entirely.\n4. INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a clear evolution from \"recent addition\" (2022) to \"mature product\" (2023) with platform integration. The LLM answer focuses more on production continuity than this strategic positioning shift.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the G600's role across the two-year period and connects it to newer models, but misses the key narrative about technological platform integration and product maturation.\n\nSEMANTIC EQUIVALENCE: While the LLM conveys some of the same information, it emphasizes production volume growth rather than the strategic shift from introduction to maturity and platform integration that characterizes the actual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 605,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted from a purely royalty‑and‑rent model to a more partnership‑oriented approach. The company now regularly co‑invests with franchisees in restaurant modernizations, digital‑platform upgrades and supply‑chain initiatives—sharing capital costs and strategic goals—while still earning revenue through rent, royalties, initial fees and technology‑recovery charges. This deeper financial collaboration reflects a move toward joint‑value creation rather than a purely transactional franchise relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of McDonald's franchisee relationships between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from a transactional model (royalties, rent, fees) to a collaborative partnership model with co-investments; (2) Accurately captures the 2022 baseline of primarily rent/royalty-based arrangements; (3) Correctly describes the 2024 evolution toward co-investment in restaurant improvements and modernization; (4) No quantitative errors or incorrect numbers/dates; (5) Properly synthesizes the multi-hop information comparing two time periods; (6) Uses semantically equivalent language ('partnership-oriented approach' vs 'collaborative partnership', 'co-invests' vs 'co-investing'); (7) Adds relevant context about technology-recovery charges and supply-chain initiatives that align with the modernization theme. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'supply-chain initiatives' which is not explicitly mentioned in the ground truth, though this is a reasonable inference about operational improvements and doesn't contradict the source material; (2) The phrase 'joint-value creation' is interpretive language that captures the spirit of the shift but goes slightly beyond the explicit ground truth framing; (3) The ground truth emphasizes 'consumer preferences' and 'local performance' as motivations, while the LLM focuses more on the mechanism (co-investment structure) rather than the underlying strategic drivers. These are minor omissions rather than errors. The answer successfully demonstrates multi-hop reasoning by comparing 2022 and 2024 positions and identifying the strategic evolution. No factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 474,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the smokeable‑products segment saw a modest dip in sales: net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023** (about a $720 million or 3.2 % decline).  Operating income also slipped only slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a reduction of roughly $18 million (≈0.2 %).  The segment therefore experienced a small revenue contraction but essentially flat operating profitability over the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - 2022 net revenues of $22,476 million, 2023 net revenues of $21,756 million, 2022 operating income of $10,688 million, and 2023 operating income of $10,670 million all match the ground truth exactly. The calculated differences are accurate: $720 million revenue decline (correct: $22,476M - $21,756M = $720M) and $18 million operating income decline (correct: $10,688M - $10,670M = $18M). The percentage calculations are also correct: 3.2% revenue decline ($720M / $22,476M ≈ 3.2%) and 0.2% operating income decline ($18M / $10,688M ≈ 0.17%, reasonably rounded to 0.2%). (2) COMPLETENESS: The answer fully addresses both components of the multi-part question - net revenues and operating income evolution from 2022 to 2023. (3) ENTITY ACCURACY: The smokeable products segment is correctly identified, and both fiscal years (2022 and 2023) are properly referenced. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted data from two different years and compared them to identify trends. The characterization of the changes as 'modest dip' and 'small revenue contraction but essentially flat operating profitability' is semantically accurate and appropriately nuanced. (5) PRESENTATION: The answer is well-structured with clear formatting of key numbers and helpful calculations that enhance understanding. The only minor consideration is that the ground truth uses the phrase 'declined marginally' while the LLM uses 'slipped only slightly' - these are semantically equivalent descriptions of the same phenomenon.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 458,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\nFrom 2022 through 2024 Opdivo shifted from being mainly a co‑developed immuno‑oncology asset with Ono (with shared development costs and a 50/50 profit split in Japan) to a broader platform that is being expanded through new collaborations and regulatory milestones.  In 2024 the FDA approved the subcutaneous formulation Opdivo Qvantig and granted fresh indications—including neoadjuvant NSCLC, urothelial carcinoma and a first‑line Opdivo + Yervoy regimen for colorectal cancer—while the partnership with Nektar on the NKTR‑214 combo entered Phase III, reinforcing Opdivo’s role as a central growth engine and a versatile backbone for BMY’s oncology pipeline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON KEY APPROVALS: The LLM claims FDA approved a 'subcutaneous formulation Opdivo Qvantig' in 2024 and lists multiple new indications (neoadjuvant NSCLC, urothelial carcinoma, first-line Opdivo + Yervoy for colorectal cancer). However, the ground truth only confirms ONE specific FDA approval in March 2024: combination with cisplatin and gemcitabine for first-line unresectable/metastatic urothelial carcinoma. The LLM appears to have fabricated or conflated multiple approvals not mentioned in the ground truth. (2) PARTNERSHIP ACCURACY: The LLM introduces a Nektar/NKTR-214 partnership and Phase III trial information that is NOT present in the ground truth answer. This represents unsupported claims about collaborative frameworks. (3) CORRECT ELEMENTS: The LLM correctly identifies the 2022 Ono partnership structure with shared development costs and profit splits (though ground truth specifies 80-20 splits for single-party compounds, not just 50/50). The LLM correctly captures the evolution from co-development to more independent expansion. (4) MISSING CONTEXT: The LLM fails to mention the broader alliance context (Yervoy, Orencia) that was part of the original structured framework in 2022. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022-2024 evolution, it does so by introducing unverified information rather than accurately synthesizing the documented facts. The core narrative of evolution from co-development to independent expansion is present but undermined by factual inaccuracies on specific approvals and partnerships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 439,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 AMT shifted from broadly describing variable‑rate benchmarks—citing SOFR + spread on Nigerian letters of credit and “interest rate … above LIBOR/EURIBOR” for its revolving facilities—to explicitly naming the fixed coupons of its latest securitizations (5.490 %/5.735 % for the 2023‑Series A/R notes and 3.652 %/4.459 % for the 2018‑Series A/R notes).  The newer filings retain the same DSCR‑based covenants (Cash‑Trap at 1.30× and Minimum DSCR at 1.15× that trigger reserve accounts and mandatory amortization) but add detailed triggers for amortization of the 2015‑2 notes and prepayment considerations, moving from generic benchmark references to precise rate disclosures and expanded covenant mechanics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific coupon rates (5.490%, 5.735%, 3.652%, 4.459%) and DSCR covenant thresholds (1.30×, 1.15×) that are not mentioned in the ground truth answer. These appear to be fabricated or from unverified sources. The ground truth mentions debt ratings-based commitment fees of 0.080% to 0.300% in 2022, which the LLM completely omits. (2) ENTITY/SCOPE CONFUSION: The LLM shifts focus to securitizations (2023-Series A/R, 2018-Series A/R, 2015-2 notes) which are not mentioned in the ground truth. The ground truth focuses on credit facilities and letters of credit, not securitization notes. This represents a fundamental misunderstanding of the question's scope. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states the evolution involved: 2022 referenced LIBOR/EURIBOR with specific covenant details, while 2024 shifted to SOFR-based instruments with simplified covenant presentation. The LLM's answer conflates securitization disclosures with credit facility benchmarks, failing to properly synthesize the 2022-to-2024 evolution. (4) MISSING KEY INFORMATION: The LLM omits the critical finding that 2024 disclosures 'focused on consequences of covenant non-compliance without specifying interest rate structures or renewal terms,' which is central to understanding the evolution. (5) ACCURACY OF CORE CLAIM: The LLM correctly identifies SOFR as appearing in 2024 disclosures, but this is the only element that aligns with ground truth. The overall narrative about moving from 'variable-rate benchmarks to fixed coupons' contradicts the ground truth's emphasis on a shift from LIBOR to SOFR. The answer demonstrates poor multi-hop reasoning and introduces unverified financial metrics that cannot be validated against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 510,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted from a primarily “land‑lord” model—where it owned or long‑term‑leased real estate and collected rent and royalties from franchisees—to a more collaborative co‑investment approach.  In the 2024 filing the company stresses that it now works hand‑in‑hand with franchisees to fund restaurant upgrades and new openings, often sharing capital and using developmental‑license or affiliate structures that give it equity stakes (especially in markets such as China and Japan).  This evolution reflects a move toward joint‑venture‑style investments that aim to modernize stores, meet consumer‑preference goals and generate higher‑margin revenue rather than relying solely on passive franchisee reinvestment.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer fundamentally misrepresents McDonald's franchise model evolution. The ground truth clearly states that McDonald's model in 2024 involves the company owning/leasing real estate while franchisees invest in equipment, signs, seating, and décor—this is NOT a shift toward co-investment or joint-venture structures. The LLM incorrectly claims McDonald's moved FROM a 'landlord model' TO a 'collaborative co-investment approach' with shared capital and equity stakes. This is backwards and factually wrong. The ground truth explicitly states the 2024 model maintains the conventional franchise structure where McDonald's owns/leases real estate and franchisees invest in interior items—not a shift toward equity partnerships. The LLM's mention of 'developmental-license or affiliate structures' and 'equity stakes' in China/Japan may exist but are NOT presented in the ground truth as evidence of the evolution described. The LLM also incorrectly characterizes the 2022 position as a 'landlord model collecting rent and royalties'—the ground truth only mentions ESG coordination in 2022, not a detailed real estate strategy. CORRECT ELEMENTS: The LLM does correctly identify the 2022-2024 timeframe and attempts to describe an evolution in franchise relationships. CRITICAL FAILURE: The LLM fundamentally inverts the actual relationship structure and mischaracterizes the nature of the evolution. The ground truth shows clarification/formalization of an existing model (2024 explicitly outlining what was implicit), not a shift from landlord to co-investment. This is a semantic and factual reversal of the actual answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 455,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\nIn the 2022 filing the 2015 Stock‑Compensation Plan for Non‑Employee Directors was still presented as a distinct, shareholder‑approved plan, with its latest amendment (effective Oct 26 2022) disclosed in the Annual Report; by the 2023 filing the plan was no longer listed as a separate plan in the equity‑compensation table, its available shares being folded into the broader 2020 Performance Incentive Plan and only a brief exhibit reference remained. This shift shows Altria’s move to consolidate director compensation into a single, streamlined equity‑incentive framework, emphasizing simplicity, transparency and alignment with its overall shareholder‑approved governance structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The ground truth specifies 703,256 shares were available in 2022, but the LLM answer does not mention this figure at all. The LLM claims the plan was 'folded into the broader 2020 Performance Incentive Plan' by 2023, which is not supported by the ground truth. (2) ENTITY/STRUCTURAL ERRORS: The ground truth clearly states the plan remained as a distinct plan in 2023, with formal amendment and restatement effective October 26, 2022, incorporated by reference from the September 30, 2022 Form 10-Q. The LLM incorrectly claims the plan was 'no longer listed as a separate plan' and 'folded into' another plan - this is a fundamental mischaracterization. (3) DOCUMENTATION ACCURACY: The ground truth indicates the plan was formally amended and restated with proper documentation/incorporation by reference. The LLM suggests the plan was consolidated/eliminated, which is factually incorrect. (4) GOVERNANCE INTERPRETATION: While both answers attempt to interpret governance implications, the LLM's interpretation is based on false premises (consolidation/elimination) rather than the actual evolution (formal amendment and restatement). The ground truth's interpretation of 'refined director compensation framework' is more accurate than the LLM's 'consolidation into single framework.' (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022-to-2023 changes, instead inventing a consolidation narrative unsupported by the source material. The answer demonstrates a fundamental misunderstanding of what actually changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 463,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\nFrom 2022 through 2024, carriers have increasingly turned to roaming, RAN‑sharing and resale arrangements—accelerated by 5G roll‑outs and cost pressures—to meet capacity needs without leasing separate tower space.  This shift has slowed new lease additions and even prompted the de‑commissioning of redundant equipment on existing sites, indicating that competitive pressures are constraining AMT’s lease growth and forcing the company to contend with lower‑cost, shared‑infrastructure alternatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of roaming/resale arrangements from 2022 to 2024, correctly identifying the progression from concerns about slowed lease activity to broader risks including equipment decommissioning. The mention of 5G acceleration and cost pressures is factually accurate and contextually appropriate. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in either the original or LLM answer, so this dimension scores perfectly. The temporal progression (2022 to 2024) is correctly maintained. (3) QUALITATIVE ACCURACY: The LLM successfully synthesizes the multi-hop reasoning: it connects the cause (roaming/RAN-sharing/resale arrangements driven by 5G and cost pressures) to the effects (slowed new lease additions and equipment decommissioning) to the broader implication (competitive pressure constraining growth). The identification of AMT as the affected company is implicit and correct. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'lower-cost, shared-infrastructure alternatives' effectively conveys the same meaning as the ground truth's 'infrastructure sharing becoming a more viable and widespread alternative to leasing.' The answer maintains the causal chain and strategic implications. (5) MINOR CONSIDERATION: The LLM answer is slightly more concise than the ground truth but loses no material information. The phrase 'forced the company to contend with' adds appropriate emphasis on competitive pressure. All key concepts are present: the evolution over time, the specific mechanisms (roaming, RAN-sharing, resale), the dual impact (new lease slowdown and decommissioning), and the competitive pressure conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 491,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a largely “hands‑off” franchise model—where franchisees were expected to fund most capital upgrades on their own and the Company’s role was limited to setting standards—to a more collaborative strategy in which the Company actively co‑invests with franchisees to finance restaurant modernizations, technology upgrades and sustainability initiatives while raising the operational bar for digital, delivery and menu innovation.  This shift is reflected in the 2022 filing’s risk discussion of franchisee‑driven capital needs (p. 28) and the 2024 disclosures that detail joint investment projects and the heightened performance expectations tied to the “Accelerating the Arches” strategy (pp. 4‑5).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of McDonald's franchise relationship evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift from a 'hands-off' model to active co-investment strategy, matching the ground truth's characterization of moving from pandemic-driven challenges to investment-backed growth. (2) Accurately captures the key elements: co-investment initiatives, restaurant modernization, technology upgrades, and heightened operational expectations. (3) Properly synthesizes the multi-hop information across 2022 and 2024 filings. (4) References specific filing locations (p. 28 for 2022, pp. 4-5 for 2024) showing document-level accuracy. (5) Correctly mentions 'Accelerating the Arches' strategy as the connecting thread. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds details about 'sustainability initiatives' and 'digital, delivery and menu innovation' that, while plausible and consistent with McDonald's strategic direction, are not explicitly mentioned in the ground truth answer. This represents minor elaboration beyond the provided ground truth rather than factual error. (2) The characterization of the 2022 model as 'largely hands-off' is a reasonable interpretation of the ground truth's description of franchisees bearing capital burden, though the ground truth uses different framing. (3) The answer could have more explicitly mentioned the pandemic context from 2022 (labor availability, supply chain disruptions) that the ground truth emphasizes, though the 'pandemic-driven challenges' reference partially addresses this. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and filing documents, correctly identifying the directional shift and its strategic implications. The logic connecting pandemic-era operational constraints to post-pandemic investment strategy is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 569,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\nFrom 2022 to 2024 the fund’s equity position turned from an unrealized loss of roughly **$1.0 bn** to an unrealized gain of about **$0.9 bn**, while proceeds from sales or maturities of those securities climbed from **$2.2 bn** to **$2.9 bn** and realized losses fell from **$141 m** to **$86 m**.  This shows NextEra shifted toward a larger, more actively‑managed equity allocation in its Special Use Funds and began realizing gains more aggressively to fund nuclear‑decommissioning obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question asked. Critical issues: (1) WRONG METRICS: The LLM discusses unrealized gains/losses, proceeds from sales, and realized losses - metrics that are NOT mentioned in the ground truth answer about Special Use Funds equity securities holdings. The ground truth specifically cites $8,922 million (2022) and $6,164 million (2024) in equity securities within Special Use Funds. (2) MISSING KEY DATA: The LLM provides no mention of the actual equity securities amounts ($8,922M in 2022, $6,164M in 2024) that are central to answering the question. (3) UNVERIFIABLE NUMBERS: The LLM's figures ($1.0bn unrealized loss, $0.9bn unrealized gain, $2.2bn to $2.9bn proceeds, $141M to $86M realized losses) cannot be verified against the ground truth and appear to reference different financial metrics entirely. (4) INCORRECT FOCUS: The ground truth emphasizes the evolution from lack of explicit breakdown (2022) to detailed disclosure of $6,164M equity allocation (2024), suggesting a shift toward transparency. The LLM instead focuses on gains/losses and proceeds, which is a different analytical framework. (5) MULTI-HOP REASONING: The LLM fails to synthesize the correct information across years - it should compare the equity securities holdings amounts, not unrealized gains/losses. The answer appears to conflate Special Use Funds with a different investment analysis entirely. The only potentially correct element is the general conclusion about 'more actively-managed equity allocation,' but this is unsupported by the specific numbers provided and contradicts the ground truth's emphasis on transparency evolution rather than aggressive management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 470,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the smokeable‑products business saw a modest pull‑back in sales: net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023**, a decline of roughly **$720 million (about 3 %)**.  Operating income also slipped slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a reduction of about **$18 million (≈0.2 %)**.  The dip in revenue was driven by lower shipment volumes, while the small dip in operating income reflects higher general‑corporate expenses and amortization that offset the modest revenue decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: 2022 net revenues of $22,476 million, 2023 net revenues of $21,756 million, 2022 operating income of $10,688 million, and 2023 operating income of $10,670 million. The calculations are accurate: revenue decline of $720 million (3.0% = 720/22,476), and operating income decline of $18 million (0.17% ≈ 0.2% = 18/10,688). The LLM correctly synthesized the multi-hop information comparing both metrics across both years. The answer goes beyond the ground truth by providing additional context about the drivers of the decline (lower shipment volumes, higher general-corporate expenses and amortization), which adds valuable insight without introducing any factual errors. The reasoning is sound and the presentation is clear. The only minor consideration is that the additional explanatory context about drivers was not explicitly in the ground truth, but this represents value-added analysis rather than an error. All entities (smokeable products segment, years 2022-2023, net revenues, operating income) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 326,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Accenture expanded the size of its share‑repurchase program and continued to use the purchases to fund treasury‑stock needs. In 2022 it bought 12.2 million Class A shares for $4.1 bn under its open‑market and other employee‑related programs, holding the shares as treasury stock for employee equity awards and other corporate purposes (page 95). After the Board’s September 2022 decision, an additional $3 bn of authority was added, bringing total repurchase authorization to $6.13 bn, indicating that the 2023 utilization of Class A shares under the program was larger and still directed toward treasury‑stock and employee‑benefit uses (pages 94‑95).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Accenture's share repurchase programs but contains significant quantitative discrepancies and incomplete synthesis compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies that Class A Ordinary Shares were held as treasury shares\n- Correctly notes the intended use for employee benefits/equity awards\n- Correctly identifies the September 2022 Board decision adding authorization\n- Appropriately addresses the evolution between 2022 and 2023\n- Correctly synthesizes the multi-hop concept of share programs and their usage\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS:\n   - States \"12.2 million Class A shares for $4.1 bn\" in 2022 - these specific numbers are not verified in the ground truth\n   - Claims \"additional $3 bn of authority was added\" bringing total to \"$6.13 bn\" - the ground truth mentions $3,129,296 aggregate available authorization in 2022, which is vastly different from the $6.13 bn figure cited\n   - The $6.13 bn total authorization figure appears inconsistent with ground truth data\n\n2. INCOMPLETE SYNTHESIS:\n   - The ground truth specifically mentions the $3,129,296 aggregate available authorization for 2022, which the LLM completely omits\n   - The ground truth notes that fiscal 2024 included share withholding for payroll tax obligations as a separate mechanism from the publicly announced authorization - the LLM does not address this distinction\n   - Missing the clarification that 2023 specifically showed the shift toward internal employee compensation mechanisms\n\n3. CITATION ISSUES:\n   - References \"pages 94-95\" but ground truth does not provide page numbers for verification\n   - The specific share count and dollar amounts cited lack verification against the ground truth\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop reasoning by connecting the Board decision to authorization increases and linking this to treasury stock usage. However, the quantitative foundation of this reasoning appears flawed based on the discrepancy between cited figures and ground truth data.\n\nOVERALL ASSESSMENT:\nThe answer captures the qualitative essence of the evolution (expansion of programs, treasury stock usage, employee benefits focus) but fails on quantitative accuracy with significantly different dollar amounts and missing the specific $3,129,296 figure from 2022. The omission of the fiscal 2024 payroll tax withholding mechanism also represents incomplete synthesis of the full picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 674,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\nBetween 2022 and 2024 the core operating‑covenant framework—reserve‑account requirements, the 1.30× cash‑trap DSCR trigger and the 1.15× amortization‑period test—remained in place, but the debt base broadened and the rate benchmarks evolved.  The company added new securitized tranches (the 2023‑1A/R and 2018 Series 2018‑1 securities) alongside the legacy 2015‑2 notes, and the floating‑rate portions of its multicurrency facilities now reference SOFR or EURIBOR with a fixed spread (e.g., 1.125 % over SOFR), while the newly issued senior notes carry fixed coupons (e.g., 5.490 % and 5.735 %).  Consequently, the covenants now govern a more layered mix of fixed‑rate securitized debt and floating‑rate credit facilities, with interest‑rate benchmarks shifted from LIBOR/EURIBOR‑based formulas to SOFR/EURIBOR spreads and fixed coupon rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: (1) ENTITY MISMATCH - The LLM answer discusses securitized tranches (2023-1A/R, 2018 Series 2018-1), reserve accounts, DSCR triggers, and amortization-period tests that appear to reference a tower/REIT structure, NOT AMT (American Tower Corporation). The ground truth specifically addresses AMT's multicurrency credit facilities and their covenant evolution. (2) BENCHMARK ACCURACY - While the LLM correctly identifies SOFR as the evolved benchmark, it introduces specific spread percentages (1.125% over SOFR, 5.490%, 5.735%) and securitized debt structures that are NOT mentioned in the ground truth and appear to be from a different company's filings. (3) COVENANT DETAILS - The ground truth focuses on the shift from LIBOR/EURIBOR to SOFR benchmarks in AMT's credit facilities and letters of credit. The LLM introduces detailed covenant mechanics (1.30× DSCR trigger, 1.15× amortization test, reserve accounts) that are not present in the ground truth and suggest confusion with a different entity's structure. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize information about AMT specifically, instead providing what appears to be information from a securitized debt structure (possibly a mortgage REIT or similar entity). (5) PARTIAL CREDIT - The LLM does correctly identify the general evolution from LIBOR to SOFR, which aligns with the ground truth's core finding, but the supporting details are factually incorrect for AMT. The specific numbers and securitized structures mentioned cannot be verified against AMT's actual filings based on the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 443,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\nIn the 2023 filing Disney + Hotstar had roughly **31 million** paid subscribers, and the 2024 filing shows that number grew to **≈36 million** paid subscribers as of September 28 2024 – an increase of about 5‑6 million (≈20 %).  At the end of June 2024 the Company merged the standalone **Star+** service into a single **Disney+** offering across Latin America, eliminating a separate brand and consolidating the region’s audience onto one DTC platform, which expands the addressable market, improves monetisation and gives Disney a unified, scalable foundation for its international streaming strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key consolidation event (Star+ merged into Disney+ in Latin America by end of June 2024) and accurately captured the strategic implications (streamlining, unified platform, operational efficiency). The qualitative analysis of the consolidation's impact is sound and well-reasoned. The answer appropriately addresses both parts of the multi-hop question.\n\nWEAKNESSES - QUANTITATIVE: The LLM states Disney+ Hotstar had '31 million' subscribers in 2023, but the ground truth does not provide this specific 2023 figure. The ground truth only confirms '36 million paid subscribers as of September 28, 2024' from the 2023 SEC filing. The LLM appears to have inferred or assumed the 31 million 2023 baseline without explicit ground truth support. The calculated growth of '5-6 million (≈20%)' is mathematically consistent with the stated 31M→36M progression, but the 31M starting point lacks verification.\n\nVERIFICATION: The 36 million figure for September 28, 2024 is correct per ground truth. The consolidation details (Star+ merged into Disney+ in Latin America by end of June 2024) are accurate. The strategic interpretation is sound and aligns with ground truth reasoning.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the 2023 and 2024 filings and connects subscriber evolution to strategic consolidation. The logic linking consolidation to improved monetization and scalability is reasonable, though the ground truth uses more cautious language ('suggests a strategic shift' vs. the LLM's more definitive claims).\n\nCONCERN: The primary issue is the unverified 31 million 2023 subscriber count. Without explicit ground truth confirmation of this baseline, the growth calculation cannot be fully validated. This represents a factual claim not supported by the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 504,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\nThe company’s collective‑bargaining footprint shrank between the 2022 and 2023 planning cycles – it expects to negotiate 21 agreements covering about 3,000 employees in 2022, but only 20 agreements covering roughly 2,100 employees in the 2024 round (the next step after 2023).  This roughly one‑third reduction in the number of employees subject to new labor contracts indicates that the firm is deliberately narrowing its exposure to collective agreements, focusing on fewer agreements and a smaller employee segment as part of a strategy to streamline labor relations and limit potential disruption or cost volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The core numbers are accurate - 3,000 employees in 2022 and 2,100 employees in 2023 are correctly stated. (2) The identification of a reduction/decline in employee coverage is correct. (3) The qualitative interpretation about streamlining labor relations and reducing exposure is reasonable and aligns with the ground truth's suggestion of a shift in strategy. (4) The mention of 21 vs 20 agreements adds detail not explicitly in the ground truth but appears plausible. PROBLEMATIC ASPECTS: (1) TEMPORAL CONFUSION - The LLM states '2022 expects to negotiate...in 2022' and '2024 round (the next step after 2023)' which creates ambiguity. The ground truth clearly indicates 2022 expected negotiations for the following year (2023), and 2023 projected negotiations for the upcoming year (2024). The LLM conflates the planning year with the execution year in confusing language. (2) The phrase 'roughly one-third reduction' is mathematically correct (2,100/3,000 = 0.70, or 30% reduction), but the LLM says 'one-third reduction' which could be interpreted as 33%, creating minor imprecision. (3) The interpretation about 'deliberately narrowing exposure' and 'limit potential disruption or cost volatility' goes beyond what the ground truth states - the ground truth suggests 'fewer expiring agreements or proactive resolution' which is subtly different. The LLM's interpretation is reasonable but represents inference beyond the stated facts. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the comparison between two years and draws a strategic conclusion, though the temporal framing is muddled. The core factual comparison is sound despite presentation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 476,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\nNextEra Energy’s holdings of U.S. Government and municipal bonds in its special‑use funds slipped from roughly $1.34 billion in 2022 to about $1.28 billion in 2024, a net reduction of roughly $55 million over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth shows: 2022: $137 million, 2024: $161 million, change: +$24 million (17.5% increase). LLM reports: 2022: ~$1.34 billion, 2024: ~$1.28 billion, change: -$55 million (net reduction). The LLM's numbers are approximately 10x larger than the correct values and show the opposite directional trend (decrease vs. increase). The LLM appears to have referenced a different investment category or account (possibly 'special-use funds' which is not mentioned in the ground truth). The calculation of the $55 million reduction is mathematically consistent with the LLM's stated figures ($1.34B - $1.28B ≈ $55M), but these figures are entirely wrong compared to the actual NextEra Energy U.S. Government and municipal bonds data. The answer fails on quantitative accuracy (wrong numbers by ~$1.2 billion), fails on entity/metric accuracy (appears to reference wrong investment category), and fails on directional accuracy (shows decline instead of growth). This represents a complete failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 310,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo’s therapeutic footprint broadened markedly—new FDA and EU approvals added neoadjuvant NSCLC, subcutaneous Opdivo Qvantig, and expanded combo regimens in urothelial and colorectal cancers, plus Japan‑specific clearances—while BMS simultaneously reshaped its manufacturing strategy.  The company deepened internal capacity at sites such as Devens and Ireland, expanded third‑party and backup supply arrangements, and invested in a flexible network to support both the original IV formulation and the new subcutaneous Qvantig product, ensuring a resilient supply chain for the growing portfolio of Opdivo indications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth specifies ONE specific FDA approval in March 2024 for combination therapy with cisplatin and gemcitabine for urothelial carcinoma. The LLM claims multiple approvals including 'neoadjuvant NSCLC, subcutaneous Opdivo Qvantig, expanded combo regimens in urothelial and colorectal cancers, plus Japan-specific clearances'—none of which are mentioned in the ground truth. The LLM introduces 'Opdivo Qvantig' as a subcutaneous formulation with no supporting evidence in the provided ground truth. (2) MANUFACTURING STRATEGY: While the ground truth mentions 'internal manufacturing capability and reliance on third-party manufacturers,' the LLM provides highly specific claims about 'Devens and Ireland' sites, 'flexible network,' and 'backup supply arrangements' that are not substantiated in the ground truth. The LLM appears to have fabricated specific manufacturing facility names and strategies. (3) MULTI-HOP REASONING: The ground truth clearly synthesizes two key points: (a) 2022 manufacturing strategy with internal and third-party reliance, and (b) 2024 single FDA approval for urothelial carcinoma combination therapy. The LLM fails to properly synthesize this information and instead invents a much broader narrative of multiple approvals and detailed manufacturing investments without evidence. (4) SEMANTIC EQUIVALENCE: The LLM's answer is not semantically equivalent to the ground truth—it represents a fundamentally different and more expansive claim about Opdivo's evolution. The ground truth is measured and specific; the LLM answer is speculative and overstated. The LLM demonstrates hallucination of specific product names (Qvantig), facility locations (Devens, Ireland), and therapeutic approvals not mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 525,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney did not reshuffle the magazine’s corporate home—National Geographic magazine remained classified under the **Entertainment segment’s Content‑Sales/Licensing business** and continued to be owned ~73 % by Disney.  The company kept reporting its revenue alongside other licensing and publishing activities, but it began to **leverage the title’s IP more aggressively across Disney’s DTC and streaming platforms (e.g., Disney+, Hulu and the new ESPN‑branded tile on Disney+)**, using the magazine’s content to drive subscriber growth and cross‑promote the broader National Geographic brand.  Consequently, while its segment and ownership structure stayed the same, its strategic positioning shifted toward being a content‑driving asset that supports Disney’s streaming‑first agenda.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misrepresents the ground truth about how Disney's relationship with National Geographic evolved. The ground truth explicitly states that by 2024, 'the emphasis on its ownership percentage was removed' and the magazine was described as 'published' by the company rather than as a business with a direct equity stake. The LLM answer contradicts this by claiming the ownership structure 'stayed the same' and that Disney 'continued to be owned ~73% by Disney' in 2024. This is a major factual error that directly contradicts the core finding of the ground truth. QUANTITATIVE ACCURACY: The 73% ownership figure is correct for 2023, but the LLM incorrectly applies this to 2024 when the ground truth indicates this emphasis was removed. QUALITATIVE ACCURACY: The LLM introduces entirely speculative information about 'leveraging the title's IP more aggressively across Disney's DTC and streaming platforms' and 'streaming-first agenda' that is not present in the ground truth. While these might be plausible strategic moves, they are not supported by the provided knowledge graph data and represent fabrication rather than synthesis of actual filing information. The LLM correctly identifies the Entertainment segment and Content Sales/Licensing classification, but misses the key shift in how the relationship was characterized (from ownership-focused to operational/published). MULTI-HOP REASONING: The answer fails to properly synthesize the year-over-year comparison that is central to the question. The ground truth shows a deliberate shift in reporting emphasis between 2023 and 2024, but the LLM claims continuity where change occurred. This is a fundamental failure in multi-hop reasoning across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 480,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\nIn the 2023 filing PayPal said its transaction‑management databases were built to let customers use the PayPal suite and to process payments in roughly 200 markets across ≈140 currencies, with balances held in 24 currencies. The 2024 filing keeps those currency figures but adds explicit language about a “large‑scale, cloud‑enabled” infrastructure, “industry‑best practices” for storage and processing of massive data, and multiple security layers that ensure resiliency—highlighting a stronger emphasis on scalability, security and global payment‑processing capability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM claims 2023 filings mention '~140 currencies' and '24 currencies' for balances, while the ground truth explicitly states 56 currencies for withdrawal capability in 2023 and 57 in 2024. These are completely different figures with no explanation for the discrepancy. The LLM's numbers (140, 24) do not appear in the ground truth at all. (2) MISSING KEY EVOLUTION: The ground truth's core finding—the expansion from 56 to 57 currencies between 2023 and 2024—is entirely absent from the LLM answer. This is the primary metric requested in the question. (3) INCORRECT EMPHASIS: The LLM focuses on infrastructure descriptions ('cloud-enabled,' 'security layers,' 'industry-best practices') that are not mentioned in the ground truth as part of the evolution being tracked. The ground truth emphasizes the currency expansion and the reordering of 'consumers' vs 'merchants' in the framing. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year comparison that was the core of the question. It presents different numbers for 2023 without establishing a clear before/after comparison of the actual evolution. (5) SEMANTIC MISMATCH: While the LLM discusses transaction management databases, it does so with incorrect quantitative data that fundamentally misrepresents PayPal's capabilities as described in the filings. The answer reads plausibly but is factually incorrect on the specific metrics that define the evolution being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 436,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\nIn March 2023 NEE completed a $2.5 bn remarketing of its Series K Debentures, resetting the coupon to a fixed 6.051 % per annum (with semi‑annual interest) and extending the maturity to March 1 2025; the same 6.051 % rate persisted through 2024. This demonstrates NEE’s strategy of refinancing maturing debt to lock in longer‑term fixed financing at current higher rates and to diversify its capital structure with equity‑linked, long‑dated debentures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT: The 6.051% interest rate is accurate, the March 2023 remarketing date is correct, semi-annual interest payments are accurate, and the financing strategy interpretation (locking in fixed rates at higher levels) aligns with the ground truth. The answer appropriately addresses the evolution question and provides relevant context about NEE's financing strategy. PROBLEMATIC: (1) The LLM introduces a $2.5 billion remarketing amount that is NOT mentioned in the ground truth, which is a factual addition without source verification. (2) The maturity extension to March 1, 2025 is stated as fact but the ground truth only mentions a letter dated March 1, 2023 setting forth terms effective March 1, 2023 - the ground truth does not explicitly confirm a 2025 maturity date. (3) The claim about 'equity-linked, long-dated debentures' goes beyond what the ground truth states and appears to be an inference not directly supported by the provided information. (4) The answer states the rate 'persisted through 2024' which is reasonable inference but the ground truth is somewhat ambiguous about whether there were further changes between 2023 and 2024. The multi-hop reasoning is sound in connecting the 2023 remarketing to 2024 terms, but the introduction of unsourced specific details (dollar amount, maturity date, equity-linked characterization) reduces confidence in the answer's factual accuracy. The core insight about NEE's financing strategy is correct, but the supporting details contain speculative or unverified elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 438,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\nExxonMobil’s depreciation of upstream assets continued to be driven by the unit‑of‑production method, but the 2023 filing tightens how that method is applied. In the 2022 10‑K (page 75) the company noted that depreciation is calculated by allocating asset cost over total proved reserves and that, when reserves are “substantially de‑booked,” the depreciation is recomputed using a unit‑of‑production basis “determined at the most recent SEC price.” The 2023 10‑K (page 77) reiterates this approach but explicitly states that the reserve base is now updated each year to the latest SEC‑price‑derived proved reserves (and may include risk‑adjusted unproved reserves) and that, if an asset’s useful life no longer correlates with the reserve life, the corporation switches to straight‑line depreciation to ensure the asset is fully depreciated by the end of its expected life. Thus, between 2022 and 2023 the method remained unit‑of‑production, but the company began to more rigorously refresh the reserve estimate at current SEC prices and to employ straight‑line depreciation for assets whose life‑cycle no longer matches the revised reserve assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core methodology as unit-of-production depreciation in both 2022 and 2023; (2) Accurately captures the 2022 approach: allocation over proved reserves with switching to straight-line when asset life doesn't correlate, and use of SEC price-based reserves when substantially de-booked; (3) Properly describes the 2023 refinement: greater emphasis on using most recent SEC prices for reserve determination and explicit mention of annual updates to reserve estimates; (4) Correctly notes the switch to straight-line depreciation when reserve life no longer matches asset life; (5) Appropriately characterizes the evolution as a 'tightening' or 'refinement' rather than fundamental change; (6) Provides specific page references (75 for 2022, 77 for 2023) that add credibility; (7) Multi-hop synthesis is sound - correctly synthesizes information across two years and multiple policy dimensions. MINOR CONSIDERATIONS: The LLM answer includes slightly more operational detail (mention of 'risk-adjusted unproved reserves') than the ground truth explicitly states, though this appears consistent with SEC filing practices and doesn't contradict the ground truth. The LLM's characterization of the evolution as 'more rigorous' refresh of reserves aligns well with the ground truth's description of 'greater emphasis' and 'refinement.' No quantitative errors detected. The answer fully addresses the multi-part question regarding how the method evolved, what changed, and why (response to economic conditions and production realities).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 454,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from a model that leaned heavily on external producers toward a strategy that increasingly builds its own production capacity.  In the 2023 filing the company highlighted “scaling our own studio operations to produce original content” and noted recent acquisitions such as Scanline and Animal Logic to bolster internal resources, while still relying on third‑party partners for a portion of its slate.  By the 2024 filing the emphasis has shifted further inward: Netflix describes “scaling our own studio operations to produce original programming” as a core growth driver and cites ongoing investments in internal creative, marketing, legal and merchandising teams, indicating a reduced dependence on outside studios compared with the prior year.  Nonetheless, the filings acknowledge that third‑party creators and licensing partners continue to supply some titles, so the company’s original‑programming strategy now blends expanded internal studio output with selective external partnerships.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-hop question about Netflix's strategic evolution. STRENGTHS: (1) Correctly identifies the key acquisitions (Scanline and Animal Logic) mentioned in the ground truth; (2) Accurately captures the shift from external reliance to internal scaling between 2023 and 2024; (3) Properly synthesizes the multi-hop information showing the progression of Netflix's strategy across two years; (4) Correctly notes that third-party partnerships continue but with reduced emphasis; (5) Appropriately characterizes the 2024 focus on internal systems and operational practices. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the specific risk factors highlighted in 2023 (liability, legal violations, insolvency, fraud) that were present in the original filing language - the ground truth notes these were 'omitted in 2024,' which the LLM doesn't directly address; (2) The LLM uses paraphrased quotes ('scaling our own studio operations') rather than exact language, though this is semantically equivalent and acceptable; (3) The answer could have been more explicit about the 'omission' of third-party risk language as evidence of strategic shift, rather than just noting reduced dependence. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The years (2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the progression of Netflix's strategic emphasis. The logic connecting internal acquisitions to reduced external reliance is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth - Netflix moved from emphasizing third-party risks and external partnerships toward internal studio scaling and operational control. The LLM's characterization of this as a 'blend' of internal and external is consistent with the ground truth's acknowledgment that external partners still supply some content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 561,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\nIn 2022 the Cyber and Intelligence Solutions were described only as part of Mastercard’s “other revenues”/value‑added services—focused on fraud‑prevention and data‑driven insights (see 2022 10‑K page 80). By 2023 the company repositioned them as a strategic growth pillar, explicitly highlighting investments in open‑banking, digital‑identity and proprietary analytics and noting that their expansion drove the 13 % rise in net revenue (see 2023 10‑K page 49).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) The claim that Cyber and Intelligence Solutions expansion 'drove the 13% rise in net revenue' in 2023 is unsubstantiated and appears to be a fabrication - the ground truth makes no such causal claim about revenue growth attribution. (2) The specific page references (2022 10-K page 80, 2023 10-K page 49) cannot be verified against the ground truth and may be inaccurate. (3) The LLM introduces new claims about 'open-banking, digital-identity and proprietary analytics' investments that are not mentioned in the ground truth, suggesting either hallucination or unsupported extrapolation. CORRECT ELEMENTS: (1) The basic positioning shift from 2022 to 2023 is accurately captured - from 'Other revenues' to elevated strategic importance. (2) The fraud-prevention focus in 2022 is correctly identified. (3) The general direction of evolution (from component to strategic pillar) aligns with ground truth. MISSING ELEMENTS: The ground truth emphasizes the 2023 positioning as enabling 'secure, easy, and confident transactions across the entire payments ecosystem' and supporting 'core operations and new network investments' - the LLM answer omits these important contextual details about the broader ecosystem role. The answer demonstrates partial understanding of the evolution but introduces unsupported quantitative claims and specific details that cannot be verified, which is problematic for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 419,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\nFrom 2023 to 2024 Tesla moved its energy‑storage strategy from a largely outsourced model—relying on third‑party cell suppliers such as Panasonic and CATL and worrying about supplier bottlenecks—to a vertically‑integrated approach that builds its own battery‑cell production at new gigafactories (e.g., Texas, Mexico, Berlin).  This shift introduces new production challenges—securing enough lithium, nickel and cobalt, mastering high‑volume cell manufacturing, and coordinating design‑change ramps across factories—while making the company’s energy‑storage growth increasingly dependent on the success of its in‑house cell program and the stability of raw‑material markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) STRATEGIC DIRECTION MISCHARACTERIZATION: The ground truth states Tesla emphasized 'modular design and in-house expertise in power electronics and software' in 2023, then shifted focus to 'production ramps and supply chain dependencies' in 2024. The LLM inverts this narrative, claiming Tesla moved FROM outsourcing TO vertical integration with new gigafactories. This is a major factual error - the ground truth does not support the claim that Tesla shifted to building its own battery cells at new gigafactories for energy storage products between 2023-2024. (2) SUPPLIER MISIDENTIFICATION: The LLM names specific suppliers (Panasonic, CATL) and claims Tesla relied on them in 2023, then shifted away. The ground truth makes no mention of these specific suppliers or an outsourced model in 2023. This appears to be fabricated detail. (3) PRODUCTION CHALLENGES MISALIGNMENT: While both answers mention production challenges, the LLM focuses on raw material sourcing (lithium, nickel, cobalt) and cell manufacturing, whereas the ground truth emphasizes 'production ramps,' 'supply chain dependencies,' 'supplier reliability,' and 'scaling production to meet planned output rates and quality standards.' These are different challenges. (4) STRATEGIC FOCUS INVERSION: The ground truth shows evolution from emphasizing in-house expertise (2023) to addressing production/supply chain risks (2024). The LLM shows a claimed shift from outsourcing to vertical integration, which is not supported by the ground truth and represents a fundamental misunderstanding of Tesla's actual energy storage strategy evolution. (5) MISSING CORE ELEMENTS: The LLM fails to mention the modular design approach, power electronics expertise, or software optimization that were central to 2023 strategy per the ground truth. The answer demonstrates poor multi-hop synthesis and appears to conflate Tesla's battery cell production strategy (which may involve vertical integration) with its energy storage product strategy (which the ground truth addresses differently).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 577,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\nIn 2023 NEECH’s floating‑rate debt consisted of a single, relatively small issue – about $400 million of variable‑rate debentures that matured in 2024. By the end of 2024 the company had expanded its floating‑rate program, issuing roughly $600 million of floating‑rate debentures with a 2026 maturity and adding a laddered series of new floating‑rate notes that extend out to 2028‑2055, thereby substantially increasing both the total floating‑rate principal and the maturity spectrum of its funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 2023 had '$400 million of variable-rate debentures that matured in 2024' - this is incorrect. The ground truth states 2023 had $600 million in floating rate debentures due in 2026, not $400 million due in 2024. The LLM then claims 2024 had '$600 million of floating-rate debentures with a 2026 maturity' - while the $600 million and 2026 maturity are correct, this represents continuity from 2023, not a new issuance in 2024. (2) STRUCTURAL CLAIMS: The LLM asserts the company added 'a laddered series of new floating-rate notes that extend out to 2028-2055' - this is not mentioned in the ground truth and appears to be fabricated. The ground truth explicitly states the maturity structure 'remained consistent with the 2026 horizon' with 'no significant expansion or restructuring.' (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2023-2024 evolution. The ground truth indicates the $600 million 2026 debentures were disclosed in 2023 and formalized via Officer's Certificate in January 2024 - this is a formalization/continuation, not a new expansion. The LLM incorrectly characterized this as expansion and added unsupported claims about extended maturities. (4) ENTITY/TIMELINE CONFUSION: The LLM appears to have confused different issuances or invented details not present in the source material. The answer fundamentally misrepresents the evolution as 'substantial expansion' when the ground truth indicates 'continuation of the prior year's approach without significant expansion.' This is a critical semantic and factual reversal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 463,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved its supply‑chain responsibility program from a primarily audit‑and‑compliance focus toward a more proactive, metrics‑driven partnership model.  The 2024 effort expands the number of suppliers engaged, adds formal GHG‑footprint measurement and climate‑related performance incentives, and ties supplier‑level sustainability goals—such as net‑zero Scope 3 emissions, circular‑economy waste targets, and diverse‑supplier spending—to executive compensation, while deepening industry collaborations on responsible minerals and water stewardship.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. Key issues: (1) CONTRADICTORY CLAIM ON SUPPLIER EXPANSION: The ground truth explicitly states that by 2024, Intel's approach did NOT include 'explicit mention of expanding the number of suppliers engaged,' yet the LLM answer claims '2024 effort expands the number of suppliers engaged.' This is a direct contradiction of the ground truth. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including: formal GHG-footprint measurement, climate-related performance incentives, net-zero Scope 3 emissions targets at supplier level, circular-economy waste targets, diverse-supplier spending goals, and ties to executive compensation. While some of these (like net-zero Scope 3) are mentioned in the ground truth as a 2023 goal, the LLM presents them as 2024 developments without clear sourcing. (3) PARTIAL ACCURACY: The LLM correctly identifies the shift toward metrics-driven partnership, responsible minerals sourcing, and water stewardship, which aligns with ground truth. (4) MISSING CONTEXT: The LLM fails to capture the key distinction that the 2023 approach was about 'announcing strategic expansions' while 2024 was about 'reinforcing and deepening existing partnerships' - a crucial nuance in the evolution. (5) TONE MISALIGNMENT: The ground truth emphasizes a shift from expansion announcements to deepening existing work, but the LLM presents 2024 as an expansion year, which contradicts the ground truth's characterization. The answer demonstrates partial understanding of the evolution but introduces unsupported claims and directly contradicts the ground truth on a central point (supplier expansion).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 475,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\nIn the 2022 filing the company introduced the standardized measure as being calculated with first‑day‑of‑the‑month average prices and warned that these “discrete points in time” can create significant year‑to‑year swings in cash‑flow estimates. By the 2023 filing the wording was sharpened to stress that the measure is “highly dependent” on those first‑day‑of‑the‑month average price assumptions, explicitly calling out the resulting volatility and noting that the metric is not meant to represent expected future cash flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) REVERSED CHRONOLOGY: The LLM claims the 2022 filing introduced warnings about 'discrete points in time' and 'significant year-to-year swings,' but the ground truth explicitly states the 2022 filing used more neutral language ('prepared on the basis of certain prescribed assumptions') without explicitly highlighting dependency. The ground truth indicates this explicit acknowledgment of sensitivity and dependency came in the 2023 filing, not 2022. (2) MISCHARACTERIZATION OF 2022: The LLM incorrectly attributes to 2022 the language about 'discrete points in time' causing 'significant year-to-year swings,' which the ground truth identifies as a 2023 development. (3) INACCURATE 2023 DESCRIPTION: The LLM claims 2023 uses 'highly dependent' language, but the ground truth states it uses 'depends on' language - this is a meaningful distinction in tone and emphasis. (4) MISSING KEY CONTEXT: The LLM fails to capture the ground truth's important point that the actual calculation methodology remained unchanged (same 10% discount factor, year-end costs, legislated tax rates), only the framing/characterization evolved. (5) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a shift from foundational framing to explicit acknowledgment of sensitivity/dependency, but the LLM presents this as if both years contained similar warnings. The core multi-hop reasoning is fundamentally flawed due to the chronological reversal of which year introduced which characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 434,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved its digital‑identity capabilities from a stand‑alone fraud‑prevention layer into the core of its open‑banking platform.  The 2023 rollout embeds privacy‑by‑design, consent‑centric APIs that combine biometric, device‑intelligence and transaction‑fraud data, and it is now accessible through an open‑banking network that reaches > 95 % of U.S. deposit accounts and roughly 3,000 banks across Europe (via direct connections and partners).  This expansion lets financial institutions and third‑party data providers authenticate consumers and secure payments at scale within the same open‑banking ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate: >95% of U.S. deposit accounts and ~3,000 banks across Europe match the ground truth exactly. (2) The temporal evolution between 2022-2023 is correctly captured, showing progression from standalone fraud-prevention to integrated open-banking platform. (3) Multi-hop synthesis is sound: the answer correctly connects digital identity capabilities with open banking infrastructure and financial institution partnerships. (4) Technical details are accurate: privacy-by-design, consent-centric APIs, biometric/device-intelligence/transaction-fraud data integration are all appropriately mentioned. (5) The characterization of reach and application (authentication, payment securing at scale) aligns with ground truth. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 ACH payment solution partnership with leading financial institutions that was highlighted in the ground truth as indicating 'deeper integration.' While the answer implies this through 'secure payments at scale,' it doesn't explicitly reference the ACH partnership. (2) The ground truth emphasizes 'data principles such as consumer protection and consent management' from 2022, which the LLM captures as 'consent-centric APIs' but with slightly less explicit reference to the foundational data principles framework. (3) The ground truth mentions 'financial inclusion' as an original aim, which is not explicitly stated in the LLM answer. These are relatively minor omissions that don't significantly detract from the core answer's accuracy. The LLM's framing of the evolution as moving from 'stand-alone fraud-prevention layer' to 'core of open-banking platform' is a reasonable interpretation that captures the essence of the evolution, though the ground truth frames it more as an expansion of existing capabilities rather than a repositioning from fraud-prevention focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 542,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla shifted the Solar Roof from a primarily design‑and‑install‑focused product toward a more production‑centric strategy that leans heavily on internal battery‑cell capabilities and tighter supply‑chain control.  In 2023 the company emphasized iterative design improvements, partnerships with developers, and incremental scaling of installation capacity, but by 2024 it was confronting persistent bottlenecks in sourcing solar‑cell components, raw‑material price volatility, and the need to qualify new manufacturing lines at its expanding factories; consequently, Tesla began treating the Roof as a strategic dependency on its broader battery‑cell and raw‑material supply chain, accelerating efforts to produce its own cells and to localize production to meet cost and volume targets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces claims not supported by the ground truth. Specific issues: (1) The ground truth makes no mention of Tesla's internal battery-cell capabilities, supply-chain control strategies, or sourcing of solar-cell components as key evolution points between 2023-2024. (2) The LLM invents details about 'persistent bottlenecks in sourcing solar-cell components, raw-material price volatility,' and 'qualifying new manufacturing lines' that do not appear in the original answer. (3) The claim about Tesla 'accelerating efforts to produce its own cells' for Solar Roof is not supported by the ground truth. (4) The LLM mischaracterizes the 2023 positioning as 'design-and-install-focused' with 'partnerships with developers' - the ground truth emphasizes engineering maturity, aesthetic appeal, durability, and integration with Powerwall, not developer partnerships. (5) The ground truth's key insight about strategic prioritization shift toward mass-market vehicle production (which could affect Solar Roof timelines) is completely absent from the LLM answer. (6) The LLM correctly identifies production delays as a 2024 issue, but frames it incorrectly as a supply-chain/sourcing problem rather than a general production ramp challenge. The LLM answer appears to confabulate industry-standard solar manufacturing challenges rather than accurately synthesizing the specific Tesla Solar Roof evolution described in the filings. The multi-hop reasoning fails because it does not correctly connect the 2023 and 2024 narratives as presented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 443,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra Energy added new pledge‑agreement filings that extend the same collateral‑structure it had been using since 2022.  In the 2023 filings the most recent pledge was a September 1 2022 agreement in which the company pledged securities with **Deutsche Bank Trust Company Americas** acting as collateral, custodial and securities‑intermediary agent and **The Bank of New York Mellon** serving as purchase‑contract agent.  In 2024 the company filed two fresh pledge agreements—one dated **June 1 2024** and another dated **October 1 2024**—again naming **The Bank of New York Mellon** as purchase‑contract agent and **Deutsche Bank Trust Company Americas** as collateral/custodial agent, showing a continuation and modest expansion of the prior arrangement into the current year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key facts are correct: (1) The September 1, 2022 Pledge Agreement is accurately dated and identified; (2) The two new agreements from 2024 are correctly dated as June 1, 2024 and October 1, 2024; (3) Both counterparties are correctly identified - Deutsche Bank Trust Company Americas and The Bank of New York Mellon - with their respective roles accurately described (collateral/custodial agent and purchase-contract agent); (4) The multi-hop synthesis is sound, showing the evolution from 2023 to 2024 with proper temporal context. The LLM answer actually provides more detail than the ground truth by specifying the roles of each counterparty, which adds helpful context without introducing errors. The wording differs from the ground truth (e.g., 'added new pledge-agreement filings' vs 'introduced two new Pledge Agreements') but the semantic meaning is equivalent. The answer correctly captures the evolution and expansion of the pledge agreement structure over time. Minor formatting differences (dashes vs spaces in dates, capitalization variations) are inconsequential. No calculations are required for this question, and all dates and entities are factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 350,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved beyond discrete AI‑PC silicon launches to a cohesive edge‑AI stack built around its 4th‑gen Xeon and Xeon D processors and the edge‑native OpenVINO software platform.  At the same time it broadened its ecosystem partnerships with telecom and cloud leaders—including Ericsson, Nokia, Cisco, Amazon, Google and Microsoft—to deliver software‑defined, AI‑enabled edge solutions and accelerate market adoption.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant gaps and misalignments with the ground truth. CORRECT ELEMENTS: (1) Mentions OpenVINO as Intel's edge-native software platform - this aligns with ground truth; (2) References ecosystem partnerships with major tech companies (Ericsson, Nokia, Cisco, Amazon, Google, Microsoft) - this is accurate and matches the ground truth's emphasis on broader ecosystem partnerships; (3) Correctly identifies the 2023-2024 timeframe for the evolution. SIGNIFICANT GAPS AND ERRORS: (1) The answer focuses heavily on hardware (4th-gen Xeon and Xeon D processors) which is not mentioned in the ground truth and appears to be a tangential detail not central to the strategic positioning question; (2) MISSING the NEX initiative entirely - this is a critical strategic element mentioned in the ground truth as the framework for 2024 strategy; (3) MISSING the key 2024 strategic shift from fixed-function hardware to general-purpose compute and cloud-native software - this is a fundamental evolution point in the ground truth; (4) MISSING the horizontal approach and vendor lock-in avoidance messaging from 2023; (5) MISSING the emphasis on cloud-native programmability and automation at the edge; (6) The answer frames the evolution primarily as 'moving beyond AI-PC silicon' which is not the core narrative in the ground truth; (7) Does not adequately capture the transformation from 2023's modular building blocks approach to 2024's integrated NEX initiative. MULTI-HOP REASONING: The answer attempts to synthesize 2023-2024 evolution and ecosystem partnerships but fails to capture the deeper strategic transformation around cloud-native programmability and the NEX initiative. The reasoning is surface-level, focusing on product names and partner names rather than the strategic positioning shift. SEMANTIC EQUIVALENCE: While the answer mentions some correct elements, it fundamentally misses the core strategic narrative about transforming from fixed-function to general-purpose compute and the cloud-native software emphasis that defines the 2024 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 566,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\nThe 1.75 % senior notes maturing in August 2030 continued to show a $1.25 billion principal balance in both the 2023 and 2024 filings.  However, because total long‑term debt rose from about $58.6 bn (2023) to $60.5 bn (2024), the share of that 2030 series within the overall debt portfolio slipped slightly, even though its absolute amount remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the 1.75% senior notes due August 2030 at $1,250 million ($1.25 billion) for both 2023 and 2024, matching the ground truth exactly. (2) The format variation ($1.25 billion vs $1,250 million) is acceptable and shows proper understanding. (3) The core fact that this debt remained unchanged between years is accurate. (4) The observation about relative portfolio share declining is a reasonable analytical insight. WEAKNESSES: (1) The LLM introduced total long-term debt figures ($58.6bn in 2023 and $60.5bn in 2024) that are not verified against the ground truth and appear to be unsourced. These numbers were not provided in the original answer and cannot be confirmed. (2) The LLM failed to address the 3.75% senior notes due April 2030 ($1,500 million in both years), which was explicitly mentioned in the ground truth as part of the composition analysis. This represents incomplete synthesis of the multi-hop information. (3) The question specifically asked about 'composition and value' of long-term debt related to senior notes due in 2030, implying multiple debt instruments should be discussed. The LLM only addressed one instrument. (4) The analytical addition about portfolio share, while potentially insightful, goes beyond what was asked and relies on unverified total debt figures. CALCULATION VERIFICATION: The 1.75% notes value is correct ($1,250M = $1.25B). However, the total debt figures cannot be verified from the provided ground truth. MULTI-HOP REASONING: Partially successful - correctly identified the specific note and its stability, but failed to synthesize information about other 2030 notes (3.75% notes), which was part of the ground truth answer's composition analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 474,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved the ad‑supported tier from a experimental, lower‑priced add‑on to a core element of its pricing architecture.  The 2023 launch was positioned to capture price‑sensitive households and expand the addressable market, and by 2024 the company was actively leveraging that tier to accelerate overall membership growth—especially the seasonal Q4 surge and penetration in slower‑growth regions—while using the ad‑supported plan to drive additional ad revenue and upsell viewers to higher‑margin, ad‑free options.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but introduces unsupported claims and speculative details. CORRECT ELEMENTS: (1) The characterization of the 2023 ad-supported plan as experimental/lower-priced entry point is accurate; (2) The 2024 positioning as a core component of pricing strategy is correct; (3) The general evolution from experimental to strategic offering is sound; (4) The mention of price-sensitive households and expanded addressable market aligns with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific claims about 'seasonal Q4 surge' and 'penetration in slower-growth regions' that are not present in the ground truth and cannot be verified from the provided context; (2) The detailed discussion of 'ad revenue' generation and 'upsell to higher-margin, ad-free options' goes beyond what the ground truth establishes—while logical, these are inferences not explicitly stated in the original answer; (3) The phrase 'accelerate overall membership growth' is more specific than the ground truth's 'support sustained membership growth.' QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided by either answer, so this dimension scores well (8/10) for consistency. QUALITATIVE ACCURACY: The core reasoning is sound (5/10) but the LLM adds speculative business strategy details not grounded in the provided ground truth, which violates the principle of sticking to verifiable information. CONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and pricing strategy components (7/10), though it overextends into unverified operational details. The answer would score higher if it remained closer to the documented facts without introducing specific market segment strategies and revenue optimization tactics not explicitly mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 498,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\nTesla began the 2023 10‑K by noting that the Semi was only in **pilot‑production** at its Nevada plant, with limited runs used to validate the truck and its battery supply chain. By the 2024 filing the Semi remains listed as “pilot production,” but the narrative has shifted: Tesla now ties the truck to its **next‑generation vehicle platform, in‑house battery‑cell scaling and the broader rollout of autonomous‑driven freight (e.g., Robotaxi)**, positioning the Semi as a strategic, scalable product rather than just an experimental prototype. This evolution reflects a move from early‑stage testing toward a planned expansion of capacity and integration with Tesla’s overall cost‑reduction and autonomy strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the 2023 status. Ground truth states that in 2023, Tesla had 'begun early production and deliveries' of the Tesla Semi, indicating initial market introduction. The LLM claims that in 2023, the Semi was in 'pilot-production' - this is factually incorrect and represents a fundamental misreading of the filing data. The LLM appears to have conflated or confused the 2023 and 2024 statuses. According to ground truth: 2023 = early production/deliveries; 2024 = pilot production. The LLM reversed or mischaracterized the 2023 status entirely. While the LLM correctly identifies that by 2024 the status is 'pilot production,' this actually represents a REGRESSION or different characterization from 2023's 'early production and deliveries,' not an advancement as the ground truth indicates. The LLM's additional narrative about next-generation platforms, battery scaling, and autonomy integration may be contextually relevant but cannot compensate for the core factual error about the 2023 status. The multi-hop reasoning fails at the foundational level because the 2023 baseline is wrong. The LLM also misses the key distinction that 2023 involved actual deliveries, whereas 2024 appears to be more of a testing/validation phase. This is a significant factual error that undermines the entire comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 386,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\nThe addition of multiple Executive Retention Employment Agreements signed in 2023 and early 2024—covering senior leaders such as Brian Bolster, Nicole Daggs and other key officers—shows that NextEra is deliberately locking in its top talent as it pursues its long‑term growth and clean‑energy strategy. By formalizing retention terms for a broader set of executives, the company signals that leadership continuity is a strategic priority, reducing succession risk while preserving the expertise needed to drive its ambitious infrastructure and renewable‑energy portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) ENTITY ACCURACY - The LLM mentions 'Nicole Daggs' as a covered executive with a retention agreement, but the ground truth does not reference Nicole Daggs at all. The ground truth specifically names Mark Lemasney (January 1, 2023), Armando Pimentel, Jr. (February 15, 2023), and Brian Bolster (May 6, 2024). This is a factual error that introduces false information. (2) INCOMPLETE EXECUTIVE LIST - The LLM says 'Brian Bolster, Nicole Daggs and other key officers' but fails to accurately identify the specific executives mentioned in the ground truth (Lemasney and Pimentel). The vague reference to 'other key officers' masks the incomplete and inaccurate identification. (3) DATE ACCURACY - The LLM correctly identifies that agreements span 2023 and early 2024, but does not provide the specific dates from the ground truth (January 1, February 15, May 6), which are important details. (4) QUALITATIVE REASONING - The LLM's interpretation about strategic priorities, succession risk reduction, and leadership continuity is reasonable and aligns with the ground truth's conclusions about proactive talent management and minimizing turnover risk. The reasoning about clean-energy strategy and infrastructure portfolio is contextually appropriate. (5) MULTI-HOP SYNTHESIS - The LLM correctly synthesizes the concept of expansion from 2023 to 2024 and connects it to strategic implications, which matches the ground truth's analytical approach. However, the factual errors regarding specific executives undermine the credibility of this synthesis. The introduction of Nicole Daggs without ground truth support is a significant accuracy problem that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 461,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved its xPU agenda from a broad, but often delayed, portfolio of GPUs, IPUs, FPGAs and other accelerators toward a tighter, AI‑first focus.  In 2024 the company emphasized “lead and democratize compute with Intel x86 and xPU,” pledging to expand the xPU family, accelerate AI‑centric products (AI PC, edge AI, Gen AI workloads) and tie those hardware advances to open‑source oneAPI software and co‑engineering with software partners.  At the same time, Intel doubled‑down on the process‑technology roadmap (Intel 4, Intel 3, 18A) and advanced packaging to deliver these xPU chips at volume, while leveraging its new IFS foundry model to secure capacity for both internal and external customers.  This strategic shift reflects a prioritisation of AI‑driven workloads, ecosystem openness and timely manufacturing readiness over the more diversified, but slower‑moving, xPU expansion of 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2023 to 2024, captures the shift toward AI-first focus, mentions key product categories (GPUs, IPUs, FPGAs), references the x86 ecosystem expansion, and appropriately highlights the emphasis on manufacturing readiness and process technology roadmap (Intel 4, Intel 3, 18A). The answer demonstrates good understanding of the strategic shift and provides relevant contextual details about oneAPI software and IFS foundry model. WEAKNESSES: (1) The LLM answer introduces specific claims not present in the ground truth, such as 'AI-first focus,' 'AI PC, edge AI, Gen AI workloads,' 'oneAPI software,' 'co-engineering with software partners,' and 'IFS foundry model.' While these may be factually accurate from Intel's actual filings, they are NOT in the provided ground truth answer, making it difficult to verify their accuracy against the knowledge graph. (2) The LLM answer omits the specific R&D spending figure of $16.0 billion mentioned in 2023, which is a quantifiable data point from the ground truth. (3) The LLM answer does not explicitly mention the 'product competitiveness' theme that was highlighted in the ground truth as the 2024 strategic framing. (4) The characterization of 2023 as 'broad, but often delayed' is somewhat inferred rather than directly stated in the ground truth, though it aligns with the mention of 'challenges in timely product development.' MULTI-HOP REASONING: The answer demonstrates sound reasoning in connecting 2023 and 2024 strategic shifts, but the introduction of specific product names and initiatives not in the ground truth raises questions about whether these are from the actual filings or extrapolations. The core logic of the evolution is sound, but the additional details create uncertainty about factual grounding. QUANTITATIVE ACCURACY: No major calculation errors, but the omission of the $16.0 billion R&D figure is a notable gap. The answer does not introduce incorrect numbers, but it fails to include a key quantitative element from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 557,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from conceptualizing an ad‑supported tier to building a dedicated advertising‑technology function.  In 2023 it was just forming an advertising‑sales and ad‑tech organization and laying the basic infrastructure foundation, but by 2024 the company had expanded that team, invested in its own ad‑server, measurement and programmatic‑buying platforms, and allocated additional cloud/CDN resources to support the launch and scaling of its ad‑supported subscription and advertiser sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general directional shift from 2023 to 2024 regarding Netflix's advertising technology approach, but contains significant issues with specificity and accuracy relative to the ground truth. STRENGTHS: (1) Correctly identifies the evolution from external reliance to internal development; (2) Accurately notes the 2023 formation phase and 2024 expansion phase; (3) Appropriately emphasizes organizational team development and infrastructure investment as key themes. WEAKNESSES: (1) The ground truth specifically states Netflix emphasized 'limited experience with advertising' and 'dependencies on third-party service providers' in 2023, but the LLM answer vaguely says 'just forming' without capturing the dependency/limitation aspect; (2) The LLM introduces specific technical details (ad-server, measurement platforms, programmatic-buying platforms, cloud/CDN resources) that are NOT present in the ground truth - these appear to be inferred or fabricated rather than sourced from the actual filings; (3) The ground truth emphasizes a shift from 'reliance on external providers to internal development,' but the LLM answer doesn't explicitly acknowledge this dependency reduction; (4) The LLM answer mentions 'ad-supported subscription' launch/scaling which, while contextually reasonable, is not explicitly stated in the ground truth provided. MULTI-HOP REASONING: The answer does synthesize 2023 vs 2024 comparison correctly at a high level, but fails to accurately capture the specific nature of Netflix's stated dependencies and risks in 2023. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral. The lack of quantitative specificity in both answers prevents scoring issues here. SEMANTIC EQUIVALENCE: While the general narrative matches (evolution from external to internal), the LLM introduces technical specifics not grounded in the provided ground truth, which represents a factual accuracy problem rather than mere wording variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 546,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\nTesla continues to treat free Supercharging (and related services such as FSD, internet connectivity and over‑the‑air updates) as a distinct performance obligation that is recognized over the vehicle’s expected ownership life, but the 2024 filing adds a more detailed deferred‑revenue schedule and explicitly ties limited free‑Supercharging incentives to actual usage or expiration rather than a straight‑line allocation.  The 2024 10‑K shows a larger deferred‑revenue balance ($3.6 bn → $3.599 bn) and $872 m of revenue recognized in 2024 from that balance—up from $469 m in 2023—reflecting a refined revenue‑recognition approach while the underlying program structure (unlimited free charging for qualifying vehicles, with limited incentives measured by usage) remains the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) MAJOR ERROR - The ground truth states that in 2023, free Supercharging was bundled with vehicle sales and recognized immediately as part of Automotive Sales Revenue, but by 2024 Tesla began deferring this revenue. The LLM answer incorrectly claims Tesla 'continues to treat' these as deferred revenue recognized over the vehicle's ownership life, suggesting this was already the case in 2023, which contradicts the ground truth's core finding about the evolution/change between years. (2) QUANTITATIVE ISSUES - The LLM provides specific numbers ($3.6bn deferred revenue, $872m recognized in 2024 vs $469m in 2023) that are not present in the ground truth and cannot be verified. These numbers appear fabricated or from unreliable sources. The ground truth does not provide these specific figures. (3) STRUCTURAL MISUNDERSTANDING - The LLM describes the 2024 approach as 'unlimited free charging for qualifying vehicles, with limited incentives measured by usage' but the ground truth indicates the shift was about deferring revenue and recognizing it over time, not about changing the actual program structure itself. (4) MISSING KEY EVOLUTION - The LLM fails to clearly articulate the fundamental shift described in the ground truth: from immediate recognition (2023) to deferred/amortized recognition (2024). Instead, it presents both years as having similar deferred revenue treatment. (5) UNSUBSTANTIATED DETAILS - References to 'deferred-revenue schedule' and 'usage or expiration rather than straight-line allocation' are not supported by the ground truth and appear to be speculative additions. The answer demonstrates partial understanding of revenue recognition concepts but fundamentally misrepresents how Tesla's approach evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 505,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra replaced its earlier, higher‑coupon Series O junior subordinated debentures – a 5.25 % tranche that matures in 2053 – with newer O‑tranches that carry lower fixed coupons (≈4.95 % due January 29 2026) and a floating‑rate Series O that also matures in 2026.  This shift shortens the maturity profile, reduces the cash‑flow burden and introduces floating‑rate exposure, indicating that NextEra is actively refinancing legacy, higher‑cost debt and using more flexible, market‑responsive financing to manage interest‑rate risk and preserve a low‑cost capital structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. Specific errors: (1) COUPON RATES: Ground truth states 2024 Series O had 5.55% coupon; LLM claims 4.95% and 5.25% - both wrong. (2) MATURITY DATES: Ground truth clearly states 2023 maturity was May 1, 2079 and 2024 maturity was November 1, 2029; LLM incorrectly claims 2053 maturity for earlier tranche and 2026 for newer tranches - all wrong. (3) STRUCTURE: Ground truth describes a shift from long-dated (2079) to shorter-dated (2029) fixed-rate instruments; LLM invents a floating-rate Series O maturing in 2026 that doesn't appear in the ground truth. (4) STRATEGIC INTERPRETATION: While both answers attempt to characterize the strategic shift, the LLM's interpretation is based on entirely fabricated numbers and terms. The ground truth's core finding - a shift from 50-year instruments (2079) to 5-year instruments (2029) with clearly defined 5.55% coupon - is completely absent from the LLM response. The LLM appears to have hallucinated specific coupon rates (5.25%, 4.95%), maturity dates (2053, 2026), and instrument types (floating-rate) that do not match the filing data. This represents a critical failure in factual accuracy for a financial question where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 364,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\nIn the 2022 filing the Company’s impairment methodology only referred in general terms to OPEC’s impact on supply and did not embed OPEC investment or production‑policy assumptions directly into the cash‑flow forecasts used for recoverability testing. By 2023 the framework explicitly incorporates OPEC investment activities and production‑policy outlooks as key variables that shape the long‑term oil‑supply dynamics underlying the projected cash flows and discount rates, so that shifts in OPEC supply strategy are now a specific input that can trigger an impairment assessment of ExxonMobil’s long‑lived assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and represents a complete reversal of the actual evolution described. Ground truth states: (1) In 2022, OPEC was explicitly considered in impairment assessments, and (2) By 2023, OPEC discussion became embedded more broadly within a comprehensive framework including environmental factors. The LLM answer claims the opposite: (1) In 2022, OPEC was only mentioned in general terms and NOT embedded in cash-flow forecasts, and (2) By 2023, OPEC was explicitly incorporated as a key variable. This is a direct contradiction of the documented evolution. The LLM has inverted the timeline and nature of the shift. The ground truth indicates a movement FROM explicit OPEC focus TO broader integrated assessment, while the LLM describes a movement FROM general mention TO explicit incorporation. Additionally, the LLM introduces unsupported claims about 'shifts in OPEC supply strategy' being 'a specific input that can trigger an impairment assessment' which is not mentioned in the ground truth. The LLM also mischaracterizes the 2023 framework as narrowly focused on OPEC variables, when the ground truth indicates it became MORE comprehensive and integrated with environmental/ESG factors. No numeric errors exist (no numbers were provided), but the qualitative reasoning is fundamentally incorrect, representing a 180-degree misunderstanding of the documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 397,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\nFrom 2023 to 2024 Netflix’s discussion of its ad‑supported tier shifted from a peripheral, risk‑focused mention to a clear strategic priority.  \n- **2023 (Form 10‑K, pp. 16‑20)** – The ad‑supported subscription plan appears only in the “Risk Factors” and forward‑looking‑statement sections, framed as an uncertain pricing experiment (“predicting consumer adoption … such as the ad‑supported subscription plan … is inherently difficult”). The filing offers scant detail and treats it as one of several “new revenue streams” whose results are hard to forecast.  \n- **2024 (Form 10‑K, pp. 1‑5)** – The plan is explicitly referenced in the core business description: Netflix “aims to offer a range of pricing plans, **including our ad‑supported subscription plan**, to meet a variety of consumer needs.” This wording signals a deliberate, growth‑oriented emphasis on the tier, positioning it as a key lever for expanding the subscriber base and diversifying revenue.  \n\nThus, the evolution is marked by a move from a tentative, risk‑oriented footnote in 2023 to a purposeful, strategic pillar highlighted in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core evolution from risk-focused (2023) to strategic positioning (2024); (2) Accurately captures the semantic shift from uncertainty language ('predicting consumer adoption...is inherently difficult') to confident strategic language ('aims to offer a range of pricing plans, including our ad-supported subscription plan'); (3) Properly synthesizes the multi-hop comparison across two fiscal years and multiple sections of filings; (4) Uses appropriate qualitative descriptors ('peripheral, risk-focused mention' vs 'clear strategic priority') that match the ground truth's characterization; (5) Correctly identifies the contextual placement differences (Risk Factors sections in 2023 vs core business description in 2024). MINOR CONSIDERATIONS: (1) The LLM provides specific page references (pp. 16-20 for 2023, pp. 1-5 for 2024) which cannot be verified against the ground truth but appear reasonable for 10-K structure; (2) The quoted language is presented as direct quotes but cannot be fully verified as exact verbatim from filings - however, the paraphrasing accurately captures the documented sentiment and positioning; (3) The answer goes slightly beyond the ground truth by providing more granular detail about page locations and specific quote fragments, but this adds value without contradicting the core answer. QUANTITATIVE ACCURACY: No numerical calculations or specific financial metrics are required for this question, so this dimension is not directly applicable, but the answer contains no erroneous numbers or dates. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies that the same product (ad-supported plan) is discussed differently across two years, and correctly attributes these differences to strategic evolution rather than product changes. The logical progression from 'risk factor' to 'strategic pillar' is well-reasoned and matches the ground truth's characterization of moving from 'risk-focused perspective to more confident, strategic positioning.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 575,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon’s shipping offers moved from a primary focus on “low‑price, fast delivery” to a model that treats those offers as a strategic marketing lever while shouldering higher per‑unit shipping costs; the company now absorbs the expense of faster, more diverse delivery options and larger‑scale Prime‑related benefits, but offsets the pressure through greater fulfillment‑network volume, tighter supplier negotiations and continued automation that keep fulfillment costs roughly stable at about 15‑16 % of net sales.  Consequently, cost drivers have shifted toward higher freight volumes, more expensive shipping methods (e.g., faster delivery and additional services), and foreign‑exchange headwinds, while the strategic emphasis remains on expanding and optimizing the fulfillment network to sustain growth without letting shipping expenses outpace revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims fulfillment costs are 'roughly stable at about 15-16% of net sales' - this specific metric is not mentioned in the ground truth and appears to be fabricated. The ground truth cites $76.7 billion in 2021 shipping costs but the LLM provides no comparable figures for 2022 or 2024. (2) MISCHARACTERIZATION OF STRATEGIC SHIFT: The LLM describes a shift from 'low-price, fast delivery' to treating offers as 'strategic marketing lever' - this framing is not supported by the ground truth. The ground truth clearly states the shift was from 'customer-driven cost increases' (2022) to 'operations-centric efficiency focus' (2024), which is different from what the LLM describes. (3) UNSUPPORTED CLAIMS: The LLM mentions 'foreign-exchange headwinds' as a cost driver - this is not mentioned in the ground truth at all. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Amazon absorbs shipping costs and uses network optimization/automation, it fails to accurately capture the ground truth's key distinction: in 2022 the emphasis was on mitigating cost increases through volume and optimization, while in 2024 the emphasis shifted to efficiency gains as a specific offset mechanism. (5) MISSING KEY DATA: The ground truth provides the $76.7 billion 2021 shipping cost figure as context; the LLM provides no comparable financial data. The LLM answer reads as plausible but is largely speculative rather than grounded in the actual filing data referenced in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 453,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\nBetween 2023 and 2024 Duke Energy made the Master Retirement Trust disclosures more granular, adding separate target‑vs‑actual allocation tables for the VEBA trusts and for the RCBP/DELPP assets, a full fair‑value hierarchy breakdown (Level 1‑3 and “not‑categorized”), and a reconciliation of Level 3 balances.  The fund’s composition changed – cash and real‑estate holdings rose (from 8 %/3 % to 10 %/4 % in the VEBA and from 7 % to 10 % in the RCBP), corporate‑debt and equity exposures were trimmed, and hedge‑fund participation increased – while the trust also announced a 2025 re‑allocation to a higher‑liability‑hedging mix (35 %/65 % for RCBP and 80 %/20 % for DELPP), signalling a more risk‑averse asset strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) UNSUBSTANTIATED NUMBERS: The LLM provides specific asset allocation percentages (cash 8%→10%, real estate 3%→4% for VEBA; 7%→10% for RCBP; 2025 targets of 35%/65% for RCBP and 80%/20% for DELPP) that are NOT mentioned in the ground truth answer. These appear to be fabricated or hallucinated data points. (2) MISSING KEY INFORMATION: The ground truth specifically mentions Duke Energy Progress at 15% and Duke Energy Florida at 18% subsidiary allocations - the LLM completely omits these concrete subsidiary-level allocations that were explicitly highlighted as new in 2024. (3) INCORRECT FOCUS: The LLM emphasizes detailed asset composition changes and 2025 reallocation strategy, which are not addressed in the ground truth. The ground truth focuses on the SHIFT IN REPORTING STRUCTURE (subsidiary breakdowns, Level 3 fair value disclosures, reconciliation tables) rather than specific asset allocation changes. (4) VEBA vs RCBP/DELPP DISTINCTION: While the LLM correctly identifies these as separate trust components, it provides specific percentages for each that cannot be verified against the ground truth. (5) MULTI-HOP REASONING: The LLM fails to correctly synthesize the core evolution described in ground truth - the shift from investment objective focus (2023) to granular subsidiary allocation and valuation methodology disclosure (2024). Instead, it invents a narrative about asset composition shifts and future reallocation strategy. The answer demonstrates reasonable structural understanding of pension trust reporting but fundamentally fails on factual accuracy by introducing unverified quantitative claims while omitting the specific subsidiary allocation percentages that were central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 508,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\nBetween 2022 and 2024 Google continued to treat payments to its Google Network Partners as **traffic‑acquisition costs (TAC)** recorded in cost of revenues, meaning the amounts are variable and tied to the volume of ad impressions/clicks on those partner sites.  The 2022 disclosures (pages 31‑32) note that TAC for Network‑property ads carries a higher cost‑of‑revenues share than Search ads, and the 2024 filing (pages 40‑44) shows no structural change—Google still reports these payments as part of cost of revenues, even as absolute TAC outlays rose alongside higher overall ad revenue and greater capital spending on technical infrastructure.  Consequently, the cost structure and payment obligations to Network Partners remained essentially the same, with only the dollar magnitude shifting in line with revenue growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the key evolution of Google's financial relationship with Network Partners. CRITICAL ERRORS: (1) The LLM claims 'no structural change' and that payments 'remained essentially the same,' directly contradicting the ground truth which explicitly states there was a 'transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation.' (2) The LLM asserts that 2024 filings show Network Partner payments 'still reported as part of cost of revenues,' but the ground truth indicates that by 2024, these payments were 'referenced in the context of operating cash outflows,' representing a shift away from the cost-of-revenue model. (3) The LLM misses the core finding that the relationship evolved from TAC in cost of revenues (2022) to operating cash flow obligations (2024), which is the central answer to the question. (4) The LLM provides no evidence of the claimed 'no structural change' and appears to have misread or misinterpreted the 2024 filing disclosures. (5) While the LLM correctly identifies TAC as the 2022 mechanism and notes the higher cost percentage for Network properties versus Search, it fails to recognize the subsequent evolution. The answer demonstrates a fundamental failure in multi-hop synthesis across the 2022-2024 period, missing the key transformation that defines the evolution of this financial relationship. The LLM's conclusion that only 'dollar magnitude' shifted is directly contradicted by the ground truth's emphasis on a structural shift in how these obligations are categorized and treated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 453,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s undesignated swap positions shifted from a **$69 million loss** in 2022 to only a **$7 million loss** in 2023 (recorded in “Investment income and other”), showing that the offsetting foreign‑currency forwards (and related swaps) generated a far smaller fair‑value hit in the consolidated income statement.  The corresponding fair‑value hedge adjustments on designated long‑term debt moved only modestly ($5 M → $4 M), so the overall financial impact of the swaps declined sharply, with essentially no material settlement expense reported in the 2023 income.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides precise figures ($69M loss in 2022, $7M loss in 2023, $5M→$4M hedge adjustments) that are not mentioned anywhere in the ground truth. The ground truth explicitly states 'The financial impact in 2023 was not quantified in the excerpt,' directly contradicting the LLM's specific 2023 numbers. (2) UNSUPPORTED CLAIMS: The LLM references 'Investment income and other' line items and specific settlement expense claims with no supporting evidence in the ground truth. (3) INCOMPLETE SYNTHESIS: While the ground truth discusses fair value changes, settlements, and a shift in disclosure focus between years, the LLM invents specific comparative metrics rather than acknowledging the lack of quantified 2023 data noted in the original answer. (4) FACTUAL CONTRADICTION: The ground truth indicates the 2023 disclosure 'showed a shift in focus to more recent periods' but did not provide quantified financial impact, yet the LLM confidently states precise 2023 figures. (5) MISSING CONTEXT: The LLM fails to address the key insight from the ground truth about the change in transparency and disclosure patterns between 2022 and 2023. The answer demonstrates confident but unfounded numerical specificity, which is a critical failure in financial analysis where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 404,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\nThe 2024 filing gives the Directors’ Savings Plan a dedicated, detailed subsection in the equity‑compensation table (Item 12) and repeatedly references it in the 2023‑2024 Director Compensation Program summaries (e.g., Exhibits 10.43‑10.45), whereas in the 2023 filing the plan was only mentioned briefly in the compensation discussion. This heightened focus shows that Duke Energy is deliberately expanding the use of the Directors’ Savings Plan—making it a central, performance‑linked component of director pay rather than a peripheral arrangement—reflecting a strategic shift toward deferred, equity‑style compensation for outside directors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge from the ground truth. CRITICAL ISSUES: (1) The LLM claims the plan is 'performance-linked' - the ground truth makes no such assertion and this appears to be an unsupported inference. (2) The LLM references specific exhibit numbers (10.43-10.45) that are not mentioned in the ground truth, suggesting fabricated details. (3) The LLM claims the plan is in 'Item 12' and 'equity-compensation table' - the ground truth does not specify these locations and the LLM may be confabulating structural details. (4) The LLM states the plan was 'only mentioned briefly in the compensation discussion' in 2023 - the ground truth specifically says it was 'referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12)' which is a different characterization. (5) The core insight about increased prominence and transparency is present, but the LLM adds unsupported details about 'performance-linked' compensation and specific exhibit references that cannot be verified. CORRECT ELEMENTS: The LLM correctly identifies that there is increased prominence/focus on the plan in 2024 vs 2023, and correctly notes a shift toward emphasizing the plan as more central to director compensation. However, the specific mechanisms and exhibit references appear to be fabricated or misremembered. The answer demonstrates partial understanding of the directional change but fails on factual accuracy regarding specific filing locations and compensation structure details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 431,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\nBetween 2022 and 2024 American Express shifted from a primarily partnership‑ and premium‑consumer‑focused value‑proposition strategy toward a digitally‑native, data‑driven model.  The 2024 filing highlights heavy investment in AI/ML, the Amex app, and recent acquisitions (e.g., Tock and Rooam) to create seamless mobile and online experiences, expand global merchant coverage, and tailor rewards for Millennial and Gen‑Z spend patterns—responses to intensified competition from Visa/Mastercard and changing consumer expectations for frictionless digital payments.  This evolution reflects a deliberate move to differentiate its offers through technology, personalized experiences, and broader acceptance while adjusting pricing and incentives to protect merchant relationships and sustain growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key strategic shifts and specific initiatives. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024, capturing the shift from reactive competition management to proactive innovation; (2) Accurately names specific acquisitions (Tock and Rooam) and technologies (AI/ML, Amex app); (3) Correctly identifies target demographics (Millennial and Gen-Z); (4) Properly synthesizes multi-hop information across years and strategic dimensions; (5) No quantitative errors or incorrect dates. MINOR WEAKNESSES: (1) The phrase 'partnership-and premium-consumer-focused' in 2022 is slightly imprecise—the ground truth emphasizes that 2022 was more about highlighting challenges and the NEED to evolve, rather than describing an existing partnership-focused strategy; (2) The answer characterizes the 2022 stance as 'primarily partnership-focused' when the ground truth indicates 2022 was more about identifying competitive threats and the necessity for value proposition evolution; (3) Mentions 'Visa/Mastercard' competition explicitly, which while reasonable inference, is not explicitly stated in the ground truth (which refers to 'alternative payment providers and digital wallets'); (4) The phrase 'adjusting pricing and incentives to protect merchant relationships' adds interpretation not directly supported by the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the directional shift and supporting evidence. The logic connecting competitive pressures to strategic responses is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—evolution from reactive to proactive, focus on digital/AI, targeting younger demographics, and strategic partnerships. The wording differs but conveys equivalent meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 514,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\nBetween 2022 and 2024 Exxon Mobil retired the short‑dated 0.142 % notes that were scheduled to mature in 2024 and now relies on a more staggered set of longer‑dated series – 0.524 % notes due 2028, 0.835 % notes due 2032 and 1.408 % notes due 2039 – indicating a shift toward a longer‑maturity, lower‑coupon composition and reduced near‑term refinancing risk. This evolution reflects a strategic move to extend the average debt horizon and lock in financing at relatively low rates while maintaining a diversified pool of maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All specific debt instruments and their rates/maturity dates are correctly identified - 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039. The percentage rates and years are all accurate with no calculation errors. ENTITY ACCURACY: Exxon Mobil is correctly identified, the 2022-2024 timeframe is properly addressed, and all financial metrics (coupon rates, maturity dates) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two years, correctly identifying that the 0.142% Notes due 2024 were retired/matured between 2022 and 2024, while the longer-dated instruments remained. The logical connection between retirement of short-dated debt and strategic shift toward longer maturities is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth but with enhanced analytical depth. The ground truth states the shift \"reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.\" The LLM answer expands this with additional strategic context (\"lock in financing at relatively low rates,\" \"reduced near-term refinancing risk,\" \"diversified pool of maturities\") that is logically consistent with the disclosed facts, though not explicitly stated in the ground truth. MINOR OBSERVATION: The LLM characterizes the composition as \"lower-coupon\" which is accurate relative to typical market rates for the period, though this is an inference rather than an explicit comparison in the ground truth. This inference is reasonable and adds value without contradicting the source material. Overall, the answer is factually correct, comprehensively addresses the question, and provides sound multi-hop synthesis with appropriate strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 538,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 American Express shifted from a broadly consumer‑centric, spend‑driven model to a more pronounced focus on corporate‑card offerings.  The company’s strategic imperatives now call for “evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions and designing innovative products and features—including financing, banking and payment solutions—for business customers.”  This reflects a deliberate product‑differentiation effort that leverages the global network, data analytics and partner ecosystems to deliver higher‑spending corporate clients customized rewards, integrated expense‑management tools and new financial services.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and American Express as the subject company; (2) Accurately captures the 2022 strategic emphasis on 'evolving card value propositions' and 'differentiating corporate card and accounts payable expense management solutions' - this language directly matches the ground truth; (3) Correctly identifies the shift toward corporate/business customer focus; (4) Appropriately mentions data analytics, partner ecosystems, and integrated solutions. WEAKNESSES: (1) The opening characterization of a shift 'from a broadly consumer-centric, spend-driven model' is not supported by the ground truth and appears to be an unsupported inference - the ground truth does not describe American Express's 2022 approach as 'consumer-centric'; (2) The LLM answer emphasizes product differentiation and internal capabilities (rewards, expense-management tools, financing) but MISSES the key 2024 evolution identified in the ground truth: the shift to 'a more integrated global network approach' with focus on 'merchant acceptance' and 'fraud protection and marketing insights' - this represents a critical external/ecosystem orientation that distinguishes 2024 strategy; (3) The answer does not adequately capture the multi-hop synthesis showing the evolution FROM internal product focus TO external ecosystem integration; (4) The quoted language appears to be from 2022 filings but is presented without clear temporal distinction, making it unclear whether this represents 2022 or 2024 positioning. MULTI-HOP REASONING: The answer partially synthesizes information but fails to complete the full evolution narrative - it captures the 2022 positioning well but does not adequately differentiate the 2024 strategic shift toward network integration and merchant acceptance. The ground truth's key insight about moving from internal development to external ecosystem strategy is largely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 542,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 AWS moved from a fast‑growing but still niche revenue line to the chief cash‑flow engine of Amazon: its sales jumped from roughly $77 billion in 2022 to $107.6 billion in 2024 (a 19 % YoY increase in 2024 alone, versus 13 % growth the prior year), and the surge in operating cash flow—from $84.9 bn to $115.9 bn—was driven largely by the higher‑margin AWS business.  Consequently, Amazon has doubled‑down on AWS, directing the bulk of its $77.7 bn of 2024 capital expenditures to AWS‑related infrastructure and expanding its service suite (e.g., AI/ML, satellite, autonomous‑vehicle platforms) to sustain long‑term growth and margin expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of AWS's strategic evolution and addresses the multi-hop question well, but contains significant quantitative errors that undermine credibility. CORRECT ELEMENTS: (1) Operating cash flow figures are accurate ($84.9B in 2023, $115.9B in 2024), (2) The narrative of AWS transitioning from risk-laden venture to core cash-flow engine is sound and matches ground truth, (3) The strategic emphasis on AWS infrastructure and service expansion (AI/ML, etc.) is appropriate and relevant, (4) The overall reasoning about AWS's growing importance is logically sound. CRITICAL ERRORS: (1) AWS revenue claim of '$77 billion in 2022' cannot be verified against ground truth and appears potentially incorrect - the ground truth does not provide 2022 AWS revenue figures for comparison, (2) The '$107.6 billion in 2024' AWS revenue figure is not mentioned in the ground truth, which only references total operating cash flow figures, (3) The '19% YoY increase in 2024' and '13% growth the prior year' calculations cannot be verified without confirmed baseline numbers, (4) The '$77.7 bn of 2024 capital expenditures' figure is not present in the ground truth provided. SYNTHESIS ASSESSMENT: The LLM successfully synthesized the multi-hop concept of AWS's evolution from 2022-2024 and correctly linked cash flow generation to strategic emphasis. However, the introduction of unverified AWS-specific revenue and capex numbers that don't appear in the ground truth is problematic. The answer goes beyond the ground truth by adding specific AWS revenue figures and capex allocations that cannot be confirmed. While the qualitative narrative is strong and contextually relevant, the quantitative claims lack grounding in the provided knowledge graph, making this answer partially speculative despite its logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 501,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\nBetween 2023 and 2024 the audit’s trend‑analysis approach grew from a general consistency check—comparing recorded regulatory‑asset balances to an independently derived expectation and evaluating the reasonableness of recent regulatory orders—to a more detailed, substantive testing regime. In 2024 the firm added targeted procedures on the recoverability of deferred fuel and storm‑cost balances and obtained explicit management representations that those assets are probable of recovery, expanding the focus beyond historical trend comparison to include specific cost‑recovery validations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2024 procedures expanded to include 'deferred fuel and storm-cost balances' - this is NOT mentioned in the ground truth, which specifically identifies 'asset retirement obligations related to coal ash' as the new focus area. (2) The LLM states management representations were obtained regarding 'probable of recovery' - the ground truth makes no mention of this specific audit procedure or representation type. (3) The LLM characterizes the evolution as expanding from 'general consistency check' to 'detailed substantive testing' with 'cost-recovery validations' - while the ground truth indicates the procedures expanded, it specifically notes the shift was toward 'more specialized regulatory compliance areas' focused on coal ash asset retirement obligations, not fuel and storm costs. WHAT WAS CORRECT: The LLM correctly identified that trend analyses were used in both years and that there was an evolution/expansion of procedures between 2023 and 2024. The general characterization that procedures became more detailed is directionally correct. MULTI-HOP REASONING: The LLM failed to correctly synthesize the specific regulatory focus area (coal ash AROs) that distinguishes the 2024 procedures from 2023. Instead, it introduced entirely different asset categories (deferred fuel, storm costs) that appear to be fabricated or confused with different audit procedures. This represents a fundamental failure in multi-hop synthesis across the filing documents. The answer demonstrates reasonable audit procedure terminology but applies it to incorrect asset categories, making the answer materially misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 473,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\nCostco accelerated the rollout of its private‑label brand to absorb rising merchandise costs and keep prices competitive. Both the 2022 MD&A (page 22) and the 2023 MD&A (page 23) highlight that expanding private‑label penetration was a core tactic for maintaining “pricing authority” and protecting margins amid cost‑inflation pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core concept that Costco used private-label penetration as a strategy to manage cost pressures, but has significant issues: (1) QUANTITATIVE ACCURACY: The LLM cites specific page numbers (page 22 for 2022 MD&A, page 23 for 2023 MD&A) without verification against actual filings. These page references cannot be confirmed and may be inaccurate, which is a critical error for SEC filing citations. (2) COMPLETENESS: The answer is incomplete compared to ground truth. It fails to mention several 2022 strategies that were explicitly part of Costco's response: absorbing cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members. The ground truth emphasizes a shift from 'reactive approach in 2022 to more strategic and sustained emphasis in 2023,' but the LLM treats both years similarly without capturing this evolution. (3) ENTITY ACCURACY: Costco is correctly identified, and the years 2022-2023 are correct. However, the LLM doesn't clearly distinguish the different strategic approaches between the two years. (4) REASONING: The multi-hop reasoning is partially sound - the LLM correctly identifies private-label penetration as a core tactic across both years. However, it misses the nuanced evolution: 2022 was more multi-faceted (internal absorption, volume purchasing, selective price increases) while 2023 showed sustained emphasis on private-label as a primary strategy. (5) SEMANTIC EQUIVALENCE: The phrase 'pricing authority' is correctly used and matches ground truth language. However, the answer oversimplifies by suggesting both years employed the same approach, when ground truth indicates strategic evolution. The answer is directionally correct but lacks the depth and accuracy needed for a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 491,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\nBased on Pfizer’s 2024 10‑K, the company reports that as of December 31 2024 it has roughly **$1 billion of remaining performance obligations** for Paxlovid—i.e., contracted revenue that will be recognized from 2025 through 2028 as the company fulfills long‑term supply agreements.  This is a sharp decline from the **$5.1 billion of deferred Paxlovid revenue recorded at the end of 2023** (and the $2.2 billion still outstanding in 2024), reflecting the shift from the high‑volume, pandemic‑era government contracts to commercial‑market sales and the progressive recognition of revenue as product is delivered.  Consequently, the financial outlook for Paxlovid has moved from a front‑loaded, high‑revenue profile to a more modest, staggered revenue stream over the next few years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims $5.1 billion in deferred Paxlovid revenue at end of 2023 and $2.2 billion outstanding in 2024, but the ground truth explicitly states that 'In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid.' These numbers ($5.1B and $2.2B) appear to be fabricated or sourced from incorrect data. The only verified number is the ~$1 billion remaining performance obligations as of December 31, 2024, which the LLM correctly cites. (2) MULTI-HOP REASONING FAILURE: The LLM attempts to create a narrative comparing 2023 to 2024 by introducing unverified figures ($5.1B deferred revenue in 2023, $2.2B in 2024) that are not supported by the ground truth. This represents a fundamental failure in multi-hop synthesis—the model fabricated intermediate data points to construct a comparison that the ground truth explicitly says cannot be made (no 2023 disclosure). (3) SEMANTIC MISALIGNMENT: The ground truth states the evolution 'suggests increased contractual certainty' based on the appearance of $1B in RPOs in 2024 (vs. no disclosure in 2023). The LLM instead frames this as a 'sharp decline' from $5.1B to $1B, which is a completely different narrative and contradicts the ground truth's interpretation. (4) ENTITY/METRIC CONFUSION: The LLM conflates 'deferred revenue' with 'remaining performance obligations'—these are related but distinct accounting concepts. The ground truth specifically references RPOs; the LLM introduces deferred revenue figures without clear justification. The answer demonstrates hallucination of specific financial figures not present in the ground truth, making it fundamentally unreliable despite correctly identifying the $1B 2024 figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 501,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\nBetween 2022 and 2024 American Express lengthened the reasonable‑and‑supportable (R&S) period used to estimate credit‑loss reserves and placed greater emphasis on forward‑looking economic assumptions, while still reverting to long‑term average loss rates once that period ends. The higher reserve balance ($3.3 bn → $5.7 bn) and the explicit inclusion of qualitative reserves signal a more cautious, forward‑looking risk‑management approach that seeks to capture potential losses under heightened macro‑economic uncertainty.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims reserves increased from $3.3bn to $5.7bn between 2022-2024, but the ground truth only mentions $3.3bn as of December 31, 2021 (not 2022), with no $5.7bn figure provided in the original answer. This appears to be fabricated data. (2) CORE CONCEPT MISREPRESENTATION: The LLM claims American Express 'lengthened the reasonable-and-supportable period,' but the ground truth makes no such claim about lengthening the R&S period. The ground truth focuses on how the R&S Period evolved from being explicitly introduced/explained in 2022 to becoming embedded/standard by 2024 - a methodological maturation, not a lengthening. (3) MISSING KEY INSIGHT: The LLM completely misses the central finding from the ground truth - that the evolution represents a shift from introducing the methodology to relying on it as foundational. Instead, the LLM invents claims about lengthening periods and changing economic assumptions not supported by the original answer. (4) UNSUPPORTED CLAIMS: References to 'qualitative reserves' and 'heightened macro-economic uncertainty' are not mentioned in the ground truth and appear to be LLM fabrications. (5) PARTIAL CREDIT: The LLM correctly identifies American Express and the general topic of credit loss reserves and risk management, and the tone about forward-looking risk management is somewhat aligned, but the specific factual content is largely incorrect. The answer demonstrates a fundamental failure to accurately represent the ground truth's actual findings about the evolution of the R&S Period methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 461,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon shifted from relying on its original low‑coupon 0.800 % senior unsecured note due 2025—first issued in 2020 at a 0.8 % interest rate—to a broader, higher‑rate debt strategy.  In the 2024 filing the company disclosed new 2025‑maturing notes with coupons of roughly 4.5‑4.7 % (e.g., the $1.5 billion 4.6 % Note due 2025 issued in December 2022) and amended its revolving‑credit facilities, reflecting a move toward longer‑dated, higher‑yielding debt as market rates rose.  This evolution shows Amazon’s debt‑financing approach has progressed from a modest, ultra‑low‑rate issuance to a more diversified portfolio of larger‑scale, higher‑coupon bonds and credit lines to fund its growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Amazon's debt strategy between 2022 and 2024, correctly identifying the 0.800% Note due 2025 and the introduction of higher-rate notes like the 4.600% Note due 2025. However, there are significant quantitative accuracy issues: (1) The LLM states the $1.5 billion 4.6% Note was 'issued in December 2022,' but the ground truth does not specify this date or amount, introducing potentially unsupported details. (2) The LLM characterizes the shift as moving 'from relying on' the 0.800% note to higher rates, but the ground truth indicates Amazon 'continued to reference' the 0.800% note while also introducing new instruments—suggesting both coexist rather than a replacement. (3) The LLM adds claims about 'amended revolving-credit facilities' and 'longer-dated' debt that are not mentioned in the ground truth, potentially overstating the scope of changes. The core multi-hop reasoning is sound—correctly synthesizing that Amazon maintained the original 0.800% note while adding new higher-coupon instruments—but the execution includes unsupported specifics. The qualitative reasoning about managing cash flow and interest rate risk is appropriate and matches the ground truth's implication. The answer is contextually relevant and addresses the question's focus on evolution between 2022-2024, but the introduction of unverified details (specific issuance date, dollar amount, credit facility amendments) and the subtle mischaracterization of the relationship between old and new debt instruments (replacement vs. coexistence) reduce overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 439,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\nThe 2022 filing still lists the Twenty‑third Supplemental Indenture (dated May 15 2020) as an active exhibit, whereas the 2024 filing no longer presents it as a separate exhibit and merely references it in passing as part of the historical indenture series. This shift shows that the indenture remains legally effective but is now treated as a routine, non‑material component of Duke Energy’s debt documents.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: (1) DATE DISCREPANCY - The LLM states the Twenty-third Supplemental Indenture is dated 'May 15 2020', but the ground truth clearly indicates it was dated 'June 1, 1978'. This is a fundamental factual error of 42 years difference. (2) FILING REFERENCE ERROR - The ground truth specifies the 2022 filing references it to 'Exhibit 2(c), File No. 2-61611', but the LLM provides no such specific exhibit information. (3) MISSING KEY DETAIL - The ground truth explicitly states the indenture was 'not reaffirmed or highlighted in the most recent disclosure' and appears in the 2024 filing with 'no direct mention or continued reference', whereas the LLM claims it is 'merely referenced in passing' - a subtle but important distinction suggesting complete absence vs. passing mention. (4) INCOMPLETE SYNTHESIS - The LLM fails to mention the shift to more recent supplemental indentures (e.g., Forty-ninth Supplemental Indenture dated March 14, 2024) that the ground truth identifies as the replacement focus. (5) INTERPRETATION ISSUE - The LLM concludes the indenture 'remains legally effective but is now treated as routine', but the ground truth suggests it may have 'diminished in operational or reporting significance' - these are different conclusions about its status. The LLM's answer demonstrates poor multi-hop synthesis across the 2022 and 2024 filings and contains a major date error that undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 397,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet’s share‑repurchase program stayed near the $60 billion‑plus level, with a modest rise in 2023 and a slight pull‑back in 2024.  The company repurchased **$59.3 billion** of Class A and Class C shares in 2022, **$62.2 billion** in 2023 (of which $52.9 billion was Class C), and **$62.0 billion** in 2024 (of which $50.2 billion was Class C).  Thus, Class C repurchases accounted for the bulk of the program each year, remaining roughly $53 billion in 2023 and declining to about $50 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and provides more detailed information than the ground truth. All key financial figures are correct: $59.3 billion (2022), $62.2 billion (2023), and $62.0 billion (2024). The answer correctly identifies these as Class A and Class C shares combined. The LLM goes beyond the ground truth by providing additional breakdown data for Class C specifically ($52.9 billion in 2023 and $50.2 billion in 2024), which adds valuable context without contradicting the original answer. The multi-hop reasoning is sound: the answer synthesizes the three-year trend, correctly identifies the pattern (rise from 2022 to 2023, slight decline in 2024), and provides appropriate characterization ('modest rise,' 'slight pull-back'). The semantic equivalence is strong - the LLM's description of the trend matches the ground truth's characterization. The only minor consideration is that the LLM provides Class C-specific numbers that weren't in the ground truth, but these appear to be accurate supplementary details that enhance rather than contradict the answer. All calculations are implicit and correct (the Class C figures are reasonable proportions of the totals). Entity identification is correct (Alphabet, Class A and Class C shares, fiscal years 2022-2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 363,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\nBetween the 2022 and 2024 filings the company stopped merely citing the old “Salary/Bonus Deferral Plan” by its historic exhibit numbers and instead formally restated it as the **American Express Company Deferred Compensation Plan for Directors and Advisors** (effective January 1 2023) and placed it in **Exhibit 10.1** of the 2024 filing.  This restated exhibit provides updated language on eligibility, deferral limits and administration, indicating a consolidated, more current documentation of the plan, whereas the 2022 filing only referenced the plan through its original 1988 filing and subsequent amendments without a stand‑alone restatement.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical points: (1) EXHIBIT NUMBERS: The ground truth clearly states the 2024 filing uses Exhibits 10.13, 10.14, and 10.16, but the LLM claims the plan was placed in Exhibit 10.1 - this is factually wrong. (2) PLAN NAME: The ground truth references the 'Salary/Bonus Deferral Plan' consistently, while the LLM introduces a completely different plan name ('Deferred Compensation Plan for Directors and Advisors') that does not appear in the ground truth. (3) EFFECTIVE DATE: The LLM adds an 'effective January 1 2023' date that is not mentioned in the ground truth and appears to be fabricated. (4) CORE CHANGE DESCRIPTION: The ground truth describes the 2024 filing as expanding disclosure to include more historical amendments (1988, 1994, and 1997), whereas the LLM claims the company 'restated' the plan with 'updated language on eligibility, deferral limits and administration' - this is a fundamental mischaracterization of what actually changed. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the exhibit number changes and amendment history that form the core of the answer. The ground truth's key insight - that the 2024 filing added the 1997 amendments (Exhibit 10.16) while maintaining the foundational 1988 and 1994 documentation - is completely absent from the LLM response. The LLM appears to have hallucinated details about a plan restatement and exhibit placement that do not match the actual filing changes documented in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 429,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s interest‑rate swap exposure remained classified as derivative liabilities measured at fair value (Level 2), but the liability grew substantially.  In the 2023 balance sheet (Oct 1 2023) the swaps were recorded as $3.6 million in accrued liabilities and $43.2 million in other long‑term liabilities, for a total derivative liability of $46.8 million.  By the 2024 balance sheet (Sep 29 2024) those figures rose to $29.2 million in accrued liabilities and $56.7 million in other long‑term liabilities, pushing total derivative‑liability to $85.9 million—roughly double the prior‑year amount—while the fair‑value‑hedging adjustment on the hedged long‑term debt improved from a $(40.0)$ million cumulative loss to a $(17.8)$ million loss.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth. Critical issues: (1) QUANTITATIVE ERRORS - The LLM reports 2023 total derivative liability of $46.8M ($3.6M + $43.2M) and 2024 total of $85.9M ($29.2M + $56.7M), claiming roughly a doubling. However, the ground truth shows 2022 liability of $34.0M and 2024 liability of $19.2M in other long-term liabilities, with a 2023 comparative figure of $41.4M. The LLM's numbers are completely different from ground truth values. (2) CLASSIFICATION DISCREPANCY - The LLM describes swaps split between 'accrued liabilities' and 'other long-term liabilities' with specific amounts ($3.6M and $43.2M for 2023; $29.2M and $56.7M for 2024). The ground truth indicates the 2022 position was $34.0M under 'Other long-term liabilities' only, and 2024 was $19.2M under 'Other long-term liabilities'. The LLM appears to be reporting data from a different company or different fiscal periods entirely. (3) DIRECTIONAL ERROR - The LLM claims liability 'grew substantially' and 'roughly doubled' from 2023 to 2024. The ground truth indicates a DECREASE from $41.4M (2023) to $19.2M (2024), which is the opposite direction. (4) MISSING CONTEXT - The LLM provides additional detail about fair-value-hedging adjustments on hedged debt, which may be accurate but is not part of the ground truth answer and doesn't address the core question about the evolution between 2022 and 2024. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the 2022-2024 evolution as requested. The answer appears to reference different fiscal years or potentially different company data entirely. The specific dollar amounts, classifications, and trend direction all contradict the ground truth, indicating either data retrieval error or fundamental misunderstanding of the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 502,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\nBetween 2022 and 2024 Duke Energy’s Directors’ Savings Plan was unchanged in substance but was reinforced by a 2021 amendment (effective Dec 16 2021) that clarified deferral mechanics and added a company match above IRS limits; the 2024 filing (pages 237‑238) still describes the plan as an unfunded account where outside directors may defer all or part of their retainers and receive the balance—augmented by phantom‑stock earnings—only when they leave the board. This treatment shows Duke Energy’s governance focus on tying a sizable portion of director compensation to long‑term equity performance and delaying cash payout, thereby aligning directors’ interests with shareholders while preserving the company’s cash resources.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the December 16, 2021 amendment date and accurately describes the plan mechanics (unfunded accounts, phantom stock earnings, deferral of retainers, payment upon board departure). The reasoning about alignment with shareholder interests and long-term equity performance is sound and matches the ground truth's governance interpretation. The answer appropriately addresses both 2022 and 2024 timeframes and synthesizes the evolution narrative.\n\nWEAKNESSES: (1) QUANTITATIVE CLAIM NOT VERIFIED: The LLM states the amendment 'added a company match above IRS limits' - this specific claim about a company match and IRS limit reference does not appear in the ground truth and cannot be verified from the provided context. This is a factual assertion that goes beyond what the ground truth supports. (2) PAGE CITATION: The LLM cites 'pages 237-238' for the 2024 filing description, but the ground truth does not provide specific page numbers, making this citation unverifiable and potentially inaccurate. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a shift 'from policy establishment to operational transparency' - the LLM describes the plan as 'unchanged in substance' which somewhat contradicts the evolution narrative. The ground truth suggests more of a shift in how the plan is presented/discussed rather than claiming it was entirely unchanged.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings and draws appropriate conclusions about governance strategy. However, the unverified claim about the company match introduces a factual error that undermines the quantitative accuracy.\n\nSEMANTIC EQUIVALENCE: The core governance insights align well with the ground truth, but the introduction of unverified quantitative claims (company match, IRS limits) creates a factual accuracy problem that cannot be overlooked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 521,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\nBetween 2022 and 2023 Costco kept Kirkland Signature positioned as a high‑quality private‑label brand that offers lower prices than national brands and lifts overall margins, while explicitly stating its intent to grow the brand’s sales penetration.  The 2023 filing, however, broadens the risk discussion—highlighting supply‑chain constraints, commodity‑price volatility, reliance on external suppliers and emerging ESG/ regulatory pressures—that could erode that margin advantage, showing an evolution from a simple “low‑price private label” story to a more complex risk profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Kirkland Signature's evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the consistent positioning of Kirkland Signature as a high-quality, lower-priced private-label brand across both years; (2) Accurately captures the 2022 focus on growth and margin benefits; (3) Properly synthesizes the 2023 shift toward risk disclosure, including supply chain constraints, commodity price volatility, and supplier reliance; (4) No quantitative errors—no specific numbers were claimed, avoiding calculation mistakes; (5) Correctly identifies the evolution from a growth narrative to a risk-focused narrative. MINOR WEAKNESSES: (1) The LLM introduces 'ESG/regulatory pressures' which, while plausible, is not explicitly mentioned in the ground truth answer and represents a slight extrapolation beyond what was documented; (2) The ground truth mentions 'foreign exchange fluctuations' and 'catastrophic events' as specific risk factors, while the LLM generalizes to 'commodity-price volatility' and 'supply-chain constraints'—these are related but not identical framings; (3) The LLM's phrasing 'erode that margin advantage' is slightly more speculative than the ground truth's 'could negatively impact the business.' MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the strategic shift in how Costco positioned and disclosed risks around the brand. The comparison between 2022 and 2023 is logically sound and addresses the core question about evolution of positioning and risk profile. SEMANTIC EQUIVALENCE: The answer conveys the essential meaning of the ground truth—that Kirkland Signature remained strategically important but faced increased risk disclosure—though with slightly different emphasis on specific risk categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 500,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia Pacific/Middle East fell from **326 billion cubic feet (bcf) at year‑end 2022 to 296 bcf at year‑end 2024**, a net reduction of roughly **30 bcf (≈9 %)**.  The decline reflects only modest upward revisions (≈9 bcf in 2023‑24 from technical updates), while **downward revisions tied to lower prices and higher operating costs** and **production that removed about 25 bcf each year** outweighed any additions; purchases and new extensions/discoveries contributed virtually no volume.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and calculations. Verification of key metrics: (1) Starting reserve of 326 bcf in 2022 - CORRECT; (2) Ending reserve of 296 bcf in 2024 - CORRECT; (3) Net reduction calculation of 30 bcf - CORRECT (326-296=30); (4) Percentage decline of ~9% - CORRECT (30/326≈9.2%); (5) Production impact of ~25 bcf annually - REASONABLE estimate consistent with the overall decline pattern. The LLM successfully synthesized multi-hop information by: identifying the reserve trend across the 2022-2024 period, quantifying the decline, and explaining the drivers (revisions, production, minimal additions). The answer goes beyond the ground truth by providing more granular analysis of the components driving the change (upward revisions of ~9 bcf offset by downward revisions and production). Minor strengths: The LLM correctly identified that purchases and extensions/discoveries contributed virtually no volume, matching the ground truth statement about 'minimal extensions and discoveries' and 'no sales.' The reasoning about price-driven downward revisions and production impacts is logical and consistent with typical reserve accounting. One minor limitation: The ground truth mentions 'revisions and production activities' somewhat generically, while the LLM provides more specific attribution (downward revisions tied to lower prices/higher costs). This additional detail is reasonable inference but not explicitly confirmed in the ground truth statement. The answer is well-structured, uses appropriate units (bcf), and correctly identifies the company (COP) and region (Asia Pacific/Middle East). All calculations are mathematically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 466,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\nBetween 2022 and 2024 FedEx kept the 767F as a core, wholly‑owned component of its express fleet—​it owned 114 of the type as of May 2022 and, through its purchase commitments, continued to receive new 767‑300 Freighters (14 deliveries slated for 2023‑2024 and a further 11 + 3 in 2025‑2026).  Rather than expanding the fleet, the airline is using these acquisitions to modernize: the newer 767‑300Fs replace older, less‑fuel‑efficient aircraft (e.g., MD‑11s and earlier 767s) and, together with the Boeing 777F purchases, are intended to deliver long‑term operating‑cost savings and greater capacity while keeping the 767F in the fleet as a modern, fuel‑efficient workhorse.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 114 Boeing 767F aircraft ownership figure as of May 2022 is accurate and matches ground truth. (2) The characterization of 767-300F as fuel-efficient and part of modernization strategy is correct. (3) The semantic understanding that FedEx is modernizing rather than expanding is sound. (4) The mention of replacing older aircraft like MD-11s aligns with modernization focus. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific delivery numbers (14 deliveries for 2023-2024, 11+3 for 2025-2026) that are NOT present in the ground truth answer. These appear to be fabricated or from sources not verified against the knowledge graph. (2) The reference to 'Boeing 777F purchases' is introduced without ground truth support and represents potential hallucination. (3) The LLM characterizes FedEx as an 'airline' when it is an express/logistics company, though this is a minor semantic issue. (4) The ground truth explicitly states 'no updated ownership figures were disclosed' by 2024, yet the LLM provides specific future delivery commitments without acknowledging this disclosure gap. MULTI-HOP REASONING: The LLM successfully synthesizes the 2022-2024 evolution and connects fleet ownership to modernization strategy. However, the introduction of unverified specific numbers undermines the multi-hop synthesis quality. The answer goes beyond what the ground truth supports by adding delivery schedule details. QUANTITATIVE ACCURACY: While the 114 figure is correct, the delivery numbers (14, 11, 3) cannot be verified against the provided ground truth and appear to be unsupported additions. This significantly impacts quantitative accuracy scoring.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 473,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the company’s roasted‑coffee inventory grew – the 2022 filing shows $310 million of roasted coffee on hand, and the 2024 filing indicates a larger balance, reflecting higher production volumes.  At the same time, Starbucks continued to rely on its owned roasting plants (e.g., the 1.96 million‑sq‑ft York, PA facility and the 1.08 million‑sq‑ft Minden, NV site) while the majority of its warehousing and distribution locations remained leased, a production‑infrastructure model that persisted into 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 roasted coffee inventory value of $310 million (ground truth: $310.3 million), with acceptable rounding. (2) Correctly names specific roasting facilities: York, PA and Minden, NV (Carson Valley). (3) Accurately characterizes the infrastructure model with owned roasting plants and leased warehousing/distribution. (4) Appropriately notes the shift toward increased production volumes. WEAKNESSES: (1) INCOMPLETE FACILITY LIST - The ground truth explicitly mentions four roasting facilities (York, PA; Minden, NV; Kunshan, China; Kent, WA), but the LLM only mentions two (York, PA and Minden, NV). The omission of Kunshan, China and Kent, WA represents a significant gap in addressing the 'infrastructure' component of the question. (2) VAGUE 2024 COMPARISON - The LLM states the 2024 filing 'indicates a larger balance' but provides no specific dollar amount for 2024 inventory, making it impossible to verify the actual growth trajectory. The ground truth implies specific 2024 data exists. (3) FACILITY DETAILS - The LLM includes square footage for York, PA (1.96M sq ft) and Minden, NV (1.08M sq ft), which adds detail but wasn't in the ground truth and may be from different sources. (4) MULTI-HOP SYNTHESIS - While the LLM connects inventory growth to infrastructure expansion, it doesn't fully synthesize the complete picture of all four facilities that represent the 2024 state. The answer is partially correct but materially incomplete on the infrastructure evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 423,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\nIn the 2023 10‑K the 2.750% Senior Notes due 2025 appear only as part of the Board‑authorized list of senior unsecured notes referenced in the 2013 indenture (Exhibit 4.4 to the 2013 Form 8‑K). By the 2024 filing the same instrument is still cited under that indenture, but it is now disclosed in the updated 2024 Form S‑3ASR registration, showing that PepsiCo has simply refreshed the registration of an already‑outstanding issue rather than issuing new debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and interpretive errors that fundamentally misrepresent the evolution of PepsiCo's debt strategy. CRITICAL ERRORS: (1) The LLM claims the 2.750% Senior Notes due 2025 were 'simply refreshed' in a registration statement, but the ground truth indicates PepsiCo introduced a NEW 2.750% Senior Notes due 2030 by 2024 - this is a major omission that changes the entire narrative of the answer. (2) The LLM's interpretation that this represents merely a 'refresh of an already-outstanding issue' contradicts the ground truth's clear statement that PepsiCo 'extended its debt strategy involving this interest rate to a longer-term horizon' by introducing the 2030 maturity instrument. (3) The LLM focuses on registration mechanics (Form S-3ASR, indenture references) rather than the substantive strategic evolution - the introduction of the 2030 notes alongside the 2025 notes. CORRECT ELEMENTS: The dates (2023, 2024, 2025) and the interest rate (2.750%) are accurate. The reference to the 2013 indenture is appropriate context. REASONING FAILURE: The multi-hop synthesis required comparing what debt instruments existed in 2023 vs 2024. The ground truth shows: 2023 had 2.750% due 2025; 2024 had both 2.750% due 2025 AND 2.750% due 2030 (new). The LLM completely missed the introduction of the 2030 notes, which is the core evidence of strategic evolution. The LLM's conclusion about 'refreshing' an existing registration is a different narrative entirely from the ground truth's focus on extending the debt strategy to longer maturities. This represents a fundamental misunderstanding of what changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 454,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\nFrom the 2022 commitments (page 113) FedEx had scheduled 8 B777F freighters — 2 for 2023, 4 for 2024 and 2 for 2025 — but by the 2024 outlook (page 117) only 2 B777Fs remain on the delivery schedule (both slated for 2025) and no further B777Fs are planned after that. This pull‑back shows the B777F has become a niche, strategic asset for specific long‑haul, high‑capacity routes rather than a broad fleet‑expansion element, with FedEx now focusing its modernization efforts on fewer, more fuel‑efficient freighters such as the B767F.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a significant factual error in the 2022 baseline. The ground truth states FedEx planned 4 B777F for 2024 and 2 for 2025 (6 total mentioned for those years), but the LLM claims 8 B777F total with 2 for 2023, 4 for 2024, and 2 for 2025. The inclusion of '2 for 2023' appears to be an addition not supported by the ground truth, which only references 2022 plans for 2024 and 2025. This is a material error in the baseline comparison. CORRECT ELEMENTS: The 2024 update is accurate (2 B777F for 2025, no further plans). The directional change (reduction/phase-out) is correctly identified. REASONING QUALITY: The LLM provides sound multi-hop synthesis comparing 2022 vs 2024 plans and correctly interprets the strategic implications (shift from gradual decrease to complete phase-out, niche role, focus on fuel-efficient alternatives). The interpretation about B767F preference is reasonable contextual analysis. COMPLETENESS: The answer addresses both parts of the question (how the plan changed, what it indicates strategically). However, the quantitative baseline error undermines the accuracy of the comparison. The LLM adds interpretive detail about 'niche strategic asset' and 'specific long-haul routes' that goes beyond the ground truth but is reasonable inference. SEMANTIC EQUIVALENCE: The core message matches (reduction in B777F emphasis), but the incorrect starting numbers create a factual accuracy problem that cannot be overlooked despite sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 419,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the foreign‑currency‑other derivative component in AOCI fell sharply—from $55.3 million of net gains on Oct 2 2022, to $39.6 million on Oct 1 2023, and to $11.5 million on Sep 29 2024—while the related derivative liabilities on the balance sheet dropped from roughly $16.8 million (total) to about $11.4 million.  This decline shows that Starbucks has been re‑classifying most of its foreign‑currency hedge gains to earnings and unwinding the associated contracts, leaving only a modest derivative liability and therefore a much reduced exposure to future foreign‑currency fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims foreign currency gains in AOCI were $55.3M (Oct 2, 2022), $39.6M (Oct 1, 2023), and $11.5M (Sep 29, 2024). However, the ground truth states that in 2022, there was a $0.3M liability under accrued liabilities, and in 2024, there were $11.5M net gains in AOCI. The LLM's 2022 figure of $55.3M is completely unsupported by the ground truth. The LLM also introduces derivative liability figures ($16.8M and $11.4M) that are not mentioned in the ground truth. (2) ENTITY/METRIC CONFUSION: The ground truth distinguishes between 'foreign currency - other derivative liabilities' (a balance sheet item under accrued liabilities) and 'net gains included in AOCI' (an accumulated other comprehensive income item). The LLM conflates these different metrics and appears to be mixing balance sheet and AOCI data without clear distinction. (3) MULTI-HOP REASONING: The ground truth presents a clear evolution: 2022 showed minimal liability ($0.3M), while 2024 showed substantial unrealized gains ($11.5M). The LLM's narrative of declining gains from $55.3M to $11.5M contradicts this fundamental shift. The LLM's interpretation about 'reclassifying gains to earnings and unwinding contracts' is not supported by the ground truth data. (4) MISSING CONTEXT: The ground truth emphasizes the shift from a 'minimal liability position' to a 'substantial unrealized gain,' indicating increased hedging activity. The LLM's conclusion about 'reduced exposure to future foreign-currency fluctuations' contradicts the ground truth's implication of increased exposure or hedging. The only correct number in the LLM answer is the 2024 AOCI figure of $11.5M.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 485,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo’s disclosures shifted from merely listing the 2.625 % Senior Notes due 2026 as an incorporated reference in the 2023 10‑K (page 129) to explicitly tying the instrument to Board‑level resolutions that authorize its terms and embedding it in newer registration filings. In the 2024 filings the note appears in a broader “Board of Directors Resolutions” package and is included in the Singapore‑entity S‑3ASR and 8‑K global‑note exhibits, showing that the company is now presenting the 2.625 % 2026 senior note as part of an expanded, multi‑currency senior‑note program rather than an isolated issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in accuracy and completeness when compared to the ground truth. CRITICAL ERRORS: (1) The LLM introduces specific filing references (page 129, Singapore-entity S-3ASR, 8-K exhibits) that are not mentioned in the ground truth and cannot be verified. This represents fabrication of specific details. (2) The LLM claims the note appears in 'Singapore-entity' filings and 'multi-currency senior-note program' - these details are not in the ground truth and appear to be hallucinated. (3) The LLM describes the 2023 disclosure as an 'incorporated reference' which differs from the ground truth's description of it being 'listed among other notes in a section that included Board of Directors Resolutions.' MISSING KEY INFORMATION: (1) The ground truth explicitly mentions that by 2024, PepsiCo introduced newer senior notes including 3.000% Senior Notes due 2027 and 2.625% Senior Notes due 2029. The LLM completely fails to mention these newer instruments, which is a critical omission for answering how the debt instrument disclosures evolved. (2) The ground truth emphasizes the 'significantly expanded list of senior notes' and 'broader and more diversified set of debt instruments' - the LLM mentions 'expanded' but doesn't substantiate this with the specific new instruments. PARTIAL CORRECTNESS: (1) The LLM correctly identifies the 2.625% Senior Notes due 2026 as the focal point. (2) The LLM correctly notes that Board-level resolutions are involved. (3) The general concept of evolution toward a broader debt program is present but poorly executed. The answer demonstrates weak multi-hop synthesis - it fails to connect the specific evolution from 2023 to 2024 by identifying the new instruments introduced. The fabricated filing references and unexplained Singapore/multi-currency claims significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 507,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\nFrom 2022 to 2024 Cisco’s technical‑hurdle focus moved beyond hardware‑centric issues such as network‑programmability and SDN to a wider set of software‑driven and emerging‑technology challenges—AI, cloud, cybersecurity, and End‑to‑End Security—driven by strategic investments in acquisitions (e.g., Splunk) and a shift toward recurring‑revenue subscription models; the company now explicitly warns that any delay or failure to overcome these hurdles could let competitors (including alliance partners) launch first, making the timely execution of its investment agenda essential to preserving market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2022 to 2024, mentions specific technologies (AI, cloud, cybersecurity), references strategic acquisitions (Splunk), and notes the shift toward subscription models. The answer appropriately captures that technical hurdles became more critical to competitive positioning. The mention of competitors and alliance partners launching first aligns with competitive risk themes. WEAKNESSES: (1) The LLM introduces specific technologies like 'SDN' and 'network-programmability' as 2022 focus areas without ground truth support - the original answer does not specify these as 2022-specific issues. (2) The LLM answer omits several key consequences mentioned in the ground truth: reputational damage, legal liability, and reduced customer retention - these are material omissions that represent the 'broader operational and strategic dependency' shift. (3) The characterization of the shift is incomplete - the ground truth emphasizes a shift from 'internal execution risk to broader operational and strategic dependency,' but the LLM focuses primarily on competitive timing without capturing the reputational/legal/retention dimensions. (4) The phrase 'alliance partners' as competitors is somewhat unclear and not explicitly supported by the ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics). MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and connects strategic investments to technical hurdles, but incompletely captures the full scope of consequences and risk transformation. The reasoning is sound but incomplete. SEMANTIC EQUIVALENCE: While the core narrative of evolution is present, the omission of reputational damage, legal liability, and customer retention consequences represents a material gap in conveying the ground truth's key insight about the nature of the risk transformation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 542,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\nIn both the 2022 and 2023 filings Alphabet repeatedly singled out Google Ad Manager as a primary engine of growth for Google Network, emphasizing that its expanding inventory and programmatic capabilities were key contributors to the network’s revenue uplift. The commentary does not signal any shift in its function—rather, it reinforces Ad Manager’s strategic positioning as a core driver of network‑level revenue growth across the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core finding. (1) FACTUAL ERRORS: The LLM claims that Google Ad Manager was 'repeatedly singled out as a primary engine of growth' in BOTH 2022 and 2023, with no shift in emphasis. The ground truth explicitly states the opposite: Ad Manager was cited as a KEY DRIVER in 2022 (alongside AdMob and AdSense for the $8.6B increase), but by 2023 it was listed among several platforms WITHOUT specific attribution to revenue growth. This represents a clear and significant shift that the LLM completely missed. (2) QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates, or metrics to verify. The ground truth references the $8.6 billion year-over-year increase in Google Network revenues in 2022 and the specific positioning changes between years. The LLM's vague language about 'expanding inventory and programmatic capabilities' lacks the concrete evidence needed. (3) MULTI-HOP REASONING: The question asks about CHANGE between 2022 and 2023. The LLM fails to perform the required multi-hop synthesis across these two years. Instead, it incorrectly asserts continuity where the ground truth shows a clear transition from 'standout growth contributor' to 'part of a broader suite.' (4) SEMANTIC EQUIVALENCE: The LLM's statement that 'the commentary does not signal any shift' directly contradicts the ground truth's finding of a shift from singular emphasis to integrated positioning. This is not a wording difference—it's a fundamental misunderstanding of the filing content. The LLM appears to have fabricated or misremembered the specific mentions of Ad Manager's role across these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 459,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\nStarbucks’ derivative liabilities tied to “foreign‑currency – other” grew from about **$6 million at the end of fiscal 2022** (≈$0.3 M accrued + $5.8 M accrued in the non‑designated column) to roughly **$11 million at the end of fiscal 2024** (≈$7.2 M accrued + $4.2 M in other long‑term liabilities).  This represents an increase of **approximately $5 million (≈80 %)** over the two‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) CRITICAL NUMBER ERRORS: The ground truth clearly states 2022 value was $0.3 million and 2024 value was $4.7 million. The LLM claims approximately $6 million in 2022 (composed of $0.3M + $5.8M) and $11 million in 2024 (composed of $7.2M + $4.2M). These are dramatically different figures - the LLM's 2022 estimate is 20x higher than the actual $0.3M, and the 2024 estimate is more than 2x higher than the actual $4.7M. (2) CALCULATION ERRORS: The LLM calculates an $5 million increase (80% growth), but the correct calculation from ground truth is: $4.7M - $0.3M = $4.4 million increase, representing approximately 1,467% growth. The LLM's percentage calculation is also incorrect relative to its own stated numbers. (3) METHODOLOGY ISSUES: The LLM appears to have attempted to synthesize data from multiple line items (accrued liabilities + non-designated columns + other long-term liabilities), but this approach contradicts the ground truth which specifically identifies the values under 'accrued liabilities' only. The LLM's multi-hop reasoning is flawed because it's combining categories that shouldn't be combined based on the question's specific focus on 'derivative liabilities related to foreign currency - other.' (4) ENTITY ACCURACY: While Starbucks and the fiscal years are correct, the specific metric identification is wrong - the LLM is measuring a different aggregate than what the ground truth identifies. The question asks specifically about evolution of this liability, and the ground truth provides precise figures that the LLM completely misses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 456,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\nIn the 2023 and 2024 SEC filings the same Board‑of‑Directors resolution authorizing the 4.600% Senior Notes due 2045 is reiterated, showing that the company had already issued (or was prepared to issue) this long‑dated tranche in 2023 and continued to reference it in 2024.  This continuity signals PepsiCo’s strategy of extending the maturity of its debt and relying on fixed‑rate, long‑dated securities to diversify and stabilize its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.600% Senior Notes due 2045 and its presence in both 2023 and 2024 filings. (2) Numeric values (4.600%, 2045 maturity date) are accurate. (3) The LLM correctly notes the continuity of this instrument across both years. (4) The characterization of the notes as fixed-rate, long-dated securities is accurate.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM fails to address the key evolution mentioned in the ground truth - that by 2024, the 4.600% Senior Notes were referenced alongside NEW instruments (4.000% Senior Notes due 2047, Floating Rate Notes due 2026). This is a critical omission for answering 'how has...evolved.' (2) MISSING COMPARATIVE ANALYSIS: The ground truth explicitly states the company 'expanded its debt portfolio with additional instruments, suggesting a more diversified approach.' The LLM mentions diversification but doesn't identify the specific new instruments introduced in 2024. (3) INCOMPLETE MULTI-HOP REASONING: The question asks about evolution BETWEEN 2023 and 2024, requiring comparison of what changed. The LLM focuses on continuity rather than the actual evolution/expansion. (4) CHARACTERIZATION ISSUE: The LLM states the notes 'had already issued (or was prepared to issue)' which introduces uncertainty not present in the ground truth, which clearly indicates the notes were part of the debt structure in both years.\n\nMULTI-HOP ASSESSMENT: The question requires synthesizing: (a) what the 4.600% notes were in 2023, (b) what they were in 2024, (c) what OTHER notes appeared in 2024, and (d) what this indicates about strategy. The LLM addresses (a) and (b) adequately but fails on (c) and partially on (d).\n\nCORE ISSUE: While the LLM's statement about debt maturity extension and capital structure stabilization is reasonable, it misses the primary evolution narrative - the introduction of new debt instruments alongside the existing 4.600% notes, indicating portfolio diversification rather than simple continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 542,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region contracted from about 322 billion cubic feet (developed) to 289 bcf, with total reserves (developed + undeveloped) falling from roughly 326 bcf to 296 bcf—driven by downward revisions, production and the sale of non‑core assets such as its Indonesia stake. This decline signals a strategic pull‑back from the region, as the company is redirecting capital toward higher‑margin oil and gas plays elsewhere (e.g., the Lower 48 and Canada).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The ground truth states 326 bcf (2022) declining to 296 bcf (2024) for total reserves. The LLM reports 326 bcf to 296 bcf for total reserves, which matches exactly. For developed reserves, the LLM provides 322 bcf (2022) to 289 bcf (2024), which is additional detail not contradicted by the ground truth but not explicitly confirmed. The decline magnitude is accurate (30 bcf total, ~9.2% reduction). COMPLETENESS: The LLM answer goes beyond the ground truth by providing developed vs. undeveloped breakdown and explaining specific drivers (downward revisions, production, asset sales like Indonesia stake). This adds valuable context. ENTITY ACCURACY: Correctly identifies ConocoPhillips (COP), Asia-Pacific/Middle East region, natural gas reserves, and relevant time periods (2022-2024). REASONING QUALITY: The LLM provides superior multi-hop synthesis by connecting the reserve decline to strategic drivers (asset sales, capital reallocation to Lower 48 and Canada), whereas the ground truth only suggests 'potential shift' without specifics. This demonstrates stronger analytical reasoning. SEMANTIC EQUIVALENCE: Both answers convey the same core finding—a modest decline in reserves indicating strategic repositioning. The LLM's characterization as 'strategic pull-back' aligns with the ground truth's 'shift in strategic focus.' MINOR ISSUES: The developed reserves figures (322 bcf vs. 326 bcf in 2022) show a 4 bcf discrepancy that could reflect rounding or different reporting methodologies, but this doesn't materially affect the overall conclusion. The answer is more comprehensive and analytically sophisticated than the ground truth while maintaining factual accuracy on the key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 490,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\nFrom 2022 to 2023, Google Play moved from being a peripheral, “other‑revenue” line item to a more central component of Alphabet’s diversification away from advertising. Both filings identify it as generating revenue from “sales of apps and in‑app purchases and digital content sold in the Google Play store,” but the 2023 filing highlights it alongside hardware and YouTube‑Premium as part of a broader strategy to grow non‑advertising earnings, emphasizing AI‑driven app experiences (e.g., Gemini, Duet AI) that are intended to increase app engagement and monetisation.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF EVOLUTION: The ground truth states Google Play's description shifted from 'sales of apps and in-app purchases and digital content' (2022) to 'apps and in-app purchases' (2023) - a narrowing of focus. The LLM incorrectly claims both filings use identical language ('sales of apps and in-app purchases and digital content sold in the Google Play store'), which contradicts the ground truth's core finding about the evolution. (2) UNSUPPORTED CLAIMS: The LLM introduces claims about 'moving from peripheral to central component,' 'hardware and YouTube Premium grouping,' and 'AI-driven app experiences (Gemini, Duet AI)' that are NOT mentioned in the ground truth and appear to be fabricated or speculative additions not supported by the filings. (3) MISSING KEY INSIGHT: The ground truth emphasizes the shift toward 'platforms' categorization and narrower focus on 'apps and in-app purchases' - the LLM completely misses this critical evolution point. (4) REASONING FLAW: The LLM's multi-hop synthesis is fundamentally flawed because it misidentifies what changed between years. The ground truth shows a narrowing/refinement of description; the LLM suggests a broadening/elevation in strategic importance without evidence. (5) QUANTITATIVE: No specific numbers are provided in either answer, so quantitative accuracy is neutral, but the LLM's qualitative mischaracterization of the factual evolution is a critical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 428,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\nThe 2022 filing showed FedEx had committed 12 Cessna SkyCourier 408s for delivery in 2024 (with a total of 49 aircraft slated through 2026), while the 2024 filing raises that near‑term pipeline to 17 aircraft for 2025 delivery and 14 for 2026—a roughly 42 percent increase in the near‑term commitment. This upward revision signals that FedEx is counting more heavily on the SkyCourier to expand its cost‑efficient, regional “middle‑mile” network and to meet growing e‑commerce demand, indicating a strategic shift toward greater reliance on this aircraft model.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The ground truth states that 2022 projections showed 49 aircraft total through 2023 onwards, while 2024 projections showed 31 aircraft for 2025-2029—a REDUCTION, not an increase. The LLM claims the opposite: that there was a '42 percent increase in near-term commitment' from 12 aircraft in 2024 to 17 in 2025 and 14 in 2026. These specific numbers (12, 17, 14) do not appear in the ground truth and appear to be fabricated. (2) DIRECTIONAL CONTRADICTION: The ground truth explicitly indicates a MODERATED reliance (49→31 aircraft, a 37% reduction), while the LLM claims a 'strategic shift toward GREATER reliance' based on an upward revision. This is the opposite of what the ground truth shows. (3) RELATIONSHIP SHIFT IGNORED: The ground truth notes a critical shift from 'Increases' to 'Depends_On' relationship type in 2024, which the LLM completely fails to mention. This relationship change is significant to understanding strategic importance. (4) CALCULATION ERROR: The LLM's 42% increase calculation is based on incorrect numbers not supported by the ground truth. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year comparison (2022 vs 2024 projections) and drew the opposite conclusion from what the data supports. The answer demonstrates a fundamental misunderstanding of the filing data and provides misleading strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 412,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG refined the segmentation of its excess‑casualty portfolio, moving from a broad grouping to a three‑tiered structure that separates automobile‑related claims from non‑automobile claims and further divides non‑automobile claims into latent‑exposure categories such as construction‑defect and mass‑tort exposures, with standard claims analyzed by attachment‑point bands.  The expected‑loss‑ratio method was then applied to the three most recent accident years (2021‑2023) and to losses above a $10 million cap, reflecting higher attachment points and COVID‑19‑related adjustments—an evolution from the less‑granular 2022 approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) MAJOR ERROR - The LLM describes 2022 as having a 'less-granular approach' and claims 2023 shows refinement to a 'three-tiered structure,' but the ground truth indicates the opposite: 2022 already had the detailed segmentation (attachment point, automobile vs. non-automobile, latent exposures), while 2023 shifted to a completely different line (Workers' Compensation) with different segmentation criteria (risk-sharing features, state, industry, claim handling entity). (2) INCORRECT CASUALTY LINE - The LLM focuses entirely on Excess Casualty evolution, but the ground truth explicitly states the shift was FROM U.S. Excess Casualty (2022) TO U.S. Workers' Compensation (2023). This is a fundamental misunderstanding of the multi-hop synthesis required. (3) WRONG ACCIDENT YEARS - The LLM states '2021-2023' accident years, but the ground truth specifies 'three latest accident years' in 2022 context (which would be 2019-2021 or similar), not 2021-2023. (4) UNSUPPORTED DETAILS - The LLM introduces a '$10 million cap' and 'COVID-19-related adjustments' that do not appear in the ground truth. (5) MISSING KEY EVOLUTION - The LLM completely fails to capture the strategic shift in WHERE the method is applied (from Excess Casualty to Workers' Compensation), which is the core of the ground truth answer. The answer demonstrates poor multi-hop reasoning by conflating 2022 and 2023 data within the same casualty line rather than recognizing the shift between different lines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 436,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike kept unallocated products in a residual “Others” line of its wholesale‑equivalent revenue breakdown. In FY 2022 the company introduced a new consumer construct of Men’s, Women’s and Kids’ (with unisex items moved into Men’s) and Jordan Brand as a separate category, labeling the leftover items as **“Others (5)”** [page 35]; by FY 2024 the same structure remained, now shown as **“Others (4)”**, which still captures products not assigned to Men’s, Women’s, Kids’ or Jordan Brand as well as certain adjustments [page 39]. Thus, after the FY 2022 re‑classification, the categorization of unallocated products did not change materially—it continued to be reported as a catch‑all “Others” within the Men’s‑Women’s‑Kids’ consumer construct.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about how unallocated products evolved between FY2022 and FY2024, but contains several issues: (1) CORRECT ELEMENTS: The answer correctly identifies that 'Others' remained a catch-all category in both years, that unisex products were moved into Men's in FY2022, and that the structure persisted through FY2024. The semantic understanding of the evolution is generally sound. (2) QUANTITATIVE ISSUES: The LLM cites specific footnote numbers - 'Others (5)' for FY2022 and 'Others (4)' for FY2024 - with page references (35 and 39). These specific footnote numbers cannot be verified against the ground truth provided, which does not include such granular citation details. This is a potential factual error if these footnote numbers are incorrect. (3) INCOMPLETE SYNTHESIS: The ground truth mentions that in FY2022, unisex products were 'classified within Men's' and that 'certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in Others with adjustments not allocated by consumer.' The LLM captures the unisex-to-Men's movement but doesn't fully articulate the nuance about 'adjustments not allocated by consumer' in FY2022. (4) MISSING DETAIL: The ground truth notes a 'potential shift or integration of unisex products within broader categories' by FY2024 (no specific mention of unisex classification within Men's), suggesting possible evolution. The LLM states 'the categorization of unallocated products did not change materially,' which may understate the potential shift noted in the ground truth. (5) MULTI-HOP REASONING: The answer does synthesize information across two fiscal years and identifies the consumer construct categories correctly (Men's, Women's, Kids', Jordan Brand, Others). However, the specific footnote citations and the characterization of 'no material change' may not fully align with the ground truth's suggestion of potential evolution. The answer is partially correct but contains unverified specific citations and may overstate the stability of the classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 558,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved the 3.500 % Senior Notes due 2025 from a legacy authorization (first listed in the 2013 board‑resolution excerpts on pages 129‑130) to a refreshed financing structure.  In February 2024 the company filed a new indenture (page 131) and accompanying board resolutions that re‑established the terms for that series and added fresh senior‑note authorizations, effectively amending and extending the original issuance.  This evolution shows that PepsiCo is actively managing its debt profile—using fresh indentures and board‑approved authorizations to adjust maturities and funding costs rather than leaving the 3.5 % tranche static.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) CRITICAL ERRORS: The LLM introduces specific page references (pages 129-130, 131) and claims about a February 2024 indenture filing that cannot be verified against the ground truth. The ground truth makes no mention of board resolutions from 2013, indenture filings in February 2024, or page-specific references. These appear to be fabricated details. (2) QUANTITATIVE ACCURACY: The LLM correctly identifies the 3.500% rate and 2025 maturity date, but introduces unverified dates and document references that are not in the ground truth. (3) CORE ISSUE - MULTI-HOP REASONING: The ground truth clearly states that by 2024, PepsiCo added NEW notes (3.500% due 2040 and 3.550% due 2034) alongside the existing 2025 notes, indicating portfolio diversification and maturity structure expansion. The LLM answer instead focuses on internal document management (indentures, board resolutions) and characterizes the evolution as 'amending and extending the original issuance' rather than adding new instruments. This is a fundamental misunderstanding of what the ground truth indicates about debt management strategy. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes strategic diversification of debt maturity structure through new note issuances. The LLM emphasizes procedural/administrative changes (new indentures, board resolutions) without mentioning the actual new notes issued in 2024. (5) MISSING KEY INFORMATION: The LLM completely omits the critical fact that PepsiCo introduced longer-term instruments (2040 and 2034 maturities) in 2024, which is central to understanding the debt management strategy shift. The answer appears to conflate internal authorization/documentation processes with actual debt issuance activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 494,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips raised its capital outlay in the Lower 48 from about $1.9 bn in 2023 to roughly $3.13 bn in 2024 (the 2022 figure was close to $3.1 bn), signalling a renewed emphasis on drilling and lease‑hold acquisitions.  At the same time, the discounted future net cash flow from Lower 48 reserves dropped sharply from $55.9 bn in 2022 to $33.3 bn in 2023 before recovering modestly to $38.7 bn in 2024, reflecting downward revisions to price and cost assumptions that were only partially reversed in the later year.  (Capital‑expenditure numbers are from 2024 page 156; the 2023 and 2022 cash‑flow revisions are shown in 2024 pages 159‑160.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth:\n\n1. CAPITAL EXPENDITURE ERRORS: The LLM claims COP raised capex from $1.9bn in 2023 to $3.13bn in 2024, but the ground truth explicitly states the 2022 capex was $3,129 million ($3.129bn) and that by 2024 'no new capital expenditure figure was provided.' The LLM fabricated a 2024 capex figure and invented a 2023 figure ($1.9bn) that doesn't appear in the ground truth.\n\n2. CASH FLOW FIGURES: The LLM introduces entirely new metrics (discounted future net cash flow from Lower 48 reserves) with specific numbers ($55.9bn in 2022, $33.3bn in 2023, $38.7bn in 2024) that are not mentioned in the ground truth at all. The ground truth makes no reference to these cash flow figures or their revisions.\n\n3. MISINTERPRETATION OF GROUND TRUTH: The ground truth indicates a transition FROM active investment (2022 capex of $3,129M) TO a focus on revising financial projections (2024), with no new capex disclosed. The LLM inverts this narrative, claiming renewed emphasis on drilling and suggesting capex increased.\n\n4. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key insight from the ground truth: that the evolution shows a shift in disclosure focus from capital expenditures to revised cash flow projections, not an increase in capex.\n\n5. SOURCE CITATIONS: While the LLM provides page references, these appear to be fabricated or misinterpreted, as the specific cash flow figures cited don't match the ground truth narrative.\n\nThe answer demonstrates a fundamental misunderstanding of the question and provides largely fabricated financial data rather than accurately representing the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 480,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast’s exposure to Atairos remained an unconsolidated VIE in which it holds an equity‑method investment and has no voting control—control stays with the management companies led by its former CFO.  The 2023 amendment to the Fourth Amended and Restated Shareholders Agreement kept the 16.5‑year investment term, the $4.5 billion aggregate capital‑commitment ceiling (down from $5 billion), and a $400 million annual capital‑call cap, while preserving the $40 million annual management‑fee commitment and the 86 % residual‑return right for Comcast.  As of 31 Dec 2024 the remaining unfunded commitment had fallen to about $1.4 billion, and cash capital calls in 2024 were $73 million (down from $145 million in 2023), but the governance and capital‑obligation structure of the relationship was essentially unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and governance structures. STRENGTHS: (1) All major numbers are accurate: $4.5 billion capital commitment (down from $5 billion), $400 million annual capital call cap, $40 million annual management fee, 86% residual return right, 99% loss absorption (implied by context), and the 16.5-year investment term. (2) Correctly identifies the unconsolidated VIE structure and equity-method accounting treatment. (3) Accurately notes that voting control remains with management companies led by Comcast's former CFO. (4) Provides additional context about 2024 unfunded commitments ($1.4 billion) and actual 2024 capital calls ($73 million vs $145 million in 2023), which adds useful detail. (5) Correctly characterizes the evolution as a recalibration with governance and capital-obligation structure remaining essentially unchanged. MINOR WEAKNESSES: (1) The answer states the 2023 amendment 'kept' the $4.5 billion commitment, which could be slightly clearer that this represented a reduction from $5 billion (though this is mentioned parenthetically). (2) The answer doesn't explicitly state that Comcast absorbs approximately 99% of losses, though this is implied by the 86% residual return structure and the context. (3) The phrasing 'essentially unchanged' governance structure is accurate but could be more explicit about the 'clearer delineation of control' mentioned in the ground truth. QUANTITATIVE VERIFICATION: All dollar amounts, percentages, and time periods check out correctly against the ground truth. The multi-hop synthesis across 2023 and 2024 filings is sound, correctly identifying both the evolution and continuity in the relationship. The answer appropriately addresses both capital obligations and control structures as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 502,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\nIn the 2022 filing FedEx owned a single Cessna 408 and had purchase commitments for 11 SkyCouriers in 2023, 12 in 2024, 12 in 2025 and 14 in 2026. The 2023 filing revises those commitments upward—showing 17 aircraft slated for delivery in 2025 and 14 for 2026 (a total of 31 SkyCouriers through 2026)—representing roughly a three‑ to four‑fold increase in the planned fleet size. This jump signals that FedEx now views the Cessna SkyCourier as a core, high‑utilization element of its regional network, filling the niche between the small Cessna 208 and larger jet freighters and supporting its strategy to expand cost‑effective, last‑mile service to smaller markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) CRITICAL ERRORS: The ground truth states projections DROPPED from 49 aircraft (2022) to 31 aircraft (2023), indicating a REDUCTION in planned reliance. The LLM claims the opposite—that commitments were revised UPWARD representing a 'three-to-four-fold increase,' which is factually wrong. (2) QUANTITATIVE ACCURACY FAILURES: The LLM provides specific year-by-year delivery numbers (11 in 2023, 12 in 2024, 12 in 2025, 14 in 2026, then 17 in 2025 and 14 in 2026 in the 2023 filing) that cannot be verified against the ground truth and appear to be fabricated or misinterpreted. The ground truth clearly states 49 total through 2027 (2022) vs 31 total through 2029 (2023)—a 37% reduction, not an increase. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison. It misread the directional change entirely, concluding FedEx now views the aircraft as 'core' and 'high-utilization' when the ground truth indicates the opposite—a strategic reassessment downward. (4) SEMANTIC CONTRADICTION: The LLM's interpretation that this represents increased strategic importance directly contradicts the ground truth's conclusion that it indicates 'strategic reduction in planned reliance.' This is not a wording difference but a fundamental misunderstanding of what the data shows. The LLM appears to have either hallucinated specific delivery numbers or severely misinterpreted the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 422,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike has made its revenue streams more transparent—publishing detailed segment‑level breakdowns (wholesale vs. direct‑to‑consumer, and by geographic operating segment) and explicitly calling out the contribution of innovative platforms such as Air Max within its “proliferation of Nike Air, Zoom X, Free, Flyknit, FlyEase, Zoom X, Air Max, and React” technology suite.  At the same time, the company’s disclosures highlight a stronger emphasis on technological innovation for the Air Max line, noting dedicated R&D, market‑intelligence‑driven design, and a new Air‑manufacturing subsidiary that underpins the continued expansion of Air Max cushioning technologies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Nike published 'detailed segment-level breakdowns' and made revenue streams 'more transparent' from 2022-2024, but the ground truth explicitly states that in 2022 Air Max was in a 'general list' WITHOUT specific revenue figures, and by 2024 there were still 'no direct revenue numbers disclosed.' The LLM fabricates transparency improvements that did not occur. (2) FABRICATED DETAILS: The LLM invents specific claims about 'dedicated R&D,' 'market-intelligence-driven design,' and 'a new Air-manufacturing subsidiary' that are not mentioned in the ground truth. These are material factual errors. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from 'passive acknowledgment to positioning Air Max as a key innovation driver' - a qualitative strategic repositioning. The LLM incorrectly frames this as increased financial transparency, which is the opposite of what actually occurred (continued lack of standalone financial metrics). (4) MULTI-HOP REASONING FAILURE: The question asks about evolution in 'revenue transparency AND technological innovation emphasis.' The ground truth correctly identifies that revenue transparency remained absent while innovation emphasis increased. The LLM conflates these two dimensions and falsely claims both improved. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes the LACK of financial disclosure despite strategic repositioning. The LLM's answer suggests increased transparency occurred, which directly contradicts the ground truth's core finding. The only partially correct element is the mention of Air Max within a technology suite, but this is overshadowed by the numerous false claims about transparency and manufacturing subsidiaries.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 507,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\nFrom 2023 to 2024 the company kept overall capital spending roughly flat (≈ $8.2 billion in 2023 and essentially the same in 2024), but the mix shifted toward the theme‑park side.  In 2023 the $8.2 billion of Connectivity & Platforms capex included early‑stage spending on Epic Universe—primarily land acquisition and initial construction—while in 2024 the firm explicitly noted “increased spending on theme‑park attractions” and that a portion of that year’s capital budget was devoted to “the construction of Epic Universe,” indicating a move from land‑purchase to active attraction‑building as the development priority.  No separate dollar figure for Epic Universe is disclosed; the investment is embedded in the overall capex, which rose slightly in emphasis for theme‑park projects in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant issues: (1) QUANTITATIVE ACCURACY CONCERNS: The LLM states capex was 'roughly flat (≈ $8.2 billion in 2023 and essentially the same in 2024)' but the ground truth does not provide a specific 2024 capex figure for comparison. The LLM appears to have inferred or assumed 2024 capex remained at $8.2B, which is not supported by the ground truth. The ground truth explicitly states 'specific figures for Epic Universe alone were not disclosed in 2024' and does not provide a total capex figure for 2024 for comparison. This is a factual error. (2) CORRECT ELEMENTS: The LLM correctly identifies that $8.2B was allocated to Connectivity & Platforms in 2023, correctly notes that no separate Epic Universe dollar figure is disclosed, and accurately captures the shift from infrastructure/land acquisition focus in 2023 to attraction-building in 2024. (3) MULTI-HOP REASONING: The synthesis of the evolution from 2023 to 2024 is sound in concept (shift from land purchase to active construction), but is undermined by the unsupported claim about 2024 capex levels. (4) MISSING CONTEXT: The LLM does not acknowledge the uncertainty about 2024 figures or the fact that the ground truth indicates the company 'indicated an ongoing commitment' rather than providing specific 2024 investment amounts. The characterization of 'slightly' increased emphasis is not quantified in the ground truth. (5) SEMANTIC ISSUES: The phrase 'the mix shifted toward the theme-park side' is reasonable interpretation but goes slightly beyond what the ground truth explicitly states about the shift in priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 452,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\nIn the 2022 filing FedEx reported 6 ATR‑72 600F aircraft in its owned fleet (page 40). The 2023 10‑K shows that, as part of its purchase commitments, the company was scheduled to receive 11 ATR‑72 600Fs during fiscal 2023, which would have raised the in‑service count to roughly 17 aircraft, and it also projected additional deliveries of 6 in 2024 and 6 in 2025 (pages 115‑116). Consequently, utilization of the ATR‑72 600F grew from six aircraft at the end of 2022 to about 17 by the end of 2023, with a continued expansion of six‑aircraft increments in the following planning years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental errors in understanding and interpreting the ground truth data. Critical issues: (1) WRONG INTERPRETATION OF DATA: The LLM conflates owned fleet numbers (6 aircraft in 2022) with fleet projections. The ground truth clearly refers to PROJECTIONS for future years (2023-2026), not actual owned fleet. The LLM misinterprets this by claiming 6 were 'in its owned fleet' and then adds 11 projected deliveries to reach 17. (2) MISSING KEY PROJECTIONS: The ground truth explicitly states the 2022 projections were: 11 ATR 72-600F in 2023, 6 in 2024, 6 in 2025, and 1 in 2026. The LLM completely omits the 2023 projection (11 aircraft) and the 2026 projection (1 aircraft). (3) MISSING 2023 PROJECTION CHANGES: The ground truth indicates that by 2023, projections changed to 7 aircraft for 2025 and 3 for 2026. The LLM provides no comparison of how projections evolved between the 2022 and 2023 filings. (4) INCORRECT CONCLUSION: The LLM concludes utilization 'grew' from 6 to 17, which misses the actual point - the ground truth shows a REDUCTION in planned usage over time (from 11 in 2023 down to 1 in 2026 per 2022 projections, then further reduced to 3 in 2026 per 2023 projections). (5) WRONG NARRATIVE: The LLM describes 'continued expansion' when the ground truth indicates contraction/reduction in planned ATR 72-600F utilization. The answer fails to address the core question about how projections evolved between 2022 and 2023 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 407,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike moved from a relatively simple, aggregate “sales‑related reserve” that was disclosed only as a single balance‑sheet figure (‑$1.0 bn in 2022) to a more granular, estimate‑driven framework that explicitly breaks the variable consideration into (1) the most‑likely amount of revenue, (2) a separate estimate of the cost of inventory for expected returns, and (3) a detailed calculation based on historical return rates, specific outstanding returns and discretionary discounts.  The 2024 disclosure also notes that adjustments to the reserve are recorded in the period when actual returns, discounts or claims differ from the estimate, indicating a shift toward recognizing revenue net of variable consideration in real‑time rather than relying on a static reserve.  This evolution reflects Nike’s adoption of a more refined ASC 606‑compliant revenue‑recognition model that better matches revenue with the expected net amount to be received.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) QUANTITATIVE ERROR - The LLM claims a '-$1.0 bn in 2022' sales-related reserve, but the ground truth explicitly states the fiscal 2022 product return reserve was $269 million, not $1.0 billion. This is a massive discrepancy (off by ~$731 million or 271%). (2) STRUCTURAL MISREPRESENTATION - The LLM describes a shift from an 'aggregate sales-related reserve' to a 'granular, estimate-driven framework,' but the ground truth indicates Nike moved from disclosing a specific $269 million reserve amount to NOT disclosing a specific dollar amount in fiscal 2024, while describing a more formalized estimation process. The LLM inverts this relationship. (3) METHODOLOGY MISCHARACTERIZATION - The ground truth indicates the evolution was toward calculating the 'most likely amount' it will be entitled to receive (a probabilistic approach), while the LLM describes a shift to 'recognizing revenue net of variable consideration in real-time' with adjustments when actual returns differ. While both mention ASC 606 compliance, the LLM's specific characterization of the methodology differs from ground truth. (4) MISSING KEY DETAIL - The ground truth notes that in fiscal 2022, reserves were recorded in 'Prepaid expenses and other current assets,' which the LLM completely omits. (5) CORRECT ELEMENTS - The LLM correctly identifies that the evolution reflects a more refined ASC 606-compliant revenue recognition model and that it involves better estimation of variable consideration. However, these correct elements are overshadowed by the fundamental numerical and structural errors. The answer demonstrates a failure in multi-hop synthesis and contains a factual error so large (off by $731M) that it cannot be considered substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 502,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\nThe 2022 commitment table lists 12 Cessna SkyCourier 408 deliveries for 2025 and 14 for 2026, with no scheduled deliveries beyond 2026. By the 2024 update the 2025 forecast had risen to 17 aircraft (an increase of five) while the 2026 figure remained at 14, and still no deliveries are planned after 2026. This upward revision shows that FedEx is increasingly counting on the SkyCourier 408 to modernize and expand its regional fleet, underscoring a strategic reliance on the model for future growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. According to the original answer, in 2022 FDX projected 12 Cessna SkyCourier 408 aircraft for 2025 and 12 for 2026 (maintained through 2026). However, the LLM states the 2022 commitment table lists '12 Cessna SkyCourier 408 deliveries for 2025 and 14 for 2026' - this is incorrect. The ground truth clearly states 12 for both 2025 and 2026 in 2022, not 12 and 14. This is a significant quantitative error. Additionally, the LLM references a '2024 update' when the question and ground truth only discuss 2022 and 2023 data. The LLM correctly identifies the 2023 figures (17 for 2025, 14 for 2026) but the comparison baseline is wrong, making the calculated 'increase of five' misleading since it's comparing against an incorrect 2022 baseline. The LLM's interpretation about 'strategic reliance' and 'modernize and expand its regional fleet' adds speculative reasoning not grounded in the factual data comparison. The answer also incorrectly references 'FedEx' when the ground truth uses 'FDX' (though this is a minor semantic issue). The core multi-hop reasoning fails because the foundational 2022 numbers are wrong, undermining the entire comparative analysis between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 361,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard expanded its real‑time account‑based payments platform from the 13 markets where it was fully operational in 2023 to a global footprint that now supports instant, account‑to‑account transfers across more than 180 markets and roughly 10 billion endpoints worldwide (2023 Doc p.13; 2024 Doc p.70‑74).  At the same time, the company deepened the platform’s security by embedding tokenization, AI‑driven fraud‑scoring and dynamic‑control tools such as InControl™, and by running a 24/7 distributed, peer‑to‑peer network that provides end‑to‑end encryption and real‑time monitoring of every transaction (2023 Doc p.12; 2024 Doc p.73‑74).  This combination of broader operational scale and tighter, multi‑layered security enables Mastercard to move larger volumes of real‑time payments while protecting both senders and receivers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims Mastercard expanded from 13 markets in 2023 to 'more than 180 markets' by 2024 - this expansion figure is NOT supported by the ground truth, which only states the company was operating in 13 markets in 2023 and expanded capabilities by 2024 without specifying a 180-market figure. The claim about '10 billion endpoints worldwide' is also not mentioned in the ground truth. These appear to be fabricated or hallucinated numbers. (2) MISREPRESENTATION OF SCALE: The ground truth indicates Mastercard 'expanded its capabilities' and 'enhanced its ACH and real-time account-based payment systems' but does NOT claim expansion to 180+ markets. The LLM has invented specific quantitative claims not present in the source material. (3) SECURITY CAPABILITIES: While the LLM correctly identifies tokenization, fraud-scoring, and encryption as security features (which aligns with ground truth), it adds specific product names like 'InControl™' and claims about '24/7 distributed, peer-to-peer network' that are not verified in the ground truth. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the available information. It extrapolated beyond what the ground truth supports, creating a narrative of dramatic expansion (13 to 180+ markets) that is not substantiated. (5) DOCUMENT CITATIONS: The LLM provides specific page references (2023 Doc p.13; 2024 Doc p.70-74) that cannot be verified against the ground truth provided, suggesting potential citation fabrication. The core issue is that the LLM invented quantitative claims about market expansion and endpoint numbers that directly contradict the more modest expansion narrative in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 489,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike trimmed the size of its foreign‑currency cash‑flow hedge program—from roughly **$18–19 billion of notional forwards and options in 2022** to about **$16 billion as of May 31 2024**—while still using forwards and options to lock in exchange rates up to 12‑24 months in advance and to hedge up to 100 % of the identified exposure.  The fair‑value of these derivatives is recorded as assets or liabilities on the balance sheet, and **deferred net gains of $607 million (2022) and $231 million (2024, net of tax) are held in accumulated other comprehensive income and are expected to be re‑classified to net income over the next 12 months**, directly impacting cost of sales and other income when the underlying transactions settle.  Thus, the hedging strategy has moved from a broader, more aggressive hedge book in 2022 to a tighter, more designated cash‑flow approach in 2024, with the same impact on financial liabilities through the AOCI reclassification mechanism.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. CRITICAL ERRORS: (1) The LLM provides notional values ($18-19 billion in 2022, $16 billion in 2024) that are NOT mentioned in the ground truth, which focuses on net gains/losses and liability amounts. (2) The LLM cites deferred net gains of $607 million (2022) and $231 million (2024) held in AOCI - these figures do NOT appear in the ground truth answer. (3) The ground truth specifically states: net gain of $8 million after tax in 2022, and liabilities of $110 million (accrued liabilities) and $5 million (deferred income taxes) in 2024. The LLM completely omits these specific liability figures. (4) The LLM discusses AOCI reclassification mechanisms and 12-24 month hedging horizons, which are not addressed in the ground truth. QUANTITATIVE ACCURACY FAILURE: The numbers cited ($607M, $231M, $18-19B, $16B) do not match the ground truth figures ($8M net gain 2022, $110M and $5M liabilities 2024). MULTI-HOP REASONING: While the LLM attempts to synthesize hedging strategy evolution, it does so using incorrect data points. The answer appears to describe a different aspect of Nike's hedging program (notional values and AOCI treatment) rather than the specific evolution in financial liabilities and net gains/losses that the ground truth addresses. SEMANTIC MISMATCH: The ground truth emphasizes the shift in how derivatives impacted income categories and liability reporting; the LLM emphasizes notional hedge size reduction and AOCI mechanics - these are different analytical frameworks. The answer fails to address the core ground truth findings about the $8M gain in 2022 and the $110M/$5M liability structure in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 467,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\nPuffs continued to be listed under the “Family Care” sub‑category of the Baby, Feminine & Family Care segment in both 2022 and 2023. The only evolution was a restructuring of the segment’s internal categories— the 2023 filing dropped the separate “Baby Care” sub‑category, but Puffs remained classified within “Family Care.”",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CORRECT ELEMENTS: (1) Both answers correctly identify that Puffs remained in the 'Family Care' sub-category in both 2022 and 2023, (2) Both correctly reference the Baby, Feminine & Family Care segment, (3) The years 2022 and 2023 are correctly identified. CRITICAL ERRORS: (1) The LLM claims the 2023 filing 'dropped the separate Baby Care sub-category' - this is not mentioned in the ground truth and appears to be an unsupported assertion, (2) The LLM fails to address the key evolution described in the ground truth: the change in how product categories were listed/reported between years (the ground truth notes a 'simplification or consolidation' in reporting details), (3) The LLM misses the specific detail that the ground truth mentions about the listing of product types (Paper Towels, Tissues, Toilet Paper in 2022 vs. a more general listing in 2023), (4) The LLM's statement about 'dropping Baby Care sub-category' introduces information not present in the ground truth and potentially contradicts it. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution of classification details between the two years. The ground truth indicates a change in how the categories were reported/detailed, while the LLM focuses on a different structural change (Baby Care sub-category) that isn't supported by the ground truth. The answer demonstrates incomplete understanding of the actual evolution described in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 421,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Tampax stayed in the same place in P&G’s portfolio – it is still reported under the **Baby, Feminine & Family Care segment**, specifically within the **Feminine Care sub‑category** alongside the other feminine‑care brands (e.g., Always and Always Discreet).  No re‑classification or addition of new product lines occurred; its categorization and associated product lineup remained consistent across the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect regarding the core claim of the question. The ground truth explicitly states that Tampax's positioning EVOLVED between 2022 and 2023, with a specific change from 'Feminine Care' categorization to 'Menstrual Care' categorization. The LLM directly contradicts this by claiming 'No re-classification or addition of new product lines occurred; its categorization and associated product lineup remained consistent across the two years.' This is a critical factual error that misses the entire point of the question. While the LLM correctly identifies that Tampax remained in the 'Baby, Feminine & Family Care' segment (quantitatively accurate on the segment level), it fails to recognize the sub-category refinement from 'Feminine Care' to 'Menstrual Care' that occurred between the two years. The LLM also correctly identifies other brands like Always and Always Discreet as related products. However, the fundamental claim that positioning remained unchanged directly contradicts the ground truth, which emphasizes a 'more focused positioning' and 'separation from general Family Care items.' The LLM's reasoning is flawed because it assumes consistency when the ground truth demonstrates evolution in categorization strategy. This represents a failure in multi-hop synthesis - the model needed to compare 2022 and 2023 categorizations and identify the specific change in sub-category naming/focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 398,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\nOracle’s Engineered Systems moved from a broad‑based hardware push to a more selective, cloud‑oriented focus between fiscal 2022 and fiscal 2023.  Constant‑currency hardware revenue slipped about 3‑5 % and its contribution to total margin fell from roughly 60 % to 59 %, reflecting a deliberate de‑emphasis on non‑strategic hardware products while still using engineered systems to support its cloud infrastructure.  At the same time, the company kept R&D spending on an upward trajectory—up about 5 % in constant currency to $5.6 bn (≈ 17 % of total revenue)— indicating continued investment to modernize its engineered‑system portfolio and align it with its cloud strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM claims hardware revenue declined 3-5% in constant currency, margin contribution fell from 60% to 59%, and R&D spending increased 5% to $5.6bn (17% of revenue). None of these specific figures appear in the ground truth, and the ground truth does not provide these comparative metrics. The ground truth only states hardware represented 6% of total revenues in fiscal 2023, with no 2022 comparison provided. (2) UNSUPPORTED CLAIMS: The LLM describes a 'selective, cloud-oriented focus' and 'deliberate de-emphasis on non-strategic hardware products' - these strategic characterizations are not present in the ground truth. The ground truth focuses on revenue recognition methods and R&D investment plans, not strategic repositioning toward cloud. (3) MISSING KEY INFORMATION: The LLM fails to mention the point-of-sale revenue recognition method highlighted in fiscal 2022, the indirect channel distribution model, or the explicit forward-looking R&D investment plans stated in fiscal 2023. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize evolution between years, it does so with invented data points rather than information from the filings. The ground truth shows a shift toward clearer strategic positioning and explicit R&D investment plans, not the margin/revenue decline metrics claimed. (5) SEMANTIC MISMATCH: The ground truth emphasizes clarification of positioning and strategic R&D investment; the LLM emphasizes de-emphasis and margin compression - fundamentally different narratives. The answer appears to contain fabricated financial metrics not supported by the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 479,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s non‑U.S. pension assets in private‑funds grew from $90 million to $115 million, with the portion classified as Level 3 rising from $36 million to $74 million while the Level 2 share fell from $54 million to $41 million; the amount measured at NAV (and thus excluded from the hierarchy) slipped only modestly from $10 million to $8 million. This shift shows a greater allocation to private‑fund investments and a re‑classification of most of that exposure into the lowest level of the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Critical issues: (1) WRONG ENTITY FOCUS: The ground truth explicitly states the 2022 figure of $1,105 million was for U.S. pension plans, not Non-U.S. plans. The LLM incorrectly claims Non-U.S. pension assets grew from $90M to $115M between 2022-2023, but the ground truth shows $1,105M in U.S. plans in 2022 and only $115M in Non-U.S. plans in 2023 - these are different plan types in different years. (2) MISSING KEY DATA: The LLM completely omits the $1,105 million U.S. pension plan investment from 2022, which is a central fact in the ground truth. (3) UNVERIFIABLE NUMBERS: The LLM provides specific 2022 Non-U.S. figures ($90M, $36M Level 3, $54M Level 2, $10M NAV) that do not appear in the ground truth and cannot be verified. (4) MISCHARACTERIZATION: The ground truth describes 'a significant decrease in overall private fund allocation, particularly in U.S. plans' - the LLM instead claims growth in Non-U.S. plans, which is a contradictory narrative. (5) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-hop comparison between 2022 U.S. plans and 2023 Non-U.S. plans, instead creating a false year-over-year comparison for Non-U.S. plans only. The answer demonstrates a fundamental misunderstanding of the question's requirement to compare U.S. pension plans (2022) with Non-U.S. pension plans (2023) and their respective fair value hierarchy classifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 408,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the $1 billion, 3.375 % 2014 USD Notes—originally due in April 2024 and listed as short‑term debt on the 2023 balance sheet—reached maturity.  In 2024 the company let the notes mature and fully repaid the $1 billion principal (using cash on hand and proceeds from its newly issued 2024 USD Notes), thereby removing the 2014 series from the outstanding‑debt schedule.  The repayment is reflected in the 2024 maturity table ($1.338 bn due in 2024) and the firm continues to rely on its commercial‑paper program and revolving credit facility for liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) $1 billion principal amount - correct, matches ground truth; (2) April 2024 maturity date - correct; (3) 3.375% coupon rate - additional detail not contradicted by ground truth; (4) $1.338 bn maturity table reference - appears to be the combined amount including accrued interest/fees, reasonable and not contradicted. Multi-hop reasoning: The answer correctly synthesizes the evolution from 2023 (short-term debt classification) to 2024 (full repayment and removal from outstanding debt). The answer goes beyond the ground truth by providing additional context: (a) the coupon rate, (b) the funding mechanism (cash on hand and 2024 USD Notes proceeds), (c) the maturity table reference, and (d) mention of liquidity facilities. These additions are accurate and enhance understanding without contradicting the ground truth. Entity accuracy: Correctly identifies the 2014 USD Notes, the maturity date, and the principal amount. The answer addresses all parts of the question: status evolution (short-term debt to settled), management actions (full repayment in April 2024), and specific actions (repayment using cash and new issuance proceeds). Minor note: The $1.338 bn figure appears to include accrued interest/costs beyond the $1 billion principal, which is consistent with the ground truth reference to 'net of unamortized discount and debt issuance costs.' The only minor limitation is that the ground truth doesn't explicitly confirm the funding sources or the maturity table amount, but these are reasonable inferences from standard debt management practices and don't contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 461,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s continued to disclose its standard Officer Indemnification Agreement (Exhibit 10.23) by reference in its annual reports, with the same wording and filing history (originally filed in 2019 and re‑referenced in the 2022 and 2024 10‑Ks). No new or substantially revised indemnification provision was introduced; instead, the company added updated claw‑back policies (Exhibits 97.1‑97.2) and a refreshed severance plan (Exhibit 10.28), indicating a modest expansion of executive‑risk oversight while preserving the core indemnification language for governance continuity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH: The LLM states the Officer Indemnification Agreement is 'Exhibit 10.23' but the ground truth clearly identifies it as 'Exhibit 10.43'. This is a factual error in entity identification that undermines credibility. (2) UNSUPPORTED CLAIMS: The LLM introduces information about 'updated claw-back policies (Exhibits 97.1-97.2)' and 'refreshed severance plan (Exhibit 10.28)' that are NOT mentioned in the ground truth answer. These appear to be fabricated details not supported by the knowledge graph. (3) PARTIAL ACCURACY: The LLM correctly identifies that the agreement was originally filed in 2019 and re-referenced in 2022 and 2024 10-Ks without amendment, which aligns with ground truth. (4) REASONING QUALITY: While the LLM's interpretation about 'modest expansion of executive-risk oversight' is reasonable inference, it contradicts the ground truth's emphasis on 'no modification' and 'consistent governance practices.' The ground truth explicitly states the agreement was 'refiled without amendment,' whereas the LLM suggests additional governance changes occurred. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the core finding - that the SAME agreement from 2019 remained unchanged through 2024, indicating stability rather than evolution. Instead, it introduced unverified exhibit numbers and policy changes. The answer demonstrates partial understanding of the continuity theme but introduces factual errors that significantly reduce reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 421,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\nIn the 2022 filing Always Discreet was described as holding “about 15 % market share” in the adult‑incontinence sub‑category, positioned as a notable but secondary player behind the category leaders. By the 2023 filing that share had slipped to “over 10 %” in the key markets, indicating a modest erosion of its position and a weaker competitive standing within the adult‑incontinence segment, even though the brand remains part of the broader Baby, Feminine & Family Care business that is still a global market‑leader in feminine care overall.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims 2022 showed 'about 15% market share' while the ground truth explicitly states 'over 10% market share' in 2022. This is a significant numerical error (15% vs 10%). The LLM then claims 2023 showed 'over 10%' which reverses the actual trajectory - the ground truth indicates 2022 had 'over 10%' and 2023 had NO specific market share figure provided. (2) DIRECTIONAL ERROR: The LLM incorrectly characterizes this as 'erosion' from 15% to 10%, when the ground truth shows the opposite pattern: 2022 had a stated figure (over 10%), and 2023 moved away from quantified disclosure entirely. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key insight from the ground truth - that the shift represents a change in disclosure methodology (from quantified to qualitative), not necessarily a market share decline. The LLM invented a narrative of competitive erosion that is not supported by the source material. (4) ENTITY/METRIC CONFUSION: While the LLM correctly identifies Always Discreet and the relevant years/segments, it misrepresents the actual market share figures and their trajectory. The ground truth's core finding - that specific market share disclosure was removed in 2023 - is fundamentally mischaracterized in the LLM response. This is a case where the LLM appears to have fabricated specific numbers (15%) not present in either the ground truth or presumably the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 436,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Oracle reframed Engineered Systems from a stand‑alone hardware line‑up into the “hardware foundation” of its cloud strategy—emphasizing that Exadata, SPARC and storage platforms are now sold primarily as pre‑integrated engines that run Oracle Cloud Infrastructure, Autonomous Database and Cloud@Customer, and can be deployed on‑premise, in OCI or as a hybrid cloud.  This shift reinforces the cloud‑transformation narrative by tying hardware sales to cloud consumption (lower‑margin, support‑contract‑driven revenue) and by positioning Engineered Systems as the differentiated, secure substrate that enables customers to move and expand workloads onto Oracle’s cloud services.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional shift in Oracle's strategic positioning of Engineered Systems between 2022-2023, correctly identifying the reframing from standalone hardware to cloud-integrated infrastructure. The qualitative narrative about positioning Engineered Systems as foundational to cloud strategy, hybrid deployment options, and the connection to cloud consumption is sound and well-articulated.\n\nHowever, there are significant quantitative gaps:\n\n1. MISSING CRITICAL NUMBERS: The ground truth explicitly states that hardware revenues (including Engineered Systems) represented 6% of total revenues in both fiscal 2023 and 2024. The LLM answer completely omits this key quantitative metric, which is essential for understanding the business significance and scale of this strategic positioning.\n\n2. INCOMPLETE PRODUCT SCOPE: The ground truth emphasizes that the 2023 positioning broadened Engineered Systems to include \"servers, storage, and operating systems\" as a combined hardware business with integrated performance obligations. The LLM answer mentions Exadata, SPARC, and storage but doesn't explicitly capture the broader hardware business integration or the accounting treatment change (combined performance obligations).\n\n3. R&D INVESTMENT CONTEXT: The ground truth notes \"ongoing R&D investments to enhance these offerings,\" which the LLM answer omits entirely.\n\n4. MARGIN ACKNOWLEDGMENT: While the LLM answer mentions \"lower-margin, support-contract-driven revenue,\" the ground truth more explicitly acknowledges \"the lower-margin nature of the hardware business\" as a contextual factor.\n\nThe LLM answer demonstrates good qualitative reasoning about the strategic narrative and multi-hop synthesis (connecting hardware positioning to cloud transformation), but fails to include quantitative specifics that ground the analysis in actual business metrics. For a financial question requiring multi-hop analysis of SEC filings, the absence of the 6% revenue figure is a material omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 547,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\nThe 2022 10‑K explicitly described the 2020 Stock Plan as “the successor to the 2011 Stock Plan” and noted that 5,530,106 shares remaining under the 2011 plan were available for grant under the new plan. In the 2023 10‑K that language was dropped; the filing simply states that the 2020 Plan was approved and outlines its award types and current share‑reserve figures, without referring to it as the successor to the 2011 plan. Thus the disclosure shifted from an explicit “successor” wording in 2022 to a more current, activity‑focused description in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in disclosure between the 2022 and 2023 10-K filings. STRENGTHS: (1) The specific share count of 5,530,106 is accurately cited and matches the ground truth. (2) The core finding is correct: the 2022 filing included explicit reference to the 2011 Stock Plan and the carry-forward of shares, while the 2023 filing omitted this. (3) The characterization of the shift is accurate - from explicit 'successor' language to a more current, activity-focused description. (4) The multi-hop reasoning is sound, correctly synthesizing the differences between two years' filings. MINOR CONSIDERATIONS: (1) The LLM uses the phrase 'the successor to the 2011 Stock Plan' in quotes for 2022, which is a reasonable characterization of the relationship described, though the ground truth uses slightly different phrasing ('carried forward and made available'). However, both convey the same substantive relationship. (2) The LLM's description of the 2023 approach as 'more current, activity-focused' is a reasonable interpretive characterization that aligns with the ground truth's observation that the company 'focusing only on the 2020 Stock Plan without linking it to its predecessor.' The answer demonstrates solid understanding of the disclosure evolution and accurately captures the key factual changes between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 381,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s private‑fund exposure in its U.S. pension portfolio grew only modestly – direct private‑investment holdings rose from **$1.284 bn to $1.293 bn** and private‑fund assets measured at NAV increased from **$1.258 bn to $1.265 bn**, moving the “other‑types” allocation from roughly **7.5 % to about 7.6 % of total plan assets**, still within the 10‑20 % target range but edging higher.  \nThis slight uptick indicates that the company is deliberately maintaining – and modestly expanding – its allocation to alternative, long‑horizon investments, reflecting a capital‑deployment priority focused on generating higher, inflation‑linked returns while preserving portfolio diversification and funding stability for future pension obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth states: $1,244 million (2022) and $1,265 million (2023) for private funds. The LLM provides: $1.284 bn (2022) and $1.293 bn (2023) for 'direct private-investment holdings' and $1.258 bn (2022) and $1.265 bn (2023) for 'private-fund assets measured at NAV.' These numbers are materially different from the ground truth figures. The LLM appears to have confused or conflated different line items from the pension disclosures, presenting multiple separate categories rather than the single 'private funds' metric cited in the ground truth. The ground truth shows a 1.7% increase ($1,244M to $1,265M), while the LLM's figures show different percentage changes depending on which metric is used. The LLM's interpretation about 'other-types' allocation at 7.5%-7.6% and a 10-20% target range is not mentioned in the ground truth and appears to be either fabricated or from a different section of the filing that doesn't align with the specific private funds figures. While the LLM's qualitative reasoning about maintaining alternative investments and seeking higher returns is reasonable and somewhat aligned with the ground truth's interpretation, the quantitative foundation is entirely wrong. The answer fails on the primary metric of factual accuracy regarding the specific dollar amounts that are central to answering this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 404,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Company moved from a situation in which **no Class B‑2 common shares were outstanding** (the 2023 tables show a “‑” for both shares and EPS) to issuing and reporting **49 million Class B‑2 shares** in its 2024 filings.  The shares were created as part of the **Class B‑1 common‑stock exchange offer** completed in May 2024, under which tendered Class B‑1 shares were retired and replaced with newly issued Class B‑2 (and Class C) shares; the newly‑issued Class B‑2 shares are convertible into Class A common stock, participate in dividends on an as‑converted basis, and their conversion rate is adjusted downward when the U.S. litigation escrow account is funded or when covered litigation is resolved.  Consequently, the 2024 disclosures now list Class B‑2 as an outstanding class with a disclosed share count, conversion mechanics, and related equity‑impact disclosures that were absent in the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2023, Class B-2 Common Stock was subject to conversion rate adjustments and dilution impacts, and that 'no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer.' The LLM answer claims the opposite: that Class B-2 shares were created in May 2024 as part of the Class B-1 exchange offer, with 49 million shares issued at that time. This is a critical misrepresentation of the timeline and nature of the Class B-2 stock. The ground truth indicates Class B-2 existed in 2023 with active conversion mechanics and dilution impacts, while the LLM suggests it was newly created in 2024. Additionally, the LLM provides a specific share count (49 million) that is not mentioned in the ground truth and appears to be fabricated or misattributed. The LLM does correctly identify that Class B-2 shares are convertible into Class A common stock and that conversion rates are adjusted based on litigation escrow account funding, which aligns with the 2023 disclosures mentioned in the ground truth. However, the core narrative about the evolution between 2023 and 2024 is inverted: the ground truth shows reduced emphasis/discontinuation in 2024, while the LLM shows increased emphasis and new issuance. The multi-hop reasoning fails because it misinterprets the temporal relationship between the two years and the nature of the Class B-1 exchange offer's relationship to Class B-2 stock.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 422,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\nBetween fiscal 2022 (ended January 29 2022) and fiscal 2024 (ended February 1 2025) the liability tied to the Target Circle loyalty program dropped sharply—from roughly **$89 million** of deferred revenue in 2022 to only **$19 million** by the end of 2024.  This reduction shows that the company is now recognizing the promised rewards more quickly (or that fewer rewards remain outstanding), indicating that the Target Circle program has evolved from a largely deferred‑revenue model toward a more immediate‑recognition/redemption structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant issues with completeness and accuracy. CORRECT ELEMENTS: The $89 million figure for 2022 (January 29, 2022) is accurate, and the $19 million figure is correctly cited. The general interpretation about the shift toward more immediate recognition/redemption is reasonable. CRITICAL ERRORS: (1) The LLM conflates fiscal 2024 with February 1, 2025 - these are different dates. The ground truth clearly distinguishes three time periods: January 29, 2022 ($89M), February 3, 2024 ($117M), and February 1, 2025 ($19M). The LLM only addresses 2022 and 2025, completely omitting the 2024 data point ($117M). (2) The LLM's framing of 'fiscal 2024 (ended February 1 2025)' is confusing and technically incorrect - February 1, 2025 would be fiscal 2025, not 2024. (3) Most importantly, the LLM misses the intermediate 2024 figure of $117 million, which is crucial to understanding the program's evolution. The ground truth shows an increase from $89M to $117M (2022-2024), followed by a sharp drop to $19M (2024-2025). This three-point trajectory is essential to the question about how obligations 'changed between 2022 and 2024' - the answer should highlight the $117M figure as the 2024 endpoint. (4) The LLM's interpretation focuses only on the 2022-to-2025 comparison, missing the important intermediate growth phase. MULTI-HOP REASONING: The LLM demonstrates reasonable interpretive reasoning about what the changes indicate, but fails at the fundamental data synthesis task by omitting a key data point. The question specifically asks about 2022-to-2024 changes, and the LLM should have reported the $117M 2024 figure as the primary comparison point, with the 2025 figure as additional context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 470,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\nThe 4.375 % Senior Notes were valued at **$980 million** on December 31 2022 and rose to **$996 million** on December 31 2023 – an increase of roughly **$16 million (about 1.6 %)**. This modest uptick suggests that investors viewed Netflix’s credit as slightly less risky or that broader market yields shifted in a way that made the notes more attractive, though the price still traded below par, indicating continued caution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $980 million (Dec 31, 2022), $996 million (Dec 31, 2023), and the calculated increase of $16 million (1.6%) are all accurate. The calculation is properly verified: ($996M - $980M) / $980M = 0.0163 or 1.6%. ENTITY ACCURACY: Netflix and the 4.375% Senior Notes are correctly identified with proper dates. REASONING QUALITY: The LLM correctly interprets the fair value movement. The original answer states the fair value 'moved closer to the principal amount at par, suggesting a stabilization or improved outlook.' The LLM answer provides a complementary interpretation - that the increase suggests investors viewed Netflix's credit as 'slightly less risky' or that 'market yields shifted in a way that made the notes more attractive.' Both interpretations are semantically equivalent and logically sound. The LLM also correctly notes that the price 'still traded below par, indicating continued caution,' which aligns with the ground truth's characterization of stabilization. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the two data points across time periods and draws appropriate conclusions about market perception. MINOR CONSIDERATIONS: The original answer uses 'decreased' language which could be confusing (the fair value increased from $980M to $996M), but the LLM correctly identifies this as an increase. The LLM's interpretation about investor perception is slightly more detailed and nuanced than the original, providing additional context about credit risk and market yields, which enhances rather than detracts from the answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 464,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the number of Visa’s Class C shares rose from 10 million (the weighted‑average shares shown for 2023) to about 16 million (the weighted‑average shares shown for 2024) – an increase of roughly 6 million shares.  This growth was driven primarily by the May 2024 exchange offer in which Visa accepted 241 million Class B‑1 shares and issued ≈ 48 million new Class C shares to those participants (see page 40).  The Class C securities remain classified as a separate series of common stock with no established public trading market, and their equity classification was unchanged; the higher share count is reflected in the 2024 EPS figures (basic $38.97 and diluted $38.92) reported on page 59.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) TIMING ERROR: The LLM states the exchange offer occurred in May 2024, but the ground truth clearly indicates it occurred in 2023. This is a major chronological error that undermines the entire answer. (2) SHARE COUNT ERROR: The LLM claims Class C shares increased from 10 million in 2023 to 16 million in 2024, but the ground truth states that by 2024, the balance of Class C common stock remained at 10 shares issued and outstanding. The LLM appears to have confused weighted-average shares (which may vary due to timing of issuances) with actual shares outstanding. The ground truth explicitly states the 2024 balance sheet shows 10 shares, not 16 million. (3) EXCHANGE OFFER DETAILS: While the LLM correctly identifies that 241 million Class B-1 shares were exchanged for approximately 48 million Class C shares, it incorrectly dates this to May 2024 when it occurred in 2023. (4) MISINTERPRETATION OF DATA: The LLM appears to have misread weighted-average share data as actual outstanding shares, leading to the false claim of growth from 10 million to 16 million. The ground truth indicates stabilization at 10 shares by 2024, not growth. (5) MISSING KEY INSIGHT: The LLM fails to capture the ground truth's important conclusion that the 2024 disclosures indicate 'stabilization or conclusion of that phase of equity restructuring,' instead presenting a narrative of continued growth. The answer demonstrates poor multi-hop synthesis and factual accuracy on the core question of how equity structure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 443,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\nLowe’s has continued to list Rough Plumbing under its Building‑Products category, but between 2022 and 2024 the company moved it from a stand‑alone product line to a service‑centric offering.  The 2024 disclosures emphasize installation services, protection‑plan coverage, and a remote “central‑selling” team that lets customers complete contracts online—showing a deeper, integrated engagement with Rough Plumbing beyond simply selling the merchandise.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Rough Plumbing from a product-focused to service-oriented offering and accurately notes the continued 'Building Products' classification. However, there are significant quantitative accuracy issues: (1) The ground truth specifies that Rough Plumbing contributed to 'approximately 5% of total sales attributed to installed sales in 2024'—a specific metric that the LLM answer completely omits. This is a material quantitative detail that should have been included. (2) The LLM introduces details about a 'remote central-selling team' and online contract completion that are not mentioned in the ground truth, which raises questions about whether these details are accurate or represent hallucination. (3) The LLM correctly captures the shift from 'stand-alone product line to service-centric offering' and mentions installation services and protection plans, which aligns with the ground truth's description of integration into 'installation services and protection plans.' The qualitative reasoning about the strategic shift is sound and well-articulated. However, the omission of the specific 5% installed sales metric is a notable gap in completeness for a multi-hop financial question that should synthesize quantitative data. The answer demonstrates good understanding of the business evolution but fails to include key financial metrics that ground the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 394,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Visa created a new Class B‑2 common‑stock class as part of its B‑1 exchange offer (see page 59 – Class B‑2 EPS appears only in 2024 and 49 million weighted‑average shares are reported; page 61 shows total B‑1 + B‑2 shares outstanding falling from 245 million in 2023 to 125 million in 2024). The exchange retired a large block of B‑1 shares and issued roughly 120 million B‑2 shares (and 48 million C shares), giving the company a distinct second‑class of shares that now figures in its capital‑structure tables. This restructuring reduces the overall B‑class share count, removes transfer restrictions on the retired B‑1 shares, and provides a new class that can be converted to Class A stock, indicating that Visa is reshaping its dual‑class capital structure to better manage litigation‑related escrow and future equity‑based incentives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) COMPANY IDENTIFICATION ERROR: The LLM identifies this as Visa, but the ground truth makes no mention of Visa. This is a fundamental entity misidentification that undermines the entire answer. (2) SHARE COUNT DISCREPANCIES: Ground truth states 77 million Class B-2 shares were outstanding in 2023, but the LLM claims 'roughly 120 million B-2 shares' were issued in 2024. The LLM also cites '49 million weighted-average shares' and '245 million in 2023 to 125 million in 2024' for B-1 + B-2 combined, which contradicts the ground truth's 77 million figure for B-2 alone in 2023. (3) STRUCTURAL MISUNDERSTANDING: The ground truth indicates Class B-2 was newly introduced in 2023 with 77 million shares, then by 2024 'no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer.' The LLM reverses this narrative, claiming B-2 was created in 2024 as part of the exchange offer, which is factually backwards. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution between 2023 and 2024. The ground truth shows introduction → restructuring/replacement, while the LLM shows creation → expansion. (5) CONTEXTUAL ISSUES: While the LLM provides detailed reasoning about capital structure implications, this reasoning is built on incorrect foundational facts. The mention of litigation-related escrow and equity incentives may be speculative additions not supported by the ground truth. The answer demonstrates some understanding of capital structure concepts but applies them to incorrect data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 460,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\nThe accrued liability for the Target Circle program was $117 million as of February 3 2024 and fell to $19 million by February 1 2025 – a reduction of roughly 84 %.  This sharp decline indicates that the program’s financial obligations have been markedly trimmed, suggesting that Target has scaled back or restructured the Circle rewards mechanism rather than continuing to expand it.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - The LLM claims the liability was $117 million as of February 3, 2024 and fell to $19 million by February 1, 2025. However, the ground truth only provides data through February 3, 2024 ($117 million in deferred revenue), with no mention of a February 1, 2025 figure or any $19 million liability. The LLM appears to have fabricated the 2025 data point. (2) TERMINOLOGY ERROR - The LLM uses 'accrued liability' when the ground truth specifically identifies this as 'deferred revenue,' which are different accounting concepts. Deferred revenue represents customer prepayments/obligations to deliver services, while accrued liabilities represent obligations to pay. (3) CALCULATION ERROR - The claimed 84% reduction ($117M to $19M) is mathematically correct IF those numbers were accurate, but since the $19M figure is not supported by the ground truth, this calculation is based on false premises. (4) DIRECTIONAL MISINTERPRETATION - The ground truth indicates growth/expansion of the program between 2022 and 2024 (from no disclosed figure to $117M), suggesting positive program evolution. The LLM's answer suggests contraction and restructuring, which contradicts the ground truth's interpretation. (5) INCOMPLETE ANSWER - The question asks about changes between 2022 and 2024; the LLM extends beyond the question scope to 2025 with unsupported data. The LLM failed to properly address the 2022-2024 comparison that was the actual focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 428,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, NVIDIA’s discussion of environmental risk shifted from a broad reference to climate‑related uncertainties to an explicit warning that new or proposed **pollution‑limit regulations** (such as emissions caps and carbon‑tax rules) could raise operating costs and **restrict the ability of data‑center customers to expand**.  This heightened focus signals that the company now sees pollution‑limit rules as a concrete regulatory hurdle that could affect its operations and the growth of its data‑center customer base.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly synthesizes the evolution of NVDA's pollution-related concerns between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from 2023 to 2024 in NVDA's regulatory concerns; (2) Accurately captures the expansion from cost-focused concerns to include permitting/land constraints; (3) Properly identifies the connection to data center customer expansion as a key concern; (4) Uses appropriate terminology ('pollution-limit regulations,' 'emissions caps,' 'carbon-tax rules'); (5) Correctly notes the impact on customer ability to expand data center capacity; (6) No quantitative errors or date misstatements. MINOR WEAKNESSES: (1) The LLM answer characterizes the 2023 position as 'broad reference to climate-related uncertainties' rather than specifically detailing the 2023 concerns about compliance, energy, and capital expenditures mentioned in ground truth; (2) The phrase 'new or proposed pollution-limit regulations' with examples in parentheses adds specificity not explicitly confirmed in the ground truth, though this is reasonable inference; (3) Could have been more explicit about the 2023 baseline (manufacturing processes and supply chain operations) before discussing the 2024 expansion. The answer demonstrates solid multi-hop reasoning by connecting regulatory evolution to customer impact and demand implications. The semantic meaning aligns well with the ground truth despite slightly different framing and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 421,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s Guaranteed Senior Notes grew primarily through a $500 issuance by its Japanese subsidiary in November 2023 (four notes with fixed rates of 1.400 %– 2.120 % and maturities 2033‑2043), which was recorded at **Level 3** fair‑value input (discounted cash‑flow valuation). In July 2024 the subsidiary repaid $77 of those notes, leaving a net carrying balance of **$919** in 2024 versus **$484** in 2023; the overall fair‑value of the long‑term debt (including the Guaranteed Senior Notes) was reported as roughly **$5.4 billion** in 2024 versus **$5.74 billion** in 2023. Thus, the notes were added at Level 3 valuation, partially reduced by a modest repayment, and remained classified as Level 3 measurements in subsequent reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CARRYING BALANCE DISCREPANCY: The LLM states carrying balances of $919 in 2024 vs $484 in 2023, but the ground truth indicates the 2023 issuance was approximately $500 total. The LLM's $919 figure in 2024 is unexplained and appears incorrect - if $500 was issued in 2023 and $77 was repaid in 2024, the balance should be approximately $423, not $919. This is a major calculation error. (2) FAIR VALUE NUMBERS: The LLM correctly identifies fair value of long-term debt as approximately $5.4 billion in 2024 vs $5.74 billion in 2023 (ground truth states $5,412 vs $5,738), with appropriate rounding. This is correct. (3) ISSUANCE DETAILS: The LLM correctly identifies the $500 issuance in 2023 by the Japanese subsidiary with four notes at 1.400%-2.120% fixed rates and Level 3 valuation. This is accurate. (4) REPAYMENT: The LLM correctly identifies the $77 repayment in July 2024. This is accurate. (5) MULTI-HOP REASONING: The LLM attempts to synthesize issuance, repayment, and fair value evolution, but the carrying balance calculation is fundamentally flawed, undermining the overall analysis. The statement about 'net carrying balance' lacks clear justification and contradicts the math. (6) SEMANTIC ISSUES: The LLM's framing of 'net carrying balance' is confusing and not clearly defined in the ground truth context. The ground truth focuses on fair value evolution rather than carrying balances. STRENGTHS: Correct identification of issuance amount, rates, dates, Level 3 classification, repayment amount, and fair value comparisons. WEAKNESSES: Major unexplained discrepancy in carrying balance figures ($919 vs expected ~$423), unclear calculation methodology, and potential confusion between different balance sheet metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 480,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\nFrom 2022 to 2024 Netflix stepped up its spending on streaming‑service upgrades—technology‑and‑development costs jumped ≈ 24 % and content‑amortization expanded—while simultaneously building a more formal cybersecurity function; the 2022 filing notes the appointment of a Vice President of Security and Privacy Engineering and board‑level risk oversight, and the 2024 filing shows that this role now receives regular external audits, bug‑bounty programs and a dedicated enterprise‑risk assessment.  Personnel‑wise, the company continued to stress the importance of its Co‑CEOs and senior technology/security leaders, while highlighting succession planning and the recruitment of skilled cybersecurity talent, shifting the risk profile from pure capital investment to heightened cyber‑risk and talent‑retention exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims 'technology-and-development costs jumped ≈24%' but provides no source or verification for this percentage. The ground truth specifies a concrete $384 million increase in personnel-related costs in 2022, which the LLM completely omits. This is a major factual error - the ground truth provides a specific dollar amount that should be included. (2) ENTITY/DETAIL ERRORS: The LLM mentions 'Vice President of Security and Privacy Engineering' and 'board-level risk oversight' in 2022, but the ground truth does not reference these specific titles or roles. These appear to be fabricated details not supported by the original answer. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the core quantitative finding - the $384 million personnel cost increase in 2022 that directly supported streaming service improvements. This is a fundamental omission of the primary financial metric. (4) PARTIAL CREDIT FOR EVOLUTION NARRATIVE: The LLM correctly identifies the shift from growth-oriented investment to risk-aware posture and mentions cybersecurity emphasis in 2024, which aligns with the ground truth's narrative arc. However, this qualitative correctness cannot compensate for the missing quantitative data. (5) UNSUPPORTED CLAIMS: References to 'external audits, bug-bounty programs' and specific percentages lack grounding in the provided ground truth, suggesting hallucination. The answer reads plausibly but introduces details not verified against the source material. VERDICT: While the LLM captures some thematic elements of the evolution from 2022 to 2024, it fails on the most critical requirement - accurate financial figures - and introduces unverified details that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 479,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\nThe 2023 filing introduced the company’s then‑current “2023 Form of Restricted Stock Unit Agreement” (Exhibit 10.24), and the 2024 filing replaced it with an updated “2024 Form of Restricted Stock Unit Agreement” (Exhibit 10.26) that revises vesting schedules, adds performance‑based conditions and other language to better align equity payouts with long‑term shareholder value. This progression shows a deliberate lifecycle‑management approach—periodically refreshing the RSU agreement to tighten the link between executive compensation and performance metrics and to keep the equity component consistent with evolving compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG FORM IDENTIFICATION: The LLM claims the 2023 filing introduced a '2023 Form of Restricted Stock Unit Agreement' (Exhibit 10.24), but the ground truth states the 2023 filing introduced the '2024 Form' marked as 'Filed herewith.' The LLM has confused the form naming convention. (2) MISSING CRITICAL EVOLUTION: The LLM completely fails to capture the key evolution described in the ground truth—that the '2024 Form' was newly filed in 2023 ('Filed herewith') but became 'Previously filed' in the 2024 filing. This is the core lifecycle management insight. (3) MISSING 2025 FORM: The ground truth explicitly mentions that the 2024 filing introduced a '2025 Form of Restricted Stock Unit Agreement' marked as 'Filed herewith,' showing forward-looking strategy. The LLM answer makes no mention of this critical development. (4) UNSUPPORTED CLAIMS: The LLM introduces specific details about 'vesting schedules,' 'performance-based conditions,' and 'shareholder value alignment' that are not present in the ground truth and appear to be fabricated. (5) INCORRECT EXHIBIT NUMBERS: The LLM cites Exhibit 10.24 and 10.26, but the ground truth does not provide these specific exhibit numbers, suggesting the LLM may be confabulating details. (6) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution between 2023 and 2024 filings, requiring synthesis of how the same forms are referenced differently across years. The LLM fails to capture this temporal evolution pattern. The LLM does correctly identify that this represents a lifecycle management approach and iterative updating, but the specific facts supporting this conclusion are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 476,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\nThe $750 million 4.90 % senior notes were issued in November 2023 with a maturity of April 15 2029 (they carry a $3.4 million discount).  Their net carrying amount increased modestly from $743 million at the end of fiscal 2023 (January 28 2024) to $744 million at the end of fiscal 2024 (February 2 2025), reflecting the ongoing amortization of the discount and accrued interest.  The notes remain unsecured, semi‑annual‑interest obligations that cannot be redeemed before maturity except under the standard change‑of‑control or optional‑redemption provisions, so their maturity timeline stays fixed at 2029.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with mostly correct information about the 4.90% Senior Notes. STRENGTHS: (1) All key numbers are accurate: $750 million principal, $3.4 million discount, April 15, 2029 maturity date, November 2023 issuance date. (2) Correctly identifies the carrying amount of $743 million as of January 28, 2024 (end of fiscal 2023). (3) Properly notes the semi-annual interest payment structure and unsecured nature of the notes. (4) Accurately describes the maturity timeline remaining fixed at 2029. (5) Good synthesis of multi-hop information across fiscal years. MINOR ISSUES: (1) The LLM states the carrying amount increased from $743 million to $744 million, but the ground truth only provides the $743 million figure as of January 28, 2024 and doesn't explicitly confirm a $744 million figure for February 2, 2025. This appears to be an inference about amortization progression rather than stated ground truth data. (2) The ground truth states the carrying amount 'slightly decreased' reflecting discount and amortization, while the LLM says it 'increased modestly' - this is a directional discrepancy, though the $1 million difference is immaterial. (3) Additional details about change-of-control and optional-redemption provisions are not mentioned in the ground truth, suggesting the LLM may have added contextual information beyond what was provided. The core answer structure and most quantitative facts are correct, but the directional change in carrying amount and the specific $744 million figure for fiscal 2024 cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 443,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\nBetween November 2023 and July 2024 the Japanese subsidiary issued roughly $500 of Guaranteed Senior Notes—four fixed‑rate notes maturing between 2033 and 2043 with coupons of 1.400% to 2.120%—and then repaid $77 of those notes in July 2024, leaving the balance of the issuance still outstanding as part of long‑term debt. This issuance marked the first time the subsidiary accessed capital through Guaranteed Senior Notes, and the subsequent partial repayment reduced the outstanding amount but did not eliminate the debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - $500 million issuance, $77 million repayment, interest rates of 1.400% to 2.120%, and maturity dates between 2033-2043. The dollar amounts match the ground truth exactly. ENTITY ACCURACY: Correctly identifies Costco's Japanese subsidiary, the instrument type (Guaranteed Senior Notes), and the time period (November 2023 to July 2024). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across the 2023 and 2024 filings, showing the evolution from issuance to partial repayment. COMPLETENESS: Addresses all aspects of the question - the issuance details (amount, rates, maturity dates), the repayment amount, and the resulting outstanding balance. ADDITIONAL CONTEXT: The LLM answer provides valuable supplementary information not explicitly in the ground truth (specific months of issuance/repayment, characterization as first-time access to this capital instrument, and clarification that the debt remains outstanding), which enhances understanding without contradicting the ground truth. MINOR CONSIDERATION: The ground truth mentions 'proceeds from the issuance referenced in 2024 filing as source of financing activity' which the LLM answer doesn't explicitly state, but this is a minor omission that doesn't affect the core accuracy of the evolution narrative. The semantic meaning and factual content align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 408,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\nThe company continues to disclose that competitors can introduce after‑market parts and services for its products—a risk that is listed among its core competitive and technological‑innovation concerns in both the 2022 and 2023 Form 10‑K filings.  While the language is essentially the same in the two years, the 2023 filing reiterates that such after‑market offerings could “detract from our sales” and thereby negatively affect revenue and profitability, but it does not indicate that the risk has grown materially; it remains a consistent, though not quantified, threat to the business and its financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant qualitative inaccuracies that undermine its overall correctness despite some accurate elements. CORRECT ELEMENTS: (1) The answer correctly identifies that both 2022 and 2023 filings mention the after-market parts risk, (2) The reference to 'detract from our sales' language is accurate, (3) The identification of DHR as the company and the correct fiscal years (2022, 2023) are correct. CRITICAL ERRORS: (1) The LLM states 'the language is essentially the same in the two years,' which directly contradicts the ground truth that shows a significant shift in framing from 2022 to 2023. The ground truth explicitly notes the risk shifted from being described as a 'direct threat' in 2022 to being 'Impacted By' competition in 2023, representing a material change in how the risk is presented. (2) The LLM fails to capture the key evolution: in 2023, the risk was recontextualized within broader healthcare industry cost containment trends and pricing pressures from managed care/government reimbursement—this is a fundamental shift in risk characterization that the LLM completely misses. (3) The LLM concludes 'it does not indicate that the risk has grown materially' and 'remains a consistent...threat,' which misses the ground truth's point that the risk was actually de-emphasized or recalibrated strategically in 2023. MULTI-HOP REASONING: The LLM failed to synthesize the evolution of risk framing across the two years. The question specifically asks 'how has...evolved,' and the ground truth shows a clear evolution in presentation and contextualization, which the LLM entirely missed by claiming the language is 'essentially the same.' This represents a failure in the core multi-hop synthesis required by the question. The answer reads as a static comparison rather than capturing the dynamic shift in risk perception and presentation between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 512,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix moved from a single‑price, three‑tier structure to a more granular, region‑specific pricing model that introduced an ad‑supported, lower‑cost tier and raised the rates on its standard and premium plans.  The company also added new service features—such as games, live programming and enhanced recommendation technology—to broaden the value proposition.  These changes were intended to slow the slowdown in paid‑membership growth, lift average revenue per user to offset rising content costs, and keep Netflix competitive against new streaming rivals and piracy.  (See NFLX‑10K 2022 pp. 22, 23, 24; NFLX‑10K 2024 pp. 4‑8.)",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key strategic changes (ad-supported tier, price increases, region-specific pricing) and accurately captures the business challenges (membership growth slowdown, competition, content costs). The answer appropriately synthesizes information across 2022-2024 and mentions relevant service features (games, live programming). The reasoning about offsetting rising content costs and competitive pressures is sound.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer provides NO specific numbers from the ground truth, which is a significant omission. The ground truth contains concrete metrics: 19% revenue increase in 2022, 11% membership growth, 7% ARPU increase, and critically, a 50% drop in paid net membership additions. These quantitative details are essential to understanding the severity of the challenges Netflix faced and are completely absent from the LLM response. This is a major gap for a financial question requiring multi-hop analysis.\n\nWEAKNESSES - COMPLETENESS: While the LLM mentions the ad-supported tier and price increases, it does not explicitly reference the enforcement of terms of use to limit multi-household usage, which was a specific strategic response mentioned in the ground truth. The LLM also does not acknowledge macroeconomic conditions as a contextual factor, though it does mention broader competitive pressures.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects strategic changes to business challenges. However, the lack of quantitative support weakens the multi-hop analysis. The answer would be significantly stronger with specific numbers showing the membership acquisition decline and revenue metrics.\n\nSEMANTIC EQUIVALENCE: The LLM's description of 'slowing the slowdown' is slightly awkward phrasing but semantically captures the intent to address membership growth challenges. The characterization of changes as addressing 'fluctuating member acquisition' and 'retention pressures' aligns with ground truth.\n\nJUSTIFICATION: This answer demonstrates good qualitative understanding of Netflix's strategic evolution but fails to incorporate critical quantitative evidence that would substantiate the analysis. For a financial question requiring multi-hop synthesis, the absence of specific numbers (19% revenue growth, 50% drop in net additions, 11% membership growth, 7% ARPU increase) represents a significant deficiency, even though the directional understanding is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 670,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\nBoeing continues to record the present‑value of in‑orbit incentive fees as revenue during the construction of a satellite, but the 2023 filing makes clear that such payments are **contingent on the spacecraft meeting performance specifications for up to 15 years after acceptance** – if the satellite under‑performs, the company may be required to refund the incentive and take a material charge.  The 2023 discussion also notes that the **risk exposure has widened** as more development programs (e.g., Commercial Crew, KC‑46A, VC‑25B and satellite contracts) now include in‑orbit incentives, leading to larger potential reach‑forward losses and greater earnings volatility.  Consequently, while the accounting treatment (recognizing revenue in the construction period) has not changed, the **financial risk and the possibility of future charge‑backs have been emphasized as more significant in 2023**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in Boeing's approach - from general risk acknowledgment in 2022 to more specific quantification and detailed explanation in 2023. It accurately captures the 15-year performance contingency period, the revenue recognition during construction period, and the emphasis on increased financial risk and potential charge-backs. The qualitative reasoning about the shift from general to specific risk disclosure is sound and well-articulated.\n\nWEAKNESSES: The LLM answer fails to include the critical quantitative anchor from the ground truth: the $1,585 million in additional losses recorded on five significant fixed-price development programs in 2023. This is a material omission - the ground truth explicitly states this specific dollar amount as evidence of the evolution in financial recognition and risk exposure. The LLM mentions 'larger potential reach-forward losses' but does not cite the actual $1,585 million figure that demonstrates the magnitude of this shift.\n\nQUANTITATIVE ACCURACY ISSUE: The ground truth provides a specific, quantifiable metric ($1,585 million in losses) that directly supports the claim about evolved financial recognition. The LLM answer discusses the concept of losses and charge-backs but omits this key number, which is a significant gap in a financial analysis question.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about the evolution across years and identifies the programs mentioned (Commercial Crew, KC-46A, VC-25B). However, it generalizes about 'satellite contracts' without the specificity of the ground truth's focus on the five most significant programs and their quantified losses.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the essence of the shift in approach and risk emphasis, the absence of the $1,585 million figure represents a material factual gap rather than merely a wording difference. This is a specific, verifiable number that should have been included in an answer about financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 550,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\nIn the 2023 filing the Directors’ Code of Conduct was mentioned only in the proxy and was posted on BNY’s website, with a statement that any future amendments or waivers would be disclosed there. The 2024 filing makes the code part of a publicly listed set of governance documents (e.g., corporate‑governance guidelines, bylaws, committee charters) that are posted on the website, thereby improving its visibility and signaling that updates will be published directly on the site.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IN CORE INTERPRETATION: The LLM answer fundamentally mischaracterizes the evolution described in the ground truth. The ground truth explicitly states that 2024 represents a SHIFT TO LESS DIRECT ACCESS (from specific URL to general reference), describing it as 'a streamlined but less direct approach.' However, the LLM answer claims the opposite - that 2024 'improving its visibility' and represents a positive change. This is a critical semantic inversion of the ground truth's key finding. SPECIFIC ISSUES: (1) The LLM states the 2024 approach 'improving its visibility' when the ground truth indicates it became LESS direct by removing the specific URL and consolidating into a general list. (2) The LLM says updates 'will be published directly on the site' - the ground truth makes no such claim about 2024; it only notes the 2023 statement about future disclosures. (3) The LLM correctly identifies that 2023 had a specific URL and 2024 had a more general reference, but then draws the opposite conclusion about what this means for accessibility. (4) The LLM correctly notes both years involved website posting and governance materials, but misinterprets the significance of the change. WHAT WAS CORRECT: The LLM accurately identifies that the 2023 filing included a specific URL, that both years involved website posting, and that 2024 consolidated the Code into a broader list of governance documents. However, these correct facts are used to support an incorrect overall conclusion about the evolution. The answer demonstrates partial understanding of the factual changes but fundamentally fails to capture the ground truth's assessment that this represents a REDUCTION in direct accessibility rather than an improvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 474,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\nBetween 2022 and 2023 Mobileye Drive shifted from a prototype‑stage L4 platform aimed at early robotaxi pilots to a commercially‑ready, fleet‑focused solution.  In 2023 the company announced OTA updates active in 22 cities, secured its first production design wins for the Chauffeur‑level system (e.g., Polestar, FAW and a major Western OEM), and deepened its go‑to‑market model by bundling Drive with Moovit’s mobility‑intelligence platform and supplying it to transportation‑network companies, public‑transit operators and AV‑ready vehicle OEMs.  This evolution reflects a move toward scaling the Drive stack through VaaS (Vehicle‑as‑a‑Service) partnerships and broader OEM collaborations rather than limited pilot deployments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM introduces specific claims NOT in the ground truth: '22 cities' with OTA updates, 'Polestar, FAW and a major Western OEM' as production design wins, and 'Chauffeur-level system' terminology. These details cannot be verified against the ground truth and appear to be hallucinated. (2) MISSING KEY INFORMATION - The LLM completely omits the 2022 collaborations mentioned in ground truth: Udelv partnership for autonomous cargo delivery, Transdev partnership for self-driving mobility services, and the Geely L4 design win. These are material facts showing the evolution from 2022 to 2023. (3) TERMINOLOGY ISSUES - The LLM uses 'VaaS (Vehicle-as-a-Service)' while ground truth specifies 'MaaS (Mobility-as-a-Service)' - these are different concepts. The ground truth also doesn't mention 'Chauffeur-level system' terminology. (4) PARTIAL ACCURACY - The LLM correctly identifies: the shift toward fleet deployment, bundling with Moovit, supplying to transportation network companies/public transit operators/AV-ready vehicle suppliers, and the evolution toward commercial readiness. However, these correct elements are undermined by the unverified claims and missing 2022 baseline information. (5) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution but does so incompletely and with invented details rather than grounding in the actual documented partnerships and milestones from both years. The answer reads more like an extrapolation than a factual synthesis of the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 425,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\nFrom 2022 through 2024 the Tower Preferred Interests moved from the original two‑series structure—Class A‑1 paying a 5.0 % quarterly distribution and Class A‑2 paying 4.75 % (both with a five‑year reset scheduled for December 2024)—to a revised framework introduced in November 2024.  The amendment split the interests into a Fixed‑Rate Class A (5.90 % distribution, resetting every five years and callable beginning in 2029) and a Floating‑Rate Class A (distribution equal to SOFR + 250 bps, also resetting every five years and callable at any time), while updating redemption and call provisions.  Thus the distribution rates shifted from the static 5.0 %/4.75 % levels in 2022 to a higher, mixed‑rate profile (5.90 % fixed plus a market‑linked floating rate) by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall evolution of Tower Preferred Interests from 2022 to 2024 and correctly identifies the key structural changes and rate shifts. However, there are significant date discrepancies that affect accuracy. CRITICAL ERRORS: (1) The LLM states the amendment occurred in 'November 2024' while the ground truth specifies 'August 2024' - this is a material factual error regarding timing. (2) The LLM mentions 'December 2024' as the five-year reset date for the original structure, which appears inconsistent with the ground truth's statement that resets occur 'every five years' from their original issuance dates. CORRECT ELEMENTS: (1) The 2022 structure is accurately described with Class A-1 at 5.0% and Class A-2 at 4.75%. (2) The dollar amounts ($1,500 and $4,500) are omitted from the LLM answer but not contradicted. (3) The 2024 fixed rate of 5.90% is correct. (4) The floating rate formula (SOFR + 250 bps) is correct. (5) The five-year reset cycle is correctly mentioned. (6) The callable provisions (2029 for fixed, any time for floating) are mentioned but not verified against ground truth. SYNTHESIS QUALITY: The LLM successfully synthesizes the multi-hop information showing evolution across years and correctly identifies this as both a structural and rate evolution. However, the date error (November vs. August 2024) is a significant factual mistake that undermines confidence in the answer's reliability. The omission of the specific dollar amounts ($1,500 and $4,500) for the 2022 series, while not contradicting the ground truth, represents incomplete information transfer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 443,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\nFrom 2022 to 2023 the Balanced Index Fund continued to be valued by a **market‑approach (Level 1) using quoted prices of identical instruments**, so the underlying investment methodology did not change.  However, the **unrealized gains/(losses) embedded in its Level 3 holdings flipped from a net loss of about $41 million in 2022 (losses of $16 m corporate, $11 m mortgage‑backed, $14 m municipal and $1 m real‑asset positions) to a modest net gain of roughly $11 million in 2023 (gains of $2 m corporate, $6 m mortgage‑backed and $3 m other fixed‑income)**, reflecting the improved market‑value performance of those Level 3 assets over the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains significant numerical errors and unsupported claims: The ground truth specifies unrealized losses of $16M (corporate) and $11M (mortgage-backed) in 2022, totaling $27M for those two categories. The LLM claims a net loss of $41M in 2022 and adds $14M for municipal and $1M for real-asset positions - these additional categories ($14M + $1M = $15M) are NOT mentioned in the ground truth answer. The LLM's 2023 calculation of $11M net gain ($2M + $6M + $3M) is also problematic - the ground truth only mentions $2M corporate and $6M mortgage-backed gains ($8M total), with no mention of $3M in 'other fixed-income' gains. The LLM appears to have fabricated or misattributed data points not present in the ground truth. (2) INVESTMENT APPROACH CLAIM - The LLM states the valuation methodology 'did not change' and remained Level 1 (market approach with quoted prices), but the ground truth explicitly states that 'the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process' - implying this was a change or clarification from 2022. The LLM's characterization of 'no change' contradicts the ground truth's implication of evolution. (3) MULTI-HOP REASONING - The question asks how the approach AND unrealized gains/losses 'evolved' from 2022 to 2023. The ground truth addresses both the shift in unrealized gains/losses AND the evolution in valuation methodology transparency. The LLM addresses the gains/losses shift but mischaracterizes the methodology evolution. (4) MISSING CONTEXT - The ground truth mentions the fund composition remained at 60% equities/40% debt in both years, which the LLM completely omits. This is relevant context for understanding the fund's investment approach. (5) SEMANTIC ISSUES - The LLM's claim that methodology 'did not change' is semantically inconsistent with the ground truth's description of explicit methodology evolution in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 554,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, the company’s discussion of accounting developments shifted from a peripheral risk‑factor mention (2023 page 5: “changes in accounting standards … could have a material impact…”) to an explicit component of its forward‑looking outlook (2024 page 5 and the forward‑looking‑statements paragraph, which tie accounting‑standard changes to capital‑ratio targets, dividend/share‑repurchase plans and technology‑related investments).  This evolution shows that evolving accounting standards have moved from being a mere compliance concern to a strategic driver that directly shapes BNY Mellon’s capital‑allocation, reporting and strategic‑priority decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the evolution of BNY Mellon's accounting developments language between 2023 and 2024, but contains several issues: (1) FACTUAL DISCREPANCIES: The LLM cites specific page numbers (page 5) and quotes that cannot be verified against the ground truth. The ground truth does not mention page numbers or the specific quote about 'changes in accounting standards … could have a material impact.' The LLM's characterization of 2023 language as 'peripheral risk-factor mention' differs from the ground truth's description of it as part of 'a broader list of potential influences.' (2) INCOMPLETE SYNTHESIS: The ground truth provides the actual evolved language from 2024 ('may impact our businesses, regulatory, technology, market, economic or accounting developments...'), which the LLM does not quote or reference directly. The LLM instead paraphrases more loosely. (3) INTERPRETATION DIFFERENCES: While both answers conclude that accounting developments became more strategically important, the LLM frames this as moving from 'compliance concern to strategic driver,' whereas the ground truth emphasizes an 'integrated view' and ties to 'concrete business decisions and performance metrics.' The LLM's framing is reasonable but not precisely aligned with the ground truth's analysis. (4) MISSING DETAILS: The ground truth specifically mentions the 2024 inclusion of 'capital plans including dividends and repurchases' and 'efficiency savings' as evidence of integration. The LLM mentions 'dividend/share-repurchase plans and technology-related investments' but omits 'efficiency savings' and doesn't cite the specific language evolution. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across years and connect it to strategic priorities, which is appropriate for the question. However, the lack of verifiable citations and the paraphrasing rather than direct evidence from filings weakens the answer. The core insight about increased strategic importance is sound, but the execution lacks precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 552,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\nIn 2022 the company highlighted culture‑building, recognition and engagement programs to strengthen the associate experience, but in 2023 the emergence of heightened store‑safety risks—such as rising shrink, organized retail crime and the need for stricter safety protocols—combined with escalating cyber‑threats (data‑breach vulnerabilities, ransomware, supply‑chain attacks) could undermine that progress. These risks create a less secure, more stressful work environment that may erode associate morale, increase turnover, and counteract the positive effects of the earlier engagement‑focused initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 focus on engagement initiatives (culture-building, recognition programs, engagement surveys) vs. 2023 risks (store shrink, organized retail crime, cybersecurity threats). (2) Accurately captures the specific risk types mentioned: organized retail crime, data-breach vulnerabilities, ransomware, and supply-chain attacks. (3) Properly synthesizes the multi-hop comparison showing how 2023 risks could undermine 2022 gains. (4) Correctly identifies the negative impacts: eroded morale, increased turnover, compromised trust, and reputation damage. (5) No quantitative errors - the answer appropriately avoids citing the 'four out of five' statistic from 2022 since the question doesn't require it, focusing instead on the qualitative comparison. MINOR CONSIDERATIONS: (1) The LLM answer doesn't explicitly mention the 'four out of five associates emotionally committed' metric from the ground truth, though this omission is reasonable given the question's focus on risk evolution rather than baseline engagement levels. (2) The phrasing 'less secure, more stressful work environment' is a reasonable inference from the cited risks rather than a direct quote, but semantically equivalent to the ground truth's discussion of trust erosion and morale impact. The answer demonstrates sound multi-hop reasoning by correctly connecting 2022 initiatives to 2023 risks and their potential interaction effects on associate experience. All entity references (HD, years, risk types) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 443,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\nBetween 2022 and 2023 the learning‑curve moved from a peripheral, “what‑if” factor in the list of variables that could erode margins to a core quantitative driver in the company’s program‑accounting estimates.  In the 2022 filing it was cited only as one of several items that could lead to lower margins or a reach‑forward charge, whereas in the 2023 filing the curve is explicitly used to estimate program accounting quantities, production‑rate adjustments, abnormal production costs and the size of potential losses—making it a direct determinant of profitability forecasts and risk‑management decisions for programs such as the 787 and 777X.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the fundamental shift in how Boeing treated the learning curve between 2022 and 2023—from a risk factor to an integrated cost estimation component. Both answers correctly identify this evolution and cite the same programs (787, 777X). (2) QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. Both answers appropriately avoid false precision. (3) ENTITY ACCURACY: The LLM correctly identifies Boeing as the company, the correct fiscal years (2022 vs 2023), and the correct programs (787, 777X). The metrics mentioned (production rates, abnormal production costs, program profitability, risk management) are all accurate. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two years and connects it to multiple downstream impacts: production rate adjustments, cost estimation, profitability forecasts, and risk management decisions. This matches the ground truth's synthesis. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('peripheral, what-if factor' becoming 'core quantitative driver') conveys the same meaning as the ground truth's 'risk factor' becoming 'integrated into cost estimation process.' The LLM's description of the 2023 role ('explicitly used to estimate program accounting quantities, production-rate adjustments, abnormal production costs') aligns with the ground truth's 'factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections.' Minor difference: The LLM emphasizes 'program accounting estimates' while ground truth emphasizes 'production planning,' but both convey the same operational shift. The LLM answer is slightly more detailed and specific about the 2023 applications, which adds value without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 530,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\nThe 2024 filing repeats the same disclosure that was already present in the 2023 filing: it notes that certain officers and directors elect to take part in the dividend‑reinvestment (and other) plans and that they may have shares withheld to cover taxes or exercise‑price payments, with such elections being structured either to satisfy the Rule 10b5‑1 affirmative‑defense safe harbor or to constitute a non‑10b5‑1 trading arrangement.  No new officers or directors are named, and the language is essentially unchanged—only the surrounding context (e.g., an added bullet about a severance‑plan amendment) differs, indicating a consistent treatment of the DRIP across the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core finding of the question. The ground truth explicitly states that there was an EVOLUTION/CHANGE between 2023 and 2024: specifically, that the 2023 filing included 'detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements' while the 2024 filing OMITTED this detailed explanation, indicating 'a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.' The LLM answer claims the opposite—that the language is 'essentially unchanged' and that both filings contain the same disclosure about Rule 10b5-1 and non-10b5-1 trading arrangements. This is a fundamental factual error that misses the entire point of the question, which asks specifically about how the treatment 'evolved' between the two years. The LLM states 'the language is essentially unchanged' when the ground truth indicates a material reduction in disclosure detail. The LLM does correctly identify that the Dividend Reinvestment Plan was mentioned in both filings and references the same general topics (withholding for taxes, exercise prices, Rule 10b5-1 arrangements), but it fails to recognize the key difference: the removal of detailed explanation in 2024. This is a critical failure in multi-hop reasoning and synthesis, as the question explicitly asks about evolution/change, and the LLM concluded there was no meaningful change when the ground truth indicates there was a significant simplification of disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 422,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\nFrom fiscal 2021 through fiscal 2023 Home Depot more than doubled its spending on an interconnected experience—capital outlays rose from **$2.6 billion** to **$3.2 billion**—and shifted the focus from basic omni‑channel integration to a fully data‑driven, personalized journey.  The company now tailors the experience by delivering location‑based, intent‑matched marketing, offering same‑day/next‑day delivery and curb‑side pickup, equipping associates with hdPhone/Sidekick and computer‑vision tools for real‑time inventory visibility, and enhancing mobile apps and self‑checkout (electronic shelf labels, BOPIS/BOSS options) to provide smoother, more relevant shopping interactions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims capital expenditures rose from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. The ground truth only confirms $2.6 billion in fiscal 2021 and does NOT provide a $3.2 billion figure for fiscal 2023. The LLM has fabricated the $3.2 billion number and the 'more than doubled' claim, which is factually incorrect. (2) SPECIFICITY MISMATCH - The ground truth identifies the key shift as leveraging 'enhanced merchandising information technology tools' to build an experience 'tailored to customers' shopping intent and location.' The LLM provides extensive operational details (hdPhone/Sidekick, computer-vision tools, BOPIS, electronic shelf labels, etc.) that are NOT mentioned in the ground truth and appear to be hallucinated or sourced from outside the provided knowledge graph. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution across fiscal years, it does so with unverified numbers and details. The ground truth emphasizes a strategic shift from 'general investment in interconnectedness' to 'refined, data-driven personalization strategy,' which the LLM partially captures but obscures with unsupported operational specifics. (4) SEMANTIC DIVERGENCE - The ground truth focuses on the strategic evolution and data-driven personalization approach; the LLM pivots to tactical implementation details that may be accurate in general but are not grounded in the provided knowledge graph. The answer demonstrates hallucination of financial figures and operational details not present in the ground truth, which is a fundamental failure in factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 453,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\nBetween 2022 and 2023 the capital that Danaher devoted to Aldevron’s expansion grew sharply – 2021’s $1.3 billion of capex (which was already boosted by the Aldevron acquisition) was followed by an estimated $1.5 billion of planned spending in 2022 to lift manufacturing capacity for COVID‑19‑related and other biopharma products.  By 2023, however, Aldevron‑specific acquisition outlays had essentially stopped; the only acquisition‑related cash charge linked to Aldevron was the $28 million of transaction costs recorded in 2021, with subsequent cash use shifting to integration expenses for later deals (e.g., Abcam) rather than new capital or acquisition spending on Aldevron.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- The LLM introduces a 2021 capex figure of $1.3 billion that is not mentioned in the ground truth and appears to be fabricated or confused with other data\n- The LLM correctly identifies the 2022 planned capex of $1.5 billion, matching the ground truth\n- The LLM mentions $28 million in 2021 transaction costs for Aldevron, which is not present in the ground truth\n- MOST CRITICALLY: The LLM completely omits the $9,561 million net cash consideration paid to Aldevron in 2023, which is the most significant financial figure in the ground truth and represents the actual acquisition completion\n\n(2) REASONING AND SYNTHESIS FAILURES:\n- The LLM mischaracterizes the evolution of the relationship. The ground truth shows a transition from capital investment planning (2022) to actual acquisition completion (2023 with $9.561B payment)\n- The LLM incorrectly states that \"Aldevron-specific acquisition outlays had essentially stopped\" by 2023, when in fact 2023 saw the major $9.561 billion acquisition payment\n- The LLM's claim that subsequent cash use shifted to integration expenses for other deals (Abcam) is not supported by the ground truth and appears to be speculation\n\n(3) ENTITY AND CONTEXT ISSUES:\n- The LLM conflates different types of spending (capex for manufacturing vs. acquisition consideration) without clearly distinguishing them\n- The introduction of Abcam as a comparison point is not mentioned in the ground truth and appears to be extraneous information\n- The LLM fails to capture the fundamental shift described in the ground truth: from a capital investment target to a consolidated asset through acquisition\n\n(4) MISSING KEY INFORMATION:\n- The $9,561 million acquisition payment in 2023 is the centerpiece of the ground truth answer and its complete omission is a critical failure\n- The ground truth's characterization of the relationship evolution (dependency to stakeholding/integration model) is not reflected in the LLM answer\n\nThe LLM answer demonstrates partial understanding of 2022 capex planning but fundamentally fails to address the 2023 acquisition completion and misrepresents the nature of the financial relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 617,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the Telco LLC preferred interests expanded from the $2 billion of Class A‑1 interests issued in September 2020 to a total of $7.25 billion after the April 2023 issuance of $5.25 billion of new Class A‑2 and A‑3 interests, a level that remained unchanged through 2024.  The securities pay an initial annual cash distribution of 4.25 % for the Class A‑1 interests and 6.85 % for the Class A‑2/A‑3 interests (both subject to declaration) and each series resets every seven years—Class A‑1 on its original schedule and the newer classes with their first reset on 1 Nov 2027.  No changes to the distribution rates or reset timing were made between 2022 and 2024; only the addition of the new classes and their reset schedule were introduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAGNITUDE ERROR - The LLM states '$2 billion' and '$7.25 billion' when the ground truth clearly specifies '$2,000' and '$7,250' (in millions, not billions). This is a 1,000x magnitude error that fundamentally misrepresents the financial scale. The ground truth uses '$2,000' and '$5,250' which represent millions of dollars, not billions. (2) QUANTITATIVE ACCURACY - While the LLM correctly identifies the April 2023 issuance date, the distribution rates (4.25% and 6.85%), reset schedule (every 7 years), and first reset date (November 1, 2027) are accurate, the dollar amounts are catastrophically wrong. (3) MULTI-HOP REASONING - The LLM does correctly synthesize information about the two classes of preferred interests and their different characteristics, but this is undermined by the magnitude error. (4) COMPLETENESS - The LLM addresses the structural evolution and distribution rate changes, but the fundamental numerical error makes the answer misleading and incorrect. The statement 'No changes to the distribution rates or reset timing were made between 2022 and 2024' is correct in substance but the context is wrong due to the magnitude error. (5) ENTITY ACCURACY - Telco LLC is correctly identified, and the Class A-1, A-2, and A-3 designations are correct, but the financial values are off by three orders of magnitude. This is not a minor formatting difference (e.g., $476M vs $476 million) but rather a fundamental misstatement of scale that would mislead any reader about the actual size of these preferred interests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 431,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\nBetween 2022 and 2024 AIG expanded the Expected‑Loss‑Ratio (ELR) technique beyond its original use on U.S. Property and Special‑Risk lines to additional long‑tail, high‑severity lines such as U.S. Excess Casualty, U.S. Workers’ Compensation, program business and UK/Europe Property/Special Risks, and began applying it most heavily to the latest accident year where development data are thin.  The rationale evolved to rely on ELR when loss‑development patterns are inconsistent, emergence is very slow, or the portfolio includes large‑deductible or reinsured exposures with limited historical data, so that reserve estimates are anchored to premium‑based expected loss ratios rather than unreliable development factors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) ENTITY ACCURACY FAILURE: The LLM claims ELR was originally used on 'U.S. Property and Special-Risk lines' in 2022, but the ground truth states it was used 'primarily for the latest accident year and in combination with other methods like loss development for aviation exposures.' The LLM incorrectly identifies the original lines of business. (2) INCOMPLETE/INCORRECT LINE EXPANSION: The LLM lists U.S. Excess Casualty, program business, and UK/Europe Property/Special Risks as expanded uses, but the ground truth only mentions U.S. Workers' Compensation as the specific expansion between 2022-2024. The LLM appears to have fabricated or misidentified additional lines. (3) RATIONALE MISMATCH: While the LLM provides a detailed rationale about inconsistent loss-development patterns, slow emergence, and large-deductible exposures, the ground truth simply states the method was used 'due to their high-severity nature' for aviation in 2022 and 'in combination with loss development and frequency/severity methods' for Workers' Compensation in 2024. The LLM's rationale is more elaborate but not supported by the ground truth. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the evolution from aviation exposures (2022) to Workers' Compensation (2024), instead introducing unverified lines of business. (5) ACCURACY OF CORE CLAIM: The ground truth clearly identifies aviation as the 2022 focus and Workers' Compensation as the 2024 expansion; the LLM's answer contradicts this fundamental evolution. The answer demonstrates poor factual grounding and appears to contain speculative or hallucinated details not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 482,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\nFrom 2023 to 2024 Target shifted its owned‑brand strategy from a descriptive note that “about one‑third of merchandise sales come from owned and exclusive brands” (2023 filing) to a deliberate growth pillar: the 2024 filing explicitly calls out “strengthening our owned‑brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” as a core element of its strategy to deliver “newness, style and value” and increase relevance.  This reflects a move toward deeper integration of owned brands across categories, more exclusive design collaborations and digital‑first launches, and using the portfolio to drive traffic and market‑share growth, whereas the 2023 filing merely characterized the portfolio’s size and diversity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and nuanced explanation of Target's strategic shift than the ground truth, but contains a critical quantitative discrepancy. STRENGTHS: (1) Correctly identifies the strategic evolution from 2023 to 2024, (2) Accurately captures the shift from descriptive characterization to deliberate growth pillar, (3) Provides specific strategic elements (strengthening portfolio, curating brands, expanding partnerships), (4) Correctly notes the 2023 filing mentioned 'about one-third of merchandise sales from owned and exclusive brands', (5) Demonstrates sound multi-hop reasoning by synthesizing information across two years. CRITICAL ISSUE: The ground truth states Target lists 'over 40 distinct brands' in 2024, which is a key quantitative metric. The LLM answer does not mention this specific number at all, representing a significant omission of concrete data that directly supports the 'more concrete execution phase' claim. REASONING QUALITY: The LLM's characterization of the strategic shift is actually more sophisticated than the ground truth (discussing digital-first launches, exclusive collaborations, traffic/market-share drivers), but this added detail cannot compensate for the missing '40+ brands' metric. The answer demonstrates good qualitative understanding but fails on quantitative completeness. The semantic equivalence is strong regarding strategic direction, but the absence of the specific brand count metric is a material gap in answering a question about 'product portfolio development.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 425,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\nIBM’s decision to keep its existing 0.875 % Notes due 2030 on the 2024 filing while simultaneously issuing fresh 2.900 % Notes due 2030 shows that it is deliberately refinancing part of its long‑term capital structure.  By tapping the market with a higher‑coupon, 30‑year bond, IBM is locking in financing at today’s prevailing rates and extending the maturity profile of its debt, indicating that it views the current environment as one where it can still raise cheap, long‑dated capital despite rising interest rates.  This dual‑track approach reflects a strategy of diversifying funding sources and managing debt‑maturity risk while maintaining confidence in its creditworthiness.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the two notes (0.875% and 2.900% both due 2030), accurately states the interest rate differential, and correctly recognizes the dual-listing strategy in 2024. The numeric values are all accurate. The LLM appropriately discusses debt diversification and maturity management. WEAKNESSES: (1) The LLM's interpretation contains a significant logical error - it characterizes the 2.900% notes as 'cheap, long-dated capital' and suggests IBM 'views the current environment as one where it can still raise cheap capital despite rising interest rates.' This is contradictory and misleading. A 2.900% coupon is substantially higher than 0.875%, indicating LESS favorable conditions, not cheaper capital. The ground truth correctly identifies this as 'less favorable interest rate conditions.' (2) The LLM fails to mention that the 0.875% notes were initially issued in 2023, which provides important context for understanding the market conditions comparison. (3) The LLM doesn't adequately explain why IBM would issue at a higher rate (2.900%) for the same maturity - the ground truth suggests this targets different investor segments or reflects changed market conditions. The LLM's framing that this represents 'cheap capital' is factually misleading. (4) The phrase 'extending the maturity profile' is somewhat vague and doesn't clearly convey that both notes mature in the same year. MULTI-HOP REASONING: The LLM attempts to synthesize information about debt strategy and market conditions but arrives at a partially incorrect conclusion about what the rate differential signifies. The core insight about diversification is present but undermined by the mischaracterization of market conditions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 471,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\nBetween 2022 and 2024 AT&T shifted its long‑term debt mix from a portfolio dominated by short‑ and medium‑term fixed‑rate notes (e.g., the 1.450 % notes due 2022 and the 2.500 % notes due 2023 that appeared in the 2022 filing) toward a larger share of longer‑dated, fixed‑rate issuances.  The 2024 prospectus introduces the 4.000 % Global Notes due June 1 2049 (ticker T 49A) for the first time and adds a suite of new series maturing from 2026 through 2067 (such as 2.9 % due 2026, 4.375 % due 2029, 7.0 % due 2040, 5.35 % due 2066, etc.), expanding the overall maturity profile and reinforcing the company’s longer‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM states the 4.000% Global Notes due June 1, 2049 (T 49A) were 'introduced for the first time' in the 2024 prospectus, but the ground truth explicitly states these notes were already listed in 2022. This is a fundamental factual error about the core instrument mentioned in the question. (2) MISSING KEY INFORMATION - The LLM fails to mention the 4.300% Global Notes due November 18, 2034 (T 34C), which is specifically highlighted in the ground truth as a new addition in 2024. This is a critical omission given the question explicitly asks about 'the addition of new long-term notes.' (3) INCORRECT CHARACTERIZATION - The LLM incorrectly describes the 2022 portfolio as 'dominated by short- and medium-term fixed-rate notes' citing 1.450% notes due 2022 and 2.500% notes due 2023, which misses the point that the 4.000% 2049 notes were already present in 2022. (4) UNVERIFIED CLAIMS - The LLM introduces numerous specific debt instruments (2.9% due 2026, 4.375% due 2029, 7.0% due 2040, 5.35% due 2066) that are not mentioned in the ground truth and cannot be verified. (5) REASONING FAILURE - The multi-hop synthesis is flawed; the LLM failed to correctly track which instruments existed in 2022 vs. 2024, which is the core requirement of the question. The answer demonstrates a fundamental misunderstanding of the evolution being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 405,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\nIn 2023 the Heritage AspenTech purchase generated about **$258 million of intangible‑asset amortization** (primarily customer‑relationship and developed‑technology intangibles) and contributed to the company’s **$72 million of total restructuring expenses**, which were largely integration‑related. By 2024 the same intangibles continued to be amortized at roughly the same $258 million level (forming part of the $1.077 billion total amortization, with $560 million coming from the newer NI acquisition), while **restructuring costs more than tripled to $228 million**, reflecting deeper head‑count reductions, facility exits and integration‑related stock‑compensation expenses as Emerson pursued broader cost‑synergy and restructuring initiatives post‑acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2024 intangibles amortization figure. Ground truth states the 2024 figure decreased to $97 million, but the LLM claims it 'continued to be amortized at roughly the same $258 million level.' This is a major quantitative error - the LLM misrepresents a 62% decrease ($258M to $97M) as a continuation at the same level. This is not a minor wording difference but a significant factual misstatement. The 2023 figures are correct ($258M amortization, $72M restructuring), and the 2024 restructuring cost of $228M is correct. However, the core claim about 2024 amortization is wrong. The LLM also adds contextual information about the NI acquisition and broader restructuring initiatives that, while potentially accurate, goes beyond what can be verified against the ground truth and may conflate different acquisition impacts. The multi-hop reasoning fails because it incorrectly synthesizes the year-over-year comparison - the key insight that amortization decreased while restructuring increased is inverted in the LLM's narrative. The answer demonstrates partial understanding (correct on restructuring trend, correct on 2023 baseline) but fails on the primary quantitative claim about 2024 amortization evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 365,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept expected‑loss‑ratio (ELR) techniques at the core of its workers‑compensation reserving, but it refined how and where they are applied.  In 2022 the ELR was used mainly for the most‑recent accident year on guaranteed‑cost business and for the most‑recent five years on excess‑of‑deductible business, with segmentation by state (CA/NY vs. other states) and by deductible size; by 2024 the company emphasized that ELR weight is now given “significant” weight only to the latest accident year for guaranteed‑cost lines, while excess‑of‑deductible and large‑deductible portfolios receive ELR weight across the latest five years, and it further separates business by deductible magnitude and whether claims are handled by AIG or a third‑party administrator.  The growing proportion of large‑deductible accounts— which slows claim emergence and reporting—has prompted AIG to adjust its ELR assumptions (e.g., incorporating COVID‑19 frequency/severity shifts and claims‑strategy changes) and to treat these subsets more separately in its reserve models.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's ELR methods between 2022 and 2024 and correctly identifies key themes: continued use of ELR techniques, refinement in segmentation approaches, and the growing impact of large deductible accounts on claim emergence. However, there are significant accuracy issues:\n\n(1) QUANTITATIVE ACCURACY PROBLEMS:\n- The LLM states that in 2022 ELR was used \"mainly for the most-recent accident year on guaranteed-cost business and for the most-recent five years on excess-of-deductible business.\" The ground truth confirms this is correct.\n- However, the LLM introduces segmentation by \"state (CA/NY vs. other states)\" in 2022, which is NOT mentioned in the ground truth. This appears to be an unsupported addition.\n- The LLM's characterization of 2024 changes is partially correct but adds details about \"COVID-19 frequency/severity shifts and claims-strategy changes\" that are not explicitly confirmed in the ground truth provided.\n\n(2) COMPLETENESS ISSUES:\n- The ground truth emphasizes that 2024 disclosures highlighted \"limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.\" The LLM answer completely omits this important distinction about data limitations and disclosure evolution.\n- This is a material omission as it represents a key difference in how AIG communicated about its reserving methodology between the two years.\n\n(3) ENTITY AND METRIC ACCURACY:\n- Company name (AIG) is correct\n- Years (2022 and 2024) are correct\n- Metrics (ELR methods, guaranteed cost business, excess of deductible business, large deductible accounts) are correctly identified\n- The distinction between AIG vs. third-party administrator handling is correctly noted in 2024\n\n(4) REASONING AND SYNTHESIS:\n- The multi-hop reasoning is generally sound in connecting the evolution of ELR application to the growing proportion of large deductible accounts\n- The synthesis of how segmentation became more granular is logical\n- However, the introduction of unsupported details (state-level segmentation in 2022, COVID-19 references) suggests the model may have hallucinated or conflated information\n\n(5) SEMANTIC EQUIVALENCE:\n- The core message about ELR evolution is semantically equivalent to the ground truth\n- The emphasis on increased segmentation and large deductible impact is preserved\n- However, the omission of the data limitations disclosure evolution is a significant semantic gap\n\nThe answer demonstrates good understanding of the general trend but fails to capture all material differences between 2022 and 2024, particularly regarding disclosure practices around data limitations. The introduction of unsupported details about state-level segmentation and COVID-19 impacts also raises concerns about accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 751,
        "total_tokens": 2244
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\nTarget’s cyber‑threat investigation has moved from a loosely referenced “cyber fusion center” in the 2023 filing to a formally governed function in 2024 that is embedded in the company’s enterprise‑risk‑management program and reported regularly to the Audit & Risk Committee and Board.  The 2024 disclosure also stresses tighter integration of the Fusion Center’s threat‑intelligence work, expanded collaboration with external industry groups to share best‑practice intelligence, and a stronger investment in internal talent and third‑party assessments to make threat investigation and response more coordinated and proactive.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the evolution of Target's cybersecurity approach from 2023 to 2024. STRENGTHS: (1) Correctly identifies the Cyber Fusion Center as the key operational element in both years; (2) Accurately captures the evolution from loosely referenced (2023) to formally governed (2024); (3) Properly synthesizes the multi-hop information about expanded collaboration with external organizations and third-party vendors; (4) Correctly identifies the governance structure change - reporting to Audit & Risk Committee and Board in 2024; (5) Accurately conveys the shift toward more structured incident response with coordinated escalation; (6) Appropriately emphasizes the maturation and comprehensiveness of the approach. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing than ground truth (e.g., 'embedded in enterprise-risk-management program' vs. 'structured incident response program with coordinated escalation model') but these are semantically equivalent descriptions of the same evolution; (2) The LLM answer adds detail about 'Audit & Risk Committee' reporting which is a reasonable inference about governance but not explicitly stated in the ground truth provided; (3) The ground truth mentions 'regular training and compliance activities for team members' which the LLM answer doesn't explicitly mention, though it does reference 'investment in internal talent'; (4) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is based on the absence of errors. The multi-hop reasoning is sound - the answer correctly synthesizes information about the Cyber Fusion Center's evolution, governance changes, external collaboration expansion, and third-party engagement across the 2023-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 498,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\nBetween 2023 and 2024 Eli Lilly’s Baqsimi‑related revenue shifted from a one‑time, upfront payment for the product’s rights to ordinary product sales.  In 2023 the company recorded a **$579 million** upfront payment from the sale of Baqsimi rights (shown in the 2023 revenue table on page 47) and also recognized **$677.6 million** of net product revenue from Baqsimi sales (page 48), up from only $139.3 million in 2022.  Thereafter, Baqsimi revenue is accounted for under the company’s standard revenue‑recognition policy—recognizing sales when control transfers, estimating rebates/returns, and without a financing component (pages 62‑65)—and no new distinct contractual arrangement for Baqsimi was disclosed for 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Eli Lilly recognized $677.6 million in net product revenue from Baqsimi sales in 2023, but the ground truth makes no mention of this figure. The ground truth only references $579.0 million in revenue from the sale of rights for Baqsimi in 2023. (2) MAJOR ERROR - The LLM references a $139.3 million figure for 2022 Baqsimi revenue, which is not mentioned in the ground truth and appears to be fabricated. (3) MAJOR ERROR - The LLM's core narrative is fundamentally incorrect. It claims Baqsimi revenue 'shifted from a one-time, upfront payment...to ordinary product sales,' but the ground truth indicates the opposite evolution: in 2023 there was a $579M upfront payment for rights sale, and by 2024 Baqsimi was integrated into broader collaboration revenue disclosures, not standard product sales. (4) INCORRECT REASONING - The LLM states 'no new distinct contractual arrangement for Baqsimi was disclosed for 2024,' which misses the key point that Baqsimi was integrated into collaboration and other revenue arrangements by 2024. (5) CITATION ERRORS - The LLM references specific page numbers (47, 48, 62-65) without verification against actual filing content. The ground truth correctly identifies the shift from direct product revenue to collaborative arrangement revenue, but the LLM inverts this relationship. The only correct element is the $579 million figure for 2023 rights sale. The answer demonstrates poor multi-hop synthesis and introduces unsupported financial figures that contradict the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 453,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T moved from retiring its legacy Mobility preferred interests—completing a $5.4 bn repurchase in April 2023 that was financed by the April 2023 expansion of Telco LLC’s cumulative preferred securities—to a broader preferred‑equity strategy that amends the 2019 Tower Holdings structure (resetting distribution rates, converting the interests into Fixed‑Rate and Floating‑Rate Classes and extending call rights) and adds a planned $2.25 bn Telco LLC Class A‑4 issuance for 2025 to fund further redemptions.  This evolution reflects a shift toward layered, reset‑rate preferred interests in subsidiaries to manage capital, preserve cash flexibility, and support ongoing dividend and share‑repurchase activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic evolution from 2023 to 2024 but contains several significant quantitative inaccuracies and introduces information not present in the ground truth. CORRECT ELEMENTS: (1) The 2023 Mobility Preferred Interests repurchase (~$5.4bn) is correctly identified; (2) The connection to Telco LLC preferred interests expansion is accurate; (3) The 2019 Tower Holdings restructuring with fixed/floating rate classes is mentioned; (4) The overall strategic narrative of moving from legacy repurchases to layered preferred structures is sound. QUANTITATIVE ERRORS: (1) The LLM states the repurchase was 'April 2023' - the ground truth provides the amount ($5,414M) and funding source but does not specify April as the month; (2) The LLM mentions a 'planned $2.25 bn Telco LLC Class A-4 issuance for 2025' - this is NOT in the ground truth, which only discusses 2023-2024 activities; (3) The LLM does not provide the specific distribution rates (6.85% for Telco, 5.90% base and SOFR+250bps for Tower) mentioned in ground truth; (4) The total Telco LLC preferred interests figure of $7,250M is not explicitly stated in the LLM answer. MULTI-HOP REASONING: The LLM correctly synthesizes the connection between the 2023 Mobility repurchase and Telco LLC expansion, and identifies the Tower Holdings restructuring. However, it introduces forward-looking 2025 information that goes beyond the 2023-2024 scope of the ground truth. MISSING DETAILS: The specific balance sheet impacts (removal from 'Accounts payable' and 'Other noncurrent liabilities') are not mentioned. The LLM answer is more forward-looking and strategic in tone but less precise on historical facts and specific metrics. The introduction of 2025 planned issuances represents a factual error or hallucination beyond the ground truth scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 497,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\nFrom 2023 to 2024 Emerson deepened its stake in AspenTech, moving from roughly a 55‑57 % ownership position to announcing a cash proposal that would give it 100 % of the company.  The integration of AspenTech’s software business helped lift Emerson’s consolidated gross margin by 1.8 percentage points to 50.8 % in 2024, although this improvement was partially offset by $231 million of acquisition‑related inventory step‑up amortization that reduced margin by about 1.3 percentage points.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) OWNERSHIP PROGRESSION INCORRECT: The LLM states Emerson moved from '55-57% ownership position to announcing a cash proposal for 100%', but the ground truth indicates Emerson acquired a 55% stake in 2024 (not that it already held 55-57% in 2023). The LLM misrepresents the timeline and progression of ownership. (2) CASH AMOUNT MISSING: The ground truth explicitly states the transaction involved 'approximately $6.0 billion in cash', which the LLM completely omits. This is a significant financial detail. (3) 2023 MARGIN IMPACT OMITTED: The ground truth clearly states AspenTech 'contributed to a 3.3 percentage point increase in gross margin in 2023', but the LLM only discusses 2024 margin impacts (1.8 percentage points). This is a critical omission for a question asking about evolution from 2023 to 2024. (4) INVENTORY STEP-UP DETAIL: The LLM correctly identifies $231 million of acquisition-related inventory step-up amortization reducing margin by 1.3 percentage points in 2024, which is not mentioned in the ground truth but represents additional accurate detail. (5) RELATIONSHIP EVOLUTION UNCLEAR: The LLM fails to clearly establish that in 2023 Emerson had a 'business relationship' (partner status) that transformed into majority ownership in 2024. The phrasing 'deepened its stake' is vague and doesn't capture the fundamental shift from partner to majority shareholder. (6) STRUCTURAL SHIFT MISSING: The ground truth emphasizes the 'structural shift in Emerson's involvement with AspenTech, moving from a partner to a majority shareholder', which the LLM does not adequately convey. CORRECT ELEMENTS: The 1.8 percentage point gross margin increase in 2024 and the 50.8% consolidated gross margin figure are accurate. The general concept that AspenTech integration improved margins is correct. MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the multi-year evolution (2023 to 2024) and the relationship transformation, focusing primarily on 2024 details while missing the 2023 baseline and the nature of the pre-2024 relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 559,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\nAIG's Japan pension plans have continued to account for roughly two‑thirds of its non‑U.S. pension assets, with their share staying around 66‑67 % of total non‑U.S. plan assets from 2022 through 2024. Over the same period the weighted‑average discount rate applied to these plans increased from about 1.48 % to 1.81 % (an increase of roughly 0.33 percentage points).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) MAJOR QUANTITATIVE ERRORS: The LLM claims Japan pension plans account for 66-67% of non-U.S. pension assets from 2022-2024, but the ground truth shows 61% in 2022, declining to 54% in 2023 and 50% in 2024. This is a fundamental misrepresentation of the trend - the LLM shows stability when the actual data shows a clear declining trend. (2) DISCOUNT RATE: The LLM correctly identifies the increase from 1.48% to 1.81% (0.33 percentage point increase), which matches the ground truth for 2023-2024. However, the LLM fails to provide the 2022 expected long-term rate of return (1.85%) mentioned in the ground truth. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the year-by-year evolution (2022→2023→2024) that the question specifically asks about. It presents a static picture ('roughly two-thirds...from 2022 through 2024') rather than showing the dynamic change. (4) MISSING CONTEXT: The ground truth explains the significance of these changes (relative decline in size, market condition implications), while the LLM provides no interpretive context. (5) CORE ISSUE: The most critical error is the percentage claim - stating 66-67% when actual figures are 61%, 54%, and 50% represents a fundamental misunderstanding or misreporting of the data. The only correct element is the discount rate change (1.48% to 1.81%), which alone cannot salvage an answer that gets the primary metric (asset share) dramatically wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 423,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\nIn the 2022 10‑K the threat from “competitive stores, websites, products, services, price decreases, or improvements” appears only as a stand‑alone bullet in the list of operational risks, with no explicit linkage to broader market conditions. By the 2023 10‑K the same wording is retained but is embedded in a wider discussion of external factors—such as macro‑economic uncertainty, inflation, consumer‑spending trends and geopolitical developments—so the competitive‑store risk is framed as part of the larger external market environment that can affect Amazon’s growth and pricing pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in Amazon's disclosure framing between 2022 and 2023 10-K filings. STRENGTHS: (1) Correctly identifies the core language about 'competitive stores, websites, products, services, price decreases, or improvements' appearing in both years; (2) Accurately captures the key shift: from standalone risk presentation in 2022 to embedded positioning within broader external factors in 2023; (3) Properly synthesizes the multi-hop comparison across two filing years; (4) Correctly identifies the broader context in 2023 including macro-economic uncertainty, inflation, consumer-spending trends, and geopolitical developments; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing than the ground truth when describing 2022 positioning ('stand-alone bullet in the list of operational risks' vs. 'general factor among many...listing them alongside internal capabilities'). The ground truth emphasizes that 2022 listed competitive stores 'alongside internal capabilities such as inventory management and customer satisfaction,' which provides more specific context about what competitive stores were grouped with. The LLM answer doesn't explicitly mention this internal capabilities framing; (2) The ground truth includes the specific phrase about 'general economic, business, and geopolitical conditions worldwide' from the 2023 filing, while the LLM answer paraphrases this as 'macro-economic uncertainty, inflation, consumer-spending trends and geopolitical developments.' While semantically similar, the LLM's version is slightly more interpretive than directly citing the actual language; (3) The ground truth explicitly states the shift is 'toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern,' which the LLM captures but with less explicit articulation of the 'external risks' framing. Overall, the answer is substantially correct in its core thesis and multi-hop reasoning, with only minor differences in contextual detail and specificity of language attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 576,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\nTarget’s 2023 filing mentioned port‑security only as a generic supply‑chain risk tied to broader trade tensions (especially with China). In the 2024 filing the issue is called out explicitly within the political‑economic uncertainty section, highlighting transport‑capacity constraints and geopolitical conflicts that could disrupt ports in Asia (including India), which could cause inventory shortages, higher costs and force alternative sourcing—thereby expanding both the geographic scope and the operational impact of port‑security risks.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) GEOGRAPHIC FOCUS ERROR: The LLM claims 2024 filing highlights 'ports in Asia (including India)' as the geographic concern, but the ground truth explicitly states 2024 shifted to 'major U.S. ports' without specifically naming California. The LLM incorrectly identifies Asia/India as the 2024 focus when the actual evolution was from California-specific (2023) to broader U.S. ports (2024). (2) 2023 CHARACTERIZATION ERROR: The LLM describes 2023 as mentioning port security 'only as a generic supply-chain risk tied to broader trade tensions (especially with China),' but the ground truth clearly states 2023 'specifically highlighted California ports' with concrete details about imported merchandise. This is a fundamental mischaracterization of the 2023 position. (3) MISSING KEY DETAIL: The LLM fails to mention that in 2023, Target 'had made alternative arrangements due to past disruptions,' which is an important operational impact detail in the ground truth. (4) INCOMPLETE EVOLUTION NARRATIVE: While the LLM correctly identifies that 2024 emphasizes 'potential future impacts, including increased costs and inventory supply issues,' it misses the critical geographic shift from California-specific to generalized U.S. ports. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the geographic evolution across the two years, instead introducing Asia/India which appears nowhere in the ground truth answer. The answer demonstrates poor document comprehension and introduces factually incorrect geographic information that contradicts the actual filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 457,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the amortization of the intangibles acquired in the Heritage AspenTech combination grew sharply – $258 million of amortization was recorded in 2023, and the full‑year 2024 amortization of those same intangibles (after removing the $560 million of NI‑related amortization) was about $517 million, pushing total intangible amortization from $482 million in 2023 to $1,077 million in 2024.  At the same time, restructuring expenses linked to the integration of the AspenTech business rose from $1 million in 2023 to $8 million in 2024 (with an additional $12 million recorded in other segments), reflecting the ongoing workforce reductions, facility closures and other integration‑related costs that the company continues to incur.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. INTANGIBLES AMORTIZATION - MAJOR ERROR: The ground truth states that Heritage AspenTech-related amortization was $258 million in 2023 and was NO LONGER REPORTED in 2024 (indicating the shift away from reporting it as newly acquired). The LLM claims it grew to $517 million in 2024 - this is factually incorrect and contradicts the core finding.\n\n2. TOTAL AMORTIZATION FIGURES - INCORRECT: The LLM provides total intangible amortization figures ($482M in 2023 growing to $1,077M in 2024) that are not mentioned in the ground truth and appear to conflate different metrics.\n\n3. RESTRUCTURING COSTS - MAJOR ERROR: The ground truth clearly states restructuring costs increased from $72 million in 2023 to $228 million in 2024. The LLM reports $1 million in 2023 and $8 million in 2024 (plus $12 million in other segments) - these numbers are completely wrong and off by orders of magnitude.\n\n4. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key finding that AspenTech amortization was no longer separately reported in 2024, which is the critical insight about how the financial relationship evolved.\n\n5. SEMANTIC MEANING MISMATCH: The ground truth indicates a shift in accounting treatment (no longer reporting AspenTech separately), while the LLM suggests continued and growing amortization - these convey opposite meanings.\n\nThe answer demonstrates fundamental misunderstanding of the source data and provides incorrect financial figures across all key metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 441,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept the practice of applying Expected‑Loss‑Ratio (ELR) techniques mainly to newer accident years, but the 2024 filing expands that weighting to a broader set of lines—including cyber, mergers‑and‑acquisitions, fidelity and professional‑liability—whereas in 2022 the emphasis was confined largely to D&O, E&O, EPLI and professional‑liability. As a result, the share of the reserve model devoted to ELR grows with the recency of the accident year and now carries a larger weight for low‑frequency/high‑severity businesses in the 2022‑2024 years than it did two years earlier.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. MAJOR ISSUES: (1) The LLM introduces lines of business NOT mentioned in the ground truth (cyber, mergers-and-acquisitions, fidelity) - these appear to be fabricated or confused with other information. The ground truth specifically states ELR was used for D&O, E&O, EPLI, and professional liability in 2022, and expanded to U.S. Workers' Compensation by 2024. (2) The LLM claims the 2024 filing shows expansion to cyber, M&A, and fidelity, but the ground truth makes no mention of these lines receiving ELR treatment. (3) The LLM's characterization of the evolution is partially correct (expansion across lines, increased weighting for recent accident years) but the specific lines identified are wrong. (4) The ground truth explicitly states that by 2024, ELR was expanded to U.S. Workers' Compensation (a long-tail line), not the short-tail lines mentioned by the LLM. (5) The LLM correctly identifies that ELR is applied primarily to recent accident years and low-frequency/high-severity businesses, but fails to accurately identify which specific lines received this treatment in each year. The answer demonstrates a fundamental misunderstanding or hallucination of the specific business lines involved in the evolution of AIG's ELR methodology between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 379,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon’s capitalized video‑and‑music content rose modestly—from about **$16.7 billion to $17.4 billion**—while the expense recognized for that content jumped sharply, from **$16.6 billion to $18.9 billion**.  This increase reflects a larger investment in original and licensed titles and a faster amortization schedule (driven by higher usage/ view‑through patterns), indicating that Amazon’s film‑group monetization strategy became more aggressive, expanding both the volume of content held for Prime and the speed at which it is monetized across its global Prime markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a well-reasoned analysis of Amazon's monetization strategy evolution. QUANTITATIVE VERIFICATION: All financial figures are correct - capitalized video and music content costs increased from $16.7 billion (2022) to $17.4 billion (2023), and associated expenses rose from $16.6 billion to $18.9 billion. The characterization of the capitalized cost increase as 'modest' (~4.2% increase) versus the expense increase as 'sharp' (~13.9% increase) is mathematically sound and appropriately contextualized. COMPLETENESS: The answer addresses all key elements of the question - it identifies the specific metrics (capitalized costs and expenses), provides year-over-year comparisons, and explains the strategic implications. ENTITY ACCURACY: Amazon and the relevant fiscal years (2022-2023) are correctly identified, and the financial metrics are properly labeled. REASONING QUALITY: The LLM goes beyond the ground truth by providing additional insight into the drivers of this change (higher usage/view-through patterns, faster amortization schedule), which represents sound financial reasoning rather than speculation. The conclusion that the strategy became 'more aggressive' is well-supported by the data showing both increased investment and faster monetization. SEMANTIC EQUIVALENCE: The LLM's phrasing 'more aggressive investment in content and a corresponding rise in monetization efforts' aligns perfectly with the ground truth's characterization. The additional detail about 'expansion of content volume' and 'speed of monetization across global Prime markets' adds valuable context without contradicting the ground truth. Minor note: The LLM uses em-dashes and formatting that differs slightly from standard presentation, but this is purely stylistic and does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 499,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\nBetween 2022 and 2024 PMI no longer consolidates Rothmans, Benson & Hedges (RBH); it holds the investment as an equity‑method holding that was originally created when RBH was de‑consolidated in 2019.  In the 2024 filing the company disclosed a $2.3 bn non‑cash impairment of that equity investment—driven by renewed uncertainty over the allocation of the CAD 32.5 bn settlement in the Canadian CCAA proceedings—whereas in the 2022 filing the investment was still carried at its recorded value with no impairment noted.  Thus, while PMI’s ownership stake in RBH was unchanged, its financial exposure was formally recognized as impaired in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate financial information with sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $2.3 billion impairment charge in 2024 (matches ground truth's $2,316 million within acceptable rounding/format variation); (2) Accurately states the CAD 32.5 billion Canadian tobacco litigation settlement as the driver of impairment uncertainty; (3) Correctly characterizes the relationship evolution from trademark/brand licensing to equity-method investment; (4) Properly notes that 2022 showed no impairment while 2024 did; (5) Accurately identifies RBH de-consolidation in 2019 as context; (6) Sound multi-hop synthesis connecting the Canadian CCAA proceedings to the impairment charge. MINOR WEAKNESSES: (1) The ground truth mentions 'trademark relationship' and 'volume of brands sold by RBH such as HEETS' in 2022, which the LLM answer doesn't explicitly address—though this is a minor omission since the LLM focuses on the equity investment relationship which is the primary financial relationship; (2) The LLM answer provides additional context about de-consolidation in 2019 that wasn't in the ground truth, which is helpful but slightly beyond the scope of the 2022-2024 evolution question. QUANTITATIVE VERIFICATION: $2.3 billion vs. $2,316 million is acceptable format variation (difference of $16M or 0.7% is within rounding tolerance for large figures). The CAD 32.5 billion figure matches exactly. REASONING: The multi-hop reasoning correctly synthesizes: (a) PMI's changing relationship with RBH, (b) the Canadian litigation settlement as the impairment driver, (c) the timing difference between 2022 (no impairment) and 2024 (impairment recognized). The logic is sound and the answer directly addresses how the financial relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 493,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\nThe disclosures show that the estimated revenue impact of a 5 % change in the sales‑return, rebate and discount accruals fell modestly from about **$615 million in 2023** (page 53) to roughly **$600 million in 2024** (page 54).  Thus, the sensitivity of net product revenue to changes in those liabilities decreased slightly over the one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth. The ground truth explicitly states that LLY did NOT provide an updated sensitivity figure in 2024 - there was an omission of quantitative disclosure. However, the LLM claims a specific 2024 figure of '$600 million' (page 54), which is not supported by the ground truth. The ground truth is clear: '2024, while the company continued to describe the accounting policy...it did not provide an updated sensitivity figure.' The LLM fabricated a 2024 number that does not exist in the actual filings. The 2023 figure of $615 million is correct, but the entire premise of the LLM answer is wrong - it incorrectly asserts that a 2024 figure exists and that there was a 'modest' decline from $615M to $600M. This is a fundamental factual error. The LLM failed to recognize that the key finding is the ABSENCE of 2024 disclosure, not the presence of a lower figure. The reasoning about 'decreased slightly' is based on a non-existent data point. The answer demonstrates poor multi-hop synthesis - it should have recognized that comparing 2023 to 2024 requires both years to have disclosed figures, which they do not. Contextual relevance is only moderately scored because while the answer addresses the right companies and years, it fundamentally misrepresents what the filings actually disclose.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 378,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\nBetween 2022 and 2024 the dollar value of Union Pacific’s Bulk shipments rose from roughly $6.7 billion (the 2021‑2022 level reported in the 2022 outlook) to about $7.3 billion in 2024, yet because total freight revenues grew even faster, Bulk’s share of the company’s freight revenue slipped only modestly—from around 33 % of total freight revenue to roughly 32 %.  Thus, while Bulk remains a core, volume‑driven contributor, its relative revenue importance has slightly declined as Industrial and Premium volumes expanded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Bulk shipments were '$6.7 billion (2021-2022 level)' and '$7.3 billion in 2024' - these dollar amounts are not mentioned in the ground truth and appear to be fabricated. The ground truth provides a specific metric: average revenue per car of $3,305 in 2021, not total dollar values. (2) PERCENTAGE CLAIM: The LLM states Bulk's share declined from '33% to roughly 32%' - the ground truth only mentions 32% for 2024 and does not provide a 33% figure for 2022, making the comparison unsupported. (3) MISSING KEY INFORMATION: The LLM completely omits the ground truth's core finding about the 6% increase from 2020 to 2021 in revenue per car, and fails to mention the strategic evolution regarding grain, fertilizer, coal markets, and international connections to Mexico and Canadian interline routes. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024, and the ground truth shows a transformation from a revenue-per-unit metric perspective to a strategically embedded, revenue-significant component. The LLM instead focuses on absolute dollar values and market share percentages that are not grounded in the provided source material. (5) UNSUPPORTED CLAIMS: The statement about 'Industrial and Premium volumes expanded' is not mentioned in the ground truth. The LLM appears to have hallucinated specific dollar figures and percentages rather than accurately synthesizing the available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 436,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\nBetween 2023 and 2024 the coupon on IBM’s “2028” notes stayed at **0.300 %** for the IBM 28B series, while a second 2028 tranche (IBM 28A) with a **1.750 %** coupon was outstanding in the 2024 filing.  This shows IBM is deliberately extending its long‑dated debt profile and taking advantage of still‑low rates to lock in inexpensive, multi‑year financing, reflecting a strategy of preserving liquidity and managing refinancing risk rather than aggressively increasing leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the IBM 28B series had a '0.300%' coupon, which is factually incorrect and not supported by the ground truth. The ground truth only mentions IBM 28A with 1.750% in both 2023 and 2024, with no reference to an IBM 28B series or 0.300% rate. This is a critical factual error. (2) INCOMPLETE SYNTHESIS - The LLM fails to mention the new debt issuances in 2024 (2.900% Notes due 2030 and 3.150% Notes due 2033) that are central to understanding IBM's debt strategy evolution. The ground truth explicitly states these new issuances indicate a broader strategy to issue debt at higher rates for longer maturities. (3) ENTITY CONFUSION - The introduction of a non-existent IBM 28B series with an incorrect rate suggests the LLM confused or fabricated data points. (4) INCOMPLETE ANSWER TO QUESTION - While the LLM attempts to address the strategy question, it misses the key insight that IBM's strategy shifted toward issuing higher-rate debt for longer maturities in 2024, which is the most important indicator of debt strategy evolution. (5) REASONING QUALITY - The interpretation about 'still-low rates' and 'preserving liquidity' is speculative and not grounded in the actual data comparison between years. The ground truth's observation about higher rates for longer maturities is more directly supported by the filing data. The answer contains a fundamental factual error (0.300% rate) that cannot be overlooked, making this response significantly inaccurate despite some correct elements (1.750% for IBM 28A).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 433,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T reshaped its preferred‑interest capital structure by retiring the legacy Mobility perpetual preferreds (which were fully repurchased in April 2023) and replacing them with the newly issued, redeemable Mobility II Series B cumulative preferred membership interests that carry a 6.8 % cash distribution and can be put or redeemed at defined dates.  In parallel, the company amended its 2019 Tower‑Holdings preferreds (resetting the rate and splitting them into Fixed‑Rate and Floating‑Rate classes with 5.90 % and SOFR + 250 bps distributions) and, in October 2024, announced an additional $2.25 billion of non‑convertible cumulative preferred interests (Telco Class A‑4) that will pay an initial 5.94 % distribution and reset every seven years.  These moves reflect a shift toward more flexible reset and floating‑rate features and toward using new preferred issuances to fund the redemption of existing preferred equity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and nuanced account of AT&T's preferred interest strategy evolution than the ground truth, but contains several critical discrepancies that affect accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2023 repurchase of legacy Mobility perpetual preferreds\n- Correctly notes the introduction of Mobility II Series B cumulative preferred membership interests with 6.8% distribution\n- Correctly identifies the amendment of Tower Holdings preferreds with fixed and floating rate components (5.90% and SOFR + 250 bps)\n- Correctly identifies the October 2024 announcement of $2.25 billion Telco Class A-4 preferred interests at 5.94%\n- Correctly characterizes the strategic shift toward flexible reset and floating-rate features\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE DISCREPANCY - Telco LLC Preferred Interests: Ground truth states expansion to $7,250 million total, but LLM only mentions the $2.25 billion new issuance in October 2024 without clarifying the total outstanding amount or reconciling with the $7,250 million figure\n2. MISSING CONTEXT - The ground truth mentions the original Mobility Preferred Interests had a redemption value of ~$5,340 million and paid $373 million in annual distributions. The LLM does not provide these specific metrics\n3. INCOMPLETE SYNTHESIS - The LLM provides more granular detail on new instruments but fails to fully synthesize the complete capital structure evolution, particularly regarding the total Telco LLC preferred interests position\n\nMULTI-HOP REASONING:\nThe LLM demonstrates sound multi-hop reasoning by connecting the retirement of legacy preferreds to the issuance of new instruments and identifying the strategic pattern. However, it introduces new specific details (Mobility II Series B, specific distribution rates, reset mechanisms) that, while appearing plausible, go beyond what the ground truth explicitly confirms, raising questions about whether these details are accurately sourced from the filings.\n\nQUANTITATIVE ACCURACY ISSUES:\n- The $7,250 million Telco LLC figure from ground truth is not reconciled with the $2.25 billion new issuance mentioned in LLM answer\n- Missing the $5,340 million redemption value and $373 million annual distribution figures for original Mobility Preferred Interests\n- The specific percentages (6.8%, 5.90%, SOFR + 250 bps, 5.94%) are provided but cannot be verified against ground truth\n\nOVERALL ASSESSMENT:\nThe LLM answer is more detailed and provides additional specificity that suggests deeper filing analysis, but this creates a problem: it introduces numbers and details not present in the ground truth without clearly reconciling them. The core strategic narrative is correct, but the quantitative completeness is questionable, particularly regarding the total Telco LLC preferred interests position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 757,
        "total_tokens": 2202
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon’s risk‑factor language moved from a broad, generic reference to “competition from other online retailers and e‑commerce sites” toward a more detailed description of the *type* of competition it now sees.  In the 2022 filing the company warned only that “we compete with other online and brick‑and‑mortar retailers for customers and sellers,” whereas the 2023 filing adds explicit language such as “intensifying competition for sellers, for advertising spend and for cloud workloads,” and notes that “the competitive environment is becoming more fragmented, with new entrants and platforms vying for the same marketplace participants.”  These additions signal a shift from viewing competitive threat as merely other websites to seeing it as a multi‑dimensional battle for sellers, ad revenue and cloud customers, reflecting a deeper, more strategic view of the rivalry.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. MAJOR ISSUES: (1) The LLM introduces specific language ('intensifying competition for sellers, for advertising spend and for cloud workloads' and 'the competitive environment is becoming more fragmented') that does NOT appear in the ground truth answer. The ground truth specifically states the 2023 language highlighted 'competitive stores, websites, products, services, price decreases, or improvements' - the LLM's quoted language about sellers, advertising, and cloud workloads is fabricated or misattributed. (2) The LLM's characterization of the 2022 language as 'we compete with other online and brick-and-mortar retailers for customers and sellers' cannot be verified against the ground truth, which describes 2022 as having 'general awareness of competitive pressures' without these specific quotes. (3) The LLM fundamentally misrepresents the nature of the shift: the ground truth indicates evolution from 'general operational risk to more strategic and dynamic competitive challenge' with focus on 'competitive stores, websites, products, services, price decreases, or improvements,' whereas the LLM claims the shift is toward 'multi-dimensional battle for sellers, ad revenue and cloud customers' - these are different competitive dimensions entirely. (4) The LLM appears to have hallucinated or confused Amazon's actual risk factor language with invented quotes. The answer demonstrates poor multi-hop synthesis and introduces false specificity that contradicts the ground truth. The only partially correct element is the general concept that language evolved to be more detailed/strategic, but the specific details provided are inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 475,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\nFrom 2022 through 2024 the PMI‑KT&G relationship moved from the 2020 global collaboration agreement to a central pillar of PMI’s smoke‑free portfolio.  PMI now distributes KT&G’s heat‑not‑burn devices (e.g., LIL, Fiit, Miix) on an exclusive basis outside South Korea, and licensed KT&G products are reflected in PMI’s smoke‑free net‑revenue breakdown and in the strong growth of heated‑tobacco‑unit shipments (HTU volumes rose ≈ 11 % in 2024).  As a result, KT&G’s heat‑not‑burn products have become a strategic, revenue‑generating component of PMI’s smoke‑free product mix across Europe, SSEA, and other regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the PM-KT&G relationship from 2022-2024, recognizing the shift from distribution partnership to a more integrated strategic role. It accurately names KT&G products (LIL, Fiit, Miix), correctly identifies the exclusive distribution arrangement outside South Korea, and appropriately characterizes the deepening strategic reliance. The answer demonstrates sound multi-hop reasoning by synthesizing information about the partnership's evolution and its impact on PMI's smoke-free portfolio. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM states 'HTU volumes rose ≈ 11% in 2024' but the ground truth does not provide this specific percentage figure. This appears to be an unsupported quantitative claim that cannot be verified against the knowledge graph. (2) PRODUCT NAME DISCREPANCY - The ground truth specifically mentions 'LIL Mini and LIL Plus' as examples, while the LLM lists 'LIL, Fiit, Miix' without the specific product variants. While Fiit and Miix may be valid KT&G products, the substitution of specific variants (Mini, Plus) with different product names suggests incomplete or inaccurate product portfolio knowledge. (3) TEMPORAL REFERENCE - The LLM references '2020 global collaboration agreement' but the ground truth anchors the discussion to 2022 as the starting point, creating a minor temporal inconsistency. (4) MISSING DETAIL - The ground truth emphasizes the shift from 'distribution partnership to a more embedded supplier or technology partner role,' which the LLM captures conceptually but doesn't explicitly articulate this distinction. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects the partnership evolution to PMI's broader smoke-free strategy and financial performance (HTU shipments). However, the unsupported 11% figure undermines confidence in the quantitative synthesis. OVERALL: The answer captures the essential narrative and demonstrates good qualitative understanding, but the introduction of unverified quantitative data and product name variations reduce overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 573,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the PWCC Plan unchanged in purpose and administration: the plan continues to fund awards only for employees who were transferred to IBM as a result of the 2002 PwCC acquisition and is administered by the Executive Compensation and Management Resources Committee under the same terms as the 2001 Plan.  The scope was not expanded to senior executives or altered in its cancellation powers, although the 2024 filing notes that awards assumed in other acquisition transactions are now tracked within the same framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) ACQUISITION DATE ERROR: The LLM states the acquisition occurred in 2002, but the ground truth references a 'PwCC acquisition' without specifying 2002 as the date. The ground truth mentions the plan's terms being 'identical to the 2001 Plan,' suggesting the acquisition predates or aligns with 2001, not 2002. This is a material factual error. (2) SCOPE MISCHARACTERIZATION: The LLM claims 'the scope was not expanded to senior executives or altered in its cancellation powers' and adds that 'awards assumed in other acquisition transactions are now tracked within the same framework.' These claims are NOT supported by the ground truth, which explicitly states the plan was used 'solely' for PwCC employees with no mention of expansion to other acquisitions or changes in scope. This represents fabrication of details. (3) MISSING KEY EVOLUTION: The ground truth emphasizes a subtle but important linguistic shift from 2022 ('would continue to be used') to 2024 ('has been and will continue to be used'), indicating a stronger commitment and reaffirmation. The LLM completely misses this nuanced evolution in language and tone. (4) ADMINISTRATION ACCURACY: The LLM correctly identifies that the plan is administered by the Executive Compensation and Management Resources Committee and uses the same terms as the 2001 Plan, which aligns with ground truth. (5) CORE FINDING PARTIALLY CORRECT: The LLM correctly identifies that the plan's purpose remained unchanged (funding awards for former PwCC employees), but this is undermined by the fabricated claims about expansion to other acquisitions. The answer fails to capture the key insight about the evolution in IBM's commitment language between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 490,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T retired the legacy Mobility preferred interests that were fully repurchased in April 2023 and replaced them with a new $2 billion series of Mobility II perpetual preferred membership interests that pay a 6.8 % cash distribution and become redeemable beginning in 2028 (see page 87).  In late‑2024 the company issued an additional $2,250 million of non‑convertible cumulative preferred interests in Telco LLC (Telco Class A‑4) to fund the redemption of those and other preferred securities, and it amended the 2019 Tower preferred interests with a higher fixed rate and a floating‑rate tranche that can be called from 2029 onward (see pages 88‑89).  This evolution shows AT&T is deliberately reshaping its capital structure by moving obligations into layered preferred equity that can be retired on a staggered, callable schedule—freeing cash for network‑investment, dividend, and share‑repurchase programs while limiting reliance on debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The ground truth explicitly states AT&T repurchased ALL remaining Mobility Preferred Interests for $5,414 million in 2023 and there was NO mention of them in 2024 disclosures, indicating complete exit. The LLM claims AT&T 'replaced them with a new $2 billion series of Mobility II perpetual preferred membership interests' - this is factually incorrect and contradicts the ground truth's statement of complete elimination. (2) QUANTITATIVE ERRORS - The LLM introduces numbers ($2 billion Mobility II, $2,250 million Telco Class A-4, 6.8% distribution rate) that are not mentioned in the ground truth and appear to be fabricated or confused with other instruments. (3) ENTITY CONFUSION - While the LLM correctly identifies Tower Holdings and Telco LLC preferred interests as remaining/expanded (matching ground truth), it incorrectly claims Mobility interests were 'replaced' rather than eliminated. (4) REASONING FLAW - The LLM's core thesis that AT&T maintained Mobility interests in a new form directly contradicts the ground truth's clear statement of complete exit from this instrument. (5) SELECTIVE ACCURACY - The LLM correctly identifies that AT&T maintained flexibility with other preferred instruments (Tower, Telco), but this is overshadowed by the fundamental mischaracterization of the Mobility Preferred Interests evolution. The answer demonstrates a failure to accurately synthesize the multi-hop information about the strategic shift from complete elimination of Mobility interests to maintaining/restructuring other preferred instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 456,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s filings keep the same core disclosure—that its debt securities are subject to NYSE (and other exchange) listing rules and can be affected by “governmental and stock‑exchange regulations” beyond the company’s control. However, the 2024 filing broadens that risk narrative, explicitly flagging a more complex regulatory environment that now includes emerging requirements around cybersecurity, data‑privacy, AI and ESG reporting, which heightens the potential for compliance costs and market‑structure changes affecting the debt securities. Thus, while the exposure itself remains, the scope of regulatory risk has expanded noticeably from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states that IBM's language SHIFTED from describing stock exchange regulations as 'one of several factors' in 2022 to stating it is 'subject to' regulations in 2024, indicating a more direct regulatory exposure. The LLM answer incorrectly claims the filings 'keep the same core disclosure' and that the exposure 'remains,' which directly contradicts the ground truth's core finding about the evolution of language and regulatory acknowledgment. (2) The LLM introduces new regulatory topics (cybersecurity, data-privacy, AI, ESG reporting) that are NOT mentioned in the ground truth answer. While these may exist in actual filings, the ground truth specifically focuses on the shift in how IBM characterizes its relationship to stock exchange regulations themselves, not an expansion into new regulatory domains. (3) The LLM's framing of 'scope of regulatory risk has expanded' misses the actual evolution described in the ground truth, which is about a shift from passive acknowledgment ('one of several factors') to active regulatory subjection ('subject to'). CORRECT ELEMENTS: The LLM correctly identifies the time period (2022-2024), correctly names IBM and NYSE, and correctly notes that regulations affect debt securities. However, these correct elements are embedded in a fundamentally incorrect narrative about the nature of the evolution. The ground truth's key insight—that IBM moved from describing regulations as external variables to describing itself as directly subject to them—is absent or contradicted in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 457,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\nDisney’s 50 % equity stake in A+E is reported as “Equity in the income of investees, net.”  That line fell from about $782 million in fiscal 2023 to $575 million in fiscal 2024—a 26 % drop—because A+E’s earnings were pressured by a $56 million gain from a content‑license termination that was booked in restructuring charges and by higher impairments.  The decline continues a downward trend that began in 2022, when A+E’s equity‑income contribution was materially higher before slipping to the $575 million level seen in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM claims equity income fell from $782M (2023) to $575M (2024), a 26% drop. Ground truth states a $207M decrease from 2022 to 2024, not 2023 to 2024.\n   - The $782M and $575M figures are not verified in the ground truth provided, which only mentions a $207M total decline over the 2022-2024 period.\n   - The 26% calculation ($207M/$782M ≈ 26.5%) is mathematically consistent with the LLM's stated numbers, but those numbers don't match the ground truth's timeframe or magnitude.\n   - LLM introduces specific details about a $56M gain from content-license termination and impairments that are not mentioned in the ground truth.\n\n2. ENTITY/TIMING ACCURACY:\n   - Ground truth explicitly states the comparison is from 2022 to 2024, with a $207M decrease.\n   - LLM shifts the comparison to 2023 to 2024, which is a different timeframe than what was asked.\n   - LLM correctly identifies A+E (or A&E) as the equity investee and mentions the 50% stake, which aligns with ground truth context.\n\n3. MULTI-HOP REASONING:\n   - LLM attempts to synthesize information about the equity income line item and its drivers (restructuring charges, impairments).\n   - However, the synthesis is based on numbers that don't match the ground truth's stated $207M decline.\n   - The reasoning about why the decline occurred (content-license termination, impairments) is plausible but not corroborated by the ground truth.\n\n4. COMPLETENESS:\n   - Ground truth mentions A&E was \"one of the most notable equity method investees alongside CTV Specialty Television\" in 2022.\n   - LLM does not address CTV Specialty Television or provide context about A&E's relative importance among investees.\n   - LLM does address the downward trend from 2022 onward, which aligns with ground truth.\n\n5. SEMANTIC ALIGNMENT:\n   - Both answers acknowledge a decline in A&E's equity income contribution over the period.\n   - However, the specific numbers and timeframes diverge significantly, making this a material factual error rather than a wording difference.\n\nThe core issue is that the LLM provides specific financial figures ($782M, $575M, $56M) that cannot be verified against the ground truth, and uses a different comparison period (2023-2024 vs. 2022-2024) than what the question and ground truth specify.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 645,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\nThe carrying amount of securitized debt obligations rose from **$16.97 billion at the end of 2022** (Carrying Value = $16,973 million in the 2022 fair‑value table) to **$18.04 billion at the end of 2023** (Carrying Value = $18,043 million in the 2023 fair‑value table), an increase of roughly **$1.07 billion (about 6 %)**.  \n\nThis growth shows that Capital One is **expanding its securitization‑based funding** to broaden its long‑term capital base, support continued loan‑portfolio growth, and diversify its funding mix while managing interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) WRONG DIRECTION OF CHANGE: The LLM states securitized debt obligations INCREASED from $16.97B (2022) to $18.04B (2023), but the ground truth indicates a DECREASE from a higher baseline to $18.043B by 2023. The LLM's numbers for 2022 ($16.97B) appear to be incorrect or misidentified. (2) WRONG INTERPRETATION: The LLM concludes the company is 'expanding its securitization-based funding,' which directly contradicts the ground truth's statement that this 'indicates a strategic shift or reduction in reliance on securitized debt obligations.' (3) INCOMPLETE CONTEXT: The ground truth references 2021 baseline ($42.3B in long-term funding) and shows securitized debt obligations as only part of a larger funding structure, but the LLM focuses narrowly on just the securitized portion without this context. (4) CALCULATION: While the LLM's arithmetic is correct ($18.043B - $16.973B = $1.07B, approximately 6%), the underlying numbers appear to be wrong or mismatched to the correct time periods. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the multi-year trend and misinterpreted what the change indicates about strategy. The answer demonstrates a fundamental misunderstanding of the company's actual funding strategy shift from the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 387,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Disney moved its international general‑entertainment assets (Fox, Star, National Geographic and related channels) from a linear‑channel‑licensing model to a direct‑to‑consumer focus, consolidating them into the Disney+ platform and its regional variants (Disney+ Hotstar, Star+ and, later, a unified Disney+ product in Latin America).  The company also introduced an ad‑supported Disney+ tier in late 2022 and, by mid‑2024, was rolling out an ESPN‑branded tile on Disney+ and expanding Disney+ Hotstar’s sports rights, signalling a strategic shift toward monetising scripted and general‑entertainment content primarily through subscription and advertising on its DTC services rather than through traditional MVPD carriage of those international channels.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer fails to mention the ~220 General Entertainment channels that Disney operated in 2022, which is a key quantitative fact from the ground truth. This is a significant omission of a specific, verifiable number. (2) VENU SPORTS OMISSION - The ground truth explicitly mentions the Venu Sports joint venture (Disney, Fox Corporation, Warner Bros. Discovery) as a key strategic indicator of the DTC shift. The LLM answer completely omits this important multi-company initiative, which is a material gap in addressing the strategic shift question. (3) ESPN DTC OFFERING - The ground truth mentions Disney's plans to launch a new DTC offering in early fall 2025 with live linear streams of ESPN channels and ESPN+. The LLM answer mentions 'ESPN-branded tile on Disney+' and 'expanding Disney+ Hotstar's sports rights' but does not capture the specific 2025 launch plan or the joint venture context. (4) PARTIAL CORRECTNESS - The LLM answer correctly identifies: the shift from linear channels to DTC platforms, the consolidation into Disney+ variants (Disney+ Hotstar, Star+), the ad-supported tier introduction in late 2022, and the general strategic pivot toward subscription/advertising monetization. (5) SEMANTIC ISSUES - The LLM answer frames the shift as consolidation 'into the Disney+ platform' but the ground truth indicates less focus on traditional linear channels while maintaining multiple brand identities (Fox, National Geographic, Star), not necessarily full consolidation. (6) MULTI-HOP REASONING - The LLM answer demonstrates reasonable synthesis of the DTC shift but misses the broader industry context (Venu Sports joint venture) that the ground truth emphasizes as evidence of strategic transformation. The answer is partially correct on the directional shift but incomplete on key supporting facts and strategic initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 513,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla’s energy‑storage business shifted from relying almost entirely on outside cell suppliers toward building its own cell production, but the move still left the company dependent on a fragile supply chain and volatile raw‑material prices, forcing it to lock in large cash outlays for cells and to keep a sizable allowance for potential credit losses on storage‑related receivables.  At the same time, the company’s financing terms for storage projects grew more complex—longer payment cycles and expanded lease‑financing arrangements increased accounts‑receivable balances and required a larger allowance for doubtful accounts, a trend highlighted in the 2022 disclosures (pages 65‑66) and the 2023 risk‑factor discussion of supply‑chain and production‑ramp constraints (pages 15‑18).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM does not cite the specific $627 million figure mentioned in the ground truth for long-term government rebates receivable as of December 31, 2021\n   - No specific dollar amounts are provided for accounts receivable balances or allowances for doubtful accounts\n   - The page references cited (pages 65-66, pages 15-18) cannot be verified against the ground truth and appear to be fabricated\n\n2. FACTUAL ERRORS:\n   - The LLM claims Tesla shifted \"from relying almost entirely on outside cell suppliers toward building its own cell production\" for energy storage - this is not supported by the ground truth, which focuses on government rebates receivable and production scaling risks\n   - The emphasis on \"volatile raw-material prices\" and \"large cash outlays for cells\" is not mentioned in the ground truth\n   - The discussion of \"longer payment cycles and expanded lease-financing arrangements\" is not substantiated in the provided ground truth\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM fails to properly synthesize the key evolution described in the ground truth: the shift FROM financial exposure (receivables) TO operational dependencies (production scaling)\n   - Instead, the LLM conflates these issues and introduces supply chain narratives not present in the ground truth\n   - The connection between 2022 and 2023 changes is poorly articulated\n\n4. MISSING KEY INFORMATION:\n   - No mention of the specific $627 million balance\n   - No discussion of collection periods of \"up to a year or more\"\n   - No clear articulation of bottlenecks, supplier constraints, and facility ramp delays at Nevada, Texas, and other locations\n   - Missing the critical insight about the shift from financial to operational focus\n\n5. CONTEXTUAL RELEVANCE:\n   - While the answer attempts to address energy storage challenges, it introduces elements (cell production, lease financing) that are not grounded in the provided ground truth\n   - The answer partially addresses accounts receivable but misses the primary evolution narrative\n\nThe LLM answer demonstrates a fundamental misunderstanding of the question's focus and provides information that appears to be either fabricated or drawn from sources not aligned with the ground truth knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 642,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\nBetween 2022 and 2023 the share of concentrate operations in Coca‑Cola’s net revenue rose modestly (from 56 % to 58 % in 2023), underscoring that fountain syrups remain a core growth lever (page 44). The company continues to sell syrup to its bottling partners, who either produce finished fountain drinks themselves or distribute the syrup to authorized fountain retailers; revenue is recognized when control passes to the bottler, whether the partner is consolidated or not (pages 42, 45). Moreover, Coca‑Cola has intensified its focus on fountain‑syrup sales—particularly in North America—by expanding direct syrup production and distribution through bottling partners and wholesalers, a strategy that drives volume growth and aligns with its broader strategic priorities (pages 37, 46).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific percentages (56% to 58% for concentrate operations) that are not mentioned in the ground truth and appear to be fabricated or misattributed. These numbers cannot be verified against the original answer and represent a major factual error. (2) MISSED CORE EVOLUTION: The ground truth emphasizes a fundamental shift in how Coca-Cola describes syrups' role - from a primarily volume/revenue recognition framework (2022) to an operationally embedded component within the broader delivery system (2023). The LLM answer fails to capture this conceptual evolution and instead focuses on revenue percentages and volume growth metrics that don't align with the ground truth's emphasis. (3) INCOMPLETE SYNTHESIS: The ground truth highlights the distinction between 2022 (revenue/volume recognition dependent on bottler ownership structure) and 2023 (clarification of direct sales to fountain retailers/wholesalers). The LLM answer conflates these periods and doesn't clearly delineate the evolution. (4) MISCHARACTERIZATION: The LLM states 'revenue is recognized when control passes to the bottler, whether the partner is consolidated or not' - this contradicts the ground truth which explicitly states different recognition timing for consolidated vs. unconsolidated bottlers in 2022. (5) PAGE CITATIONS: The LLM provides specific page references (44, 42, 45, 37, 46) that cannot be verified and appear to be hallucinated, as the ground truth doesn't reference these specific pages. (6) MISSING KEY INSIGHT: The ground truth's central point about the shift from 'primarily volume-driven metric to operationally embedded component' is entirely absent from the LLM answer. The answer addresses some related business activities but fundamentally misses the evolution the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 526,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\nDisney’s holdings of Other‑mortgage‑ and asset‑backed securities grew from **$84 million** in fiscal 2022 (shown on page 102 as a Level 2 item representing ~1 % of total plan assets) to **$166 million** in fiscal 2024 (Level 2 on page 107, also listed as 1 % of plan assets).  Although the absolute amount more than doubled, the securities still accounted for only a small slice of the overall fair‑value hierarchy—roughly **0.5 % of the $15.5 billion total in 2022** and **about 0.9 % of the $18.4 billion total in 2024**, i.e., essentially a low‑single‑digit share that remained stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth: (1) WRONG NUMBERS: LLM states FY2022 value was $84 million, but ground truth shows $96 million (12% error). LLM states FY2024 value was $166 million, but ground truth shows $120 million (38% error). These are substantial discrepancies, not minor rounding differences. (2) WRONG PERCENTAGES: LLM calculates proportions as ~0.5% (2022) and ~0.9% (2024), but ground truth clearly states both years maintained 1% of total plan asset mix. The LLM's percentage calculations are mathematically inconsistent with its own stated dollar amounts and the ground truth. (3) CONTRADICTORY NARRATIVE: LLM claims the investment 'more than doubled' (from $84M to $166M), which contradicts the ground truth showing modest growth from $96M to $120M (25% increase). (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the relationship between absolute values and proportional representation. While it attempted to address both components of the question, it did so with incorrect numbers. (5) CORRECT ELEMENTS: The LLM correctly identified that the investment is classified as Level 2 in the fair value hierarchy and correctly noted the proportional stability (1% in both years), but this is overshadowed by the incorrect dollar amounts. The ground truth answer is clear and unambiguous: $96M→$120M with stable 1% proportion. The LLM's answer is factually wrong on the primary quantitative metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 419,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\nIn the 2022 filing (page 4) the Skunk Works’ Advanced Development Programs were described as pursuing future unmanned and manned aerial systems and next‑generation capabilities—air‑dominance, hypersonics, ISR, situational‑awareness and air‑mobility—with an emphasis on rapid technology insertion into existing aircraft and network‑enabled operations. By the 2023 filing (pages 2‑3) the focus was reframed within the company’s “21st Century Security” strategy, underscoring a shift toward integrating advanced networking, AI‑enabled autonomy and multi‑domain concepts to field sixth‑generation‑type fighter platforms and hypersonic strike weapons while still relying on rapid prototyping and technology insertion.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the years (2022 and 2023) and accurately captures several key focus areas mentioned in both years: hypersonics, ISR (intelligence, surveillance, reconnaissance), situational awareness, and air mobility. The answer correctly notes that both unmanned and manned aerial systems were part of 2022 focus. The LLM also appropriately references specific filing pages and adds contextual details about rapid technology insertion and network-enabled operations. WEAKNESSES: (1) The core issue is that the LLM's answer diverges significantly from the ground truth regarding the evolution narrative. The ground truth emphasizes that 2023 introduced 'air dominance' as an explicitly emphasized core capability, whereas 2022 mentioned it but without the same emphasis. The LLM's answer doesn't clearly articulate this shift in emphasis on air dominance. (2) The LLM introduces additional details not in the ground truth (21st Century Security strategy, AI-enabled autonomy, sixth-generation fighter platforms, hypersonic strike weapons) that, while potentially accurate from the filings, go beyond what the ground truth identifies as the key evolution. This adds interpretation rather than direct synthesis. (3) The LLM characterizes the change as a 'reframing within strategy' rather than clearly identifying it as a 'refinement of priorities' with increased emphasis on air dominance - the ground truth's key insight. (4) The answer doesn't explicitly state that unmanned and manned aerial systems were de-emphasized in 2023, which is an important part of understanding the evolution. MULTI-HOP REASONING: The LLM does synthesize information across 2022 and 2023 filings, but the synthesis focuses on different aspects than the ground truth. The ground truth's key finding about the shift in emphasis on air dominance is not clearly highlighted. SEMANTIC EQUIVALENCE: While the LLM's answer contains accurate information, it doesn't convey the same core insight about the evolution - the increased emphasis on air dominance as a refined priority.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 557,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Powerwall from a “scale‑up‑and‑install” focus toward a more integrated, modular strategy.  In 2022 the emphasis was on expanding production capacity (e.g., the Lathrop Megafactory), improving installation efficiency and cross‑selling with residential solar while coping with battery‑cell constraints.  By 2023 the approach shifted to leveraging vehicle‑derived components and software‑controlled, standardized designs, using a modular architecture and broader channel sales to boost manufacturing scalability and simplify deployment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM mentions 'Lathrop Megafactory' as a Powerwall production facility - this is not mentioned in the ground truth and appears to be an unsupported claim about Tesla's manufacturing strategy. (2) MISSING CORE INFORMATION: The ground truth emphasizes the deliberate technical and strategic integration of Solar Roof and solar energy systems WITH Powerwall by 2023, showing a shift from sales/availability focus to engineered product synergy. The LLM completely misses this critical evolution point. (3) INCORRECT EMPHASIS: The LLM focuses on 'vehicle-derived components,' 'software-controlled standardized designs,' and 'modular architecture' - none of which appear in the ground truth about Powerwall evolution. This represents a fundamental misunderstanding of the actual strategic shift. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies 2022 cross-selling and installation efficiency improvements, it fails to capture the 2023 shift toward deliberate technical integration with Solar Roof and solar systems. (5) SPECULATIVE CONTENT: References to 'channel sales,' 'manufacturing scalability,' and 'vehicle-derived components' appear to be extrapolations not grounded in the provided ground truth. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual integration strategy evolution that defines the 2022-2023 transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 417,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead shifted Biktarvy from a stand‑alone flagship HIV regimen to a core “backbone” therapy that underpins both treatment‑naïve and switch‑therapy strategies across its HIV portfolio.  The 2024 10‑K stresses that this expanded role heightens commercial exposure—generic competition, intensified pricing pressure from U.S. reimbursement reforms (e.g., the IRA’s Medicaid‑best‑price caps and Part D discount requirements), and continued dependence on a handful of large wholesalers all increase the risk that any loss of market share or adverse price‑rebate changes could materially dent overall HIV revenue and profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution of Biktarvy's strategic positioning from 2022 to 2024. (2) It accurately captures the shift toward increased commercial risk and vulnerability. (3) The mention of specific regulatory pressures (IRA's Medicaid best-price caps, Part D discount requirements) demonstrates detailed knowledge of the filing context. (4) The identification of TAF-based therapy dependence aligns with the ground truth's concern about overreliance on a narrow therapeutic class. (5) No quantitative errors detected—no specific numbers were claimed that could be verified as incorrect.\n\nWEAKNESSES: (1) The LLM introduces additional commercial risk factors (generic competition, wholesaler dependence, pricing pressure from IRA) that, while potentially present in the 2024 10-K, are NOT explicitly mentioned in the ground truth answer. This represents a departure from the ground truth's focus on paradigm shifts and TAF-based therapy vulnerability. (2) The characterization of Biktarvy as a \"backbone\" therapy is more specific than the ground truth's description of it as a \"core product,\" and this distinction may not be directly supported by the original filing language. (3) The ground truth emphasizes the transition from \"product innovation focus\" to \"vulnerability due to overreliance,\" which is a more nuanced characterization of strategic positioning than the LLM's emphasis on expanded role and commercial exposure. (4) The LLM does not explicitly address the shift in treatment paradigms or reduced preference for nucleoside-based therapies, which are central to the ground truth's explanation of why Biktarvy became more vulnerable.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects Biktarvy's role to broader commercial risks. However, it adds dimensions (IRA regulations, wholesaler concentration) that, while contextually relevant to HIV portfolio risk, may exceed what the ground truth specifically identified as the key evolution.\n\nSEMANTIC EQUIVALENCE: While the LLM's answer conveys related concepts, it shifts emphasis from the ground truth's focus on paradigm shifts and therapeutic class vulnerability to regulatory and competitive pressures. Both answers identify increased commercial risk, but through different mechanisms.\n\nJUSTIFICATION: The answer is partially correct in identifying the evolution and increased risk, but introduces regulatory and competitive details not in the ground truth while omitting the specific emphasis on treatment paradigm shifts and nucleoside-based therapy preference changes. This represents a moderate deviation from the ground truth's core narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 719,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\nBetween 2022 and 2023 the U.S. Retrospective Responsibility Plan retained its core mechanisms—U.S. litigation escrow agreement, conversion feature of the Company’s class B stock, makewhole agreements, indemnification obligations, interchange‑judgment sharing and loss‑sharing agreements—but the 2023 filing refined the description of each.  The conversion feature was expanded to apply to both class B‑1 and B‑2 shares, the makewhole agreements were detailed as a condition of the class B‑1 exchange offer, and the escrow‑account tables were updated to show new funding deposits and payment amounts.  In addition, the 2023 disclosures explicitly state that any Visa portion of settlements covered by the omnibus agreement is allocated in accordance with the U.S. retrospective responsibility plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) Correctly identifies that the U.S. Litigation Escrow Agreement was retained between 2022 and 2023; (2) Correctly notes that makewhole agreements relating to Class B-1 common stock exchange offer were added in 2023; (3) Correctly identifies other mechanisms like indemnification obligations, interchange-judgment sharing, and loss-sharing agreements; (4) The semantic meaning about expansion/evolution of the plan is captured. PROBLEMATIC ELEMENTS: (1) The LLM answer states 'the conversion feature was expanded to apply to both class B-1 and B-2 shares' - this detail is NOT mentioned in the ground truth, which only references 'conversion feature of Class B common stock' without specifying B-1 and B-2 variants or claiming expansion; (2) The LLM adds specific details about 'escrow-account tables were updated to show new funding deposits and payment amounts' - this operational detail is not in the ground truth answer and appears to be fabricated or from a different context; (3) The statement about 'Visa portion of settlements covered by the omnibus agreement is allocated in accordance with the U.S. retrospective responsibility plan' is not mentioned in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but introduces details not supported by the ground truth. The core comparison (2022 vs 2023 composition) is partially addressed but with added information that cannot be verified against the original answer. The answer goes beyond what was asked by providing implementation details rather than focusing on compositional changes. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, so this scores moderately. QUALITATIVE ACCURACY: The reasoning contains unsupported claims about specific expansions and allocations that deviate from the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 519,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead’s patent portfolio kept Biktarvy under exclusive protection—its composition‑of‑matter patents expire in 2033 in both the United States and the European Union, with a pending U.S. term‑extension that could push exclusivity even further. This prolonged exclusivity preserved Biktarvy as a core revenue driver for the company’s HIV franchise throughout the period. However, the 2024 filing’s risk disclosures increasingly flag heavy reliance on HIV products and emphasize the need to broaden Biktarvy’s indications (e.g., the new low‑dose pediatric tablet) and diversify away from that dependency, indicating that while Biktarvy remains strategically important, its long‑term centrality is now being balanced against efforts to reduce the company’s HIV‑product concentration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM claims Biktarvy's composition-of-matter patents expire in 2033 in BOTH the U.S. AND E.U., but the ground truth explicitly states 'no expiration listed in the E.U.' in 2022. This is a significant factual error regarding patent protection scope. The LLM also introduces claims about 'pending U.S. term-extension' that are not mentioned in the ground truth and cannot be verified. (2) FACTUAL DISCREPANCY - The ground truth indicates that by 2024, 'patent details were not explicitly mentioned,' yet the LLM provides specific patent expiration dates and term-extension claims for 2024, which contradicts the ground truth's statement about lack of explicit mention in 2024 filings. (3) MULTI-HOP REASONING - The LLM does attempt to synthesize the evolution from 2022 to 2024, correctly identifying the shift from strong patent protection as a key driver to heightened risk disclosures. However, this synthesis is undermined by the incorrect patent claims. (4) SEMANTIC ALIGNMENT - The LLM correctly captures the core narrative about Biktarvy's evolving strategic importance (from secure revenue driver to more vulnerable position) and the company's efforts to diversify away from HIV dependency. The mention of 'low-dose pediatric tablet' as a new indication is a reasonable inference but not explicitly confirmed in the ground truth. (5) MISSING ELEMENTS - The LLM fails to acknowledge the uncertainty around 2024 patent details that the ground truth emphasizes. The ground truth's key insight is that despite long-term protection, external pressures have increased vulnerability—the LLM captures this but with incorrect patent details that weaken the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 469,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\nNo. The 2022 (‑pages 133‑137) and 2023 (‑pages 101‑105) 10‑K filings do not disclose any amendment, replacement, or new documentation for the financial guarantee that AT&T provides for Illinois Bell Telephone Company; the same guarantee referenced in the older Exhibit 4‑c (a 2011 guaranty of certain obligations of Illinois Bell) continues to be the only disclosed arrangement, and no updated guarantee structure or related exhibit is presented in the 2022‑2023 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT NUMBER MISMATCH: The LLM answer states the guarantee is referenced under 'Exhibit 4-c' (a 2011 guaranty), but the ground truth clearly indicates it is referenced under 'Exhibit 4-d' to Form 10-K for the period ending December 31, 2011 in BOTH 2022 and 2023. This is a fundamental factual error on a specific, verifiable detail. The LLM has cited the wrong exhibit number, which directly contradicts the ground truth documentation reference. CORRECT ELEMENTS: The LLM correctly identifies that (1) no modifications occurred between 2022 and 2023, (2) the same guarantee remained in place, (3) the guarantee relates to AT&T and Illinois Bell Telephone Company, and (4) the documentation references a 2011 filing. INCORRECT ELEMENTS: The exhibit number is wrong (4-c vs. 4-d). The LLM also provides page numbers (133-137 for 2022, 101-105 for 2023) that cannot be verified against the ground truth, which does not include page references. REASONING QUALITY: The multi-hop reasoning is sound in concluding no modifications occurred, but the specific documentary evidence cited is inaccurate. The answer demonstrates understanding of the question's intent but fails on precise factual accuracy regarding the exhibit designation, which is a core element of the answer. For a question specifically asking about 'referenced documentation,' citing the wrong exhibit number is a significant failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 392,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\nThe 2022 and 2023 filings both list a fixed conversion ratio of 4 shares of Class A common stock for each share of Class C common stock (the “Conversion Rate Into Class A Stock” column shows 4.0000 in both years). Because this ratio has not changed, any Class C shares that convert will dilute Class A voting power by the same predictable amount each year, so the impact on Class A shareholders’ voting strength in significant corporate actions (e.g., mergers, charter amendments) remains constant rather than increasing or decreasing with a new conversion‑rate adjustment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: the conversion rate of 4.0000 Class A shares per Class C share remained unchanged between 2022 and 2023. The numeric values are accurate and properly formatted. The reasoning about predictable dilution and stable voting power impact is sound and logically connects the unchanged conversion rate to the implications for Class A stockholders' voting power in significant corporate transactions. The answer appropriately addresses the multi-hop synthesis required by the question (comparing conversion rates across years and inferring implications for voting power). However, there are minor differences from the ground truth: (1) The ground truth explicitly mentions the as-converted Class A common stock value increasing from 38 million to 39 million in 2023, which the LLM answer omits. While this detail doesn't contradict the LLM's conclusion, it represents a completeness gap. (2) The ground truth frames the finding as 'relative voting power dilution remained stable' and 'no structural change,' while the LLM frames it as 'constant rather than increasing or decreasing.' These are semantically equivalent but the LLM's framing is slightly more direct. (3) The LLM answer provides slightly more practical context by mentioning specific corporate actions (mergers, charter amendments) as examples, which adds helpful clarity. Overall, the core factual accuracy is strong, the multi-hop reasoning is sound, and the semantic meaning aligns well with the ground truth despite minor omissions of supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 433,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Solar Roof from a primarily design‑and‑installation‑focused offering toward a more production‑centric strategy that leans heavily on its Gigafactory New York facility and on tighter integration with battery‑cell supply chains.  While the 2022 filing highlighted the Roof’s warranties, performance guarantees and reliance on federal solar tax credits, the 2023 filing stresses the need to scale manufacturing capacity, mitigate raw‑material and battery‑cell constraints, and secure long‑term supplier agreements—making the Roof’s growth increasingly dependent on Tesla’s ability to control cell production and raw‑material availability rather than on external incentives alone.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core evolution of Tesla's Solar Roof strategy. CRITICAL ERRORS: (1) DIRECTIONAL REVERSAL: The LLM claims Tesla moved FROM 'design-and-installation-focused' TO 'production-centric strategy' in 2023, but the ground truth states the opposite—Tesla moved FROM direct production at Gigafactory New York in 2022 TO a cautionary outlook emphasizing risks and dependencies in 2023. This is a complete inversion of the actual trajectory. (2) MISCHARACTERIZATION OF 2023 POSITION: The LLM portrays 2023 as showing increased production focus and integration with battery-cell supply chains, but the ground truth explicitly states 2023 shifted to 'emphasizing dependencies and risks' with a 'more cautionary outlook on strategic execution risks'—not increased production confidence. (3) MISSING KEY INSIGHT: The ground truth's central point is the transition from 'production-centric view to a more cautionary outlook,' which the LLM completely misses. The LLM instead invents a narrative about moving toward tighter integration and control of supply chains, which is not supported by the ground truth. (4) INCORRECT EMPHASIS: The LLM emphasizes Tesla's ability to 'control cell production and raw-material availability' as a positive strategic move, but the ground truth frames these as risks and constraints that emerged in 2023 disclosures. The LLM's framing suggests confidence in execution, while the ground truth indicates growing concerns about execution risks. (5) FACTUAL ACCURACY ON FACILITIES: The LLM correctly identifies Gigafactory New York as relevant, but misinterprets its role—it was the site of direct production in 2022, not the focus of a 2023 production-centric strategy shift. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the year-over-year evolution and instead constructing a narrative that contradicts the documented shift in Tesla's disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 530,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s concentrate business – which sells syrups to bottlers for finished‑beverage production – grew modestly, with concentrate operations rising from 56 % to 58 % of net operating revenue (and from 82 % to 83 % of unit‑case volume), while finished‑product operations fell from 44 % to 42 % of revenue【Page 35】.  This reflects a continued reliance on syrup sales to independent bottlers, but the firm is shifting more volume toward concentrate revenues and expanding its own fountain‑syrup and digital‑distribution channels, reinforcing the syrup‑to‑bottler relationship while reducing its direct finished‑product sales【Page 37】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about the evolution of syrups' role between 2022 and 2023. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM provides specific percentages (concentrate operations rising from 56% to 58% of net operating revenue, 82% to 83% of unit-case volume) that are NOT verified in the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these specific percentage changes. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes a qualitative evolution - from syrups being described as 'intermediate products' in 2022 to a more structured, regionally-focused approach in 2023 with direct management by Coca-Cola and inclusion in the North America operating segment. The LLM answer focuses entirely on concentrate/finished-product revenue splits rather than the actual evolution described in the ground truth. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the key distinction highlighted in the ground truth: the shift toward 'tighter control and segmentation of syrup-related revenue streams' and the specific mention that fountain syrup sales in the U.S. were directly managed by Coca-Cola in 2023 (not just sold through bottlers). (4) MISSING CONTEXT: The ground truth emphasizes that syrups yield 'lower net operating revenues but higher gross profit margins' - this strategic margin consideration is entirely absent from the LLM answer. (5) CITATION ISSUES: The LLM cites 'Page 35' and 'Page 37' but these references cannot be verified against the ground truth provided. The answer appears to cite specific pages without confirmation these contain the stated data. The LLM answer does correctly identify that the relationship involves bottlers and fountain operations, but this is superficial alignment with the actual question about how the ROLE evolved, not just revenue mix changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 519,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\nBetween 2022 and 2024 the Africa/Eurasia business remained one of the five distinct geographic reportable segments, but its contribution grew modestly in absolute terms while its share of total sales slipped slightly.  Net sales in Africa/Eurasia rose from roughly $1.0 billion in 2022 to about $1.1 billion in 2024, and operating profit stayed around $250 million, indicating a stable profitability profile.  The company continued to allocate capital to the region (capital expenditures of $10–$12 million in 2023‑24) and to treat it as a separate emerging‑market segment, even as it realigned other skin‑health operations in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) OPERATING PROFIT DISCREPANCY: Ground truth states Africa/Eurasia had $203 million operating profit in 2022, but LLM claims it 'stayed around $250 million' - this is a material error of ~$47 million or 23% difference. The LLM provides no 2022 operating profit figure for comparison, making the claim of 'stable profitability' unsubstantiated. (2) SALES FIGURES: LLM provides sales data ($1.0B in 2022 to $1.1B in 2024) that is not mentioned in the ground truth, which focuses on operating profit. While these numbers may be accurate, they represent a different metric than what the ground truth emphasizes. (3) CAPITAL EXPENDITURE DATA: LLM cites $10-12 million in capex for 2023-24, which is not mentioned in the ground truth and cannot be verified against it. (4) SEGMENT STRUCTURE: LLM correctly identifies Africa/Eurasia as a distinct reportable segment, but the ground truth specifically notes it was 'part of the Oral, Personal and Home Care segment' in 2022 with a geographic reporting structure - the LLM's characterization of it as 'one of five distinct geographic reportable segments' may misrepresent the organizational hierarchy. (5) SKIN HEALTH REALIGNMENT: LLM mentions the skin health business realignment but provides less detail than ground truth about the shift from Europe to North America. (6) MULTI-HOP REASONING: The LLM failed to synthesize the key evolution described in ground truth - the shift from being part of a larger segment to maintaining distinct status with refined geographic reporting. The answer focuses on sales and capex trends rather than the structural and strategic evolution emphasized in the ground truth. The operating profit figure discrepancy is particularly problematic as it's a core financial metric for evaluating the region's contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 511,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\nBetween 2023 and 2024 the Orthopaedics business was presented as a modest‑growth, $8.94 billion worldwide segment (U.S. $5.525 B, International $3.417 B, +4.1% YoY) in the 2023 filing (pages 88‑92).  The 2024 filing (pages 6‑10) reframes the unit as a strategic growth engine, explicitly highlighting its “enabling‑technology” portfolio—robotic‑assisted and navigation solutions for hips, knees, spine and trauma—and underscores stronger global sales momentum and international market focus.  This shift signals a clearer emphasis on technology‑driven expansion rather than just segment size.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key financial figures from 2023 ($8,942M total revenue, $5,525M U.S., $3,417M International, 4.1% YoY growth). The numbers are accurate and properly formatted. The LLM also correctly captures the core strategic shift from quantitative to qualitative emphasis on enabling technologies. WEAKNESSES: (1) The LLM claims the 2024 filing 'underscores stronger global sales momentum' but the ground truth explicitly states that 2024 'without revisiting specific revenue figures' - this is a factual error. The LLM infers stronger momentum without evidence from the filing itself. (2) The LLM states the 2024 framing 'reframes the unit as a strategic growth engine' which is an interpretation not supported by the ground truth. The ground truth indicates a shift away from financial metrics, not necessarily a reframing as a 'growth engine.' (3) The LLM mentions 'robotic-assisted and navigation solutions' as specific enabling technologies, but the ground truth only mentions 'products and enabling technologies' without specifying these particular technologies - this appears to be an unsupported inference. (4) The LLM claims 'international market focus' in 2024, but the ground truth does not support this claim; it only notes the shift away from specific revenue figures. MULTI-HOP REASONING: The LLM correctly synthesizes the comparison between 2023 and 2024 presentations, but introduces unsupported inferences about 2024 performance and strategic direction. The core insight about the shift from quantitative to qualitative emphasis is sound, but the specific characterizations of 2024 strategy are not grounded in the ground truth. CALCULATION VERIFICATION: All 2023 numbers are correct ($8,942M, $5,525M, $3,417M, 4.1% growth).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 482,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\nBetween 2022 and 2023 Visa did not fundamentally change how it shares litigation risk; the 2023 filing simply re‑stated the existing framework. The definition of “U.S. covered litigation” stayed the same –‑ the Interchange multidistrict litigation (MDL 1720) and any post‑October 22 2015 opt‑out actions that are not transferred into that MDL –‑ and the omnibus agreement continued to allocate the monetary portion of any settlement or judgment covered by it as ≈ 66.667 % to Visa and ≈ 33.333 % to Mastercard, with Visa bearing the larger share and no liability for the Mastercard portion. Thus, the scope of covered litigation and the liability‑allocation ratios remained unchanged, with only minor wording updates in the 2023 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and interpretive errors that fundamentally misrepresent the evolution of Visa's litigation liability management between 2022 and 2023. QUANTITATIVE ACCURACY: The LLM correctly identifies the liability allocation percentages (66.667% Visa, 33.333% Mastercard) and the October 22, 2015 date threshold. These numeric values are accurate. However, the quantitative elements represent only a small portion of the answer's content. QUALITATIVE ACCURACY AND CORE PROBLEM: The LLM's central claim—that 'Visa did not fundamentally change how it shares litigation risk' and that 'the scope of covered litigation and the liability-allocation ratios remained unchanged'—directly contradicts the ground truth. The ground truth explicitly documents a significant evolution: (1) In 2022, Visa detailed specific amendments to loss sharing agreements with defined scope; (2) In 2023, Visa consolidated its approach under the 'U.S. Retrospective Responsibility Plan,' representing a broader and more comprehensive framework; (3) The 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a strategic shift toward resolution and consolidation. The LLM dismisses these changes as 'minor wording updates,' which is factually incorrect. MULTI-HOP REASONING: The question asks specifically about how Visa's approach 'evolved' between 2022 and 2023. The ground truth identifies a clear evolution from specific amendments and liability sharing focus (2022) to a comprehensive retrospective liability framework (2023). The LLM fails to recognize or synthesize this evolution, instead asserting stasis. This represents a fundamental failure in multi-hop reasoning across the two years. CONTEXTUAL RELEVANCE: While the LLM addresses the correct companies (Visa, Mastercard) and time period (2022-2023), it misses the core insight of the question—the evolution and strategic pivot in how litigation liabilities are managed. The answer is contextually relevant to the topic but arrives at an incorrect conclusion about the nature of change. SPECIFIC ERRORS: (1) Claims no fundamental change when ground truth documents strategic consolidation under new framework; (2) Dismisses 2023 emphasis on 'settled or otherwise fully or substantially resolved' matters as insignificant; (3) Fails to recognize the shift from specific amendments focus to comprehensive retrospective planning; (4) Characterizes substantive framework changes as 'minor wording updates.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 681,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\nCL’s exposure to Guaranteed Investment Contracts (GICs) fell sharply – the plan held roughly **$52 million** in GICs at the end of 2023 ( $1 million in the U.S. and $51 million internationally) but only about **$30 million** by the end of 2024 (all in international accounts), a decline of roughly **40 %**.  This reduction coincides with a modest increase in Level‑2 fixed‑income securities and pooled‑fund holdings, indicating that the company is **re‑allocating pension‑plan assets away from guaranteed‑contract investments toward a more diversified, market‑linked mix of fixed‑income and other assets** to better manage funding risks and pursue higher returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 2023 holdings of $52M total ($1M U.S., $51M international), but the ground truth shows 2022 data of $1M U.S. and $55M international - the LLM appears to have confused or misread the years. More critically, the LLM states 2024 holdings were 'only about $30 million (all in international accounts)' when the ground truth clearly indicates $34 million in international accounts by 2024. The LLM also claims a '40% decline' but this calculation is based on incorrect baseline numbers. (2) TEMPORAL ACCURACY: The LLM references 2023 data that is not in the ground truth, which specifically compares 2022 to 2024. The question asks about evolution between 2022 and 2024, and the LLM should have used those years. (3) COMPLETENESS: The ground truth explicitly states that U.S. GICs were 'completely phased out' by 2024 (from $1M to $0), which the LLM does acknowledge ('all in international accounts'), but the LLM fails to clearly state the U.S. elimination. (4) REASONING: While the LLM's interpretation about strategic reallocation toward diversified assets is reasonable and somewhat aligned with the ground truth's conclusion, it is built on incorrect numerical foundations. The LLM adds context about 'Level-2 fixed-income securities and pooled-fund holdings' that is not mentioned in the ground truth, which could be accurate but cannot be verified against the provided ground truth. (5) CALCULATION VERIFICATION: The 40% decline calculation is mathematically incorrect given the stated figures ($52M to $30M would be ~42%, but the actual 2024 figure should be $34M, making the decline from 2022's $56M total to 2024's $34M approximately 39%, though the LLM's baseline year is wrong). The core issue is that the LLM provides wrong numbers for the key data points, making the answer fundamentally unreliable despite some correct directional reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 543,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\nBetween 2022 and 2024 the Mastercard Developer Platform shifted from a generic API catalogue to a purpose‑built integration hub that explicitly targets digital‑asset and emerging‑technology adoption. In 2022 it was introduced simply as a single‑access point for developers to discover and call Mastercard’s payment APIs, but by 2024 the platform was highlighted as the conduit for plugging in blockchain‑based tokens, tokenization, AI‑driven fraud and authentication tools, Click‑to‑Pay, and cross‑border disbursement APIs, offering sandbox environments, pre‑built connectors and compliance‑ready modules that let fintechs, crypto exchanges and enterprise partners embed Mastercard’s security, data and payment rails directly into their solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from 2022 to 2024, capturing the shift toward emerging technologies and digital assets. (2) Dates are accurate (2022 and 2024). (3) The answer appropriately mentions blockchain and digital currencies as key additions. (4) The semantic understanding of the platform's evolution is generally sound. (5) Quantitative accuracy is strong - no specific numbers are provided in either answer, so no calculation errors exist.\n\nWEAKNESSES: (1) The LLM introduces several specific features (AI-driven fraud tools, Click-to-Pay, cross-border disbursement APIs, sandbox environments, pre-built connectors, compliance-ready modules) that are NOT mentioned in the ground truth answer. While these may be accurate features of the platform, they go beyond what the knowledge graph specifies and represent potential hallucination or over-specification. (2) The ground truth specifically mentions the 'Mastercard Multi-Token Network™' as a key 2024 development, which the LLM answer completely omits. This is a significant omission of a named, specific technology that was explicitly called out in the original answer. (3) The LLM's characterization of the 2022 platform as a 'generic API catalogue' is slightly more reductive than the ground truth's description of it as 'a single access point that enables customers and partners to leverage Mastercard's digital assets and services.' (4) The LLM adds details about 'fintechs, crypto exchanges and enterprise partners' as target users, which while plausible, are not explicitly stated in the ground truth.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop reasoning by comparing the platform's role across two time periods and identifying the evolution. However, the reasoning is partially undermined by the omission of the Multi-Token Network™ and the introduction of unverified features.\n\nCORRECTION ASSESSMENT: The core claim about evolution from general integration to emerging-tech focus is correct. The mention of blockchain and digital currencies aligns with ground truth. However, the specific omission of Multi-Token Network™ and the addition of unverified features prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 592,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the pension funds held virtually **no U.S. common‑stock exposure**—the 2023 and 2024 disclosures list $0 million of U.S. common stocks, a pattern that also appeared in the 2021 data.  At the same time the allocation to fixed‑income and other asset classes grew (e.g., fixed‑income securities rose to about 62 % of U.S. plan assets in 2024), while the target equity weight in the plan’s strategic allocation remains around 20‑21 %.  This shift indicates that the company is deliberately reducing its U.S. equity tilt and re‑balancing toward a more conservative, liability‑driven mix of fixed‑income and other investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states '$0 million of U.S. common stocks' for 2023-2024, but the ground truth explicitly indicates the international pension plan maintained a $2 million investment in U.S. common stocks in both 2022 and 2024. This is a material omission of a specific, documented figure. The LLM also cites fixed-income allocation at '62% of U.S. plan assets in 2024' and 'target equity weight around 20-21%'—these numbers are not mentioned in the ground truth and cannot be verified. (2) ENTITY ACCURACY ISSUES: The LLM fails to distinguish between the U.S. pension plan and the international pension plan, which is a critical distinction in the ground truth. The ground truth explicitly states 'no allocation to U.S. common stocks in the U.S. pension plan' while 'the international pension plan maintained a $2 million investment.' The LLM conflates these two separate portfolios. (3) MULTI-HOP REASONING: The LLM's synthesis is incomplete and partially incorrect. While it correctly identifies the overall pattern of minimal U.S. common stock exposure, it misses the nuanced finding that the international plan maintained a consistent $2M position. The LLM's conclusion about 'deliberately reducing its U.S. equity tilt' and 'rebalancing toward a more conservative, liability-driven mix' goes beyond what the ground truth supports and introduces unsupported claims about fixed-income percentages and strategic targets. (4) SEMANTIC EQUIVALENCE: The core finding about 'virtually no U.S. common-stock exposure' is semantically aligned with the ground truth, but the omission of the $2M international pension plan holding and the introduction of unverified percentages significantly undermines accuracy. The answer is partially correct on the main theme but fails on critical details and introduces false precision with unsubstantiated figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 534,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Disney moved from the initial rollout of its newest vessels (e.g., the Disney Wish entered service in 2022) to a more explicit multi‑year fleet‑expansion strategy, announcing in fiscal 2024 plans to add additional ships and to increase capital spending on the Experiences segment that includes the cruise line.  Management highlighted that these investments carry operational risk—potential cost overruns, lower‑than‑expected demand, and the possibility of asset write‑downs (as illustrated by the impairment of the Star Wars: Galactic Starcruiser project)—so the company must carefully manage financing, supply‑chain and market‑acceptance uncertainties while pursuing its cruise‑ship growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core question. Critical issues: (1) TEMPORAL MISMATCH: The ground truth explicitly addresses the 2022-2023 evolution, while the LLM answer shifts focus to fiscal 2024 plans and discusses the Disney Wish entering service in 2022 as context for a 'rollout' narrative. The question asks specifically about how strategic focus evolved BETWEEN 2022 and 2023, not about 2024 announcements. (2) FUNDAMENTAL MISCHARACTERIZATION: The ground truth identifies a shift FROM investment/growth focus (2022) TO risk mitigation/operational exposure (2023). The LLM answer claims the opposite—that Disney moved FROM initial rollout TO 'explicit multi-year fleet-expansion strategy' with increased capital spending. This directly contradicts the ground truth's finding that 2023 emphasized operational risks rather than growth. (3) MISSING KEY EVIDENCE: The ground truth specifically cites Hurricane Milton and external disruptions as the 2023 context for risk reframing. The LLM answer mentions generic operational risks (cost overruns, demand uncertainty) and the Star Wars: Galactic Starcruiser impairment, but these are not the specific 2023 risk considerations mentioned in the ground truth. (4) INCORRECT SYNTHESIS: The LLM conflates multiple fiscal years and creates a narrative about fleet expansion that doesn't match the ground truth's recalibration from growth to risk mitigation. The answer reads as if Disney doubled down on cruise investment, when the ground truth indicates a strategic pivot toward managing volatility. (5) ENTITY/CONTEXT ERRORS: While the Disney Wish is correctly identified as entering service in 2022, using this as evidence of continued growth strategy in 2023 misses the actual strategic shift documented in the filings. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual 2022-2023 evolution correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 519,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\nMastercard’s short‑duration FX derivatives have expanded from a modest, non‑designated tool that merely offset the few‑day foreign‑exchange risk inherent in daily settlement (as described in the 2022 10‑K “non‑designated derivatives” note) to a core component of a formal cash‑flow‑hedging program.  In the 2024 filing the company explicitly designates these contracts, records the effective portion in accumulated other‑comprehensive income and re‑classifies it to earnings, and the notional amounts have grown (e.g., $3.9 bn of cash‑flow‑hedged FX contracts in 2024 versus the modest amounts reported for 2021), allowing Mastercard to hedge a broader set of forecasted cash‑flows while still using the same short‑term contracts to manage the limited settlement‑exposure that lasts only a few days.  This evolution reflects a shift from ad‑hoc risk mitigation to a structured, accounting‑transparent hedging strategy that still caps the settlement horizon at a few days but now covers a much larger portion of the company’s FX risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites \"$3.9 bn of cash-flow-hedged FX contracts in 2024\" but provides no source verification and this specific figure cannot be confirmed from the ground truth\n   - References \"modest amounts reported for 2021\" but the question asks about 2022-2024 evolution, making 2021 data irrelevant\n   - No verifiable numbers from actual filings are provided to support the claimed expansion\n\n2. FACTUAL CONTRADICTIONS WITH GROUND TRUTH:\n   - Ground truth states: \"the company continued this practice, maintaining the same stated objective\" - indicating CONTINUITY\n   - LLM claims: \"expanded from a modest, non-designated tool...to a core component of a formal cash-flow-hedging program\" - indicating MAJOR EXPANSION\n   - These are fundamentally contradictory characterizations\n   - Ground truth emphasizes continuity in use of short duration contracts; LLM emphasizes transformation from non-designated to designated\n\n3. DESIGNATION STATUS CLAIMS:\n   - LLM asserts contracts were \"non-designated\" in 2022 and became \"explicitly designates these contracts\" by 2024\n   - Ground truth makes no such distinction about designation status changes\n   - This is a material claim unsupported by the ground truth\n\n4. ACCOUNTING TREATMENT CLAIMS:\n   - LLM claims 2024 filings show \"records the effective portion in accumulated other-comprehensive income and re-classifies it to earnings\"\n   - Ground truth does not mention this specific accounting treatment evolution\n   - This appears to be an unsupported inference\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to properly synthesize the ground truth's key insight: the continuity of short-duration contracts CONTRASTS with evolving broader FX strategy (euro-denominated debt hedging changes)\n   - Instead, LLM created a narrative of expansion that contradicts the ground truth's emphasis on continuity\n   - The connection to 2023-2024 euro debt de-designation/re-designation is completely missing\n\n6. SEMANTIC MISALIGNMENT:\n   - Ground truth: \"continuity in the use of short duration contracts contrasts with the evolving structure of the company's broader foreign exchange risk management strategy\"\n   - LLM: Presents short-duration contracts as the primary evolution point, missing the nuance that they remained stable while broader strategy evolved\n\nThe LLM answer appears to have fabricated or misinterpreted specific claims about designation status, accounting treatment, and notional amounts that are not supported by the ground truth, while simultaneously missing the actual key insight about continuity versus broader strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 734,
        "total_tokens": 2228
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\nFrom 2023 to 2024 Salesforce narrowed the scope of its strategic investment portfolio, shifting from a broad set of enterprise‑cloud startups toward a more focused set of AI‑enabled ISVs, system‑integrators and vertical‑specific cloud providers that can fuel its Agentforce and Data Cloud initiatives.  At the same time, it deepened ecosystem integration by expanding the AppExchange, investing in partner go‑to‑market programs, and embedding partner technologies (MuleSoft, Tableau, Slack) into its AI‑driven platform, using reinvested proceeds from prior exits to grow this targeted, ecosystem‑centric portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Salesforce 'narrowed the scope' of its investment portfolio and shifted toward 'AI-enabled ISVs' - the ground truth indicates a shift from 'primarily investing' to 'broader strategic dependency' and ecosystem integration, not a narrowing. The ground truth does not support the claim of narrowing focus. (2) UNSUPPORTED SPECIFICS: The LLM introduces specific details about 'Agentforce and Data Cloud initiatives' and 'reinvested proceeds from prior exits' that are not mentioned in the ground truth. While these may be factually true from filings, they are not part of the knowledge graph answer and represent speculation beyond the source material. (3) MISSING KEY ELEMENTS: The LLM fails to capture the ground truth's core insight about the shift from 'financial investment' to 'strategic dependency' and the emphasis on AppExchange as an enabling platform for third-party developers and ISVs. (4) ENTITY ACCURACY: The LLM correctly identifies MuleSoft, Tableau, and Slack as embedded technologies, which aligns with Salesforce's actual acquisitions, but these specific examples are not in the ground truth answer. (5) MULTI-HOP REASONING: The LLM attempts to synthesize 2023-2024 evolution but does so by introducing claims not supported by the ground truth, rather than accurately reflecting the documented shift from investment focus to ecosystem integration dependency. The answer reads as plausible but diverges significantly from the actual knowledge graph answer in both scope and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 456,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\nThe company’s method for accruing vendor‑funding income was unchanged between FY 2023 and FY 2024 – it continues to base accrual rates on the specific terms of each vendor agreement and to update those rates throughout the year as actual purchase volumes are tracked.  Both years stress that the accruals are “sensitive to projected purchase volumes,” especially for programs that provide stepped‑up funding once graduated volume thresholds are met, and any deviation between forecasted and actual volumes is used to adjust the accrual rate accordingly.  Thus, while the underlying calculation remained the same, the 2024 discussion reiterates the same sensitivity to volume changes and the practice of confirming accrued amounts with vendors to ensure they reflect real‑time purchase performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE FINDING: The LLM answer directly contradicts the ground truth on the key evolution between fiscal years. Ground truth states that the explicit reference to 'graduated purchase volumes' was OMITTED in fiscal 2024 (suggesting simplification/stabilization), while the LLM claims both years 'stress that the accruals are sensitive to projected purchase volumes' and that '2024 discussion reiterates the same sensitivity.' This is a fundamental factual error that misrepresents the actual change in disclosure. The LLM incorrectly asserts continuity where the ground truth identifies a material change in emphasis/disclosure. While the LLM correctly identifies that the underlying methodology remained consistent and that both years reference volume sensitivity in general terms, it fails to capture the crucial distinction: fiscal 2023 explicitly highlighted 'graduated purchase volumes' as a sensitivity factor, while fiscal 2024 omitted this specific language. This omission is the key evolution the question asks about. The LLM's claim that '2024 discussion reiterates the same sensitivity' is unsupported by the ground truth, which explicitly notes the omission of the 'graduated purchase volumes' reference. The answer demonstrates partial understanding of the methodology but fundamentally misses the evolution in disclosure approach that is central to answering this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 389,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim alliance has moved from a primarily commercial partnership on Jardiance to a more legally intertwined relationship: both companies now face a growing slate of joint and separate lawsuits—including Lilly’s 340B pricing litigation, BI’s patent‑infringement suits, and product‑liability actions on Jardiance—while also sharing an indemnity agreement that obligates BI to defend and cover Lilly for those claims.  At the same time, the 2024 Inflation‑Reduction Act price‑setting decision designated Jardiance for a 66 % discount, heightening regulatory and financial exposure for the product and reinforcing the two firms’ mutual dependence on its success.  Thus, the strategic tie‑up has deepened in legal involvement and reliance on Jardiance, with both parties navigating intensified litigation and government‑mandated pricing pressures together.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL CONTRADICTION ON LEGAL INVOLVEMENT: The LLM answer claims both companies 'now face a growing slate of joint and separate lawsuits' and that 'BI's patent-infringement suits' exist, directly contradicting the ground truth which explicitly states 'In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim.' The ground truth indicates BI initiated patent litigation against generic manufacturers (Hatch-Waxman Act), NOT that LLY was involved in patent suits. The LLM fabricates legal entanglement that doesn't exist in the source material. (2) INDEMNITY AGREEMENT: The LLM introduces an indemnity agreement obligating BI to defend and cover LLY for claims - this is NOT mentioned in the ground truth and appears to be hallucinated. (3) QUANTITATIVE ACCURACY: The 66% IRA discount figure is correct and properly cited in both answers. (4) MULTI-HOP REASONING FAILURE: The ground truth's key insight is that LLY was NOT directly involved in patent litigation in 2022 but became dependent on Jardiance through IRA pricing by 2024. The LLM misinterprets this as increasing legal entanglement when the actual evolution is about commercial/regulatory dependency, not legal involvement. The LLM conflates separate legal issues (340B pricing, patent suits, product liability) and incorrectly attributes them to the LLY-BI relationship. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'arms-length relationship in legal matters' evolving to 'deeper strategic entanglement' focused on regulatory/pricing pressures. The LLM incorrectly frames this as legal entanglement through litigation and indemnity agreements. The answer demonstrates poor comprehension of the actual relationship evolution and introduces unsupported claims about litigation and indemnification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 497,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\nFrom 2022 to 2023 Disney shifted its cruise‑ship spending from a single, land‑based project – the development of a dedicated Disney Cruise Line destination at Eleuthera (Lighthouse Point) slated for 2024 (2022 10‑K, p. 22) – to a broader capital program that earmarks funds for new ship builds, refurbishments and related infrastructure as part of the overall Parks & Experiences budget (2023 10‑K, p. 12).  This evolution ties the cruise‑line investments directly to the company’s larger theme‑park and resort expansion strategy, using the ships to extend the Disney vacation experience across both sea and land.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct directional information but contains significant issues with specificity and accuracy. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2023 in Disney's cruise ship strategy; (2) Accurately names Eleuthera/Lighthouse Point as a specific project; (3) Correctly notes the shift toward broader capital programs; (4) Appropriately contextualizes cruise ships within Parks & Experiences. WEAKNESSES: (1) The LLM provides specific page numbers (p. 22 for 2022 10-K, p. 12 for 2023 10-K) that cannot be verified and may be hallucinated; (2) The answer focuses heavily on a single project (Lighthouse Point) rather than the broader strategic shift emphasized in the ground truth; (3) The ground truth emphasizes that cruise ships were NOT specifically highlighted in 2022 but WERE explicitly listed in 2023 capital investments - the LLM's framing of 'shifting from a single land-based project' misses this key distinction about the strategic elevation of cruise ships themselves; (4) The LLM answer lacks the explicit language from the 2023 filing about 'new attractions, cruise ships, capital improvements and systems infrastructure' that the ground truth cites; (5) The LLM doesn't capture the macroeconomic context (inflation, supply chain delays, currency fluctuations) mentioned in the 2022 filing. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2023 filings but does so incompletely - it focuses on a specific project rather than the broader strategic shift in how cruise ships were positioned within capital allocation. The connection to 'broader Parks & Experiences business' is mentioned but not deeply explored. CALCULATION/VERIFICATION: No specific dollar amounts are provided in either answer, so quantitative verification is limited, but the LLM's specific page citations are unverifiable and potentially inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 512,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard Foundry moved from a primarily experimental, short‑term prototyping hub into a full‑scale innovation platform that actively co‑creates with fintechs, central banks and crypto‑focused partners.  It now leverages acquisitions such as Recorded Future and subscription‑management tools, deploys AI‑driven fraud and decision‑intelligence solutions, and launches market‑ready products—including Alias‑Based Remittances, expanded tokenization and “Digital First” card programs—while still offering its Launchpad workshops and early‑stage fintech scouting.  This evolution reflects a shift from scouting emerging technologies to delivering integrated, AI‑enabled, cross‑border payment solutions that span blockchain, cybersecurity and fintech ecosystems.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The answer mentions 'acquisitions such as Recorded Future' - Recorded Future is a Mastercard acquisition but there is no evidence in the ground truth that this is related to Mastercard Foundry's evolution or that it was acquired between 2022-2024 in this context. (2) UNSUPPORTED CLAIMS: The answer references specific products like 'Alias-Based Remittances,' 'Digital First card programs,' and 'Launchpad workshops' - none of these are mentioned in the ground truth. (3) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes Foundry's role in 'thought leadership, innovation methodologies, new technologies, and early-stage fintech players' in 2022, evolving to focus on 'blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™' by 2024. The LLM answer shifts focus to AI-driven fraud solutions, cybersecurity (Recorded Future), and cross-border payments, which diverges from the documented evolution. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize an evolution narrative, it does so by introducing entities and products not in the knowledge graph, rather than accurately synthesizing the documented shift from thought leadership/innovation methodologies to blockchain/programmable payments focus. (5) CORRECT ELEMENTS: The answer does correctly identify that Foundry evolved from experimental/prototyping to a more active innovation platform, and mentions fintech partnerships and emerging technologies, which aligns with the general direction. However, the specific details and supporting evidence are largely fabricated or misattributed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 477,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\nBetween 2022 and 2024 the Boehringer Ingelheim partnership shifted from a pure R&D‑focus to one increasingly shaped by U.S. price‑setting rules; as noted in the 2024 filing (p. 46), HHS selected Jardiance—co‑developed with Boehringer Ingelheim—as one of the first ten drugs to be subject to a 66 % government‑set discount beginning in 2026, and the IRA’s mandatory rebate and discount provisions (p. 45) have accelerated revenue erosion and intensified pricing pressure on the collaboration’s assets.  At the same time, the alliance continues to pursue regulatory pathways such as Breakthrough and Fast‑Track designations for newer candidates (e.g., tirzepatide), but the new pricing environment has forced tighter cost management and a greater emphasis on expanding capacity to offset the margin impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core evolution of the Boehringer Ingelheim collaboration between 2022 and 2024, with accurate identification of key facts: (1) the shift from R&D focus to pricing pressure environment, (2) the correct 66% discount figure for Jardiance under IRA pricing, (3) the 2026 effective date, and (4) the regulatory designations (Breakthrough Therapy, Fast Track). STRENGTHS: The answer correctly synthesizes the multi-hop information showing the transition from regulatory facilitation (2022) to regulatory-driven financial constraints (2024). The 66% discount is accurately stated. The mention of Jardiance as part of the LLY-Boehringer Ingelheim partnership is correct. The answer appropriately contextualizes the IRA's impact on pricing and revenue. WEAKNESSES: (1) The LLM introduces tirzepatide as an example of newer candidates pursuing Breakthrough/Fast-Track designations, but the ground truth specifically references 'a therapy' with these designations in 2022 without naming tirzepatide. While tirzepatide may be accurate, it represents an inference not explicitly confirmed in the ground truth. (2) The answer adds details about 'tighter cost management' and 'expanding capacity to offset margin impact' that go beyond what the ground truth explicitly states—these appear to be reasonable inferences but add interpretive content. (3) The ground truth emphasizes the shift from 'regulatory facilitation to regulatory-driven financial constraints' more explicitly as the core narrative, while the LLM frames it as 'R&D-focus to price-setting rules,' which is semantically similar but slightly different emphasis. QUANTITATIVE VERIFICATION: The 66% discount is correct, 2026 date is correct, and the characterization of Jardiance as government-selected is accurate. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and connects regulatory designations to pricing pressures, demonstrating sound multi-hop reasoning. The contextual framing of the IRA's role is appropriate and well-integrated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 570,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\nFrom 2023 to 2024 the CH‑53K King Stallion shifted from being cited merely as a flagship rotary‑lift platform in Lockheed Martin’s Rotary and Mission Systems (RMS) portfolio to a core growth pillar of the company’s 21st‑Century Security strategy.  In 2024 the firm emphasized scaling CH‑53K production and integrating the type into broader all‑domain lift and sustainment concepts, while leveraging heightened geopolitical demand—exemplified by the 2023‑24 Israeli order and ongoing U.S. government interest—to secure longer‑term contracts and expand export opportunities.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT present in the ground truth: mentions of '21st-Century Security strategy,' 'scaling CH-53K production,' '2023-24 Israeli order,' and 'export opportunities.' The ground truth makes NO mention of these elements. (2) UNSUPPORTED SPECIFICITY - The ground truth explicitly states 'no specific revenue figures are provided,' yet the LLM answer makes definitive claims about production scaling and contract expansion without evidence. (3) MISCHARACTERIZATION OF EVOLUTION - Ground truth describes shift from 'growth driver among several others' to 'part of integrated, technologically advanced portfolio' with emphasis on AI/ML and autonomy. LLM answer instead emphasizes production scaling and geopolitical demand, which contradicts the actual positioning described. (4) QUANTITATIVE ACCURACY - The LLM references a '2023-24 Israeli order' as fact, but this is not mentioned in the ground truth and cannot be verified from the provided context. This is a significant factual claim without support. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution across years, it does so by introducing information not in the ground truth rather than accurately synthesizing what was provided. The core evolution (from near-to-mid-term growth element to integrated all-domain solutions with digital tech focus) is largely absent from the LLM answer. CORRECT ELEMENTS: The LLM correctly identifies the CH-53K as part of RMS segment and acknowledges it remained highlighted in 2024. However, these correct elements are overshadowed by substantial factual errors and unsupported claims that deviate significantly from the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 471,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\nThe 2022 10‑K (page 5) lists a seven‑product co‑commercial diabetes suite with Boehringer Ingelheim—including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar—whereas the 2024 10‑K (pages 6‑10) no longer references most of those partners‑branded agents and instead spotlights only a few higher‑value diabetes assets. This contraction signals that Lilly is shifting its strategic focus toward higher‑margin, cardiovascular‑outcome‑driven diabetes medicines and scaling back the breadth of its Boehringer Ingelheim collaboration.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 portfolio as containing seven products (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, Basaglar) - all product names match ground truth exactly. (2) The LLM correctly identifies that by 2024, the portfolio had narrowed significantly. (3) The LLM accurately cites the 2022 10-K page 5 and 2024 10-K pages 6-10 references. (4) The core multi-hop synthesis is sound: comparing 2022 vs 2024 portfolios and drawing conclusions about strategic shifts. (5) The interpretation about shifting toward 'higher-margin, cardiovascular-outcome-driven diabetes medicines' is reasonable and aligns with the ground truth's mention of 'stronger commercial performance' and 'therapeutic differentiation.' WEAKNESSES: (1) The LLM states the 2024 portfolio includes 'only a few higher-value diabetes assets' but does not explicitly list which four products remained (Jardiance, Glyxambi, Synjardy, Trijardy XR). The ground truth explicitly names these four remaining products. (2) The LLM does not specifically mention the three removed products (Trajenta, Jentadueto, Basaglar) by name when discussing the contraction, though it implies their removal. (3) The LLM's explanation focuses on 'higher-margin, cardiovascular-outcome-driven' positioning, which is a reasonable inference but the ground truth mentions multiple possible drivers: 'lifecycle management, shifting market demand, declining market relevance, generic competition.' The LLM's narrower focus on cardiovascular outcomes is not explicitly supported in the ground truth. QUANTITATIVE ACCURACY: All product names and counts are correct (7 in 2022, 4 in 2024). QUALITATIVE ACCURACY: The reasoning about strategic refocusing is sound, though the LLM could have been more explicit about which products remained and which were removed. The interpretation about cardiovascular focus is plausible but somewhat speculative compared to the ground truth's more balanced discussion of multiple possible drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 543,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the JASSM program helped drive a sharp rise in Missiles & Fire Control backlog—backlog grew from $32.2 billion in 2023 to $38.8 billion in 2024, with higher orders on JASSM (alongside PAC‑3 and GMLRS) cited as the primary cause.  Production activity accelerated, lifting MFC net sales by $1.4 billion (13 %) in 2024, but the program’s profitability came under pressure: operating profit fell from $1.54 billion in 2023 to just $0.41 billion in 2024, reflecting large profit‑booking adjustments and a $1.4 billion loss on a classified contract.  Thus, while JASSM remained strategically important for backlog growth and sales volume, its financial contribution weakened in 2024 due to margin‑eroding losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific numbers NOT in the ground truth: backlog figures ($32.2B to $38.8B), MFC net sales increase ($1.4B, 13%), and operating profit figures ($1.54B to $0.41B). The ground truth only mentions '$1.2 billion increase in tactical and strike missile programs' - NOT $1.4B. The ground truth contains NO information about operating profit, classified contract losses, or specific backlog dollar amounts. These appear to be fabricated or from different source documents not validated by the knowledge graph. (2) CALCULATION DISCREPANCY - LLM states MFC net sales increased by $1.4B (13%), but this specific figure contradicts the ground truth's $1.2B figure for tactical and strike missile programs. (3) CONTENT BEYOND GROUND TRUTH - The LLM introduces substantial information about profitability decline, classified contract losses, and margin erosion that is completely absent from the ground truth. While this information might be factually correct from the actual 10-K, it cannot be verified against the provided ground truth and represents significant extrapolation. (4) WHAT WAS CORRECT - The LLM correctly identifies: JASSM's role in backlog growth, PAC-3 and GMLRS as co-contributors, production ramp-up in 2024, and the strategic importance shift. (5) MULTI-HOP REASONING - The synthesis of JASSM's evolution is logically sound, but relies on unverified numbers. The ground truth explicitly states 'no specific mention of significant changes' in 2023, which the LLM respects by focusing on 2024 changes. VERDICT: While the LLM demonstrates good understanding of the question's multi-hop nature and correctly identifies key themes (production ramp-up, backlog contribution, strategic importance), it introduces numerous specific financial figures that contradict or exceed the ground truth data, making it unreliable for quantitative assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 518,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\nBetween 2023 and 2024 JPM moved from a largely rating‑driven, portfolio‑level assessment of Business Banking Loans to a more granular, borrower‑specific risk‑monitoring framework that emphasizes early‑warning metrics such as delinquency age, refreshed FICO scores, combined LTV and geographic concentration (see pages 242, 250‑252).  This shift enables the Firm to spot early signs of borrower distress—e.g., rising 30‑149‑day delinquencies or deteriorating credit scores—so that loss‑mitigation actions can be taken sooner.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2023 to 2024, capturing the shift toward delinquency-based metrics and early-warning indicators. The mention of 30+ day delinquencies as early warning signals aligns with the ground truth. The answer appropriately emphasizes the move toward more granular, borrower-specific monitoring and earlier intervention. The semantic understanding of the strategic shift is sound.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE: The LLM cites specific page numbers (242, 250-252) without verification against the actual filing. The ground truth does not reference these page numbers, raising concerns about citation accuracy. This is a significant issue as it suggests potential hallucination of source references. (2) MISSING CONTEXT: The ground truth explicitly mentions 'Consumer, excluding credit card loan portfolio' segment and 'loan performance and scoring models' as 2023 focus areas. The LLM answer omits the scoring models component and doesn't clearly establish the 2023 baseline framework. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes alignment with 'broader consumer loan risk frameworks' - the LLM doesn't explicitly connect Business Banking Loans to this broader framework context. (4) SPECIFICITY GAP: The ground truth mentions 'loans more than 30 days past due' as the specific metric; the LLM generalizes to '30-149-day delinquencies' which is more granular but not directly supported by the ground truth statement.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop synthesis by connecting the evolution to implications for early intervention, but the reasoning lacks the explicit connection to the broader consumer loan risk framework mentioned in the ground truth.\n\nJUSTIFICATION: The answer captures the directional shift correctly but introduces unsupported page citations and omits key contextual details about the 2023 baseline and framework alignment. The core insight about moving toward delinquency-based early warning is correct, but the execution lacks precision in sourcing and completeness in addressing all ground truth elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 576,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\nTarget’s SPP II long‑term incentive plan was first disclosed in the 2022 10‑K as the “Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3 2016)”. The 2023 10‑K reproduces the identical exhibit reference and does not list any subsequent amendment, indicating that the plan’s terms were unchanged between the two filings. This continuity reflects Target’s compensation philosophy of relying on a stable, pre‑approved equity‑based incentive structure rather than frequent revisions, underscoring a disciplined, performance‑driven executive‑pay framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. (1) CRITICAL ERROR - FACTUAL CONTRADICTION: The ground truth explicitly states that the SPP II plan evolved from the '2016 Plan Statement, as amended and restated effective April 3, 2016' in the 2022 filing to the '2022 Plan Statement, as amended and restated effective May 1, 2022' in the 2023 filing. The LLM answer claims the plan terms were 'unchanged between the two filings' and that 'the 2023 10-K reproduces the identical exhibit reference,' which directly contradicts the ground truth. The dates themselves (April 3, 2016 vs. May 1, 2022) are materially different and represent a significant plan update. (2) QUANTITATIVE ACCURACY: The dates provided in the ground truth (April 3, 2016 and May 1, 2022) are specific and verifiable facts. The LLM failed to identify these date changes, which are the primary evidence of plan evolution. (3) MULTI-HOP REASONING FAILURE: The question asks how the plan 'evolved' between 2022 and 2023 filings. The ground truth correctly synthesizes that there was an evolution (from 2016 Plan Statement to 2022 Plan Statement). The LLM incorrectly concluded there was no evolution, fundamentally failing the multi-hop synthesis task. (4) INTERPRETATION ERROR: The LLM's interpretation that 'continuity reflects Target's compensation philosophy' is based on a false premise (that there was no change). The ground truth correctly identifies that the plan revision 'could signal adjustments in the company's executive compensation strategy.' The LLM's conclusion about a 'stable, pre-approved equity-based incentive structure' is unsupported by the actual facts of the plan update. (5) SEMANTIC EQUIVALENCE: While the LLM uses appropriate language and structure, the semantic content is factually wrong—it asserts the opposite of what the ground truth establishes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 514,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\nFrom 2022 through 2024 the only contractual milestone exposure tied to the Incyte/Olumiant partnership remained the **up‑to‑$100 million of regulatory‑milestone payments and up‑to‑$100 million of sales‑based milestone payments** that Incyte could earn under the collaboration agreement (the same caps that were disclosed as of Dec 31 2021).  The company had already capitalized $260 million of regulatory milestones in 2021 and $210 million of earlier milestones, and it continues to record royalties on Olumiant sales (up to 20 % plus a low‑teens royalty on COVID‑19 sales) as cost of sales; no additional milestone amounts were recognized in 2022‑2024, so the future payments remain contingent on achieving later regulatory approvals or sales thresholds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) The LLM claims the milestone amounts 'remained the same' from 2022-2024 at $100M regulatory and $100M sales-based, but the ground truth explicitly states that by 2024 'there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable.' This is a fundamental contradiction. (2) The LLM introduces unsupported information about $260 million and $210 million in previously capitalized milestones from 2021, which is not mentioned in the ground truth and appears to be fabricated or from a different context. (3) The LLM states 'no additional milestone amounts were recognized in 2022-2024' which contradicts the core finding that the milestone structure evolved/changed between 2022 and 2024. (4) The LLM fails to capture the key insight from the ground truth: the shift from a structure with BOTH regulatory and sales milestones to one focused PRIMARILY on sales-based compensation. Instead, it suggests the same obligations persisted throughout. CORRECT ELEMENTS: The royalty rates (up to 20% plus low-teens for COVID-19) are accurately stated. The company name (Incyte/Olumiant) and general timeframe are correct. REASONING FAILURE: The LLM did not properly synthesize the evolution of obligations from 2022 to 2024. The ground truth indicates a material change in the milestone structure, but the LLM presents it as static. This is a critical failure in multi-hop reasoning and temporal analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 426,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Cisco’s APJC segment revenue grew only modestly—from about **$8.03 bn** (page 105) to roughly **$8.06 bn**, and its gross margin rose from **$5.24 bn** to **$5.28 bn** (page 105).  The goodwill allocated to APJC increased slightly from **$5.36 bn** to **$5.38 bn** (page 76), while the net balance of purchased finite‑life intangible assets in the region stayed flat at roughly **$1.65 bn** (page 77), and long‑lived assets in the International (which includes APJC) were essentially unchanged around **$1 bn** (page 106).  Consequently, Cisco’s financial exposure in APJC remained stable during the 2022‑2023 period, with only minor increases in revenue, gross margin and goodwill before the larger post‑FY2023 investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) QUANTITATIVE ERRORS: The ground truth explicitly states that 'specific financial figures for APJC were not disclosed in the provided data' for fiscal 2022, and only mentions APJC assets of $5,382 million as of July 29, 2023. The LLM fabricates specific revenue figures ($8.03bn to $8.06bn), gross margin figures ($5.24bn to $5.28bn), and goodwill figures ($5.36bn to $5.38bn) that are not supported by the ground truth. These appear to be hallucinated numbers with page references that cannot be verified. (2) ENTITY/METRIC CONFUSION: The LLM conflates different metrics - it mentions goodwill of $5.38bn which is close to the ground truth's $5,382 million in assets, but misidentifies what this represents and adds unsupported revenue/margin data. (3) MULTI-HOP REASONING FAILURE: The LLM fails to recognize that the ground truth indicates fiscal 2022 APJC data was not disclosed, making year-over-year comparisons impossible. Instead, it presents detailed comparisons as fact. (4) CONTRADICTION WITH GROUND TRUTH: The ground truth emphasizes 'specific financial figures for APJC were not disclosed' in 2022, while the LLM provides precise figures for both years. (5) MISSING KEY INSIGHT: The LLM misses the ground truth's main point - that 2023 showed more detailed disclosure than 2022, not that financial exposure remained stable. The answer demonstrates hallucination of financial data rather than synthesis of actual filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 426,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim collaboration on Jardiance shifted from a routine co‑development and marketing partnership to one increasingly shaped by U.S. price‑setting under the Inflation Reduction Act.  In August 2023 HHS designated Jardiance as one of the first ten drugs subject to mandatory government‑set pricing, and in August 2024 it announced a 66 % discount off the 2023 list price, forcing the partners to anticipate substantial revenue erosion and to adjust their pricing, reimbursement, and capacity‑expansion strategies to mitigate the regulatory impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core regulatory evolution and correctly identifies key facts: (1) The August 2023 designation of Jardiance as one of the first ten drugs subject to government-set pricing is accurate. (2) The 66% discount applied in August 2024 compared to 2023 list price is correctly stated. (3) The characterization of the shift from routine partnership to one shaped by IRA pricing is appropriate and well-reasoned. However, there are notable omissions: (1) The LLM answer fails to include the 2022 baseline growth metrics (30% U.S. increase, 28% outside U.S.) that are explicitly stated in the ground truth and provide important context for understanding the magnitude of the regulatory impact. (2) The answer does not quantify or reference the specific revenue growth drivers from 2022 (increased demand and volume) that establish the pre-regulatory baseline. The multi-hop reasoning is sound - the answer correctly synthesizes the partnership evolution across the 2022-2024 period and connects it to regulatory changes. The numeric facts that are included (August 2023 designation, August 2024 66% discount) are accurate. The answer appropriately addresses the strategic collaboration aspect and regulatory response, though it could be more complete by including the 2022 growth context. The omission of 2022 growth data represents a meaningful gap in completeness for a question specifically asking about evolution 'from 2022 to 2024,' as it prevents full understanding of the before/after impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 425,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\nBetween 2022 and 2023 GM’s risk discussion shifted from a generic warning that product‑safety recalls—particularly those involving global platforms—could harm its finances and reputation, to a concrete focus on the Chevrolet Bolt EV recall and the broader EV/AV strategy, emphasizing that safety controversies now directly jeopardize its positioning in electric and autonomous vehicles. This evolution reflects a heightened awareness that recalls tied to its EV/AV platforms could have outsized financial and brand‑reputation consequences.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key entities (GM, Chevrolet Bolt EV, EV/AV technologies) and years (2022 vs 2023). (2) No quantitative errors present - no specific numbers, dates, or calculations to verify. (3) The LLM captures the general evolution narrative: shift from generic warnings to concrete focus on Bolt EV and broader strategic implications. (4) Correctly emphasizes the reputational/brand damage aspect alongside financial concerns.\n\nWEAKNESSES: (1) DIRECTIONAL INVERSION: The LLM states the shift was from 'generic warning' to 'concrete focus on Chevrolet Bolt EV,' but the ground truth indicates the opposite temporal sequence - 2022 specifically highlighted the Bolt EV as a concrete example, while 2023 expanded to broader reputational concerns. The LLM reverses this progression. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes a shift from 'primarily cost-centric concern' (2022) to 'broader strategic risk tied to innovation and market positioning' (2023). The LLM mentions both financial and reputational consequences but doesn't clearly articulate this cost-centric-to-strategic shift. (3) MISSING NUANCE: The ground truth distinguishes between 'financial burden and logistical complexity' (2022 focus) versus 'reputational damage to brand image and equity' (2023 focus). The LLM conflates these rather than showing the evolution. (4) VAGUE PHRASING: 'Heightened awareness that recalls tied to its EV/AV platforms could have outsized consequences' is less precise than the ground truth's explicit contrast between cost-focused (2022) and strategic positioning (2023) concerns.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years and connect it to strategic positioning, but the temporal sequence appears inverted, suggesting incomplete or misaligned synthesis of the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 502,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\nBetween 2022 and 2024 the Guaranteed Senior Notes issued by Costco’s Japanese subsidiary expanded from an existing balance of roughly $590 million (reported in 2022) to a new issuance of about $500 million in November 2023, and after a $77 million repayment in July 2024 the outstanding amount rose to $919 million by year‑end 2024. This evolution shows that Costco is deliberately using its Japan entity to tap long‑dated, low‑coupon capital markets—issuing notes maturing as far out as 2033‑2043—to build a stable, diversified source of financing that supports its long‑term capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific numbers NOT present in the ground truth: claims a 2022 balance of 'roughly $590 million' and a 2024 outstanding amount of '$919 million' - these figures are fabricated and not supported by the original answer. The ground truth explicitly states that in 2022 the notes were 'described in general terms' with no specific valuation disclosed. The LLM also calculates $590M + $500M - $77M = $1,013M, not $919M, indicating internal calculation inconsistency. (2) FACTUAL ERRORS - The ground truth does NOT provide a 2022 baseline balance figure; the LLM invented this. The ground truth does NOT provide a 2024 year-end outstanding balance; the LLM fabricated this as well. (3) PARTIAL CORRECTNESS - The LLM correctly identifies: the November 2023 issuance of approximately $500 million, the July 2024 repayment of $77 million, the maturity range of 2033-2043, and the fixed interest rate structure (1.400%-2.120%). (4) REASONING QUALITY - The LLM's interpretation about Costco's financing strategy (long-dated, low-coupon capital markets, diversified financing) is reasonable and aligns with the ground truth's conclusion about 'transparent and strategic approach to long-term financing.' However, this qualitative reasoning cannot compensate for the fabricated quantitative data. (5) MULTI-HOP SYNTHESIS - The LLM attempts to synthesize evolution over time but does so by inventing numbers rather than working from actual disclosed data. The ground truth's key insight is about the EVOLUTION IN DISCLOSURE TRANSPARENCY (from general terms in 2022 to detailed specifics in 2024), which the LLM misses entirely. CRITICAL ISSUE: The LLM presents invented financial figures as fact, which is a fundamental failure in financial analysis where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 498,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the carrying amount of Cisco’s available‑for‑sale debt securities rose from **$11.9 billion** (as reported on July 30 2022) to **$15.6 billion** (as reported on July 29 2023), an increase of roughly **$3.6 billion (≈30 %)**.  This growth shows that Cisco deliberately expanded its portfolio of high‑quality, investment‑grade debt instruments—using excess cash to earn modest yields while preserving a low‑risk, liquid investment position that supports future strategic opportunities such as acquisitions or share‑holder returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) DIRECTIONAL ERROR: The LLM states available-for-sale debt investments INCREASED from $11.9B to $15.6B (+$3.6B), but the ground truth clearly indicates they DECREASED from $15,592M ($15.6B) to $9,865M ($9.9B), a decline of $5,727M. This is a critical reversal of the actual trend. (2) QUANTITATIVE ERRORS: The LLM's starting value of $11.9B is incorrect (should be $15.6B per ground truth). The ending value of $15.6B is also wrong (should be $9.9B). The calculated change of +$3.6B is incorrect; the actual change was -$5.7B. The percentage increase of 30% is mathematically wrong and directionally opposite to reality. (3) STRATEGIC INTERPRETATION ERROR: The LLM interprets this as a deliberate expansion and growth strategy, when the ground truth indicates a strategic REDUCTION in holdings. The LLM's narrative about 'deliberately expanded its portfolio' and 'growth' is completely inconsistent with the actual decrease in investment values. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison. It appears to have confused or misread the financial data, possibly mixing up different time periods or metrics. (5) SEMANTIC MISMATCH: The ground truth indicates risk management and strategic reduction; the LLM suggests expansion and growth—these are opposite conclusions. The only partially correct element is the mention of fiscal years 2022-2023, but all numerical values and the directional trend are fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 430,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\nFrom 2023 to 2024, JPMorgan Chase’s exposure to system‑damage risk has risen as its dependence on third‑party service providers has deepened and the frequency and sophistication of attacks against those vendors have increased, heightening the chance of data breaches and ransomware incidents. As a result, the firm now confronts greater uncertainty in fully recovering and restoring compromised data—often facing extended outages, higher remediation costs, and amplified regulatory and reputational penalties.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key themes from the ground truth but has significant gaps and lacks specific details. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024; (2) Appropriately emphasizes third-party vendor risks and ransomware; (3) Mentions data recovery challenges and financial implications; (4) No quantitative errors (no specific numbers were provided to verify). WEAKNESSES: (1) Missing specific 2023 risk factors mentioned in ground truth: unauthorized access, zero-day vulnerabilities, DDoS attacks, and undetected vulnerabilities from incomplete system enhancements; (2) Omits the specific 2024 concern about inability to prevent systems from processing fraudulent transactions—a key new risk element; (3) Does not mention cyber insurance coverage limitations, which was explicitly noted in the ground truth as a 2024 evolution; (4) The answer is somewhat generic and could apply to many financial institutions, lacking the specificity of JPMorgan Chase's particular risk articulation; (5) Does not adequately synthesize the multi-hop comparison between 2023 and 2024 risk profiles—it focuses more on general trends rather than the specific evolution described in the ground truth. MULTI-HOP REASONING: The answer attempts to connect third-party vendor risks to data recovery challenges, but fails to comprehensively synthesize all the specific risk factors that evolved between the two years. The ground truth shows a more nuanced progression from internal vulnerabilities (2023) to external threats and financial/operational impacts (2024), which the LLM answer only partially captures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 444,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\nBy the end of 2024 Costco had poured capital into expanding its physical footprint and private‑label production capacity to fuel the “increase the penetration of our private‑label items” strategy outlined in the 2022 filing.  The company opened 29 new warehouses in 2024 (adding roughly 130 million sq ft of floor space) and, as noted in the 2024 property disclosure, operates additional processing, packaging and manufacturing facilities that produce Kirkland‑Signature merchandise.  These investments—combined with upgrades to its supply‑chain and e‑commerce platforms—were designed to broaden the availability and sales of private‑label products across its U.S., Canadian and other international operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core operational investments Costco made to support private-label growth: processing, packaging, and manufacturing facilities for Kirkland Signature products. The answer appropriately synthesizes the 2022 strategic focus with 2024 operational execution, demonstrating sound multi-hop reasoning across filing years. The semantic equivalence is strong—the answer conveys that Costco shifted from external sourcing to internal production capabilities.\n\nHowever, there are quantitative accuracy concerns: The LLM introduces specific numbers (29 new warehouses, 130 million sq ft) that are not present in the ground truth answer. While these may be factually correct from the 2024 filing, they represent additional detail beyond what the ground truth explicitly validates. The ground truth focuses specifically on processing/packaging/manufacturing facilities for private-label production, while the LLM expands to include warehouse expansion and supply-chain/e-commerce upgrades. While these investments may be related to the strategy, the ground truth does not explicitly validate them as direct responses to the private-label growth strategy question.\n\nThe answer correctly identifies: (1) the 2022 strategic emphasis on private-label penetration, (2) the 2024 operational facilities (processing, packaging, manufacturing), (3) the shift from external sourcing to internal production, and (4) the geographic scope (U.S., Canadian, international operations). The reasoning is logically sound and appropriately multi-hop.\n\nThe main weakness is the introduction of unvalidated quantitative claims (warehouse count, square footage) and the broadening of scope beyond what the ground truth explicitly confirms. The answer would score higher if it stuck more closely to the validated operational investments (the facilities themselves) rather than adding warehouse expansion metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 519,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth’s Medicaid‑managed‑care bidding continued to rely on assumptions about enrollment growth, utilization and medical‑cost trends, but the 2023 filing highlighted that bid accuracy is now tightly linked to potential policy changes, competitive‑bid pressure and CMS risk‑adjustment audits that can produce retrospective payment adjustments or contract loss. Consequently, the company explicitly warned that any material mis‑estimation of those assumptions could materially and adversely affect its results of operations, financial position and cash flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but introduces elements not present in the ground truth and misses the core distinction. CORRECT ELEMENTS: (1) The answer correctly identifies that 2023 emphasized assumptions about enrollment, utilization, and medical costs; (2) It correctly notes that material mis-estimation of assumptions could adversely affect results of operations and cash flows; (3) The general theme of increased focus on bid accuracy risks is present. PROBLEMATIC ELEMENTS: (1) The ground truth emphasizes a shift FROM 'contract renewal risk' (2022) TO 'assumptions and competitive dynamics' (2023). The LLM answer doesn't clearly articulate this evolution or the 2022 baseline about losing Medicaid members if contracts aren't renewed; (2) The LLM introduces specific elements not mentioned in the ground truth: 'CMS risk-adjustment audits,' 'retrospective payment adjustments,' and 'policy changes' as distinct new concerns. While these may be related to Medicaid bidding risks, they are not explicitly part of the ground truth's characterization of the evolution; (3) The phrase 'bid accuracy is now tightly linked to' suggests causation or new linkages that aren't clearly established in the ground truth; (4) The answer lacks the explicit comparison structure that makes the ground truth clear: 2022 focused on X, 2023 focused on Y. MULTI-HOP REASONING: The answer attempts to synthesize information about how assumptions and risks evolved, but it doesn't clearly establish the before/after comparison that defines the evolution. The reasoning is somewhat muddled by introducing elements that may be inferred but aren't explicitly stated in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores well (8/10) - the years 2022 and 2023 are correctly referenced. QUALITATIVE ACCURACY: The answer partially captures the evolution but misses the key structural shift from renewal risk to assumption risk, and introduces elements not in the ground truth (5/10). CONTEXTUAL RELEVANCE: The answer is relevant to the question about evolution in bidding approach and does address assumptions and risks (7/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 592,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\nMET’s municipal securities remained classified in Level 2 of the fair‑value hierarchy in both years.  The fair‑value of those holdings slipped modestly from roughly $159 million at the end of 2022 (page 308) to about $147 million at the end of 2023 (page 309), but the hierarchy level did not change.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) QUANTITATIVE ERRORS - The LLM states 2022 Municipals were ~$159 million, but ground truth shows $14,212 million (off by ~$14,053 million or 98.9% error). The LLM states 2023 was ~$147 million, but ground truth shows $159 million (off by ~$12 million). These are not minor discrepancies but represent fundamental misstatement of the investment values. (2) VALUATION HIERARCHY CLASSIFICATION - The LLM claims Level 2 classification in BOTH years, but ground truth explicitly states 2022 had 'Estimated Fair Value' without detailed hierarchy breakdown, while 2023 was classified as Level 2. This is a significant difference in how the investments were categorized. (3) DIRECTIONAL ACCURACY - The LLM correctly identifies a decrease from 2022 to 2023, but the magnitude is completely wrong. Ground truth shows a massive 98.9% reduction ($14,212M to $159M), while LLM shows only a 7.5% reduction ($159M to $147M). (4) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the evolution of both the valuation amounts AND the hierarchy classification changes across the two years. The answer appears to confuse or transpose the 2022 and 2023 figures. The ground truth clearly indicates a dramatic restructuring of the Municipals portfolio with both a massive reduction in size and a shift to explicit Level 2 classification, neither of which is accurately captured in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 411,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Microsoft moved Office 365 from a mainly multi‑year volume‑licensing approach (Enterprise Agreements with optional Software Assurance) to a broader set of non‑expiring, digitally‑executed agreements—including the Microsoft Customer Agreement and the Microsoft Online Subscription Agreement—while expanding monthly/annual subscription options and the Cloud Solution Provider channel. This evolution gave customers greater flexibility to obtain Office 365 as a perpetual license with optional SA, as a pure subscription, or as a hybrid, and to adjust terms more easily through direct Microsoft sales or partner‑managed CSP arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) FACTUAL ERROR - The LLM answer introduces 'perpetual license with optional SA' as part of Office 365's evolution, which is fundamentally incorrect. Office 365 is a subscription-based cloud service, not a perpetual licensing model. This represents a major conceptual error about the product itself. (2) MISSING KEY INFORMATION - The ground truth specifically mentions 'unearned revenue' recognition and 'invoiced annually at the beginning of each contract period and recognized ratably over the coverage period' for FY2022, which the LLM answer completely omits. This is important accounting/revenue recognition detail. (3) INACCURATE CHARACTERIZATION - The LLM answer suggests Office 365 could be obtained 'as a perpetual license' which contradicts the fundamental nature of Office 365 as a subscription service. The ground truth does not make this claim. (4) PARTIAL CREDIT FOR CORRECT ELEMENTS - The LLM answer correctly identifies: the shift from volume licensing to more flexible models, the introduction of Microsoft Customer Agreement and Microsoft Online Subscription Agreement, expansion of monthly/annual subscription options, and the role of Cloud Solution Provider channel. (5) SYNTHESIS QUALITY - While the LLM attempts multi-hop reasoning across fiscal years, it introduces incorrect information about perpetual licensing that wasn't in the ground truth and mischaracterizes the product offering. The ground truth focuses on licensing flexibility and customer agreement models; the LLM adds unsupported claims about perpetual licensing options. (6) SEMANTIC ISSUES - The phrase 'non-expiring, digitally-executed agreements' is vague and potentially misleading compared to the ground truth's clearer description of subscription flexibility. The ground truth emphasizes 'no organization-wide commitment' which the LLM doesn't explicitly capture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 511,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the Level 3 Fixed‑Maturity‑Securities‑AFS portfolio shifted modestly away from foreign‑government bonds (down from $55 m to $54 m) and toward corporate bonds and other less‑liquid securities (corporate up from $3 m to $8 m; “other” up from $3 m to $12 m), lifting the total Level 3 balance from roughly $61 m to $74 m.  This reallocation shows MetLife is deliberately increasing exposure to higher‑yielding, higher‑risk assets—particularly corporate and alternative securities—to boost returns and better match the pension fund’s liability cash‑flow needs, indicating a more return‑focused investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it almost entirely incorrect. Specific issues: (1) QUANTITATIVE ERRORS - The LLM provides completely different numbers than the ground truth. For example, it claims Foreign Bonds decreased from $55M to $54M, when the ground truth shows they went from $1M to $2M. It states Corporate bonds increased from $3M to $8M, when ground truth shows $1M to $54M. It claims 'Other' increased from $3M to $12M, when ground truth shows $0M to $828M. The total is stated as $61M to $74M, when ground truth indicates $13M to $884M. (2) MISSING KEY INFORMATION - The LLM completely fails to identify the most significant change: the massive increase in 'Other Investments' from essentially $0 to $828M, which is the dominant feature of the portfolio shift and the primary indicator of investment strategy change. The LLM also misses Equity Securities ($11M in 2022). (3) ENTITY/METRIC CONFUSION - The LLM incorrectly references 'foreign-government bonds' when the ground truth specifies 'Foreign Bonds,' and the numbers don't match either category. (4) REASONING FLAWS - While the LLM attempts to interpret the strategy shift, it does so based on incorrect data. The actual strategy shift (toward Other Investments) is far more dramatic than the modest reallocation the LLM describes. The LLM's conclusion about 'return-focused investment strategy' and 'pension fund liability matching' appears to be speculative interpretation not supported by the actual data composition. (5) MULTI-HOP SYNTHESIS - The LLM fails to properly synthesize the year-over-year comparison across all security types. The answer demonstrates a fundamental misunderstanding or misreading of the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 473,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft folded Office 365 into a broader “Microsoft 365” cloud suite that is tightly coupled with Azure AI and generative‑AI services such as Copilot, turning the productivity bundle into a primary gateway for customers to consume the company’s AI‑driven cloud platform.  To counter competitive pressure from AI‑focused rivals (e.g., Google Workspace, Amazon Bedrock, Snowflake), Microsoft accelerated the infusion of generative‑AI capabilities, marketed Office 365 as an AI‑enhanced, subscription‑based service that unlocks new monetisation paths (AI‑powered features, usage‑based pricing), and emphasized cross‑device, platform‑agnostic availability to preserve its market share while driving growth in the larger Azure cloud ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains a mix of accurate directional insights and problematic unsupported claims that deviate from the ground truth.\n\nCORRECT ELEMENTS:\n1. The core evolution narrative is directionally accurate - Office 365 did shift toward AI integration between 2022-2024\n2. The mention of Copilot and generative AI infusion aligns with ground truth\n3. Recognition of competitive pressures from AI-focused competitors is accurate\n4. The broader positioning within cloud services portfolio is correct\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIM: \"folded Office 365 into a broader 'Microsoft 365' cloud suite\" - The ground truth does not mention this rebranding or structural reorganization. This appears to be an inference not supported by the filing data.\n2. UNSUPPORTED CLAIM: \"tightly coupled with Azure AI\" - While both are part of the portfolio, the ground truth does not specify this level of technical coupling.\n3. UNSUPPORTED CLAIM: Specific competitors listed (Google Workspace, Amazon Bedrock, Snowflake) - The ground truth mentions \"companies entering the AI market\" and \"free applications funded by advertising or open-source AI models\" but does not name these specific competitors.\n4. UNSUPPORTED CLAIM: \"new monetisation paths (AI-powered features, usage-based pricing)\" - The ground truth does not discuss specific monetization strategy changes or usage-based pricing models.\n5. UNSUPPORTED CLAIM: \"cross-device, platform-agnostic availability\" - This specific strategic positioning is not mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM synthesized information about the evolution from 2022-2024 and competitive pressures, but added substantial details not present in the ground truth, suggesting hallucination rather than faithful synthesis.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or metrics were provided by either answer, so this dimension is neutral (7/10 for not introducing false numbers).\n\nQUALITATIVE ACCURACY: While the answer demonstrates understanding of the general trend, it introduces multiple unsupported claims that contradict the principle of grounding answers in actual filing data. The reasoning appears to extrapolate beyond what the knowledge graph contains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 605,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\nUnitedHealth Group continued to assess its available‑for‑sale debt securities for credit‑related impairment by applying a present‑value cash‑flow test and reviewing each issuer’s credit ratings and financial condition. In both the 2022 and 2023 filings the Company concluded that the unrealized losses were driven by interest‑rate movements rather than any deterioration in credit quality, so no material allowance for credit losses was recorded and the impairment methodology and financial impact remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about how credit-related impairment handling EVOLVED between 2022 and 2023. Specific issues: (1) MAJOR ERROR - The LLM claims the methodology and financial impact 'remained essentially unchanged' between 2022 and 2023, which directly contradicts the ground truth showing a clear evolution. The ground truth explicitly states that by 2023, the company 'formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments' and adopted a 'more detailed and segmented approach.' (2) MISSING KEY INFORMATION - The LLM fails to mention the critical 2023 development: the distinction between credit-related impairments (recorded as allowance against investment income) versus non-credit-related impairments (through other comprehensive income). This is a fundamental change in accounting treatment. (3) INCOMPLETE METHODOLOGY DESCRIPTION - While the LLM correctly identifies some 2022 evaluation factors (cash flows, credit ratings, interest rate analysis), it fails to capture the enhanced 2023 framework that includes 'present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions' as a more structured approach. (4) MISCHARACTERIZATION - The LLM's statement that methodology 'remained essentially unchanged' is factually incorrect based on the ground truth's clear documentation of formalization and segmentation of the impairment process. The quantitative accuracy score is higher (7) because the LLM correctly identifies that no material allowance was recorded and that interest rates were the primary driver, but the qualitative accuracy is very low (2) because the answer fundamentally misses the evolution narrative that is central to the question. The contextual relevance is low (4) because while the answer addresses impairment evaluation, it fails to address the 'evolution' aspect that is explicitly requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 552,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\nFrom 2022 to 2023 the Fixed‑Maturity‑Securities‑AFS component stayed the dominant part of the plan’s asset mix but its share slipped slightly: in the pension fund it moved from about 84 % of actual assets (near the 85 % target) in 2022 to **82 %** in 2023, while in the other post‑retirement fund it fell from roughly 95 % to **94 %** of the actual allocation.  At the same time the fair‑value of these securities rose in the pension portfolio from **$3.0 bn (Dec 31 2022)** to **$3.1 bn (Dec 31 2023)**, whereas the amount held for other post‑retirement benefits declined from **$205 m** to **$167 m**; the hierarchy classification remained largely Level 2, with only a small Level 3 exposure that stayed roughly stable (≈ $55 m in 2022 vs $54 m in 2023).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) PERCENTAGE ALLOCATIONS: Ground truth states 84% for Pension Benefits in 2022 and 95% for Other Postretirement Benefits in 2022. The LLM claims these fell to 82% and 94% respectively in 2023, but the ground truth provides NO 2023 percentage allocations - only 2023 fair values. The LLM fabricated 2023 percentage figures. (2) FAIR VALUE AMOUNTS - CRITICAL ERRORS: Ground truth clearly states 2023 fair values were $6,714 million (Pension Benefits) and $1,274 million (Other Postretirement Benefits). The LLM claims pension fair value was $3.0-3.1 billion and other postretirement was $205-167 million - these are WRONG by a factor of 2x for pensions and completely incorrect for other postretirement benefits. The LLM's $3.1bn figure is less than half the actual $6,714 million. The $167m figure is drastically lower than the actual $1,274 million. (3) MISSING DATA: The LLM provides 2022 fair values ($3.0bn pension, $205m other postretirement) that are not in the ground truth, suggesting the LLM may have confused or misread source data. (4) LEVEL 2/LEVEL 3 HIERARCHY: The LLM introduces fair value hierarchy information ($55m Level 3 in 2022, $54m in 2023) that is not mentioned in the ground truth at all - this appears to be fabricated or from incorrect sources. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution from 2022 percentage-based allocation to 2023 valuation breakdown. Instead of explaining this shift, it invented intermediate percentage figures for 2023. The core answer structure is fundamentally flawed due to incorrect numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 464,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Lowe’s pushed the Kitchens & Bath line from a generic “Home Décor” bucket into a dedicated growth pillar of its “Total Home” strategy.  The 2022 filing lists Kitchens & Bath as part of the Home Décor category, which accounted for roughly 35 % of net sales, and the 2023 discussion emphasizes “Elevate assortment” – a specific initiative to deepen private‑brand depth, expand installation services and improve omnichannel fulfillment for the category.  This focus indicates that Kitchens & Bath has become a strategically important, high‑margin segment that the company is actively investing in and integrating across its product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic repositioning narrative correctly - that Kitchens & Bath moved from Home Décor positioning in 2022 to a more prominent growth pillar in 2023 aligned with the 'Total Home' strategy. The qualitative reasoning about higher-margin segments and strategic importance is sound and aligns with the ground truth's conclusion about greater emphasis on Kitchens & Bath as a key growth area. However, there are significant quantitative accuracy issues: (1) The LLM states Home Décor 'accounted for roughly 35% of net sales' in 2022 - this specific percentage is not verified in the ground truth and appears to be an unsupported claim that introduces a potentially incorrect metric. (2) The LLM mentions 'Elevate assortment' as a 2023 initiative with specific details about private-brand depth, installation services, and omnichannel fulfillment - while these details sound plausible and align with strategic direction, they are not explicitly confirmed in the ground truth provided. The ground truth states Kitchens & Bath was 'listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing' in 2023, but the LLM doesn't explicitly mention this repositioning alongside these specific categories. The multi-hop reasoning is partially sound - the LLM correctly identifies the 2022-to-2023 shift and connects it to the Total Home strategy - but it introduces unverified quantitative claims (the 35% figure) and specific initiative names that go beyond what can be confirmed from the ground truth. The answer is contextually relevant and addresses the question's core inquiry about strategic positioning evolution and relative importance, but the introduction of unverified metrics and specific program names without clear sourcing reduces confidence in the quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 503,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Mondelez moved cheese & grocery from a peripheral, “adjacent” line‑item in its portfolio to a deliberately‑targeted growth pillar.  The 2024 MD&A (p. 34) explicitly lists cheese & grocery among the “locally relevant” categories that support the company’s “global leader in snacking” strategy, and the 2024 acquisition of Evirh (cakes and pastries in China) (p. 36) shows the firm is investing to expand that segment.  This shift signals that Mondelez is prioritizing cheese & grocery—alongside chocolate, biscuits and baked snacks—as a key category for delivering long‑term, sustainable snack‑category growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) DIRECTIONAL ERROR: The ground truth states Mondelez moved FROM direct production of Cheese & Grocery ($1,990M in 2022) TO a lighter strategic stake by 2024, representing a REDUCTION in focus. The LLM claims the opposite—that Cheese & Grocery moved from 'peripheral' to a 'deliberately-targeted growth pillar,' which is factually incorrect. (2) QUANTITATIVE INACCURACY: The ground truth provides a specific 2022 revenue figure of $1,990 million for Cheese & Grocery. The LLM provides no quantitative data and makes no attempt to address the revenue trajectory or scale of this category. (3) STRATEGIC MISINTERPRETATION: The ground truth indicates the shift reflects 'refocusing on core snack categories like biscuits and chocolate' with a 'lighter footprint' in Cheese & Grocery. The LLM incorrectly characterizes this as prioritizing Cheese & Grocery 'alongside chocolate, biscuits and baked snacks' as a 'key category,' which inverts the actual strategic priority. (4) UNSUPPORTED CLAIMS: The LLM cites the Evirh acquisition (cakes and pastries in China) as evidence of Cheese & Grocery expansion, but this is a different product category (baked goods/pastries) and does not support the claim about Cheese & Grocery strategic focus. (5) MISSING CONTEXT: The LLM fails to acknowledge the actual shift from direct production to a strategic stake, which is the core factual change between 2022 and 2024. The answer demonstrates a fundamental misunderstanding of the question and provides information that contradicts the ground truth on the primary direction and nature of Mondelez's strategic evolution in this category.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 470,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\nIn the 2022 filing (page 5 of ABT_10k_2022.pdf) Jevity is listed merely as one of the “nutritional products used in enteral feeding… including Jevity, Glucerna …, Freego™ (Enteral Pump) and Freego™ sets,” with no explicit hierarchy or comparative wording. The 2023 filing (page 5 of ABT_10k_2023.pdf) keeps the same product list but adds language that describes Jevity as a “leading brand of enteral nutrition” and positions Freego™ as a “pump platform that delivers Jevity and other enteral formulas,” thereby shifting the presentation to place Jevity as the flagship product and Freego™ as its supporting delivery system.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Product Listing Order: The ground truth explicitly states that in 2022, Jevity was listed first followed by Glucerna products, Osmolite, Oxepa, and then Freego products at the end. In 2023, Freego products moved to immediately after Jevity. The LLM claims both years had the same product list with no explicit hierarchy in 2022, which directly contradicts the ground truth's detailed ordering information. (2) CRITICAL ERROR - Nature of Change: The ground truth identifies the key change as a shift in LISTING ORDER/POSITIONING (Freego moved from last to second position). The LLM instead claims the change was the addition of descriptive language about Jevity being a 'leading brand' and Freego being a 'supporting delivery system.' This is a fundamental mischaracterization of what actually changed between the filings. (3) MISSING INFORMATION: The LLM fails to mention the specific products (Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite, Oxepa) and their positioning relative to Freego in both years. (4) UNSUPPORTED CLAIMS: The LLM's description of added language about Jevity as 'leading brand' and Freego as 'pump platform' is not verified against the actual ground truth, which focuses on listing order changes, not new descriptive language. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative positioning information across the two filing years. The answer demonstrates a fundamental misunderstanding of what changed between the two filings - it was about product listing sequence, not about added marketing language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 453,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of MET’s municipal‑bond holdings in its AFS portfolio fell from roughly **$159 million to $147 million** (about an 8 % decline).  The securities remained **classified as Level 2**—valued from observable market inputs—so the decline reflects a deliberate reduction in exposure rather than a change in valuation methodology.  This modest pull‑back signals that MET is actively **de‑risking its municipal allocation**, shifting assets toward more liquid, higher‑return instruments as part of a conservative credit‑risk management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022-2023 municipal holdings fell from '$159 million to $147 million' - this is completely wrong. Ground truth shows: 2022 = $14,212 million, 2023 = $159 million. The LLM has reversed the years and used the 2023 figure ($159M) as the 2022 baseline, then fabricated a 2023 figure of $147M that doesn't exist in the source data. The actual decline is from $14,212M to $159M (98.9% reduction), not 8%. (2) MISSING KEY INFORMATION: The LLM completely omits critical details from ground truth: the $2,464 million in gross unrealized gains and $13 million in gross unrealized losses in 2022, which are essential to understanding the portfolio composition and risk profile. (3) MISCHARACTERIZATION OF MAGNITUDE: The LLM describes this as a 'modest pull-back' when the ground truth indicates a 'dramatic reduction' - this is a semantic misrepresentation of a 98.9% decline. (4) PARTIAL CREDIT ON CLASSIFICATION: The LLM correctly identifies Level 2 classification, which aligns with ground truth, but this is overshadowed by the massive numerical errors. (5) REASONING QUALITY: While the LLM's logic about de-risking and credit risk management is conceptually sound, it is built on entirely false numerical premises, making the analysis fundamentally unreliable. The answer fails the primary requirement of factual accuracy on the core quantitative data that defines the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 423,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott trimmed the size of its interest‑rate hedge program by about **$700 million** of notional swaps that matured and were not replaced, shrinking the pool of contracts used to protect its fixed‑rate debt.  As a result, the amount re‑classified from accumulated other‑comprehensive income into interest expense changed from a **$243 million benefit in 2022** to a **modest $61 million charge in 2023**, reflecting the reduced hedge coverage and the resulting shift in the effective interest rate on the remaining fixed‑rate obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The ground truth states Abbott's interest rate hedge contracts were approximately $2.2 billion in both 2022 and 2023 with consistent notional value. The LLM claims a $700 million reduction, which is factually incorrect. The LLM also introduces specific numbers ($243 million benefit in 2022, $61 million charge in 2023) that are not mentioned in the ground truth and appear to be fabricated. (2) DIRECTIONAL ERROR: The ground truth explicitly states the notional value 'remained consistent at approximately $2.2 billion,' while the LLM claims the company 'trimmed the size' by $700 million - a fundamental contradiction. (3) MISSING KEY INFORMATION: The LLM fails to mention that the notional value remained at approximately $2.2 billion in both years, which is the core finding. (4) UNSUPPORTED CLAIMS: The specific reclassification amounts ($243M and $61M) and the characterization of the 2023 amount as a 'charge' versus 2022 'benefit' are not supported by the ground truth and appear to be hallucinated details. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information about hedge contracts and their impact on debt management, it does so with incorrect data points. The answer demonstrates poor factual accuracy despite addressing the general topic area. The ground truth indicates consistency and refinement of disclosures, while the LLM incorrectly portrays a significant reduction in hedge coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 424,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\nBetween 2022 and 2024 3M repaid a sizable amount of its fixed‑rate registered and medium‑term notes—$1 bn of notes in 2023, $1.1 bn of medium‑term notes that matured in 2024, plus earlier Euro‑bond and 2022‑maturing issues—while simultaneously issuing new fixed‑rate registered notes (e.g., $1 bn of 2029 notes at ~2.4% and $750 m of 2025 notes at ~2.0%).  At the same time the company converted portions of its longest‑dated fixed‑rate debt (the 2049‑2050 notes) into floating‑rate exposure through interest‑rate swaps, using put‑option provisions to manage redemptions.  This mix of targeted repayments, strategic new issuances and fixed‑to‑floating swaps reflects a debt‑management strategy aimed at reducing leverage, locking in lower coupons when possible, and controlling interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of 3M's debt management strategy and correctly identifies key themes (repayments, new issuances, fixed-to-floating swaps). However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies $1.1 billion in medium-term notes repaid in 2024\n- Correctly identifies $500 million in fixed-rate registered notes repaid in 2023 (though stated as \"$1 bn of notes in 2023\" which is incorrect)\n- Correctly identifies the strategic use of interest rate swaps converting 2049-2050 notes to floating rate\n- Correctly identifies the overall debt management strategy of reducing leverage and controlling interest rate risk\n- Appropriately synthesizes multi-hop information across years 2022-2024\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERROR: States \"$1 bn of notes in 2023\" but ground truth shows $500 million repaid in 2023, not $1 billion. This is a 100% overstatement.\n2. COUPON RATES: LLM provides coupon rates (~2.4% for 2029 notes, ~2.0% for 2025 notes) that are NOT mentioned in the ground truth. Ground truth specifies 3.05% for 2030 notes and 3.70% for 2050 notes from 2022. The LLM appears to have introduced unsupported numbers.\n3. MISSING SPECIFIC DETAILS: Ground truth mentions specific note amounts ($600M of 10-year notes due 2030, $650M of 30-year notes due 2050, $1.0B of 10-year notes due 2029, $1.0B of 30-year notes due 2049). LLM provides generic references without these specifics.\n4. VAGUE REFERENCES: \"earlier Euro-bond and 2022-maturing issues\" are mentioned but not substantiated in ground truth.\n5. PUT-OPTION PROVISIONS: LLM mentions \"put-option provisions to manage redemptions\" which is not mentioned in the ground truth.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across 2022-2024 and identifies the evolution of the debt portfolio. However, the synthesis is undermined by the quantitative inaccuracies.\n\nSEMANTIC EQUIVALENCE:\nWhile the overall narrative about debt management strategy is semantically equivalent to the ground truth, the specific financial figures are not accurate enough to support this narrative with confidence.\n\nJUSTIFICATION:\nThe answer loses points primarily due to: (1) incorrect repayment amount for 2023 ($1B vs $500M), (2) unsupported coupon rates, (3) missing specific note details from ground truth, and (4) introduction of elements (put-options) not in ground truth. The qualitative understanding is sound, but quantitative accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 680,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab moved from an active issuance phase—issuing roughly $9 bn of senior unsecured notes and preferred stock in 2023 (see page 58)—to a defensive stance in 2024, highlighted by the full redemption of its floating‑rate Senior Notes in February 2024 and the expiration of its $2.1 bn unsecured revolving credit line (see page 54). As a result, external securities issuances now play a far smaller role in the capital structure; funding has shifted toward internally generated cash, client deposits and the use of existing borrowing facilities (e.g., FHLB lines, brokered CDs), while the firm emphasizes preserving regulatory capital ratios and returning excess capital through dividends and share repurchases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific numbers ($9bn in senior unsecured notes and preferred stock in 2023, $2.1bn unsecured revolving credit line expiration, February 2024 redemption) that cannot be verified against the ground truth and appear to be hallucinated or incorrectly sourced. The ground truth does not provide these specific dollar amounts or dates. (2) CONCEPTUAL MISALIGNMENT: The ground truth describes a shift from securities issuances as a 'primary source' in 2023 to being 'positioned among a broader set of liquidity tools' in 2024—a diversification strategy. The LLM characterizes this as a shift from 'active issuance phase' to 'defensive stance' with 'far smaller role,' which is a different narrative than the ground truth's emphasis on integration within a wider framework. (3) MISSING CONTEXT: The ground truth specifically mentions FHLB borrowings, repurchase agreements, and CDs as part of the diversified approach in 2024. While the LLM mentions FHLB lines and brokered CDs, it frames this as a shift away from securities issuances rather than a complementary diversification. (4) UNSUPPORTED CLAIMS: References to 'full redemption of floating-rate Senior Notes,' 'expiration of credit line,' and emphasis on 'preserving regulatory capital ratios' and 'returning excess capital through dividends and share repurchases' are not substantiated in the ground truth provided. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution described in the ground truth—that securities issuances remained important but became more integrated within a broader capital structure, rather than becoming less important. The answer demonstrates reasonable structure and addresses the 2023-2024 comparison, but the factual inaccuracies and unsupported specific numbers significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 525,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\nFrom 2022 through 2024 the contingent payment tied to fairlife moved from the $270 million accrual recorded at acquisition (page 75) to a $100 million payment made in 2021 when fairlife hit its 2020 targets, then to a $275 million milestone paid in 2023 (page 112).  By the end of 2024 the remaining milestone was re‑measured at roughly $6 billion of contingent consideration (page 112), reflecting updated projections that fairlife will meet the performance goals through 2024.  This upward revision and the milestone payments indicate that fairlife has been progressing toward—and ultimately achieving—its financial targets, justifying the larger final contingent payout.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent the fairlife contingent payment situation: (1) MAJOR QUANTITATIVE ERRORS: The LLM claims a $275 million milestone was paid in 2023 and a $6 billion contingent consideration re-measurement by end of 2024 - neither of these figures appear in the ground truth. The ground truth shows $270 million liability in 2022 and a remaining contingent payment through 2024, with no mention of $275M or $6B figures. (2) CHRONOLOGICAL CONFUSION: The LLM incorrectly sequences events, stating the $270M was 'recorded at acquisition' when the ground truth indicates this was the 2022 disclosure amount. The LLM also confuses the timeline by discussing a 2023 payment that isn't mentioned in the ground truth. (3) MISREPRESENTATION OF PERFORMANCE: The ground truth indicates fairlife 'remained on track to potentially meet' targets, suggesting cautious optimism. The LLM claims fairlife 'ultimately achieving' targets and justifying a 'larger final contingent payout,' which overstates the certainty and contradicts the ground truth's more measured assessment. (4) MISSING KEY CONTEXT: The LLM fails to properly explain that the $100M payment in 2021 was for 2020 targets, and that the remaining obligation was contingent on 2024 targets being met - this is crucial context for understanding the evolution. (5) UNSUPPORTED PAGE REFERENCES: The LLM cites specific page numbers (75, 112) with figures that don't match the ground truth, suggesting fabricated or misread source material. The core answer structure is fundamentally broken due to invented financial figures that are orders of magnitude different from the ground truth ($6B vs $270M).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 467,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle moved OCI from a peripheral cloud add‑on to a central strategic pillar, explicitly branding it as a globally‑scaled infrastructure platform that is tightly woven into the company’s broader cloud‑services portfolio.  The 2022 10‑K (pp. 45‑49) highlighted growth in cloud‑and‑license revenues and a shift away from certain hardware, while the 2024 10‑K (pp. 70‑74) expands the narrative to describe OCI as a differentiated IaaS offering that integrates with Oracle’s SaaS and PaaS services and is sold through a worldwide direct‑sales force to support hybrid, enterprise‑wide IT deployments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic narrative - Oracle's evolution of OCI from a peripheral offering to a central strategic pillar between 2022 and 2024. The qualitative characterization of the shift (peripheral add-on → central pillar, integration with SaaS/PaaS, enterprise IT focus, worldwide direct-sales force) aligns well with the ground truth. The answer appropriately addresses both the global market positioning and enterprise IT integration aspects of the question.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer cites specific page numbers (2022 10-K pp. 45-49, 2024 10-K pp. 70-74) without verification against ground truth. More critically, the LLM completely omits the specific financial metric from the ground truth: the $36.052 billion cloud and license revenue figure representing 85% of total revenues in 2022. This is a significant quantitative omission that weakens the answer's factual grounding.\n\nWEAKNESSES - COMPLETENESS: While the LLM captures the strategic evolution narrative, it fails to include the concrete financial context provided in the ground truth. The ground truth explicitly states '2022 financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues' - this quantitative foundation is absent from the LLM answer.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting 2022 positioning with 2024 positioning and identifying the strategic shift. However, the reasoning would be stronger with the financial metrics that contextualize the strategic importance.\n\nSEMANTIC EQUIVALENCE: The LLM's description of OCI as 'differentiated IaaS offering that integrates with Oracle's SaaS and PaaS services' is semantically equivalent to the ground truth's 'comprehensive and integrated applications and infrastructure services.' The characterization of deployment model flexibility is also present in both.\n\nJUSTIFICATION: The answer scores 6/10 because while it captures the strategic narrative correctly (qualitative accuracy 7/10, contextual relevance 8/10), it fails to include critical quantitative data from the ground truth (quantitative accuracy 4/10). The omission of the $36.052 billion figure and 85% revenue contribution is a material gap in a financial analysis context, even though the strategic positioning narrative is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 645,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab continued to record **no allowance for credit losses on its Pledged‑Asset Lines** – the allowance balance remained $‑ (i.e., zero) in both years – and the company reiterated that **all PALs are fully collateralized by securities whose fair value exceeds the outstanding balances**, a condition that persisted unchanged.  The PAL segment’s share of the total loan portfolio slipped only modestly (from roughly 36 % to 33 % of total bank loans), while delinquency indicators improved (the proportion of PALs on non‑accrual fell to 0.07 % in 2024), reinforcing the low‑risk, fully‑collateralized profile that has been maintained across the two periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about PAL evolution between 2023 and 2024, correctly identifying that: (1) no allowance for credit losses was recorded in both years, (2) all PALs were fully collateralized, and (3) the risk profile strengthened. However, there are significant issues with quantitative accuracy and unverified claims:\n\nCORRECT ELEMENTS:\n- Zero allowance for credit losses in both 2023 and 2024 matches ground truth\n- Full collateralization by securities with fair values exceeding borrowings is accurate\n- Reference to ASC 326 collateral maintenance practical expedient aligns with ground truth\n- Overall characterization of strengthening risk profile is correct\n\nPROBLEMATIC ELEMENTS:\n1. UNVERIFIED NUMBERS: The LLM provides specific percentages (36% to 33% of total bank loans, 0.07% non-accrual rate in 2024) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from unstated documents. The ground truth does not mention these specific metrics.\n2. COMPANY ATTRIBUTION: The answer attributes information to \"Schwab\" without clear verification that the ground truth data is from Schwab filings. While plausible, this is an assumption not explicitly confirmed in the ground truth.\n3. INCOMPLETE SYNTHESIS: While the LLM adds detail about delinquency indicators and portfolio composition, these additions go beyond what the ground truth specifies and cannot be verified against it.\n4. MISSING GROUND TRUTH DETAIL: The ground truth specifically mentions \"improved credit quality metrics and lower projected loss rates\" in 2023, which the LLM answer does not address.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution narrative (2023 to 2024 comparison) and connects collateralization to risk profile, which is sound reasoning. However, the introduction of unverified quantitative details undermines the reliability of the synthesis.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth, but the addition of specific percentages and metrics creates factual claims that cannot be verified and may be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 568,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\nBetween FY 2023 and FY 2024 Nike formalized APLA as a distinct geographic operating segment and placed it under the new “President, Geographies & Marketplace” leadership (Craig Williams), integrating its NIKE Brand and Converse businesses into the regional profit‑and‑loss.  Revenue from the region edged up to **$6.73 bn** (≈ 5 % growth from $6.43 bn), and the company highlighted expanding direct‑to‑consumer and digital channels while building alternative supply sources to mitigate trade‑protection risks—aligning APLA’s growth with Nike’s broader DEI, sustainability and community‑investment priorities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth on multiple critical dimensions: (1) STRUCTURAL MISMATCH: The ground truth describes an evolution from direct operational involvement (FY2023) to outsourced third-party distributor model (FY2024), emphasizing workforce structure changes and operational complexity reduction. The LLM answer instead focuses on formalization of APLA as a distinct segment, leadership reorganization under Craig Williams, and integration of profit-and-loss structures—these are organizational/reporting changes, not the operational outsourcing transition described in ground truth. (2) QUANTITATIVE ISSUES: The LLM provides specific revenue figures ($6.73bn in FY2024, $6.43bn in FY2023, ~5% growth) that cannot be verified against the ground truth, which contains no revenue data. While these numbers may be factually accurate from the 10-K, they are not part of the ground truth answer and don't address the core question about operational structure evolution. (3) STRATEGIC EMPHASIS MISMATCH: The LLM emphasizes DTC/digital channels, supply chain diversification, DEI, sustainability, and community investment. The ground truth emphasizes the shift from direct control to outsourced distributor model and workforce representation changes. These represent different strategic narratives. (4) MULTI-HOP REASONING: The LLM fails to synthesize the key multi-hop insight: the relationship evolution involved moving from direct employee-based operations (with union representation) to third-party distributor arrangements. Instead, it synthesizes organizational restructuring and segment formalization. (5) MISSING CORE ELEMENTS: The LLM completely omits discussion of trade union representation, workforce structure changes, and the shift to third-party distributors—all central to the ground truth answer. The answer addresses a different aspect of Nike's APLA evolution (organizational structure/reporting) rather than the operational and employment model evolution described in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 548,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott moved Pedialyte from a steady‑growth product to a focal point of its U.S. pediatric‑nutrition strategy.  The 2022 10‑K shows U.S. Pediatric Nutritionals sales rising 10 % in 2021, with Pedialyte (alongside Similac and PediaSure) cited as a key growth driver, and the 2023 10‑K’s narrative emphasizes expanding the Pedialyte line (new flavors/formats) and boosting consumer‑direct and physician‑recommendation marketing to capture more of the pediatric‑hydration market.  Consequently, Abbott’s positioning shifted toward a deliberate portfolio‑expansion and brand‑building emphasis on Pedialyte within its U.S. pediatric nutritional business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Pedialyte from 2022 to 2023, capturing the shift toward portfolio expansion and brand-building emphasis. The answer appropriately references the 10.3% growth figure (though stated as '10%' - a minor rounding) and correctly names the comparison products (Similac, PediaSure). The qualitative assessment of strategic positioning is sound and addresses the multi-hop synthesis required. CRITICAL ERRORS: (1) QUANTITATIVE INACCURACY: The LLM states 'U.S. Pediatric Nutritionals sales rising 10% in 2021' when the ground truth specifies '10.3% for the year' (2022). This conflates the year reference - the 10.3% figure applies to 2022 performance, not 2021. (2) INCOMPLETE SYNTHESIS: The LLM answer adds details about 'new flavors/formats' and 'consumer-direct and physician-recommendation marketing' that are not present in the ground truth. While these may be accurate from the 2023 10-K, they represent information beyond what the knowledge graph provided and cannot be verified against the original answer. (3) MISSING KEY ELEMENT: The ground truth emphasizes formal inclusion in the Nutritional Products segment portfolio listing alongside Ensure and Glucerna in 2023 - this structural/organizational aspect is not captured in the LLM answer. The LLM focuses on marketing and product expansion rather than the formal portfolio integration mentioned in the ground truth. REASONING ASSESSMENT: The multi-hop synthesis is partially sound but introduces unverified details and misattributes the year for the growth percentage. The core narrative of strategic evolution is correct, but the execution contains factual inconsistencies with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 471,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\nThe 7.100 % notes maturing in 2027 continued to be carried at roughly **$135 million** at the end of 2022 and remained at the same $135 million level at the end of 2023 (no repayment or additional issuance of that tranche is shown in the schedules).  This stability occurred while total long‑term debt rose from about **$31.4 billion** (2022) to **$43.6 billion** (2023), indicating that RTX is deliberately **preserving its legacy, lower‑cost debt** and using newer, longer‑dated issuances to refinance near‑term maturities rather than retiring the 7.100 % notes early.  The strategy reflects a focus on extending overall debt maturity and managing liquidity while keeping the inexpensive 7.100 % obligation on the books until it naturally matures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth clearly states that in 2022, RTX had $6 million in 7.100% notes due 2027, and by 2023 this increased to $135 million. The LLM answer claims the notes were 'roughly $135 million at the end of 2022 and remained at the same $135 million level at the end of 2023' - this is completely incorrect. The LLM reversed the 2022 figure (should be $6M, not $135M) and missed the significant increase from $6M to $135M that is central to the question. (2) MULTI-HOP REASONING FAILURE: The question specifically asks how the financial position 'evolved from 2022 to 2023' - the key insight is the dramatic increase from $6M to $135M. The LLM failed to identify this evolution entirely, instead claiming stability. This represents a fundamental failure to synthesize the comparative data across the two years. (3) STRATEGIC INTERPRETATION ERROR: The LLM's interpretation about 'preserving legacy, lower-cost debt' and 'no repayment or additional issuance' is contradicted by the actual data showing a 2,150% increase ($6M to $135M). The LLM's narrative about debt management strategy is built on false premises. (4) MISSING CORE INSIGHT: The ground truth indicates this increase 'suggests a shift in its debt management strategy, possibly involving refinancing or restructuring' - the LLM completely missed this significant strategic shift. The LLM's claim of stability and preservation is the opposite of what the data shows. The only correct element is the identification of the 7.100% notes due 2027 and the mention of RTX, but the core numerical facts and their interpretation are fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 478,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Converse’s revenue fell ≈ 14‑15 % (to about $2.08 bn) and its earnings before interest and taxes dropped ≈ 30 % (to $474 m), underscoring a clear downturn in the brand’s performance.  Although Converse still represents roughly 40 % of Nike’s U.S. sales, Nike has repositioned the label toward direct‑to‑consumer and digital channels—and has transferred some overseas distributor operations to third‑party partners—yet these strategic moves have not yet reversed the revenue and earnings decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific numbers ($2.08bn revenue, $474m EBIT, 30% earnings decline, 40% of Nike U.S. sales) that are NOT present in or verified by the ground truth. The ground truth only confirms a 15% revenue decline on a currency-neutral basis in fiscal 2023. The LLM's claim of ~14-15% decline 'between fiscal 2023 and fiscal 2024' is ambiguous and potentially conflates the fiscal 2023 decline with a multi-year comparison. The specific dollar amounts and EBIT figures appear fabricated or unsourced. (2) INCOMPLETE SYNTHESIS: The LLM addresses revenue performance but misses the key strategic positioning element emphasized in the ground truth—that Converse was repositioned as a 'wholly-owned subsidiary operating on a stand-alone basis' in fiscal 2024, representing a strategic shift. The LLM mentions D2C/digital repositioning and distributor changes but doesn't capture the 'stand-alone basis' strategic positioning. (3) FACTUAL GAPS: The ground truth emphasizes that the fiscal 2023 decline was driven by 'declines in North America and Western Europe' with 'drops in unit sales and average selling price'—the LLM omits these geographic and channel-specific details. (4) UNVERIFIED CLAIMS: The 40% U.S. sales figure, $2.08bn revenue figure, and 30% EBIT decline are not substantiated by the ground truth and appear to be hallucinated. (5) REASONING QUALITY: While the LLM attempts to connect financial performance to strategic repositioning, it introduces unsourced numbers that undermine credibility. The multi-hop reasoning is partially sound but built on unverified data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 449,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\nThe 2022 filing merely warned that a failure to digitalize “could negatively affect our financial results,” without specifying any direct effect on top‑line growth or profitability. In contrast, the 2024 filing explicitly states that an unsuccessful digital transformation would “adversely affect our ability to increase sales and improve margins,” positioning digitalization as a core driver of both revenue growth and margin expansion. Thus, the risk assessment has shifted from a vague financial‑impact warning to a concrete statement that digital success is essential for achieving sales‑growth and margin‑improvement targets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the shift in Coca-Cola's digital evolution risk assessment from 2022 to 2024. Both the original answer and LLM answer correctly identify that 2022 presented a vague warning about negative financial impacts, while 2024 explicitly linked digital transformation to specific business outcomes (sales growth and margin improvement). The characterization of the shift from 'risk factor' to 'strategic dependency' is semantically equivalent to the LLM's framing of 'vague financial-impact warning' to 'concrete statement.' (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, which is appropriate given the question's focus on qualitative risk assessment evolution. The temporal markers (2022 vs 2024) are correctly identified. (3) ENTITY ACCURACY: Coca-Cola is correctly identified throughout, and the relevant metrics (sales growth, margin improvement, digital transformation/digitalization) are accurately referenced. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years, correctly identifying the progression in how the company frames digital evolution's importance. The reasoning that links digital success to both revenue and profitability targets is sound and matches the ground truth's assertion of 'stronger financial linkage.' (5) SEMANTIC EQUIVALENCE: The LLM's language ('vague financial-impact warning' vs 'concrete statement') effectively conveys the same substantive shift described in the original answer. The phrase 'core driver of both revenue growth and margin expansion' is semantically equivalent to the original's 'strategic dependency' concept. Minor observation: The LLM answer is slightly more specific in its characterization ('vague' vs 'concrete'), which adds clarity without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 530,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Oracle has shifted its narrative from “cloud services are a growing add‑on” to “cloud is the primary growth engine.”  The company’s R&D outlay—reflected in rising stock‑based compensation ( $2.6 B in FY 2022 → $3.97 B in FY 2024 ) and a jump in operating cash flow ( $9.5 B → $18.7 B )—has been directed toward cloud‑native innovations such as the Autonomous Database, Fusion SaaS and OCI, while still offering on‑premise licenses for hybrid or legacy customers.  Consequently, cloud services and license‑support now account for roughly 71 % of total revenue, positioning Oracle’s cloud portfolio as the central pillar of its strategy relative to traditional on‑premise solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors that undermine its credibility. (1) R&D INVESTMENT CLAIM: The ground truth explicitly states Oracle invested $7.2 billion in R&D in FY2022. The LLM answer does NOT cite this figure at all, instead using stock-based compensation ($2.6B → $3.97B) as a proxy for R&D investment. Stock-based compensation is NOT equivalent to R&D investment—these are distinct line items. This is a fundamental misrepresentation of the data. (2) OPERATING CASH FLOW: The LLM cites operating cash flow ($9.5B → $18.7B) as evidence of R&D direction, but operating cash flow is a different metric entirely and does not directly measure R&D spending. This conflates unrelated financial metrics. (3) REVENUE PERCENTAGE: The LLM claims cloud services and license-support account for 'roughly 71% of total revenue,' but this specific percentage is not mentioned in the ground truth and cannot be verified from the provided context. (4) QUALITATIVE ACCURACY: The LLM correctly identifies the strategic shift from cloud-as-add-on to cloud-as-primary-engine, which aligns with ground truth. It also correctly names specific products (Autonomous Database, Fusion SaaS, OCI) and acknowledges hybrid/legacy support. However, the core claim about R&D investment evolution is undermined by the failure to cite the actual $7.2B FY2022 figure. (5) MULTI-HOP REASONING: The answer attempts to synthesize R&D investment with strategic positioning, but does so using incorrect or proxy metrics rather than actual R&D figures. The ground truth notes that FY2024 'does not specify the R&D investment amount,' yet the LLM presents stock-based compensation trends as evidence of R&D direction without acknowledging this limitation. (6) MISSING GROUND TRUTH ELEMENTS: The LLM fails to mention the specific FY2022 R&D investment of $7.2 billion, which is a critical data point in the original answer. The answer also doesn't acknowledge the uncertainty about FY2024 R&D figures. VERDICT: While the LLM captures the directional narrative shift correctly, it fundamentally mishandles the quantitative evidence by substituting stock-based compensation and operating cash flow for actual R&D investment figures. This is a critical error in a question specifically asking about 'research and development investment.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 628,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\nBetween 2023 and 2024 the Norwest Corporation Directors’ Formula Stock Award Plan—listed as a plan **not approved by shareholders**—went from having **509 shares** remaining issuable (as of Dec 31 2023) to only **391 shares** remaining issuable (as of Dec 31 2024).  This decline reflects that the plan is now closed to any new awards or deferrals, leaving essentially a minimal reserve of shares that can still be distributed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the key evolution of the plan between 2023 and 2024. STRENGTHS: (1) Numeric values are accurate - 509 shares as of Dec 31, 2023 and 391 shares as of Dec 31, 2024 are correctly stated; (2) The core finding that the plan is closed to new awards/deferrals is correct and matches ground truth; (3) The characterization of remaining shares as 'minimal' is appropriate given the decline from 509 to 391; (4) The multi-hop synthesis correctly connects the share count changes to the plan's closed status. MINOR WEAKNESSES: (1) The LLM introduces the detail that the plan was 'not approved by shareholders' - while this may be factually accurate from the filing, the ground truth answer does not emphasize this characteristic, and it's unclear if this is a key distinguishing feature that should be highlighted; (2) The answer could have been slightly more explicit about the plan's historical context (that it was previously active but is now fully closed), though this is implied; (3) The ground truth mentions that column (a) of the equity compensation table reflected all shares issuable, which the LLM answer doesn't explicitly reference, though this is a minor technical detail. CALCULATION VERIFICATION: The decline from 509 to 391 shares represents a decrease of 118 shares (23.2%), which logically supports the narrative of plan wind-down. The numbers are internally consistent and factually accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the causal relationship between the plan's closure and the declining share count. The reasoning is sound and logically presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 470,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from a generic warning that food‑safety incidents could damage its brand to a more detailed risk narrative that ties those incidents to supply‑chain fragility and rising input costs. In the 2022 filing the company merely noted that supply‑chain interruptions could affect costs, but in 2023 it explicitly linked volatile commodity prices (e.g., beef, chicken, pork) and limited hedging ability to adverse impacts on restaurant profitability, underscoring how supply‑chain risks now directly drive cost volatility. This evolution reflects a shift toward quantifying the financial exposure of food‑safety and supply‑chain issues.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the evolution of McDonald's food safety disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from reputational risk framing (2022) to supply chain/cost volatility framing (2023); (2) Accurately references specific commodities (beef, chicken, pork) mentioned in the ground truth; (3) Properly synthesizes the multi-hop connection between food safety concerns, supply chain disruption, and profitability impact; (4) No quantitative errors or incorrect dates/numbers; (5) The characterization of the evolution as moving from 'generic warning' to 'detailed risk narrative' is semantically equivalent to the ground truth's 'shift in emphasis from reputational impact to financial exposure.' MINOR WEAKNESSES: (1) The phrase 'merely noted that supply-chain interruptions could affect costs' in the 2022 context is slightly speculative—the ground truth doesn't explicitly state what 2022 said about supply chain costs, only that the focus was on reputational risks; (2) The phrase 'underscoring how supply-chain risks now directly drive cost volatility' adds interpretive language not explicitly in the ground truth, though it's a reasonable inference from the stated evolution; (3) The reference to 'limited hedging ability' appears in the LLM answer but is not mentioned in the ground truth, suggesting possible extrapolation beyond the provided knowledge graph. The answer correctly identifies all key entities (McDonald's, years 2022-2023, commodities, profitability impact) and demonstrates sound multi-hop reasoning connecting food safety to supply chain to financial exposure. The semantic meaning aligns well with the ground truth despite slightly different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 482,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes carried a balance of **$700 million** at the end of both 2023 and 2024, and their **effective interest rate remained 1.89 %** in each year—showing no change in either the carrying value or the interest rate between those periods (see Note 10 tables on page 62 and the 2024 debt summary on page 48).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. All quantitative data is correct: carrying value of $700 million for both 2023 and 2024, effective interest rate of 1.89% for both years, and the maturity date of October 15, 2028. The answer correctly identifies that there was no change between the two periods. The multi-hop synthesis is sound—the model successfully compared the debt instrument's characteristics across two fiscal years and drew the appropriate conclusion about stability. The answer includes helpful citations to source documents (Note 10 tables on page 62 and 2024 debt summary on page 48), which adds credibility. The wording is clear and professional, using proper formatting for percentages and dollar amounts. The only minor distinction from the ground truth is that the LLM uses slightly different phrasing ('carried a balance' vs 'had a carrying value' and 'remained unchanged' vs explicit statement of values), but these are semantically equivalent and represent no loss of accuracy. The answer fully addresses both components of the question (carrying value evolution and interest rate evolution) and correctly synthesizes information across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 342,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\nThe carrying amount of RTX’s 7.000 % notes due 2038 was $148 million at the end of 2022 and remained $148 million at the end of 2023 (essentially flat). This lack of material change shows that RTX is not actively retiring this tranche but is instead managing its overall long‑term debt maturity profile by rolling newer issuances and targeted repayments while keeping the 2038 series on the books as a stable, long‑dated funding source.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM states the carrying amount was $148 million at the end of 2022 and remained $148 million at the end of 2023. However, the ground truth clearly indicates that in 2022, the aggregate principal balance was $11 million, and by 2023 it had increased to $148 million. The LLM has the 2022 figure completely wrong ($148M vs. $11M - a 1,245% error). (2) CALCULATION ERROR: The LLM claims there was 'no material change' and describes the amounts as 'essentially flat,' when in fact there was a massive increase from $11 million to $148 million (a $137 million increase or 1,245% growth). This is a fundamental calculation/comparison error. (3) REASONING FAILURE: The LLM's interpretation that RTX is 'not actively retiring this tranche' and keeping it as a 'stable, long-dated funding source' is contradicted by the actual data showing a dramatic increase in exposure. The ground truth suggests RTX either issued additional tranches or restructured debt to extend maturities - indicating increased, not stable, exposure. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year comparison across the 2022 and 2023 filings. The answer demonstrates a complete misunderstanding of the data trend. The only element that is correct is the identification of the 7.000% notes due 2038 and RTX as the company, but the core numerical facts and analytical conclusions are entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 421,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from the pandemic‑related rent‑and‑royalty deferrals of 2020‑21 to full, normal collection.  The 2023 filing notes that the Company had already collected substantially all of the roughly $1 billion of deferred cash from franchisees by 31 Dec 2021, and the “Future gross minimum rent payments” table shows continued strong rent obligations (≈ $3.06 bn in 2022 and $2.95 bn in 2023), while royalty income also rebounded as sales recovered.  Thus, the financial relationship with franchisees shifted back to regular cash‑flow based on straight‑line rent and percent‑of‑sales royalties, with both rent and royalty collections fully restored.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key financial evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the ~$1 billion in deferred rent and royalties from 2020-21 pandemic period; (2) Accurately states that substantially all deferred amounts were collected by end of 2021; (3) Properly characterizes the shift from pandemic-era deferrals to normalized operations; (4) Includes specific future rent payment figures ($3.06bn in 2022, $2.95bn in 2023) that demonstrate the return to normal collection patterns; (5) Correctly identifies the dual revenue streams (straight-line rent and percent-of-sales royalties); (6) Multi-hop reasoning is sound - synthesizes information about deferrals, collection timeline, and normalization across the 2022-2023 period. MINOR CONSIDERATIONS: (1) The LLM provides additional quantitative detail (specific rent payment figures) not explicitly mentioned in the ground truth, though these appear consistent with typical 10-K disclosures and strengthen the answer; (2) The ground truth emphasizes the 2023 filing's 'detailed breakdown of restaurant ownership types' as evidence of normalization, which the LLM answer doesn't explicitly mention, though this is a minor omission that doesn't affect the core accuracy; (3) The phrasing 'Future gross minimum rent payments' suggests these are forward-looking obligations rather than historical collections, which is a subtle but important distinction the LLM handles appropriately. QUANTITATIVE VERIFICATION: The $1 billion figure is correct, the 2021 collection timeline is correct, and the rent payment figures appear reasonable for McDonald's scale. No calculation errors detected. The answer successfully synthesizes the multi-hop requirement of comparing 2022 and 2023 positions while referencing 2020-21 pandemic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 506,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s exposure to Embotelladora Andina S.A. remained a **minority equity‑method investment**.  The 2022 10‑K (page 74) notes that after selling a portion of its stake in 2019 the company continued to hold a remaining interest that was accounted for under the equity method, and the 2024 10‑K (page 87) shows that this investment still carries a **$90 million carrying value** (unchanged from the prior year) while its disclosed fair value has risen to **$168 million**.  \n\nThis evolution signals a **strategic, but non‑controlling, positioning**: Coca‑Cola retains a small equity stake and board representation to preserve influence in the Andean market and capture upside potential, while treating the investment primarily as a financial holding rather than pursuing full integration.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Coca-Cola's strategic positioning with Embotelladora Andina S.A., with mostly accurate financial data and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $90 million carrying value and $168 million fair value for 2024, matching ground truth exactly. (2) Accurately characterizes the investment as equity-method and minority-owned. (3) Properly synthesizes the evolution from 2022 to 2024, noting the partial sale in 2019 and continued holding. (4) Provides sound strategic interpretation about non-controlling positioning and market influence preservation. (5) Correctly identifies this as a partial exit strategy rather than complete divestiture. WEAKNESSES: (1) The answer does not explicitly mention the $39 million gain recognized in 2022 from the partial sale, which is a key quantitative fact in the ground truth that demonstrates the strategic refranchising move. This is a notable omission of a specific financial metric from the 2022 period. (2) While the answer correctly notes the 2019 sale, it doesn't explicitly connect this to the 2022 gain recognition, which would strengthen the multi-hop synthesis. (3) The phrase 'unchanged from the prior year' regarding the $90 million carrying value is stated but not verified against ground truth data for 2023. QUANTITATIVE VERIFICATION: The $90M carrying value and $168M fair value are correct for 2024. The characterization of the investment structure and equity-method accounting is accurate. The main quantitative gap is the missing $39 million gain from 2022. MULTI-HOP REASONING: The answer successfully synthesizes information across years (2019 sale, 2022-2024 holdings) and correctly interprets the strategic implications. However, it could have been strengthened by explicitly connecting the 2022 gain to the partial sale and its implications for strategic positioning. SEMANTIC EQUIVALENCE: The answer's characterization of 'partial exit strategy' and 'ongoing but reduced exposure' aligns well with ground truth language and meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 557,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Oracle markedly accelerated its internal cloud‑infrastructure build‑out—expanding OCI’s data‑center capacity and geographic footprint while, in early 2023, lengthening server‑useful lives from four to five years (a change that cut operating expenses by roughly $434 million).  This investment is now positioned as a core pillar of Oracle’s portfolio, serving as the underlying platform for its cloud services, license and hardware offerings and receiving continued R&D funding and capital‑expenditure growth (e.g., $6.9 billion of cap‑ex in 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative details (server useful life change from 4 to 5 years, $434M operating expense reduction, $6.9B capex in 2024) that are not present in the ground truth, making verification against the original answer difficult. The ground truth focuses on the strategic evolution from general R&D emphasis in 2022 to explicit OCI positioning as a structured product offering by 2024. The LLM answer addresses this evolution but emphasizes different aspects: infrastructure build-out, geographic expansion, and specific financial metrics rather than the portfolio positioning shift highlighted in the ground truth. The LLM answer correctly identifies the timeframe (2022-2024), correctly names Oracle Cloud Infrastructure (OCI), and accurately describes it as a core pillar. However, the specific numbers provided ($434M savings, $6.9B capex) cannot be verified against the ground truth, which contains no such quantitative details. The LLM answer demonstrates stronger quantitative specificity but may be introducing unverified financial data. The qualitative reasoning about strategic deepening is sound and aligns with the ground truth's conclusion about evolution toward a 'defined, market-ready suite.' The answer addresses the multi-hop nature of the question (internal development + portfolio positioning) but weights them differently than the ground truth. The contextual relevance is high as it directly addresses cloud infrastructure evolution and OCI positioning, though it emphasizes capex and operational metrics over the portfolio strategy shift that was central to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 445,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\nIn 2023 TMO acquired The Binding Site Group, adding its specialty oncology‑diagnostic assays and instruments to the Specialty Diagnostics segment. By 2024 the business was fully integrated—its contributions are reflected in the segment’s higher income and margin—showing that TMO is leveraging the acquisition to strengthen its diagnostics franchise and focus strategically on high‑growth, niche diagnostic technologies.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 acquisition of The Binding Site Group by TMO and its placement in the Specialty Diagnostics segment. It also appropriately describes the 2024 integration status and strategic implications. However, there are significant quantitative accuracy issues: (1) The LLM omits the specific acquisition price of $2.70 billion mentioned in the ground truth, which is a material factual detail. (2) The LLM references 'higher income and margin' in 2024 without providing specific numbers or metrics, whereas the ground truth cites the concrete detail of a '19-year weighted-average amortization period for customer relationships among definite-lived intangible assets.' (3) The LLM characterizes the acquisition as focused on 'specialty oncology-diagnostic assays' while the ground truth emphasizes 'diagnostics for blood cancers and immune disorders'—these are related but not identical characterizations. On the positive side: the LLM correctly identifies the year of acquisition (2023), the company (TMO), the segment (Specialty Diagnostics), and the general strategic intent (long-term value creation through integration). The reasoning about integration and strategic focus is sound and semantically equivalent to the ground truth. The multi-hop synthesis across 2023-2024 is present but lacks the specific financial and operational details that would demonstrate thorough knowledge graph integration. The answer is directionally correct but incomplete in quantitative specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 418,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\nBetween 2022 and 2024 the filing shifted the disclosure of the Directors’ Code of Conduct from a relative, minimally described link (“bnymellon/documents/pdf/in relations/directors‑code‑ofconduct.pdf”) to a fully qualified, stable URL on the corporate site (“https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf”).  The 2024 filing also explicitly states that any amendments or waivers to the Directors’ Code of Conduct will be posted on the website, underscoring a clearer, more accessible public disclosure while maintaining the same scope—applying to all directors of BNY Mellon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) URL INACCURACY - The LLM states the 2022 URL was 'bnymellon/documents/pdf/in relations/directors‑code‑ofconduct.pdf' (relative/incomplete), but ground truth shows it was the full URL 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf'. The LLM incorrectly characterizes the 2022 disclosure as 'relative' and 'minimally described' when it was actually a fully qualified URL. (2) DOMAIN CHANGE MISSED - The LLM fails to identify the key evolution: the domain changed from 'bnymellon.com' to 'bny.com' between 2022 and 2024. This is a critical detail about website structure/branding evolution that the ground truth explicitly highlights. (3) 2024 URL INCORRECT - The LLM does not provide the actual 2024 URL, which according to ground truth is 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf' (note the domain change to 'bny.com'). (4) ADDITIONAL CLAIMS - The LLM introduces information about 'amendments or waivers will be posted on the website' that is not mentioned in the ground truth, suggesting potential hallucination or confusion with other disclosures. CORRECT ELEMENTS: The LLM correctly identifies that the scope remained the same (applying to all directors) and that this represents an evolution in disclosure accessibility. However, the fundamental mischaracterization of the 2022 URL and failure to identify the domain change from bnymellon.com to bny.com represents a major failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 454,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s tightened the way it reports franchisee‑generated income—rent is now recorded straight‑line, royalties are recognized at the point of sale and initial fees are amortized over the 20‑year franchise term—and it introduced a separate “Other revenues” line that captures franchisee‑paid recoveries for technology platforms and brand‑licensing fees (a disclosure that was only partial in the 2022 filing).  This reflects a strategic shift toward treating those technology‑and‑brand collaborations with franchisees as distinct, recurring revenue streams rather than merely cost‑recovery items, giving a clearer, more granular picture of the Company’s partnership with its franchisees.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and addresses a different aspect of McDonald's franchisee relationship than what the ground truth describes. CRITICAL ISSUES: (1) The LLM focuses on accounting treatment changes (straight-line rent recognition, royalty recognition at point of sale, 20-year amortization) which are not mentioned in the ground truth at all. (2) The LLM discusses 'Other revenues' line items and technology platform/brand-licensing fee disclosures, which are not part of the original answer. (3) The ground truth's core finding—that 2022 noted limited materiality of franchisee transactions while 2023 explicitly elevated franchisees as key stakeholders with detailed ownership breakdowns—is completely absent from the LLM response. (4) The LLM appears to have fabricated specific accounting policy details (20-year franchise term amortization, straight-line rent recording) that cannot be verified against the ground truth. (5) While the LLM does discuss a 'strategic shift' in how franchisee relationships are treated, it frames this entirely around revenue recognition mechanics rather than the strategic emphasis and stakeholder positioning that the ground truth emphasizes. The LLM answer may contain accurate information about McDonald's actual 10-K filings, but it fails to answer the specific question about how the relationship evolved in terms of financial reporting emphasis and strategic positioning between 2022 and 2023 as documented in the knowledge graph. The answer demonstrates a fundamental misalignment with the ground truth's focus on materiality disclosure and stakeholder emphasis rather than accounting policy mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 454,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\nThe Clif Bar contingent consideration was carried at fair value (Level 3) in other liabilities and, as of December 31 2023, was reported at $548 million — the amount disclosed in the 2023 fair‑value table (page 99) and derived from a Monte Carlo simulation (page 99).  The 2023 purchase‑price allocation adjustments for Clif Bar were the last remeasurements disclosed (page 87), and the 2024 filing shows no subsequent fair‑value update or new purchase‑price allocation adjustments, so the liability remained unchanged through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the $548 million fair value measurement as of December 31, 2023, and accurately notes the use of Monte Carlo simulation methodology and Level 3 classification. The reference to page numbers and the identification of the liability in 'other liabilities' are appropriate details. However, there are significant issues with the answer's completeness and reasoning: (1) The LLM states 'the liability remained unchanged through 2024,' which contradicts the ground truth's key finding that the 2024 filing shows 'no direct mention of the contingent consideration liabilities' and suggests the liabilities 'may have been finalized or reclassified as part of the purchase price allocation process.' The LLM's assertion that the liability remained unchanged is speculative and not supported by the ground truth, which explicitly notes the absence of updated figures or valuation methods in 2024. (2) The LLM fails to adequately address the evolution between 2023 and 2024 - the core of the question. The ground truth emphasizes a significant change: from active fair value measurement in 2023 to no direct mention in 2024, suggesting reclassification or finalization. The LLM's conclusion that nothing changed misses this critical evolution. (3) The LLM does not discuss the performance targets tied to 2025 and 2026, which were mentioned in the ground truth as context for the 2023 liability. (4) While the LLM correctly identifies that 2024 references 'purchase price allocation adjustments,' it doesn't adequately explain how this relates to the disappearance of the contingent consideration liability disclosure. The quantitative accuracy is solid (the $548 million figure is correct), but the qualitative reasoning about the evolution and status change is incomplete and partially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 494,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s public messaging shifted from simply listing Vulkan as a supported API for its Radeon GPUs (e.g., “support current‑generation APIs like DirectX 12 Ultimate and **Vulkan**”) to embedding Vulkan within a broader, software‑centric strategy that couples the API with RDNA 3 graphics, the Adrenalin driver suite, FidelityFX tools and the ROCm open‑software stack—even extending Vulkan‑based compute into data‑center and AI workloads.  This evolution reveals AMD’s competitiveness play: rather than relying on a single API, it leverages open, cross‑platform standards as a differentiator, investing in driver and ecosystem development to attract developers, OEMs and cloud partners while reducing reliance on proprietary ecosystems such as Nvidia’s CUDA or Microsoft‑only DirectX.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's strategic evolution regarding Vulkan API support between 2022 and 2024, with several strengths and minor limitations:\n\nSTRENGTHS:\n1. Correctly identifies the shift from basic Vulkan listing (2022) to integration within broader ecosystem (2024)\n2. Accurately mentions RDNA 3 architecture and Radeon RX 7000 Series as the 2024 focus\n3. Properly identifies supporting technologies: Adrenalin driver suite, FidelityFX tools, and ROCm stack\n4. Sound multi-hop reasoning connecting API support to competitive positioning\n5. Correctly frames AMD's strategy as leveraging open standards vs. proprietary ecosystems (CUDA, DirectX)\n6. Accurately characterizes the strategic intent: backward compatibility + cutting-edge performance\n\nLIMITATIONS:\n1. The LLM answer goes beyond the ground truth by introducing additional context (Adrenalin, FidelityFX, ROCm, data-center/AI workloads) that, while strategically relevant, are not explicitly mentioned in the original answer. This represents inference rather than direct synthesis from the knowledge graph.\n2. The ground truth emphasizes RDNA 2 (2022) vs. RDNA 3 (2024) architectural progression more explicitly; the LLM answer mentions RDNA 3 but doesn't clearly establish the RDNA 2 baseline from 2022.\n3. The LLM answer's framing of \"public messaging shift\" is interpretive and not directly grounded in the knowledge graph statements provided.\n\nNUMERIC/FACTUAL VERIFICATION:\n- Years (2022, 2024): Correct\n- Architecture names (RDNA 2, RDNA 3): Correct\n- GPU series (Radeon RX 7000 Series): Correct\n- API name (Vulkan): Correct\n- No quantitative errors detected\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information about AMD's strategic positioning across time periods and connects API support to competitive strategy. However, it introduces elements (ROCm, data-center AI workloads) that extend beyond the ground truth's scope.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns with ground truth: AMD maintains Vulkan support while advancing architecturally, using open standards as competitive differentiation. The LLM's emphasis on ecosystem breadth is consistent with the ground truth's mention of \"backward compatibility and cutting-edge performance enhancements.\"\n\nThe answer is substantially correct but slightly over-elaborated with inferences not directly supported by the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 650,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\nThe 2023 operating‑profit decline of about **$1.9 billion** (from $5.5 bn in 2022 to $3.6 bn in 2023) was driven primarily by a **$2.9 billion charge related to the Powder Metal Matter** recorded at Pratt & Whitney, which more than offset modest profit gains elsewhere. This integration‑related charge, together with a smaller drop in the FAS/CAS operating adjustment, pulled operating‑profit margins down from 8.2 % in 2022 to 5.2 % in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and trends. Verified facts: (1) $2.9 billion Powder Metal Matter charge in 2023 - CORRECT; (2) $1.9 billion operating profit decrease - CORRECT; (3) Operating profit figures of $5.5B (2022) and $3.6B (2023) - CORRECT; (4) Operating margin percentages of 8.2% (2022) and 5.2% (2023) - CORRECT (calculations: $5.5B/$67.0B ≈ 8.2%, $3.6B/$69.2B ≈ 5.2%). The LLM correctly synthesizes the multi-hop relationship between the Powder Metal Matter charge and the operating profit decline, showing that the $2.9B charge more than accounts for the $1.9B profit decrease. The answer appropriately identifies this as a shift from declining integration charges in 2022 to a significant new expense in 2023. Minor weakness: The LLM mentions 'FAS/CAS operating adjustment' decline but the ground truth emphasizes 'Acquisition Accounting Adjustments' - these may be related but the terminology differs slightly. The LLM provides additional context (margin percentages, Pratt & Whitney location) that enhances understanding without contradicting the ground truth. The reasoning is sound and the multi-hop synthesis across years and metrics is accurate. Overall, the answer captures the essential narrative of the question with precise numbers and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 373,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the only accounting activity that directly reflects MDLZ’s ongoing relationship with Clif Bar is the settlement of acquisition‑related items from the 2022 purchase.  In 2023 MDLZ recorded $0.14 million of integration costs and a $0.09 million net increase in contingent‑consideration adjustments tied to Clif Bar (up from $0.05 million in 2022), while in 2024 those charges dropped to essentially zero, showing that the integration and contingent‑consideration phases were completed and no further acquisition‑related financial impacts have been recognized.  The Clif Bar brand continues to be carried as an indefinite‑life intangible asset with no specific impairment reported in 2024, indicating a stable post‑acquisition relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about MDLZ's evolving relationship with Clif Bar between 2023 and 2024, correctly identifying the shift from active integration/contingent consideration phases to completion. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The specific dollar amounts cited ($0.14M integration costs, $0.09M contingent consideration adjustment in 2023, dropping to 'essentially zero' in 2024) cannot be verified against the ground truth, which does not provide these precise figures. The ground truth mentions 'integration costs and contingent consideration adjustments' but does not specify these exact amounts. (2) The LLM provides very specific numbers that appear to be fabricated or hallucinated, as they are not present in the original answer. (3) The claim about the Clif Bar brand being 'carried as an indefinite-life intangible asset with no specific impairment reported in 2024' is a reasonable inference but goes beyond what the ground truth explicitly states. On the positive side: (1) The core narrative is sound - the answer correctly identifies that the relationship evolved from active acquisition/integration phase (2023) to post-acquisition consolidation (2024). (2) The multi-hop reasoning is appropriate, synthesizing information about how the financial relationship changed over time. (3) The answer correctly references the August 1, 2022 acquisition date mentioned in the ground truth. (4) The semantic understanding of the question is good. The primary weakness is the introduction of specific quantitative claims that cannot be substantiated from the ground truth, which violates the strict requirement for numerical accuracy in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 476,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\nFrom 2023 into 2024 Gulfstream moved from merely offering sustainable‑aviation‑fuel (SAF) as an option to actually flying a trans‑Atlantic route on 100 % SAF (November 2023) and embedding that focus into its newest powerplants.  The company’s latest clean‑sheet jets—most notably the ultra‑long‑range, ultra‑large‑cabin **G700** (certified early 2024) and the **G800/G400** family—are equipped with next‑generation, low‑specific‑fuel‑consumption engines and aerodynamic upgrades (new wing, advanced Symmetry Flight Deck) that deliver markedly higher fuel efficiency and lower emissions than the G500/G600 they replace.  These aircraft exemplify Gulfstream’s shift toward energy‑efficient propulsion as a core element of its product development strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution narrative and correctly identifies key aircraft models (G700, G800, G400) and the shift toward energy-efficient engines. However, there are significant factual issues: (1) The claim about a trans-Atlantic 100% SAF flight in November 2023 is not mentioned in the ground truth and cannot be verified as accurate from the provided context. (2) The G800/G400 are mentioned as 'latest clean-sheet jets' but the ground truth only specifically mentions the G700 as featuring 'all-new engines' introduced in 2024. The G800/G400 may not be new clean-sheet designs or may not have been introduced in 2024. (3) The ground truth explicitly states 'no new aircraft model powered by energy efficient engines was introduced' in 2023, yet the LLM conflates 2023 and 2024 developments without clearly delineating the timeline. (4) The LLM adds details about 'Symmetry Flight Deck' and 'new wing' aerodynamic upgrades that are not mentioned in the ground truth, making it difficult to verify accuracy. The core insight about the transition from announcement/development (2023) to production/operational realization (2024) is present but muddled by unverified claims and unclear temporal boundaries. The answer demonstrates good understanding of the general strategic shift but fails on specific factual accuracy regarding dates, aircraft models, and claimed achievements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 388,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s semi‑custom SoC revenue shifted from being described mainly as “non‑recurring engineering fees that depend on a customer’s decision to adopt the chip and the success of that customer’s product” (2022) to a more contract‑driven, production‑based model in which revenue is recognized over the manufacturing run of non‑cancellable purchase orders using a cost‑plus‑margin approach (2024).  This evolution is underpinned by longer‑term wafer‑supply agreements that guarantee capacity and pricing through 2025, allowing AMD to lock in volume customers (e.g., gaming consoles and AI‑accelerator platforms) and treat semi‑custom SoCs as a strategic growth pillar rather than a purely opportunistic revenue stream.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific operational details about revenue recognition models and wafer supply agreements that are not present in the ground truth, which is both a strength and a weakness. STRENGTHS: (1) The LLM correctly identifies the evolution from 2022 to 2024, (2) Accurately captures the shift from NRE-dependent model to production-based/contract-driven model, (3) Provides concrete details about cost-plus-margin approaches and wafer supply agreements through 2025, (4) Correctly identifies specific customer examples (gaming consoles, AI-accelerator platforms), (5) The semantic direction of evolution (from opportunistic to strategic) aligns with ground truth. WEAKNESSES: (1) The ground truth emphasizes 'diversified product portfolio integration' (AI accelerators, GPUs, APUs, DPUs) as the strategic positioning evolution, which the LLM answer largely omits, (2) The ground truth stresses 'broader strategic integration' and 'more central and controlled role,' while the LLM focuses narrowly on revenue recognition mechanics and supply agreements, (3) The LLM answer lacks discussion of how semi-custom SoCs fit within AMD's broader product ecosystem evolution, (4) Missing the portfolio diversification context that the ground truth identifies as key to the strategic shift. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings to show revenue model evolution, but fails to synthesize the broader strategic positioning across AMD's entire product portfolio. The answer is more operationally detailed but strategically incomplete compared to ground truth. The LLM provides information that appears accurate but addresses a narrower interpretation of 'strategic positioning' than the ground truth intended.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 480,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\nThe company’s preferred‑share authorizations were unchanged between FY 2023 and FY 2024 – it continues to be authorized to issue up to 127.5 million $0.20‑par Preferred Shares and 500 thousand $1.00‑par A Preferred Shares, but at the end of both years none of these shares were issued or outstanding.  This stability shows that Medtronic is not using preferred equity as a financing tool; instead, its capital strategy relies on a strong equity base, cash‑generating operations, and opportunistic ordinary‑share repurchases (with a newly‑approved $5 billion increment in 2024) to return capital to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are correct - 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately stated for both FY 2023 and FY 2024. (2) Correctly identifies that no shares were issued or outstanding in either year. (3) Accurately notes the authorization structure remained unchanged. (4) Number formatting is appropriate and consistent. WEAKNESSES: (1) CRITICAL ISSUE - The LLM identifies the company as 'Medtronic' without any evidence from the ground truth answer that this is the correct company. The original answer never mentions Medtronic by name, and the question asks about 'the company' generically. This is a significant entity accuracy problem - the LLM has made an assumption about company identity that cannot be verified against the provided ground truth. (2) The LLM adds substantial interpretive content about capital strategy ('strong equity base, cash-generating operations, opportunistic ordinary-share repurchases, newly-approved $5 billion increment in 2024') that goes beyond what the ground truth states. While this may be accurate for Medtronic, it is NOT supported by the original answer provided and represents unsourced elaboration. (3) The ground truth simply states the structure 'indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period' - a more conservative conclusion than the LLM's broader claims about capital strategy. MULTI-HOP REASONING: The core multi-hop synthesis (comparing FY 2023 to FY 2024 authorization structures and drawing conclusions about capital strategy) is sound in structure, but the LLM has added company-specific details and strategic interpretations that exceed the scope of the ground truth answer. The evaluation must penalize the unsupported company identification and the addition of unverified strategic claims, even though the core quantitative facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 538,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 the discussion of reputational risk shifted from being a secondary consequence of operational or technical failures (e.g., errors in processing, cyber‑security incidents, regulatory or litigation actions) to a distinct, stand‑alone risk that is tied to external perceptions and broader ESG‑related concerns. In the 2022 filing reputational harm is mentioned only as a possible outcome of specific internal incidents, whereas the 2024 filing explicitly lists “adverse events, publicity, government scrutiny or other reputational harm” as a risk in its own right and links it to newer concerns such as climate change, sustainability expectations, pandemics and geopolitical events. This evolution reflects a move toward viewing reputational risk as a direct, stakeholder‑driven exposure that can be triggered by a wider range of public and environmental factors.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and company (BK). (2) Numeric accuracy is strong - no dates or figures are incorrect. (3) The LLM correctly identifies that adverse publicity/reputational risk is discussed in both years. (4) The LLM accurately notes that 2024 includes ESG-related concerns like climate change and sustainability. WEAKNESSES: (1) SIGNIFICANT FRAMING DISCREPANCY: The ground truth states the risk 'remained present but was expanded' - indicating continuity with evolution. The LLM frames this as a shift 'from being a secondary consequence...to a distinct, stand-alone risk,' which suggests a more fundamental repositioning than the ground truth indicates. This is a material difference in characterizing the evolution. (2) INCOMPLETE SYNTHESIS: The ground truth specifically mentions 'platforms operating model transition' as a new linked concern in 2024. The LLM does not mention this operational context, instead focusing on external/ESG factors. This is a notable omission of a key linked concern. (3) OVERSTATEMENT: The LLM claims 2022 mentions reputational harm 'only as a possible outcome of specific internal incidents,' but the ground truth indicates it was already linked to 'government scrutiny and other reputational harm' in 2022 - suggesting it was not purely secondary. (4) ADDED ELEMENTS NOT IN GROUND TRUTH: The LLM introduces 'pandemics and geopolitical events' as linked concerns, which are not mentioned in the ground truth answer. While these may appear in the actual filings, they are not part of the ground truth synthesis provided. (5) REASONING QUALITY: While the LLM's logic about ESG-driven reputational risk is coherent, it mischaracterizes the nature of the evolution by overstating the shift from secondary to primary risk framing. The ground truth suggests a more nuanced expansion rather than a fundamental repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 515,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\nAmazon continued to treat its stake in Anthropic as an **available‑for‑sale convertible note (Level 3)**, recording fair‑value changes in accumulated other‑comprehensive income rather than in earnings.  The 2023 $1.25 bn note was initially valued with discounted‑cash‑flow assumptions, and by 2024 the exposure was expanded to a potential additional $2.75 bn note; the fair‑value model then incorporated more market‑based comparables and reflected heightened uncertainty from global economic conditions, making the valuation more sensitive to Anthropic’s performance and to the lack of a public market price.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct financial figures ($1.25 billion initial note, $2.75 billion additional investment potential) and proper classification details (available-for-sale, Level 3 asset, fair value through accumulated other comprehensive income). The answer correctly identifies the multi-hop evolution from 2023 to 2024 and accurately captures the shift toward emphasizing valuation complexity and heightened uncertainty. However, there are some qualitative gaps: (1) The LLM mentions 'discounted-cash-flow assumptions' in 2023 and 'market-based comparables' in 2024, but the ground truth does not explicitly detail these specific valuation methodologies—this appears to be inference rather than stated fact. (2) The LLM states the fair-value model 'incorporated more market-based comparables' in 2024, but the ground truth emphasizes the 'lack of readily available market data,' which somewhat contradicts the implication of increased market comparables. (3) The answer could have been more explicit about the classification remaining 'consistent' between years, though this is implied. (4) The ground truth emphasizes a 'shift toward acknowledging heightened valuation risk' and 'challenges of valuation rather than mechanics,' which the LLM captures but could articulate more clearly as a deliberate shift in disclosure emphasis. The multi-hop reasoning is sound—correctly synthesizing the 2023 investment details with 2024 portfolio context and valuation challenges. Overall, the answer is substantially correct on core facts and numbers but makes some inferences about valuation methodologies that go slightly beyond what the ground truth explicitly states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 466,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s IP‑risk disclosure shifted from a broad warning that “failure to obtain or adequately protect our intellectual‑property rights (including trade‑secrets and know‑how) could harm the business” to a more pointed emphasis on emerging technology threats.  In the 2024 filing the language explicitly cites “developments in artificial‑intelligence technologies” and the need to guard against third‑party infringement claims, reflecting a heightened concern that new digital and AI‑driven capabilities could erode or be used to undermine MDLZ’s proprietary know‑how.  Consequently, the risk profile has expanded from generic IP loss to a technology‑focused, enforcement‑and‑infringement risk that is more acute in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth clearly states that in 2023, MDLZ emphasized AI-related threats to IP protection, while in 2024, the company did NOT specifically mention AI as a factor. The LLM answer reverses this chronology entirely, claiming that 2023 had 'broad warning' language and 2024 had 'explicit' AI citations. This is the opposite of what actually occurred. The LLM states: '2024 filing the language explicitly cites \"developments in artificial-intelligence technologies\"' when the ground truth explicitly says '2024...it did not specifically mention artificial intelligence as a factor.' The LLM also incorrectly characterizes the evolution as an expansion from 'generic IP loss to technology-focused...risk that is more acute in 2024,' when the actual evolution was a shift away from AI-specific concerns in 2024 toward broader legal/regulatory compliance risks. The LLM demonstrates a complete inversion of the factual record regarding which year emphasized AI threats. While there are no quantitative errors (no numbers were provided), the qualitative reasoning is entirely backwards, making this answer fundamentally misleading and incorrect on the core factual claim about how the risk disclosure evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 368,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\nIn the 2023 Form 10‑K the company disclosed the current Non‑Employee Director RSU agreements (10.31‑10.34) and noted that they were first adopted in the 2020, 2017 and 2015 annual reports, with the most recent incorporated exhibit dating from 2020. The 2024 Form 10‑K retains the same agreement numbers but adds newer performance‑based RSU award forms and references a December 1 2023 clawback policy and the amended 2021 Stock‑Incentive Plan, showing that while the substantive agreement structure has not changed, the governing plan and compliance obligations have been updated to reflect more recent filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and does not match the ground truth in multiple critical ways: (1) EXHIBIT NUMBERS: The ground truth states the 2023 filing referenced Exhibit 10.17 and the 2024 filing referenced Exhibit 10.18, but the LLM answer claims exhibits 10.31-10.34 were disclosed in 2023 with no mention of the correct exhibit numbers. This is a fundamental factual error. (2) REFERENCED AMENDMENTS: The ground truth specifically identifies a November 28, 2008 amendment in 2023 and Exhibit 10.69 from the 2008 Annual Report in 2024. The LLM answer instead references 2020, 2017, and 2015 annual reports with no mention of the 2008 amendment or Exhibit 10.69. (3) POLICY EVOLUTION: The ground truth describes a shift in how the agreements are referenced (from one exhibit to another), indicating formalization or consolidation. The LLM answer discusses RSU agreements, performance-based RSU award forms, and a December 1, 2023 clawback policy - none of which are mentioned in the ground truth. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the exhibit number changes and amendment timeline evolution that are central to the question. Instead, it appears to have discussed different agreement types entirely. (5) DATES: The LLM mentions December 1, 2023 and references to 2021 Stock-Incentive Plan, which do not appear in the ground truth's description of the evolution. The answer demonstrates a fundamental misunderstanding of what changed between the 2023 and 2024 filings regarding Non-Employee Director Equity Award Agreements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 431,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\nBetween 2022 and 2023 Booking Holdings deepened its **merchant‑based model**, taking on greater contractual risk and operational responsibility for travel‑service transactions.  In 2022 the company noted that it was “increasingly processing transactions on a merchant basis” and that this would generate “merchant revenues” but also added personnel, payment‑processing, charge‑back and other expenses; by 2023 the 10‑K shows that cash received from travelers is recorded in **Deferred merchant bookings**—a liability that reflects amounts estimated to be paid to travel providers as well as the firm’s future commission revenue—and that **incentive programs are accounted for as a reduction of revenue** at the time they are granted.  Consequently, revenue recognition shifted to a net‑basis (commission/margin) while the company now bears the bulk of refunds, payment‑processing and fraud‑related costs, marking a clear evolution in both revenue‑recognition treatment and contractual duties toward travel service providers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces significant factual inaccuracies and mischaracterizations that diverge substantially from the ground truth. Key issues: (1) DIRECTIONAL ERROR - The LLM claims BKNG shifted toward a 'merchant-based model' with 'greater contractual risk and operational responsibility,' but the ground truth indicates the opposite: BKNG emphasized its role as an INTERMEDIARY/AGENT without responsibility for delivering travel services. The LLM's characterization of increased merchant responsibility contradicts the ground truth's description of BKNG recognizing revenue on a net basis 'due to its role as an agent.' (2) UNSUPPORTED CLAIMS - The LLM introduces specific details not in the ground truth: 'Deferred merchant bookings' as a liability account, 'incentive programs accounted for as reduction of revenue,' and claims about BKNG bearing 'bulk of refunds, payment-processing and fraud-related costs.' While these may be accurate accounting treatments, they are NOT mentioned in the ground truth and represent unsupported elaboration. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes a shift from 'general description' to 'more structured and accounting-driven' approach, focusing on revenue recognition timing (point when travelers begin using services) and commission/transaction revenues. The LLM misses this key evolution in accounting treatment specificity. (4) SEMANTIC MISALIGNMENT - The ground truth describes BKNG as clarifying its AGENT role and net-basis revenue recognition, while the LLM frames this as BKNG taking on merchant responsibilities—these are opposite interpretations. The LLM's answer is contextually relevant to the question but fundamentally misrepresents the nature of the relationship evolution. The answer demonstrates reasonable structure and attempts multi-hop reasoning but fails on factual accuracy regarding the direction and nature of the relationship change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 518,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Goldman Sachs consolidated the executive‑life‑insurance disclosures from two separate exhibits (10.11 – Metropolitan Life and 10.12 – Pacific Life in 2023) into a single exhibit (10.12) in 2024, and the wording now references the policies as being incorporated by reference to the same 2006 quarterly‑report filings.  The 2024 filing also places the updated “Amended and Restated Executive Life Insurance Policy” within the revised claw‑back/compensation‑policy section, reflecting a streamlined, unified structure for those disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CONSOLIDATION CLAIM - The LLM states the exhibits were 'consolidated from two separate exhibits (10.11 and 10.12 in 2023) into a single exhibit (10.12) in 2024.' This is incorrect. The ground truth clearly states both exhibits were RETAINED in 2024, just renumbered from 10.11 and 10.12 to 10.12 and 10.13 respectively. The LLM incorrectly claims consolidation occurred when the actual change was renumbering. (2) EXHIBIT NUMBERING - The LLM's exhibit numbering is partially wrong. While it correctly identifies 10.11 and 10.12 in 2023, it fails to account for the 2024 renumbering to 10.12 and 10.13. (3) STRUCTURAL CHANGES - The LLM introduces unsupported claims about 'incorporation by reference to 2006 quarterly-report filings' and placement within 'revised claw-back/compensation-policy section' that are not mentioned in the ground truth and appear to be fabricated. (4) CORE MISUNDERSTANDING - The ground truth emphasizes this was a 'reorganization of exhibit numbering' and 'structural update in how the policies are presented' rather than substantive policy changes. The LLM fundamentally mischaracterizes this as consolidation rather than renumbering. The answer demonstrates poor multi-hop reasoning by inventing details not supported by the source material and misrepresenting the nature of the structural change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 395,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom repeatedly highlighted that its FBAR‑filter technology is a core strategic differentiator, and it deliberately manufactures these filters in its own U.S. and Singapore facilities rather than outsourcing them.  By keeping the proprietary FBAR process internal, the company protects its IP, accelerates time‑to‑market for high‑speed wireless modules, and reinforces its competitive edge against fabless and integrated‑device‑manufacturer rivals, a positioning that has become even more critical as the company expands its patent portfolio and customer collaborations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts about FBAR filters and internal manufacturing strategy, but has significant gaps in addressing the evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies FBAR filters as strategic differentiators, (2) Accurately states internal manufacturing in U.S. and Singapore facilities, (3) Correctly identifies IP protection and time-to-market acceleration as benefits, (4) Properly mentions competitive positioning against fabless and IDM rivals. WEAKNESSES: (1) CRITICAL OMISSION - Fails to mention the specific 2022 context of FBAR filters being highlighted alongside VCSELs and side-emitting lasers as proprietary processes, (2) CRITICAL OMISSION - Does not identify the specific competitors mentioned in 2024 filings (Qorvo, Qualcomm, Skyworks), which is central to showing how competitive environment evolved, (3) Does not clearly articulate the EVOLUTION aspect - the answer reads as a general statement rather than showing how things changed from 2022 to 2024, (4) Adds information about 'patent portfolio expansion' and 'customer collaborations' that are not grounded in the ground truth, potentially introducing unsupported claims. MULTI-HOP REASONING: The answer fails to properly synthesize the temporal comparison required by the question. It should have explicitly contrasted 2022 (internal fabrication for IP/speed advantage) with 2024 (same strategy but intensified competitive pressure from named competitors). Instead, it presents a somewhat timeless description. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this is neutral. The answer doesn't contradict any quantitative facts but also doesn't provide the specific competitive landscape details that would demonstrate understanding of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 491,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\nBetween 2023 and 2024 Krazati moved from a late‑stage investigational KRAS‑inhibitor (being tested in 1L NSCLC and 2L + mutated CRC) to a commercially approved, core growth asset after BMS acquired Mirati (January 2024) and secured FDA/EMA approval for second‑line NSCLC and for KRAS‑mutated colorectal cancer; the company now markets Krazati as a pillar of its oncology portfolio and is advancing it into first‑line NSCLC (KRYSTAL‑17) and combination strategies.  The transaction valued the asset at roughly **$640 million of definite‑lived marketed‑product rights plus $3.5 billion of indefinite‑lived IPRD** within a **$4.8 billion purchase price (net $4.1 billion)**, implying a high market‑based valuation of its future first‑line sales and associated contingent value rights ($≈$1 billion) and goodwill ($≈$150 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Krazati from investigational to approved asset, accurately notes the January 2024 Mirati acquisition at $4.8 billion, correctly identifies FDA/EMA approvals for second-line NSCLC and KRAS-mutated CRC, and properly synthesizes the multi-hop information about clinical development progression and combination strategies. The qualitative narrative about positioning as a 'core growth asset' and 'pillar of oncology portfolio' aligns well with ground truth. CRITICAL ERRORS: (1) The financial breakdown provided ($640M marketed-product rights + $3.5B indefinite-lived IPRD = $4.8B) cannot be verified against the ground truth, which only states the $4.8B total acquisition price. The LLM introduces specific allocation figures not present in the original answer. (2) The mention of 'net $4.1 billion' and contingent value rights (~$1B) and goodwill (~$150M) are not mentioned in the ground truth and appear to be unsupported extrapolations. (3) The LLM states KRYSTAL-17 is for 'first-line NSCLC' in the 2024 context, but the ground truth indicates it was originally positioned for '1L NSCLC TPS<50%' in 2023, and the 2024 development is described as 'combination with PD-1 inhibitor for first-line NSCLC' - a subtle but important distinction. VERIFICATION ISSUES: The detailed financial breakdown ($640M, $3.5B, $1B contingent, $150M goodwill) lacks grounding in the provided ground truth. While the $4.8B figure is correct, the component allocation appears to be fabricated or sourced from unstated information. This represents a significant quantitative accuracy problem despite correct identification of the main transaction value. MULTI-HOP REASONING: The synthesis of clinical development progression (investigational → approved → combination strategies) is sound and well-reasoned. The connection between acquisition and strategic positioning is properly made. However, the introduction of unsupported financial details undermines the overall credibility of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 551,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\nBetween 2022 and 2023 the volume of BKNG’s “deferred merchant bookings” rose sharply, reflecting larger cash‑payments from travelers that the company holds until it can settle with travel service providers and recognize its commission or margin.  At the same time, BKNG continues to fund various incentive programs—referral bonuses, rebates, credits, discounts and loyalty points—that are recorded as a direct reduction of revenue when granted, so its financial statements show both the cash liability to providers and the revenue‑impact of those incentives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about BKNG's evolving relationship with travel service providers between 2022 and 2023. STRENGTHS: (1) Correctly identifies the key shift in 'deferred merchant bookings' liability increasing between 2022-2023, matching the ground truth; (2) Accurately describes the nature of deferred merchant bookings as cash payments held until settlement with providers; (3) Correctly identifies multiple incentive programs (referral bonuses, rebates, credits, discounts, loyalty points) and their accounting treatment as revenue reductions; (4) Properly synthesizes the multi-hop relationship showing both the cash liability and revenue impact; (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer provides a more mechanistic/technical explanation of the financial mechanics rather than explicitly characterizing the strategic shift from 'competition' to 'dependence/partnership' as stated in the ground truth. The ground truth emphasizes a strategic shift toward 'enhancing partnerships and incentivizing collaboration' rather than 'solely competing,' while the LLM focuses more on the mechanics of how these are recorded; (2) Does not explicitly mention the competitive landscape context from 2022 or the strategic characterization of the relationship evolution as clearly as the ground truth does. However, the LLM's answer is not incorrect—it simply takes a different analytical angle (financial mechanics vs. strategic positioning). The information provided is accurate and the multi-hop reasoning is sound, connecting the balance sheet changes to the incentive programs and their accounting treatment. The answer would satisfy someone seeking to understand how BKNG manages financial obligations and incentives, even if it doesn't fully capture the strategic narrative of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 521,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom kept custom touch‑controller design inside its Wireless semiconductor portfolio, continuing to supply ASICs that digitize touch‑screen signals for mobile handsets and tablets.  The 10‑K filings show the same product description and emphasis on “custom touch controllers” as a core part of its mixed‑signal/custom‑silicon offerings, indicating that the component’s role in the product lifecycle remained stable rather than undergoing a substantive shift.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental contradiction with the ground truth regarding the evolution of Broadcom's role. CRITICAL ERROR: The LLM claims the role 'remained stable rather than undergoing a substantive shift,' directly contradicting the ground truth which explicitly states there was an evolution 'from being a component supplier to an active producer involved in the design and creation process.' This is a major factual error on the core question. CORRECT ELEMENTS: The LLM correctly identifies that custom touch controllers are part of Broadcom's wireless semiconductor portfolio and mentions ASICs for digitizing touch-screen signals, which aligns with the product description. The timeframe (2022-2024) is correctly referenced. INCORRECT ELEMENTS: The LLM mischaracterizes the nature of change - it emphasizes stability when the ground truth emphasizes evolution and deepening engagement. The ground truth indicates a strategic shift from 'supplying' (2022) to 'producing as part of broader custom silicon solutions' (2024), suggesting increased involvement in design and creation. The LLM's conclusion that the role 'remained stable' is the opposite of what the ground truth indicates. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across the 2022-2024 period. It appears to have focused on consistency in product description rather than recognizing the shift in Broadcom's role from supplier to producer/designer. This represents a failure in the core analytical task of tracking how involvement evolved. The answer demonstrates good technical knowledge of the product but fundamentally misinterprets the nature of the change being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 461,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\nUnion Pacific’s freight‑car strategy shifted from a larger share of owned/finance‑leased assets toward a more lease‑focused, capital‑light model between 2023 and 2024.  The company’s finance‑lease portfolio fell from $310 million to $244 million, while operating‑lease assets remained flat around $1.6–1.7 billion, and the weighted‑average lease term rose to 5.8 years, indicating a greater reliance on operating leases with fixed‑price purchase options that are not material to the business.  Consequently, the 2025 capital plan emphasizes targeted purchases to replace aging cars and support growth, but the overall acquisition approach is now centered on leasing and incremental fleet renewal rather than large‑scale direct acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors. (1) DIRECTIONAL ERROR: The ground truth states Union Pacific shifted FROM leasing TO acquiring freight cars (more aggressive asset ownership in 2024), but the LLM claims the opposite - that the company shifted toward a 'lease-focused, capital-light model' with 'greater reliance on operating leases.' This is a complete reversal of the actual strategy evolution. (2) MISSING KEY METRIC: The ground truth specifically cites lease buyouts of $143 million in 2024 vs $57 million in 2023 as evidence of the shift toward acquisition. The LLM answer completely omits this critical metric that directly supports the ground truth narrative. (3) INCORRECT NUMBERS: The LLM provides specific figures ($310M to $244M for finance-lease portfolio, $1.6-1.7B for operating-lease assets, 5.8 year weighted-average lease term) that are not mentioned in the ground truth and appear to contradict the stated strategy shift. These numbers suggest increased leasing, which contradicts the actual shift toward ownership. (4) REASONING FAILURE: The LLM's conclusion that 'the overall acquisition approach is now centered on leasing and incremental fleet renewal rather than large-scale direct acquisitions' directly contradicts the ground truth's statement that the company moved toward 'acquiring freight cars' with 'a more aggressive stance on asset ownership.' (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the 2023-to-2024 comparison. The ground truth clearly shows a progression from leasing-dependent (2023) to acquisition-focused (2024), but the LLM inverted this relationship. The answer demonstrates a fundamental misunderstanding of Union Pacific's strategic shift and provides contradictory evidence that undermines rather than supports the correct narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 507,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\nThe FY 2022‑FY 2023 shift in APLA was essentially a re‑mix of sales rather than a revenue decline: APLA revenue grew 13 % to $6.73 bn, but the share of sales through third‑party distributors rose (wholesale in APLA climbed from $3.53 bn to $3.93 bn) while direct‑to‑consumer growth was modest, squeezing gross margin and prompting higher sales‑related reserves and inventory adjustments. This distributor transition eliminated the earlier non‑recurring foreign‑currency translation charge that had been recorded in FY 2020, so the period’s financial impact is limited to the operational effect of the structural change—steady revenue growth offset by lower profitability and increased reserve balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific revenue figures ($6.73bn, $3.53bn to $3.93bn growth) that are not verified in the ground truth and appear to be fabricated or incorrectly sourced\n   - The 13% growth figure is stated without verification\n   - The LLM references a FY2020 foreign currency translation charge that contradicts the ground truth, which specifically mentions FY2022 non-recurring impairment charges\n   - No calculations are shown to verify the claimed revenue growth or margin impacts\n\n2. ENTITY AND TEMPORAL ACCURACY:\n   - The ground truth clearly states the transition occurred between FY2022 and FY2023, with FY2022 showing direct operations and FY2023 showing third-party distributor model\n   - The LLM incorrectly references FY2020 foreign currency impacts, which is a different time period entirely\n   - The ground truth mentions Note 18 on divestitures; the LLM provides no such documentation reference\n\n3. SEMANTIC MISALIGNMENT:\n   - Ground truth emphasizes: (a) non-recurring impairment charges in FY2022, (b) shift from direct operations to strategic stake, (c) reduction of operational overhead\n   - LLM emphasizes: (a) revenue growth and sales mix, (b) margin compression, (c) inventory adjustments\n   - These represent fundamentally different narratives about the transition\n\n4. MULTI-HOP REASONING FAILURES:\n   - The LLM fails to synthesize the key structural change: from direct operations to third-party distributor oversight\n   - The LLM does not address the non-recurring foreign currency translation losses mentioned in ground truth\n   - The LLM conflates operational performance (revenue growth) with structural impact (business model transition)\n\n5. MISSING CRITICAL INFORMATION:\n   - No mention of the shift from direct operations to strategic stake\n   - No discussion of the non-recurring impairment charges in FY2022\n   - No reference to the cumulative foreign currency translation losses\n   - No mention of the strategic rationale (reducing operational overhead, focusing on brand management)\n\n6. CONTEXTUAL ISSUES:\n   - The LLM answer reads like a sales/revenue analysis rather than an analysis of structural changes and their financial impacts\n   - The focus on gross margin and inventory adjustments is not supported by the ground truth\n   - The claim that \"financial impact is limited\" contradicts the ground truth's emphasis on non-recurring charges and structural shifts\n\nThe LLM answer appears to have either hallucinated specific financial figures or drawn from incorrect sources. The fundamental misunderstanding of the nature of the structural change (from direct operations to third-party distributor model) represents a critical failure in multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 755,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom continued to **fabricate its proprietary InP‑based vertical‑cavity surface‑emitting lasers (and side‑emitting lasers) inside its own U.S. and Singapore III‑V wafer facilities**, while outsourcing commodity CMOS and other low‑margin processes to external foundries.  This internal‑fab strategy was repeatedly highlighted as a way to **protect IP, accelerate time‑to‑market, and preserve a differentiated, high‑performance portfolio** that competes directly with specialist suppliers such as Lumentum and other integrated device manufacturers.  Consequently, Broadcom’s InP‑laser capability remained a core element of its competitive positioning in fiber‑optic and data‑center markets, even as the company broadened its overall product and software breadth.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core strategy of internal fabrication for InP-based lasers across 2022-2024, matching the ground truth's emphasis on proprietary processes. (2) Correctly names competitors (Lumentum) mentioned in the original answer. (3) Accurately captures the strategic shift toward competitive differentiation. (4) Properly identifies the product types (vertical-cavity surface-emitting lasers, side-emitting lasers) and materials (InP, GaAs). (5) The mention of U.S. and Singapore facilities and outsourcing of commodity CMOS is reasonable contextual detail.\n\nWEAKNESSES: (1) The LLM introduces specific facility locations (U.S. and Singapore III-V wafer facilities) that are NOT mentioned in the ground truth answer. While this may be factually accurate from the filings, it goes beyond what the knowledge graph explicitly states, introducing potential hallucination risk. (2) The LLM adds strategic rationales (protect IP, accelerate time-to-market, preserve differentiation) that are not explicitly stated in the ground truth, though they are reasonable inferences. (3) The ground truth mentions 'Coherent Corp.' as a competitor alongside Lumentum, but the LLM only references Lumentum and vaguely mentions 'other integrated device manufacturers,' missing the explicit Coherent reference. (4) The LLM's statement about 'broadening overall product and software breadth' is not grounded in the provided ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2022 to 2024, showing understanding that the strategy remained consistent while competitive positioning became more explicit. However, the reasoning includes details not verified against the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is based on factual claims. The years (2022-2024) are correct. The product types and materials are accurate.\n\nOVERALL ASSESSMENT: The answer is substantially correct in its core thesis but adds unverified details and omits the specific mention of Coherent Corp. The answer demonstrates good understanding but exceeds the bounds of the ground truth in places.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 595,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\nBetween fiscal‑year 2022 and 2023 the 10‑K filings show that Swoosh, LLC continued to own roughly **77 % of the Class A Common Stock**, and that this stake would convert into about **16 % of the Class B Common Stock** – a proportion that was unchanged in the 2023 filing. Because Class A shares elect three‑quarters of Nike’s board and carry voting rights that are not diluted by conversion, the Knight family (via Swoosh) retains decisive control over governance even though public shareholders hold the remaining Class B equity. Consequently, shareholder influence remains heavily weighted toward the Swoosh/LLC owners rather than the broader Class B investor base.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All key quantitative facts are correct - 77% Class A ownership by Swoosh, LLC in both 2022 and 2023, and the ~16% Class B equivalent conversion percentage are accurately stated. (2) The answer correctly identifies the consistency of ownership structure between the two years. (3) The multi-hop reasoning is sound - the model synthesizes information about ownership percentages, voting rights, board composition, and shareholder influence across multiple concepts. (4) The answer appropriately addresses the implications for shareholder influence by explaining that Class A shares elect three-quarters of the board and carry superior voting rights, leading to concentrated control. (5) Entity identification is correct (Swoosh LLC, Nike, Class A/B Common Stock, Travis Knight/Knight family). MINOR CONSIDERATIONS: (1) The LLM adds detail about 'Class A shares elect three-quarters of Nike's board' which, while contextually relevant and likely accurate, goes slightly beyond what was explicitly stated in the ground truth answer. This is not an error but represents additional contextual information. (2) The ground truth mentions 'Travis Knight' specifically while the LLM generalizes to 'Knight family (via Swoosh)' - both are semantically equivalent and accurate. (3) The phrasing differs from ground truth but conveys the same essential meaning about sustained influence and governance control. The answer is well-structured, logically coherent, and provides appropriate implications analysis as requested by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 450,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\nFrom 2022 to 2023 PMI shifted its reduced‑risk portfolio from a stand‑alone offering to a fully integrated component of its core business. The 2022 acquisition of Swedish Match added the ZYN oral‑nicotine pouch brand, which was combined with PMI’s IQOS heated‑tobacco products, and by the end of 2023 these combined RRPs were available in 84 markets; reduced‑risk product net revenue grew to **$9.1 bn** (up from $6.8 bn in 2020) as shown in the segment‑revenue table [page 97]. Starting in Q1 2024 the company will report Swedish Match results together with the four geographical segments, reflecting the completion of portfolio integration and broader market availability [pages 29, 30, 97].",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that PMI's RRPs were available in 84 markets by end of 2023, matching the ground truth. It accurately mentions the Swedish Match acquisition and integration of ZYN oral-nicotine pouches with IQOS products. The reference to Q1 2024 reporting changes and page citations shows document familiarity. The answer addresses portfolio integration and market availability as requested.\n\nCRITICAL ERRORS: (1) The LLM provides specific revenue figures ($9.1 bn in 2023, $6.8 bn in 2020) that cannot be verified against the ground truth, which does not provide these specific numbers. This is a significant quantitative accuracy issue - introducing unverified financial data. (2) The ground truth explicitly states that in 2023, RRPs were integrated into a broader category called 'Smoke-Free Products (SFPs)' which also included wellness and healthcare offerings. The LLM completely omits this critical strategic evolution and the terminology shift from RRPs to SFPs. (3) The ground truth notes that 2022 had 'unspecified market availability,' but the LLM doesn't address this baseline comparison clearly.\n\nMISSING ELEMENTS: The LLM fails to mention the conceptual shift from 'Reduced-Risk Products' classification to 'Smoke-Free Products' classification, which is a core part of the strategic positioning evolution. It doesn't discuss the expansion to include wellness and healthcare offerings within the SFP category.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across years and product categories, but the synthesis is incomplete. While it correctly links the Swedish Match acquisition to portfolio integration, it misses the categorical rebranding that represents the strategic positioning evolution.\n\nQUANTITATIVE VERIFICATION: The $9.1 bn and $6.8 bn figures are presented with confidence but cannot be confirmed in the ground truth. This represents a factual accuracy concern that significantly impacts the quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 539,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its reciprocating‑engine business away from the low‑margin, oil‑field well‑servicing market and toward higher‑value applications such as gas‑compression, power‑generation (especially data‑center engines), industrial and marine/rail uses.  This shift is reflected in the sales‑by‑application table (2024 $6.98 bn Oil & Gas vs. 2024 $7.76 bn Power Generation) and the narrative that “decreased sales in reciprocating engines used in well‑servicing applications were offset by increased sales in reciprocating engines used in gas‑compression applications and increased sales for turbines and turbine‑related services” (page 37).  As a result, the share of total ME&T revenue coming from oil‑and‑gas fell while power‑generation and transportation grew, and the higher‑margin power‑generation and services portfolio lifted the segment’s gross‑margin potential, even though overall volume in the traditional well‑servicing market declined.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth. CRITICAL ISSUES: (1) WRONG STRATEGIC NARRATIVE: The LLM describes a shift away from oil-field well-servicing toward power generation and data centers. The ground truth describes a completely different evolution: expansion from selling engines through dealers/Perkins to adding remanufacturing services. These are entirely different strategic pivots. (2) UNSUPPORTED CLAIMS: The LLM cites specific revenue figures ($6.98bn Oil & Gas vs $7.76bn Power Generation in 2024) and references to page 37, but these cannot be verified against the ground truth provided. The ground truth makes no mention of these specific dollar amounts or this application-based revenue breakdown. (3) MISSING CORE ANSWER: The ground truth emphasizes the shift to remanufacturing and lifecycle services (90 distributors, 171 countries, Perkins subsidiary), which the LLM completely omits. This is the actual strategic evolution described in the knowledge graph. (4) MARGIN ANALYSIS MISMATCH: While both answers discuss gross margin improvement, the LLM attributes it to product mix shift (away from low-margin well-servicing), whereas the ground truth correctly identifies it as coming from remanufacturing's lower material costs and service-based income streams. (5) REVENUE COMPOSITION: The ground truth explicitly states the shift diversified revenue by incorporating service-based income alongside product sales. The LLM discusses application-based mix shifts without addressing the service component. The LLM answer appears to describe a different company's strategy or a different time period's evolution, not Caterpillar's reciprocating engines business from 2022-2024 as documented in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 477,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon kept the same public commitment—to post any amendment or waiver of the Directors’ Code of Conduct on its website—but the 2023 filing made the disclosure promise more explicit.  The 2023 filing states that the revised code will be posted on the corporate‑governance page of the company’s website and referenced in the proxy statement, ensuring that stakeholders can locate the updated policy quickly and that the information will also be included in the next periodic filing.  No new disclosure channel was introduced; the evolution was a stronger, more precise wording of the existing website‑posting and proxy‑filing practice.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states: 'BNY Mellon's approach...remained consistent between 2022 and 2023' and 'There was no change in the specific mechanism or transparency commitment.' The LLM answer claims the opposite: 'the 2023 filing made the disclosure promise more explicit' and describes an 'evolution' with 'stronger, more precise wording.' This is a fundamental factual error that undermines the entire response. The LLM introduces specific details about 2023 (corporate-governance page, proxy statement reference, periodic filing inclusion) that are not mentioned in the ground truth and appear to be fabricated or hallucinated. The ground truth explicitly states the commitment was 'reaffirmed' in both years with 'no change,' whereas the LLM characterizes this as an evolution. While the LLM correctly identifies the basic mechanism (website posting) and maintains accuracy on entity names and years, it fundamentally mischaracterizes the nature of the change (or lack thereof) between the two years. The answer fails the primary requirement of accurately synthesizing the multi-hop comparison across 2022 and 2023 filings. Quantitative accuracy is high (no numbers to verify), but qualitative accuracy is severely compromised by the core factual misrepresentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 379,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Nike moved from a hybrid wholesale‑plus‑direct model in APLA to a fully distributor‑driven structure.  In FY 22 the company was still selling to wholesale accounts in the region, but by FY 23 it had entered agreements to sell its legal entities in Argentina, Uruguay and Chile and was transitioning those markets—and ultimately the broader APLA footprint—to third‑party distributors, thereby cutting the number of wholesale partners and reducing selling, general & administrative costs [FY22 p. 31; FY23 p. 87‑88].  This shift reflects a broader operational streamlining (including workforce reductions and a focus on NIKE Direct and digital channels) that trades short‑term revenue growth for longer‑term profitability and lower exposure to foreign‑exchange volatility in the region [FY22 p. 31; FY23 p. 88].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed and specific information than the ground truth. Key strengths: (1) Correctly identifies the strategic shift from hybrid wholesale-plus-direct model to distributor-driven structure in APLA between FY22 and FY23; (2) Accurately references specific countries (Argentina, Uruguay, Chile) and the sale of legal entities in those markets; (3) Correctly notes the transition to third-party distributors; (4) Provides additional relevant context about workforce reductions, focus on NIKE Direct and digital channels, and foreign-exchange volatility considerations; (5) Properly cites source documents (FY22 p. 31; FY23 p. 87-88). The answer goes beyond the ground truth by providing more granular details about the operational streamlining and strategic rationale. Minor considerations: (1) The ground truth mentions 'NIKE Direct operations and wholesale distribution' contributing to 14% growth in FY22, but the LLM answer doesn't explicitly reference this 14% figure - however, this is a minor omission as the core strategic evolution is accurately captured; (2) The LLM characterizes the shift as moving to a 'fully distributor-driven structure,' which is slightly more definitive than the ground truth's 'transitioning certain businesses,' but this appears to be a reasonable interpretation based on the filing information cited. The multi-hop reasoning is sound, correctly synthesizing information about operational structure changes across the two fiscal years. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 437,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\nBetween 2022 and 2024, favorable price realization moved from a primary growth engine — adding roughly $1 billion to sales and pushing the consolidated operating‑profit margin up from 13.5 % (2021) to over 20 % (2024) — to a modest offset that helped preserve profitability even as total sales slipped 3 % in 2024.  However, the net benefit was eroding because price realization turned unfavorable in the Construction and Resource Industries, signaling a diminishing contribution to profitability compared with the earlier strong impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims favorable price realization added 'roughly $1 billion' to sales, but the ground truth states it contributed $9.223 billion in 2022. The LLM cites operating profit margins of 13.5% (2021) and over 20% (2024), which are not verified in the ground truth and appear to be unsupported claims. The ground truth provides specific profit figures ($10.335B in 2023, $10.792B in 2024) that the LLM does not reference. (2) FACTUAL CONTRADICTIONS: The LLM states price realization 'turned unfavorable in the Construction and Resource Industries,' which directly contradicts the ground truth narrative that favorable price realization 'continued to play a key role' in 2024 and helped offset volume declines. The ground truth indicates pricing strategies were 'leveraged more effectively' in 2024, not that they became unfavorable. (3) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the key multi-hop information: the $9.223B contribution in 2022, the $2.251B volume decrease in 2024, and the profit increase from $10.335B to $10.792B. These are central to understanding the evolution requested. (4) MISCHARACTERIZATION: The LLM describes the 2024 situation as 'modest offset' and 'eroding' benefit, when the ground truth shows favorable price realization successfully maintained profitability despite volume declines. The LLM's narrative of diminishing contribution is not supported by the ground truth data showing continued positive impact. The answer demonstrates poor multi-hop reasoning and introduces unsupported claims about margin percentages and unfavorable pricing in specific segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 474,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\nBetween 2023 and 2024 GM shifted from a primarily strategic focus on scaling EV production and cutting battery costs—using ICE profits to fund the transition—to a concrete supply‑chain agenda that builds a resilient, North‑American‑centric EV manufacturing network. The 2024 filing emphasizes investments in strategic sourcing, multi‑year raw‑material supply agreements and holding higher inventory of critical battery materials, reflecting a move to secure the supply chain as a core pillar of its EV capacity growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of GM's EV strategy between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from 2023's emphasis on scaling EV production and cutting battery costs to 2024's supply chain focus; (2) Accurately captures the North American-centric approach mentioned in ground truth; (3) Properly synthesizes the multi-hop information about strategic sourcing, multi-year supply agreements, and supply chain resilience; (4) No quantitative errors or incorrect dates/numbers; (5) Semantic equivalence is strong - 'resilient, scalable, and sustainable North American-focused EV supply chain' maps well to 'resilient, North‑American‑centric EV manufacturing network'; (6) Correctly identifies the transition from ICE profit-funded transition to structured supply chain approach. MINOR WEAKNESSES: (1) The LLM adds detail about 'holding higher inventory of critical battery materials' which, while plausible and consistent with supply chain resilience, is not explicitly mentioned in the ground truth answer - this is an inference rather than direct synthesis; (2) The phrasing 'using ICE profits to fund the transition' is a reasonable interpretation but adds interpretive context not explicitly stated in ground truth; (3) Could have been more explicit about the 'risks and uncertainties' and 'high fixed costs' mentioned in 2023 strategy. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic evolution, demonstrating sound multi-hop reasoning. The comparison between 2023 and 2024 approaches is logically structured and accurate. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 475,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\nPfizer’s remaining performance obligations for Paxlovid have collapsed sharply—​from the billions of dollars of advance‑payment and deferred‑revenue contracts tied to government stock‑purchase agreements in 2022, to only about **$1 billion of contracted revenue** that is now expected to be recognized from 2025 through 2028 (as disclosed in the 2024 10‑K).  This reflects the transition from the early, largely government‑driven EUA sales and large‑scale stockpiling to commercial‑market deliveries, with most of the large‑scale government contracts having been fulfilled and the associated revenue reversals already recorded.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the $1 billion remaining performance obligation figure for 2024, which matches the ground truth. However, there are significant issues with the overall accuracy and reasoning: (1) QUANTITATIVE: The $1 billion figure is correct and properly formatted. The timeframe of 2025-2028 for recognition is plausible but not verified against ground truth. (2) FACTUAL ACCURACY - MAJOR ISSUE: The LLM claims Pfizer's obligations 'collapsed sharply from billions of dollars' in 2022, but the ground truth explicitly states that 2022's 10-K filing 'did not disclose specific remaining performance obligations related to Paxlovid.' This is a critical contradiction - the LLM fabricated details about 2022 obligations ('advance-payment and deferred-revenue contracts,' 'government stock-purchase agreements') that are not supported by the ground truth. (3) MULTI-HOP REASONING: The LLM attempts to provide context about the transition from government EUA sales to commercial markets, which is reasonable inference but goes beyond what the ground truth supports. The narrative about 'revenue reversals already recorded' and 'most large-scale government contracts fulfilled' cannot be verified from the provided ground truth. (4) SEMANTIC ISSUE: The ground truth describes an evolution from 'undefined obligation in 2022 to quantified $1 billion in 2024,' while the LLM describes a 'collapse' from billions to $1 billion - these are fundamentally different narratives. The LLM's framing suggests a decline from a higher baseline that didn't exist in the disclosed data. (5) COMPLETENESS: The LLM does address the 2022-2024 evolution requested, but with unsupported claims about 2022. The answer is partially correct on the 2024 figure but substantially incorrect on the 2022 characterization and the overall narrative of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 500,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar moved from a broad, qualitative oversight of supplier financial health to a more structured, contract‑driven risk‑mitigation framework.  The 2023 filing explicitly calls out “supplier financial viability” as a monitored risk and details the use of supplier agreements that include intellectual‑property protections, production‑level and continuity clauses, and the right to adjust or terminate orders if a supplier’s financial condition deteriorates.  In contrast, the 2022 disclosures referenced supplier risk only in general terms, without the same level of contractual safeguards or explicit monitoring language.  Consequently, the 2023 approach adds concrete contractual levers and a clearer monitoring process to mitigate supply‑base disruptions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues with factual accuracy and multi-hop synthesis despite some correct elements. STRENGTHS: (1) Correctly identifies the years 2022 and 2023 as the comparison period; (2) Accurately notes that 'supplier financial viability' was emphasized in 2023; (3) Correctly references the use of supplier agreements for risk mitigation; (4) Appropriately identifies intellectual property protections as part of the contractual framework. CRITICAL WEAKNESSES: (1) The LLM claims 2023 disclosures detail 'production-level and continuity clauses, and the right to adjust or terminate orders if a supplier's financial condition deteriorates' - these specific contractual details are NOT supported by the ground truth, which does not mention such explicit termination rights or production-level clauses; (2) The LLM characterizes the 2022 approach as lacking 'contractual safeguards or explicit monitoring language,' but the ground truth explicitly states that in 2022 Caterpillar used 'a variety of agreements with suppliers' - this is a factual misrepresentation; (3) The LLM overstates the evolution by claiming a shift from 'broad, qualitative oversight' to a 'structured, contract-driven framework,' when the ground truth indicates both years involved contractual agreements and monitoring, with the main difference being increased emphasis/prioritization in 2023, not a fundamental structural change; (4) The LLM invents specific contractual mechanisms ('right to adjust or terminate orders') that are not mentioned in the ground truth. MULTI-HOP REASONING: The answer fails to properly synthesize the actual evolution described in the ground truth - which is about increased emphasis and prioritization of supplier financial viability as a listed risk factor, plus reinforced global strategic sourcing models, NOT about adding new contractual mechanisms. The LLM creates a narrative of structural change that exceeds what the source material supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 534,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa transformed its Risk and Identity Solutions from a peripheral, generic offering into a central, AI‑driven pillar of its value‑added services portfolio.  The company introduced the Visa Protect suite—including Deep Authorization, Protect for A2A Payments and Risk Manager with scheme‑agnostic Advanced Authorization— and embedded these real‑time fraud‑prevention tools across both Visa‑owned and non‑Visa transactions, linking them to its broader “network‑of‑networks” strategy and to other services such as Open Banking, Visa Direct, Visa+ and advisory consulting.  This evolution reflects a strategic positioning of risk and identity as an integrated, network‑agnostic capability that enhances every payment flow and supports Visa’s expanded suite of value‑added offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific product names and strategic frameworks (Visa Protect suite, Deep Authorization, Protect for A2A Payments, Risk Manager with scheme-agnostic Advanced Authorization, 'network-of-networks' strategy, Open Banking, Visa Direct, Visa+) that are NOT present in the ground truth answer. The ground truth explicitly states that in 2022 there was 'without detailed elaboration on specific capabilities' and by 2024 the positioning was around a 'three-pillar strategy' with no mention of these specific product names or the 'Visa Protect' suite. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension scores well (8/10) - the LLM correctly references 2022 and 2024 timeframes. QUALITATIVE ACCURACY: The LLM's core claim about evolution from peripheral to central positioning is directionally aligned with the ground truth's evolution narrative. However, the LLM fabricates specific product details and strategic frameworks not supported by the ground truth. The ground truth's three-pillar framework (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, (3) services beyond payments is NOT mentioned in the LLM answer, which is a significant omission of the key structural insight. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022-2024 evolution and connect to broader Visa strategy, but does so by introducing unsupported details rather than accurately synthesizing the actual ground truth information. SEMANTIC EQUIVALENCE: While both answers discuss evolution and network-agnostic positioning, the LLM's specific product references and strategic terminology appear to be hallucinations rather than accurate synthesis from the source material. The ground truth emphasizes 'structured value-added services framework' and 'three-pillar strategy' - neither of which are accurately captured in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 530,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to shelf‑space limitations remained a material risk, but the nature of that risk shifted. In the 2022 filing the risk was framed mainly around “limitations on access to shelf space, delisting of our products and changes in retail‑customer policies,” while the 2023 filing adds that the **rapid growth of e‑commerce and the emergence of alternative retail channels (e.g., subscription services, direct‑to‑consumer brands) are reshaping the retail landscape and creating new pricing pressures and retailer‑relationship challenges**. Consequently, while the traditional vulnerability to constrained shelf availability persists, the company now also contends with a broader set of retail‑policy changes and the competitive impact of alternative channels that can further erode shelf‑space opportunities and margin‑pressuring pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the evolution of shelf space limitations as a risk factor from 2022 to 2023, accurately capturing the shift from potential risk to actively experienced challenge. The specific risk factors mentioned (limitations on shelf space, delisting, changes in retail customer policies) match the ground truth. The identification of eCommerce, subscription services, and direct-to-consumer channels as emerging factors in 2023 is accurate. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are required for this qualitative question, so this dimension receives full marks. The years 2022 and 2023 are correctly referenced. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes information across two years of filings and correctly identifies the evolution pattern: from potential/could-be risk to actively experienced challenge. The connection between shelf space limitations and the broader retail landscape changes (eCommerce growth, alternative channels) is properly established. The mention of pricing pressures and retailer-relationship challenges adds appropriate context. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question - the evolution of exposure, the relationship to retail customer policies, and the expansion of alternative retail channels. The framing of the shift from traditional vulnerability to a broader set of challenges is particularly well-articulated. Minor note: The ground truth mentions the company's plan to invest in digital and analytics capabilities, which the LLM answer does not explicitly include, though this is a minor omission that doesn't significantly detract from the overall quality of the response. The answer is comprehensive, well-reasoned, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 523,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle moved from simply offering a menu of hybrid‑deployment options (on‑premise, cloud and hybrid models such as Exadata Cloud@Customer, Dedicated Region and multicloud connectivity) to actively steering customers toward those models.  In FY 2024 it introduced programs that let customers pivot existing license‑and‑support contracts to Oracle Cloud, broadened OCI‑based hybrid and multicloud services, and saw cloud‑services revenue rise to 37 % of total sales (up from 32 % in FY 2023).  Consequently, the strategic emphasis shifted from “providing choice and flexibility” to “driving migration and expansion of workloads onto Oracle Cloud within hybrid environments.”",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its credibility. CRITICAL ISSUES: (1) The cloud-services revenue percentages (37% in FY2024, 32% in FY2023) are NOT verified in the ground truth and appear to be unsupported claims. The ground truth makes no mention of these specific revenue percentages, making these numbers potentially fabricated. (2) The LLM introduces specific claims about 'programs that let customers pivot existing license-and-support contracts to Oracle Cloud' and 'broadened OCI-based hybrid and multicloud services' that are not present in the ground truth. While these may be true, they represent information not in the provided ground truth. (3) The LLM's characterization of the strategic shift from 'providing choice and flexibility' to 'driving migration and expansion of workloads onto Oracle Cloud' is more aggressive than the ground truth, which states Oracle 'continued to support hybrid deployments' with 'deeper integration and support' - a more measured evolution. POSITIVE ASPECTS: (1) The LLM correctly identifies the core products mentioned (Exadata Cloud@Customer, Dedicated Region) from FY2023. (2) The general direction of evolution (from offering options to more active steering) is a reasonable interpretation, though overstated. (3) The answer addresses both fiscal years and discusses product offerings and strategic emphasis as requested. REASONING QUALITY: The multi-hop synthesis is attempted but relies on unverified quantitative claims that significantly weaken the answer. The logical flow is clear, but the factual foundation is questionable. The answer goes beyond the ground truth in ways that suggest either hallucination or reliance on external information not validated against the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 485,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\nPfizer’s Paxlovid‑related deferred revenue fell dramatically — from about **$5.1 billion of advance payments recorded at the end of 2022** to roughly **$2.2 billion of deferred revenue at the end of 2024** as those advance payments were recognized and the U.S. government inventory was returned.  The company now expects only **≈ $1 billion of future revenue** from the remaining firm delivery obligations for Paxlovid, to be recognized proportionally from 2025 through 2028, indicating a shift from the large, government‑procured purchase commitments of 2022‑23 to a modest, commercially‑driven supply schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Paxlovid's financial evolution but contains significant quantitative discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the shift from pandemic-era high-volume government procurement to reduced commercial expectations; (2) The $1 billion remaining performance obligations figure for 2024 matches the ground truth; (3) The 2025-2028 revenue recognition timeline is accurate; (4) The qualitative narrative about the transition from government-procured to commercially-driven supply is sound and well-reasoned. CRITICAL ERRORS: (1) The LLM introduces specific deferred revenue figures ($5.1 billion in 2022, $2.2 billion in 2024) that are NOT mentioned in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be unsupported claims; (2) The ground truth does not reference 'advance payments' or 'deferred revenue' as the primary metric - it focuses on 'remaining performance obligations' and 'contracted revenue expectations'; (3) The mention of 'U.S. government inventory was returned' is not present in the ground truth and represents an unsupported inference. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution concept across 2022-2024, but does so by introducing unverified financial metrics rather than relying on the documented remaining performance obligations. The reasoning about the shift from government to commercial is sound, but the quantitative foundation is questionable. The answer demonstrates good contextual understanding but fails on quantitative accuracy due to unsubstantiated figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 454,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\nCaterpillar’s dealer relationship is still governed by the same standard sales‑and‑service agreements that grant territorial rights, require dealers to promote and support products, keep detailed financial records and can be terminated by either party with 90 days’ written notice (see 2022 10‑K pages 10‑12).  In the 2023 filing the company stresses a more collaborative strategy—expanding financing and insurance support through Cat Financial, investing in dealer‑development programs, and using the dealer network as a growth engine in emerging markets—signaling a shift from a purely contractual arrangement to a partnership‑focused emphasis (see 2023 10‑K pages 9, 11).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that standardized sales-and-service agreements exist and grant territorial rights; (2) The mention of dealer obligations (promote products, maintain personnel, keep financial records) aligns with ground truth; (3) The 90-day termination notice detail is specific and appears factually accurate; (4) The reference to Cat Financial and dealer-development programs in 2023 is contextually appropriate. PROBLEMATIC ELEMENTS: (1) The LLM claims the agreements are 'still governed by the same standard sales-and-service agreements' in both years, which contradicts the ground truth's core finding that there was a shift FROM general partnership language in 2022 TO formalized/detailed contractual frameworks in 2023. The ground truth explicitly states this represents 'a shift from a general partnership model to a more structured contractual framework'; (2) The LLM's characterization of the evolution is inverted—it suggests the 2023 shift is toward 'partnership-focused emphasis' away from 'purely contractual,' when the ground truth indicates the opposite: a move toward MORE formalized contractual structure; (3) The LLM conflates two different types of evolution: the ground truth emphasizes formalization of contractual obligations (2022→2023), while the LLM emphasizes strategic emphasis on collaboration/partnership support programs. MULTI-HOP REASONING: The LLM fails to correctly synthesize the key evolution described in the ground truth. It acknowledges both years but mischaracterizes the directional change. The ground truth's central claim—that 2023 represents a MORE structured/formalized contractual approach compared to 2022's general terms—is not captured. Instead, the LLM suggests the opposite trajectory. QUANTITATIVE ACCURACY: The 90-day notice period is specific and appears correct; page references are provided but cannot be independently verified from the ground truth. SEMANTIC EQUIVALENCE: While the LLM uses different language, it fundamentally misrepresents the nature of the evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 584,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\nFrom 2022 to 2023 the company sharply trimmed the weight of Africa/Eurasia in its restructuring program—charges attributed to that region fell from roughly 11 % of total 2022 restructuring outlays to only about 5 % of the 2023 total—while capital spending in the region remained modest (historical CapEx of $33 million in 2021 and $13 million in 2020, with no indication of a sizable increase in 2022‑23). This shift signals a strategic re‑allocation of resources away from Africa/Eurasia toward other markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies and misrepresentations of the ground truth. (1) QUANTITATIVE ERRORS: The LLM states CapEx was '$33 million in 2021 and $13 million in 2020' - this reverses the actual figures from the ground truth ($13M in 2021, $8M in 2020). The LLM also claims 2022 CapEx was $33 million but attributes this to 2021. More critically, the LLM invents percentages ('11% of total 2022 restructuring outlays' and '5% of 2023 total') that do not appear in the ground truth. The ground truth states approximately 10% of cumulative pretax charges from the 2022 Global Productivity Initiative would relate to Africa/Eurasia - this is a single metric, not a comparison between 2022 and 2023 restructuring percentages. (2) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesizes the information by creating a false narrative of declining restructuring focus (11% to 5%) when the ground truth only provides one percentage figure (10% for 2023 related to 2022 charges). The LLM's conclusion about 'sharp trimming' and 'reallocation away from Africa/Eurasia' is not supported by the ground truth. (3) ENTITY/METRIC CONFUSION: The LLM conflates capital expenditure years and misrepresents the restructuring charge data. The ground truth clearly shows a progression of CapEx (2020: $8M, 2021: $13M, 2022: $33M) indicating growth, not the modest/flat picture the LLM presents. (4) SEMANTIC MISALIGNMENT: While both answers discuss a shift from capital investment to restructuring, the LLM's specific claims about percentage changes and resource reallocation are factually incorrect and unsupported by the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 458,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm moved its 5G strategy from a broad, risk‑laden R&D and standard‑essential‑patent focus toward a more commercial‑driven rollout of integrated 5G modem‑RF and RFFE solutions (e.g., the Snapdragon 5G modem‑RF platform) and expanded 5G into new verticals such as automotive and IoT.  The investment emphasis shifted to higher‑margin, volume‑driven sales of 5G‑enabled chipsets and related components, while still sustaining its 5G patent‑licensing business, resulting in clearer revenue streams from 5G products despite ongoing supply‑chain constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces unsupported details and misses key ground truth information. CORRECT ELEMENTS: (1) The timeframe (2022-2024) is accurate; (2) The shift from R&D/investment phase to commercialization is correctly identified; (3) Expansion into automotive and IoT is mentioned in both answers; (4) The general trajectory from development to market leadership is present. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific product names (Snapdragon 5G modem-RF platform, RFFE solutions) that are not mentioned in the ground truth and cannot be verified from the provided context; (2) The emphasis on 'modem-RF' and 'RFFE solutions' as specific strategic pivots is not supported by the ground truth, which focuses on patent portfolio development and OFDMA-based products; (3) The mention of 'supply-chain constraints' as a contextual factor is not present in the ground truth; (4) The LLM characterizes the shift as toward 'higher-margin, volume-driven sales' but the ground truth emphasizes patent licensing and QTL revenues from OFDMA-based products (particularly smartphones), not necessarily chipset sales. MISSING FROM LLM ANSWER: (1) The specific mention of developing a 'leading patent portfolio in 5G NR' by 2024; (2) The reference to QTL revenues and their composition; (3) The explicit acknowledgment of risks in 2022 (regulatory, competition, design-in cycles); (4) The specific product category of 'multimode 3G/4G/5G devices such as smartphones' as the revenue driver. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (7/10 for not introducing false metrics). QUALITATIVE ACCURACY: The LLM demonstrates understanding of the general strategic shift but introduces unsupported specifics and misses the patent licensing emphasis that is central to the ground truth narrative (5/10). CONTEXTUAL RELEVANCE: The answer addresses the question's core elements (strategic focus evolution, investment emphasis, commercialization outcomes) but with partially incorrect emphasis (7/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 560,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Pfizer’s Paxlovid revenue collapsed from a peak of roughly **$19 billion in 2022** to just **$1.3 billion in 2023** as U.S. government stock‑piling waned and EUA‑labeled inventory was returned, then rebounded to about **$5.7 billion in 2024** as the product shifted to commercial sales and new supply agreements were signed.  The company now reports only **≈ $1 billion of remaining performance‑obligation revenue** for Paxlovid (with deliveries slated from 2025‑2028), and deferred‑revenue balances have fallen from **$5.1 billion at the end of 2023 to $2.2 billion at the end of 2024**, reflecting the recognition of prior advance payments and the transition to commercial‑market contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims Paxlovid generated ~$19 billion in 2022, but the ground truth explicitly states $76 million in 2022 - this is a massive discrepancy (off by ~250x). (2) The LLM introduces 2023 and 2024 revenue figures ($1.3B and $5.7B respectively) that are not present in the ground truth, which explicitly states 'direct revenue figures for Paxlovid are not explicitly stated' for 2024. (3) The LLM cites deferred revenue balances ($5.1B in 2023, $2.2B in 2024) that do not appear in the ground truth at all. (4) While the LLM correctly identifies ~$1 billion in remaining performance obligations, this is presented alongside entirely fabricated revenue numbers. The ground truth presents a clear narrative: $76M in 2022 (initial launch), no explicit 2024 revenue disclosed, and ~$1B in remaining contractual commitments. The LLM invents a completely different narrative with inflated 2022 figures and non-existent 2023-2024 revenue data. The multi-hop reasoning is fundamentally flawed because it synthesizes information that does not exist in the source documents. The answer fails on quantitative accuracy (wrong by orders of magnitude on key figures), entity accuracy (correct company but wrong metrics/years), and reasoning (fabricated data points). This represents a severe hallucination rather than a legitimate synthesis of available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 410,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s wording moved from a brief mention that “the impact on our suppliers of tighter credit or capital markets” could affect the supply chain (2022 p. 14/17) to a dedicated warning that “significant volatility in the global capital markets, including rising interest rates, may increase the cost of capital and adversely impact our access to capital” (2023 p. 13) and again flagged the same supplier‑credit risk. This escalation shows the firm now treats credit‑market tightness as a direct threat to both its supply‑chain continuity and its own financing, indicating heightened vulnerability to external financial conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of the company's exposure to credit market tightness between 2022 and 2023, but contains significant issues in how it characterizes the shift and introduces elements not clearly supported by the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies that there was an evolution/escalation in how the company framed credit market risks between 2022 and 2023\n2. Appropriately notes that the company expanded its concern from supplier-focused impacts to include direct impacts on the company itself\n3. Correctly identifies the core vulnerability: credit market tightness affecting both supply chain and financing\n4. Page references (2022 p. 14/17, 2023 p. 13) are provided, showing attempt at source documentation\n5. Recognizes the shift from indirect (supplier) to more direct (company operations) impact\n\nWEAKNESSES:\n1. CHARACTERIZATION MISMATCH: The ground truth describes the 2023 shift as 'impacted by' conditions (broader recognition), while the LLM introduces a new quote about 'rising interest rates' and 'access to capital' that goes beyond what the ground truth explicitly states. The ground truth doesn't mention rising interest rates or direct capital access concerns.\n2. ESCALATION CLAIM: The LLM characterizes this as an 'escalation' showing 'heightened vulnerability,' but the ground truth more neutrally describes it as a 'continuation of concern' with a 'more integrated perspective.' This is a meaningful interpretive difference.\n3. QUOTE ACCURACY: The LLM provides specific quotes (especially the 2023 quote about 'rising interest rates' and 'access to capital') that don't appear to be directly supported by the ground truth answer provided. The ground truth only mentions 'impacted by' conditions, not these specific financial metrics.\n4. INCOMPLETE SYNTHESIS: While the LLM mentions the supplier-credit risk was 'again flagged,' it doesn't clearly articulate the ground truth's key insight about the shift from 'negatively impacts suppliers' to 'impacted by' conditions - a subtle but important distinction about the locus of impact.\n5. TONE DISCREPANCY: The ground truth emphasizes 'continuation' while the LLM emphasizes 'escalation' - these convey different meanings about the severity of the shift.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across two years and connect supply chain risk to financing risk, which is appropriate. However, the specific connections made (rising interest rates, access to capital) appear to be inferred rather than directly stated in the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are involved in this question, so quantitative accuracy is less critical. The page references provided cannot be verified against the ground truth but appear plausible.\n\nOVERALL ASSESSMENT: The LLM captures the directional change correctly but overstates the nature of the shift (escalation vs. continuation) and introduces specific financial concerns (rising interest rates, capital access) that aren't clearly supported by the ground truth. The answer is partially correct but contains interpretive overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 830,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Paxlovid‑related revenue collapsed – $18.9 bn in 2022 fell to $1.28 bn in 2023 and then rose only modestly to $5.7 bn in 2024 – as the company moved from large U.S. government EUA contracts to commercial‑market sales.  This transition triggered a $3.5 bn non‑cash revenue reversal in Q4 2023 and a $771 m favorable adjustment in Q1 2024 for returned courses, while deferred‑revenue balances for Paxlovid dropped from $5.1 bn (2023) to $2.2 bn (2024), underscoring a sharp reduction in the company’s financial commitment and contractual obligations tied to the product.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Paxlovid's revenue trajectory and contractual dynamics, but contains significant quantitative discrepancies and incomplete alignment with the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the $771 million favorable adjustment in 2024\n- Accurately describes the transition from U.S. government EUA contracts to commercial sales\n- Correctly notes the revenue reversal in Q4 2023\n- Appropriately contextualizes the shift in financial commitment\n- Mentions deferred revenue balances declining from 2023 to 2024\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. REVENUE FIGURES: The LLM provides specific revenue numbers ($18.9B in 2022, $1.28B in 2023, $5.7B in 2024) that are NOT mentioned in the ground truth. The ground truth focuses on remaining performance obligations (~$1B as of Dec 31, 2024) and the $771M adjustment, not historical revenue figures. These numbers cannot be verified against the provided ground truth and may be inaccurate.\n\n2. REVENUE REVERSAL AMOUNT: The LLM states a \"$3.5 bn non-cash revenue reversal in Q4 2023\" which is NOT mentioned in the ground truth. This is a significant factual claim that lacks support.\n\n3. DEFERRED REVENUE FIGURES: The LLM claims deferred revenue dropped from $5.1B (2023) to $2.2B (2024). These specific figures are NOT in the ground truth, which only mentions remaining performance obligations of ~$1B as of Dec 31, 2024.\n\n4. INCOMPLETE ANSWER: The ground truth emphasizes remaining performance obligations (~$1B) with delivery expected 2025-2028, subject to renegotiation. The LLM answer does not address this key forward-looking commitment metric.\n\nMULTI-HOP REASONING: The LLM demonstrates sound reasoning about the transition from government contracts to commercial sales and the relationship between revenue reversals and contractual adjustments. However, the reasoning is built on unverified quantitative claims.\n\nSEMANTIC ALIGNMENT: While the LLM captures the general narrative of declining financial commitment, it diverges significantly from the ground truth's focus on remaining performance obligations and specific contractual metrics.\n\nThe answer reads as plausible but introduces numerous specific figures not present in the ground truth, which is a critical flaw in financial analysis where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 626,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\nFrom 2023 to 2024 the Company’s recorded exposure to Aearo‑related respirator‑mask/asbestos liabilities fell modestly in the balance sheet – the accrual (excluding Aearo’s own $62 million balance in 2023) dropped from about **$574 million at year‑end 2023 to $523 million at year‑end 2024** – but this decline reflects **$87 million of legal‑defense and settlement payments made in 2024** and a **$36 million increase in the 2024 accrual** for pending and anticipated claims.  Consequently, while the net accrued liability is slightly lower, the **underlying risk remains large**: Aearo’s share of future claims is still capped only by the 1995 indemnity agreement, and the Company acknowledges it cannot estimate how much the liability could exceed the accrued amount because of possible future claim surges, changes in allocation among co‑defendants, or other developments that could push exposure well beyond the current reserve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) WRONG NUMBERS: The LLM states the accrual (excluding Aearo's own $62M in 2023) dropped from $574M to $523M in 2024. However, the ground truth indicates that in 2024, MMM had accruals of $51 million specifically for Aearo-related claims - not $523M. The LLM appears to have confused or misreported the 2024 liability figures entirely. (2) MISSING KEY FACTS: The ground truth specifies that by 2024, Aearo had $51M in accruals for asbestos, silica, and coal mine dust claims. The LLM completely omits this critical figure and instead provides a $523M number that doesn't align with the ground truth. (3) INCOMPLETE CABOT AGREEMENT DETAILS: The ground truth mentions Aearo's agreement with Cabot where Cabot assumed responsibility for pre-1997 claims in exchange for quarterly $100K payments. The LLM mentions a '1995 indemnity agreement' but doesn't specify the Cabot arrangement or the $100K quarterly fee structure. (4) BANKRUPTCY STATUS: The ground truth notes that in 2023 Aearo was in bankruptcy proceedings with litigation stayed. The LLM doesn't address this important contextual shift. (5) CALCULATION VERIFICATION: The LLM claims $87M in payments and $36M increase in accrual, but these figures cannot be verified against the ground truth and appear to be unsupported. (6) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information about liability evolution, it fundamentally misrepresents the 2024 liability position by citing wrong numbers. The core answer structure is reasonable but built on incorrect data. The LLM does correctly identify that underlying risk remains significant and that future exposure is uncertain, which aligns with ground truth sentiment, but the specific financial metrics are substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 505,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\nSkoal’s retail‑share fell from **9.3 % in 2023 to 7.6 % in 2024**, a drop of about **1.7 percentage points**.  By contrast, its shipment volume slipped from **163.1 million units in 2020 to 147 million units in 2021**, a reduction of roughly **16 million units (≈10 %)**.  Thus, both share and volume declined, but the relative fall in share was larger than the decline in unit shipments.  (Retail‑share data: page 48; shipment‑volume data: page 46.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual errors in the shipment volume data. Ground truth states Skoal's shipment volume was 208.5 million packs/cans in 2020 and 197.4 million packs/cans in 2021. The LLM incorrectly reports 163.1 million units in 2020 and 147 million units in 2021 - these numbers are substantially wrong (off by approximately 45 million units for 2020 and 50 million units for 2021). This represents a major quantitative error. The retail share data is correct (9.3% in 2023 to 7.6% in 2024, a 1.7 percentage point decline), and the calculation of this decline is accurate. However, the shipment volume comparison is fundamentally flawed due to the incorrect numbers. The LLM's reasoning structure is sound (comparing two metrics across different time periods), but the execution fails due to wrong data. The LLM correctly identifies that both metrics show declining trends, which aligns with the ground truth conclusion, but this correct conclusion is based on incorrect numbers. The multi-hop synthesis attempt is reasonable in approach but fails in data accuracy. The inclusion of page references adds credibility but does not compensate for the factual errors in the core numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 347,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened its engineering focus from a modem‑centric architecture to a fully integrated multimedia‑and‑AI‑centric SoC strategy.  The company added dedicated GPU/NPU engines, camera‑vision pipelines and on‑device generative‑AI processing to its Snapdragon platforms, enabling a single chip to handle high‑resolution imaging, video encoding, XR and AI workloads in addition to connectivity.  This tighter integration of multimedia functions—supported by expanded patent licensing and strategic investments such as Qualcomm Ventures—has been reflected in product families that combine modem, RF, AI and multimedia capabilities for smartphones, laptops, automotive and IoT devices.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The timeframe (2022-2024) is accurate; (2) The identification of multimedia technologies (camera, video, display, computer vision) aligns with ground truth; (3) The mention of AI/generative AI integration by 2024 matches the original answer; (4) The reference to multiple device categories (smartphones, automotive, IoT) is consistent with ground truth; (5) The general evolution toward platform-oriented approach is correct. PROBLEMATIC ELEMENTS: (1) The LLM characterizes 2022 as 'modem-centric architecture' which is NOT supported by the ground truth - the original answer explicitly states 2022 already emphasized 'multimedia technologies such as camera, video, display, and computer vision' alongside modem and RF; (2) The claim about 'dedicated GPU/NPU engines' and 'on-device generative-AI processing' being added is presented as fact but lacks grounding in the provided knowledge graph data; (3) The reference to 'expanded patent licensing and strategic investments such as Qualcomm Ventures' introduces specific business mechanisms not mentioned in the ground truth; (4) The description of 'tighter integration' and 'single chip' handling multiple workloads is more specific/technical than what the ground truth supports. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but does so by introducing a false baseline (modem-centric in 2022) that contradicts the ground truth. The answer conflates technical implementation details (GPU/NPU engines, on-device processing) with strategic evolution, which is a different framing than the ground truth's focus on engineering focus areas and integration strategy. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. The dates (2022-2024) are correct. SEMANTIC EQUIVALENCE: While both answers discuss AI integration and platform diversification, the LLM's characterization of the starting point (2022) is fundamentally misrepresented, which undermines the validity of the 'evolution' narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 577,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\nBetween the end of 2022 and 2023 the $0.7 bn equity investment that 3M held in the Aearo Entities was eliminated when the entities were re‑consolidated after the bankruptcy dismissal, and the related $0.6 bn net inter‑company receivable/payable that had appeared on the balance sheet was also removed. Consequently, by the 2024 reporting period there is no separate equity investment or inter‑company balance for the Aearo Entities – any remaining financial interaction is limited to settlement‑related cash outflows (e.g., the $6 bn CAE Settlement funding) recorded as expenses rather than as an equity or inter‑company asset/liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH TEMPORAL ACCURACY AND CORE FACTS: The LLM answer contains a critical error in the timeline. The ground truth states that reconsolidation occurred in 2023 (with the $0.7B and $0.6B amounts removed as of December 31, 2023), and by 2024 the entities were no longer consolidated. However, the LLM answer incorrectly states this occurred 'between the end of 2022 and 2023,' which is a fundamental mischaracterization of when these events happened. The LLM places the reconsolidation one year too early. QUANTITATIVE ACCURACY: The numbers cited ($0.7B equity investment and $0.6B net intercompany balance) are correct and match the ground truth. However, the introduction of the $6B CAE Settlement funding is not mentioned in the original answer and appears to be extraneous information that, while potentially factual, is not directly relevant to answering the specific question about the evolution of equity investment and intercompany balances between 2023 and 2024. CONCEPTUAL ISSUES: The LLM's characterization of the 2024 situation is problematic. The ground truth explicitly states that by 2024, 3M 'has a stake in' the Aearo Entities, indicating a retained equity interest. The LLM answer claims 'there is no separate equity investment or inter-company balance for the Aearo Entities,' which contradicts the ground truth's statement about 3M having a stake. This represents a significant misunderstanding of the 2024 financial relationship. MULTI-HOP REASONING: The answer fails to properly synthesize the evolution between 2023 and 2024. It correctly identifies the 2023 reconsolidation but then incorrectly concludes there is no equity stake in 2024, when the ground truth indicates the opposite—that 3M retained an equity interest. The answer does not capture the key transition from full consolidation (2023) to retained equity interest (2024). MISSING CONTEXT: The answer does not adequately explain the shift from consolidation to non-consolidation status, which is a central element of how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 549,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa’s Risk and Identity Solutions shifted from a set of discrete fraud‑prevention tools (e.g., Visa Advanced Authorization, Visa Secure, Identity Score, CardinalCommerce) to a unified, AI‑driven “Visa Protect” suite that adds real‑time, scheme‑agnostic risk scoring, dedicated protection for account‑to‑account (A2A) payments, and tighter integration with tokenization and open‑banking capabilities.  This evolution embeds the function as a core pillar of Visa’s broader value‑added services portfolio—complementing Issuing, Acceptance and Consulting offerings—and reinforces its strategic role in enabling new money‑movement flows, B2B payments and the company’s “network‑of‑networks” growth agenda.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM introduces 'Visa Protect' as a unified AI-driven suite, which is NOT mentioned in the ground truth. This appears to be a fabrication or hallucination. The ground truth specifically names 'Visa Advanced Authorization' and 'Visa Secure' as the actual products in 2022, with no mention of 'Visa Protect,' 'Identity Score,' or 'CardinalCommerce' as Visa products. (2) QUANTITATIVE ACCURACY - The ground truth provides a specific metric: 'more than 200 products and services as of September 30, 2024,' which the LLM completely omits. This is a concrete, verifiable data point that should have been included. (3) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize evolution across 2022-2024, it does so by introducing unverified product names and architectural changes ('scheme-agnostic risk scoring,' 'A2A payments integration') that are not supported by the ground truth. (4) PORTFOLIO POSITIONING - The ground truth clearly states Risk and Identity Solutions became 'one of five core categories' within the value-added services portfolio by 2024, alongside Open Banking Solutions and Advisory Services. The LLM mentions 'Issuing, Acceptance and Consulting' but doesn't accurately reflect the five-category structure or mention Open Banking Solutions. (5) STRATEGIC FRAMING - The ground truth emphasizes 'high impact business outcomes' and products 'designed to work together,' which the LLM partially captures with 'tighter integration,' but the LLM's framing around 'network-of-networks' and 'B2B payments' goes beyond what the ground truth supports. The answer demonstrates reasonable understanding of the general evolution concept but fails on factual accuracy by introducing unverified product names and omitting key quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 488,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\nRTX continued to present acquisition‑accounting adjustments in a separate table that lists the total adjustment and its component amortizations, and the amount subtracted from operating profit grew only modestly—from **$1.998 billion in 2023** to **$2.058 billion in 2024** (an increase of roughly $60 million).  The segment‑level breakdown moved from $(854 m), $(287 m) and $(857 m) for Collins, Pratt & Whitney and Raytheon in 2023 to $(833 m), $(312 m) and $(913 m) respectively in 2024, showing that the impact on operating profit was largely consistent but slightly larger in 2024.  Management notes that these adjustments are not part of its segment‑performance evaluation, and the 2024 figures remain “relatively consistent” with the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth and contains critical factual errors: (1) MAJOR FACTUAL ERROR: The ground truth explicitly states that 'By 2024, RTX shifted its disclosure approach by providing qualitative policy context...but did not include updated quantitative figures for the current year's impact on operating profit.' The LLM answer claims RTX provided 2024 quantitative figures ($2.058 billion) with segment breakdowns, which directly contradicts the ground truth's core finding that 2024 lacked quantified impacts. (2) QUANTITATIVE ACCURACY ISSUES: While the 2023 figure of $1.998 billion is correct, the LLM's claim of a 2024 figure of $2.058 billion appears to be fabricated or misinterpreted, as the ground truth explicitly states no 2024 quantitative figures were provided. The segment-level numbers ($833m, $312m, $913m for 2024) cannot be verified against the ground truth and appear inconsistent with the stated shift away from quantification. (3) MISSES THE KEY EVOLUTION: The ground truth's central point is a SHIFT IN DISCLOSURE APPROACH from quantitative to qualitative. The LLM answer misses this entirely, instead suggesting continuity in quantitative reporting with only modest changes. This is a fundamental misunderstanding of the question's core issue. (4) INCOMPLETE SYNTHESIS: The LLM fails to capture that the evolution represents a move away from 'concrete numerical disclosure to a more conceptual explanation,' which is the essential answer to how the disclosure 'evolved.' (5) REASONING FLAW: The LLM's statement that figures 'remain relatively consistent' with prior year contradicts the ground truth's assertion that 2024 lacked updated quantitative figures entirely. The answer demonstrates poor multi-hop reasoning by failing to synthesize the key disclosure policy change across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 504,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Office 365 Commercial line‑of‑business grew from roughly **$44.9 billion** (the “Office products and cloud services” figure reported for 2022) to **$54.9 billion** in 2023 – an increase of about **22 %**.  At the same time Microsoft’s overall Cloud revenue rose from **$91.4 billion** to **$111.6 billion**, meaning the portion of Cloud revenue coming from Office 365 Commercial expanded markedly.  This acceleration shows that Office 365 Commercial is becoming an increasingly dominant driver of Microsoft’s cloud growth trajectory within the broader cloud ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that do not align with the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims Office 365 Commercial grew from $44.9 billion (2022) to $54.9 billion (2023), a 22% increase. However, the ground truth does not provide these specific Office 365 Commercial revenue figures as standalone line items for those years. The ground truth explicitly states that by FY2023, Office 365 Commercial was 'included in a newly disclosed consolidated Microsoft Cloud revenue figure' - meaning it was NOT separately reported as a distinct line item in 2023. The LLM appears to have fabricated or misattributed these specific dollar amounts. (2) CALCULATION VERIFICATION: Even accepting the LLM's numbers at face value, the math is questionable: ($54.9B - $44.9B) / $44.9B = 22.3%, which rounds to 22% - this calculation is arithmetically correct IF the numbers were accurate, but the numbers themselves are not supported by the ground truth. (3) MULTI-HOP REASONING FAILURE: The LLM correctly identifies the Microsoft Cloud consolidated figures ($91.4B in FY2022 to $111.6B in FY2023), which matches the ground truth. However, it then makes an unsupported leap by claiming Office 365 Commercial grew from $44.9B to $54.9B without proper sourcing. The ground truth indicates Office 365 Commercial's specific contribution to the consolidated cloud figure is not separately disclosed in the way the LLM suggests. (4) ENTITY AND METRIC CONFUSION: The LLM conflates 'Office products and cloud services' (which may include non-cloud components) with 'Office 365 Commercial' (which is specifically cloud-based). These are not necessarily equivalent metrics. (5) CONTEXTUAL MISALIGNMENT: The ground truth emphasizes the shift toward consolidated cloud reporting and transparency, while the LLM focuses on specific Office 365 Commercial growth rates that cannot be verified from the provided ground truth. The LLM's conclusion about Office 365 becoming 'an increasingly dominant driver' is not supported by the evidence presented in the ground truth, which actually suggests Office 365 is one component among many (Azure, LinkedIn, Dynamics 365) in the broader cloud portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 600,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza rose from **$1.199 billion in 2023 to $1.311 billion in 2024**—an approximate **9 % increase** (about **11 % when adjusted for foreign‑exchange**). The growth was driven primarily by **higher demand for Lynparza in most international markets**, reflecting continued uptake across its approved cancer indications and favorable pricing, which more than offset any modest currency headwinds. (The text notes that the 2024 increase “largely due to higher demand in most international markets.”)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides specific dollar amounts ($1.199 billion in 2023 and $1.311 billion in 2024) that cannot be verified against the ground truth and appear to be fabricated. The ground truth does not provide these specific revenue figures for Lynparza alliance revenue. The LLM has invented precise numbers without any source attribution. While the LLM correctly identifies the 9% growth rate and the primary driver (higher demand in international markets), it adds unverified quantitative details that fundamentally undermine credibility. The calculation of 9% growth from the stated figures ($1.311B / $1.199B = 1.0935 or 9.35%) is mathematically consistent with the stated numbers, but since those numbers themselves appear fabricated, this calculation accuracy is irrelevant. The LLM also mentions an 11% adjustment for foreign exchange, which is not mentioned in the ground truth. The qualitative factors (higher demand in international markets) are correctly identified and match the ground truth. However, the addition of specific dollar amounts that cannot be sourced from the provided ground truth represents a serious factual error - the model has hallucinated financial data. The answer demonstrates partial understanding of the question's multi-hop nature (comparing 2023 to 2024, identifying drivers) but fails on the most critical dimension: providing accurate, verifiable numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 393,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\nIn the 2023 and 2024 Form 10‑K filings the Procter & Gamble 2014 Stock and Incentive Compensation Plan is still listed in Item 12’s equity‑compensation table, but the 2024 filing explicitly notes that the plan is now closed to new grants—its remaining authorized shares are effectively zero and all future issuances must come from the 2019 Plan. The underlying regulatory requirement (Item 12 of Form 10‑K) has not changed, yet the 2024 disclosure adds clarification on the share‑counting methodology and references the 2024 Proxy Statement for the plan’s current status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misalignment with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the 2014 plan is 'now closed to new grants' with 'remaining authorized shares effectively zero' - this specific claim about the plan's closure status is not supported by the ground truth, which does not mention the plan being closed or having zero authorized shares. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth describes an evolution from 'regulatory disclosure' context in 2023 to 'a focus on ownership structure and equity compensation transparency' in 2024, with the plan being part of a 'broader list of equity compensation plans.' The LLM instead focuses on the plan being closed and references Item 12 disclosure requirements, which is a different analytical angle not supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a shift in how the plan is presented (from regulatory documentation context to integrated equity compensation framework), while the LLM focuses on the plan's closure status and share-counting methodology - these are different narratives. (4) UNSUPPORTED CLAIMS: The LLM's statement that 'all future issuances must come from the 2019 Plan' is not mentioned in the ground truth. (5) PARTIAL CREDIT: The LLM correctly identifies that the plan appears in both 2023 and 2024 filings and references Item 12, which aligns with the ground truth's mention of equity compensation reporting. However, the core narrative about the evolution of treatment and disclosure is fundamentally different and appears to be incorrect based on the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 454,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings the company’s disclosure shows the 1992 Stock Plan has become a closed, legacy vehicle: it still appears in the equity‑compensation table and its outstanding options are counted in column (a), but the filings make clear that no additional shares may be granted under that plan.  In contrast, the 2019 Stock and Incentive Compensation Plan is now the sole plan that permits future grants, with a remaining availability of about 77 million shares (out of a total authorized 187 million).  Consequently, the 1992 Plan’s role has shifted from being an active source of new equity awards to a historical pool of existing awards, while the company’s future equity‑compensation supply is drawn exclusively from the 2019 Plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Key issues: (1) QUANTITATIVE ERRORS: The LLM states the 2019 Plan has 'about 77 million shares' remaining availability out of '187 million' authorized. These specific numbers are not present in the ground truth and cannot be verified. The ground truth makes no mention of these specific share counts. (2) FACTUAL CLAIMS NOT IN GROUND TRUTH: The LLM claims the 1992 Plan is 'closed' and that 'no additional shares may be granted under that plan.' The ground truth does not explicitly state this. The LLM also claims the 2019 Plan is 'the sole plan that permits future grants' - this is a definitive statement not supported by the ground truth provided. (3) MULTI-HOP REASONING: While the LLM does attempt to synthesize information across the two filings and compare the plans, it does so by introducing unsourced numerical data and claims. The ground truth describes a shift from 'standalone referenced plan' to 'tracked alongside newer plans' and from 'active adoption to passive stake,' which is more nuanced than the LLM's 'closed legacy vehicle' characterization. (4) SEMANTIC ALIGNMENT: The core concept that the 1992 Plan's role has diminished is present in both answers, but the LLM overstates this with unverified claims about closure and exclusivity. The ground truth is more cautious, describing a transition rather than a definitive closure. (5) MISSING ELEMENTS: The LLM does not address the key ground truth finding about the shift from 'standalone referenced plan' to being 'listed among other equity compensation plans in a consolidated table.' This is an important structural change in disclosure that the LLM overlooks in favor of unverified quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 491,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s messaging shifted from simply noting that large‑scale transformations were a growth opportunity to emphasizing that clients are now **prioritizing multi‑year, high‑value deals** and are **cutting back on shorter‑duration, smaller contracts**—a change driven by volatile economic conditions.  As a result, the **revenue from these transformations is recognized over a longer horizon**, meaning the conversion timeline has lengthened as the business now depends more on sustained, large‑scale engagements rather than quick‑turn consulting work.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 regarding client spending patterns - accurately captures that clients reduced/deferred smaller contracts while prioritizing large-scale transformations; (2) Accurately reflects the extended revenue conversion timeline for these transformations; (3) Properly synthesizes the multi-hop information across both fiscal years; (4) Correctly notes the economic volatility context; (5) No quantitative errors - appropriately avoids citing specific numbers since the ground truth explicitly states 'no explicit quantitative metric provided.' MINOR CONSIDERATIONS: (1) The LLM uses slightly more interpretive language ('messaging shifted,' 'now depends more on') compared to the ground truth's more measured 'repeated emphasis' and 'strategic reinforcement,' though this is semantically equivalent and not factually incorrect; (2) The phrase 'multi-year, high-value deals' is a reasonable characterization of 'longer-duration contracts' but adds interpretive framing not explicitly stated in the ground truth; (3) The LLM's emphasis on 'volatile economic conditions' as the driver is supported by the ground truth's mention of 'ongoing economic volatility' but frames it slightly more definitively. MULTI-HOP REASONING: The answer successfully synthesizes information across both fiscal years and correctly identifies the pattern of evolution in client behavior and company strategy. The logic connecting economic conditions to spending pattern changes is sound. OVERALL: The answer is factually accurate, addresses all parts of the question, and demonstrates proper multi-hop synthesis without introducing false quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 486,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\nAccenture’s Class A ordinary‑share issuance for employee compensation fell from about **8.88 million shares in fiscal 2023 to roughly 7.87 million shares in fiscal 2024** (a decline of ~1.0 million shares, or ≈11 %).  The smaller issuance generated **$2.28 billion of additional paid‑in capital** in 2024 versus **$2.15 billion in 2023**, and resulted in a **smaller reduction of treasury stock** ($131 million vs $1.34 billion), which together produced only a modest rise in total shareholders’ equity ($28.29 billion in 2024 versus $25.69 billion in 2023) and a slightly lower dilution of existing shareholders.  (Pages 72 & 82 of the 2024 and 2023 Consolidated Shareholders’ Equity statements.)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and misrepresents the ground truth data. Critical issues: (1) WRONG NUMBERS: The LLM claims 8.88 million shares issued in fiscal 2023 and 7.87 million in fiscal 2024, but the ground truth states 7,970 shares issued in fiscal 2024 (not millions). The ground truth shows Class A Ordinary Shares outstanding increased from 15,656,591 to 15,664,561 (approximately 15.66 million), not the 8.88 million claimed. (2) MISCHARACTERIZATION: The LLM describes a 'decline' in issuance, but the ground truth indicates an 'increase' or 'shift' toward more active use of shares for compensation in 2024. (3) INCORRECT TREASURY STOCK FIGURES: The LLM cites treasury stock reductions of $131M vs $1.34B, but the ground truth shows treasury shares decreased in VALUE from $(3,408,491) million to $(6,678,037) million - a significant increase in absolute value (more negative), not a decrease. (4) EQUITY STRUCTURE IMPACT MISREPRESENTED: The LLM's description of 'modest rise' and 'slightly lower dilution' contradicts the ground truth's characterization of 'significant reallocation.' (5) MISSING KEY DETAILS: The LLM fails to mention the 12,181 treasury shares purchased in 2024 or the specific share withholding context from fiscal 2023. (6) CALCULATION ERRORS: The percentage decline calculation (11%) is based on incorrect base numbers. The LLM appears to have confused share counts with dollar amounts and misread the treasury stock data entirely. The answer demonstrates a fundamental failure to accurately synthesize the multi-hop information about share issuance, treasury stock, and equity structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 451,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the notional amount of Canadian‑denominated debt that MDLZ uses in its net‑investment‑hedge program rose from **$443 million to $453 million** (≈ 2 % growth).  This modest uptick occurs as the company’s overall foreign‑currency hedge base expanded slightly (total net‑investment‑hedge derivatives grew from $7.3 bn to $7.5 bn) and the composition shifted – Canadian exposure increased while Swiss‑franc and other currency notional fell – indicating a small but deliberate scaling of its Canadian‑currency hedging relative to the broader foreign‑currency‑debt management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference entirely different data than what the ground truth provides. Critical issues: (1) QUANTITATIVE ERRORS - The LLM cites Canadian-denominated debt of $443 million in 2022 and $453 million in 2023, but the ground truth explicitly states Canadian notes were $3 million in 2021 and increased by $8 million in 2023 (implying ~$11 million in 2023). The LLM's figures are off by approximately 40-50x the actual amounts. (2) METRIC CONFUSION - The LLM appears to be discussing 'net-investment-hedge program' notional amounts and derivatives, which is a different financial metric than the actual Canadian-denominated debt instruments referenced in the ground truth. The ground truth discusses Canadian notes (debt instruments), not hedge derivatives. (3) INCOMPLETE SYNTHESIS - The ground truth requires comparing the 2022-2023 change ($3M to $11M, a $8M increase) against the broader trend of declining Canadian exposure from 2019-2021 ($17M→$7M→$3M), then contextualizing this against other currency trends (Euro notes declining from $211M to $81M). The LLM fails to address the historical context or the reversal of the downward trend. (4) DIRECTIONAL ACCURACY - While the LLM correctly identifies an increase in Canadian exposure, the magnitude is completely wrong and the underlying data source appears misidentified. (5) MISSING CONTEXT - The ground truth emphasizes this as a 'notable deviation from the prior year's trend of reducing exposure,' which the LLM does not capture. The answer demonstrates a fundamental misunderstanding of which financial metrics to reference and provides numbers that are orders of magnitude different from the actual data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 468,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Accenture moved from a largely exploratory stance toward growth‑stage firms to a deliberately strategic partnership model.  The company deepened its engagement by formalizing Accenture Ventures as the primary vehicle for investing in and co‑creating solutions with high‑potential startups, expanding the use of Innovation Centers, Labs and the broader ecosystem to integrate those firms into client‑focused transformation programs.  This shift was accompanied by a measurable rise in venture‑investment activity and partnership deals in fiscal 2024, signaling a more structured, long‑term investment pipeline that ties growth‑stage technology providers directly to Accenture’s service‑delivery and innovation agenda.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) DIRECTIONAL REVERSAL - The LLM answer fundamentally misrepresents the evolution. Ground truth states the shift was FROM 'partners with' (2023) TO 'invests in' (2024), indicating movement toward MORE direct investment. The LLM claims the opposite - that Accenture moved FROM 'exploratory stance' TO 'partnership model,' which contradicts the ground truth's core finding. (2) MISSING KEY QUANTITATIVE DATA - The ground truth explicitly cites R&D spending figures ($1.3B fiscal 2023, $1.2B fiscal 2024) as supporting evidence for the innovation strategy. The LLM answer completely omits these specific financial metrics, which are essential to the multi-hop reasoning. (3) VAGUE CLAIMS - The LLM references 'measurable rise in venture-investment activity' and 'structured, long-term investment pipeline' but provides NO actual numbers, percentages, or concrete evidence. The ground truth is more precise about the nature of the shift (partnership vs. investment approach). (4) ENTITY/CONCEPT ACCURACY - While the LLM correctly identifies Accenture Ventures and mentions Innovation Centers/Labs, it mischaracterizes the strategic evolution. The ground truth's key insight is that the relationship became MORE direct and capital-intensive (investment-focused), not just more formalized as a partnership. (5) MULTI-HOP SYNTHESIS - The LLM fails to properly synthesize the connection between R&D spending and the shift in venture engagement strategy. The ground truth uses R&D figures to contextualize the broader innovation commitment. WHAT WAS CORRECT: The LLM correctly identifies Accenture Ventures as the vehicle, mentions fiscal 2024, and acknowledges increased engagement. However, these correct elements are embedded in a fundamentally incorrect narrative about the direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 491,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s share of Lynparza sales (reported as “Alliance revenue – Lynparza”) grew from **$1.12 bn in 2022 to $1.199 bn in 2023 and $1.311 bn in 2024**, a roughly **9 % year‑over‑year increase and an 18 % rise over the two‑year span**.  The collaboration’s intangible asset balance tied to Lynparza—primarily capitalized milestone payments—remained at about **$1.1 bn** and is being **amortized over its estimated useful life through 2028**, with the amortization expense continuing to flow through cost of sales.  This steady amortization schedule and the uninterrupted growth in alliance revenue reflect a stable strategic partnership that has deepened rather than shifted dramatically between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with specific revenue figures ($1.12bn in 2022, $1.199bn in 2023, $1.311bn in 2024) and correctly identifies the 9% YoY growth and 18% two-year growth rates. The intangible asset balance of $1.1bn and amortization timeline through 2028 are accurately stated. The multi-hop synthesis across financial metrics and strategic evolution is sound. However, there are notable omissions: (1) The LLM does not mention the 2025 China approval for adjuvant treatment in early breast cancer, which the ground truth identifies as a significant strategic development indicating expansion of therapeutic footprint. (2) The LLM characterizes the evolution as 'stable partnership that has deepened' rather than explicitly noting the shift 'from asset amortization to revenue growth' as the primary strategic focus change. (3) The LLM provides more granular revenue data than the ground truth but misses the forward-looking strategic implication of the new indication approval. The answer is factually correct on financial metrics and calculations but incomplete in capturing the full strategic narrative of the collaboration's evolution, particularly the recent regulatory milestone that signals future growth potential. The characterization of the partnership as 'stable' is reasonable but somewhat understates the strategic shift toward revenue expansion and market expansion indicated by the China approval.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 401,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Broadcom moved ValueOps from a peripheral “domain” listed under its Distributed‑Software portfolio (2023 pages 8‑10) to a stand‑alone, prominently featured offering in the Private‑Cloud and Distributed‑Software sections, with a detailed description of its value‑stream management capabilities that align business, development and operations to boost transparency, efficiency and time‑to‑value (2024 pages 8‑9). This shift signals that Broadcom is positioning ValueOps as a core growth engine and the primary vehicle for delivering end‑to‑end visibility and business outcomes across its Distributed‑Software portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic shift of ValueOps from 2023 to 2024, capturing the essential narrative that ValueOps moved from a peripheral listing to a more prominent, core positioning within AVGO's (Broadcom's) Distributed Software portfolio. The answer accurately conveys that ValueOps became more central to the value proposition with emphasis on end-to-end visibility and business outcomes. STRENGTHS: (1) Correctly identifies the company as Broadcom/AVGO; (2) Accurately captures the temporal shift between 2023 and 2024; (3) Properly synthesizes the multi-hop information about ValueOps' evolving role; (4) Correctly emphasizes the shift from peripheral to core positioning; (5) Accurately describes the value-stream management capabilities and alignment of business/development/operations; (6) Correctly identifies the strategic implication about positioning as a growth engine. MINOR WEAKNESSES: (1) The LLM describes ValueOps as moving to 'stand-alone, prominently featured offering' which is slightly stronger language than the ground truth's characterization of it being 'elevated to be one of the three core domains'—the ground truth emphasizes it as one of three domains (alongside DevOps and AIOps), not necessarily stand-alone; (2) The LLM mentions 'Private-Cloud and Distributed-Software sections' but the ground truth focuses specifically on the Distributed Software portfolio positioning; (3) Minor semantic difference: ground truth emphasizes 'foundational pillar' while LLM emphasizes 'core growth engine'—both convey similar strategic importance but with slightly different framings. QUANTITATIVE ELEMENTS: No specific numbers, percentages, or dollar amounts are present in either answer, so quantitative accuracy is based on correct year identification (2023 vs 2024) and page references, which appear reasonable though not verifiable against the original filings. The answer demonstrates sound multi-hop reasoning by synthesizing information about ValueOps' positioning across two fiscal years and connecting it to broader portfolio strategy. Overall, the answer captures the essential truth of the strategic shift with only minor variations in emphasis and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 592,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx moved Network 2.0 from a high‑level strategic concept into an active integration program – the 2023 filing introduced the DRIVE transformation and Network 2.0 as a multi‑year effort to consolidate FedEx Ground and Services, redesign the international air network (the “Tricolor” initiative), and achieve permanent cost‑structure reductions and greater network efficiency. By the 2024 filing the company had completed the new “one FedEx” legal structure and was actively merging the networks, but it explicitly warned that the integration could generate higher‑than‑expected costs, deliver less‑than‑projected savings, and encounter labor, regulatory, customer‑retention and other execution risks, making the timing and magnitude of the anticipated cost savings uncertain.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of FedEx's Network 2.0 evolution between 2023 and 2024, with accurate identification of key strategic shifts and risk factors. STRENGTHS: (1) Correctly identifies the transition from strategic planning/investment justification (2023) to operational integration and risk mitigation (2024); (2) Accurately mentions the 'one FedEx' legal structure completion and active network merging; (3) Properly identifies the Tricolor initiative for international air network redesign; (4) Correctly notes the shift from expected cost savings to uncertainty about timing and magnitude; (5) Appropriately highlights integration risks including labor, regulatory, and customer-retention concerns; (6) No quantitative errors in dates or timeframes. WEAKNESSES: (1) The answer mentions 'consolidate FedEx Ground and Services' which is somewhat vague compared to the ground truth's more specific discussion of harmonizing operating practices and service provider agreements; (2) Missing explicit mention of asset impairment charges, tax impacts, and litigation risks that the 2024 filing noted; (3) Does not explicitly state that the 2023 filing 'acknowledged that failure to successfully execute Network 2.0 within expected time frame and cost could adversely affect future results' - this is an important risk acknowledgment that shows continuity of risk awareness; (4) The phrase 'higher-than-expected costs, deliver less-than-projected savings' is accurate but the ground truth notes more specifically that 'actual amount and timing of cost savings and permanent cost reductions might differ from expectations.' MULTI-HOP REASONING: The answer successfully synthesizes information across two years and identifies the strategic evolution, though it could have been more comprehensive in capturing all the specific financial and legal risks mentioned in the 2024 filing. The core narrative of evolution from planning to integration is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 537,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the earnings impact from equity‑method investment contracts shifted from essentially $0 million in 2022 to a $7 million gain in 2023 (up from $2 million in 2021 and a near‑zero result the prior year).  This jump reflects a larger fair‑value exposure and more active use of the bifurcated embedded‑derivative structure tied to its JDE Peet’s investment, signalling that MDLZ is increasingly relying on these contracts to manage and monetize its equity‑method stake.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CRITICAL NUMBER ERROR: The LLM states 2022 was 'essentially $0 million' when the ground truth clearly indicates a net LIABILITY of $3 million in 2022. This is a fundamental misrepresentation of the 2022 position. (2) The 2023 figure of $7 million gain is correct and matches ground truth. (3) The LLM introduces additional years (2021 with $2 million) that are not part of the ground truth answer and appear to be unsupported information. (4) REASONING ISSUE: The LLM's interpretation about 'bifurcated embedded-derivative structure tied to its JDE Peet's investment' and claims about 'monetizing equity-method stake' go beyond what the ground truth supports. While the ground truth mentions 'strategic or operational shift,' the LLM's specific claims about derivative structures and JDE Peet's are not validated by the provided ground truth. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the 2022-2023 comparison - it should show a shift FROM a $3M liability TO a $7M gain (a $10M swing), but instead presents 2022 as near-zero. (6) The core finding about 'reversal in financial impact' from the ground truth is obscured by the incorrect 2022 baseline. The answer demonstrates partial understanding of the 2023 position but fundamentally misrepresents the 2022 starting point, which is critical for evaluating the 'evolution' requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 412,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\nThe estimated cost to complete for the July 2024 VMware Cloud Foundation releases fell from roughly $45 million in fiscal 2023 to $38 million in fiscal 2024, while the percentage of completion rose from about 55 % to 67 %. This reduction in remaining cost and higher completion rate indicate that the releases are progressing ahead of schedule and are on track for delivery within fiscal 2024, exceeding prior expectations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Numbers: The LLM states the estimated cost to complete fell from $45 million in FY2023 to $38 million in FY2024. However, the ground truth explicitly states the cost remained UNCHANGED at $38 million in both years. The LLM fabricated the $45 million figure for FY2023. (2) CRITICAL ERROR - Percentages: The LLM introduces completion percentages (55% to 67%) that do not appear in the ground truth answer and appear to be fabricated data points. (3) REASONING ERROR - Interpretation: The LLM's conclusion that the project is 'progressing ahead of schedule and exceeding prior expectations' is contradicted by the ground truth, which states the consistency in cost estimates indicates development 'proceeding largely as planned' with 'actual expenditures aligning with earlier projections.' The LLM misinterprets a stable cost estimate as evidence of acceleration rather than on-track progress. (4) ENTITY ACCURACY: The company (Broadcom/AVGO), product (VMware Cloud Foundation July 2024 releases), and fiscal years are correctly identified. (5) MULTI-HOP SYNTHESIS: While the question structure is addressed, the synthesis is based on incorrect underlying data. The LLM appears to have hallucinated specific numbers rather than accurately retrieving them from the source documents. This is a severe failure in quantitative accuracy that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 409,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 the Ship & Go kiosk was broadened both in reach and capability: the kiosk network stayed around 1,300 sites but its functionality was deepened—customers can now create a label via mobile/QR code, drop packages into a secure bin, and, importantly, use the same locations for **label‑less, in‑store returns** through FedEx Consolidated Returns.  This expansion ties the kiosk to a larger digital‑design‑to‑print and returns platform, positioning FedEx Office as an omnichannel hub that links e‑commerce fulfillment with reverse‑logistics.  The move signals that FedEx is leveraging its retail footprint to offer a seamless, technology‑driven shipping‑and‑returns experience, reinforcing its strategy of integrating physical stores into the end‑to‑end e‑commerce logistics chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct—the ~1,300 locations figure is accurately cited for both 2023 and 2024, with no calculation errors. ENTITY ACCURACY: All entities are correctly identified (FedEx Office, Ship and Go kiosk, FedEx Returns Technology, FedEx Consolidated Returns, e-commerce logistics/returns management). MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years, correctly identifying that while the physical footprint remained constant, the functional emphasis shifted from general shipping to integrated returns management. The connection between Ship and Go and FedEx Consolidated Returns is properly established. SEMANTIC EQUIVALENCE: The LLM's phrasing of 'label-less, in-store returns' and 'omnichannel hub' conveys the same strategic positioning as the ground truth's emphasis on 'in-store printing of return labels' and 'key node in FedEx's broader e-commerce returns infrastructure.' The characterization of the shift as strategic repositioning is accurate. COMPLETENESS: The answer addresses all aspects of the question—the evolution between years, the specific capabilities, and the strategic implications for e-commerce logistics and returns management. MINOR CONSIDERATIONS: The LLM uses slightly more interpretive language ('digital-design-to-print,' 'reverse-logistics,' 'omnichannel hub') compared to the ground truth's more direct description, but this represents appropriate elaboration rather than inaccuracy. The core factual content matches the ground truth precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 451,
        "total_tokens": 1888
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 999,
    "failed_evaluations": 1,
    "average_correctness_score": 4.96,
    "average_quantitative_accuracy": 5.14,
    "average_qualitative_accuracy": 5.25,
    "average_contextual_relevance": 6.43,
    "score_distribution": {
      "excellent": 111,
      "good": 156,
      "fair": 352,
      "poor": 380
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 10349.58,
    "timestamp": "2026-02-02T18:32:55.327939"
  }
}